PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Du, ZH; Wang, W; Zeng, WJ; Zeng, H				Du, Zhihong; Wang, Wei; Zeng, Wenjing; Zeng, Hui			Nitrogen Deposition Enhances Carbon Sequestration by Plantations in Northern China	PLOS ONE			English	Article							ELEVATED ATMOSPHERIC CO2; SOIL MICROBIAL BIOMASS; FINE-ROOT PRODUCTION; FATTY-ACID PROFILES; TEMPERATE FOREST; CONSTANT FRACTION; EXTRACTION METHOD; FOLIAR CHEMISTRY; USE EFFICIENCY; N DEPOSITION	Nitrogen (N) deposition and its ecological effects on forest ecosystems have received global attention. Plantations play an important role in mitigating climate change through assimilating atmospheric CO2. However, the mechanisms by which increasing N additions affect net ecosystem production (NEP) of plantations remain poorly understood. A field experiment was initialized in May 2009, which incorporated additions of four rates of N (control (no N addition), low-N (5 g N m(-2) yr(-1)), medium-N (10 g N m(-2) yr(-1)), and high-N (15 g N m(-2) yr(-1))) at the Saihanba Forestry Center, Hebei Province, northern China, a locality that contains the largest area of plantations in China. Net primary production (NPP), soil respiration, and its autotrophic and heterotrophic components were measured. Plant tissue carbon (C) and N concentrations (including foliage, litter, and fine roots), microbial biomass, microbial community composition, extracellular enzyme activities, and soil pH were also measured. N addition significantly increased NPP, which was associated with increased litter N concentrations. Autotrophic respiration (AR) increased but heterotrophic respiration (HR) decreased in the high N compared with the medium N plots, although the HR in high and medium N plots did not significantly differ from that in the control. The increased AR may derive from mycorrhizal respiration and rhizospheric microbial respiration, not live root respiration, because fine root biomass and N concentrations showed no significant differences. Although the HR was significantly suppressed in the high-N plots, soil microbial biomass, composition, or activity of extracellular enzymes were not significantly changed. Reduced pH with fertilization also could not explain the pattern of HR. The reduction of HR may be related to altered microbial C use efficiency. NEP was significantly enhanced by N addition, from 149 to 426.6 g C m(-2) yr(-1). Short-term N addition may significantly enhance the role of plantations as an important C sink.	[Du, Zhihong; Wang, Wei; Zeng, Wenjing] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Du, Zhihong; Zeng, Hui] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China	Peking University; Peking University	Wang, W (corresponding author), Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China.	wangw@urban.pku.edu.cn	Zeng, Wen/GPS-8058-2022		National Basic Research Program of China [2010CB950600, 2013CB956303]; National Natural Science Foundation of China [31222011, 31270363, 31070428]; Projects of Innovative Research Groups of the National Natural Science Foundation of China [31021001]; University Construction Projects from Central Authorities in Beijing	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University Construction Projects from Central Authorities in Beijing	This research was supported by the National Basic Research Program of China (No. 2010CB950600 and 2013CB956303), Projects of the National Natural Science Foundation of China (No. 31222011, 31270363, and 31070428), Projects of Innovative Research Groups of the National Natural Science Foundation of China (No. 31021001) and University Construction Projects from Central Authorities in Beijing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; Aber JD, 2003, BIOSCIENCE, V53, P375, DOI 10.1641/0006-3568(2003)053[0375:INDATN]2.0.CO;2; Boggs JL, 2005, CAN J FOREST RES, V35, P1901, DOI 10.1139/x05-128; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Burton AJ, 2004, GLOBAL CHANGE BIOL, V10, P1080, DOI 10.1111/j.1365-2486.2004.00737.x; Burton AJ, 2012, GLOBAL CHANGE BIOL, V18, P258, DOI 10.1111/j.1365-2486.2011.02527.x; Chen GS, 2005, ANN FOREST SCI, V62, P659, DOI 10.1051/forest:2005073; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; De Nobili M, 2001, SOIL BIOL BIOCHEM, V33, P1163, DOI 10.1016/S0038-0717(01)00020-7; de Vries W, 2008, NATURE, V451, pE1, DOI 10.1038/nature06579; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; DeLucia EH, 2007, GLOBAL CHANGE BIOL, V13, P1157, DOI 10.1111/j.1365-2486.2007.01365.x; Drake JE, 2011, GLOBAL CHANGE BIOL, V17, P1522, DOI 10.1111/j.1365-2486.2010.02342.x; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; Edwards IP, 2011, GLOBAL CHANGE BIOL, V17, P2184, DOI 10.1111/j.1365-2486.2010.02376.x; Elvir JA, 2005, CAN J FOREST RES, V35, P1402, DOI 10.1139/X05-072; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1993, APPL ENVIRON MICROB, V59, P3605; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Goulden ML, 2011, GLOBAL CHANGE BIOL, V17, P855, DOI 10.1111/j.1365-2486.2010.02274.x; Guerrieri R, 2011, GLOBAL CHANGE BIOL, V17, P1946, DOI 10.1111/j.1365-2486.2010.02362.x; Hagedorn F, 2012, GLOBAL CHANGE BIOL, V18, P1412, DOI 10.1111/j.1365-2486.2011.02603.x; HARMON ME, 1990, SCIENCE, V247, P699, DOI 10.1126/science.247.4943.699; Hasselquist NJ, 2012, GLOBAL CHANGE BIOL, V18, P3596, DOI 10.1111/gcb.12001; He HH, 2011, PLANT CELL ENVIRON, V34, P2060, DOI 10.1111/j.1365-3040.2011.02403.x; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/NGEO844, 10.1038/ngeo844]; Janssens IA, 1998, GLOBAL CHANGE BIOL, V4, P871, DOI 10.1046/j.1365-2486.1998.00199.x; Jia SX, 2010, PLANT SOIL, V333, P325, DOI 10.1007/s11104-010-0348-8; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Li XF, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009099; Liao CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010867; Liu LL, 2009, ECOL LETT, V12, P1103, DOI 10.1111/j.1461-0248.2009.01351.x; Magnani F, 2008, NATURE, V451, pE3, DOI 10.1038/nature06580; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Manzoni S, 2012, NEW PHYTOL, V196, P79, DOI 10.1111/j.1469-8137.2012.04225.x; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; May JD, 2005, CAN J FOREST RES, V35, P1023, DOI 10.1139/X05-036; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; Paterson E, 2003, EUR J SOIL SCI, V54, P741, DOI 10.1046/j.1351-0754.2003.0557.x; Phillips RP, 2007, NEW PHYTOL, V176, P655, DOI 10.1111/j.1469-8137.2007.02204.x; Phoenix GK, 2012, GLOBAL CHANGE BIOL, V18, P1197, DOI 10.1111/j.1365-2486.2011.02590.x; Pregitzer KS, 1998, TREE PHYSIOL, V18, P665; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Ramirez KS, 2010, SOIL BIOL BIOCHEM, V42, P2336, DOI 10.1016/j.soilbio.2010.08.032; Reich PB, 2008, ECOL LETT, V11, P793, DOI 10.1111/j.1461-0248.2008.01185.x; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Sullivan PF, 2007, OECOLOGIA, V153, P643, DOI 10.1007/s00442-007-0753-8; Talbot JM, 2008, FUNCT ECOL, V22, P955, DOI 10.1111/j.1365-2435.2008.01402.x; Thomas DC, 2012, SOIL BIOL BIOCHEM, V54, P7, DOI 10.1016/j.soilbio.2012.05.010; Tomaszewski T, 2007, TELLUS B, V59, P493, DOI 10.1111/j.1600-0889.2007.00265.x; Tu LH, 2011, PLANT SOIL, V340, P383, DOI 10.1007/s11104-010-0610-0; van Heerwaarden LM, 2003, J ECOL, V91, P1060, DOI 10.1046/j.1365-2745.2003.00828.x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vergutz L, 2012, ECOL MONOGR, V82, P205, DOI 10.1890/11-0416.1; Vicca S, 2012, ECOL LETT, V15, P520, DOI 10.1111/j.1461-0248.2012.01775.x; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Wang CK, 2006, FOREST ECOL MANAG, V222, P9, DOI 10.1016/j.foreco.2005.10.074; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P451, DOI 10.1016/j.soilbio.2009.11.028; Waring RH, 1998, TREE PHYSIOL, V18, P129; Wieder WR, 2009, ECOLOGY, V90, P3333, DOI 10.1890/08-2294.1; Wood TE, 2009, ECOLOGY, V90, P109, DOI 10.1890/07-1146.1; Yang YS, 2005, FOREST ECOL MANAG, V216, P216, DOI 10.1016/j.foreco.2005.05.030; Zak DR, 2011, FUNGAL ECOL, V4, P386, DOI 10.1016/j.funeco.2011.04.001; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0; Zhao MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055376	76	30	35	8	221	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87975	10.1371/journal.pone.0087975	http://dx.doi.org/10.1371/journal.pone.0087975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498416	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900162
J	N'Guessan, R; Ngufor, C; Kudom, AA; Boko, P; Odjo, A; Malone, D; Rowland, M				N'Guessan, Raphael; Ngufor, Corine; Kudom, Andreas A.; Boko, Pelagie; Odjo, Abibathou; Malone, David; Rowland, Mark			Mosquito Nets Treated with a Mixture of Chlorfenapyr and Alphacypermethrin Control Pyrethroid Resistant Anopheles gambiae and Culex quinquefasciatus Mosquitoes in West Africa	PLOS ONE			English	Article							PYRROLE INSECTICIDE CHLORFENAPYR; EXPERIMENTAL HUT EVALUATION; COMBINATION NET; BED NETS; DIPTERA; IDENTIFICATION; CARBAMATE; CULICIDAE; EFFICACY; TRIAL	Background: The effectiveness of insecticide treated nets is under threat across Africa south of the Sahara from the selection of pyrethroid resistance in Anopheles gambiae mosquitoes. To maintain progress against malaria it is necessary to identify alternative residual insecticides for mosquito nets. Mixtures of pyrethroid and insecticides with novel mode of action provide scope for both improved control and management of resistance through concurrent exposure to unrelated insecticides. Methods: The pyrrole chlorfenapyr and the pyrethroid alphacypermethrin were tested individually and as a mixture on mosquito nets in an experimental hut trial in southern Benin against pyrethroid resistant An gambiae and Culex quinquefasciatus mosquitoes. The nets were deliberately holed to simulate the effect of wear and tear. Results: The nets treated with the mixture of chlorfenapyr 200 mg/m(2) and alphacypermethrin 25 mg/m(2) killed a proportion of An gambiae (77%, 95% CI: 66-86%) significantly greater than nets treated with alphacypermethrin 25 mg/m(2) (30%, 95% CI: 21-41%) but not significantly different from nets treated with chlorfenapyr 200 mg/m(2) (69%, 95% CI: 57-78%). The nets treated with the mixtures procured personal protection against An gambiae biting(58-62%) by a greater margin than the alphacypermethrin treated net (39%), whereas the chlorfenapyr treated net was not protective. A similar trend in mortality and blood feeding inhibition between treatments was observed in Cx quinquefasciatus to that seen in An. gambiae, although the effects were lower. A mixture of alphacypermethrin with chlorfenapyr applied at 100 mg/m(2) had an effect similar to the mixture with chlorfenapyr at 200 mg/m(2). Conclusion: The effectiveness of ITNs against pyrethroid resistant mosquitoes was restored by the mixture: the alphacypermethrin component reduced human-vector contact while the chlorfenapyr controlled pyrethroid-resistant mosquitoes. The complementary action of these unrelated insecticides demonstrates that the combination on nets has potential for preventing malaria transmission in areas compromised by the spread of pyrethroid resistance.	[N'Guessan, Raphael; Ngufor, Corine; Boko, Pelagie; Odjo, Abibathou] Ctr Rech Entomol Cotonou, Cotonou, Benin; [N'Guessan, Raphael; Ngufor, Corine; Rowland, Mark] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [N'Guessan, Raphael; Ngufor, Corine; Rowland, Mark] Pan African Malaria Vector Res Consortium PAMVERC, London, England; [Kudom, Andreas A.] Univ Cape Coast, Sch Biol Sci, Dept Entomol & Wildlife, Cape Coast, Ghana; [Malone, David] Innovat Vector Control Consortium, Liverpool, Merseyside, England	Entomological Research Center of Cotonou (CREC); University of London; London School of Hygiene & Tropical Medicine; University of Cape Coast	N'Guessan, R (corresponding author), Ctr Rech Entomol Cotonou, Cotonou, Benin.	Raphael.N'Guessan@lshtm.ac.uk	; Kudom, Andreas/V-4153-2018	Ngufor, Corine/0000-0002-7755-9609; Kudom, Andreas/0000-0002-7577-9368	Innovative Vector Control Consortium (IVCC), Liverpool, UK from the Bill & Melinda Gates Foundation	Innovative Vector Control Consortium (IVCC), Liverpool, UK from the Bill & Melinda Gates Foundation	Project grant was obtained from Innovative Vector Control Consortium (IVCC), Liverpool, UK from a programme grant of the Bill & Melinda Gates Foundation (http://www.ivcc.com/). The Bill & Melinda Gates Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However the IVCC did advise on the study design via their Expert Scientific Committee.	Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Asidi AN, 2004, MED VET ENTOMOL, V18, P134, DOI 10.1111/j.0269-283X.2004.00485.x; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; CURTIS CF, 1986, T ROY SOC TROP MED H, V80, P889, DOI 10.1016/0035-9203(86)90248-8; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Hougard JM, 2003, B ENTOMOL RES, V93, P491, DOI 10.1079/BER2003261; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; LOVELL JB, 1990, BRIGHTON CROP PROTECTION CONFERENCE - PESTS AND DISEASES, 1990 : PROCEEDINGS, VOLS 1-3, P37; Malima RC, 2009, MED VET ENTOMOL, V23, P317, DOI 10.1111/j.1365-2915.2009.00837.x; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mosha FW, 2008, TROP MED INT HEALTH, V13, P644, DOI 10.1111/j.1365-3156.2008.02058.x; N'Guessan R, 2007, ACTA TROP, V102, P69, DOI 10.1016/j.actatropica.2007.03.003; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; N'Guessan R, 2010, T ROY SOC TROP MED H, V104, P758, DOI 10.1016/j.trstmh.2010.08.008; N'Guessan R, 2009, TROP MED INT HEALTH, V14, P389, DOI 10.1111/j.1365-3156.2009.02245.x; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; Oliver SV, 2010, TROP MED INT HEALTH, V15, P127, DOI 10.1111/j.1365-3156.2009.02416.x; Oxborough RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055781; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Tomlin C., 2000, PESTICIDE MANUAL WOR; Tungu P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-21; West P, 2013, LANCET INFECT DIS IN; WHO, 2012, ROLL BACK MALARIA; WHO, 2012, PLOS MED; WHO, 2006, GUIDELINES FORTESTIN; World Health Organization, 2004, GEN RISK ASS MOD INS; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x	31	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87710	10.1371/journal.pone.0087710	http://dx.doi.org/10.1371/journal.pone.0087710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498360	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000330626900106
J	Takasato, F; Morita, R; Schichita, T; Sekiya, T; Morikawa, Y; Kuroda, T; Niimi, M; Yoshimura, A				Takasato, Fumika; Morita, Rimpei; Schichita, Takashi; Sekiya, Takashi; Morikawa, Yasuhide; Kuroda, Tatsuo; Niimi, Masanori; Yoshimura, Akihiko			Prevention of Allogeneic Cardiac Graft Rejection by Transfer of Ex Vivo Expanded Antigen-Specific Regulatory T-Cells	PLOS ONE			English	Article							TOLEROGENIC DENDRITIC CELLS; TGF-BETA; INTRATRACHEAL DELIVERY; TRANSPLANT TOLERANCE; FOXP3 EXPRESSION; CUTTING EDGE; IN-VIVO; INDUCTION; MICE; SUPPRESSION	The rate of graft survival has dramatically increased using calcineurin inhibitors, however chronic graft rejection and risk of infection are difficult to manage. Induction of allograft-specific regulatory T-cells (Tregs) is considered an ideal way to achieve long-term tolerance for allografts. However, efficient in vitro methods for developing allograft-specific Tregs which is applicable to MHC full-mismatched cardiac transplant models have not been established. We compared antigen-nonspecific polyclonal-induced Tregs (iTregs) as well as antigen-specific iTregs and thymus-derived Tregs (nTregs) that were expanded via direct and indirect pathways. We found that iTregs induced via the indirect pathway had the greatest ability to prolong graft survival and suppress angiitis. Antigen-specific iTregs generated ex vivo via both direct and indirect pathways using dendritic cells from F1 mice also induced long-term engraftment without using MHC peptides. In antigen-specific Treg transferred models, activation of dendritic cells and allograft-specific CTL generation were suppressed. The present study demonstrated the potential of ex vivo antigen-specific Treg expansion for clinical cell-based therapeutic approaches to induce lifelong immunological tolerance for allogeneic cardiac transplants.	[Takasato, Fumika; Morita, Rimpei; Schichita, Takashi; Sekiya, Takashi; Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Sch Med, Tokyo, Japan; [Takasato, Fumika; Kuroda, Tatsuo] Keio Univ, Sch Med, Dept Pediat Surg, Tokyo, Japan; [Morikawa, Yasuhide] Int Univ Med Welf Hosp, Dept Pediat Surg, Nasushiobara, Tochigi, Japan; [Niimi, Masanori] Teikyo Univ, Sch Med, Dept Surg, Tokyo 173, Japan; [Takasato, Fumika; Morita, Rimpei; Schichita, Takashi; Sekiya, Takashi; Yoshimura, Akihiko] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Keio University; Keio University; Teikyo University; Japan Science & Technology Agency (JST)	Yoshimura, A (corresponding author), Keio Univ, Dept Microbiol & Immunol, Sch Med, Tokyo, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013		Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society of the Promotion of Science; Takeda Science Foundation; Uehara Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; SENSHIN Medical Research Foundation; Astellas Foundation for Research on Metabolic Disorders; Mochida Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Astellas Foundation for Research on Metabolic Disorders; Mochida Memorial Foundation	This work was supported by special grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan Society of the Promotion of Science, the Takeda Science Foundation, the Uehara Memorial Foundation, Kanae Foundation for the Promotion of Medical Science, SENSHIN Medical Research Foundation, Astellas Foundation for Research on Metabolic Disorders, and the Mochida Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2002, HUM IMMUNOL, V63, P888, DOI 10.1016/S0198-8859(02)00456-1; Aramaki O, 2003, TRANSPLANTATION, V76, P1305, DOI 10.1097/01.TP.0000084398.10572.C6; Brennan TV, 2009, AM J TRANSPLANT, V9, P709, DOI 10.1111/j.1600-6143.2009.02578.x; Burrell BE, 2012, J IMMUNOL, V189, P4705, DOI 10.4049/jimmunol.1202027; Cervera C, 2011, TRANSPL INFECT DIS, V13, P598, DOI 10.1111/j.1399-3062.2011.00646.x; Chai JG, 2008, J IMMUNOL, V180, P858, DOI 10.4049/jimmunol.180.2.858; Fernandez MA, 2008, J IMMUNOL, V180, P1556, DOI 10.4049/jimmunol.180.3.1556; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Gupta S, 2011, TRANSPLANTATION, V91, pE65, DOI 10.1097/TP.0b013e3182157d44; Hasegawa E, 2013, J IMMUNOL, V190, P1778, DOI 10.4049/jimmunol.1202495; Ichiyama K, 2011, IMMUNITY, V34, P741, DOI 10.1016/j.immuni.2011.02.021; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Jones ND, 2010, EUR J IMMUNOL, V40, P3107, DOI 10.1002/eji.201040671; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Kang SM, 2007, AM J TRANSPLANT, V7, P1457, DOI 10.1111/j.1600-6143.2007.01829.x; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Koenecke C, 2009, EUR J IMMUNOL, V39, P3091, DOI 10.1002/eji.200939432; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Latek R, 2009, TRANSPLANTATION, V87, P926, DOI 10.1097/TP.0b013e31819b5a58; Li M, 2008, INT IMMUNOL, V20, P285, DOI 10.1093/intimm/dxm142; Lu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024590; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Niimi M, 2001, J HEART LUNG TRANSPL, V20, P1123, DOI 10.1016/S1053-2498(01)00309-6; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sampaio MS, 2012, TRANSPLANTATION, V94, P990, DOI 10.1097/TP.0b013e318270bc7b; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Sela U, 2011, J EXP MED, V208, P2489, DOI 10.1084/jem.20110466; Shevach EM, 2008, J CLIN IMMUNOL, V28, P640, DOI 10.1007/s10875-008-9240-1; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tamiya T, 2013, J IMMUNOL, V191, P2360, DOI 10.4049/jimmunol.1301276; Taner T, 2005, AM J TRANSPLANT, V5, P228, DOI 10.1046/j.1600-6143.2004.00673.x; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; van Kooten C, 2011, TRANSPLANTATION, V91, P2, DOI 10.1097/TP.0b013e31820263b3; van Maurik A, 2002, J IMMUNOL, V169, P5401; Waldmann H, 2008, NAT IMMUNOL, V9, P1001, DOI 10.1038/ni0908-1001; Woltman AM, 2006, AM J TRANSPLANT, V6, P2580, DOI 10.1111/j.1600-6143.2006.01520.x; Wood KJ, 2011, TRANSPL P, V43, P2135, DOI 10.1016/j.transproceed.2011.06.050; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Zhang XS, 2008, CLIN IMMUNOL, V127, P313, DOI 10.1016/j.clim.2008.01.013; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zhou XH, 2010, J IMMUNOL, V185, P2675, DOI 10.4049/jimmunol.1000598; Zuppan CW, 2009, J HEART LUNG TRANSPL, V28, P579, DOI 10.1016/j.healun.2009.02.012	47	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87722	10.1371/journal.pone.0087722	http://dx.doi.org/10.1371/journal.pone.0087722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498362	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900108
J	Amaral, AT; Manara, MC; Berghuis, D; Ordonez, JL; Biscuola, M; Lopez-Garcia, MA; Osuna, D; Lucarelli, E; Alviano, F; Lankester, A; Scotlandi, K; de Alava, E				Teresa Amaral, Ana; Manara, Maria Cristina; Berghuis, Dagmar; Luis Ordonez, Jose; Biscuola, Michele; Angeles Lopez-Garcia, Maria; Osuna, Daniel; Lucarelli, Enrico; Alviano, Francesco; Lankester, Arjan; Scotlandi, Katia; de Alava, Enrique			Characterization of Human Mesenchymal Stem Cells from Ewing Sarcoma Patients. Pathogenetic Implications	PLOS ONE			English	Article							FAMILY; DOXORUBICIN; EXPRESSION; PHENOTYPE; PROFILE; CD99	Background: Ewing Sarcoma (EWS) is a mesenchymal-derived tumor that generally arises in bone and soft tissue. Intensive research regarding the pathogenesis of EWS has been insufficient to pinpoint the early events of Ewing sarcomagenesis. However, the Mesenchymal Stem Cell (MSC) is currently accepted as the most probable cell of origin. Materials and Methods: In an initial study regarding a deep characterization of MSC obtained specifically from EWS patients (MSC-P), we compared them with MSC derived from healthy donors (MSC-HD) and EWS cell lines. We evaluated the presence of the EWS-FLI1 gene fusion and EWSR1 gene rearrangements in MSC-P. The presence of the EWS transcript was confirmed by q-RT-PCR. In order to determine early events possibly involved in malignant transformation, we used a multiparameter quantitative strategy that included both MSC immunophenotypic negative/positive markers, and EWS intrinsic phenotypical features. Markers CD105, CD90, CD34 and CD45 were confirmed in EWS samples. Results: We determined that MSC-P lack the most prevalent gene fusion, EWSR1-FLI1 as well as EWSR1 gene rearrangements. Our study also revealed that MSC-P are more alike to MSC-HD than to EWS cells. Nonetheless, we also observed that EWS cells had a few overlapping features with MSC. As a relevant example, also MSC showed CD99 expression, hallmark of EWS diagnosis. However, we observed that, in contrast to EWS cells, MSC were not sensitive to the inhibition of CD99. Conclusions: In conclusion, our results suggest that MSC from EWS patients behave like MSC-HD and are phenotypically different from EWS cells, thus raising important questions regarding MSC role in sarcomagenesis.	[Teresa Amaral, Ana; Luis Ordonez, Jose; Osuna, Daniel; de Alava, Enrique] Ctr Invest Canc, Inst Biomed Res Salamanca, Mol Pathol Program, IBSAL, Salamanca, Spain; [Manara, Maria Cristina; Scotlandi, Katia] Ist Ortoped Rizzoli, CRS Sviluppo Terapie Biomol, Bologna, Italy; [Berghuis, Dagmar; Lankester, Arjan] Leiden Univ Med Ctr LUMC, Dept Pediat & Biobank, Leiden, Netherlands; [Lucarelli, Enrico] Ist Ortoped Rizzoli, Osteoarticolar Regenerat Lab, Bologna, Italy; [Alviano, Francesco] Ist Ortoped Rizzoli, Dipartimento Istol Embriol & Biol, Bologna, Italy; [Teresa Amaral, Ana; Biscuola, Michele; Angeles Lopez-Garcia, Maria; de Alava, Enrique] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Dept Pathol & Biobank,IBiS, Seville, Spain	IRCCS Istituto Ortopedico Rizzoli; Leiden University; Leiden University Medical Center (LUMC); IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	de Alava, E (corresponding author), Ctr Invest Canc, Inst Biomed Res Salamanca, Mol Pathol Program, IBSAL, Salamanca, Spain.	edealava@usal.es	Lucarelli, Enrico/AAF-1612-2021; Manara, Maria Cristina/K-3366-2018; Ordóñez, José Luis/B-6069-2017; Enrico, Lucarelli/G-3588-2015; IBIS, SARCOMAS/O-1893-2015; Scotlandi, Katia/J-9009-2016; Osuna, Daniel/I-1535-2015; de Alava, Enrique/GOH-0368-2022	Lucarelli, Enrico/0000-0002-6681-6374; Manara, Maria Cristina/0000-0001-5686-720X; Ordóñez, José Luis/0000-0002-3791-4215; Enrico, Lucarelli/0000-0002-6681-6374; Scotlandi, Katia/0000-0001-6114-9499; Osuna, Daniel/0000-0002-7515-3007; de Alava, Enrique/0000-0001-8400-046X; Amaral, Ana/0000-0001-7887-4814	Red Tematica de investigacion del cancer (RTICC, Spain); Italian Association for cancer research [AIRC IG10452]	Red Tematica de investigacion del cancer (RTICC, Spain); Italian Association for cancer research(Fondazione AIRC per la ricerca sul cancro)	Enrique de Alava's lab is also sourced by the Red Tematica de investigacion del cancer (RTICC, Spain). Katia Scotlandi's lab is also sourced by the Italian Association for cancer research (AIRC IG10452). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci G, 2009, EUR SPINE J, V18, P1091, DOI 10.1007/s00586-009-0921-0; Cerisano V, 2004, ONCOGENE, V23, P5664, DOI 10.1038/sj.onc.1207741; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Garayoa M, 2009, LEUKEMIA, V23, P1515, DOI 10.1038/leu.2009.65; Gelin C ZM, 1995, P 5 INT WORKSH C; Hu-Lieskovan S, 2005, CANCER RES, V65, P4633, DOI 10.1158/0008-5472.CAN-04-2857; Johnson JJ, 2003, BLOOD, V101, P3229, DOI 10.1182/blood-2002-05-1515; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Kovar H, 2005, SEMIN CANCER BIOL, V15, P189, DOI 10.1016/j.semcancer.2005.01.004; Ladenstein R, 2010, J CLIN ONCOL, V28, P3284, DOI 10.1200/JCO.2009.22.9864; Landuzzi L, 2000, AM J PATHOL, V157, P2123, DOI 10.1016/S0002-9440(10)64850-X; Li N, 2009, CANCER-AM CANCER SOC, V115, P4795, DOI 10.1002/cncr.24519; Lin Patrick P., 2011, Sarcoma, V2011, P276463, DOI 10.1155/2011/276463; Lopez-Beltran A, 2010, VIRCHOWS ARCH, V457, P555, DOI 10.1007/s00428-010-0969-6; Lopez-Villar O, 2009, LEUKEMIA, V23, P664, DOI 10.1038/leu.2008.361; Ordonez JL, 2010, ADV ANAT PATHOL, V17, P162, DOI 10.1097/PAP.0b013e3181d98cbf; Ordonez JL, 2009, CANCER RES, V69, P7140, DOI 10.1158/0008-5472.CAN-08-4041; Martins AS, 2006, CLIN CANCER RES, V12, P3532, DOI 10.1158/1078-0432.CCR-05-1778; Miyagawa Y, 2008, MOL CELL BIOL, V28, P2125, DOI 10.1128/MCB.00740-07; Mohseny AB, 2009, J PATHOL, V219, P294, DOI 10.1002/path.2603; Naka N, 2010, STEM CELLS, V28, P1119, DOI 10.1002/stem.452; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Rocchi A, 2010, J CLIN INVEST, V120, P668, DOI 10.1172/JCI36667; Rodriguez R, 2011, STEM CELLS, V29, P179, DOI 10.1002/stem.571; Ross KA, 2013, ISRN ONCOL; Rubio R, 2010, CANCER RES, V70, P4185, DOI 10.1158/0008-5472.CAN-09-4640; Scotlandi K, 2000, CANCER RES, V60, P5134; Scotlandi K, 2006, EUR J CANCER, V42, P91, DOI 10.1016/j.ejca.2005.09.015; Scotlandi K, 2003, J CLIN ONCOL, V21, P1952, DOI 10.1200/JCO.2003.11.111; Scotlandi K, 2006, ADV EXP MED BIOL, V587, P13; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305	36	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e85814	10.1371/journal.pone.0085814	http://dx.doi.org/10.1371/journal.pone.0085814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498265	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900011
J	Tilstam, PV; Gijbels, MJ; Habbeddine, M; Cudejko, C; Asare, Y; Theelen, W; Zhou, BX; Doring, Y; Drechsler, M; Pawig, L; Simsekyilmaz, S; Koenen, RR; de Winther, MPJ; Lawrence, T; Bernhagen, J; Zernecke, A; Weber, C; Noels, H				Tilstam, Pathricia V.; Gijbels, Marion J.; Habbeddine, Mohamed; Cudejko, Celine; Asare, Yaw; Theelen, Wendy; Zhou, Baixue; Doering, Yvonne; Drechsler, Maik; Pawig, Lukas; Simsekyilmaz, Sakine; Koenen, Rory R.; de Winther, Menno P. J.; Lawrence, Toby; Bernhagen, Juergen; Zernecke, Alma; Weber, Christian; Noels, Heidi			Bone Marrow-Specific Knock-In of a Non-Activatable Ikk alpha Kinase Mutant Influences Haematopoiesis but Not Atherosclerosis in Apoe-Deficient Mice	PLOS ONE			English	Article							NF-KAPPA-B; REGULATORY T-CELLS; DENDRITIC CELLS; INDOLEAMINE 2,3-DIOXYGENASE; INCREASES ATHEROSCLEROSIS; GENE-EXPRESSION; RECEPTOR; INHIBITION; PATHWAY; BETA	Background: The Ikk alpha kinase, a subunit of the NF-kappa B-activating IKK complex, has emerged as an important regulator of inflammatory gene expression. However, the role of Ikk alpha-mediated phosphorylation in haematopoiesis and atherogenesis remains unexplored. In this study, we investigated the effect of a bone marrow (BM)-specific activation-resistant Ikk alpha mutant knock-in on haematopoiesis and atherosclerosis in mice. Methods and Results: Apolipoprotein E (Apoe)-deficient mice were transplanted with BM carrying an activation-resistant Ikk alpha gene (Ikk alpha(AA/AA) Apoe(-/-)) or with Ikk alpha(+/+) Apoe(-/-) BM as control and were fed a high-cholesterol diet for 8 or 13 weeks. Interestingly, haematopoietic profiling by flow cytometry revealed a significant decrease in B-cells, regulatory T-cells and effector memory T-cells in Ikk alpha(AA/AA) Apoe(-/-) BM-chimeras, whereas the naive T-cell population was increased. Surprisingly, no differences were observed in the size, stage or cellular composition of atherosclerotic lesions in the aorta and aortic root of Ikk alpha(AA/AA) Apoe(-/-) vs Ikk alpha(+/+) Apoe(-/-) BM-transplanted mice, as shown by histological and immunofluorescent stainings. Necrotic core sizes, apoptosis, and intracellular lipid deposits in aortic root lesions were unaltered. In vitro, BM-derived macrophages from Ikk alpha(AA/AA) Apoe(-/-) vs Ikk alpha(+/+) Apoe(-/-) mice did not show significant differences in the uptake of oxidized low-density lipoproteins (oxLDL), and, with the exception of Il-12, the secretion of inflammatory proteins in conditions of Tnf-alpha or oxLDL stimulation was not significantly altered. Furthermore, serum levels of inflammatory proteins as measured with a cytokine bead array were comparable. Conclusion: Our data reveal an important and previously unrecognized role of haematopoietic Ikk alpha kinase activation in the homeostasis of B-cells and regulatory T-cells. However, transplantation of Ikk alpha AA mutant BM did not affect atherosclerosis in Apoe(-/-) mice. This suggests that the diverse functions of Ikk alpha in haematopoietic cells may counterbalance each other or may not be strong enough to influence atherogenesis, and reveals that targeting haematopoietic Ikka kinase activity alone does not represent a therapeutic approach.	[Tilstam, Pathricia V.; Asare, Yaw; Theelen, Wendy; Zhou, Baixue; Pawig, Lukas; Simsekyilmaz, Sakine; Noels, Heidi] Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res, Aachen, Germany; [Gijbels, Marion J.; Koenen, Rory R.; de Winther, Menno P. J.; Weber, Christian] Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Gijbels, Marion J.; de Winther, Menno P. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Habbeddine, Mohamed; Cudejko, Celine; Lawrence, Toby] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France; [Asare, Yaw; Bernhagen, Juergen] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany; [Doering, Yvonne; Drechsler, Maik; Weber, Christian] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Bernhagen, Juergen] Univ Munich, Inst Cardiovasc Res, August Lenz Stiftung, Munich, Germany; [Zernecke, Alma] Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany; [Zernecke, Alma] Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97070 Wurzburg, Germany; [Zernecke, Alma] Tech Univ Munich, Klinikum Rechts Isar, Dept Vasc Surg, D-80290 Munich, Germany; [Zernecke, Alma; Weber, Christian] German Ctr Cardiovasc Res, Munich, Germany	RWTH Aachen University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; RWTH Aachen University; University of Munich; University of Munich; University of Wurzburg; University of Wurzburg; Technical University of Munich; German Centre for Cardiovascular Research	Weber, C (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.	kreislaufinstitut@med.uni-muenchen.de; hnoels@ukaachen.de	Weber, Christian/AAW-2153-2020; Asare, Yaw/AAY-1626-2021; Lawrence, Toby/GLU-3895-2022; Doring, Yvonne/E-1796-2013; Koenen, Rory/H-4172-2012; Drechsler, Maik/C-3829-2008; Döring, Yvonne/AAA-3018-2022; Döring, Yvonne/E-9414-2017; Noels, Heidi/AAQ-2622-2020	Weber, Christian/0000-0003-4610-8714; Asare, Yaw/0000-0002-8946-5650; Lawrence, Toby/0000-0003-0967-6122; Koenen, Rory/0000-0002-9955-9730; Döring, Yvonne/0000-0001-9307-3396; de Winther, Menno/0000-0002-4038-6636; Tilstam, Pathricia/0000-0003-3620-6775	Deutsche Forschungsgemeinschaft (DFG) [WE1913/11-2, KO2948/1-2]; DFG International graduate school grant [IRTG1508/1-TP6]; Alexander von Humboldt Foundation [3.3 BEL/1129548]; START Program of the Faculty of Medicine of RWTH Aachen; Netherlands Organization for Health Research and Development; Netherlands Heart Foundation [2007T067]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG International graduate school grant; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); START Program of the Faculty of Medicine of RWTH Aachen; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de) (WE1913/11-2 to CW, KO2948/1-2 to RRK and CW), by the DFG International graduate school grant IRTG1508/1-TP6 (to CW, PVT, JB, MPJdW), by the Alexander von Humboldt Foundation (http://www.humboldt-foundation.de/web/home.html) (3.3 BEL/1129548, to HN), by the START Program of the Faculty of Medicine of RWTH Aachen (http://www.medizin.rwth-aachen.de/go/id/tfy) (to HN and AZ), and by the Netherlands Organization for Health Research and Development (http://www.zonmw.nl/en/) (to MPJdW). MPJdW is an established investigator of the Netherlands Heart Foundation (2007T067) (www.hartstichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Ammirati E, 2012, J AM HEART ASSOC, V1, P27, DOI 10.1161/JAHA.111.000125; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Balkhi MY, 2012, BLOOD, V119, P5467, DOI 10.1182/blood-2012-01-401547; Bavendiek U, 2005, ARTERIOSCL THROM VAS, V25, P1244, DOI 10.1161/01.ATV.0000161420.55482.ef; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Chiba T, 2006, J ATHEROSCLER THROMB, V13, P308, DOI 10.5551/jat.13.308; Cudejko C, 2011, BLOOD, V118, P2556, DOI 10.1182/blood-2010-10-313106; Davies J, 2005, ISOLATION CULTURE MU; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hacker H, 2012, J IMMUNOL, V188, P4602, DOI 10.4049/jimmunol.1200021; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hofmann J, 2011, J EXP MED, V208, P1917, DOI 10.1084/jem.20110128; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Kanters E, 2004, BLOOD, V103, P934, DOI 10.1182/blood-2003-05-1450; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Kyaw T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029371; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Major AS, 2002, ARTERIOSCL THROM VAS, V22, P1892, DOI 10.1161/01.ATV.0000039169.47943.EE; Mancino A, 2013, EMBO J, V32, P816, DOI 10.1038/emboj.2013.28; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; Monaco C, 2004, P NATL ACAD SCI USA, V101, P5634, DOI 10.1073/pnas.0401060101; Murray SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076216; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Perry HM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00373; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Sage AP, 2012, ARTERIOSCL THROM VAS, V32, P1573, DOI 10.1161/ATVBAHA.111.244731; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shembade N, 2011, NAT IMMUNOL, V12, P834, DOI 10.1038/ni.2066; Smook MLF, 2005, ATHEROSCLEROSIS, V183, P275, DOI 10.1016/j.atherosclerosis.2005.03.051; Stachon P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011589; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tamura C, 2006, AUTOIMMUNITY, V39, P445, DOI 10.1080/08916930600833390; Tas SW, 2007, BLOOD, V110, P1540, DOI 10.1182/blood-2006-11-056010; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wilson SH, 2002, ATHEROSCLEROSIS, V160, P147, DOI 10.1016/S0021-9150(01)00546-9; Wouters K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032440; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576	63	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87452	10.1371/journal.pone.0087452	http://dx.doi.org/10.1371/journal.pone.0087452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498325	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900071
J	Azuma, K; Komatsu, N; Hattori, S; Matsueda, S; Kawahara, A; Sasada, T; Itoh, K; Hoshino, T				Azuma, Koichi; Komatsu, Nobukazu; Hattori, Satoshi; Matsueda, Satoko; Kawahara, Akihiko; Sasada, Tetsuro; Itoh, Kyogo; Hoshino, Tomoaki			Humoral Immune Responses to EGFR-Derived Peptides Predict Progression-Free and Overall Survival of Non-Small Cell Lung Cancer Patients Receiving Gefitinib	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; MELANOMA PATIENTS; CRYSTAL-STRUCTURE; KINASE DOMAIN; POLYMORPHISMS; ACTIVATION; MUTATIONS; BINDING; IMPACT	Somatic mutations in the epidermal growth factor receptor (EGFR) gene are associated with clinical response to EGFR tyrosine kinase inhibitors (TKIs), such as gefitinib, in patients with non-small cell lung cancer (NSCLC). However, humoral immune responses to EGFR in NSCLC patients have not been well studied. In this study, we investigated the clinical significance of immunoglobulin G (IgG) responses to EGFR-derived peptides in NSCLC patients receiving gefitinib. Plasma IgG titers to each of 60 different EGFR-derived 20-mer peptides were measured by the Luminex system in 42 NSCLC patients receiving gefitinib therapy. The relationships between the peptide-specific IgG titers and presence of EGFR mutations or patient survival were evaluated statistically. IgG titers against the egfr_481-500, egfr_721-740, and egfr_741-760 peptides were significantly higher in patients with exon 21 mutation than in those without it. On the other hand, IgG titers against the egfr_841-860 and egfr_1001-1020 peptides were significantly lower and higher, respectively, in patients with deletion in exon 19. Multivariate Cox regression analysis showed that IgG responses to egfr_41_60, egfr_61_80 and egfr_481_500 were significantly prognostic for progression-free survival independent of other clinicopathological characteristics, whereas those to the egfr_41_60 and egfr_481_500 peptides were significantly prognostic for overall survival. Detection of IgG responses to EGFR-derived peptides may be a promising method for prognostication of NSCLC patients receiving gefitinib. Our results may provide new insight for better understanding of humoral responses to EGFR in NSCLC patients.	[Azuma, Koichi; Hoshino, Tomoaki] Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Internal Med, Kurume, Fukuoka 830, Japan; [Komatsu, Nobukazu; Matsueda, Satoko; Sasada, Tetsuro; Itoh, Kyogo] Kurume Univ, Sch Med, Dept Immunol, Kurume, Fukuoka 830, Japan; [Hattori, Satoshi] Kurume Univ, Ctr Biostat, Kurume, Fukuoka 830, Japan; [Kawahara, Akihiko] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan	Kurume University; Kurume University; Kurume University; Kurume University	Azuma, K (corresponding author), Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Internal Med, Kurume, Fukuoka 830, Japan.	azuma@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS KAKENHI [19790571]; Grants-in-Aid for Scientific Research [23591913] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan: Grant-in-Aid for Young Scientists (B), JSPS KAKENHI Grant number 19790571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedognetti D, 2010, EXPERT REV VACCINES, V9, P555, DOI [10.1586/erv.10.55, 10.1586/ERV.10.55]; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Bose R, 2009, EXP CELL RES, V315, P649, DOI 10.1016/j.yexcr.2008.07.031; Breunis WB, 2008, J IMMUNOTHER, V31, P586, DOI 10.1097/CJI.0b013e31817fd8f3; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Everitt BS, 2005, R S PLUS COM MULT AN; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Harada M, 2003, PROSTATE, V57, P152, DOI 10.1002/pros.10280; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Kimura H, 2006, CLIN CANCER RES, V12, P3915, DOI 10.1158/1078-0432.CCR-05-2324; Komatsu N, 2004, SCAND J CLIN LAB INV, V64, P535, DOI 10.1080/00365510410007008; Leibovici D, 2005, J CLIN ONCOL, V23, P5746, DOI 10.1200/JCO.2005.01.598; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Liu DX, 2005, CLIN CANCER RES, V11, P1237; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Matsueda S, 2013, DEV COMP IMMUNOL, V41, P68, DOI 10.1016/j.dci.2013.04.004; Mine T, 2004, CLIN CANCER RES, V10, P929, DOI 10.1158/1078-0432.CCR-1117-3; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Noguchi M, 2010, CANCER IMMUNOL IMMUN, V59, P1001, DOI 10.1007/s00262-010-0822-4; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pham MX, 2010, NEW ENGL J MED, V362, P1890, DOI 10.1056/NEJMoa0912965; Sabatino M, 2009, J CLIN ONCOL, V27, P2645, DOI 10.1200/JCO.2008.19.1106; Sasada T, 2010, EUR J CANCER, V46, P1514, DOI 10.1016/j.ejca.2010.03.013; Schmiedel J, 2008, CANCER CELL, V13, P365, DOI 10.1016/j.ccr.2008.02.019; Talavera A, 2009, CANCER RES, V69, P5851, DOI 10.1158/0008-5472.CAN-08-4518; Ugurel S, 2008, CANCER IMMUNOL IMMUN, V57, P685, DOI 10.1007/s00262-007-0407-z; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yurkovetsky ZR, 2007, CLIN CANCER RES, V13, P2422, DOI 10.1158/1078-0432.CCR-06-1805; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	38	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86667	10.1371/journal.pone.0086667	http://dx.doi.org/10.1371/journal.pone.0086667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497964	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900032
J	Nagamachi, A; Nakata, Y; Ueda, T; Yamasaki, N; Ebihara, Y; Tsuji, K; Honda, Z; Takubo, K; Suda, T; Oda, H; Inaba, T; Honda, H				Nagamachi, Akiko; Nakata, Yuichiro; Ueda, Takeshi; Yamasaki, Norimasa; Ebihara, Yasuhiro; Tsuji, Kohichiro; Honda, Zen-ichiro; Takubo, Keiyo; Suda, Toshio; Oda, Hideaki; Inaba, Toshiya; Honda, Hiroaki			Acquired Deficiency of A20 Results in Rapid Apoptosis, Systemic Inflammation, and Abnormal Hematopoietic Stem Cell Function	PLOS ONE			English	Article							NF-KAPPA-B; TNFAIP3; GENE; EXPRESSION; PROTEIN; REGION; PROLIFERATION; ASSOCIATION; GAMMA; 6Q23	A20 is a negative regulator of NF-kappa B, and mutational loss of A20 expression is involved in the pathogenesis of autoimmune diseases and B-cell lymphomas. To clarify the role of A20 in adult hematopoiesis, we generated conditional A20 knockout mice (A20(flox/flox)) and crossed them with Mx-1Cre (MxCre(+)) and ERT2Cre (ERT2Cre(+)) transgenic mice in which Cre is inducibly activated by endogenous interferon and exogenous tamoxifen, respectively. A20(flox/flox) MxCre(+) (A20Mx) mice spontaneously exhibited myeloid proliferation, B cell apoptosis, and anemia with overproduction of pro-inflammatory cytokines. Bone marrow transplantation demonstrated that these changes were caused by hematopoietic cells. NF-kappa B was constitutively activated in A20Mx hematopoietic stem cells (HSCs), which caused enhanced cell cycle entry and impaired repopulating ability. Tamoxifen stimulation of A20(flox/flox) ERT2Cre(+) (A20ERT2) mice induced fulminant apoptosis and subsequent myeloproliferation, lymphocytopenia, and progressive anemia with excessive production of pro-inflammatory cytokines, as observed in A20Mx mice. These results demonstrate that A20 plays essential roles in the homeostasis of adult hematopoiesis by preventing apoptosis and inflammation. Our findings provide insights into the mechanism underlying A20 dysfunction and human diseases in which A20 expression is impaired.	[Nagamachi, Akiko; Inaba, Toshiya] Hiroshima Univ, Dept Mol Oncol, Res Inst Radiat Biol & Med, Minami Ku, Hiroshima, Japan; [Nakata, Yuichiro; Ueda, Takeshi; Yamasaki, Norimasa; Honda, Hiroaki] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Minami Ku, Hiroshima, Japan; [Ebihara, Yasuhiro; Tsuji, Kohichiro] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Adv Clin Res Ctr,Minato Ku, Tokyo, Japan; [Honda, Zen-ichiro] Ochanomizu Univ, Hlth Care Ctr, Bunkyo Ku, Tokyo 112, Japan; [Honda, Zen-ichiro] Ochanomizu Univ, Grad Sch Humanities & Sci, Inst Environm Sci Human Life, Bunkyo Ku, Tokyo 112, Japan; [Takubo, Keiyo; Suda, Toshio] Keio Univ, Sch Med, Sakaguchi Lab, Dept Cell Differentiat,Shinjuku Ku, Tokyo, Japan; [Oda, Hideaki] Tokyo Womens Med Univ, Dept Pathol, Shinjuku Ku, Tokyo, Japan	Hiroshima University; Hiroshima University; University of Tokyo; Ochanomizu University; Ochanomizu University; Keio University; Tokyo Women's Medical University	Honda, H (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Minami Ku, Hiroshima, Japan.	hhonda@hiroshima-u.ac.jp	Takubo, Keiyo/AAX-5546-2020	Takubo, Keiyo/0000-0002-1736-7592; Ueda, Takeshi/0000-0001-9823-6764	Grants-in-Aid for Scientific Research [25118724] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Hovelmeyer N, 2011, EUR J IMMUNOL, V41, P595, DOI 10.1002/eji.201041313; Honda H, 2011, P NATL ACAD SCI USA, V108, P2468, DOI 10.1073/pnas.1003403108; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Iwai K, 2012, TRENDS CELL BIOL, V22, P355, DOI 10.1016/j.tcb.2012.04.001; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lippens S, 2011, CELL DEATH DIFFER, V18, P1845, DOI 10.1038/cdd.2011.55; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Miyamoto K, 2008, BLOOD, V112, P4485, DOI 10.1182/blood-2008-05-159848; Mochizuki-Kashio M, 2011, BLOOD, V118, P6553, DOI 10.1182/blood-2011-03-340554; Morceau F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/405016; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nagamachi A, 2010, DEV BIOL, V345, P226, DOI 10.1016/j.ydbio.2010.07.015; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Rezzoug F, 2008, J IMMUNOL, V180, P49, DOI 10.4049/jimmunol.180.1.49; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Sinclair A, 1996, BLOOD, V87, P2750, DOI 10.1182/blood.V87.7.2750.bloodjournal8772750; Tanaka S, 2012, BLOOD, V120, P1107, DOI 10.1182/blood-2011-11-394932; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Vicente-Duenas C, 2012, P NATL ACAD SCI USA, V109, P10534, DOI 10.1073/pnas.1204127109; Yamasaki N, 2010, ONCOGENE, V29, P1963, DOI 10.1038/onc.2009.475	41	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87425	10.1371/journal.pone.0087425	http://dx.doi.org/10.1371/journal.pone.0087425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498102	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900110
J	Blanco, RGF; Califano, J; Messing, B; Richmon, J; Liu, J; Quon, H; Neuner, G; Saunders, J; Ha, PK; Sheth, S; Gillison, M; Fakhry, C				Blanco, Ray Gervacio F.; Califano, Joseph; Messing, Barbara; Richmon, Jeremy; Liu, Jia; Quon, Harry; Neuner, Geoffrey; Saunders, John; Ha, Patrick K.; Sheth, Sheila; Gillison, Maura; Fakhry, Carole			Transcervical Ultrasonography Is Feasible to Visualize and Evaluate Base of Tongue Cancers	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; UNITED-STATES; ORAL-CAVITY; ULTRASOUND; ACCURATE; HEAD	Background: Base of tongue (BOT) is a difficult subsite to examine clinically and radiographically. Yet, anatomic delineation of the primary tumor site, its extension to adjacent sites or across midline, and endophytic vs. exophytic extent are important characteristics for staging and treatment planning. We hypothesized that ultrasound could be used to visualize and describe BOT tumors. Methods: Transcervical ultrasound was performed using a standardized protocol in cases and controls. Cases had suspected or confirmed BOT malignancy. Controls were healthy individuals without known malignancy. Results: 100% of BOT tumors were visualized. On ultrasound BOT tumors were hypoechoic (90.9%) with irregular margins (95.5%). Ultrasound could be used to characterize adjacent site involvement, midline extent, and endophytic extent, and visualize the lingual artery. No tumors were suspected for controls. Conclusions: Ultrasonography can be used to transcervically visualize BOT tumors and provides clinically relevant characteristics that may not otherwise be appreciable.	[Blanco, Ray Gervacio F.; Califano, Joseph; Richmon, Jeremy; Liu, Jia; Quon, Harry; Saunders, John; Ha, Patrick K.; Fakhry, Carole] Johns Hopkins Med, Dept Otolaryngol Head & Neck Surg, Div Head & Neck Surg, Baltimore, MD 21218 USA; [Blanco, Ray Gervacio F.; Califano, Joseph; Messing, Barbara; Saunders, John; Ha, Patrick K.; Fakhry, Carole] Greater Baltimore Med Ctr, Milton J Dance Jr Head & Neck Ctr, Baltimore, MD USA; [Quon, Harry] Johns Hopkins Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA; [Neuner, Geoffrey] Greater Baltimore Med Ctr, Dept Radiol, Baltimore, MD USA; [Sheth, Sheila] Johns Hopkins Med, Dept Radiol, Baltimore, MD USA; [Gillison, Maura] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Columbus, OH 43210 USA; [Fakhry, Carole] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center; Johns Hopkins University; Johns Hopkins Medicine; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fakhry, C (corresponding author), Johns Hopkins Med, Dept Otolaryngol Head & Neck Surg, Div Head & Neck Surg, Baltimore, MD 21218 USA.	cfakhry@jhmi.edu	Richmon, Jeremy/ABI-4295-2020	Richmon, Jeremy/0000-0002-6588-6549				Adelstein DJ, 2011, HEAD NECK-J SCI SPEC, V34, P1681; [Anonymous], NATL COMPREHENSIVE C; Bartlett C, 2009, J OTOLARYNGOL-HEAD N, V38, P197, DOI 10.2310/7070.2008.OA0214; BLACK WC, 1986, AM J ROENTGENOL, V147, P1313, DOI 10.2214/ajr.147.6.1313; Branstetter BF, 2005, RADIOLOGY, V235, P580, DOI 10.1148/radiol.2352040134; BRUNETON JN, 1986, RADIOLOGY, V158, P743, DOI 10.1148/radiology.158.3.3511504; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Corey AS, 2012, HEAD NECK PATHOL, V6, pS25, DOI 10.1007/s12105-012-0374-3; Fakhry C, 2011, CANCER PREV RES, V4, P1378, DOI 10.1158/1940-6207.CAPR-11-0284; FRUEHWALD F, 1987, J ULTRAS MED, V6, P121; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Koch WM, 2012, OTOLARYNG CLIN N AM, V45, P779, DOI 10.1016/j.otc.2012.04.004; Lahav Y, 2009, ANN OTO RHINOL LARYN, V118, P179, DOI 10.1177/000348940911800304; Meacham RK, 2012, OTOLARYNG HEAD NECK, V147, P864, DOI 10.1177/0194599812446677; METTLER FA, 1979, RADIOLOGY, V133, P781, DOI 10.1148/133.3.781; SHAWKER TH, 1984, BRAIN LANG, V21, P335, DOI 10.1016/0093-934X(84)90056-7; Shintani S, 2001, INT J ORAL MAX SURG, V30, P139, DOI 10.1054/ijom.2000.0035; Trotta BM, 2011, RADIOGRAPHICS, V31, P339, DOI 10.1148/rg.312105107; Westra WH, 2012, HEAD NECK PATHOL, V6, pS48, DOI 10.1007/s12105-012-0371-6	20	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87565	10.1371/journal.pone.0087565	http://dx.doi.org/10.1371/journal.pone.0087565			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498138	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100095
J	Ndisang, JF; Jadhav, A; Mishra, M				Ndisang, Joseph Fomusi; Jadhav, Ashok; Mishra, Manish			The Heme Oxygenase System Suppresses Perirenal Visceral Adiposity, Abates Renal Inflammation and Ameliorates Diabetic Nephropathy in Zucker Diabetic Fatty Rats	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; CHRONIC KIDNEY-DISEASE; ENHANCES INSULIN SENSITIVITY; CHRONIC HEART-FAILURE; FACTOR-KAPPA-B; GLUCOSE-METABOLISM; HYPERTENSIVE-RATS; IN-VIVO; TISSUE INFLAMMATION; WAIST CIRCUMFERENCE	The growing incidence of chronic kidney disease remains a global health problem. Obesity is a major risk factor for type-2 diabetes and renal impairment. Perirenal adiposity, by virtue of its anatomical proximity to the kidneys may cause kidney disease through paracrine mechanisms that include increased production of inflammatory cytokines. Although hemeoxygenase (HO) is cytoprotective, its effects on perirenal adiposity and diabetic nephropathy in Zucker-diabetic fatty rats (ZDFs) remains largely unclear. Upregulating the HO-system with hemin normalised glycemia, reduced perirenal adiposity and suppressed several pro-inflammatory/oxidative mediators in perirenal fat including macrophage-inflammatory-protein-1 alpha (MIP-1 alpha), endothelin (ET-1), 8-isoprostane, TNF-alpha, IL-6 and IL-1 beta. Furthermore, hemin reduced ED1, a marker of pro-inflammatory macrophage-M1-phenotype, but interestingly, enhanced markers associated with anti-inflammatory M2-phenotype such as ED2, CD206 and IL-10, suggesting that hemin selectively modulates macrophage polarization towards the anti-inflammatory M2-phenotype. These effects were accompanied by increased adiponectin, HO-1, HO-activity, atrial-natriuretic peptide (ANP), and its surrogate marker, urinary-cGMP. Furthermore, hemin reduced renal histological lesions and abated pro-fibrotic/extracellular-matrix proteins like collagen and fibronectin that deplete nephrin, an important transmembrane protein which forms the scaffolding of the podocyte slit-diaphragm allowing ions to filter but not massive excretion of proteins, hence proteinuria. Correspondingly, hemin increased nephrin expression in ZDFs, reduced markers of renal damage including, albuminuria/proteinuria, but increased creatinine-clearance, suggesting improved renal function. Conversely, the HO-blocker, stannous-mesoporphyrin nullified the hemin effects, aggravating glucose metabolism, and exacerbating renal injury and function. The hemin effects were less-pronounced in Zucker-lean controls with healthy status, suggesting greater selectivity of HO in ZDFs with disease. We conclude that the concomitant reduction of pro-inflammatory/oxidative mediators, macrophage infiltration and profibrotic/extracellular-matrix proteins, coupled to increased nephrin, adiponectin, ANP, cGMP and creatinine clearance may account for improved renal function in hemin-treated ZDFs. These findings suggest that HO-inducers like hemin may be explored against the co-morbidity of perirenal adiposity and diabetic nephropathy.	[Ndisang, Joseph Fomusi; Jadhav, Ashok; Mishra, Manish] Univ Saskatchewan, Coll Med, Dept Physiol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	Ndisang, JF (corresponding author), Univ Saskatchewan, Coll Med, Dept Physiol, Saskatoon, SK S7N 0W0, Canada.	joseph.ndisang@usask.ca			Heart & Stroke Foundation of Saskatchewan of Canada	Heart & Stroke Foundation of Saskatchewan of Canada	This work was supported by Heart & Stroke Foundation of Saskatchewan of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Aki K, 2010, AM J PHYSIOL-RENAL, V298, pF870, DOI 10.1152/ajprenal.00374.2009; Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Ballarin J, 2011, NEPHROL DIAL TRANSPL, V26, P3408, DOI 10.1093/ndt/gfr391; Bedard ELR, 2005, TRANSPL INT, V18, P341, DOI 10.1111/j.1432-2277.2004.00062.x; Benigni A, 2004, KIDNEY INT, V66, P1959, DOI 10.1111/j.1523-1755.2004.00982.x; Burgess A, 2010, HYPERTENSION, V56, P1124, DOI 10.1161/HYPERTENSIONAHA.110.151423; Delanty N, 1997, CIRCULATION, V95, P2492, DOI 10.1161/01.CIR.95.11.2492; Finucane OM, 2012, P NUTR SOC, V22, P1; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Ford ES, 2003, OBES RES, V11, P1223, DOI 10.1038/oby.2003.168; FUKUNAGA M, 1995, J CARDIOVASC PHARM, V26, pS51; FURUTA T, 1993, AM J KIDNEY DIS, V21, P480, DOI 10.1016/S0272-6386(12)80393-3; Giunti S, 2006, HYPERTENSION, V48, P519, DOI 10.1161/01.HYP.0000240331.32352.0c; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Iwai T, 2008, UROLOGY, V72, P432, DOI 10.1016/j.urology.2007.11.123; Jadhav A, 2008, HYPERTENSION, V52, P910, DOI 10.1161/HYPERTENSIONAHA.108.114801; Jadhav A, 2013, J PHARMACOL EXP THER, V345, P239, DOI 10.1124/jpet.112.200808; Jadhav A, 2012, FREE RADICAL BIO MED, V53, P2277, DOI 10.1016/j.freeradbiomed.2012.10.529; Jadhav A, 2009, AM J PHYSIOL-RENAL, V296, pF521, DOI 10.1152/ajprenal.00510.2007; Jim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036041; Jing F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060067; Jonas JC, 2003, DIABETOLOGIA, V46, P1234, DOI 10.1007/s00125-003-1174-9; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kim DH, 2008, AM J PHYSIOL-ENDOC M, V295, pE1038, DOI 10.1152/ajpendo.00061.2008; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lamacchia O, 2011, NEPHROL DIAL TRANSPL, V26, P892, DOI 10.1093/ndt/gfq522; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Li YZ, 2012, AM J PHYSIOL-RENAL, V302, pF561, DOI 10.1152/ajprenal.00355.2011; Li YW, 2006, CARDIOVASC RES, V71, P684, DOI 10.1016/j.cardiores.2006.06.003; Marshall SM, 2007, CURR PHARM DESIGN, V13, P2713, DOI 10.2174/138161207781662957; Menne J, 2006, KIDNEY INT, V70, P1456, DOI 10.1038/sj.ki.5001830; Mishra M., 2013, CURR PHARM DES; Mohri T, 2006, J TRAUMA, V61, P616, DOI 10.1097/01.ta.0000238228.67894.d7; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moro C, 2007, DIABETOLOGIA, V50, P1038, DOI 10.1007/s00125-007-0614-3; Ndisang J. F., 2009, AM J PHYSL REGUL INT; Ndisang J. F., 2013, CURR PHARM DES; Ndisang JF, 2004, J HYPERTENS, V22, P1057, DOI 10.1097/00004872-200406000-00002; Ndisang JF, 2003, EXP BIOL MED, V228, P557, DOI 10.1177/15353702-0322805-27; Ndisang JF, 2003, BLOOD, V101, P3893, DOI 10.1182/blood-2002-08-2608; Ndisang JF, 2002, HYPERTENSION, V40, P315, DOI 10.1161/01.HYP.0000028488.71068.16; Ndisang JF, 2002, EXPERT OPIN THER PAT, V12, P1237; Ndisang JF, 2013, ENDOCRINOLOGY; Ndisang JF, 2013, DIABETES OBES METAB; Ndisang JF, 2002, CARBON MONOXIDE CARD, P165; Ndisang JF, 2008, J HYPERTENS, V26, P1188, DOI 10.1097/HJH.0b013e3282fad93d; Ndisang JF, 2010, J PHARMACOL EXP THER, V334, P87, DOI 10.1124/jpet.109.164871; Ndisang JF, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/359732; Ndisang JF, 2010, HYPERTENS RES, V33, P338, DOI 10.1038/hr.2010.1; Ndisang JF, 2010, ENDOCRINOLOGY, V151, P549, DOI 10.1210/en.2009-0471; Ndisang JF, 2009, J CARD FAIL, V15, P616, DOI 10.1016/j.cardfail.2009.02.003; Ndisang JF, 2009, ENDOCRINOLOGY, V150, P2627, DOI 10.1210/en.2008-1370; Ndisang JF, 2009, ENDOCRINOLOGY, V150, P2098, DOI 10.1210/en.2008-0239; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE1029, DOI 10.1152/ajpendo.90241.2008; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE829, DOI 10.1152/ajpendo.90783.2008; Notaro R, 2000, FASEB J, V14, P485, DOI 10.1096/fasebj.14.3.485; Odermatt A, 2011, AM J PHYSIOL-RENAL, V301, pF919, DOI 10.1152/ajprenal.00068.2011; Pan Y, 2012, BRIT J PHARMACOL, V166, P1169, DOI 10.1111/j.1476-5381.2012.01854.x; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; Piechota A, 2011, J PHYSIOL PHARMACOL, V62, P183; Piechota M, 2007, CELL MOL BIOL LETT, V12, P162, DOI 10.2478/s11658-006-0062-y; Postorino M, 2009, J AM COLL CARDIOL, V53, P1265, DOI 10.1016/j.jacc.2008.12.040; Riba R, 2008, J THROMB HAEMOST, V6, P2121, DOI 10.1111/j.1538-7836.2008.03179.x; Roson MI, 2006, AM J NEPHROL, V26, P590, DOI 10.1159/000098148; Rovira A, 2000, BLOOD, V96, P4111; Salley TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079270; Sanches FMR, 2008, AM J KIDNEY DIS, V52, P66, DOI 10.1053/j.ajkd.2008.02.004; Satchell SC, 2008, DIABETOLOGIA, V51, P714, DOI 10.1007/s00125-008-0961-8; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; SHIRAKAMI G, 1993, ENDOCRINOLOGY, V132, P1905, DOI 10.1210/en.132.5.1905; Soares TD, 2007, LIFE SCI, V81, P647, DOI 10.1016/j.lfs.2007.06.032; Tesch GH, 2010, SEMIN NEPHROL, V30, P290, DOI 10.1016/j.semnephrol.2010.03.007; Ting SMS, 2009, NEPHRON CLIN PRACT, V112, pC121, DOI 10.1159/000214206; Tiwari S, 2013, CURR PHARM DES; Tsukamoto O, 2009, J AM COLL CARDIOL, V53, P2070, DOI 10.1016/j.jacc.2009.02.038; Wang YP, 2011, MOL MED, V17, P1204, DOI 10.2119/molmed.2011.00063; Wang YR, 2005, KIDNEY INT, V68, P47, DOI 10.1111/j.1523-1755.2005.00380.x; Wei Y, 2009, AM J PHYSIOL-CELL PH, V297, pC907, DOI 10.1152/ajpcell.00536.2008; Xu SW, 2007, ARTHRITIS RHEUM-US, V56, P4189, DOI 10.1002/art.23134	82	46	46	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87936	10.1371/journal.pone.0087936	http://dx.doi.org/10.1371/journal.pone.0087936			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498225	gold, Green Published, Green Submitted			2022-12-25	WOS:000330617100121
J	Sparacino-Watkins, CE; Tejero, J; Sun, B; Gauthier, MC; Thomas, J; Ragireddy, V; Merchant, BA; Wang, J; Azarov, I; Basu, P; Gladwin, MT				Sparacino-Watkins, Courtney E.; Tejero, Jesus; Sun, Bin; Gauthier, Marc C.; Thomas, John; Ragireddy, Venkata; Merchant, Bonnie A.; Wang, Jun; Azarov, Ivan; Basu, Partha; Gladwin, Mark T.			Nitrite Reductase and Nitric-oxide Synthase Activity of the Mitochondrial Molybdopterin Enzymes mARC1 and mARC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hypoxia; Mitochondria; Molybdenum; Nitric Oxide; Reductase; Vascular Biology	XANTHINE OXIDOREDUCTASE; PULMONARY-HYPERTENSION; LUNG INJURY; MOLYBDENUM COFACTOR; HYPOXIC CONDITIONS; ELECTRON-TRANSFER; ESCHERICHIA-COLI; SULFITE OXIDASE; DIETARY NITRATE; ANOXIC TISSUES	Background: Nitrite reduction pathways are critical for biological NO production under hypoxia. Results: The mitochondrial enzyme mARC reduces nitrite to NO using cytochrome b(5) as electron donor. Conclusion: mARC forms an electron transfer chain with NADH, cytochrome b(5), and cytochrome b(5) reductase to reduce nitrite to NO. Significance: mARC proteins may constitute a new pathway for hypoxic NO production in vivo. Mitochondrial amidoxime reducing component (mARC) proteins are molybdopterin-containing enzymes of unclear physiological function. Both human isoforms mARC-1 and mARC-2 are able to catalyze the reduction of nitrite when they are in the reduced form. Moreover, our results indicate that mARC can generate nitric oxide (NO) from nitrite when forming an electron transfer chain with NADH, cytochrome b(5), and NADH-dependent cytochrome b(5) reductase. The rate of NO formation increases almost 3-fold when pH was lowered from 7.5 to 6.5. To determine if nitrite reduction is catalyzed by molybdenum in the active site of mARC-1, we mutated the putative active site cysteine residue (Cys-273), known to coordinate molybdenum binding. NO formation was abolished by the C273A mutation in mARC-1. Supplementation of transformed Escherichia coli with tungsten facilitated the replacement of molybdenum in recombinant mARC-1 and abolished NO formation. Therefore, we conclude that human mARC-1 and mARC-2 are capable of catalyzing reduction of nitrite to NO through reaction with its molybdenum cofactor. Finally, expression of mARC-1 in HEK cells using a lentivirus vector was used to confirm cellular nitrite reduction to NO. A comparison of NO formation profiles between mARC and xanthine oxidase reveals similar K-cat and V-max values but more sustained NO formation from mARC, possibly because it is not vulnerable to autoinhibition via molybdenum desulfuration. The reduction of nitrite by mARC in the mitochondria may represent a new signaling pathway for NADH-dependent hypoxic NO production.	[Sparacino-Watkins, Courtney E.; Tejero, Jesus; Sun, Bin; Gauthier, Marc C.; Ragireddy, Venkata; Merchant, Bonnie A.; Wang, Jun; Azarov, Ivan; Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15261 USA; [Sparacino-Watkins, Courtney E.; Sun, Bin; Gauthier, Marc C.; Gladwin, Mark T.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Thomas, John; Basu, Partha] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duquesne University	Gladwin, MT (corresponding author), Univ Pittsburgh, Vasc Med Inst, Div Pulm Allergy & Crit Care Med, E1244 Biomed Sci Tower,200 Lothrope St, Pittsburgh, PA 15261 USA.	gladwinmt@upmc.edu	Tejero, Jesus/G-3953-2017	Tejero, Jesus/0000-0003-3245-9978; Azarov, Ivan/0000-0002-9886-3298; Sparacino-Watkins, Courtney/0000-0002-2954-9633; Gauthier, Marc/0000-0001-5037-2804; Wang, Jun/0000-0001-7564-2364	National Institutes of Health [HL098032, HL096973, DK085852, 2T32HL007563-26]; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; Competitive Medical Research Fund of the UPMC Health System; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007563, R01HL098032, R01HL096973, P01HL103455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK085852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; Competitive Medical Research Fund of the UPMC Health System; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL098032, HL096973, and DK085852. This work was also supported by the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania (to M. T. G.) and by the Competitive Medical Research Fund of the UPMC Health System (to J. T.).; Supported by National Institute of Health Institutional Training Grant 2T32HL007563-26 (to the division of Pulmonary, Allergy, and Critical Care Medicine at the University of Pittsburgh).	Alef MJ, 2011, J CLIN INVEST, V121, P1646, DOI 10.1172/JCI44079; Allen JD, 2012, NITRIC OXIDE-BIOL CH, V26, P217, DOI 10.1016/j.niox.2012.03.003; Altuve A, 2004, BIOCHEM BIOPH RES CO, V314, P602, DOI 10.1016/j.bbrc.2003.12.138; Ascenzi P, 2013, J BIOL INORG CHEM, V18, P939, DOI 10.1007/s00775-013-1040-2; Baker JE, 2007, J MOL CELL CARDIOL, V43, P437, DOI 10.1016/j.yjmcc.2007.07.057; Baliga RS, 2012, CIRCULATION, V125, P2922, DOI 10.1161/CIRCULATIONAHA.112.100586; Basu S, 2008, J BIOL CHEM, V283, P32590, DOI 10.1074/jbc.M806934200; Bueno M, 2013, ANTIOXID REDOX SIGN, V18, P1797, DOI 10.1089/ars.2012.4833; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Chamizo-Ampudia A, 2011, EUKARYOT CELL, V10, P1270, DOI 10.1128/EC.05096-11; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; DOYLE MP, 1984, J BIOL CHEM, V259, P80; Garrett RM, 1996, J BIOL CHEM, V271, P7387, DOI 10.1074/jbc.271.13.7387; Gharib SA, 2005, PHYSIOL GENOMICS, V22, P14, DOI 10.1152/physiolgenomics.00265.2004; Ghorbel MT, 2012, PHYSIOL GENOMICS, V44, P1098, DOI 10.1152/physiolgenomics.00072.2012; Gladwin MT, 2006, AM J PHYSIOL-HEART C, V291, pH2026, DOI 10.1152/ajpheart.00407.2006; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Havemeyer A, 2011, DRUG METAB REV, V43, P524, DOI 10.3109/03602532.2011.608682; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; Klein JM, 2012, J BIOL CHEM, V287, P42795, DOI 10.1074/jbc.M112.419424; Kotthaus J, 2011, BIOCHEM J, V433, P383, DOI 10.1042/BJ20100960; Kozlov AV, 1999, FEBS LETT, V454, P127, DOI 10.1016/S0014-5793(99)00788-7; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Li HT, 2009, J BIOL CHEM, V284, P33850, DOI 10.1074/jbc.M109.019125; Li HT, 2004, J BIOL CHEM, V279, P16939, DOI 10.1074/jbc.M314336200; Li HT, 2003, BIOCHEMISTRY-US, V42, P1150, DOI 10.1021/bi026385a; Li HT, 2001, J BIOL CHEM, V276, P24482, DOI 10.1074/jbc.M011648200; Lu Ping, 2005, Hepatobiliary Pancreat Dis Int, V4, P350; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MacArthur PH, 2007, J CHROMATOGR B, V851, P93, DOI 10.1016/j.jchromb.2006.12.012; Maia LB, 2011, J BIOL INORG CHEM, V16, P443, DOI 10.1007/s00775-010-0741-z; Mendel RR, 2011, COORDIN CHEM REV, V255, P1145, DOI 10.1016/j.ccr.2011.01.054; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Navas-Acien A, 2005, ENVIRON HEALTH PERSP, V113, P164, DOI 10.1289/ehp.7329; Neumann M, 2008, FEBS J, V275, P5678, DOI 10.1111/j.1742-4658.2008.06694.x; Nohl H, 2005, REDOX REP, V10, P281, DOI 10.1179/135100005X83707; Nohl H, 2000, ACTA BIOCHIM POL, V47, P913, DOI 10.18388/abp.2000_3946; OZOLS J, 1974, BIOCHEMISTRY-US, V13, P426, DOI 10.1021/bi00700a005; PAI TG, 1987, ANAL BIOCHEM, V166, P150, DOI 10.1016/0003-2697(87)90557-4; Pickerodt PA, 2012, ANESTHESIOLOGY, V117, P592, DOI 10.1097/ALN.0b013e3182655f80; Plitzko B, 2013, J BIOL CHEM, V288, P20228, DOI 10.1074/jbc.M113.474916; Pollock VV, 2002, ARCH BIOCHEM BIOPHYS, V403, P237, DOI 10.1016/S0003-9861(02)00215-1; Poyton RO, 2011, DISCOV MED, V11, P154; Qiu JA, 2010, BIOCHEMISTRY-US, V49, P3989, DOI 10.1021/bi1001954; Samal AA, 2012, FREE RADICAL BIO MED, V53, P1431, DOI 10.1016/j.freeradbiomed.2012.08.007; SHIRABE K, 1989, BIOCHIM BIOPHYS ACTA, V1008, P189, DOI 10.1016/0167-4781(80)90007-X; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Shiva S, 2010, NITRIC OXIDE-BIOL CH, V22, P64, DOI 10.1016/j.niox.2009.09.002; Sparacino-Watkins C, 2014, CHEM SOC REV, V43, P676, DOI 10.1039/c3cs60249d; Sparacino-Watkins CE, 2012, CIRCULATION, V125, P2824, DOI 10.1161/CIRCULATIONAHA.112.107821; Sugimoto R, 2012, AM J TRANSPLANT, V12, P2938, DOI 10.1111/j.1600-6143.2012.04169.x; TAN S, 1993, FREE RADICAL BIO MED, V15, P407, DOI 10.1016/0891-5849(93)90040-2; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Wang J, 2013, NITRIC OXIDE-BIOL CH, V31, pS39, DOI 10.1016/j.niox.2013.02.064; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Zuckerbraun BS, 2010, CIRCULATION, V121, P98, DOI 10.1161/CIRCULATIONAHA.109.891077	63	105	108	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10345	10358		10.1074/jbc.M114.555177	http://dx.doi.org/10.1074/jbc.M114.555177			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24500710	Green Published, hybrid			2022-12-25	WOS:000334226400010
J	Hinde, K; Carpenter, AJ; Clay, JS; Bradford, BJ				Hinde, Katie; Carpenter, Abigail J.; Clay, John S.; Bradford, Barry J.			Holsteins Favor Heifers, Not Bulls: Biased Milk Production Programmed during Pregnancy as a Function of Fetal Sex	PLOS ONE			English	Article							TRIVERS-WILLARD HYPOTHESIS; LOCAL RESOURCE COMPETITION; MATERNAL INVESTMENT; MAMMARY-GLAND; BOVINE SOMATOTROPIN; LIFE-HISTORY; CALF SEX; FACULTATIVE ADJUSTMENT; PARENTAL INVESTMENT; SUCKLING BEHAVIOR	Mammalian females pay high energetic costs for reproduction, the greatest of which is imposed by lactation. The synthesis of milk requires, in part, the mobilization of bodily reserves to nourish developing young. Numerous hypotheses have been advanced to predict how mothers will differentially invest in sons and daughters, however few studies have addressed sex-biased milk synthesis. Here we leverage the dairy cow model to investigate such phenomena. Using 2.39 million lactation records from 1.49 million dairy cows, we demonstrate that the sex of the fetus influences the capacity of the mammary gland to synthesize milk during lactation. Cows favor daughters, producing significantly more milk for daughters than for sons across lactation. Using a sub-sample of this dataset (N = 113,750 subjects) we further demonstrate that the effects of fetal sex interact dynamically across parities, whereby the sex of the fetus being gestated can enhance or diminish the production of milk during an established lactation. Moreover the sex of the fetus gestated on the first parity has persistent consequences for milk synthesis on the subsequent parity. Specifically, gestation of a daughter on the first parity increases milk production by similar to 445 kg over the first two lactations. Our results identify a dramatic and sustained programming of mammary function by offspring in utero. Nutritional and endocrine conditions in utero are known to have pronounced and long-term effects on progeny, but the ways in which the progeny has sustained physiological effects on the dam have received little attention to date.	[Hinde, Katie] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Carpenter, Abigail J.; Bradford, Barry J.] Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA; [Clay, John S.] Dairy Records Management Syst, Raleigh, NC USA; [Hinde, Katie] Smithsonian Conservat Biol Inst, Nutr Lab, Washington, DE USA; [Hinde, Katie] Univ Calif Davis, Calif Natl Primate Res Ctr, Brain Mind & Behav Unit, Davis, CA 95616 USA	Harvard University; Kansas State University; University of California System; University of California Davis	Hinde, K (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	khinde@fas.harvard.edu	Bradford, Barry/B-7870-2010	Bradford, Barry/0000-0002-6775-4961; Hinde, Katie/0000-0002-0528-866X	Kansas Agricultural Experiment Station [13-391-J]	Kansas Agricultural Experiment Station	Contribution no. 13-391-J from the Kansas Agricultural Experiment Station to BJB and AJC supported, in part, the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Ajmone-Marsan P, 2010, EVOL ANTHROPOL, V19, P148, DOI 10.1002/evan.20267; Akers R.M., 2002, LACTATION MAMMARY GL, V1st; Akers RM, 2006, J DAIRY SCI, V89, P1222, DOI 10.3168/jds.S0022-0302(06)72191-9; Anand-Ivell R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019821; ANDERSON RR, 1983, J DAIRY SCI, V66, P29, DOI 10.3168/jds.S0022-0302(83)81749-4; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; BAUMAN DE, 1993, ANNU REV NUTR, V13, P437, DOI 10.1146/annurev.nu.13.070193.002253; Baur R, 1981, PLACENTA S, V2, P35; Bercovitch FB, 2002, INT J PRIMATOL, V23, P905, DOI 10.1023/A:1015585117114; Bercovitch FB, 2000, BEHAV ECOL SOCIOBIOL, V48, P1, DOI 10.1007/s002650000204; Berry DP, 2008, J DAIRY SCI, V91, P329, DOI 10.3168/jds.2007-0438; Blomquist GE, 2009, BIOL LETTERS, V5, P339, DOI 10.1098/rsbl.2009.0009; Brown GR, 2001, ANIM BEHAV, V61, P683, DOI 10.1006/anbe.2000.1659; BYERS JA, 1990, BEHAV ECOL SOCIOBIOL, V26, P157; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Cameron EZ, 1998, ANIM BEHAV, V56, P521, DOI 10.1006/anbe.1998.0793; Cameron EZ, 1999, ANIM BEHAV, V57, P673, DOI 10.1006/anbe.1998.0997; Cameron EZ, 2000, BEHAV ECOL SOCIOBIOL, V47, P243, DOI 10.1007/s002650050661; Capellini I, 2012, PLACENTA, V33, P763, DOI 10.1016/j.placenta.2012.07.004; Carlsen SM, 2010, ACTA OBSTET GYN SCAN, V89, P87, DOI 10.3109/00016340903318006; CHILLIARD Y, 1988, ANN ZOOTECH, V37, P159, DOI 10.1051/animres:19880304; CHRISTIA.LL, 1965, J ANIM SCI, V24, P652; CLARK AB, 1978, SCIENCE, V201, P163, DOI 10.1126/science.201.4351.163; CLUTTONBROCK TH, 1981, NATURE, V289, P487, DOI 10.1038/289487a0; Cockburn A, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P266, DOI 10.1017/CBO9780511542053.014; Daly S E, 1995, J Hum Lact, V11, P21, DOI 10.1177/089033449501100119; De Vries A, 2008, J DAIRY SCI, V91, P847, DOI 10.3168/jds.2007-0536; del Rio NS, 2007, J DAIRY SCI, V90, P1255, DOI 10.3168/jds.S0022-0302(07)71614-4; Dematawewa CMB, 1997, J DAIRY SCI, V80, P754, DOI 10.3168/jds.S0022-0302(97)75995-2; EMLEN ST, 1986, AM NAT, V127, P1, DOI 10.1086/284463; Festa-Bianchet M, 2012, CAN J ZOOL, V90, P1072, DOI 10.1139/Z2012-080; FOOTE RH, 1977, THERIOGENOLOGY, V8, P349, DOI 10.1016/0093-691X(77)90186-8; Fujita M, 2012, AM J PHYS ANTHROPOL, V149, P52, DOI 10.1002/ajpa.22092; Garner DL, 2008, THERIOGENOLOGY, V69, P886, DOI 10.1016/j.theriogenology.2008.01.006; GIANOLA D, 1974, J DAIRY SCI, V57, P235, DOI 10.3168/jds.S0022-0302(74)84864-2; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; Gonzalez-Recio O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051816; GRIGSON C, 1978, J ARCHAEOL SCI, V5, P123, DOI 10.1016/0305-4403(78)90028-6; HAYDEN TJ, 1979, J DAIRY SCI, V62, P53, DOI 10.3168/jds.S0022-0302(79)83201-4; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Hinde K, 2007, CURR BIOL, V17, pR958, DOI 10.1016/j.cub.2007.09.029; Hinde K, 2009, AM J HUM BIOL, V21, P512, DOI 10.1002/ajhb.20917; Hinde K, 2013, AM J PHYS ANTHROPOL, V151, P144, DOI 10.1002/ajpa.22229; Hinde K, 2011, EVOL ANTHROPOL, V20, P9, DOI 10.1002/evan.20289; HOGG JT, 1992, BEHAV ECOL SOCIOBIOL, V31, P243, DOI 10.1007/BF00171679; Hohenbrink S, 2012, J DAIRY SCI, V95, P5694, DOI 10.3168/jds.2011-5281; Johnson TL, 2013, DOMEST ANIM ENDOCRIN, V44, P26, DOI 10.1016/j.domaniend.2012.08.001; Klisch K, 2007, PLACENTA, V28, P353, DOI 10.1016/j.placenta.2006.03.014; Koskela E, 2009, J ANIM ECOL, V78, P1007, DOI 10.1111/j.1365-2656.2009.01574.x; Landete-Castillejos T, 2005, BEHAV ECOL SOCIOBIOL, V57, P267, DOI 10.1007/s00265-004-0848-8; Lang SLC, 2012, J EXP BIOL, V215, P2904, DOI 10.1242/jeb.067058; Leimar O, 1996, BEHAV ECOL, V7, P316, DOI 10.1093/beheco/7.3.316; Lemay DG, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r43; Loor JJ, 2011, SYSTEMS BIOLOGY AND LIVESTOCK SCIENCE, P211; Martin JGA, 2012, OIKOS, V121, P752, DOI 10.1111/j.1600-0706.2011.19962.x; MAYNARDSMITH J, 1980, BEHAV ECOL SOCIOBIOL, V7, P247; Meier S, 2010, J DAIRY SCI, V93, P5408, DOI 10.3168/jds.2009-2935; Miller N, 2006, J DAIRY SCI, V89, P4669, DOI 10.3168/jds.S0022-0302(06)72517-6; Minick JA, 2001, J ANIM SCI, V79, P1386; Moore T, 2012, PLACENTA, V33, pS33, DOI 10.1016/j.placenta.2011.11.016; Neville MC, 2012, J MAMMARY GLAND BIOL, V17, P167, DOI 10.1007/s10911-012-9261-5; Nilsson EE, 2009, MOL CELL ENDOCRINOL, V313, P9, DOI 10.1016/j.mce.2009.09.004; Norman HD, 2010, J DAIRY SCI, V93, P3880, DOI 10.3168/jds.2009-2781; Olynk NJ, 2007, J DAIRY SCI, V90, P2569, DOI 10.3168/jds.2006-460; PELABON C, 1995, BEHAV ECOL SOCIOBIOL, V37, P311; Plath-Gabler A, 2001, J ENDOCRINOL, V168, P39, DOI 10.1677/joe.0.1680039; Powe CE, 2010, AM J HUM BIOL, V22, P50, DOI 10.1002/ajhb.20941; Quinn EA, 2013, AM J PHYS ANTHROPOL, V152, P209, DOI 10.1002/ajpa.22346; RATTRAY PV, 1974, J ANIM SCI, V38, P613, DOI 10.2527/jas1974.383613x; Ribeiro ES, 2012, ANIM REPROD, V9, P370; Robert KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051099; Roche JR, 2006, J DAIRY SCI, V89, P2119, DOI 10.3168/jds.S0022-0302(06)72282-2; Rose MT, 2004, J DAIRY SCI, V87, P2024, DOI 10.3168/jds.S0022-0302(04)70020-X; Rowson AR, 2012, SEMIN CELL DEV BIOL, V23, P557, DOI 10.1016/j.semcdb.2012.03.018; Rudolph MC, 2003, J MAMMARY GLAND BIOL, V8, P287, DOI 10.1023/B:JOMG.0000010030.73983.57; Rutherford JN, 2013, BUILDING BABIES PRIM, P27, DOI DOI 10.1007/978-1-4614-4060-4_2; RUTLEDGE JJ, 1971, J ANIM SCI, V33, P205; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Shibata F, 2009, BEHAV ECOL SOCIOBIOL, V63, P1307, DOI 10.1007/s00265-009-0772-z; SILK JB, 1983, AM NAT, V121, P56, DOI 10.1086/284039; Silk JB, 2008, P ROY SOC B-BIOL SCI, V275, P1761, DOI 10.1098/rspb.2008.0340; SIMPSON MJA, 1982, NATURE, V300, P440, DOI 10.1038/300440a0; Stehulova I, 2013, APPL ANIM BEHAV SCI, V144, P89, DOI 10.1016/j.applanim.2013.01.003; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Thakkar Sagar K, 2013, Am J Hum Biol, V25, P770, DOI 10.1002/ajhb.22446; TRIVERS RL, 1974, AM ZOOL, V14, P249; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Vanraden PM, 1997, J DAIRY SCI, V80, P3015, DOI 10.3168/jds.S0022-0302(97)76268-4; WIGGANS GR, 1991, J ANIM SCI, V69, P3853, DOI 10.2527/1991.6993853x; Williams G. C., 1966, P307; Willisch CS, 2012, EVOL ECOL, V26, P187, DOI 10.1007/s10682-011-9486-6; Windig JJ, 2006, J DAIRY SCI, V89, P1765, DOI 10.3168/jds.S0022-0302(06)72245-7; Yang MY, 2008, BIOL REPROD, V78, P1153, DOI 10.1095/biolreprod.107.066688	95	75	79	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86169	10.1371/journal.pone.0086169	http://dx.doi.org/10.1371/journal.pone.0086169			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498270	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900016
J	Liang, CC; Muo, CH; Wang, IK; Chang, CT; Chou, CY; Liu, JH; Yen, TH; Huang, CC; Chung, CJ				Liang, Chih-Chia; Muo, Chih-Hsin; Wang, I-Kuan; Chang, Chiz-Tzung; Chou, Che-Yi; Liu, Jiung-Hsiun; Yen, Tzung-Hai; Huang, Chiu-Ching; Chung, Chi-Jung			Peptic Ulcer Disease Risk in Chronic Kidney Disease: Ten-Year Incidence, Ulcer Location, and Ulcerogenic Effect of Medications	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; UNIVERSAL HEALTH-INSURANCE; PREVALENCE; ASPIRIN; TRENDS; PATHOPHYSIOLOGY; POPULATION; PREVENTION; MORTALITY	Objectives: We aimed at determining peptic ulcer disease (PUD) incidence among chronic kidney disease (CKD) patients during 1998-2008, compared to patients without CKD, and at examining associations between CKD and PUD. Methods: Data for 1998-2008 were extracted from the National Health Insurance Research Database in Taiwan. The annual PUD incidence (cases per thousand persons per year) was calculated separately for patients with and without CKD. Characteristics of patients with newly diagnosed PUD (n = 16322) were compared to those of a control group without PUD (n = 32644). The 2 groups were matched for age, sex, and index year. Odds ratios (OR) and 95% confidence intervals (CI) were estimated by logistic regression. Results: Over the 10-year period, the PUD incidence was similar to 10-12 times higher in CKD patients than in those without CKD. Its incidence in elderly CKD patients increased rapidly over time. For CKD patients, most PUD events (>95%) were managed during hospitalization. Peptic ulcer risk, adjusted for all potential confounders, was much higher in CKD patients undergoing hemodialysis (adjusted OR, 9.74; 95% CI, 7.11-13.31). Maintenance hemodialysis patients were 2 times more likely to have gastric ulcers than duodenal ulcers, while CKD patients not on dialysis had similar risks for both. There were no significant interactions between medications and CKD status on the peptic ulcer risk. Unlike CKD patients on nonsteroidal anti-inflammatory drugs and clopidogrel, those on aspirin did not have a higher peptic ulcer risk (adjusted OR, 0.88; 95% CI, 0.44-1.77). Conclusions: CKD patients have a substantially increased PUD risk, and the majority of CKD patients with PUD require hospital management. Further, peptic ulcer risk is affected by hemodialysis therapy, patient status (inpatient vs. outpatient), and ulcerogenic medications.	[Liang, Chih-Chia; Wang, I-Kuan; Chang, Chiz-Tzung; Chou, Che-Yi; Liu, Jiung-Hsiun; Huang, Chiu-Ching] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Liang, Chih-Chia; Wang, I-Kuan; Chang, Chiz-Tzung; Chou, Che-Yi; Liu, Jiung-Hsiun; Huang, Chiu-Ching] China Med Univ Hosp, Kidney Inst, Taichung, Taiwan; [Liang, Chih-Chia; Wang, I-Kuan; Chang, Chiz-Tzung; Chou, Che-Yi; Liu, Jiung-Hsiun; Huang, Chiu-Ching] China Med Univ, Coll Med, Dept Med, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Yen, Tzung-Hai] Chang Gung Mem Hosp, Dept Nephrol, Taipei 10591, Taiwan; [Yen, Tzung-Hai] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chung, Chi-Jung] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Chung, CJ (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	cjchung@mail.cmu.edu.tw	Chung, Chi-Jung/G-4755-2013; Yen, Tzung-Hai/AAQ-4525-2020; Chou, Che-Yi/N-8887-2015	Yen, Tzung-Hai/0000-0002-0907-1505; Chou, Che-Yi/0000-0003-4029-9097	National Sciences Council, Executive Yuan [DOH 97-HP-1101]; China Medical University Hospital [1MS1, DMR-100-027]; Taiwan Department of Health Clinical Trial and Research Center for Excellence [DOH100-TD-B-111-004]; Taiwan Department of Health Cancer Research Center of Excellence [DOH100-TD-C-111-005]	National Sciences Council, Executive Yuan; China Medical University Hospital; Taiwan Department of Health Clinical Trial and Research Center for Excellence; Taiwan Department of Health Cancer Research Center of Excellence	This study was funded by the National Sciences Council, Executive Yuan (grant numbers: DOH 97-HP-1101, 2008-2010), China Medical University Hospital (grant numbers: 1MS1 and DMR-100-027), Taiwan Department of Health Clinical Trial and Research Center for Excellence (grant number: DOH100-TD-B-111-004) and Taiwan Department of Health Cancer Research Center of Excellence (grant number: DOH100-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsberg K, 2010, ALIMENT PHARM THER, V32, P801, DOI 10.1111/j.1365-2036.2010.04399.x; Barkun A, 2010, AM J MED, V123, P358, DOI 10.1016/j.amjmed.2009.09.031; Chan FKL, 2005, NEW ENGL J MED, V352, P238, DOI 10.1056/NEJMoa042087; Chen YT, 2010, AM J NEPHROL, V32, P212, DOI 10.1159/000316963; Cheung J, 2010, GASTROINTEST ENDOSC, V71, P44, DOI 10.1016/j.gie.2009.04.014; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ethier J, 2007, AM J KIDNEY DIS, V50, P602, DOI 10.1053/j.ajkd.2007.07.007; Garrow D, 2010, DIGEST DIS SCI, V55, P66, DOI 10.1007/s10620-008-0708-x; Holle GE, 2010, INT J MOL MED, V25, P483, DOI 10.3892/ijmm_00000368; Hsu PI, 2012, J GASTROEN HEPATOL, V27, P654, DOI 10.1111/j.1440-1746.2012.07085.x; Hsu PI, 2011, GASTROENTEROLOGY, V140, P791, DOI 10.1053/j.gastro.2010.11.056; Huang KW, 2012, ALIMENT PHARM THER, V35, P796, DOI 10.1111/j.1365-2036.2012.05028.x; Laine L, 2004, GASTROENTEROLOGY, V127, P395, DOI 10.1053/j.gastro.2004.05.001; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Luo JC, 2011, CAN MED ASSOC J, V183, pE1345, DOI 10.1503/cmaj.110299; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Muller T, 2009, AM J GASTROENTEROL, V104, P330, DOI 10.1038/ajg.2008.62; Palmer BF, 2008, J AM SOC NEPHROL, V19, P8, DOI 10.1681/ASN.2007091006; PARASA S, 2013, GASTROINTESTINAL END; PENG YL, 2013, J GASTROENTEROLOGY H; Perez-Aisa MA, 2005, ALIMENT PHARM THER, V21, P65, DOI 10.1111/j.1365-2036.2004.02297.x; Plantinga L, 2011, ANN FAM MED, V9, P423, DOI 10.1370/afm.1302; SCHLEMPER RJ, 1993, SCAND J GASTROENTERO, V28, P33, DOI 10.3109/00365529309101573; Shiotani A, 2009, J GASTROENTEROL, V44, P126, DOI 10.1007/s00535-008-2290-6; Stollman N, 2005, J CRIT CARE, V20, P35, DOI 10.1016/j.jcrc.2004.10.003; Strid H, 2004, SCAND J GASTROENTERO, V39, P516, DOI 10.1080/00365520410004505; Sugimoto M, 2009, KIDNEY INT, V75, P96, DOI 10.1038/ki.2008.508; Sung JJY, 2009, ALIMENT PHARM THER, V29, P938, DOI 10.1111/j.1365-2036.2009.03960.x; Tseng GY, 2007, ALIMENT PHARM THER, V26, P925, DOI 10.1111/j.1365-2036.2007.03438.x; Wasse H, 2003, KIDNEY INT, V64, P1455, DOI 10.1046/j.1523-1755.2003.00225.x; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; *WORLD HLTH ORG CO, 2003, ATC IND DDDS; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060; Xia B, 2005, ALIMENT PHARM THER, V22, P243, DOI 10.1111/j.1365-2036.2005.02554.x; Yang JY, 2012, J AM SOC NEPHROL, V23, P495, DOI 10.1681/ASN.2011070658	38	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87952	10.1371/journal.pone.0087952	http://dx.doi.org/10.1371/journal.pone.0087952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498412	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900158
J	Parsons, BN; Wigley, P; Simpson, HL; Williams, JM; Humphrey, S; Salisbury, AM; Watson, AJM; Fry, SC; O'Brien, D; Roberts, CL; O'Kennedy, N; Keita, AV; Soderholm, JD; Rhodes, JM; Campbell, BJ				Parsons, Bryony N.; Wigley, Paul; Simpson, Hannah L.; Williams, Jonathan M.; Humphrey, Suzie; Salisbury, Anne-Marie; Watson, Alastair J. M.; Fry, Stephen C.; O'Brien, David; Roberts, Carol L.; O'Kennedy, Niamh; Keita, Asa V.; Soderholm, Johan D.; Rhodes, Jonathan M.; Campbell, Barry J.			Dietary Supplementation with Soluble Plantain Non-Starch Polysaccharides Inhibits Intestinal Invasion of Salmonella Typhimurium in the Chicken	PLOS ONE			English	Article							M-CELLS; ESCHERICHIA-COLI; EPITHELIAL-CELLS; CROHNS-DISEASE; ENTERICA; BROILER; COLONIZATION; INFECTION; SEROTYPE; FOOD	Soluble fibres (non-starch polysaccharides, NSP) from edible plants but particularly plantain banana (Musa spp.), have been shown in vitro and ex vivo to prevent various enteric pathogens from adhering to, or translocating across, the human intestinal epithelium, a property that we have termed contrabiotic. Here we report that dietary plantain fibre prevents invasion of the chicken intestinal mucosa by Salmonella. In vivo experiments were performed with chicks fed from hatch on a pellet diet containing soluble plantain NSP (0 to 200 mg/d) and orally infected with S. Typhimurium 4/74 at 8 d of age. Birds were sacrificed 3, 6 and 10 d post-infection. Bacteria were enumerated from liver, spleen and caecal contents. In vitro studies were performed using chicken caecal crypts and porcine intestinal epithelial cells infected with Salmonella enterica serovars following pre-treatment separately with soluble plantain NSP and acidic or neutral polysaccharide fractions of plantain NSP, each compared with saline vehicle. Bacterial adherence and invasion were assessed by gentamicin protection assay. In vivo dietary supplementation with plantain NSP 50 mg/d reduced invasion by S. Typhimurium, as reflected by viable bacterial counts from splenic tissue, by 98.9% (95% CI, 98.1-99.7; P<0.0001). In vitro studies confirmed that plantain NSP (5-10 mg/ml) inhibited adhesion of S. Typhimurium 4/74 to a porcine epithelial cell-line (73% mean inhibition (95% CI, 64-81); P<0.001) and to primary chick caecal crypts (82% mean inhibition (95% CI, 75-90); P<0.001). Adherence inhibition was shown to be mediated via an effect on the epithelial cells and Ussing chamber experiments with ex-vivo human ileal mucosa showed that this effect was associated with increased short circuit current but no change in electrical resistance. The inhibitory activity of plantain NSP lay mainly within the acidic/pectic (homogalacturonan-rich) component. Supplementation of chick feed with plantain NSP was well tolerated and shows promise as a simple approach for reducing invasive salmonellosis.	[Parsons, Bryony N.; Simpson, Hannah L.; Williams, Jonathan M.; Watson, Alastair J. M.; Roberts, Carol L.; Rhodes, Jonathan M.; Campbell, Barry J.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Wigley, Paul; Humphrey, Suzie; Salisbury, Anne-Marie] Univ Liverpool, Inst Infect & Global Hlth, Leahurst, England; [Watson, Alastair J. M.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Fry, Stephen C.] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh Cell Wall Grp, Edinburgh, Midlothian, Scotland; [O'Brien, David; Roberts, Carol L.; O'Kennedy, Niamh] Provexis Plc, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Keita, Asa V.; Soderholm, Johan D.] Linkoping Univ, Fac Hlth Sci, Div Surg, Linkoping, Sweden	University of Liverpool; University of Liverpool; University of East Anglia; University of Edinburgh; University of Aberdeen; Linkoping University	Campbell, BJ (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	bjcampbl@liv.ac.uk		Keita, Asa/0000-0002-6820-0215; Wigley, Paul/0000-0001-6563-0773; Williams, Jonathan/0000-0002-6617-0323; Parsons, Bryony/0000-0003-3599-1089	BBSRC Link award [BB/G01969X/1]; Provexis plc.; BBSRC Industrial CASE Training Grant [BB/I016783/1]; Bo & Vera Ax: son Johnson Foundation for Nature Medicine; BBSRC [BB/E013651/1]; European Science Foundation (ESF), in the framework of the Research Networking Programme, The European Network for Gastrointestinal Health Research; Biotechnology and Biological Sciences Research Council [BB/G01969X/1, BB/E013651/1, 1091516] Funding Source: researchfish; BBSRC [BB/G01969X/1] Funding Source: UKRI	BBSRC Link award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Provexis plc.; BBSRC Industrial CASE Training Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bo & Vera Ax: son Johnson Foundation for Nature Medicine; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Science Foundation (ESF), in the framework of the Research Networking Programme, The European Network for Gastrointestinal Health Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	BNP and CLR were supported by a BBSRC Link award (BB/G01969X/1) to AJMW, BJC, JMR and PW, with matched funding from Provexis plc. HLS was supported by a BBSRC Industrial CASE Training Grant (BB/I016783/1) and The Bo & Vera Ax: son Johnson Foundation for Nature Medicine. SCF was supported by BBSRC award (BB/E013651/1). BJC acknowledges support of the European Science Foundation (ESF), in the framework of the Research Networking Programme, The European Network for Gastrointestinal Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnaqdy A, 2005, INT J FOOD MICROBIOL, V103, P347, DOI 10.1016/j.ijfoodmicro.2004.11.042; Austin C, 2008, JAMA-J AM MED ASSOC, V299, P2850, DOI 10.1001/jama.299.24.2850; Awad WA, 2010, J ANIM PHYSIOL AN N, V94, P486, DOI 10.1111/j.1439-0396.2009.00933.x; BARROW PA, 1988, AVIAN PATHOL, V17, P571, DOI 10.1080/03079458808436478; Braden CR, 2006, CLIN INFECT DIS, V43, P512, DOI 10.1086/505973; Bueno SM, 2010, IMMUNOLOGY, V130, P273, DOI 10.1111/j.1365-2567.2009.03233.x; Casteleyn C, 2010, AVIAN PATHOL, V39, P143, DOI 10.1080/03079451003786105; Cencic A, 2010, INT J FOOD MICROBIOL, V141, pS4, DOI 10.1016/j.ijfoodmicro.2010.03.026; Chappell L, 2009, VET IMMUNOL IMMUNOP, V128, P53, DOI 10.1016/j.vetimm.2008.10.295; CLARK MJR, 1976, J CHEM EDUC, V53, P770, DOI 10.1021/ed053p770; Currie A, 2005, EPIDEMIOL INFECT, V133, P809, DOI 10.1017/S0950268805004383; de Oliveira SD, 2005, INT J FOOD MICROBIOL, V97, P297, DOI 10.1016/j.ijfoodmicro.2004.04.022; Department for Environment Food and Rural Affairs, 2010, ZOON REP UK 2010; Dick-Perez M, 2012, MAGN RESON CHEM, V50, P539, DOI 10.1002/mrc.3836; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; ENGLYST HN, 1986, AM J CLIN NUTR, V44, P42, DOI 10.1093/ajcn/44.1.42; Fasina YO, 2010, POULTRY SCI, V89, P1042, DOI 10.3382/ps.2009-00415; Ferraris RP, 2000, ANNU REV NUTR, V20, P195, DOI 10.1146/annurev.nutr.20.1.195; Flanagan P, 2011, BIOCHEM SOC T, V39, P1067, DOI 10.1042/BST0391067; Fry S. C., 2011, ANN PLANT REV, V41, P1, DOI [10.1002/9781444391015.ch1, DOI 10.1002/9781444391015.CH1]; Fry SC, 2011, METHODS MOL BIOL, V715, P55, DOI 10.1007/978-1-61779-008-9_4; Gardner SL, 2002, PHYTOCHEMISTRY, V60, P241, DOI 10.1016/S0031-9422(02)00046-8; Gormley FJ, 2011, EPIDEMIOL INFECT, V139, P688, DOI 10.1017/S0950268810001858; GRAY DF, 1993, BRIT J NUTR, V69, P189, DOI 10.1079/BJN19930021; Heres L, 2004, VET MICROBIOL, V99, P259, DOI 10.1016/j.vetmic.2003.12.008; Jepson MA, 2001, MICROBES INFECT, V3, P1183, DOI 10.1016/S1286-4579(01)01478-2; Jones MA, 2001, INFECT IMMUN, V69, P5471, DOI 10.1128/IAI.69.9.5471-5476.2001; KATO A, 1992, J VET MED SCI, V54, P999, DOI 10.1292/jvms.54.999; Keely S, 2012, GUT MICROBES, V3, P250, DOI [10.4161/gutmic.20529, 10.4161/gmic.20529]; Kitagawa H, 2003, J VET MED SCI, V65, P171, DOI 10.1292/jvms.65.171; Lee JH, 2006, CARBOHYD RES, V341, P1154, DOI 10.1016/j.carres.2006.03.032; Lim JS, 2009, BIOCHEM BIOPH RES CO, V390, P1322, DOI 10.1016/j.bbrc.2009.10.145; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Merle R, 2011, PREV VET MED, V99, P229, DOI 10.1016/j.prevetmed.2011.02.007; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Morrissey PEW, 2010, FOOD CONTROL, V21, P1113, DOI 10.1016/j.foodcont.2010.01.005; Murugkar H, 2005, INDIAN J MED RES, V122, P237; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Perrone P, 2002, PHYTOCHEMISTRY, V60, P67, DOI 10.1016/S0031-9422(02)00039-0; Piras F, 2011, INT J FOOD MICROBIOL, V151, P201, DOI 10.1016/j.ijfoodmicro.2011.08.025; Popper ZA, 2008, PLANTA, V227, P781, DOI 10.1007/s00425-007-0656-2; Roberts CL, 2013, J NUTR BIOCHEM, V24, P97, DOI 10.1016/j.jnutbio.2012.02.013; Roberts CL, 2010, GUT, V59, P1331, DOI 10.1136/gut.2009.195370; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Steube KG, 2012, CYTOTECHNOLOGY, V64, P373, DOI 10.1007/s10616-011-9420-3; Sunkara LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027225; Tahoun A, 2012, CELL HOST MICROBE, V12, P645, DOI 10.1016/j.chom.2012.10.009; Van Deun K, 2008, VET MICROBIOL, V130, P285, DOI 10.1016/j.vetmic.2007.11.027; WATSON PR, 1995, INFECT IMMUN, V63, P2743, DOI 10.1128/IAI.63.7.2743-2754.1995; Willamil J, 2011, ARCH ANIM NUTR, V65, P431, DOI 10.1080/1745039X.2011.623047; Withanage GSK, 2005, INFECT IMMUN, V73, P5173, DOI 10.1128/IAI.73.8.5173-5182.2005; Yang BC, 2008, FOOD RES INT, V41, P594, DOI 10.1016/j.foodres.2008.04.009	52	21	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87658	10.1371/journal.pone.0087658	http://dx.doi.org/10.1371/journal.pone.0087658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498347	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000330626900093
J	Zha, RP; Guo, WJ; Zhang, ZF; Qiu, ZP; Wang, QF; Ding, J; Huang, SL; Chen, TY; Gu, JR; Yao, M; He, XH				Zha, Ruopeng; Guo, Weijie; Zhang, Zhenfeng; Qiu, Zhaoping; Wang, Qifeng; Ding, Jie; Huang, Shenglin; Chen, Taoyang; Gu, Jianren; Yao, Ming; He, Xianghuo			Genome-Wide Screening Identified That miR-134 Acts as a Metastasis Suppressor by Targeting Integrin beta 1 in Hepatocellular Carcinoma	PLOS ONE			English	Article							TUMOR-METASTASIS; CELL-MIGRATION; CANCER CELLS; LUNG-CANCER; ADHESION; MICRORNAS; EXPRESSION; INVASION; INSIGHTS; RHO	MicroRNAs (miRNAs) are small, single-stranded, non-coding RNAs that play pivotal roles in human cancer development and progression, such as tumor metastasis. Here, we identified the miRNAs that regulate hepatocellular carcinoma (HCC) cell migration by a high-throughput screening method using the classical wound-healing assay with time-lapse video microscopy and validation with a transwell migration assay. Eleven miRNAs (miR-134, -146b-3p, -188-3p, -525-3p, -661, -767-5p, -891a, -891b, -1244, -1247 and miR-1471) were found to promote or inhibit HCC cell migration. Further investigation revealed that miR-134 suppressed the invasion and metastasis of HCC cells in vitro and in vivo, and integrin beta 1 (ITGB1) was a direct and functional target gene of miR-134. Moreover, miR-134 inhibited the phosphorylation of focal adhesion kinase (FAK) and the activation of RhoA downstream of the ITGB1 pathway, thereby decreasing stress fiber formation and cell adhesion in HCC cells. In conclusion, we demonstrated that miR-134 is a novel metastasis suppressor in HCC and could be a potential therapeutic target for the treatment of HCC.	[Zha, Ruopeng; Guo, Weijie] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zha, Ruopeng; Guo, Weijie; Zhang, Zhenfeng; Qiu, Zhaoping; Ding, Jie; Huang, Shenglin; Gu, Jianren; Yao, Ming; He, Xianghuo] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200030, Peoples R China; [Wang, Qifeng] Fudan Univ, Shanghai Canc Hosp, Shanghai 200433, Peoples R China; [Chen, Taoyang] Qi Dong Liver Canc Inst, Qi Dong, Jiangsu, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University	He, XH (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200030, Peoples R China.	xhhe@shsci.org	He, Xianghuo/I-1497-2014; Huang, Shenglin/N-9472-2018	He, Xianghuo/0000-0001-8872-668X; Huang, Shenglin/0000-0003-1279-0794	National 973 Key Basic Research Program [2013CB910500]; National Natural Science Foundation of China [81125016, 81071637, 91029728]; Key Specialized Project for the Infectious Diseases [2012ZX10002-009013]; Shanghai Science and Technology Commission [11XD1404500]; Shanghai Municipal Education Commission; Shanghai Municipal Health Bureau [11SG18, XBR2011039, 20114Y159]	National 973 Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Specialized Project for the Infectious Diseases; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Municipal Health Bureau	This work was supported by grants from the National 973 Key Basic Research Program (2013CB910500); the National Natural Science Foundation of China (81125016, 81071637, and 91029728); The Key Specialized Project for the Infectious Diseases (2012ZX10002-009013); Shanghai Science and Technology Commission (11XD1404500); Shanghai Municipal Education Commission and Shanghai Municipal Health Bureau (11SG18, XBR2011039, and 20114Y159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2011, J PATHOL, V223, P646, DOI 10.1002/path.2833; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; Caccavari F, 2010, CELL ADHES MIGR, V4, P124, DOI 10.4161/cam.4.1.10976; Ding J, 2013, HEPATOLOGY, V58, P654, DOI 10.1002/hep.26378; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Felding-Habermann B, 2003, CLIN EXP METASTAS, V20, P203, DOI 10.1023/A:1022983000355; Fotos JS, 2006, CYTOTECHNOLOGY, V51, P7, DOI 10.1007/s10616-006-9006-7; Fu BH, 2011, MOL BIOL REP, V38, P3271, DOI 10.1007/s11033-010-0308-7; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Grzesiak JJ, 2011, INT J CANCER, V129, P2905, DOI 10.1002/ijc.25942; Haller F, 2010, J PATHOL, V220, P71, DOI 10.1002/path.2610; Huang S, 2011, BRIT J CANCER, V104, P235, DOI 10.1038/sj.bjc.6606010; Huang SL, 2010, PROTEIN CELL, V1, P916, DOI 10.1007/s13238-010-0116-9; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Lages E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020600; Le XF, 2010, CANCER MICROENVIRON, V3, P137, DOI 10.1007/s12307-010-0037-4; Li JP, 2012, FEBS LETT, V586, P3761, DOI 10.1016/j.febslet.2012.09.016; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Li Y, 2012, ANN HEPATOL, V11, P272, DOI 10.1016/S1665-2681(19)31036-1; Liu LX, 2002, WORLD J GASTROENTERO, V8, P631, DOI 10.3748/wjg.v8.i4.631; Masumoto A, 1999, HEPATOLOGY, V29, P68, DOI 10.1002/hep.510290146; Mizuno H, 2008, BBA-GEN SUBJECTS, V1780, P564, DOI 10.1016/j.bbagen.2007.09.007; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Sarver AL, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-7; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tian Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048958; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wu XM, 2011, ACTA PHARMACOL SIN, V32, P259, DOI 10.1038/aps.2010.204; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Ying Q, 2011, HEPATOLOGY, V54, P2064, DOI 10.1002/hep.24614; Zhang XY, 2012, IN VITRO CELL DEV-AN, V48, P131, DOI 10.1007/s11626-012-9482-3	39	67	71	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87665	10.1371/journal.pone.0087665	http://dx.doi.org/10.1371/journal.pone.0087665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498348	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900094
J	Erbakan, M; Shen, YX; Grzelakowski, M; Butler, PJ; Kumar, M; Curtis, WR				Erbakan, Mustafa; Shen, Yue-xiao; Grzelakowski, Mariusz; Butler, Peter J.; Kumar, Manish; Curtis, Wayne R.			Molecular Cloning, Overexpression and Characterization of a Novel Water Channel Protein from Rhodobacter sphaeroides	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURE; AQUAPORIN; MEMBRANES; RECONSTITUTION; EXPRESSION; RED; PERMEABILITY; LIPOSOMES; FAMILY; AQPZ	Aquaporins are highly selective water channel proteins integrated into plasma membranes of single cell organisms; plant roots and stromae; eye lenses, renal and red blood cells in vertebrates. To date, only a few microbial aquaporins have been characterized and their physiological importance is not well understood. Here we report on the cloning, expression and characterization of a novel aquaporin, RsAqpZ, from a purple photosynthetic bacterium, Rhodobacter sphaeroides ATCC 17023. The protein was expressed homologously at a high yield (similar to 20 mg/L culture) under anaerobic photoheterotrophic growth conditions. Stopped-flow light scattering experiments demonstrated its high water permeability (0.17 +/- 0.05 cm/s) and low energy of activation for water transport (2.93 +/- 0.60 kcal/mol) in reconstituted proteoliposomes at a protein to lipid ratio (w/w) of 0.04. We developed a fluorescence correlation spectroscopy based technique and utilized a fluorescent protein fusion of RsAqpZ, to estimate the single channel water permeability of RsAqpZ as 1.24 (+/- 0.41) x 10(-12) cm(3)/s or 4.17 (+/- 1.38) x 10(10) H2O molecules/s, which is among the highest single channel permeability reported for aquaporins. Towards application to water purification technologies, we also demonstrated functional incorporation of RsAqpZ in amphiphilic block copolymer membranes.	[Erbakan, Mustafa; Butler, Peter J.; Curtis, Wayne R.] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA; [Shen, Yue-xiao; Kumar, Manish; Curtis, Wayne R.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Grzelakowski, Mariusz] AquaZ Inc, Cincinnati, OH USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kumar, M (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	manish.kumar@psu.edu; wrc2@psu.edu	Kumar, Manish/ABD-7273-2021; Kumar, Manish/HCH-7832-2022	Kumar, Manish/0000-0001-5545-3793; Curtis, Wayne/0000-0001-6976-0890	Grace-Woodward Foundation	Grace-Woodward Foundation	Grace-Woodward Foundation provided support for development of Rhodobacter as a membrane protein expression platform, which set the basis for this work. ARPA-E's support helped development of genetic transformation methods for Rhodobacter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PG, 2012, BBA-BIOENERGETICS, V1817, P1616, DOI 10.1016/j.bbabio.2012.05.013; Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Bai HJ, 2008, BIORESOURCE TECHNOL, V99, P7716, DOI 10.1016/j.biortech.2008.01.071; Bernaudat F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029191; BEURON F, 1995, J BIOL CHEM, V270, P17414, DOI 10.1074/jbc.270.29.17414; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; CALAMITA G, 1995, J BIOL CHEM, V270, P29063, DOI 10.1074/jbc.270.49.29063; Calamita G, 1998, P NATL ACAD SCI USA, V95, P3627, DOI 10.1073/pnas.95.7.3627; Ding XD, 2013, BIOL CELL, V105, P118, DOI 10.1111/boc.201200057; DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X; DONOHUE TJ, 1991, METHOD ENZYMOL, V204, P459; Duong PHH, 2012, J MEMBRANE SCI, V409, P34, DOI 10.1016/j.memsci.2012.03.004; Eroglu I, 1998, BIOHYDROGEN, P143; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gullapalli RR, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2673245; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Hoomann T, 2013, P NATL ACAD SCI US; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Knyazev DG, 2013, J BIOL CHEM, V288, P17941, DOI 10.1074/jbc.M113.477893; Kozono D, 2003, J BIOL CHEM, V278, P10649, DOI 10.1074/jbc.M212418200; Kumar M, 2007, P NATL ACAD SCI USA, V104, P20719, DOI 10.1073/pnas.0708762104; Kumar M, 2012, J AM CHEM SOC, V134, P18631, DOI 10.1021/ja304721r; Laible PD, 2008, PURPLE PHOTOTROPHIC, P839; Laible Philip D., 2005, Journal of Structural and Functional Genomics, V6, P95, DOI 10.1007/s10969-005-1936-3; Laible Philip D., 2004, Journal of Structural and Functional Genomics, V5, P167, DOI 10.1023/B:JSFG.0000029201.33710.46; LASCELLES J, 1956, BIOCHEM J, V62, P78, DOI 10.1042/bj0620078; LATIMER P, 1972, BIOPHYS J, V12, P764, DOI 10.1016/S0006-3495(72)86120-4; LEE JK, 1989, J BACTERIOL, V171, P3391, DOI 10.1128/jb.171.6.3391-3405.1989; Maiti S, 1997, P NATL ACAD SCI USA, V94, P11753, DOI 10.1073/pnas.94.22.11753; MAUREL C, 1993, EMBO J, V12, P2241, DOI 10.1002/j.1460-2075.1993.tb05877.x; Nardin C, 2000, LANGMUIR, V16, P1035, DOI 10.1021/la990951u; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rigler P, 2006, J AM CHEM SOC, V128, P367, DOI 10.1021/ja056719u; Roy A, 2008, BIOL CHEM, V389, P69, DOI 10.1515/BC.2008.001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; Schilling M, 2005, FEBS J, V272, P6400, DOI 10.1111/j.1742-4658.2005.05037.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; TAGUCHI AKW, 1992, BIOCHEMISTRY-US, V31, P10345, DOI 10.1021/bi00157a024; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang CY, 2013, DESALINATION, V308, P34, DOI 10.1016/j.desal.2012.07.007; Tanghe A, 2006, TRENDS MICROBIOL, V14, P78, DOI 10.1016/j.tim.2005.12.001; Tanghe A, 2004, APPL ENVIRON MICROB, V70, P3377, DOI 10.1128/AEM.70.6.3377-3382.2004; WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002	54	23	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86830	10.1371/journal.pone.0086830	http://dx.doi.org/10.1371/journal.pone.0086830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497982	gold, Green Submitted, Green Published			2022-12-25	WOS:000330621900040
J	Gill, AC				Gill, Andrew C.			beta-Hairpin-Mediated Formation of Structurally Distinct Multimers of Neurotoxic Prion Peptides	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CALCIUM-CHANNEL ACTIVITY; APOPTOTIC CELL-DEATH; AMYLOID FIBRILS; MONTE-CARLO; CONFORMATIONAL POLYMORPHISM; COMPUTER-SIMULATION; H1 PEPTIDE; IN-SILICO; PROTEIN	Protein misfolding disorders are associated with conformational changes in specific proteins, leading to the formation of potentially neurotoxic amyloid fibrils. During pathogenesis of prion disease, the prion protein misfolds into beta-sheet rich, protease-resistant isoforms. A key, hydrophobic domain within the prion protein, comprising residues 109-122, recapitulates many properties of the full protein, such as helix-to-sheet structural transition, formation of fibrils and cytotoxicity of the misfolded isoform. Using all-atom, molecular simulations, it is demonstrated that the monomeric 109122 peptide has a preference for alpha-helical conformations, but that this peptide can also form beta-hairpin structures resulting from turns around specific glycine residues of the peptide. Altering a single amino acid within the 109-122 peptide (A(117)V, associated with familial prion disease) increases the prevalence of beta-hairpin formation and these observations are replicated in a longer peptide, comprising residues 106-126. Multi-molecule simulations of aggregation yield different assemblies of peptide molecules composed of conformationally-distinct monomer units. Small molecular assemblies, consistent with oligomers, comprise peptide monomers in a beta-hairpin-like conformation and in many simulations appear to exist only transiently. Conversely, larger assemblies are comprised of extended peptides in predominately antiparallel beta-sheets and are stable relative to the length of the simulations. These larger assemblies are consistent with amyloid fibrils, show cross-beta structure and can form through elongation of monomer units within pre-existing oligomers. In some simulations, assemblies containing both beta-hairpin and linear peptides are evident. Thus, in this work oligomers are on pathway to fibril formation and a preference for beta-hairpin structure should enhance oligomer formation whilst inhibiting maturation into fibrils. These simulations provide an important new atomic-level model for the formation of oligomers and fibrils of the prion protein and suggest that stabilization of beta-hairpin structure may enhance cellular toxicity by altering the balance between oligomeric and fibrillar protein assemblies.	[Gill, Andrew C.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Gill, Andrew C.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Gill, AC (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh, Midlothian, Scotland.	andrew.gill@roslin.ed.ac.uk	Gill, ANdrew/GRO-1248-2022; Gill, Andrew C/A-5219-2009	Gill, Andrew C/0000-0001-5201-9473	Biotechnology and Biological Sciences Research Council, UK [BB/J004332/1]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: researchfish; BBSRC [BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	ACG is supported, in part, by the Biotechnology and Biological Sciences Research Council, UK, through strategic program grants awarded to The Roslin Institute, particularly grant reference BB/J004332/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader R, 2006, J MOL BIOL, V356, P189, DOI 10.1016/j.jmb.2005.11.034; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Brown DR, 2000, BIOCHEM J, V346, P785, DOI 10.1042/0264-6021:3460785; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Cao ZX, 2011, J BIOMOL STRUCT DYN, V29, P527, DOI 10.1080/07391102.2011.10507403; Cao ZX, 2010, J BIOMOL STRUCT DYN, V27, P651, DOI 10.1080/07391102.2010.10508579; Cashman NR, 2009, ANN NEUROL, V66, pS64; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Chiesa R, 1996, EUR J NEUROSCI, V8, P589, DOI 10.1111/j.1460-9568.1996.tb01244.x; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CLARK A, 1995, DIABETES RES CLIN PR, V28, pS39, DOI 10.1016/0168-8227(95)01075-O; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cruz L, 2012, J PHYS CHEM B, V116, P6311, DOI 10.1021/jp301619v; Daidone I, 2005, J AM CHEM SOC, V127, P14825, DOI 10.1021/ja053383f; Daidone I, 2005, PROTEINS, V59, P510, DOI 10.1002/prot.20427; Daidone I, 2004, PROTEINS, V57, P198, DOI 10.1002/prot.20178; Daidone I, 2011, BIOPHYS J, V100, P3000, DOI 10.1016/j.bpj.2011.04.053; DEGIOIA L, 1994, J BIOL CHEM, V269, P7859; Di Natale G, 2005, ORG BIOMOL CHEM, V3, P490, DOI 10.1039/b407928k; Diaz-Espinoza R, 2012, NAT STRUCT MOL BIOL, V19, P370, DOI 10.1038/nsmb.2266; DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Fioriti L, 2005, MOL CELL NEUROSCI, V28, P165, DOI 10.1016/j.mcn.2004.09.006; Florio T, 1998, J NEUROSCI RES, V54, P341, DOI 10.1002/(SICI)1097-4547(19981101)54:3<341::AID-JNR5>3.0.CO;2-G; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Gill AC, 2011, CAB REV, V6; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Grabenauer M, 2010, J AM CHEM SOC, V132, P532, DOI 10.1021/ja905595k; Harbi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031785; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helmus JJ, 2011, J AM CHEM SOC, V133, P13934, DOI 10.1021/ja206469q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hope J, 1996, NEURODEGENERATION, V5, P1, DOI 10.1006/neur.1996.0001; Hosia W, 2004, BIOCHEMISTRY-US, V43, P4655, DOI 10.1021/bi036248t; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Huggins KNL, 2011, BIOCHEMISTRY-US, V50, P8202, DOI 10.1021/bi200760h; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Irback A, 2006, J COMPUT CHEM, V27, P1548, DOI 10.1002/jcc.20452; Irback A, 2010, ABSTR PAP AM CHEM S, V239; Irback Anders, 2009, PMC Biophys, V2, P2, DOI 10.1186/1757-5036-2-2; Irback A, 2008, PROTEINS, V71, P207, DOI 10.1002/prot.21682; Jang S, 2006, J PHYS CHEM B, V110, P1955, DOI 10.1021/jp055568e; Jobling MF, 1999, J NEUROCHEM, V73, P1557, DOI 10.1046/j.1471-4159.1999.0731557.x; Kim JS, 2010, SCIENCE, V330, P918, DOI 10.1126/science.1198314; Kim M, 2013, PRION, V7, P221, DOI 10.4161/pri.23807; Kittner M, 2010, J PHYS CHEM B, V114, P15288, DOI 10.1021/jp1065264; Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x; Kopito R, 2010, BIOCHEM CELL BIOL, V88, P413; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Larini L, 2012, BIOPHYS J, V103, P576, DOI 10.1016/j.bpj.2012.06.027; Lee SW, 2008, J MOL BIOL, V378, P1142, DOI 10.1016/j.jmb.2008.03.035; Li DW, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000238; Lu Y, 2011, J PHYS CHEM B, V115, P1282, DOI 10.1021/jp110269a; Malkov SN, 2009, PROTEIN J, V28, P74, DOI 10.1007/s10930-009-9166-3; Mitternacht S, 2011, J MOL BIOL, V410, P357, DOI 10.1016/j.jmb.2011.05.014; Mitternacht S, 2010, PROTEINS, V78, P2600, DOI 10.1002/prot.22775; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Orzi F, 2013, NEUROL SCI, V34, P1035, DOI 10.1007/s10072-012-1148-0; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Petty SA, 2004, J PEPT SCI, V10, P222; Petty SA, 2005, BIOPOLYMERS, V80, P498; Petty SA, 2005, P NATL ACAD SCI USA, V102, P14272, DOI 10.1073/pnas.0502804102; Petty SA, 2005, J AM CHEM SOC, V127, P13488, DOI 10.1021/ja054663y; Pevtsova CA, 2004, BIOPHYS J, V86, p506A; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; Polzi LZ, 2011, J AM CHEM SOC, V133, P11414, DOI 10.1021/ja2028662; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Ragg E, 1999, EUR J BIOCHEM, V266, P1192, DOI 10.1046/j.1432-1327.1999.00985.x; Rajadas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021776; Reddy AS, 2010, BIOPHYS J, V99, P2208, DOI 10.1016/j.bpj.2010.07.014; Rizzardini M, 1997, J NEUROCHEM, V68, P715; Roychaudhuri R, 2013, J MOL BIOL, V425, P292, DOI 10.1016/j.jmb.2012.11.006; Rymer DL, 2000, J NEUROCHEM, V75, P2536, DOI 10.1046/j.1471-4159.2000.0752536.x; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Santini S, 2004, J AM CHEM SOC, V126, P11509, DOI 10.1021/ja047286i; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Silva RAGD, 2003, J AM CHEM SOC, V125, P13674, DOI 10.1021/ja036725v; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Singh S, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4798460; Sivanesan S, 2013, CURR ALZHEIMER RES, V10, P316, DOI 10.2174/1567205011310030011; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Sydow A, 2010, NEURODEGENER DIS, V7, P28, DOI 10.1159/000283479; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; Tashiro S, 2006, J AM CHEM SOC, V128, P9280, DOI 10.1021/ja061722e; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Thellung S, 2000, NEUROBIOL DIS, V7, P299, DOI 10.1006/nbdi.2000.0301; Trevino SR, 2007, J MOL BIOL, V373, P211, DOI 10.1016/j.jmb.2007.07.061; van der Wel PCA, 2010, BIOCHEMISTRY-US, V49, P9457, DOI 10.1021/bi100077x; Villa A, 2006, J PHYS CHEM B, V110, P1423, DOI 10.1021/jp052722o; Wagoner VA, 2011, PROTEINS, V79, P2132, DOI 10.1002/prot.23034; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Wei GH, 2006, BIOPHYS J, V91, P1638, DOI 10.1529/biophysj.105.079186; WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Yamin G, 2009, BIOCHEMISTRY-US, V48, P11329, DOI 10.1021/bi901325g; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n	108	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87354	10.1371/journal.pone.0087354	http://dx.doi.org/10.1371/journal.pone.0087354			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498083	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000330621900097
J	Lopez-Martinez, G; Hahn, DA				Lopez-Martinez, Giancarlo; Hahn, Daniel A.			Early Life Hormetic Treatments Decrease Irradiation-Induced Oxidative Damage, Increase Longevity, and Enhance Sexual Performance during Old Age in the Caribbean Fruit Fly	PLOS ONE			English	Article							TREHALOSE PHOSPHATE SYNTHASE; MN SUPEROXIDE-DISMUTASE; DROSOPHILA-MELANOGASTER; ANTIOXIDANT DEFENSES; CALORIC RESTRICTION; STRESS THEORY; SPAN; HYPOXIA; OVEREXPRESSION; TEPHRITIDAE	Early life events can have dramatic consequences on performance later in life. Exposure to stressors at a young age affects development, the rate of aging, risk of disease, and overall lifespan. In spite of this, mild stress exposure early in life can have beneficial effects on performance later in life. These positive effects of mild stress are referred to as physiological conditioning hormesis. In our current study we used anoxia conditioning hormesis as a pretreatment to reduce oxidative stress and improve organismal performance, lifespan, and healthspan of Caribbean fruit flies. We used gamma irradiation to induce mild oxidative damage in a low-dose experiment, and massive oxidative damage in a separate high-dose experiment, in pharate adult fruit flies just prior to adult emergence. Irradiation-induced oxidative stress leads to reduced adult emergence, flight ability, mating performance, and lifespan. We used a hormetic approach, one hour of exposure to anoxia plus irradiation in anoxia, to lower post-irradiation oxidative damage. We have previously shown that this anoxic-conditioning treatment elevates total antioxidant capacity and lowers post-irradiation oxidative damage to lipids and proteins. In this study, conditioned flies had lower mortality rates and longer lifespan compared to those irradiated without hormetic conditioning. As a metric of healthspan, we tracked mating both at a young age (10 d) and old age (30 d). We found that anoxia-conditioned male flies were more competitive at young ages when compared to unconditioned irradiation stressed male flies, and that the positive effects of anoxic conditioning hormesis on mating success were even more pronounced in older males. Our data shows that physiological conditioning hormesis at a young age, not only improves immediate metrics of organismal performance (emergence, flight, mating), but the beneficial effects also carry into old age by reducing late life oxidative damage and improving lifespan and healthspan.	[Lopez-Martinez, Giancarlo; Hahn, Daniel A.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Lopez-Martinez, Giancarlo] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA	State University System of Florida; University of Florida; New Mexico State University	Lopez-Martinez, G (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	gclopez@nmsu.edu	Lopez-Martinez, Giancarlo/AAE-8134-2020	Lopez-Martinez, Giancarlo/0000-0002-7937-5002	United States Department of Agriculture [TSTARc-0905 1246, NIFA 2011-67012-30671]; United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA)); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by theUnited States Department of Agriculture -TSTARc-0905 1246 and the United States Department of Agriculture -NIFA 2011-67012-30671. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BELL WJ, 1975, BIOL REV, V50, P373, DOI 10.1111/j.1469-185X.1975.tb01058.x; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; BOLLER EF, 1968, J ECON ENTOMOL, V61, P850, DOI 10.1093/jee/61.3.850; Burditt A.K. Jr., 1975, P93; Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015; Calkins CO, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P269, DOI 10.1007/1-4020-4051-2_10; Carey JR, 2006, EXP GERONTOL, V41, P93, DOI 10.1016/j.exger.2005.09.014; Chapman T, 1998, P ROY SOC B-BIOL SCI, V265, P1879, DOI 10.1098/rspb.1998.0516; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; Chen QF, 2002, J BIOL CHEM, V277, P3274, DOI 10.1074/jbc.M109479200; Costantini D, 2012, J EXP BIOL, V215, P2820, DOI 10.1242/jeb.072231; Costantini D, 2010, ECOL LETT, V13, P1435, DOI 10.1111/j.1461-0248.2010.01531.x; Costantini D, 2010, FUNCT ECOL, V24, P950, DOI 10.1111/j.1365-2435.2010.01746.x; Cox RM, 2010, EVOLUTION, V64, P1321, DOI 10.1111/j.1558-5646.2009.00906.x; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Flatt T, 2011, EXP GERONTOL, V46, P369, DOI 10.1016/j.exger.2010.10.008; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; Hatle JD, 2008, EXP GERONTOL, V43, P900, DOI 10.1016/j.exger.2008.08.005; Hermes-Lima M, 1998, COMP BIOCHEM PHYS B, V120, P437, DOI 10.1016/S0305-0491(98)10053-6; Honda Y, 2010, AGING CELL, V9, P558, DOI 10.1111/j.1474-9726.2010.00582.x; Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100; Kajantie E, 2010, NEUROSCI BIOBEHAV R, V35, P23, DOI 10.1016/j.neubiorev.2009.11.013; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; Le Bourg E, 2011, EXP GERONTOL, V46, P345, DOI 10.1016/j.exger.2010.08.003; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Liu GW, 2006, PHYSIOL GENOMICS, V25, P134, DOI 10.1152/physiolgenomics.00262.2005; Lopez-Martinez G, 2008, INSECT BIOCHEM MOLEC, V38, P796, DOI 10.1016/j.ibmb.2008.05.006; Lopez-Martinez G, 2012, J EXP BIOL, V215, P2150, DOI 10.1242/jeb.065631; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Michaud MR, 2011, J INSECT PHYSIOL, V57, P203, DOI 10.1016/j.jinsphys.2010.11.007; Milton SL, 2007, J NEUROCHEM, V101, P993, DOI 10.1111/j.1471-4159.2007.04466.x; Montgomery MK, 2012, EXP GERONTOL, V47, P211, DOI 10.1016/j.exger.2011.11.014; Nestel D, 2007, FLA ENTOMOL, V90, P80, DOI 10.1653/0015-4040(2007)90[80:EOPCOM]2.0.CO;2; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Papadopoulos NT, 2002, P ROY SOC B-BIOL SCI, V269, P1633, DOI 10.1098/rspb.2002.2078; Perez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015; SERGHIOU CS, 1977, J ECON ENTOMOL, V70, P351, DOI 10.1093/jee/70.3.351; SHARP J L, 1975, Journal of the Georgia Entomological Society, V10, P241; Shim JK, 2009, J STORED PROD RES, V45, P75, DOI 10.1016/j.jspr.2008.09.005; SIVINSKI JM, 1993, FLA ENTOMOL, V76, P635, DOI 10.2307/3495798; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132; Sun JT, 2004, MECH AGEING DEV, V125, P341, DOI 10.1016/j.mad.2004.01.009; Tapia PC, 2006, MED HYPOTHESES, V66, P832, DOI 10.1016/j.mehy.2005.09.009; Tower J, 2011, EXP GERONTOL, V46, P355, DOI 10.1016/j.exger.2010.09.002; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Verweij M, 2011, LIVER TRANSPLANT, V17, P695, DOI 10.1002/lt.22243; Vreysen MJB, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P325, DOI 10.1007/1-4020-4051-2_12; Weindruch R, 2004, FREE RADICAL BIO MED, V37, pS7; WHITE LD, 1970, J ECON ENTOMOL, V63, P866, DOI 10.1093/jee/63.3.866; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221	61	31	31	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e88128	10.1371/journal.pone.0088128	http://dx.doi.org/10.1371/journal.pone.0088128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498251	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900215
J	Torres, AFC; Huang, C; Chong, CM; Leung, SW; Prieto-da-Silva, ARB; Havt, A; Quinet, YP; Martins, AMC; Lee, SMY; Radis-Baptista, G				Torres, Alba F. C.; Huang, Chen; Chong, Cheong-Meng; Leung, Siu Wai; Prieto-da-Silva, Alvaro R. B.; Havt, Alexandre; Quinet, Yves P.; Martins, Alice M. C.; Lee, Simon M. Y.; Radis-Baptista, Gandhi			Transcriptome Analysis in Venom Gland of the Predatory Giant Ant Dinoponera quadriceps: Insights into the Polypeptide Toxin Arsenal of Hymenopterans	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; SEXUAL ORIENTATION; CROSS-REACTIVITY; PHOSPHOLIPASE-D; PONERINE ANT; HUMAN BREAST; PROTEINS; DROSOPHILA; FRUITLESS; GENE	Background: Dinoponera quadriceps is a predatory giant ant that inhabits the Neotropical region and subdues its prey (insects) with stings that deliver a toxic cocktail of molecules. Human accidents occasionally occur and cause local pain and systemic symptoms. A comprehensive study of the D. quadriceps venom gland transcriptome is required to advance our knowledge about the toxin repertoire of the giant ant venom and to understand the physiopathological basis of Hymenoptera envenomation. Results: We conducted a transcriptome analysis of a cDNA library from the D. quadriceps venom gland with Sanger sequencing in combination with whole-transcriptome shotgun deep sequencing. From the cDNA library, a total of 420 independent clones were analyzed. Although the proportion of dinoponeratoxin isoform precursors was high, the first giant ant venom inhibitor cysteine-knot (ICK) toxin was found. The deep next generation sequencing yielded a total of 2,514,767 raw reads that were assembled into 18,546 contigs. A BLAST search of the assembled contigs against non-redundant and Swiss-Prot databases showed that 6,463 contigs corresponded to BLASTx hits and indicated an interesting diversity of transcripts related to venom gene expression. The majority of these venom-related sequences code for a major polypeptide core, which comprises venom allergens, lethal-like proteins and esterases, and a minor peptide framework composed of inter-specific structurally conserved cysteine-rich toxins. Both the cDNA library and deep sequencing yielded large proportions of contigs that showed no similarities with known sequences. Conclusions: To our knowledge, this is the first report of the venom gland transcriptome of the New World giant ant D. quadriceps. The glandular venom system was dissected, and the toxin arsenal was revealed; this process brought to light novel sequences that included an ICK-folded toxins, allergen proteins, esterases (phospholipases and carboxylesterases), and lethal-like toxins. These findings contribute to the understanding of the ecology, behavior and venomics of hymenopterans.	[Torres, Alba F. C.; Martins, Alice M. C.] Univ Fed Ceara, Fac Pharm, Dept Clin & Toxicol Anal, Fortaleza, Ceara, Brazil; [Huang, Chen; Chong, Cheong-Meng; Leung, Siu Wai; Lee, Simon M. Y.] Univ Macau, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Huang, Chen; Chong, Cheong-Meng; Leung, Siu Wai; Lee, Simon M. Y.] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China; [Prieto-da-Silva, Alvaro R. B.] Inst Butantan, Genet Lab, Sao Paulo, Brazil; [Havt, Alexandre] Univ Fed Ceara, Fac Med, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil; [Quinet, Yves P.] Univ Estadual Ceara, Entomol Lab, Fortaleza, Ceara, Brazil; [Radis-Baptista, Gandhi] Univ Fed Ceara, Inst Marine Sci, Lab Biochem & Biotechnol, Fortaleza, Ceara, Brazil	Universidade Federal do Ceara; University of Macau; University of Macau; Instituto Butantan; Universidade Federal do Ceara; Universidade Estadual do Ceara; Universidade Federal do Ceara	Martins, AMC (corresponding author), Univ Fed Ceara, Fac Pharm, Dept Clin & Toxicol Anal, Fortaleza, Ceara, Brazil.	martinsalice@gmail.com; gandhi.radis@ufc.br	Martins, Alice Maria Costa/AAX-3093-2020; Havt, Alexandre/AAM-8585-2020; RADIS-BAPTISTA, GANDHI/H-9574-2016; Prieto, Alvaro/G-8505-2017; Quinet, Yves P./H-9525-2012; RADIS-BAPTISTA, GANDHI/J-4991-2019	RADIS-BAPTISTA, GANDHI/0000-0001-9210-092X; Prieto, Alvaro/0000-0003-0289-9809; RADIS-BAPTISTA, GANDHI/0000-0001-9210-092X; Havt, Alexandre/0000-0002-4546-2976; Chen, Huang/0000-0003-1401-7279	National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology, Federal Government of Brazil [PRN-0040-00067.01.00/10, SPU 10582724-0]; Science and Technology Development Fund of Macau, China [045/2007, 078/2011/A3]; CNPq; Coordination for the Improvement of Higher Education Personnel (CAPES) Program on Toxinology, Ministry of Education of the Federal Government of Brazil	National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology, Federal Government of Brazil; Science and Technology Development Fund of Macau, China; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES) Program on Toxinology, Ministry of Education of the Federal Government of Brazil	The giant ant project was sponsored by the program for funding new research groups of The National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology, Federal Government of Brazil (program PRONEM/FUNCAP/CNPq, Ref. numbers PRN-0040-00067.01.00/10 and SPU 10582724-0). This study was partly supported by grants from the Science and Technology Development Fund of Macau, China (Ref. no. from 045/2007 to 078/2011/A3). GR-B and ARBPS are grateful to CNPq and the Coordination for the Improvement of Higher Education Personnel (CAPES) Program on Toxinology (Issued 2010), Ministry of Education of the Federal Government of Brazil for partial financial support for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2002, BBA-MOL CELL BIOL L, V1582, P26, DOI 10.1016/S1388-1981(02)00134-8; Asgari S, 2003, INSECT BIOCHEM MOLEC, V33, P1017, DOI 10.1016/S0965-1748(03)00116-4; Badr G, 2012, CELL IMMUNOL, V273, P10, DOI 10.1016/j.cellimm.2011.12.003; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; Blank S, 2008, IDENTIFICATION RECOM; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Boulogne I, 2012, PEST MANAG SCI, V68, P313, DOI 10.1002/ps.2267; Bouzid W, 2013, TOXICON, V70, P70, DOI 10.1016/j.toxicon.2013.03.010; Chaim OM, 2011, TOXINS, V3, P309, DOI 10.3390/toxins3030309; Cherniack EP, 2010, ALTERN MED REV, V15, P124; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui F, 2011, INSECT BIOCHEM MOLEC, V41, P1, DOI 10.1016/j.ibmb.2010.09.004; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Dkhil MA, 2010, AFR J PHARM PHARMACO, V4, P115; Pinto JRAD, 2012, J PROTEOME RES, V11, P4643, DOI 10.1021/pr300451g; DUVAL A, 1992, PFLUG ARCH EUR J PHY, V420, P239, DOI 10.1007/BF00374453; Ebaid H, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-93; Fitzgerald KT, 2006, CLIN TECH SMALL AN P, V21, P194, DOI 10.1053/j.ctsap.2006.10.002; Gelly JC, 2004, NUCLEIC ACIDS RES, V32, pD156, DOI 10.1093/nar/gkh015; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gibbs GM, 2006, J BIOL CHEM, V281, P4156, DOI 10.1074/jbc.M506849200; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gracy J, 2011, CURR PHARM DESIGN, V17, P4337, DOI 10.2174/138161211798999339; Gruber CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032559; Haddad Jr V, 2001, MANUAL DIAGNOSTICO T, P65; Haddad Junior V., 1996, Anais Brasileiros de Dermatologia, V71, P527; Haddad Junior Vidal, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P235, DOI 10.1590/S0036-46652005000400012; Hatfield MJ, 2011, EXPERT OPIN THER PAT, V21, P1159, DOI 10.1517/13543776.2011.586339; Heinrichs V, 1998, MOL CELL BIOL, V18, P450, DOI 10.1128/MCB.18.1.450; Hoffman DR, 2008, J ALLERGY CLIN IMMUN, V121, pS30, DOI 10.1016/j.jaci.2007.12.122; Hoffman DR, 2010, CURR OPIN ALLERGY CL, V10, P342, DOI 10.1097/ACI.0b013e328339f325; Hoffman DR, 2005, J ALLERGY CLIN IMMUN, V115, P611, DOI 10.1016/j.jaci.2004.11.020; HOFFMAN DR, 1988, J ALLERGY CLIN IMMUN, V82, P828, DOI 10.1016/0091-6749(88)90085-1; Holldobler B., 1990, pi; Huang WN, 2011, LANGMUIR, V27, P7034, DOI 10.1021/la200255r; Huang YB, 2010, PROTEIN CELL, V1, P143, DOI 10.1007/s13238-010-0004-3; Inagaki H, 2004, ARCH BIOCHEM BIOPHYS, V428, P170, DOI 10.1016/j.abb.2004.05.013; Inagaki H, 2008, ARCH BIOCHEM BIOPHYS, V477, P411, DOI 10.1016/j.abb.2008.05.014; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Johnson SR, 2010, TOXICON, V55, P702, DOI 10.1016/j.toxicon.2009.10.021; Karnaky KJ, 2003, J EXP ZOOL PART A, V300A, P91, DOI 10.1002/jez.a.10314; Kempf W. W., 1971, Studia Ent, V14, P369; King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Lattke J.E., 2003, P261; Lenhart PA, 2013, J HYMENOPT RES, V31, P119, DOI 10.3897/JHR.31.4335; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Lopes KS, 2013, NEUROCHEM INT, V63, P141, DOI 10.1016/j.neuint.2013.06.001; Lopes KS, 2011, RENC TOX M TOX SFET; Lopez LC, 1997, J CHEM ECOL, V23, P705, DOI 10.1023/B:JOEC.0000006405.26872.ef; Magalhaes GS, 2013, BIOCHIMIE, V95, P1773, DOI 10.1016/j.biochi.2013.06.002; Masek T, 2005, ANAL BIOCHEM, V336, P46, DOI 10.1016/j.ab.2004.09.010; Mathias MIC, 2007, BIOLOGICO, V69, P229; MATUSZEK MA, 1992, TOXICON, V30, P1081, DOI 10.1016/0041-0101(92)90053-8; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Menne KML, 2000, BIOINFORMATICS, V16, P741, DOI 10.1093/bioinformatics/16.8.741; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Monnin T, 1998, ANIM BEHAV, V55, P299, DOI 10.1006/anbe.1997.0601; Muller UR, 2002, ALLERGY, V57, P570, DOI 10.1034/j.1398-9995.2002.02157.x; Munoz-Torres MC, 2012, NUCLEIC ACIDS RES, V39, P658; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; O'Donnell MJ, 2009, J EXP BIOL, V212, P363, DOI 10.1242/jeb.023739; Orivel J, 2001, TOXICON, V39, P195, DOI 10.1016/S0041-0101(00)00113-6; Padavattan S, 2008, J MOL BIOL, V383, P178, DOI 10.1016/j.jmb.2008.08.023; Paiva RVS, 1995, ETHOL ECOL EVOL, V7, P297, DOI 10.1080/08927014.1995.9522938; Parkinson NM, 2004, INSECT BIOCHEM MOLEC, V34, P565, DOI 10.1016/j.ibmb.2004.03.003; Quinet Y, 2012, J VENOM ANIM TOXINS, V18, P441, DOI 10.1590/S1678-91992012000400013; Raidis-Baptista G, 2011, MOL CLONING SELECTED, P161; Richmond GS, 2011, INT J MOL SCI, V12, P588, DOI 10.3390/ijms12010588; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; SCHMIDT JO, 1978, SCIENCE, V200, P1064, DOI 10.1126/science.653354; SCHOETERS E, 1995, INT J INSECT MORPHOL, V24, P323, DOI 10.1016/0020-7322(94)00024-K; Seismann Henning, 2010, Clin Mol Allergy, V8, P7, DOI 10.1186/1476-7961-8-7; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Sin BA, 2011, ALLERGY, V66, P1513, DOI 10.1111/j.1398-9995.2011.02689.x; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Sousa PL, 2012, J ETHNOPHARMACOL, V144, P213, DOI 10.1016/j.jep.2012.08.033; Szolajska E, 2004, EUR J BIOCHEM, V271, P2127, DOI 10.1111/j.1432-1033.2004.04128.x; Torres A.F., 2013, INTEGRATED VIEW MOL, P207; Vasconcellos A., 2004, Braz. J. Biol., V64, P357, DOI 10.1590/S1519-69842004000200022; Vines CM, 2012, ADV EXP MED BIOL, V740, P235, DOI 10.1007/978-94-007-2888-2_10; Ward PS, 2006, CURR BIOL, V16, pR152, DOI 10.1016/j.cub.2006.02.054; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zalat Samy, 2003, Egyptian Journal of Biology, V5, P138; Zelezetsky I, 2005, ARCH BIOCHEM BIOPHYS, V434, P358, DOI 10.1016/j.abb.2004.11.006; Zhang ZT, 2012, DEV COMP IMMUNOL, V38, P262, DOI 10.1016/j.dci.2012.05.003; Zientz E, 2005, ARCH MICROBIOL, V184, P199, DOI 10.1007/s00203-005-0041-0; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	92	52	60	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87556	10.1371/journal.pone.0087556	http://dx.doi.org/10.1371/journal.pone.0087556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498135	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900132
J	Lyyra, P; Makela, H; Hietanen, JK; Astikainen, P				Lyyra, Pessi; Makela, Hanna; Hietanen, Jari K.; Astikainen, Piia			Implicit Binding of Facial Features During Change Blindness	PLOS ONE			English	Article							CONSCIOUS PERCEPTION; NEURAL MECHANISMS; INVISIBLE FACES; TIME-COURSE; ATTENTION; BRAIN; EXPRESSION; RESPONSES; AWARENESS; ERP	Change blindness refers to the inability to detect visual changes if introduced together with an eye-movement, blink, flash of light, or with distracting stimuli. Evidence of implicit detection of changed visual features during change blindness has been reported in a number of studies using both behavioral and neurophysiological measurements. However, it is not known whether implicit detection occurs only at the level of single features or whether complex organizations of features can be implicitly detected as well. We tested this in adult humans using intact and scrambled versions of schematic faces as stimuli in a change blindness paradigm while recording event-related potentials (ERPs). An enlargement of the face-sensitive N170 ERP component was observed at the right temporal electrode site to changes from scrambled to intact faces, even if the participants were not consciously able to report such changes (change blindness). Similarly, the disintegration of an intact face to scrambled features resulted in attenuated N170 responses during change blindness. Other ERP deflections were modulated by changes, but unlike the N170 component, they were indifferent to the direction of the change. The bidirectional modulation of the N170 component during change blindness suggests that implicit change detection can also occur at the level of complex features in the case of facial stimuli.	[Lyyra, Pessi; Makela, Hanna; Astikainen, Piia] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland; [Lyyra, Pessi; Hietanen, Jari K.] Univ Tampere, Sch Social Sci & Humanities, Human Informat Proc Lab, FIN-33101 Tampere, Finland	University of Jyvaskyla; Tampere University	Lyyra, P (corresponding author), Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland.	pessi.lyyra@jyu.fi	Astikainen, Piia/ABE-4699-2020	Astikainen, Piia/0000-0003-4842-7460; Lyyra, Pessi/0000-0001-6230-4024	Finnish National Doctoral Programme of Psychology	Finnish National Doctoral Programme of Psychology	Finnish National Doctoral Programme of Psychology http://www.dopsy.fi/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Blau VC, 2007, BEHAV BRAIN FUNCT, V3; Block N, 2011, TRENDS COGN SCI, V15, P567, DOI 10.1016/j.tics.2011.11.001; Bracco F, 2009, COGN PROCESS, V10, P41, DOI 10.1007/s10339-008-0246-7; Busch NA, 2010, J COGNITIVE NEUROSCI, V22, P1852, DOI 10.1162/jocn.2009.21294; Busch NA, 2010, NEUROREPORT, V21, P371, DOI 10.1097/WNR.0b013e3283378379; Cohen MA, 2012, TRENDS COGN SCI, V16, P411, DOI 10.1016/j.tics.2012.06.013; Czigler I, 2009, BIOL PSYCHOL, V80, P339, DOI 10.1016/j.biopsycho.2008.12.001; David E, 2006, PSYCHOL BELG, V46, P253, DOI 10.5334/pb-46-4-253; Eastwood JD, 2003, PERCEPT PSYCHOPHYS, V65, P352, DOI 10.3758/BF03194566; Eimer M, 2005, PSYCHOPHYSIOLOGY, V42, P328, DOI 10.1111/j.1469-8986.2005.00285.x; Eimer M, 2000, COGNITIVE NEUROPSYCH, V17, P103, DOI 10.1080/026432900380517; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Eimer M, 2003, COGN AFFECT BEHAV NE, V3, P97, DOI 10.3758/CABN.3.2.97; Eimer M, 2010, CEREB CORTEX, V20, P2442, DOI 10.1093/cercor/bhp312; Fernandez-Duque D, 2000, VIS COGN, V7, P323, DOI 10.1080/135062800394838; Fernandez-Duque D, 2003, J COGNITIVE NEUROSCI, V15, P491, DOI 10.1162/089892903321662895; Ganis G, 2008, NEUROIMAGE, V42, P1714, DOI 10.1016/j.neuroimage.2008.07.004; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Harris A, 2007, CEREB CORTEX, V17, P63, DOI 10.1093/cercor/bhj124; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hayhoe MM, 1998, VISION RES, V38, P125, DOI 10.1016/S0042-6989(97)00116-8; Hollingworth AR, 2001, DISS ABSTR INT B, V61, P4439; Huettel SA, 2001, J COGNITIVE NEUROSCI, V13, P1006, DOI 10.1162/089892901753165908; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Jiang Y, 2009, NEUROIMAGE, V44, P1171, DOI 10.1016/j.neuroimage.2008.09.038; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Khittl B, 2009, J NEURAL TRANSM, V116, P67, DOI 10.1007/s00702-008-0125-5; Kikuchi Y, 2009, CHILD DEV, V80, P1421, DOI 10.1111/j.1467-8624.2009.01342.x; Kimura M, 2008, NEUROSCI LETT, V448, P236, DOI 10.1016/j.neulet.2008.10.064; Leppanen JM, 2007, BRAIN RES, V1166, P103, DOI 10.1016/j.brainres.2007.06.060; Li XY, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-7; Lyyra P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00048; Lyyra P, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-12; Marr D., 1982, VISION COMPUTATIONAL; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Niedeggen M, 2001, EUR J NEUROSCI, V14, P1719, DOI 10.1046/j.0953-816x.2001.01785.x; Pessoa L, 2004, CEREB CORTEX, V14, P511, DOI 10.1093/cercor/bhh013; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Schankin A, 2008, PSYCHOPHYSIOLOGY, V45, P742, DOI 10.1111/j.1469-8986.2008.00685.x; Schankin A, 2007, EXP BRAIN RES, V183, P95, DOI 10.1007/s00221-007-1023-z; Sheth BR, 2011, J AUTISM DEV DISORD, V41, P434, DOI 10.1007/s10803-010-1062-3; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; TANAKA JW, 1991, PERCEPT PSYCHOPHYS, V50, P367, DOI 10.3758/BF03212229; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; Thornton IM, 2000, SPATIAL VISION, V14, P21, DOI 10.1163/156856801741341; TREISMAN A, 1982, COGNITIVE PSYCHOL, V14, P107, DOI 10.1016/0010-0285(82)90006-8; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Treisman A. M., 2003, UNITY CONSCIOUSNESS, P95; Treisman AM, 1998, CURR OPIN NEUROBIOL, V8, P218, DOI 10.1016/S0959-4388(98)80143-8; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treisman A, 2006, VIS COGN, V14, P411, DOI 10.1080/13506280500195250; Turatto M, 2005, EXP BRAIN RES, V167, P595, DOI 10.1007/s00221-005-0056-4; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Watanabe K, 2003, COGNITION, V88, P243, DOI 10.1016/S0010-0277(03)00025-8; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154; Wolfe JM, 1997, VISION RES, V37, P25, DOI 10.1016/S0042-6989(96)00111-3; Wronka E, 2011, PSYCHOPHYSIOLOGY, V48, P1047, DOI 10.1111/j.1469-8986.2011.01180.x	67	10	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87682	10.1371/journal.pone.0087682	http://dx.doi.org/10.1371/journal.pone.0087682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302PJ	24498165	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100107
J	Cone, AC; Cavin, G; Ambrosi, C; Hakozaki, H; Wu-Zhang, AX; Kunkel, MT; Newton, AC; Sosinsky, GE				Cone, Angela C.; Cavin, Gabriel; Ambrosi, Cinzia; Hakozaki, Hiroyuki; Wu-Zhang, Alyssa X.; Kunkel, Maya T.; Newton, Alexandra C.; Sosinsky, Gina E.			Protein Kinase C delta- mediated Phosphorylation of Connexin43 Gap Junction Channels Causes Movement within Gap Junctions followed by Vesicle Internalization and Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Junctions; Connexin; Gap Junctions; Protein Kinase C (PKC); Protein Phosphorylation; Hemichannels; Intercellular Communication; Membrane Protein Degradation; Membrane Protein Trafficking	INTERCELLULAR COMMUNICATION; PLASMA-MEMBRANE; ZONULA OCCLUDENS-1; STRUCTURAL-CHANGES; ACTIVITY REPORTER; LIVING CELLS; LIFE-CYCLE; SERINE 368; ENDOCYTOSIS; TRAFFICKING	Background: Connexin43, a ubiquitous gap junction protein, is phosphorylated by protein kinase C on serine 368. Results: After PKC activation, phospho-Ser-368 Connexin43 channels segregated into the gap junction center and were subsequently internalized and degraded. Conclusion: PKC phosphorylation triggered internalization and degradation of Connexin43 channels without dephosphorylation. Significance: Differential phosphorylation events are used to sort and traffic Connexin43 channels within gap junctions and into the cytoplasm. Phosphorylation of gap junction proteins, connexins, plays a role in global signaling events involving kinases. Connexin43 (Cx43), a ubiquitous and important connexin, has several phosphorylation sites for specific kinases. We appended an imaging reporter tag for the activity of the isoform of protein kinase C (PKC) to the carboxyl terminus of Cx43. The FRET signal of this reporter is inversely related to the phosphorylation of serine 368 of Cx43. By activating PKC with the phorbol ester phorbol 12,13-dibutyrate (PDBu) or a natural stimulant, UTP, time lapse live cell imaging movies indicated phosphorylated Ser-368 Cx43 separated into discrete domains within gap junctions and was internalized in small vesicles, after which it was degraded by lysosomes and proteasomes. Mutation of Ser-368 to an Ala eliminated the response to PDBu and changes in phosphorylation of the reporter. A phosphatase inhibitor, calyculin A, does not change this pattern, indicating PKC phosphorylation causes degradation of Cx43 without dephosphorylation, which is in accordance with current hypotheses that cells control their intercellular communication by a fast and constant turnover of connexins, using phosphorylation as part of this mechanism.	[Cone, Angela C.; Cavin, Gabriel; Ambrosi, Cinzia; Hakozaki, Hiroyuki; Sosinsky, Gina E.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, San Diego, CA 92093 USA; [Wu-Zhang, Alyssa X.; Kunkel, Maya T.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92093 USA; [Wu-Zhang, Alyssa X.] Univ Calif San Diego, Biomed Sci Grad Program, San Diego, CA 92093 USA; [Sosinsky, Gina E.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Sosinsky, GE (corresponding author), BSB 1070,9500 Gilman Dr, La Jolla, CA 92093 USA.	gsosinsky@ucsd.edu			National Institutes of Health [GM072881, GM043154, P01 DK054441, GM103412]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072881, P41GM103412, R01GM065937, R37GM043154, R01GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072881 (to G. E. S.) and GM043154 and P01 DK054441 (to A. C. N.). Most of the work presented here was conducted at the National Center for Microscopy and Imaging Research at San Diego, supported by National Institutes of Health Grant GM103412 (to M. Ellisman).	Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Cochrane K, 2013, CELL COMMUN ADHES, V20, P53, DOI 10.3109/15419061.2013.784745; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Fagerholm AE, 2010, MAR DRUGS, V8, P122, DOI 10.3390/md80100122; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Gilleron J, 2011, INT J BIOCHEM CELL B, V43, P1208, DOI 10.1016/j.biocel.2011.04.014; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gumpert AM, 2008, FEBS LETT, V582, P2887, DOI 10.1016/j.febslet.2008.07.024; Hatanka K, 2004, JPN HEART J, V45, P1007, DOI 10.1536/jhj.45.1007; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Johnson RG, 2012, MOL BIOL CELL, V23, P71, DOI 10.1091/mbc.E11-02-0141; Kajimoto T, 2010, J BIOL CHEM, V285, P41896, DOI 10.1074/jbc.M110.184028; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; Lan Z, 2005, BIOCHEMISTRY-US, V44, P2385, DOI 10.1021/bi048306w; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Leithe E, 2003, CARCINOGENESIS, V24, P1239, DOI 10.1093/carcin/bgg066; Leithe E, 2012, BBA-BIOMEMBRANES, V1818, P1870, DOI 10.1016/j.bbamem.2011.09.029; Liang JY, 2008, CELL BIOL INT, V32, P1371, DOI 10.1016/j.cellbi.2008.08.007; Macia E, 2011, CIRC-ARRHYTHMIA ELEC, V4, P344, DOI 10.1161/CIRCEP.110.959312; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mohrmann K, 2002, J BIOL CHEM, V277, P32029, DOI 10.1074/jbc.M203064200; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nickel BM, 2008, BIOCHEM BIOPH RES CO, V374, P679, DOI 10.1016/j.bbrc.2008.07.108; Niger C, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-14; Palatinus JA, 2011, CHANNELS, V5, P236, DOI 10.4161/chan.5.3.15834; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Ren P, 1998, CARCINOGENESIS, V19, P169, DOI 10.1093/carcin/19.1.169; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Saez JC, 1997, J MOL CELL CARDIOL, V29, P2131, DOI 10.1006/jmcc.1997.0447; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sirnes S, 2009, BIOCHEM BIOPH RES CO, V382, P41, DOI 10.1016/j.bbrc.2009.02.141; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Su V, 2012, J MEMBRANE BIOL, V245, P389, DOI 10.1007/s00232-012-9461-3; Su V, 2012, ARCH BIOCHEM BIOPHYS, V524, P16, DOI 10.1016/j.abb.2011.12.027; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; Wu-Zhang AX, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412635	57	32	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8781	8798		10.1074/jbc.M113.533265	http://dx.doi.org/10.1074/jbc.M113.533265			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24500718	hybrid, Green Published			2022-12-25	WOS:000333472100005
J	Cavalheiro, GR; Matos-Rodrigues, GE; Gomes, AL; Rodrigues, PMG; Martins, RAP				Cavalheiro, Gabriel R.; Matos-Rodrigues, Gabriel E.; Gomes, Anielle L.; Rodrigues, Paulo M. G.; Martins, Rodrigo A. P.			c-myc Regulates Cell Proliferation during Lens Development	PLOS ONE			English	Article							MOUSE LENS; EMBRYONIC-DEVELOPMENT; TRANSGENIC MICE; DIFFERENTIATION; GROWTH; GENE; RECEPTOR; PROX1; EXPRESSION; EYE	Myc protooncogenes play important roles in the regulation of cell proliferation, growth, differentiation and survival during development. In various developing organs, c-myc has been shown to control the expression of cell cycle regulators and its misregulated expression is detected in many human tumors. Here, we show that c-myc gene (Myc) is highly expressed in developing mouse lens. Targeted deletion of c-myc gene from head surface ectoderm dramatically impaired ocular organogenesis, resulting in severe microphtalmia, defective anterior segment development, formation of a lens stalk and/or aphakia. In particular, lenses lacking c-myc presented thinner epithelial cell layer and growth impairment that was detectable soon after its inactivation. Defective development of c-myc-null lens was not caused by increased cell death of lens progenitor cells. Instead, c-myc loss reduced cell proliferation, what was associated with an ectopic expression of Prox1 and p27(Kip1) proteins within epithelial cells. Interestingly, a sharp decrease in the expression of the forkhead box transcription factor Foxe3 was also observed following c-myc inactivation. These data represent the first description of the physiological roles played by a Myc family member in mouse lens development. Our findings support the conclusion that c-myc regulates the proliferation of lens epithelial cells in vivo and may, directly or indirectly, modulate the expression of classical cell cycle regulators in developing mouse lens.	[Cavalheiro, Gabriel R.; Matos-Rodrigues, Gabriel E.; Gomes, Anielle L.; Rodrigues, Paulo M. G.; Martins, Rodrigo A. P.] Univ Fed Rio de Janeiro, Programa Biol Celular & Desenvolvimento, Inst Ciencias Biomed, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Martins, RAP (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Celular & Desenvolvimento, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	rodrigo.martins@icb.ufrj.br	Martins, Rodrigo/W-7604-2019; Martins, Rodrigo A. P./A-4701-2010	Martins, Rodrigo/0000-0002-8420-6991; Martins, Rodrigo A. P./0000-0002-8420-6991; de Matos Rodrigues, Gabriel Eduardo/0000-0003-4085-7810; Rodrigues Cavalheiro, Gabriel/0000-0002-8534-5555	International Brain Research Organization (IBRO); International Retinal Research Foundation (IRRF); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); PIBIC program (CNPq/UFRJ); FAPERJ	International Brain Research Organization (IBRO); International Retinal Research Foundation (IRRF); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PIBIC program (CNPq/UFRJ); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	International Brain Research Organization (IBRO); International Retinal Research Foundation (IRRF); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). GRC, ALG and PMRG received undergrad student fellowships from the PIBIC program (CNPq/UFRJ) or from FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Beebe D, 2004, INT J DEV BIOL, V48, P845, DOI 10.1387/ijdb.041869db; Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Belecky-Adams TL, 2002, DEVELOPMENT, V129, P3795; Blixt A, 2000, GENE DEV, V14, P245; Cain S, 2008, DEV BIOL, V321, P420, DOI 10.1016/j.ydbio.2008.07.002; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Dickmeis T, 2002, MECH DEVELOP, V113, P99, DOI 10.1016/S0925-4773(02)00006-0; Dudas J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-92; Duncan MK, 2002, MECH DEVELOP, V112, P195, DOI 10.1016/S0925-4773(01)00645-1; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Faber SC, 2001, DEVELOPMENT, V128, P4425; Foskolou IP, 2013, ONCOGENE, V32, P947, DOI 10.1038/onc.2012.129; Gallant P, 2009, CELL CYCLE, V8, P3848, DOI 10.4161/cc.8.23.10088; Garcia CM, 2005, DEV DYNAM, V233, P516, DOI 10.1002/dvdy.20356; Gartel AL, 2003, EXP CELL RES, V283, P17, DOI 10.1016/S0014-4827(02)00020-4; Griep AE, 2006, SEMIN CELL DEV BIOL, V17, P686, DOI 10.1016/j.semcdb.2006.10.004; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; HOURDRY J, 1988, DEVELOPMENT, V104, P631; Ishibashi K, 1999, JPN J OPHTHALMOL, V43, P201, DOI 10.1016/S0021-5155(99)00014-3; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Kim JI, 1999, P NATL ACAD SCI USA, V96, P3781, DOI 10.1073/pnas.96.7.3781; Kuracha MR, 2011, INVEST OPHTH VIS SCI, V52, P6887, DOI 10.1167/iovs.11-7531; Kuzsac JR, 2004, DEV OCULAR LENS, P71; Liu SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017904; Lovicu FJ, 2011, PHILOS T R SOC B, V366, P1204, DOI 10.1098/rstb.2010.0339; Lovicu FJ, 2001, DEVELOPMENT, V128, P5075; Martins RAP, 2008, GENE DEV, V22, P179, DOI 10.1101/gad.1608008; Martins RAP, 2006, EUR J NEUROSCI, V24, P969, DOI 10.1111/j.1460-9568.2006.04966.x; Medina-Martinez O, 2005, MOL CELL BIOL, V25, P8854, DOI 10.1128/MCB.25.20.8854-8863.2005; Medina-Martinez O, 2009, DEV DYNAM, V238, P2193, DOI 10.1002/dvdy.21924; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; MORGENBESSER SD, 1995, EMBO J, V14, P743, DOI 10.1002/j.1460-2075.1995.tb07053.x; MORGENBESSER SD, 1994, NATURE, V371, P72, DOI 10.1038/371072a0; Ozeki H, 2001, EXP EYE RES, V72, P63, DOI 10.1006/exer.2000.0923; Rajagopal R, 2008, INVEST OPHTH VIS SCI, V49, P4953, DOI 10.1167/iovs.08-2217; Ring BZ, 2000, DEVELOPMENT, V127, P307; Robinson ML, 1995, DEVELOPMENT, V121, P3959; Rowan S, 2008, DEV BIOL, V321, P111, DOI 10.1016/j.ydbio.2008.06.002; Saravanamuthu SS, 2012, DEV BIOL, V362, P219, DOI 10.1016/j.ydbio.2011.11.011; Shimoda M, 2006, CLIN CANCER RES, V12, P6005, DOI 10.1158/1078-0432.CCR-06-0712; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Wang WL, 2010, MOL BIOL CELL, V21, P2453, DOI 10.1091/mbc.E09-12-1031; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Xie Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054507; Xie Q, 2011, J BIOL CHEM, V286, P43259, DOI 10.1074/jbc.M111.264580; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Young H, 2005, DEV BIOL, V284, P464; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Zhao HT, 2008, DEV BIOL, V318, P276, DOI 10.1016/j.ydbio.2008.03.028	55	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87182	10.1371/journal.pone.0087182	http://dx.doi.org/10.1371/journal.pone.0087182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503550	Green Published, Green Submitted, gold			2022-12-25	WOS:000330631800018
J	Langfeldt, D; Neulinger, SC; Heuer, W; Staufenbiel, I; Kunzel, S; Baines, JF; Eberhard, J; Schmitz, RA				Langfeldt, Daniela; Neulinger, Sven C.; Heuer, Wieland; Staufenbiel, Ingmar; Kuenzel, Sven; Baines, John F.; Eberhard, Joerg; Schmitz, Ruth A.			Composition of Microbial Oral Biofilms during Maturation in Young Healthy Adults	PLOS ONE			English	Article							STREPTOCOCCUS-SALIVARIUS; PORPHYROMONAS-GINGIVALIS; PERIODONTAL INFECTIONS; BACTERIAL DIVERSITY; DISEASE; IDENTIFICATION; VISUALIZATION; GINGIVITIS; KINEMAGE; PLAQUE	In the present study we aimed to analyze the bacterial community structure of oral biofilms at different maturation stages in young healthy adults. Oral biofilms established on membrane filters were collected from 32 human subjects after 5 different maturation intervals (1, 3, 5, 9 and 14 days) and the respective phylogenetic diversity was analyzed by 16S rDNA amplicon sequencing. Our analyses revealed highly diverse entire colonization profiles, spread into 8 phyla/candidate divisions and in 15 different bacterial classes. A large inter-individual difference in the subjects' microbiota was observed, comprising 35% of the total variance, but lacking conspicuous general temporal trends in both alpha and beta diversity. We further obtained strong evidence that subjects can be categorized into three clusters based on three differently occurring and mutually exclusive species clusters.	[Langfeldt, Daniela; Neulinger, Sven C.; Schmitz, Ruth A.] Univ Kiel, Inst Gen Microbiol, Kiel, Germany; [Heuer, Wieland; Eberhard, Joerg] Hannover Med Sch, Dept Prosthet Dent & Biomat Sci, Hannover, Germany; [Staufenbiel, Ingmar] Hannover Med Sch, Dept Conservat Dent Periodontol & Prevent Dent, Hannover, Germany; [Kuenzel, Sven; Baines, John F.] Max Planck Inst Evolutionary Biol, Plon, Germany; [Baines, John F.] Univ Kiel, Inst Expt Med, Kiel, Germany	University of Kiel; Hannover Medical School; Hannover Medical School; Max Planck Society; University of Kiel	Schmitz, RA (corresponding author), Univ Kiel, Inst Gen Microbiol, Kiel, Germany.	rschmitz@ifam.uni-kiel.de	Staufenbiel, Ingmar/K-7675-2018; Eberhard, Joerg/AAY-9034-2020; Baines, John F/B-3580-2010	Eberhard, Joerg/0000-0001-8060-2893; Baines, John F/0000-0002-8132-4909; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829	Deutsche Forschungsgemeinschaft (DFG) [SCHM 1032/10-1, EB223/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) through grant SCHM 1032/10-1 and grant EB223/5-1 (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Beck JD, 2005, J PERIODONTOL, V76, P2089, DOI 10.1902/jop.2005.76.11-S.2089; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Christopher AB, 2010, MICROBIOL-SGM, V156, P3469, DOI 10.1099/mic.0.042671-0; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Eberhard J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055265; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; HOLMBERG K, 1973, ARCH ORAL BIOL, V18, P423, DOI 10.1016/0003-9969(73)90167-2; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; Jakubovics NS, 2010, ORAL DIS, V16, P729, DOI 10.1111/j.1601-0825.2010.01701.x; Jakubovics NS, 2008, FEMS MICROBIOL ECOL, V66, P637, DOI 10.1111/j.1574-6941.2008.00585.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kaewsrichan J, 2004, LETT APPL MICROBIOL, V39, P451, DOI 10.1111/j.1472-765X.2004.01608.x; Kamaguchi A, 2001, MICROBIOL IMMUNOL, V45, P649, DOI 10.1111/j.1348-0421.2001.tb01298.x; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kremer BHA, 2000, J PERIODONTOL, V71, P209, DOI 10.1902/jop.2000.71.2.209; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Macuch PJ, 2000, J DENT RES, V79, P785, DOI 10.1177/00220345000790021301; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MOMBELLI A, 1990, J PERIODONTAL RES, V25, P331, DOI 10.1111/j.1600-0765.1990.tb00924.x; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Paju S, 2007, ORAL DIS, V13, P508, DOI 10.1111/j.1601-0825.2007.01410a.x; Parahitiyawa NB, 2010, ORAL DIS, V16, P136, DOI 10.1111/j.1601-0825.2009.01607.x; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Paster BJ, 2002, J CLIN MICROBIOL, V40, P2187, DOI 10.1128/JCM.40.6.2187-2191.2002; Pennisi E, 2005, SCIENCE, V307, P1899, DOI 10.1126/science.307.5717.1899; Periasamy S, 2009, J BACTERIOL, V191, P6804, DOI 10.1128/JB.01006-09; Periasamy S, 2009, INFECT IMMUN, V77, P3542, DOI 10.1128/IAI.00345-09; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Core Team, 2012, R LANG ENV STAT COMP; Rasiah IA, 2005, ARCH ORAL BIOL, V50, P779, DOI 10.1016/j.archoralbio.2005.02.001; RICHARDSON DC, 1992, PROTEIN SCI, V1, P3; Sarkar D, 2008, USE R, P1; Scannapleco FA, 1999, J PERIODONTAL RES, V34, P340, DOI 10.1111/j.1600-0765.1999.tb02263.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.22; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Seymour GJ, 2007, CLIN MICROBIOL INFEC, V13, P3, DOI 10.1111/j.1469-0691.2007.01798.x; Socransky SS, 2002, J CLIN PERIODONTOL, V29, P260, DOI 10.1034/j.1600-051x.2002.290313.x; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Stingu C-S, 2013, J INVESTIGATIVE CLIN, V4; Stingu CS, 2008, J MED MICROBIOL, V57, P495, DOI 10.1099/jmm.0.47649-0; Stingu CS, 2011, CLIN MICROBIOL INFEC, V17, pS508; Tanner A, 1998, J CLIN PERIODONTOL, V25, P85, DOI 10.1111/j.1600-051X.1998.tb02414.x; Theilade E, 1966, J PERIODONTAL RES, V1; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van der Ploeg JR, 2005, J BACTERIOL, V187, P3980, DOI 10.1128/JB.187.12.3980-3989.2005; Wang BY, 2009, J CLIN MICROBIOL, V47, P3902, DOI 10.1128/JCM.00072-09; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wescombe PA, 2009, FUTURE MICROBIOL, V4, P819, DOI 10.2217/FMB.09.61; Wilkerson M, 2011, CONSENSUSCLUSTERPLUS; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zuur Alain F., 2009, P1	70	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87449	10.1371/journal.pone.0087449	http://dx.doi.org/10.1371/journal.pone.0087449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503584	Green Submitted, gold, Green Published			2022-12-25	WOS:000330631800038
J	Bele, S; Jiang, W; Lu, H; You, H; Fan, H; Huang, LF; Wang, QG; Shen, HB; Wang, JM				Bele, Sumedh; Jiang, Wei; Lu, Hui; You, Hua; Fan, Hong; Huang, Lifang; Wang, Qungang; Shen, Hongbing; Wang, Jianming			Population Aging and Migrant Workers: Bottlenecks in Tuberculosis Control in Rural China	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; PULMONARY TUBERCULOSIS; STOPPING TUBERCULOSIS; CARE SEEKING; HEALTH; HOSPITALS; INDIA; COLLABORATION; EPIDEMIOLOGY; DETERMINANTS	Background: Tuberculosis is a serious global health problem. Its paradigms are shifting through time, especially in rapidly developing countries such as China. Health providers in China are at the forefront of the battle against tuberculosis; however, there are few empirical studies on health providers' perspectives on the challenges they face in tuberculosis control at the county level in China. This study was conducted among health providers to explore their experiences with tuberculosis control in order to identify bottlenecks and emerging challenges in controlling tuberculosis in rural China. Methods: A qualitative approach was used. Semi-structured, in-depth interviews were conducted with 17 health providers working in various positions within the health system of one rural county (ZJG) of China. Data were analyzed based on thematic content analysis using MAXQDA 10 qualitative data analysis software. Results: Health providers reported several problems in tuberculosis control in ZJG county. Migrant workers and the elderly were repeatedly documented as the main obstacles in effective tuberculosis control in the county. At a personal level, doctors showed their frustration with the lack of new drugs for treating tuberculosis patients, and their opinions varied regarding incentives for referring patients. Conclusion: The results suggest that several problems still remain for controlling tuberculosis in rural China. Tuberculosis control efforts need to make reaching the most vulnerable populations a priority and encourage local health providers to adopt innovative practices in the local context based on national guidelines to achieve the best results. Considerable changes in China's National Tuberculosis Control Program are needed to tackle these emerging challenges faced by health workers at the county level.	[Bele, Sumedh; Lu, Hui; You, Hua; Fan, Hong; Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Nanjing, Jiangsu, Peoples R China; [Bele, Sumedh; Shen, Hongbing; Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Jiang, Wei; Huang, Lifang; Wang, Qungang] Ctr Dis Control & Prevent Zhangjiagang, Dept TB, Suzhou, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Nanjing, Jiangsu, Peoples R China.	jmwang@njmu.edu.cn		Wang, Jianming/0000-0002-9151-284X	National Natural Science Foundation of China [81072351]; Jiangsu Science Supported Planning/Social Development Foundation [BE2011841]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Science Supported Planning/Social Development Foundation; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study is partly supported by the National Natural Science Foundation of China (81072351), Jiangsu Science Supported Planning/Social Development Foundation (BE2011841), and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abioye IA, 2011, AFR HEALTH SCI, V11, pS100; [Anonymous], 2011, GLOB TUB CONTR 2011; Aryal S, 2012, Kathmandu Univ Med J (KUMJ), V10, P48; Atun R, 2010, LANCET, V375, P2169, DOI 10.1016/S0140-6736(10)60493-X; Cantalice Filho João Paulo, 2007, J. bras. pneumol., V33, P691, DOI 10.1590/S1806-37132007000600013; Chatterji S, 2008, HEALTH AFFAIR, V27, P1052, DOI 10.1377/hlthaff.27.4.1052; Chen J, 2011, SOC SCI MED, V72, P1294, DOI 10.1016/j.socscimed.2011.02.016; Christodoulou M, 2011, LANCET INFECT DIS, V11, P663, DOI 10.1016/S1473-3099(11)70228-6; Das S K, 2007, J Indian Med Assoc, V105, P438; Das SK, 2007, J INDIAN MED ASSOC, V105, P436; Das SK, 2007, J INDIAN MED ASSOC, V105, P432; Duanmu Hongjin, 2002, Zhonghua Jiehe He Huxi Zazhi, V25, P3; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Falzon D, 2013, LANCET INFECT DIS, V13, P690, DOI 10.1016/S1473-3099(13)70130-0; Jassal MS, 2010, CLIN INFECT DIS, V50, pS156, DOI 10.1086/651486; Laokri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056752; Liu XY, 2007, TROP MED INT HEALTH, V12, P1464, DOI 10.1111/j.1365-3156.2007.01953.x; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; O'Brien RJ, 2001, AM J RESP CRIT CARE, V163, P1055, DOI 10.1164/ajrccm.163.5.2007122; Onozaki I, 2010, RESPIROLOGY, V15, P32, DOI 10.1111/j.1440-1843.2009.01673.x; Pan HQ, 2013, INT J TUBERC LUNG D, V17, P1575, DOI 10.5588/ijtld.13.0144; Patra S, 2013, T ROY SOC TROP MED H, V107, P763, DOI 10.1093/trstmh/trt094; Peabody JW, 2005, HEALTH POLICY PLANN, V20, P347, DOI 10.1093/heapol/czi041; Shao Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-110; Shen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051133; Small P, 2012, INDIAN J MED RES, V135, P685; Sonika Ujjwal, 2012, Trop Gastroenterol, V33, P102; Tam C. M., 2003, Hong Kong Medical Journal, V9, P83; Tao T, 2013, INT J HLTH PLANN MAN; Tobe RG, 2011, BIOSCI TRENDS, V5, P226, DOI 10.5582/bst.2011.v5.6.226; Toure NO, 2010, REV MAL RESPIR, V27, P1062, DOI 10.1016/j.rmr.2010.04.017; Toyota Makoto, 2010, Kekkaku, V85, P881; Uplekar M, 2008, INT J TUBERC LUNG D, V12, P986; Wang L, 2009, INT J TUBERC LUNG D, V13, P1486; Wang LX, 2010, B WORLD HEALTH ORGAN, V88, P937, DOI 10.2471/BLT.09.071753; Wei XL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-93; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2013, COUNTD 2015 GLOB TUB; *WHO, 1995, LEPROSY REV, V66, P270; World Health Organization, 2009, GLOB TUB CONTR EP ST; Xu B, 2004, HEALTH POLICY, V69, P139, DOI 10.1016/j.healthpol.2003.11.006; Xu WG, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-169; Zhang NJ, 2012, GERONTOLOGIST, V52, P589, DOI 10.1093/geront/gns105; Zhang TH, 2007, HEALTH POLICY, V81, P155, DOI 10.1016/j.healthpol.2005.12.009; Zhao P, 2012, J INT MED RES, V40, P436, DOI 10.1177/147323001204000205; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zhou CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052334	47	20	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88290	10.1371/journal.pone.0088290	http://dx.doi.org/10.1371/journal.pone.0088290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302TD	24498440	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900186
J	Dluhosova, M; Curik, N; Vargova, J; Jonasova, A; Zikmund, T; Stopka, T				Dluhosova, Martina; Curik, Nikola; Vargova, Jarmila; Jonasova, Anna; Zikmund, Tomas; Stopka, Tomas			Epigenetic Control of SPI1 Gene by CTCF and ISWI ATPase SMARCA5	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEX; TRANSCRIPTION-FACTOR; PU.1; DIFFERENTIATION; EXPRESSION; LEUKEMIA; METHYLATION; COHESIN; CELLS; INSULATOR	CCCTC-binding factor (CTCF) can both activate as well as inhibit transcription by forming chromatin loops between regulatory regions and promoters. In this regard, Ctcf binding on non-methylated DNA and its interaction with the Cohesin complex results in differential regulation of the H19/Igf2 locus. Similarly, a role for CTCF has been established in normal hematopoietic development; however its involvement in leukemia remains elusive. Here, we show that Ctcf binds to the imprinting control region of H19/Igf2 in AML blasts. We also demonstrate that Smarca5, which also associates with the Cohesin complex, facilitates Ctcf binding to its target sites on DNA. Furthermore, Smarca5 supports Ctcf functionally and is needed for enhancer-blocking effect at ICR. We next asked whether CTCF and SMARCA5 control the expression of key hematopoiesis regulators. In normally differentiating myeloid cells both CTCF and SMARCA5 together with members of the Cohesin complex are recruited to the SPI1 gene, a key hematopoiesis regulator and leukemia suppressor. Due to DNA methylation, CTCF binding to the SPI1 gene is blocked in AML blasts. Upon AZA-mediated DNA demethylation of human AML blasts, CTCF and SMARCA5 are recruited to the -14.4 Enhancer of SPI1 gene and block its expression. Our data provide new insight into complex SPI1 gene regulation now involving additional key epigenetic factors, CTCF and SMARCA5 that control PU. 1 expression at the -14.4 Enhancer.	[Dluhosova, Martina; Curik, Nikola; Vargova, Jarmila; Jonasova, Anna; Zikmund, Tomas; Stopka, Tomas] Charles Univ Prague, Fac Med 1, Dept Pathophysiol, Prague, Czech Republic; [Jonasova, Anna; Stopka, Tomas] Charles Univ Prague, Fac Med 1, Dept Med Hematol, Prague, Czech Republic	Charles University Prague; Charles University Prague	Stopka, T (corresponding author), Charles Univ Prague, Fac Med 1, Dept Pathophysiol, Prague, Czech Republic.	tstopka@lf1.cuni.cz	Stopka, Tomáš/D-5864-2017; Zikmund, Tomas/I-9159-2017; Curik, Nikola/J-6354-2017; Dluhošová, Martina/AAQ-7694-2021; Vargova, Jarmila/AAO-8636-2020; Anna, Jonasona/U-6166-2017	Stopka, Tomáš/0000-0001-7236-6894; Zikmund, Tomas/0000-0003-2452-3749; Curik, Nikola/0000-0002-5876-1326; Anna, Jonasona/0000-0003-0246-1524	GAUK [251070 45410]; GACR [P305/12/1033]; BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University [CZ.1.05/1.1.00/02.0109]; European Regional Development Fund;  [UNCE 204021];  [PRVOUK-P24/LF1/3];  [SVV-2013-264507]	GAUK; GACR(Grant Agency of the Czech Republic); BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University; European Regional Development Fund(European Commission); ; ; 	Primary grant support came from the following: GAUK 251070 45410 (MK) & GACR P305/12/1033 (TS). Institutional support came from the following: UNCE 204021, PRVOUK-P24/LF1/3, SVV-2013-264507, CZ.1.05/1.1.00/02.0109., BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (CZ.1.05/1.1.00/02.0109), from the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Burda P, 2010, LEUKEMIA, V24, P1249, DOI 10.1038/leu.2010.104; Burda P, 2009, MOL CANCER RES, V7, P1693, DOI 10.1158/1541-7786.MCR-09-0031; Curik N, 2012, LEUKEMIA, V26, P1804, DOI 10.1038/leu.2012.47; Davey C, 2003, J MOL BIOL, V325, P873, DOI 10.1016/S0022-2836(02)01340-2; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hu ZB, 2010, MOL CANCER THER, V9, P1536, DOI 10.1158/1535-7163.MCT-10-0191; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Loyola A, 2003, MOL CELL BIOL, V23, P6759, DOI 10.1128/MCB.23.19.6759-6768.2003; Loyola A, 2001, GENE DEV, V15, P2837; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Randhawa GS, 1998, BLOOD, V91, P3144, DOI 10.1182/blood.V91.9.3144.3144_3144_3147; Rao G, 1997, ONCOGENE, V14, P123, DOI 10.1038/sj.onc.1200807; Rosenbauer F, 2005, BLOOD, V106, P1519, DOI 10.1182/blood-2005-02-0717; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Stopka T, 2000, LEUKEMIA, V14, P1247, DOI 10.1038/sj.leu.2401807; Torrano V, 2005, J BIOL CHEM, V280, P28152, DOI 10.1074/jbc.M501481200; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634	31	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87448	10.1371/journal.pone.0087448	http://dx.doi.org/10.1371/journal.pone.0087448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498324	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900070
J	Kelly, G; Sade, N; Attia, Z; Secchi, F; Zwieniecki, M; Holbrook, NM; Levi, A; Alchanatis, V; Moshelion, M; Granot, D				Kelly, Gilor; Sade, Nir; Attia, Ziv; Secchi, Francesca; Zwieniecki, Maciej; Holbrook, N. Michele; Levi, Asher; Alchanatis, Victor; Moshelion, Menachem; Granot, David			Relationship between Hexokinase and the Aquaporin PIP1 in the Regulation of Photosynthesis and Plant Growth	PLOS ONE			English	Article							PLASMA-MEMBRANE AQUAPORINS; MESOPHYLL CONDUCTANCE; INTRINSIC PROTEINS; TRANSGENIC TOBACCO; YIELD PRODUCTION; WATER-TRANSPORT; CO2; LIGHT; NTAQP1; SUGAR	Increased expression of the aquaporin NtAQP1, which is known to function as a plasmalemma channel for CO2 and water, increases the rate of both photosynthesis and transpiration. In contrast, increased expression of Arabidopsis hexokinase1 (AtHXK1), a dual-function enzyme that mediates sugar sensing, decreases the expression of photosynthetic genes and the rate of transpiration and inhibits growth. Here, we show that AtHXK1 also decreases root and stem hydraulic conductivity and leaf mesophyll CO2 conductance (gm). Due to their opposite effects on plant development and physiology, we examined the relationship between NtAQP1 and AtHXK1 at the whole-plant level using transgenic tomato plants expressing both genes simultaneously. NtAQP1 significantly improved growth and increased the transpiration rates of AtHXK1-expressing plants. Reciprocal grafting experiments indicated that this complementation occurs when both genes are expressed simultaneously in the shoot. Yet, NtAQP1 had only a marginal effect on the hydraulic conductivity of the double-transgenic plants, suggesting that the complementary effect of NtAQP1 is unrelated to shoot water transport. Rather, NtAQP1 significantly increased leaf mesophyll CO2 conductance and enhanced the rate of photosynthesis, suggesting that NtAQP1 facilitated the growth of the double-transgenic plants by enhancing mesophyll conductance of CO2.	[Kelly, Gilor; Granot, David] Volcani Ctr, Inst Plant Sci, Bet Dagan, Israel; [Kelly, Gilor; Sade, Nir; Attia, Ziv; Moshelion, Menachem] Hebrew Univ Jerusalem, Inst Plant Sci & Genet Agr, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Secchi, Francesca; Zwieniecki, Maciej] Univ Calif Davis, Davis, CA 95616 USA; [Holbrook, N. Michele] Harvard Univ, Cambridge, MA 02138 USA; [Levi, Asher; Alchanatis, Victor] Volcani Ctr, Inst Agr Engn, Agr Res Org, Bet Dagan, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem; University of California System; University of California Davis; Harvard University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Granot, D (corresponding author), Volcani Ctr, Inst Plant Sci, Bet Dagan, Israel.	granot@agri.gov.il	Alchanatis, Victor/AAL-7245-2020	SECCHI, Francesca/0000-0002-3161-1643; Zwieniecki, Maciej/0000-0002-3774-4455	Israel Ministry of Agriculture [261-0865, 261-0845]; BARD, the United States-Israel Binational Agricultural and Development Fund [IS-4541-12]	Israel Ministry of Agriculture; BARD, the United States-Israel Binational Agricultural and Development Fund	This research was supported by the Israel Ministry of Agriculture, Chief Scientist Research Grants 261-0865 and 261-0845 (http://www.moag.gov.il/agri/yhidotmisrad/madanrashi/); and by grant no. IS-4541-12 from BARD, the United States-Israel Binational Agricultural and Development Fund (http://www.bardisus.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Barg R, 1997, J EXP BOT, V48, P1919, DOI 10.1093/jexbot/48.316.1919; Bernacchi CJ, 2002, PLANT PHYSIOL, V130, P1992, DOI 10.1104/pp.008250; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Dai N, 1999, PLANT CELL, V11, P1253, DOI 10.1105/tpc.11.7.1253; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; Eppel A, 2013, PLANT SCI, V201, P74, DOI 10.1016/j.plantsci.2012.12.002; Evans JR, 2009, J EXP BOT, V60, P2235, DOI 10.1093/jxb/erp117; Evans JR, 1996, PLANT PHYSIOL, V110, P339, DOI 10.1104/pp.110.2.339; EVANS JR, 1994, AUST J PLANT PHYSIOL, V21, P475, DOI 10.1071/PP9940475; Flexas J, 2007, NEW PHYTOL, V175, P501, DOI 10.1111/j.1469-8137.2007.02111.x; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Flexas J, 2006, PLANT J, V48, P427, DOI 10.1111/j.1365-313X.2006.02879.x; FRAY RG, 1994, PLANT MOL BIOL, V24, P539, DOI 10.1007/BF00024122; Gaspar M, 2003, PLANT SCI, V165, P21, DOI 10.1016/S0168-9452(03)00117-1; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; German MA, 2003, PLANT SCI, V164, P183, DOI 10.1016/S0168-9452(02)00381-3; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Heckwolf M, 2011, PLANT J, V67, P795, DOI 10.1111/j.1365-313X.2011.04634.x; Heinen RB, 2009, J EXP BOT, V60, P2971, DOI 10.1093/jxb/erp171; Hendrickson L, 2004, PHOTOSYNTH RES, V82, P73, DOI 10.1023/B:PRES.0000040446.87305.f4; JANG JC, 1994, PLANT CELL, V6, P1665, DOI 10.1105/tpc.6.11.1665; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Kaldenhoff R, 1998, PLANT J, V14, P121, DOI 10.1046/j.1365-313X.1998.00111.x; Kelly G, 2013, PLANT J, V75, P977, DOI 10.1111/tpj.12258; Kelly G, 2012, PLANT PHYSIOL, V159, P47, DOI 10.1104/pp.112.196105; KRALL JP, 1992, PHYSIOL PLANTARUM, V86, P180, DOI 10.1111/j.1399-3054.1992.tb01328.x; Marin-Olivier M, 2000, PLANT J, V24, P231, DOI 10.1046/j.1365-313x.2000.00874.x; Martre P, 2002, PLANT PHYSIOL, V130, P2101, DOI 10.1104/pp.009019; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Messinger SM, 2006, PLANT PHYSIOL, V140, P771, DOI 10.1104/pp.105.073676; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moshelion M, 2002, PLANT CELL, V14, P727, DOI 10.1105/tpc.010351; Mott KA, 2008, PLANT CELL ENVIRON, V31, P1299, DOI 10.1111/j.1365-3040.2008.01845.x; Postaire O, 2010, PLANT PHYSIOL, V152, P1418, DOI 10.1104/pp.109.145326; Sade N, 2009, NEW PHYTOL, V181, P651, DOI 10.1111/j.1469-8137.2008.02689.x; Sade N, 2014, PLANTA, V239, P357, DOI 10.1007/s00425-013-1988-8; Sade N, 2010, PLANT PHYSIOL, V152, P245, DOI 10.1104/pp.109.145854; Schreiber U., 1995, ECOL STUD, P49, DOI DOI 10.1007/978-3-642-79354-7_3; Schultz HR, 1996, SCI HORTIC-AMSTERDAM, V66, P93, DOI 10.1016/0304-4238(96)00876-X; Siefritz F, 2004, PLANT J, V37, P147, DOI 10.1046/j.1365-313X.2003.01947.x; Siefritz F, 2002, PLANT CELL, V14, P869, DOI 10.1105/tpc.000901; Suga S, 2004, PLANT CELL PHYSIOL, V45, P823, DOI 10.1093/pcp/pch120; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Uehlein N, 2012, PLANT CELL ENVIRON, V35, P1077, DOI 10.1111/j.1365-3040.2011.02473.x; VILLAR R, 1995, PLANT PHYSIOL, V107, P421, DOI 10.1104/pp.107.2.421; Xiao WY, 2000, PLANT MOL BIOL, V44, P451, DOI 10.1023/A:1026501430422	50	27	34	4	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87888	10.1371/journal.pone.0087888	http://dx.doi.org/10.1371/journal.pone.0087888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498392	gold, Green Published			2022-12-25	WOS:000330626900138
J	Lagler, H; Poeppl, W; Winkler, H; Herkner, H; Faas, A; Mooseder, G; Burgmann, H				Lagler, Heimo; Poeppl, Wolfgang; Winkler, Heidi; Herkner, Harald; Faas, Angelus; Mooseder, Gerhard; Burgmann, Heinz			Hepatitis E Virus Seroprevalence in Austrian Adults: A Nationwide Cross-Sectional Study among Civilians and Military Professionals	PLOS ONE			English	Article							NON-B HEPATITIS; BLOOD-DONORS; IGG SEROPREVALENCE; LARGE OUTBREAK; UNITED-STATES; NON-A; ANTIBODIES; TRANSMISSION; PREVALENCE; EPIDEMIC	Background: Hepatitis E Virus (HEV) infection is globally increasing. The present study was performed to investigate the HEV seroprevalence, exposure risks as well as occupational risks for military personnel in Austria, a Central European country. Methods and Findings: A nationwide cross-sectional seroprevalence study was performed in 997 healthy Austrian adults, professional soldiers and civilians. Routine laboratory and HEV specific antibodies were determined. In addition, epidemiological information on possible risk factors for exposure to HEV was obtained. The overall seropositivity for HEV antibodies was 14.3% and significantly increased with age. Seroprevalence was significantly higher among individuals with previous military employments abroad (21.4% vs. 9.9%) and among professional soldiers aged 30-39 years (20.2% vs. 7.3%). No association was found for private travel, occupational or private animal contact or regular outdoor activities. Individuals who tested positive for antibodies against HEV had significantly higher laboratory values regarding liver enzymes, lipid levels and blood fasting glucose. Conclusions: Exposure to HEV is common in Austria. Military employment abroad could be a potential risk factor for HEV infection. Further studies are required to investigate the significance of pathological laboratory results found among asymptomatic individuals previously exposed to HEV.	[Lagler, Heimo; Poeppl, Wolfgang; Winkler, Heidi; Burgmann, Heinz] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria; [Poeppl, Wolfgang; Mooseder, Gerhard] Mil Hosp Vienna, Dept Dermatol & Trop Med, Vienna, Austria; [Herkner, Harald] Med Univ Vienna, Dept Emergency Med, Vienna, Austria; [Faas, Angelus] Mil Hosp Vienna, Inst Med Support, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Burgmann, H (corresponding author), Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria.	heinz.burgmann@meduniwien.ac.at		Herkner, Harald/0000-0003-1329-6149; Burgmann, Heinz/0000-0002-2114-0999; Lagler, Heimo/0000-0003-3240-7385	Austrian Federal Ministry of Defence and Sports; Medical University of Vienna, Austria	Austrian Federal Ministry of Defence and Sports; Medical University of Vienna, Austria	The study was supported by the Austrian Federal Ministry of Defence and Sports and by the Medical University of Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Bryan JP, 2002, AM J TROP MED HYG, V67, P662, DOI 10.4269/ajtmh.2002.67.662; Christensen PB, 2008, CLIN INFECT DIS, V47, P1026, DOI 10.1086/591970; Clayson ET, 1998, J MED VIROL, V54, P178, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;178::AID-JMV6&gt;3.0.CO;2-2; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Dalton HR, 2008, EUR J GASTROEN HEPAT, V20, P784, DOI 10.1097/MEG.0b013e3282f5195a; Eick A, 2010, J INFECT DIS, V202, P1302, DOI 10.1086/656598; Faber MS, 2012, EMERG INFECT DIS, V18, P1654, DOI 10.3201/eid1810.111756; Guthmann JP, 2006, CLIN INFECT DIS, V42, P1685, DOI 10.1086/504321; HOFMANN H, 1995, WIEN KLIN WOCHENSCHR, V107, P336; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kasorndorkbua C, 2005, APPL ENVIRON MICROB, V71, P7831, DOI 10.1128/AEM.71.12.7831-7837.2005; Kaufmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021150; La Rosa G, 2010, APPL ENVIRON MICROB, V76, P5870, DOI 10.1128/AEM.00336-10; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; McCreary C, 2008, VET REC, V163, P261, DOI 10.1136/vr.163.9.261; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002; Myint KSA, 2007, MIL MED, V172, P1217, DOI 10.7205/MILMED.172.11.1217; Parashar D, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03652.x; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Said B, 2009, EMERG INFECT DIS, V15, P1738, DOI 10.3201/eid1511.091094; Schnegg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062980; Stefanidis I, 2004, INT J ARTIF ORGANS, V27, P842, DOI 10.1177/039139880402701005; Teo CG, 2012, EPIDEMIOL INFECT, V140, P767, DOI 10.1017/S0950268811002925; Teo CG, 2010, CLIN MICROBIOL INFEC, V16, P24, DOI 10.1111/j.1469-0691.2009.03111.x; Teshale EH, 2010, CLIN INFECT DIS, V50, P1006, DOI 10.1086/651077; Vernier M, 2013, INT J INFECT DIS, V17, pE1082, DOI 10.1016/j.ijid.2013.06.013; WONG DC, 1980, LANCET, V2, P876; Xu CY, 2013, TRANSFUSION, V53, P2505, DOI 10.1111/trf.12326; Zwettler D, 2012, BERL MUNCH TIERARZTL, V125, P281, DOI 10.2376/0005-9366-125-281	31	23	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87669	10.1371/journal.pone.0087669	http://dx.doi.org/10.1371/journal.pone.0087669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498349	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900095
J	Li, FY; Wu, SG; Zhou, J; Sun, JY; Lin, Q; Lin, HX; Guan, XX; He, ZY				Li, Feng-yan; Wu, San-gang; Zhou, Juan; Sun, Jia-yuan; Lin, Qin; Lin, Huan-xin; Guan, Xun-xing; He, Zhen-yu			Prognostic Value of Ki-67 in Breast Cancer Patients with Positive Axillary Lymph Nodes: A Retrospective Cohort Study	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; PRIMARY THERAPY; ST-GALLEN; PROLIFERATIVE ACTIVITY; SUBTYPES; MARKER; HIGHLIGHTS; EXPRESSION; KI67; METAANALYSIS	Introduction: Ki-67 expression is a biomarker for proliferation. Its prognostic value is recognized in breast cancer (BC) patients with negative axillary nodes, but is less clear in BC patients with positive axillary lymph nodes. Methods: We retrospectively reviewed the medical records of 1131 Chinese BC patients treated from January 2002 to June 2007 and 450 patients met the inclusion criteria: positive nodes, adjuvant therapy, and complete biomarker profile (estrogen receptor (ER), progesterone receptor (PR), HER2, p53, Ki-67). Univariate and multivariate regression analysis were used to correlate biomarkers and tumor characteristics with metastasis free survival (MFS) and overall survival (OS). Results: Median follow-up time was 46 months (range 5-76 months). The Ki-67 expression was associated significantly with histological grade, ER, PR, HER2, and P53 status (P < 0.05). Tumor stage, nodal stage, and ER status were independent prognostic factors for MFS. Ki-67 status was associated significantly with OS but not MFS. To determine whether the extent of LN involvement in the BC patients influenced the role of Ki-67 in survival rates, we compared these variables in patients with 1-3 positive lymph nodes (N1) to those of patients with >= 4 positive lymph nodes. Ki-67 status was an independent prognostic factor for MFS (Hazard Ratio, 3.27, P = 0.026) and overall survival (HR, 10.64, P = 0.007) in patients with 1-3 positive nodes (N1). Conclusions: The possibility that Ki-67 expression together with clinical factors can improve prediction of the prognosis of BC patients with 1 similar to 3 positive axillary lymph nodes warrants further studies.	[Li, Feng-yan; Sun, Jia-yuan; Lin, Huan-xin; Guan, Xun-xing; He, Zhen-yu] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr,Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Wu, San-gang; Lin, Qin] Xiamen Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xiamen Canc Ctr, Xiamen, Peoples R China; [Zhou, Juan] Xiamen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Xiamen Canc Ctr, Xiamen, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Xiamen University; Xiamen University	He, ZY (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr,Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China.	hezhy@sysucc.org.cn	Wu, San-Gang/AAA-8959-2022		Sci-Tech Office of Guangdong Province [2008B060600019]; Youth Foundation of the First Affiliated Hospital of Xiamen University [XYY2012005]; education scientific research project of young teachers in Fujian Province [JB13131]	Sci-Tech Office of Guangdong Province; Youth Foundation of the First Affiliated Hospital of Xiamen University; education scientific research project of young teachers in Fujian Province	This study was supported by a grant from the Sci-Tech Office of Guangdong Province (No. 2008B060600019), the Youth Foundation of the First Affiliated Hospital of Xiamen University (No. XYY2012005) and the education scientific research project of young teachers in Fujian Province (No. JB13131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Bhatavdekar JM, 2000, ANN SURG ONCOL, V7, P305, DOI 10.1007/s10434-000-0305-5; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Couture C, 2002, CANCER-AM CANCER SOC, V94, P713, DOI 10.1002/cncr.10232; Crabb SJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1847; Danko ME, 2010, J AM COLL SURGEONS, V210, P797, DOI 10.1016/j.jamcollsurg.2010.02.045; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; de Bono JS, 2003, BREAST CANCER RES, V5, P154, DOI 10.1186/bcr597; Dikicioglu E, 2005, INT J CLIN PRACT, V59, P1039, DOI 10.1111/j.1742-1241.2005.00546.x; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Jalava P, 2006, HISTOPATHOLOGY, V48, P674, DOI 10.1111/j.1365-2559.2006.02402.x; Joensuu K, 2013, BREAST CANCER-BASIC, V7, P23, DOI 10.4137/BCBCR.S10701; Kelleher M, 2003, INT J CLIN PRACT, V57, P195; Kruger K, 2013, Breast, V22, P282, DOI 10.1016/j.breast.2012.07.008; [李宝江 Li Baojiang], 2004, [癌症, Chinese  Journal  of  Cancer], V23, P1176; Luporsi E, 2012, BREAST CANCER RES TR, V132, P895, DOI 10.1007/s10549-011-1837-z; Matsubara N, 2013, BREAST CANCER RES TR, V137, P203, DOI 10.1007/s10549-012-2344-6; Matsubara N, 2011, ONCOLOGY-BASEL, V81, P345, DOI 10.1159/000334920; Mohammed ZMA, 2012, BRIT J CANCER, V106, P383, DOI 10.1038/bjc.2011.569; Neri A, 2008, EJSO-EUR J SURG ONC, V34, P1299, DOI 10.1016/j.ejso.2007.11.009; Nishimura R, 2010, EXP THER MED, V1, P747, DOI 10.3892/etm.2010.133; Park D, 2007, VIRCHOWS ARCH, V451, P11, DOI 10.1007/s00428-007-0435-2; Sayer HG, 2002, DRUGS, V62, P2025, DOI 10.2165/00003495-200262140-00003; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; SULLIVAN HC, 2013, APPL IMMUNOHISTOCHEM; Tawfik K, 2013, HUM PATHOL, V44, P39, DOI 10.1016/j.humpath.2012.05.007; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Wiesner FG, 2009, BREAST, V18, P135, DOI 10.1016/j.breast.2009.02.009; Wu SG, 2012, BREAST, V21, P657, DOI 10.1016/j.breast.2012.07.004; Xue C, 2012, CANCER SCI, V103, P1679, DOI 10.1111/j.1349-7006.2012.02339.x; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Yoshioka T, 2013, BREAST CANC	35	17	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87264	10.1371/journal.pone.0087264	http://dx.doi.org/10.1371/journal.pone.0087264			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498305	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900051
J	Lowe, MM; Mold, JE; Kanwar, B; Huang, Y; Louie, A; Pollastri, MP; Wang, CH; Patel, G; Franks, DG; Schlezinger, J; Sherr, DH; Silverstone, AE; Hahn, ME; McCune, JM				Lowe, Margaret M.; Mold, Jeff E.; Kanwar, Bittoo; Huang, Yong; Louie, Alexander; Pollastri, Michael P.; Wang, Cuihua; Patel, Gautam; Franks, Diana G.; Schlezinger, Jennifer; Sherr, David H.; Silverstone, Allen E.; Hahn, Mark E.; McCune, Joseph M.			Identification of Cinnabarinic Acid as a Novel Endogenous Aryl Hydrocarbon Receptor Ligand That Drives IL-22 Production	PLOS ONE			English	Article							BREAST-CANCER CELLS; REGULATORY T-CELLS; 3-HYDROXYANTHRANILIC ACID; TRYPTOPHAN CATABOLISM; AH RECEPTOR; DENDRITIC CELLS; INDOLEAMINE 2,3-DIOXYGENASE; EXPERIMENTAL ASTHMA; GENE-EXPRESSION; IN-VIVO	The aryl hydrocarbon receptor (AHR) binds to environmental toxicants including synthetic halogenated aromatic hydrocarbons and is involved in a diverse array of biological processes. Recently, the AHR was shown to control host immunity by affecting the balance between inflammatory T cells that produce IL-17 (Th17) and IL-22 versus regulatory T cells (Treg) involved in tolerance. While environmental AHR ligands can mediate this effect, endogenous ligands are likely to be more relevant in host immune responses. We investigated downstream metabolites of tryptophan as potential AHR ligands because (1) tryptophan metabolites have been implicated in regulating the balance between Th17 and Treg cells and (2) many of the AHR ligands identified thus far are derivatives of tryptophan. We characterized the ability of tryptophan metabolites to bind and activate the AHR and to increase IL-22 production in human T cells. We report that the tryptophan metabolite, cinnabarinic acid (CA), is an AHR ligand that stimulates the differentiation of human and mouse T cells producing IL-22. We compare the IL-22-stimulating activity of CA to that of other tryptophan metabolites and define stimulation conditions that lead to CA production from immune cells. Our findings link tryptophan metabolism to AHR activation and define a novel endogenous AHR agonist with potentially broad biological functions.	[Lowe, Margaret M.; Mold, Jeff E.; Kanwar, Bittoo; McCune, Joseph M.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Kanwar, Bittoo] Univ Calif San Francisco, Dept Pediat, Div Gastroenterol, San Francisco, CA USA; [Huang, Yong; Louie, Alexander] Univ Calif San Francisco, Drug Studies Unit, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Pollastri, Michael P.; Wang, Cuihua; Patel, Gautam] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA USA; [Franks, Diana G.; Hahn, Mark E.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Schlezinger, Jennifer; Sherr, David H.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Silverstone, Allen E.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northeastern University; Woods Hole Oceanographic Institution; Boston University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	McCune, JM (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	mike.mccune@ucsf.edu	pollastri, Michael/AAR-5790-2020; Hahn, Mark/AAV-7516-2020	pollastri, Michael/0000-0001-9943-7197; Hahn, Mark/0000-0003-4358-2082; Schlezinger, Jennifer/0000-0001-6834-4369; Mold, Jeffrey/0000-0003-2195-2978	National Institutes of Health (NIH) [OD000329, R01AI40312, R01ES006272, P42ES007381, R21CA134882, T32 GM007175]; Harvey V. Berneking Living Trust; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [DK083334]; NASPGHAN Foundation; Human Frontiers Science Program Long-Term Fellowship [LT000231/2011-L]; NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research [DPI OD00329]; NATIONAL CANCER INSTITUTE [R21CA134882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, R01AI040312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, T32DK007762, K24DK060617, K08DK083334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007381, R01ES006272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007175] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvey V. Berneking Living Trust; NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NASPGHAN Foundation; Human Frontiers Science Program Long-Term Fellowship; NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health (NIH) grants OD000329 and R01AI40312 (to JMM), R01ES006272 (to MEH), P42ES007381 (Superfund Research Program at Boston University to JS, DHS and MEH), R21CA134882 (to JS), NIH Training Grant T32 GM007175 (MML), and the Harvey V. Berneking Living Trust. BK is supported by Career Development Awards from the NIH/National Institute of Diabetes and Digestive and Kidney Diseases (DK083334) and the NASPGHAN Foundation. JEM is a recipient of the Human Frontiers Science Program Long-Term Fellowship (LT000231/2011-L). JMM is a recipient of the NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research, through grant DPI OD00329. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhautdin B, 2013, GUT, V62, P209, DOI 10.1136/gutjnl-2011-300694; Besteman E G, 2005, J Immunotoxicol, V2, P107, DOI 10.1080/15476910500182541; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bozza S, 2005, J IMMUNOL, V174, P2910, DOI 10.4049/jimmunol.174.5.2910; Chen I, 1998, CARCINOGENESIS, V19, P1631, DOI 10.1093/carcin/19.9.1631; CHRISTEN S, 1992, BIOCHEMISTRY-US, V31, P8090, DOI 10.1021/bi00149a045; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; DiNatale BC, 2010, TOXICOL SCI, V115, P89, DOI 10.1093/toxsci/kfq024; DOLWICK KM, 1993, MOL PHARMACOL, V44, P911; EGGERT C, 1995, FEBS LETT, V376, P202, DOI 10.1016/0014-5793(95)01274-9; Evans BR, 2005, ARCH BIOCHEM BIOPHYS, V441, P151, DOI 10.1016/j.abb.2005.07.008; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Favre D, 2010, SCI TRANSL MED, V19, P2, DOI DOI 10.1126/SCITRANSLMED.3000632); Fazio F, 2012, MOL PHARMACOL, V81, P643, DOI 10.1124/mol.111.074765; Hayashi T, 2004, J CLIN INVEST, V114, P270, DOI 10.1172/JCI200421275; Hayashi T, 2001, INFECT IMMUN, V69, P6156, DOI 10.1128/IAI.69.10.6156-6164.2001; Hayashi T, 2007, P NATL ACAD SCI USA, V104, P18619, DOI 10.1073/pnas.0709261104; Hestermann EV, 2000, TOXICOL SCI, V53, P316, DOI 10.1093/toxsci/53.2.316; Hing JP, 2001, J PHARMACOKINET PHAR, V28, P465, DOI 10.1023/A:1012247131190; Hiramatsu R, 2008, J CELL BIOCHEM, V103, P42, DOI 10.1002/jcb.21384; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Jin UH, 2012, J PHARMACOL EXP THER, V343, P333, DOI 10.1124/jpet.112.195339; JO N, 2009, CHEM-BIOL INTERACT, V181, P447, DOI DOI 10.1016/J.CBI.2009.07.003; Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Levine-Fridman A, 2004, MOL PHARMACOL, V65, P461, DOI 10.1124/mol.65.2.461; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; MANTHEY MK, 1990, BIOCHIM BIOPHYS ACTA, V1034, P207, DOI 10.1016/0304-4165(90)90078-B; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Murray IA, 2010, MOL PHARMACOL, V77, P247, DOI 10.1124/mol.109.061788; Nagy SR, 2002, TOXICOL SCI, V65, P200, DOI 10.1093/toxsci/65.2.200; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Patel RD, 2009, LAB INVEST, V89, P695, DOI 10.1038/labinvest.2009.24; Pulecio J, 2010, J EXP MED, V207, P2719, DOI 10.1084/jem.20100007; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Romani L, 2008, J IMMUNOL, V180, P5157, DOI 10.4049/jimmunol.180.8.5157; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Safe S, 2002, INT J ONCOL, V20, P1123; SAITO K, 1993, BIOCHEM J, V291, P11, DOI 10.1042/bj2910011; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; TODD WP, 1989, PREP BIOCHEM, V19, P155, DOI 10.1080/10826068908544905; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Wahlstrom N, 2004, EUR J ORG CHEM, V2004, P2593, DOI 10.1002/ejoc.200400087; Wahlstrom N, 2004, SYNTHESIS-STUTTGART, P1187, DOI 10.1055/s-2004-822347; Wincent E, 2012, P NATL ACAD SCI USA, V109, P4479, DOI 10.1073/pnas.1118467109; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhang S, 2012, MOL CANCER THER, V11, P108, DOI 10.1158/1535-7163.MCT-11-0548	58	81	86	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87877	10.1371/journal.pone.0087877	http://dx.doi.org/10.1371/journal.pone.0087877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498387	Green Published, gold			2022-12-25	WOS:000330626900133
J	Petta, S; Miele, L; Bugianesi, E; Camma, C; Rosso, C; Boccia, S; Cabibi, D; Di Marco, V; Grimaudo, S; Grieco, A; Pipitone, RM; Marchesini, G; Craxi, A				Petta, Salvatore; Miele, Luca; Bugianesi, Elisabetta; Camma, Calogero; Rosso, Chiara; Boccia, Stefania; Cabibi, Daniela; Di Marco, Vito; Grimaudo, Stefania; Grieco, Antonio; Pipitone, Rosaria Maria; Marchesini, Giulio; Craxi, Antonio			Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							INSULIN-RESISTANCE; HISTOLOGICAL SEVERITY; INCREASED RISK; HEPATITIS-C; PNPLA3; VARIANT; IL28B; STEATOHEPATITIS	Background and Aims: Variant in glucokinase regulatory protein (GCKR), associated with lipid and glucose traits, has been suggested to affect fatty liver infiltration. We aimed to assess whether GCKR rs780094 C -> T SNP influences the expression of steatosis, lobular inflammation and fibrosis in NAFLD patients, after correction for PNPLA3 genotype. Methods: In 366 consecutive NAFLD patients (197 from Sicily, and 169 from center/northern Italy), we assessed anthropometric, biochemical and metabolic features; liver biopsy was scored according to Kleiner. PNPLA3 rs738409 C>G and GCKR rs780094 C>T single nucleotide polymorphisms were also assessed. Results: At multivariate logistic regression analysis in the entire NAFLD cohort, the presence of significant liver fibrosis (>F1) was independently linked to high HOMA (OR 1.12, 95% CI 1.01-1.23, p = 0.02), NAFLD activity score >= 5 (OR 4.09, 95% CI 2.45-6.81, p<0.001), and GCKR C>T SNP (OR 2.06, 95% CI 1.43-2.98, p<0.001). Similar results were observed considering separately the two different NAFLD cohorts. GCKR C>T SNP was also associated with higher serum triglycerides (ANOVA, p = 0.02) in the entire cohort. Conclusions: In patients with NAFLD, GCKR rs780094 C>T is associated with the severity of liver fibrosis and with higher serum triglyceride levels.	[Petta, Salvatore; Camma, Calogero; Di Marco, Vito; Grimaudo, Stefania; Pipitone, Rosaria Maria; Craxi, Antonio] Univ Palermo, Dipartimento Biomed Med Interna & Specialist, Sez Gastroenterol, Palermo, Italy; [Miele, Luca; Boccia, Stefania; Grieco, Antonio] Univ Cattolica Sacro Cuore, Sch Med, Inst Internal Med, I-00168 Rome, Italy; [Bugianesi, Elisabetta; Rosso, Chiara] Univ Turin, Dept Med Sci, Div Gastroenterol, Turin, Italy; [Cabibi, Daniela] Univ Palermo, Cattedra Anat Patol, Palermo, Italy; [Marchesini, Giulio] Univ Bologna, Alma Mater Studiorum, Dipartimento Med & Gastroenterol, Bologna, Italy	University of Palermo; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Turin; University of Palermo; University of Bologna	Petta, S (corresponding author), Univ Palermo, Dipartimento Biomed Med Interna & Specialist, Sez Gastroenterol, Palermo, Italy.	petsa@inwind.it	Miele, Luca/C-2255-2015; Rosso, Chiara/AAY-4336-2021; Boccia, Stefania/AAB-9533-2022; cabibi, daniela/D-7438-2013; Di Marco, Vito/AAC-4612-2022; Boccia, Stefania/AFN-1666-2022; Craxi, Antonio/K-9529-2016	Miele, Luca/0000-0003-3464-0068; Rosso, Chiara/0000-0001-6518-7089; Boccia, Stefania/0000-0002-1864-749X; cabibi, daniela/0000-0001-6571-6577; Boccia, Stefania/0000-0002-1864-749X; Marchesini, Giulio/0000-0003-2407-9860; PIPITONE, Rosaria Maria/0000-0002-6721-3962; DI MARCO, VITO/0000-0001-6397-4206; Craxi, Antonio/0000-0002-4480-9544; CAMMA', CALOGERO/0000-0002-9224-1914; grieco, antonio/0000-0002-0544-8993; Grimaudo, Stefania/0000-0003-3225-4112; Petta, Salvatore/0000-0002-0822-9673	FP7 [Health-F2-2009-241762]; PRIN [2009ARYX4T_004, 2010C4JJWB_001]	FP7; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This study was funded by grants from the FP7/2007-2013 (noHealth-F2-2009-241762), from PRIN 2009 (Prot. N. 2009ARYX4T_004), and from PRIN 2010-2011 (Prot. N. 2010C4JJWB_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee QM, 2013, J HEPATOL, V58, pS46, DOI 10.1016/S0168-8278(13)60106-3; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Bechmann LP, 2012, HEPATOLOGY, V55, P1083, DOI 10.1002/hep.24793; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Bugianesi E, 2006, HEPATOLOGY, V44, P1648, DOI 10.1002/hep.21429; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Gavin JR, 2000, DIABETES CARE, V23, pS4; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hernaez R, 2013, CLIN GASTROENTEROL H, V11, P1183, DOI 10.1016/j.cgh.2013.02.011; Ikeda Y, 2001, ENDOCR J, V48, P81, DOI 10.1507/endocrj.48.81; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Palmer ND, 2013, HEPATOLOGY, V58, P966, DOI 10.1002/hep.26440; Peter A, 2011, J CLIN ENDOCR METAB, V96, pE1126, DOI 10.1210/jc.2010-2017; Petta S, 2010, CURR PHARM DESIGN, V16, P741, DOI 10.2174/138161210790883787; Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004; Petta S, 2012, ANTIVIR THER, V17, P823, DOI 10.3851/IMP2100; Petta S, 2012, J HEPATOL, V56, P1356, DOI 10.1016/j.jhep.2012.01.007; Petta S, 2011, DIGEST LIVER DIS, V43, P404, DOI 10.1016/j.dld.2010.12.013; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Santoro N, 2012, HEPATOLOGY, V55, P781, DOI 10.1002/hep.24806; *SAS I INC, 1992, SAS STAT SOFTW CHANG; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; TAN HL, 2013, J GASTROENTEROL, P943; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Tilg H, 2010, CURR OPIN CLIN NUTR, V13, P391, DOI 10.1097/MCO.0b013e32833a87cc; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350; Yang Z, 2011, MOL BIOL REP, V38, P1145, DOI 10.1007/s11033-010-0212-1	34	85	89	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87523	10.1371/journal.pone.0087523	http://dx.doi.org/10.1371/journal.pone.0087523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498332	Green Published, gold			2022-12-25	WOS:000330626900078
J	Schmiesing, J; Schluter, H; Ullrich, K; Braulke, T; Muhlhausen, C				Schmiesing, Jessica; Schlueter, Hartmut; Ullrich, Kurt; Braulke, Thomas; Muehlhausen, Chris			Interaction of Glutaric Aciduria Type 1-Related glutaryl-CoA Dehydrogenase with Mitochondrial Matrix Proteins	PLOS ONE			English	Article							COENZYME-A DEHYDROGENASE; ELECTRON-TRANSFER; OXIDATIVE STRESS; HUMAN-LIVER; DEFICIENCY; MUTATIONS; MECHANISM; CELLS; DECARBOXYLATION; FLAVOPROTEINS	Glutaric aciduria type 1 (GA1) is an inherited neurometabolic disorder caused by mutations in the GCDH gene encoding glutaryl-CoA dehydrogenase (GCDH), which forms homo- and heteromeric complexes in the mitochondrial matrix. GA1 patients are prone to the development of encephalopathic crises which lead to an irreversible disabling dystonic movement disorder. The clinical and biochemical manifestations of GA1 vary considerably and lack correlations to the genotype. Using an affinity chromatography approach we report here for the first time on the identification of mitochondrial proteins interacting directly with GCDH. Among others, dihydrolipoamide S-succinyltransferase (DLST) involved in the formation of glutaryl-CoA, and the beta-subunit of the electron transfer flavoprotein (ETFB) serving as electron acceptor, were identified as GCDH binding partners. We have adapted the yellow fluorescent protein-based fragment complementation assay and visualized the oligomerization of GCDH as well as its direct interaction with DLST and ETFB in mitochondria of living cells. These data suggest that GCDH is a constituent of multimeric mitochondrial dehydrogenase complexes, and the characterization of their interrelated functions may provide new insights into the regulation of lysine oxidation and the pathophysiology of GA1.	[Schmiesing, Jessica; Ullrich, Kurt; Braulke, Thomas; Muehlhausen, Chris] Childrens Hosp, Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Hamburg, Germany; [Schlueter, Hartmut] Univ Med Ctr Hamburg Eppendorf, Lab Mass Spectrometr Prote, Dept Clin Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Braulke, T (corresponding author), Childrens Hosp, Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Hamburg, Germany.	braulke@uke.de; muehlhausen@uke.de	Braulke, Thomas/AAV-9121-2020	Braulke, Thomas/0000-0002-2336-8532; Muhlhausen, Chris/0000-0003-0516-1826	Deutsche Forschungsgemeinschaft, DFG [MU1778/2-2, MU1778/3-1]	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (www.dfg.de), DFG grants MU1778/2-2 and MU1778/3-1 to JL and CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGA G, 1979, J CELL SCI, V35, P417; Bross P, 1999, MOL GENET METAB, V67, P138, DOI 10.1006/mgme.1999.2856; Busquets C, 2000, PEDIATR RES, V48, P315, DOI 10.1203/00006450-200009000-00009; Christensen E, 2004, J INHERIT METAB DIS, V27, P861, DOI 10.1023/B:BOLI.0000045770.93429.3c; CLINKENBEARD KD, 1975, J BIOL CHEM, V250, P3108; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Eriksson C J, 1977, Adv Exp Med Biol, V85A, P319; Frigerio F, 2012, J NEUROCHEM, V123, P342, DOI 10.1111/j.1471-4159.2012.07933.x; Fu ZJ, 2004, BIOCHEMISTRY-US, V43, P9674, DOI 10.1021/bi049290c; Gibson GE, 1999, ANN NY ACAD SCI, V893, P79, DOI 10.1111/j.1749-6632.1999.tb07819.x; GOODMAN SI, 1995, HUM MOL GENET, V4, P1493; Goodman SI, 1998, HUM MUTAT, V12, P141, DOI 10.1002/(SICI)1098-1004(1998)12:3<141::AID-HUMU1>3.0.CO;2-K; Goodman SI, 2001, METABOLIC MOL BASES, P2195; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0305s06, 10.1002/0471143030.cb0303s04, 10.1002/0471143030.cb0304s04]; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; Huh JY, 2012, ANTIOXID REDOX SIGN, V16, P229, DOI [10.1089/ars.2010.3766, 10.1089/ars.2011.3952]; Jafari P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053735; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Keyser B, 2008, HUM MOL GENET, V17, P3854, DOI 10.1093/hmg/ddn284; Khoriaty R, 2012, BLOOD, V120, P31, DOI 10.1182/blood-2012-01-292086; Lamp J, 2011, J BIOL CHEM, V286, P17777, DOI 10.1074/jbc.M111.232744; LENICH AC, 1986, J BIOL CHEM, V261, P4090; Makrypidi G, 2012, MOL CELL BIOL, V32, P774, DOI 10.1128/MCB.06195-11; Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7; MU H, 2004, J INHERIT METAB DIS, V27, P885; Muhlhausen C, 2003, J INHERIT METAB DIS, V27, P713; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; PRZYREMBEL H, 1976, CLIN CHIM ACTA, V66, P227, DOI 10.1016/0009-8981(76)90060-7; REED LJ, 1990, J BIOL CHEM, V265, P8971; ROBERTS DL, 1995, PROTEIN SCI, V4, P1654, DOI 10.1002/pro.5560040825; Sauer SW, 2005, J BIOL CHEM, V280, P21830, DOI 10.1074/jbc.M502845200; Sheu KFR, 1999, ANN NY ACAD SCI, V893, P61; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; THORPE C, 1995, FASEB J, V9, P718, DOI 10.1096/fasebj.9.9.7601336; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Westover JB, 2001, BIOCHEMISTRY-US, V40, P14106, DOI 10.1021/bi015637p; Zschocke J, 2000, J MED GENET, V37, P177, DOI 10.1136/jmg.37.3.177	39	12	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87715	10.1371/journal.pone.0087715	http://dx.doi.org/10.1371/journal.pone.0087715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498361	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900107
J	Tsutsumi, K; Saito, N; Kawazoe, Y; Ooi, HK; Shiba, T				Tsutsumi, Kaori; Saito, Nagahito; Kawazoe, Yumi; Ooi, Hong-Kean; Shiba, Toshikazu			Morphogenetic Study on the Maturation of Osteoblastic Cell as Induced by Inorganic Polyphosphate	PLOS ONE			English	Article							MINERALIZATION; INDUCTION; GROWTH; DIFFERENTIATION; CALCIFICATION; EXPRESSION; CALCIUM	Since inorganic polyphosphates [poly(P)] have an activity to induce bone differenciation in vitro and in vivo, we examined an effect of poly(P) on organelle by light microscopy and electron microscopy in Murine MC3T3-E1 osteoblastic cells. The MC3T3-E1 cells were ultrastructurally observed to possess morphological characteristics of osteoblasts. Cells cultured with poly(P) were strongly stained with an anti-collagen type I antibody but not in those cultured without poly(P). Ultrastructural analysis of cells cultured with poly(P) revealed a well-developed Golgi apparatus, swollen and elongated rough endoplasmic reticulum, large mitochondria and many coated pits. Since MC3T3-E1 cells can be transformed from a resting phase to an active blastic cell phase after supplementation with poly(P), it implies that poly(P) can be an effective material for bone regeneration.	[Tsutsumi, Kaori] Hokkaido Univ, Dept Biol Sci & Engn, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Saito, Nagahito] Hokkaido Univ, Dept Internal Med, Gastroenterol & Hematol Sect, Grad Sch Med,Kita ku, Sapporo, Hokkaido, Japan; [Kawazoe, Yumi; Shiba, Toshikazu] Regenetiss Inc, Kunitachi, Tokyo, Japan; [Ooi, Hong-Kean] Azabu Univ, Dept Vet Med, Chuo Ku, Sagamihara, Kanagawa, Japan; [Shiba, Toshikazu] Kitasato Univ, Lab Polyphosphate Res, Kitasato Inst, Kitasato Inst Life Sci,Minato Ku, Tokyo, Japan	Hokkaido University; Hokkaido University; Azabu University; Kitasato University	Tsutsumi, K (corresponding author), Hokkaido Univ, Dept Biol Sci & Engn, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan.	tsutsumi@hs.hokudai.ac.jp	Tsutsumi, Kaori/A-4039-2012		RegeneTiss Corporation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Faculty of Health Sciences, Hokkaido University, Japan	RegeneTiss Corporation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Faculty of Health Sciences, Hokkaido University, Japan	This study was supported in parts by grants from the RegeneTiss Corporation; a Grant-in-Aid for Innovations through Business-Academic-Public Sector Cooperation; a Grant-in-Aid for Scientific Research on Priority Areas (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a Grant-in-Aid for Scientific Research from the Faculty of Health Sciences, Hokkaido University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bessis M, 1972, LIVING BLOOD CELLS T; Cheema Faisal H, 2012, Recent Pat Cardiovasc Drug Discov, V7, P10; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Rodriguez FD, 2011, CURR STEM CELL RES T, V6, P73; Erdmann J, 1999, MECH AGEING DEV, V110, P73, DOI 10.1016/S0047-6374(99)00043-3; Griffin M, 2011, J BONE JOINT SURG BR, V93B, P427, DOI 10.1302/0301-620X.93B4.25249; Hernandez-Ruiz L, 2006, HAEMATOLOGICA, V91, P1180; Holmstrom KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2364; IBA K, 1995, CELL STRUCT FUNCT, V20, P319, DOI 10.1247/csf.20.319; Jimenez-Nunez MD, 2012, HAEMATOL-HEMATOL J, V97, P1264, DOI 10.3324/haematol.2011.051409; Kawano Michio M, 2006, Haematologica, V91, p1154A; Kawazoe Y, 2004, J DENT RES, V83, P613, DOI 10.1177/154405910408300806; Kawazoe Y, 2008, INT J BIOL SCI, V4, P37, DOI 10.7150/ijbs.4.37; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kwan MD, 2008, HUM MOL GENET, V17, pR93, DOI 10.1093/hmg/ddn071; Leyhausen G, 1998, J BONE MINER RES, V13, P803, DOI 10.1359/jbmr.1998.13.5.803; MATSUMOTO T, 1991, BONE, V12, P27, DOI 10.1016/8756-3282(91)90051-J; Meldolesi J, 2001, PROG NEUROBIOL, V65, P309, DOI 10.1016/S0301-0082(01)00004-1; Orriss IR, 2012, BONE, V51, P389, DOI 10.1016/j.bone.2012.06.013; Pivovarova NB, 2002, J NEUROSCI, V22, P10653; Sakurai Hidetoshi, 2011, Nihon Rinsho, V69, P2114; Schroder HC, 2000, BIOCHEMISTRY-MOSCOW+, V65, P296; Seong JM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/062001; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; Shiba T, 1997, P NATL ACAD SCI USA, V94, P11210, DOI 10.1073/pnas.94.21.11210; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Tsutsumi K, 2000, BBA-GENE STRUCT EXPR, V1493, P73, DOI 10.1016/S0167-4781(00)00165-2; Ueda M, 2001, ARTIF ORGANS, V25, P164, DOI 10.1046/j.1525-1594.2001.025003164.x	30	29	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86834	10.1371/journal.pone.0086834	http://dx.doi.org/10.1371/journal.pone.0086834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498284	Green Published, gold			2022-12-25	WOS:000330626900030
J	Fagerlund, A; Dubois, T; Okstad, OA; Verplaetse, E; Gilois, N; Bennaceur, I; Perchat, S; Gominet, M; Aymerich, S; Kolsto, AB; Lereclus, D; Gohar, M				Fagerlund, Annette; Dubois, Thomas; Okstad, Ole-Andreas; Verplaetse, Emilie; Gilois, Nathalie; Bennaceur, Imene; Perchat, Stephane; Gominet, Myriam; Aymerich, Stephane; Kolsto, Anne-Brit; Lereclus, Didier; Gohar, Michel			SinR Controls Enterotoxin Expression in Bacillus thuringiensis Biofilms	PLOS ONE			English	Article							HEMOLYSIN BL; MASTER REGULATOR; CEREUS GROUP; SUBTILIS; GENE; PLCR; SPORULATION; PROTEIN; IDENTIFICATION; TARGETS	The entomopathogen Bacillus thuringiensis produces dense biofilms under various conditions. Here, we report that the transition phase regulators Spo0A, AbrB and SinR control biofilm formation and swimming motility in B. thuringiensis, just as they control biofilm formation and swarming motility in the closely related saprophyte species B. subtilis. However, microarray analysis indicated that in B. thuringiensis, in contrast to B. subtilis, SinR does not control an eps operon involved in exopolysaccharides production, but regulates genes involved in the biosynthesis of the lipopeptide kurstakin. This lipopeptide is required for biofilm formation and was previously shown to be important for survival in the host cadaver (necrotrophism). Microarray analysis also revealed that the SinR regulon contains genes coding for the Hbl enterotoxin. Transcriptional fusion assays, Western blots and hemolysis assays confirmed that SinR controls Hbl expression, together with PlcR, the main virulence regulator in B. thuringiensis. We show that Hbl is expressed in a sustained way in a small subpopulation of the biofilm, whereas almost all the planktonic population transiently expresses Hbl. The gene coding for SinI, an antagonist of SinR, is expressed in the same biofilm subpopulation as hbl, suggesting that hbl transcription heterogeneity is SinI-dependent. B. thuringiensis and B. cereus are enteric bacteria which possibly form biofilms lining the host intestinal epithelium. Toxins produced in biofilms could therefore be delivered directly to the target tissue.	[Fagerlund, Annette; Okstad, Ole-Andreas; Kolsto, Anne-Brit] Univ Oslo, Sch Pharm, Lab Microbial Dynam LaMDa, Oslo, Norway; [Fagerlund, Annette; Okstad, Ole-Andreas; Kolsto, Anne-Brit] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Dubois, Thomas; Verplaetse, Emilie; Gilois, Nathalie; Bennaceur, Imene; Perchat, Stephane; Aymerich, Stephane; Lereclus, Didier; Gohar, Michel] INRA, UMR1319, Micalis, Jouy En Josas, France; [Dubois, Thomas; Verplaetse, Emilie; Gilois, Nathalie; Bennaceur, Imene; Perchat, Stephane; Aymerich, Stephane; Lereclus, Didier; Gohar, Michel] AgroParistech, UMR1319, Micalis, Jouy En Josas, France; [Gominet, Myriam] Inst Pasteur, CNRS, URA 2172, Unite Biol Bacteries Pathogenes Gram Positif, Paris, France	University of Oslo; University of Oslo; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gohar, M (corresponding author), INRA, UMR1319, Micalis, Jouy En Josas, France.	michel.gohar@jouy.inra.fr	Okstad, Ole Andreas/ABE-4202-2020; Lereclus, Didier/AAD-8293-2019	DUBOIS, Thomas/0000-0003-2712-5877; Fagerlund, Annette/0000-0001-7146-4265; Okstad, Ole Andreas/0000-0001-9351-8535; Lereclus, Didier/0000-0001-9047-9104; GOHAR, Michel/0000-0001-8341-3297; Verplaetse, Emilie/0000-0001-8200-140X	'Direction Generale a L'Armement', France; 'Region Ile de France', France; Norwegian Research Council [183421]	'Direction Generale a L'Armement', France; 'Region Ile de France', France(Region Ile-de-France); Norwegian Research Council(Research Council of NorwayEuropean Commission)	TD was funded by the 'Direction Generale a L'Armement', France and IB was funded by the 'Region Ile de France', France. AF, OAO and ABK were funded by a project grant from the Norwegian Research Council through the FUGE II Programme (Channel 3 grant; project nr. 183421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; AGAISSE H, 1994, MOL MICROBIOL, V13, P97, DOI 10.1111/j.1365-2958.1994.tb00405.x; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Auger S, 2006, APPL ENVIRON MICROB, V72, P937, DOI 10.1128/AEM.72.1.937-941.2006; BEECHER DJ, 1995, INFECT IMMUN, V63, P4423, DOI 10.1128/IAI.63.11.4423-4428.1995; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chai YR, 2009, MOL MICROBIOL, V74, P876, DOI 10.1111/j.1365-2958.2009.06900.x; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Chu F, 2008, MOL MICROBIOL, V68, P1117, DOI 10.1111/j.1365-2958.2008.06201.x; DALHAMMAR G, 1984, EUR J BIOCHEM, V139, P247, DOI 10.1111/j.1432-1033.1984.tb08000.x; Dietrich R, 1999, APPL ENVIRON MICROB, V65, P4470; Dubois T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002629; Frenzel E, 2012, MOL MICROBIOL, V85, P67, DOI 10.1111/j.1365-2958.2012.08090.x; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Gohar M, 2002, PROTEOMICS, V2, P784, DOI 10.1002/1615-9861(200206)2:6<784::AID-PROT784>3.0.CO;2-R; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Grandvalet C, 2001, MICROBIOL-SGM, V147, P1805, DOI 10.1099/00221287-147-7-1805; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Hamon MA, 2004, MOL MICROBIOL, V52, P847, DOI 10.1111/j.1365-2958.2004.04023.x; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Houry A, 2012, P NATL ACAD SCI USA, V109, P13088, DOI 10.1073/pnas.1200791109; Hsueh YH, 2008, ARCH MICROBIOL, V189, P557, DOI 10.1007/s00203-008-0348-8; Hsueh YH, 2006, APPL ENVIRON MICROB, V72, P5089, DOI 10.1128/AEM.00573-06; Irnov I, 2010, MOL MICROBIOL, V76, P559, DOI 10.1111/j.1365-2958.2010.07131.x; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kobayashi K, 2008, MOL MICROBIOL, V69, P1399, DOI 10.1111/j.1365-2958.2008.06369.x; Kobayashi K, 2007, J BACTERIOL, V189, P4920, DOI 10.1128/JB.00157-07; Kristoffersen SM, 2007, J BACTERIOL, V189, P5302, DOI 10.1128/JB.00239-07; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lereclus D, 1996, J BACTERIOL, V178, P2749, DOI 10.1128/jb.178.10.2749-2756.1996; LERECLUS D, 1992, BIO-TECHNOL, V10, P418, DOI 10.1038/nbt0492-418; Lindback T, 1999, MICROBIOL-SGM, V145, P3139, DOI 10.1099/00221287-145-11-3139; Lindback T, 2012, ENVIRON MICROBIOL, V14, P13; Mader U, 2004, J BACTERIOL, V186, P2240, DOI 10.1128/JB.186.8.2240-2252.2004; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Msadek T, 1999, TRENDS MICROBIOL, V7, P201, DOI 10.1016/S0966-842X(99)01479-1; Okstad OA, 1999, MICROBIOL-UK, V145, P3129, DOI 10.1099/00221287-145-11-3129; Perchat S, 2011, MOL MICROBIOL, V82, P619, DOI 10.1111/j.1365-2958.2011.07839.x; Pflughoeft KJ, 2011, J BACTERIOL, V193, P631, DOI 10.1128/JB.01083-10; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Priest Fergus G., 1993, P3; Ramarao N, 2005, CELL MICROBIOL, V7, P1357, DOI 10.1111/j.1462-5822.2005.00562.x; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Sanchis V, 1996, J BIOTECHNOL, V48, P81, DOI 10.1016/0168-1656(96)01404-6; Shafikhani SH, 2002, J BACTERIOL, V184, P564, DOI 10.1128/JB.184.2.564-571.2002; Sheppard AE, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00158-12; STRAUCH M, 1990, P NATL ACAD SCI USA, V87, P1801, DOI 10.1073/pnas.87.5.1801; Tourasse NJ, 2006, J APPL MICROBIOL, V101, P579, DOI 10.1111/j.1365-2672.2006.03087.x; van Schaik W, 2005, CURR OPIN BIOTECH, V16, P218, DOI 10.1016/j.copbio.2005.01.008	58	56	57	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87532	10.1371/journal.pone.0087532	http://dx.doi.org/10.1371/journal.pone.0087532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498128	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900129
J	Hall, SL; McCulley, RL; Barney, RJ; Phillips, TD				Hall, Sarah L.; McCulley, Rebecca L.; Barney, Robert J.; Phillips, Timothy D.			Does Fungal Endophyte Infection Improve Tall Fescue's Growth Response to Fire and Water Limitation?	PLOS ONE			English	Article							TALLGRASS PRAIRIE; LOLIUM-PERENNE; COENOPHIALUM; HERBICIDE; SYMBIOSIS; PASTURES; DROUGHT; RESTORATION; PERFORMANCE; TOLERANCE	Invasive species may owe some of their success in competing and co-existing with native species to microbial symbioses they are capable of forming. Tall fescue is a cool-season, non-native, invasive grass capable of co-existing with native warm-season grasses in North American grasslands that frequently experience fire, drought, and cold winters, conditions to which the native species should be better-adapted than tall fescue. We hypothesized that tall fescue's ability to form a symbiosis with Neotyphodium coenophialum, an aboveground fungal endophyte, may enhance its environmental stress tolerance and persistence in these environments. We used a greenhouse experiment to examine the effects of endophyte infection (E+ vs. E-), prescribed fire (1 burn vs. 2 burn vs. unburned control), and watering regime (dry vs. wet) on tall fescue growth. We assessed treatment effects for growth rates and the following response variables: total tiller length, number of tillers recruited during the experiment, number of reproductive tillers, tiller biomass, root biomass, and total biomass. Water regime significantly affected all response variables, with less growth and lower growth rates observed under the dry water regime compared to the wet. The burn treatments significantly affected total tiller length, number of reproductive tillers, total tiller biomass, and total biomass, but treatment differences were not consistent across parameters. Overall, fire seemed to enhance growth. Endophyte status significantly affected total tiller length and tiller biomass, but the effect was opposite what we predicted (E->E+). The results from our experiment indicated that tall fescue was relatively tolerant of fire, even when combined with dry conditions, and that the fungal endophyte symbiosis was not important in governing this ecological ability. The persistence of tall fescue in native grassland ecosystems may be linked to other endophyte-conferred abilities not measured here (e.g., herbivory release) or may not be related to this plant-microbial symbiosis.	[Hall, Sarah L.; McCulley, Rebecca L.; Phillips, Timothy D.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Hall, Sarah L.; Barney, Robert J.] Kentucky State Univ, Community Res Serv, Frankfort, KY USA	University of Kentucky; Kentucky State University	Hall, SL (corresponding author), Berea Coll, Dept Agr & Nat Resources, CPO 2161, Berea, KY 40404 USA.	sarah_hall@berea.edu			Forage-Animal Production Research Unit of USDA-ARS [58-6440-7-135]; University of Kentucky, Kentucky Agricultural Experiment Station [58-6440-7-135, KY006045]; DOE-NICCR [08-SC-NICCR-1073]; USDACSREES [KYX-10-05-39P]; University of Kentucky Graduate School	Forage-Animal Production Research Unit of USDA-ARS; University of Kentucky, Kentucky Agricultural Experiment Station; DOE-NICCR(United States Department of Energy (DOE)); USDACSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); University of Kentucky Graduate School	Funding for this project was provided by a Specific Cooperative Agreement (58-6440-7-135) between the Forage-Animal Production Research Unit of USDA-ARS and the University of Kentucky, Kentucky Agricultural Experiment Station Award KY006045, DOE-NICCR award #08-SC-NICCR-1073, USDACSREES Project KYX-10-05-39P, and a fellowship from the University of Kentucky Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1987, AM MIDL NAT, V117, P442, DOI 10.2307/2425988; Aiub MMV, 2001, WEED RES, V41, P265, DOI 10.1046/j.1365-3180.2001.00236.x; Ansley RJ, 2007, RANGELAND ECOL MANAG, V60, P154, DOI 10.2111/06-098R1.1; ARACHEVALETA M, 1989, AGRON J, V81, P83, DOI 10.2134/agronj1989.00021962008100010015x; Assuero SG, 2006, NEW ZEAL J AGR RES, V49, P359, DOI 10.1080/00288233.2006.9513726; Assuero SG, 2000, NEW ZEAL J AGR RES, V43, P49, DOI 10.1080/00288233.2000.9513408; BACON C W, 1988, Journal of Production Agriculture, V1, P45; BALL DM, 1993, AM SCI, V81, P370; Barnes TG, 2004, WEED TECHNOL, V18, P1364, DOI 10.1614/0890-037X(2004)018[1364:STCEGP]2.0.CO;2; Barnes TG, 2007, NAT AREA J, V27, P56, DOI 10.3375/0885-8608(2007)27[56:UHTRNG]2.0.CO;2; Bayat F, 2009, RUSS J PLANT PHYSL+, V56, P510, DOI 10.1134/S1021443709040104; Belesky DP, 2008, ENVIRON EXP BOT, V63, P368, DOI 10.1016/j.envexpbot.2007.12.013; BELESKY DP, 1995, CROP SCI, V35, P529, DOI 10.2135/cropsci1995.0011183X003500020041x; Belesky DP, 1996, ANN BOT-LONDON, V78, P499, DOI 10.1006/anbo.1996.0147; Brosi G. B., 2011, THESIS U KENTUCKY LE; Buck GW, 1997, NEOTYPHODIUM/GRASS INTERACTIONS, P141; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; CHEPLICK GP, 1989, NEW PHYTOL, V111, P89, DOI 10.1111/j.1469-8137.1989.tb04222.x; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; CLAY K, 1990, ECOLOGY, V71, P558, DOI 10.2307/1940309; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; Collins SL, 2006, ECOLOGY, V87, P2058, DOI 10.1890/0012-9658(2006)87[2058:SIOFAG]2.0.CO;2; Cuomo GJ, 1998, J RANGE MANAGE, V51, P32, DOI 10.2307/4003560; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; DiTomaso JM, 2006, WEED TECHNOL, V20, P535, DOI 10.1614/WT-05-086R1.1; Elbersen HW, 1996, GRASS FORAGE SCI, V51, P333, DOI 10.1111/j.1365-2494.1996.tb02068.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Friesen ML, 2011, ANNU REV ECOL EVOL S, V42, P23, DOI 10.1146/annurev-ecolsys-102710-145039; Gwinn KD, 1998, CROP SCI, V38, P201, DOI 10.2135/cropsci1998.0011183X003800010033x; Hall SL, 2012, RESTOR ECOL, V20, P194, DOI 10.1111/j.1526-100X.2010.00749.x; Hall SL, 2011, THESIS U KENTUCKY LE; Hannaway D, 1999, OREGON STATE U EXTEN, V504; Hesse U, 2003, GRASS FORAGE SCI, V58, P407, DOI 10.1111/j.1365-2494.2003.00393.x; HILL NS, 1990, CROP SCI, V30, P156, DOI 10.2135/cropsci1990.0011183X003000010034x; Hill NS, 1998, ANN BOT-LONDON, V81, P483, DOI 10.1006/anbo.1998.0583; Hopkins AA, 2006, AGRON J, V98, P1221, DOI 10.2134/agronj2006.0007; Inderjit, 2010, TRENDS ECOL EVOL, V25, P512, DOI 10.1016/j.tree.2010.06.006; KELRICK MI, 1990, P INT S ACR GRASS IN, P21; Lacefield GD, 1986, AGR119 U KENT AGR EX; Lacefield GD, 2003, AGR59 U KENT AGR EXP; Madison LA, 2001, WILDLIFE SOC B, V29, P706; Malinowski DP, 1997, NEOTYPHODIUM/GRASS INTERACTIONS, P183; Marks S, 1996, NEW PHYTOL, V133, P727, DOI 10.1111/j.1469-8137.1996.tb01941.x; McGranahan DA, 2013, ECOSYSTEMS, V16, P158, DOI 10.1007/s10021-012-9605-4; Moyes AB, 2005, RESTOR ECOL, V13, P659, DOI 10.1111/j.1526-100X.2005.00084.x; Newman JA, 2003, GLOBAL CHANGE BIOL, V9, P425, DOI 10.1046/j.1365-2486.2003.00601.x; Pecetti L, 2008, J AGRON CROP SCI, V194, P244, DOI 10.1111/j.1439-037X.2008.00302.x; Pyke DA, 2010, RESTOR ECOL, V18, P274, DOI 10.1111/j.1526-100X.2010.00658.x; Rahman MH, 2005, PLANT SOIL, V272, P163, DOI 10.1007/s11104-004-4682-6; Raunkiaer C, 1934, LIFE FORMS PLANTS ST; Rhoades C, 2002, RESTOR ECOL, V10, P656, DOI 10.1046/j.1526-100X.2002.01046.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Roberts CA, 2002, J AGR FOOD CHEM, V50, P5742, DOI 10.1021/jf020336n; Rudgers Jennifer A., 2007, Fungal Biology Reviews, V21, P107, DOI 10.1016/j.fbr.2007.05.002; Rudgers JA, 2010, J APPL ECOL, V47, P468, DOI 10.1111/j.1365-2664.2010.01788.x; Rudgers JA, 2009, ECOLOGY, V90, P1531, DOI 10.1890/08-0116.1; Ruffner CM, 2006, J FOREST, V104, P78; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; SHELBY RA, 1987, PLANT DIS, V71, P783, DOI 10.1094/PD-71-0783; SIEGEL MR, 1984, PHYTOPATHOLOGY, V74, P937, DOI 10.1094/Phyto-74-937; Siegrist JA, 2010, FUNCT ECOL, V24, P460, DOI 10.1111/j.1365-2435.2009.01649.x; Spyreas G, 2001, J TORREY BOT SOC, V128, P25, DOI 10.2307/3088657; Taft JB, 2003, J TORREY BOT SOC, V130, P170, DOI 10.2307/3557552; Timper P, 2005, NEMATOLOGY, V7, P105, DOI 10.1163/1568541054192216; Towne EG, 2008, RANGELAND ECOL MANAG, V61, P509, DOI 10.2111/08-043.1; Uchitel A, 2011, OECOLOGIA, V165, P465, DOI 10.1007/s00442-010-1740-z; Vila-Aiub MM, 2003, EVOL ECOL, V17, P441, DOI 10.1023/B:EVEC.0000005580.19018.fb; Volaire F, 2006, ANN BOT-LONDON, V98, P927, DOI 10.1093/aob/mcl195; Washburn BE, 2000, WILDLIFE SOC B, V28, P97; Young CA, 2013, J ANIM SCI, V91, P2379, DOI 10.2527/jas.2012-5951	70	15	16	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86904	10.1371/journal.pone.0086904	http://dx.doi.org/10.1371/journal.pone.0086904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497994	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900046
J	Lozoya, T; Dominguez, F; Romero-Ruiz, A; Steffani, L; Martinez, S; Monterde, M; Ferri, B; Nunez, MJ; AinhoaRomero-Espinos; Zamora, O; Gurrea, M; Sangiao-Alvarellos, S; Vega, O; Simon, C; Pellicer, A; Tena-Sempere, M				Lozoya, Teresa; Dominguez, Francisco; Romero-Ruiz, Antonio; Steffani, Liliana; Martinez, Sebastian; Monterde, Mercedes; Ferri, Blanca; Jose Nunez, Maria; AinhoaRomero-Espinos; Zamora, Omar; Gurrea, Marta; Sangiao-Alvarellos, Susana; Vega, Olivia; Simon, Carlos; Pellicer, Antonio; Tena-Sempere, Manuel			The Lin28/Let-7 System in Early Human Embryonic Tissue and Ectopic Pregnancy	PLOS ONE			English	Article							MICRORNAS; EXPRESSION; LIN28; LET-7; IDENTIFICATION; REGULATOR; LIN-28; EPIGENETICS; BIOMARKER; MIRNAS	Our objective was to determine the expression of the elements of the Lin28/Let-7 system, and related microRNAs (miRNAs), in early stages of human placentation and ectopic pregnancy, as a means to assess the potential role of this molecular hub in the pathogenesis of ectopic gestation. Seventeen patients suffering from tubal ectopic pregnancy (cases) and forty-three women with normal on-going gestation that desired voluntary termination of pregnancy (VTOP; controls) were recruited for the study. Embryonic tissues were subjected to RNA extraction and quantitative PCR analyses for LIN28B, Let-7a, miR-132, miR-145 and mir-323-3p were performed. Our results demonstrate that the expression of LIN28B mRNA was barely detectable in embryonic tissue from early stages of gestation and sharply increased thereafter to plateau between gestational weeks 7-9. In contrast, expression levels of Let-7, mir-132 and mir-145 were high in embryonic tissue from early gestations (<= 6-weeks) and abruptly declined thereafter, especially for Let-7. Opposite trends were detected for mir-323-3p. Embryonic expression of LIN28B mRNA was higher in early stages (<= 6-weeks) of ectopic pregnancy than in normal gestation. In contrast, Let-7a expression was significantly lower in early ectopic pregnancies, while miR-132 and miR-145 levels were not altered. Expression of mir-323-3p was also suppressed in ectopic embryonic tissue. We are the first to document reciprocal changes in the expression profiles of the gene encoding the RNA-binding protein, LIN28B, and the related miRNAs, Let-7a, mir-132 and mir-145, in early stages of human placentation. This finding suggests the potential involvement of LIN28B/Let-7 (de) regulated pathways in the pathophysiology of ectopic pregnancy in humans.	[Lozoya, Teresa; Monterde, Mercedes; Ferri, Blanca; Jose Nunez, Maria; AinhoaRomero-Espinos; Zamora, Omar; Gurrea, Marta; Vega, Olivia; Pellicer, Antonio] Hosp Univ La Fe, Valencia, Spain; [Dominguez, Francisco] INCLIVA Biomed Res Inst, Valencia, Spain; [Romero-Ruiz, Antonio; Steffani, Liliana; Sangiao-Alvarellos, Susana; Tena-Sempere, Manuel] Univ Cordoba, CIBER Obesidad & Nutr CIBERobn, Cordoba, Spain; [Romero-Ruiz, Antonio; Steffani, Liliana; Sangiao-Alvarellos, Susana; Tena-Sempere, Manuel] IMIBIC HURS, Cordoba, Spain; [Martinez, Sebastian; Simon, Carlos] Univ Valencia, FIVI, Valencia, Spain; [Martinez, Sebastian; Simon, Carlos] Univ Valencia, Inst Univ IVI INCLIVA, Valencia, Spain; [Simon, Carlos] Stanford Univ, Dept Obstet & Gynecol, Sch Med, Stanford, CA 94305 USA	Hospital Universitari i Politecnic La Fe; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidad de Cordoba; University of Valencia; University of Valencia; Stanford University	Dominguez, F (corresponding author), INCLIVA Biomed Res Inst, Valencia, Spain.	francisco.dominguez@ivi.es; fi1tesem@uco.es	IBIS, NEURONAL/O-9910-2015; Sangiao-Alvarellos, Susana/AAQ-5752-2020; MARTINEZ, ANTONIO PELLICER/C-4832-2015; Tena-Sempere, Manuel/AAX-3602-2021; Simon, Carlos/G-2186-2014; Sangiao-Alvarellos, Susana/J-1758-2016; Dominguez, Francisco/AAA-7260-2020; Romero-Ruiz, Antonio/K-3902-2014; Romero-Ruiz, Antonio/ABF-2083-2020; Pellicer, Antonio/AAA-6005-2020	Sangiao-Alvarellos, Susana/0000-0003-1207-4667; Tena-Sempere, Manuel/0000-0002-4741-5567; Simon, Carlos/0000-0003-0902-9531; Sangiao-Alvarellos, Susana/0000-0003-1207-4667; Dominguez, Francisco/0000-0002-7620-8081; Romero-Ruiz, Antonio/0000-0002-7651-9402; Pellicer, Antonio/0000-0002-8254-863X	Ministerio de Economia y Competitividad, Spain [BFU 2011-25021]; EDER Program from EU; Spanish Ministry of Economy and Competitiveness, through Miguel Servet Programme [CP13/00075];  [P08-CVI-03788]	Ministerio de Economia y Competitividad, Spain; EDER Program from EU; Spanish Ministry of Economy and Competitiveness, through Miguel Servet Programme; 	This work was funded by grant BFU 2011-25021 from Ministerio de Economia y Competitividad, Spain (co-funded by FEDER Program from EU) and Project P08-CVI-03788 (Junta de Andalucia, Spain) (to MTS). CIBER Fisiopatologia de la Obesidad y Nutricion is an initiative of Instituto de Salud Carlos III, Ministerio de Sanidad, Spain. The participation of FD in this work was supported by the Spanish Ministry of Economy and Competitiveness, through Miguel Servet Programme (CP13/00075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeckerle N, 2012, MOL HUM REPROD, V18, P477, DOI 10.1093/molehr/gas025; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Barnhart KT, 2009, NEW ENGL J MED, V361, P379, DOI 10.1056/NEJMcp0810384; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chan HW, 2013, PLACENTA, V34, P443, DOI 10.1016/j.placenta.2013.02.008; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Dart R, 2002, AM J EMERG MED, V20, P575, DOI 10.1053/ajem.2002.35460; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Farquhar CM, 2005, LANCET, V366, P583, DOI 10.1016/S0140-6736(05)67103-6; Gaytan F, 2013, ENDOCRINOLOGY, V154, P1321, DOI 10.1210/en.2012-1745; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Horne AW, 2010, ACTA OBSTET GYN SCAN, V89, P299, DOI 10.3109/00016340903568191; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Prieto DMM, 2011, J REPROD IMMUNOL, V88, P106, DOI 10.1016/j.jri.2011.01.004; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sangiao-Alvarellos S, 2013, ENDOCRINOLOGY, V154, P942, DOI 10.1210/en.2012-2006; Scholer N, 2010, EXP HEMATOL, V38, P1126, DOI 10.1016/j.exphem.2010.10.004; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wilkins-Haug L, 2009, CURR OPIN OBSTET GYN, V21, P201, DOI 10.1097/GCO.0b013e32832d7b95; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao Z, 2013, CLIN BIOCHEM, V46, P953, DOI 10.1016/j.clinbiochem.2013.01.026; Zhao Z, 2012, CLIN CHEM, V58, P896, DOI 10.1373/clinchem.2011.179283; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	31	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87698	10.1371/journal.pone.0087698	http://dx.doi.org/10.1371/journal.pone.0087698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498170	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900154
J	Omidi, K; Hooshyar, M; Jessulat, M; Samanfar, B; Sanders, M; Burnside, D; Pitre, S; Schoenrock, A; Xu, JH; Babu, M; Golshani, A				Omidi, Katayoun; Hooshyar, Mohsen; Jessulat, Matthew; Samanfar, Bahram; Sanders, Megan; Burnside, Daniel; Pitre, Sylvain; Schoenrock, Andrew; Xu, Jianhua; Babu, Mohan; Golshani, Ashkan			Phosphatase Complex Pph3/Psy2 Is Involved in Regulation of Efficient Non-Homologous End-Joining Pathway in the Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							STRAND BREAK REPAIR; PROTEIN-PROTEIN INTERACTIONS; GENETIC PROFILE ANALYSIS; INTERACTION NETWORKS; DNA-REPAIR; RAD53; ACTIVATION; DELETION; PHOSPHORYLATION; RECOMBINATION	One of the main mechanisms for double stranded DNA break (DSB) repair is through the non-homologous end-joining (NHEJ) pathway. Using plasmid and chromosomal repair assays, we showed that deletion mutant strains for interacting proteins Pph3p and Psy2p had reduced efficiencies in NHEJ. We further observed that this activity of Pph3p and Psy2p appeared linked to cell cycle Rad53p and Chk1p checkpoint proteins. Pph3/Psy2 is a phosphatase complex, which regulates recovery from the Rad53p DNA damage checkpoint. Overexpression of Chk1p checkpoint protein in a parallel pathway to Rad53p compensated for the deletion of PPH3 or PSY2 in a chromosomal repair assay. Double mutant strains Delta pph3/Delta chk1 and Delta psy2/Delta chk1 showed additional reductions in the efficiency of plasmid repair, compared to both single deletions which is in agreement with the activity of Pph3p and Psy2p in a parallel pathway to Chk1p. Genetic interaction analyses also supported a role for Pph3p and Psy2p in DNA damage repair, the NHEJ pathway, as well as cell cycle progression. Collectively, we report that the activity of Pph3p and Psy2p further connects NHEJ repair to cell cycle progression.	[Omidi, Katayoun; Hooshyar, Mohsen; Jessulat, Matthew; Samanfar, Bahram; Sanders, Megan; Burnside, Daniel; Golshani, Ashkan] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Omidi, Katayoun; Hooshyar, Mohsen; Samanfar, Bahram; Sanders, Megan; Burnside, Daniel; Golshani, Ashkan] Carleton Univ, Ottawa Inst Syst Biol, Ottawa, ON K1S 5B6, Canada; [Jessulat, Matthew; Babu, Mohan] Univ Regina, Res & Innovat Ctr, Dept Biochem, Regina, SK S4S 0A2, Canada; [Pitre, Sylvain; Schoenrock, Andrew] Carleton Univ, Dept Comp Sci, Ottawa, ON K1S 5B6, Canada; [Xu, Jianhua] Zhejian Univ, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China	Carleton University; Carleton University; University of Ottawa; University of Regina; Carleton University; Zhejiang University	Golshani, A (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	ashkan_golshani@carleton.ca	Samanfar, Bahram/AAV-7678-2021; Mohan, Babu P./I-7362-2019		Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Alamgir M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-583; Amos-Binks A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-225; Ataian Y, 2006, BIOCHEM CELL BIOL, V84, P490, DOI 10.1139/O06-075; Baryshnikova A, 2010, METHOD ENZYMOL, V470, P145, DOI 10.1016/S0076-6879(10)70007-0; Blankley RT, 2004, J CELL SCI, V117, P601, DOI 10.1242/jcs.00907; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; BRADLEY MO, 1979, NUCLEIC ACIDS RES, V7, P793, DOI 10.1093/nar/7.3.793; Chen SH, 2007, J BIOL CHEM, V282, P986, DOI 10.1074/jbc.M609322200; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Chen X, 2011, J BIOL CHEM, V286, P4931, DOI 10.1074/jbc.M110.195024; Clerici M, 2006, EMBO REP, V7, P212, DOI 10.1038/sj.embor.7400593; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Deshpande RA, 2007, DNA REPAIR, V6, P1507, DOI 10.1016/j.dnarep.2007.04.014; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Douglas AC, 2012, G3-GENES GENOM GENET, V2, P1279, DOI 10.1534/g3.112.003400; Dudas A, 2004, MUTAT RES-REV MUTAT, V566, P131, DOI 10.1016/j.mrrev.2003.07.001; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Jessulat M, 2008, ARCH BIOCHEM BIOPHYS, V469, P157, DOI 10.1016/j.abb.2007.11.001; Jessulat M, 2011, EXPERT OPIN DRUG DIS, V6, P921, DOI 10.1517/17460441.2011.603722; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kim JA, 2011, MOL CELL BIOL, V31, P507, DOI 10.1128/MCB.01168-10; Kroll ES, 1996, GENETICS, V143, P95; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Li FY, 2013, EMBO J, V32, P461, DOI 10.1038/emboj.2012.345; Limbo O, 2011, MOL CELL BIOL, V31, P573, DOI 10.1128/MCB.00994-10; Ma JL, 2006, J BIOL CHEM, V281, P3954, DOI 10.1074/jbc.M507508200; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Memarian N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-117; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Myung K, 2002, P NATL ACAD SCI USA, V99, P4500, DOI 10.1073/pnas.062702199; Naiki T, 2004, MOL CELL BIOL, V24, P3277, DOI 10.1128/MCB.24.8.3277-3285.2004; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; Oike T, 2012, INT J RADIAT ONCOL, V84, P815, DOI 10.1016/j.ijrobp.2012.01.017; Pierce AJ, 2001, MOL CELL, V8, P1160, DOI 10.1016/S1097-2765(01)00424-5; Pitre S, 2008, NUCLEIC ACIDS RES, V36, P4286, DOI 10.1093/nar/gkn390; Pitre S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00239; RITTBERG DAH, 1989, BIOCHEM CELL BIOL, V67, P352, DOI 10.1139/o89-055; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Samanfar B, 2013, MOL BIOSYST, V9, P1351, DOI 10.1039/c3mb25516f; Sharifpoor S, 2012, GENOME RES, V22, P791, DOI 10.1101/gr.129213.111; Shim EY, 2005, MOL CELL BIOL, V25, P3934, DOI 10.1128/MCB.25.10.3934-3944.2005; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zha S, 2009, NAT STRUCT MOL BIOL, V16, P798, DOI 10.1038/nsmb0809-798; Zhang Y, 2009, DNA REPAIR, V8, P1235, DOI 10.1016/j.dnarep.2009.07.007	63	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87248	10.1371/journal.pone.0087248	http://dx.doi.org/10.1371/journal.pone.0087248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498054	gold, Green Published			2022-12-25	WOS:000330621900079
J	Ribalet, F; Bastianini, M; Vidoudez, C; Acri, F; Berges, J; Ianora, A; Miralto, A; Pohnert, G; Romano, G; Wichard, T; Casotti, R				Ribalet, Francois; Bastianini, Mauro; Vidoudez, Charles; Acri, Francesco; Berges, John; Ianora, Adrianna; Miralto, Antonio; Pohnert, Georg; Romano, Giovanna; Wichard, Thomas; Casotti, Raffaella			Phytoplankton Cell Lysis Associated with Polyunsaturated Aldehyde Release in the Northern Adriatic Sea	PLOS ONE			English	Article							ACTIVATED CHEMICAL DEFENSE; SHORT-CHAIN ALDEHYDES; SKELETONEMA-COSTATUM; MARINE-PHYTOPLANKTON; LIPID-PEROXIDATION; CYTOPHAGA SP; DIATOMS; NITROGEN; QUANTIFICATION; PHOSPHORUS	Diatoms are able to react to biotic and abiotic stress, such as competition, predation and unfavorable growth conditions, by producing bioactive compounds including polyunsaturated aldehydes (PUAs). PUAs have been shown to act against grazers and either enhance or inhibit the growth of different phytoplankton and bacteria both in culture and in the field. Presence of nanomolar concentrations of dissolved PUAs in seawater has been reported in the North Adriatic Sea (Mediterranean), suggesting that these compounds are released in seawater following diatom cell lysis. However, the origin of the PUAs and their effects on natural phytoplankton assemblages remain unclear. Here we present data from four oceanographic cruises that took place during diatom blooms in the northern Adriatic Sea where concentrations of particulate and dissolved PUAs were monitored along with phytoplankton cell lysis. Cell lysis was positively correlated with both concentrations of particulate and dissolved PUAs (R = 0.69 and R = 0.77, respectively), supporting the hypothesis that these compounds are released by cell lysis. However, the highest concentration of dissolved PUAs (2.53 nM) was measured when cell lysis was high (0.24 d(-1)) but no known PUA-producing diatoms were detected, suggesting either that other organisms can produce PUAs or that PUA-producing enzymes retain activity extracellularly after diatom cells have lysed. Although in situ concentrations of dissolved PUAs were one to three orders of magnitude lower than those typically used in laboratory culture experiments, we argue that concentrations produced in the field could induce similar effects to those observed in culture and therefore may help shape plankton community composition and function in the oceans.	[Ribalet, Francois; Ianora, Adrianna; Miralto, Antonio; Romano, Giovanna; Casotti, Raffaella] Stn Zool Anton Dohrn Napoli, Naples, Italy; [Bastianini, Mauro; Acri, Francesco] ISMAR CNR Ist Sci Marine, Venice, Italy; [Vidoudez, Charles; Pohnert, Georg; Wichard, Thomas] Univ Jena, Inst Inorgan & Analyt Chem, Jena Sch Microbial Commun, Jena, Germany; [Berges, John] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Berges, John] Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA	Stazione Zoologica Anton Dohrn di Napoli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Friedrich Schiller University of Jena; University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee	Casotti, R (corresponding author), Stn Zool Anton Dohrn Napoli, Naples, Italy.	raffa@szn.it	Wichard, Thomas/L-9861-2019; Ianora, Adrianna/O-3408-2019; Berges, John A/D-9520-2012; Casotti, Raffaella/I-9833-2019; Romano, Giovanna/F-4561-2015; Pohnert, Georg/D-3721-2013; Wichard, Thomas/C-2794-2009; Casotti, Raffaella/H-1697-2016; CNR, Ismar/P-1247-2014	Wichard, Thomas/0000-0003-0061-4160; Berges, John A/0000-0002-3124-4783; Casotti, Raffaella/0000-0002-9876-4601; Romano, Giovanna/0000-0002-4898-7153; Pohnert, Georg/0000-0003-2351-6336; Wichard, Thomas/0000-0003-0061-4160; Casotti, Raffaella/0000-0002-9876-4601; Ribalet, Francois/0000-0002-7431-0234; Bastianini, Mauro/0000-0001-6758-4192; CNR, Ismar/0000-0001-5351-1486; Vidoudez, Charles/0000-0003-0953-7800	INTERREG - GRANT EU INTERREG III Italy-Slovenian Project.; Volkswagen Foundation; Swiss National Fonds; VECTOR Project; Stazione Zoologica Anton Dohrn (SZN) under the Associate Research Center PhD Program of The Open University, Milton Keynes, UK; Biological Oceanography of the Northern Adriatic (OBAS)	INTERREG - GRANT EU INTERREG III Italy-Slovenian Project.; Volkswagen Foundation(Volkswagen); Swiss National Fonds(Swiss National Science Foundation (SNSF)); VECTOR Project; Stazione Zoologica Anton Dohrn (SZN) under the Associate Research Center PhD Program of The Open University, Milton Keynes, UK; Biological Oceanography of the Northern Adriatic (OBAS)	The project was funded by INTERREG - GRANT EU INTERREG III Italy-Slovenian Project. Biological Oceanography of the Northern Adriatic (OBAS 2003-2006), the Volkswagen Foundation, the Swiss National Fonds and the VECTOR Project. This work was also part of the PhD project of FR funded by the Stazione Zoologica Anton Dohrn (SZN) under the Associate Research Center PhD Program of The Open University, Milton Keynes, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph S, 2004, J EXP BIOL, V207, P2935, DOI 10.1242/jeb.01105; Agusti S, 1998, LIMNOL OCEANOGR, V43, P1836; Balestra C, 2011, AQUAT MICROB ECOL, V63, P123, DOI 10.3354/ame01486; Barofsky A, 2007, ORG LETT, V9, P1017, DOI 10.1021/ol063051v; Berges JA, 1998, LIMNOL OCEANOGR, V43, P129, DOI 10.4319/lo.1998.43.1.0129; Bidle KD, 2008, EUKARYOT CELL, V7, P223, DOI 10.1128/EC.00296-07; Brussaard CPD, 1997, J PHYCOL, V33, P980, DOI 10.1111/j.0022-3646.1997.00980.x; BRUSSAARD CPD, 1995, MAR ECOL PROG SER, V123, P259, DOI 10.3354/meps123259; Brussaard CPD, 1998, AQUAT MICROB ECOL, V14, P271, DOI 10.3354/ame014271; CONLEY DJ, 1992, MAR ECOL PROG SER, V81, P121, DOI 10.3354/meps081121; d'Ippolito G, 2004, BBA-MOL CELL BIOL L, V1686, P100, DOI 10.1016/j.bbalip.2004.09.002; d'Ippolito G, 2002, TETRAHEDRON LETT, V43, P6133, DOI 10.1016/S0040-4039(02)01285-6; d'Ippolito G, 2002, TETRAHEDRON LETT, V43, P6137, DOI 10.1016/S0040-4039(02)01283-2; Dittami SM, 2010, NOVA HEDWIGIA, P231, DOI 10.1127/1438-9134/2010/0136-0231; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Fontana A, 2007, CHEMBIOCHEM, V8, P1810, DOI 10.1002/cbic.200700269; Fontana A, 2007, PURE APPL CHEM, V79, P481, DOI 10.1351/pac200779040481; Grasshoff K, 1999, WILEY ONLINE LIB, P660, DOI [10.1002/9783527613984.fmatter, DOI 10.1002/9783527613984.FMATTER]; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; IMAI I, 1993, MAR BIOL, V116, P527, DOI 10.1007/BF00355470; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; LAWS EA, 1981, MAR BIOL, V65, P13, DOI 10.1007/BF00397062; Legrand C, 2003, PHYCOLOGIA, V42, P406, DOI 10.2216/i0031-8884-42-4-406.1; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; MITSUTANI A, 1992, NIPPON SUISAN GAKK, V58, P2159; Nagasaki K, 2005, APPL ENVIRON MICROB, V71, P3528, DOI 10.1128/AEM.71.7.3528-3535.2005; Nagasaki K, 2004, APPL ENVIRON MICROB, V70, P704, DOI 10.1128/AEM.70.2.704-711.2004; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Pohnert G, 2002, PLANT PHYSIOL, V129, P103, DOI 10.1104/pp.010974; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; Pohnert G, 2007, TRENDS ECOL EVOL, V22, P198, DOI 10.1016/j.tree.2007.01.005; Pugnetti Alessandra, 2004, Chemistry and Ecology, V20, P399, DOI 10.1080/02757540412331294902; Ribalet F, 2008, AQUAT TOXICOL, V86, P249, DOI 10.1016/j.aquatox.2007.11.005; Ribalet F, 2007, AQUAT TOXICOL, V85, P219, DOI 10.1016/j.aquatox.2007.09.006; Ribalet F, 2007, PHYTOCHEMISTRY, V68, P2059, DOI 10.1016/j.phytochem.2007.05.012; Ribalet F, 2009, PROTIST, V160, P444, DOI 10.1016/j.protis.2009.01.003; Riegman R, 2003, ACTA OECOL, V24, pS133, DOI 10.1016/S1146-609X(03)00010-9; Rijstenbil JW, 2002, J PLANKTON RES, V24, P1277, DOI 10.1093/plankt/24.12.1277; Socal G, 2002, CHEM ECOL, V18, P61, DOI 10.1080/02757540212686; Soelberg SD, 2009, ANAL CHEM, V81, P2357, DOI 10.1021/ac900007c; Spiteller G, 2003, PHYSIOL PLANTARUM, V119, P5, DOI 10.1034/j.1399-3054.2003.00097.x; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; VANBOEKEL WHM, 1992, MAR ECOL PROG SER, V81, P269, DOI 10.3354/meps081269; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vidoudez C, 2008, J PLANKTON RES, V30, P1305, DOI 10.1093/plankt/fbn085; Vidoudez C, 2011, MAR DRUGS, V9, P500, DOI 10.3390/md9040500; Vidoudez C, 2011, MAR DRUGS, V9, P345, DOI 10.3390/md9030345; Wichard T, 2005, J CHEM ECOL, V31, P949, DOI 10.1007/s10886-005-3615-z; Wichard T, 2005, J CHROMATOGR B, V814, P155, DOI 10.1016/j.jchromb.2004.10.021; Wichard T, 2007, CHEMBIOCHEM, V8, P1146, DOI 10.1002/cbic.200700053; Wichard T, 2006, J AM CHEM SOC, V128, P7114, DOI 10.1021/ja057942u	52	41	41	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e85947	10.1371/journal.pone.0085947	http://dx.doi.org/10.1371/journal.pone.0085947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497933	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900013
J	Lazary, J; Dome, P; Csala, I; Kovacs, G; Faludi, G; Kaunisto, M; Dome, B				Lazary, Judit; Dome, Peter; Csala, Iren; Kovacs, Gabor; Faludi, Gabor; Kaunisto, Mari; Dome, Balazs			Massive Withdrawal Symptoms and Affective Vulnerability Are Associated with Variants of the CHRNA4 Gene in a Subgroup of Smokers	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; NICOTINE WITHDRAWAL; SMOKING-CESSATION; ADULT TWINS; DEPRESSION; HAPLOTYPE; DEPENDENCE; TOLERANCE; TOBACCO	Heterogeneous phenotypes of complex disorders pose a great challenge for genetic association studies and for the development of personalized treatment strategies. Cluster analysis of phenotypic data has been recently proposed as a reliable auxiliary method for such studies. A cohort of 236 treatment-seeking smokers was investigated after overnight nicotine abstinence. Alpha4 nicotinic acetylcholine receptor (nAChR) subunit-related phenotypes were assessed by the Fagerstrom Test for Nicotine Dependence (FTND), exhaled carbon monoxide (CO) measurements, the Minnesota Nicotine Withdrawal Scale (MNWS) and the Zung Self-Rating Depression Scale (ZSDS). Seven tag SNPs (single-nucleotide polymorphisms) across CHRNA4 (the gene encoding alpha4 subunit of the nicotinic acetylcholine receptor) were genotyped and two-step cluster analysis was used for phenotypic cluster characterization. Haplotype estimation was determined by HapStat module of R 2.0 software. Three different phenotypic clusters were identified and the C3 cluster was characterized by the highest ZSDS and MNWS scores compared to others. Furthermore, lifetime prevalence of major depression was significantly higher in the C3 cluster (p = 0.019). In genetic association tests, this cluster was also significantly associated with rs3787138 genotypes (p = 0.004) while haplotype analyses of three SNPs (rs3787138, rs1044396, rs3787140) revealed that the risk for C3 phenotype was almost three times higher in GCC haplotype carriers compared to others (p(perm) = 0.013). This is the first report on a significant association between CHRNA4 variants and a subgroup of smokers characterized by massive withdrawal symptoms and affective vulnerability. Identification of such a phenotypic cluster can be a pivotal step for further pharmacogenetic studies on ligands of the alpha4 nAChR subunit. Our results suggest that performing cluster analysis in genetic association studies can be proposed for complex disorders.	[Lazary, Judit; Dome, Peter; Csala, Iren; Faludi, Gabor] Semmelweis Univ, Dept Clin & Theoret Mental Hlth, H-1085 Budapest, Hungary; [Dome, Peter] Natl Inst Psychiat & Addict, Budapest, Hungary; [Csala, Iren] Semmelweis Univ, Inst Behav Sci, H-1085 Budapest, Hungary; [Kovacs, Gabor; Dome, Balazs] Natl Koranyi Inst Pulmonol, Dept Tumor Biol, Budapest, Hungary; [Kaunisto, Mari] Univ Helsinki, FIMM, Helsinki, Finland; [Kaunisto, Mari] Folkhalsan Inst Genet, Helsinki, Finland; [Dome, Balazs] Natl Inst Oncol, Dept Thorac Surg, Budapest, Hungary; [Dome, Balazs] Med Univ Vienna, Dept Thorac Surg, Translat Thorac Oncol Lab, Vienna, Austria	Semmelweis University; Semmelweis University; University of Helsinki; National Institute of Oncology Hungary; Medical University of Vienna	Lazary, J (corresponding author), Semmelweis Univ, Dept Clin & Theoret Mental Hlth, H-1085 Budapest, Hungary.	lazaryjudit@gmail.com; balazs.dome@meduniwien.ac.at		Dome, Balazs/0000-0001-8799-8624; Kaunisto, Mari/0000-0002-6946-9195	Norwegian Financial Mechanism [HU0125]; OTKA [K108465, K109626]; TAMOP [424A/1-11-1-2012-0001]; KTIA AIK [12-1-2013-0041]; Hungarian Academy of Sciences	Norwegian Financial Mechanism; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP; KTIA AIK; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This study was supported by the Norwegian Financial Mechanism (HU0125) (J Lazary, P Dome, G Kovacs, G Faludi, B Dome); OTKA K108465 (B Dome); TAMOP 424A/1-11-1-2012-0001 (B Dome); KTIA AIK 12-1-2013-0041 (B Dome); OTKA K109626 (B Dome). P Dome is a recipient of the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Breitling LP, 2009, PHARMACOGENOMICS J, V9, P219, DOI 10.1038/tpj.2009.6; COVEY LS, 1990, COMPR PSYCHIAT, V31, P350, DOI 10.1016/0010-440X(90)90042-Q; Dome P, 2010, NEUROSCI BIOBEHAV R, V34, P295, DOI 10.1016/j.neubiorev.2009.07.013; Etter JF, 2009, ADDICT BEHAV, V34, P772, DOI 10.1016/j.addbeh.2009.05.010; Feng Y, 2004, AM J HUM GENET, V75, P112, DOI 10.1086/422194; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glassman AH, 2001, LANCET, V357, P1929, DOI 10.1016/S0140-6736(00)05064-9; Gold A.B., 2012, HUM GENET; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; Kaneko Y, 2013, ALLERGOL INT, V62, P113, DOI 10.2332/allergolint.12-OA-0467; Lazary J, 2008, BIOL PSYCHIAT, V64, P498, DOI 10.1016/j.biopsych.2008.03.030; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Madden PAF, 1997, ADDICTION, V92, P889, DOI 10.1046/j.1360-0443.1997.92788911.x; Markett S, 2011, EMOTION, V11, P450, DOI 10.1037/a0021784; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Perera S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041407; Pergadia ML, 2006, PSYCHOL MED, V36, P963, DOI 10.1017/S0033291706007495; Pergadia ML, 2010, TWIN RES HUM GENET, V13, P359, DOI 10.1375/twin.13.4.359; Roe BE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006704; Ross SA, 2000, J NEUROSCI, V20, P6431, DOI 10.1523/JNEUROSCI.20-17-06431.2000; Saccone SF, 2007, AM J HUM GENET, V80, P856, DOI 10.1086/513703; Spruell T, 2012, NICOTINE TOB RES, V14, P993, DOI 10.1093/ntr/ntr246; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Sun JW, 2012, ADDICT BEHAV, V37, P1138, DOI 10.1016/j.addbeh.2012.05.010; Szadoczky E, 1998, J AFFECT DISORDERS, V50, P153, DOI 10.1016/S0165-0327(98)00056-1; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Tsai SJ, 2012, GENES BRAIN BEHAV, V11, P230, DOI 10.1111/j.1601-183X.2011.00741.x; Winterer G, 2007, HUM MOL GENET, V16, P2165, DOI 10.1093/hmg/ddm168; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	33	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87141	10.1371/journal.pone.0087141	http://dx.doi.org/10.1371/journal.pone.0087141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498031	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000330617100052
J	Lu, J; Zheng, HY; Zhang, Y; Guo, X; Wu, D; Li, H; Liu, L; Zeng, HR; Yi, LN; Fang, L; Mo, YL; Xu, WB; Ke, CW				Lu, Jing; Zheng, Huanying; Zhang, Yong; Guo, Xue; Wu, De; Li, Hui; Liu, Leng; Zeng, Hanri; Yi, Lina; Fang, Ling; Mo, Yanling; Xu, Wenbo; Ke, Changwen			Whole Genomic Sequence and Replication Kinetics of a New Enterovirus C96 Isolated from Guangdong, China with a Different Cell Tropism	PLOS ONE			English	Article							MOLECULAR-IDENTIFICATION; INTRATYPIC RECOMBINATION; PCR AMPLIFICATION; MOUTH-DISEASE; ENCEPHALITIS; SEROTYPES; EPIDEMIOLOGY; DIVERSITY; EVOLUTION; REVEALS	Enterovirus 96 (EV-C96) is a newly described serotype within the enterovirus C (EV-C) species, and its biological and pathological characters are largely unknown. In this study, we sequenced the whole genome of a novel EV-C96 strain that was isolated in 2011 from a patient with acute flaccid paralysis (AFP) in Guangdong province, China and characterized the properties of its infection. Sequence analysis revealed the close relationship between the EV-C96 strains isolated from the Guangdong and Shandong provinces of China, and suggested that recombination events occurred both between these EV-C96 strains and with other EV-C viruses. Moreover, the virus replication kinetics showed EV-C96 Guangdong strain replicated at a high rate in RD cells and presented a different cell tropism to other strains isolated from Shandong recently. These findings gave further insight into the evolutionary processes and extensive biodiversity of EV-C96.	[Lu, Jing; Zheng, Huanying; Guo, Xue; Wu, De; Li, Hui; Liu, Leng; Zeng, Hanri; Yi, Lina; Fang, Ling; Mo, Yanling; Ke, Changwen] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Lu, Jing; Yi, Lina] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Zhang, Yong; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Yong; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Minist Hlth Key Lab Med Virol, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zheng, HY (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	zhenghy.gdcdc@gmail.com		Zhang, Yong/0000-0002-2692-5437	Bill & Melinda Gates Foundation [OPP1039272]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This project was funded by Bill & Melinda Gates Foundation (Project No. OPP1039272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostol LNG, 2012, VIRUS GENES, V45, P207, DOI 10.1007/s11262-012-0776-z; Arita M, 2005, J VIROL, V79, P12650, DOI 10.1128/JVI.79.20.12650-12657.2005; Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Benschop K, 2010, DIAGN MICR INFEC DIS, V68, P166, DOI 10.1016/j.diagmicrobio.2010.05.016; Bingjun T, 2008, J MED VIROL, V80, P670, DOI 10.1002/jmv.21122; Blomqvist S, 2008, J CLIN MICROBIOL, V46, P2410, DOI 10.1128/JCM.00313-08; Cohen BJ, 2007, VACCINE, V26, P59, DOI 10.1016/j.vaccine.2007.10.046; Cordey S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002826; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Dumaine A, 2008, ANN BIOL CLIN-PARIS, V66, P433, DOI 10.1684/abc.2008.0230; Fowlkes AL, 2008, J INFECT DIS, V198, P1685, DOI 10.1086/592988; Guillot S, 2000, J VIROL, V74, P8434, DOI 10.1128/JVI.74.18.8434-8443.2000; Hamaguchi T, 2008, EMERG INFECT DIS, V14, P828, DOI 10.3201/eid1405.071121; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Knowles N., 2011, VIRUS TAXONOMY CLASS, P855; Kolb AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076267; Kung CM, 2007, J MED VIROL, V79, P60, DOI 10.1002/jmv.20761; Lu J, 2011, WORLD J GASTROENTERO, V17, P4135, DOI 10.3748/wjg.v17.i36.4135; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Nix WA, 2013, J GEN VIROL, V94, P2017, DOI 10.1099/vir.0.053827-0; Oberste MS, 2006, J GEN VIROL, V87, P119, DOI 10.1099/vir.0.81179-0; Oberste MS, 2005, J GEN VIROL, V86, P445, DOI 10.1099/vir.0.80475-0; Oberste MS, 2004, J GEN VIROL, V85, P3205, DOI 10.1099/vir.0.80148-0; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Pliaka V, 2010, VIRUS GENES, V40, P200, DOI 10.1007/s11262-010-0448-9; Rakoto-Andrianarivelo M, 2007, PLOS PATHOG, V3, P1950, DOI 10.1371/journal.ppat.0030191; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Smura T, 2009, ARCH VIROL, V154, P1157, DOI 10.1007/s00705-009-0418-5; Smura TP, 2007, J GEN VIROL, V88, P849, DOI 10.1099/vir.0.82510-0; Sun Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055480; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsai HP, 2011, J MED MICROBIOL, V60, P1360, DOI 10.1099/jmm.0.027698-0; Wu W, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059749, 10.1371/journal.pone.0059016]; Xu AQ, 2011, VIRUS GENES, V42, P323, DOI 10.1007/s11262-011-0584-x; Yip CCY, 2011, J VIROL, V85, P12098, DOI 10.1128/JVI.05944-11; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	42	12	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86877	10.1371/journal.pone.0086877	http://dx.doi.org/10.1371/journal.pone.0086877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497989	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100037
J	Chen, Y; Zhu, J; Ying, SH; Feng, MG				Chen, Ying; Zhu, Jing; Ying, Sheng-Hua; Feng, Ming-Guang			Three Mitogen-Activated Protein Kinases Required for Cell Wall Integrity Contribute Greatly to Biocontrol Potential of a Fungal Entomopathogen	PLOS ONE			English	Article							MAP KINASE; TRANSCRIPTION FACTOR; BEAUVERIA-BASSIANA; ASPERGILLUS-NIDULANS; ASEXUAL DEVELOPMENT; PATHWAYS; CONIDIATION; STRESS; GROWTH; TREHALOSE	Bck1, Mkk1 and Slt2 are three mitogen-activated protein (MAP) kinases constituting cell wall integrity (CWI) pathway that may control multi-stress responses via crosstalk with high-osmolarity glycerol (HOG) pathway in budding yeast. In this study, Bck1, Mkk1 and Slt2 orthologues in Beauveria bassiana were confirmed as the three-module cascade essential for CWI because cell wall impairment occurred in the hyphae and conidia of Delta bck1, Delta mkk1 and Delta slt2 examined in multiple experiments. Strikingly, all the deletion mutants became more sensitive to hyperosmotic NaCl and sorbitol with the Western blot of Hog1 phosphorylation being weakened in Delta bck1 and absent in Delta mkk1 and Delta slt2. Apart from crossing responses to cell wall perturbation and high osmolarity, three deletion mutants exhibited faster growth and conidiation on nutrition-rich medium, much less virulence to Galleria mellonella larvae, and higher sensitivity to nutritional, fungicidal, thermal and UV-B irradiative stresses, accompanied with less accumulation of intracellular mannitol and trehalose. Moreover, Delta mkk1 and Delta slt2 were equally more sensitive to all the stresses of different types except wet-heat stress than wild type and more or less different from Delta bck1 in sensitivity to most of the stresses despite their null responses to two oxidants. All the changes in three deletion mutants were restored by each targeted gene complementation. Taken together, the CWI-required Bck1, Mkk1 and Slt2 are all positive, but differential, regulators of multi-stress tolerance and virulence perhaps due to interplay with the HOG pathway essential for osmoregulation, thereby contributing greatly to the biocontrol potential of the fungal entomopathogen.	[Chen, Ying; Zhu, Jing; Ying, Sheng-Hua; Feng, Ming-Guang] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Feng, MG (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	mgfeng@zju.edu.cn			Ministry of Science and Technology of China [2011AA10A204]; Natural Science Foundation of China [31270537, 31021003]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Ministry of Science and Technology of China (Grant No.: 2011AA10A204) and the Natural Science Foundation of China (Grant Nos.: 31270537 and 31021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arratia-Quijada J, 2012, EUKARYOT CELL, V11, P1132, DOI 10.1128/EC.00101-12; Baltanas R, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003312; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Carbo N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001009; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Doehlemann G, 2006, MICROBIOL-SGM, V152, P2625, DOI 10.1099/mic.0.29044-0; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Etxebeste O, 2009, MOL MICROBIOL, V73, P775, DOI 10.1111/j.1365-2958.2009.06804.x; Fang WG, 2004, J INVERTEBR PATHOL, V85, P18, DOI 10.1016/j.jip.2003.12.003; FENG MG, 1994, BIOCONTROL SCI TECHN, V4, P3, DOI 10.1080/09583159409355309; Fuchs BB, 2009, EUKARYOT CELL, V8, P1616, DOI 10.1128/EC.00193-09; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Gerik KJ, 2005, MOL MICROBIOL, V58, P393, DOI 10.1111/j.1365-2958.2005.04843.x; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Huang BF, 2009, MYCOPATHOLOGIA, V168, P145, DOI 10.1007/s11046-009-9207-7; Jacoby JJ, 1999, J MOL BIOL, V288, P337, DOI 10.1006/jmbi.1999.2682; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Joubert A, 2011, CELL MICROBIOL, V13, P62, DOI 10.1111/j.1462-5822.2010.01520.x; Kikuma T, 2007, AUTOPHAGY, V3, P128, DOI 10.4161/auto.3560; Kwon NJ, 2010, MOL MICROBIOL, V77, P1203, DOI 10.1111/j.1365-2958.2010.07282.x; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Liu Q, 2009, ANTON LEEUW INT J G, V95, P65, DOI 10.1007/s10482-008-9288-1; Liu WW, 2011, FUNGAL GENET BIOL, V48, P377, DOI 10.1016/j.fgb.2010.12.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo XD, 2012, FUNGAL GENET BIOL, V49, P544, DOI 10.1016/j.fgb.2012.05.002; Rodriguez-Pena JM, 2010, YEAST, V27, P495, DOI 10.1002/yea.1792; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Mey G, 2002, MOL MICROBIOL, V46, P305, DOI 10.1046/j.1365-2958.2002.03133.x; Rangel DEN, 2008, MYCOL RES, V112, P1362, DOI 10.1016/j.mycres.2008.04.013; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Rui O, 2007, MOL PLANT PATHOL, V8, P173, DOI 10.1111/J.1364-3703.2007.00383.X; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Seo JA, 2006, GENETICS, V172, P1535, DOI 10.1534/genetics.105.052258; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Wanchoo A, 2009, MICROBIOL-SGM, V155, P3121, DOI 10.1099/mic.0.029157-0; Wang ZL, 2012, ENVIRON MICROBIOL, V14, P2139, DOI 10.1111/j.1462-2920.2011.02654.x; Xiao GH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00483; Xiao P, 2010, EUKARYOT CELL, V9, P1711, DOI 10.1128/EC.00198-10; Xie XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030298; Yao SL, 2010, BIOCONTROL, V55, P413, DOI 10.1007/s10526-009-9265-2; Zeng FY, 2012, FUNGAL GENET BIOL, V49, P347, DOI 10.1016/j.fgb.2012.02.008; Zhang L, 2013, MICROBIOL-SGM, V159, P243, DOI 10.1099/mic.0.062646-0	45	46	46	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87948	10.1371/journal.pone.0087948	http://dx.doi.org/10.1371/journal.pone.0087948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498410	gold, Green Submitted, Green Published			2022-12-25	WOS:000330626900156
J	Clavica, F; Zhao, XF; ElMahdy, M; Drake, MJ; Zhang, XL; Carugo, D				Clavica, Francesco; Zhao, Xuefeng; ElMahdy, Motaz; Drake, Marcus J.; Zhang, Xunli; Carugo, Dario			Investigating the Flow Dynamics in the Obstructed and Stented Ureter by Means of a Biomimetic Artificial Model	PLOS ONE			English	Article							PERCUTANEOUS NEPHROSTOMY; IN-VITRO; PERISTALSIS; ENCRUSTATION; POLYMERS	Double-J stenting is the most common clinical method employed to restore the upper urinary tract drainage, in the presence of a ureteric obstruction. After implant, stents provide an immediate pain relief by decreasing the pressure in the renal pelvis (P). However, their long-term usage can cause infections and encrustations, due to bacterial colonization and crystal deposition on the stent surface, respectively. The performance of double-J stents - and in general of all ureteric stents - is thought to depend significantly on urine flow field within the stented ureter. However very little fundamental research about the role played by fluid dynamic parameters on stent functionality has been conducted so far. These parameters are often difficult to assess in-vivo, requiring the implementation of laborious and expensive experimental protocols. The aim of the present work was therefore to develop an artificial model of the ureter (i.e. ureter model, UM) to mimic the fluid dynamic environment in a stented ureter. The UM was designed to reflect the geometry of pig ureters, and to investigate the values of fluid dynamic viscosity (mu), volumetric flow rate (Q) and severity of ureteric obstruction (OB%) which may cause critical pressures in the renal pelvis. The distributed obstruction derived by the sole stent insertion was also quantified. In addition, flow visualisation experiments and computational simulations were performed in order to further characterise the flow field in the UM. Unique characteristics of the flow dynamics in the obstructed and stented ureter have been revealed with using the developed UM.	[Clavica, Francesco] Erasmus MC, Dept Urol, Sect FURORE, Rotterdam, Netherlands; [Clavica, Francesco; Zhao, Xuefeng; Zhang, Xunli; Carugo, Dario] Univ Southampton, Fac Engn & Environm, Southampton, Hants, England; [Clavica, Francesco; ElMahdy, Motaz; Drake, Marcus J.] Southmead Hosp, Bristol Urol Inst, Bristol, Avon, England; [Drake, Marcus J.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Zhang, Xunli] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Zhao, Xuefeng] Cent S Univ, Sch Geosci & Infophys, Dept Biomed Engn, Changsha, Hunan, Peoples R China	Erasmus University Rotterdam; Erasmus MC; University of Southampton; Southmead Hospital; University of Bristol; University of Southampton; Central South University	Clavica, F (corresponding author), Erasmus MC, Dept Urol, Sect FURORE, Rotterdam, Netherlands.	francesco.clavica@libero.it	Drake, Marcus/C-4542-2014	Drake, Marcus/0000-0002-6230-2552; Clavica, Francesco/0000-0002-8967-5877; Carugo, Dario/0000-0002-1148-179X; Zhang, Xunli/0000-0002-4375-1571	 [238541]		Grant number: 238541; http://www.eutrustproject.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LG, 2013, NZ VET J, P1; Bonkat G, 2012, TRANSPL INFECT DIS, V14, P57, DOI 10.1111/j.1399-3062.2011.00671.x; Boyarsky S, 1981, PRINCIPLES URETERAL, P71; Brewer AV, 1999, J ENDOUROL, V13, P269, DOI 10.1089/end.1999.13.269; Choong SKS, 2000, BJU INT, V86, P414, DOI 10.1046/j.1464-410X.2000.00861.x; CONSTANTINOU CE, 1974, AM J PHYSIOL, V226, P1413, DOI 10.1152/ajplegacy.1974.226.6.1413; Cummings LJ, 2004, J MATH BIOL, V49, P56, DOI 10.1007/s00285-003-0252-4; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; FINE H, 1989, UROL RADIOL, V11, P37, DOI 10.1007/BF02926471; Fung LCT, 1998, J UROLOGY, V159, P212, DOI 10.1016/S0022-5347(01)64070-9; GORDON NSI, 1989, BRIT J UROL, V64, P195, DOI 10.1111/j.1464-410X.1989.tb05987.x; Gorman SP, 2003, J PHARM PHARMACOL, V55, P461, DOI 10.1211/002235702856; Gorman SP, 1997, BIOMATERIALS, V18, P1379, DOI 10.1016/S0142-9612(97)00070-7; Gregersen H, 1996, SCAND J UROL NEPHROL, V30, P343, DOI 10.3109/00365599609181308; Haleblian G, 2008, J UROLOGY, V179, P424, DOI 10.1016/j.juro.2007.09.026; Hausegger KA, 2006, EUR RADIOL, V16, P2016, DOI 10.1007/s00330-005-0136-7; Kinn AC, 2002, UROL RES, V30, P213, DOI 10.1007/s00240-002-0258-1; Kundu SD, 2009, ADV UROL, V2009, DOI 10.1155/2009/181927; Lam JS, 2007, CURR CLIN UROL, P465, DOI 10.1007/978-1-59259-972-1_25; Lee BR, 1998, UROLOGY, V51, P820, DOI 10.1016/S0090-4295(98)00013-2; Lennon GM, 1997, EUR UROL, V31, P24; Liepsch D., 2012, PERSPECT MED, V1, P132, DOI [DOI 10.1016/J.PERMED.2012.04.005, 10.1016/j.permed.2012.04.005]; MARDIS HK, 1982, UROL CLIN N AM, V9, P95; Patel U, 1996, BRIT J UROL, V77, P530, DOI 10.1046/j.1464-410X.1996.09298.x; Pezzone MA, 2003, AM J PHYSIOL-RENAL, V284, pF925, DOI 10.1152/ajprenal.00138.2002; RAMSAY JWA, 1985, BRIT J UROL, V57, P630, DOI 10.1111/j.1464-410X.1985.tb07021.x; Richter S, 2000, BJU INT, V85, P408, DOI 10.1046/j.1464-410x.2000.00478.x; ROOS R, 1971, J FLUID MECH, V46, P625, DOI 10.1017/S0022112071000752; RYAN PC, 1994, BRIT J UROL, V74, P434, DOI 10.1111/j.1464-410X.1994.tb00418.x; SEGUR JB, 1951, IND ENG CHEM, V43, P2117, DOI 10.1021/ie50501a040; Siggers JH, 2009, MATH MED BIOL, V26, P1, DOI 10.1093/imammb/dqn020; Stoller ML, 2000, BJU INT, V85, P628, DOI 10.1046/j.1464-410x.2000.00489.x; TOFFT HP, 1986, UROL INT, V41, P292, DOI 10.1159/000281221; Venkatesan N, 2011, UROL RES, V39, P29, DOI 10.1007/s00240-010-0280-7; Venkatesan N, 2010, J ENDOUROL, V24, P191, DOI 10.1089/end.2009.0516; Waters SL, 2008, P I MECH ENG H, V222, P551, DOI 10.1243/09544119JEIM317; Zhang XL, 2006, MRS BULL, V31, P95, DOI 10.1557/mrs2006.22	37	34	34	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87433	10.1371/journal.pone.0087433	http://dx.doi.org/10.1371/journal.pone.0087433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498322	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000330626900068
J	Hjorth, JJJ; van Pelt, J; Mansvelder, HD; van Ooyen, A				Hjorth, J. J. Johannes; van Pelt, Jaap; Mansvelder, Huibert D.; van Ooyen, Arjen			Competitive Dynamics during Resource-Driven Neurite Outgrowth	PLOS ONE			English	Article							GROWING NEURITES; MICROTUBULE POLYMERIZATION; INDIVIDUAL MICROTUBULES; AXONAL ELONGATION; TRANSPORT; TUBULIN; GROWTH; ACTIN; MODEL; NEURONS	Neurons form networks by growing out neurites that synaptically connect to other neurons. During this process, neurites develop complex branched trees. Interestingly, the outgrowth of neurite branches is often accompanied by the simultaneous withdrawal of other branches belonging to the same tree. This apparent competitive outgrowth between branches of the same neuron is relevant for the formation of synaptic connectivity, but the underlying mechanisms are unknown. An essential component of neurites is the cytoskeleton of microtubules, long polymers of tubulin dimers running throughout the entire neurite. To investigate whether competition between neurites can emerge from the dynamics of a resource such as tubulin, we developed a multi-compartmental model of neurite growth. In the model, tubulin is produced in the soma and transported by diffusion and active transport to the growth cones at the tip of the neurites, where it is assembled into microtubules to elongate the neurite. Just as in experimental studies, we find that the outgrowth of a neurite branch can lead to the simultaneous retraction of its neighboring branches. We show that these competitive interactions occur in simple neurite morphologies as well as in complex neurite arborizations and that in developing neurons competition for a growth resource such as tubulin can account for the differential outgrowth of neurite branches. The model predicts that competition between neurite branches decreases with path distance between growth cones, increases with path distance from growth cone to soma, and decreases with a higher rate of active transport. Together, our results suggest that competition between outgrowing neurites can already emerge from relatively simple and basic dynamics of a growth resource. Our findings point to the need to test the model predictions and to determine, by monitoring tubulin concentrations in outgrowing neurons, whether tubulin is the resource for which neurites compete.	[Hjorth, J. J. Johannes; van Pelt, Jaap; Mansvelder, Huibert D.; van Ooyen, Arjen] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Ooyen, A (corresponding author), Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands.	arjen.van.ooyen@falw.vu.nl	Mansvelder, Huibert/N-6138-2018; Hjorth, Johannes/A-2043-2009	Mansvelder, Huibert/0000-0003-1365-5340; Hjorth, Johannes/0000-0002-9302-0750	Computational Life Sciences program of the Netherlands Organization for Scientific Research (NWO) [635.100.017]	Computational Life Sciences program of the Netherlands Organization for Scientific Research (NWO)	JJJH was funded by grant 635.100.017, awarded to AvO, of the Computational Life Sciences program of the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAAS PW, 1993, J CELL BIOL, V120, P1427, DOI 10.1083/jcb.120.6.1427; Campenot RB, 2000, J NEUROCYTOL, V29, P793, DOI 10.1023/A:1010939307434; Chang SH, 1999, NAT CELL BIOL, V1, P399, DOI 10.1038/15629; Costa LD, 2002, NETWORK-COMP NEURAL, V13, P283, DOI 10.1088/0954-898X/13/3/303; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; FORGUE ST, 1978, J NEUROCHEM, V31, P1289, DOI 10.1111/j.1471-4159.1978.tb06254.x; Galbraith JA, 1999, P NATL ACAD SCI USA, V96, P11589, DOI 10.1073/pnas.96.20.11589; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Graham BP, 2004, J THEOR BIOL, V230, P421, DOI 10.1016/j.jtbi.2004.06.007; Graham BP, 2001, NEUROCOMPUTING, V38, P31, DOI 10.1016/S0925-2312(01)00463-5; HALLORAN MC, 1994, J NEUROSCI, V14, P2161; Hely TA, 2001, J THEOR BIOL, V210, P375, DOI 10.1006/jtbi.2001.2314; HILLE B, 1984, IONIC CHANNELS EXCIT, V174; Hutchins BI, 2008, J NEUROSCI, V28, P143, DOI 10.1523/JNEUROSCI.4548-07.2008; Janulevicius A, 2006, BIOPHYS J, V90, P788, DOI 10.1529/biophysj.105.059410; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; KEITH CH, 1990, CELL MOTIL CYTOSKEL, V17, P95, DOI 10.1002/cm.970170205; Koene RA, 2009, NEUROINFORMATICS, V7, P195, DOI 10.1007/s12021-009-9052-3; Krouglova T, 2004, BIOPHYS J, V87, P2635, DOI 10.1529/biophysj.104.040717; Laferriere NB, 1997, BIOCHEM CELL BIOL, V75, P103, DOI 10.1139/bcb-75-2-103; Lu W, 2013, CURR BIOL, V23, P1018, DOI 10.1016/j.cub.2013.04.050; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Miller KE, 1996, J CELL BIOL, V133, P1355, DOI 10.1083/jcb.133.6.1355; Miller KE, 1997, J THEOR BIOL, V186, P373, DOI 10.1006/jtbi.1996.0355; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Morrison EE, 2002, MOL BRAIN RES, V98, P145, DOI 10.1016/S0169-328X(01)00290-X; Mudrakola HV, 2009, STRUCTURE, V17, P1433, DOI 10.1016/j.str.2009.09.008; O'Toole M, 2008, BIOPHYS J, V94, P2610, DOI 10.1529/biophysj.107.117424; Odde DJ, 1997, BIOPHYS J, V73, P88, DOI 10.1016/S0006-3495(97)78050-0; OKABE S, 1990, NATURE, V343, P479, DOI 10.1038/343479a0; REINSCH SS, 1991, J CELL BIOL, V115, P365, DOI 10.1083/jcb.115.2.365; Sanford SD, 2008, EUR J NEUROSCI, V28, P268, DOI 10.1111/j.1460-9568.2008.06327.x; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Singh KK, 2005, NEURON, V45, P837, DOI 10.1016/j.neuron.2005.01.049; Sugimura K, 2007, PLOS COMPUT BIOL, V3, P2143, DOI 10.1371/journal.pcbi.0030212; Toriyama M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.51; Tsaneva-Atanasova K, 2009, BIOPHYS J, V96, P840, DOI 10.1016/j.bpj.2008.10.036; van Ooyen A, 2001, NEUROCOMPUTING, V38, P73, DOI 10.1016/S0925-2312(01)00487-8; van Ooyen A, 2011, NAT REV NEUROSCI, V12, P311, DOI 10.1038/nrn3031; van Pelt J, 2002, NETWORK-COMP NEURAL, V13, P261, DOI 10.1088/0954-898X/13/3/302; vanPelt J, 1997, J COMP NEUROL, V387, P325; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang L, 2002, CURR BIOL, V12, P1496, DOI 10.1016/S0960-9822(02)01078-3; Zakharenko S, 1998, J CELL BIOL, V143, P1077, DOI 10.1083/jcb.143.4.1077	47	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86741	10.1371/journal.pone.0086741	http://dx.doi.org/10.1371/journal.pone.0086741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498280	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900026
J	Kowalczyk, N; Rousvoal, S; Herve, C; Boyen, C; Collen, J				Kowalczyk, Nathalie; Rousvoal, Sylvie; Herve, Cecile; Boyen, Catherine; Collen, Jonas			RT-qPCR Normalization Genes in the Red Alga Chondrus crispus	PLOS ONE			English	Article							MASTOCARPUS-STELLATUS; HOUSEKEEPING GENES; INTERNAL CONTROL; EXPRESSION; PCR; RHODOPHYTA; VALIDATION; SELECTION; PHOTOSYNTHESIS; TRANSCRIPTOME	Chondrus crispus is a common red macroalga living on the rocky shores of the North Atlantic Ocean. It has a long research history, being a major source of carrageenan, a thickener widely used in the food industry, but also for physiological and ecological studies. To establish it as a model for red algae, its genome has been sequenced, allowing the development of molecular tools such as quantification of gene expression, including RNAseq and RT-qPCR. To determine appropriate genes for RT-qPCR normalization, the expression of 14 genes was monitored in 18 conditions using two sets of algal samples: samples from the sequenced strain, cultured and stressed in laboratory conditions and C. crispus collected on the shore and stressed in situ. The expression stability of the genes between the samples was evaluated by comparing the Ct range and using the programs geNorm and NormFinder. The candidate genes encoded translation related proteins (initiation factors IF4A-1 and IF4A-2, elongation factor EF1 alpha and eRF3, an eukaryotic polypeptide chain release factor), cytoskeleton proteins (two beta-tubulins, alpha-tubulin and actin), enzymes involved in the pentose phosphate pathway (glucose 6-phosphate deshydrogenase), protein recycling process (ubiquitin and ubiquitin-conjugating enzyme) and glycolysis (isocitrate dehydrogenase). The two sets of samples showed different expression patterns. Most of the genes were stable in the algae cultivated in the laboratory, whereas environmental samples showed a more important variation in gene expression. When analyzing the two sets separately, the ranking of the most stables genes were different from one method to another. When considering all samples, the two statistical methods were concordant, revealing translation initiation factor 4A-2 and eukaryotic polypeptide chain release factor 3 as pertinent normalization genes. This study highlights thus the importance of testing reference genes according to the experiments as well as the genetic and physiological background of the organism.	[Kowalczyk, Nathalie; Rousvoal, Sylvie; Herve, Cecile; Boyen, Catherine; Collen, Jonas] CNRS, Stn Biol Roscoff, Vegetaux Marins & Biomol UMR7139, Roscoff, Brittany, France; [Kowalczyk, Nathalie; Rousvoal, Sylvie; Herve, Cecile; Boyen, Catherine; Collen, Jonas] Univ Paris 06, Stn Biol Roscoff, Roscoff, Brittany, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Collen, J (corresponding author), CNRS, Stn Biol Roscoff, Vegetaux Marins & Biomol UMR7139, Roscoff, Brittany, France.	collen@sb-roscoff.fr		Herve, Cecile/0000-0001-6649-8137	IDEALG, Biotechnologies-Bioressources [ANR-10-BTBR-04-02, 04-04]	IDEALG, Biotechnologies-Bioressources	This work was supported by funding from IDEALG Grants ANR-10-BTBR-04-02 and 04-04 "investissements d'avenir," Biotechnologies-Bioressources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Cabello-Pasini A, 2000, J PHOTOCH PHOTOBIO B, V57, P169, DOI 10.1016/S1011-1344(00)00095-6; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Collen J, 1999, PLANT CELL ENVIRON, V22, P1143, DOI 10.1046/j.1365-3040.1999.00477.x; Collen J, 2007, NEW PHYTOL, V176, P45, DOI 10.1111/j.1469-8137.2007.02152.x; Collen J, 2006, J EXP BOT, V57, P3869, DOI 10.1093/jxb/erl171; Collen J, 2013, P NATL ACAD SCI USA, V110, P5247, DOI 10.1073/pnas.1221259110; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Herve C, 2006, CURR GENET, V49, P190, DOI 10.1007/s00294-005-0044-z; Herve C, 2008, BIOCHEM J, V412, P535, DOI 10.1042/BJ20071464; Ho CL, 2009, MAR BIOTECHNOL, V11, P513, DOI 10.1007/s10126-008-9166-x; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Le Bail A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-75; Lohrmann NL, 2004, BIOL BULL-US, V207, P225, DOI 10.2307/1543211; Lu N, 2012, MOLECULES, V17, P4522, DOI 10.3390/molecules17044522; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Spinsanti G, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-32; Teo SS, 2009, J PHYCOL, V45, P1093, DOI 10.1111/j.1529-8817.2009.00724.x; Thomas F, 2011, J MICROBIOL METH, V84, P61, DOI 10.1016/j.mimet.2010.10.016; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu XJ, 2012, J PHYCOL, V48, P1040, DOI 10.1111/j.1529-8817.2012.01188.x	25	8	8	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86574	10.1371/journal.pone.0086574	http://dx.doi.org/10.1371/journal.pone.0086574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498277	Green Published, gold			2022-12-25	WOS:000330626900023
J	Lima, IS; Silva, JS; Almeida, VA; Leal, FG; Souza, PAN; Larangeira, DF; Moura-Neto, JP; Fraga, DBM; de Freitas, LAR; dos-Santos, WLC				Lima, Isadora S.; Silva, Joselli S.; Almeida, Valter A.; Leal Junior, Floriano G.; Souza, Patricio A. N.; Larangeira, Daniela F.; Moura-Neto, Jose P.; Fraga, Deborah B. M.; de Freitas, Luiz A. R.; dos-Santos, Washington L. C.			Severe Clinical Presentation of Visceral Leishmaniasis in Naturally Infected Dogs with Disruption of the Splenic White Pulp	PLOS ONE			English	Article							SPLEEN; LYMPHOCYTES; HISTOPATHOLOGY; APOPTOSIS; DIAGNOSIS; CHAGASI; CXCL13; TISSUE; MICE	In this work, we investigated the association between the disruption of splenic lymphoid tissue and the severity of visceral leishmaniasis in dogs. Clinical and laboratory data from 206 dogs were reviewed. Spleen sections collected during the euthanasia of these animals were analyzed, and the splenic lymphoid tissue samples were classified as well organized (spleen type 1), slightly disorganized (spleen type 2), or moderately to extensively disorganized (spleen type 3). Of 199 dogs with evidence of Leishmania infection, 54 (27%) had spleen type 1, 99 (50%) had spleen type 2, and 46 (23%) had spleen type 3. The number of clinical signs associated with visceral leishmaniasis was significantly higher in the animals with evidence of Leishmania infection and spleen type 2 or 3 than in the animals with spleen type 1. Alopecia, anemia, dehydration, dermatitis, lymphadenopathy, and onychogryphosis were all more frequent among animals with evidence of Leishmania infection and spleen type 3 than among the dogs with evidence of Leishmania infection and spleen type 1. The association between the severity of canine visceral leishmaniasis and the disorganization of the splenic lymphoid tissue was even more evident in the group of animals with positive spleen culture. Conjunctivitis and ulceration were also more common in the animals with spleen type 3 than in the animals with spleen type 1. The serum levels (median, interquartile range) of albumin (1.8, 1.4-2.3 g/dL) and creatinine (0.7, 0.4-0.8 mg/dL) were significantly lower and the serum levels of aspartate aminotransferase were significantly higher (57, 39-95 U) in animals with spleen type 3 than in animals with spleen type 1 (2.8, 2.4-3.4 g/dL; 0.9, 0.7-1.2 mg/dL and 23, 20-32 U, respectively). Our data confirm the hypothesis that disruption of the splenic lymphoid tissue is associated with a more severe clinical presentation of canine visceral leishmaniasis.	[Lima, Isadora S.; Silva, Joselli S.; Almeida, Valter A.; Fraga, Deborah B. M.; de Freitas, Luiz A. R.; dos-Santos, Washington L. C.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil; [Leal Junior, Floriano G.; Souza, Patricio A. N.] Ctr Referencia Doencas Endem Piraja da Silva PIEJ, Jequie, BA, Brazil; [Larangeira, Daniela F.; Fraga, Deborah B. M.] Univ Fed Bahia, Escola Med Vet, Salvador, BA, Brazil; [Moura-Neto, Jose P.] Univ Fed Amazonia, Fac Ciencias Farmaceut, Manaus, Amazonas, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal de Amazonas	dos-Santos, WLC (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.	wluis@bahia.fiocruz.br	Moura Neto, Jose Pereira/GLT-8680-2022; DOS-SANTOS, WASHINGTON/B-4173-2009; dos-Santos, Washington LC/AAO-4649-2021; Fraga, Deborah/AAL-5342-2021	DOS-SANTOS, WASHINGTON/0000-0003-1445-2318; dos-Santos, Washington LC/0000-0002-5075-1254; Almeida, Valter/0000-0001-8380-3391; Lima, Isadora/0000-0002-5325-5299	Fundacao de Amparo a Pesquisa do Estado da Bahia (Fapesb) [APR0434/2005, DTE0037/2011]; Fundacao Oswaldo Cruz (Fiocruz) [403470/2008-0]	Fundacao de Amparo a Pesquisa do Estado da Bahia (Fapesb)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Fundacao Oswaldo Cruz (Fiocruz)	This work was supported by Fundacao de Amparo a Pesquisa do Estado da Bahia (Fapesb. http://www.fapesb.ba.gov.br) grant no. APR0434/2005, Grant no. DTE0037/2011 and Fundacao Oswaldo Cruz (Fiocruz. http://portal.fiocruz.br/pt-br) PAPES V grant 403470/2008-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE TM, 1990, J INFECT DIS, V162, P1354, DOI 10.1093/infdis/162.6.1354; Aust G, 2004, EUR J ENDOCRINOL, V150, P225, DOI 10.1530/eje.0.1500225; Barrouin-Melo SM, 2006, VET J, V171, P331, DOI 10.1016/j.tvjl.2004.11.010; Barrouin-Melo SM, 2006, VET IMMUNOL IMMUNOP, V111, P251, DOI 10.1016/j.vetimm.2006.01.021; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Berrahal F, 1996, AM J TROP MED HYG, V55, P273, DOI 10.4269/ajtmh.1996.55.273; Carrion J, 2006, PARASITE IMMUNOL, V28, P173, DOI 10.1111/j.1365-3024.2006.00817.x; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; CORBETT CEP, 1992, INT J EXP PATHOL, V73, P417; Dos-Santos WLC, 2008, VET IMMUNOL IMMUNOP, V123, P251, DOI 10.1016/j.vetimm.2008.02.004; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; de Lima VMF, 2012, VET PARASITOL, V184, P147, DOI 10.1016/j.vetpar.2011.08.024; Fraga DBM, 2012, VET PARASITOL, V190, P591, DOI 10.1016/j.vetpar.2012.06.025; Francino O, 2006, VET PARASITOL, V137, P214, DOI 10.1016/j.vetpar.2006.01.011; Giunchetti RC, 2008, VET IMMUNOL IMMUNOP, V121, P23, DOI 10.1016/j.vetimm.2007.07.009; Hansen K, 2001, PEDIATR DEVEL PATHOL, V4, P105, DOI 10.1007/s100240010145; Henry RA, 2010, J IMMUNOL, V185, P1460, DOI 10.4049/jimmunol.0903710; Ikezawa F, 2008, J TRAUMA, V65, P360, DOI 10.1097/TA.0b013e31817c9711; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; KEENAN CM, 1984, VET PATHOL, V21, P80, DOI 10.1177/030098588402100114; Kemming G, 2004, EUR SURG RES, V36, P198, DOI 10.1159/000078853; KIRKWOOD BR, 2001, ESSENTIALS MED STAT; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; Kumagai K, 2004, J VET MED SCI, V66, P175, DOI 10.1292/jvms.66.175; LESTER SJ, 1995, CAN VET J, V36, P444; Lima WG, 2004, ACTA TROP, V92, P43, DOI 10.1016/j.actatropica.2004.04.007; MCCULLOUGH B, 1974, AM J PATHOL, V74, P155; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Ministerio da Saude do Brasil S, 2006, MANUAL VIGILANCIA CO; Paranhos-Silva M, 2003, VET PARASITOL, V114, P97, DOI 10.1016/S0304-4017(03)00132-8; Paxian S, 2002, GASTROENTEROLOGY, V122, P1853, DOI 10.1053/gast.2002.33651; Santana CC, 2008, PARASITE IMMUNOL, V30, P515, DOI 10.1111/j.1365-3024.2008.01051.x; Silva JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029103; Smelt SC, 1997, J IMMUNOL, V158, P3813; Steiniger B, 1999, MICROANATOMY FUNCTIO; STEVENS DR, 1976, J AM VET MED ASSOC, V168, P493; VERESS B, 1983, BRIT J EXP PATHOL, V64, P505; VERESS B, 1977, IMMUNOLOGY, V33, P605	38	23	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87742	10.1371/journal.pone.0087742	http://dx.doi.org/10.1371/journal.pone.0087742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498367	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900113
J	Mallet, B; Martos, F; Blambert, L; Pailler, T; Humeau, L				Mallet, Bertrand; Martos, Florent; Blambert, Laury; Pailler, Thierry; Humeau, Laurence			Evidence for Isolation-by-Habitat among Populations of an Epiphytic Orchid Species on a Small Oceanic Island	PLOS ONE			English	Article							GENE FLOW; ECOLOGICAL SPECIATION; REPRODUCTIVE ISOLATION; SEEDLING RECRUITMENT; REUNION ISLAND; SPUR LENGTH; DIFFERENTIATION; PLASTICITY; DISPERSAL; EVOLUTION	Identifying factors that promote population differentiation is of interest for understanding the early stages of speciation. Gene flow among populations inhabiting different environments can be reduced by geographical distance (isolation-by-distance) or by divergent selection resulting from local adaptation (isolation-by-ecology). Few studies have investigated the influence of these factors in small oceanic islands where the influence of geographic distance is expected to be null but where habitat diversity could have a strong effect on population differentiation. In this study, we tested for the spatial divergence of phenotypes (floral morphology and floral scent) and genotypes (microsatellites) among ten populations of Jumellea rossii, an epiphytic orchid endemic to Reunion growing in three different habitats. We found a significant genetic differentiation between populations that is structured by habitat heterogeneity rather than by geographic distance between populations. These results suggest that ecological factors might reduce gene flow among populations located in different habitats. This pattern of isolation-by-habitat may be the result of both isolation-by-ecology by habitat filtering and asynchrony in flowering phenology. Furthermore, data on floral morphology match these findings, with multivariate analysis grouping populations by habitat type but could be only due to phenotypic plasticity. Indeed floral scent compounds were not significantly different between populations indicating that specific plant-pollinator mutualism does not seem to play a major role in the population differentiation of J. rossii. In conclusion, the results from our study emphasize the importance of habitat diversity of small oceanic islands as a factor of population differentiation.	[Mallet, Bertrand; Blambert, Laury; Pailler, Thierry; Humeau, Laurence] Univ La Reunion, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Denis, Reunion, France; [Martos, Florent] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa	University of La Reunion; University of Kwazulu Natal	Mallet, B (corresponding author), Univ La Reunion, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Denis, Reunion, France.	bertrand.mallet@univ-reunion.fr	Humeau, Laurence/AAF-3600-2019; Florent, Martos/B-5151-2014	Florent, Martos/0000-0003-1213-5466; Pailler, Thierry/0000-0002-6854-9126	Conseil General de La Reunion; Universite de La Reunion; Ministere francais des Outre-mer through the ORCHIFAH project	Conseil General de La Reunion; Universite de La Reunion; Ministere francais des Outre-mer through the ORCHIFAH project	This work was supported by the Conseil General de La Reunion, the Universite de La Reunion and by the Ministere francais des Outre-mer through the ORCHIFAH project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JD, 1996, OECOLOGIA, V106, P192, DOI 10.1007/BF00328598; ACKERMAN JD, 1994, P 14 WORLD ORCH C, P125; Adams R.P., 2004, IDENTIFICATION ESSEN, V3rd ed.; [Anonymous], 1930, CR HEBD ACAD SCI; Arditti J, 2000, NEW PHYTOL, V145, P367, DOI 10.1046/j.1469-8137.2000.00587.x; Carroll AB, 2001, AM J BOT, V88, P438, DOI 10.2307/2657108; Caruso CM, 2006, AM J BOT, V93, P531, DOI 10.3732/ajb.93.4.531; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Coyne JA, 2004, SPECIATION; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dorken ME, 2004, J ECOL, V92, P32, DOI 10.1111/j.1365-2745.2004.00857.x; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Faubet P, 2008, GENETICS, V178, P1491, DOI 10.1534/genetics.107.082560; Frankham R., 2004, PRIMER CONSERVATION, DOI [10.1017/CBO9780511817359, DOI 10.1017/CBO9780511817359]; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Givnish TJ, 2010, TAXON, V59, P1326, DOI 10.1002/tax.595003; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Grant V., 1981, PLANT SPECIATION, Vsecond; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hardy OJ, 2003, GENETICS, V163, P1467; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; HERRERA CM, 1988, BIOL J LINN SOC, V35, P95, DOI 10.1111/j.1095-8312.1988.tb00461.x; Humeau L, 2010, MOL ECOLOGY RESOURCE, V10, P1098; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jacquemyn H, 2005, J BIOGEOGR, V32, P1751, DOI 10.1111/j.1365-2699.2005.01307.x; Jacquemyn H, 2007, NEW PHYTOL, V176, P448, DOI 10.1111/j.1469-8137.2007.02179.x; Jacquemyn H, 2007, BIOL CONSERV, V136, P388, DOI 10.1016/j.biocon.2006.12.008; Jersakova J, 2007, NEW PHYTOL, V176, P237, DOI 10.1111/j.1469-8137.2007.02223.x; Johnson SD, 1997, EVOLUTION, V51, P45, DOI 10.1111/j.1558-5646.1997.tb02387.x; Johnson SD, 2011, P ROY SOC B-BIOL SCI, V278, P2303, DOI 10.1098/rspb.2010.2175; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Le Pechon T, 2010, ANN BOT-LONDON, V106, P343, DOI 10.1093/aob/mcq116; Lee CR, 2011, MOL ECOL, V20, P4631, DOI 10.1111/j.1365-294X.2011.05310.x; Levin D. A., 2000, OX ECOL EV; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Lowry DB, 2008, EVOLUTION, V62, P2196, DOI 10.1111/j.1558-5646.2008.00457.x; Machon N, 2003, NEW PHYTOL, V157, P677, DOI 10.1046/j.1469-8137.2003.00694.x; Magurran AE, 1998, PHILOS T R SOC B, V353, P275, DOI 10.1098/rstb.1998.0209; Mallet B, 2012, REV ECOL-TERRE VIE, P73; Micheneau C, 2008, MOL PHYLOGENET EVOL, V46, P908, DOI 10.1016/j.ympev.2007.12.001; Mila B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-158; NILSSON LA, 1988, NATURE, V334, P147, DOI 10.1038/334147a0; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; Orsini L, 2013, MOL ECOL, V22, P5983, DOI 10.1111/mec.12561; Osborne OG, 2013, GENOME BIOL EVOL, V5, P1704, DOI 10.1093/gbe/evt127; Papadopulos AST, 2011, P NATL ACAD SCI USA, V108, P13188, DOI 10.1073/pnas.1106085108; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Phillips RD, 2012, MOL ECOL, V21, P5208, DOI 10.1111/mec.12036; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2012, R LANG ENV STAT COMP; Raguso RA, 2003, PHYTOCHEMISTRY, V63, P265, DOI 10.1016/S0031-9422(03)00113-4; Rakotoarivelo FP, 2012, TAXON, V61, P534, DOI 10.1002/tax.613004; Rasmussen HN, 2002, PLANT SOIL, V244, P149, DOI 10.1023/A:1020246715436; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Salzmann CC, 2007, ANN BOT-LONDON, V100, P757, DOI 10.1093/aob/mcm161; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Shafer ABA, 2013, ECOL LETT, V16, P940, DOI 10.1111/ele.12120; SLATKIN M, 1995, GENETICS, V139, P457; Sletvold N, 2010, INT J PLANT SCI, V171, P999, DOI 10.1086/656597; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Strasberg D, 2005, BIODIVERS CONSERV, V14, P3015, DOI 10.1007/s10531-004-0258-2; Strijk JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042932; Surget-Groba Y, 2012, ECOLOGY, V2012, P1; Tremblay RL, 2005, BIOL J LINN SOC, V84, P1, DOI 10.1111/j.1095-8312.2004.00400.x; Wang IJ, 2013, EVOLUTION; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Weinig C, 2002, AM J BOT, V89, P230, DOI 10.3732/ajb.89.2.230; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1946, GENETICS, V31, P39; Wright S, 1943, GENETICS, V28, P114	86	27	28	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87469	10.1371/journal.pone.0087469	http://dx.doi.org/10.1371/journal.pone.0087469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498329	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900075
J	Ryan, DM; Vincent, TL; Salit, J; Walters, MS; Agosto-Perez, F; Shaykhiev, R; Strulovici-Barel, Y; Downey, RJ; Buro-Auriemma, LJ; Staudt, MR; Hackett, NR; Mezey, JG; Crystal, RG				Ryan, Dorothy M.; Vincent, Thomas L.; Salit, Jacqueline; Walters, Matthew S.; Agosto-Perez, Francisco; Shaykhiev, Renat; Strulovici-Barel, Yael; Downey, Robert J.; Buro-Auriemma, Lauren J.; Staudt, Michelle R.; Hackett, Neil R.; Mezey, Jason G.; Crystal, Ronald G.			Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD Risk Locus 19q13.2	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENOME-WIDE ASSOCIATION; EPITHELIAL-CELLS; STEM-CELLS; LUNG-CANCER; GROWTH; BETA; GENE; HYPOXIA; KINASE	Genome-wide association studies (GWAS) and candidate gene studies have identified a number of risk loci associated with the smoking-related disease COPD, a disorder that originates in the airway epithelium. Since airway basal cell (BC) stem/progenitor cells exhibit the earliest abnormalities associated with smoking (hyperplasia, squamous metaplasia), we hypothesized that smoker BC have a dysregulated transcriptome, enriched, in part, at known GWAS/candidate gene loci. Massive parallel RNA sequencing was used to compare the transcriptome of BC purified from the airway epithelium of healthy nonsmokers (n = 10) and healthy smokers (n = 7). The chromosomal location of the differentially expressed genes was compared to loci identified by GWAS to confer risk for COPD. Smoker BC have 676 genes differentially expressed compared to nonsmoker BC, dominated by smoking up-regulation. Strikingly, 166 (25%) of these genes are located on chromosome 19, with 13 localized to 19q13.2 (p < 10(-4) compared to chance), including 4 genes (NFKBIB, LTBP4, EGLN2 and TGFB1) associated with risk for COPD. These observations provide the first direct connection between known genetic risks for smoking-related lung disease and airway BC, the population of lung cells that undergo the earliest changes associated with smoking.	[Ryan, Dorothy M.; Vincent, Thomas L.; Salit, Jacqueline; Walters, Matthew S.; Shaykhiev, Renat; Strulovici-Barel, Yael; Buro-Auriemma, Lauren J.; Staudt, Michelle R.; Hackett, Neil R.; Mezey, Jason G.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Agosto-Perez, Francisco; Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Downey, Robert J.] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center	Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu	Shaykhiev, Renat/D-2855-2011	Staudt, Michelle/0000-0002-3364-0894; Walters, Matthew/0000-0003-0010-8444	National Institutes of Health [P50HL51746, R01HL107882, T32HL094284, UL1RR024143, UL1TR000457]; Parker B. Francis Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051746, T32HL094284, R01HL107882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by National Institutes of Health [P50HL51746, R01HL107882, T32HL094284, UL1RR024143, and UL1TR000457]; and the Parker B. Francis Foundation [to RS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERBACH O, 1957, NEW ENGL J MED, V256, P97, DOI 10.1056/NEJM195701172560301; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Becker W, 2012, CELL CYCLE, V11, P3389, DOI 10.4161/cc.21404; Berndt A, 2012, EMBO MOL MED, V4, P1144, DOI 10.1002/emmm.201100627; Boezen H Marike, 2009, Proc Am Thorac Soc, V6, P701, DOI 10.1513/pats.200907-058DP; Bucci C, 1999, BIOCHEM BIOPH RES CO, V258, P657, DOI 10.1006/bbrc.1999.0651; Buro-Auriemma LJ, 2013, HUM MOL GEN IN PRESS, V22; Castaldi PJ, 2010, HUM MOL GENET, V19, P526, DOI 10.1093/hmg/ddp519; Chen YT, 2010, AM J PATHOL, V177, P1255, DOI 10.2353/ajpath.2010.091129; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Churg A, 2006, AM J RESP CRIT CARE, V174, P1327, DOI 10.1164/rccm.200605-585OC; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Crystal Ronald G, 2008, Proc Am Thorac Soc, V5, P772, DOI 10.1513/pats.200805-041HR; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Darwish H, 2007, ONCOGENE, V26, P4319, DOI 10.1038/sj.onc.1210195; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Hackett NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018378; Hansel NN, 2013, HUM GENET, V132, P79, DOI 10.1007/s00439-012-1219-6; HIGGINS MW, 1984, AM REV RESPIR DIS, V130, P380; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hong SW, 2011, CANCER BIOL THER, V12, P421, DOI 10.4161/cbt.12.5.15972; Houghton AM, 2013, NAT REV CANCER, V13, P233, DOI 10.1038/nrc3477; Hsu YC, 2009, CLIN CANCER RES, V15, P7309, DOI 10.1158/1078-0432.CCR-09-1572; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Ishida H, 2005, FEBS LETT, V579, P71, DOI 10.1016/j.febslet.2004.11.037; Jimenez G, 2012, J CELL SCI, V125, P1383, DOI 10.1242/jcs.092965; Kim DK, 2012, AM J RESP CRIT CARE, V186, P1238, DOI 10.1164/rccm.201206-1013OC; Kong XY, 2011, AM J RESP CRIT CARE, V183, P43, DOI 10.1164/rccm.201004-0541OC; Lee CJ, 2005, J NEURO-ONCOL, V73, P101, DOI 10.1007/s11060-004-4598-2; Li Y, 2010, CANCER RES, V70, P5695, DOI 10.1158/0008-5472.CAN-10-0392; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; Randell Scott H, 2006, Proc Am Thorac Soc, V3, P718, DOI 10.1513/pats.200605-117SF; Ray Prabir, 2005, Proc Am Thorac Soc, V2, P221, DOI 10.1513/pats.200502-012AC; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Shaykhiev R, 2011, CELL MOL LIFE SCI, V68, P877, DOI 10.1007/s00018-010-0500-x; Siedlinski M, 2011, THORAX, V66, P894, DOI 10.1136/thoraxjnl-2011-200154; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Tambuwala MM, 2010, GASTROENTEROLOGY, V139, P2093, DOI 10.1053/j.gastro.2010.06.068; Taylor RC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000166; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Urban Z, 2009, AM J HUM GENET, V85, P593, DOI 10.1016/j.ajhg.2009.09.013; Vaira V, 2013, CANCER RES, V73, P2695, DOI 10.1158/0008-5472.CAN-12-4232; Wallace SW, 2010, MOL BIOL CELL, V21, P2996, DOI 10.1091/mbc.E10-05-0429; Yasuo M, 2011, EUR RESPIR J, V37, P775, DOI 10.1183/09031936.00022910; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Zhang Q, 2009, CANCER CELL, V16, P413, DOI 10.1016/j.ccr.2009.09.029	54	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88051	10.1371/journal.pone.0088051	http://dx.doi.org/10.1371/journal.pone.0088051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498427	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900173
J	Bello-Gil, D; Maestro, B; Fonseca, J; Feliu, JM; Climent, V; Sanz, JM				Bello-Gil, Daniel; Maestro, Beatriz; Fonseca, Jennifer; Feliu, Juan M.; Climent, Victor; Sanz, Jesus M.			Specific and Reversible Immobilization of Proteins Tagged to the Affinity Polypeptide C-LytA on Functionalized Graphite Electrodes	PLOS ONE			English	Article							CHOLINE-BINDING DOMAIN; BETA-GALACTOSIDASE; DIAZONIUM SALTS; FUSION PROTEINS; SURFACES; CARBON; PURIFICATION; STRATEGIES; BIOSENSORS; REDUCTION	We have developed a general method for the specific and reversible immobilization of proteins fused to the choline-binding module C-LytA on functionalized graphite electrodes. Graphite electrode surfaces were modified by diazonium chemistry to introduce carboxylic groups that were subsequently used to anchor mixed self-assembled monolayers consisting of N, N-diethylethylenediamine groups, acting as choline analogs, and ethanolamine groups as spacers. The ability of the prepared electrodes to specifically bind C-LytA-tagged recombinant proteins was tested with a C-LytA-beta-galactosidase fusion protein. The binding, activity and stability of the immobilized protein was evaluated by electrochemically monitoring the formation of an electroactive product in the enzymatic hydrolysis of the synthetic substrate 4-aminophenyl beta-D-galactopyranoside. The hybrid protein was immobilized in an specific and reversible way, while retaining the catalytic activity. Moreover, these functionalized electrodes were shown to be highly stable and reusable. The method developed here can be envisaged as a general, immobilization procedure on the protein biosensor field.	[Bello-Gil, Daniel; Fonseca, Jennifer; Sanz, Jesus M.] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain; [Bello-Gil, Daniel; Maestro, Beatriz; Feliu, Juan M.; Climent, Victor] Univ Alicante, Inst Univ Electroquim, E-03080 Alicante, Spain	Universidad Miguel Hernandez de Elche; Universitat d'Alacant	Sanz, JM (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain.	jmsanz@umh.es	Maestro, Beatriz/F-3857-2016; Bello, Daniel/R-9448-2019; Sanz, Jesus M/B-2244-2008; Feliu, Juan M./D-1890-2010; Climent, Víctor/F-6491-2011	Maestro, Beatriz/0000-0001-5317-650X; Sanz, Jesus M/0000-0002-4421-9376; Feliu, Juan M./0000-0003-4751-3279; Climent, Víctor/0000-0002-2033-5284	Spanish Ministerio de Economia y Competitividad [BFU2010-17824, CTQ2008-04492-E, CTQ2010-18570]; Valentian Government, Spain [FPA-2010-055]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Valentian Government, Spain	This work was supported by grants BFU2010-17824, CTQ2008-04492-E and CTQ2010-18570 (Spanish Ministerio de Economia y Competitividad) and FPA-2010-055 (Valentian Government, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allongue P, 1997, J AM CHEM SOC, V119, P201, DOI 10.1021/ja963354s; Ash PA, 2012, CHEM COMMUN, V48, P1400, DOI 10.1039/c1cc15871f; Asraf S. S., 2010, CURRENT RES TECHNOLO; Bilitewski U, 2006, ANAL CHIM ACTA, V568, P232, DOI 10.1016/j.aca.2005.12.073; BLANKENBURG R, 1989, BIOCHEMISTRY-US, V28, P8214, DOI 10.1021/bi00446a037; Brady D, 2009, BIOTECHNOL LETT, V31, P1639, DOI 10.1007/s10529-009-0076-4; BRENT R, 1981, P NATL ACAD SCI-BIOL, V78, P4204, DOI 10.1073/pnas.78.7.4204; Charlton Adam, 2008, V421, P137; Corgier BP, 2005, J AM CHEM SOC, V127, P18328, DOI 10.1021/ja056946w; DOBLHOFER K, 1992, LANGMUIR, V8, P1811, DOI 10.1021/la00043a021; dos Santos L, 2010, PHYS CHEM CHEM PHYS, V12, P13962, DOI 10.1039/c0cp00018c; Fernandez-Lafuente R, 2009, ENZYME MICROB TECH, V45, P405, DOI 10.1016/j.enzmictec.2009.08.009; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; Garcia JL, 1998, MICROB DRUG RESIST, V4, P25, DOI 10.1089/mdr.1998.4.25; Gooding JJ, 2008, ELECTROANAL, V20, P573, DOI 10.1002/elan.200704124; Hernandez-Rocamora VM, 2008, PROTEIN ENG DES SEL, V21, P709, DOI 10.1093/protein/gzn046; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDERBERG EM, 1974, J BACTERIOL, V119, P1072, DOI 10.1128/JB.119.3.1072-1074.1974; Ley C, 2011, COLLOID SURFACE B, V88, P539, DOI 10.1016/j.colsurfb.2011.07.044; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Madoz J, 1997, J AM CHEM SOC, V119, P1043, DOI 10.1021/ja963465r; Maestro B, 2005, BIOCHEM J, V387, P479, DOI 10.1042/BJ20041194; Maestro B, 2008, J CHROMATOGR A, V1208, P189, DOI 10.1016/j.chroma.2008.08.106; Maestro B, 2007, FEBS J, V274, P364, DOI 10.1111/j.1742-4658.2006.05584.x; MASSON M, 1995, ANAL CHIM ACTA, V304, P353, DOI 10.1016/0003-2670(94)00645-3; Michaelis L, 1913, BIOCHEM Z, V49, P333; Millner PA, 2009, SEMIN CELL DEV BIOL, V20, P34, DOI 10.1016/j.semcdb.2009.01.011; Moreno-Guzman M, 2012, BIOSENS BIOELECTRON, V35, P82, DOI 10.1016/j.bios.2012.02.015; Nakanishi Kazuhiro, 2008, Current Proteomics, V5, P161, DOI 10.2174/157016408785909622; Rao SV, 1998, MIKROCHIM ACTA, V128, P127, DOI 10.1007/BF01243043; Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b; Sambrook J, 2001, MOL CLONING LAB MANU; SANCHEZPUELLES JM, 1990, GENE, V89, P69, DOI 10.1016/0378-1119(90)90207-8; SANCHEZPUELLES JM, 1992, EUR J BIOCHEM, V203, P153, DOI 10.1111/j.1432-1033.1992.tb19840.x; SANZ JM, 1988, FEBS LETT, V232, P308, DOI 10.1016/0014-5793(88)80759-2; Sassolas A, 2012, BIOTECHNOL ADV, V30, P489, DOI 10.1016/j.biotechadv.2011.09.003; Schroper F, 2012, BIOSENS BIOELECTRON, V34, P171, DOI 10.1016/j.bios.2012.01.039; Schroper F, 2010, CHEM COMMUN, V46, P5295, DOI 10.1039/c0cc00850h; Serafin V, 2012, ANAL BIOANAL CHEM, V403, P939, DOI 10.1007/s00216-012-5753-9; Sharma SK, 2004, BIOSENS BIOELECTRON, V20, P651, DOI 10.1016/j.bios.2004.03.020; Tammeveski K, 2001, J ELECTROANAL CHEM, V515, P101, DOI 10.1016/S0022-0728(01)00633-7; TENU JP, 1971, EUR J BIOCHEM, V20, P363, DOI 10.1111/j.1432-1033.1971.tb01402.x; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; VIRATELLE OM, 1973, EUR J BIOCHEM, V33, P110, DOI 10.1111/j.1432-1033.1973.tb02661.x; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012	46	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87995	10.1371/journal.pone.0087995	http://dx.doi.org/10.1371/journal.pone.0087995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498237	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900204
J	Bunet, R; Riclea, R; Laureti, L; Hotel, L; Paris, C; Girardet, JM; Spiteller, D; Dickschat, JS; Leblond, P; Aigle, B				Bunet, Robert; Riclea, Ramona; Laureti, Luisa; Hotel, Laurence; Paris, Cedric; Girardet, Jean-Michel; Spiteller, Dieter; Dickschat, Jeroen S.; Leblond, Pierre; Aigle, Bertrand			A Single Sfp-Type Phosphopantetheinyl Transferase Plays a Major Role in the Biosynthesis of PKS and NRPS Derived Metabolites in Streptomyces ambofaciens ATCC23877	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; GENE-CLUSTER; POLYKETIDE SYNTHASE; BACILLUS-SUBTILIS; COELICOLOR A3(2); IDENTIFICATION; CLONING; ORGANIZATION; SUPERFAMILY	The phosphopantetheinyl transferases (PPTases) are responsible for the activation of the carrier protein domains of the polyketide synthases (PKS), non ribosomal peptide synthases (NRPS) and fatty acid synthases (FAS). The analysis of the Streptomyces ambofaciens ATCC23877 genome has revealed the presence of four putative PPTase encoding genes. One of these genes appears to be essential and is likely involved in fatty acid biosynthesis. Two other PPTase genes, samT0172 (alpN) and samL0372, are located within a type II PKS gene cluster responsible for the kinamycin production and an hybrid NRPS-PKS cluster involved in antimycin production, respectively, and their products were shown to be specifically involved in the biosynthesis of these secondary metabolites. Surprisingly, the fourth PPTase gene, which is not located within a secondary metabolite gene cluster, appears to play a pleiotropic role. Its product is likely involved in the activation of the acyl-and peptidyl-carrier protein domains within all the other PKS and NRPS complexes encoded by S. ambofaciens. Indeed, the deletion of this gene affects the production of the spiramycin and stambomycin macrolide antibiotics and of the grey spore pigment, all three being PKS-derived metabolites, as well as the production of the nonribosomally produced compounds, the hydroxamate siderophore coelichelin and the pyrrolamide antibiotic congocidine. In addition, this PPTase seems to act in concert with the product of samL0372 to activate the ACP and/or PCP domains of the antimycin biosynthesis cluster which is also responsible for the production of volatile lactones.	[Bunet, Robert; Laureti, Luisa; Hotel, Laurence; Leblond, Pierre; Aigle, Bertrand] Univ Lorraine, UMR 1128, Vandoeuvre Les Nancy, France; [Bunet, Robert; Laureti, Luisa; Hotel, Laurence; Leblond, Pierre; Aigle, Bertrand] INRA, UMR 1128, Vandoeuvre Les Nancy, France; [Riclea, Ramona; Dickschat, Jeroen S.] TU Braunschweig, Inst Organ Chem, Braunschweig, Germany; [Paris, Cedric] Univ Lorraine, Lab Inge Biomol, Ecole Natl Super Agron & Ind Alimentaires, Vandoeuvre Les Nancy, France; [Girardet, Jean-Michel] Univ Lorraine, URAFPA, Vandoeuvre Les Nancy, France; [Girardet, Jean-Michel] INRA, URAFPA, USC 340, Vandoeuvre Les Nancy, France; [Spiteller, Dieter] Univ Konstanz, Dept Biol, Constance, Germany	Universite de Lorraine; INRAE; Braunschweig University of Technology; Universite de Lorraine; Universite de Lorraine; INRAE; Universite de Lorraine; University of Konstanz	Aigle, B (corresponding author), Univ Lorraine, UMR 1128, Vandoeuvre Les Nancy, France.	bertrand.aigle@univ-lorraine.fr	PARIS, CEDRIC/ABN-7326-2022; Aigle, Bertrand/AAN-8229-2021; LEBLOND, Pierre/AGN-3691-2022	LEBLOND, Pierre/0000-0002-8703-454X; Laureti, Luisa/0000-0002-7863-4922; Aigle, Bertrand/0000-0001-5266-5926	French National Research Agency through the Laboratory of Excellence ARBRE [ANR-12- LABXARBRE-01]; Region Lorraine; Deutsche Forschungsgemeinschaft (DFG) [DI1536/1-3, DI1536/4-1]; DFG [DI1536/3-1]	French National Research Agency through the Laboratory of Excellence ARBRE(French National Research Agency (ANR)); Region Lorraine(Region Grand-Est); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by the French National Research Agency through the Laboratory of Excellence ARBRE (ANR-12- LABXARBRE-01), the Region Lorraine and by the Deutsche Forschungsgemeinschaft (DFG) with an Emmy Noether fellowship (DI1536/1-3) and a Heisenberg fellowship (DI1536/4-1) to JSD, and with a DFG grant "Biologische Chemie der Antimycine und Blastmycinone in Streptomyces ambofaciens" (DI1536/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigle B, 2005, J BACTERIOL, V187, P2491, DOI 10.1128/JB.187.7.2491-2500.2005; Aigle B, 2013, J IND MICROBIOL BIOT; Asghar AH, 2011, MICROBIOL-SGM, V157, P349, DOI 10.1099/mic.0.045559-0; Barona-Gomez F, 2006, MICROBIOL-SGM, V152, P3355, DOI 10.1099/mic.0.29161-0; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bunet R, 2008, J BACTERIOL, V190, P3293, DOI 10.1128/JB.01989-07; Bunet R, 2011, J BACTERIOL, V193, P1142, DOI 10.1128/JB.01269-10; Cerdeno AM, 2001, CHEM BIOL, V8, P817, DOI 10.1016/S1074-5521(01)00054-0; Choulet F, 2006, MOL BIOL EVOL, V23, P2361, DOI 10.1093/molbev/msl108; Copp JN, 2006, APPL ENVIRON MICROB, V72, P2298, DOI 10.1128/AEM.72.4.2298-2305.2006; Craig M, 2012, ENV MICROBIOL REP, V4, P512, DOI 10.1111/j.1758-2229.2012.00354.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dickschat JS, 2004, CHEMBIOCHEM, V5, P778, DOI 10.1002/cbic.200300813; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Gehring AM, 1997, CHEM BIOL, V4, P17, DOI 10.1016/S1074-5521(97)90233-7; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Jiang H, 2013, APPL ENVIRON MICROB, V79, P3346, DOI 10.1128/AEM.00099-13; Juguet M, 2009, CHEM BIOL, V16, P421, DOI 10.1016/j.chembiol.2009.03.010; Karray F, 2007, MICROBIOL-SGM, V153, P4111, DOI 10.1099/mic.0.2007/009746-0; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; LEBLOND P, 1990, FEMS MICROBIOL LETT, V72, P79, DOI 10.1111/j.1574-6968.1990.tb03866.x; Lu YW, 2008, J BACTERIOL, V190, P6903, DOI 10.1128/JB.00865-08; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Mochizuki S, 2003, MOL MICROBIOL, V48, P1501, DOI 10.1046/j.1365-2958.2003.03523.x; Mofid MR, 2004, BIOCHEMISTRY-US, V43, P4128, DOI 10.1021/bi036013h; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; NAKANO MM, 1988, J BACTERIOL, V170, P5662, DOI 10.1128/jb.170.12.5662-5668.1988; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Pavlidou M, 2011, FEMS MICROBIOL LETT, V319, P26, DOI 10.1111/j.1574-6968.2011.02263.x; PINNERTSINDICO S, 1954, ANN I PASTEUR PARIS, V87, P702; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Raynal A, 2006, APPL ENVIRON MICROB, V72, P4839, DOI 10.1128/AEM.00167-06; Riclea R, 2012, CHEMBIOCHEM, V13, P1635, DOI 10.1002/cbic.201200260; Roberts AA, 2009, CHEMBIOCHEM, V10, P1869, DOI 10.1002/cbic.200900095; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Sandy M, 2012, ACS CHEM BIOL, V7, P1956, DOI 10.1021/cb300416w; Schoenian I, 2012, CHEMBIOCHEM, V13, P769, DOI 10.1002/cbic.201200033; Seipke RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022028; Silakowski B, 1999, J BIOL CHEM, V274, P37391, DOI 10.1074/jbc.274.52.37391; Stanley AE, 2006, CHEM COMMUN, P3981, DOI 10.1039/b609556a; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; Wilkinson CJ, 2002, J MOL MICROB BIOTECH, V4, P417	53	29	30	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87607	10.1371/journal.pone.0087607	http://dx.doi.org/10.1371/journal.pone.0087607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498152	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900143
J	Cheng, Y; Moraski, GC; Cramer, J; Miller, MJ; Schorey, JS				Cheng, Yong; Moraski, Garrett C.; Cramer, Jeffrey; Miller, Marvin J.; Schorey, Jeffrey S.			Bactericidal Activity of an Imidazo[1, 2-a]pyridine Using a Mouse M. tuberculosis Infection Model	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DRUG CANDIDATE; IN-VITRO; RESISTANT; CHEMOTHERAPY; CHALLENGES; PROSPECTS; RIFAMPIN; IMMUNITY; TB	Tuberculosis remains a global threat due in part to the long treatment regimen and the increased prevalence of drug resistant M. tuberculosis strains. Therefore, new drug regimens are urgently required to combat this deadly disease. We previously synthesized and evaluated a series of new anti-tuberculosis compounds which belong to the family of imidazo[1,2-a]pyridines. This family of compounds showed low nM MIC (minimal inhibitory concentration) values against M. tuberculosis in vitro. In this study, a derivative of imidazo[1,2-a]pyridines, (N-(4-(4-chlorophenoxy)benzyl)-2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamide) (ND-09759), was selected as a promising lead compound to determine its protective efficacy using a mouse infection model. Pharmacokinetic analysis of ND-09759 determined that at a dosage of 30 mg/kg mouse body weight (PO) gave a maximum serum drug concentration (C-max) of 2.9 mu g/ml and a half-life of 20.1 h. M. tuberculosis burden in the lungs and spleens was significantly decreased in mice treated once daily 6 days per week for 4-weeks with ND-09759 compared to untreated mice and this antibiotic activity was equivalent to isoniazid (INH) and rifampicin (RMP), two first-line anti-TB drugs. We observed slightly higher efficacy when using a combination of ND-09759 with either INH or RMP. Finally, the histopathological analysis revealed that infected mice treated with ND-09759 had significantly reduced inflammation relative to untreated mice. In conclusion, our findings indicate ND-09759 might be a potent candidate for the treatment of active TB in combination with current standard anti-TB drugs.	[Cheng, Yong; Schorey, Jeffrey S.] Univ Notre Dame, Dept Biol Sci, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Cheng, Yong; Schorey, Jeffrey S.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Moraski, Garrett C.; Miller, Marvin J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Cramer, Jeffrey] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; Eli Lilly	Schorey, JS (corresponding author), Univ Notre Dame, Dept Biol Sci, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA.	schorey.1@nd.edu	Moraski, Garrett/AAH-3616-2021	Moraski, Garrett/0000-0002-6992-5584	University of Notre Dame; Hsiri Therapeutics, LLC.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054193] Funding Source: NIH RePORTER	University of Notre Dame; Hsiri Therapeutics, LLC.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received partial funding through University of Notre Dame and Hsiri Therapeutics, LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Alcala L, 2003, ANTIMICROB AGENTS CH, V47, P416, DOI 10.1128/AAC.47.1.416-417.2003; Almeida D, 2009, ANTIMICROB AGENTS CH, V53, P4178, DOI 10.1128/AAC.00830-09; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Engohang-Ndong J, 2012, EXPERT OPIN INV DRUG, V21, P1789, DOI 10.1517/13543784.2012.724397; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Ginsberg A, 2011, FUTURE MED CHEM, V3, P1247, DOI [10.4155/fmc.11.82, 10.4155/FMC.11.82]; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; GROSSET J, 1992, ANTIMICROB AGENTS CH, V36, P548, DOI 10.1128/AAC.36.3.548; Grosset J, 2012, P NATL ACAD SCI USA, V109, P15001, DOI 10.1073/pnas.1203636109; Jayaram R, 2004, ANTIMICROB AGENTS CH, V48, P2951, DOI 10.1128/AAC.48.8.2951-2957.2004; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; Kaushal D, 2012, J MED PRIMATOL, V41, P191, DOI 10.1111/j.1600-0684.2012.00536.x; Lienhardt C, 2012, J INFECT DIS, V205, pS241, DOI 10.1093/infdis/jis034; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Moraski GC, 2013, ACS MED CHEM LETT, V4, P110, DOI 10.1021/ml400088y; Moraski GC, 2011, ACS MED CHEM LETT, V2, P466, DOI 10.1021/ml200036r; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Nuermberger EL, 2010, RESPIROLOGY, V15, P764, DOI 10.1111/j.1440-1843.2010.01775.x; Ollinger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060531; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Prasad R, 2006, Indian J Chest Dis Allied Sci, V48, P183; Protopopova M, 2005, J ANTIMICROB CHEMOTH, V56, P968, DOI 10.1093/jac/dki319; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; WHO, 2010, GLOB TUB CONTR 2010; Young DL, 2009, EUR J IMMUNOL, V39, P2011, DOI 10.1002/eji.200939542	33	44	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87483	10.1371/journal.pone.0087483	http://dx.doi.org/10.1371/journal.pone.0087483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498115	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900120
J	Domenici, P; Allan, BJM; Watson, SA; McCormick, MI; Munday, PL				Domenici, Paolo; Allan, Bridie J. M.; Watson, Sue-Ann; McCormick, Mark I.; Munday, Philip L.			Shifting from Right to Left: The Combined Effect of Elevated CO2 and Temperature on Behavioural Lateralization in a Coral Reef Fish	PLOS ONE			English	Article							OCEAN ACIDIFICATION; DETOUR BEHAVIOR; CARBONIC-ACID; PERFORMANCE; DISSOCIATION; CONSTANTS; SEAWATER; BRAIN	Recent studies have shown that elevated CO2 can affect the behaviour of larval and juvenile fishes. In particular, behavioural lateralization, an expression of brain functional asymmetries, is affected by elevated CO2 in both coral reef and temperate fishes. However, the potentially interacting effects of rising temperatures and CO2 on lateralization are unknown. Here, we tested the combined effect of near-future elevated-CO2 concentrations (930 mu atm) and temperature variation on behavioural lateralization of a marine damselfish, Pomacentrus wardi. Individuals exposed to one of four treatments (two CO2 levels and two temperatures) were observed in a detour test where they made repeated decisions about turning left or right. Individuals exposed to current CO2 and ambient temperature levels showed a significant right-turning bias at the population level. This biased was reversed (i.e. to the left side) in fish exposed to the elevated-CO2 treatment. Increased temperature attenuated this effect, resulting in lower values of relative lateralization. Consequently, rising temperature and elevated CO2 may have different and interactive effects on behavioural lateralization and therefore future studies on the effect of climate change on brain functions need to consider both these critical variables in order to assess the potential consequences for the ecological interactions of marine fishes.	[Domenici, Paolo] CNR, IAMC, Torregrande, Oristano, Italy; [Allan, Bridie J. M.; Watson, Sue-Ann; McCormick, Mark I.; Munday, Philip L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Allan, Bridie J. M.; Watson, Sue-Ann; McCormick, Mark I.; Munday, Philip L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); James Cook University; James Cook University	Domenici, P (corresponding author), CNR, IAMC, Torregrande, Oristano, Italy.	paolo.domenici@cnr.it	McCormick, Mark I/J-8301-2014; Munday, Philip L/F-5443-2011; Watson, Sue-Ann/C-3172-2013; Domenici, Paolo/F-6958-2010	McCormick, Mark I/0000-0001-9289-1645; Munday, Philip L/0000-0001-9725-2498; Watson, Sue-Ann/0000-0002-9818-7429; 	ARC Centre of Excellence for Coral Reef Studies; ARC Discovery grant	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); ARC Discovery grant(Australian Research Council)	Funding was provided by the ARC Centre of Excellence for Coral Reef Studies and an ARC Discovery grant (MIM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058520; Bisazza A, 1997, ANIM BEHAV, V54, P1273, DOI 10.1006/anbe.1997.0522; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; Bisazza A, 1998, BEHAV BRAIN RES, V91, P157, DOI 10.1016/S0166-4328(97)00114-9; Bisazza A, 2005, P ROY SOC B-BIOL SCI, V272, P1677, DOI 10.1098/rspb.2005.3145; Briffa M, 2012, MAR POLLUT BULL, V64, P1519, DOI 10.1016/j.marpolbul.2012.05.032; Brown C, 2004, P ROY SOC B-BIOL SCI, V271, pS455, DOI 10.1098/rsbl.2004.0222; Chivers DP, 2013, GLOB CHANGE IN PRESS; Dadda M, 2006, ANIM BEHAV, V72, P523, DOI 10.1016/j.anbehav.2005.10.019; Dadda M, 2010, BIOL LETTERS, V6, P414, DOI 10.1098/rsbl.2009.0904; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Domenici P, 2012, BIOL LETTERS, V8, P78, DOI 10.1098/rsbl.2011.0591; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Ferrari MCO, 2011, ECOL LETT, V14, P1143, DOI 10.1111/j.1461-0248.2011.01683.x; Jutfelt F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065825; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Munday PL, 2012, J EXP BIOL, V215, P3865, DOI 10.1242/jeb.074765; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Nilsson GE, 2009, GLOBAL CHANGE BIOL, V15, P1405, DOI 10.1111/j.1365-2486.2008.01767.x; Pierrot D., 2006, ORNLCDIAC105A US DEP; Rogers LJ, 2010, APPL ANIM BEHAV SCI, V127, P1, DOI 10.1016/j.applanim.2010.06.008; Sale PF, 1980, B MAR SCI, V30, P147; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; Vallortigara G, 1999, COGNITIVE BRAIN RES, V7, P307, DOI 10.1016/S0926-6410(98)00033-0; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Weetman D, 1999, ANIM BEHAV, V58, P735, DOI 10.1006/anbe.1999.1191	29	50	52	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87969	10.1371/journal.pone.0087969	http://dx.doi.org/10.1371/journal.pone.0087969			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498231	Green Published, gold, Green Accepted			2022-12-25	WOS:000330621900199
J	Wan, HT; Zhao, YG; Leung, PY; Wong, CKC				Wan, Hin T.; Zhao, Yin G.; Leung, Pik Y.; Wong, Chris K. C.			Perinatal Exposure to Perfluorooctane Sulfonate Affects Glucose Metabolism in Adult Offspring	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; GROWTH-FACTOR-I; INSULIN-RESISTANCE; PERFLUORINATED COMPOUNDS; GENE-EXPRESSION; POLYFLUOROALKYL CHEMICALS; ENDOCRINE DISRUPTORS; PERFLUOROALKYL ACIDS; NUCLEAR RECEPTORS; RISK-ASSESSMENT	Perfluoroalkyl acids (PFAAs) are globally present in the environment and are widely distributed in human populations and wildlife. The chemicals are ubiquitous in human body fluids and have a long serum elimination half-life. The notorious member of PFAAs, perfluorooctane sulfonate (PFOS) is prioritized as a global concerning chemical at the Stockholm Convention in 2009, due to its harmful effects in mammals and aquatic organisms. PFOS is known to affect lipid metabolism in adults and was found to be able to cross human placenta. However the effects of in utero exposure to the susceptibility of metabolic disorders in offspring have not yet been elucidated. In this study, pregnant CD-1 mice (F-0) were fed with 0, 0.3 or 3 mg PFOS/kg body weight/day in corn oil by oral gavage daily throughout gestational and lactation periods. We investigated the immediate effects of perinatal exposure to PFOS on glucose metabolism in both maternal and offspring after weaning (PND 21). To determine if the perinatal exposure predisposes the risk for metabolic disorder to the offspring, weaned animals without further PFOS exposure, were fed with either standard or high-fat diet until PND 63. Fasting glucose and insulin levels were measured while HOMA-IR index and glucose AUCs were reported. Our data illustrated the first time the effects of the environmental equivalent dose of PFOS exposure on the disturbance of glucose metabolism in F-1 pups and F-1 adults at PND 21 and 63, respectively. Although the biological effects of PFOS on the elevated levels of fasting serum glucose and insulin levels were observed in both pups and adults of F-1, the phenotypes of insulin resistance and glucose intolerance were only evident in the F-1 adults. The effects were exacerbated under HFD, highlighting the synergistic action at postnatal growth on the development of metabolic disorders.	[Wan, Hin T.; Zhao, Yin G.; Leung, Pik Y.; Wong, Chris K. C.] Hong Kong Baptist Univ, Partner State Key Lab Environm & Biol Anal, Croucher Inst Environm Sci, Dept Biol, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University	Wong, CKC (corresponding author), Hong Kong Baptist Univ, Partner State Key Lab Environm & Biol Anal, Croucher Inst Environm Sci, Dept Biol, Hong Kong, Hong Kong, Peoples R China.	ckcwong@hkbu.edu.hk	Wong, Kristy/C-8748-2015; wong, chris/GSN-0962-2022		General Research Fund, University Grants Committee [HKBU 261812]	General Research Fund, University Grants Committee	This work is supported by the General Research Fund (HKBU 261812), University Grants Committee (CKC Wong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Apelberg BJ, 2007, ENVIRON SCI TECHNOL, V41, P3891, DOI 10.1021/es0700911; Beach SA, 2006, REV ENVIRON CONTAM T, V186, P133, DOI 10.1007/0-387-32883-1_5; Beesoon S, 2011, ENVIRON HEALTH PERSP, V119, P1659, DOI 10.1289/ehp.1003265; Ben-Jonathan N, 2006, TRENDS ENDOCRIN MET, V17, P110, DOI 10.1016/j.tem.2006.02.005; Bjork JA, 2008, TOXICOLOGY, V251, P8, DOI 10.1016/j.tox.2008.06.007; Bjork JA, 2009, TOXICOL SCI, V111, P89, DOI 10.1093/toxsci/kfp093; Borai A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-158; Calafat AM, 2007, ENVIRON HEALTH PERSP, V115, P1596, DOI 10.1289/ehp.10598; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Chang SC, 2012, REPROD TOXICOL, V33, P428, DOI 10.1016/j.reprotox.2011.07.002; Chiang DAJ, 2011, AM J PHYSIOL-GASTR L, V300, pG697, DOI 10.1152/ajpgi.00426.2010; Clarke DB, 2010, FOOD ADDIT CONTAM A, V27, P530, DOI 10.1080/19440040903476590; Clemmons DR, 2006, CURR OPIN PHARMACOL, V6, P620, DOI 10.1016/j.coph.2006.08.006; Clemmons DR, 2012, ENDOCRIN METAB CLIN, V41, P425, DOI 10.1016/j.ecl.2012.04.017; Cui L, 2009, ARCH ENVIRON CON TOX, V56, P338, DOI 10.1007/s00244-008-9194-6; Guruge KS, 2006, TOXICOL SCI, V89, P93, DOI 10.1093/toxsci/kfj011; Hennig B, 2012, ENVIRON HEALTH PERSP, V120, P771, DOI 10.1289/ehp.1104712; Hernandez JP, 2006, TOXICOL APPL PHARM, V216, P186, DOI 10.1016/j.taap.2006.05.014; Ismail MH, 2011, AM J MED SCI, V341, P485, DOI 10.1097/MAJ.0b013e3182018598; Karrman A, 2006, ENVIRON SCI TECHNOL, V40, P3742, DOI 10.1021/es060301u; Kato K, 2011, J CHROMATOGR A, V1218, P2133, DOI 10.1016/j.chroma.2010.10.051; Kim S, 2011, ENVIRON SCI TECHNOL, V45, P7465, DOI 10.1021/es202408a; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lien GW, 2013, CHEMOSPHERE, V92, P843, DOI 10.1016/j.chemosphere.2013.04.038; Lin CY, 2009, DIABETES CARE, V32, P702, DOI 10.2337/dc08-1816; Lin Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE527, DOI 10.1152/ajpendo.00233.2011; Liu JY, 2011, ENVIRON INT, V37, P1206, DOI 10.1016/j.envint.2011.05.001; Loccisano AE, 2012, REPROD TOXICOL, V33, P468, DOI 10.1016/j.reprotox.2011.07.003; Martin MT, 2007, TOXICOL SCI, V97, P595, DOI 10.1093/toxsci/kfm065; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meibohm B, 2002, CLIN PHARMACOKINET, V41, P329, DOI 10.2165/00003088-200241050-00002; Misra A, 2010, J AM COLL NUTR, V29, p289S, DOI 10.1080/07315724.2010.10719844; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Olsen GW, 2003, ENVIRON SCI TECHNOL, V37, P888, DOI 10.1021/es020955c; PURVES RD, 1992, J PHARMACOKINET BIOP, V20, P211, DOI 10.1007/BF01062525; Rinaudo P, 2011, ANN REV PHYSL; Rosen MB, 2009, REPROD TOXICOL, V27, P278, DOI 10.1016/j.reprotox.2009.01.007; Ryan KK, 2010, ENDOCRINOLOGY, V151, P2603, DOI 10.1210/en.2009-1218; Salvalaglio M, 2010, J PHYS CHEM B, V114, P14860, DOI 10.1021/jp106584b; Sarafidis PA, 2007, J HUM HYPERTENS, V21, P709, DOI 10.1038/sj.jhh.1002201; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seacat AM, 2002, TOXICOL SCI, V68, P249, DOI 10.1093/toxsci/68.1.249; Sierra-Santoyo A, 2000, TOXICOL SCI, V54, P81, DOI 10.1093/toxsci/54.1.81; So MK, 2006, ENVIRON SCI TECHNOL, V40, P2924, DOI 10.1021/es060031f; Sugden MC, 2008, BIOCHEM SOC T, V36, P891, DOI 10.1042/BST0360891; Takacs ML, 2007, TOXICOL SCI, V95, P108, DOI 10.1093/toxsci/kfl135; Takamura T, 2012, ENDOCR J, V59, P745, DOI 10.1507/endocrj.EJ12-0228; Targher G, 2013, J CLIN ENDOCRINOL ME, V98, P483; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Vanden Heuvel JP, 2006, TOXICOL SCI, V92, P476, DOI 10.1093/toxsci/kfl014; Wan HT, 2013, J HAZARD MATER, V261, P763, DOI 10.1016/j.jhazmat.2013.01.034; Wan HT, 2012, BBA-GEN SUBJECTS, V1820, P1092, DOI 10.1016/j.bbagen.2012.03.010; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393; Yu WG, 2009, ENVIRON SCI TECHNOL, V43, P8416, DOI 10.1021/es901602d; Zhang H, 2008, TOXICOL APPL PHARM, V227, P16, DOI 10.1016/j.taap.2007.09.026; Zhao YG, 2011, CHEMOSPHERE, V85, P277, DOI 10.1016/j.chemosphere.2011.06.002	59	71	74	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87137	10.1371/journal.pone.0087137	http://dx.doi.org/10.1371/journal.pone.0087137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498028	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900070
J	Zheng, W; Zhang, XY; Yang, ZR; Wu, JH; Li, FL; Duan, LL; Liu, CL; Lu, LL; Zhang, CJ; Li, FG				Zheng, Wu; Zhang, Xueyan; Yang, Zuoren; Wu, Jiahe; Li, Fenglian; Duan, Lanling; Liu, Chuanliang; Lu, Lili; Zhang, Chaojun; Li, Fuguang			AtWuschel Promotes Formation of the Embryogenic Callus in Gossypium hirsutum	PLOS ONE			English	Article							CAUSES ECTOPIC MORPHOGENESIS; TO-EMBRYONIC TRANSITION; STEM-CELL HOMEOSTASIS; SOMATIC EMBRYOGENESIS; TRANSGENIC PLANTS; LEAFY COTYLEDON1; GENE-EXPRESSION; WUSCHEL GENE; AUXIN FLOW; ARABIDOPSIS	Upland cotton (Gossypium hirsutum) is one of the most recalcitrant species for in vitro plant regeneration through somatic embryogenesis. Callus from only a few cultivars can produce embryogenic callus (EC), but the mechanism is not well elucidated. Here we screened a cultivar, CRI24, with high efficiency of EC produce. The expression of genes relevant to EC production was analyzed between the materials easy to or difficult to produce EC. Quantitative PCR showed that CRI24, which had a 100% EC differentiation rate, had the highest expression of the genes GhLEC1, GhLEC2, and GhFUS3. Three other cultivars, CRI12, CRI41, and Lu28 that formed few ECs expressed these genes only at low levels. Each of the genes involved in auxin transport (GhPIN7) and signaling (GhSHY2) was most highly expressed in CRI24, with low levels in the other three cultivars. WUSCHEL (WUS) is a homeodomain transcription factor that promotes the vegetative-to-embryogenic transition. We thus obtained the calli that ectopically expressed Arabidopsis thaliana Wus (AtWus) in G. hirsutum cultivar CRI12, with a consequent increase of 47.75% in EC differentiation rate compared with 0.61% for the control. Ectopic expression of AtWus in CRI12 resulted in upregulation of GhPIN7, GhSHY2, GhLEC1, GhLEC2, and GhFUS3. AtWus may therefore increase the differentiation potential of cotton callus by triggering the auxin transport and signaling pathways.	[Zheng, Wu; Zhang, Xueyan; Yang, Zuoren; Wu, Jiahe; Li, Fenglian; Duan, Lanling; Liu, Chuanliang; Lu, Lili; Zhang, Chaojun; Li, Fuguang] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Wu, Jiahe] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Zhang, CJ (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	zcj1999@yeah.net; aylifug@163.com	Yang, Zuoren/AAF-5040-2020	Yang, Zuoren/0000-0001-5898-6309; Zheng, Wu/0000-0002-5091-9694	National Science Fund for Distinguished Young Scholars [31125020]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This study was supported by National Science Fund for Distinguished Young Scholars (Grant no. 31125020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Herrera A, 2008, PLANT CELL TISS ORG, V94, P171, DOI 10.1007/s11240-008-9401-1; Bouchabke-Coussa O, 2013, PLANT CELL REP, V32, P675, DOI 10.1007/s00299-013-1402-9; Fambrini M, 2006, DEV GENES EVOL, V216, P253, DOI 10.1007/s00427-005-0050-7; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; Goh T, 2012, PHILOS T R SOC B, V367, P1461, DOI 10.1098/rstb.2011.0232; Hu LS, 2011, PLANT BIOTECHNOL J, V9, P1038, DOI 10.1111/j.1467-7652.2011.00617.x; Ikeda-Iwai M, 2002, J EXP BOT, V53, P1575, DOI 10.1093/jxb/erf006; Jin SX, 2005, PLANT CELL TISS ORG, V81, P229, DOI 10.1007/s11240-004-5209-9; Kamiya N, 2003, PLANT J, V35, P429, DOI 10.1046/j.1365-313X.2003.01816.x; Laux T, 1996, DEVELOPMENT, V122, P87; Leelavathi S, 2004, PLANT CELL REP, V22, P465, DOI 10.1007/s00299-003-0710-x; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Parcy F, 1997, PLANT CELL, V9, P1265, DOI 10.1105/tpc.9.8.1265; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Solis-Ramos LY, 2009, PLANT CELL TISS ORG, V96, P279, DOI 10.1007/s11240-008-9485-7; Stone SL, 2008, P NATL ACAD SCI USA, V105, P3151, DOI 10.1073/pnas.0712364105; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Su YH, 2009, PLANT J, V59, P448, DOI 10.1111/j.1365-313X.2009.03880.x; THOMAS TL, 1993, PLANT CELL, V5, P1401, DOI 10.1105/tpc.5.10.1401; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang XC, 2009, CELL RES, V19, P224, DOI 10.1038/cr.2008.276; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Weijers D, 2005, PLANT CELL, V17, P2517, DOI 10.1105/tpc.105.034637; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Wu JH, 2004, IN VITRO CELL DEV-PL, V40, P371, DOI 10.1079/IVP2004535; Xu Z, 2013, J INTEGR PLANT BIOL; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yadav RK, 2011, PLANT SIGNAL BEHAV, V6, P544, DOI 10.4161/psb.6.4.14838; Yadav RK, 2010, DEVELOPMENT, V137, P3581, DOI 10.1242/dev.054973; Yang XY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-110; Zazimalova E, 2007, CELL MOL LIFE SCI, V64, P1621, DOI 10.1007/s00018-007-6566-4; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	37	37	45	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87502	10.1371/journal.pone.0087502	http://dx.doi.org/10.1371/journal.pone.0087502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498119	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900121
J	Zhou, Q; Zhao, F; Lv, ZP; Zheng, CG; Zheng, WD; Sun, L; Wang, NN; Pang, SH; de Andrade, FM; Fu, M; He, XH; Hui, J; Jiang, WY; Yang, CY; Shi, XH; Zhu, XQ; Pang, GF; Yang, YG; Xie, HQ; Zhang, WD; Hu, CY; Yang, Z				Zhou, Qin; Zhao, Fan; Lv, Ze-ping; Zheng, Chen-guang; Zheng, Wei-dong; Sun, Liang; Wang, Na-na; Pang, Shenghang; de Andrade, Fabiana Michelsen; Fu, Mian; He, Xiang-hua; Hui, Juan; Jiang, Wen-yu; Yang, Chu-yu; Shi, Xiao-hong; Zhu, Xiao-quan; Pang, Guo-fang; Yang, Yi-ge; Xie, Hai-qun; Zhang, Wan-dong; Hu, Cai-you; Yang, Ze			Association between APOC1 Polymorphism and Alzheimer's Disease: A Case-Control Study and Meta-Analysis	PLOS ONE			English	Article							C-I EXPRESSION; APOLIPOPROTEIN-E; GENETIC ASSOCIATION; RISK-FACTOR; MEMORY FUNCTIONS; POPULATION; DEMENTIA; IDENTIFY; CHINESE; MARKERS	Background: Previous association studies examining the relationship between the APOC1 polymorphism and susceptibility to Alzheimer's disease (AD) have shown conflicting results, and it is not clear if an APOC1 variant acts as a genetic risk factor in AD etiology across multiple populations. Methods: To confirm the risk association between APOC1 and AD, we designed a case-control study and also performed a meta-analysis of previously published studies. Results: Seventy-nine patients with AD and one hundred fifty-six unrelated controls were included in case-control study. No association was found between the variation of APOC1 and AD in stage 1 of our study. However, our meta-analysis pooled a total of 2092 AD patients and 2685 controls. The APOC1 rs11568822 polymorphism was associated with increased AD risk in Caucasians, Asians and Caribbean Hispanics, but not in African Americans. APOE epsilon 4 carriers harboring the APOC1 insertion allele, were more prevalent in AD patients than controls (chi(2) = 119.46, OR = 2.79, 95% CI = 2.31-3.36, P<0.01). Conclusions: The APOC1 insertion allele, in combination with APOE epsilon 4, likely serves as a potential risk factor for developing AD.	[Zhou, Qin; Zhao, Fan; Zheng, Wei-dong; Sun, Liang; Wang, Na-na; Hui, Juan; Shi, Xiao-hong; Zhu, Xiao-quan; Yang, Yi-ge; Yang, Ze] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Zhou, Qin; Zhao, Fan; Zheng, Wei-dong; Sun, Liang; Wang, Na-na; Hui, Juan; Shi, Xiao-hong; Zhu, Xiao-quan; Yang, Yi-ge; Yang, Ze] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Zhou, Qin; Lv, Ze-ping; Zheng, Chen-guang; Pang, Shenghang; Fu, Mian; He, Xiang-hua; Jiang, Wen-yu; Yang, Chu-yu; Pang, Guo-fang; Xie, Hai-qun; Hu, Cai-you] Jiangbin Hosp, Dept Neurol, Nanning, Peoples R China; [de Andrade, Fabiana Michelsen] Univ Feevale, Hlth Sci Inst, Novo Hamburgo, RS, Brazil; [Zhang, Wan-dong] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	Beijing Hospital; Universidade Feevale; National Research Council Canada	Hu, CY (corresponding author), Jiangbin Hosp, Dept Neurol, Nanning, Peoples R China.	hucaiyoujb@163.com; yang.ze@live.cn	de Andrade, Fabiana M/E-8513-2010		Natural Science Foundation of China [81061120527, 81241082, 81370445]; Beijing Hospital [BJ-2010-30]; key project of clinical disciplines at the subordinate hospital, Ministry Of Health [10120101]; National Department Public Benefit Research Foundation by Ministry of Health P. R. China [201302008]; Ministry of Scientific Technology [2012BAI10B01]; science and technology development foundation of Guangxi Zhuang Autonomous Region [1355005-6-2]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Hospital; key project of clinical disciplines at the subordinate hospital, Ministry Of Health; National Department Public Benefit Research Foundation by Ministry of Health P. R. China; Ministry of Scientific Technology; science and technology development foundation of Guangxi Zhuang Autonomous Region	This study was funded by the Natural Science Foundation of China (81061120527, 81241082, 81370445), the major funding from Beijing Hospital (BJ-2010-30), funding from the key project of clinical disciplines at the subordinate hospital, Ministry Of Health (10120101), National Department Public Benefit Research Foundation by Ministry of Health P. R. China (201302008), 12th 5 year national program from Ministry of Scientific Technology (2012BAI10B01), and the science and technology development foundation of Guangxi Zhuang Autonomous Region (1355005-6-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildayeva K, 2008, J LIPID RES, V49, P856, DOI 10.1194/jlr.M700518-JLR200; Berbee JFP, 2011, J ALZHEIMERS DIS, V23, P737, DOI 10.3233/JAD-2010-100576; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; CHARTIERHARLIN MC, 1994, HUM MOL GENET, V3, P569, DOI 10.1093/hmg/3.4.569; Chuang WL, 2010, J GERIATR PSYCH NEUR, V23, P42, DOI 10.1177/0891988709351804; Deeks J., 2011, COCHRANE HDB SYST RE, V5; Devan WJ, 2013, STROKE, V44, P1578, DOI 10.1161/STROKEAHA.111.000089; Dou C, 2013, CURR ALZHEIMER RES, V10, P63; Drigalenko E, 1998, NEUROLOGY, V51, P131, DOI 10.1212/WNL.51.1.131; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Kamino K, 1996, GERONTOLOGY, V42, P12; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Ki CS, 2002, NEUROSCI LETT, V319, P75, DOI 10.1016/S0304-3940(01)02559-9; Leduc V, 2010, TRENDS MOL MED, V16, P469, DOI 10.1016/j.molmed.2010.07.008; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; LOPAREV VN, 1991, J VIROL METHODS, V34, P105, DOI 10.1016/0166-0934(91)90126-K; Lucatelli JF, 2011, NEUROCHEM RES, V36, P1533, DOI 10.1007/s11064-011-0481-7; Majumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025416; Mullan M, 1996, ANN NY ACAD SCI, V802, P16, DOI 10.1111/j.1749-6632.1996.tb32594.x; Olgiati P, 2012, CURR ALZHEIMER RES, V9, P491, DOI 10.2174/156720512800492431; Petit-Turcotte C, 2001, NEUROBIOL DIS, V8, P953, DOI 10.1006/nbdi.2001.0441; Poduslo SE, 1998, NEUROCHEM RES, V23, P361, DOI 10.1023/A:1022409617539; Qi HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037858; Retz W, 2001, PSYCHIATR GENET, V11, P115, DOI 10.1097/00041444-200109000-00002; Scacchi R, 1999, NEUROSCI LETT, V259, P33, DOI 10.1016/S0304-3940(98)00889-1; Serra-Grabulosa JM, 2003, NEUROGENETICS, V4, P141, DOI 10.1007/s10048-002-0142-8; Shi J, 2004, ACTA NEUROL SCAND, V109, P140, DOI 10.1034/j.1600-0404.2003.00193.x; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Takei N, 2009, GENOMICS, V93, P441, DOI 10.1016/j.ygeno.2009.01.003; Tycko B, 2004, ARCH NEUROL-CHICAGO, V61, P1434, DOI 10.1001/archneur.61.9.1434; Vestergaard M, 2010, CURR ALZHEIMER RES, V7, P262, DOI 10.2174/156720510791050821; Yang JD, 2003, NEUROSCI LETT, V350, P25, DOI 10.1016/S0304-3940(03)00815-2; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	33	36	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87017	10.1371/journal.pone.0087017	http://dx.doi.org/10.1371/journal.pone.0087017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498013	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900059
J	Nie, Y; Walsh, P; Clarke, DL; Rowley, JA; Fellner, T				Nie, Ying; Walsh, Patrick; Clarke, Diana L.; Rowley, Jon A.; Fellner, Thomas			Scalable Passaging of Adherent Human Pluripotent Stem Cells	PLOS ONE			English	Article							SURVIVAL; CULTURE; MOLECULES	Current laboratory methods used to passage adherent human pluripotent stem cells (hPSCs) are labor intensive, result in reduced cell viability and are incompatible with larger scale production necessary for many clinical applications. To meet the current demand for hPSCs, we have developed a new non-enzymatic passaging method using sodium citrate. Sodium citrate, formulated as a hypertonic solution, gently and efficiently detaches adherent cultures of hPSCs as small multicellular aggregates with minimal manual intervention. These multicellular aggregates are easily and reproducibly recovered in calcium-containing medium, retain a high post-detachment cell viability of 97%+/- 61% and readily attach to fresh substrates. Together, this significantly reduces the time required to expand hPSCs as high quality adherent cultures. Cells subcultured for 25 passages using this novel sodium citrate passaging solution exhibit characteristic hPSC morphology, high levels (>80%) of pluripotency markers OCT4, SSEA-4, TRA-1-60 andTRA-1-81, a normal G-banded karyotype and the ability to differentiate into cells representing all three germ layers, both in vivo and in vitro.	[Nie, Ying; Walsh, Patrick; Clarke, Diana L.; Rowley, Jon A.; Fellner, Thomas] Lonza Walkersville Inc, Cell Therapy Dev Serv, Walkersville, MD 21793 USA		Fellner, T (corresponding author), Lonza Walkersville Inc, Cell Therapy Dev Serv, Walkersville, MD 21793 USA.	thomas.fellner@lonza.com						Ahrlund-Richter L, 2009, CELL STEM CELL, V4, P20, DOI 10.1016/j.stem.2008.11.012; [Anonymous], 2004, NIST STANDARD REFERE; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Li L, 2012, CELL ADHES MIGR, V6, P59, DOI 10.4161/cam.19583; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Meng Y, 2010, FASEB J, V24, P1056, DOI 10.1096/fj.08-126821; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Nishigaki T, 2011, INT J DEV BIOL, V55, P305, DOI 10.1387/ijdb.103145tn; Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107	14	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e88012	10.1371/journal.pone.0088012	http://dx.doi.org/10.1371/journal.pone.0088012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498239	gold, Green Submitted, Green Published			2022-12-25	WOS:000330617100125
J	van Alphen, LB; Wenzel, CQ; Richards, MR; Fodor, C; Ashmus, RA; Stahl, M; Karlyshev, AV; Wren, BW; Stintzi, A; Miller, WG; Lowary, TL; Szymanski, CM				van Alphen, Lieke B.; Wenzel, Cory Q.; Richards, Michele R.; Fodor, Christopher; Ashmus, Roger A.; Stahl, Martin; Karlyshev, Andrey V.; Wren, Brendan W.; Stintzi, Alain; Miller, William G.; Lowary, Todd L.; Szymanski, Christine M.			Biological Roles of the O-Methyl Phosphoramidate Capsule Modification in Campylobacter jejuni	PLOS ONE			English	Article							SP-NOV.; POLYSACCHARIDE; INFECTION; SEQUENCE; PATHOGEN; LIPOOLIGOSACCHARIDE; LIPOPOLYSACCHARIDES; SEROSTRAIN; SPUTORUM; HUMANS	Campylobacter jejuni is a major cause of bacterial gastroenteritis worldwide, and the capsular polysaccharide (CPS) of this organism is required for persistence and disease. C. jejuni produces over 47 different capsular structures, including a unique O-methyl phosphoramidate (MeOPN) modification present on most C. jejuni isolates. Although the MeOPN structure is rare in nature it has structural similarity to some synthetic pesticides. In this study, we have demonstrated, by whole genome comparisons and high resolution magic angle spinning NMR, that MeOPN modifications are common to several Campylobacter species. Using MeOPN biosynthesis and transferase mutants generated in C. jejuni strain 81-176, we observed that loss of MeOPN from the cell surface correlated with increased invasion of Caco-2 epithelial cells and reduced resistance to killing by human serum. In C. jejuni, the observed serum mediated killing was determined to result primarily from activation of the classical complement pathway. The C. jejuni MeOPN transferase mutant showed similar levels of colonization relative to the wild-type in chickens, but showed a five-fold drop in colonization when co-infected with the wild-type in piglets. In Galleria mellonella waxmoth larvae, the MeOPN transferase mutant was able to kill the insects at wildtype levels. Furthermore, injection of the larvae with MeOPN-linked monosaccharides or CPS purified from the wild-type strain did not result in larval killing, indicating that MeOPN does not have inherent insecticidal activity.	[van Alphen, Lieke B.; Wenzel, Cory Q.; Richards, Michele R.; Fodor, Christopher; Szymanski, Christine M.] Univ Alberta, Dept Biol Sci, Alberta Glyc Ctr, Edmonton, AB, Canada; [Ashmus, Roger A.; Lowary, Todd L.] Univ Alberta, Dept Chem, Alberta Glyc Ctr, Edmonton, AB, Canada; [Stahl, Martin; Stintzi, Alain] Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Karlyshev, Andrey V.] Univ Kingston, Sch Life Sci, London, England; [Wren, Brendan W.] London Sch Hyg & Trop Med, London WC1, England; [Miller, William G.] ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA	University of Alberta; University of Alberta; University of Ottawa; Kingston University; University of London; London School of Hygiene & Tropical Medicine; United States Department of Agriculture (USDA)	Szymanski, CM (corresponding author), Univ Alberta, Dept Biol Sci, Alberta Glyc Ctr, Edmonton, AB, Canada.	cszymans@ualberta.ca	Karlyshev, Andrey/D-2797-2011; Lowary, Todd L/F-9608-2019; Richards, Mickey/E-8140-2011	Karlyshev, Andrey/0000-0003-3124-019X; Lowary, Todd L/0000-0002-8331-8211; Richards, Mickey/0000-0002-1973-5678; Ashmus, Roger/0000-0001-9580-7533	Alberta Innovates Health Solutions Postdoctoral Fellowship; Alberta Innovates Technology Futures Scholarship; Biotechnology and Biological Sciences Research Council [BB/C519670/1, EGA16167] Funding Source: researchfish	Alberta Innovates Health Solutions Postdoctoral Fellowship; Alberta Innovates Technology Futures Scholarship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	LVA held an Alberta Innovates Health Solutions Postdoctoral Fellowship. RAA is an Alberta Innovates Technology Futures Scholarship awardee. CMS is an Alberta Innovates Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2005, J CLIN MICROBIOL, V43, P5091, DOI 10.1128/JCM.43.10.5091-5096.2005; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; ASPINALL GO, 1992, CARBOHYD RES, V231, P13, DOI 10.1016/0008-6215(92)84003-B; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BLASER MJ, 1985, J INFECT DIS, V151, P227, DOI 10.1093/infdis/151.2.227; Bleumink-Pluym NMC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003393; BOLTON FJ, 1984, J CLIN PATHOL, V37, P677, DOI 10.1136/jcp.37.6.677; Champion OL, 2010, J INFECT DIS, V201, P776, DOI 10.1086/650494; Debruyne L, 2010, INT J SYST EVOL MICR, V60, P815, DOI 10.1099/ijs.0.011056-0; Debruyne L, 2009, INT J SYST EVOL MICR, V59, P1126, DOI 10.1099/ijs.0.000851-0; Dingle KE, 2005, J CLIN MICROBIOL, V43, P340, DOI 10.1128/JCM.43.1.340-347.2005; ETOH Y, 1993, INT J SYST BACTERIOL, V43, P631, DOI 10.1099/00207713-43-4-631; FORSGREN A, 1975, J LAB CLIN MED, V85, P904; Foster G, 2004, INT J SYST EVOL MICR, V54, P2369, DOI 10.1099/ijs.0.63147-0; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Friedman CR, 2004, CLIN INFECT DIS, V38, pS285, DOI 10.1086/381598; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Jones MA, 2004, INFECT IMMUN, V72, P3769, DOI 10.1128/IAI.72.7.3769-3776.2004; Kanipes MI, 2006, J BACTERIOL, V188, P3273, DOI 10.1128/JB.188.9.3273-3279.2006; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Labarca JA, 2002, CLIN INFECT DIS, V34, pE59, DOI 10.1086/340266; Lawson AJ, 2001, INT J SYST EVOL MICR, V51, P651, DOI 10.1099/00207713-51-2-651; LAWSON GHK, 1976, J MED MICROBIOL, V9, P163, DOI 10.1099/00222615-9-2-163; Logan JMJ, 2000, INT J SYST EVOL MICR, V50, P865, DOI 10.1099/00207713-50-2-865; Maue AC, 2013, INFECT IMMUN, V81, P665, DOI 10.1128/IAI.01008-12; McNally DJ, 2007, J BIOL CHEM, V282, P28566, DOI 10.1074/jbc.M704413200; McNally DJ, 2006, FEBS J, V273, P3975, DOI 10.1111/j.1742-4658.2006.05401.x; McNally DJ, 2005, FEBS J, V272, P4407, DOI 10.1111/j.1742-4658.2005.04856.x; MISHU B, 1993, CLIN INFECT DIS, V17, P104, DOI 10.1093/clinids/17.1.104; Miyamoto T, 1999, PESTIC BIOCHEM PHYS, V63, P151, DOI 10.1006/pest.1999.2399; OELSCHLAEGER TA, 1993, P NATL ACAD SCI USA, V90, P6884, DOI 10.1073/pnas.90.14.6884; On SLW, 1998, INT J SYST BACTERIOL, V48, P195, DOI 10.1099/00207713-48-1-195; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PEREZ GIP, 1985, INFECT IMMUN, V48, P528, DOI 10.1128/IAI.48.2.528-533.1985; Rossi M, 2009, INT J SYST EVOL MICR, V59, P2364, DOI 10.1099/ijs.0.007419-0; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Silipo A, 2005, J BIOL CHEM, V280, P33660, DOI 10.1074/jbc.M506254200; Sorensen MCH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00011; Sorensen MCH, 2011, J BACTERIOL, V193, P6742, DOI 10.1128/JB.05276-11; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; TANNER ACR, 1981, INT J SYST BACTERIOL, V31, P432, DOI 10.1099/00207713-31-4-432; van Bergen MAP, 2005, J CLIN MICROBIOL, V43, P5888, DOI 10.1128/JCM.43.12.5888-5898.2005; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; Vinogradov E, 2008, CARBOHYD RES, V343, P2701, DOI 10.1016/j.carres.2008.06.006; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Zanoni RG, 2009, INT J SYST EVOL MICR, V59, P1666, DOI 10.1099/ijs.0.007286-0	47	40	42	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87051	10.1371/journal.pone.0087051	http://dx.doi.org/10.1371/journal.pone.0087051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498018	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000330617100047
J	D'Annibale, S; Kim, J; Magliozzi, R; Low, TY; Mohammed, S; Heck, AJR; Guardavaccaro, D				D'Annibale, Sara; Kim, Jihoon; Magliozzi, Roberto; Low, Teck Yew; Mohammed, Shabaz; Heck, Albert J. R.; Guardavaccaro, Daniele			Proteasome-dependent Degradation of Transcription Factor Activating Enhancer-binding Protein 4 (TFAP4) Controls Mitotic Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; E3 Ubiquitin Ligase; Mitosis; Protein Degradation; Ubiquitin; TFAP4; BetaTrCP	TRCP-MEDIATED DEGRADATION; SCF-BETA-TRCP; PEPTIDE IDENTIFICATION; DESTRUCTION MOTIF; UBIQUITIN LIGASE; DNA-DAMAGE; CANCER; PROGRESSION; CDC25A; PHASE	Background: TFAP4 is a transcription factor that controls cell proliferation, stemness and epithelial-mesenchymal transition and is up-regulated in colorectal cancer. Results: TFAP4 is targeted for degradation by the SCFTrCP ubiquitin ligase. Failure to degrade TFAP4 leads to aberrant mitosis. Conclusion: TFAP4 degradation is required for the fidelity of mitosis. Significance: Misregulation of TFAP4 might contribute to genomic instability and tumorigenesis. TFAP4, a basic helix-loop-helix transcription factor that regulates the expression of a multitude of genes involved in the regulation of cellular proliferation, stemness, and epithelial-mesenchymal transition, is up-regulated in colorectal cancer and a number of other human malignancies. We have found that, during the G(2) phase of the cell division cycle, TFAP4 is targeted for proteasome-dependent degradation by the SCFTrCP ubiquitin ligase. This event requires phosphorylation of TFAP4 on a conserved degron. Expression of a stable TFAP4 mutant unable to interact with TrCP results in a number of mitotic defects, including chromosome missegregation and multipolar spindles, which eventually lead to the activation of the DNA damage response. Our findings reveal that TrCP-dependent degradation of TFAP4 is required for the fidelity of mitotic division.	[D'Annibale, Sara; Kim, Jihoon; Magliozzi, Roberto; Guardavaccaro, Daniele] Hubrecht Inst KNAW, NL-3584 CH Utrecht, Netherlands; [D'Annibale, Sara; Kim, Jihoon; Magliozzi, Roberto; Guardavaccaro, Daniele] Univ Med Ctr Utrecht, NL-3584 CH Utrecht, Netherlands; [Low, Teck Yew; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Low, Teck Yew; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Low, Teck Yew; Mohammed, Shabaz; Heck, Albert J. R.] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Guardavaccaro, D (corresponding author), Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	d.guardavaccaro@hubrecht.eu	Mohammed, Shabaz/AAY-6313-2020; Mohammed, Shabaz/D-1042-2010; Low, Teck Yew/J-4403-2014; Low, Teck Yew/Q-5946-2019; Heck, Albert/D-7098-2011	Mohammed, Shabaz/0000-0003-2640-9560; Mohammed, Shabaz/0000-0003-2640-9560; Low, Teck Yew/0000-0001-7878-7534; Low, Teck Yew/0000-0001-7878-7534; Heck, Albert/0000-0002-2405-4404; Guardavaccaro, Daniele/0000-0002-4517-1765	Royal Dutch Academy of Arts and Sciences; Dutch Cancer Society; Cancer Genomics Center; European Union under Marie Curie Actions (FP7)	Royal Dutch Academy of Arts and Sciences; Dutch Cancer Society(KWF Kankerbestrijding); Cancer Genomics Center; European Union under Marie Curie Actions (FP7)	Work in the Guardavaccaro laboratory was supported by the Royal Dutch Academy of Arts and Sciences, the Dutch Cancer Society, the Cancer Genomics Center, and the European Union under Marie Curie Actions (FP7).	Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Frese CK, 2011, J PROTEOME RES, V10, P2377, DOI 10.1021/pr1011729; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hu BS, 2013, TUMOR BIOL, V34, P271, DOI 10.1007/s13277-012-0547-4; Jackstadt R, 2013, J EXP MED, V210, P1331, DOI 10.1084/jem.20120812; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jung P, 2009, CELL CYCLE, V8, P982, DOI 10.4161/cc.8.7.7949; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Kruiswijk F, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002718; Liu XH, 2012, MED ONCOL, V29, P871, DOI 10.1007/s12032-011-9845-8; Magliozzi R, 2013, DEV CELL, V27, P574, DOI 10.1016/j.devcel.2013.10.023; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Ping Z, 2012, CELL CYCLE, V11, P1999, DOI 10.4161/cc.20402; Raijmakers R, 2008, MOL CELL PROTEOMICS, V7, P1755, DOI 10.1074/mcp.M800093-MCP200; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Swaney DL, 2008, NAT METHODS, V5, P959, DOI 10.1038/nmeth.1260; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X	27	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7730	7737		10.1074/jbc.M114.549535	http://dx.doi.org/10.1074/jbc.M114.549535			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24500709	hybrid, Green Published			2022-12-25	WOS:000332761500040
J	Yang, SF; Li, X; Chao, BT; Wu, LB; Cheng, ZP; Duan, YH; Wu, DW; Zhan, YQ; Chen, JH; Liu, B; Ji, XP; Nie, P; Wang, XM				Yang, Shifeng; Li, Xia; Chao, Baoting; Wu, Lebin; Cheng, Zhaoping; Duan, Yanhua; Wu, Dawei; Zhan, Yiqiang; Chen, Jiuhong; Liu, Bo; Ji, Xiaopeng; Nie, Pei; Wang, Ximing			Abdominal Aortic Intimal Flap Motion Characterization in Acute Aortic Dissection: Assessed with Retrospective ECG-Gated Thoracoabdominal Aorta Dual-Source CT Angiography	PLOS ONE			English	Article							MULTIDETECTOR-ROW CT; ACUTE TYPE-A; MALPERFUSION SYNDROME; IMAGE-QUALITY; INSIGHTS; IMPACT; LUMEN; NOISE; PITCH	Objectives: To evaluate the feasibility of dose-modulated retrospective ECG-gated thoracoabdominal aorta CT angiography (CTA) assessing abdominal aortic intimal flap motion and investigate the motion characteristics of intimal flap in acute aortic dissection (AAD). Materials and Methods: 49 patients who had thoracoabdominal aorta retrospective ECG-gated CTA scan were enrolled. 20 datasets were reconstructed in 5% steps between 0 and 95% of the R-R interval in each case. The aortic intimal flap motion was assessed by measuring the short axis diameters of the true lumen and false lumen 2 cm above of celiac trunk ostium in different R-R intervals. Intimal flap motion and configuration was assessed by two independent observers. Results: In these 49 patients, 37 had AAD, 7 had intramural hematoma, and 5 had negative result for acute aortic disorder. 620 datasets of 31 patients who showed double lumens in abdominal aorta were enrolled in evaluating intimal flap motion. The maximum and minimum true lumen diameter were 12.2 +/- 4.1 mm (range 2.6 similar to 17.4) and 6.7 +/- 4.1 mm (range 0 similar to 15.3) respectively. The range of intimal flap motion in all patients was 5.5 +/- 2.6 mm (range 1.8 similar to 10.2). The extent of maximum true lumen diameter decreased during a cardiac cycle was 49.5%+/- 23.5% (range 12%similar to 100%). The maximum motion phase of true lumen diameter was in systolic phase (5%similar to 40% of R-R interval). Maximum and minimum intimal flap motion was at 15% and 75% of the R-R interval respectively. Intimal flap configuration had correlation with the phase of cardiac cycle. Conclusions: Abdominal intimal flap position and configuration varied greatly during a cardiac cycle. Retrospective ECG-gated thoracoabdominal aorta CTA can reflect the actual status of the true lumen and provide more information about true lumen collapse. This information may be helpful to diagnosis and differential diagnosis of dynamic abstraction.	[Yang, Shifeng; Chao, Baoting; Wu, Lebin; Cheng, Zhaoping; Duan, Yanhua; Wu, Dawei; Ji, Xiaopeng; Nie, Pei; Wang, Ximing] Shandong Univ, Shandong Med Imaging Res Inst, Jinan 250100, Shandong, Peoples R China; [Li, Xia] Shandong Prov Hosp, Dept Ultrasound, Jinan, Shandong, Peoples R China; [Zhan, Yiqiang] Ernst Moritz Arndt Univ Greifswald, Unit Periodontol, Greifswald, Germany; [Chen, Jiuhong] Siemens Ltd, CT Res Collaborat, Beijing, Peoples R China; [Liu, Bo] Siemens Ltd, Healthcare Sect, Shanghai, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Ernst Moritz Arndt Universitat Greifswald; Siemens AG; Siemens AG	Wang, XM (corresponding author), Shandong Univ, Shandong Med Imaging Res Inst, Jinan 250100, Shandong, Peoples R China.	wxming369@163.com		Cheng, Zhaoping/0000-0001-7217-7284				Alkadhi H, 2011, EUR J RADIOL, V80, P36, DOI 10.1016/j.ejrad.2010.12.099; [Anonymous], 2001, Ann ICRP, V31, P33; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blanke P, 2010, RADIOLOGY, V255, P207, DOI 10.1148/radiol.09090860; Budde RPJ, 2010, EUR J VASC ENDOVASC, V40, P196, DOI 10.1016/j.ejvs.2010.03.032; Cornfeld D, 2011, AM J ROENTGENOL, V196, pW336, DOI 10.2214/AJR.10.4573; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; DEBAKEY ME, 1965, J THORAC CARDIOV SUR, V49, P130, DOI 10.1016/S0022-5223(19)33323-9; Deeb GM, 2010, J THORAC CARDIOV SUR, V140, pS98, DOI 10.1016/j.jtcvs.2010.07.036; Fleischmann D, 2008, SEMIN THORAC CARDIOV, V20, P340, DOI 10.1053/j.semtcvs.2008.11.011; Ganten MK, 2009, EUR J RADIOL, V72, P146, DOI 10.1016/j.ejrad.2008.06.024; Gaxotte V, 2003, J ENDOVASC THER, V10, P719, DOI 10.1583/1545-1550(2003)010<0719:ROIFPT>2.0.CO;2; Goetti R, 2010, AM J ROENTGENOL, V194, P938, DOI 10.2214/AJR.09.3482; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Husmann L, 2007, RADIOLOGY, V245, P567, DOI 10.1148/radiol.2451061791; Jakobs TF, 2002, EUR RADIOL, V12, P1081; Karmonik C, 2011, EUR J VASC ENDOVASC, V42, P172, DOI 10.1016/j.ejvs.2011.04.008; Krissak R, 2012, EUR J RADIOL, V81, P3691, DOI 10.1016/j.ejrad.2010.11.021; LePage MA, 2001, AM J ROENTGENOL, V177, P207, DOI 10.2214/ajr.177.1.1770207; Li Y, 2012, EUR RADIOL, V22, P2432, DOI 10.1007/s00330-012-2497-z; McCollough CH, 2007, RADIOLOGY, V243, P775, DOI 10.1148/radiol.2433061165; McMahon MA, 2010, RADIOGRAPHICS, V30, P445, DOI 10.1148/rg.302095104; Midulla M, 2013, RADIOL MED, V118, P74, DOI 10.1007/s11547-012-0815-9; Morgan-Hughes GJ, 2003, RADIOLOGY, V228, P583, DOI 10.1148/radiol.2282020873; Mulkens TH, 2005, RADIOLOGY, V237, P213, DOI 10.1148/radiol.2363041220; Murayama T, 2010, INT J CARDIOL, V142, P177, DOI 10.1016/j.ijcard.2008.12.194; Patel HJ, 2008, J THORAC CARDIOV SUR, V135, P1288, DOI 10.1016/j.jtcvs.2008.01.026; Primak AN, 2006, RADIOGRAPHICS, V26, P1785, DOI 10.1148/rg.266065063; Schernthaner RE, 2012, EUR J RADIOL, V81, pE585, DOI 10.1016/j.ejrad.2011.06.053; Schindera ST, 2009, INVEST RADIOL, V44, P650, DOI 10.1097/RLI.0b013e3181acaf8a; Tsai TT, 2008, J VASC SURG, V47, P844, DOI 10.1016/j.jvs.2007.11.059; Weber TF, 2009, EUR RADIOL, V19, P245, DOI 10.1007/s00330-008-1103-x; Willemink MJ, 2013, EUR RADIOL, V23, P968, DOI 10.1007/s00330-012-2673-1; Williams DM, 1997, RADIOLOGY, V203, P37, DOI 10.1148/radiology.203.1.9122414; Williams DM, 1997, J VASC INTERV RADIOL, V8, P605, DOI 10.1016/S1051-0443(97)70619-5; Wu WH, 2009, AM J ROENTGENOL, V193, P955, DOI 10.2214/AJR.08.2158; Yagdi T, 2006, J CARDIAC SURG, V21, P363, DOI 10.1111/j.1540-8191.2006.00246.x; Yoo SM, 2010, RADIOL CLIN N AM, V48, P67, DOI 10.1016/j.rcl.2009.09.006	38	14	16	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87664	10.1371/journal.pone.0087664	http://dx.doi.org/10.1371/journal.pone.0087664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503676	gold, Green Submitted, Green Published			2022-12-25	WOS:000330631800059
J	Abu Irqeba, A; Li, Y; Panahi, M; Zhu, M; Wang, YQ				Abu Irqeba, Ameair; Li, Yang; Panahi, Mahmoud; Zhu, Ming; Wang, Yuqi			Regulating Global Sumoylation by a MAP Kinase Hog1 and Its Potential Role in Osmo-Tolerance in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN MODIFICATION; PATHWAY; PHOSPHORYLATION; ACCUMULATION; ACTIVATION; INDUCTION	Sumoylation, a post-translational protein modification by small ubiquitin-like modifier (SUMO), has been implicated in many stress responses. Here we analyzed the potential role of sumoylation in osmo-response in yeast. We find that osmotic stress induces rapid accumulation of sumoylated species in normal yeast cells. Interestingly, disruption of MAP kinase Hog1 leads to a much higher level of accumulation of sumoylated conjugates that are independent of new protein synthesis. We also find that the accumulation of sumoylated species is dependent on a SUMO ligase Siz1. Notably, overexpression of SIZ1 in HOG1-disruption mutants (hog1 Delta) but not in wild type cells leads to a markedly increased and prolonged accumulation of sumoylated species. Examination of osmo-tolerance of yeast mutants that display either an increase or a decrease in the global sumoylation level revealed an inverse relationship between accumulation of sumoylated conjugates and osmo-tolerance. Further investigation has shown that many of the sumoylated species induced by hyperosmotic stress are actually poly-sumoylated. Together, these findings indicate that abnormal accumulation of poly-sumoylated conjugates is harmful for osmo-tolerance in yeast, and suggest that Hog1 promotes adaptation to hyperosmotic stress partially via regulation of global sumoylation level.	[Abu Irqeba, Ameair; Li, Yang; Panahi, Mahmoud; Wang, Yuqi] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Zhu, Ming] Yunnan Univ, Sch Med, Kunming, Yunnan, Peoples R China	Saint Louis University; Yunnan University	Wang, YQ (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63103 USA.	ywang8@slu.edu		Li, Yang/0000-0001-5714-0416; Abu Irqeba, Ameair/0000-0002-6664-8892	Saint Louis University; National Institutes of Health (NIH) [1R15GM106330-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM106330] Funding Source: NIH RePORTER	Saint Louis University; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a start-up fund from Saint Louis University and a National Institutes of Health (NIH) grant 1R15GM106330-01 (to Y.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardwell L, 1996, MOL CELL BIOL, V16, P3637; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Conti L, 2008, PLANT CELL, V20, P2894, DOI 10.1105/tpc.108.058669; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hao N, 2008, J BIOL CHEM, V283, P33798, DOI 10.1074/jbc.C800179200; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Kurepa J, 2003, J BIOL CHEM, V278, P6862, DOI 10.1074/jbc.M209694200; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Mullen JR, 2008, J BIOL CHEM; Nagiec MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002437; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Regot S, 2013, J BIOL CHEM, V288, P17384, DOI 10.1074/jbc.M112.444042; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MOL CELL BIOL, V19, P5474; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Srikumar T, 2013, J CELL BIOL, V201, P145, DOI 10.1083/jcb.201210019; Wang YQ, 2006, J BIOL CHEM, V281, P1964, DOI 10.1074/jbc.M508985200; Wang YQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007456; Westerbeck JW, 2013, MOL BIOL CELL; Westfall P, 2006, AM STAT, V60, P1, DOI 10.1198/000313006X93258; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Witowsky JA, 2003, J BIOL CHEM, V278, P1403, DOI 10.1074/jbc.C200616200; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	33	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87306	10.1371/journal.pone.0087306	http://dx.doi.org/10.1371/journal.pone.0087306			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498309	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900055
J	Boene, H; Gonzalez, R; Vala, A; Ruperez, M; Velasco, C; Machevo, S; Sacoor, C; Sevene, E; Macete, E; Menendez, C; Munguambe, K				Boene, Helena; Gonzalez, Raquel; Vala, Anifa; Ruperez, Maria; Velasco, Cesar; Machevo, Sonia; Sacoor, Charfudin; Sevene, Esperanca; Macete, Eusebio; Menendez, Clara; Munguambe, Khatia			Perceptions of Malaria in Pregnancy and Acceptability of Preventive Interventions among Mozambican Pregnant Women: Implications for Effectiveness of Malaria Control in Pregnancy	PLOS ONE			English	Article							POLICY IMPLICATIONS	Background: Intermittent Preventive Treatment (IPTp) and insecticide treated nets (ITNs) are recommended malaria in pregnancy preventive interventions in sub-Saharan Africa. Despite their cost-effectiveness and seemingly straight-forward delivery mechanism, their uptake remains low. We aimed at describing perceptions of pregnant women regarding malaria and the recommended prevention interventions to understand barriers to uptake and help to improve their effectiveness. Methods and findings: We used mixed methods to collect data among 85 pregnant women from a rural area of Southern Mozambique. Information was obtained through observations, in-depth interviews, and focused ethnographic exercises (Free-listing and Pairwise comparisons). Thematic analysis was performed on qualitative data. Data from focused ethnographic exercises were summarized into frequency distribution tables and matrices. Malaria was not viewed as a threat to pregnancy. Participants were not fully aware of malaria-associated adverse maternal and birth outcomes. ITNs were the most preferred and used malaria preventive intervention, while IPTp fell between second and third. Indoor Residual Spraying (IRS) was the least preferred intervention. Conclusions: Low awareness of the risks and adverse consequences of malaria in pregnancy did not seem to affect acceptability or uptake to the different malaria preventive interventions in the same manner. Perceived convenience, the delivery approach, and type of provider were the key factors. Pregnant women, through antenatal care (ANC) services, can be the vehicles of ITN distribution in the communities to maximise overall ITN coverage. There is a need to improve knowledge about neonatal health and malaria to improve uptake of interventions delivered through channels other than the health facility.	[Boene, Helena; Gonzalez, Raquel; Vala, Anifa; Ruperez, Maria; Machevo, Sonia; Sacoor, Charfudin; Sevene, Esperanca; Macete, Eusebio; Menendez, Clara; Munguambe, Khatia] Ctr Invest Saude Manhica, Manhica, Mozambique; [Gonzalez, Raquel; Ruperez, Maria; Velasco, Cesar; Menendez, Clara] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Macete, Eusebio] Minist Saude, Direccao Nacl Saude Publ, Maputo, Mozambique; [Machevo, Sonia; Sevene, Esperanca; Munguambe, Khatia] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique	Centro de Investigacao em Saude de Manhica; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Eduardo Mondlane University	Munguambe, K (corresponding author), Ctr Invest Saude Manhica, Manhica, Mozambique.	khatia.munguambe@manhica.net	Sevene, Esperança/AAI-3532-2020; Gonzalez, Raquel/J-3604-2017; Menéndez, Clara/Q-3446-2016	Gonzalez, Raquel/0000-0001-5487-801X; Menéndez, Clara/0000-0002-2641-6907; Velasco Munoz, Cesar/0000-0001-8566-1155; Ruperez, Maria/0000-0001-8322-7881	European and Developing Countries Clinical Trials Partnership [EDCTP-IP.07.31080.002]; EDCTP [EDCTP-CT.2006.33111.001]; Spanish Agency for International Cooperation and Development;  [CM11/00278]	European and Developing Countries Clinical Trials Partnership; EDCTP; Spanish Agency for International Cooperation and Development(Spanish Government); 	This work was supported by a grant from the European and Developing Countries Clinical Trials Partnership (EDCTP-IP.07.31080.002). Helena Boene is supported by a grant by EDCTP (EDCTP-CT.2006.33111.001). Maria Ruperez is supported by a grant by Rio Hortega (CM11/00278). The Manhic, a Health Research Center receives core funding from the Spanish Agency for International Cooperation and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardaji A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-27; Borgatti S, 1998, ETHNOGRAPHERS TOOLKI; Brabin L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-25; Brentlinger PE, 2007, B WORLD HEALTH ORGAN, V85, P873, DOI 10.2471/BLT.06.033381; Brentlinger PE, 2007, AM J TROP MED HYG, V77, P228, DOI 10.4269/ajtmh.2007.77.228; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Direcao Geral de Saude, 2013, PLAN NAC SAUD 2012 2; Direccao Nacional de Saude, 2006, POL NAC SAUD NEON IN; Enato EFO, 2007, ACTA OBSTET GYN SCAN, V86, P33, DOI 10.1080/00016340600984670; Fontanella BJB, 2008, CADERNOS SAUDE PUBLI, V24; Gonzalez R, 2012, HIV MED; Gove S, 1994, Med Anthropol, V15, P409; Green J., 2018, QUALITATIVE METHODS, VFourth; Heggenhougen HK, 2003, 03 UNDP WHO TDR WORL, V03, P1; INE, 2012, EST DISTR MANH; INE, 2012, MOC INQ DEM SAUD 201; INE, 2007, 3 REC GER POP HAB; Lewis-Beck MichaelS., 2011, SAGE ENCY SOCIAL SCI, P1193; Mbonye AK, 2007, HEALTH POLICY, V81, P228, DOI 10.1016/j.healthpol.2006.05.018; Mbonye AK, 2006, HEALTH POLICY, V77, P279, DOI 10.1016/j.healthpol.2005.07.020; Menendez C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009438; Microsoft Corporation, 2007, MICR EXC 2007; MindTools, 1996, PAIR COMP AN WORK OU; MindTools Ltd, 2012, PAIR COMP WORKSH LON; MISAU, 2006, NORM MAN CAS MAL MOC; Montgomery CM, 2010, SOC SCI MED, V70, P1648, DOI 10.1016/j.socscimed.2010.01.020; Munguambe K, 2006, PATTERNS FACTORS ASS; Munguambe K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-344; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Pelto Gretel H., 1992, RAPID ASSESSMENT PRO, P215; Ribera JM, 2007, PLOS MED, V4, P631, DOI 10.1371/journal.pmed.0040092; Saute F, 2002, TROP MED INT HEALTH, V7, P19, DOI 10.1046/j.1365-3156.2002.00831.x; Saute F, 2003, T ROY SOC TROP MED H, V97, P661, DOI 10.1016/S0035-9203(03)80098-6; Sicuri E, 2010, PLOS ONE, V5; Smith LA, 2010, MALAR J, V9; Straus L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-556; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; WHO UNICEF, 2005, 57 WHO UNICEF HTMRBM	38	23	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86038	10.1371/journal.pone.0086038	http://dx.doi.org/10.1371/journal.pone.0086038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498268	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900014
J	Dong, B; Duan, XB; Chow, HY; Chen, LX; Lu, H; Wu, WM; Hauck, B; Wright, F; Kapranov, P; Xiao, WD				Dong, Biao; Duan, Xunbao; Chow, Hoi Yee; Chen, Lingxia; Lu, Hui; Wu, Wenman; Hauck, Bernd; Wright, Fraser; Kapranov, Philipp; Xiao, Weidong			Proteomics Analysis of Co-Purifying Cellular Proteins Associated with rAAV Vectors	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS TYPE-2; HIGH-EFFICIENCY TRANSDUCTION; GENE-TRANSFER; VIRAL VECTOR; HUMAN PNEUMOCYTES; AAV2 VECTORS; HEMOPHILIA-B; SEROTYPE; IDENTIFICATION; ENHANCEMENT	Recombinant adeno-associated vectors (rAAV) are commonly purified by either chromatography or equilibrium CsCl gradient. Nevertheless, even after purification various cellular proteins often associate with rAAV vector capsids. Such co-purifying cellular proteins may raise concern about safety of gene therapy. Here we report identification and characterization of the co-purifying cellular protein in the vector preparations by using a combination of two proteomics approaches, GeLC-MS (gel electrophoresis liquid chromatography-mass spectrometry) and 2DE (two-dimensional gel electrophoresis). Most prominent bands revealed by Coomassie Blue staining were mostly similar to the AAV capsid proteins. Posttranslational modifications of capsid proteins were detected by the proteomics analysis. A total of 13 cellular proteins were identified in the rAAV vectors purified by two rounds of cesium chloride gradient centrifugation, including 9 by the GeLC-MS analysis and 4 by the 2DE analysis. Selected cellular proteins were verified by western blot. Furthermore, the cellular proteins could be consistently found associated with different AAV serotypes and carrying different transgenes. Yet, the proteins were not integral components of the viral capsis since a stringent washing procedure by column purification could remove them. These co-purified proteins in AAV vector preparations may have a role in various stages of the AAV life cycle.	[Dong, Biao; Duan, Xunbao; Chen, Lingxia; Lu, Hui; Wu, Wenman; Xiao, Weidong] Temple Univ, Sol Sherry Thrombosis Res Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19122 USA; [Chow, Hoi Yee] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Hauck, Bernd; Wright, Fraser] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Hauck, Bernd; Wright, Fraser] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Kapranov, Philipp] St Laurent Inst, Cambridge, MA 01240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Fox Chase Cancer Center; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Kapranov, P (corresponding author), St Laurent Inst, Cambridge, MA 01240 USA.	philippk08@gmail.com; wxiao@temple.edu			National Institutes of Health (NIH) [R01HL080789, R01HL084381]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114152, R01HL130871, R01HL080789, R01HL084381] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health (NIH) grants R01HL080789 and R01HL084381. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allay JA, 2011, HUM GENE THER, V22, P595, DOI 10.1089/hum.2010.202; Aslanidi GV, 2012, VACCINE, V30, P3908, DOI 10.1016/j.vaccine.2012.03.079; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Bevington JM, 2007, VIROLOGY, V357, P102, DOI 10.1016/j.virol.2006.07.050; Duan XB, 2008, J PROTEOME RES, V7, P4955, DOI 10.1021/pr800295j; Duan XB, 2010, PROTEOMICS, V10, P2165, DOI 10.1002/pmic.201000020; Flotte T, 1996, HUM GENE THER, V7, P1145, DOI 10.1089/hum.1996.7.9-1145; Gray Steven J, 2011, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0417s57; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Hansen J, 2001, J VIROL, V75, P4080, DOI 10.1128/JVI.75.9.4080-4090.2001; Jayandharan GR, 2008, GENE THER, V15, P1287, DOI 10.1038/gt.2008.89; Johnson JS, 2009, J VIROL, V83, P2632, DOI 10.1128/JVI.02309-08; Lock M, 2012, HUM GENE THER METHOD, V23, P56, DOI 10.1089/hgtb.2011.217; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Murray S, 2006, J VIROL, V80, P6171, DOI 10.1128/JVI.02417-05; MUZYCZKA N, 2001, FIELDS VIROLOGY, V2, P2327; Nash K, 2009, J VIROL, V83, P454, DOI 10.1128/JVI.01939-08; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Qiu JM, 1999, VIROLOGY, V257, P373, DOI 10.1006/viro.1999.9664; Sanlioglu S, 2000, J VIROL, V74, P9184, DOI 10.1128/JVI.74.19.9184-9196.2000; Shen WY, 2004, VISION RES, V44, P339, DOI 10.1016/j.visres.2003.09.032; Van Vliet K, 2009, J VIROL METHODS, V159, P167, DOI 10.1016/j.jviromet.2009.03.020; Wang JH, 2007, P NATL ACAD SCI USA, V104, P13104, DOI 10.1073/pnas.0702778104; Wright JF, 2011, HUM GENE THER, V22, P913, DOI 10.1089/hum.2011.2514; Wright JF, 2009, HUM GENE THER, V20, P698, DOI 10.1089/hum.2009.064; Zhong L, 2008, VIROLOGY, V381, P194, DOI 10.1016/j.virol.2008.08.027; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	28	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86453	10.1371/journal.pone.0086453	http://dx.doi.org/10.1371/journal.pone.0086453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498275	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900021
J	Huang, ZP; Qi, XG; Garber, PA; Jin, T; Guo, ST; Li, S; Li, BG				Huang, Zhi-Pang; Qi, Xiao-Guang; Garber, Paul A.; Jin, Tong; Guo, Song-Tao; Li, Sheng; Li, Bao-Guo			The Use of Camera Traps to Identify the Set of Scavengers Preying on the Carcass of a Golden Snub-Nosed Monkey (Rhinopithecus roxellana)	PLOS ONE			English	Article							SOCIETIES; RELEVANCE; BEHAVIOR; BIETI	There exists very limited information on the set of scavengers that feed on the carcasses of wild primates. Here, we describe, based on information collected using a remote camera trap, carnivores consuming/scavenging the carcass of a wild golden snub-nosed monkey (Rhinopithecus roxellana) in the Laohegou Nature Reserve, Sichuan, China. During a 3 month behavioral and ecology study of a band of golden snub-nosed monkeys (March through May 2013), we encountered the carcass of an adult male (male golden snub-nosed monkeys weigh approximately 12-16 kg). After examining the dead monkey, we returned it to the death site and set out a camera trap to record the behavior and identity of scavengers. Over the course of 25 days, we collected 4145 photographs taken by the camera trap. Scavengers identified from these photographs include a masked civet (Paguma larvata), Asiatic black bear (Ursus thibetanus), large-billed crow (Corvus macrorhynchos) and the chestnut rat (Rattus fulvescens). No member of the golden snub-nosed monkey's social group, which was composed of approximately 120 individuals, was found to return to the general area of the death site. The masked civet fed principally on the face and intestines of the corpse at night, while the black bear consumed most of the body of the dead monkey during both the daytime and nighttime. These two taxa consumed virtually the entire carcass in one week. We suggest that the use of camera traps offers a powerful research tool to identify the scavenger community of a given ecosystem.	[Huang, Zhi-Pang; Qi, Xiao-Guang; Guo, Song-Tao; Li, Bao-Guo] NW Univ Xian, Coll Life Sci, Xian 710069, Shannxi, Peoples R China; [Jin, Tong] Nat Conservancy TNC China Program, Beijing, Peoples R China; [Li, Sheng] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Qi, Xiao-Guang; Garber, Paul A.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Huang, Zhi-Pang] Dali Univ, Inst Eastern Himalaya Biodivers Res, Dali, Yunnan, Peoples R China	Northwest University Xi'an; Peking University; University of Illinois System; University of Illinois Urbana-Champaign; Dali University	Qi, XG (corresponding author), NW Univ Xian, Coll Life Sci, Xian 710069, Shannxi, Peoples R China.	qixg@nwu.edu.cn; baoguoli@nwu.edu.cn		Qi, Xiao-Guang/0000-0003-2602-4441; Guo, Songtao/0000-0002-8291-5487	Key Program of National Nature Science Foundation of China National [31130061]; Natural Science Foundation of China [31270438, 31270441, 31201721]; Research Fund for the Doctoral Program of Higher Education of China [20106101110005]; Specialized Foundation of Department of Education of Shaanxi Province, China [12JK0825]; Key Program of Academy of Sciences of Shaanxi Province [2012k-01]	Key Program of National Nature Science Foundation of China National(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Specialized Foundation of Department of Education of Shaanxi Province, China; Key Program of Academy of Sciences of Shaanxi Province	The Key Program of National Nature Science Foundation of China National; Contract grant number: 31130061; Natural Science Foundation of China; Contract grant number: 31270438, 31270441 and 31201721; Contract grant sponsor: the Research Fund for the Doctoral Program of Higher Education of China; Contract grant number: 20106101110005; Contract grant sponsor: Specialized Foundation of Department of Education of Shaanxi Province, China; Contract grant number: 12JK0825; Contract grant sponsor: Key Program of Academy of Sciences of Shaanxi Province; Contract grant number: 2012k-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2013, WILSON J ORNITHOL, V125, P417, DOI 10.1676/12-176.1; Anderson JR, 2011, AM J PRIMATOL, V73, P410, DOI 10.1002/ajp.20922; Anderson JR, 2010, CURR BIOL, V20, pR349, DOI 10.1016/j.cub.2010.02.010; Bacon MM, 2010, CAN FIELD NAT, V124, P242, DOI 10.22621/cfn.v124i3.1080; Bennett Elizabeth L., 1994, P129; Biro D, 2010, CURR BIOL, V20, pR351, DOI 10.1016/j.cub.2010.02.031; BLUMENSCHINE RJ, 1987, CURR ANTHROPOL, V28, P383, DOI 10.1086/203544; Boesch C, 2000, CHIMPANZEES TAI FORE; Castaneda Franklin E., 2013, Cat News, V58, P11; Chen F, 1989, PROGR STUDIES GOLDEN, P207; Cronin KA, 2011, AM J PRIMATOL, V73, P415, DOI 10.1002/ajp.20927; Cui LW, 2003, FOLIA PRIMATOL, V74, P51, DOI 10.1159/000068393; Davies A. Glyn, 1994, P285; DeVault TL, 2004, CAN J ZOOL, V82, P502, DOI 10.1139/Z04-022; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Fashing PJ, 2011, AM J PRIMATOL, V73, P405, DOI 10.1002/ajp.20902; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Grueter CC, 2010, BEHAV ECOL, V21, P63, DOI 10.1093/beheco/arp149; HASEGAWA T, 1983, CURR ANTHROPOL, V24, P231, DOI 10.1086/202974; HU JC, 1980, J NANCHONG TEACHERS, V2, P1; Jin K, 1998, J FORESTRY RES, V9, P136; Kirkpatrick R.C., 1998, NATURAL HIST DOUCS S, P155, DOI [10.1142/9789812817020_0008, DOI 10.1142/9789812817020_0008]; Kirkpatrick RC, 2010, EVOL ANTHROPOL, V19, P98, DOI 10.1002/evan.20259; Lewis ME, 1997, J HUM EVOL, V32, P257, DOI 10.1006/jhev.1996.0103; Li B, 2003, PRIMATES FRAGMENTATI; Li B. G., 2001, BIOSPHERE CONSERVATI, V3, P107; Li BG, 2007, PRIMATES, V48, P190, DOI 10.1007/s10329-006-0029-7; Li TF, 2012, PRIMATES, V53, P127, DOI 10.1007/s10329-012-0293-7; Lu Jiu-Quan, 2007, Acta Zoologica Sinica, V53, P175; MAREAN CW, 1989, J HUM EVOL, V18, P559, DOI 10.1016/0047-2484(89)90018-3; Nishida Toshisada, 1994, P373, DOI 10.1145/192161.192261; OCONNELL JF, 1988, CURR ANTHROPOL, V29, P356, DOI 10.1086/203648; Qi XG, 2008, AM J PRIMATOL, V70, P311, DOI 10.1002/ajp.20480; Qi XG, 2009, AM J PRIMATOL, V71, P670, DOI 10.1002/ajp.20702; Ren R, 2000, FIELD STUDY SOC RHIN; Reynolds V., 2005, CHIMPANZEES BUDONGO; Wang Dajun, 2012, International Bear News, V21, P7; Watts DP, 2008, J HUM EVOL, V54, P125, DOI 10.1016/j.jhevol.2007.07.008; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; Wilton M. L., 1986, ALCES, V22, P155; Xiang Z, AM J PRIMATOL UNPUB; Xiang ZF, 2007, AM J PRIMATOL, V69, P249, DOI 10.1002/ajp.20333; Zhang SY, 1999, FOLIA PRIMATOL, V70, P175, DOI 10.1159/000021693	43	13	18	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87318	10.1371/journal.pone.0087318	http://dx.doi.org/10.1371/journal.pone.0087318			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498311	gold, Green Submitted, Green Published			2022-12-25	WOS:000330626900057
J	Kong, FL; Zhao, JC; Han, SS; Zeng, B; Yang, JD; Si, XH; Yang, BQ; Yang, MY; Xu, HL; Li, Y				Kong, Fanli; Zhao, Jiangchao; Han, Shushu; Zeng, Bo; Yang, Jiandong; Si, Xiaohui; Yang, Benqing; Yang, Mingyao; Xu, Huailiang; Li, Ying			Characterization of the Gut Microbiota in the Red Panda (Ailurus fulgens)	PLOS ONE			English	Article							GIANT PANDA; SIMILARITY; DIET	The red panda is the only living species of the genus Ailurus. Like giant pandas, red pandas are also highly specialized to feed mainly on highly fibrous bamboo. Although several studies have focused on the gut microbiota in the giant panda, little is known about the gut microbiota of the red panda. In this study, we characterized the fecal microbiota from both wild (n = 16) and captive (n = 6) red pandas using a pyrosequecing based approach targeting the V1-V3 hypervariable regions of the 16S rRNA gene. Distinct bacterial communities were observed between the two groups based on both membership and structure. Wild red pandas maintained significantly higher community diversity, richness and evenness than captive red pandas, the communities of which were skewed and dominated by taxa associated with Firmicutes. Phylogenetic analysis of the top 50 OTUs revealed that 10 of them were related to known cellulose degraders. To the best of our knowledge, this is the first study of the gut microbiota of the red panda. Our data suggest that, similar to the giant panda, the gut microbiota in the red panda might also play important roles in the digestion of bamboo.	[Kong, Fanli; Han, Shushu; Zeng, Bo; Yang, Mingyao; Li, Ying] Sichuan Agr Univ, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China; [Zhao, Jiangchao] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Yang, Jiandong; Si, Xiaohui; Xu, Huailiang] Sichuan Agr Univ, Coll Anim Sci & Technol, Yaan, Sichuan, Peoples R China; [Yang, Benqing] Sichuan Fengtongzhai Natl Nat Reserve, Baoxing, Sichuan, Peoples R China	Sichuan Agricultural University; University of Michigan System; University of Michigan; Sichuan Agricultural University	Xu, HL (corresponding author), Sichuan Agr Univ, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China.	huailxu@yahoo.com; yingli.sau@gmail.com	Zhao, Jiangchao/J-4627-2014; Yang, Mingyao/AAX-9927-2020	Zhao, Jiangchao/0000-0002-2992-8967; Yang, Mingyao/0000-0001-6508-2738; Zeng, Bo/0000-0001-7482-7340	"100-Talent Program" in Sichuan; Science Foundation for Youths of Sichuan Province; Innovative Research Team in University of Sichuan Bureau of Education; National Natural Science Foundation of China [31370407]	"100-Talent Program" in Sichuan; Science Foundation for Youths of Sichuan Province; Innovative Research Team in University of Sichuan Bureau of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the "100-Talent Program" in Sichuan, the Science Foundation for Youths of Sichuan Province and the Innovative Research Team in University of Sichuan Bureau of Education to YL. HX was supported by The National Natural Science Foundation of China (No. 31370407). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin T, 2012, J TEXT I, V103, P844, DOI 10.1080/00405000.2011.614742; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Fang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050312; Flynn JJ, 2000, MOL PHYLOGENET EVOL, V17, P190, DOI 10.1006/mpev.2000.0819; Glatston A, 2007, RED PANDA INT STUDBO; Glatston A.R, 1994, STATUS SURVEY CONSER; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shannon C., 1964, MATH THEORY COMMUNIC; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang X, 2009, AILURUS FULGENS; Wei F, 2010, RED PANDA ECOLOGY RE, V193; Wei FW, 1999, J ZOOL, V248, P535, DOI 10.1111/j.1469-7998.1999.tb01053.x; Wei FW, 2000, J MAMMAL, V81, P448, DOI 10.1644/1545-1542(2000)081<0448:HUASBT>2.0.CO;2; Williams CL, 2013, J ANIM PHYSIOL AN N, V97, P577, DOI 10.1111/j.1439-0396.2012.01299.x; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	31	30	37	9	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87885	10.1371/journal.pone.0087885	http://dx.doi.org/10.1371/journal.pone.0087885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498390	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900136
J	Liu, Y; Dong, QZ; Wang, S; Xu, HT; Miao, Y; Wang, L; Wang, EH				Liu, Yang; Dong, Qian-Ze; Wang, Si; Xu, Hong-Tao; Miao, Yuan; Wang, Liang; Wang, En-Hua			Kaiso Interacts with p120-Catenin to Regulate beta-Catenin Expression at the Transcriptional Level	PLOS ONE			English	Article							LUNG-CANCER CELLS; P120 CATENIN; PARTNER KAISO; CADHERIN; P120(CTN); ADHESION; INVASION; ISOFORMS; EPIGENOMICS; PROGRESSION	Background: We have reported that p120-catenin could regulate beta-catenin transcription in lung cancer cells, but the specific mechanism is unclear. Methods and Results: In this study, bisulfite sequencing PCR showed that the beta-catenin promoter region in SPC-A-1 and LTEP-a-2 lung cancer cell lines has Kaiso binding sites sequences and CpG islands which may combine with Kaiso. The demethylating reagent 5-Aza-2'-deoxycytidine significantly upregulated b-catenin mRNA expression in lung cancer cell lines, whereas expression was significantly reduced following transfection with Kaiso. However, the upregulation of beta-catenin mRNA expression after treatment with 5-Aza-2'-deoxycytidine was not reduced by subsequent transfection with Kaiso cDNA. Chromatin immunoprecipitation showed that, in lung cancer cell lines, methylated CpG-dinucleotides sequences combined with Kaiso and the Kaiso binding sites sequence did not. The capacity of Kaiso to combine with p120-catenin isoforms was confirmed by immunoprecipitation. Conclusions: Based on these results, we concluded that Kaiso participates in the regulation by p120ctn of beta-catenin mRNA expression in the lung cancer cell lines.	[Liu, Yang; Dong, Qian-Ze; Xu, Hong-Tao; Miao, Yuan; Wang, Liang; Wang, En-Hua] China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China; [Liu, Yang; Dong, Qian-Ze; Xu, Hong-Tao; Miao, Yuan; Wang, Liang; Wang, En-Hua] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Wang, Si] China Med Univ, Coll Basic Med Sci, Dept Med Microbiol & Parasitol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Wang, EH (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China.	wangeh@hotmail.com	Miao, Yuan/AAG-9754-2021; Wang, Liang/AAM-2378-2021; Xu, Hong-Tao/AAI-7055-2020	Wang, Liang/0000-0003-4015-9385; Xu, Hong-Tao/0000-0001-5062-3108	National Natural Science Foundation of China [30900562, 81000942]; Ph.D. Programs Foundation of Ministry of Education of China [20092104120022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from the National Natural Science Foundation of China (No. 30900562 to YL, No. 81000942 to YM) and the Ph.D. Programs Foundation of Ministry of Education of China (No. 20092104120022 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho S, 2002, J CELL SCI, V115, P1391; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Dai SD, 2010, LUNG CANCER, V67, P205, DOI 10.1016/j.lungcan.2009.06.013; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Ferber EC, 2008, J BIOL CHEM, V283, P12691, DOI 10.1074/jbc.M708887200; Golenhofen N, 2000, HISTOCHEM CELL BIOL, V114, P147; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jiang GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030303; Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860; Liu Y, 2007, APMIS, V115, P848, DOI 10.1111/j.1600-0463.2007.apm_673.x; Liu Y, 2009, LUNG CANCER, V63, P375, DOI 10.1016/j.lungcan.2008.12.012; Liu Y, 2009, EXP CELL RES, V315, P890, DOI 10.1016/j.yexcr.2008.12.016; Liu Y, 2009, CANCER SCI, V100, P441, DOI 10.1111/j.1349-7006.2008.01067.x; Montonen O, 2001, J HISTOCHEM CYTOCHEM, V49, P1487, DOI 10.1177/002215540104901202; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; van Hengel J, 2007, BBA-MOL CELL RES, V1773, P78, DOI 10.1016/j.bbamcr.2006.08.033; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Xiao K, 2007, BBA-MOL CELL RES, V1773, P8, DOI 10.1016/j.bbamcr.2006.07.005; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Zhang PX, 2011, INT J ONCOL, V38, P1625, DOI 10.3892/ijo.2011.995	31	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87537	10.1371/journal.pone.0087537	http://dx.doi.org/10.1371/journal.pone.0087537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498333	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900079
J	Satoh, T; Suzuki, K; Yamaguchi, T; Kato, K				Satoh, Tadashi; Suzuki, Kousuke; Yamaguchi, Takumi; Kato, Koichi			Structural Basis for Disparate Sugar-Binding Specificities in the Homologous Cargo Receptors ERGIC-53 and VIP36	PLOS ONE			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; EARLY SECRETORY PATHWAY; L-TYPE LECTINS; ENDOPLASMIC-RETICULUM; TRANSPORT RECEPTOR; CRYSTAL-STRUCTURE; FACTOR-VIII; COMBINED DEFICIENCY; FACTOR-V; PROTEIN	ERGIC-53 and VIP36 are categorized as leguminous type (L-type) lectins, and they function as cargo receptors for trafficking certain N-linked glycoproteins in the secretory pathway in animal cells. They share structural similarities in their carbohydrate recognition domains (CRDs) but exhibit distinct sugar-binding specificities and affinities. VIP36 specifically interacts with the alpha 1,2-linked D1 mannosyl arm without terminal glucosylation, while ERGIC-53 shows a broader specificity and lower binding affinity to the high-mannose-type oligosaccharides, irrespective of the presence or absence of the non-reducing terminal glucose residue at the D1 arm. In this study, we determined the crystal structure of ERGIC-53-CRD in complex with their binding partner, MCFD2 and the alpha 1,2 mannotriose which corresponds to the trisaccharide of the D1 arm of high-mannose-type glycans. ERGIC-53 can interact with the D1 trimannosyl arm in two alternative modes, one of which is similar but distinct from that previously observed for VIP36. ERGIC-53 has a shallower sugar-binding pocket than VIP36 because of the single amino acid substitution, Asp-to-Gly. This enables ERGIC-53 to accommodate the non-reducing terminal glucose of the D1 arm in its CRD. In the other interaction mode, the 3-OH group of the terminal mannose was situated outward with respect to the sugar binding pocket, also enabling the Glc alpha 1-3 linkage formation without steric hindrance. Our findings thus provide a structural basis for the broad sugar-binding specificity of the ERGIC-53/MCFD2 cargo receptor complex.	[Satoh, Tadashi; Suzuki, Kousuke; Yamaguchi, Takumi; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi, Japan; [Satoh, Tadashi] JST, PRESTO, Mizuho Ku, Nagoya, Aichi, Japan; [Suzuki, Kousuke; Yamaguchi, Takumi; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Suzuki, Kousuke; Yamaguchi, Takumi; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan	Nagoya City University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Kato, K (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi, Japan.	kkatonmr@ims.ac.jp	Satoh, Tadashi/M-5157-2017	Kato, Koichi/0000-0001-7187-9612; Yamaguchi, Takumi/0000-0003-1521-1153; Satoh, Tadashi/0000-0002-4493-4978	JSPS KAKENHI [24770102, 25121730, 25102008, 24249002]; Okazaki ORION project; Grants-in-Aid for Scientific Research [25102008, 24770102] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Okazaki ORION project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI (Grant Numbers 24770102, 25121730 to T. S., and 25102008, 24249002 to K. K.) and by the Okazaki ORION project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FIEDLER K, 1994, EMBO J, V13, P1729, DOI 10.1002/j.1460-2075.1994.tb06437.x; Fullekrug J, 1999, J CELL SCI, V112, P2813; Hauri HP, 2000, J CELL SCI, V113, P587; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Itin C, 1996, MOL BIOL CELL, V7, P483, DOI 10.1091/mbc.7.3.483; Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Kamiya Y, 2012, BBA-GEN SUBJECTS, V1820, P1327, DOI 10.1016/j.bbagen.2011.12.017; Kato K, 2007, GLYCOBIOLOGY, V17, P1031, DOI 10.1093/glycob/cwm046; Lahtinen U, 1999, EUR J BIOCHEM, V260, P392, DOI 10.1046/j.1432-1327.1999.00158.x; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lutteke T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-69; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Moothoo DN, 1999, GLYCOBIOLOGY, V9, P539, DOI 10.1093/glycob/9.6.539; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naismith JH, 1996, J BIOL CHEM, V271, P972, DOI 10.1074/jbc.271.2.972; Nishio M, 2010, P NATL ACAD SCI USA, V107, P4034, DOI 10.1073/pnas.0908526107; Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200; Nyfeler B, 2006, TRAFFIC, V7, P1473, DOI 10.1111/j.1600-0854.2006.00483.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qin SY, 2012, GLYCOBIOLOGY, V22, P1709, DOI 10.1093/glycob/cws114; Reiterer V, 2010, TRAFFIC, V11, P1044, DOI 10.1111/j.1600-0854.2010.01078.x; Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Shirakabe K, 2011, J BIOL CHEM, V286, P43154, DOI 10.1074/jbc.M111.275586; Takeda Y, 2009, CURR OPIN CHEM BIOL, V13, P582, DOI 10.1016/j.cbpa.2009.09.011; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Velloso LM, 2003, J MOL BIOL, V334, P845, DOI 10.1016/j.jmb.2003.10.031; Velloso LM, 2002, J BIOL CHEM, V277, P15979, DOI 10.1074/jbc.M112098200; Wigren E, 2010, FEBS LETT, V584, P878, DOI 10.1016/j.febslet.2010.02.009; Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153; Zhang B, 2009, BRIT J HAEMATOL, V145, P15, DOI 10.1111/j.1365-2141.2008.07559.x; Zheng CL, 2013, J BIOL CHEM, V288, P20499, DOI 10.1074/jbc.M113.461434	40	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87963	10.1371/journal.pone.0087963	http://dx.doi.org/10.1371/journal.pone.0087963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498414	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900160
J	Smith, CM; Fry, SC; Gough, KC; Patel, AJF; Glenn, S; Goldrick, M; Roberts, IS; Whitelam, GC; Andrew, PW				Smith, Claire M.; Fry, Stephen C.; Gough, Kevin C.; Patel, Alexandra J. F.; Glenn, Sarah; Goldrick, Marie; Roberts, Ian S.; Whitelam, Garry C.; Andrew, Peter W.			Recombinant Plants Provide a New Approach to the Production of Bacterial Polysaccharide for Vaccines	PLOS ONE			English	Article							ESCHERICHIA-COLI; CAPSULAR POLYSACCHARIDES; EXPRESSION; PATHWAYS; ANIMALS; PROTEIN; DISEASE	Bacterial polysaccharides have numerous clinical or industrial uses. Recombinant plants could offer the possibility of producing bacterial polysaccharides on a large scale and free of contaminating bacterial toxins and antigens. We investigated the feasibility of this proposal by cloning and expressing the gene for the type 3 synthase (cps3S) of Streptococcus pneumoniae in Nicotinia tabacum, using the pCambia2301 vector and Agrobacterium tumefaciens-mediated gene transfer. In planta the recombinant synthase polymerised plant-derived UDP-glucose and UDP-glucuronic acid to form type 3 polysaccharide. Expression of the cps3S gene was detected by RT-PCR and production of the pneumococcal polysaccharide was detected in tobacco leaf extracts by double immunodiffusion, Western blotting and high-voltage paper electrophoresis. Because it is used a component of anti-pneumococcal vaccines, the immunogenicity of the plant-derived type 3 polysaccharide was tested. Mice immunised with extracts from recombinant plants were protected from challenge with a lethal dose of pneumococci in a model of pneumonia and the immunised mice had significantly elevated levels of serum anti-pneumococcal polysaccharide antibodies. This study provides the proof of the principle that bacterial polysaccharide can be successfully synthesised in plants and that these recombinant polysaccharides could be used as vaccines to protect against life-threatening infections.	[Smith, Claire M.; Patel, Alexandra J. F.; Glenn, Sarah; Andrew, Peter W.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Fry, Stephen C.] Univ Edinburgh, Inst Mol Plant Sci, Sch Biol Sci, Edinburgh Cell Wall Grp, Edinburgh, Midlothian, Scotland; [Gough, Kevin C.] Univ Nottingham, Sch Vet Med & Sci, Nottingham, Leics, England; [Goldrick, Marie; Roberts, Ian S.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Whitelam, Garry C.] Univ Leicester, Dept Biol, Leicester, Leics, England	University of Leicester; University of Edinburgh; University of Nottingham; University of Manchester; University of Leicester	Andrew, PW (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	pwa@le.ac.uk	Andrew, Peter W/G-7526-2012	Gough, Kevin/0000-0001-5211-2088; Smith, Claire/0000-0002-8913-0009	Welcome Trust [067697]; UK Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/E013651/1, BB/J019070/1] Funding Source: researchfish; BBSRC [BB/J019070/1, BB/E013651/1] Funding Source: UKRI	Welcome Trust(Wellcome Trust); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Welcome Trust (067697) to PWA, GCW and ISR. SCF thanks the UK Biotechnology and Biological Sciences Research Council for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrecubieta C, 1996, J BACTERIOL, V178, P2971, DOI 10.1128/jb.178.10.2971-2974.1996; DOUGLAS RM, 1983, J INFECT DIS, V148, P131, DOI 10.1093/infdis/148.1.131; Draper J., 1988, PLANT GENETIC TRANSF; Fry S. C, 1988, GROWING PLANT CELL W, DOI DOI 10.1016/0031-9422(88)83079-6; Fry SC, 2011, METHODS MOL BIOL, V715, P55, DOI 10.1007/978-1-61779-008-9_4; Gao Y, 2003, WORLD J GASTROENTERO, V9, P996; Gilbert C, 2000, INFECT IMMUN, V68, P3251, DOI 10.1128/IAI.68.6.3251-3260.2000; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Imohl M, 2010, INT J MICROBIOL, V2010, P1; JENNINGS HJ, 1983, ADV CARBOHYD CHEM BI, V41, P155, DOI 10.1016/S0065-2318(08)60058-X; Kalin M, 1998, THORAX, V53, P159, DOI 10.1136/thx.53.3.159; Kunze R, 2002, METAB ENG, V4, P57, DOI 10.1006/mben.2001.0207; Levine MM, 1997, LANCET, V350, P1386, DOI 10.1016/S0140-6736(97)03253-4; LUND P, 1992, PLANT MOL BIOL, V18, P47, DOI 10.1007/BF00018455; MASON HS, 1995, TRENDS BIOTECHNOL, V13, P388, DOI 10.1016/S0167-7799(00)88986-6; McNulty C, 2006, MOL MICROBIOL, V59, P907, DOI 10.1111/j.1365-2958.2005.05010.x; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Ouchterlony O, 1973, IMMUNODIFFUSION IMMU; Parsons HT, 2011, BIOCHEM J, V440, P375, DOI 10.1042/BJ20110939; Rigano MM, 2004, PLANT CELL REP, V22, P502, DOI 10.1007/s00299-003-0718-2; SAWADA H, 1995, APPL ENVIRON MICROB, V61, P828, DOI 10.1128/AEM.61.2.828-831.1995; Sharples SC, 2007, PLANT J, V52, P252, DOI 10.1111/j.1365-313X.2007.03225.x; Smith CK, 1999, PHYTOCHEMISTRY, V52, P387, DOI 10.1016/S0031-9422(99)00269-1; SNIADACK DH, 1995, PEDIATR INFECT DIS J, V14, P503, DOI 10.1097/00006454-199506000-00007; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000	26	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88144	10.1371/journal.pone.0088144	http://dx.doi.org/10.1371/journal.pone.0088144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498433	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900179
J	Windhager, L; Zierer, J; Kuffner, R				Windhager, Lukas; Zierer, Jonas; Kueffner, Robert			Refining Ensembles of Predicted Gene Regulatory Networks Based on Characteristic Interaction Sets	PLOS ONE			English	Article							INFERENCE; MODEL	Different ensemble voting approaches have been successfully applied for reverse-engineering of gene regulatory networks. They are based on the assumption that a good approximation of true network structure can be derived by considering the frequencies of individual interactions in a large number of predicted networks. Such approximations are typically superior in terms of prediction quality and robustness as compared to considering a single best scoring network only. Nevertheless, ensemble approaches only work well if the predicted gene regulatory networks are sufficiently similar to each other. If the topologies of predicted networks are considerably different, an ensemble of all networks obscures interesting individual characteristics. Instead, networks should be grouped according to local topological similarities and ensemble voting performed for each group separately. We argue that the presence of sets of co-occurring interactions is a suitable indicator for grouping predicted networks. A stepwise bottom-up procedure is proposed, where first mutual dependencies between pairs of interactions are derived from predicted networks. Pairs of co-occurring interactions are subsequently extended to derive characteristic interaction sets that distinguish groups of networks. Finally, ensemble voting is applied separately to the resulting topologically similar groups of networks to create distinct group-ensembles. Ensembles of topologically similar networks constitute distinct hypotheses about the reference network structure. Such group-ensembles are easier to interpret as their characteristic topology becomes clear and dependencies between interactions are known. The availability of distinct hypotheses facilitates the design of further experiments to distinguish between plausible network structures. The proposed procedure is a reasonable refinement step for non-deterministic reverse-engineering applications that produce a large number of candidate predictions for a gene regulatory network, e. g. due to probabilistic optimization or a cross-validation procedure.	[Windhager, Lukas; Zierer, Jonas; Kueffner, Robert] Univ Munich, Inst Informat, D-80539 Munich, Germany	University of Munich	Kuffner, R (corresponding author), Univ Munich, Inst Informat, D-80539 Munich, Germany.	robert.kueffner@bio.ifi.lmu.de		Zierer, Jonas/0000-0002-9693-1859				Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Altay G, 2010, BIOINFORMATICS, V26, P1738, DOI 10.1093/bioinformatics/btq259; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; Chen Ming, 2003, In Silico Biology, V3, P347; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hickman Graham J., 2009, Journal of Bioinformatics and Computational Biology, V7, P1013, DOI 10.1142/S0219720009004448; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kim H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-37; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Kuffner R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012807; Li S, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040009, 10.1371/journal.pcbi.0040009.eor]; Liu J.S., 2008, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-76371-2, DOI 10.1007/978-0-387-76371-2]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, ANN NY ACAD SCI, V1158, P102, DOI 10.1111/j.1749-6632.2008.03945.x; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; MENDEL JM, 1995, P IEEE, V83, P345, DOI 10.1109/5.364485; Peleg M, 2002, BIOINFORMATICS, V18, P825, DOI 10.1093/bioinformatics/18.6.825; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Tomshine J, 2006, BIOPHYS J, V91, P3196, DOI 10.1529/biophysj.106.083485; von Stosch M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-131; Windhager L., 2008, GERM C BIOINF, V136, P106	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e84596	10.1371/journal.pone.0084596	http://dx.doi.org/10.1371/journal.pone.0084596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498260	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900006
J	Wu, DJ; Zhou, WB; Enouz, S; Orru, V; Stanford, SM; Maine, CJ; Rapini, N; Sawatzke, K; Engel, I; Fiorillo, E; Sherman, LA; Kronenberg, M; Zehn, D; Peterson, E; Bottini, N				Wu, Dennis J.; Zhou, Wenbo; Enouz, Sarah; Orru, Valeria; Stanford, Stephanie M.; Maine, Christian J.; Rapini, Novella; Sawatzke, Kristy; Engel, Isaac; Fiorillo, Edoardo; Sherman, Linda A.; Kronenberg, Mitch; Zehn, Dietmar; Peterson, Erik; Bottini, Nunzio			Autoimmunity-Associated LYP-W620 Does Not Impair Thymic Negative Selection of Autoreactive T Cells	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; PTPN22; VARIANT; ARTHRITIS; ANTIGEN; GENE; EXPRESSION; POLYMORPHISM; ACTIVATION; INDUCTION	A C1858T (R620W) variation in the PTPN22 gene encoding the tyrosine phosphatase LYP is a major risk factor for human autoimmunity. LYP is a known negative regulator of signaling through the T cell receptor (TCR), and murine Ptpn22 plays a role in thymic selection. However, the mechanism of action of the R620W variant in autoimmunity remains unclear. One model holds that LYP-W620 is a gain-of-function phosphatase that causes alterations in thymic negative selection and/or thymic output of regulatory T cells (T-reg) through inhibition of thymic TCR signaling. To test this model, we generated mice in which the human LYP-W620 variant or its phosphatase-inactive mutant are expressed in developing thymocytes under control of the proximal Lck promoter. We found that LYP-W620 expression results in diminished thymocyte TCR signaling, thus modeling a "gain-of-function" of LYP at the signaling level. However, LYP-W620 transgenic mice display no alterations of thymic negative selection and no anomalies in thymic output of CD4(+)Foxp3(+) T-reg were detected in these mice. Lck promoter-directed expression of the human transgene also causes no alteration in thymic repertoire or increase in disease severity in a model of rheumatoid arthritis, which depends on skewed thymic selection of CD4(+) T cells. Our data suggest that a gain-of-function of LYP is unlikely to increase risk of autoimmunity through alterations of thymic selection and that LYP likely acts in the periphery perhaps selectively in regulatory T cells or in another cell type to increase risk of autoimmunity.	[Wu, Dennis J.; Stanford, Stephanie M.; Rapini, Novella; Bottini, Nunzio] La Jolla Inst Allergy & Immunol, Div Cellular Biol, La Jolla, CA USA; [Zhou, Wenbo; Sawatzke, Kristy; Peterson, Erik] Univ Minnesota, Dept Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Enouz, Sarah; Zehn, Dietmar] Swiss Vaccine Res Inst, Epalinges, Switzerland; [Enouz, Sarah; Zehn, Dietmar] Univ Lausanne Hosp, Dept Med, Div Immunol & Allergy, Lausanne, Switzerland; [Orru, Valeria; Fiorillo, Edoardo; Bottini, Nunzio] Univ So Calif, Inst Med Genet, Los Angeles, CA USA; [Orru, Valeria; Fiorillo, Edoardo] CNR, IRGB, Monserrato, Italy; [Maine, Christian J.; Sherman, Linda A.] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Engel, Isaac; Kronenberg, Mitch] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA	La Jolla Institute for Immunology; University of Minnesota System; University of Minnesota Twin Cities; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Southern California; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Scripps Research Institute; La Jolla Institute for Immunology	Peterson, E (corresponding author), Univ Minnesota, Dept Med, Ctr Immunol, Box 736 UMHC, Minneapolis, MN 55455 USA.	peter899@umn.edu; nunzio@lji.org	Fiorillo, Edoardo/AAY-3804-2020; Kronenberg, Mitchell/AAT-6078-2021; Enouz, Sarah/H-1558-2017; Valeria, Orru/AAY-3805-2020; novella, rapini/AAA-7970-2020; Ingegnoli, Francesca/B-6226-2017	Enouz, Sarah/0000-0002-3046-8881; novella, rapini/0000-0002-3104-5776; Ingegnoli, Francesca/0000-0002-6727-1273; Orru, Valeria/0000-0002-6047-4625; Sherman, Linda/0000-0001-6422-7069; maine, christian/0000-0003-4338-3526	NIH [R21AI065643, R01AI070544, R01AR057781, R37AI71922]; Juvenile Diabetes Research Foundation (JDRF); American College of Rheumatology Research and Education Foundation; Alliance for Lupus Research; Lupus Foundation of Minnesota; Sardinian government; JDRF; Swiss National Science Foundation [PP00P3_144883, PDFMP3_137128, CRSII3_141879]; Swiss Vaccine Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065643, R37AI071922, R01AI070544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057781] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); American College of Rheumatology Research and Education Foundation; Alliance for Lupus Research; Lupus Foundation of Minnesota; Sardinian government(Regione Sardegna); JDRF(Juvenile Diabetes Research Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Vaccine Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by NIH grants R21AI065643 and R01AI070544 and an Innovative Grant from the Juvenile Diabetes Research Foundation (JDRF) to N.B., grant NIH R01AR057781, the American College of Rheumatology Research and Education Foundation, the Alliance for Lupus Research, and Lupus Foundation of Minnesota to E.J.P., grant NIH R37AI71922 to M. K. Valeria Orru and Edoardo Fiorillo were supported by Master and Back fellowships from the Sardinian government. Stephanie M. Stanford is supported by a fellowship from JDRF. DZ was supported by grants from the Swiss National Science Foundation [PP00P3_144883, PDFMP3_137128, CRSII3_141879] and funds from the Swiss Vaccine Research Foundation. This is publication # 1650 from the La Jolla Institute for Allergy and Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnisalo J, 2008, J AUTOIMMUN, V31, P13, DOI 10.1016/j.jaut.2008.01.001; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Brownlie RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003365; Cao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042783; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; CHANG HH, 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0033067; Chuang WY, 2009, GENES IMMUN, V10, P667, DOI 10.1038/gene.2009.64; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Dai XZ, 2013, J CLIN INVEST, V123, P2024, DOI 10.1172/JCI66963; DILLON SR, 1994, J IMMUNOL, V152, P1790; Enouz S, 2012, J EXP MED, V209, P1769, DOI 10.1084/jem.20120905; Fiorillo E, 2010, J BIOL CHEM, V285, P26506, DOI 10.1074/jbc.M110.111104; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Habib T, 2012, J IMMUNOL, V188, P487, DOI 10.4049/jimmunol.1102176; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hogquist KA, 2000, METH MOL B, V156, P219; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Lefvert AK, 2008, J NEUROIMMUNOL, V197, P110, DOI 10.1016/j.jneuroim.2008.04.004; Maine CJ, 2012, J IMMUNOL, V188, P5267, DOI 10.4049/jimmunol.1200150; Menard L, 2011, J CLIN INVEST, V121, P3635, DOI 10.1172/JCI45790; Montalibet J, 2005, METHODS, V35, P2, DOI 10.1016/j.ymeth.2004.07.002; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sakaguchi S, 2006, SEMIN IMMUNOL, V18, P199, DOI 10.1016/j.smim.2006.03.007; Sakaguchi S, 2011, FEBS LETT, V585, P3633, DOI 10.1016/j.febslet.2011.10.026; Stanford SM, 2010, SEMIN IMMUNOPATHOL, V32, P127, DOI 10.1007/s00281-010-0201-4; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Tanaka S, 2010, J IMMUNOL, V185, P2295, DOI 10.4049/jimmunol.1000848; Teh H S, 1990, Dev Immunol, V1, P1, DOI 10.1155/1990/18208; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vang T, 2013, HUM IMMUNOL, V74, P574, DOI 10.1016/j.humimm.2012.12.017; Vang T, 2012, NAT CHEM BIOL, V8, P437, DOI [10.1038/NCHEMBIO.916, 10.1038/nchembio.916]; Veillette A, 2009, IMMUNOL REV, V228, P312, DOI 10.1111/j.1600-065X.2008.00747.x; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; YEH LT, 2013, J IMMUNOLOGY; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	53	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86677	10.1371/journal.pone.0086677	http://dx.doi.org/10.1371/journal.pone.0086677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498279	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900025
J	Atyame, CM; Labbe, P; Dumas, E; Milesi, P; Charlat, S; Fort, P; Weill, M				Atyame, Celestine M.; Labbe, Pierrick; Dumas, Emilie; Milesi, Pascal; Charlat, Sylvain; Fort, Philippe; Weill, Mylene			Wolbachia Divergence and the Evolution of Cytoplasmic Incompatibility in Culex pipiens	PLOS ONE			English	Article							AEDES-ALBOPICTUS; CROSSING TYPE; MOSQUITO; VARIABILITY; POPULATIONS; INFECTIONS; RESISTANCE; COMPLEX; DIPTERA; INTROGRESSION	Many insect species harbor Wolbachia bacteria that induce cytoplasmic incompatibility (CI), i.e. embryonic lethality in crosses between infected males and uninfected females, or between males and females carrying incompatible Wolbachia strains. The molecular mechanism of CI remains unknown, but the available data are best interpreted under a modification-rescue model, where a mod function disables the reproductive success of infected males' sperm, unless the eggs are infected and express a compatible resc function. Here we examine the evolution of CI in the mosquito Culex pipiens, harbouring a large number of closely related Wolbachia strains structured in five distinct phylogenetic groups. Specifically, we used a worldwide sample of mosquito lines to assess the hypothesis that genetic divergence should correlate with the divergence of CI properties on a low evolutionary scale. We observed a significant association of Wolbachia genetic divergence with CI patterns. Most Wolbachia strains from the same group were compatible whereas those from different groups were often incompatible. Consistently, we found a strong association between Wolbachia groups and their mod-resc properties. Finally, lines from the same geographical area were rarely incompatible, confirming the conjecture that the spatial distribution of Wolbachia compatibility types should be constrained by selection. This study indicates a clear correlation between Wolbachia genotypes and CI properties, paving the way toward the identification of the molecular basis of CI through comparative genomics.	[Atyame, Celestine M.; Labbe, Pierrick; Dumas, Emilie; Milesi, Pascal; Weill, Mylene] Univ Montpellier 2, CNRS, ISEM, UMR 5554, Montpellier, France; [Charlat, Sylvain] Univ Lyon 1, CNRS, LBBE, UMR 5558, F-69622 Villeurbanne, France; [Fort, Philippe] Univ Montpellier 2, CNRS, CRBM, UMR 5237, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Atyame, CM (corresponding author), Univ La Reunion, CRVOI, Ste Clotilde, Reunion Island, France.	celestine.atyame-nten@univ-reunion.fr	Labbé, Pïerrick/AAL-5806-2020; Fort, Philippe/M-9498-2015; Milesi, Pascal/K-3234-2019	Labbé, Pïerrick/0000-0003-0806-1919; Fort, Philippe/0000-0001-5997-8722; Charlat, Sylvain/0000-0003-0760-0087; Weill, Mylene/0000-0002-4043-1601	Institut des Sciences de l'Evolution de Montpellier (Unitee Mixte de Recherche) [CNRS-IRD-UM2 5554]	Institut des Sciences de l'Evolution de Montpellier (Unitee Mixte de Recherche)	This study is the contribution of the Institut des Sciences de l'Evolution de Montpellier (Unitee Mixte de Recherche, CNRS-IRD-UM2 5554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atyame CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001440; Atyame CM, 2011, MOL BIOL EVOL, V28, P2761, DOI 10.1093/molbev/msr083; Atyame CM, 2011, MOL ECOL, V20, P286, DOI 10.1111/j.1365-294X.2010.04937.x; BARR AR, 1980, NATURE, V283, P71, DOI 10.1038/283071a0; Bordenstein SR, 2007, HEREDITY, V99, P278, DOI 10.1038/sj.hdy.6800994; Callaini G, 1997, J CELL SCI, V110, P271; Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140; Charlat S, 2004, EVOLUTION, V58, P1901, DOI 10.1111/j.0014-3820.2004.tb00478.x; Charlat S, 2002, EVOLUTION, V56, P1735, DOI 10.1111/j.0014-3820.2002.tb00187.x; Charlat S, 2001, GENETICS, V159, P1415; Crawley MJ., 2007, R BOOK; Dobson SL, 2002, GENETICS, V160, P1087; Dobson SL, 2001, J MED ENTOMOL, V38, P382, DOI 10.1603/0022-2585-38.3.382; Dumas E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-181; Duron O, 2007, HEREDITY, V98, P368, DOI 10.1038/sj.hdy.6800948; Duron O, 2006, P ROY SOC B-BIOL SCI, V273, P495, DOI 10.1098/rspb.2005.3336; Duron O, 2006, HEREDITY, V96, P493, DOI 10.1038/sj.hdy.6800831; Duron O, 2005, MOL ECOL, V14, P1561, DOI 10.1111/j.1365-294X.2005.02495.x; Duron O, 2007, J BACTERIOL, V189, P4442, DOI 10.1128/JB.00142-07; Duron O, 2006, MOL ECOL, V15, P3061, DOI 10.1111/j.1365-294X.2006.02996.x; Duron O, 2012, P ROY SOC B-BIOL SCI, V279, P4473, DOI 10.1098/rspb.2012.1368; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; GEORGHIOU GP, 1966, B WORLD HEALTH ORGAN, V35, P691; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; LAVEN H, 1967, GENETICS INSECT VECT; Mercot H, 2004, GENETICA, V120, P51, DOI 10.1023/B:GENE.0000017629.31383.8f; Nor I, 2013, AM NAT, V182, pE15, DOI 10.1086/670612; Nor I, 2012, INFORM COMPUT, V213, P23, DOI 10.1016/j.ic.2011.03.008; ONEILL SL, 1992, MED VET ENTOMOL, V6, P209, DOI 10.1111/j.1365-2915.1992.tb00608.x; Poinsot D, 2003, BIOESSAYS, V25, P259, DOI 10.1002/bies.10234; Rasgon JL, 2003, GENETICS, V165, P2029; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; Riegler M, 2002, MOL ECOL, V11, P2425, DOI 10.1046/j.1365-294X.2002.01614.x; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; ROUSSET F, 1991, J EVOLUTION BIOL, V4, P69, DOI 10.1046/j.1420-9101.1991.4010069.x; Sanogo YO, 2004, INSECT MOL BIOL, V13, P365, DOI 10.1111/j.0962-1075.2004.00498.x; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; Sinkins SP, 2005, NATURE, V436, P257, DOI 10.1038/nature03629; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tram U, 2006, J CELL SCI, V119, P3655, DOI 10.1242/jcs.03095; Vavre F, 2012, CURR OPIN MICROBIOL, V15, P263, DOI 10.1016/j.mib.2012.03.005; Walker T, 2009, J HERED, V100, P192, DOI 10.1093/jhered/esn079; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	51	37	38	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87336	10.1371/journal.pone.0087336	http://dx.doi.org/10.1371/journal.pone.0087336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498078	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900094
J	Bartosik, AA; Glabski, K; Jecz, P; Mikulska, S; Fogtman, A; Koblowska, M; Jagura-Burdzy, G				Bartosik, Aneta A.; Glabski, Krzysztof; Jecz, Paulina; Mikulska, Sylwia; Fogtman, Anna; Koblowska, Marta; Jagura-Burdzy, Grazyna			Transcriptional Profiling of ParA and ParB Mutants in Actively Dividing Cells of an Opportunistic Human Pathogen Pseudomonas aeruginosa	PLOS ONE			English	Article							C-DI-GMP; BACTERIAL CHROMOSOME SEGREGATION; GENE-EXPRESSION; REPLICATION INITIATION; PROTEIN; PLASMID; IDENTIFICATION; REGION; REGULATOR; BINDING	Accurate chromosome segregation to progeny cells is a fundamental process ensuring proper inheritance of genetic material. In bacteria with simple cell cycle, chromosome segregation follows replication initiation since duplicated oriC domains start segregating to opposite halves of the cell soon after they are made. ParA and ParB proteins together with specific DNA sequences are parts of the segregation machinery. ParA and ParB proteins in Pseudomonas aeruginosa are important for optimal growth, nucleoid segregation, cell division and motility. Comparative transcriptome analysis of parA(null) and parB(null) mutants versus parental P. aeruginosa PAO1161 strain demonstrated global changes in gene expression pattern in logarithmically growing planktonic cultures. The set of genes similarly affected in both mutant strains is designated Par regulon and comprises 536 genes. The Par regulon includes genes controlled by two sigma factors (RpoN and PvdS) as well as known and putative transcriptional regulators. In the absence of Par proteins, a large number of genes from RpoS regulon is induced, reflecting the need for slowing down the cell growth rate and decelerating the metabolic processes. Changes in the expression profiles of genes involved in c-di-GMP turnover point out the role of this effector in such signal transmission. Microarray data for chosen genes were confirmed by RT-qPCR analysis. The promoter regions of selected genes were cloned upstream of the promoter-less lacZ gene and analyzed in the heterologous host E. coli Delta lac. Regulation by ParA and ParB of P. aeruginosa was confirmed for some of the tested promoters. Our data demonstrate that ParA and ParB besides their role in accurate chromosome segregation may act as modulators of genes expression. Directly or indirectly, Par proteins are part of the wider regulatory network in P. aeruginosa linking the process of chromosome segregation with the cell growth, division and motility.	[Bartosik, Aneta A.; Glabski, Krzysztof; Jecz, Paulina; Mikulska, Sylwia; Jagura-Burdzy, Grazyna] Polish Acad Sci, Inst Biochem & Biophys, Dept Microbial Biochem, Warsaw, Poland; [Fogtman, Anna; Koblowska, Marta] Polish Acad Sci, Inst Biochem & Biophys, Lab Microarray Anal, Warsaw, Poland; [Koblowska, Marta] Univ Warsaw, Fac Biol, Dept Syst Biol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Bartosik, AA (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Dept Microbial Biochem, Warsaw, Poland.	anetab2@ibb.waw.pl	Bartosik, Aneta/AAR-9347-2021; Jecz, Paulina/S-7566-2018; Jagura-Burdzy, Grazyna/AAU-7423-2021	Bartosik, Aneta/0000-0002-2091-3101; Jagura-Burdzy, Grazyna/0000-0002-0794-2565; Jecz, Paulina/0000-0001-7612-8631; Koblowska, Marta/0000-0003-4497-6200; Fogtman, Anna/0000-0002-5331-7840	MNiSW/NCN [N N303 457038(4570/B/P01/2010/38)]	MNiSW/NCN	This work was supported by MNiSW/NCN grant N N303 457038(4570/B/P01/2010/38) awarded to AAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018; Arai H, 2005, J BACTERIOL, V187, P3960, DOI 10.1128/JB.187.12.3960-3968.2005; Attila C, 2008, APPL MICROBIOL BIOT, V78, P293, DOI 10.1007/s00253-007-1308-y; Balasubramanian Deepak, 2009, Human Genomics, V3, P349; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Bartosik AA, 2009, MICROBIOL-SGM, V155, P1080, DOI 10.1099/mic.0.024661-0; Bartosik AA, 2004, J BACTERIOL, V186, P6983, DOI 10.1128/JB.186.20.6983-6998.2004; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; Cirz RT, 2006, J BACTERIOL, V188, P7101, DOI 10.1128/JB.00807-06; Cowles KN, 2010, MOL MICROBIOL, V76, P1411, DOI 10.1111/j.1365-2958.2010.07132.x; Damron FH, 2012, J BACTERIOL, V194, P1317, DOI 10.1128/JB.06105-11; Dong YH, 2005, MOL MICROBIOL, V56, P1287, DOI 10.1111/j.1365-2958.2005.04612.x; Dubarry N, 2006, J BACTERIOL, V188, P1489, DOI 10.1128/JB.188.4.1489-1496.2006; Duvel J, 2012, J MICROBIOL METH, V88, P229, DOI 10.1016/j.mimet.2011.11.015; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Heurlier K, 2006, INT J MED MICROBIOL, V296, P93, DOI 10.1016/j.ijmm.2006.01.043; JAGURA-BURDZY G, 1991, J BACTERIOL, V173, P826, DOI 10.1128/jb.173.2.826-833.1991; Jakimowicz D, 2002, MOL MICROBIOL, V45, P1365, DOI 10.1046/j.1365-2958.2002.03102.x; Jakimowicz D, 2007, MOL MICROBIOL, V65, P625, DOI 10.1111/j.1365-2958.2007.05815.x; JENSEN RB, 1994, J MOL BIOL, V236, P1299, DOI 10.1016/0022-2836(94)90059-0; JIN SG, 1994, J BACTERIOL, V176, P1316, DOI 10.1128/jb.176.5.1316-1322.1994; Kahn M, 1979, Methods Enzymol, V68, P268; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kusiak M, 2011, J BACTERIOL, V193, P3342, DOI 10.1128/JB.00328-11; Kwong SM, 2001, MOL MICROBIOL, V40, P621, DOI 10.1046/j.1365-2958.2001.02405.x; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Lasocki K, 2007, J BACTERIOL, V189, P5762, DOI 10.1128/JB.00371-07; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lewis RA, 2002, MICROBIOL-SGM, V148, P537, DOI 10.1099/00221287-148-2-537; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065, DOI 10.1099/00221287-147-8-2065; MATSUI H, 1993, J BACTERIOL, V175, P1257, DOI 10.1128/JB.175.5.1257-1263.1993; Meddows TR, 2005, MOL MICROBIOL, V57, P97, DOI 10.1111/j.1365-2958.2005.04677.x; Mierzejewska J, 2012, MICROBIOL-SGM, V158, P1183, DOI 10.1099/mic.0.056234-0; Mierzejewska J, 2012, PLASMID, V67, P1, DOI 10.1016/j.plasmid.2011.08.003; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ogasawara H, 2007, J BACTERIOL, V189, P4791, DOI 10.1128/JB.00319-07; OGASAWARA N, 1992, MOL MICROBIOL, V6, P629, DOI 10.1111/j.1365-2958.1992.tb01510.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Ramos-Aires J, 2004, ANTIMICROB AGENTS CH, V48, P843, DOI 10.1128/AAC.48.3.843-851.2004; Rampioni G, 2006, J BACTERIOL, V188, P815, DOI 10.1128/JB.188.2.815-819.2006; Rampioni G, 2007, MOL MICROBIOL, V66, P1557, DOI 10.1111/j.1365-2958.2007.06029.x; Rampioni G, 2007, J BACTERIOL, V189, P1922, DOI 10.1128/JB.01552-06; ROMEROSTEINER S, 1994, J BACTERIOL, V176, P5771, DOI 10.1128/JB.176.18.5771-5779.1994; Ryan RP, 2012, TRENDS MICROBIOL, V20, P235, DOI 10.1016/j.tim.2012.02.008; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2004, MOL MICROBIOL, V51, P973, DOI 10.1046/j.1365-2958.2003.03886.x; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Vallet-Gely I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003492; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Venkova-Canova T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003579; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; Wang YP, 2003, ANTIMICROB AGENTS CH, V47, P95, DOI 10.1128/AAC.47.1.95-101.2003; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Wu WH, 2005, J BACTERIOL, V187, P6058, DOI 10.1128/JB.187.17.6058-6068.2005; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2	72	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87276	10.1371/journal.pone.0087276	http://dx.doi.org/10.1371/journal.pone.0087276			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498062	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900082
J	Bi, HS; Ji, RB; Liu, H; Jo, YH; Hare, JA				Bi, Hongsheng; Ji, Rubao; Liu, Hui; Jo, Young-Heon; Hare, Jonathan A.			Decadal Changes in Zooplankton of the Northeast US Continental Shelf	PLOS ONE			English	Article							MIDDLE ATLANTIC BIGHT; CALANUS-FINMARCHICUS POPULATIONS; GULF-STREAM; INTERANNUAL VARIATIONS; COPEPOD POPULATIONS; NORTHWEST ATLANTIC; CLIMATE-CHANGE; UNITED-STATES; LIFE-HISTORY; GEORGES-BANK	The abundance of the subarctic copepod, Calanus finmarchicus, and temperate, shelf copepod, Centropages typicus, was estimated from samples collected bi-monthly over the Northeast U. S. continental shelf (NEUS) from 1977-2010. Latitudinal variation in long term trends and seasonal patterns for the two copepod species were examined for four sub-regions: the Gulf of Maine (GOM), Georges Bank (GB), Southern New England (SNE), and Mid-Atlantic Bight (MAB). Results suggested that there was significant difference in long term variation between northern region (GOM and GB), and the MAB for both species. C. finmarchicus generally peaked in May - June throughout the entire study region and Cen. typicus had a more complex seasonal pattern. Time series analysis revealed that the peak time for Cen. typicus switched from November December to January - March after 1985 in the MAB. The long term abundance of C. finmarchicus showed more fluctuation in the MAB than the GOM and GB, whereas the long term abundance of Cen. typicus was more variable in the GB than other sub-regions. Alongshore transport was significantly correlated with the abundance of C. finmarchicus, i.e., more water from north, higher abundance for C. finmarchicus. The abundance of Cen. typicus showed positive relationship with the Gulf Stream north wall index (GSNWI) in the GOM and GB, but the GSNWI only explained 12-15% of variation in Cen. typicus abundance. In general, the alongshore current was negatively correlated with the GSNWI, suggesting that Cen. typicus is more abundant when advection from the north is less. However, the relationship between Cen. typicus and alongshore transport was not significant. The present study highlights the importance of spatial scales in the study of marine populations: observed long term changes in the northern region were different from the south for both species.	[Bi, Hongsheng] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [Ji, Rubao] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Liu, Hui] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Jo, Young-Heon] Pusan Natl Univ, Dept Oceanog, Pusan, South Korea; [Hare, Jonathan A.] NOAA, Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr Narragansett Lab, Narragansett, RI 02882 USA	University System of Maryland; University of Maryland Center for Environmental Science; Woods Hole Oceanographic Institution; Texas A&M University System; Pusan National University; National Oceanic Atmospheric Admin (NOAA) - USA	Bi, HS (corresponding author), Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA.	hbi@cbl.umces.edu	Bi, Hongsheng/B-9409-2012; Ji, Rubao/I-1970-2015	Bi, Hongsheng/0000-0003-2595-6271; Ji, Rubao/0000-0002-8839-5427	Cnes	Cnes(Centre National D'etudes Spatiales)	This synthesis research utilized data collected by the NOAA's Northeast Fisheries Science Center as part of an ongoing mission to monitor and assess the Northeast Continental Shelf ecosystem. RJ worked on this paper as a CINAR (Cooperative Institute for the North Atlantic Region) Fellow. The altimeter products were produced by Ssalto/Duacs and distributed by Aviso with support from Cnes.	BEARDSLEY RC, 1985, J PHYS OCEANOGR, V15, P713, DOI 10.1175/1520-0485(1985)015<0713:TNSFEP>2.0.CO;2; Beaugrand G, 2003, FISH OCEANOGR, V12, P270, DOI 10.1046/j.1365-2419.2003.00248.x; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Bi HS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047927; Cadden DDH, 2009, MAR GEOD, V32, P334, DOI 10.1080/01490410903094908; CHAPMAN DC, 1989, J PHYS OCEANOGR, V19, P384, DOI 10.1175/1520-0485(1989)019<0384:OTOOSW>2.0.CO;2; COX J, 1979, ESTUAR COAST MAR SCI, V9, P509, DOI 10.1016/0302-3524(79)90076-8; Curry RG, 2001, J PHYS OCEANOGR, V31, P3374, DOI 10.1175/1520-0485(2001)031<3374:OGCCAW>2.0.CO;2; Dong SF, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001357; Durbin E, 2007, PROG OCEANOGR, V72, P249, DOI 10.1016/j.pocean.2007.01.008; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Feng H, 2011, MAR GEOD, V34, P340, DOI 10.1080/01490419.2011.584828; Flagg CN, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003116; Flagg CN, 1998, J ATMOS OCEAN TECH, V15, P257, DOI 10.1175/1520-0426(1998)015<0257:OAADCP>2.0.CO;2; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; GANGOPADHYAY A, 1992, J PHYS OCEANOGR, V22, P1286, DOI 10.1175/1520-0485(1992)022<1286:ATOTPH>2.0.CO;2; Greene CH, 2003, PROG OCEANOGR, V58, P301, DOI 10.1016/j.pocean.2003.08.009; Greene CH, 2000, ICES J MAR SCI, V57, P1536, DOI 10.1006/jmsc.2000.0966; Greene CH, 2008, ECOLOGY, V89, pS24, DOI 10.1890/07-0550.1; Greene CH, 2007, SCIENCE, V315, P1084, DOI 10.1126/science.1136495; Han GQ, 2001, J PHYS OCEANOGR, V31, P199, DOI 10.1175/1520-0485(2001)031<0199:IVOVTI>2.0.CO;2; Han GQ, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006091; Hare JA, 2001, FISH OCEANOGR, V10, P164, DOI 10.1046/j.1365-2419.2001.00168.x; Hare JA, 2012, AM FISH S S, V79, P115; Harvey A.C., 1993, HDB STAT, V11, P261, DOI [10.1016/S0169-7161(05)80045-8, DOI 10.1016/S0169-7161(05)80045-8]; Harvey AC, 1990, FORECASTING STRUCTUR; Hatun H, 2003, CONT SHELF RES, V23, P859, DOI 10.1016/S0278-4343(03)00059-1; Ji RB, 2013, J PLANKTON RES, V35, P66, DOI 10.1093/plankt/fbs070; Ji RB, 2010, J PLANKTON RES, V32, P1355, DOI 10.1093/plankt/fbq062; Ji RB, 2009, MAR ECOL PROG SER, V384, P187, DOI 10.3354/meps08032; JUNE FC, 1971, FISH BULL NATL OC AT, V68, P493; Kane J, 2005, J PLANKTON RES, V27, P401, DOI 10.1093/plankt/fbi009; KANE J., 2011, J NW ATLANTIC FISHER, V43, P81, DOI DOI 10.2960/J.V43.M674; Kane J, 2007, ICES J MAR SCI, V64, P909, DOI 10.1093/icesjms/fsm066; Keigwin LD, 1999, SCIENCE, V286, P520, DOI 10.1126/science.286.5439.520; KJELSON MA, 1975, FISH B-NOAA, V73, P137; Koch AO, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005704; Lillibridge JL, 2013, DEEP-SEA RES PT II, V85, P127, DOI 10.1016/j.dsr2.2012.07.034; Liu H, J MAR SYS; Mountain DG, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001044; Peng JY, 2011, J STAT SOFTW, V41, P1; Pershing AJ, 2005, ICES J MAR SCI, V62, P1511, DOI 10.1016/j.icesjms.2005.04.025; Pershing AJ, 2010, J PLANKTON RES, V32, P1661, DOI 10.1093/plankt/fbq058; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Pickart RS, 1999, J PHYS OCEANOGR, V29, P2541, DOI 10.1175/1520-0485(1999)029<2541:MSAIVO>2.0.CO;2; Rossby T, 2000, GEOPHYS RES LETT, V27, P117, DOI 10.1029/1999GL002356; Saraceno M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004756; SHERMAN K, 1984, MAR ECOL PROG SER, V18, P1, DOI 10.3354/meps018001; SMITH PC, 1991, CONT SHELF RES, V11, P977, DOI 10.1016/0278-4343(91)90088-N; Taylor AH, 1998, TELLUS A, V50, P134, DOI 10.1034/j.1600-0870.1998.00010.x; Volkov DL, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003765	51	14	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87720	10.1371/journal.pone.0087720	http://dx.doi.org/10.1371/journal.pone.0087720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498177	Green Submitted, gold, Green Published			2022-12-25	WOS:000330621900160
J	Blanchet, C; Jouvion, G; Fitting, C; Cavaillon, JM; Adib-Conquy, M				Blanchet, Charlene; Jouvion, Gregory; Fitting, Catherine; Cavaillon, Jean-Marc; Adib-Conquy, Minou			Protective or Deleterious Role of Scavenger Receptors SR-A and CD36 on Host Resistance to Staphylococcus aureus Depends on the Site of Infection	PLOS ONE			English	Article							IN-VIVO; NEUTROPHIL RECRUITMENT; INFLAMMATORY RESPONSE; MEDIATED PHAGOCYTOSIS; ALVEOLAR MACROPHAGES; ESCHERICHIA-COLI; SEPSIS; RECOGNITION; NOD2; CLEARANCE	Staphylococcus aureus is a major human opportunistic pathogen responsible for a broad spectrum of infections ranging from benign skin infection to more severe life threatening disorders (e. g. pneumonia, sepsis), particularly in intensive care patients. Scavenger receptors (SR-A and CD36) are known to be involved in S. aureus recognition by immune cells in addition to MARCO, TLR2, NOD2 and alpha 5 beta 1 integrin. In the present study, we further deciphered the contribution of SR-A and CD36 scavenger receptors in the control of infection of mice by S. aureus. Using double SR-A/CD36 knockout mice (S/C-KO) and S. aureus strain HG001, a clinically relevant non-mutagenized strain, we showed that the absence of these two scavenger receptors was protective in peritoneal infection. In contrast, the deletion of these two receptors was detrimental in pulmonary infection following intranasal instillation. For pulmonary infection, susceptible mice (S/C-KO) had more colony-forming units (CFU) in their broncho-alveolar lavages fluids, associated with increased recruitment of macrophages and neutrophils. For peritoneal infection, susceptible mice (wild-type) had more CFU in their blood, but recruited less macrophages and neutrophils in the peritoneal cavity than resistant mice. Exacerbated cytokine levels were often observed in the susceptible mice in the infected compartment as well as in the plasma. The exception was the enhanced compartmentalized expression of IL-1 beta for the resistant mice (S/C-KO) after peritoneal infection. A similar mirrored susceptibility to S. aureus infection was also observed for MARCO and TLR2. Marco and tlr2 -/- mice were more resistant to peritoneal infection but more susceptible to pulmonary infection than wild type mice. In conclusion, our results show that innate immune receptors can play distinct and opposite roles depending on the site of infection. Their presence is protective for local pulmonary infection, whereas it becomes detrimental in the peritoneal infection.	[Blanchet, Charlene; Fitting, Catherine; Cavaillon, Jean-Marc; Adib-Conquy, Minou] Inst Pasteur, Dept Infect & Epidemiol, Paris, France; [Jouvion, Gregory] Inst Pasteur, Dept Infect & Epidemiol, Unite Histopathol Humaine & Modeles Animaux, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cavaillon, JM (corresponding author), Inst Pasteur, Dept Infect & Epidemiol, Paris, France.	jean-marc.cavaillon@pasteur.fr	Jouvion, Grégory/AAL-2620-2021		Institut Pasteur, Programme Transversal de Recherche [PTR336]	Institut Pasteur, Programme Transversal de Recherche	This study and Charlene Blanchet were supported by Institut Pasteur, Programme Transversal de Recherche (grant and fellowship PTR336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2007, FEBS LETT, V581, P3723, DOI 10.1016/j.febslet.2007.03.074; Ahn JY, 2006, FEMS IMMUNOL MED MIC, V46, P187, DOI 10.1111/j.1574-695X.2005.00021.x; Amiel E, 2009, J LEUKOCYTE BIOL, V85, P595, DOI 10.1189/jlb.1008631; Arredouani MS, 2005, J IMMUNOL, V175, P6058, DOI 10.4049/jimmunol.175.9.6058; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034378; Bocharov AV, 2004, J BIOL CHEM, V279, P36072, DOI 10.1074/jbc.M314264200; Cavaillon JM, 2006, J ENDOTOXIN RES, V12, P151, DOI 10.1179/096805106X102246; Deng MH, 2013, J IMMUNOL, V190, P5152, DOI 10.4049/jimmunol.1300496; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; FERNANDES DM, 1995, INFECT IMMUN, V63, P1130, DOI 10.1128/IAI.63.3.1130-1133.1995; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gillaspy A. F., 2006, GRAM POSITIVE PATHOG, P381, DOI DOI 10.1128/; Gillrie MR, 2010, EUR J IMMUNOL, V40, P1639, DOI 10.1002/eji.200939929; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Guest CB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000511; Guo YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024774; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Hultgren OH, 2002, J IMMUNOL, V168, P5207, DOI 10.4049/jimmunol.168.10.5207; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; Jozefowski S, 2004, J LEUKOCYTE BIOL, V76, P1066, DOI 10.1189/jlb.0504270; Kapetanovic R, 2011, AM J PHYSIOL-CELL PH, V300, pC850, DOI 10.1152/ajpcell.00187.2010; Kapetanovic R, 2010, MICROBES INFECT, V12, P759, DOI 10.1016/j.micinf.2010.05.003; Liang XD, 2007, CELL MICROBIOL, V9, P1809, DOI 10.1111/j.1462-5822.2007.00917.x; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Makinen PI, 2010, CARDIOVASC RES, V88, P530, DOI 10.1093/cvr/cvq235; Martin FJ, 2011, INFECT IMMUN, V79, P1898, DOI 10.1128/IAI.01299-10; Metzger DW, 2013, INFECT IMMUN, V81, P2022, DOI 10.1128/IAI.00024-13; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Mullaly SC, 2006, J IMMUNOL, V177, P8154, DOI 10.4049/jimmunol.177.11.8154; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Ono K, 2006, J IMMUNOL, V177, P5517, DOI 10.4049/jimmunol.177.8.5517; Peiser L, 2000, INFECT IMMUN, V68, P1953, DOI 10.1128/IAI.68.4.1953-1963.2000; Philippart F, 2012, CRIT CARE MED, V40, P2987, DOI 10.1097/CCM.0b013e31825b8d57; Schmaler M, 2009, J IMMUNOL, V182, P7110, DOI 10.4049/jimmunol.0804292; Schwartz J, 2009, J IMMUNOL, V183, P2632, DOI 10.4049/jimmunol.0804110; Sever-Chroneos Z, 2011, J BIOL CHEM, V286, P4854, DOI 10.1074/jbc.M110.125567; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; van der Laan LJW, 1999, J IMMUNOL, V162, P939; Verdrengh M, 2000, ARTHRITIS RHEUM, V43, P2276, DOI 10.1002/1529-0131(200010)43:10<2276::AID-ANR15>3.0.CO;2-C; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Wang MJ, 1999, IMMUNOLOGY, V98, P90; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103; Yang X, 1996, J IMMUNOL, V156, P4338; Zhao YX, 1998, IMMUNOLOGY, V93, P80	56	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87927	10.1371/journal.pone.0087927	http://dx.doi.org/10.1371/journal.pone.0087927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498223	gold, Green Submitted, Green Published			2022-12-25	WOS:000330621900194
J	Hung, JE; Fogle, EJ; Garg, N; Chekan, JR; Nair, SK; van der Donk, WA				Hung, John E.; Fogle, Emily J.; Garg, Neha; Chekan, Jonathan R.; Nair, Satish K.; van der Donk, Wilfred A.			Chemical Rescue and Inhibition Studies to Determine the Role of Arg301 in Phosphite Dehydrogenase	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; BAEYER-VILLIGER MONOOXYGENASES; L-ASPARTATE OXIDASE; ACTIVE-SITE; GUANIDINE DERIVATIVES; IMP DEHYDROGENASE; STEADY-STATE; ARGININE; ENZYME; RESIDUES	Phosphite dehydrogenase (PTDH) catalyzes the NAD(+)-dependent oxidation of phosphite to phosphate. This reaction requires the deprotonation of a water nucleophile for attack on phosphite. A crystal structure was recently solved that identified Arg301 as a potential base given its proximity and orientation to the substrates and a water molecule within the active site. Mutants of this residue showed its importance for efficient catalysis, with about a 100-fold loss in k(cat) and substantially increased K-m,K-phosphite for the Ala mutant (R301A). The 2.35 angstrom resolution crystal structure of the R301A mutant with NAD(+) bound shows that removal of the guanidine group renders the active site solvent exposed, suggesting the possibility of chemical rescue of activity. We show that the catalytic activity of this mutant is restored to near wild-type levels by the addition of exogenous guanidinium analogues; Bronsted analysis of the rates of chemical rescue suggests that protonation of the rescue reagent is complete in the transition state of the rate-limiting step. Kinetic isotope effects on the reaction in the presence of rescue agents show that hydride transfer remains at least partially rate-limiting, and inhibition experiments show that K-i of sulfite with R301A is similar to 400-fold increased compared to the parent enzyme, similar to the increase in K-m for phosphite in this mutant. The results of our experiments indicate that Arg301 plays an important role in phosphite binding as well as catalysis, but that it is not likely to act as an active site base.	[Hung, John E.; Fogle, Emily J.; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Garg, Neha; Chekan, Jonathan R.; Nair, Satish K.; van der Donk, Wilfred A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	van der Donk, WA (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	vddonk@illinois.edu	Garg, Neha/L-3120-2018; Chekan, Jonathan/AAN-8499-2020; Nair, Satish/AAY-2510-2021; van der Donk, Wilfred/K-2961-2015	Garg, Neha/0000-0002-2760-7123; van der Donk, Wilfred/0000-0002-5467-7071; Chekan, Jonathan/0000-0003-4651-0594	National Science Foundation [NSF 0822536]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF 0822536 to WAvdD). WAvdD is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Berkowitz O, 2011, ANAL BIOCHEM, V412, P74, DOI 10.1016/j.ab.2011.01.014; Bossi RT, 2002, BIOCHEMISTRY-US, V41, P3018, DOI 10.1021/bi015939r; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Cook P. F., 2007, ENZYME KINETICS MECH; Costas AMG, 2001, J BIOL CHEM, V276, P17429, DOI 10.1074/jbc.M011764200; Doherty MK, 2000, BIOCHEMISTRY-US, V39, P10695, DOI 10.1021/bi000871l; Fogle EJ, 2007, BIOCHEMISTRY-US, V46, P13101, DOI 10.1021/bi701550c; Goedl C, 2008, FEBS J, V275, P903, DOI [10.1111/j.1742-4658.2008.06254.x, 10.1111/j.1742-4658.2007.06254.x]; Hansch C, 1979, SUBSTITUENT CONSTANT; HARPEL MR, 1994, BIOCHEMISTRY-US, V33, P5553, DOI 10.1021/bi00184a026; Hedstrom L, 2006, CURR OPIN CHEM BIOL, V10, P520, DOI 10.1016/j.cbpa.2006.08.005; Hirota R, 2012, J BIOSCI BIOENG, V113, P445, DOI 10.1016/j.jbiosc.2011.11.027; Hung JE, 2012, BIOCHEMISTRY-US, V51, P4254, DOI 10.1021/bi201691w; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; Johannes TW, 2005, APPL ENVIRON MICROB, V71, P5728, DOI 10.1128/AEM.71.10.5728-5734.2005; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; KLINMAN JP, 1985, J AM CHEM SOC, V107, P1058, DOI 10.1021/ja00290a052; Leatherbarrow RJ, 2009, GRAFIT VERSION 7 7 0; Lehoux IE, 2000, BIOCHEMISTRY-US, V39, P10055, DOI 10.1021/bi000161f; Liu DF, 2012, APPL BIOCHEM BIOTECH, V166, P1301, DOI 10.1007/s12010-011-9518-2; Martinez A, 2012, ENVIRON MICROBIOL, V14, P1363, DOI 10.1111/j.1462-2920.2011.02612.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mowat CG, 2001, BIOCHEMISTRY-US, V40, P12292, DOI 10.1021/bi011360h; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pazmino DET, 2008, ANGEW CHEM INT EDIT, V47, P2275, DOI 10.1002/anie.200704630; Pazmino DET, 2009, CHEMBIOCHEM, V10, P2595, DOI 10.1002/cbic.200900480; Perrin DD, 1965, INT UNION PURE APPL; Relyea HA, 2005, BIOCHEMISTRY-US, V44, P6640, DOI 10.1021/bi047640p; Rioz-Martinez A, 2011, ORG BIOMOL CHEM, V9, P1337, DOI 10.1039/c0ob00988a; Rynkiewicz MJ, 1996, BIOCHEMISTRY-US, V35, P16174, DOI 10.1021/bi961311i; Sanchez-Torres P, 2003, BIOCHEM J, V370, P331, DOI 10.1042/BJ20021071; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Schlippe YVG, 2005, BIOCHEMISTRY-US, V44, P16695, DOI 10.1021/bi051603w; Schlippe YVG, 2005, BIOCHEMISTRY-US, V44, P11700, DOI 10.1021/bi048342v; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Tedeschi G, 2001, BIOCHEMISTRY-US, V40, P4738, DOI 10.1021/bi002406u; TONEY MD, 1989, SCIENCE, V243, P1485, DOI 10.1126/science.2538921; van Beek HL, 2012, CHEM COMMUN, V48, P3288, DOI 10.1039/c2cc17656d; van der Kamp MW, 2008, CHEM COMMUN, P1874, DOI 10.1039/b800496j; Vrtis JM, 2001, J AM CHEM SOC, V123, P2672, DOI 10.1021/ja004301k; Vrtis JM, 2002, ANGEW CHEM INT EDIT, V41, P3257, DOI 10.1002/1521-3773(20020902)41:17<3257::AID-ANIE3257>3.0.CO;2-N; Woodyer R, 2003, BIOCHEMISTRY-US, V42, P11604, DOI 10.1021/bi035018b; Woodyer R, 2005, BIOCHEMISTRY-US, V44, P4765, DOI 10.1021/bi047868c; Zou YZ, 2012, BIOCHEMISTRY-US, V51, P4263, DOI 10.1021/bi2016926	48	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87134	10.1371/journal.pone.0087134	http://dx.doi.org/10.1371/journal.pone.0087134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498026	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900069
J	Lee, WJ; Kim, SC; Lee, SJ; Lee, J; Park, JH; Yu, KS; Lim, J; Kwon, SW				Lee, Won Jun; Kim, Sang Cheol; Lee, Seul Ji; Lee, Jeongmi; Park, Jeong Hill; Yu, Kyung-Sang; Lim, Johan; Kwon, Sung Won			Investigating the Different Mechanisms of Genotoxic and Non-Genotoxic Carcinogens by a Gene Set Analysis	PLOS ONE			English	Article							CANCER; DISCRIMINATION; SENSITIVITY; CLASSIFICATION; ASSAYS; LIVER; HEPG2	Based on the process of carcinogenesis, carcinogens are classified as either genotoxic or non-genotoxic. In contrast to non-genotoxic carcinogens, many genotoxic carcinogens have been reported to cause tumor in carcinogenic bioassays in animals. Thus evaluating the genotoxicity potential of chemicals is important to discriminate genotoxic from non-genotoxic carcinogens for health care and pharmaceutical industry safety. Additionally, investigating the difference between the mechanisms of genotoxic and non-genotoxic carcinogens could provide the foundation for a mechanism-based classification for unknown compounds. In this study, we investigated the gene expression of HepG2 cells treated with genotoxic or non-genotoxic carcinogens and compared their mechanisms of action. To enhance our understanding of the differences in the mechanisms of genotoxic and non-genotoxic carcinogens, we implemented a gene set analysis using 12 compounds for the training set (12, 24, 48 h) and validated significant gene sets using 22 compounds for the test set (24, 48 h). For a direct biological translation, we conducted a gene set analysis using Globaltest and selected significant gene sets. To validate the results, training and test compounds were predicted by the significant gene sets using a prediction analysis for microarrays (PAM). Finally, we obtained 6 gene sets, including sets enriched for genes involved in the adherens junction, bladder cancer, p53 signaling pathway, pathways in cancer, peroxisome and RNA degradation. Among the 6 gene sets, the bladder cancer and p53 signaling pathway sets were significant at 12, 24 and 48 h. We also found that the DDB2, RRM2B and GADD45A, genes related to the repair and damage prevention of DNA, were consistently up-regulated for genotoxic carcinogens. Our results suggest that a gene set analysis could provide a robust tool in the investigation of the different mechanisms of genotoxic and non-genotoxic carcinogens and construct a more detailed understanding of the perturbation of significant pathways.	[Lee, Won Jun; Lee, Seul Ji; Park, Jeong Hill; Kwon, Sung Won] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Lee, Won Jun; Lee, Seul Ji; Park, Jeong Hill; Kwon, Sung Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Kim, Sang Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; [Lee, Jeongmi] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea; [Yu, Kyung-Sang] Seoul Natl Univ, Coll Med & Hosp, Seoul, South Korea; [Lim, Johan] Seoul Natl Univ, Dept Stat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Seoul National University (SNU); Seoul National University (SNU)	Kim, SC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea.	sckim.sgi@gmail.com; swkwon@snu.ac.kr	Lee, Jeongmi/AAJ-7720-2020; Yu, Kyung-Sang/J-2770-2012	Lee, Jeongmi/0000-0002-9948-7554; 	National Research Foundation (NRF); Korean government (Ministry of Education, Science and Technology) [NRF- 2011-0019639]; NRF of Korea; Ministry of Education, Science and Technology [NRF-2011-0023057]; Korean government (MSIP) [NRF-2011-0030810]	National Research Foundation (NRF); Korean government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NRF of Korea; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean government (MSIP)	This research was supported by Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (Ministry of Education, Science and Technology) (NRF- 2011-0019639), Basic Science Research Program through the NRF of Korea funded by the Ministry of Education, Science and Technology (NRF-2011-0023057) and NRF of Korea grant funded by the Korean government (MSIP)(NRF-2011-0030810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; AMES BN, 1973, P NATL ACAD SCI USA, V70, P782, DOI 10.1073/pnas.70.3.782; Barckhausen C, 2013, ONCOGENE; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bruin SC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-662; Bylesjo M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-106; Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004; Gollapudi BB, 2011, ENVIRON MOL MUTAGEN, V52, DOI 10.1002/em.20611; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Hulsegge Ina, 2009, BMC Proc, V3 Suppl 4, pS10, DOI 10.1186/1753-6561-3-S4-S10; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jennen DGJ, 2010, TOXICOL SCI, V115, P66, DOI 10.1093/toxsci/kfq026; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim HS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-348; Kirkland D, 2005, MUTAT RES-GEN TOX EN, V584, P1, DOI 10.1016/j.mrgentox.2005.02.004; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; Magkoufopoulou C, 2012, CARCINOGENESIS, V33, P1421, DOI 10.1093/carcin/bgs182; Mathijs K, 2009, TOXICOL SCI, V112, P374, DOI 10.1093/toxsci/kfp229; Oberthuer A, 2007, CANCER LETT, V250, P250, DOI 10.1016/j.canlet.2006.10.016; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; van Delft JHM, 2004, CARCINOGENESIS, V25, P1265, DOI 10.1093/carcin/bgh108; Watanabe T, 2012, MUTAT RES-GEN TOX EN, V747, P164, DOI 10.1016/j.mrgentox.2012.04.011; Westerink WMA, 2010, MUTAT RES-GEN TOX EN, V696, P21, DOI 10.1016/j.mrgentox.2009.12.007; Williams GM, 2001, TOXICOLOGY, V166, P3, DOI 10.1016/S0300-483X(01)00442-5	28	9	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86700	10.1371/journal.pone.0086700	http://dx.doi.org/10.1371/journal.pone.0086700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497971	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900037
J	Liang, P; Guo, YJ; Zhou, XG; Gao, XW				Liang, Pei; Guo, Yajie; Zhou, Xuguo; Gao, Xiwu			Expression Profiling in Bemisia tabaci under Insecticide Treatment: Indicating the Necessity for Custom Reference Gene Selection	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE CHAIN-REACTION; VALID REFERENCE GENES; HOUSEKEEPING GENES; RT-PCR; CROSS-RESISTANCE; QUANTITATIVE PCR; B-BIOTYPE; NORMALIZATION; IDENTIFICATION	Finding a suitable reference gene is the key for qRT-PCR analysis. However, none of the reference gene discovered thus far can be utilized universally under various biotic and abiotic experimental conditions. In this study, we further examine the stability of candidate reference genes under a single abiotic factor, insecticide treatment. After being exposed to eight commercially available insecticides, which belong to five different classes, the expression profiles of eight housekeeping genes in the sweetpotato whitefly, Bemisia tabaci, one of the most invasive and destructive pests in the world, were investigated using qRT-PCR analysis. In summary, elongation factor 1 alpha (EF1 alpha), alpha-tubulin (TUB1 alpha) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were identified as the most stable reference genes under the insecticide treatment. The initial assessment of candidate reference genes was further validated with the expression of two target genes, a P450 (Cyp6cm1) and a glutathione S-transferase (GST). However, ranking of reference genes varied substantially among intra- and inter-classes of insecticides. These combined data strongly suggested the necessity of conducting custom reference gene selection designed for each and every experimental condition, even when examining the same abiotic or biotic factor.	[Liang, Pei; Guo, Yajie; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	China Agricultural University; University of Kentucky	Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	xuguozhou@uky.edu; gaoxiwu@263.net.cn	Liang, Pei/S-7748-2019	Liang, Pei/0000-0002-3083-8918	National Basic Research and Development Program [2009CB119200]; National 863 Plan [2012AA101502]	National Basic Research and Development Program(National Basic Research Program of China); National 863 Plan(National High Technology Research and Development Program of China)	This research was supported by the National Basic Research and Development Program (2009CB119200) and the National 863 Plan (project 2012AA101502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2002, PEST MANAG SCI, V58, P203, DOI 10.1021/ps.440; An Y, 2012, BIOCHEM BIOPH RES CO, V421, P736, DOI 10.1016/j.bbrc.2012.04.073; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Byrne FJ, 2000, PEST MANAG SCI, V56, P867, DOI 10.1002/1526-4998(200010)56:10<867::AID-PS218>3.0.CO;2-P; Cao SN, 2012, BIOCHEM BIOPH RES CO, V424, P118, DOI 10.1016/j.bbrc.2012.06.086; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; Citri A, 2012, NAT PROTOC, V7, P118, DOI 10.1038/nprot.2011.430; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; El Kady H, 2003, PEST MANAG SCI, V59, P865, DOI 10.1002/ps.687; Feng YT, 2010, PEST MANAG SCI, V66, P313, DOI 10.1002/ps.1877; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Karunker I, 2009, INSECT BIOCHEM MOLEC, V39, P697, DOI 10.1016/j.ibmb.2009.08.006; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Liang P, 2012, ECOTOXICOLOGY, V21, P1889, DOI 10.1007/s10646-012-0922-3; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Luo C, 2010, CROP PROT, V29, P429, DOI 10.1016/j.cropro.2009.10.001; Markussen MDK, 2010, PEST MANAG SCI, V66, P1257, DOI 10.1002/ps.2007; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Rajarapu SP, 2012, INSECT SCI, V19, P41, DOI 10.1111/j.1744-7917.2011.01447.x; Rauch N, 2003, ARCH INSECT BIOCHEM, V54, P165, DOI 10.1002/arch.10114; Roditakis E, 2005, PEST MANAG SCI, V61, P577, DOI 10.1002/ps.1029; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang ZY, 2010, PEST MANAG SCI, V66, P1360, DOI 10.1002/ps.2023; Wen YC, 2009, PESTIC BIOCHEM PHYS, V94, P36, DOI 10.1016/j.pestbp.2009.02.009; Yuan LZ, 2012, CROP PROT, V31, P67, DOI 10.1016/j.cropro.2011.09.017; Zhang NN, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.4101	51	47	56	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87514	10.1371/journal.pone.0087514	http://dx.doi.org/10.1371/journal.pone.0087514			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498122	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900123
J	Pavlou, S; Astell, K; Kasioulis, I; Gakovic, M; Baldock, R; van Heyningen, V; Coutinho, P				Pavlou, Sofia; Astell, Katy; Kasioulis, Ioannis; Gakovic, Milica; Baldock, Richard; van Heyningen, Veronica; Coutinho, Pedro			Pleiotropic Effects of Sox2 during the Development of the Zebrafish Epithalamus	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; FLOATING HEAD; F-ACTIN; EXPRESSION; GENE; MUTATIONS; ANOPHTHALMIA; MALFORMATIONS; NEUROGENESIS; ESTABLISHES	The zebrafish epithalamus is part of the diencephalon and encompasses three major components: the pineal, the parapineal and the habenular nuclei. Using sox2 knockdown, we show here that this key transcriptional regulator has pleiotropic effects during the development of these structures. Sox2 negatively regulates pineal neurogenesis. Also, Sox2 is identified as the unknown factor responsible for pineal photoreceptor prepatterning and performs this function independently of the BMP signaling. The correct levels of sox2 are critical for the functionally important asymmetrical positioning of the parapineal organ and for the migration of parapineal cells as a coherent structure. Deviations from this strict control result in defects associated with abnormal habenular laterality, which we have documented and quantified in sox2 morphants.	[Pavlou, Sofia; Astell, Katy; Kasioulis, Ioannis; Gakovic, Milica; Baldock, Richard; van Heyningen, Veronica; Coutinho, Pedro] Univ Edinburgh, Human Genet Unit, Biomed Syst Anal Sect,Med Res Council, Med Dev Genet Sect,Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh	Coutinho, P (corresponding author), Univ Edinburgh, Human Genet Unit, Biomed Syst Anal Sect,Med Res Council, Med Dev Genet Sect,Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland.	pedro.coutinho@igmm.ed.ac.uk	van Heyningen, Veronica/B-8039-2008; VAN HEYNINGEN, Veronica/GYE-0531-2022	van Heyningen, Veronica/0000-0003-0359-0141; Baldock, Richard/0000-0003-0332-6877	Medical Research Council-Human Genetics Unit; MRC [MC_PC_U127527199, MC_PC_U127527203, MC_U127527199] Funding Source: UKRI; Medical Research Council [MC_PC_U127527199, MC_U127527199, MC_PC_U127527203] Funding Source: researchfish	Medical Research Council-Human Genetics Unit; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by Medical Research Council-Human Genetics Unit core funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilina-Beck A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-126; Bakrania P, 2007, BRIT J OPHTHALMOL, V91, P1471, DOI 10.1136/bjo.2007.117929; Barth KA, 1999, DEVELOPMENT, V126, P4977; Bianco IH, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-9; Cau E, 2003, DEVELOPMENT, V130, P2455, DOI 10.1242/dev.00452; Cau E, 2008, DEVELOPMENT, V135, P2391, DOI 10.1242/dev.013482; Collery RF, 2011, DEV DYNAM, V240, P712, DOI 10.1002/dvdy.22567; Concha ML, 2003, NEURON, V39, P423, DOI 10.1016/S0896-6273(03)00437-9; Concha ML, 2000, NEURON, V28, P399, DOI 10.1016/S0896-6273(00)00120-3; Doll CA, 2011, DEV BIOL, V360, P44, DOI 10.1016/j.ydbio.2011.09.003; Dufourcq P, 2004, GENE EXPR PATTERNS, V4, P53, DOI 10.1016/S1567-133X(03)00148-0; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Frambach I, 2004, J COMP NEUROL, V475, P303, DOI 10.1002/cne.20165; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Gamse JT, 2003, DEVELOPMENT, V130, P1059, DOI 10.1242/dev.00270; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Gothilf Y, 2002, DEV DYNAM, V225, P241, DOI 10.1002/dvdy.10152; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hagstrom SA, 2005, AM J MED GENET A, V138A, P95, DOI 10.1002/ajmg.a.30803; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hever AM, 2006, CLIN GENET, V69, P459, DOI 10.1111/j.1399-0004.2006.00619.x; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Lu PN, 2013, DEV BIOL, V374, P333, DOI 10.1016/j.ydbio.2012.11.025; Macchi MM, 2004, FRONT NEUROENDOCRIN, V25, P177, DOI 10.1016/j.yfrne.2004.08.001; Perez-Perez JM, 2009, TRENDS GENET, V25, P368, DOI 10.1016/j.tig.2009.06.004; Masai I, 1997, NEURON, V18, P43, DOI 10.1016/S0896-6273(01)80045-3; Matsumata M, 2005, DEV BIOL, V286, P601, DOI 10.1016/j.ydbio.2005.08.005; Millimaki BB, 2010, DEV BIOL, V338, P262, DOI 10.1016/j.ydbio.2009.12.011; Okuda Y, 2006, DEV DYNAM, V235, P811, DOI 10.1002/dvdy.20678; Okuda Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000936; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Pujic Z, 2006, DEV BIOL, V293, P330, DOI 10.1016/j.ydbio.2005.12.056; Quillien A, 2011, DEVELOPMENT, V138, P2293, DOI 10.1242/dev.060988; Ragge NK, 2005, AM J MED GENET A, V135A, P1, DOI 10.1002/ajmg.a.30642; Regan JC, 2009, NEURON, V61, P27, DOI 10.1016/j.neuron.2008.11.030; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rorth P, 2012, EMBO REP, V13, P984, DOI 10.1038/embor.2012.149; Rossler W, 2002, CHEM SENSES, V27, P803, DOI 10.1093/chemse/27.9.803; Roussigne M, 2009, DEVELOPMENT, V136, P1549, DOI 10.1242/dev.034793; Scheer N, 2001, DEVELOPMENT, V128, P1099; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Shelton L, 2012, PROG NEUROBIOL, V96, P208, DOI 10.1016/j.pneurobio.2012.01.004; Sisodiya SM, 2006, EPILEPSIA, V47, P534, DOI 10.1111/j.1528-1167.2006.00464.x; Snelson CD, 2008, DEVELOPMENT, V135, P1693, DOI 10.1242/dev.016576; Snelson CD, 2009, SEMIN CELL DEV BIOL, V20, P491, DOI 10.1016/j.semcdb.2008.11.008; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Taylor RW, 2011, J NEUROSCI, V31, P9869, DOI 10.1523/JNEUROSCI.0435-11.2011; THISSE C, 1993, DEVELOPMENT, V119, P1203; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	57	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87546	10.1371/journal.pone.0087546	http://dx.doi.org/10.1371/journal.pone.0087546			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498133	gold, Green Submitted, Green Published			2022-12-25	WOS:000330621900131
J	Zhou, L; Situ, SJ; Feng, ZJ; Atkins, CY; Fung, ICH; Xu, Z; Huang, T; Hu, SX; Wang, XJ; Meltzer, MI				Zhou, Lei; Situ, Sujian; Feng, Zijian; Atkins, Charisma Y.; Fung, Isaac Chun-Hai; Xu, Zhen; Huang, Ting; Hu, Shixiong; Wang, Xianjun; Meltzer, Martin I.			Cost-Effectiveness of Alternative Strategies for Annual Influenza Vaccination among Children Aged 6 Months to 14 Years in Four Provinces in China	PLOS ONE			English	Article							IMMUNIZATION; NETWORK	Background: To support policy making, we developed an initial model to assess the cost-effectiveness of potential strategies to increase influenza vaccination rates among children in China. Methods: We studied on children aged 6 months to 14 years in four provinces (Shandong, Henan, Hunan, and Sichuan), with a health care system perspective. We used data from 2005/6 to 2010/11, excluding 2009/10. Costs are reported in 2010 U.S. dollars. Results: In comparison with no vaccination, the mean (range) of Medically Attended Cases averted by the current self-payment policy for the two age groups (6 to 59 months and 60 months to 14 years) was 1,465 (23,11,132) and 792 (36 similar to 4,247), and the cost effectiveness ratios were $ 0 (-11-51) and $ 37 (6-125) per case adverted, respectively. In comparison with the current policy, the incremental cost effectiveness ratio (ICER) of alternative strategies, OPTION One-reminder and OPTION Two-comprehensive package, decreased as vaccination rate increased. The ICER for children aged 6 to 59 months was lower than that for children aged 60 months to 14 years. Conclusions: The model is a useful tool in identifying elements for evaluating vaccination strategies. However, more data are needed to produce more accurate cost-effectiveness estimates of potential vaccination policies.	[Zhou, Lei; Feng, Zijian] Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing, Peoples R China; [Situ, Sujian] US Ctr Dis Control & Prevent, Beijing, Peoples R China; [Atkins, Charisma Y.; Fung, Isaac Chun-Hai; Meltzer, Martin I.] US Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Preparedness & Emerging Infect, Atlanta, GA USA; [Fung, Isaac Chun-Hai] Georgia So Univ, Dept Epidemiol, Jiann Ping Hsu Coll Publ Hlth, Statesboro, GA 30460 USA; [Xu, Zhen] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Div Infect Dis, Beijing, Peoples R China; [Huang, Ting] Sichuan Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China; [Hu, Shixiong] Hunan Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Wang, Xianjun] Shandong Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China	Chinese Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia Southern University; Chinese Center for Disease Control & Prevention	Zhou, L (corresponding author), Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing, Peoples R China.	zhoulei@chinacdc.cn; fengzj@chinacdc.cn	Meltzer, Martin/AAT-3235-2021	Meltzer, Martin/0000-0002-7250-0472; Fung, Isaac Chun-Hai/0000-0001-5496-2529	China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases	China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases	This study was supported by the China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beijing Center for Disease Control and Prevention, NEWS ELD PEOPL SCH C; Britto MT, 2007, QUAL SAF HEALTH CARE, V16, P363, DOI 10.1136/qshc.2006.019380; Chinese Center for Disease Control and Prevention, 2009, GUID SEAS INFL VACC; Chinese Center for Disease Control and Prevention, 2008, GUID SEAS INFL VACC; Chinese Center for Disease Control and Prevention, 2011, SARI SURV PROT; Chinese Center for Disease Control and Prevention, 2010, GUID SEAS INFL VACC; Chinese Center for Disease Control and Prevention, 2007, ZHONG HUA LIU XING B, V28, P1144; Daley MF, 2004, PEDIATRICS, V113, pE26, DOI 10.1542/peds.113.1.e26; Feng LZ, 2010, VACCINE, V28, P6778, DOI 10.1016/j.vaccine.2010.07.064; Hak E, 2000, SCAND J PRIM HEALTH, V18, P237; Liang W, 2012, PUBLIC HEALTH, V126, P427, DOI 10.1016/j.puhe.2012.02.008; Meltzer MI, 2005, VACCINE, V23, P1004, DOI 10.1016/j.vaccine.2004.07.040; Ministry of Health of People's Republic of China, 2008, 4 NAT HLTH SERV SURV; Ministry of Health of People's Republic of China, GUID SEAS INFL VACC; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; National Bureau of Statistics of China, 2010, CHIN STAT YB 2010; Prosser LA, 2006, EMERG INFECT DIS, V12, P1548, DOI 10.3201/eid1210.051015; Rance F, 2008, ARCH PEDIATRIE, V15, P1724, DOI 10.1016/j.arcped.2008.09.004; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Steens A, 2011, EUROSURVEILLANCE, V16, P23; Szucs T, 1999, J ANTIMICROB CHEMOTH, V44, P11, DOI 10.1093/jac/44.suppl_2.11; van Essen GA, 2003, VACCINE, V21, P1780, DOI 10.1016/S0264-410X(03)00072-0; World Health Organization, VACC US WHO REC ANN; Yu WZ, 2006, CHINESE J VACCINES I, V4, P280; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044391; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073724; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063788	28	12	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87590	10.1371/journal.pone.0087590	http://dx.doi.org/10.1371/journal.pone.0087590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498145	Green Published, gold			2022-12-25	WOS:000330621900139
J	Kojima, K; April, C; Canasto-Chibuque, C; Chen, XT; Deshmukh, M; Venkatesh, A; Tan, PS; Kobayashi, M; Kumada, H; Fan, JB; Hoshida, Y				Kojima, Kensuke; April, Craig; Canasto-Chibuque, Claudia; Chen, Xintong; Deshmukh, Manjeet; Venkatesh, Anu; Tan, Poh Seng; Kobayashi, Masahiro; Kumada, Hiromitsu; Fan, Jian-Bing; Hoshida, Yujin			Transcriptome Profiling of Archived Sectioned Formalin-Fixed Paraffin-Embedded (AS-FFPE) Tissue for Disease Classification	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; HEPATOCELLULAR-CARCINOMA; CANCER	Background: Archived tissues from previously completed prospective trials represent invaluable resource for biomarker development. However, such specimens are often stored as sections on glass slides, in which RNA is severely degraded due to prolonged air exposure. We evaluated whether a proportion of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissues yield transcriptome profiles comparable to freshly cut (FC) FFPE tissues, which can be used for retrospective class prediction analysis. Methods: Genome-wide transcriptome profiles of 6 to 7-year-old AS-FFPE tissue sections (generated from 5 to 16-year-old blocks) of 83 hepatocellular carcinoma (HCC) and 47 liver cirrhosis samples were generated by using whole-genome DASL assay (Illumina) and digital transcript counting (nCounter) assay (NanoString), and gene signature-based prediction of HCC subclasses and prognosis was compared with previously generated FC-FFPE profiles from the same tissue blocks. Results: RNA quality and assay reproducibility of AS-FFPE RNA were comparable to intermediate to poor quality FC-FFPE samples (RNA Integrity Number: up to 2.50, R-square for technical replicates: up to 0.93). Analyzable transcriptome profiles were obtained in 64 (77%) HCC and 36 (77%) cirrhosis samples. Statistically more confident predictions based on random resampling-based method (nearest template prediction) were obtained in 37 (58%) HCC and 13 (36%) cirrhosis samples. Predictions made in FC-FFPE profiles were reproduced in 36 (97%) HCC and 11 (85%) cirrhosis AS-FFPE profiles. nCounter assay was tested in 24 cirrhosis samples, which yielded confident prediction in 15 samples (63%), of which 10 samples (67%) showed concordant predictions with FC-FFPE profiles. Conclusions: AS-FFPE tissues yielded poorer quality RNA and transcriptome profiles compared to FC-FFPE tissues. Statistically more confident class prediction was feasible in 37 of 83 HCC samples and 13 of 47 cirrhosis samples. These results suggest that AS-FFPE tissues can be regarded as a resource for retrospective transcriptome-based class prediction analysis when they are the only available materials.	[Kojima, Kensuke; Canasto-Chibuque, Claudia; Chen, Xintong; Deshmukh, Manjeet; Venkatesh, Anu; Tan, Poh Seng; Hoshida, Yujin] Icahn Sch Med Mt Sinai, Liver Canc Program, Tisch Canc Inst, Div Liver Dis,Dept Med, New York, NY 10029 USA; [April, Craig; Fan, Jian-Bing] Illumina Inc, San Diego, CA USA; [Kobayashi, Masahiro; Kumada, Hiromitsu] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan	Icahn School of Medicine at Mount Sinai; Illumina; Toranomon Hospital	Hoshida, Y (corresponding author), Icahn Sch Med Mt Sinai, Liver Canc Program, Tisch Canc Inst, Div Liver Dis,Dept Med, New York, NY 10029 USA.	yujin.hoshida@mssm.edu	Chen, Xintong/I-4800-2019; Hoshida, Yujin/R-7513-2019	Chen, Xintong/0000-0002-2536-165X; 	National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK099558]; European Commission-FP7 Framework (HEPTROMIC) [259744]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099558] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Commission-FP7 Framework (HEPTROMIC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	YH is supported by National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK099558) and European Commission-FP7 Framework (HEPTROMIC, No. 259744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2013, GASTROENTEROLOGY, V144, P1024, DOI 10.1053/j.gastro.2013.01.021; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Korbler T, 2003, EXP MOL PATHOL, V74, P336, DOI 10.1016/S0014-4800(03)00024-8; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Lachenmayer A, 2012, CLIN CANCER RES, V18, P4997, DOI 10.1158/1078-0432.CCR-11-2322; Minguez B, 2011, J HEPATOL, V55, P1325, DOI 10.1016/j.jhep.2011.02.034; Nault JC, 2013, GASTROENTEROLOGY, V145, P176, DOI 10.1053/j.gastro.2013.03.051; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Penney KL, 2011, J CLIN ONCOL, V29, P2391, DOI 10.1200/JCO.2010.32.6421; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; RHEE Y, 1995, NUCLEIC ACIDS RES, V23, P3275, DOI 10.1093/nar/23.16.3275; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Sia D, 2013, GASTROENTEROLOGY, V144, P829, DOI 10.1053/j.gastro.2013.01.001; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Tanabe KK, 2013, ANN SURG ONCOL, V20, P3707, DOI 10.1245/s10434-013-3071-x; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Waldron L, 2012, CLIN CANCER RES, V18, P6136, DOI 10.1158/1078-0432.CCR-12-1915; WORKMAN C, 2002, GENOME BIOL, V0003; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865	32	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86961	10.1371/journal.pone.0086961	http://dx.doi.org/10.1371/journal.pone.0086961			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498002	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100042
J	Lavrijsen, ICM; Leegwater, PAJ; Martin, AJ; Harris, SJ; Tryfonidou, MA; Heuven, HCM; Hazewinkel, HAW				Lavrijsen, Ineke C. M.; Leegwater, Peter A. J.; Martin, Alan J.; Harris, Stephen J.; Tryfonidou, Marianna A.; Heuven, Henri C. M.; Hazewinkel, Herman A. W.			Genome Wide Analysis Indicates Genes for Basement Membrane and Cartilage Matrix Proteins as Candidates for Hip Dysplasia in Labrador Retrievers	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SINGLE NUCLEOTIDE POLYMORPHISM; GERMAN-SHEPHERD DOGS; CONGENITAL MUSCULAR-DYSTROPHY; DEVELOPMENTAL DYSPLASIA; ELBOW DYSPLASIA; ASSOCIATION; OSTEOARTHRITIS; MUTATIONS; LAMININ	Hip dysplasia, an abnormal laxity of the hip joint, is seen in humans as well as dogs and is one of the most common skeletal disorders in dogs. Canine hip dysplasia is considered multifactorial and polygenic, and a variety of chromosomal regions have been associated with the disorder. We performed a genome-wide association study in Dutch Labrador Retrievers, comparing data of nearly 18,000 single nucleotide polymorphisms (SNPs) in 48 cases and 30 controls using two different statistical methods. An individual SNP analysis based on comparison of allele frequencies with a chi(2) statistic was used, as well as a simultaneous SNP analysis based on Bayesian variable selection. Significant association with canine hip dysplasia was observed on chromosome 8, as well as suggestive association on chromosomes 1, 5, 15, 20, 25 and 32. Next-generation DNA sequencing of the exons of genes of seven regions identified multiple associated alleles on chromosome 1, 5, 8, 20, 25 and 32 (p<0.001). Candidate genes located in the associated regions on chromosomes 1, 8 and 25 included LAMA2, LRR1 and COL6A3, respectively. The associated region on CFA20 contained candidate genes GDF15, COMP and CILP2. In conclusion, our study identified candidate genes that might affect susceptibility to canine hip dysplasia. These genes are involved in hypertrophic differentiation of chondrocytes and extracellular matrix integrity of basement membrane and cartilage. The functions of the genes are in agreement with the notion that disruptions in endochondral bone formation in combination with soft tissue defects are involved in the etiology of hip dysplasia.	[Lavrijsen, Ineke C. M.; Leegwater, Peter A. J.; Tryfonidou, Marianna A.; Heuven, Henri C. M.; Hazewinkel, Herman A. W.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Martin, Alan J.; Harris, Stephen J.] Waltham Ctr Pet Nutr, Waltham, Leics, England	Utrecht University; Mars; WALTHAM Petcare Science Institute	Leegwater, PAJ (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	P.A.J.Leegwater@uu.nl	; Tryfonidou, Marianna/O-3114-2017	Harris, Stephen/0000-0002-3843-159X; Tryfonidou, Marianna/0000-0002-2333-7162; Leegwater, Peter/0000-0002-4100-015X; Harris, Stephen/0000-0002-4422-612X	Waltham Centre for Pet Nutrition, a division of Mars Petcare UK	Waltham Centre for Pet Nutrition, a division of Mars Petcare UK	This study was funded by the Waltham Centre for Pet Nutrition, a division of Mars Petcare UK (http://www.mars.com/global/brands/petcare.aspx). The co-authors Alan J Martin and Stephen J Harris were employed by Mars Petcare UK. They took part in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Bernardo BC, 2011, J BIOL CHEM, V286, P37758, DOI 10.1074/jbc.M111.248039; Boere-Boonekamp MM., 1998, SEMINARS NEONATOLOGY, V3, P49, DOI [10.1016/S1084-2756(98)80148-6, DOI 10.1016/S1084-2756(98)80148-6]; CARDINET GH, 1983, J AM VET MED ASSOC, V182, P393; Chase K, 2004, AM J MED GENET A, V124A, P239, DOI 10.1002/ajmg.a.20363; Chowdhury TT, 2008, INFLAMM RES, V57, P306, DOI 10.1007/s00011-007-7126-y; Dai J, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2540; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; Durr J, 1996, EXP CELL RES, V222, P225, DOI 10.1006/excr.1996.0028; Foels WS, 2000, P 46 ANN M ORTH RES; Friedenberg SG, 2011, AM J VET RES, V72, P530, DOI 10.2460/ajvr.72.4.530; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Heuven Henri C M, 2010, BMC Proc, V4 Suppl 1, pS12; Hinke V, 2001, CALCIFIED TISSUE INT, V69, P315, DOI 10.1007/s002230020024; Hinoi E, 2012, J BONE MINER RES, V27, P938, DOI 10.1002/jbmr.1538; IHEMELANDU EC, 1983, AM J VET RES, V44, P411; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jang IK, 2001, MOL CELLS, V12, P304; Janutta V, 2006, J HERED, V97, P13, DOI 10.1093/jhered/esi128; Jia JY, 2012, OSTEOARTHR CARTILAGE, V20, P60, DOI 10.1016/j.joca.2011.10.004; Kapoor B, 2007, J NEGAT RESULTS BIOM, V6, DOI 10.1186/1477-5751-6-7; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kolundzic R, 2011, CYTOKINE, V54, P125, DOI 10.1016/j.cyto.2011.02.004; LUST G, 1972, AM J VET RES, V33, P1097; MADSEN JS, 1991, J SMALL ANIM PRACT, V32, P351, DOI 10.1111/j.1748-5827.1991.tb00948.x; Maki K, 2004, HEREDITY, V92, P402, DOI 10.1038/sj.hdy.6800434; Malm S, 2007, PREV VET MED, V78, P196, DOI 10.1016/j.prevetmed.2006.10.005; Marschall Y, 2007, MAMM GENOME, V18, P861, DOI 10.1007/s00335-007-9071-z; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; PAATSAMA S, 2000, HEREDITARY BONE JOIN, P263; Peled E, 2008, CLIN ORTHOP RELAT R, V466, P771, DOI 10.1007/s11999-008-0132-8; Peters HC, 2011, TISSUE ENG PT A, V17, P2017, DOI [10.1089/ten.tea.2010.0601, 10.1089/ten.TEA.2010.0601]; Phavaphutanon J, 2009, AM J VET RES, V70, P1094, DOI 10.2460/ajvr.70.9.1094; PRIESTER WA, 1972, J AM VET MED ASSOC, V160, P735; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RISER WH, 1975, VET PATHOL, V12, P235, DOI 10.1177/030098587501200401; Shibuya Seiji, 2003, Medical Electron Microscopy, V36, P213, DOI 10.1007/s00795-003-0227-y; Steeve KT, 2004, CYTOKINE GROWTH F R, V15, P49, DOI 10.1016/j.cytogfr.2003.10.005; Todhunter RJ, 1997, J AM VET MED ASSOC, V210, P1458; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Todhunter RJ, 2003, TXB SMALL ANIMAL SUR, P2009; Wang K, 2010, OSTEOARTHR CARTILAGE, V18, P1592, DOI 10.1016/j.joca.2010.09.008; Zhou Y, 2007, OSTEOARTHR CARTILAGE, V15, P884, DOI 10.1016/j.joca.2007.02.001; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219; Zhu L, 2008, ANIM GENET, V39, P141, DOI 10.1111/j.1365-2052.2007.01691.x	46	23	26	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87735	10.1371/journal.pone.0087735	http://dx.doi.org/10.1371/journal.pone.0087735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498183	Green Published, gold			2022-12-25	WOS:000330617100111
J	Mohannath, G; Jackel, JN; Lee, YH; Buchmann, RC; Wang, H; Patil, V; Adams, AK; Bisaro, DM				Mohannath, Gireesha; Jackel, Jamie N.; Lee, Youn Hyung; Buchmann, R. Cody; Wang, Hui; Patil, Veena; Adams, Allie K.; Bisaro, David M.			A Complex Containing SNF1-Related Kinase (SnRK1) and Adenosine Kinase in Arabidopsis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PHOSPHORYLATED NITRATE REDUCTASE; GEMINIVIRUS AL2; L2 PROTEINS; SACCHAROMYCES-CEREVISIAE; GLOBAL REGULATORS; UPSTREAM KINASE; ENERGY; EXPRESSION; BINDING	SNF1-related kinase (SnRK1) in plants belongs to a conserved family that includes sucrose non-fermenting 1 kinase (SNF1) in yeast and AMP-activated protein kinase (AMPK) in animals. These kinases play important roles in the regulation of cellular energy homeostasis and in response to stresses that deplete ATP, they inhibit energy consuming anabolic pathways and promote catabolism. Energy stress is sensed by increased AMP: ATP ratios and in plants, 5'-AMP inhibits inactivation of phosphorylated SnRK1 by phosphatase. In previous studies, we showed that geminivirus pathogenicity proteins interact with both SnRK1 and adenosine kinase (ADK), which phosphorylates adenosine to generate 5'-AMP. This suggested a relationship between SnRK1 and ADK, which we investigate in the studies described here. We demonstrate that SnRK1 and ADK physically associate in the cytoplasm, and that SnRK1 stimulates ADK in vitro by an unknown, non-enzymatic mechanism. Further, altering SnRK1 or ADK activity in transgenic plants altered the activity of the other kinase, providing evidence for in vivo linkage but also revealing that in vivo regulation of these activities is complex. This study establishes the existence of SnRK1-ADK complexes that may play important roles in energy homeostasis and cellular responses to biotic and abiotic stress.	[Mohannath, Gireesha; Jackel, Jamie N.; Buchmann, R. Cody; Wang, Hui; Patil, Veena; Adams, Allie K.; Bisaro, David M.] Ohio State Univ, Dept Mol Genet, Ctr Appl Plant Sci, Columbus, OH 43210 USA; [Mohannath, Gireesha; Jackel, Jamie N.; Buchmann, R. Cody; Wang, Hui; Patil, Veena; Adams, Allie K.; Bisaro, David M.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Lee, Youn Hyung] Kyung Hee Univ, Dept Hort Biotechnol, Yongin, South Korea	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Kyung Hee University	Bisaro, DM (corresponding author), Ohio State Univ, Dept Mol Genet, Ctr Appl Plant Sci, Columbus, OH 43210 USA.	bisaro.1@osu.edu			National Science Foundation [MCB-0743261, MCB-1158262]; Ohio State University Center for RNA Biology and Pelotonia	National Science Foundation(National Science Foundation (NSF)); Ohio State University Center for RNA Biology and Pelotonia	This research was supported by grants from the National Science Foundation (MCB-0743261 and MCB-1158262) to DMB. JNJ was supported by Fellowships from the Ohio State University Center for RNA Biology and Pelotonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananieva EA, 2008, PLANT PHYSIOL, V148, P1868, DOI 10.1104/pp.108.130575; Bachmann M, 1996, FEBS LETT, V387, P127, DOI 10.1016/0014-5793(96)00478-4; Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Baliji S, 2007, MOL PLANT MICROBE IN, V20, P194, DOI 10.1094/MPMI-20-2-0194; Baliji S, 2010, VIROLOGY, V402, P238, DOI 10.1016/j.virol.2010.03.023; Buchmann RC, 2009, J VIROL, V83, P5005, DOI 10.1128/JVI.01771-08; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; CELENZA JL, 1989, MOL CELL BIOL, V9, P5034, DOI 10.1128/MCB.9.11.5034; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Crozet P, 2010, J BIOL CHEM, V285, P12071, DOI 10.1074/jbc.M109.079194; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Delatte TL, 2011, PLANT PHYSIOL, V157, P160, DOI 10.1104/pp.111.180422; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Ghillebert R, 2011, FEBS J, V278, P3978, DOI 10.1111/j.1742-4658.2011.08315.x; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; Halford NG, 1998, PLANT MOL BIOL, V37, P735, DOI 10.1023/A:1006024231305; Halford NG, 2009, BIOCHEM J, V419, P247, DOI 10.1042/BJ20082408; Hao LH, 2003, PLANT CELL, V15, P1034, DOI 10.1105/tpc.009530; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HARPER JW, 1993, CELL, V75, P805; Harthill JE, 2006, PLANT J, V47, P211, DOI 10.1111/j.1365-313X.2006.02780.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Ikeda Y, 2000, J BIOL CHEM, V275, P31695, DOI 10.1074/jbc.M004892200; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; Kishimoto A, 2006, MOL BIOTECHNOL, V32, P17, DOI 10.1385/MB:32:1:017; Kudchodkar SB, 2007, J VIROL, V81, P3649, DOI 10.1128/JVI.02079-06; Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09; Lecoq K, 2001, YEAST, V18, P335, DOI 10.1002/1097-0061(20010315)18:4<335::AID-YEA674>3.0.CO;2-X; Lindbo JA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-52; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107; McNellis TW, 1998, PLANT J, V14, P247, DOI 10.1046/j.1365-313X.1998.00106.x; Moffatt BA, 2002, PLANT PHYSIOL, V128, P812, DOI 10.1104/pp.010880; Moffatt BA, 2000, PLANT PHYSIOL, V124, P1775, DOI 10.1104/pp.124.4.1775; Moorhead G, 1996, CURR BIOL, V6, P1104, DOI 10.1016/S0960-9822(02)70677-5; Nakazawa Y, 2007, PLANT MOL BIOL, V63, P777, DOI 10.1007/s11103-006-9125-8; Polge C, 2007, TRENDS PLANT SCI, V12, P20, DOI 10.1016/j.tplants.2006.11.005; Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08; Raja P, 2010, BBA-GENE REGUL MECH, V1799, P337, DOI 10.1016/j.bbagrm.2010.01.004; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shen W, 2006, PLANT PHYSIOL, V142, P1642, DOI 10.1104/pp.106.088476; Shen W, 2009, PLANT PHYSIOL, V150, P996, DOI 10.1104/pp.108.132787; Shin R, 2007, P NATL ACAD SCI USA, V104, P6460, DOI 10.1073/pnas.0610208104; Sugden C, 1999, PLANT J, V19, P433, DOI 10.1046/j.1365-313X.1999.00532.x; Sugden C, 1999, PLANT PHYSIOL, V120, P257, DOI 10.1104/pp.120.1.257; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; von Schwartzenberg K, 1998, PLANT J, V13, P249, DOI 10.1046/j.1365-313X.1998.00011.x; Wang H, 2005, J VIROL, V79, P7410, DOI 10.1128/JVI.79.12.7410-7418.2005; Wang H, 2003, PLANT CELL, V15, P3020, DOI 10.1105/tpc.015180; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Yang X, 2007, J VIROL, V81, P11972, DOI 10.1128/JVI.00617-07; Zhang HS, 2009, VIRUS RES, V146, P51, DOI 10.1016/j.virusres.2009.08.005; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934	64	28	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87592	10.1371/journal.pone.0087592	http://dx.doi.org/10.1371/journal.pone.0087592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498147	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100098
J	Park, HK; Jung, JW; Cho, SH; Min, KU; Kang, HR				Park, Han-Ki; Jung, Jae-Woo; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun			What Makes a Difference in Exercise-Induced Bronchoconstriction: An 8 Year Retrospective Analysis	PLOS ONE			English	Article							INDUCED ASTHMA; INDUCED BRONCHOSPASM; BRONCHIAL RESPONSIVENESS; COLD-AIR; METHACHOLINE; CHALLENGE; CHILDREN; PATHOGENESIS; SENSITIVITY; MECHANISMS	Background: Exercise-induced bronchoconstriction (EIB) was recently classified into EIB alone and EIB with asthma, based on the presence of concurrent asthma. Objective: Differences between EIB alone and EIB with asthma have not been fully described. Methods: We retrospectively reviewed who visited an allergy clinic for respiratory symptoms after exercise and underwent exercise bronchial provocation testing. More than a 15% decrease of forced expiratory volume in 1 second (FEV1) from baseline to the end of a 6 min free-running challenge test was interpreted as positive EIB. Results: EIB was observed in 66.9% of the study subjects (89/133). EIB-positive subjects showed higher positivity to methacholine provocation testing (61.4% vs. 18.9%, p<0.001) compared with EIB-negative subjects. In addition, sputum eosinophilia was more frequently observed in EIB-positive subjects than in EIB-negative subjects (56% vs. 23.5%, p = 0.037). The temperature and relative humidity on exercise test day were significantly related with the EIB-positive rate. Positive EIB status was correlated with both temperature (p = 0.001) and relative humidity (p = 0.038) in the methacholine-negative EIB group while such a correlation was not observed in the methacholine-positive EIB group. In the methacholine-positive EIB group the time to reach a 15% decrease in FEV1 during exercise was significantly shorter than that in the methacholine-negative EIB group (3.2 +/- 0.7 min vs. 8.6 +/- 1.6 min, p = 0.004). Conclusions: EIB alone may be a distinct clinical entity from EIB with asthma. Conditions such as temperature and humidity should be considered when performing exercise tests, especially in subjects with EIB alone.	[Park, Han-Ki; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Park, Han-Ki; Jung, Jae-Woo; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea; [Jung, Jae-Woo] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea	Seoul National University (SNU); Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital	Kang, HR (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	helenmed@snu.ac.kr	Park, Han-Ki/AAY-3102-2020; Park, Heung-Woo/AAW-7690-2020	Park, Heung-Woo/0000-0002-6970-3228; Park, Han-Ki/0000-0002-5460-9917	Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Z, 2012, J ASTHMA, V49, P480, DOI 10.3109/02770903.2012.676123; Anderson SD, 2008, J ALLERGY CLIN IMMUN, V122, P225, DOI 10.1016/j.jaci.2008.05.001; Anderson SD, 2008, CURR OPIN PULM MED, V14, P39, DOI 10.1097/MCP.0b013e3282f197f6; Anderson Sandra D, 2004, Treat Respir Med, V3, P365, DOI 10.2165/00151829-200403060-00004; ANDERSON SD, 1985, EUR J RESPIR DIS, V67, P20; Anderson SD, 2000, J ALLERGY CLIN IMMUN, V106, P453, DOI 10.1067/mai.2000.109822; Anderson SD, 2003, J ALLERGY CLIN IMMUN, V111, P45, DOI 10.1067/mai.2003.1; Anderson SD, 2013, IMMUNOLOGY ALLERGY C; Atkinson RW, 2001, AM J RESP CRIT CARE, V164, P1860, DOI 10.1164/ajrccm.164.10.2010138; Avital A, 2000, PEDIATR PULM, V30, P207, DOI 10.1002/1099-0496(200009)30:3<207::AID-PPUL5>3.0.CO;2-Z; BRUTSCHE M, 1995, ALLERGY, V50, P905, DOI 10.1111/j.1398-9995.1995.tb02497.x; Choi IS, 2012, ALLERGY ASTHMA IMMUN, V4, P192, DOI 10.4168/aair.2012.4.4.192; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Goldberg S, 2005, CHEST, V128, P2408, DOI 10.1378/chest.128.4.2408; Goldberg S, 2012, ALLERGY ASTHMA PROC, V33, P416, DOI 10.2500/aap.2012.33.3586; HAHN A, 1984, AM REV RESPIR DIS, V130, P575; Hallstrand TS, 2012, CURR OPIN ALLERGY CL, V12, P42, DOI 10.1097/ACI.0b013e32834ecc67; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; Hallstrand TS, 2005, AM J RESP CRIT CARE, V172, P679, DOI 10.1164/rccm.200412-1667OC; Helenius IJ, 1998, BRIT J SPORT MED, V32, P125, DOI 10.1136/bjsm.32.2.125; Helenius IJ, 1998, J ALLERGY CLIN IMMUN, V101, P646, DOI 10.1016/S0091-6749(98)70173-3; Holz O, 2002, CLIN EXP ALLERGY, V32, P681, DOI 10.1046/j.1365-2222.2002.01358.x; Lazo-Velasquez JC, 2005, PEDIATR PULM, V40, P457, DOI 10.1002/ppul.20275; Lecomte J, 2002, Rev Med Brux, V23, pA206; MCFADDEN ER, 1990, LANCET, V335, P880, DOI 10.1016/0140-6736(90)90478-N; MCFADDEN ER, 1994, NEW ENGL J MED, V330, P1362, DOI 10.1056/NEJM199405123301907; Min KU, 2000, CLIN EXP ALLERGY, V30, P1129, DOI 10.1046/j.1365-2222.2000.00862.x; Park HW, 2007, ANN ALLERG ASTHMA IM, V98, P533, DOI 10.1016/S1081-1206(10)60731-4; Parsons JP, 2007, MED SCI SPORT EXER, V39, P1487, DOI 10.1249/mss.0b013e3180986e45; Parsons JP, 2013, AM J RESP CRIT CARE, V187, P1016, DOI 10.1164/rccm.201303-0437ST; Pohjantahti H, 2005, SCAND J MED SCI SPOR, V15, P324, DOI 10.1111/j.1600-0838.2004.00423.x; Randolph C, 2009, CURR ALLERGY ASTHM R, V9, P433, DOI 10.1007/s11882-009-0064-8; STRAUSS RH, 1977, NEW ENGL J MED, V297, P743, DOI 10.1056/NEJM197710062971402; TABKA Z, 1988, CHEST, V94, P81, DOI 10.1378/chest.94.1.81; van Leeuwen JC, 2013, IMMUNOLOGY ALLERGY C; Van Schoor J, 2000, EUR RESPIR J, V16, P514, DOI 10.1034/j.1399-3003.2000.016003514.x; Weiler JM, 2007, J ALLERGY CLIN IMMUN, V119, P1349, DOI 10.1016/j.jaci.2007.02.041; Weiler John M, 2010, Ann Allergy Asthma Immunol, V105, pS1, DOI 10.1016/j.anai.2010.09.021	39	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87155	10.1371/journal.pone.0087155	http://dx.doi.org/10.1371/journal.pone.0087155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498034	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100054
J	Pekkinen, M; Saarnio, E; Viljakainen, HT; Kokkonen, E; Jakobsen, J; Cashman, K; Makitie, O; Lamberg-Allardt, C				Pekkinen, Minna; Saarnio, Elisa; Viljakainen, Heli T.; Kokkonen, Elina; Jakobsen, Jette; Cashman, Kevin; Makitie, Outi; Lamberg-Allardt, Christel			Vitamin D Binding Protein Genotype Is Associated with Serum 25-Hydroxyvitamin D and PTH Concentrations, as Well as Bone Health in Children and Adolescents in Finland	PLOS ONE			English	Article							GROUP-SPECIFIC COMPONENT; MINERAL DENSITY; GC-GLOBULIN; PLASMA-CONCENTRATIONS; FRACTURE RISK; GENE; POLYMORPHISMS; OSTEOPOROSIS; HAPLOTYPES; PHENOTYPE	Vitamin D binding protein (DBP)/group-specific component (Gc), correlates positively with serum vitamin D metabolites, and phenotype influences serum 25-hydroxyvitamin D (S-25(OH)D) concentration. The protein isoform has been associated with decreased bone mineral density (BMD) and increased fracture risk. We examined the role of GC genotypes in S-25(OH)D status and BMD in 231 Finnish children and adolescents aged 7-19 yr. BMD was measured with DXA from lumbar spine (LS), total hip, and whole body, and for 175 subjects, radial volumetric BMD was measured with pQCT. Background characteristic and total dietary intakes of vitamin D and calcium were collected. The concentrations of 25(OH)D, parathyroid hormone (PTH), calcium and other markers of calcium homeostasis were determined from blood and urine. Genotyping was based on single-nucleotide polymorphism (rs4588) in the GC gene. The genotype distribution was: GC 1/1 68%, GC 1/2 26% and GC 2/2 6%. A significant difference emerged in 25(OH)D and PTH concentrations between the genotypes, (p = 0.001 and 0.028 respectively, ANCOVA). There was also a linear trend in: Gc 2/2 had the lowest 25(OH) D and PTH concentrations (p = 0.025 and 0.012, respectively). Total hip bone mineral content was associated with GC genotype (BMC) (p = 0.05, ANCOVA) in boys. In regression analysis, after adjusting for relevant covariates, GC genotype was associated with LS BMC and strength and strain index (SSI) Z-score in both genders, and LS BMD in boys. In conclusion, the present study demonstrates the association between GC genotypes and S-25(OH)D and PTH concentrations. The results show the influence of DBP genetic variation on bone mass accrual in adolescence.	[Pekkinen, Minna; Saarnio, Elisa; Kokkonen, Elina; Lamberg-Allardt, Christel] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Pekkinen, Minna; Makitie, Outi] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland; [Viljakainen, Heli T.; Makitie, Outi] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Viljakainen, Heli T.; Makitie, Outi] Univ Helsinki, Helsinki, Finland; [Jakobsen, Jette] Tech Univ Denmark, Natl Food Inst, Div Nutr, Soborg, Denmark; [Cashman, Kevin] Natl Univ Ireland Univ Coll Cork, Dept Food & Nutr Sci, Cork, Ireland	University of Helsinki; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Technical University of Denmark; University College Cork	Pekkinen, M (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	minna.pekkinen@helsinki.fi	Saarnio, Elisa/L-2611-2019	Saarnio, Elisa/0000-0003-1227-567X; Jakobsen, Jette/0000-0003-4199-3427; Lamberg-Allardt, Christel/0000-0001-7326-1904; Makitie, Outi/0000-0002-4547-001X	Foundation for Pediatric Research; Yrjo Jahnsson Foundation; Academy of Finland; Helsinki University Hospital research funds; Sigrid Juselius Foundation; Ella and Georg Ehrnrooth Foundation; University of Helsinki Research Foundation; Maud Kuistila Memorial Foundation; Folkhalsan Research Foundation; National Doctoral Programme of Musculoskeletal Disorders and Biomaterials (TBDP); Finnish Graduate School on Applied Biosciences (ABS)	Foundation for Pediatric Research; Yrjo Jahnsson Foundation; Academy of Finland(Academy of Finland); Helsinki University Hospital research funds; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Ella and Georg Ehrnrooth Foundation; University of Helsinki Research Foundation; Maud Kuistila Memorial Foundation; Folkhalsan Research Foundation; National Doctoral Programme of Musculoskeletal Disorders and Biomaterials (TBDP); Finnish Graduate School on Applied Biosciences (ABS)	This work was financially supported by the Foundation for Pediatric Research, the Yrjo Jahnsson Foundation, the Academy of Finland, the Helsinki University Hospital research funds, the Sigrid Juselius Foundation, the Ella and Georg Ehrnrooth Foundation, the University of Helsinki Research Foundation, the Maud Kuistila Memorial Foundation, the Folkhalsan Research Foundation, National Doctoral Programme of Musculoskeletal Disorders and Biomaterials (TBDP) and the Finnish Graduate School on Applied Biosciences (ABS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebanjo OA, 1998, BIOCHEM BIOPH RES CO, V249, P668, DOI 10.1006/bbrc.1998.9037; Al-Oanzi ZH, 2008, OSTEOPOROSIS INT, V19, P951, DOI 10.1007/s00198-007-0516-8; ARNAUD J, 1993, HUM GENET, V92, P183; BIKLE DD, 1985, J CLIN ENDOCR METAB, V61, P969, DOI 10.1210/jcem-61-5-969; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Bu FX, 2010, HUM GENET, V128, P549, DOI 10.1007/s00439-010-0881-9; Carpenter TO, 2013, J BONE MINER RES, V28, P213, DOI 10.1002/jbmr.1735; CLEVE H, 1988, VOX SANG, V54, P215, DOI 10.1111/j.1423-0410.1988.tb03908.x; Ezura Y, 2003, J BONE MINER RES, V18, P1642, DOI 10.1359/jbmr.2003.18.9.1642; Fang Y, 2009, CALCIFIED TISSUE INT, V85, P85, DOI 10.1007/s00223-009-9251-9; Giroux S, 2010, BONE, V47, P975, DOI 10.1016/j.bone.2010.06.030; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; HADDAD JG, 1995, J STEROID BIOCHEM, V53, P579, DOI 10.1016/0960-0760(95)00104-8; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Hernandez CJ, 2003, OSTEOPOROSIS INT, V14, P843, DOI 10.1007/s00198-003-1454-8; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Kalkwarf HJ, 2011, OSTEOPOROSIS INT, V22, P607, DOI 10.1007/s00198-010-1333-z; KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950; Kasuga I, 2003, THORAX, V58, P790, DOI 10.1136/thorax.58.9.790; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Lauridsen AL, 2004, J BONE MINER RES, V19, P875, DOI 10.1359/JBMR.040133; Lauridsen AL, 2001, CLIN CHEM, V47, P753; Lehtonen-Veromaa MKM, 2002, AM J CLIN NUTR, V76, P1446, DOI 10.1093/ajcn/76.6.1446; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Nordic Nutrition Recommendations, 2004, INT NUTR PHYS ACT; Outila TA, 2001, AM J CLIN NUTR, V74, P206; Papiha SS, 1999, CALCIFIED TISSUE INT, V65, P262, DOI 10.1007/s002239900695; Pekkinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040090; Pere A, 2000, ANN HUM BIOL, V27, P35, DOI 10.1080/030144600282361; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Rauch F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P119; Rauch F., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P217; Rauch F, 2001, J BONE MINER RES, V16, P1547, DOI 10.1359/jbmr.2001.16.8.1547; Ritter CS, 2011, J MOL ENDOCRINOL, V46, P63, DOI 10.1677/JME-10-0128; Robien K, 2012, BR J NUTR, V15, P1; Sai AJ, 2011, J CLIN ENDOCR METAB, V96, pE436, DOI 10.1210/jc.2010-1886; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Sinotte M, 2009, AM J CLIN NUTR, V89, P634, DOI 10.3945/ajcn.2008.26445; SORVA R, 1990, ACTA PAEDIATR SCAND, V79, P498, DOI 10.1111/j.1651-2227.1990.tb11503.x; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Taes YEC, 2006, BONE, V38, P701, DOI 10.1016/j.bone.2005.10.006; Viljakainen HT, 2006, BRIT J NUTR, V96, P124, DOI 10.1079/BJN20061719; Viljakainen HT, 2011, BONE, V48, P212, DOI 10.1016/j.bone.2010.09.022; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wjst M, 2007, J STEROID BIOCHEM, V103, P799, DOI 10.1016/j.jsbmb.2006.12.053; Xu XH, 2010, OSTEOPOROSIS INT, V21, P99, DOI 10.1007/s00198-009-0929-7; YAMAMOTO N, 1993, J IMMUNOL, V151, P2794	47	30	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87292	10.1371/journal.pone.0087292	http://dx.doi.org/10.1371/journal.pone.0087292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498064	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100073
J	Truong, T; Boshra, H; Embury-Hyatt, C; Nfon, C; Gerdts, V; Tikoo, S; Babiuk, LA; Kara, P; Chetty, T; Mather, A; Wallace, DB; Babiuk, S				Thang Truong; Boshra, Hani; Embury-Hyatt, Carissa; Nfon, Charles; Gerdts, Volker; Tikoo, Suresh; Babiuk, Lorne A.; Kara, Pravesh; Chetty, Thireshni; Mather, Arshad; Wallace, David B.; Babiuk, Shawn			Peste des Petits Ruminants Virus Tissue Tropism and Pathogenesis in Sheep and Goats following Experimental Infection	PLOS ONE			English	Article							LUMPY SKIN-DISEASE; HEMAGGLUTININ PROTEIN; RINDERPEST VIRUS; PROTECTION; VACCINE; FUSION; CATTLE; MORBILLIVIRUS; PREVALENCE; GENES	Peste des petits ruminants (PPR) is a viral disease which primarily affects small ruminants, causing significant economic losses for the livestock industry in developing countries. It is endemic in Saharan and sub-Saharan Africa, the Middle East and the Indian sub-continent. The primary hosts for peste des petits ruminants virus (PPRV) are goats and sheep; however recent models studying the pathology, disease progression and viremia of PPRV have focused primarily on goat models. This study evaluates the tissue tropism and pathogenesis of PPR following experimental infection of sheep and goats using a quantitative time-course study. Upon infection with a virulent strain of PPRV, both sheep and goats developed clinical signs and lesions typical of PPR, although sheep displayed milder clinical disease compared to goats. Tissue tropism of PPRV was evaluated by real-time RT-PCR and immunohistochemistry. Lymph nodes, lymphoid tissue and digestive tract organs were the predominant sites of virus replication. The results presented in this study provide models for the comparative evaluation of PPRV pathogenesis and tissue tropism in both sheep and goats. These models are suitable for the establishment of experimental parameters necessary for the evaluation of vaccines, as well as further studies into PPRV-host interactions.	[Thang Truong; Boshra, Hani; Embury-Hyatt, Carissa; Nfon, Charles; Babiuk, Shawn] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Gerdts, Volker; Tikoo, Suresh] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Tikoo, Suresh] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada; [Babiuk, Lorne A.] Univ Alberta, Edmonton, AB, Canada; [Kara, Pravesh; Chetty, Thireshni; Mather, Arshad; Wallace, David B.] ARC Onderstepoort Vet Inst, Onderstepoort, South Africa; [Wallace, David B.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa; [Babiuk, Shawn] Univ Manitoba, Winnipeg, MB, Canada	Canadian Food Inspection Agency; University of Saskatchewan; University of Saskatchewan; University of Alberta; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria; University of Manitoba	Babiuk, S (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.	shawn.babiuk@inspection.gc.ca	Boshra, Hani/M-2619-2014; Truong, Thang/HGF-0213-2022; Mather, Arshad/AAW-9138-2021	Boshra, Hani/0000-0001-9924-8126; Truong, Thang/0000-0002-0707-7452; Mather, Arshad/0000-0001-7455-2738; Gerdts, Volker/0000-0001-8229-1611; kara, Pravesh/0000-0002-0468-7896; Chetty, Thireshni/0000-0003-4770-6476	Canadian International Development Research Centre (IDRC) [106930]; Canadian International Development Agency (CIDA)	Canadian International Development Research Centre (IDRC); Canadian International Development Agency (CIDA)	This work was funded from a Canadian International Food Security Research Fund (CIFSRF) grant (no. 106930: Livestock vaccines against viral diseases for sub-Saharan Africa) by the Canadian International Development Research Centre (IDRC) and Canadian International Development Agency (CIDA) and is supported by the respective research institutions to which the authors belong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African Union International Bureau for Animal Resources, 2012, IMP LIV DIS AFR; Ayari-Fakhfakh E, 2011, VET J, V187, P402, DOI 10.1016/j.tvjl.2010.01.007; Ba JY, 2008, J VIROL METHODS, V148, P232, DOI 10.1016/j.jviromet.2007.12.003; Babiuk S, 2009, J GEN VIROL, V90, P105, DOI 10.1099/vir.0.004507-0; Bailey D, 2005, VIRUS RES, V110, P119, DOI 10.1016/j.virusres.2005.01.013; Balamurugan V, 2012, J VET SCI, V13, P279, DOI 10.4142/jvs.2012.13.3.279; Baron MD, 2011, VET REC, V169, P16, DOI 10.1136/vr.d3947; Berhe G, 2003, J VIROL, V77, P1571, DOI 10.1128/JVI.77.2.1571-1577.2003; Boshra H, 2013, ANTIVIR RES, V98, P217, DOI 10.1016/j.antiviral.2013.02.016; BUNDZA A, 1988, CAN J VET RES, V52, P46; Chandran D, 2010, INDIAN J MICROBIOL, V50, P266, DOI 10.1007/s12088-010-0026-9; Chen WY, 2010, VACCINE, V28, P4742, DOI 10.1016/j.vaccine.2010.04.102; de Vries RD, 2012, CURR OPIN VIROL, V2, P248, DOI 10.1016/j.coviro.2012.03.005; Diallo A, 2007, VACCINE, V25, P5591, DOI 10.1016/j.vaccine.2007.02.013; Diallo A, 1989, Rev Elev Med Vet Pays Trop, V42, P311; Diallo A., 2003, VVolume 114, P113; Diallo A, 2002, ANN NY ACAD SCI, V969, P88, DOI 10.1111/j.1749-6632.2002.tb04356.x; El Harrak M, 2012, J CLIN MICROBIOL, V50, P3738, DOI 10.1128/JCM.01785-12; Emikpe BO, 2010, VET RES COMMUN, V34, P569, DOI 10.1007/s11259-010-9425-y; GARGADENNEC L., 1942, Bulletin des Services zootechniques et des epizooties de l'Afrique occidentale francaise, V5, P16; Hammouchi M, 2012, VET MICROBIOL, V160, P240, DOI 10.1016/j.vetmic.2012.04.043; JANIGAN DT, 1961, CAN MED ASSOC J, V85, P741; Kumar P, 2004, J VET MED B, V51, P153, DOI 10.1111/j.1439-0450.2004.00747.x; Malik YS, 2011, TRANSBOUND EMERG DIS, V58, P268, DOI 10.1111/j.1865-1682.2011.01201.x; NAWATHE DR, 1979, TROP ANIM HEALTH PRO, V11, P120, DOI 10.1007/BF02237785; Ngichabe CK, 2002, EPIDEMIOL INFECT, V128, P343, DOI 10.1017/S0950268801006513; Pope RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055830; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; ROMERO CH, 1995, VACCINE, V13, P36, DOI 10.1016/0264-410X(95)80008-2; ROMERO CH, 1994, VIROLOGY, V204, P425, DOI 10.1006/viro.1994.1548; ROMERO CH, 1994, VET REC, V135, P152, DOI 10.1136/vr.135.7.152; Saravanan P, 2004, ACTA VIROL, V48, P249; Saravanan P, 2010, BIOLOGICALS, V38, P479, DOI 10.1016/j.biologicals.2010.02.003; Shaila MS, 1996, VIRUS RES, V43, P149, DOI 10.1016/0168-1702(96)01312-3; Singh RP, 2004, REV SCI TECH OIE, V23, P807, DOI 10.20506/rst.23.3.1522; TAYLOR WP, 1979, RES VET SCI, V26, P236, DOI 10.1016/S0034-5288(18)32924-2; TAYLOR WP, 1979, RES VET SCI, V27, P321, DOI 10.1016/S0034-5288(18)32800-5; Toplu N, 2004, J COMP PATHOL, V131, P135, DOI 10.1016/j.jcpa.2004.02.004; Tourais-Esteves I, 2008, DEV COMP IMMUNOL, V32, P1231, DOI 10.1016/j.dci.2008.03.011; von Messling V, 2004, P NATL ACAD SCI USA, V101, P14216, DOI 10.1073/pnas.0403597101; Wang ZL, 2009, EMERG INFECT DIS, V15, P299, DOI 10.3201/eid1502.080817	41	84	86	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87145	10.1371/journal.pone.0087145	http://dx.doi.org/10.1371/journal.pone.0087145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498032	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100053
J	Verheijen, MHG; Peviani, M; Hendricusdottir, R; Bell, EM; Lammens, M; Smit, AB; Bendotti, C; van Minnen, J				Verheijen, Mark H. G.; Peviani, Marco; Hendricusdottir, Rita; Bell, Erin M.; Lammens, Martin; Smit, August B.; Bendotti, Caterina; van Minnen, Jan			Increased Axonal Ribosome Numbers Is an Early Event in the Pathogenesis of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MYELINATING SCHWANN-CELLS; LINKED SOD1 MUTANTS; DISEASE PROGRESSION; LOCAL TRANSLATION; MOTOR-NEURONS; PROTEIN-SYNTHESIS; TRANSPORT; ALS; MECHANISMS; MICE	Myelinating glia cells support axon survival and functions through mechanisms independent of myelination, and their dysfunction leads to axonal degeneration in several diseases. In amyotrophic lateral sclerosis (ALS), spinal motor neurons undergo retrograde degeneration, and slowing of axonal transport is an early event that in ALS mutant mice occurs well before motor neuron degeneration. Interestingly, in familial forms of ALS, Schwann cells have been proposed to slow disease progression. We demonstrated previously that Schwann cells transfer polyribosomes to diseased and regenerating axons, a possible rescue mechanism for disease-induced reductions in axonal proteins. Here, we investigated whether elevated levels of axonal ribosomes are also found in ALS, by analysis of a superoxide dismutase 1 (SOD1)(G93A) mouse model for human familial ALS and a patient suffering from sporadic ALS. In both cases, we found that the disorder was associated with an increase in the population of axonal ribosomes in myelinated axons. Importantly, in SOD1(G93A) mice, the appearance of axonal ribosomes preceded the manifestation of behavioral symptoms, indicating that upregulation of axonal ribosomes occurs early in the pathogenesis of ALS. In line with our previous studies, electron microscopy analysis showed that Schwann cells might serve as a source of axonal ribosomes in the disease-compromised axons. The early appearance of axonal ribosomes indicates an involvement of Schwann cells early in ALS neuropathology, and may serve as an early marker for disease-affected axons, not only in ALS, but also for other central and peripheral neurodegenerative disorders.	[Verheijen, Mark H. G.; Hendricusdottir, Rita; Smit, August B.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, Amsterdam, Netherlands; [Peviani, Marco; Bendotti, Caterina] Mario Negri Inst Pharmacol Res, Dept Neurosci, Mol Neurobiol Lab, Milan, Italy; [Bell, Erin M.; van Minnen, Jan] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Lammens, Martin] Univ Antwerp, Univ Antwerp Hosp, Dept Pathol, B-2020 Antwerp, Belgium	Vrije Universiteit Amsterdam; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Calgary; University of Antwerp	van Minnen, J (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	jvanminn@ucalgary.ca	Lammens, Martin/AAI-9343-2021; Lammens, Martin/H-1503-2011; Verheijen, Mark/AAD-8112-2019; Bendotti, Caterina/AAB-2273-2020; Peviani, Marco/X-7214-2019; Verheijen, Mark/GQY-5157-2022	Lammens, Martin/0000-0002-3881-6692; Verheijen, Mark/0000-0002-3739-3755; Bendotti, Caterina/0000-0003-1055-1271; Bell, Erin/0000-0001-6713-8088; Peviani, Marco/0000-0002-0576-6166	Natural Sciences and Engineering Research Council of Canada (NSERC) [355356]; MS Society of Canada; NSERC; European Union [STREP 12702]; Center for Medical Systems Biology (CMSB)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); MS Society of Canada; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Union(European Commission); Center for Medical Systems Biology (CMSB)	JvM was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC, grant 355356) and by the MS Society of Canada. EB was supported by a summer student award from NSERC. M. H. G. V., M. P., C. B., and J.v.M were supported by a European Union grant (STREP 12702). A. B. S. was supported by the Center for Medical Systems Biology (CMSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Lopez-Verrilli MA, 2013, GLIA, V61, P1795, DOI 10.1002/glia.22558; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Basso M, 2006, J BIOL CHEM, V281, P33325, DOI 10.1074/jbc.M603489200; BAUMAN JGJ, 1988, CYTOMETRY, V9, P517, DOI 10.1002/cyto.990090602; Bendotti C, 2004, TRENDS MOL MED, V10, P393, DOI 10.1016/j.molmed.2004.06.009; Bendotti C, 2001, J NEUROL SCI, V191, P25, DOI 10.1016/S0022-510X(01)00627-X; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Court FA, 2008, J NEUROSCI, V28, P11024, DOI 10.1523/JNEUROSCI.2429-08.2008; Court FA, 2011, GLIA, V59, P1529, DOI 10.1002/glia.21196; CRISPINO M, 1993, J NEUROCHEM, V61, P1144, DOI 10.1111/j.1471-4159.1993.tb03632.x; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Eng H, 1999, J NEUROSCI, V19, P1; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Fruhbeis C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00119; GABREELSFESTEN AAWM, 1992, J NEUROL SCI, V107, P145, DOI 10.1016/0022-510X(92)90282-P; Girault JA, 2002, CURR OPIN NEUROBIOL, V12, P476, DOI 10.1016/S0959-4388(02)00370-7; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Kalichman MW, 1998, ACTA NEUROPATHOL, V95, P47, DOI 10.1007/s004010050764; Kun A, 2007, J NEUROSCI RES, V85, P2087, DOI 10.1002/jnr.21340; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Li YC, 2005, NEUROSCI RES, V53, P298, DOI 10.1016/j.neures.2005.07.006; Li YC, 2005, J ANAT, V206, P535, DOI 10.1111/j.1469-7580.2005.00418.x; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Lobsiger CS, 2009, P NATL ACAD SCI USA, V106, P4465, DOI 10.1073/pnas.0813339106; Lopez-Verrilli MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00205; Luigetti M, 2012, NEUROL SCI, V33, P1095, DOI 10.1007/s10072-011-0909-5; Martini R, 2001, MUSCLE NERVE, V24, P456, DOI 10.1002/mus.1027; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Pizzasegola C, 2009, AMYOTROPH LATERAL SC, V10, P221, DOI 10.1080/17482960902803440; Scherer SS, 2008, GLIA, V56, P1578, DOI 10.1002/glia.20751; Sotelo-Silveira JR, 2006, TRAFFIC, V7, P508, DOI 10.1111/j.1600-0854.2006.00405.x; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; Turner BJ, 2010, HUM MOL GENET, V19, P815, DOI 10.1093/hmg/ddp550; VanMinnen J, 1997, NEUROSCIENCE, V80, P1; Verheijen MHG, 2011, J PERIPHER NERV SYST, V16, P71, DOI 10.1111/j.1529-8027.2011.00322.x; Vessey JP, 2008, P NATL ACAD SCI USA, V105, P16374, DOI 10.1073/pnas.0804583105; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yoon BC, 2012, CELL, V148, P752, DOI 10.1016/j.cell.2011.11.064; ZELENA J, 1972, Z ZELLFORSCH MIK ANA, V124, P217, DOI 10.1007/BF00335680	50	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87255	10.1371/journal.pone.0087255	http://dx.doi.org/10.1371/journal.pone.0087255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498056	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100068
J	Zhang, S; He, YZ; Yu, HY; Dong, ZY				Zhang, Shan; He, Yongzhi; Yu, Haiying; Dong, Zhiyang			Seven N-terminal Residues of a Thermophilic Xylanase Are Sufficient to Confer Hyperthermostability on Its Mesophilic Counterpart	PLOS ONE			English	Article							DIRECTED EVOLUTION; GH11 XYLANASE; ENGINEERING HYPERTHERMOSTABILITY; PROLINE SUBSTITUTIONS; THERMOSTABLE ENZYMES; FAMILY-11 XYLANASE; STABILITY; MIXTURE	Xylanases, and especially thermostable xylanases, are increasingly of interest for the deconstruction of lignocellulosic biomass. In this paper, the termini of a pair of xylanases, mesophilic SoxB and thermophilic TfxA, were studied. Two regions in the N-terminus of TfxA were discovered to be potentially important for the thermostability. By focusing on Region 4, it was demonstrated that only two mutations, N32G and S33P cooperated to improve the thermostability of mesophilic SoxB. By introducing two potential regions into SoxB in combination, the most thermostable mutant, M2-N32G-S33P, was obtained. The M2-N32G-S33P had a melting temperature (Tm) that was 25.6 degrees C higher than the Tm of SoxB. Moreover, M2-N32G-S33P was even three-fold more stable than TfxA and had a Tm value that was 9 degrees C higher than the Tm of TfxA. Thus, for the first time, the mesophilic SoxB "pupil'' outperformed its thermophilic TfxA "master'' and acquired hyperthermostability simply by introducing seven thermostabilizing residues from the extreme N-terminus of TfxA. This work suggested that mutations in the extreme N-terminus were sufficient for the mesophilic xylanase SoxB to acquire hyperthermostability.	[Zhang, Shan; He, Yongzhi; Yu, Haiying; Dong, Zhiyang] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Dong, ZY (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	dongzy@sun.im.ac.cn	Zhang, Shan/L-9188-2019	Zhang, Shan/0000-0002-1530-7561	National Basic Research Program of China [2011CB707402]; National Natural Science Foundation of China [30970073]; National High Technology Research and Development Program of China [2012AA092103]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (2011CB707402), the National Natural Science Foundation of China (30970073) and the National High Technology Research and Development Program of China (2012AA092103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnorsdottir J, 2009, J BIOCHEM, V145, P325, DOI 10.1093/jb/mvn168; BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Dana CM, 2012, BIOTECHNOL BIOENG, V109, P2710, DOI 10.1002/bit.24708; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Dumon C, 2008, J BIOL CHEM, V283, P22557, DOI 10.1074/jbc.M800936200; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Gao SJ, 2013, BIOTECHNOL BIOENG, V110, P1028, DOI 10.1002/bit.24768; Goihberg E, 2007, PROTEINS, V66, P196, DOI 10.1002/prot.21170; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hu JG, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-112; Jeong MY, 2007, J BIOTECHNOL, V127, P300, DOI 10.1016/j.jbiotec.2006.07.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Miyazaki K, 2006, J BIOL CHEM, V281, P10236, DOI 10.1074/jbc.M511948200; Morais S, 2010, MBIO, V1, DOI 10.1128/mBio.00285-10; Paes G, 2006, J BIOTECHNOL, V125, P338, DOI 10.1016/j.jbiotec.2006.03.025; Palackal N, 2004, PROTEIN SCI, V13, P494, DOI 10.1110/ps.03333504; Penttila PA, 2013, BIORESOURCE TECHNOL, V129, P135, DOI 10.1016/j.biortech.2012.11.017; Ruller R, 2008, PROTEINS, V70, P1280, DOI 10.1002/prot.21617; RUSSELL RJM, 1995, CURR OPIN BIOTECH, V6, P370, DOI 10.1016/0958-1669(95)80064-6; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Shen BZ, 2012, NAT BIOTECHNOL, V30, P1131, DOI 10.1038/nbt.2402; Shibuya H, 2000, BIOCHEM J, V349, P651, DOI 10.1042/0264-6021:3490651; Song LT, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-3; Stephens DE, 2007, J BIOTECHNOL, V127, P348, DOI 10.1016/j.jbiotec.2006.06.015; Su XY, 2013, APPL ENVIRON MICROB, V79, P1481, DOI 10.1128/AEM.03265-12; Sun JY, 2005, PROTEIN EXPRES PURIF, V42, P122, DOI 10.1016/j.pep.2005.03.009; SUZUKI Y, 1991, APPL MICROBIOL BIOT, V34, P707; Tian JA, 2010, FEBS J, V277, P4901, DOI 10.1111/j.1742-4658.2010.07895.x; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; Wang YW, 2012, BIORESOURCE TECHNOL, V112, P275, DOI 10.1016/j.biortech.2012.02.092; WATANABE K, 1994, EUR J BIOCHEM, V226, P277, DOI 10.1111/j.1432-1033.1994.tb20051.x; Weng XY, 2005, CURR MICROBIOL, V51, P188, DOI 10.1007/s00284-005-4543-4; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Zhang S, 2010, BIOCHEM BIOPH RES CO, V395, P200, DOI 10.1016/j.bbrc.2010.03.159; Zhang ZG, 2010, BIORESOURCE TECHNOL, V101, P9272, DOI 10.1016/j.biortech.2010.07.060	37	14	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87632	10.1371/journal.pone.0087632	http://dx.doi.org/10.1371/journal.pone.0087632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498158	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100104
J	Braunger, JA; Bruckner, BR; Nehls, S; Pietuch, A; Gerke, V; Mey, I; Janshoff, A; Steinem, C				Braunger, Julia A.; Brueckner, Bastian R.; Nehls, Stefan; Pietuch, Anna; Gerke, Volker; Mey, Ingo; Janshoff, Andreas; Steinem, Claudia			Phosphatidylinositol 4,5-Bisphosphate Alters the Number of Attachment Sites between Ezrin and Actin Filaments A COLLOIDAL PROBE STUDY*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Atomic Force Microscopy; Ezrin; Phosphatidylinositol; Phosphorylation	ATOMIC-FORCE MICROSCOPE; ERM PROTEINS; PLASMA-MEMBRANE; 4,5 BISPHOSPHATE; CELL-ADHESION; IN-VIVO; ACTIVATION; BINDING; PHOSPHORYLATION; MOESIN	Background: Ezrin can establish a dynamic linkage between plasma membrane and cytoskeleton. Results: The individual bond strength between ezrin and F-actin is small, but the number of attachment sites is significantly altered by phosphatidylinositol 4,5-bisphosphate (PIP2). Conclusion: PIP2 activates ezrin to establish multiple weak ezrin/F-actin interactions. Significance: Plasma membrane tension is maintained by ezrin/F-actin interactions. Direct linkage between the plasma membrane and the actin cytoskeleton is controlled by the protein ezrin, a member of the ezrin-radixin-moesin protein family. To function as a membrane-cytoskeleton linker, ezrin needs to be activated in a process that involves binding of ezrin to phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphorylation of a conserved threonine residue. Here, we used colloidal probe microscopy to quantitatively analyze the interaction between ezrin and F-actin as a function of these activating factors. We show that the measured individual unbinding forces between ezrin and F-actin are independent of the activating parameters, in the range of approximately 50 piconewtons. However, the cumulative adhesion energy greatly increases in the presence of PIP2 demonstrating that a larger number of bonds between ezrin and F-actin has formed. In contrast, the phosphorylation state, represented by phosphor-mimetic mutants of ezrin, only plays a minor role in the activation process. These results are in line with in vivo experiments demonstrating that an increase in PIP2 concentration recruits more ezrin to the apical plasma membrane of polarized cells and significantly increases the membrane tension serving as a measure of the adhesion sites between the plasma membrane and the F-actin network.	[Steinem, Claudia] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; [Brueckner, Bastian R.; Nehls, Stefan; Pietuch, Anna; Janshoff, Andreas] Univ Gottingen, Inst Phys Chem, D-37077 Gottingen, Germany; [Gerke, Volker] Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, D-48149 Munster, Germany	University of Gottingen; University of Gottingen; University of Munster	Steinem, C (corresponding author), Univ Gottingen, Inst Organ & Biomol Chem, Tammannstr 2, D-37077 Gottingen, Germany.	csteine@gwdg.de	Steinem, Claudia/K-7534-2018; Steinem, Claudia/O-4801-2019	Steinem, Claudia/0000-0001-8778-9283; Janshoff, Andreas/0000-0002-0773-2963; Bruckner, Bastian Rouven/0000-0002-2860-3538	Deutsche Forschungsgemeinschaft [STE 884/11-1, GE 514/8-1, GE 514/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant STE 884/11-1, GE 514/8-1, and GE 514/9-1.	Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Ben-Aissa K, 2012, J BIOL CHEM, V287, P16311, DOI 10.1074/jbc.M111.304881; Bizzarri AR, 2010, CHEM SOC REV, V39, P734, DOI 10.1039/b811426a; Bosk S, 2011, BIOPHYS J, V100, P1708, DOI 10.1016/j.bpj.2011.02.039; Brambilla D, 2009, INT J CANCER, V125, P2239, DOI 10.1002/ijc.24734; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 1997, J CELL SCI, V110, P3011; Brochard-Wyart F, 2006, P NATL ACAD SCI USA, V103, P7660, DOI 10.1073/pnas.0602012103; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; Carvalho K, 2010, BIOCHEMISTRY-US, V49, P9318, DOI 10.1021/bi101141d; Chambers DN, 2005, BIOCHEMISTRY-US, V44, P3926, DOI 10.1021/bi0480382; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Erdmann T, 2004, J CHEM PHYS, V121, P8997, DOI 10.1063/1.1805496; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Herrig A, 2006, BIOCHEMISTRY-US, V45, P13025, DOI 10.1021/bi061064a; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Hochmuth RM, 2002, BIOPHYS J, V82, P2964, DOI 10.1016/S0006-3495(02)75637-3; Hoeflich KP, 2003, BIOCHEMISTRY-US, V42, P11634, DOI 10.1021/bi0350497; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Janke M, 2008, BIOCHEMISTRY-US, V47, P3762, DOI 10.1021/bi702542s; Jayasundar JJ, 2012, J BIOL CHEM, V287, P37119, DOI 10.1074/jbc.M112.380972; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; Krieg M, 2008, ANGEW CHEM INT EDIT, V47, P9775, DOI 10.1002/anie.200803552; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; Larson SM, 2010, MOL BIOL CELL, V21, P3182, DOI 10.1091/mbc.E10-01-0066; Liu Y, 2012, BLOOD, V119, P445, DOI 10.1182/blood-2011-07-368860; Lorenz B, 2012, J AM CHEM SOC, V134, P3326, DOI 10.1021/ja210304j; Lorenz B, 2010, BIOPHYS CHEM, V150, P54, DOI 10.1016/j.bpc.2010.02.008; Maniti O, 2012, BBA-BIOMEMBRANES, V1818, P2839, DOI 10.1016/j.bbamem.2012.07.004; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Moens PDJ, 2007, BBA-BIOMEMBRANES, V1768, P439, DOI 10.1016/j.bbamem.2006.12.012; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Pietuch A, 2013, SOFT MATTER, V9, P11490, DOI 10.1039/c3sm51610e; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; Roch F, 2010, J CELL SCI, V123, P2057, DOI 10.1242/jcs.064550; Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Seifert U, 2000, PHYS REV LETT, V84, P2750, DOI 10.1103/PhysRevLett.84.2750; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Yonemura S, 2002, J CELL SCI, V115, P2569; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Zwaenepoel I, 2012, MOL BIOL CELL, V23, P1080, DOI 10.1091/mbc.E11-07-0588	57	26	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9833	9843		10.1074/jbc.M113.530659	http://dx.doi.org/10.1074/jbc.M113.530659			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24500715	Green Published, hybrid			2022-12-25	WOS:000333807000033
J	Levy, OE; Jodka, CM; Ren, SS; Mamedova, L; Sharma, A; Samant, M; D'Souza, LJ; Soares, CJ; Yuskin, DR; Jin, LJ; Parkes, DG; Tatarkiewicz, K; Ghosh, SS				Levy, Odile E.; Jodka, Carolyn M.; Ren, Shijun Steven; Mamedova, Lala; Sharma, Abhinandini; Samant, Manoj; D'Souza, Lawrence J.; Soares, Christopher J.; Yuskin, Diane R.; Jin, Li Jenny; Parkes, David G.; Tatarkiewicz, Krystyna; Ghosh, Soumitra S.			Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; SALMON-CALCITONIN; IN-VIVO; POLYETHYLENE-GLYCOL; GLP-1 RECEPTOR; PROTEIN; EXENDIN-4; INSULIN; FCRN; PHARMACOKINETICS	The design, synthesis and pharmacology of novel long-acting exenatide analogs for the treatment of metabolic diseases are described. These molecules display enhanced pharmacokinetic profile and potent glucoregulatory and weight lowering actions compared to native exenatide. [Leu(14)]exenatide-ABD is an 88 residue peptide amide incorporating an Albumin Binding Domain (ABD) scaffold. [Leu(14)]exenatide-ABP is a 53 residue peptide incorporating a short Albumin Binding Peptide (ABP). [Leu(14)]exenatide-ABD and [Leu(14)]exenatide-ABP exhibited nanomolar functional GLP-1 receptor potency and were metabolically stable in vitro in human plasma and in a pancreatic digestive enzyme mixture. Both molecules displayed picomolar and nanomolar binding association with albumin across multiple species and circulating half lives of 16 and 11 hours, respectively, post a single IV dose in rats. Unlike exenatide, both molecules elicited robust glucose lowering when injected 1 day prior to an oral glucose tolerance test, indicative of their extended duration of action. [Leu(14)]exenatide-ABD was compared to exenatide in a Lep(ob/ob) mouse model of diabetes. Twice-weekly subcutaneously dosed [Leu(14)]exenatide-ABD displayed superior glucose lowering and weight loss in diabetic mice when compared to continuously infused exenatide at the same total weekly dose. A single oral administration of each molecule via an enteric coated capsule to cynomolgus monkeys showed superior pharmacokinetics for [Leu(14)]exenatide-ABD as compared to [Leu(14)]exenatide-ABP with detectable exposure longer than 14 days. These studies support the potential use of these novel long acting exenatide analogs with different routes of administration for the treatment of type 2 diabetes.	[Levy, Odile E.; Jodka, Carolyn M.; Ren, Shijun Steven; Mamedova, Lala; Sharma, Abhinandini; Samant, Manoj; D'Souza, Lawrence J.; Soares, Christopher J.; Yuskin, Diane R.; Jin, Li Jenny; Parkes, David G.; Tatarkiewicz, Krystyna; Ghosh, Soumitra S.] Amylin Pharmaceut LLC, San Diego, CA 92121 USA		Ghosh, SS (corresponding author), Amylin Pharmaceut LLC, San Diego, CA 92121 USA.	sghosh1@san.rr.com	Soares, Carlos José/D-2126-2013	Soares, Carlos José/0000-0002-8830-605X	Amylin Pharmaceuticals LLC.	Amylin Pharmaceuticals LLC.	The authors have read the journal's policy and have the following conflicts. All authors were employed by and were shareholders in Amylin Pharmaceuticals during the study period. This study was funded by Amylin Pharmaceuticals LLC. Patents filed or issued: "Engineered polypeptides having enhanced duration of action" WO 2012050923 A2. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alters SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050630; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; Anderson CL, 2006, TRENDS IMMUNOL, V27, P343, DOI 10.1016/j.it.2006.05.004; Ashkenazi A, 1997, CURR OPIN IMMUNOL, V9, P195, DOI 10.1016/S0952-7915(97)80135-5; AZRIA M, 1995, CALCIFIED TISSUE INT, V57, P405, DOI 10.1007/BF00301940; Baggio LL, 2004, DIABETES, V53, P2492, DOI 10.2337/diabetes.53.9.2492; Baruah Manash P, 2012, J Indian Med Assoc, V110, P335; Chesnut CH, 2008, OSTEOPOROSIS INT, V19, P479, DOI 10.1007/s00198-007-0490-1; Clark R, 1996, J BIOL CHEM, V271, P21969, DOI 10.1074/jbc.271.36.21969; Deacon CF, 2009, VASC HEALTH RISK MAN, V5, P199; DECHATEAU M, 1994, J BIOL CHEM, V269, P12147; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Dharmalingam Mala, 2011, Indian J Endocrinol Metab, V15, P9, DOI 10.4103/2230-8210.77571; Eldor R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059524; Fineman M, 2011, CLIN PHARMACOKINET, V50, P65, DOI 10.2165/11585880-000000000-00000; Freda PU, 2002, J CLIN ENDOCR METAB, V87, P3013, DOI 10.1210/jc.87.7.3013; Hargrove DM, 2007, REGUL PEPTIDES, V141, P113, DOI 10.1016/j.regpep.2006.12.021; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Havelund S, 2004, PHARM RES-DORDR, V21, P1498, DOI 10.1023/B:PHAM.0000036926.54824.37; Henriksen K, 2010, EXPERT OPIN BIOL TH, V10, P1617, DOI 10.1517/14712598.2010.526104; Jazayeri JA, 2008, BIODRUGS, V22, P11, DOI 10.2165/00063030-200822010-00002; Jimenez-Solem E, 2010, CURR OPIN MOL THER, V12, P790; Johansson MU, 2002, J BIOL CHEM, V277, P8114, DOI 10.1074/jbc.M109943200; Jonsson A, 2008, PROTEIN ENG DES SEL, V21, P515, DOI 10.1093/protein/gzn028; Keating GM, 2012, DRUGS, V72, P2255, DOI 10.2165/11470200-000000000-00000; Knudsen LB, 2010, INT J CLIN PRACT, V64, P4, DOI 10.1111/j.1742-1241.2010.02499.x; Knudsen LB, 2004, J MED CHEM, V47, P4128, DOI 10.1021/jm030630m; Kraenzlin ME, 2011, NAT REV ENDOCRINOL, V7, P647, DOI 10.1038/nrendo.2011.108; Kurtzhals P, 1995, BIOCHEM J, V312, P725, DOI 10.1042/bj3120725; Lee LS, 1999, BIOCONJUGATE CHEM, V10, P973, DOI 10.1021/bc990076o; Lejon S, 2004, J BIOL CHEM, V279, P42924, DOI 10.1074/jbc.M406957200; Linhult M, 2002, PROTEIN SCI, V11, P206, DOI 10.1110/ps.02802; Mack CM, 2006, INT J OBESITY, V30, P1332, DOI 10.1038/sj.ijo.0803284; Mannucci PM, 1997, BLOOD, V90, P2515, DOI 10.1182/blood.V90.7.2515.2515_2515_2521; Markussen J, 1996, DIABETOLOGIA, V39, P281; McCurdy TR, 2004, J LAB CLIN MED, V143, P115, DOI 10.1016/j.lab.2003.10.008; Meibohm B, 2012, J CLIN PHARMACOL, V52, p54S, DOI 10.1177/0091270011413894; NELSONPIERCY C, 1994, J CLIN ENDOCR METAB, V78, P329, DOI 10.1210/jc.78.2.329; Raufman JP, 1996, REGUL PEPTIDES, V61, P1, DOI 10.1016/0167-0115(96)00135-8; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Sturis J, 2003, BRIT J PHARMACOL, V140, P123, DOI 10.1038/sj.bjp.0705397; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Wallis K, 2009, CURR OPIN CLIN NUTR, V12, P526, DOI 10.1097/MCO.0b013e32832d23cd; Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812; Young AA, 1999, DIABETES, V48, P1026, DOI 10.2337/diabetes.48.5.1026	47	31	40	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87704	10.1371/journal.pone.0087704	http://dx.doi.org/10.1371/journal.pone.0087704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503632	Green Submitted, Green Published, gold			2022-12-25	WOS:000330631800062
J	Wang, LL; Chen, DD; Lee, JH; Gu, XH; Alaaeddine, G; Li, JM; Wei, L; Yu, SP				Wang, Li-Li; Chen, Dongdong; Lee, Jinhwan; Gu, Xiaohuan; Alaaeddine, Ghina; Li, Jimei; Wei, Ling; Yu, Shan Ping			Mobilization of Endogenous Bone Marrow Derived Endothelial Progenitor Cells and Therapeutic Potential of Parathyroid Hormone after Ischemic Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; STEM-CELLS; ENHANCES ANGIOGENESIS; MYOCARDIAL-INFARCTION; FUNCTIONAL RECOVERY; BARREL CORTEX; NEUROGENESIS; RECEPTOR; BLOOD; BRAIN	Stroke is a major neurovascular disorder threatening human life and health. Very limited clinical treatments are currently available for stroke patients. Stem cell transplantation has shown promising potential as a regenerative treatment after ischemic stroke. The present investigation explores a new concept of mobilizing endogenous stem cells/progenitor cells from the bone marrow using a parathyroid hormone (PTH) therapy after ischemic stroke in adult mice. PTH 1-34 (80 mu g/kg, i.p.) was administered 1 hour after focal ischemia and then daily for 6 consecutive days. After 6 days of PTH treatment, there was a significant increase in bone marrow derived CD-34/Fetal liver kinase-1 (Flk-1) positive endothelial progenitor cells (EPCs) in the peripheral blood. PTH treatment significantly increased the expression of trophic/regenerative factors including VEGF, SDF-1, BDNF and Tie-1 in the brain peri-infarct region. Angiogenesis, assessed by co-labeled Glut-1 and BrdU vessels, was significantly increased in PTH-treated ischemic brain compared to vehicle controls. PTH treatment also promoted neuroblast migration from the subventricular zone (SVZ) and increased the number of newly formed neurons in the peri-infarct cortex. PTH-treated mice showed significantly better sensorimotor functional recovery compared to stroke controls. Our data suggests that PTH therapy improves endogenous repair mechanisms after ischemic stroke with functional benefits. Mobilizing endogenous bone marrow-derived stem cells/progenitor cells using PTH and other mobilizers appears an effective and feasible regenerative treatment after ischemic stroke.	[Wang, Li-Li; Chen, Dongdong; Lee, Jinhwan; Gu, Xiaohuan; Alaaeddine, Ghina; Wei, Ling; Yu, Shan Ping] Emory Univ Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA; [Wang, Li-Li; Li, Jimei] Capital Med Univ, Beijing Friendship Hosp, Dept Neurol, Beijing, Peoples R China; [Wei, Ling] Emory Univ Sch Med, Dept Neurol, Atlanta, GA USA	Emory University; Capital Medical University; Emory University	Yu, SP (corresponding author), Emory Univ Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA.	spyu@emory.edu	Alaaeddine, Ghina/HHN-7143-2022; wang, lili/HDL-7210-2022		NIH [NS0458710, NS075338, NS062097]; AHA Established Investigator Award; AHA [12GRNT12060222]; National Natural Science Foundation of China [81350012]; NIH from the Extramural Research Facilities Program of the National Center for Research Resources [C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS075338, R01NS062097] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Established Investigator Award(American Heart Association); AHA(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH from the Extramural Research Facilities Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by NIH grants NS0458710 (SPY), NS075338 (LW), NS062097 (LW), AHA Established Investigator Award (LW), AHA Grant-in-Aid grant 12GRNT12060222 (SPY) and by a grant 81350012 (JL) from National Natural Science Foundation of China. This work was also supported by the NIH grant C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources. The funders had no role in interfering with study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; AKMAL M, 1984, P SOC EXP BIOL MED, V176, P434; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Ballen KK, 2007, BIOL BLOOD MARROW TR, V13, P838, DOI 10.1016/j.bbmt.2007.03.007; Bensinger W, 2009, BONE MARROW TRANSPL, V43, P181, DOI 10.1038/bmt.2008.410; Bieglmayer C, 2002, CLIN CHEM, V48, P1731; Borlongan CV, 2011, PROG NEUROBIOL, V95, P213, DOI 10.1016/j.pneurobio.2011.08.005; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Brines ML, 1999, NEUROSCI LETT, V274, P13, DOI 10.1016/S0304-3940(99)00664-3; Brunner S, 2008, EXP HEMATOL, V36, P1157, DOI 10.1016/j.exphem.2008.03.014; Brunner S, 2007, AM J PHYSIOL-ENDOC M, V293, pE1670, DOI 10.1152/ajpendo.00287.2007; CHAUBAL A, 1994, ACTA NEUROPATHOL, V88, P454; Chizh BA, 2007, J PSYCHOPHARMACOL, V21, P259, DOI 10.1177/0269881105062484; Coppolino G, 2011, J INVEST MED, V59, P823, DOI 10.2310/JIM.0b013e318214edf8; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dunac A, 2007, J NEUROL, V254, P327, DOI 10.1007/s00415-006-0362-1; Espinera AR, 2013, NEUROSCIENCE, V247, P1, DOI 10.1016/j.neuroscience.2013.04.011; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; FEOLA M, 1986, SURG GYNECOL OBSTET, V163, P523; Freret T, 2009, BEHAV NEUROSCI, V123, P224, DOI 10.1037/a0014157; Ghani U, 2005, STROKE, V36, P151, DOI 10.1161/01.STR.0000149944.15406.16; Hess DC, 2008, CELL PROLIFERAT, V41, P94, DOI 10.1111/j.1365-2184.2008.00486.x; Horn T, 2010, NEUROCHEM INT, V57, P940, DOI 10.1016/j.neuint.2010.09.014; Huber BC, 2011, CARDIOVASC RES, V90, P529, DOI 10.1093/cvr/cvr014; Huber BC, 2010, AM J PHYSIOL-HEART C, V298, pH1466, DOI 10.1152/ajpheart.00033.2010; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Lemoli RM, 2008, HAEMATOLOGICA, V93, P321, DOI 10.3324/haematol.12616; Lemoli RM, 2006, STEM CELLS, V24, P2817, DOI 10.1634/stemcells.2006-0333; Li WL, 2013, NEUROSCIENCE, V244, P16, DOI 10.1016/j.neuroscience.2013.03.045; Li WL, 2008, DEV NEUROBIOL, V68, P1474, DOI 10.1002/dneu.20674; Li Y, 2007, J CEREBR BLOOD F MET, V27, P1043, DOI 10.1038/sj.jcbfm.9600417; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Lin TN, 2000, J CEREBR BLOOD F MET, V20, P387, DOI 10.1097/00004647-200002000-00021; Lubjuhn J, 2009, J NEUROSCI METH, V184, P95, DOI 10.1016/j.jneumeth.2009.07.029; Manzerra P, 2001, P NATL ACAD SCI USA, V98, P11055, DOI 10.1073/pnas.191353598; Misra V, 2012, NEUROLOGY, V79, pS207, DOI 10.1212/WNL.0b013e31826959d2; Moubarik C, 2011, STEM CELL REV REP, V7, P208, DOI 10.1007/s12015-010-9157-y; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Navarro-Sobrino M, 2010, MICROVASC RES, V80, P317, DOI 10.1016/j.mvr.2010.05.008; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Ovbiagele B, 2008, STROKE, V39, P2231, DOI 10.1161/STROKEAHA.107.513499; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schwarzkopf TM, 2013, EXP BIOL MED, V238, P84, DOI 10.1258/ebm.2012.012261; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Sigler A, 2009, P NATL ACAD SCI USA, V106, P11759, DOI 10.1073/pnas.0812695106; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Taylor CW, 2012, BIOCHEM SOC T, V40, P147, DOI 10.1042/BST20110615; Usdin TB, 1997, ENDOCRINOLOGY, V138, P831, DOI 10.1210/en.138.2.831; Usdin TB, 2003, TRENDS ENDOCRIN MET, V14, P14, DOI 10.1016/S1043-2760(02)00002-4; USDIN TB, 1995, J BIOL CHEM, V270, P15455, DOI 10.1074/jbc.270.26.15455; WEI L, 1995, STROKE, V26, P1459, DOI 10.1161/01.STR.26.8.1459; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; WEISS SW, 1993, AM J SURG PATHOL, V17, P1039, DOI 10.1097/00000478-199310000-00009; Whitaker VR, 2007, J CEREBR BLOOD F MET, V27, P57, DOI 10.1038/sj.jcbfm.9600318; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020219; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zaruba MM, 2008, CARDIOVASC RES, V77, P722, DOI 10.1093/cvr/cvm080; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	65	29	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87284	10.1371/journal.pone.0087284	http://dx.doi.org/10.1371/journal.pone.0087284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503654	gold, Green Published, Green Submitted			2022-12-25	WOS:000330631800026
J	Ariki, R; Morikawa, S; Mabuchi, Y; Suzuki, S; Nakatake, M; Yoshioka, K; Hidano, S; Nakauchi, H; Matsuzaki, Y; Nakamura, T; Goitsuka, R				Ariki, Reina; Morikawa, Satoru; Mabuchi, Yo; Suzuki, Sadafumi; Nakatake, Mayuka; Yoshioka, Kentaro; Hidano, Shinya; Nakauchi, Hiromitsu; Matsuzaki, Yumi; Nakamura, Takuro; Goitsuka, Ryo			Homeodomain Transcription Factor Meis1 Is a Critical Regulator of Adult Bone Marrow Hematopoiesis	PLOS ONE			English	Article							STEM-CELL QUIESCENCE; SELF-RENEWAL; IN-VIVO; MYELOID-LEUKEMIA; GENES; MICE; MLL; PROLIFERATION; NICHE; THROMBOPOIETIN	Hematopoietic stem cells in the bone marrow have the capacity to both self-renew and to generate all cells of the hematopoietic system. The balance of these two activities is controlled by hematopoietic stem cell-intrinsic regulatory mechanisms as well as extrinsic signals from the microenvironment. Here we demonstrate that Meis1, a TALE family homeodomain transcription factor involved in numerous embryonic developmental processes, is selectively expressed in hematopoietic stem/progenitor cells. Conditional Meis1 knockout in adult hematopoietic cells resulted in a significant reduction in the hematopoietic stem/progenitor cells. Suppression of hematopoiesis by Meis1 deletion appears to be caused by impaired self-renewal activity and reduced cellular quiescence of hematopoietic stem/progenitor cells in a cell autonomous manner, resulting in stem cell exhaustion and defective long-term hematopoiesis. Meis1 deficiency down-regulated a subset of Pbx1-dependent hematopoietic stem cell signature genes, suggesting a functional link between them in the maintenance of hematopoietic stem/progenitor cells. These results show the importance of Meis1 in adult hematopoiesis.	[Ariki, Reina; Yoshioka, Kentaro; Hidano, Shinya; Goitsuka, Ryo] Univ Tokyo, Res Inst Biomed Sci, Div Dev & Aging, Noda, Chiba, Japan; [Morikawa, Satoru; Mabuchi, Yo; Suzuki, Sadafumi; Matsuzaki, Yumi] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Nakatake, Mayuka; Nakamura, Takuro] Japanese Fdn Canc Res, Inst Canc, Div Carcinogenesis, Koto Ku, Tokyo 170, Japan; [Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Minato Ku, Tokyo, Japan	University of Tokyo; Keio University; Japanese Foundation for Cancer Research; University of Tokyo	Nakamura, T (corresponding author), Japanese Fdn Canc Res, Inst Canc, Div Carcinogenesis, Koto Ku, Tokyo 170, Japan.	takuro-ind@umin.net; ryogoi@rs.noda.tus.ac.jp	Morikawa, Satoru/AFL-5621-2022; Mabuchi, Yo/L-1535-2013	Morikawa, Satoru/0000-0001-8859-2888; Mabuchi, Yo/0000-0001-8008-3966; Matsuzaki, Yumi/0000-0002-3729-2997	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21658105, 25111513]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work has been supported by Grant-in-Aid for Scientific Research (21658105 and 25111513 to R. G.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arata Y, 2006, DEV CELL, V11, P105, DOI 10.1016/j.devcel.2006.04.020; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Bagger FO, 2012, BLOOD, V119, P6394, DOI 10.1182/blood-2012-05-427310; Bessa J, 2008, DEVELOPMENT, V135, P799, DOI 10.1242/dev.011932; Bradford GB, 1997, EXP HEMATOL, V25, P445; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; de Andres-Aguayo L, 2011, BLOOD, V118, P554, DOI 10.1182/blood-2010-12-322081; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Heine P, 2008, DEVELOPMENT, V135, P805, DOI 10.1242/dev.012088; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hodohara K, 2000, BLOOD, V95, P769, DOI 10.1182/blood.V95.3.769.003a49_769_775; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Iwasaki M, 2005, BLOOD, V105, P784, DOI 10.1182/blood-2004-04-1508; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Unnisa Z, 2012, BLOOD, V120, P4973, DOI 10.1182/blood-2012-06-435800; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419	44	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87646	10.1371/journal.pone.0087646	http://dx.doi.org/10.1371/journal.pone.0087646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498346	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900092
J	Couret, J; Dotson, E; Benedict, MQ				Couret, Jannelle; Dotson, Ellen; Benedict, Mark Q.			Temperature, Larval Diet, and Density Effects on Development Rate and Survival of Aedes aegypti (Diptera: Culicidae)	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; DEPENDENT DEVELOPMENT; REACTION NORMS; CULEX-QUINQUEFASCIATUS; EMBRYONIC-DEVELOPMENT; ALBOPICTUS DIPTERA; ANOPHELES-GAMBIAE; CLINAL VARIATION; ADULT LONGEVITY; DENGUE-FEVER	Many environmental factors, biotic and abiotic interact to influence organismal development. Given the importance of Aedes aegypti as a vector of human pathogens including dengue and yellow fever, understanding the impact of environmental factors such as temperature, resource availability, and intraspecific competition during development is critical for population control purposes. Despite known associations between developmental traits and factors of diet and density, temperature has been considered the primary driver of development rate and survival. To determine the relative importance of these critical factors, wide gradients of conditions must be considered. We hypothesize that 1) diet and density, as well as temperature influence the variation in development rate and survival, 2) that these factors interact, and this interaction is also necessary to understand variation in developmental traits. Temperature, diet, density, and their two-way interactions are significant factors in explaining development rate variation of the larval stages of Ae. aegypti mosquitoes. These factors as well as two and three-way interactions are significantly associated with the development rate from hatch to emergence. Temperature, but not diet or density, significantly impacted juvenile mortality. Development time was heteroskedastic with the highest variation occurring at the extremes of diet and density conditions. All three factors significantly impacted survival curves of experimental larvae that died during development. Complex interactions may contribute to variation in development rate. To better predict variation in development rate and survival in Ae. aegypti, factors of resource availability and intraspecific density must be considered in addition, but never to the exclusion of temperature.	[Couret, Jannelle] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Dotson, Ellen] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Benedict, Mark Q.] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, I-06100 Perugia, Italy	Emory University; Centers for Disease Control & Prevention - USA; University of Perugia	Couret, J (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	nelle.couret@gmail.com		Couret, Jannelle/0000-0002-5001-9039	National Institutes of Health Training Grant for Population Biology of Infectious Disease at Emory University	National Institutes of Health Training Grant for Population Biology of Infectious Disease at Emory University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for stipend and supplies provided by the National Institutes of Health Training Grant for Population Biology of Infectious Disease at Emory University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x; AMEEN M-U, 1973, Dacca University Studies Part B, V21, P15; Arnqvist G, 1998, ECOLOGY, V79, P1847, DOI 10.2307/176693; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; ATKINSON D, 1995, J THERM BIOL, V20, P61, DOI 10.1016/0306-4565(94)00028-H; BAR-ZEEV MICHA, 1958, BULL ENT RES, V49, P157, DOI 10.1017/S0007485300053499; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020699; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; BEENAKKERS AMT, 1985, PROG LIPID RES, V24, P19; BENTZ BJ, 1991, CAN ENTOMOL, V123, P1083, DOI 10.4039/Ent1231083-5; Callahan HS, 1997, BIOESSAYS, V19, P519, DOI 10.1002/bies.950190611; Chang LH, 2007, J MED ENTOMOL, V44, P205, DOI 10.1603/0022-2585(2007)44[205:DSOAAA]2.0.CO;2; Chaves L, 2011, B ENTOMOL RES, P1; CLAY ME, 1972, J INSECT PHYSIOL, V18, P1441, DOI 10.1016/0022-1910(72)90223-5; Damiens D, 2012, J MED ENTOMOL, V49, P1001, DOI 10.1603/ME11289; Damos Petros, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/123405; David JR, 1997, J THERM BIOL, V22, P441, DOI 10.1016/S0306-4565(97)00063-6; de Jong G, 2010, J THERM BIOL, V35, P85, DOI 10.1016/j.jtherbio.2009.12.001; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; DIJKSTRA LJ, 1986, NETH J ZOOL, V36, P177; DYE C, 1984, ECOL ENTOMOL, V9, P355, DOI 10.1111/j.1365-2311.1984.tb00859.x; Tejerina EF, 2009, ACTA TROP, V109, P45, DOI 10.1016/j.actatropica.2008.09.014; Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x; Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020; Flenner I, 2010, FRESHWATER BIOL, V55, P397, DOI 10.1111/j.1365-2427.2009.02289.x; Folguera G, 2008, BIOL J LINN SOC, V95, P233, DOI 10.1111/j.1095-8312.2008.01053.x; Folguera G, 2010, J INSECT PHYSIOL, V56, P1679, DOI 10.1016/j.jinsphys.2010.06.015; Garland T, 2008, J EXP BIOL, V211, P2725, DOI 10.1242/jeb.022673; Gilles J, 2010, J MED ENTOMOL, V49, P1001; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442; HOWE RW, 1967, ANNU REV ENTOMOL, V12, P15, DOI 10.1146/annurev.en.12.010167.000311; Huffaker Carl B., 1944, ANN ENT SOC AMER, V37, P1, DOI 10.1093/aesa/37.1.1; Ikemoto T, 2000, ENVIRON ENTOMOL, V29, P671, DOI 10.1603/0046-225X-29.4.671; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; Jarosik V, 2002, AM NAT, V160, P497, DOI 10.1086/342077; Joshi DS, 1996, J THERM BIOL, V21, P151, DOI 10.1016/0306-4565(95)00035-6; JULIANO SA, 1994, OECOLOGIA, V97, P369, DOI 10.1007/BF00317327; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Kamimura Kiyoshi, 2002, Medical Entomology and Zoology, V53, P53; Karl I, 2008, OECOLOGIA, V155, P215, DOI 10.1007/s00442-007-0902-0; Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x; Kingsolver JG, 2004, EVOLUTION, V58, P1608; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Kirby MJ, 2009, ACTA TROP, V109, P118, DOI 10.1016/j.actatropica.2008.09.025; Knies JL, 2010, AM NAT, V176, P227, DOI 10.1086/653662; Kontodimas DC, 2004, ENVIRON ENTOMOL, V33, P1, DOI 10.1603/0046-225X-33.1.1; LAKE P, 1968, J INSECT PHYSIOL, V14, P543, DOI 10.1016/0022-1910(68)90070-X; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Laudien H, 1973, TEMPERATURE LIFE, P355; Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301; Little TJ, 2012, NAT MED, V18, P217, DOI 10.1038/nm.2572; Lounibos LP, 2002, J VECTOR ECOL, V27, P86; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; Mead S. S., 1987, Proceedings and Papers of the Annual Conference of the California Mosquito and Vector Control Association, V55, P133; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Moehrlin GS, 1998, OECOLOGIA, V115, P492, DOI 10.1007/s004420050546; MOORE CG, 1969, ANN ENTOMOL SOC AM, V62, P1325, DOI 10.1093/aesa/62.6.1325; MORI A, 1988, Tropical Medicine, V30, P155; MORI A, 1979, Tropical Medicine, V21, P85; NAYAR JK, 1970, J MED ENTOMOL, V7, P163, DOI 10.1093/jmedent/7.2.163; Nijhout HF, 2010, PHILOS T R SOC B, V365, P567, DOI 10.1098/rstb.2009.0249; OFUJI K., 1963, Endemic Diseases Bulletin of Nagasaki University, V5, P209; Padmanabha H, 2011, MED VET ENTOMOL, V25, P445, DOI 10.1111/j.1365-2915.2011.00950.x; Petavy G, 2001, PHYSIOL ENTOMOL, V26, P351, DOI 10.1046/j.0307-6962.2001.00255.x; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pinheiro J, 2016, NLME LINEAR NONLINEA, DOI DOI 10.1016/S0006-3207(01)00201-4; Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x; Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630; Roberts D, 1998, J MED ENTOMOL, V35, P665, DOI 10.1093/jmedent/35.5.665; Roberts D, 2010, ENTOMOL EXP APPL, V135, P271, DOI 10.1111/j.1570-7458.2010.00993.x; Robinson SJW, 2001, J EVOLUTION BIOL, V14, P14, DOI 10.1046/j.1420-9101.2001.00259.x; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; RUSSELL RC, 1986, AUST J ZOOL, V34, P527, DOI 10.1071/ZO9860527; Silva HHG, 1999, REV SOC BRASILEIRA M, V32, P349, DOI DOI 10.1590/S0037-86821999000400003; Smith Henry., 2013, PHILOS FDN PROPERTY, P1, DOI [https://doi.org/10.1093/acprof:oso/9780199673582.003.0001, DOI 10.1093/ACPROF:OSO/9780199673582.003.0001]; SOUTHWOOD T R E, 1972, Bulletin of the World Health Organization, V46, P211; Stav G, 2005, ECOL APPL, V15, P587, DOI 10.1890/03-5191; Stav G, 2010, ISR J ECOL EVOL, V56, P9, DOI 10.1560/IJEE.56.1.9; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Tsuda Y, 2001, ENVIRON ENTOMOL, V30, P855, DOI 10.1603/0046-225X-30.5.855; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; Wada Y, 1965, WHO125 VECT CONTR, V65, P119; WADA YOSHITO, 1965, QUAEST ENTOMOL, V1, P223; WAGNER TL, 1991, J AGR ENTOMOL, V8, P251; WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953; WIGGLESWORTH V B, 1972, P827; WORNER SP, 1992, ENVIRON ENTOMOL, V21, P689, DOI 10.1093/ee/21.4.689; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; Yoshioka M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-225; ZIEGLER R, 1991, J COMP PHYSIOL B, V161, P125, DOI 10.1007/BF00262874	95	141	148	1	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87468	10.1371/journal.pone.0087468	http://dx.doi.org/10.1371/journal.pone.0087468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498328	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900074
J	Guo, CM; Chen, RR; Kalhoro, DH; Wang, ZF; Liu, GJ; Lu, CP; Liu, YJ				Guo, Chang-Ming; Chen, Rong-Rong; Kalhoro, Dildar Hussain; Wang, Zhao-Fei; Liu, Guang-Jin; Lu, Cheng-Ping; Liu, Yong-Jie			Identification of Genes Preferentially Expressed by Highly Virulent Piscine Streptococcus agalactiae upon Interaction with Macrophages	PLOS ONE			English	Article							TRANSCRIBED SEQUENCES SCOTS; GROUP-B STREPTOCOCCUS; MICROVASCULAR ENDOTHELIAL-CELLS; ALANYL-LIPOTEICHOIC ACID; GRAM-POSITIVE BACTERIA; LISTERIA-MONOCYTOGENES; SELECTIVE CAPTURE; TEICHOIC-ACIDS; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR SURVIVAL	Streptococcus agalactiae, long recognized as a mammalian pathogen, is an emerging concern with regard to fish. In this study, we used a mouse model and in vitro cell infection to evaluate the pathogenetic characteristics of S. agalactiae GD201008-001, isolated from tilapia in China. This bacterium was found to be highly virulent and capable of inducing brain damage by migrating into the brain by crossing the blood-brain barrier (BBB). The phagocytosis assays indicated that this bacterium could be internalized by murine macrophages and survive intracellularly for more than 24 h, inducing injury to macrophages. Further, selective capture of transcribed sequences (SCOTS) was used to investigate microbial gene expression associated with intracellular survival. This positive cDNA selection technique identified 60 distinct genes that could be characterized into 6 functional categories. More than 50% of the differentially expressed genes were involved in metabolic adaptation. Some genes have previously been described as associated with virulence in other bacteria, and four showed no significant similarities to any other previously described genes. This study constitutes the first step in further gene expression analyses that will lead to a better understanding of the molecular mechanisms used by S. agalactiae to survive in macrophages and to cross the BBB.	[Guo, Chang-Ming; Chen, Rong-Rong; Kalhoro, Dildar Hussain; Wang, Zhao-Fei; Liu, Guang-Jin; Lu, Cheng-Ping; Liu, Yong-Jie] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, YJ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	liuyongjie@njau.edu.cn	Kalhoro, Dildar Hussain/AAN-3857-2020	Hussain Kalhoro, Dildar/0000-0002-2874-8833	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The study was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Abuseliana AF, 2011, J ANIM VET ADV, V10, P914, DOI 10.3923/javaa.2011.914.919; Bowater RO, 2012, J FISH DIS, V35, P173, DOI 10.1111/j.1365-2761.2011.01332.x; Brassard J, 2004, VET MICROBIOL, V102, P87, DOI 10.1016/j.vetmic.2004.05.008; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Chen M, 2012, VET MICROBIOL, V159, P526, DOI 10.1016/j.vetmic.2012.04.035; Cornacchione P, 1998, IMMUNOLOGY, V93, P86; Cumley NJ, 2012, INFECT IMMUN, V80, P1650, DOI 10.1128/IAI.05443-11; Daigle F, 2002, METHOD ENZYMOL, V358, P108; Daigle F, 2001, MOL MICROBIOL, V41, P1211, DOI 10.1046/j.1365-2958.2001.02593.x; Derr AM, 2012, APPL ENVIRON MICROB, V78, P1215, DOI 10.1128/AEM.06890-11; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; DREVETS DA, 1995, INFECT IMMUN, V63, P4268, DOI 10.1128/IAI.63.11.4268-4276.1995; Drevets DA, 1999, INFECT IMMUN, V67, P3512, DOI 10.1128/IAI.67.7.3512-3517.1999; Drevets DA, 2001, INFECT IMMUN, V69, P1344, DOI 10.1128/IAI.69.3.1344-1350.2001; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; ELDAR A, 1995, VET MICROBIOL, V43, P33, DOI 10.1016/0378-1135(94)00052-X; ELLIOTT JA, 1990, J CLIN MICROBIOL, V28, P628, DOI 10.1128/JCM.28.3.628-630.1990; Evans JJ, 2002, J FISH DIS, V25, P505, DOI 10.1046/j.1365-2761.2002.00392.x; Evans JJ, 2009, EMERG INFECT DIS, V15, P774, DOI 10.3201/eid1505.080222; Ferrando ML, 2010, MICROBIOL-SGM, V156, P2818, DOI 10.1099/mic.0.037960-0; Fettucciari K, 2000, J IMMUNOL, V165, P3923, DOI 10.4049/jimmunol.165.7.3923; Fittipaldi N, 2007, APPL ENVIRON MICROB, V73, P7802, DOI 10.1128/AEM.02295-07; FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gourlay LJ, 2009, J BACTERIOL, V191, P3544, DOI 10.1128/JB.01755-08; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Greiffenberg L, 1998, INFECT IMMUN, V66, P5260, DOI 10.1128/IAI.66.11.5260-5267.1998; Guo DC, 2012, FEMS MICROBIOL LETT, V331, P105, DOI 10.1111/j.1574-6968.2012.02559.x; Hertzen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035218; Hou JY, 2002, INFECT IMMUN, V70, P3714, DOI 10.1128/IAI.70.7.3714-3726.2002; Hytonen J, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-18; Hytonen J, 2003, INFECT IMMUN, V71, P784, DOI 10.1128/IAI.71.2.784-793.2003; Jin H, 2008, ENVIRON MICROBIOL, V10, P3326, DOI 10.1111/j.1462-2920.2008.01729.x; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Julian DJ, 2009, ANTON LEEUW INT J G, V96, P149, DOI 10.1007/s10482-008-9293-4; Kaplan EL, 2006, CLIN INFECT DIS, V43, P1398, DOI 10.1086/508773; Kovacs M, 2006, J BACTERIOL, V188, P5797, DOI 10.1128/JB.00336-06; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; Limia A, 2001, FEMS MICROBIOL LETT, V197, P151, DOI 10.1111/j.1574-6968.2001.tb10597.x; Liu GJ, 2012, J BACTERIOL, V194, P6653, DOI 10.1128/JB.01788-12; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun SC, 2004, J MICROBIOL METH, V56, P401, DOI 10.1016/j.mimet.2003.11.012; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Muller M, 2011, MICROBIOL-SGM, V157, P3104, DOI 10.1099/mic.0.053157-0; Nair S, 1999, MOL MICROBIOL, V31, P185, DOI 10.1046/j.1365-2958.1999.01159.x; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Oliveira L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029963; Owens MU, 1996, ANN NY ACAD SCI, V797, P240, DOI 10.1111/j.1749-6632.1996.tb52964.x; Park SH, 2010, MICROB PATHOGENESIS, V49, P323, DOI 10.1016/j.micpath.2010.08.001; Poyart C, 2003, MOL MICROBIOL, V49, P1615, DOI 10.1046/j.1365-2958.2003.03655.x; Qi FX, 2004, INFECT IMMUN, V72, P4895, DOI 10.1128/IAI.72.8.4895-4899.2004; Rajagopal L, 2006, MOL MICROBIOL, V62, P941, DOI 10.1111/j.1365-2958.2006.05431.x; Sagar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060160; Sendi P, 2009, EMERG INFECT DIS, V15, P223, DOI 10.3201/eid1502.080990; Suanyuk N, 2008, AQUACULTURE, V284, P35, DOI 10.1016/j.aquaculture.2008.07.034; ValentinWeigand P, 1996, INFECT IMMUN, V64, P2467, DOI 10.1128/IAI.64.7.2467-2473.1996; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; Vanier G, 2004, INFECT IMMUN, V72, P1441, DOI 10.1128/IAI.72.3.1441-1449.2004; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005; Willenborg J, 2011, MICROBIOL-SGM, V157, P1823, DOI 10.1099/mic.0.046417-0; Zhang Q, 2009, CAN J MICROBIOL, V55, P1187, DOI [10.1139/W09-078, 10.1139/w09-078]; Zhao C, 2010, INFECT IMMUN, V78, P3889, DOI 10.1128/IAI.00165-10	65	23	26	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87980	10.1371/journal.pone.0087980	http://dx.doi.org/10.1371/journal.pone.0087980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498419	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900165
J	Janahi, EM				Janahi, Essam M.			Prevalence and Risk Factors of Hepatitis B Virus Infection in Bahrain, 2000 through 2010	PLOS ONE			English	Article							SURFACE-ANTIGEN; DISEASE BURDEN; HBV INFECTION; VACCINATION; EPIDEMIOLOGY; BRAZIL	Hepatitis B infection is one of the world's major infectious diseases with about 350 million chronic carriers. Because no data is published on the prevalence and risk factors of this important disease in Bahrain, this article evaluates the available data from 2000 to 2010 to estimate the prevalence of the infection and to evaluate the risk factors. Epidemiologic data on HBV cases were collected from the major hospitals and health centers in Bahrain and statistically analyzed. Over this indicated decade, 877,892 individuals were screened for HBV infection and 5055 positive cases were reported in Bahrain. The prevalence of HBV infection during that period was 0.58%. Although there was no significant difference in the prevalence over the period of 10 years, the actual number of positive cases has almost doubled in the later years especially in 2007 and 2008. The prevalence was significantly higher among males (62.3%; P<0.01). Most cases were associated with non Bahrainis and the prevalence was significantly higher among them (68.3%; P<0.01) than it was among Bahrainis (31.7%). Seventy eight percent (2877/3690) of non Bahraini cases were for citizens of six countries which are highly endemic for HBV, namely India, Pakistan, Bangladesh, Philippines, Indonesia and Ethiopia. Dental procedures and surgical operations were the main risk factors of infection as 37.2% and 35.6% of the patients were probably infected through this route. The prevalence of hepatitis B virus infection in Bahrain indicates that Bahrain had low HBV endemicity for the last 10 years (2000-2010). Our study verifies the significant role played by expatriates/immigrants in the present epidemiology of hepatitis B in Bahrain. Increasing HBV vaccination of high risk groups, active educational and media campaign, screening HBV infection during pregnancy, and surveillance of hepatitis B infected individuals will further decrease the prevalence of the disease in Bahrain.	Univ Bahrain, Dept Biol, Coll Sci, Sakhir, Bahrain	University of Bahrain	Janahi, EM (corresponding author), Univ Bahrain, Dept Biol, Coll Sci, Sakhir, Bahrain.	emohammed@uob.edu.bh		Janahi, Essam/0000-0001-7991-0151	TECHNOCHEM TRADING	TECHNOCHEM TRADING	It is my pleasure to acknowledge with gratitude the financial support of "TECHNOCHEM TRADING", and my sincere thanks and appreciation is extended to its president Mr. Mark Anthony T. Napule for his generous support. The funders had covered the publication fees but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shamahy H, 2000, ANN SAUDI MED, V20, P464, DOI 10.5144/0256-4947.2000.464; Alavian SM, 2007, J GASTROINTEST LIVER, V16, P403; Ali H Y M, 2004, East Mediterr Health J, V10, P6; Andre F, 2000, VACCINE, V18, pS20, DOI 10.1016/S0264-410X(99)00456-9; Baig S, 2009, JCPSP-J COLL PHYSICI, V19, P598, DOI 09.2009/JCPSP.598600; Bashawri LAM, 2004, CLIN LAB HAEMATOL, V26, P225, DOI 10.1111/j.1365-2257.2004.00601.x; Fung SK, 2006, LIVER INT, V26, P796, DOI 10.1111/j.1478-3231.2006.01297.x; Giacchino R, 2001, INFECTION, V29, P188, DOI 10.1007/s15010-001-1146-2; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Goldstein ST, 2002, J INFECT DIS, V185, P713, DOI 10.1086/339192; Knipe D.M.H., 2013, PETER FIELDS VIROLOG, V6th; Kowdley KV, 2004, J CLIN GASTROENTEROL, V38, pS132, DOI 10.1097/00004836-200411003-00002; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Ministry of Cabinet Affairs Kingdom of Bahrain, 2010, BAS RES POP HOUS BUI; Miri SM, 2011, HEPAT MON, V11, P238; Motta-Castro ARC, 2005, J MED VIROL, V77, P188, DOI 10.1002/jmv.20435; Nicoletta P., 2002, HEPATITIS B; Pereira LMMB, 2009, AM J TROP MED HYG, V81, P240; Salleras L, 2007, VACCINE, V25, P8726, DOI 10.1016/j.vaccine.2007.10.027; Serufo JC, 1998, MEM I OSWALDO CRUZ, V93, P249, DOI 10.1590/S0074-02761998000700046; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Souto F J, 2001, Rev Panam Salud Publica, V10, P388, DOI 10.1590/S1020-49892001001200004; Thomas H, 2005, VIRAL HEPATITIS, 3RD EDITION, pVII; Weinbaum CM, 2009, HEPATOLOGY, V49, pS35, DOI 10.1002/hep.22882; World Health Organization (WHO), HEP B; Wright TL, 2006, AM J GASTROENTEROL, V101, pS1, DOI 10.1111/j.1572-0241.2006.00469.x; Zali M R, 2005, East Mediterr Health J, V11, P62; WKLY EPIDEMIOL REC, V67, P325	29	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87599	10.1371/journal.pone.0087599	http://dx.doi.org/10.1371/journal.pone.0087599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498341	Green Submitted, gold, Green Published			2022-12-25	WOS:000330626900087
J	Li, F; Sun, JJ; Wang, DH; Bai, SN; Clarke, AK; Holm, M				Li, Feng; Sun, Jinjing; Wang, Donghui; Bai, Shunong; Clarke, Adrian K.; Holm, Magnus			The B-Box Family Gene STO (BBX24) in Arabidopsis thaliana Regulates Flowering Time in Different Pathways	PLOS ONE			English	Article							MADS DOMAIN PROTEIN; CONSTANS-LIKE GENE; FLORAL-INDUCTION; LOCUS-C; CIRCADIAN CLOCK; SALT TOLERANCE; VERNALIZATION; FLC; REPRESSOR; SIGNALS	Flowering at the appropriate time is crucial for reproductive success and is strongly influenced by various pathways such as photoperiod, circadian clock, FRIGIDA and vernalization. Although each separate pathway has been extensively studied, much less is known about the interactions between them. In this study we have investigated the relationship between the photoperiod/circadian clock gene and FRIGIDA/FLC by characterizing the function of the B-box STO gene family. STO has two B-box Zn-finger domains but lacks the CCT domain. Its expression is controlled by circadian rhythm and is affected by environmental factors and phytohormones. Loss and gain of function mutants show diversiform phenotypes from seed germination to flowering. The sto-1 mutant flowers later than the wild type (WT) under short day growth conditions, while over-expression of STO causes early flowering both in long and short days. STO over-expression not only reduces FLC expression level but it also activates FT and SOC1 expression. It also does not rely on the other B-box gene CO or change the circadian clock system to activate FT and SOC1. Furthermore, the STO activation of FT and SOC1 expression is independent of the repression of FLC; rather STO and FLC compete with each other to regulate downstream genes. Our results indicate that photoperiod and the circadian clock pathway gene STO can affect the key flowering time genes FLC and FT/SOC1 separately, and reveals a novel perspective to the mechanism of flowering regulation.	[Li, Feng; Sun, Jinjing; Wang, Donghui; Bai, Shunong] Peking Univ, Peking Univ Yale Joint Res Ctr Agr & Plant Mol Bi, Natl Key Lab Prot Engn & Plant Gene Engn, Coll Life Sci, Beijing 100871, Peoples R China; [Li, Feng; Clarke, Adrian K.; Holm, Magnus] Gothenburg Univ, Dept Biol & Environm Sci, Gothenburg, Sweden	Peking University; University of Gothenburg	Clarke, AK (corresponding author), Gothenburg Univ, Dept Biol & Environm Sci, Gothenburg, Sweden.	adrian.clarke@bioenv.gu.se						Achard P, 2007, P NATL ACAD SCI USA, V104, P6484, DOI 10.1073/pnas.0610717104; Almada R, 2009, PLANT CELL REP, V28, P1193, DOI 10.1007/s00299-009-0720-4; Amasino RM, 2010, PLANT PHYSIOL, V154, P516, DOI 10.1104/pp.110.161653; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; BERNIER G, 1993, PLANT CELL, V5, P1147, DOI 10.1105/tpc.5.10.1147; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; Clouse SD, 1997, PHYSIOL PLANTARUM, V100, P702, DOI 10.1034/j.1399-3054.1997.1000334.x; Crevillen P, 2011, CURR OPIN PLANT BIOL, V14, P38, DOI 10.1016/j.pbi.2010.08.015; Deng WW, 2011, P NATL ACAD SCI USA, V108, P6680, DOI 10.1073/pnas.1103175108; Domagalska MA, 2007, DEVELOPMENT, V134, P2841, DOI 10.1242/dev.02866; Fujiwara S, 2008, PLANT CELL, V20, P2960, DOI 10.1105/tpc.108.061531; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hassidim M, 2009, PLANTA, V230, P481, DOI 10.1007/s00425-009-0958-7; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; Indorf M, 2007, PLANT J, V51, P563, DOI 10.1111/j.1365-313X.2007.03162.x; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Jiang L, 2012, CELL RES, V22, P1046, DOI 10.1038/cr.2012.34; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kim SK, 2013, PLANT SCI, V199, P71, DOI 10.1016/j.plantsci.2012.09.019; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kotchoni SO, 2009, PLANT PHYSIOL, V149, P803, DOI 10.1104/pp.108.132324; Kumagai T, 2008, BIOSCI BIOTECH BIOCH, V72, P1539, DOI 10.1271/bbb.80041; Lagercrantz U, 2000, MOL BIOL EVOL, V17, P1499, DOI 10.1093/oxfordjournals.molbev.a026249; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Li JH, 2010, J EXP BOT, V61, P4221, DOI 10.1093/jxb/erq241; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Lippuner V, 1996, J BIOL CHEM, V271, P12859, DOI 10.1074/jbc.271.22.12859; Luo XM, 2010, DEV CELL, V19, P872, DOI 10.1016/j.devcel.2010.10.023; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Schmitz RJ, 2008, P NATL ACAD SCI USA, V105, P411, DOI 10.1073/pnas.0710423104; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Song YH, 2012, SCIENCE, V336, P1045, DOI 10.1126/science.1219644; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Willmann MR, 2011, DEVELOPMENT, V138, P677, DOI 10.1242/dev.057448	55	34	39	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87544	10.1371/journal.pone.0087544	http://dx.doi.org/10.1371/journal.pone.0087544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498334	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900080
J	Ota, VK; Bellucco, FT; Gadelha, A; Santoro, ML; Noto, C; Christofolini, DM; Assuncao, IB; Yamada, KM; Ribeiro-dos-Santos, AK; Santos, S; Mari, JJ; Smith, MAC; Melaragno, MI; Bressan, RA; Sato, JR; Jackowski, AP; Belangero, SI				Ota, Vanessa K.; Bellucco, Fernanda T.; Gadelha, Ary; Santoro, Marcos L.; Noto, Cristiano; Christofolini, Denise M.; Assuncao, Idaiane B.; Yamada, Karen M.; Ribeiro-dos-Santos, Andrea K.; Santos, Sidney; Mari, Jair J.; Smith, Marilia A. C.; Melaragno, Maria I.; Bressan, Rodrigo A.; Sato, Joao R.; Jackowski, Andrea P.; Belangero, Sintia I.			PRODH Polymorphisms, Cortical Volumes and Thickness in Schizophrenia	PLOS ONE			English	Article							PROLINE DEHYDROGENASE; MISSENSE MUTATIONS; DELETION SYNDROME; AMINO-ACIDS; HYPERPROLINEMIA; MICE; ASSOCIATION; PREVALENCE; DISORDER; METABOLISM	Schizophrenia is a neurodevelopmental disorder with high heritability. Several lines of evidence indicate that the PRODH gene may be related to the disorder. Therefore, our study investigates the effects of 12 polymorphisms of PRODH on schizophrenia and its phenotypes. To further evaluate the roles of the associated variants in the disorder, we have conducted magnetic resonance imaging (MRI) scans to assess cortical volumes and thicknesses. A total of 192 patients were evaluated using the Structured Clinical Interview for DSM-IV (SCID), Positive and Negative Syndrome Scale (PANSS), Calgary Depression Scale, Global Assessment of Functioning (GAF) and Clinical Global Impression (CGI) instruments. The study included 179 controls paired by age and gender. The samples were genotyped using the real-time polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP)-PCR and Sanger sequencing methods. A sample of 138 patients and 34 healthy controls underwent MRI scans. One polymorphism was associated with schizophrenia (rs2904552), with the G-allele more frequent in patients than in controls. This polymorphism is likely functional, as predicted by PolyPhen and SIFT, but it was not associated with brain morphology in our study. In summary, we report a functional PRODH variant associated with schizophrenia that may have a neurochemical impact, altering brain function, but is not responsible for the cortical reductions found in the disorder.	[Ota, Vanessa K.; Bellucco, Fernanda T.; Santoro, Marcos L.; Yamada, Karen M.; Smith, Marilia A. C.; Melaragno, Maria I.; Belangero, Sintia I.] Univ Fed Sao Paulo UNIFESP, Disciplina Genet, Dept Morfol & Genet, Sao Paulo, Brazil; [Ota, Vanessa K.; Gadelha, Ary; Santoro, Marcos L.; Noto, Cristiano; Bressan, Rodrigo A.; Sato, Joao R.; Jackowski, Andrea P.; Belangero, Sintia I.] Univ Fed Sao Paulo UNIFESP, LiNC, Sao Paulo, Brazil; [Gadelha, Ary; Noto, Cristiano; Assuncao, Idaiane B.; Mari, Jair J.; Bressan, Rodrigo A.; Belangero, Sintia I.] Univ Fed Sao Paulo UNIFESP, Dept Psiquiatria, Sao Paulo, Brazil; [Christofolini, Denise M.] Fac Med ABC FMABC, Dept Ginecol & Obstet, Disciplina Genet & Reprod Humana, Sao Paulo, Brazil; [Ribeiro-dos-Santos, Andrea K.; Santos, Sidney] Fed Univ Para, Lab Genet Humana & Med, BR-66059 Belem, Para, Brazil; [Sato, Joao R.] Univ Fed ABC, Ctr Math Computat & Cognit, Santo Andre, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Faculdade de Medicina do ABC; Universidade Federal do Para; Universidade Federal do ABC (UFABC)	Belangero, SI (corresponding author), Univ Fed Sao Paulo UNIFESP, Disciplina Genet, Dept Morfol & Genet, Sao Paulo, Brazil.	sinbelangero@gmail.com	Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Santos, Ândrea Ribeiro dos/B-6061-2013; Belangero, Sintia I/A-6818-2009; CHRISTOFOLINI, DENISE MARIA/AAS-5648-2021; Melaragno, Maria Isabel/W-8714-2019; Bellucco, Fernanda T. S./H-6532-2016; Noto, Cristiano/I-6957-2013; de A. C. Smith, Marilia/C-4397-2012; Santoro, Marcos L/I-3142-2014; Jackowski, Andrea P/D-8616-2012; Christofolini, Denise Maria/H-6984-2012; de Jesus Mari, Jair/A-7309-2008; Bressan, Rodrigo A/E-9178-2010; Ota, Vanessa/J-6442-2012	Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Belangero, Sintia I/0000-0002-2419-4351; Noto, Cristiano/0000-0002-2706-9118; de A. C. Smith, Marilia/0000-0002-1441-1033; Santoro, Marcos L/0000-0001-5714-9509; Jackowski, Andrea P/0000-0001-8842-5406; de Jesus Mari, Jair/0000-0002-5403-0112; Bressan, Rodrigo A/0000-0002-0868-4449; Ota, Vanessa/0000-0003-0129-6360; Gadelha de Alencar Araripe Neto, Ary/0000-0002-0993-8017; CHRISTOFOLINI, DENISE MARIA/0000-0001-9589-6417; Sato, Joao Ricardo/0000-0002-7503-9781	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Brazil) [2011/50740-5, 2007/58736-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding for this study was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2011/50740-5 and 2007/58736-1, Brazil), which had no further role in study design, data collection and analysis, in the writing of the paper, and in the decision of submitting the paper for publication.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Savio LEB, 2012, PROG NEURO-PSYCHOPH, V36, P258, DOI 10.1016/j.pnpbp.2011.10.002; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BAXTER CF, 1985, PHARMACOL BIOCHEM BE, V22, P1053, DOI 10.1016/0091-3057(85)90316-8; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; Bressan RA, 1998, SCHIZOPHR RES, V32, P41; Bressan Rodrigo A, 2003, Rev. Bras. Psiquiatr., V25, P177, DOI 10.1590/S1516-44462003000300011; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P67, DOI 10.1001/archpsyc.55.1.67; Christofolini DM, 2011, SCHIZOPHR RES, V132, P99, DOI 10.1016/j.schres.2011.07.007; Clelland CL, 2011, SCHIZOPHR RES, V131, P139, DOI 10.1016/j.schres.2011.05.006; Cohen SM, 1997, BRAIN RES, V761, P271, DOI 10.1016/S0006-8993(97)00352-1; DAVIS JL, 1987, BEHAV NEURAL BIOL, V48, P128, DOI 10.1016/S0163-1047(87)90649-2; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Gejman PV, 2011, ANNU REV GENOM HUM G, V12, P121, DOI 10.1146/annurev-genom-082410-101459; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Goodman BK, 2000, J INHERIT METAB DIS, V23, P847, DOI 10.1023/A:1026773005303; Hoogendoorn MLC, 2008, SCHIZOPHR RES, V98, P84, DOI 10.1016/j.schres.2007.09.025; Horowitz A, 2005, SCHIZOPHR RES, V73, P263, DOI 10.1016/j.schres.2004.02.008; Jacquet H, 2002, HUM MOL GENET, V11, P2243, DOI 10.1093/hmg/11.19.2243; Jacquet H, 2005, MOL PSYCHIATR, V10, P479, DOI 10.1038/sj.mp.4001597; Jacquet H, 2006, AM J MED GENET B, V141B, P192, DOI 10.1002/ajmg.b.30263; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kempf L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000252; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Levine SZ, 2007, J CLIN PSYCHOPHARM, V27, P431, DOI 10.1097/jcp/.0b013e31814cfabd; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; LIMA MS, 2007, REV BRAS PSIQUIATR, V29, P246; Liu W, 2012, AUTOPHAGY, V8, P1407, DOI 10.4161/auto.21152; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Mitsubuchi H, 2008, J NUTR, V138, p2016S, DOI 10.1093/jn/138.10.2016S; MURRAY RM, 1987, BRIT MED J, V295, P681, DOI 10.1136/bmj.295.6600.681; NADLER JV, 1987, J NEUROCHEM, V49, P1155; NADLER JV, 1992, HIPPOCAMPUS, V2, P269, DOI 10.1002/hipo.450020306; Oresic M, 2011, GENOME MED, V3, DOI 10.1186/gm233; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Phang J. M., 2001, METABOLIC MOL BASES, P1821; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; RAO ML, 1990, PSYCHIAT RES, V34, P243, DOI 10.1016/0165-1781(90)90003-N; Raux G, 2007, HUM MOL GENET, V16, P83, DOI 10.1093/hmg/ddl443; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Sawa A, 2009, BIOL PSYCHIAT, V66, P530, DOI 10.1016/j.biopsych.2009.07.016; Servet C, 2012, FRONT BIOSCI-LANDMRK, V17, P607, DOI 10.2741/3947; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; Tan GM, 2009, SCHIZOPHR RES, V115, P173, DOI 10.1016/j.schres.2009.09.010; Tomiya M, 2007, CLIN CHIM ACTA, V380, P186, DOI 10.1016/j.cca.2007.02.011; Walter H, 2008, ALCOHOL ALCOHOLISM, V43, P653, DOI 10.1093/alcalc/agn076; WEINBERGER DR, 1995, LANCET, V346, P552, DOI 10.1016/S0140-6736(95)91386-6; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Williams HJ, 2003, MOL PSYCHIATR, V8, P644, DOI 10.1038/sj.mp.4001276; Zinkstok J, 2008, GENES BRAIN BEHAV, V7, P61, DOI 10.1111/j.1601-183X.2007.00326.x; Zugman A, 2013, SCHIZOPHR RES, V148, P81, DOI 10.1016/j.schres.2013.05.002	55	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87686	10.1371/journal.pone.0087686	http://dx.doi.org/10.1371/journal.pone.0087686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498354	Green Submitted, gold, Green Published			2022-12-25	WOS:000330626900100
J	Deng, YY; Xie, D; Fang, M; Zhu, GF; Chen, CB; Zeng, HK; Lu, J; Charanjit, K				Deng, Yiyu; Xie, Di; Fang, Ming; Zhu, Gaofeng; Chen, Chunbo; Zeng, Hongke; Lu, Jia; Charanjit, Kaur			Astrocyte-Derived Proinflammatory Cytokines Induce Hypomyelination in the Periventricular White Matter in the Hypoxic Neonatal Brain	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ACTIVATED MICROGLIA; TNF-ALPHA; DAMAGE; OLIGODENDROCYTE; LEUKOMALACIA; INFLAMMATION; EXPRESSION; INJURY; MYELIN	Hypoxic exposure in the perinatal period causes periventricular white matter damage (PWMD), a condition associated with myelination abnormalities. Under hypoxic conditions, glial cells were activated and released a large number of inflammatory mediators in the PWM in neonatal brain, which may result in oligodendrocyte (OL) loss and axonal injury. This study aims to determine if astrocytes are activated and generate proinflammatory cytokines that may be coupled with the oligodendroglial loss and hypomyelination observed in hypoxic PWMD. Twenty-four 1-day-old Wistar rats were exposed to hypoxia for 2 h. The rats were then allowed to recover under normoxic conditions for 7 or 28 days before being killed. Another group of 24 rats kept outside the chamber was used as age-matched controls. Upregulated expression of TNF-alpha and IL-1 beta was observed in astrocytes in the PWM of P7 hypoxic rats by double immunofluorescence, western blotting and real time RT-PCR. This was linked to apoptosis and enhanced expression of TNF-R-1 and IL-1R(1) in APC(+) OLs. PLP expression was decreased significantly in the PWM of P28d hypoxic rats. The proportion of myelinated axons was markedly reduced by electron microscopy (EM) and the average g-ratios were higher in P28d hypoxic rats. Upregulated expression of TNF-alpha and IL-1 beta in primary cultured astrocytes as well as their corresponding receptors in primary culture APC+ oligodendrocytes were detected under hypoxic conditions. Our results suggest that following a hypoxic insult, astrocytes in the PWM of neonatal rats produce inflammatory cytokines such as TNF-alpha and IL-1 beta, which induce apoptosis of OLs via their corresponding receptors associated with them. This results in hypomyelination in the PWM of hypoxic rats.	[Deng, Yiyu; Xie, Di; Fang, Ming; Zhu, Gaofeng; Chen, Chunbo; Zeng, Hongke] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Crit Care & Emergency, Guangzhou, Guangdong, Peoples R China; [Xie, Di] Southern Med Univ, Grad Sch, Guangzhou, Guangdong, Peoples R China; [Lu, Jia] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore; [Charanjit, Kaur] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; National University of Singapore	Deng, YY (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Crit Care & Emergency, Guangzhou, Guangdong, Peoples R China.	yiyudeng666@163.com	Chen, Chunbo/ABI-2835-2020; Chen, Chunbo/AAU-6567-2021; Chen, Chunbo/GRJ-9058-2022	Chen, Chunbo/0000-0001-5662-497X; Chen, Chunbo/0000-0001-5662-497X	National Natural Science Foundation of China [81271329]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 81271329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; CINAT M, 1995, J TRAUMA, V39, P112, DOI 10.1097/00005373-199507000-00015; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Deguchi K, 1997, PEDIATR NEUROL, V16, P296, DOI 10.1016/S0887-8994(97)00041-6; Delgado M, 2003, FASEB J, V17, P1922, DOI 10.1096/fj.02-1029fje; Deng Yi Yu, 2011, Front Biosci (Schol Ed), V3, P884; Deng YY, 2010, BRAIN PATHOL, V20, P909, DOI 10.1111/j.1750-3639.2010.00387.x; Deng YY, 2008, BRAIN PATHOL, V18, P387, DOI 10.1111/j.1750-3639.2008.00138.x; Dheen ST, 2005, GLIA, V50, P21, DOI 10.1002/glia.20153; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Folkerth RD, 2006, PEDIATR DEVEL PATHOL, V9, P3, DOI 10.2350/06-01-0024.1; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; GUY J, 1989, J COMP NEUROL, V287, P446, DOI 10.1002/cne.902870404; Han HJ, 2013, BIOFACTORS, V39, P233, DOI 10.1002/biof.1076; Kaur C, 2004, ACTA NEUROPATHOL, V107, P204, DOI 10.1007/s00401-003-0798-7; Kaur C, 2009, PROG NEUROBIOL, V87, P264, DOI 10.1016/j.pneurobio.2009.01.003; Kaur C, 2007, ACTA PHARMACOL SIN, V28, P1087, DOI 10.1111/j.1745-7254.2007.00625.x; Kaur C, 2006, J NEUROCHEM, V98, P1200, DOI 10.1111/j.1471-4159.2006.03964.x; Kaur C, 2013, J NEUROIMMUNE PHARM, V8, P66, DOI 10.1007/s11481-012-9347-2; Kaur C, 2008, CURR MED CHEM, V15, P3068, DOI 10.2174/092986708786848640; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Leviton A, 2004, PEDIATR RES, V55, P541, DOI 10.1203/01.PDR.0000121197.24154.82; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048001; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mu DZ, 2003, NEUROBIOL DIS, V14, P524, DOI 10.1016/j.nbd.2003.08.020; Pang Y, 2010, PEDIATR RES, V67, P579, DOI 10.1203/PDR.0b013e3181dc240f; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; PATERSON JA, 1973, J COMP NEUROL, V149, P83, DOI 10.1002/cne.901490106; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Schmitz T, 2011, J NEUROSCI, V31, P4327, DOI 10.1523/JNEUROSCI.3942-10.2011; Sheldon RA, 1996, BIOL NEONATE, V69, P327; Soldan MMP, 2012, SEMIN NEUROL, V32, P9, DOI 10.1055/s-0032-1306381; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Thomas JL, 2000, J NEUROSCI RES, V59, P471, DOI 10.1002/(SICI)1097-4547(20000215)59:4<471::AID-JNR1>3.0.CO;2-3; Vela JM, 2002, MOL CELL NEUROSCI, V20, P489, DOI 10.1006/mcne.2002.1127; Verklan MT, 2009, J PERINAT NEONAT NUR, V23, P59, DOI 10.1097/01.JPN.0000346221.48202.7e; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010	41	58	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87420	10.1371/journal.pone.0087420	http://dx.doi.org/10.1371/journal.pone.0087420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498101	gold, Green Submitted, Green Published			2022-12-25	WOS:000330621900109
J	Hong, MZ; Huang, WQ; Min, F; Xu, JC; Lin, Z; Fang, KN; Pan, JS				Hong, Mei-Zhu; Huang, Wen-Qi; Min, Feng; Xu, Jin-Chao; Lin, Zhen; Fang, Kuang-Nan; Pan, Jin-Shui			Enhanced HBsAg Synthesis Correlates with Increased Severity of Fibrosis in Chronic Hepatitis B Patients	PLOS ONE			English	Article							SURFACE-ANTIGEN LEVELS; SERUM HBSAG; HEPATOCELLULAR-CARCINOMA; CLINICAL-SIGNIFICANCE; VIRUS; LEVEL; LIVER; RISK; SEROCLEARANCE; THERAPY	Background and Aims: Little is known about whether low serum HBsAg levels result from impaired HBsAg synthesis or a reduced number of hepatocytes caused by advanced liver fibrosis. Therefore, we investigated the capacity for HBsAg synthesis in a cross-sectional cohort of treatment-naive chronic hepatitis B patients. Methods: Chronic hepatitis B patients (n = 362) were enrolled; liver biopsies were performed and liver histology was scored, and serum HBsAg and HBV DNA levels were investigated. In the enrolled patients, 183 out of 362 have quantitative serum HBsAg levels. Tissue HBsAg was determined by immunohistochemistry. Results: A positive correlation between serum HBsAg and HBV DNA levels was revealed in HBeAg(+) patients (r = 0.2613, p = 0.0050). In HBeAg(+) patients, serum HBsAg and severity of fibrosis were inversely correlated (p = 0.0094), whereas tissue HBsAg levels correlated positively with the stage of fibrosis (p = 0.0280). After applying the mean aminopyrine breath test as a correction factor, adjusted serum HBsAg showed a strong positive correlation with fibrosis severity in HBeAg(+) patients (r = 0.5655, p<0.0001). The adjusted serum HBsAg values predicted 'moderate to severe' fibrosis with nearly perfect performance in both HBeAg(+) patients (area under the curve: 0.994, 95% CI: 0.983-1.000) and HBeAg(-) patients (area under the curve: 1.000, 95% CI: 1.000-1.000). Conclusions: Although serum HBsAg levels were negatively correlated with fibrosis severity in HBeAg(+) patients, aminopyrine breath test-adjusted serum HBsAg and tissue HBsAg, two indices that are unaffected by the number of residual hepatocytes, were positively correlated with fibrosis severity. Furthermore, adjusted serum HBsAg has an accurate prediction capability.	[Hong, Mei-Zhu; Huang, Wen-Qi; Min, Feng; Xu, Jin-Chao] Xiamen Univ, Chenggong Hosp, Dept Infect Dis, Hosp PLA 174, Xiamen, Peoples R China; [Lin, Zhen] Xiamen Univ, Chenggong Hosp, Dept Pathol, Hosp PLA 174, Xiamen, Peoples R China; [Fang, Kuang-Nan] Xiamen Univ, Sch Econ, Dept Stat, Xiamen, Peoples R China; [Pan, Jin-Shui] Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University; Xiamen University	Fang, KN (corresponding author), Xiamen Univ, Sch Econ, Dept Stat, Xiamen, Peoples R China.	ruiqwy@163.com; j.s.pan76@gmail.com	huang, wen/GXW-0661-2022; Pan, Jin-Shui/AAL-3125-2020	Pan, Jin-Shui/0000-0002-9586-7760	National Science Foundation for Young Scholars, China [81100285]; Natural Science Foundation of Fujian Province, China [2010J05086]; Science Fund for Distinguished Young Scholars of Xiamen, China [3502Z20105011]	National Science Foundation for Young Scholars, China; Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province); Science Fund for Distinguished Young Scholars of Xiamen, China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	The study was funded by National Science Foundation for Young Scholars, China (No. 81100285) http://www.nsfc.gov.cn/Portal0/default152.htm; Natural Science Foundation of Fujian Province, China (No. 2010J05086) http://www.fjkjt.gov.cn/; Science Fund for Distinguished Young Scholars of Xiamen, China (No. 3502Z20105011) http://www.xminfo.net.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SNS, 2010, EXPERT REV GASTROENT, V4, P37, DOI [10.1586/EGH.09.65, 10.1586/egh.09.65]; Ayoub WS, 2011, ALIMENT PHARM THER, V34, P1145, DOI 10.1111/j.1365-2036.2011.04869.x; Bock CT, 2002, GASTROENTEROLOGY, V122, P264, DOI 10.1053/gast.2002.31015; Bortolotti F, 2006, HEPATOLOGY, V43, P556, DOI 10.1002/hep.21077; Chan HLY, 2007, CLIN GASTROENTEROL H, V5, P1462, DOI 10.1016/j.cgh.2007.09.005; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen YC, 2002, GASTROENTEROLOGY, V123, P1084, DOI 10.1053/gast.2002.36026; Cheng PN, 2013, J CLIN VIROL, V57, P323, DOI 10.1016/j.jcv.2013.04.012; Fattovich G, 1998, AM J GASTROENTEROL, V93, P896, DOI 10.1111/j.1572-0241.1998.00272.x; Herold C, 2001, LIVER, V21, P260, DOI 10.1034/j.1600-0676.2001.021004260.x; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; LOK ASF, 1987, GASTROENTEROLOGY, V92, P1839, DOI 10.1016/0016-5085(87)90613-5; Martinot-Peignoux M, 2013, J HEPATOL, V58, P1089, DOI 10.1016/j.jhep.2013.01.028; Moucari R, 2009, HEPATOLOGY, V49, P1151, DOI 10.1002/hep.22744; Nguyen T, 2010, J HEPATOL, V52, P508, DOI 10.1016/j.jhep.2010.01.007; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Reijnders JGP, 2011, J HEPATOL, V54, P449, DOI 10.1016/j.jhep.2010.07.046; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043087; Simonetti J, 2010, HEPATOLOGY, V51, P1531, DOI 10.1002/hep.23464; Su TH, 2010, ANTIVIR THER, V15, P1133, DOI 10.3851/IMP1696; Torresi J, 2002, J CLIN VIROL, V25, P97, DOI 10.1016/S1386-6532(02)00049-5; Tseng TC, 2013, HEPATOLOGY, V57, P441, DOI 10.1002/hep.26041; Tseng TC, 2012, GASTROENTEROLOGY, V142, P1140, DOI 10.1053/j.gastro.2012.02.007; Xun YH, 2013, J GASTROENTEROL HEPA; Yuen MF, 2008, GASTROENTEROLOGY, V135, P1192, DOI 10.1053/j.gastro.2008.07.008; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x	28	8	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87344	10.1371/journal.pone.0087344	http://dx.doi.org/10.1371/journal.pone.0087344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498079	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900095
J	Zhu, JQ; Fan, XH; Cheng, YY; Agarwal, R; Moore, CMV; Chen, ST; Tong, WD				Zhu, Jieqiang; Fan, Xiaohui; Cheng, Yiyu; Agarwal, Rajiv; Moore, Christine M. V.; Chen, Shaw T.; Tong, Weida			Chemometric Analysis for Identification of Botanical Raw Materials for Pharmaceutical Use: A Case Study Using Panax notoginseng	PLOS ONE			English	Article							CHROMATOGRAPHIC FINGERPRINTS; QUALITY-CONTROL; DISCRIMINATION; SAPONINS; ROOTS	The overall control of the quality of botanical drugs starts from the botanical raw material, continues through preparation of the botanical drug substance and culminates with the botanical drug product. Chromatographic and spectroscopic fingerprinting has been widely used as a tool for the quality control of herbal/botanical medicines. However, discussions are still on-going on whether a single technique provides adequate information to control the quality of botanical drugs. In this study, high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC), capillary electrophoresis (CE) and near infrared spectroscopy (NIR) were used to generate fingerprints of different plant parts of Panax notoginseng. The power of these chromatographic and spectroscopic techniques to evaluate the identity of botanical raw materials were further compared and investigated in light of the capability to distinguishing different parts of Panax notoginseng. Principal component analysis (PCA) and clustering results showed that samples were classified better when UPLC- and HPLC-based fingerprints were employed, which suggested that UPLC- and HPLC-based fingerprinting are superior to CE- and NIR-based fingerprinting. The UPLC- and HPLC-based fingerprinting with PCA were able to correctly distinguish between samples sourced from rhizomes and main root. Using chemometrics and its ability to distinguish between different plant parts could be a powerful tool to help assure the identity and quality of the botanical raw materials and to support the safety and efficacy of the botanical drug products.	[Zhu, Jieqiang; Fan, Xiaohui; Cheng, Yiyu] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Agarwal, Rajiv; Moore, Christine M. V.] US FDA, Off New Drug Qual Assessment, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Chen, Shaw T.] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Tong, Weida] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	Zhejiang University; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Fan, XH (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	fanxh@zju.edu.cn; rajiv.agarwal@fda.hhs.gov; weida.tong@fda.hhs.gov	FAN, Xiaohui/F-6458-2010	FAN, Xiaohui/0000-0002-6336-3007	US FDA; National Basic Research Program of China [2012CB518405]	US FDA(United States Department of Health & Human Services); National Basic Research Program of China(National Basic Research Program of China)	The authors thank US FDA for financial assistance given under CDER's Regulatory Science and Review Enhancement (RSR) Program to RA. Participants from Zhejiang University were partially supported by the National Basic Research Program of China (No. 2012CB518405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, GUID IND BOT DRUG PR; Chen P, 2011, J AOAC INT, V94, P1411, DOI 10.5740/jaoacint.10-291; Chen Y, 2008, ANAL CHIM ACTA, V623, P146, DOI 10.1016/j.aca.2008.06.018; Cheng YY, 2003, J CHEM INF COMP SCI, V43, P1068, DOI 10.1021/ci034034c; Cicero AFG, 2003, PHYTOTHER RES, V17, P174, DOI 10.1002/ptr.1262; Dan M, 2009, PHYTOCHEM ANALYSIS, V20, P68, DOI 10.1002/pca.1099; European Medicines Agency, 2011, GUID SPEC TEST PROC; Ibanez C, 2012, ELECTROPHORESIS, V33, P2328, DOI 10.1002/elps.201200143; Jiang C, 2013, SEP PURIF TECHNOL, V116, P287, DOI 10.1016/j.seppur.2013.05.049; Konoshima T, 1999, BIOL PHARM BULL, V22, P1150, DOI 10.1248/bpb.22.1150; LEI XL, 1986, AM J CHINESE MED, V14, P145, DOI 10.1142/S0192415X86000235; Li BY, 2004, ANAL CHIM ACTA, V514, P69, DOI 10.1016/j.aca.2004.03.041; LIU J, 1994, J ETHNOPHARMACOL, V42, P183, DOI 10.1016/0378-8741(94)90084-1; Novakova L, 2006, TALANTA, V68, P908, DOI 10.1016/j.talanta.2005.06.035; Pan RJ, 2011, J PHARMACEUT BIOMED, V55, P391, DOI 10.1016/j.jpba.2011.01.016; Shen DADA, 2012, FOOD CHEM, V130, P1003, DOI 10.1016/j.foodchem.2011.07.121; Shen Xu, 2011, Zhongguo Zhong Yao Za Zhi, V36, P718; State Food and Drug Administration of China, 2000, TECHN REQ DEV FING T; Thiangthum S, 2012, J CHROMATOGR B, V910, P114, DOI 10.1016/j.jchromb.2012.06.025; Wang CZ, 2006, J NAT MED-TOKYO, V60, P97, DOI 10.1007/s11418-005-0027-x; Wang LB, 2012, BIOCHEM SYST ECOL, V40, P138, DOI 10.1016/j.bse.2011.10.014; Wang SF, 2006, J CHROMATOGR A, V1109, P279, DOI 10.1016/j.chroma.2006.01.023; [吴海 WU Hai], 2007, [中草药, Chinese Traditional and Herbal Drugs], V38, P1298; Zang QD, 2011, ANAL BIOANAL CHEM, V399, P635, DOI 10.1007/s00216-010-4268-5; Zang QD, 2011, J PHARMACEUT BIOMED, V54, P1020, DOI 10.1016/j.jpba.2010.12.008; Zhang QF, 2011, PHYTOCHEM ANALYSIS, V22, P18, DOI 10.1002/pca.1245	26	39	45	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87462	10.1371/journal.pone.0087462	http://dx.doi.org/10.1371/journal.pone.0087462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498109	gold, Green Submitted, Green Published			2022-12-25	WOS:000330621900115
J	Dalton, RM; Rodriguez, JF				Dalton, Romy M.; Rodriguez, Jose F.			Rescue of Infectious Birnavirus from Recombinant Ribonucleoprotein Complexes	PLOS ONE			English	Article							BURSAL-DISEASE-VIRUS; DEPENDENT RNA-POLYMERASE; PANCREATIC NECROSIS VIRUS; DOUBLE-STRANDED-RNA; CAPSID PROTEIN VP2; REPLICATION COMPLEXES; STRUCTURAL PROTEIN; VIRAL REPLICATION; LIFE-CYCLE; PARTICLES	Birnaviruses are unconventional members of the icosahedral double-stranded (dsRNA) RNA virus group. The main differential birnavirus trait is the lack of the inner icosahedral transcriptional core, a ubiquitous structure conserved in all other icosahedral dsRNA viruses, that shelters the genome from cellular dsRNA sensors and provide the enzymatic machinery to produce and extrude mature messenger RNAs. In contrast, birnaviral particles enclose ribonucleoprotein (RNP) complexes formed by the genome segments, the dsRNA-binding VP3 polypeptide and the virus-encoded RNA polymerase (RdRp). The presence of RNPs suggests that the birnavirus replication program might exhibit significant differences with respect to those of prototypal dsRNA viruses. However, experimental evidences supporting this hypothesis are as yet scarce. Of particular relevance for the understanding of birnavirus replication is to determine whether RNPs act as intracellular capsid-independent transcriptional units. Our study was focused to answer this question using the infectious bursal disease virus (IBDV), the best characterized birnavirus, as model virus. Here, we describe the intracellular assembly of functional IBDV RNPs in the absence of the virus-encoded VP2 capsid polypeptide. Recombinant RNPs are generated upon coexpression of the IBDV VP1 and RdRp polypeptides and transfection of purified virus dsRNA. Presented data show that recombinant RNPs direct the expression of the IBDV polypeptide repertoire and the production of infectious virus in culture cells. Results described in this report constitute the first direct experimental evidence showing that birnaviral RNPs are intracellularly active in the absence of the virus capsid. This finding is consistent with presented data indicating that RNP formation precedes virus assembly in IBDV-infected cells, and supports the recently proposed IBDV replication model entailing the release of RNPs during the initial stages of the infection. Indeed, results presented here also support the previously proposed evolutionary connection between birnaviruses and positive-strand single-stranded RNA viruses.	[Dalton, Romy M.; Rodriguez, Jose F.] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Rodriguez, JF (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	jfrodrig@cnb.csic.es	Rodríguez, José F/T-8500-2017	Rodríguez, José F/0000-0001-7944-5341	Spanish Ministry of Economy and Competitiveness [AGL2011-24758]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by grant AGL2011-24758 from the Spanish Ministry of Economy and Competitiveness to J.F. Rodriguez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2005, CURR BIOL, V15, pR465, DOI 10.1016/j.cub.2005.06.016; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Bottcher B, 1997, J VIROL, V71, P325; Busnadiego I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046768; Caston JR, 2001, J VIROL, V75, P10815, DOI 10.1128/JVI.75.22.10815-10828.2001; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Delgui LR, 2013, J VIROL, V87, P8993, DOI 10.1128/JVI.03152-12; Delmas B KF, 2005, BIRNAVIRIDAE VIRUS T; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Fernandez-Arias A, 1998, J GEN VIROL, V79, P1047, DOI 10.1099/0022-1317-79-5-1047; FernandezArias A, 1997, J VIROL, V71, P8014; Galloux M, 2007, J BIOL CHEM, V282, P20774, DOI 10.1074/jbc.M701048200; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Heljasvaara R, 2001, J VIROL, V75, P5778, DOI 10.1128/JVI.75.13.5778-5795.2001; Hjalmarsson A, 1999, J VIROL, V73, P3484, DOI 10.1128/JVI.73.4.3484-3490.1999; Irigoyen N, 2009, J BIOL CHEM, V284, P8064, DOI 10.1074/jbc.M808942200; KIBENGE FSB, 1988, J GEN VIROL, V69, P1757, DOI 10.1099/0022-1317-69-8-1757; Kochan G, 2003, ARCH VIROL, V148, P723, DOI 10.1007/s00705-002-0949-5; Lamontagne B, 2001, Curr Issues Mol Biol, V3, P71; Lombardo E, 1999, J VIROL, V73, P6973, DOI 10.1128/JVI.73.8.6973-6983.1999; Lombardo E, 2000, VIROLOGY, V277, P345, DOI 10.1006/viro.2000.0595; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; Magliano D, 1998, VIROLOGY, V240, P57, DOI 10.1006/viro.1997.8906; Maraver A, 2003, J VIROL, V77, P2459, DOI 10.1128/JVI.77.4.2459-2468.2003; McDonald SM, 2011, J VIROL, V85, P3095, DOI 10.1128/JVI.02360-10; Mertens PPC, 2004, VIRUS RES, V101, P29, DOI 10.1016/j.virusres.2003.12.004; MERTENS PPC, 1982, J GEN VIROL, V59, P47, DOI 10.1099/0022-1317-59-1-47; Mundt E, 1996, P NATL ACAD SCI USA, V93, P11131, DOI 10.1073/pnas.93.20.11131; Mundt E, 1997, J VIROL, V71, P5647, DOI 10.1128/JVI.71.7.5647-5651.1997; Pedersen T, 2007, J VIROL, V81, P6652, DOI 10.1128/JVI.02831-06; Sabanadzovic S, 2009, VIROLOGY, V394, P1, DOI 10.1016/j.virol.2009.08.006; Takahashi K, 1970, Adv Biophys, V1, P53; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Valli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045957; von Einem UI, 2004, J GEN VIROL, V85, P2221, DOI 10.1099/vir.0.19772-0	37	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87790	10.1371/journal.pone.0087790	http://dx.doi.org/10.1371/journal.pone.0087790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498196	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100115
J	Huang, YY; Wille, M; Dobbin, A; Walzthoni, NM; Robertson, GJ; Ojkic, D; Whitney, H; Lang, AS				Huang, Yanyan; Wille, Michelle; Dobbin, Ashley; Walzthoeni, Natasha M.; Robertson, Gregory J.; Ojkic, Davor; Whitney, Hugh; Lang, Andrew S.			Genetic Structure of Avian Influenza Viruses from Ducks of the Atlantic Flyway of North America	PLOS ONE			English	Article							WATER-BORNE TRANSMISSION; A VIRUSES; INTERSPECIES TRANSMISSION; PERSISTENCE; EVOLUTION; ALASKA; AMPLIFICATION; REASSORTMENT; PREVALENCE; DIVERSITY	Wild birds, including waterfowl such as ducks, are reservoir hosts of influenza A viruses. Despite the increased number of avian influenza virus (AIV) genome sequences available, our understanding of AIV genetic structure and transmission through space and time in waterfowl in North America is still limited. In particular, AIVs in ducks of the Atlantic flyway of North America have not been thoroughly investigated. To begin to address this gap, we analyzed 109 AIV genome sequences from ducks in the Atlantic flyway to determine their genetic structure and to document the extent of gene flow in the context of sequences from other locations and other avian and mammalian host groups. The analyses included 25 AIVs from ducks from Newfoundland, Canada, from 2008-2011 and 84 available reference duck AIVs from the Atlantic flyway from 2006-2011. A vast diversity of viral genes and genomes was identified in the 109 viruses. The genetic structure differed amongst the 8 viral segments with predominant single lineages found for the PB2, PB1 and M segments, increased diversity found for the PA, NP and NS segments (2, 3 and 3 lineages, respectively), and the highest diversity found for the HA and NA segments (12 and 9 lineages, respectively). Identification of inter-hemispheric transmissions was rare with only 2% of the genes of Eurasian origin. Virus transmission between ducks and other bird groups was investigated, with 57.3% of the genes having highly similar (>= 99% nucleotide identity) genes detected in birds other than ducks. Transmission between North American flyways has been frequent and 75.8% of the genes were highly similar to genes found in other North American flyways. However, the duck AIV genes did display spatial distribution bias, which was demonstrated by the different population sizes of specific viral genes in one or two neighbouring flyways compared to more distant flyways.	[Huang, Yanyan; Wille, Michelle; Dobbin, Ashley; Walzthoeni, Natasha M.; Lang, Andrew S.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Robertson, Gregory J.] Environm Canada, Wildlife Res Div, Mt Pearl, NF, Canada; [Ojkic, Davor] Univ Guelph, Hlth Anim Lab, Guelph, ON N1G 2W1, Canada; [Whitney, Hugh] Newfoundland & Labrador Dept Nat Resources, St John, NF, Canada	Memorial University Newfoundland; Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada; University of Guelph	Lang, AS (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	aslang@mun.ca	Robertson, Greg/AAI-5849-2020; Wille, Michelle/F-4819-2013; huang, yan/GWM-4747-2022	Robertson, Greg/0000-0001-8452-5506; Wille, Michelle/0000-0002-5629-0196; Lang, Andrew/0000-0002-4510-7683	Newfoundland and Labrador Department of Natural Resources; Environment Canada's Strategic Technology Applications of Genomics in the Environment program; Wildlife and Landscape Science Directorate; Natural Sciences and Engineering Research Council (NSERC); Canada Foundation for Innovation; Memorial University School of Graduate Studies; Postgraduate Study Abroad Program from the China Scholarship Council; CGS-M fellowship from NSERC; Memorial University Biology Department Honours program	Newfoundland and Labrador Department of Natural Resources; Environment Canada's Strategic Technology Applications of Genomics in the Environment program; Wildlife and Landscape Science Directorate; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Memorial University School of Graduate Studies; Postgraduate Study Abroad Program from the China Scholarship Council; CGS-M fellowship from NSERC; Memorial University Biology Department Honours program	Funding from the Newfoundland and Labrador Department of Natural Resources (www.nr.gov.nl.ca/nr/), Environment Canada's Strategic Technology Applications of Genomics in the Environment program (www.ec.gc.ca/scitech/) and Wildlife and Landscape Science Directorate (http://www.ec.gc.ca/faunescience-wildlifescience/), the Natural Sciences and Engineering Research Council (NSERC) (http://www.nserc-crsng.gc.ca/Index_eng.asp), and the Canada Foundation for Innovation (www.innovation.ca/en) supported this research. YH was also supported by a fellowship from Memorial University School of Graduate Studies(http://www.mun.ca/sgs/) and by the Postgraduate Study Abroad Program from the China Scholarship Council (http://en.csc.edu.cn/). MW was supported by a CGS-M fellowship from NSERC and a merit fellowship from Memorial University School of Graduate Studies. AD and NMW's research was supported in part by funding from the Memorial University Biology Department (www.mun.ca/biology/) Honours program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahl J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003570; Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Chan CH, 2006, J VIROL METHODS, V136, P38, DOI 10.1016/j.jviromet.2006.03.027; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; Chen R, 2009, VIROLOGY, V383, P156, DOI 10.1016/j.virol.2008.10.015; Dohna HZ, 2009, EMERG INFECT DIS, V15, P1040, DOI 10.3201/eid1507.090245; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Girard YA, 2012, VIRUS GENES, V44, P415, DOI 10.1007/s11262-011-0706-5; Gonzalez-Reiche AS, 2012, AVIAN DIS, V56, P1025, DOI 10.1637/10203-041412-Reg.1; Hall JS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-179; Hatchette TF, 2004, J GEN VIROL, V85, P2327, DOI 10.1099/vir.0.79878-0; Henaux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031471; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Huang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081842; Huang YY, 2013, CAN J MICROBIOL, V59, P701, DOI 10.1139/cjm-2013-0507; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lam TTY, 2012, ECOL LETT, V15, P24, DOI 10.1111/j.1461-0248.2011.01703.x; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Lebarbenchon C, 2012, P ROY SOC B-BIOL SCI, V279, P3967, DOI 10.1098/rspb.2012.1271; Lu G, 2007, NUCLEIC ACIDS RES, V35, pW275, DOI 10.1093/nar/gkm365; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; Nazir J, 2011, APPL ENVIRON MICROB, V77, P4981, DOI 10.1128/AEM.00415-11; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pearce JM, 2011, MOL ECOL, V20, P1015, DOI 10.1111/j.1365-294X.2010.04908.x; Pearce JM, 2009, EVOL APPL, V2, P457, DOI 10.1111/j.1752-4571.2009.00071.x; Pereda AJ, 2008, VIROLOGY, V378, P363, DOI 10.1016/j.virol.2008.06.010; Peterson AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000261; Phipps LP, 2004, J VIROL METHODS, V122, P119, DOI 10.1016/j.jviromet.2004.08.008; Ramey AM, 2010, VIROLOGY, V406, P352, DOI 10.1016/j.virol.2010.07.031; Ramey AM, 2010, VIROLOGY, V401, P179, DOI 10.1016/j.virol.2010.02.006; Reeves AB, 2011, INFECT GENET EVOL, V11, P2004, DOI 10.1016/j.meegid.2011.09.011; Roche B, 2009, INFECT GENET EVOL, V9, P800, DOI 10.1016/j.meegid.2009.04.009; Spackman E, 2005, VIRUS RES, V114, P89, DOI 10.1016/j.virusres.2005.05.013; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Borm S, 2012, ARCH VIROL, V157, P1509, DOI 10.1007/s00705-012-1323-x; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1	45	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86999	10.1371/journal.pone.0086999	http://dx.doi.org/10.1371/journal.pone.0086999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498009	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000330617100044
J	Jiang, CH; Cui, JH; Liu, FY; Gao, L; Luo, YJ; Li, P; Guan, LB; Gao, YQ				Jiang, Chunhua; Cui, Jianhua; Liu, Fuyu; Gao, Liang; Luo, Yongjun; Li, Peng; Guan, Libin; Gao, Yuqi			Mitochondrial DNA 10609T Promotes Hypoxia-Induced Increase of Intracellular ROS and Is a Risk Factor of High Altitude Polycythemia	PLOS ONE			English	Article							COMPLEX-I; MUTATION; CELL; ADAPTATION; DISEASES	Hypobaric hypoxia is the primary cause of high altitude polycythemia (HAPC). Mitochondria are critical organelles that consume high levels of oxygen and generate ATP. We hypothesize that the mitochondrion may be at the center of HAPC, and mitochondrial DNA (mtDNA) SNPs may be involved in its development. First, we conducted a case-control study to investigate the association of mtDNA variants with HAPC in Han Chinese migrating to the Qinghai-Tibetan Plateau. Pearson's chi-square tests revealed that mtDNA 8414T (MU) frequency (19.5%) in the HAPC group was significantly higher than that of the control (13.0%, P = 0.04, OR = 1.615, 95% CI: 1.020-2.555). The multivariate logistic regression analysis, after adjustment for environmental factors, revealed that mtDNA 10609T (WT) was significantly associated with an increased risk of HAPC (P<0.01, OR = 2.558, 95% CI: 1.250-5.236). Second, to verify the association, in vitro experiments of transmitochondrial cybrids was performed and revealed that the mtDNA 10609 variant promoted hypoxia-induced increase of intracellular ROS, but the mtDNA 8414 variant did not. Our findings provide evidence that, in Han Chinese, mtDNA 10609T promotes hypoxia-induced increase of intracellular ROS and is a HAPC risk factor.	[Jiang, Chunhua; Guan, Libin; Gao, Yuqi] Third Mil Med Univ, Coll High Altitude Mil Med, Dept Pathophysiol & High Altitude Physiol, Chongqing, Peoples R China; [Jiang, Chunhua; Liu, Fuyu; Luo, Yongjun; Li, Peng; Guan, Libin; Gao, Yuqi] Minist Educ, Key Lab High Altitude Med, Chongqing, Peoples R China; [Jiang, Chunhua; Liu, Fuyu; Luo, Yongjun; Li, Peng; Guan, Libin; Gao, Yuqi] PLA, Key Lab High Altitude Med, Chongqing, Peoples R China; [Cui, Jianhua; Gao, Liang] 18th Hosp PLA, Res Ctr PLA Prevent & Treatment High Mt Sickness, Yecheng, Xinjiang, Peoples R China	Army Medical University	Gao, YQ (corresponding author), Third Mil Med Univ, Coll High Altitude Mil Med, Dept Pathophysiol & High Altitude Physiol, Chongqing, Peoples R China.	gaoy66@gmail.com			National Science Foundation of China [81101469, 30971426]; 973 Project of China [2012CB518201]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project of China(National Basic Research Program of China)	This work was supported by grants from the National Science Foundation of China (nos. 81101469 and 30971426)(http://www.nsfc.gov.cn/Portal0/default152.htm) and 973 Project of China (no. 2012CB518201)(http://www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEALL CM, 1990, AM J HUM BIOL, V2, P639, DOI 10.1002/ajhb.1310020607; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; [蔡明春 Cai Mingchun], 2002, [中国病理生理杂志, Chinese Journal of Pathophysiology], V18, P1038; Cardol P, 2006, EUKARYOT CELL, V5, P1460, DOI 10.1128/EC.00118-06; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Fang J, 2007, BLOOD, V110, P2361, DOI 10.1182/blood-2006-12-063503; Gao W X, 2001, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V17, P323; Gao Y., 2005, HIGH ALTITUDE MILITA; Gorlach A, 2007, METHOD ENZYMOL, V435, P421, DOI 10.1016/S0076-6879(07)35022-2; Gordeuk VR, 2004, BLOOD, V103, P3924, DOI 10.1182/blood-2003-07-2535; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109; Jiang CH, 2011, MOL MED REP, V5, P287; Kang DC, 2005, CURR MED CHEM, V12, P429, DOI 10.2174/0929867053363081; Leon-Velarde F, 2005, HIGH ALT MED BIOL, V6, P147, DOI 10.1089/ham.2005.6.147; LEONVELARDE F, 1993, J WILDERNESS MED, V4, P183, DOI 10.1580/0953-9859-4.2.183; Li FX, 2011, MITOCHONDRION, V11, P553, DOI 10.1016/j.mito.2011.02.003; Li P, 2011, EXP HEMATOL, V39, P37, DOI 10.1016/j.exphem.2010.10.006; Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MONGE C, 1992, INT J SPORTS MED, V13, pS79, DOI 10.1055/s-2007-1024603; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; Palmer BF, 2010, AM J MED SCI, V340, P69, DOI 10.1097/MAJ.0b013e3181d3cdbe; Pei T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-401; Pialoux V, 2009, FREE RADICAL BIO MED, V46, P321, DOI 10.1016/j.freeradbiomed.2008.10.047; Pon L. A., 2007, MITOCHONDRIA; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Takasaki S, 2008, COMPUT BIOL CHEM, V32, P332, DOI 10.1016/j.compbiolchem.2008.03.014; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Vithayathil SA, 2012, METHODS MOL BIOL, V837, P219, DOI 10.1007/978-1-61779-504-6_15; Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049; Voet D, 2006, FUNDAMENTALS BIOCH; Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479; Wu T, 2005, CHINESE MED J-PEKING, V118, P161; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Zheng SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031322	38	12	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87775	10.1371/journal.pone.0087775	http://dx.doi.org/10.1371/journal.pone.0087775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498190	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100113
J	Mora, A; Dahbi, G; Lopez, C; Mamani, R; Marzoa, J; Dion, S; Picard, B; Blanco, M; Alonso, MP; Denamur, E; Blanco, J				Mora, Azucena; Dahbi, Ghizlane; Lopez, Cecilia; Mamani, Rosalia; Marzoa, Juan; Dion, Sara; Picard, Bertrand; Blanco, Miguel; Pilar Alonso, Maria; Denamur, Erick; Blanco, Jorge			Virulence Patterns in a Murine Sepsis Model of ST131 Escherichia coli Clinical Isolates Belonging to Serotypes O25b:H4 and O16:H5 Are Associated to Specific Virotypes	PLOS ONE			English	Article							SEQUENCE TYPE ST131; SPECTRUM BETA-LACTAMASES; EXTENDED-SPECTRUM; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC GROUP; CLONAL GROUP; EMERGENCE; CTX-M-15; RESISTANCE; STRAINS	Escherichia coli sequence type (ST) 131 is an emerging disseminated public health threat implicated in multidrug-resistant extraintestinal infections worldwide. Although the majority of ST131 isolates belong to O25b:H4 serotype, new variants with different serotypes, STs using the discriminative multilocus sequence typing scheme of Pasteur Institute, and virulence-gene profiles (virotypes) have been reported with unknown implications on the pattern of spread, persistence and virulence. The aim of the present study was to compare virulence in a mouse subcutaneous sepsis model of representative ST131 clinical isolates belonging to 2 serotypes (O25b:H4, O16:H5) and nine virotypes and subtypes (A, B, C, D1, D2, D3, D4, D5 and E). Fourteen out of the 23 ST131 isolates tested (61%) killed 90 to 100% of mice challenged, and 18 of 23 (78%) at least 50%. Interestingly, different virulence patterns in association with virotypes were observed, from highly rapid lethality (death in less than 24 h) to low final lethality (death at 7 days) but with presence of an acute inflammation. This is the first study to assess virulence of ST131 isolates belonging to serotype O16:H5, which exhibited virotype C. In spite of their low virulence-gene score, O16:H5 isolates did not show significant differences in final lethality compared with highly virulent O25b:H4 isolates of virotypes A, B and C, but killed mice less rapidly. Significant differences were found, however, between virotypes A, B, C (final lethality >= 80% of mice challenged) and virotypes D, E. Particularly unexpected was the low lethality of the newly assigned virotype E taking into account that it exhibited high virulence-gene score, and the same clonotype H30 as highly virulent O25b:H4 isolates of virotypes A, B and C. In vivo virulence diversity reported in this study would reflect the genetic variability within ST131 clonal group evidenced by molecular typing.	[Mora, Azucena; Dahbi, Ghizlane; Lopez, Cecilia; Mamani, Rosalia; Marzoa, Juan; Blanco, Miguel; Blanco, Jorge] USC, LREC, Dept Microbiol & Parasitoloxia, Fac Vet, Lugo, Spain; [Dion, Sara; Picard, Bertrand; Denamur, Erick] INSERM, IAME, UMR 1137, Paris, France; [Dion, Sara; Denamur, Erick] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Picard, Bertrand] Univ Paris 13, Sorbonne Paris Cite, Paris, France; [Pilar Alonso, Maria] HULA, Unidade Microbiol Clin, Lugo, Spain	Universidade de Santiago de Compostela; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Hospital Universitario Lucus Augusti-Lugo	Mora, A (corresponding author), USC, LREC, Dept Microbiol & Parasitoloxia, Fac Vet, Lugo, Spain.	azucena.mora@usc.es	Marzoa Fandiño, Juan/F-8993-2016; ALVAREZ, JORGE BLANCO/C-7161-2013; López, Cecilia/T-3281-2019; Gutiérrez, Azucena Mora/F-4612-2016	Marzoa Fandiño, Juan/0000-0001-6866-600X; ALVAREZ, JORGE BLANCO/0000-0003-0264-4136; López, Cecilia/0000-0002-4290-9250; Gutiérrez, Azucena Mora/0000-0002-0785-5795; Blanco Alvarez, Miguel/0000-0002-0572-0571; Alonso Garcia, Maria Pilar/0000-0002-6094-3903	Red Espanola de Investigacion en Patologia Infecciosa [REIPI RD06/0008/1018-1016]; Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria, Ministerio de Economia y Competitividad, Gobierno de Espana [PI09/01273]; FEDER-INNTERCONECTA-COLIVAC (CDTI, Ministerio de Economia y Competitividad, Gobierno de Espana; Conselleria de Economia e Industria, Xunta de Galicia; The European Regional Development Fund, ERDF); (Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia) [CN2012/303]; ERDF	Red Espanola de Investigacion en Patologia Infecciosa; Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria, Ministerio de Economia y Competitividad, Gobierno de Espana; FEDER-INNTERCONECTA-COLIVAC (CDTI, Ministerio de Economia y Competitividad, Gobierno de Espana; Conselleria de Economia e Industria, Xunta de Galicia; The European Regional Development Fund, ERDF); (Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia); ERDF(European Commission)	This work was partially supported by the Red Espanola de Investigacion en Patologia Infecciosa (REIPI RD06/0008/1018-1016) and grants PI09/01273 (Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria, Ministerio de Economia y Competitividad, Gobierno de Espana), FEDER-INNTERCONECTA-COLIVAC (CDTI, Ministerio de Economia y Competitividad, Gobierno de Espana; Conselleria de Economia e Industria, Xunta de Galicia; The European Regional Development Fund, ERDF) and CN2012/303 (Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia and the ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2013, ANTIMICROB AGENTS CH, V57, P6385, DOI 10.1128/AAC.01604-13; Blanco J, 2013, J CLIN MICROBIOL, V51, P3358, DOI 10.1128/JCM.01555-13; Blanco M, 2009, J ANTIMICROB CHEMOTH, V63, P1135, DOI 10.1093/jac/dkp122; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Coelho A, 2011, J ANTIMICROB CHEMOTH, V66, P517, DOI 10.1093/jac/dkq491; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Dahbi G, 2013, INT J ANTIMICROB AG, V42, P347, DOI 10.1016/j.ijantimicag.2013.06.017; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Greenacre M, 1992, Stat Methods Med Res, V1, P97, DOI 10.1177/096228029200100106; Johnson JR, 2006, J INFECT DIS, V194, P1141, DOI 10.1086/507305; Johnson JR, 2012, EMERG INFECT DIS, V18, P598, DOI 10.3201/eid1804.111627; Johnson JR, 2012, INFECT IMMUN, V80, P1554, DOI 10.1128/IAI.06388-11; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson JR, 2003, ANTIMICROB AGENTS CH, V47, P2161, DOI 10.1128/AAC.47.7.2161-2168.2003; Kudinha T, 2013, CLIN MICROBIOL INFEC, V19, pE173, DOI 10.1111/1469-0691.12123; Kudinha T, 2013, J CLIN MICROBIOL, V51, P3270, DOI 10.1128/JCM.01315-13; Lavigne JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034294; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Matsumura Y, 2012, J ANTIMICROB CHEMOTH, V67, P2612, DOI 10.1093/jac/dks278; Mora A, 2010, APPL ENVIRON MICROB, V76, P6991, DOI 10.1128/AEM.01112-10; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Platell JL, 2011, VET MICROBIOL, V153, P99, DOI 10.1016/j.vetmic.2011.05.007; Tchesnokova V, 2013, J CLIN MICROBIOL, V51, P2991, DOI 10.1128/JCM.00984-13; Vredenburg J, 2013, ENVIRON MICROBIOL, V1, DOI [10.1111/1462-2920.12231, DOI 10.1111/1462-2920.12231.[]; Weissman SJ, 2012, APPL ENVIRON MICROB, V78, P1353, DOI 10.1128/AEM.06663-11	26	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87025	10.1371/journal.pone.0087025	http://dx.doi.org/10.1371/journal.pone.0087025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498015	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100046
J	Wang, F; Zhao, SC; Li, F; Zhang, B; Qu, Y; Sun, TL; Luo, T; Li, DP				Wang, Fei; Zhao, Shancang; Li, Feng; Zhang, Bo; Qu, Yi; Sun, Tianlei; Luo, Ting; Li, Dapeng			Investigation of Antioxidant Interactions between Radix Astragali and Cimicifuga foetida and Identification of Synergistic Antioxidant Compounds	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; LIQUID-CHROMATOGRAPHY; METHANOL EXTRACTS; IN-VITRO; ACID; MONGHOLICUS; FLAVONOIDS; LEAF	The medicinal plants of Huang-qi (Radix Astragali) and Sheng-ma (Cimicifuga foetida) demonstrate significantly better antioxidant effects when used in combination than when used alone. However, the bioactive components and interactional mechanism underlying this synergistic action are still not well understood. In the present study, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay was employed to investigate the antioxidant capacity of single herbs and their combination with the purpose of screening synergistic antioxidant compounds from them. Chromatographic isolation was performed on silica gel, Sephadex LH-20 columns and HPLC, and consequently to yield formononetin, calycosin, ferulic acid and isoferulic acid, which were identified by their retention time, UV lambda(max), MS and MS/MS data. The combination of isoferulic acid and calycosin at a dose ratio of 1:1 resulted in significant synergy in scavenging DPPH radicals and ferric reducing antioxidant power (FRAP) assay. Furthermore, the protective effects of these four potential synergistic compounds were examined using H2O2-induced HepG2 Cells bioassay. Results revealed that the similar synergy was observed in the combination of isoferulic acid and calycosin. These findings might provide some theoretical basis for the purported synergistic efficiency of Huang-qi and Sheng-ma as functional foods, dietary supplements and medicinal drugs.	[Wang, Fei; Li, Feng; Zhang, Bo; Qu, Yi; Sun, Tianlei; Luo, Ting; Li, Dapeng] Shandong Agr Univ, Dept Food Sci, Tai An, Shandong, Peoples R China; [Zhao, Shancang] Shandong Acad Agr Sci, Shandong Prov Key Lab Test Technol Food Qual & Sa, Jinan, Shandong, Peoples R China; [Zhao, Shancang] Shandong Acad Agr Sci, Cent Lab, Jinan, Shandong, Peoples R China	Shandong Agricultural University; Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Li, DP (corresponding author), Shandong Agr Univ, Dept Food Sci, Tai An, Shandong, Peoples R China.	dpli73@sdau.edu.cn	DaPeng, Li/G-4164-2010; li, dapeng/G-4166-2010	DaPeng, Li/0000-0002-1816-3217; li, dapeng/0000-0002-1816-3217	National Key Technology R&D Program in the 12th five-year Plan of China [2012BAK17B05]; Shandong Provincial Natural Science Foundation [2009ZRB019PD]; National Natural Science Foundation of China [31201417]	National Key Technology R&D Program in the 12th five-year Plan of China(National Key Technology R&D Program); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Technology R&D Program in the 12th five-year Plan of China (2012BAK17B05), Shandong Provincial Natural Science Foundation (2009ZRB019PD), and National Natural Science Foundation of China (31201417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cai YZ, 2006, LIFE SCI, V78, P2872, DOI 10.1016/j.lfs.2005.11.004; Costa RM, 2009, FOOD CHEM TOXICOL, V47, P860, DOI 10.1016/j.fct.2009.01.019; Dai F, 2008, BIOCHIMIE, V90, P1499, DOI 10.1016/j.biochi.2008.05.007; Facino RM, 1998, PLANTA MED, V64, P343, DOI 10.1055/s-2006-957448; Freeman BL, 2010, J FOOD SCI, V75, pC570, DOI 10.1111/j.1750-3841.2010.01717.x; Fridlender ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031524; Fu SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019604; Goupy P, 2007, FREE RADICAL BIO MED, V43, P933, DOI 10.1016/j.freeradbiomed.2007.06.013; Guo FQ, 2006, J PHARMACEUT BIOMED, V40, P623, DOI 10.1016/j.jpba.2005.07.034; HUDSON BJF, 1983, FOOD CHEM, V10, P111, DOI 10.1016/0308-8146(83)90027-4; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kumaran A, 2007, LWT-FOOD SCI TECHNOL, V40, P344, DOI 10.1016/j.lwt.2005.09.011; Li HB, 2008, LWT-FOOD SCI TECHNOL, V41, P385, DOI 10.1016/j.lwt.2007.03.011; Li M, 2011, LWT FOOD SCI TECHNOL; Li XC, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-140; Lin LZ, 2000, J CHROMATOGR A, V876, P87, DOI 10.1016/S0021-9673(00)00149-7; Liu DH, 2008, LWT-FOOD SCI TECHNOL, V41, P1344, DOI 10.1016/j.lwt.2007.08.001; Lopez-Alarcon C, 2012, ANAL CHIMICA ACTA; Palafox-Carlos H, 2012, MOLECULES, V17, P12657, DOI 10.3390/molecules171112657; Pan RL, 2009, ARCH PHARM RES, V32, P185, DOI 10.1007/s12272-009-1133-1; Peng ZF, 2003, PHYTOCHEMISTRY, V62, P219, DOI 10.1016/S0031-9422(02)00504-6; Peyrat-Maillard MN, 2003, J AM OIL CHEM SOC, V80, P1007, DOI 10.1007/s11746-003-0812-z; Prior R. L., 2013, AM J BIOMEDICAL SCI, V5, P126, DOI DOI 10.5099/AJ130200126; Rathee JS, 2006, J AGR FOOD CHEM, V54, P9046, DOI 10.1021/jf061679e; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Wang CC, 2010, FOOD CHEM, V120, P184, DOI 10.1016/j.foodchem.2009.10.005; Wang XZ, 2011, NAT PROD COMMUN, V6, P1285; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060; Yang WJ, 2009, BIOL PHARM BULL, V32, P1021, DOI 10.1248/bpb.32.1021; Yu DH, 2005, BIOMED ENVIRON SCI, V18, P297	32	31	32	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87221	10.1371/journal.pone.0087221	http://dx.doi.org/10.1371/journal.pone.0087221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498048	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100063
J	Ferrand, N; Gnanapragasam, A; Dorothee, G; Redeuilh, G; Larsen, AK; Sabbah, M				Ferrand, Nathalie; Gnanapragasam, Anne; Dorothee, Guillaume; Redeuilh, Gerard; Larsen, Annette K.; Sabbah, Michele			Loss of WISP2/CCN5 in Estrogen-Dependent MCF7 Human Breast Cancer Cells Promotes a Stem-Like Cell Phenotype	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL-TRANSITION; GROWTH-FACTOR-BETA; MOLECULAR CROSS-TALKS; TUMOR-CELLS; CCN FAMILY; TGF-BETA; ALDEHYDE DEHYDROGENASE; CCN5/WISP-2 EXPRESSION; EXTRACELLULAR-MATRIX; INVASIVE PHENOTYPES	It has been proposed that the epithelial-mesenchymal transition (EMT) in mammary epithelial cells and breast cancer cells generates stem cell features. WISP2 (Wnt-1-induced signaling protein-2) plays an important role in maintenance of the differentiated phenotype of estrogen receptor-positive breast cancer cells and loss of WISP2 is associated with EMT. We now report that loss of WISP2 in MCF7 breast cancer cells can also promote the emergence of a cancer stem-like cell phenotype characterized by high expression of CD44, increased aldehyde dehydrogenase activity and mammosphere formation. Higher levels of the stem cell markers Nanog and Oct3/4 were observed in those mammospheres. In addition we show that low-cell inoculums are capable of tumor formation in the mammary fat pad of immunodeficient mice. Gene expression analysis show an enrichment of markers linked to stem cell function such as SOX9 and IGFBP7 which is linked to TGF-beta inducible, SMAD3-dependent transcription. Taken together, our data demonstrate that WISP2 loss promotes both EMT and the stem-like cell phenotype.	[Ferrand, Nathalie; Gnanapragasam, Anne; Dorothee, Guillaume; Redeuilh, Gerard; Larsen, Annette K.; Sabbah, Michele] Ctr Rech Saint Antoine, Paris, France; [Dorothee, Guillaume] Ctr Rech St Antoine, Paris, France; [Ferrand, Nathalie; Gnanapragasam, Anne; Dorothee, Guillaume; Redeuilh, Gerard; Larsen, Annette K.; Sabbah, Michele] Inst Natl Sante & Rech Med, Paris, France; [Ferrand, Nathalie; Gnanapragasam, Anne; Dorothee, Guillaume; Redeuilh, Gerard; Larsen, Annette K.; Sabbah, Michele] Univ Paris 06, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Sabbah, M (corresponding author), Ctr Rech Saint Antoine, Paris, France.	michele.sabbah@inserm.fr	Sabbah, Michèle/GSN-8858-2022; DOROTHEE, Guillaume/O-9760-2016	Sabbah, Michèle/0000-0001-5368-9022; DOROTHEE, Guillaume/0000-0001-5763-3632	Institut National de la sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Universite Pierre et Marie Curie	Institut National de la sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie	This work was supported by Institut National de la sante et de la Recherche Medicale, Centre National de la Recherche Scientifique and Universite Pierre et Marie Curie. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Banerjee S, 2005, MOL CANCER RES, V3, P151, DOI 10.1158/1541-7786.MCR-04-0130; Banerjee S, 2003, NEOPLASIA, V5, P63, DOI 10.1016/S1476-5586(03)80018-0; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Banerjee SK, 2012, J CELL COMMUN SIGNAL, V6, P63, DOI 10.1007/s12079-012-0158-2; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; Dhar G, 2008, CANCER RES, V68, P4580, DOI 10.1158/0008-5472.CAN-08-0316; Dhar G, 2007, CANCER LETT, V254, P63, DOI 10.1016/j.canlet.2007.02.012; Dhar K, 2007, CANCER RES, V67, P1520, DOI 10.1158/0008-5472.CAN-06-3753; Ferrand N, 2012, BIOCHEM J, V447, P71, DOI 10.1042/BJ20120311; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; Fritah A, 2006, J ENDOCRINOL, V191, P613, DOI 10.1677/joe.1.07009; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Haque I, 2011, J BIOL CHEM, V286, P43475, DOI 10.1074/jbc.M111.284158; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Ivascu A, 2007, INT J ONCOL, V31, P1403; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; KALKHOVEN E, 1995, CELL GROWTH DIFFER, V6, P1151; Kim M, 2002, CLIN CANCER RES, V8, P22; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maciejczyk A, 2012, PATHOL ONCOL RES, V18, P331, DOI 10.1007/s12253-011-9449-9; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakanishi T, 2010, BRIT J CANCER, V102, P815, DOI 10.1038/sj.bjc.6605553; Ouelaa-Benslama R, 2012, INT J ONCOL, V41, P189, DOI 10.3892/ijo.2012.1457; Pen A, 2008, ONCOGENE, V27, P6834, DOI 10.1038/onc.2008.287; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Sabbah M, 2011, MOL CELL BIOL, V31, P1459, DOI 10.1128/MCB.01316-10; Sakaki-Yumoto M, 2013, BBA-GEN SUBJECTS, V1830, P2280, DOI 10.1016/j.bbagen.2012.08.008; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Vesuna F, 2009, NEOPLASIA, V11, P1318, DOI 10.1593/neo.91084; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; WRANA JL, 1991, EUR J BIOCHEM, V197, P519, DOI 10.1111/j.1432-1033.1991.tb15940.x; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; YUE W, 1993, J STEROID BIOCHEM, V44, P671, DOI 10.1016/0960-0760(93)90278-5; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Zoubine MN, 2001, BIOCHEM BIOPH RES CO, V282, P421, DOI 10.1006/bbrc.2001.4584	60	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87878	10.1371/journal.pone.0087878	http://dx.doi.org/10.1371/journal.pone.0087878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498388	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900134
J	Hakobyan, D; Heuer, A				Hakobyan, Davit; Heuer, Andreas			Key Molecular Requirements for Raft Formation in Lipid/Cholesterol Membranes	PLOS ONE			English	Article							COARSE-GRAINED MODEL; MARTINI FORCE-FIELD; LIPID-BILAYERS; DYNAMICS SIMULATIONS; PHASE-SEPARATION; DOMAIN FORMATION; CELL-MEMBRANES; CHOLESTEROL; PHOSPHATIDYLCHOLINE; MONOLAYERS	The lipid mixture of DPPC (saturated lipid)/DUPC (unsaturated lipid)/CHOL (cholesterol) is studied with respect to its ability to form liquid-ordered and liquid-disordered phases. We employ coarse-grained simulations with MARTINI force field. All three components are systematically modified in order to explore the relevant molecular properties, leading to phase separation. Specifically, we show that the DPPC/DUPC/CHOL system unmixes due to enthalpic DPPC-DPPC and DPPC-CHOL interactions. The phase separation remains unchanged, except for the formation of a gel phase at long times after decreasing the conformational degrees of freedom of the unsaturated DUPC. In contrast, the phase separation can be suppressed by softening the DPPC chains. In an attempt to mimic the ordering and unmixing effect of CHOL the latter is replaced by a stiff and shortened DPPC-like lipid. One still observes phase separation, suggesting that it is mainly the rigid and planar structure of CHOL which is important for raft formation. Addition of an extra bead to the head of CHOL has no notable impact on the phase separation of the system, supporting the irrelevance of the Umbrella model for the phase separation. Reduction of the conformational entropy of CHOL by stiffening its last bead results in a significant increase of the order of the DPPC/CHOL domain. This suggests that the conformational entropy of CHOL is important to prohibit the gelation process. The interleaflet interactions as mediated by the terminal molecular groups seem to have a strong impact on the possibility of a subsequent gelation process after phase separation.	[Hakobyan, Davit; Heuer, Andreas] Univ Munster, D-48149 Munster, Germany	University of Munster	Hakobyan, D (corresponding author), Univ Munster, D-48149 Munster, Germany.	dhako_01@uni-muenster.de			Deutsche Forschungsgemeinschaft, DFG, Cluster of Excellence, Munster, Germany [SFB 858, EXC 1003]	Deutsche Forschungsgemeinschaft, DFG, Cluster of Excellence, Munster, Germany	This work was supported by the Deutsche Forschungsgemeinschaft, DFG SFB 858 and EXC 1003 Cells in Motion - Cluster of Excellence, Munster, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatolli LA, 2000, BIOPHYS J, V79, P434, DOI 10.1016/S0006-3495(00)76305-3; Baoukina S, 2013, FARADAY DISCUSS, V161, P63, DOI 10.1039/c2fd20117h; Baoukina S, 2012, J AM CHEM SOC, V134, P17543, DOI 10.1021/ja304792p; Bennett WFD, 2009, J AM CHEM SOC, V131, P12714, DOI 10.1021/ja903529f; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; Brzustowicz MR, 2002, BIOPHYS J, V82, P285, DOI 10.1016/S0006-3495(02)75394-0; Dai J, 2010, J PHYS CHEM B, V114, P840, DOI 10.1021/jp909061h; Davis RS, 2013, J PHYS CHEM B, V117, P4072, DOI 10.1021/jp4000686; de Joannis J, 2011, J AM CHEM SOC, V133, P3625, DOI 10.1021/ja110425s; de Meyer F, 2009, P NATL ACAD SCI USA, V106, P3654, DOI 10.1073/pnas.0809959106; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Hakobyan D, 2013, J PHYS CHEM B, V117, P3841, DOI 10.1021/jp312245y; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hofsass C, 2003, BIOPHYS J, V84, P2192, DOI 10.1016/S0006-3495(03)75025-5; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Izvekov S, 2008, J PHYS CHEM B, V112, P4711, DOI 10.1021/jp710339n; Kahya N, 2004, J STRUCT BIOL, V147, P77, DOI 10.1016/j.jsb.2003.09.021; Kucerka N, 2010, BIOCHEMISTRY-US, V49, P7485, DOI 10.1021/bi100891z; Lee H, 2008, J PHYS CHEM B, V112, P7778, DOI 10.1021/jp802606y; Lindblom G, 2009, BBA-BIOMEMBRANES, V1788, P234, DOI 10.1016/j.bbamem.2008.08.016; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lyubartsev AP, 2003, SOFT MATER, V1, P121, DOI 10.1081/SMTS-120016746; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2005, CHEM PHYS LIPIDS, V135, P223, DOI 10.1016/j.chemphyslip.2005.03.001; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Martinez-Cabrera H. I., 2014, PLOS ONE, V9, DOI [10.1371/journal.pone, DOI 10.1371/journal.pone.0011162]; Mills TT, 2008, BIOPHYS J, V95, P682, DOI 10.1529/biophysj.107.127910; MOURITSEN OG, 1994, CHEM PHYS LIPIDS, V73, P3, DOI 10.1016/0009-3084(94)90171-6; Patra M, 2004, J PHYS CHEM B, V108, P4485, DOI 10.1021/jp031281a; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Rog T, 2007, BIOPHYS J, V92, P3346, DOI 10.1529/biophysj.106.095497; Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022; Scherfeld D, 2003, BIOPHYS J, V85, P3758, DOI 10.1016/S0006-3495(03)74791-2; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; Zhang Z, 2008, J PHYS CHEM B, V112, P3807, DOI 10.1021/jp077735b; Zhang Z, 2007, J PHYS CHEM B, V111, P12888, DOI 10.1021/jp074037i	44	39	39	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87369	10.1371/journal.pone.0087369	http://dx.doi.org/10.1371/journal.pone.0087369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498317	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900063
J	Okanga, S; Cumming, GS; Hockey, PAR; Nupen, L; Peters, JL				Okanga, Sharon; Cumming, Graeme S.; Hockey, Philip A. R.; Nupen, Lisa; Peters, Jeffrey L.			Host Specificity and Co-Speciation in Avian Haemosporidia in the Western Cape, South Africa	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; BLOOD PARASITES; MALARIAL PARASITES; BLUE TITS; PREVALENCE; PLASMODIUM; DIVERSITY; BIRDS; POPULATION; SPECIALIZATION	Host and pathogen ecology are often closely linked, with evolutionary processes often leading to the development of host specificity traits in some pathogens. Host specificity may range from 'generalist', where pathogens infect any available competent host; to 'specialist', where pathogens repeatedly infect specific host species or families. Avian malaria ecology in the region remains largely unexplored, despite the presence of vulnerable endemic avian species. We analysed the expression of host specificity in avian haemosporidia, by applying a previously developed host specificity index to lineages isolated from wetland passerines in the Western Cape, South Africa. Parasite lineages were isolated using PCR and identified when possible using matching lineages deposited in GenBank and in MalAvi. Parasitic clades were constructed from phylogenetic trees consisting of Plasmodium and Haemoproteus lineages. Isolated lineages matched some strains of Plasmodium relictum, P. elongatum, Haemoproteus sylvae and H. lanii. Plasmodium lineages infected a wide range of hosts from several avian families in a generalist pattern of infection. Plasmodium spp. also exhibited an infection trend according to host abundance rather than host species. By contrast, Haemoproteus lineages were typically restricted to one or two host species or families, and displayed higher host fidelity than Plasmodium spp. The findings confirm that a range of host specificity traits are exhibited by avian haemosporidia in the region. The traits show the potential to not only impact infection prevalence within specific host species, but also to affect patterns of infection at the community level.	[Okanga, Sharon; Cumming, Graeme S.; Hockey, Philip A. R.; Nupen, Lisa] Univ Cape Town, Percy FitzPatrick Inst, Dept Sci & Technol, ZA-7925 Cape Town, South Africa; [Okanga, Sharon; Cumming, Graeme S.; Hockey, Philip A. R.; Nupen, Lisa] Univ Cape Town, Natl Res Fdn, ZA-7925 Cape Town, South Africa; [Peters, Jeffrey L.] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA	University of Cape Town; National Research Foundation - South Africa; University of Cape Town; University System of Ohio; Wright State University Dayton	Okanga, S (corresponding author), Univ Cape Town, Percy FitzPatrick Inst, Dept Sci & Technol, ZA-7925 Cape Town, South Africa.	sokanga@gmail.com	Cumming, Graeme S./B-6551-2008; Peters, Jeffrey/I-5116-2012	Cumming, Graeme S./0000-0002-3678-1326; Peters, Jeffrey/0000-0002-5920-7976; Nupen, Lisa/0000-0003-1030-6057	DST/NRF Centre of Excellence at the Percy FitzPatrick Institute of African Ornithology; International Foundation for Science [D/4995-1]	DST/NRF Centre of Excellence at the Percy FitzPatrick Institute of African Ornithology; International Foundation for Science(International Foundation for Science)	This work was supported by grants from the DST/NRF Centre of Excellence at the Percy FitzPatrick Institute of African Ornithology and the International Foundation for Science (www.ifs.se; grant no. D/4995-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; Beadell JS, 2009, INT J PARASITOL, V39, P257, DOI 10.1016/j.ijpara.2008.06.005; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Beadell JS, 2005, J PARASITOL, V91, P683, DOI 10.1645/GE-3412RN; BENNETT G F, 1974, Journal of Wildlife Diseases, V10, P458; BENNETT GF, 1982, J WILDLIFE DIS, V18, P81, DOI 10.7589/0090-3558-18.1.81; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Cosgrove CL, 2008, J ANIM ECOL, V77, P540, DOI 10.1111/j.1365-2656.2008.01370.x; Cumming GS, 2013, PARASITOLOGY, V140, P193, DOI 10.1017/S0031182012001461; Cumming GS, 1998, B ENTOMOL RES, V88, P379, DOI 10.1017/S0007485300042139; Durrant KL, 2007, J AVIAN BIOL, V38, P662, DOI 10.1111/j.0908-8857.2007.04034.x; Ezenwa VO, 2003, PARASITOLOGY, V126, P379, DOI 10.1017/S0031182002002913; Gandon S, 2004, EVOLUTION, V58, P455, DOI 10.1111/j.0014-3820.2004.tb01669.x; GRACZYK TK, 1994, J PARASITOL, V80, P302, DOI 10.2307/3283762; GREINER EC, 1975, CAN J ZOOL, V53, P1762, DOI 10.1139/z75-211; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hellgren O, 2006, MOL PHYLOGENET UNPUB; Hellgren O, 2007, J PARASITOL, V93, P889, DOI 10.1645/GE-1051R1.1; Hellgren O, 2007, MOL ECOL, V16, P1281, DOI 10.1111/j.1365-294X.2007.03227.x; Hellgren O, 2009, ECOLOGY, V90, P2840, DOI 10.1890/08-1059.1; Hockey P.A.R., 2005, ROBERTSBIRDS SO AFRI, V7th; Iezhova TA, 2005, J PARASITOL, V91, P472, DOI 10.1645/GE-3377RN; Ishtiaq F, 2007, J WILDLIFE DIS, V43, P382, DOI 10.7589/0090-3558-43.3.382; Ishtiaq F, 2012, PARASITOLOGY, V139, P221, DOI 10.1017/S0031182011001831; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; KUCERA J, 1981, FOLIA PARASIT, V28, P303; Loiseau C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044729; Loiseau C, 2012, MOL ECOL, V21, P431, DOI 10.1111/j.1365-294X.2011.05341.x; LYMBERY AJ, 1989, PARASITOL TODAY, V5, P298, DOI 10.1016/0169-4758(89)90021-5; Merino S, 1997, J WILDLIFE DIS, V33, P638, DOI 10.7589/0090-3558-33.3.638; Merino S, 2008, AUSTRAL ECOL, V33, P329, DOI 10.1111/j.1442-9993.2008.01820.x; Oksanen J, 2013, PACKAGE VEGAN COMMUN, P2; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Palinauskas V, 2008, EXP PARASITOL, V120, P372, DOI 10.1016/j.exppara.2008.09.001; Paracuellos M, 2004, WATERBIRDS, V27, P446, DOI 10.1675/1524-4695(2004)027[0446:FATDOA]2.0.CO;2; Perez-Rodriguez AD, 2011, PLASMODIUM SP UNPUB; Perez-Tris J, 2005, ECOL LETT, V8, P838, DOI 10.1111/j.1461-0248.2005.00788.x; Perez-Tris J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000235; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Poulin R, 2003, PARASITOLOGY, V126, P473, DOI 10.1017/S0031182003002993; Reed Kurt D, 2003, Clin Med Res, V1, P5; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Ricklefs RE, 2011, J BIOGEOGR, V38, P2045, DOI 10.1111/j.1365-2699.2011.02520.x; Ricklefs Robert E., 2009, P257; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sasal P, 1999, J ANIM ECOL, V68, P437, DOI 10.1046/j.1365-2656.1999.00313.x; Schultz A, 2011, OSTRICH, V82, P141, DOI 10.2989/00306525.2011.603478; Schultz A, 2010, OSTRICH, V81, P69, DOI 10.2989/00306521003690630; Silva-Iturriza A, 2012, PARASITOL INT, V61, P650, DOI 10.1016/j.parint.2012.07.003; Soltis PS, 2003, STAT SCI, V18, P256; Sutherland W.J., 2004, TECHNIQUES ECOLOGY C; Szymanski MM, 2005, J PARASITOL, V91, P768, DOI 10.1645/GE-417R1.1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valkiunas G, 2005, AVIAN MALARIA PARASI; Valkiunas Gediminas, 2000, Acta Zoologica Lituanica, V10, P48; Valkiunas G, 2008, TRENDS PARASITOL, V24, P247, DOI 10.1016/j.pt.2008.03.004; Ventim R, 2012, J ORNITHOL, V153, P1253, DOI 10.1007/s10336-012-0860-0; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026	63	16	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86382	10.1371/journal.pone.0086382	http://dx.doi.org/10.1371/journal.pone.0086382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498273	gold, Green Accepted, Green Published			2022-12-25	WOS:000330626900019
J	Sefideh, FA; Moon, MJ; Yun, S; Hong, SI; Hwang, JI; Seong, JY				Sefideh, Fatemeh Ameri; Moon, Mi Jin; Yun, Seongsik; Hong, Sung In; Hwang, Jong-Ik; Seong, Jae Young			Local Duplication of Gonadotropin-Releasing Hormone (GnRH) Receptor before Two Rounds of Whole Genome Duplication and Origin of the Mammalian GnRH Receptor	PLOS ONE			English	Article							NEUROPEPTIDE-Y RECEPTOR; DIFFERENTIAL LIGAND SELECTIVITY; PROTEIN-COUPLED RECEPTORS; MOLECULAR-CLONING; CHROMOSOME DUPLICATIONS; EXTRACELLULAR LOOP-3; CRITICAL DETERMINANT; SIGNAL-TRANSDUCTION; CIONA-INTESTINALIS; GENE REGIONS	Gonadotropin-releasing hormone (GnRH) and the GnRH receptor (GnRHR) play an important role in vertebrate reproduction. Although many GnRHR genes have been identified in a large variety of vertebrate species, the evolutionary history of GnRHR in vertebrates is unclear. To trace the evolutionary origin of GnRHR we examined the conserved synteny of chromosomes harboring GnRHR genes and matched the genes to linkage groups of reconstructed vertebrate ancestor chromosomes. Consistent with the phylogenetic tree, three pairs of GnRHR subtypes were identified in three paralogous linkage groups, indicating that an ancestral pair emerged through local duplication before two rounds of whole genome duplication (2R). The 2R then led to the generation of six subtypes of GnRHR. Some subtypes were lost during vertebrate evolution after the divergence of teleosts and tetrapods. One subtype includes mammalian GnRHR and a coelacanth GnRHR that showed the greatest response to GnRH1 among the three types of GnRH. This study provides new insight into the evolutionary relationship of vertebrate GnRHRs.	[Sefideh, Fatemeh Ameri; Moon, Mi Jin; Yun, Seongsik; Hwang, Jong-Ik; Seong, Jae Young] Korea Univ, Grad Sch Med, Seoul, South Korea; [Hong, Sung In] Gachon Univ, Coll Oriental Med, Dept East West Integrated Med, Inchon, South Korea	Korea University; Korea University Medicine (KU Medicine); Gachon University	Seong, JY (corresponding author), Korea Univ, Grad Sch Med, Seoul, South Korea.	jyseong@korea.ac.kr	Seong, Jae Young/A-5794-2012	Seong, Jae Young/0000-0002-3312-6924; Hwang, Jong-Ik/0000-0002-0729-1782	Brain Research Program of the National Research Foundation of Korea [2011-0019205]; Basic Science Research Program of the National Research Foundation of Korea [2013R1A2A2A01068295]	Brain Research Program of the National Research Foundation of Korea(National Research Foundation of Korea); Basic Science Research Program of the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by grants from the Brain Research Program (2011-0019205) and Basic Science Research Program (2013R1A2A2A01068295) of the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davidson JS, 1996, J BIOL CHEM, V271, P15510, DOI 10.1074/jbc.271.26.15510; Daza DO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-231; Fernald RD, 1999, FRONT NEUROENDOCRIN, V20, P224, DOI 10.1006/frne.1999.0181; Fianagan CA, 1999, J BIOL CHEM, V274, P28880, DOI 10.1074/jbc.274.41.28880; FLANAGAN CA, 1994, J BIOL CHEM, V269, P22636; Flanagan CA, 2000, BIOCHEMISTRY-US, V39, P8133, DOI 10.1021/bi000085g; Flanagan CA, 2007, ENDOCRINOLOGY, V148, P5060, DOI 10.1210/en.2006-1400; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hauser F, 1998, BIOCHEM BIOPH RES CO, V249, P822, DOI 10.1006/bbrc.1998.9230; Heding A, 1998, J BIOL CHEM, V273, P11472, DOI 10.1074/jbc.273.19.11472; Hovelmann S, 2002, BIOCHEMISTRY-US, V41, P1129, DOI 10.1021/bi0113162; Hwang JI, 2013, MOL BIOL EVOL, V30, P1119, DOI 10.1093/molbev/mst031; Ikemoto T, 2005, MOL CELL ENDOCRINOL, V242, P67, DOI 10.1016/j.mce.2005.07.004; Joseph NT, 2012, ENDOCRINOLOGY, V153, P3345, DOI 10.1210/en.2012-1217; Kah O, 2007, GEN COMP ENDOCR, V153, P346, DOI 10.1016/j.ygcen.2007.01.030; KAKAR SS, 1992, BIOCHEM BIOPH RES CO, V189, P289, DOI 10.1016/0006-291X(92)91556-6; Karges B, 2003, HUM REPROD UPDATE, V9, P523, DOI 10.1093/humupd/dmg040; Kim DK, 2011, GEN COMP ENDOCR, V170, P68, DOI 10.1016/j.ygcen.2010.10.018; Kusakabe T, 2003, GENE, V322, P77, DOI 10.1016/j.gene.2003.08.013; Lagerstrom MC, 2005, GENOMICS, V85, P688, DOI 10.1016/j.ygeno.2005.02.007; Larhammar D, 2002, GENOME RES, V12, P1910, DOI 10.1101/gr.445702; Larsson TA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-184; Lee LTO, 2007, P NATL ACAD SCI USA, V104, P2133, DOI 10.1073/pnas.0611008104; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Li JH, 2005, MOL PHARMACOL, V67, P1099, DOI 10.1124/mol.104.004887; Lindemans M, 2009, P NATL ACAD SCI USA, V106, P1642, DOI 10.1073/pnas.0809881106; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; MATSUO H, 1971, BIOCHEM BIOPH RES CO, V43, P1334, DOI 10.1016/S0006-291X(71)80019-0; Millar R, 2001, P NATL ACAD SCI USA, V98, P9636, DOI 10.1073/pnas.141048498; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Moncaut N, 2005, J MOL ENDOCRINOL, V34, P767, DOI 10.1677/jme.1.01757; Morgan K, 2004, GEN COMP ENDOCR, V139, P191, DOI 10.1016/j.ygcen.2004.09.015; Morgan K, 2003, ENDOCRINOLOGY, V144, P423, DOI 10.1210/en.2002-220622; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Naor Z, 2012, FRONTIERS NEUROENDOC; Oh DY, 2005, MOL ENDOCRINOL, V19, P722, DOI 10.1210/me.2004-0220; POWELL JFF, 1994, P NATL ACAD SCI USA, V91, P12081, DOI 10.1073/pnas.91.25.12081; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; REINHART J, 1992, J BIOL CHEM, V267, P21281; Seong JY, 2003, ENDOCRINOLOGY, V144, P454, DOI 10.1210/en.2002-220683; Silver MR, 2004, GEN COMP ENDOCR, V139, P85, DOI 10.1016/j.ygcen.2004.07.011; Tello JA, 2005, ENDOCRINOLOGY, V146, P4061, DOI 10.1210/en.2004-1558; Tello JA, 2009, ENDOCRINOLOGY, V150, P2847, DOI 10.1210/en.2009-0028; Tostivint H, 2006, P NATL ACAD SCI USA, V103, P2237, DOI 10.1073/pnas.0510700103; Um HN, 2010, ANN NY ACAD SCI, V1200, P67, DOI 10.1111/j.1749-6632.2010.05508.x; Wang CB, 2004, MOL ENDOCRINOL, V18, P105, DOI 10.1210/me.2003-0101; Wang L, 2001, P NATL ACAD SCI USA, V98, P361, DOI 10.1073/pnas.011508498; White RB, 1998, P NATL ACAD SCI USA, V95, P305, DOI 10.1073/pnas.95.1.305; Wraith A, 2000, GENOME RES, V10, P302, DOI 10.1101/gr.10.3.302; Yegorov S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032923; ZHOU W, 1994, MOL PHARMACOL, V45, P165	51	21	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87901	10.1371/journal.pone.0087901	http://dx.doi.org/10.1371/journal.pone.0087901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498396	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900142
J	Tarhini, AA; Edington, H; Butterfield, LH; Lin, Y; Shuai, YL; Tawbi, H; Sander, C; Yin, Y; Holtzman, M; Johnson, J; Rao, UNM; Kirkwood, JM				Tarhini, Ahmad A.; Edington, Howard; Butterfield, Lisa H.; Lin, Yan; Shuai, Yongli; Tawbi, Hussein; Sander, Cindy; Yin, Yan; Holtzman, Matthew; Johnson, Jonas; Rao, Uma N. M.; Kirkwood, John M.			Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab	PLOS ONE			English	Article							REGULATORY T-CELLS; MYELOID SUPPRESSOR-CELLS; CANCER; EFFICACY; CHEMOTHERAPY; MARGINS; BREAST; STAGE; MM	We evaluated neoadjuvant ipilimumab in patients with surgically operable regionally advanced melanoma in order to define markers of activity in the blood and tumor as assessed at baseline (before ipilimumab) and early on-treatment. Patients were treated with ipilimumab (10 mg/kg intravenously every 3 weeks 62 doses) bracketing surgery. Tumor and blood biospecimens were obtained at baseline and at surgery. Flow cytometry and immunohistochemistry for select biomarkers were performed. Thirty five patients were enrolled; IIIB (3; N2b), IIIC (32; N2c, N3), IV (2). Worst toxicities included Grade 3 diarrhea/colitis (5; 14%), hepatitis (2; 6%), rash (1; 3%), elevated lipase (3; 9%). Median follow up was 18 months: among 33 evaluable patients, median progression free survival (PFS) was 11 months, 95% CI (6.2-19.2). There was a significant decrease in circulating myeloid derived suppressor cells (MDSC). Greater decrease in circulating monocyte gate MDSC Lin1-/HLA-DR-/CD33+/CD11b+ was associated with improved PFS (p = 0.03). There was a significant increase in circulating regulatory T cells (Treg; CD4+CD25hi+Foxp3+) that, unexpectedly, was associated with improved PFS (HR = 0.57; p = 0.034). Baseline evidence of fully activated type I CD4(+) and CD8(+) antigen-specific T cell immunity against cancer-testis (NY-ESO-1) and melanocytic lineage (MART-1, gp100) antigens was detected and was significantly potentiated after ipilimumab. In tumor, there was a significant increase in CD8(+) T cells after ipilimumab (p = 0.02). Ipilimumab induced increased tumor infiltration by fully activated (CD69(+)) CD3(+)/CD4(+) and CD3(+)/CD8(+) T cells with evidence of induction/potentiation of memory T cells (CD45RO(+)). The change in Treg observed within the tumor showed an inverse relationship with clinical benefit and greater decrease in tumor MDSC subset Lin1-/HLA-DR-/CD33(+)/CD11b(+) was associated with improved PFS at one year. Neoadjuvant evaluation revealed a significant immunomodulating role for ipilimumab on Treg, MDSC and effector T cells in the circulation and tumor microenvironment that warrants further pursuit in the quest for optimizing melanoma immunotherapy.	[Tarhini, Ahmad A.; Butterfield, Lisa H.; Tawbi, Hussein; Sander, Cindy; Yin, Yan; Kirkwood, John M.] Univ Pittsburgh, Dept Med, Inst Canc, Pittsburgh, PA 15213 USA; [Edington, Howard] West Penn Allegheny Hlth Syst, Dept Surg, Pittsburgh, PA USA; [Lin, Yan; Shuai, Yongli] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Holtzman, Matthew] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Johnson, Jonas] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; [Rao, Uma N. M.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tarhini, AA (corresponding author), Univ Pittsburgh, Dept Med, Inst Canc, Pittsburgh, PA 15213 USA.	tarhiniaa@upmc.edu	Butterfield, Lisa H./W-1564-2019	Butterfield, Lisa H./0000-0002-3439-9844	Bristol-Myers Squibb; National Institutes of Health (NIH) [P50CA121973]; NIH [P30CA047904]; NATIONAL CANCER INSTITUTE [P50CA121973, P30CA047904] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigator-initiated study was supported by a grant from Bristol-Myers Squibb and in part by National Institutes of Health (NIH) award P50CA121973. UPCI shared resources, including Immunologic Monitoring Laboratory and Tissue Procurement Facility that are supported in part by NIH award P30CA047904 were used for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, ANN SURG ONCOL, V8, P101, DOI 10.1007/s10434-001-0101-x; BALCH CM, 1993, ANN SURG, V218, P262, DOI 10.1097/00000658-199309000-00005; Bancewicz J, 2002, LANCET, V359, P1727; Carthon BC, 2010, CLIN CANCER RES, V16, P2861, DOI 10.1158/1078-0432.CCR-10-0569; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; DiLillo DJ, 2010, J IMMUNOL, V184, P4006, DOI 10.4049/jimmunol.0903009; Erdag G, 2012, CANCER RES, V72, P1070, DOI 10.1158/0008-5472.CAN-11-3218; Estevez LG, 2004, CLIN CANCER RES, V10, P3249, DOI 10.1158/1078-0432.CCR-03-0133; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Filipazzi P, 2012, CANCER IMMUNOL IMMUN, V61, P255, DOI 10.1007/s00262-011-1161-9; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gabitass RF, 2011, CANCER IMMUNOL IMMUN, V60, P1419, DOI 10.1007/s00262-011-1028-0; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Hamid O, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-204; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Karakousis CP, 1996, ANN SURG ONCOL, V3, P446, DOI 10.1007/BF02305762; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Menard C, 2008, CLIN CANCER RES, V14, P5242, DOI 10.1158/1078-0432.CCR-07-4797; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Rao UNM, 2010, AM J CLIN PATHOL, V133, P646, DOI 10.1309/AJCPTXMEFOVYWDA6; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; TARHINI A, 2013, SCIENTIFICA, DOI DOI 10.1155/2013/857519; Tarhini AA, 2012, J IMMUNOTHER, V35, P702, DOI 10.1097/CJI.0b013e318272569b; Tarhini AA, 2012, J CLIN ONCOL, V30, P322, DOI 10.1200/JCO.2011.37.5394; United Sates National Institutes of Health, 2008, EFF STUD IP VERS PLA; United Sates National Institutes of Health, 2013, IP HIGH DOS INT ALF; Vence L, 2007, P NATL ACAD SCI USA, V104, P20884, DOI 10.1073/pnas.0710557105; Walter S., 2012, NAT MED; Whiteside TL, 2010, EXPERT OPIN BIOL TH, V10, P1019, DOI 10.1517/14712598.2010.482207; Wolchok JD, 2010, LANCET ONCOL, V11, P155, DOI 10.1016/S1470-2045(09)70334-1; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505	39	208	222	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87705	10.1371/journal.pone.0087705	http://dx.doi.org/10.1371/journal.pone.0087705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498358	Green Accepted, Green Published, gold			2022-12-25	WOS:000330626900104
J	Gauvin, L; Panisson, A; Cattuto, C				Gauvin, Laetitia; Panisson, Andre; Cattuto, Ciro			Detecting the Community Structure and Activity Patterns of Temporal Networks: A Non-Negative Tensor Factorization Approach	PLOS ONE			English	Article							DECOMPOSITIONS	The increasing availability of temporal network data is calling for more research on extracting and characterizing mesoscopic structures in temporal networks and on relating such structure to specific functions or properties of the system. An outstanding challenge is the extension of the results achieved for static networks to time-varying networks, where the topological structure of the system and the temporal activity patterns of its components are intertwined. Here we investigate the use of a latent factor decomposition technique, non-negative tensor factorization, to extract the community-activity structure of temporal networks. The method is intrinsically temporal and allows to simultaneously identify communities and to track their activity over time. We represent the time-varying adjacency matrix of a temporal network as a three-way tensor and approximate this tensor as a sum of terms that can be interpreted as communities of nodes with an associated activity time series. We summarize known computational techniques for tensor decomposition and discuss some quality metrics that can be used to tune the complexity of the factorized representation. We subsequently apply tensor factorization to a temporal network for which a ground truth is available for both the community structure and the temporal activity patterns. The data we use describe the social interactions of students in a school, the associations between students and school classes, and the spatio-temporal trajectories of students over time. We show that non-negative tensor factorization is capable of recovering the class structure with high accuracy. In particular, the extracted tensor components can be validated either as known school classes, or in terms of correlated activity patterns, i.e., of spatial and temporal coincidences that are determined by the known school activity schedule.	[Gauvin, Laetitia; Panisson, Andre; Cattuto, Ciro] ISI Fdn, Data Sci Lab, Turin, Italy		Gauvin, L (corresponding author), ISI Fdn, Data Sci Lab, Turin, Italy.	laetitia.gauvin@isi.it		Panisson, Andre/0000-0002-3336-0374	Lagrange Project; CRT Foundation; Q-ARACNE project; Fondazione Compagnia di San Paolo; FET Multiplex Project [EU-FET-317532]; European Commission	Lagrange Project; CRT Foundation; Q-ARACNE project; Fondazione Compagnia di San Paolo(Compagnia di San Paolo); FET Multiplex Project; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors acknowledge partial support from the Lagrange Project funded by the CRT Foundation, the Q-ARACNE project funded by the Fondazione Compagnia di San Paolo, and the FET Multiplex Project (EU-FET-317532) funded by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Phan AH, 2012, NEURAL COMPUT APPL, V21, P623, DOI 10.1007/s00521-011-0652-0; Bassett DS, 2013, CHAOS, V23, DOI 10.1063/1.4790830; Bertsekas D. P., 1999, NONLINEAR PROGRAMMIN, P334; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bro R, 2003, J CHEMOMETR, V17, P274, DOI 10.1002/cem.801; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Chen Y., 2013, ARXIV13037226; Cichocki A., 2009, NONNEGATIVE MATRIX T, DOI DOI 10.1002/9780470747278; De Domenico M, 2013, ARXIV13074977; Dunlavy DM, 2011, ACM T KNOWL DISCOV D, V5, DOI 10.1145/1921632.1921636; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Greene D, 2010, 2010 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2010), P176, DOI 10.1109/ASONAM.2010.17; Harshman R. A., 1970, FDN PARAFAC PROCEDUR, P1; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hopcroft J, 2004, P NATL ACAD SCI USA, V101, P5249, DOI 10.1073/pnas.0307750100; Kim J., 2012, HIGH PERFORMANCE SCI, P311, DOI DOI 10.1007/978-1-4471-2437-5_16; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Morup M, 2011, WIRES DATA MIN KNOWL, V1, P24, DOI 10.1002/widm.1; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Nickel M., 2011, PROC 28 INT C MACH L, V11, P809, DOI DOI 10.5555/3104482.3104584; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Ronhovde P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00329; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Shashua A., 2005, P 22 INT C MACHINE L, P792, DOI [10.1145/1102351.1102451, DOI 10.1145/1102351.1102451]; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Sun J., 2006, P 12 ACM SIGKDD INT, P374, DOI DOI 10.1145/1150402.1150445; Van de Cruys Tim, 2009, P WORKSHOP GEOMETRIC, P83; Wang F, 2011, DATA MIN KNOWL DISC, V22, P493, DOI 10.1007/s10618-010-0181-y; Wang Y, 2011, PROCEEDINGS OF THE 34TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL (SIGIR'11), P1145; Yang Jaewon, 2013, P 6 ACM INT C WEB SE, P587, DOI [DOI 10.1145/2433396.2433471, 10.1145/2433396.2433471]	36	134	139	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86028	10.1371/journal.pone.0086028	http://dx.doi.org/10.1371/journal.pone.0086028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497935	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900015
J	Harshaw, C; Culligan, JJ; Alberts, JR				Harshaw, Christopher; Culligan, Jay J.; Alberts, Jeffrey R.			Sex Differences in Thermogenesis Structure Behavior and Contact within Huddles of Infant Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; SYRIAN GOLDEN-HAMSTERS; RATS RATTUS-NORVEGICUS; BODY-TEMPERATURE; MUS-MUSCULUS; NORWAY RATS; AMBIENT-TEMPERATURE; LITTER HUDDLE; PUPS; C57BL/6J	Brown adipose tissue (BAT) is a thermogenic effector abundant in most mammalian infants. For multiparous species such as rats and mice, the interscapular BAT deposit provides both an emergency "thermal blanket" and a target for nestmates seeking warmth, thereby increasing the cohesiveness of huddling groups. Sex differences in BAT regulation and thermogenesis have been documented in a number of species, including mice (Mus musculus)-with females generally exhibiting relative upregulation of BAT. It is nonetheless unknown whether this difference affects the behavioral dynamics occurring within huddles of infant rodents. We investigated sex differences in BAT thermogenesis and its relation to contact while huddling in eight-day-old C57BL/6 mouse pups using infrared thermography, scoring of contact, and causal modeling of the relation between interscapular temperature relative to other pups in the huddle (T-IS(rel)) and contacts while huddling. We found that females were warmer than their male siblings during cold challenge, under conditions both in which pups were isolated and in which pups could actively huddle in groups of six (3 male, 3 female). This difference garnered females significantly more contacts from other pups than males during cold-induced huddling. Granger analyses revealed a significant negative feedback relationship between contacts with males and T-IS(rel) for females, and positive feedback between contacts with females and T-IS(rel) for males, indicating that male pups drained heat from female siblings while huddling. Significant sex assortment nonetheless occurred, such that females made more contacts with other females than expected by chance, apparently outcompeting males for access to each other. These results provide further evidence of enhanced BAT thermogenesis in female mice. Slight differences in BAT can significantly structure the behavioral dynamics occurring in huddles, resulting in differences in the quantity and quality of contacts obtained by the individuals therein, creating sex differences in behavioral interactions beginning in early infancy.	[Harshaw, Christopher; Culligan, Jay J.; Alberts, Jeffrey R.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Harshaw, C (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	chrisharshaw@yahoo.com	Harshaw, Christopher/O-2586-2013	Harshaw, Christopher/0000-0002-1400-7356	NIMH [RO1-MH082019]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082019] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by NIMH grant RO1-MH082019 to JRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JR, 2007, DEV PSYCHOBIOL, V49, P22, DOI 10.1002/dev.20190; ALBERTS JR, 1978, J COMP PHYSIOL PSYCH, V92, P231, DOI 10.1037/h0077459; ALBERTS JR, 1978, J COMP PHYSIOL PSYCH, V92, P220, DOI 10.1037/h0077458; ALBERTS JR, 1978, J COMP PHYSIOL PSYCH, V92, P897, DOI 10.1037/h0077533; Allee W., 1938, SOCIAL LIFE ANIMALS; Arakawa H, 2007, BEHAV BRAIN RES, V176, P27, DOI 10.1016/j.bbr.2006.07.027; Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; BARNETT SA, 1956, J EXP BIOL, V33, P124; Bautista A, 2010, DEV PSYCHOBIOL, V52, P35, DOI 10.1002/dev.20409; BEVAN WILLIAM, 1960, ANIMAL BEHAVIOUR, V8, P6, DOI 10.1016/0003-3472(60)90003-8; Blumberg M.S., 2001, HDB BEHAV NEUROBIOLO, V13, P199; BLUMBERG MS, 1992, DEV PSYCHOBIOL, V25, P497, DOI 10.1002/dev.420250704; BLUMBERG MS, 1990, BEHAV NEUROSCI, V104, P808, DOI 10.1037/0735-7044.104.5.808; Blumberg MS, 1997, PHYSIOL ZOOL, V70, P324, DOI 10.1086/639608; Bond TLY, 2002, PHYSIOL BEHAV, V75, P551, DOI 10.1016/S0031-9384(02)00659-5; Branchi I, 2009, NEUROSCI BIOBEHAV R, V33, P551, DOI 10.1016/j.neubiorev.2008.03.011; Broders HG, 2004, J WILDLIFE MANAGE, V68, P602, DOI 10.2193/0022-541X(2004)068[0602:IAIVIR]2.0.CO;2; Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; BRYANT DM, 1975, COMP BIOCHEM PHYSIOL, V50, P99, DOI 10.1016/S0010-406X(75)80208-8; CAIRNS RB, 1971, J COMP PHYSIOL PSYCH, V74, P354, DOI 10.1037/h0030584; Canals M, 1998, ACTA THERIOL, V43, P337, DOI 10.4098/AT.arch.98-45; Champagne FA, 2007, PHYSIOL BEHAV, V91, P325, DOI 10.1016/j.physbeh.2007.03.014; Conradt L, 1998, P ROY SOC B-BIOL SCI, V265, P1359, DOI 10.1098/rspb.1998.0442; Crews D, 2011, HORM BEHAV, V59, P393, DOI 10.1016/j.yhbeh.2010.07.001; Crowcroft P., 1966, MICE ALL; CROWCROFT PETER, 1963, PROC ZOOL SOC LONDON, V140, P517; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; D'Eath RB, 2004, ANIM BEHAV, V67, P501, DOI 10.1016/j.anbehav.2003.06.010; de Medeiros CB, 2010, PSYCHOL SCI, V21, P1494, DOI 10.1177/0956797610382122; DEFRIES JC, 1970, AM NAT, V104, P408, DOI 10.1086/282675; Dimitsantos E, 2007, PHYSIOL BEHAV, V92, P708, DOI 10.1016/j.physbeh.2007.05.066; Fairless AH, 2012, BEHAV BRAIN RES, V228, P299, DOI 10.1016/j.bbr.2011.12.001; FISHER RA, 1950, BIOMETRICS, V6, P17, DOI 10.2307/3001420; FRANCIS RC, 1988, ETHOLOGY, V78, P223; Gaskill BN, 2013, PHYSIOL BEHAV, V110, P87, DOI 10.1016/j.physbeh.2012.12.018; Gaskill BN, 2011, J THERM BIOL, V36, P193, DOI 10.1016/j.jtherbio.2011.02.004; Gaskill BN, 2009, APPL ANIM BEHAV SCI, V116, P279, DOI 10.1016/j.applanim.2008.10.002; Gilbert C, 2007, AM J PHYSIOL-REG I, V293, pR867, DOI 10.1152/ajpregu.00081.2007; Gilbert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033553; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; Girardier L., 1983, P50; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Gordon CJ, 2012, J THERM BIOL, V37, P286, DOI 10.1016/j.jtherbio.2011.06.008; Gordon CJ, 2009, J THERM BIOL, V34, P213, DOI 10.1016/j.jtherbio.2009.02.002; Gordon CJ, 1998, PHYSIOL BEHAV, V65, P255, DOI 10.1016/S0031-9384(98)00148-6; GRANGER CWJ, 1988, J ECONOMETRICS, V39, P199, DOI 10.1016/0304-4076(88)90045-0; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; Haig D, 2004, ANNU REV GENET, V38, P553, DOI 10.1146/annurev.genet.37.110801.142741; Haig D, 2008, CURR BIOL, V18, pR172, DOI 10.1016/j.cub.2007.12.040; Haig D, 2012, BIOL PHILOS, V27, P461, DOI 10.1007/s10539-012-9315-5; Harremoes P, 2012, IEEE INT SYMP INFO, P533, DOI 10.1109/ISIT.2012.6284247; Harshaw C, 2012, PHYSIOL BEHAV, V106, P670, DOI 10.1016/j.physbeh.2012.05.002; Hoffman CM, 1999, DEV PSYCHOBIOL, V34, P87, DOI 10.1002/(SICI)1098-2302(199903)34:2<87::AID-DEV2>3.0.CO;2-W; Hoffman CM, 1999, DEV PSYCHOBIOL, V34, P73, DOI 10.1002/(SICI)1098-2302(199903)34:2<73::AID-DEV1>3.0.CO;2-B; Hudson R, 2011, DEV PSYCHOBIOL, V53, P564, DOI 10.1002/dev.20535; Hull D., 1973, P167; JOHANSON IB, 1979, PHYSIOL BEHAV, V23, P871, DOI 10.1016/0031-9384(79)90193-8; Johnson JS, 2012, J MAMMAL, V93, P1545, DOI 10.1644/12-MAMM-A-097.1; Justo R, 2005, LIFE SCI, V76, P1147, DOI 10.1016/j.lfs.2004.08.019; Kerth G, 1999, BEHAVIOUR, V136, P1187, DOI 10.1163/156853999501711; KING JOHN A., 1955, PHYSIOL ZOOL, V28, P233; LEONARD CM, 1974, J COMP PHYSIOL PSYCH, V86, P458, DOI 10.1037/h0036135; LISK RD, 1971, ANIM BEHAV, V19, P606, DOI 10.1016/S0003-3472(71)80118-5; LYNCH CB, 1988, AM NAT, V132, P521, DOI 10.1086/284869; MACKINTO.JH, 1970, ANIM BEHAV, V18, P177, DOI 10.1016/0003-3472(70)90088-6; MCDONALD RB, 1993, P SOC EXP BIOL MED, V204, P117; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Meyer P., 2010, MATERNAL BEHAV C57BL; Monjo M, 2003, ENDOCRINOLOGY, V144, P4923, DOI 10.1210/en.2003-0537; Ootsuka Y, 2009, NEUROSCIENCE, V164, P849, DOI 10.1016/j.neuroscience.2009.08.013; PEARSON OP, 1947, ECOLOGY, V28, P127, DOI 10.2307/1930947; PHILLIPS PK, 1995, J THERM BIOL, V20, P281, DOI 10.1016/0306-4565(94)00061-M; POOLE TB, 1976, ANIM BEHAV, V24, P476, DOI 10.1016/S0003-3472(76)80056-5; PRYCHODKO W, 1958, ECOLOGY, V39, P500, DOI 10.2307/1931760; Quevedo S, 1998, PFLUG ARCH EUR J PHY, V436, P689, DOI 10.1007/s004240050690; Retzlaff EG, 1939, J EXP ZOOL, V81, P343, DOI 10.1002/jez.1400810303; Reyes-Meza V, 2011, PHYSIOL BEHAV, V104, P778, DOI 10.1016/j.physbeh.2011.07.019; Rodriguez AM, 2002, CELL MOL LIFE SCI, V59, P1714, DOI 10.1007/PL00012499; Rodriguez E, 2001, PFLUG ARCH EUR J PHY, V442, P396, DOI 10.1007/s004240100556; Rodriguez-Cuenca S, 2002, J BIOL CHEM, V277, P42958, DOI 10.1074/jbc.M207229200; Rodel HG, 2008, PHYSIOL BEHAV, V95, P441, DOI 10.1016/j.physbeh.2008.07.011; Rodel HG, 2009, PHYSIOL BEHAV, V97, P495, DOI 10.1016/j.physbeh.2009.04.005; Ruckstuhl KE, 1998, ANIM BEHAV, V56, P99, DOI 10.1006/anbe.1998.0745; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; SAAL FSV, 1989, J ANIM SCI, V67, P1824; Sack R, 2005, BRAIN RES BULL, V66, P30, DOI 10.1016/j.brainresbull.2005.02.032; SALES GD, 1979, J ZOOL, V187, P265; SAYLER A, 1971, BEHAVIOUR, V40, P62, DOI 10.1163/156853971X00339; SCOTT JP, 1951, PHYSIOL ZOOL, V24, P273, DOI 10.1086/physzool.24.4.30152137; Small W. S., 1899, AM J PSYCHOL, V11, P80, DOI DOI 10.2307/1412730); SMITH RE, 1964, SCIENCE, V146, P1686, DOI 10.1126/science.146.3652.1686; Sokal R. R., 1981, BIOMETRY; Sokoloff G, 2000, BEHAV NEUROSCI, V114, P585; Sokoloff G, 2002, J COMP PSYCHOL, V116, P240, DOI 10.1037/0735-7036.116.3.240; Sokoloff G, 2002, J COMP PSYCHOL, V116, P228, DOI 10.1037//0735-7036.116.3.228; Sokoloff G, 2001, DEV PSYCHOBIOL, V39, P65, DOI 10.1002/dev.1030; STANIER MW, 1975, COMP BIOCHEM PHYS A, V51, P79, DOI 10.1016/0300-9629(75)90416-8; Uhrich J, 1938, J COMP PSYCHOL, V25, P373, DOI 10.1037/h0056350; Valle A, 2005, AM J PHYSIOL-ENDOC M, V289, pE15, DOI 10.1152/ajpendo.00553.2004; Valle A, 2007, CELL PHYSIOL BIOCHEM, V19, P195, DOI 10.1159/000099207; VETULANI T., 1931, BIOL GENERALIS, V7-10, P71; WILLIAMS E, 1953, BEHAVIOUR, V6, P35, DOI 10.1163/156853954X00031	103	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87405	10.1371/journal.pone.0087405	http://dx.doi.org/10.1371/journal.pone.0087405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498099	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900107
J	Kamke, J; Rinke, C; Schwientek, P; Mavromatis, K; Ivanova, N; Sczyrba, A; Woyke, T; Hentschel, U				Kamke, Janine; Rinke, Christian; Schwientek, Patrick; Mavromatis, Kostas; Ivanova, Natalia; Sczyrba, Alexander; Woyke, Tanja; Hentschel, Ute			The Candidate Phylum Poribacteria by Single-Cell Genomics: New Insights into Phylogeny, Cell-Compartmentation, Eukaryote-Like Repeat Proteins, and Other Genomic Features	PLOS ONE			English	Article							PHOSPHONATE UTILIZATION; MARINE; FIBRONECTIN; BACTERIA; REVEALS; TRANSMISSION; COMMUNITIES; ORGANELLES; DIVERSITY; ALIGNMENT	The candidate phylum Poribacteria is one of the most dominant and widespread members of the microbial communities residing within marine sponges. Cell compartmentalization had been postulated along with their discovery about a decade ago and their phylogenetic association to the Planctomycetes, Verrucomicrobia, Chlamydiae superphylum was proposed soon thereafter. In the present study we revised these features based on genomic data obtained from six poribacterial single cells. We propose that Poribacteria form a distinct monophyletic phylum contiguous to the PVC superphylum together with other candidate phyla. Our genomic analyses supported the possibility of cell compartmentalization in form of bacterial microcompartments. Further analyses of eukaryote-like protein domains stressed the importance of such proteins with features including tetratricopeptide repeats, leucin rich repeats as well as low density lipoproteins receptor repeats, the latter of which are reported here for the first time from a sponge symbiont. Finally, examining the most abundant protein domain family on poribacterial genomes revealed diverse phyH family proteins, some of which may be related to dissolved organic posphorus uptake.	[Kamke, Janine; Hentschel, Ute] Univ Wurzburg, Julius von Sachs Inst Biol Sci, Dept Bot 2, D-97070 Wurzburg, Germany; [Rinke, Christian; Schwientek, Patrick; Mavromatis, Kostas; Ivanova, Natalia; Sczyrba, Alexander; Woyke, Tanja] Dept Energy Joint Genome Inst, Walnut Creek, CA USA; [Sczyrba, Alexander] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany	University of Wurzburg; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Bielefeld	Hentschel, U (corresponding author), Univ Wurzburg, Julius von Sachs Inst Biol Sci, Dept Bot 2, D-97070 Wurzburg, Germany.	ute.hentschel@uni-wuerzburg.de	Rinke, Christian/AAE-8100-2019; Hentschel, Ute/ABD-6624-2021; Hentschel, Ute/H-8343-2013; Rinke, Christian/ABA-3139-2021; t, lf/AAJ-4924-2020	Rinke, Christian/0000-0003-4632-1187; Hentschel, Ute/0000-0003-0596-790X; Hentschel, Ute/0000-0003-0596-790X; Sczyrba, Alexander/0000-0002-4405-3847; Ivanova, Natalia/0000-0002-5802-9485; Kamke, Janine/0000-0001-5475-1238; Mavrommatis, Konstantinos/0000-0003-4549-385X	German Research Foundation (DFG); University of Wuerzburg; grant TPA5 [SFB630]; grant TPC3 [SFB567]; Bavaria California Technology Center (BaCaTeC); United States Department of Energy Joint Genome Institute, Office of Science of the United States Department of Energy [DE-AC02-05CH11231]	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; grant TPA5; grant TPC3; Bavaria California Technology Center (BaCaTeC); United States Department of Energy Joint Genome Institute, Office of Science of the United States Department of Energy	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. URL: http://www.bibliothek.uni-wuerzburg.de/en/homepage/. Financial support to U.H. was provided by the SFB630-grant TPA5, the SFB567-grant TPC3, and by the Bavaria California Technology Center (BaCaTeC). T.W., C.R., P.S., N.I and K.M. were funded by the United States Department of Energy Joint Genome Institute, Office of Science of the United States Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bierne H, 2002, J CELL SCI, V115, P3357; Cerveny L, 2013, INFECT IMMUN, V81, P629, DOI 10.1128/IAI.01035-12; Clark LL, 1999, AM J SCI, V299, P724, DOI 10.2475/ajs.299.7-9.724; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; Dembitskii VM, 1988, CHEM NAT COMPD, V24, P642; Dembitsky VM, 2003, CHEM PHYS LIPIDS, V123, P117, DOI 10.1016/S0009-3084(03)00020-3; Dyhrman ST, 2009, NAT GEOSCI, V2, P696, DOI 10.1038/NGEO639; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fan L, 2012, P NATL ACAD SCI USA, V109, pE1878, DOI 10.1073/pnas.1203287109; Fieseler L, 2006, ENVIRON MICROBIOL, V8, P612, DOI 10.1111/j.1462-2920.2005.00937.x; Fieseler L, 2004, APPL ENVIRON MICROB, V70, P3724, DOI 10.1128/aem.70.6.3724-3732.2004; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fuerst JA, 2005, ANNU REV MICROBIOL, V59, P299, DOI 10.1146/annurev.micro.59.030804.121258; FUERST JA, 1991, P NATL ACAD SCI USA, V88, P8184, DOI 10.1073/pnas.88.18.8184; Gupta RS, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00327; Hao YA, 2010, ENVIRON MICROBIOL, V12, P105, DOI 10.1111/j.1462-2920.2009.02049.x; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kamke J, 2013, ISME J, V7, P2287, DOI 10.1038/ismej.2013.111; Kamke J, 2012, BIOL BULL-US, V223, P30, DOI 10.1086/BBLv223n1p30; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kolowith LC, 2001, LIMNOL OCEANOGR, V46, P309, DOI 10.4319/lo.2001.46.2.0309; Lafi FF, 2009, APPL ENVIRON MICROB, V75, P5695, DOI 10.1128/AEM.00035-09; Lagkouvardos I, 2014, APPL ENVIRON MICROB, V80, P440, DOI 10.1128/AEM.02655-13; Lang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062510; Liu MY, 2011, ISME J, V5, P427, DOI 10.1038/ismej.2010.139; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markowitz Victor M., 2007, V395, P35; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; Mukhamedova KS, 2000, CHEM NAT COMPD+, V36, P329, DOI 10.1023/A:1002804409503; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; Nguyen MTHD, 2014, MOL ECOL, V23, P1635, DOI 10.1111/mec.12384; Pham VD, 2008, ENVIRON MICROBIOL, V10, P2313, DOI 10.1111/j.1462-2920.2008.01657.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reuter K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010647; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Santarella-Mellwig R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001565; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Schmitt S, 2008, APPL ENVIRON MICROB, V74, P7694, DOI 10.1128/AEM.00878-08; Schofield CJ, 2007, BIOCHEM SOC T, V35, P870, DOI 10.1042/BST0350870; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Siegl A, 2010, ENV MICROBIOL REP, V2, P507, DOI 10.1111/j.1758-2229.2009.00057.x; Stamatakis A, 2012, BIOINFORMATICS, V28, P2064, DOI 10.1093/bioinformatics/bts309; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stepanauskas R, 2012, CURR OPIN MICROBIOL, V15, P613, DOI 10.1016/j.mib.2012.09.001; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2013, ISME J, V7, P438, DOI 10.1038/ismej.2012.111; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Villarreal-Chiu JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00019; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; White AK, 2007, ANNU REV MICROBIOL, V61, P379, DOI 10.1146/annurev.micro.61.080706.093357; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418	68	56	56	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87353	10.1371/journal.pone.0087353	http://dx.doi.org/10.1371/journal.pone.0087353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498082	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000330621900096
J	Lehmann, D; Spanholtz, J; Sturtzel, C; Tordoir, M; Schlechta, B; Groenewegen, D; Hofer, E				Lehmann, Dorit; Spanholtz, Jan; Sturtzel, Caterina; Tordoir, Marleen; Schlechta, Bernhard; Groenewegen, Dirk; Hofer, Erhard			IL-12 Directs Further Maturation of Ex Vivo Differentiated NK Cells with Improved Therapeutic Potential	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; TRANSCRIPTION FACTOR; L-SELECTIN; MANNOSE RECEPTOR; GENE-EXPRESSION; CD56(BRIGHT); IMMUNOTHERAPY; CYTOTOXICITY; BIOLOGY; DISPLAY	The possibility to modulate ex vivo human NK cell differentiation towards specific phenotypes will contribute to a better understanding of NK cell differentiation and facilitate tailored production of NK cells for immunotherapy. In this study, we show that addition of a specific low dose of IL-12 to an ex vivo NK cell differentiation system from cord blood CD34(+) stem cells will result in significantly increased proportions of cells with expression of CD62L as well as KIRs and CD16 which are preferentially expressed on mature CD56(dim) peripheral blood NK cells. In addition, the cells displayed decreased expression of receptors such as CCR6 and CXCR3, which are typically expressed to a lower extent by CD56(dim) than CD56(bright) peripheral blood NK cells. The increased number of CD62L and KIR positive cells prevailed in a population of CD33(+)NKG2A(+) NK cells, supporting that maturation occurs via this subtype. Among a series of transcription factors tested we found Gata3 and TOX to be significantly downregulated, whereas ID3 was upregulated in the IL-12-modulated ex vivo NK cells, implicating these factors in the observed changes. Importantly, the cells differentiated in the presence of IL-12 showed enhanced cytokine production and cytolytic activity against MHC class I negative and positive targets. Moreover, in line with the enhanced CD16 expression, these cells exhibited improved antibody-dependent cellular cytotoxicity for B-cell leukemia target cells in the presence of the clinically applied antibody rituximab. Altogether, these data provide evidence that IL-12 directs human ex vivo NK cell differentiation towards more mature NK cells with improved properties for potential cancer therapies.	[Lehmann, Dorit; Sturtzel, Caterina; Hofer, Erhard] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria; [Spanholtz, Jan; Tordoir, Marleen; Groenewegen, Dirk] Glycostem Therapeut, Nijmegen, Netherlands; [Schlechta, Bernhard] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Hofer, E (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria.	erhard.hofer@meduniwien.ac.at		Sturtzel, Caterina/0000-0003-1002-5634; Spanholtz, Jan/0000-0001-7152-6956	Marie Curie research training network grants of the EC [MRTN-CT-2005-019248, FP7-People-2012-ITN-317013]	Marie Curie research training network grants of the EC	This work was supported by Marie Curie research training network grants of the EC to EH (MRTN-CT-2005-019248 and FP7-People-2012-ITN-317013). DL was a Marie Curie fellow in the network MRTN-CT-2005-019248. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Bennett IM, 1996, J EXP MED, V184, P1845, DOI 10.1084/jem.184.5.1845; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Bhat R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000326; Billot K, 2009, LEUKEMIA RES, V34, P289; Binyamin L, 2008, J IMMUNOL, V180, P6392, DOI 10.4049/jimmunol.180.9.6392; BLOMBERG K, 1986, J IMMUNOL METHODS, V86, P225, DOI 10.1016/0022-1759(86)90457-6; Bremer E, 2008, CANCER RES, V68, P597, DOI 10.1158/0008-5472.CAN-07-5171; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Di Santo JP, 2008, NAT IMMUNOL, V9, P473, DOI 10.1038/ni.f.201; Eissens DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030930; Galon J, 1999, J IMMUNOL, V162, P7256; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Guia S, 2008, BLOOD, V111, P5008, DOI 10.1182/blood-2007-11-122259; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; Ikawa T, 2001, P NATL ACAD SCI USA, V98, P5164, DOI 10.1073/pnas.091537598; Irjala H, 2001, J EXP MED, V194, P1033, DOI 10.1084/jem.194.8.1033; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Lehmann D, 2012, STEM CELLS DEV, V21, P2926, DOI 10.1089/scd.2011.0659; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Loza MJ, 2004, J IMMUNOL, V172, P88, DOI 10.4049/jimmunol.172.1.88; Loza MJ, 2001, NAT IMMUNOL, V2, P917, DOI 10.1038/ni1001-917; Marttila-Ichihara F, 2008, BLOOD, V112, P64, DOI 10.1182/blood-2007-10-118984; Marusina AI, 2005, J IMMUNOL, V174, P2152, DOI 10.4049/jimmunol.174.4.2152; McDyer JF, 1998, J ALLERGY CLIN IMMUN, V102, P11; Morandi F, 2011, BLOOD, V118, P5840, DOI 10.1182/blood-2011-05-352393; Moretta L, 2010, BLOOD, V116, P3689, DOI 10.1182/blood-2010-09-303057; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Niederleithner H, 2012, J INVEST DERMATOL, V132, P2235, DOI 10.1038/jid.2012.138; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Saez-Borderias A, 2009, J IMMUNOL, V182, P829, DOI 10.4049/jimmunol.182.2.829; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Sutlu T, 2009, J INTERN MED, V266, P154, DOI 10.1111/j.1365-2796.2009.02121.x; Takahashi E, 2007, SCAND J IMMUNOL, V65, P126, DOI 10.1111/j.1365-3083.2006.01883.x; Tayade C, 2005, J LEUKOCYTE BIOL, V78, P1347, DOI 10.1189/jlb.0305142; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; Trinchieri G, 1996, J LEUKOCYTE BIOL, V59, P505, DOI 10.1002/jlb.59.4.505; WOJTA J, 1989, J BIOL CHEM, V264, P2846; Yamamoto K, 2002, BIOCHEM BIOPH RES CO, V297, P1245, DOI 10.1016/S0006-291X(02)02378-1; Yun S, 2011, IMMUNOL LETT, V136, P29, DOI 10.1016/j.imlet.2010.11.008	47	25	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87131	10.1371/journal.pone.0087131	http://dx.doi.org/10.1371/journal.pone.0087131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498025	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900068
J	McFarlane, C; Vajjala, A; Arigela, H; Lokireddy, S; Ge, XJ; Bonala, S; Manickam, R; Kambadur, R; Sharma, M				McFarlane, Craig; Vajjala, Anuradha; Arigela, Harikumar; Lokireddy, Sudarsanareddy; Ge, XiaoJia; Bonala, Sabeera; Manickam, Ravikumar; Kambadur, Ravi; Sharma, Mridula			Negative Auto-Regulation of Myostatin Expression is Mediated by Smad3 and MicroRNA-27	PLOS ONE			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; BETA SUPERFAMILY MEMBER; MYOBLAST DIFFERENTIATION; SARCOMERIC PROTEINS; CARDIAC-HYPERTROPHY; MESSENGER-RNA; SELF-RENEWAL; GROWTH; MICE; PROMOTES	Growth factors, such as myostatin (Mstn), play an important role in regulating post-natal myogenesis. In fact, loss of Mstn has been shown to result in increased post-natal muscle growth through enhanced satellite cell functionality; while elevated levels of Mstn result in dramatic skeletal muscle wasting through a mechanism involving reduced protein synthesis and increased ubiquitin-mediated protein degradation. Here we show that miR-27a/b plays an important role in feed back autoregulation of Mstn and thus regulation of post-natal myogenesis. Sequence analysis of Mstn 39 UTR showed a single highly conserved miR-27a/b binding site and increased expression of miR-27a/b was correlated with decreased expression of Mstn and vice versa both in vitro and in mice in vivo. Moreover, we also show that Mstn gene expression was regulated by miR-27a/b. Treatment with miR-27a/b-specific AntagomiRs resulted in increased Mstn expression, reduced myoblast proliferation, impaired satellite cell activation and induction of skeletal muscle atrophy that was rescued upon either blockade of, or complete absence of, Mstn. Consistent with this, miR-27a over expression resulted in reduced Mstn expression, skeletal muscle hypertrophy and an increase in the number of activated satellite cells, all features consistent with impaired Mstn function. Loss of Smad3 was associated with increased levels of Mstn, concomitant with decreased miR-27a/b expression, which is consistent with impaired satellite cell function and muscular atrophy previously reported in Smad3-null mice. Interestingly, treatment with Mstn resulted in increased miR-27a/b expression, which was shown to be dependent on the activity of Smad3. These data highlight a novel auto-regulatory mechanism in which Mstn, via Smad3 signaling, regulates miR-27a/b and in turn its own expression. In support, Mstn-mediated inhibition of Mstn 39 UTR reporter activity was reversed upon miR-27a/b-specific AntagomiR transfection. Therefore, miR-27a/b, through negatively regulating Mstn, plays a role in promoting satellite cell activation, myoblast proliferation and preventing muscle wasting.	[McFarlane, Craig; Kambadur, Ravi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Vajjala, Anuradha; Arigela, Harikumar; Lokireddy, Sudarsanareddy; Ge, XiaoJia; Bonala, Sabeera; Manickam, Ravikumar; Kambadur, Ravi] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Sharma, Mridula] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Sharma, M (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchmridu@nus.edu.sg	McFarlane, Craig/R-2968-2019; ARIGELA, HARIKUMAR/J-9872-2019	McFarlane, Craig/0000-0002-7056-8887; ARIGELA, HARIKUMAR/0000-0003-3293-7618; Bonala, Sabeerabi/0000-0002-0783-0862	Biomedical Research Council (BMRC) [M4070097.080]; National Research Foundation (NRF) [M4092014.0S4 CRP]; Agency for Science, Technology and Research (A*STAR), Singapore [C08031]	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); National Research Foundation (NRF); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	The work performed in this manuscript was supported by the following grants: Biomedical Research Council (BMRC; M4070097.080) http://www.a-star.edu.sg/AboutASTAR/BiomedicalResearchCouncil/tabid/64/Default.aspx, National Research Foundation (NRF; M4092014.0S4 CRP) http://www.nrf.gov.sg/nrf/default.aspx and intramural research funding (C08031) from Agency for Science, Technology and Research (A*STAR), Singapore http://www.a-star.edu.sg/Default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Allen DL, 2011, AM J PHYSIOL-CELL PH, V300, pC124, DOI 10.1152/ajpcell.00142.2010; Bell ML, 2010, MOL CELL BIOL, V30, P1937, DOI 10.1128/MCB.01370-09; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601, DOI 10.1152/ajpregu.1999.277.2.R601; Chen XL, 2014, CELL BIOL INT, V38, P266, DOI 10.1002/cbin.10192; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Deveaux W, 2003, REPROD NUTR DEV, V43, P527, DOI 10.1051/rnd:2004003; Drummond MJ, 2009, J NUTR, V139, P2279, DOI 10.3945/jn.109.112797; Forbes D, 2006, J CELL PHYSIOL, V206, P264, DOI 10.1002/jcp.20477; Ge XJ, 2011, CELL RES, V21, P1591, DOI 10.1038/cr.2011.72; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Huang ZQ, 2012, BIOCHEM BIOPH RES CO, V423, P265, DOI 10.1016/j.bbrc.2012.05.106; Jiao J, 2011, J ANIM SCI, V89, P3099, DOI 10.2527/jas.2010-3827; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lee SJ, 2012, P NATL ACAD SCI USA, V109, pE2353, DOI 10.1073/pnas.1206410109; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lokireddy S, 2011, AM J PHYSIOL-CELL PH, V301, pC1316, DOI 10.1152/ajpcell.00114.2011; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; Manickam R, 2008, MOL REPROD DEV, V75, P1783, DOI 10.1002/mrd.20918; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McCroskery S, 2005, J CELL SCI, V118, P3531, DOI 10.1242/jcs.02482; McFarlane C, 2005, DEV BIOL, V283, P58, DOI 10.1016/j.ydbio.2005.03.039; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; OLIVER MH, 1989, J CELL SCI, V92, P513; Partridge T A, 1997, Methods Mol Biol, V75, P131; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Spiller MP, 2002, MOL CELL BIOL, V22, P7066, DOI 10.1128/MCB.22.20.7066-7082.2002; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Sundaresan NR, 2008, RES VET SCI, V85, P86, DOI 10.1016/j.rvsc.2007.09.014; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Wang Q, 2012, J PHYSIOL-LONDON, V590, P2151, DOI 10.1113/jphysiol.2011.226001; Xi G, 2007, J ANIM SCI, V85, P143, DOI 10.2527/jas.2006-351; Zhang C, 2011, DIABETOLOGIA, V54, P1491, DOI 10.1007/s00125-011-2079-7; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	46	49	55	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87687	10.1371/journal.pone.0087687	http://dx.doi.org/10.1371/journal.pone.0087687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498167	Green Published, Green Accepted, gold			2022-12-25	WOS:000330621900151
J	Treskatsch, S; Feldheiser, A; Rosin, AT; Sifringer, M; Habazettl, H; Mousa, SA; Shakibaei, M; Schafer, M; Spies, CD				Treskatsch, Sascha; Feldheiser, Aarne; Rosin, Adrian T.; Sifringer, Marco; Habazettl, Helmut; Mousa, Shaaban A.; Shakibaei, Mehdi; Schaefer, Michael; Spies, Claudia D.			A Modified Approach to Induce Predictable Congestive Heart Failure by Volume Overload in Rats	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; BETA(3)-ADRENERGIC RECEPTOR; DIFFERENTIAL REGULATION; CONTRACTILE RESPONSE; UP-REGULATION; APOPTOSIS; NOREPINEPHRINE; HYPERTROPHY; PLASMA; ACTIVATION	The model of infrarenal aortocaval fistula (ACF) has recently gained new interest in its use to investigate cardiac pathophysiology. Since in previous investigations the development of congestive heart failure (CHF) was inconsistent and started to develop earliest 8-10 weeks after fistula induction using a 18G needle, this project aimed to induce a predictable degree of CHF within a definite time period using a modified approach. An aortocaval fistula was induced in male Wistar rats using a 16G needle as a modification of the former 18G needle-technique described by Garcia and Diebold. Results revealed within 28 +/- 2 days of ACF significantly increased heart and lung weight indices in the ACF group accompanied by elevated filling pressure. All hemodynamic parameters derived from a pressure-volume conductance-catheter in vivo were significantly altered in the ACF consistent with severe systolic and diastolic left ventricular dysfunction. This was accompanied by systemic neurohumoral activation as demonstrated by elevated rBNP-45 plasma concentrations in every rat of the ACF group. Furthermore, the restriction in overall cardiac function was associated with a beta 1- and beta 2-adrenoreceptor mRNA downregulation in the left ventricle. In contrast, beta 3-adrenoreceptor mRNA was upregulated. Finally, electron microscopy of the left ventricle of rats in the ACF group showed signs of progressive subcellular myocardial fragmentation. In conclusion, the morphometric, hemodynamic and neurohumoral characterization of the modified approach revealed predictable and consistent signs of congestive heart failure within 28 +/- 2 days. Therefore, this modified approach might facilitate the examination of various questions specific to CHF and allow for pharmacological interventions to determine pathophysiological pathways.	[Treskatsch, Sascha; Feldheiser, Aarne; Rosin, Adrian T.; Sifringer, Marco; Mousa, Shaaban A.; Schaefer, Michael; Spies, Claudia D.] Campus Charite, Dept Anesthesiol & Intens Care Med, Mitte, Germany; [Treskatsch, Sascha; Feldheiser, Aarne; Rosin, Adrian T.; Sifringer, Marco; Mousa, Shaaban A.; Schaefer, Michael; Spies, Claudia D.] Charite, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Habazettl, Helmut] Charite, Campus Charite Mitte, Inst Physiol, D-13353 Berlin, Germany; [Shakibaei, Mehdi] Univ Munich, Inst Anat, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich	Spies, CD (corresponding author), Campus Charite, Dept Anesthesiol & Intens Care Med, Mitte, Germany.	claudia.spies@charite.de	Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020; Feldheiser, Aarne/AAH-1503-2019; Treskatsch, Sascha/ABB-2449-2021; Feldheiser, Aarne/GRS-9593-2022; Schäfer, Michael/AAB-1395-2020	Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Feldheiser, Aarne/0000-0002-0014-8879; Schaefer, Michael/0000-0002-1581-706X; Treskatsch, Sascha/0000-0002-0549-7680; Spies, Claudia/0000-0002-1062-0495				Abassi Z, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/729497; Abbate A, 2007, INT J CARDIOL, V114, P118, DOI 10.1016/j.ijcard.2005.11.025; Apostolakis S, 2010, CARDIOVASC RES, V85, P649, DOI 10.1093/cvr/cvp327; Berthiaume JM, 2010, AM J PHYSIOL-HEART C, V299, pH410, DOI 10.1152/ajpheart.00270.2010; Bohm M, 2011, CLIN RES CARDIOL, V100, P973, DOI 10.1007/s00392-011-0341-0; BOHM M, 1994, EUR HEART J, V15, P30, DOI 10.1093/eurheartj/15.suppl_D.30; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; Brower GL, 1996, AM J PHYSIOL-HEART C, V271, pH2071, DOI 10.1152/ajpheart.1996.271.5.H2071; Chen YW, 2011, AM J PHYSIOL-HEART C, V300, pH2251, DOI 10.1152/ajpheart.01104.2010; Cheng HJ, 2001, CIRC RES, V89, P599, DOI 10.1161/hh1901.098042; CHIDSEY CA, 1963, NEW ENGL J MED, V269, P653, DOI 10.1056/NEJM196309262691302; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Dent MR, 2007, J MOL CELL CARDIOL, V43, P726, DOI 10.1016/j.yjmcc.2007.09.001; Dent MR, 2010, APOPTOSIS, V15, P499, DOI 10.1007/s10495-009-0441-8; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; FLAIM SF, 1979, AM J PHYSIOL, V236, pH698, DOI 10.1152/ajpheart.1979.236.5.H698; Frederick JR, 2010, CIRCULATION, V122, pS107, DOI 10.1161/CIRCULATIONAHA.109.930404; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; GARCIA R, 1990, CARDIOVASC RES, V24, P430, DOI 10.1093/cvr/24.5.430; Gauthier C, 1998, J CLIN INVEST, V102, P1377, DOI 10.1172/JCI2191; Gauthier C, 2007, CLIN HEMORHEOL MICRO, V37, P193; Goltsman I, 2011, CIRC-HEART FAIL, V4, P345, DOI 10.1161/CIRCHEARTFAILURE.110.960179; HAMMOND HK, 1992, CIRCULATION, V85, P269, DOI 10.1161/01.CIR.85.1.269; Hasenfuss G, 1998, CARDIOVASC RES, V39, P60, DOI 10.1016/S0008-6363(98)00110-2; HASKING GJ, 1986, CIRCULATION, V73, P615, DOI 10.1161/01.CIR.73.4.615; Hatakeyama Y, 2004, AM J PHYSIOL-REG I, V287, pR336, DOI 10.1152/ajpregu.00131.2004; Heidrich FM, 2008, CIRC RES, V102, P1230, DOI 10.1161/CIRCRESAHA.107.166033; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; HUANG M, 1994, J APPL PHYSIOL, V77, P2907, DOI 10.1152/jappl.1994.77.6.2907; Hutchinson KR, 2011, J APPL PHYSIOL, V111, P1778, DOI 10.1152/japplphysiol.00691.2011; IhlVahl R, 1996, J MOL CELL CARDIOL, V28, P1, DOI 10.1006/jmcc.1996.0001; Khoynezhad A, 2007, TEX HEART I J, V34, P352; Langenickel T, 2000, AM J PHYSIOL-HEART C, V278, pH1500, DOI 10.1152/ajpheart.2000.278.5.H1500; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; LEIMBACH WN, 1986, CIRCULATION, V73, P913, DOI 10.1161/01.CIR.73.5.913; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Melenovsky V, 2012, KIDNEY BLOOD PRESS R, V35, P167, DOI 10.1159/000331562; Melenovsky V, 2011, MOL CELL BIOCHEM, V354, P83, DOI 10.1007/s11010-011-0808-3; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Mousa SA, 2004, ENDOCRINOLOGY, V145, P1331, DOI 10.1210/en.2003-1287; Mousa SA, 2011, J COMP NEUROL, V519, P957, DOI 10.1002/cne.22560; Murray DB, 2008, AM J PHYSIOL-HEART C, V294, pH1251, DOI 10.1152/ajpheart.00622.2007; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Palazzuoli A, 2012, MINERVA CARDIOANGIOL, V60, P183; Saha DC, 2007, J AM ASSOC LAB ANIM, V46, P74; Sato S, 2008, J PHARMACOL SCI, V107, P393, DOI 10.1254/jphs.08097FP; Searle J, 2011, MINERVA CARDIOANGIOL, V59, P203; Takeda Y, 2004, AM J CARDIOL, V94, P448, DOI 10.1016/j.amjcard.2004.05.004; Wang X, 2003, J APPL PHYSIOL, V94, P752, DOI 10.1152/japplphysiol.00248.2002	49	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87531	10.1371/journal.pone.0087531	http://dx.doi.org/10.1371/journal.pone.0087531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498127	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900128
J	Velasco-Castrillon, A; Schultz, MB; Colombo, F; Gibson, JAE; Davies, KA; Austin, AD; Stevens, MI				Velasco-Castrillon, Alejandro; Schultz, Mark B.; Colombo, Federica; Gibson, John A. E.; Davies, Kerrie A.; Austin, Andrew D.; Stevens, Mark I.			Distribution and Diversity of Soil Microfauna from East Antarctica: Assessing the Link between Biotic and Abiotic Factors	PLOS ONE			English	Article							MCMURDO DRY VALLEYS; SOUTHERN VICTORIA-LAND; DRONNING-MAUD-LAND; ICE-FREE AREAS; ROSS ISLAND; TERRESTRIAL NEMATODES; COMMUNITY STRUCTURE; VESTFOLD-HILLS; TAYLOR VALLEY; BUNGER HILLS	Terrestrial life in Antarctica has been described as some of the simplest on the planet, and mainly confined to soil microfaunal communities. Studies have suggested that the lack of diversity is due to extreme environmental conditions and thought to be driven by abiotic factors. In this study we investigated soil microfauna composition, abundance, and distribution in East Antarctica, and assessed correlations with soil geochemistry and environmental variables. We examined 109 soil samples from a wide range of ice-free habitats, spanning 2000 km from Framnes Mountains to Bailey Peninsula. Microfauna across all samples were patchily distributed, from complete absence of invertebrates to over 1600 specimens/gram of dry weight of soil (gdw), with highest microfauna abundance observed in samples with visible vegetation. Bdelloid rotifers were on average the most widespread found in 87% of sampled sites and the most abundant (44 specimens/gdw). Tardigrades occurred in 57% of the sampled sites with an abundance of 12 specimens/gdw. Nematodes occurred in 71% of samples with a total abundance of 3 specimens/gdw. Ciliates and mites were rarely found in soil samples, with an average abundance of 1.3 and 0.04 specimens/gdw, respectively. We found that microfaunal composition and abundance were mostly correlated with the soil geochemical parameters; phosphorus, NO3- and salinity, and likely to be the result of soil properties and historic landscape formation and alteration, rather than the geographic region they were sampled from. Studies focusing on Antarctic biodiversity must take into account soil geochemical and environmental factors that influence population and species heterogeneity.	[Velasco-Castrillon, Alejandro; Austin, Andrew D.] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia; [Schultz, Mark B.] Univ Melbourne, Dept Genet, Inst Bio21, Parkville, Vic 3052, Australia; [Colombo, Federica] Univ Western Sydney, Hawkesbury Inst Environm, Richmond, NSW, Australia; [Gibson, John A. E.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Davies, Kerrie A.] Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia; [Stevens, Mark I.] S Australian Museum, Adelaide, SA 5000, Australia; [Stevens, Mark I.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	University of Adelaide; University of Melbourne; Western Sydney University; University of Tasmania; University of Adelaide; University of South Australia	Velasco-Castrillon, A (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia.	macalusio@yahoo.com	Schultz, Mark B/R-1179-2019	Schultz, Mark B/0000-0002-7689-6531	Australian Antarctic Division [ASAC 2355]; University of Adelaide; South Australian Museum Mawson Trust	Australian Antarctic Division; University of Adelaide; South Australian Museum Mawson Trust	This study was partially funded by an Australian Antarctic Division (http://www.antarctica.gov.au/) Project (ASAC 2355 to MIS). Additional funding was provided by The University of Adelaide (http://www.sciences.adelaide.edu.au/) through a doctoral scholarship to Alejandro Velasco-Castrillon and the South Australian Museum Mawson Trust for providing funding for the Sir Douglas Mawson Doctoral Scholarship (http://www.samuseum.sa.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BJ, 2007, POLAR BIOL, V30, P809, DOI 10.1007/s00300-006-0241-3; Adams BJ, 2006, SOIL BIOL BIOCHEM, V38, P3003, DOI 10.1016/j.soilbio.2006.04.030; Andrassy I., 2008, Journal of Nematode Morphology and Systematics, V11, P49; Andrassy I., 2008, Journal of Nematode Morphology and Systematics, V11, P87; Andrassy Istvan, 2006, Meiofauna Marina, V15, P11; Andrassy I, 2007, POLAR BIOL, V30, P669, DOI 10.1007/s00300-006-0224-4; Andrassy Istvan, 1998, Journal of Nematode Morphology and Systematics, V1, P107; Bamforth SS, 2005, POLAR BIOL, V28, P756, DOI 10.1007/s00300-005-0006-4; BAMFORTH SS, 1980, J PROTOZOOL, V27, P33, DOI 10.1111/j.1550-7408.1980.tb04227.x; Barrett JE, 2006, SOIL BIOL BIOCHEM, V38, P3019, DOI 10.1016/j.soilbio.2006.04.041; Barrett JE, 2004, ECOLOGY, V85, P3105, DOI 10.1890/03-0213; Bergstrom Dana M., 2006, P1; Block W., 1984, P163; Bostrom S., 2010, POLAR BIOL, P1; Burkins MB, 2000, ECOLOGY, V81, P2377, DOI 10.1890/0012-9658(2000)081[2377:OADOSO]2.0.CO;2; Cary SC, 2010, NAT REV MICROBIOL, V8, P129, DOI 10.1038/nrmicro2281; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke K. R., 2001, CHANGES MARINE COMMU; Convey P, 2005, ECOLOGY, V86, P519, DOI 10.1890/04-0684; Convey P, 2000, CRYOLETTERS, V21, P73; Convey P., 2007, ENCY BIODIVERSITY HA, P1; Convey P, 2001, TERRESTRIAL ECOSYSTE; Convey P, 2008, BIOL REV, V83, P103, DOI 10.1111/j.1469-185X.2008.00034.x; Corvino AF, 2011, PRECAMBRIAN RES, V184, P70, DOI 10.1016/j.precamres.2010.11.001; Courtright EM, 2001, ANTARCT SCI, V13, P9, DOI 10.1017/S0954102001000037; Kuppers GC, 2009, REV MEX BIODIVERS, V80, P581; Czechowski P, 2012, INVERTEBR SYST, V26, P526, DOI 10.1071/IS12034; Dartnall Herbert J. G., 2005, Quekett Journal of Microscopy, V40, P137; Dartnall Herbert J. G., 1995, Papers and Proceedings of the Royal Society of Tasmania, V129, P17; Dartnall HJG, 2000, ANARE REPORTS, V141, P1; DASTYCH H, 1984, Acta Zoologica Cracoviensia, V27, P377; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; FORTUNER R, 1990, NEMATOLOGICA, V36, P205, DOI 10.1163/002925990X00176; Freckman D.W., 1990, Antarctic Journal of the United States, V25, P229; FRECKMAN DW, 1993, POLAR BIOL, V13, P483, DOI 10.1007/BF00233139; Freckman DW, 1998, ANTARCT RES SER, V72, P323; FRECKMAN DW, 1989, ECOLOGY, V70, P1665, DOI 10.2307/1938101; Freckman DW, 1997, ECOLOGY, V78, P363, DOI 10.1890/0012-9658(1997)078[0363:LDASNC]2.0.CO;2; Gore DB, 2001, GEOLOGY, V29, P1103, DOI 10.1130/0091-7613(2001)029<1103:BHEAIF>2.0.CO;2; Graca MAS, 2004, INT REV HYDROBIOL, V89, P151, DOI 10.1002/iroh.200310705; Harley SL, 2007, CHEM GEOL, V241, P62, DOI 10.1016/j.chemgeo.2007.02.011; Heatwole H, 1999, ANARE REPORTS, V140, P1; Hogg ID, 2006, SOIL BIOL BIOCHEM, V38, P3035, DOI 10.1016/j.soilbio.2006.04.026; Hohberg K, 2005, BIOL FERT SOILS, V41, P419, DOI 10.1007/s00374-005-0852-9; KENNEDY AD, 1993, ARCTIC ALPINE RES, V25, P308, DOI 10.2307/1551914; Kennedy AD, 1999, ANTARCT SCI, V11, P27, DOI 10.1017/S095410209900005X; Kito K, 1996, POLAR BIOL, V16, P163, DOI 10.1007/BF02329204; KITO K, 1991, NEMATOLOGICA, V37, P252, DOI 10.1163/187529291X00259; Kito K, 2008, ZOOTAXA, P43; Knox MA, 2012, DEEP-SEA RES PT I, V62, P1, DOI 10.1016/j.dsr.2011.12.011; Kraufvelin P, 2011, MAR ECOL PROG SER, V426, P13, DOI 10.3354/meps09038; Liang WJ, 2002, PEDOBIOLOGIA, V46, P63, DOI 10.1078/0031-4056-00114; Marshall DJ, 1996, POLAR BIOL, V16, P287, DOI 10.1007/s003000050055; McGaughran Angela, 2011, Insects, V2, P62, DOI 10.3390/insects2020062; MCINNES SJ, 1994, J NAT HIST, V28, P257, DOI 10.1080/00222939400770131; MILLER JD, 1988, HYDROBIOLOGIA, V165, P197, DOI 10.1007/BF00025588; MILLER WR, 1994, T AM MICROSC SOC, V113, P142, DOI 10.2307/3226642; MILLER WR, 1995, INVERTEBR BIOL, V114, P27, DOI 10.2307/3226950; Miller WR, 1996, ZOOL J LINN SOC-LOND, V116, P175; Pen-Mouratov S, 2008, EUR J SOIL BIOL, V44, P298, DOI 10.1016/j.ejsobi.2008.03.005; Poage MA, 2008, ARCT ANTARCT ALP RES, V40, P119, DOI 10.1657/1523-0430(06-051)[POAGE]2.0.CO;2; Pointing SB, 2009, P NATL ACAD SCI USA, V106, P19964, DOI 10.1073/pnas.0908274106; Porazinska DL, 2002, POLAR BIOL, V25, P569, DOI 10.1007/s00300-002-0386-7; Powers LE, 1998, ARCTIC ALPINE RES, V30, P133, DOI 10.2307/1552128; POWERS LE, 1995, POLAR BIOL, V15, P325, DOI 10.1007/BF00238482; Pugh PJA, 2008, J BIOGEOGR, V35, P2176, DOI 10.1111/j.1365-2699.2008.01953.x; Rayment GE., 2010, SOIL CHEM METHODS AU; Raymond M, 2010, COLD TEMPERATURE ADA; Rounsevell D, 1981, POPULATION NANORCHES; Rounsevell D.E., 1986, P309; Sands Chester J., 2008, BMC Ecology, V8, P7, DOI 10.1186/1472-6785-8-7; SCHWARZ AMJ, 1993, POLAR BIOL, V13, P157; Shishida Y., 1986, Memoirs of National Institute of Polar Research Special Issue, P259; Sinclair BJ, 2001, POLAR BIOL, V24, P394, DOI 10.1007/s003000000223; Sinclair BJ, 2001, PEDOBIOLOGIA, V45, P134, DOI 10.1078/0031-4056-00075; SOHLENIUS B, 1988, NEMATOLOGICA, V34, P208, DOI 10.1163/002825988X00305; Sohlenius B, 2008, POLAR BIOL, V31, P817, DOI 10.1007/s00300-008-0420-5; Sohlenius B, 2005, POLAR BIOL, V28, P439, DOI 10.1007/s00300-004-0708-z; Sohlenius B, 2004, PEDOBIOLOGIA, V48, P395, DOI 10.1016/j.pedobi.2004.06.001; Sohlenius B, 1996, POLAR BIOL, V16, P191, DOI 10.1007/BF02329207; SOHLENIUS B, 1995, POLAR BIOL, V15, P51, DOI 10.1007/BF00236124; Sohlenius B, 2009, NEMATOLOGY, V11, P189, DOI 10.1163/156854109X429538; Stevens MI, 2003, MOL ECOL, V12, P2357, DOI 10.1046/j.1365-294X.2003.01907.x; Stevens MI, 2006, MOL BIOL EVOL, V23, P874, DOI 10.1093/molbev/msj073; Stevens MI, 2002, PEDOBIOLOGIA, V46, P485, DOI 10.1078/0031-4056-00154; Strode C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044578, 10.1371/journal.pone.0039439]; Virginia RA, 1999, BIOSCIENCE, V49, P973, DOI 10.2307/1313731; Wall DH, 1999, APPL SOIL ECOL, V13, P137, DOI 10.1016/S0929-1393(99)00029-3; Wall DH, 2007, PHILOS T R SOC B, V362, P2291, DOI 10.1098/rstb.2006.1950; Wharton DA, 2003, J COMP PHYSIOL B, V173, P621, DOI 10.1007/s00360-003-0378-0; Wharton DA, 2002, CRYOLETTERS, V23, P5; WORLAND MR, 1986, J INSECT PHYSIOL, V32, P579, DOI 10.1016/0022-1910(86)90075-2; YEATES GW, 1979, NEW ZEAL J ZOOL, V6, P641, DOI 10.1080/03014223.1979.10428408; YEATES GW, 1993, J NEMATOL, V25, P315	94	25	27	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87529	10.1371/journal.pone.0087529	http://dx.doi.org/10.1371/journal.pone.0087529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498126	gold, Green Published, Green Accepted			2022-12-25	WOS:000330621900127
J	Caniato, FF; Hamblin, MT; Guimaraes, CT; Zhang, ZW; Schaffert, RE; Kochian, LV; Magalhaes, JV				Caniato, Fernanda F.; Hamblin, Martha T.; Guimaraes, Claudia T.; Zhang, Zhiwu; Schaffert, Robert E.; Kochian, Leon V.; Magalhaes, Jurandir V.			Association Mapping Provides Insights into the Origin and the Fine Structure of the Sorghum Aluminum Tolerance Locus, Alt(SB)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; ACID SOILS; GENETIC DIVERSITY; ACTIVATED CITRATE; ARABIDOPSIS; TRANSPORTER; RESISTANCE; EXPRESSION; MATE	Root damage caused by aluminum (Al) toxicity is a major cause of grain yield reduction on acid soils, which are prevalent in tropical and subtropical regions of the world where food security is most tenuous. In sorghum, Al tolerance is conferred by SbMATE, an Al-activated root citrate efflux transporter that underlies the major Al tolerance locus, Alt(SB), on sorghum chromosome 3. We used association mapping to gain insights into the origin and evolution of Al tolerance in sorghum and to detect functional variants amenable to allele mining applications. Linkage disequilibrium across the Alt(SB) locus decreased much faster than in previous reports in sorghum, and reached basal levels at approximately 1000 bp. Accordingly, intra-locus recombination events were found to be extensive. SNPs and indels highly associated with Al tolerance showed a narrow frequency range, between 0.06 and 0.1, suggesting a rather recent origin of Al tolerance mutations within Alt(SB). A haplotype network analysis suggested a single geographic and racial origin of causative mutations in primordial guinea domesticates in West Africa. Al tolerance assessment in accessions harboring recombinant haplotypes suggests that causative polymorphisms are localized to a similar to 6 kb region including intronic polymorphisms and a transposon (MITE) insertion, whose size variation has been shown to be positively correlated with Al tolerance. The SNP with the strongest association signal, located in the second SbMATE intron, recovers 9 of the 14 highly Al tolerant accessions and 80% of all the Al tolerant and intermediately tolerant accessions in the association panel. Our results also demonstrate the pivotal importance of knowledge on the origin and evolution of Al tolerance mutations in molecular breeding applications. Allele mining strategies based on associated loci are expected to lead to the efficient identification, in diverse sorghum germplasm, of Al tolerant accessions able maintain grain yields under Al toxicity.	[Caniato, Fernanda F.; Guimaraes, Claudia T.; Schaffert, Robert E.; Magalhaes, Jurandir V.] Embrapa Maize & Sorghum, Sete Lagoas, MG, Brazil; [Hamblin, Martha T.; Zhang, Zhiwu] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Kochian, Leon V.] Cornell Univ, USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Cornell University; Cornell University; United States Department of Agriculture (USDA)	Magalhaes, JV (corresponding author), Embrapa Maize & Sorghum, Sete Lagoas, MG, Brazil.	jurandir.magalhaes@embrapa.br	Magalhaes, Jurandir/AAH-4349-2020; Kochian, Leon/ABH-6148-2020; Zhang, zs/GXN-3521-2022; Zhang, Zhiwu/P-6156-2016	Magalhaes, Jurandir/0000-0002-6673-6497; Kochian, Leon/0000-0003-3416-089X; Zhang, Zhiwu/0000-0002-5784-9684	CGIAR Generation Challenge Program [G3007.04]; Embrapa Macroprogram; McKnight Foundation Collaborative Crop Research Program; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); National Council for Scientific and Technological Development (CNPq)	CGIAR Generation Challenge Program(CGIAR); Embrapa Macroprogram(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); McKnight Foundation Collaborative Crop Research Program; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge funding from the CGIAR Generation Challenge Program (project G3007.04), the Embrapa Macroprogram and the McKnight Foundation Collaborative Crop Research Program. The authors are also thankful to the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) for a post-doctoral fellowship granted to FFC and to The National Council for Scientific and Technological Development (CNPq) for support to JVM and CTG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059714; Bouchet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033470; Caniato FF, 2007, THEOR APPL GENET, V114, P863, DOI 10.1007/s00122-006-0485-x; Caniato FF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020830; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Delhaize E, 2007, FEBS LETT, V581, P2255, DOI 10.1016/j.febslet.2007.03.057; Deu M, 2006, GENOME, V49, P168, DOI 10.1139/G05-092; DEWET JMJ, 1978, AM J BOT, V65, P477, DOI 10.2307/2442706; Doumbia MD, 1998, ARID SOIL RES REHAB, V12, P179, DOI 10.1080/15324989809381507; DOUMBIA MD, 1993, ARID SOIL RES REHAB, V7, P335, DOI 10.1080/15324989309381366; Falush D, 2003, GENETICS, V164, P1567; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; Figueiredo LFD, 2008, GENETICS, V179, P997, DOI 10.1534/genetics.108.087312; FOY CD, 1993, J PLANT NUTR, V16, P97, DOI 10.1080/01904169309364517; Fujii M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1726; Furukawa J, 2007, PLANT CELL PHYSIOL, V48, P1081, DOI 10.1093/pcp/pcm091; Garvin D. F., 2003, Handbook of soil acidity, P387; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Hamblin MT, 2011, PLANT GENOME-US, V4, P145, DOI 10.3835/plantgenome2011.03.0008; Hamblin MT, 2005, GENETICS, V171, P1247, DOI 10.1534/genetics.105.041566; HARLAN JR, 1972, CROP SCI, V12, P172, DOI 10.2135/cropsci1972.0011183X001200020005x; HEDRICK PW, 1987, GENETICS, V117, P331; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huang CF, 2012, PLANT J, V69, P857, DOI 10.1111/j.1365-313X.2011.04837.x; HUDSON RR, 1985, GENETICS, V111, P147; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iuchi S, 2007, P NATL ACAD SCI USA, V104, P9900, DOI 10.1073/pnas.0700117104; JIN L, 1994, MOL BIOL EVOL, V11, P120; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Larsson SJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003246; LEWONTIN RC, 1964, GENETICS, V49, P49; Lin ZW, 2012, NAT GENET, V44, P720, DOI 10.1038/ng.2281; Liu JP, 2012, PLANT J, V71, P327, DOI 10.1111/j.1365-313X.2012.04994.x; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LONG JC, 1990, AM J PHYS ANTHROPOL, V81, P113, DOI 10.1002/ajpa.1330810112; Lorenz AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014079; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; Magalhaes JV, 2004, GENETICS, V167, P1905, DOI 10.1534/genetics.103.023580; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Melo JO, 2013, PLANT J, V73, P276, DOI 10.1111/tpj.12029; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Parker D. R., 1995, Chemical equilibrium and reaction models. Proceedings San Antonio, Texas, USA, 23 and 24 October, 1990., P253; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Pritchard JK, 2000, GENETICS, V155, P945; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rose AB, 2008, CURR TOP MICROBIOL, V326, P277; Rose AB, 2000, PLANT PHYSIOL, V122, P535, DOI 10.1104/pp.122.2.535; Ryan PR, 2010, PLANT J, V64, P446, DOI 10.1111/j.1365-313X.2010.04338.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shaff JE, 2010, PLANT SOIL, V330, P207, DOI 10.1007/s11104-009-0193-9; Smouse PE, 1998, MOL ECOL, V7, P399, DOI 10.1046/j.1365-294x.1998.00370.x; SVED J A, 1971, Theoretical Population Biology, V2, P125; Tovkach A, 2013, PLANT PHYSIOL, V161, P880, DOI 10.1104/pp.112.207142; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; Weltzien E., 2006, Enhancing the use of crop genetic diversity to manage abiotic stress in agricultural production systems. Proceedings of a workshop, Budapest, Hungary, 23-27 May, 2005, P31; Wet J. M. J. de, 1972, East African Agricultural and Forestry Journal, V38, P114; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yokosho K, 2011, PLANT J, V68, P1061, DOI 10.1111/j.1365-313X.2011.04757.x; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	71	31	32	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87438	10.1371/journal.pone.0087438	http://dx.doi.org/10.1371/journal.pone.0087438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498106	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100085
J	de Andrade, L; Vissoci, JRN; Rodrigues, CG; Finato, K; Carvalho, E; Pietrobon, R; de Souza, EM; Nihei, OK; Lynch, C; Carvalho, MDD				de Andrade, Luciano; Nickenig Vissoci, Joao Ricardo; Rodrigues, Clarissa Garcia; Finato, Karen; Carvalho, Elias; Pietrobon, Ricardo; de Souza, Eniuce Menezes; Nihei, Oscar Kenji; Lynch, Catherine; de Barros Carvalho, Maria Dalva			Brazilian Road Traffic Fatalities: A Spatial and Environmental Analysis	PLOS ONE			English	Article							ACCIDENTS; HOTSPOTS; CRASHES; SAFETY; TRENDS; RISK	Background: Road traffic injuries (RTI) are a major public health epidemic killing thousands of people daily. Low and middle-income countries, such as Brazil, have the highest annual rates of road traffic fatalities. In order to improve road safety, this study mapped road traffic fatalities on a Brazilian highway to determine the main environmental factors affecting road traffic fatalities. Methods and Findings: Four techniques were utilized to identify and analyze RTI hotspots. We used spatial analysis by points by applying kernel density estimator, and wavelet analysis to identify the main hot regions. Additionally, built environment analysis, and principal component analysis were conducted to verify patterns contributing to crash occurrence in the hotspots. Between 2007 and 2009, 379 crashes were notified, with 466 fatalities on BR277. Higher incidence of crashes occurred on sections of highway with double lanes (ratio 2: 1). The hotspot analysis demonstrated that both the eastern and western regions had higher incidences of crashes when compared to the central region. Through the built environment analysis, we have identified five different patterns, demonstrating that specific environmental characteristics are associated with different types of fatal crashes. Patterns 2 and 4 are constituted mainly by predominantly urban characteristics and have frequent fatal pedestrian crashes. Patterns 1, 3 and 5 display mainly rural characteristics and have higher prevalence of vehicular collisions. In the built environment analysis, the variables length of road in urban area, limited lighting, double lanes roadways, and less auxiliary lanes were associated with a higher incidence of fatal crashes. Conclusions: By combining different techniques of analyses, we have identified numerous hotspots and environmental characteristics, which governmental or regulatory agencies could make use to plan strategies to reduce RTI and support life-saving policies.	[de Andrade, Luciano; Finato, Karen; Nihei, Oscar Kenji] State Univ West Parana, Dept Nursing, Foz Do Iguacu, Parana, Brazil; [de Andrade, Luciano; Pietrobon, Ricardo; Lynch, Catherine] Duke Univ Hlth Syst, Dept Surg, Durham, NC 27710 USA; [de Andrade, Luciano; Nickenig Vissoci, Joao Ricardo; Rodrigues, Clarissa Garcia; Carvalho, Elias; Lynch, Catherine] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Nickenig Vissoci, Joao Ricardo] Fac Inga, Dept Med, Maringa, Parana, Brazil; [Rodrigues, Clarissa Garcia] RS Fundacao Univ Cardiol, Inst Cardiol, Porto Alegre, RS, Brazil; [Carvalho, Elias] PUC PR, Grad Program Informat PPGIA, Curitiba, Parana, Brazil; [Carvalho, Elias; de Souza, Eniuce Menezes; de Barros Carvalho, Maria Dalva] Univ Estadual Maringa, Dept Hlth Sci, Maringa, Parana, Brazil	Universidade Estadual do Oeste do Parana; Duke University; Duke University; Centro Universitario Inga (UNINGA); Fundacao Universitaria de Cardiologia; Universidade Estadual de Maringa	Lynch, C (corresponding author), Duke Univ Hlth Syst, Dept Surg, Durham, NC 27710 USA.	catherine.lynch@duke.edu	Carvalho, Maria Dalva/AAK-8411-2021; Souza, Eniuce/Q-1421-2019; Carvalho, Elias/J-7086-2012	Carvalho, Maria Dalva/0000-0002-1377-3331; Souza, Eniuce/0000-0003-0265-7586; Staton, Catherine/0000-0002-6468-2894; Carvalho, Elias/0000-0002-2638-7202	Science Without Borders Program, Brazilian Government	Science Without Borders Program, Brazilian Government	LA and JRNV were funded by Science Without Borders Program, Brazilian Government (http://www.cienciasemfronteiras.gov.br/web/csf-eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hemoud AM, 2010, J SAFETY RES, V41, P307, DOI 10.1016/j.jsr.2010.06.001; American Traffic Safety Services Association, 2008, LOW COST LOC ROAD SA; Anderson T, 2007, J MAPS, P55, DOI 10.4113/jom.2007.72; Anderson TK, 2009, ACCIDENT ANAL PREV, V41, P359, DOI 10.1016/j.aap.2008.12.014; [Anonymous], 1995, LECT NOTES STAT; Bacchieri G, 2011, REV SAUDE PUBL, V45, P949, DOI 10.1590/S0034-89102011005000069; Bailey T, 1995, INTERACTIVE SPATIAL; Bates D, 2013, R PROJECT STAT COMPU; Brazil Ministry of Health, 2008, HLTH INF NOT; Brugmann Jeb, 2009, WELCOME URBAN REVOLU; Cafiso S, 2010, ACCIDENT ANAL PREV, V42, P1072, DOI 10.1016/j.aap.2009.12.015; Camara G, 2002, ANALISE ESPACIAL EVE; Cho GY, 2009, ACCIDENT ANAL PREV, V41, P692, DOI 10.1016/j.aap.2009.03.008; Clifton KJ, 2009, TRANSPORT RES D-TR E, V14, P425, DOI 10.1016/j.trd.2009.01.001; Coll B, 2013, ACCIDENT ANAL PREV, V59, P604, DOI 10.1016/j.aap.2013.07.012; Constant A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000228; Almeida LVC, 2009, CAD SAUDE PUBLICA, V25, P303, DOI 10.1590/S0102-311X2009000200008; Neto OLD, 2012, CIENC SAUDE COLETIVA, V17, P2223; Erdogan S, 2008, ACCIDENT ANAL PREV, V40, P174, DOI 10.1016/j.aap.2007.05.004; Ewing R, 2009, J PLAN LIT, V23, P347, DOI 10.1177/0885412209335553; Koehlmoos TP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001464; Kwon OH, 2013, ACCIDENT ANAL PREV, V51, P141, DOI 10.1016/j.aap.2012.10.019; Lockhart PA, 2013, TRAFFIC INJ PREV, V14, P509, DOI 10.1080/15389588.2012.732718; Lopez R, 2008, J HEALTH POLIT POLIC, V33, P617, DOI 10.1215/03616878-2008-010; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luoma J, 2013, ACCIDENT ANAL PREV, V50, P1207, DOI 10.1016/j.aap.2012.09.023; Montella A, 2010, ACCIDENT ANAL PREV, V42, P571, DOI 10.1016/j.aap.2009.09.025; Noland RB, 2004, ACCIDENT ANAL PREV, V36, P525, DOI 10.1016/S0001-4575(03)00058-7; Paun S, 2011, CHIRURGIA-BUCHAREST, V106, P439; Redelmeier DA, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001463; Rzeznikiewiz D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1125; Sutton T, 2011, DOCUMENTATION QGIS 1; The PLoS Medicine Editors, 2010, PLOS MED, V7; Wang Y., 2008, COST EFFECTIVE SAFET; World Health Organization, 2013, GLOB STAT REP ROAD S; World Health Organization, 2004, WORLD REPORT ROAD TR; Xie Z, 2008, COMPUT ENV URBAN SYS, V32, P5396; Yan XD, 2008, TRAFFIC INJ PREV, V9, P173, DOI 10.1080/15389580701869356; Zegeer CV, 2012, ACCIDENT ANAL PREV, V44, P3, DOI 10.1016/j.aap.2010.12.007	39	14	16	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87244	10.1371/journal.pone.0087244	http://dx.doi.org/10.1371/journal.pone.0087244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498051	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100065
J	Mars, LT; Mas, M; Beaudoin, L; Bauer, J; Leite-de-Moraes, M; Lehuen, A; Bureau, JF; Liblau, RS				Mars, Lennart T.; Mas, Magali; Beaudoin, Lucie; Bauer, Jan; Leite-de-Moraes, Maria; Lehuen, Agnes; Bureau, Jean-Francois; Liblau, Roland S.			Invariant NKT Cells Regulate the CD8 T Cell Response during Theiler's Virus Infection	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NONOBESE DIABETIC MICE; IN-VIVO; PERSISTENT INFECTION; ANTIGEN PRESENTATION; MICROGLIAL CELLS; CHOROID-PLEXUS; PROTECTS MICE; CUTTING EDGE	Invariant NKT cells are innate lymphocytes with a broad tissue distribution. Here we demonstrate that iNKT cells reside in the central nervous system (CNS) in the absence of inflammation. Their presence in the CNS dramatically augments following inoculation of C57Bl/6 mice with the neurotropic Theiler's murine encephalomyelitis virus (TMEV). At the peak of inflammation the cellular infiltrate comprises 45 000 iNKT cells for 1 250 CD8 T cells specific for the immunodominant TMEV epitope. To study the interaction between these two T cell subsets, we infected both iNKT cell deficient J alpha 18(-/-) mice and iNKT cell enriched V alpha 14 transgenic mice with TMEV. The CD8 T cell response readily cleared TMEV infection in the iNKT cell deficient mice. However, in the iNKT cell enriched mice TMEV infection persisted and was associated with significant mortality. This was caused by the inhibition of the CD8 T cell response in the cervical lymph nodes and spleen after T cell priming. Taken together we demonstrate that iNKT cells reside in the CNS in the absence of inflammation and that their enrichment is associated with the inhibition of the anti-viral CD8 T cell response and an augmented mortality during acute encephalomyelitis.	[Mars, Lennart T.; Liblau, Roland S.] Fac Med Toulouse, INSERM, Unite Mixte Rech UMR 1043, F-31073 Toulouse, France; [Mars, Lennart T.; Liblau, Roland S.] CNRS, UMR 5282, Toulouse, France; [Mars, Lennart T.; Liblau, Roland S.] Univ Toulouse, CPTP, UPS, Toulouse, France; [Mas, Magali; Beaudoin, Lucie; Lehuen, Agnes] Univ Paris Decartes, Inst Cochin, CNRS UMR 8104, INSERM UMR 1016, Paris, France; [Bauer, Jan] Med Univ Vienna, Dept Neuroimmunol, Ctr Brain Res, Vienna, Austria; [Leite-de-Moraes, Maria] Univ Paris 05, CNRS UMR 8147, Sorbonne Paris Cite, Inst Necker Enfants Malad, Paris, France; [Bureau, Jean-Francois] Inst Pasteur, Unite Genet Fonct Malad Infect, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Medical University of Vienna; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Mars, LT (corresponding author), Fac Med Toulouse, INSERM, Unite Mixte Rech UMR 1043, U317, F-31073 Toulouse, France.	Lennart.Mars@inserm.fr	Liblau, Roland/J-3530-2014; Mas, Magali/O-8837-2017; Mars, Lennart T/K-7593-2014; de Moraes, Maria Leite/AAV-9159-2020; Bauer, Jan/F-5429-2011	Mars, Lennart T/0000-0001-7997-1974; de Moraes, Maria Leite/0000-0002-2891-2269; Bauer, Jan/0000-0001-5802-8047; LIBLAU, Roland/0000-0001-5477-5475; Lehuen, Agnes/0000-0002-0450-3321; Bureau, Jean-Francois/0000-0003-1945-1883	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); French MS society (ARSEP); Midi-Pyrenees Region; Agence National de la Recherche [ANR-06-MIME]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French MS society (ARSEP); Midi-Pyrenees Region(Region Occitanie); Agence National de la Recherche(French National Research Agency (ANR))	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), the French MS society (ARSEP), the Midi-Pyrenees Region, and the Agence National de la Recherche (ANR-06-MIME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay-Cayla A, 2000, J VIROL, V74, P5470, DOI 10.1128/JVI.74.12.5470-5476.2000; Azoulay-Cayla A, 2001, J GEN VIROL, V82, P1043, DOI 10.1099/0022-1317-82-5-1043; Barcia C, 2008, J IMMUNOL, V180, P1344, DOI 10.4049/jimmunol.180.3.1344; Bauer J, 2007, ANN NEUROL, V62, P67, DOI 10.1002/ana.21148; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; BILLINGHAM RE, 1953, PROC R SOC SER B-BIO, V141, P392, DOI 10.1098/rspb.1953.0049; Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242; Brahic M, 2002, VIROLOGY, V301, P1, DOI 10.1006/viro.2002.1607; BRAHIC M, 1984, P NATL ACAD SCI-BIOL, V81, P5445, DOI 10.1073/pnas.81.17.5445; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chang YJ, 2011, J CLIN INVEST, V121, P57, DOI 10.1172/JCI44845; Chevalier G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002393; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245; FIETTE L, 1993, J VIROL, V67, P589, DOI 10.1128/JVI.67.1.589-592.1993; FONTANA A, 1984, NATURE, V307, P273, DOI 10.1038/307273a0; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Furlan R, 2003, EUR J IMMUNOL, V33, P1830, DOI 10.1002/eji.200323885; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Hoftberger R, 2004, BRAIN PATHOL, V14, P43; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Kivisakk P, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-14; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Levillayer F, 2007, GENETICS, V176, P1835, DOI 10.1534/genetics.107.073536; Liblau RS, 2013, TRENDS NEUROSCI, V36, P315, DOI 10.1016/j.tins.2013.01.008; LIPTON HL, 1975, INFECT IMMUN, V11, P1147, DOI 10.1128/IAI.11.5.1147-1155.1975; Mars LT, 2008, J IMMUNOL, V181, P2321, DOI 10.4049/jimmunol.181.4.2321; Mars LT, 2007, J IMMUNOL, V179, P5090, DOI 10.4049/jimmunol.179.8.5090; Mars LT, 2009, P NATL ACAD SCI USA, V106, P6238, DOI 10.1073/pnas.0809317106; Mars LT, 2004, TRENDS IMMUNOL, V25, P471, DOI 10.1016/j.it.2004.07.001; Mars LT, 2002, J IMMUNOL, V168, P6007, DOI 10.4049/jimmunol.168.12.6007; Martin-Blondel G, 2011, BRAIN, V134, P928, DOI 10.1093/brain/awq365; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; MCALLISTER A, 1989, MICROB PATHOGENESIS, V7, P381, DOI 10.1016/0882-4010(89)90041-7; McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Michiels T, 1997, J VIROL, V71, P9549, DOI 10.1128/JVI.71.12.9549-9556.1997; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; RODRIGUEZ M, 1993, J IMMUNOL, V151, P266; Saxena A, 2008, J IMMUNOL, V181, P1617, DOI 10.4049/jimmunol.181.3.1617; Shirai Y., 1921, JAP MED WORLD, V1, P14, DOI DOI 10.1038/NM.4041; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Speak AO, 2007, P NATL ACAD SCI USA, V104, P5971, DOI 10.1073/pnas.0607285104; Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Wingender G, 2011, J EXP MED, V208, P1151, DOI 10.1084/jem.20102229; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Zeissig S, 2012, NAT MED, V18, P1060, DOI 10.1038/nm.2811; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	66	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87717	10.1371/journal.pone.0087717	http://dx.doi.org/10.1371/journal.pone.0087717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498175	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100108
J	Whelly, S; Serobian, G; Borchardt, C; Powell, J; Johnson, S; Hakansson, K; Lindstrom, V; Abrahamson, M; Grubb, A; Cornwall, GA				Whelly, Sandra; Serobian, Gaiane; Borchardt, Clinton; Powell, Jonathan; Johnson, Seethal; Hakansson, Katarina; Lindstrom, Veronica; Abrahamson, Magnus; Grubb, Anders; Cornwall, Gail A.			Fertility Defects in Mice Expressing the L68Q Variant of Human Cystatin C A ROLE FOR AMYLOID IN MALE INFERTILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Animal models; Epididymis; Neurodegenerative Diseases; Protein Aggregation; Reproduction; Spermatozoa; Cystatin C; Hereditary Cystatin c Amyloid Angiopathy; Male Fertility	HEREDITARY CEREBRAL-HEMORRHAGE; CATHEPSIN-B; IN-VITRO; CRYSTAL-STRUCTURE; PROTEIN; GENE; ANGIOPATHY; FIBRILS; BRAIN; INHIBITORS	Background: The L68Q variant of cystatin C is highly amyloidogenic forming aggregates in individuals with HCCAA. Results: Spermatozoa from mice expressing human L68Q cystatin C exhibit fertility defects and increased levels of amyloid. Conclusion: L68Q epididymal fluid containing cystatin C amyloid is harmful for sperm function. Significance: Amyloid in the reproductive tract may contribute to male factor infertility. Hereditary cystatin C amyloid angiopathy is an autosomal dominant disorder in which a variant form of cystatin C (L68Q) readily forms amyloid deposits in cerebral arteries in affected individuals resulting in early death. L68Q protein deposits in human cystatin C amyloid angiopathy patients have also been found in tissues outside of the brain including the testis, suggesting possible effects on fertility. Heterozygous transgenic mice (L68Q) that express the human L68Q variant of cystatin C under the control of the mouse cystatin C promoter were unable to generate offspring, suggesting the presence of L68Q cystatin C amyloid affected sperm function. In vitro studies showed that epididymal spermatozoa from L68Q mice were unable to fertilize oocytes and exhibited poor sperm motility. Furthermore, spermatozoa from L68Q mice exhibited reduced cell viability compared with wild type (WT) spermatozoa and often were detected in large agglutinated clumps. Examination of the epididymal fluid and spermatozoa from L68Q mice showed increased levels and distinct forms of cystatin C amyloid that were not present in WT mice. The addition of epididymal fluid from L68Q mice to WT spermatozoa resulted in a recapitulation of the L68Q phenotype in that WT spermatozoa showed reduced cell viability and motility compared with WT spermatozoa incubated in epididymal fluid from WT mice. L68Q epididymal fluid that was depleted of cystatin C amyloids, however, did not impair the motility of WT spermatozoa. Taken together these studies suggest that amyloids in the epididymal fluid can be cytotoxic to the maturing spermatozoa resulting in male infertility.	[Whelly, Sandra; Serobian, Gaiane; Borchardt, Clinton; Powell, Jonathan; Johnson, Seethal; Cornwall, Gail A.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Hakansson, Katarina; Lindstrom, Veronica; Abrahamson, Magnus; Grubb, Anders] Lund Univ, Dept Clin Chem & Pharmacol, S-22185 Lund, Sweden	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Lund University	Cornwall, GA (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, 3601 4th St, Lubbock, TX 79430 USA.	gail.cornwall@ttuhsc.edu	Abrahamson, Magnus/CAG-9507-2022	Grubb, Anders/0000-0002-0125-3662	National Institutes of Health [RO1HD056182]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HD056182 (to G. A. C.).	ABRAHAMSON M, 1989, HUM GENET, V82, P223, DOI 10.1007/BF00291159; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Brage M, 2005, CALCIFIED TISSUE INT, V76, P439, DOI 10.1007/s00223-004-0043-y; Calero M, 2001, J NEUROCHEM, V77, P628, DOI 10.1046/j.1471-4159.2001.00256.x; CALKINS CC, 1995, BIOL CHEM H-S, V376, P71; Chau KM, 2011, BIOL REPROD, V84, P140, DOI 10.1095/biolreprod.110.084855; Cornwall GA, 1999, BIOCHEM J, V340, P85, DOI 10.1042/0264-6021:3400085; Cornwall GA, 2003, MOL CELL ENDOCRINOL, V200, P1, DOI 10.1016/S0303-7207(02)00408-2; Crawford FC, 2000, NEUROLOGY, V55, P763, DOI 10.1212/WNL.55.6.763; ESNARD A, 1992, FEBS LETT, V300, P131, DOI 10.1016/0014-5793(92)80180-O; Finckh U, 2000, ARCH NEUROL-CHICAGO, V57, P1579, DOI 10.1001/archneur.57.11.1579; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Gerhartz B, 2002, BIOL CHEM, V383, P301, DOI 10.1515/BC.2002.032; GHISO J, 1986, P NATL ACAD SCI USA, V83, P2974, DOI 10.1073/pnas.83.9.2974; Grubb AO, 2001, ADV CLIN CHEM, V35, P63, DOI 10.1016/S0065-2423(01)35015-1; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; Janowski R, 2005, PROTEINS, V61, P570, DOI 10.1002/prot.20633; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jaskolski M, 2001, ACTA BIOCHIM POL, V48, P807; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; JOHNSON WG, 1995, AM J MED GENET, V59, P149, DOI 10.1002/ajmg.1320590206; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kolodziejczyk R, 2010, FEBS J, V277, P1726, DOI 10.1111/j.1742-4658.2010.07596.x; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; LOFBERG H, 1987, STROKE, V18, P431, DOI 10.1161/01.STR.18.2.431; Loksztejn A, 2009, BIOCHEMISTRY-US, V48, P4846, DOI 10.1021/bi900394b; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Nilsson M, 2004, J BIOL CHEM, V279, P24236, DOI 10.1074/jbc.M402621200; Olafsson I, 1996, BRAIN PATHOL, V6, P121, DOI 10.1111/j.1750-3639.1996.tb00795.x; OLAFSSON I, 1988, SCAND J CLIN LAB INV, V48, P573, DOI 10.3109/00365518809085775; Orlikowska M, 2011, J STRUCT BIOL, V173, P406, DOI 10.1016/j.jsb.2010.11.009; Palsdottir A, 2006, BRAIN PATHOL, V16, P55; Palsdottir A, 1989, Prog Clin Biol Res, V317, P241; Pawlik M, 2004, J MOL NEUROSCI, V22, P13, DOI 10.1385/JMN:22:1-2:13; Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Scalvini T, 2007, J UROLOGY, V178, P344, DOI 10.1016/j.juro.2007.03.005; SCHNITTGER S, 1993, GENOMICS, V16, P50, DOI 10.1006/geno.1993.1139; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; Siricoon S, 2012, MOL BIOCHEM PARASIT, V186, P126, DOI 10.1016/j.molbiopara.2012.10.003; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; TURNER TT, 1982, AM J PHYSIOL, V242, pR199, DOI 10.1152/ajpregu.1982.242.3.R199; Wahlbom M., 2007, THESIS LUND U LUND; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; WANG PH, 1991, J BIOL CHEM, V266, P12633; Wei LH, 1998, J BIOL CHEM, V273, P11806, DOI 10.1074/jbc.273.19.11806; Whelly S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036394	54	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7718	7729		10.1074/jbc.M113.515759	http://dx.doi.org/10.1074/jbc.M113.515759			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24500719	hybrid, Green Published			2022-12-25	WOS:000332761500039
J	Axt, K; French, SL; Beyer, AL; Tollervey, D				Axt, Konstantin; French, Sarah L.; Beyer, Ann L.; Tollervey, David			Kinetic Analysis Demonstrates a Requirement for the Rat1 Exonuclease in Cotranscriptional Pre-rRNA Cleavage	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; 5' END; YEAST; POLYMERASE; DEGRADATION; TRANSCRIPTION; TERMINATION; BIOGENESIS; PRECURSORS	During yeast ribosome synthesis, three early cleavages generate the 20S precursor to the 18S rRNA component of the 40S subunits. These cleavages can occur either on the nascent transcript (nascent transcript cleavage; NTC) or on the 35S pre-rRNA that has been fully transcribed and released from the rDNA (released transcript cleavage; RTC). These alternative pathways cannot be assessed by conventional RNA analyses, since the pre-rRNA products of NTC and RTC are identical. They can, however, be distinguished kinetically by metabolic labeling and quantified by modeling of the kinetic data. The aim of this work was to use these approaches as a practical tool to identify factors that mediate the decision between utilization of NTC and RTC. The maturation pathways of the 40S and 60S ribosomal subunits are largely distinct. However, depletion of some early-acting 60S synthesis factors, including the 5'-exonuclease Rat1, leads to accumulation of the 35S pre-rRNA and delayed 20S pre-rRNA synthesis. We speculated that this might reflect the loss of NTC. Rat1 acts catalytically in 5.8S and 25S rRNA processing but binds to the pre-rRNA prior to these activities. Kinetic data for strains depleted of Rat1 match well with the modeled effects of strongly reduced NTC. This was confirmed by EM visualization of "Miller" chromatin spreads of nascent pre-rRNA transcripts. Modeling further indicates that NTC takes place in a limited time window, when the polymerase has transcribed similar to 1.5Kb past the A2 cleavage site. We speculate that assembly of early-acting 60S synthesis factors is monitored as a quality control system prior to NTC.	[Axt, Konstantin; Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [French, Sarah L.; Beyer, Ann L.] Univ Virginia Hlth Syst, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA	University of Edinburgh; University of Virginia	Tollervey, D (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	d.tollervey@ed.ac.uk	Tollervey, David/AAR-6662-2020	Tollervey, David/0000-0003-2894-2772	European Union FP7 Network UniCellSys; Wellcome Trust [077248, 092076]; National Institute of General Medical Sciences; National Institutes of Health [RO1-GM63952]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063952] Funding Source: NIH RePORTER	European Union FP7 Network UniCellSys; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the European Union FP7 Network UniCellSys (KA), the Wellcome Trust (DT) [077248], the National Institute of General Medical Sciences and National Institutes of Health (SLF and ALB) [RO1-GM63952]. Work in the Wellcome Trust Centre for Cell Biology is supported by Wellcome Trust core funding [092076]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; de la Cruz J, 1998, RNA, V4, P1268, DOI 10.1017/S1355838298981158; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; El Hage A, 2008, GENE DEV, V22, P1069, DOI 10.1101/gad.463708; Fang F, 2005, RNA, V11, P1571, DOI 10.1261/rna.2900205; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Gudipati RK, 2012, MOL CELL UNPUB; HENRY Y, 1994, EMBO J, V13, P2452, DOI 10.1002/j.1460-2075.1994.tb06530.x; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Kressler D, 1998, MOL CELL BIOL, V18, P1855, DOI 10.1128/MCB.18.4.1855; Lygerou Z, 1996, SCIENCE, V272, P268, DOI 10.1126/science.272.5259.268; Oeffinger M, 2009, MOL CELL, V36, P768, DOI 10.1016/j.molcel.2009.11.011; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; RUBIN GM, 1974, EUR J BIOCHEM, V41, P197, DOI 10.1111/j.1432-1033.1974.tb03260.x; Sahasranaman A, 2011, EMBO J, V30, P4020, DOI 10.1038/emboj.2011.338; SCHMITT ME, 1992, GENE DEV, V6, P1975, DOI 10.1101/gad.6.10.1975; Schneider S, 2012, MOL CELL; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Xue Y, 2000, MOL CELL BIOL, V20, P4006, DOI 10.1128/MCB.20.11.4006-4015.2000; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001	27	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e85703	10.1371/journal.pone.0085703	http://dx.doi.org/10.1371/journal.pone.0085703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498264	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900010
J	Park, C; Ahn, J; Kim, H; Park, S				Park, Chihyun; Ahn, Jaegyoon; Kim, Hyunjin; Park, Sanghyun			Integrative Gene Network Construction to Analyze Cancer Recurrence Using Semi-Supervised Learning	PLOS ONE			English	Article							EXPRESSION; METASTASIS; PREDICTION; CYTOSCAPE	Background: The prognosis of cancer recurrence is an important research area in bioinformatics and is challenging due to the small sample sizes compared to the vast number of genes. There have been several attempts to predict cancer recurrence. Most studies employed a supervised approach, which uses only a few labeled samples. Semi-supervised learning can be a great alternative to solve this problem. There have been few attempts based on manifold assumptions to reveal the detailed roles of identified cancer genes in recurrence. Results: In order to predict cancer recurrence, we proposed a novel semi-supervised learning algorithm based on a graph regularization approach. We transformed the gene expression data into a graph structure for semi-supervised learning and integrated protein interaction data with the gene expression data to select functionally-related gene pairs. Then, we predicted the recurrence of cancer by applying a regularization approach to the constructed graph containing both labeled and unlabeled nodes. Conclusions: The average improvement rate of accuracy for three different cancer datasets was 24.9% compared to existing supervised and semi-supervised methods. We performed functional enrichment on the gene networks used for learning. We identified that those gene networks are significantly associated with cancer-recurrence-related biological functions. Our algorithm was developed with standard C++ and is available in Linux and MS Windows formats in the STL library. The executable program is freely available at: http://embio.yonsei.ac.kr/Park/ssl.php.	[Park, Chihyun; Ahn, Jaegyoon; Kim, Hyunjin; Park, Sanghyun] Yonsei Univ, Dept Comp Sci, Seoul 120749, South Korea	Yonsei University	Park, S (corresponding author), Yonsei Univ, Dept Comp Sci, Seoul 120749, South Korea.	sanghyun@cs.yonsei.ac.kr			National Research Foundation of Korea(NRF); Korea government(MSIP) [NRF-2012R1A2A1A01010775]	National Research Foundation of Korea(NRF)(National Research Foundation of Korea); Korea government(MSIP)	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIP) NRF-2012R1A2A1A01010775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, BIOINFORMATICS, V27, P1846, DOI 10.1093/bioinformatics/btr283; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bonato V, 2011, BIOINFORMATICS, V27, P359, DOI 10.1093/bioinformatics/btq660; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chapelle O, 2008, J MACH LEARN RES, V9, P203; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Hu JH, 2007, BIOMETRICS, V63, P41, DOI 10.1111/j.1541-0420.2006.00675.x; John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi M, 2011, BIOINFORMATICS, V27, P3017, DOI 10.1093/bioinformatics/btr502; Shu XO, 2005, CANCER EPIDEM BIOMAR, V14, P91; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Nguyen TP, 2012, ARTIF INTELL MED, V54, P63, DOI 10.1016/j.artmed.2011.09.003; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; You ZH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-343; Yu LB, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1701; Zhu X., 2003, P 20 INT C MACH LEAR, V3, P912, DOI DOI 10.1109/18.850663	23	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86309	10.1371/journal.pone.0086309	http://dx.doi.org/10.1371/journal.pone.0086309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497942	Green Submitted, gold, Green Published			2022-12-25	WOS:000330621900021
J	Sasportas, LS; Gambhir, SS				Sasportas, Laura Sarah; Gambhir, Sanjiv Sam			Imaging Circulating Tumor Cells in Freely Moving Awake Small Animals Using a Miniaturized Intravital Microscope	PLOS ONE			English	Article							IN-VIVO; BREAST-CANCER; METASTASIS; HALLMARKS; MARKERS	Metastasis, the cause for 90% of cancer mortality, is a complex and poorly understood process involving the invasion of circulating tumor cells (CTCs) into blood vessels. These cells have potential prognostic value as biomarkers for early metastatic risk. But their rarity and the lack of specificity and sensitivity in measuring them render their interrogation by current techniques very challenging. How and when these cells are circulating in the blood, on their way to potentially give rise to metastasis, is a question that remains largely unanswered. In order to provide an insight into this "black box" using non-invasive imaging, we developed a novel miniature intravital microscopy (mIVM) strategy capable of real-time long-term monitoring of CTCs in awake small animals. We established an experimental 4T1-GL mouse model of metastatic breast cancer, in which tumor cells express both fluorescent and bioluminescent reporter genes to enable both single cell and whole body tumor imaging. Using mIVM, we monitored blood vessels of different diameters in awake mice in an experimental model of metastasis. Using an in-house software algorithm we developed, we demonstrated in vivo CTC enumeration and computation of CTC trajectory and speed. These data represent the first reported use we know of for a miniature mountable intravital microscopy setup for in vivo imaging of CTCs in awake animals.	[Sasportas, Laura Sarah; Gambhir, Sanjiv Sam] Stanford Univ, Dept Radiol, Mol Imaging Program, Stanford, CA 94305 USA; [Sasportas, Laura Sarah; Gambhir, Sanjiv Sam] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University	Gambhir, SS (corresponding author), Stanford Univ, Dept Radiol, Mol Imaging Program, Stanford, CA 94305 USA.	sgambhir@stanford.edu			Fulbright Science and Technology Fellowship; Stanford Weiland Fellowship; Society for Nuclear Medicine; Howard Hughes Medical Institute; National Cancer Institute (NCI) Center for Cancer Nanotechnology Excellence [U54 U54CA151459]; NCI ICMIC [P50CA114747]; Canary Foundation; NATIONAL CANCER INSTITUTE [P50CA114747, U54CA151459] Funding Source: NIH RePORTER	Fulbright Science and Technology Fellowship; Stanford Weiland Fellowship; Society for Nuclear Medicine; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute (NCI) Center for Cancer Nanotechnology Excellence; NCI ICMIC; Canary Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Fulbright Science and Technology Fellowship, a Stanford Weiland Fellowship, a Student Fellowship from the Society for Nuclear Medicine, an International Student Fellowship from the Howard Hughes Medical Institute, a National Cancer Institute (NCI) Center for Cancer Nanotechnology Excellence grant U54 U54CA151459 (SSG), NCI ICMIC P50CA114747 (SSG), and the Canary Foundation (SSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2012, CLIN CHEM; Balic M, 2005, CYTOM PART B-CLIN CY, V68B, P25, DOI 10.1002/cyto.b.20065; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Brown E, 2010, COLD SPRING HARB PRO, P5452; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Eifler RL, 2010, CYTOMETRY B; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Galanzha EI, 2009, NAT NANOTECHNOL, V4, P855, DOI [10.1038/nnano.2009.333, 10.1038/NNANO.2009.333]; Georgakoudi I, 2004, CANCER RES, V64, P5044, DOI 10.1158/0008-5472.CAN-04-1058; Gervasoni A, 2011, ONCOL REP, V25, P1669, DOI 10.3892/or.2011.1231; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Gradilone A, 2011, J CELL MOL MED, V15, P1066, DOI 10.1111/j.1582-4934.2011.01285.x; Gray JW, 2003, CANCER CELL, V4, P4, DOI 10.1016/S1535-6108(03)00167-3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashi N., 2011, INT J CLIN ONCOL; He W, 2007, P NATL ACAD SCI USA, V104, P11760, DOI 10.1073/pnas.0703875104; Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kraeft Stine-Kathrein, 2003, Methods Mol Med, V75, P423; Krebs MG, 2011, J THORACIC ONCOLOGY; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Paterlini-Brechot P, 2011, FUTURE ONCOL, V7, P849, DOI [10.2217/FON.11.32, 10.2217/fon.11.32]; Pierga JY, 2011, ANN ONCOL; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Van der Auwera I, 2010, BRIT J CANCER, V102, P276, DOI 10.1038/sj.bjc.6605472; Vaska P, 2004, IEEE T NUCL SCI, V51, P2718, DOI 10.1109/TNS.2004.835740; Weigert R, 2010, HISTOCHEM CELL BIOL, V133, P481, DOI 10.1007/s00418-010-0692-z; Wittekind C, 2005, ONCOLOGY-BASEL, V69, P14, DOI 10.1159/000086626; Witz IP, 2008, CANCER METAST REV, V27, P19, DOI 10.1007/s10555-007-9101-z; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yew NS, 2001, MOL THER, V4, P75, DOI 10.1006/mthe.2001.0415	38	28	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86759	10.1371/journal.pone.0086759	http://dx.doi.org/10.1371/journal.pone.0086759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497977	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900038
J	Warden, CH; Slupsky, C; Griffey, SM; Bettaieb, A; Min, E; Le, A; Fisler, JS; Hansen, S; Haj, F; Stern, JS				Warden, Craig H.; Slupsky, Carolyn; Griffey, Stephen M.; Bettaieb, Ahmed; Min, Esther; Anh Le; Fisler, Janis S.; Hansen, Susan; Haj, Fawaz; Stern, Judith S.			Brown Norway Chromosome 1 Congenic Reduces Symptoms of Renal Disease in Fatty Zucker Rats	PLOS ONE			English	Article							580 FLUORESCENCE ASSAY; INJURY; GENE; MICE; HYPERPHAGIA; EXCRETION; ALBUMIN	We previously reported that a congenic rat with Brown Norway (BN) alleles on chromosome 1 reduces renal disease of 15-week old fatty Zucker rats (ZUC). Development of renal disease in fatty BN congenic and fatty ZUC rats from 9 through 28 weeks is now examined. Analysis of urine metabolites by 1 H nuclear magnetic resonance (NMR) spectroscopy revealed a significantly increased urinary loss of glucose, myo-inositol, urea, creatine, and valine in ZUC. Food intake was lower in the BN congenic rats at weeks 9-24, but they weighed significantly more at 28 weeks compared with the ZUC group. Fasting glucose was significantly higher in ZUC than congenic and adiponectin levels were significantly lower in ZUC, but there was no significant genotype effect on Insulin levels. Glucose tolerance tests exhibited no significant differences between ZUC and congenic when values were normalized to basal glucose levels. Quantitative PCR on livers revealed evidence for higher gluconeogenesis in congenics than ZUC at 9 weeks. Plasma urea nitrogen and creatinine were more than 2-fold higher in 28-week ZUC. Twelve urine protein markers of glomerular, proximal and distal tubule disease were assayed at three ages. Several proteins that indicate glomerular and proximal tubular disease increased with age in both congenic and ZUC. Epidermal growth factor (EGF) level, a marker whose levels decrease with distal tubule disease, was significantly higher in congenics. Quantitative histology of 28 week old animals revealed the most significant genotype effect was for tubular dilation and intratubular protein. The congenic donor region is protective of kidney disease, and effects on Type 2 diabetes are likely limited to fasting glucose and adiponectin. The loss of urea together with a small increase of food intake in ZUC support the hypothesis that nitrogen balance is altered in ZUC from an early age.	[Warden, Craig H.] Univ Calif Davis, Dept Pediat, Sch Vet Med, Davis, CA 95616 USA; [Warden, Craig H.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Sch Vet Med, Davis, CA 95616 USA; [Slupsky, Carolyn; Bettaieb, Ahmed; Min, Esther; Anh Le; Fisler, Janis S.; Hansen, Susan; Haj, Fawaz; Stern, Judith S.] Univ Calif Davis, Dept Nutr, Sch Vet Med, Davis, CA 95616 USA; [Griffey, Stephen M.] Univ Calif Davis, Comparat Pathol Lab, Sch Vet Med, Davis, CA 95616 USA; [Haj, Fawaz; Stern, Judith S.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Warden, CH (corresponding author), Univ Calif Davis, Dept Pediat, Sch Vet Med, Davis, CA 95616 USA.	chwarden@ucdavis.edu			Nora Eccles Treadwell Foundation; NIH [U24 DK092993, R01DK090492]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090492] Funding Source: NIH RePORTER	Nora Eccles Treadwell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Nora Eccles Treadwell Foundation to JSS. CHW is also supported by NIH U24 DK092993. FGH is also supported by NIH grant R01DK090492. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audrezet MP, 2012, HUM MUTAT, V33, P1239, DOI 10.1002/humu.22103; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dieterle F, 2010, NAT BIOTECHNOL, V28, P455, DOI 10.1038/nbt.1625; Gades MD, 1999, KIDNEY INT, V56, P1779, DOI 10.1046/j.1523-1755.1999.00731.x; Haloui M, 2013, HYPERTENSION, V62, P731, DOI 10.1161/HYPERTENSIONAHA.113.01295; Holmes RP, 2012, MOL ASPECTS MED, V33, P547, DOI 10.1016/j.mam.2012.01.001; KASISKE BL, 1986, AM J CLIN NUTR, V44, P56, DOI 10.1093/ajcn/44.1.56; Kessler MA, 1997, ANAL BIOCHEM, V248, P180, DOI 10.1006/abio.1997.2113; Kessler MA, 1997, CLIN CHEM, V43, P996; Kim K, 2010, PHYSL GENOMICS; Kotlo K, 2007, HYPERTENSION, V49, P467, DOI 10.1161/01.HYP.0000256303.40359.38; Lazar J, 2013, PHYSIOL GENOMICS, V45, P720, DOI 10.1152/physiolgenomics.00089.2013; Luijerink MC, 2004, KIDNEY INT, V66, P990, DOI 10.1111/j.1523-1755.2004.00788.x; Murdoch TB, 2008, ANAL CHEM, V80, P5524, DOI 10.1021/ac8005236; Nagata N, 2012, ENDOCRINOLOGY, V153, P3158, DOI 10.1210/en.2012-1406; Rangel A, 2013, J AM SOC NEPHROL, V24, P283, DOI 10.1681/ASN.2012090927; Reznichenko A, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-78; SATINK HPWM, 1989, CLIN CHIM ACTA, V179, P305, DOI 10.1016/0009-8981(89)90093-4; Slupsky CM, 2009, J PROTEOME RES, V8, P3029, DOI 10.1021/pr900103y; Stevenson FT, 2001, OBES RES, V9, P492, DOI 10.1038/oby.2001.64; Warden CH, 2012, PHYSIOL GENOMICS, V44, P1052, DOI 10.1152/physiolgenomics.00134.2011; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Williams JM, 2012, HYPERTENSION, V60, P1157, DOI 10.1161/HYPERTENSIONAHA.112.199240; Zeng F, 2007, MOL BIOL CELL, V18, P4446, DOI 10.1091/mbc.E07-03-0223; Zeng FH, 2009, EXP CELL RES, V315, P602, DOI 10.1016/j.yexcr.2008.08.005	25	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87770	10.1371/journal.pone.0087770	http://dx.doi.org/10.1371/journal.pone.0087770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498189	Green Published, gold			2022-12-25	WOS:000330621900168
J	Zhang, XQ; Zhang, HH; Shao, HJ; Xue, QS; Yu, BW				Zhang, Xiaoqin; Zhang, Honghai; Shao, Haijun; Xue, Qingsheng; Yu, Buwei			ERK MAP Kinase Activation in Spinal Cord Regulates Phosphorylation of Cdk5 at Serine 159 and Contributes to Peripheral Inflammation Induced Pain/Hypersensitivity	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; DORSAL-HORN NEURONS; PROTEIN-KINASE; UP-REGULATION; P35; RECEPTOR; PAIN; RAT; BRAIN; PATHWAY	Cyclin-dependent kinase 5 is a proline-directed serine/threonine kinase and its activity participates in the regulation of nociceptive signaling. Like binding with the activators (P35 or P25), the phosphorylation of Cdk5 plays a critical role in Cdk5 activation. However, it is still unclear whether Cdk5 phosphorylation (p-Cdk5) contributes to pain hyperalgesia. The aim of our current study was to identify the roles of p-Cdk5 and its upstream regulator in response to peripheral inflammation. Complete Freund's adjuvant (CFA) injection induced acute peripheral inflammation and heat hyperalgesia, which was accompanied by sustained increases in phospho-ERK1/2 (p-ERK1/2) and phospho-Cdk5(S159) (p-Cdk5(S159)) in the spinal cord dorsal horn (SCDH). CFA-induced p-ERK primarily colocalized with p-Cdk5 S159 in superficial dorsal horn neurons. Levels in p-ERK and p-Cdk5 were also increased in the 2 nd phase of hyperalgesia induced by formalin injection, which can produce acute and tonic inflammatory pain. MAP kinase kinase inhibitor U0126 intrathecal delivery significantly suppressed the elevation of p-Cdk5(S159), Cdk5 activity and pain response behavior (Heat hyperalgesia, Spontaneous flinches) induced by CFA or formalin injection. Cdk5 inhibitor roscovitine intrathecal administration also suppressed CFA-induced heat hyperalgesia and Cdk5 phosphorylation, but did not attenuate ERK activation. All these findings suggested that p-Cdk5 S159 regulated by ERK pathway activity may be a critical mechanism involved in the activation of Cdk5 in nociceptive spinal neurons contributes to peripheral inflammatory pain hypersensitivity.	[Zhang, Xiaoqin; Zhang, Honghai; Shao, Haijun; Xue, Qingsheng; Yu, Buwei] Shanghai Jiao Tong Univ, Dept Anesthesia, Rui Jin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhang, Honghai] Nanjing Med Univ, Dept Anesthesia, Hangzhou Peoples Hosp 1, Nanjing, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University	Yu, BW (corresponding author), Shanghai Jiao Tong Univ, Dept Anesthesia, Rui Jin Hosp, Sch Med, Shanghai 200030, Peoples R China.	yu.buwei@yahoo.com			National Natural Science Foundation, Beijing, P.R. China [81072703, 81373492]	National Natural Science Foundation, Beijing, P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation, Beijing, P.R. China, grant No. 81072703 and No. 81373492 to Dr. Buwei Yu (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adwanikar H, 2004, PAIN, V111, P125, DOI 10.1016/j.pain.2004.06.009; Cho IH, 2006, BRAIN RES, V1072, P208, DOI 10.1016/j.brainres.2005.12.039; Cruz CD, 2005, PAIN, V116, P411, DOI 10.1016/j.pain.2005.05.031; Czapski GA, 2011, FEBS LETT, V585, P1243, DOI 10.1016/j.febslet.2011.03.058; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fang JF, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-134; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; INO H, 1994, BRAIN RES, V661, P196, DOI 10.1016/0006-8993(94)91197-5; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004; Ko J, 2001, J NEUROSCI, V21, P6758; Lee MJ, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-40; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Matsushita M, 1996, BRAIN RES, V734, P319, DOI 10.1016/S0006-8993(96)00702-0; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; Pareek TK, 2007, P NATL ACAD SCI USA, V104, P660, DOI 10.1073/pnas.0609916104; Pareek TK, 2006, CELL CYCLE, V5, P585, DOI 10.4161/cc.5.6.2578; Pareek TK, 2006, P NATL ACAD SCI USA, V103, P791, DOI 10.1073/pnas.0510405103; Park HJ, 2009, PSYCHIAT RES, V170, P91, DOI 10.1016/j.psychres.2008.07.002; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Peng HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE416, DOI 10.1152/ajpendo.00129.2009; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Ramos-Miguel A, 2012, NEUROSCIENCE, V215, P17, DOI 10.1016/j.neuroscience.2012.04.035; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Rosales JL, 2003, CELL PHYSIOL BIOCHEM, V13, P285, DOI 10.1159/000074543; Saikkonen B, 2008, CELL CYCLE, V7, P750, DOI 10.4161/cc.7.6.5494; Saito T, 2007, J NEUROCHEM, V102, P133, DOI 10.1111/j.1471-4159.2007.04540.x; Sharma P, 1999, P NATL ACAD SCI USA, V96, P11156, DOI 10.1073/pnas.96.20.11156; Sharma P, 2002, J BIOL CHEM, V277, P528, DOI 10.1074/jbc.M109324200; Slack SE, 2004, EUR J NEUROSCI, V20, P1769, DOI 10.1111/j.1460-9568.2004.03656.x; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Utreras E, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-49; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; Veeranna GJ, 2000, MOL BRAIN RES, V76, P229, DOI 10.1016/S0169-328X(00)00003-6; Wang CH, 2005, ACTA PHARMACOL SIN, V26, P46, DOI 10.1111/j.1745-7254.2005.00007.x; Wang WY, 2014, NEUROPHARMACOLOGY, V77, P90, DOI 10.1016/j.neuropharm.2013.09.006; Yang YR, 2007, PAIN, V127, P109, DOI 10.1016/j.pain.2006.08.008; Zhang HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046666; Zhao CT, 2009, P NATL ACAD SCI USA, V106, P21353, DOI 10.1073/pnas.0812872106	51	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87788	10.1371/journal.pone.0087788	http://dx.doi.org/10.1371/journal.pone.0087788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498195	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900172
J	Li, A; Liu, YN; Zhao, QH; Feng, HQ; Harris, L; Wang, MH				Li, Ao; Liu, Yuanning; Zhao, Qihong; Feng, Huanqing; Harris, Lyndsay; Wang, Minghui			Genome-Wide Identification of Somatic Aberrations from Paired Normal-Tumor Samples	PLOS ONE			English	Article							COPY NUMBER ALTERATIONS; HIDDEN MARKOV MODEL; CHROMOSOMAL-ABERRATIONS; EXPRESSION ANALYSES; CANCER-CELLS; SINGLE; HETEROZYGOSITY; TOOL; REARRANGEMENT; LANDSCAPE	Genomic copy number alteration and allelic imbalance are distinct features of cancer cells, and recent advances in the genotyping technology have greatly boosted the research in the cancer genome. However, the complicated nature of tumor usually hampers the dissection of the SNP arrays. In this study, we describe a bioinformatic tool, named GIANT, for genome-wide identification of somatic aberrations from paired normal-tumor samples measured with SNP arrays. By efficiently incorporating genotype information of matched normal sample, it accurately detects different types of aberrations in cancer genome, even for aneuploid tumor samples with severe normal cell contamination. Furthermore, it allows for discovery of recurrent aberrations with critical biological properties in tumorigenesis by using statistical significance test. We demonstrate the superior performance of the proposed method on various datasets including tumor replicate pairs, simulated SNP arrays and dilution series of normal-cancer cell lines. Results show that GIANT has the potential to detect the genomic aberration even when the cancer cell proportion is as low as 5 similar to 10%. Application on a large number of paired tumor samples delivers a genome-wide profile of the statistical significance of the various aberrations, including amplification, deletion and LOH. We believe that GIANT represents a powerful bioinformatic tool for interpreting the complex genomic aberration, and thus assisting both academic study and the clinical treatment of cancer.	[Li, Ao; Wang, Minghui] Univ Sci & Technol China, Ctr Biomed Engn, Hefei 230026, Peoples R China; [Li, Ao; Liu, Yuanning; Feng, Huanqing; Wang, Minghui] Univ Sci & Technol China, Sch Informat Sci & Technol, Hefei 230026, Peoples R China; [Zhao, Qihong] Anhui Med Univ, Sch Publ Hlth, Hefei, Peoples R China; [Harris, Lyndsay] Case Western Reserve Univ, Sch Med, Seidman Canc Ctr, Cleveland, OH USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Case Western Reserve University	Li, A (corresponding author), Univ Sci & Technol China, Ctr Biomed Engn, Hefei 230026, Peoples R China.	aoli@ustc.edu.cn	Li, Ao/GRR-5311-2022; Li, aoyu/GXV-4925-2022		National Natural Science Foundation of China [31100955, 61101061]; Fundamental Research Funds for the Central Universities [WK2100230007]; United States Department of Defense [W81XWH-04-1-0 549]; Breast Cancer Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); United States Department of Defense(United States Department of Defense); Breast Cancer Research Foundation	This work was supported by grants from National Natural Science Foundation of China [31100955 and 61101061], and Fundamental Research Funds for the Central Universities (WK2100230007), United States Department of Defense (W81XWH-04-1-0 549) and the Breast Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Attiyeh EF, 2009, GENOME RES, V19, P276, DOI 10.1101/gr.075671.107; Bengtsson H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-245; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001060; Curtis C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-588; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Li A, 2011, NUCLEIC ACIDS RES, V39, P4928, DOI 10.1093/nar/gkr014; Liu ZZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010909; Mayrhofer M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r24; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Olshen AB, 2011, BIOINFORMATICS, V27, P2038, DOI 10.1093/bioinformatics/btr329; Ortiz-Estevez M, 2012, BIOINFORMATICS, V28, P1793, DOI 10.1093/bioinformatics/bts248; Park P, 2008, CANCER INVEST, V26, P923, DOI 10.1080/07357900801993432; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Rasmussen M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r108; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Staaf J, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3075; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sun W, 2009, NUCLEIC ACIDS RES, V37, P5365, DOI 10.1093/nar/gkp493; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Yau C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r92; Yuan XG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-342	40	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87212	10.1371/journal.pone.0087212	http://dx.doi.org/10.1371/journal.pone.0087212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498045	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100060
J	Xue, SC; Gong, H; Jiang, T; Luo, WH; Meng, YZ; Liu, Q; Chen, SB; Li, AA				Xue, Songchao; Gong, Hui; Jiang, Tao; Luo, Weihua; Meng, Yuanzheng; Liu, Qian; Chen, Shangbin; Li, Anan			Indian-Ink Perfusion Based Method for Reconstructing Continuous Vascular Networks in Whole Mouse Brain	PLOS ONE			English	Article							MICROSCOPY; CORTEX; ATLAS	The topology of the cerebral vasculature, which is the energy transport corridor of the brain, can be used to study cerebral circulatory pathways. Limited by the restrictions of the vascular markers and imaging methods, studies on cerebral vascular structure now mainly focus on either observation of the macro vessels in a whole brain or imaging of the micro vessels in a small region. Simultaneous vascular studies of arteries, veins and capillaries have not been achieved in the whole brain of mammals. Here, we have combined the improved gelatin-Indian ink vessel perfusion process with Micro-Optical Sectioning Tomography for imaging the vessel network of an entire mouse brain. With 17 days of work, an integral dataset for the entire cerebral vessels was acquired. The voxel resolution is 0.35x0.46x2.0 mu m(3) for the whole brain. Besides the observations of fine and complex vascular networks in the reconstructed slices and entire brain views, a representative continuous vascular tracking has been demonstrated in the deep thalamus. This study provided an effective method for studying the entire macro and micro vascular networks of mouse brain simultaneously.	[Xue, Songchao; Gong, Hui; Jiang, Tao; Luo, Weihua; Meng, Yuanzheng; Liu, Qian; Chen, Shangbin; Li, Anan] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China; [Xue, Songchao; Gong, Hui; Jiang, Tao; Luo, Weihua; Meng, Yuanzheng; Liu, Qian; Chen, Shangbin; Li, Anan] Huazhong Univ Sci & Technol, MoE Key Lab Biomed Photon, Dept Biomed Engn, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Li, AA (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China.	aali@mail.hust.edu.cn	Qian, Liu/GYU-5886-2022; Liu, Qian/D-8184-2011; jiang, tao/GWC-7108-2022; liu, qian/HDM-2936-2022	Liu, Qian/0000-0002-8398-1021; LI, Anan/0000-0002-5877-4813	National Natural Science Foundation of China [81171067, 61102122]; 863 program [2012AA02A602, 2012AA020401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 program(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81171067, 61102122), 863 program (Grant Nos. 2012AA02A602, 2012AA020401). National Natural Science Foundation of China: http://www.nsfc.gov.cn/publish/portal1. 863 program: http://www.863.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen SB, 2012, J NEUROSCI, V32, P13510, DOI 10.1523/JNEUROSCI.1439-12.2012; Chugh BP, 2009, NEUROIMAGE, V47, P1312, DOI 10.1016/j.neuroimage.2009.03.083; Dorr A, 2007, NEUROIMAGE, V35, P1409, DOI 10.1016/j.neuroimage.2006.12.040; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Harrison RV, 2002, CEREB CORTEX, V12, P225, DOI 10.1093/cercor/12.3.225; Hashimoto H, 2008, MICROSC RES TECHNIQ, V71, P51, DOI 10.1002/jemt.20522; Heinzer S, 2006, NEUROIMAGE, V32, P626, DOI 10.1016/j.neuroimage.2006.03.043; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Jahrling N, 2009, ORGANOGENESIS, V5, P227, DOI 10.4161/org.5.4.10403; Klohs J, 2012, J NEUROSCI, V32, P1705, DOI 10.1523/JNEUROSCI.5626-11.2012; Krucker T, 2006, MICROSC RES TECHNIQ, V69, P138, DOI 10.1002/jemt.20263; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Mayerich D, 2011, BIOMED OPT EXPRESS, V2, P2888, DOI 10.1364/BOE.2.002888; Pathak AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022643; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Tata DA, 2002, J NEUROSCI METH, V113, P199, DOI 10.1016/S0165-0270(01)00494-0; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Yang XQ, 2010, J X-RAY SCI TECHNOL, V18, P381, DOI 10.3233/XST-2010-0269; Zhang B, 2011, J NEUROSCI METH, V197, P1, DOI 10.1016/j.jneumeth.2010.10.001	25	30	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e88067	10.1371/journal.pone.0088067	http://dx.doi.org/10.1371/journal.pone.0088067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498247	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100126
J	Bibee, KP; Cheng, YJ; Ching, JK; Marsh, JN; Li, AJ; Keeling, RM; Connolly, AM; Golumbek, PT; Myerson, JW; Hu, G; Chen, JJ; Shannon, WD; Lanza, GM; Weihl, CC; Wickline, SA				Bibee, Kristin P.; Cheng, Ya-Jian; Ching, James K.; Marsh, Jon N.; Li, Allison J.; Keeling, Richard M.; Connolly, Anne M.; Golumbek, Paul T.; Myerson, Jacob W.; Hu, Grace; Chen, Junjie; Shannon, William D.; Lanza, Gregory M.; Weihl, Conrad C.; Wickline, Samuel A.			Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function	FASEB JOURNAL			English	Article						perfluorocarbon; Duchenne; cardiomyopathy; nanomedicine; drug delivery	SKELETAL-MUSCLE; MDX MICE; CORTICOSTEROID TREATMENT; THERAPEUTIC TARGET; STEROID-THERAPY; SIROLIMUS; PHARMACOKINETICS; ATHEROSCLEROSIS; NANOSTRUCTURES; DYSFUNCTION	Duchenne muscular dystrophy in boys progresses rapidly to severe impairment of muscle function and death in the second or third decade of life. Current supportive therapy with corticosteroids results in a modest increase in strength as a consequence of a general reduction in inflammation, albeit with potential untoward long-term side effects and ultimate failure of the agent to maintain strength. Here, we demonstrate that alternative approaches that rescue defective autophagy in mdx mice, a model of Duchenne muscular dystrophy, with the use of rapamycin-loaded nanoparticles induce a reproducible increase in both skeletal muscle strength and cardiac contractile performance that is not achievable with conventional oral rapamycin, even in pharmacological doses. This increase in physical performance occurs in both young and adult mice, and, surprisingly, even in aged wild-type mice, which sets the stage for consideration of systemic therapies to facilitate improved cell function by autophagic disposal of toxic byproducts of cell death and regeneration.Bibee, K. P., Cheng, Y.-J., Ching, J. K., Marsh, J. N., Li, A. J., Keeling, R. M., Connolly, A. M., Golumbek, P. T., Myerson, J. W., Hu, G., Chen, J., Shannon, W. D., Lanza, G. M., Weihl, C. C., Wickline, S. A. Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function.	[Bibee, Kristin P.; Cheng, Ya-Jian; Marsh, Jon N.; Li, Allison J.; Myerson, Jacob W.; Hu, Grace; Chen, Junjie; Lanza, Gregory M.; Wickline, Samuel A.] Washington Univ, Sch Med, Ctr Translat Res Adv Imaging & Nanomed, St Louis, MO 63110 USA; [Bibee, Kristin P.; Cheng, Ya-Jian; Marsh, Jon N.; Li, Allison J.; Myerson, Jacob W.; Hu, Grace; Chen, Junjie; Shannon, William D.; Lanza, Gregory M.; Wickline, Samuel A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Ching, James K.; Keeling, Richard M.; Connolly, Anne M.; Golumbek, Paul T.; Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wickline, SA (corresponding author), Washington Univ, Sch Med, Dept Med, Ctr Translat Res Adv Imaging & Nanomed, 660 South Euclid Ave, St Louis, MO 63110 USA.	saw@wuphys.wustl.edu	Connolly, Anne/GYD-3128-2022	Connolly, Anne/0000-0002-9193-2457	U.S. National Institutes of Health (NIH) [R01 AR056223, HL073646]; NIH [HL112518, HL113392, NS073457ss, K02 AG042095]; Muscular Dystrophy Association; American Heart Association [12PRE9310044]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113392, R42HL112518, R01HL073646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG042095, R01AG031867] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors acknowledge contributions of other colleagues to this study: Kefeng Wang (statistical analysis); John Allen, Cordelia Caradine, and Xiaoxia Yang (animal preparation); Huiying Zhang and Noriko Yanaba (histology); and Ralph W. Fuhrhop, Michael J. Scott, and Angana Senpan (NP formulation). This work was supported by U.S. National Institutes of Health (NIH) grants R01 AR056223 and HL073646 (S.A.W.); NIH HL112518, HL113392, and NS073457ss (G.M.L.); and NIH K02 AG042095 (C.C.W.); the Muscular Dystrophy Association (C.C.W., A.M.C., and P.T.G.); and American Heart Association graduate fellowship award 12PRE9310044 (Y.-J.C.).	Adelman SJ, 2010, CURR PHARM DESIGN, V16, P4002; Ahern GP, 1997, NEUROSCI LETT, V225, P81, DOI 10.1016/S0304-3940(97)00193-6; Ashford MW, 2005, CIRCULATION, V112, P2462, DOI 10.1161/CIRCULATIONAHA.104.516716; Avila G, 2005, CELL CALCIUM, V38, P35, DOI 10.1016/j.ceca.2005.05.001; Avila G, 2003, J BIOL CHEM, V278, P22600, DOI 10.1074/jbc.M205866200; Balaban B, 2005, AM J PHYS MED REHAB, V84, P843, DOI 10.1097/01.phm.0000184156.98671.d0; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Biggar WD, 2006, NEUROMUSCULAR DISORD, V16, P249, DOI 10.1016/j.nmd.2006.01.010; Cheng YJ, 2012, AM J PHYSIOL-HEART C, V303, pH559, DOI 10.1152/ajpheart.00321.2012; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Crowe A, 1999, DRUG METAB DISPOS, V27, P627; Cyrus T, 2008, ARTERIOSCL THROM VAS, V28, P820, DOI 10.1161/ATVBAHA.107.156281; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; DOLBER PC, 1987, STAIN TECHNOL, V62, P23, DOI 10.3109/10520298709107961; Eghtesad S, 2011, MOL MED, V17, P917, DOI 10.2119/molmed.2010.00256; Etheridge ML, 2013, NANOMED-NANOTECHNOL, V9, P1, DOI 10.1016/j.nano.2012.05.013; Ferron GM, 1997, J CHROMATOGR B, V703, P243, DOI 10.1016/S0378-4347(97)00415-5; FLAIM SF, 1994, ARTIF CELL BLOOD SUB, V22, P1043, DOI 10.3109/10731199409138801; Flynn JM, 2013, AGING CELL, V12, P851, DOI 10.1111/acel.12109; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hu G, 2007, INT J CANCER, V120, P1951, DOI 10.1002/ijc.22581; Ju JS, 2009, AUTOPHAGY, V5, P511, DOI 10.4161/auto.5.4.7761; Keeling RM, 2007, MUSCLE NERVE, V35, P43, DOI 10.1002/mus.20646; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lien CF, 2012, J BIOL CHEM, V287, P41374, DOI 10.1074/jbc.M112.400044; Markham LW, 2005, PEDIATR CARDIOL, V26, P768, DOI 10.1007/s00246-005-0909-4; Morawski AM, 2004, MAGN RESON MED, V52, P1255, DOI 10.1002/mrm.20287; Mouisel E, 2010, MUSCLE NERVE, V41, P809, DOI 10.1002/mus.21624; Moxley RT, 2005, NEUROLOGY, V64, P13, DOI 10.1212/01.WNL.0000148485.00049.B7; Napoli KL, 1997, CLIN BIOCHEM, V30, P135, DOI 10.1016/S0009-9120(96)00157-9; Neubauer AM, 2008, MAGN RESON MED, V60, P1353, DOI 10.1002/mrm.21795; O'Reilly T, 2010, CANCER CHEMOTH PHARM, V65, P625, DOI 10.1007/s00280-009-1068-8; Palladino M, 2013, ARTERIOSCL THROM VAS, V33, P2867, DOI 10.1161/ATVBAHA.112.301172; Pan H, 2012, METHOD ENZYMOL, V508, P17, DOI 10.1016/B978-0-12-391860-4.00002-1; Pauly M, 2012, AM J PATHOL, V181, P583, DOI 10.1016/j.ajpath.2012.04.004; Schram G, 2013, J AM COLL CARDIOL, V61, P948, DOI 10.1016/j.jacc.2012.12.008; Shigemitsu K, 1999, J BIOL CHEM, V274, P1058, DOI 10.1074/jbc.274.2.1058; Soman NR, 2008, NANO LETT, V8, P1131, DOI 10.1021/nl073290r; Soman NR, 2009, J CLIN INVEST, V119, P2830, DOI 10.1172/JCI38842; Stepkowski SM, 2003, TRANSPLANT P, V35, p219S, DOI 10.1016/S0041-1345(03)00222-7; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Vidal B, 2012, HUM MOL GENET, V21, P1989, DOI 10.1093/hmg/dds012; VILQUIN JT, 1995, TRANSPLANTATION, V59, P422, DOI 10.1097/00007890-199502150-00020; Wickline SA, 2006, ARTERIOSCL THROM VAS, V26, P435, DOI 10.1161/01.ATV.0000201069.47550.8b; Wickline SA, 2010, MOL IMAGING PRINCIPL, P542; WILLIAMS DA, 1990, J PHYSIOL-LONDON, V428, P243, DOI 10.1113/jphysiol.1990.sp018210; Winter PM, 2006, ARTERIOSCL THROM VAS, V26, P2103, DOI 10.1161/01.ATV.0000235724.11299.76; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; ZEMAN RJ, 1986, BIOCHEM J, V240, P269, DOI 10.1042/bj2400269; Zhang HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026385	55	47	48	0	35	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2047	2061		10.1096/fj.13-237388	http://dx.doi.org/10.1096/fj.13-237388			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24500923	Green Published			2022-12-25	WOS:000335336000010
J	Antoine, TE; Yakoub, A; Maus, E; Shukla, D; Tiwari, V				Antoine, Thessicar E.; Yakoub, Abraam; Maus, Erika; Shukla, Deepak; Tiwari, Vaibhav			Zebrafish 3-O-Sulfotransferase-4 Generated Heparan Sulfate Mediates HSV-1 Entry and Spread	PLOS ONE			English	Article							COMBINATORIAL EXPRESSION PATTERNS; SIMPLEX-VIRUS TYPE-1; D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE; HERPES-SIMPLEX; SULFOTRANSFERASES; GLYCOSAMINOGLYCANS; DIVERSITY; RECEPTOR; FAMILY	Rare modification of heparan sulfate (HS) by glucosaminyl 3-O sulfotransferase (3-OST) isforms generates an entry receptor for herpes simplex virus type-1 (HSV-1). In the zebrafish (ZF) model multiple 3-OST isoforms are differentially expressed. One such isoform is 3-OST-4 which is widely expressed in the central nervous system of ZF. In this report we characterize the role of ZF encoded 3-OST-4 isoform for HSV-1 entry. Expression of ZF 3-OST-4 into resistant Chinese hamster ovary (CHO-K1) cells promoted susceptibility to HSV-1 infection. This entry was 3-O sulfated HS (3-OS HS) dependent as pre-treatment of ZF 3-OST-4 cells with enzyme HS lyases (heparinase II/III) significantly reduced HSV-1 entry. Interestingly, co-expression of ZF 3-OST-4 along with ZF 3-OST-2 which is also expressed in brain rendered cells more susceptible to HSV-1 than 3-OST-4 alone. The role of ZF-3-OST-4 in the spread of HSV-1 was also evaluated as CHO-K1 cells that expressed HSV-1 glycoproteins fused with ZF 3-OST-4 expressing effector CHO-K1 cells. Finally, adding further evidence ZF 3-OST-4 mediated HSV-1 entry was inhibited by anti-3O HS G2 peptide. Taken together our results demonstrate a role for ZF 3-OST-4 in HSV-1 pathogenesis and support the use of ZF as a model to study it.	[Antoine, Thessicar E.; Yakoub, Abraam; Shukla, Deepak; Tiwari, Vaibhav] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA; [Antoine, Thessicar E.; Yakoub, Abraam; Shukla, Deepak; Tiwari, Vaibhav] Univ Illinois, Dept Microbiol Immunol, Chicago, IL USA; [Maus, Erika; Tiwari, Vaibhav] Midwestern Univ, Dept Microbiol & Immunol, Downers Grove, IL 60515 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Midwestern University	Tiwari, V (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	vtiwar@midwestern.edu		Shukla, Deepak/0000-0002-3039-6953	National Institutes of Health (NIH) [AI088429-01A1, AI081869]; Research to Prevent Blindness, Inc.; NEI core grant [EY001792]; NATIONAL EYE INSTITUTE [P30EY001792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI081869, R15AI088429] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NEI core grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported from National Institutes of Health (NIH) grants to VT (AI088429-01A1) and DS (AI081869), an unrestricted grant from Research to Prevent Blindness, Inc. and an NEI core grant EY001792. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2012, J VIROL, V86, P6434, DOI 10.1128/JVI.00433-12; Baldwin J, 2013, BIOCHEM BIOPH RES CO, V432, P672, DOI 10.1016/j.bbrc.2013.02.020; Baldwin John, 2013, Open Virol J, V7, P5, DOI 10.2174/1874357901307010005; Cadwallader AB, 2007, DEV DYNAM, V236, P581, DOI 10.1002/dvdy.21051; Cadwallader AB, 2006, DEV DYNAM, V235, P3432, DOI 10.1002/dvdy.20990; Cadwallader AB, 2006, DEV DYNAM, V235, P3423, DOI 10.1002/dvdy.20991; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Hubbard S, 2010, ZEBRAFISH, V7, P181, DOI 10.1089/zeb.2009.0621; Kreuger J, 2012, J HISTOCHEM CYTOCHEM, V60, P898, DOI 10.1369/0022155412464972; Lindahl U, 2013, J INTERN MED, V273, P555, DOI 10.1111/joim.12061; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; O'Donnell CD, 2006, VIROLOGY, V346, P452, DOI 10.1016/j.virol.2005.11.003; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; Steiner I, 2007, LANCET NEUROL, V6, P1015, DOI 10.1016/S1474-4422(07)70267-3; Tiwari V, 2005, BIOCHEM BIOPH RES CO, V338, P930, DOI 10.1016/j.bbrc.2005.10.056; Tiwari V, 2004, J GEN VIROL, V85, P805, DOI 10.1099/vir.0.19641-0; Tiwari V, 2012, GLYCOBIOLOGY, V22, P1402, DOI 10.1093/glycob/cws106; Tiwari V, 2011, J BIOL CHEM, V286, P25406, DOI 10.1074/jbc.M110.201103; Zhang FM, 2009, GLYCOCONJUGATE J, V26, P211, DOI 10.1007/s10719-008-9177-x	27	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87302	10.1371/journal.pone.0087302	http://dx.doi.org/10.1371/journal.pone.0087302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498308	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900054
J	Aversi-Ferreira, RAGMF; Maior, RS; Aziz, A; Ziermann, JM; Nishijo, H; Tomaz, C; Tavares, MCH; Aversi-Ferreira, TA				Aversi-Ferreira, Roqueline A. G. M. F.; Maior, Rafael Souto; Aziz, Ashraf; Ziermann, Janine M.; Nishijo, Hisao; Tomaz, Carlos; Tavares, Maria Clotilde H.; Aversi-Ferreira, Tales Alexandre			Anatomical Analysis of Thumb Opponency Movement in the Capuchin Monkey (Sapajus sp)	PLOS ONE			English	Article							CEBUS-LIBIDINOSUS; METACARPAL JOINT; MODERN HUMANS; TOOL USE; HAND; PAN; EVOLUTION; APELLA	Capuchin monkeys present a wide variety of manipulatory skills and make routine use of tools both in captivity and in the wild. Efficient handling of objects in this genus has led several investigators to assume near-human thumb movements despite the lack of anatomical studies. Here we perform an anatomical analysis of muscles and bones in the capuchin hand. Trapezo-metacarpal joint surfaces observed in capuchins indicate that medial rotation of metacarpal I is either absent or very limited. Overall, bone structural arrangement and thumb position relative to the other digits and the hand's palm suggest that capuchins are unable to perform any kind of thumb opponency, but rather a 'lateral pinch' movement. Although the capuchin hand apparatus bears other features necessary for complex tool use, the lack thumb opposition movements suggests that a developed cognitive and motor nervous system may be even more important for high manipulatory skills than traditionally held.	[Aversi-Ferreira, Roqueline A. G. M. F.; Aversi-Ferreira, Tales Alexandre] Fed Univ Tocantins, Lab Anthropol Biochem Neurosci & Primate Behav, Palmas, TO, Brazil; [Aversi-Ferreira, Roqueline A. G. M. F.; Maior, Rafael Souto; Tomaz, Carlos; Tavares, Maria Clotilde H.] Univ Brasilia, Ctr Primate, Brasilia, DF, Brazil; [Aversi-Ferreira, Roqueline A. G. M. F.; Maior, Rafael Souto; Tomaz, Carlos; Tavares, Maria Clotilde H.] Univ Brasilia, Inst Biol, Dept Physiol Sci, Lab Neurosci & Behav, Brasilia, DF, Brazil; [Aziz, Ashraf; Ziermann, Janine M.] Howard Univ, Coll Med, Dept Anat, Washington, DC USA; [Nishijo, Hisao; Aversi-Ferreira, Tales Alexandre] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan	Universidade Federal do Tocantins (UFT); Universidade de Brasilia; Universidade de Brasilia; Howard University; University of Toyama	Aversi-Ferreira, TA (corresponding author), Fed Univ Tocantins, Lab Anthropol Biochem Neurosci & Primate Behav, Palmas, TO, Brazil.	aversiferreira@gmail.com	Ziermann, Janine M./C-7155-2014; Maior, Rafael S./F-3994-2012; Tomaz, Carlos A B/F-8626-2012	Ziermann, Janine M./0000-0002-1264-9240; Maior, Rafael S./0000-0001-7219-8675; 	JSPS Asian Core Program, Japan; CAPES/Brazil; National Council of Technology and Development (CNPq/Brazil)	JSPS Asian Core Program, Japan; CAPES/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Technology and Development (CNPq/Brazil)	This research was supported in part by the JSPS Asian Core Program, Japan. R.A.G.M.F. Aversi-Ferreira was recipient of a doctoral fellowship from CAPES/Brazil and T.A. Aversi-Ferreira received a research fellowship from National Council of Technology and Development (CNPq/Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankel- Simons F, 2000, PRIMATE ANATOMY INTR; Aversi-Ferreira TA, 2010, ANAT REC, V293, P2056, DOI 10.1002/ar.21275; Aversi-Ferreira TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022165; Christel MI, 1998, INT J PRIMATOL, V19, P165, DOI 10.1023/A:1020319313219; Christel MI, 2000, INT J PRIMATOL, V21, P697, DOI 10.1023/A:1005521522418; COSTELLO MB, 1988, AM J PRIMATOL, V15, P235, DOI 10.1002/ajp.1350150306; Diogo R., 2011, PHOTOGRAPHIC DESCRIP; FCAT, 1998, FED COMM AN TERM TER, DOI 10.1046/j.1469-7580.2001.199607412.x; Fragaszy D, 2004, AM J PRIMATOL, V64, P359, DOI 10.1002/ajp.20085; Hopkins WD, 2002, J EXP PSYCHOL GEN, V131, P412, DOI 10.1037//0096-3445.131.3.412; Lacreuse A, 1997, Laterality, V2, P247, DOI 10.1080/713754275; Meulman EJM, 2012, EVOL ANTHROPOL, V21, P58, DOI 10.1002/evan.21304; NAPIER J. R., 1961, SYMPOSIA ZOOL SOC LONDON, V5, P115; Napier J.R., 1980, HANDS; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; NAPIER JR, 1955, J ANAT, V89, P362; Napier JR, 1967, HDB LIVING PRIMATES; Panger MA, 1998, AM J PHYS ANTHROPOL, V106, P311, DOI 10.1002/(SICI)1096-8644(199807)106:3<311::AID-AJPA4>3.0.CO;2-P; Pouydebat E, 2009, J BIOMECH, V42, P266, DOI 10.1016/j.jbiomech.2008.10.026; Rilling JK, 1999, J HUM EVOL, V37, P191, DOI 10.1006/jhev.1999.0313; ROSE MD, 1992, J HUM EVOL, V22, P255, DOI 10.1016/0047-2484(92)90058-H; Schwartz JH, 1998, ANTHROPOL SCI, V106, P47, DOI 10.1537/ase.106.Supplement_47; Spinozzi G, 2004, AM J PHYS ANTHROPOL, V125, P30, DOI 10.1002/ajpa.10362; Standring S, 2008, FOREARM WRIST HAND G, P839; Swindler DR, 1973, SUPERIOR MEMBER ATLA, P148; Tocheri MW, 2008, J ANAT, V212, P544, DOI 10.1111/j.1469-7580.2008.00865.x; Tocheri MW, 2005, J HUM EVOL, V49, P570, DOI 10.1016/j.jhevol.2005.06.005; VISALBERGHI E, 1989, PRIMATES, V30, P511, DOI 10.1007/BF02380877; Waga IC, 2006, FOLIA PRIMATOL, V77, P337, DOI 10.1159/000093698; WESTERGAARD GC, 1987, J COMP PSYCHOL, V101, P159, DOI 10.1037/0735-7036.101.2.159; Young RW, 2003, J ANAT, V202, P165, DOI 10.1046/j.1469-7580.2003.00144.x	31	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87288	10.1371/journal.pone.0087288	http://dx.doi.org/10.1371/journal.pone.0087288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498307	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900053
J	McQueen, J; Reimer, MM; Holland, PR; Manso, Y; McLaughlin, M; Fowler, JH; Horsburgh, K				McQueen, Jamie; Reimer, Michell M.; Holland, Philip R.; Manso, Yasmina; McLaughlin, Mark; Fowler, Jill H.; Horsburgh, Karen			Restoration of Oligodendrocyte Pools in a Mouse Model of Chronic Cerebral Hypoperfusion	PLOS ONE			English	Article							WHITE-MATTER LESIONS; THERAPEUTIC TARGET; PROGENITOR CELLS; RECEPTOR GPR17; STEM-CELLS; RAT-BRAIN; DAMAGE; ISCHEMIA; MYELINATION; PATHOLOGY	Chronic cerebral hypoperfusion, a sustained modest reduction in cerebral blood flow, is associated with damage to myelinated axons and cognitive decline with ageing. Oligodendrocytes (the myelin producing cells) and their precursor cells (OPCs) may be vulnerable to the effects of hypoperfusion and in some forms of injury OPCs have the potential to respond and repair damage by increased proliferation and differentiation. Using a mouse model of cerebral hypoperfusion we have characterised the acute and long term responses of oligodendrocytes and OPCs to hypoperfusion in the corpus callosum. Following 3 days of hypoperfusion, numbers of OPCs and mature oligodendrocytes were significantly decreased compared to controls. However following 1 month of hypoperfusion, the OPC pool was restored and increased numbers of oligodendrocytes were observed. Assessment of proliferation using PCNA showed no significant differences between groups at either time point but showed reduced numbers of proliferating oligodendroglia at 3 days consistent with the loss of OPCs. Cumulative BrdU labelling experiments revealed higher numbers of proliferating cells in hypoperfused animals compared to controls and showed a proportion of these newly generated cells had differentiated into oligodendrocytes in a subset of animals. Expression of GPR17, a receptor important for the regulation of OPC differentiation following injury, was decreased following short term hypoperfusion. Despite changes to oligodendrocyte numbers there were no changes to the myelin sheath as revealed by ultrastructural assessment and fluoromyelin however axon-glial integrity was disrupted after both 3 days and 1 month hypoperfusion. Taken together, our results demonstrate the initial vulnerability of oligodendroglial pools to modest reductions in blood flow and highlight the regenerative capacity of these cells.	[McQueen, Jamie; Reimer, Michell M.; Holland, Philip R.; Manso, Yasmina; Fowler, Jill H.; Horsburgh, Karen] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [McQueen, Jamie; Reimer, Michell M.; Holland, Philip R.; Horsburgh, Karen] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [McLaughlin, Mark] Univ Glasgow, Sch Vet Med, Div Vet Biosci, Glasgow, Lanark, Scotland	University of Edinburgh; University of Edinburgh; University of Glasgow	Horsburgh, K (corresponding author), Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland.	Karen.Horsburgh@ed.ac.uk	Reimer, Michell MMR/I-6314-2012	Horsburgh, Karen/0000-0002-9620-3691; Manso Sanz, Yasmina/0000-0002-5788-4180; Reimer, Michell Mario/0000-0001-5510-8471; Fowler, Jill/0000-0003-3204-1221; McQueen, Jamie/0000-0001-7172-7504; Holland, Philip Robert/0000-0003-3345-4853	Lifelong Health and Wellbeing Initiative; BBSRC; EPSRC; ESRC; MRC; Disconnected Mind; Age UK; Alzheimer's Research UK (ARUK); Alzheimer's Society; Alzheimers Research UK [ART-NCG2007A-2, ART-PG2010-3] Funding Source: researchfish; Royal Osteoporosis Society [128] Funding Source: researchfish	Lifelong Health and Wellbeing Initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Disconnected Mind; Age UK; Alzheimer's Research UK (ARUK)(Alzheimer's Research UK (ARUK)); Alzheimer's Society; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Royal Osteoporosis Society	The funding of the Lifelong Health and Wellbeing Initiative (supported by the BBSRC, EPSRC, ESRC and MRC), The Disconnected Mind (supported by Age UK) and Alzheimer's Research UK (ARUK) is gratefully acknowledged. JHF is supported by a research fellowship from the Alzheimer's Society. Confocal imaging was performed at the IMPACT Imaging facility and at the Euan MacDonald Centre at the University of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; Agresti C, 2005, BRAIN RES REV, V48, P157, DOI 10.1016/j.brainresrev.2004.12.005; Alix JJP, 2009, ANN NEUROL, V66, P682, DOI 10.1002/ana.21767; Back SA, 1998, J NEUROSCI, V18, P6241; Back SA, 2011, ANN NEUROL, V70, P465, DOI 10.1002/ana.22484; Bhat RV, 1996, GLIA, V17, P169; Boda E, 2011, GLIA, V59, P1958, DOI 10.1002/glia.21237; Cavaliere F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.144; Ceruti S, 2011, GLIA, V59, P363, DOI 10.1002/glia.21107; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Coltman R, 2011, NEUROBIOL AGING, V32; Deng YY, 2008, BRAIN PATHOL, V18, P387, DOI 10.1111/j.1750-3639.2008.00138.x; Desai MK, 2010, AM J PATHOL, V177, P1422, DOI 10.2353/ajpath.2010.100087; Duan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052566; Fujita Y, 2010, STROKE, V41, P2938, DOI 10.1161/STROKEAHA.110.596379; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Holland PR, 2011, NEUROBIOL AGING, V32; HUSAIN J, 1995, BRAIN RES, V698, P86, DOI 10.1016/0006-8993(95)00832-B; Kohama SG, 2012, AGE, V34, P1093, DOI 10.1007/s11357-011-9357-7; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Lyons SA, 1998, J CEREBR BLOOD F MET, V18, P521, DOI 10.1097/00004647-199805000-00007; Mabuchi T, 2000, STROKE, V31, P1735, DOI 10.1161/01.STR.31.7.1735; Maki T, 2011, STROKE, V42, P1122, DOI 10.1161/STROKEAHA.110.603399; McDonald JW, 1998, NEUROREPORT, V9, P2757, DOI 10.1097/00001756-199808240-00014; McIver SR, 2010, NEUROSCIENCE, V169, P1364, DOI 10.1016/j.neuroscience.2010.04.070; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Merrill JE, 1999, NEUROPATH APPL NEURO, V25, P435; Miyamoto N, 2013, STROKE; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Oluich LJ, 2012, J NEUROSCI, V32, P8317, DOI 10.1523/JNEUROSCI.1053-12.2012; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Reimer MM, 2011, J NEUROSCI, V31, P18185, DOI 10.1523/JNEUROSCI.4936-11.2011; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Simpson JE, 2007, NEUROPATH APPL NEURO, V33, P410, DOI 10.1111/j.1365-2990.2007.00828.x; Stys PK, 2007, TRENDS PHARMACOL SCI, V28, P561, DOI 10.1016/j.tips.2007.10.003; Tanaka K, 2003, BRAIN RES, V989, P172, DOI 10.1016/S0006-8993(03)03317-1; Tanaka K, 2001, NEUROREPORT, V12, P2169, DOI 10.1097/00001756-200107200-00025; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Tomimoto H, 2003, ACTA NEUROPATHOL, V106, P527, DOI 10.1007/s00401-003-0749-3; Valeriani V, 2000, J CEREBR BLOOD F MET, V20, P765, DOI 10.1097/00004647-200005000-00002; Yool DA, 2001, J NEUROSCI RES, V63, P151; Yuan XQ, 1998, DEVELOPMENT, V125, P2901; Zaidi AU, 2004, GLIA, V46, P380, DOI 10.1002/glia.20013	47	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87227	10.1371/journal.pone.0087227	http://dx.doi.org/10.1371/journal.pone.0087227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498301	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000330626900047
J	Ross, BH; Lin, Y; Corales, EA; Burgos, PV; Mardones, GA				Ross, Breyan H.; Lin, Yimo; Corales, Esteban A.; Burgos, Patricia V.; Mardones, Gonzalo A.			Structural and Functional Characterization of Cargo-Binding Sites on the mu 4-Subunit of Adaptor Protein Complex 4	PLOS ONE			English	Article							AP2 CLATHRIN ADAPTER; SORTING SIGNALS; MEDIUM CHAINS; ALZHEIMERS-DISEASE; MEMBRANE-PROTEINS; HIV-1 NEF; AP-4; ENDOCYTOSIS; RECOGNITION; PRECURSOR	Adaptor protein (AP) complexes facilitate protein trafficking by playing key roles in the selection of cargo molecules to be sorted in post-Golgi compartments. Four AP complexes (AP-1 to AP-4) contain a medium-sized subunit (mu 1-mu 4) that recognizes YXXO-sequences (O is a bulky hydrophobic residue), which are sorting signals in transmembrane proteins. A conserved, canonical region in m subunits mediates recognition of YXXO-signals by means of a critical aspartic acid. Recently we found that a non-canonical YXXO-signal on the cytosolic tail of the Alzheimer's disease amyloid precursor protein (APP) binds to a distinct region of the mu 4 subunit of the AP-4 complex. In this study we aimed to determine the functionality of both binding sites of mu 4 on the recognition of the non-canonical YXXO-signal of APP. We found that substitutions in either binding site abrogated the interaction with the APP-tail in yeast-two hybrid experiments. Further characterization by isothermal titration calorimetry showed instead loss of binding to the APP signal with only the substitution R283D at the non-canonical site, in contrast to a decrease in binding affinity with the substitution D190A at the canonical site. We solved the crystal structure of the C-terminal domain of the D190A mutant bound to this non-canonical YXXO-signal. This structure showed no significant difference compared to that of wild-type mu 4. Both differential scanning fluorimetry and limited proteolysis analyses demonstrated that the D190A substitution rendered mu 4 less stable, suggesting an explanation for its lower binding affinity to the APP signal. Finally, in contrast to overexpression of the D190A mutant, and acting in a dominant-negative manner, overexpression of mu 4 with either a F255A or a R283D substitution at the non-canonical site halted APP transport at the Golgi apparatus. Together, our analyses support that the functional recognition of the non-canonical YXXO-signal of APP is limited to the non-canonical site of mu 4.	[Mardones, Gonzalo A.] Univ Austral Chile, Fac Med, Inst Fisiol, Valdivia, Chile; Univ Austral Chile, Ctr Invest Sur Austral Enfermedades Sistema Nervi, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile	Mardones, GA (corresponding author), Univ Austral Chile, Fac Med, Inst Fisiol, Valdivia, Chile.	gonzalo.mardones@uach.cl			FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile) [1100896]; DID-UACh (Direccion de Investigacion y Desarrollo, Universidad Austral de Chile)	FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DID-UACh (Direccion de Investigacion y Desarrollo, Universidad Austral de Chile)	This work was funded by FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile; http://www.conicyt.cl/fondecyt) Grant 1100896 (G. A. M.), and DID-UACh (Direccion de Investigacion y Desarrollo, Universidad Austral de Chile; http://www.uach.cl/investigacion/direccion-de-investigacion/portada) (G.A.M. and P.V.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar RC, 1997, J BIOL CHEM, V272, P27160, DOI 10.1074/jbc.272.43.27160; Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Dell'Angelica EC, 1999, J BIOL CHEM, V274, P7278, DOI 10.1074/jbc.274.11.7278; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Hirst J, 2013, TRAFFIC, V14, P153, DOI 10.1111/tra.12028; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Mardones GA, 2006, MOL BIOL CELL, V17, P525, DOI 10.1091/mbc.E05-05-0447; Mardones GA, 2013, J BIOL CHEM; Mardones GA, 2007, MOL BIOL CELL, V18, P3486, DOI 10.1091/mbc.E07-02-0190; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montpetit A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000296; Moreno-De-Luca A, 2011, J MED GENET, V48, P141, DOI 10.1136/jmg.2010.082263; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Ohno H, 2006, J BIOCHEM, V139, P943, DOI 10.1093/jb/mvj120; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Simmen T, 2002, NAT CELL BIOL, V4, P154, DOI 10.1038/ncb745; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Stephens DJ, 1998, BIOCHEM J, V335, P567, DOI 10.1042/bj3350567; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Verkerk AJMH, 2009, AM J HUM GENET, V85, P40, DOI 10.1016/j.ajhg.2009.06.004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yap CC, 2003, MOL CELL NEUROSCI, V24, P283, DOI 10.1016/S1044-7431(03)00164-7	51	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88147	10.1371/journal.pone.0088147	http://dx.doi.org/10.1371/journal.pone.0088147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498434	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900180
J	Sato, H; Chuang, VTG; Yamasaki, K; Yamaotsu, N; Watanabe, H; Nagumo, K; Anraku, M; Kadowaki, D; Ishima, Y; Hirono, S; Otagiri, M; Maruyama, T				Sato, Hiroki; Chuang, Victor Tuan Giam; Yamasaki, Keishi; Yamaotsu, Noriyuki; Watanabe, Hiroshi; Nagumo, Kohei; Anraku, Makoto; Kadowaki, Daisuke; Ishima, Yu; Hirono, Shuichi; Otagiri, Masaki; Maruyama, Toru			Differential Effects of Methoxy Group on the Interaction of Curcuminoids with Two Major Ligand Binding Sites of Human Serum Albumin	PLOS ONE			English	Article							CIRCULAR-DICHROISM; FATTY-ACIDS; BISDEMETHOXYCURCUMIN; WARFARIN; STABILITY; OXIDATION; ARG-410	Curcuminoids are a group of compounds with a similar chemical backbone structure but containing different numbers of methoxy groups that have therapeutic potential due to their anti-inflammatory and anti-oxidant properties. They mainly bind to albumin in plasma. These findings influence their body disposition and biological activities. Spectroscopic analysis using site specific probes on human serum albumin (HSA) clearly indicated that curcumin (Cur), demethylcurcumin (Dmc) and bisdemethoxycurcumin (Bdmc) bind to both Site I (sub-site Ia and Ib) and Site II on HSA. At pH 7.4, the binding constants for Site I were relatively comparable between curcuminoids, while the binding constants for Site II at pH 7.4 were increased in order Cur, Dmc, Bdmc. Binding experiments using HSA mutants showed that Trp214 and Arg218 at Site I, and Tyr411 and Arg410 at Site II are involved in the binding of curcuminoids. The molecular docking of all curcuminoids to the Site I pocket showed that curcuminoids stacked with Phe211 and Trp214, and interacted with hydrophobic and aromatic amino acid residues. In contrast, each curcuminoid interacted with Site II in a different manner depending whether a methoxy group was present or absent. A detailed analysis of curcuminoids-albumin interactions would provide valuable information in terms of understanding the pharmacokinetics and the biological activities of this class of compounds.	[Sato, Hiroki; Watanabe, Hiroshi; Nagumo, Kohei; Kadowaki, Daisuke; Ishima, Yu; Maruyama, Toru] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto, Japan; [Chuang, Victor Tuan Giam] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA 6845, Australia; [Yamasaki, Keishi; Anraku, Makoto; Otagiri, Masaki] Sojo Univ, DDS Res Inst, Fac Pharmaceut Sci, Kumamoto, Japan; [Yamaotsu, Noriyuki; Hirono, Shuichi] Kitasato Univ, Sch Pharm, Tokyo, Japan	Kumamoto University; Curtin University; Sojo University; Kitasato University	Maruyama, T (corresponding author), Kumamoto Univ, Ctr Clin Pharmaceut Sci, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto, Japan.	tomaru@gpo.kumamoto-u.ac.jp	Chuang, Victor/A-3644-2011; Yamaotsu, Noriyuki/AAW-2545-2020; Anraku, Makoto/AAA-3935-2020; Chuang, Victor/A-3644-2011	Chuang, Victor/0000-0002-2141-630X; Yamaotsu, Noriyuki/0000-0002-4302-1085; Chuang, Victor/0000-0003-4543-2256; Yamasaki, Keishi/0000-0003-0537-2367; Kadowaki, Daisuke/0000-0001-5166-7145	Japan Society for the Promotion of Science (JSPS) [KAKENHI 21390177, 23390142, 25860118]; Japan Science and Technology Agency (JST) [10801043]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	The study was supported by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) (KAKENHI 21390177, 23390142, 25860118) and by Japan Science and Technology Agency (JST), A-step feasibility study program (10801043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Ahmed T, 2011, SYNAPSE, V65, P572, DOI 10.1002/syn.20876; Anraku M, 2001, PHARMACEUT RES, V18, P632, DOI 10.1023/A:1011029226072; Bertucci C, 2002, CURR MED CHEM, V9, P1463, DOI 10.2174/0929867023369673; CHEN RF, 1967, J BIOL CHEM, V242, P173; Cui L, 2007, ANTIMICROB AGENTS CH, V51, P488, DOI 10.1128/AAC.01238-06; Duvoix A, 2005, CANCER LETT, V223, P181, DOI 10.1016/j.canlet.2004.09.041; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Iwao Y, 2006, BBA-PROTEINS PROTEOM, V1764, P743, DOI 10.1016/j.bbapap.2006.01.011; Ji JL, 2012, ANTI-CANCER AGENT ME, V12, P210, DOI 10.2174/187152012800228733; Kim JE, 2003, PHYTOTHER RES, V17, P481, DOI 10.1002/ptr.1179; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; KRAGHHANSEN U, 1988, MOL PHARMACOL, V34, P160; Kunwar A, 2011, FREE RADICAL RES, V45, P959, DOI 10.3109/10715762.2011.571681; Mandeville JS, 2009, J PHARMACEUT BIOMED, V49, P468, DOI 10.1016/j.jpba.2008.11.035; MARUYAMA K, 1985, CHEM PHARM BULL, V33, P5002; MEUCCI E, 1991, J BIOL CHEM, V266, P4692; Mohammadi F, 2009, PROTEIN J, V28, P189, DOI 10.1007/s10930-009-9184-1; PANJEHSHAHIN MR, 1991, BIOCHEM PHARMACOL, V41, P1227, DOI 10.1016/0006-2952(91)90662-O; PERSON RV, 1994, J AM CHEM SOC, V116, P42, DOI 10.1021/ja00080a006; Peters T., 1996, ALL ALBUMIN BIOCH GE; Priyadarsini KI, 2003, FREE RADICAL BIO MED, V35, P475, DOI 10.1016/S0891-5849(03)00325-3; Reddy ACP, 1999, LIPIDS, V34, P1025, DOI 10.1007/s11745-999-0453-x; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Somparn P, 2007, BIOL PHARM BULL, V30, P74, DOI 10.1248/bpb.30.74; SUDLOW G, 1973, MOL PHARMACOL, V9, P649; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; Watanabe H, 2000, BIOCHEM J, V349, P813, DOI 10.1042/bj3490813; Watanabe H, 2001, BIOCHEM J, V357, P269, DOI 10.1042/0264-6021:3570269; Yamasaki K, 1996, BBA-PROTEIN STRUCT M, V1295, P147, DOI 10.1016/0167-4838(96)00013-1; Yamasaki K, 2013, BBA-GEN SUBJECTS, V1830, P5435, DOI 10.1016/j.bbagen.2013.05.005; Yodkeeree S, 2009, J NUTR BIOCHEM, V20, P87, DOI 10.1016/j.jnutbio.2007.12.003; Zsila F, 2003, TETRAHEDRON-ASYMMETR, V14, P2433, DOI 10.1016/S0957-4166(03)00486-5; Zsila F, 2003, BIOCHEM BIOPH RES CO, V301, P776, DOI 10.1016/S0006-291X(03)00030-5	42	16	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87919	10.1371/journal.pone.0087919	http://dx.doi.org/10.1371/journal.pone.0087919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498401	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900147
J	Vilaprinyo, E; Forne, C; Carles, M; Sala, M; Pla, R; Castells, X; Domingo, L; Rue, M				Vilaprinyo, Ester; Forne, Carles; Carles, Misericordia; Sala, Maria; Pla, Roger; Castells, Xavier; Domingo, Laia; Rue, Montserrat		Interval Canc INCA Study Grp	Cost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer	PLOS ONE			English	Article							MAMMOGRAPHY; DENSITY; OVERDIAGNOSIS; WOMEN; AGE; PREDICTION; MORTALITY; PROGRAM; PERFORMANCE; DIAGNOSIS	The one-size-fits-all paradigm in organized screening of breast cancer is shifting towards a personalized approach. The present study has two objectives: 1) To perform an economic evaluation and to assess the harm-benefit ratios of screening strategies that vary in their intensity and interval ages based on breast cancer risk; and 2) To estimate the gain in terms of cost and harm reductions using risk-based screening with respect to the usual practice. We used a probabilistic model and input data from Spanish population registries and screening programs, as well as from clinical studies, to estimate the benefit, harm, and costs over time of 2,624 screening strategies, uniform or risk-based. We defined four risk groups, low, moderate-low, moderate-high and high, based on breast density, family history of breast cancer and personal history of breast biopsy. The risk-based strategies were obtained combining the exam periodicity (annual, biennial, triennial and quinquennial), the starting ages (40, 45 and 50 years) and the ending ages (69 and 74 years) in the four risk groups. Incremental cost-effectiveness and harm-benefit ratios were used to select the optimal strategies. Compared to risk-based strategies, the uniform ones result in a much lower benefit for a specific cost. Reductions close to 10% in costs and higher than 20% in false-positive results and overdiagnosed cases were obtained for risk-based strategies. Optimal screening is characterized by quinquennial or triennial periodicities for the low or moderate risk-groups and annual periodicity for the high-risk group. Risk-based strategies can reduce harm and costs. It is necessary to develop accurate measures of individual risk and to work on how to implement risk-based screening strategies.	[Vilaprinyo, Ester; Forne, Carles; Rue, Montserrat] Biomed Res Inst Lleida IRBLLEIDA, Basic Med Sci Dept, Lleida, Catalonia, Spain; [Vilaprinyo, Ester; Forne, Carles; Rue, Montserrat] Univ Lleida, Basic Med Sci Dept, Lleida, Catalonia, Spain; [Carles, Misericordia] Univ Rovira & Virgili, Dept Econ, E-43201 Reus, Catalonia, Spain; [Carles, Misericordia] Univ Rovira & Virgili, CREIP, E-43201 Reus, Catalonia, Spain; [Sala, Maria; Castells, Xavier; Domingo, Laia] Mar Teaching Hosp, Inst Municipal Invest Med Parc Salut Mar, Dept Epidemiol & Evaluat, Barcelona, Catalonia, Spain; [Sala, Maria; Castells, Xavier; Rue, Montserrat] Hlth Serv Res Network Chron Dis REDISSEC, Bizkaia, Spain; [Pla, Roger] Univ Rovira & Virgili, Dept Surg, E-43201 Reus, Catalonia, Spain; [Pla, Roger] Joan XXIII Teaching Hosp, Gen & Digest Surg Dept, Tarragona, Catalonia, Spain	Universitat de Lleida; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Universitat Rovira i Virgili	Rue, M (corresponding author), Biomed Res Inst Lleida IRBLLEIDA, Basic Med Sci Dept, Lleida, Catalonia, Spain.	montse.rue@cmb.udl.cat	Sala, Maria/H-2562-2013; Lluch, Ana/R-5493-2019; Forne, Carles/R-7652-2016; Rue, Montserrat/B-5663-2009; Macià, Francesc/N-2776-2017; Gregori, Aleix/E-8598-2019; Marcos-Gragera, Rafael/A-1437-2017; Castells, Xavier/S-7798-2016; Cabanell, Josefa Ibáñez/S-1131-2017; Martínez-Alonso, Montserrat/B-5582-2009; Bare, Marisa/H-4806-2011; Blanch, Jordi/K-1685-2017; Vilaprinyo, Ester/A-6702-2010; VICENS, GEMMA RENART/H-1872-2015; Serra, Maria Sala/O-9420-2019; Carles-Lavila, Misericòrdia/AGZ-4035-2022; , 0000-0001-8085-2833/ABI-7466-2020; Domingo, Laia/E-5705-2016	Sala, Maria/0000-0002-9955-8746; Lluch, Ana/0000-0003-2766-407X; Forne, Carles/0000-0002-8133-3274; Rue, Montserrat/0000-0002-7862-9365; Macià, Francesc/0000-0002-6090-5894; Gregori, Aleix/0000-0002-3131-9765; Marcos-Gragera, Rafael/0000-0001-9824-3657; Castells, Xavier/0000-0002-2528-0382; Cabanell, Josefa Ibáñez/0000-0002-7681-310X; Martínez-Alonso, Montserrat/0000-0003-1504-8552; Bare, Marisa/0000-0001-8085-2833; Blanch, Jordi/0000-0001-8211-3292; Vilaprinyo, Ester/0000-0002-5787-5890; VICENS, GEMMA RENART/0000-0001-6037-9225; Serra, Maria Sala/0000-0002-9955-8746; , 0000-0001-8085-2833/0000-0001-8085-2833; Domingo, Laia/0000-0003-4420-0891; Roman, Marta/0000-0001-9076-8918; Tora Suarez, Nuria/0000-0002-3934-4674; Sala Serra, Maria/0000-0002-5516-5967	Spanish Ministry of Health [PS09/01340, PS09/01153]; National Cancer Institute [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, HHSN261201100031C]; NATIONAL CANCER INSTITUTE [U01CA086082, U01CA070040, U01CA070013, U01CA086076, U01CA063740, U01CA069976, U01CA063731, U01CA063736] Funding Source: NIH RePORTER	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by grants PS09/01340 and PS09/01153 from the Health Research Fund (Fondo de Investigacion Sanitaria) of the Spanish Ministry of Health. The authors thank the Breast Cancer Surveillance Consortium and the funding that the BCSC received from the National Cancer Institute (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, and HHSN261201100031C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Radiology (ACR), 2003, ILL BREAST IM REP DA; Ancelle-Park R, 2012, J MED SCREEN, V19, P5, DOI 10.1258/jms.2012.012077; Ayer T, 2012, OPER RES, V60, P1019, DOI 10.1287/opre.1110.1019; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Carles M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-192; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Darabi H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3110; DAY NE, 1984, BIOMETRICS, V40, P1, DOI 10.2307/2530739; de Koning HJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1369; Domingo L, 2010, CANCER CAUSE CONTROL, V21, P1155, DOI 10.1007/s10552-010-9541-6; Erbas B, 2004, CANCER EPIDEM BIOMAR, V13, P1569; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Feuer E, 2006, J NATL CANC I MONOGR, P1; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Izquierdo A, 2008, Med Clin (Barc), V131 Suppl 1, P50; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Joy JE, 2005, SAVING WOMENS LIVES; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Karolinska Institutet, KAR MAMM PROJ RISK P; Karssemeijer N, 2009, RADIOLOGY, V253, P353, DOI 10.1148/radiol.2532090225; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; Kirsh VA, 2011, JNCI-J NATL CANCER I, V103, P942, DOI 10.1093/jnci/djr138; Lee Sandra, 2006, J Natl Cancer Inst Monogr, P79, DOI 10.1093/jncimonographs/lgj011; Lee SJ, 2008, BIOMETRICS, V64, P386, DOI 10.1111/j.1541-0420.2007.00893.x; Lee SJ, 1998, J AM STAT ASSOC, V93, P1271, DOI 10.2307/2670042; Li JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3238; Lidgren M, 2007, QUAL LIFE RES, V16, P1073, DOI 10.1007/s11136-007-9202-8; Bastida JL, 2010, GAC SANIT, V24, P154, DOI 10.1016/j.gaceta.2009.07.011; Mandelblatt JS, 2011, ANN INTERN MED, V155, P58, DOI 10.7326/0003-4819-155-1-201107050-00008; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Martinez-Alonso M, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2620; McCann J, 2001, J MED SCREEN, V8, P77, DOI 10.1136/jms.8.2.77; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Lacasta MJP, 2010, REV ESP SALUD PUBLIC, V84, P691, DOI 10.1590/s1135-57272010000600002; Perry N, 2008, ANN ONCOL, V19, P614, DOI 10.1093/annonc/mdm481; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Roman R, 2012, ANN ONCOL, V23, P104, DOI 10.1093/annonc/mdr032; Rue M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-326; Rue M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-336; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; van Ravesteyn NT, 2012, ANN INTERN MED, V156, P609, DOI 10.7326/0003-4819-156-9-201205010-00002; Vilaprinyo E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-98; Vilaprinyo E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-331; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311; ZELEN M, 1969, BIOMETRIKA, V56, P601, DOI 10.2307/2334668	49	92	92	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86858	10.1371/journal.pone.0086858	http://dx.doi.org/10.1371/journal.pone.0086858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498285	gold, Green Submitted, Green Published			2022-12-25	WOS:000330626900031
J	Campbell, EM; Chao, L				Campbell, Ellsworth M.; Chao, Lin			A Population Model Evaluating the Consequences of the Evolution of Double-Resistance and Tradeoffs on the Benefits of Two-Drug Antibiotic Treatments	PLOS ONE			English	Article							CROSS-RESISTANCE; DRUG-RESISTANCE	The evolution of antibiotic resistance in microbes poses one of the greatest challenges to the management of human health. Because addressing the problem experimentally has been difficult, research on strategies to slow the evolution of resistance through the rational use of antibiotics has resorted to mathematical and computational models. However, despite many advances, several questions remain unsettled. Here we present a population model for rational antibiotic usage by adding three key features that have been overlooked: 1) the maximization of the frequency of uninfected patients in the human population rather than the minimization of antibiotic resistance in the bacterial population, 2) the use of cocktails containing antibiotic pairs, and 3) the imposition of tradeoff constraints on bacterial resistance to multiple drugs. Because of tradeoffs, bacterial resistance does not evolve directionally and the system reaches an equilibrium state. When considering the equilibrium frequency of uninfected patients, both cycling and mixing improve upon single-drug treatment strategies. Mixing outperforms optimal cycling regimens. Cocktails further improve upon aforementioned strategies. Moreover, conditions that increase the population frequency of uninfected patients also increase the recovery rate of infected individual patients. Thus, a rational strategy does not necessarily result in a tragedy of the commons because benefits to the individual patient and general public are not in conflict. Our identification of cocktails as the best strategy when tradeoffs between multiple-resistance are operating could also be extended to other host-pathogen systems. Cocktails or other multiple-drug treatments are additionally attractive because they allow re-using antibiotics whose utility has been negated by the evolution of single resistance.	[Campbell, Ellsworth M.; Chao, Lin] Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Campbell, EM (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	ells@psu.edu						Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Bacon CW, 1996, APPL ENV MICROBIOLOG; Baquero F, 2003, Rev Esp Quimioter, V16, P11; Beardmore RE, 2010, MATH BIOSCI ENG, V7, P527, DOI 10.3934/mbe.2010.7.527; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Bochner BR, 1980, J BACTERIOLOGY; Bollenbach T, 2011, MOL CELL, V42, P413, DOI 10.1016/j.molcel.2011.04.016; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Brown EM, 2005, J ANTIMICROB CHEMOTH, V55, P6, DOI 10.1093/jac/dkh482; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Chait R, 2012, NAT CHEM BIOL, V8, P2, DOI 10.1038/nchembio.745; Chait R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015179; Chao L, 1986, ANBURY REPORT 24 ANT, P71; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Dumon L, 1979, ANTIMICROBIAL AGENTS; Dybul M, 2001, P NATL ACAD SCI USA, V98, P15161, DOI 10.1073/pnas.261568398; Falconer D. S., 1981, INTRO QUANTITATIVE G; Foster K, 2006, PLOS MED, P1; Hall AR, 2011, GENETICS, V187, P817, DOI 10.1534/genetics.110.124628; Hegreness M, 2008, P NATL ACAD SCI USA, V105, P13977, DOI 10.1073/pnas.0805965105; Kunin CM, 1993, ANN INTERNAL MED; Maloy SR, 1981, J BACTERIOLOGY; Michel JB, 2008, DRUG INTERACTIONS MO; Opatowski L, 2011, CURR OPIN INFECT DIS, V24, P279, DOI 10.1097/QCO.0b013e3283462362; Palmer AC, 2010, NATURE CHEM BIOL; Rahal JJ, 1998, JAMA-J AM MED ASSOC, V280, P1233, DOI 10.1001/jama.280.14.1233; RANK GH, 1975, GENETICS, V80, P483; Read AF, 2011, P NATL ACAD SCI USA, V108, P10871, DOI 10.1073/pnas.1100299108; Reading C, 1977, ANTIMICROBIAL AGENTS; Regoes RR, 2004, ANTIMICROB AGENTS CH, V48, P3670, DOI 10.1128/AAC.48.10.3670-3676.2004; Reluga TC, 2005, MATH MED BIOL, V22, P187, DOI 10.1093/imammb/dqi002; Resistance ITFOA, 2012, PUBL HLTH ACT PLAN C, P1; RISKA B, 1986, EVOLUTION, V40, P1303, DOI 10.1111/j.1558-5646.1986.tb05753.x; Roff DA, 2012, EVOLUTION, V66, P2461, DOI 10.1111/j.1558-5646.2012.01634.x; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN, P274; Spagnolo F, 2011, Q REV BIOL, V86, P366, DOI 10.1086/662513; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050; Yeh PJ, 2009, NATURE REV MICROBIOL; zur Wiesch PA, 2011, LANCET INFECT DIS, V11, P236, DOI 10.1016/S1473-3099(10)70264-4	42	8	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86971	10.1371/journal.pone.0086971	http://dx.doi.org/10.1371/journal.pone.0086971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498003	gold, Green Published			2022-12-25	WOS:000330621900052
J	Gardner, JPA; Garton, DW; Collen, JD; Zwartz, D				Gardner, Jonathan P. A.; Garton, David W.; Collen, John D.; Zwartz, Daniel			Distant Storms as Drivers of Environmental Change at Pacific Atolls	PLOS ONE			English	Article							CLIMATE EXTREMES; CLIPPERTON; CYCLONES; WEATHER; FUTURE; ISLAND	The central Pacific Ocean with its many low lying islands and atolls is under threat from sea level rise and increased storm activity. Here, we illustrate how increasing frequency and severity of large scale storm events associated with global climate change may be particularly profound at the local scale for human populations that rely on lagoon systems for provision of a variety of goods and services. In August 2011 a storm originating in the Southern Ocean caused a large amplitude ocean swell to move northward through the Pacific Ocean. Its arrival at Palmyra Atoll coincided with transient elevated sea surface height and triggered turnover of the lagoon water column. This storm-induced change to the lagoon reflects long distance connectivity with propagated wave energy from the Southern Ocean and illustrates the increasing threats generated by climate change that are faced by human populations on most low-lying Pacific islands and atolls.	[Gardner, Jonathan P. A.; Collen, John D.] Victoria Univ Wellington, Ctr Marine Environm & Econ Res, Wellington, New Zealand; [Garton, David W.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Zwartz, Daniel] Victoria Univ Wellington, Antarctic Res Ctr, Wellington, New Zealand	Victoria University Wellington; University System of Georgia; Georgia Institute of Technology; Victoria University Wellington	Gardner, JPA (corresponding author), Victoria Univ Wellington, Ctr Marine Environm & Econ Res, Wellington, New Zealand.	jonathan.gardner@vuw.ac.nz	Gardner, Jonathan/M-3224-2016	Gardner, Jonathan/0000-0002-6943-2413	Victoria University of Wellington (NZ); Georgia Institute of Technology (USA)	Victoria University of Wellington (NZ); Georgia Institute of Technology (USA)	This research was supported by funding from Victoria University of Wellington (NZ) to JPAG, JDC and DZ, and by Georgia Institute of Technology (USA) to DWG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, REGIONAL IMPACTS CLI; Bender FAM, 2012, CLIM DYNAM, V38, P2037, DOI 10.1007/s00382-011-1065-6; Bengtsson L, 2006, J CLIMATE, V19, P3518, DOI 10.1175/JCLI3815.1; Bengtsson L, 2009, J CLIMATE, V22, P2276, DOI 10.1175/2008JCLI2678.1; Changnon SA, 2000, B AM METEOROL SOC, V81, P437, DOI 10.1175/1520-0477(2000)081<0437:HFETIL>2.3.CO;2; Charpy L, 2010, CORAL REEFS, V29, P771, DOI 10.1007/s00338-010-0627-0; Collen JD, 2009, J COASTAL RES, V25, P711, DOI 10.2112/08-1007.1; Collen JD, 2011, MAR POLLUT BULL, V62, P251, DOI 10.1016/j.marpolbul.2010.11.004; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; DAWSON E. YALE, 1959, PACIFIC NAT, V1, P1; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Gardner JPA, 2011, CORAL REEFS, V30, P271, DOI 10.1007/s00338-010-0701-7; Graham NE, 2001, B AM METEOROL SOC, V82, P1869, DOI 10.1175/1520-0477(2001)082<1869:EFIONP>2.3.CO;2; Husson R, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052334; Jost Christian H., 2006, Pacific Conservation Biology, V12, P207; Kettle NP, 2012, J COASTAL RES, V28, P161, DOI 10.2112/JCOASTRES-D-10-00011.1; King DA, 2004, SCIENCE, V303, P176, DOI 10.1126/science.1094329; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kunkel KE, 1999, B AM METEOROL SOC, V80, P1077, DOI 10.1175/1520-0477(1999)080<1077:TFIWAC>2.0.CO;2; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Locke JT, 2009, GEOGR J, V175, P171, DOI 10.1111/j.1475-4959.2008.00317.x; MacAyeal DR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027235; McCauley DJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00409; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; SNODGRAS.FE, 1966, PHILOS TR R SOC S-A, V259, P431, DOI 10.1098/rsta.1966.0022; Tolman H.L., 2009, USER MANUAL SYSTEM D; Trenberth K, 2005, SCIENCE, V308, P1753, DOI 10.1126/science.1112551; Woodroffe CD, 2008, GLOBAL PLANET CHANGE, V62, P77, DOI 10.1016/j.gloplacha.2007.11.001; Zalasiewicz J., 2008, GSA TODAY, V18, P4, DOI DOI 10.1130/GSAT01802A.1	30	5	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87971	10.1371/journal.pone.0087971	http://dx.doi.org/10.1371/journal.pone.0087971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498232	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900200
J	Li, J; Pak, SC; O'Reilly, LP; Benson, JA; Wang, Y; Hidvegi, T; Hale, P; Dippold, C; Ewing, M; Silverman, GA; Perlmutter, DH				Li, Jie; Pak, Stephen C.; O'Reilly, Linda P.; Benson, Joshua A.; Wang, Yan; Hidvegi, Tunda; Hale, Pamela; Dippold, Christine; Ewing, Michael; Silverman, Gary A.; Perlmutter, David H.			Fluphenazine Reduces Proteotoxicity in C-elegans and Mammalian Models of Alpha-1-Antitrypsin Deficiency	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MUTANT ALPHA(1)-ANTITRYPSIN-Z; LIVER-DISEASE; PROTEIN; AUTOPHAGY; DEGRADATION; GENE; FIBROSIS	The classical form of alpha 1-antitrypsin deficiency (ATD) is associated with hepatic fibrosis and hepatocellular carcinoma. It is caused by the proteotoxic effect of a mutant secretory protein that aberrantly accumulates in the endoplasmic reticulum of liver cells. Recently we developed a model of this deficiency in C. Elegans and adapted it for high-content drug screening using an automated, image-based array scanning. Screening of the Library of Pharmacologically Active Compounds identified fluphenazine (Flu) among several other compounds as a drug which reduced intracellular accumulation of mutant alpha 1-antitrypsin Z (ATZ). Because it is representative of the phenothiazine drug class that appears to have autophagy enhancer properties in addition to mood stabilizing activity, and can be relatively easily re-purposed, we further investigated its effects on mutant ATZ. The results indicate that Flu reverses the phenotypic effects of ATZ accumulation in the C. elegans model of ATD at doses which increase the number of autophagosomes in vivo. Furthermore, in nanomolar concentrations, Flu enhances the rate of intracellular degradation of ATZ and reduces the cellular ATZ load in mammalian cell line models. In the PiZ mouse model Flu reduces the accumulation of ATZ in the liver and mediates a decrease in hepatic fibrosis. These results show that Flu can reduce the proteotoxicity of ATZ accumulation in vivo and, because it has been used safely in humans, this drug can be moved rapidly into trials for liver disease due to ATD. The results also provide further validation for drug discovery using C. elegans models that can be adapted to high-content drug screening platforms and used together with mammalian cell line and animal models.	[Li, Jie; Pak, Stephen C.; O'Reilly, Linda P.; Benson, Joshua A.; Wang, Yan; Hidvegi, Tunda; Hale, Pamela; Dippold, Christine; Ewing, Michael; Silverman, Gary A.; Perlmutter, David H.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Silverman, Gary A.; Perlmutter, David H.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Li, Jie; Pak, Stephen C.; O'Reilly, Linda P.; Benson, Joshua A.; Wang, Yan; Hidvegi, Tunda; Hale, Pamela; Dippold, Christine; Ewing, Michael; Silverman, Gary A.; Perlmutter, David H.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Perlmutter, DH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.	david.perlmutter@chp.edu	Silverman, Gary/AAJ-1269-2020	Pak, Stephen/0000-0002-8089-3237	US Public Health Service [DK079806, DK081422, DK076918, P01DK096990]; Hartwell Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079806, R01DK081422, P01DK096990, R01DK076918] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Hartwell Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the US Public Health Service DK079806 (Silverman), DK081422 (Silverman), DK076918 (Perlmutter), P01DK096990 (Perlmutter, Silverman), and a grant from the Hartwell Foundation (Silverman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisson WH, 2007, P NATL ACAD SCI USA, V104, P11927, DOI 10.1073/pnas.0609752104; Chung E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024844; De Preter K, 2009, CLIN CANCER RES, V15, P3690, DOI 10.1158/1078-0432.CCR-08-2699; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Gelling CL, 2012, GENETICS, V192, P889, DOI 10.1534/genetics.112.143487; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; KREMERS MS, 1985, AM J PHYSIOL, V248, pH291, DOI 10.1152/ajpheart.1985.248.2.H291; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maurice N, 2012, CTS-CLIN TRANSL SCI, V5, P289, DOI 10.1111/j.1752-8062.2011.00363.x; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Osterreicher CH, 2009, HEPATOLOGY, V50, P929, DOI 10.1002/hep.23104; Paranjpe S, 2007, HEPATOLOGY, V45, P1471, DOI 10.1002/hep.21570; Perlmutter D.H., 2011, COLD SPRING HARB PER, V3, P181; Perlmutter DH, 2007, HEPATOLOGY, V45, P1313, DOI 10.1002/hep.21628; Perlmutter DH, 2011, ANNU REV MED, V62, P333, DOI 10.1146/annurev-med-042409-151920; POLYA GM, 1983, BIOCHIM BIOPHYS ACTA, V761, P1, DOI 10.1016/0304-4165(83)90355-0; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	25	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87260	10.1371/journal.pone.0087260	http://dx.doi.org/10.1371/journal.pone.0087260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498058	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900080
J	Seifers, DL; Haber, S; Martin, TJ; McCallum, BD				Seifers, Dallas L.; Haber, Steve; Martin, Terry J.; McCallum, Brent D.			Heritable, De Novo Resistance to Leaf Rust and Other Novel Traits in Selfed Descendants of Wheat Responding to Inoculation with Wheat Streak Mosaic Virus	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; ABERRANT RATIO; PLANT; METHYLATION; INHERITANCE; EFFICACY; GENOME	Stable resistance to infection with Wheat streak mosaic virus (WSMV) can be evolved de novo in selfing bread wheat lines subjected to cycles of WSMV inoculation and selection of best-performing plants or tillers. To learn whether this phenomenon might be applied to evolve resistance de novo to pathogens unrelated to WSMV, we examined the responses to leaf rust of succeeding generations of the rust-and WSMV-susceptible cultivar 'Lakin' following WSMV inoculation and derived rust-resistant sublines. After three cycles of the iterative protocol five plants, in contrast to all others, expressed resistance to leaf and stripe rust. A subset of descendant sublines of one of these, 'R1', heritably and uniformly expressed the new trait of resistance to leaf rust. Such sublines, into which no genes from a known source of resistance had been introgressed, conferred resistance to progeny of crosses with susceptible parents. The F-1 populations produced from crosses between, respectively, susceptible and resistant 'Lakin' sublines 4-3-3 and 4-12-3 were not all uniform in their response to seedling inoculation with race TDBG. In seedling tests against TDBG and MKPS races the F(2)s from F-1 populations that were uniformly resistant had 3: 1 ratios of resistant to susceptible individuals but the F(2)s from susceptible F-1 progenitors were uniformly susceptible. True-breeding lines derived from resistant individuals in F-2 populations were resistant to natural stripe and leaf rust inoculum in the field, while the 'Lakin' progenitor was susceptible. The next generation of six of the 'Lakin'-derived lines exhibited moderate to strong de novo resistance to stem rust races TPMK, QFCS and RKQQ in seedling tests while the 'Lakin' progenitor was susceptible. These apparently epigenetic effects in response to virus infection may help researchers fashion a new tool that expands the range of genetic resources already available in adapted germplasm.	[Seifers, Dallas L.; Martin, Terry J.] Kansas State Univ, Agr Res Ctr Hays, Hays, KS USA; [Haber, Steve; McCallum, Brent D.] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada	Kansas State University; Agriculture & Agri Food Canada	Haber, S (corresponding author), Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada.	Steve.Haber@AGR.GC.CA						Akimoto K, 2007, ANN BOT-LONDON, V100, P205, DOI 10.1093/aob/mcm110; ALI I, 1994, PLANT DIS, V78, P383, DOI 10.1094/PD-78-0383; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; BRAKKE MK, 1981, PHYTOPATHOLOGY, V71, P823, DOI 10.1094/Phyto-71-823; BRAKKE MK, 1984, ANNU REV PHYTOPATHOL, V22, P77, DOI 10.1146/annurev.py.22.090184.000453; Browder LE, 1971, USDA AGR RES SERV TE; Brown GN, 1997, EUPHYTICA, V95, P67, DOI 10.1023/A:1002985326256; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Comeau A, 2010, GEN-RES ISSUES, P401; Haber S., 2011, AM J PLANT SCI BIOTE, V5, P95; Haber S, 1993, ANN WHEAT NEWSLETTER, V39, P121; Haber S, 2008, CEREAL RES COMMUN, V36, P63, DOI 10.1556/CRC.36.2008.Suppl.B.10; Harper G, 2002, ANNU REV PHYTOPATHOL, V40, P119, DOI 10.1146/annurev.phyto.40.120301.105642; Hauben M, 2009, P NATL ACAD SCI USA, V106, P20109, DOI 10.1073/pnas.0908755106; Jones AL, 1998, EMBO J, V17, P6385, DOI 10.1093/emboj/17.21.6385; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Lin F, 2007, THEOR APPL GENET, V114, P1277, DOI 10.1007/s00122-007-0518-0; LONG DL, 1989, PHYTOPATHOLOGY, V79, P525, DOI 10.1094/Phyto-79-525; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Martin TJ, 2002, APPL PLANT IN PRESS; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Seifers DL, 2008, PLANT DIS, V92, P808, DOI 10.1094/PDIS-92-5-0808; Seifers DL, 2006, PLANT DIS, V90, P623, DOI 10.1094/PD-90-0623; SEIFERS DL, 1988, PHYTOPATHOLOGY, V78, P703, DOI 10.1094/Phyto-78-703; SEIFERS DL, 1995, PLANT DIS, V79, P1104, DOI 10.1094/PD-79-1104; Shelton DR, 1993, ANN WHEAT NEWSLETTER, V39, P321; Snedecor G.W., 1989, AMES IOWA STATE U PR; SPRAGUE GF, 1963, SCIENCE, V141, P1052, DOI 10.1126/science.141.3585.1052; SPRAGUE GF, 1971, GENETICS, V67, P533; SPRAGUE GF, 1966, GENETICS, V54, P1287; Springer NM, 2013, TRENDS GENET, V29, P241, DOI 10.1016/j.tig.2012.10.009; Wada Y, 2004, MOL GENET GENOMICS, V271, P658, DOI 10.1007/s00438-004-1018-4; Wessler SR, 1996, CURR BIOL, V6, P959, DOI 10.1016/S0960-9822(02)00638-3; Wu SY, 2009, CROP SCI, V49, P1681, DOI 10.2135/cropsci2008.11.0666	36	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86307	10.1371/journal.pone.0086307	http://dx.doi.org/10.1371/journal.pone.0086307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497941	gold, Green Submitted, Green Published			2022-12-25	WOS:000330621900020
J	Tarjuelo, R; Morales, MB; Traba, J; Delgado, MP				Tarjuelo, Rocio; Morales, Manuel B.; Traba, Juan; Delgado, M. Paula			Are Species Coexistence Areas a Good Option for Conservation Management? Applications from Fine Scale Modelling in Two Steppe Birds	PLOS ONE			English	Article							BUSTARD TETRAX-TETRAX; BIOCLIMATE ENVELOPE MODELS; HABITAT SELECTION; CLIMATE-CHANGE; BIOTIC INTERACTIONS; SAMPLE-SIZE; DISTRIBUTIONS; DENSITY; PERFORMANCE; PREDICTION	Biotic interactions and land uses have been proposed as factors that determine the distribution of the species at local scale. The presence of heterospecifics may modify the habitat selection pattern of the individuals and this may have important implications for the design of effective conservation strategies. However, conservation proposals are often focused on a single flagship or umbrella species taken as representative of an entire assemblage requirements. Our aim is to identify and evaluate the role of coexistence areas at local scale as conservation tools, by using distribution data of two endangered birds, the Little Bustard and the Great Bustard. Presence-only based suitability models for each species were built with MaxEnt using variables of substrate type and topography. Probability maps of habitat suitability for each species were combined to generate a map in which coexistence and exclusive use areas were delimitated. Probabilities of suitable habitat for each species inside coexistence and exclusive areas were compared. As expected, habitat requirements of Little and Great Bustards differed. Coexistence areas presented lower probabilities of habitat suitability than exclusive use ones. We conclude that differences in species' habitat preferences can hinder the efficiency of protected areas with multi-species conservation purposes. Our results highlight the importance of taking into account the role of biotic interactions when designing conservation measurements.	[Tarjuelo, Rocio; Morales, Manuel B.; Traba, Juan; Delgado, M. Paula] Univ Autonoma Madrid, Dept Ecol, TEG, Madrid, Spain	Autonomous University of Madrid	Tarjuelo, R (corresponding author), Univ Autonoma Madrid, Dept Ecol, TEG, Madrid, Spain.	rocio.tarjuelo@gmail.com	Delgado, M. Paula/P-5086-2014; Tarjuelo, Rocío/ABG-9983-2020; Morales, Manuel B./B-1448-2014; Traba, Juan/D-9191-2012	Tarjuelo, Rocío/0000-0002-0638-1911; Traba, Juan/0000-0001-6326-8942; Delgado, M. Paula/0000-0002-3776-2354	Spanish Ministry of Education (FPU); Spanish Ministry of Science [CGL2009-13029/BOS]; CAM [S-2009/AMB/1783]; Aeropuerto de Ciudad Real, S. A.	Spanish Ministry of Education (FPU)(Spanish Government); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CAM; Aeropuerto de Ciudad Real, S. A.	R. Tarjuelo was supported by a PhD grant from the Spanish Ministry of Education (FPU). This paper is a contribution to project CGL2009-13029/BOS of the Spanish Ministry of Science, as well as to the REMEDINAL2 network of the CAM (S-2009/AMB/1783). Field work in Ciudad Real was partly supported by Aeropuerto de Ciudad Real, S. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JC, 2004, BIODIVERS CONSERV, V13, P1659, DOI 10.1023/B:BIOC.0000029329.44373.47; Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; [Anonymous], 2010, ASP APPL BIOL; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Aspbury A, 2004, ANIM BEHAV, V67, P1127, DOI 10.1016/j.anbehav.2003.06.021; Braunisch V, 2011, ECOL APPL, V21, P955, DOI 10.1890/09-2167.1; Caro T, 2004, ANIM CONSERV, V7, P63, DOI 10.1017/S136794300300115X; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cramer JS, 2003, LOGIT MODELS FROM EC; Cramp S, 1980, THE BIRDS OF THE WES, VII; Delgado MP, 2013, J ORNITHOL, V154, P469, DOI 10.1007/s10336-012-0914-3; Delgado MP, 2010, ARDEA, V98, P185, DOI 10.5253/078.098.0208; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2007, GIS AND MAPPING SOFT; Garcia de la Morena EL, 2006, EL SISON COMUN EN ES; Gaston KJ, 2003, THE STRUCTURE AND DY; Hampe A, 2004, GLOBAL ECOL BIOGEOGR, V13, P469, DOI 10.1111/j.1466-822X.2004.00090.x; Hanski I., 1999, METAPOPULATION ECOLO; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans R. J., 2012, DISMO SPECIES DISTRI; IUCN, 2012, RED LIST OF THREATEN; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jenness J., 2006, TOPOGRAPHIC POSITION; Jiguet F, 2000, BEHAV PROCESS, V51, P63, DOI 10.1016/S0376-6357(00)00119-4; KOTLER BP, 1988, ANNU REV ECOL SYST, V19, P281, DOI 10.1146/annurev.es.19.110188.001433; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Lane SJ, 2001, J APPL ECOL, V38, P193, DOI 10.1046/j.1365-2664.2001.00577.x; Lapiedra O, 2011, BIOL CONSERV, P2882; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lopez-Jamar J, 2011, BIRD CONSERV INT, V21, P328, DOI 10.1017/S0959270910000535; Martin B, 2009, THESIS; Martin PR, 2001, ECOLOGY, V82, P189, DOI 10.1890/0012-9658(2001)082[0189:EAFCOS]2.0.CO;2; Martin TE, 2001, ECOLOGY, V82, P175, DOI 10.2307/2680095; MARTINEZ C, 1994, BIOL CONSERV, V67, P125, DOI 10.1016/0006-3207(94)90357-3; Martinez-Meyer E, 2006, ORYX, V40, P411, DOI 10.1017/S0030605306001360; Morales MB, 2006, REV ECOL-TERRE VIE, V61, P261; Morales Manuel B., 2002, BWP Update, V4, P217; Morales MB, 2005, ANIM CONSERV, V8, P167, DOI 10.1017/S1367943005001988; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; MORRIS DW, 1989, EVOL ECOL, V3, P80, DOI 10.1007/BF02147934; Palacin C, 2008, ARDEOLA, V55, P13; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2011, ECOLOGICAL NICHES AN; Phillips SJ, 2004, PROCEEDINGS OF THE T; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; Salamolard M, 1999, BIRD STUDY, V46, P25, DOI 10.1080/00063659909461112; Silva JP, 2004, BIOL CONSERV, V117, P521, DOI 10.1016/j.biocon.2003.09.001; Suarez Francisco, 1997, P297; Suarez-Seoane S, 2002, J APPL ECOL, V39, P755, DOI 10.1046/j.1365-2664.2002.00751.x; Titeux N, 2007, BIOL CONSERV, V138, P207, DOI 10.1016/j.biocon.2007.04.019; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wilson CD, 2011, DIVERS DISTRIB, V17, P182, DOI 10.1111/j.1472-4642.2010.00723.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wolff A, 2001, J APPL ECOL, V38, P963, DOI 10.1046/j.1365-2664.2001.00651.x; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016	62	13	14	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87847	10.1371/journal.pone.0087847	http://dx.doi.org/10.1371/journal.pone.0087847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498210	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900183
J	van den Heuvel, JK; Eggels, L; Fliers, E; Kalsbeek, A; Adan, RAH; la Fleur, SE				van den Heuvel, Jose K.; Eggels, Leslie; Fliers, Eric; Kalsbeek, Andries; Adan, Roger A. H.; la Fleur, Susanne E.			Differential Modulation of Arcuate Nucleus and Mesolimbic Gene Expression Levels by Central Leptin in Rats on Short-Term High-Fat High-Sugar Diet	PLOS ONE			English	Article							ENERGY-BALANCE; MESSENGER-RNA; DOPAMINE; RESISTANCE; HYPOTHALAMUS; NEURONS; INSULIN; FOOD; RECEPTORS; ACCUMBENS	Objective: Leptin resistance is a common hallmark of obesity. Rats on a free-choice high-fat high-sugar (fcHFHS) diet are resistant to peripherally administered leptin. The aim of this study was to investigate feeding responses to central leptin as well as the associated changes in mRNA levels in hypothalamic and mesolimbic brain areas. Design and Methods: Rats on a CHOW or fcHFHS diet for 8 days received leptin or vehicle intracerebro(lateral) ventricularly (ICV) and food intake was measured 5 h and 24 h later. Four days later, rats were sacrificed after ICV leptin or vehicle and mRNA levels were quantified for hypothalamic pro-opiomelanocortin (POMC) and neuropeptide Y (NPY) and for preproenkephalin (ppENK) in nucleus accumbens and tyrosine hydroxylase (TH) in ventral tegmental area (VTA). Results: ICV leptin decreased caloric intake both in CHOW and fcHFHS rats. In fcHFHS, leptin preferentially decreased chow and fat intake. Leptin increased POMC and decreased NPY mRNA in CHOW, but not in fcHFHS rats. In CHOW rats, leptin had no effect on ppENK mRNA and decreased TH mRNA. In fcHFHS, leptin decreased ppENK mRNA and increased TH mRNA. Conclusion: Despite peripheral and arcuate leptin resistance, central leptin suppresses feeding in fcHFHS rats. As the VTA and nucleus accumbens are still responsive to leptin, these brain areas may therefore, at least partly, account for the leptininduced feeding suppression in rats on a fcHFHS diet.	[van den Heuvel, Jose K.; Eggels, Leslie; Fliers, Eric; Kalsbeek, Andries; la Fleur, Susanne E.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands; [Kalsbeek, Andries] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Adan, Roger A. H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Utrecht University; Utrecht University Medical Center	la Fleur, SE (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.e.lafleur@amc.uva.nl	Kalsbeek, Andries/H-3076-2019	Kalsbeek, Andries/0000-0001-9606-8453; Fliers, Eric/0000-0001-8048-9050	Netherlands Organization for Scientific Research [ZonMw VIDI 91796331]; ZonMw [TOP 91207036]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ZonMw(Netherlands Organization for Health Research and Development)	This research was supported by the Netherlands Organization for Scientific Research (ZonMw VIDI 91796331); LE was supported by a grant from ZonMw (TOP 91207036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati S, 2007, BIOFACTORS, V31, P133, DOI 10.1002/biof.5520310204; Apolzan JW, 2013, APPETITE, V60, P65, DOI 10.1016/j.appet.2012.09.020; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; Choi YH, 2008, BEHAV BRAIN RES, V188, P100, DOI 10.1016/j.bbr.2007.10.024; Davis JF, 2011, BIOL PSYCHIAT, V69, P668, DOI 10.1016/j.biopsych.2010.08.028; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Fam BC, 2007, DIABETES OBES METAB, V9, P840, DOI 10.1111/j.1463-1326.2006.00653.x; Figlewicz DP, 2006, PHYSIOL BEHAV, V89, P611, DOI 10.1016/j.physbeh.2006.07.023; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; Harris RBS, 2007, ENDOCRINOLOGY, V148, P4623, DOI 10.1210/en.2006-1565; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Krugel U, 2003, EUR J PHARMACOL, V482, P185, DOI 10.1016/j.ejphar.2003.09.047; la Fleur SE, 2010, INT J OBESITY, V34, P537, DOI 10.1038/ijo.2009.257; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Leshan RL, 2010, J NEUROSCI, V30, P5713, DOI 10.1523/JNEUROSCI.1001-10.2010; Li YL, 2009, BRAIN RES, V1268, P181, DOI 10.1016/j.brainres.2009.02.075; MARKS JL, 1992, MOL CELL NEUROSCI, V3, P199, DOI 10.1016/1044-7431(92)90039-5; Matheny M, 2011, NEUROPHARMACOLOGY, V60, P480, DOI 10.1016/j.neuropharm.2010.11.002; Munzberg H, 2010, FORUM NUTR, V63, P123, DOI 10.1159/000264400; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Pecina S, 2003, J NEUROSCI, V23, P9395; Rada P, 2010, PHYSIOL BEHAV, V101, P394, DOI 10.1016/j.physbeh.2010.07.005; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; Roseberry AG, 2007, J NEUROSCI, V27, P7021, DOI 10.1523/JNEUROSCI.1235-07.2007; Scarpace PJ, 2013, NEUROPHARMACOLOGY, V65, P90, DOI 10.1016/j.neuropharm.2012.09.005; Scarpace PJ, 2010, PHYSIOL BEHAV, V100, P173, DOI 10.1016/j.physbeh.2010.02.017; Schiltz CA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-16; Seeley RJ, 1996, HORM METAB RES, V28, P664, DOI 10.1055/s-2007-979874; Sharma S., 2012, INT J OBES LOND; Smagin GN, 1999, AM J PHYSIOL-REG I, V276, pR1461, DOI 10.1152/ajpregu.1999.276.5.R1461; vanDijk G, 1996, AM J PHYSIOL-REG I, V271, pR1096, DOI 10.1152/ajpregu.1996.271.4.R1096; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Verhagen LAW, 2011, EUR NEUROPSYCHOPHARM, V21, P274, DOI 10.1016/j.euroneuro.2010.11.006; Wetzler S, 2005, BEHAV BRAIN RES, V159, P119, DOI 10.1016/j.bbr.2004.10.008; Will MJ, 2007, AM J PHYSIOL-REG I, V292, pR217, DOI 10.1152/ajpregu.00852.2005; Zhang M, 1998, J PHARMACOL EXP THER, V285, P908; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	41	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87729	10.1371/journal.pone.0087729	http://dx.doi.org/10.1371/journal.pone.0087729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498181	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900163
J	Aoki, K; Ueno, S; Kamijo, T; Setoguchi, H; Murakami, N; Kato, M; Tsumura, Y				Aoki, Kyoko; Ueno, Saneyoshi; Kamijo, Takashi; Setoguchi, Hiroaki; Murakami, Noriaki; Kato, Makoto; Tsumura, Yoshihiko			Genetic Differentiation and Genetic Diversity of Castanopsis (Fagaceae), the Dominant Tree Species in Japanese Broadleaved Evergreen Forests, Revealed by Analysis of EST-Associated Microsatellites	PLOS ONE			English	Article							MONGOLICA VAR. CRISPULA; BROAD-LEAVED FORESTS; COMPARATIVE PHYLOGEOGRAPHY; CHLOROPLAST DNA; POPULATION BOTTLENECKS; COMPUTER-PROGRAM; JAPONICA; MARKERS; NUMBER; PACKAGE	The broadleaved evergreen forests of the East Asian warm temperate zone are characterised by their high biodiversity and endemism, and there is therefore a need to extend our understanding of its genetic diversity and phylogeographic patterns. Castanopsis (Fagaceae) is one of the dominant tree species in the broadleaved evergreen forests of Japan. In this study we investigate the genetic diversity, genetic structure and leaf epidermal morphology of 63 natural populations of C. sieboldii and C. cuspidata, using 32 Expressed Sequence Tag associated microsatellites. The overall genetic differentiation between populations was low (G(ST) = 0.069 in C. sieboldii and G(ST) = 0.057 in C. cuspidata). Neighbor-joining tree and Bayesian clustering analyses revealed that the populations of C. sieboldii and C. cuspidata were genetically clearly differentiated, a result which is consistent with the morphology of their epidermal cell layers. This suggests that C. sieboldii and C. cuspidata should be treated as independent species, although intermediate morphologies are often observed, especially at sites where the two species coexist. The higher level of genetic diversity observed in the Kyushu region (for both species) and the Ryukyu Islands (for C. sieboldii) is consistent with the available fossil pollen data for Castanopsis-type broadleaved evergreen trees during the Last Glacial Maximum and suggests the existence of refugia for Castanopsis forests in southern Japan. Within the C. sieboldii populations, Bayesian clustering analyses detected three clusters, in the western and eastern parts of the main islands and in the Ryukyu Islands. The west-east genetic differentiation observed for this species in the main islands, a pattern which is also found in several plant and animal species inhabiting Castanopsis forests in Japan, suggests that they have been isolated from each other in the western and eastern populations for an extended period of time, and may imply the existence of eastern refugia.	[Aoki, Kyoko; Setoguchi, Hiroaki; Kato, Makoto] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan; [Ueno, Saneyoshi; Tsumura, Yoshihiko] Forestry & Forest Prod Res Inst, Dept Forest Genet, Tsukuba, Ibaraki 305, Japan; [Kamijo, Takashi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Murakami, Noriaki] Tokyo Metropolitan Univ, Makino Herbarium, Hachioji, Tokyo, Japan	Kyoto University; Forestry & Forest Products Research Institute - Japan; University of Tsukuba; Tokyo Metropolitan University	Ueno, S (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Genet, Tsukuba, Ibaraki 305, Japan.	saueno@ffpri.affrc.go.jp	Setoguchi, Hiroaki/AAM-5312-2021	Kamijo, Takashi/0000-0003-2827-8568	Ministry of Environment, Japan; Japan Society for the Promotion of Science [1701416, 21770087, 2240030]; Research Institute for Humanity and Nature, Kyoto, Japan	Ministry of Environment, Japan(Ministry of the Environment, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Institute for Humanity and Nature, Kyoto, Japan	This research was partly supported by a grant for research on Genetic Guidelines for Restoration Programs using Genetic Diversity Information from the Ministry of Environment, Japan, Grants-in-Aid from the Japan Society for the Promotion of Science (nos. 1701416, 21770087, and 2240030 to K. A.), and the Research Project "A new cultural and historical exploration into human-nature relationships in the Japanese archipelago" of the Research Institute for Humanity and Nature, Kyoto, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Aoki K, 2003, J PLANT RES, V116, P337, DOI 10.1007/s10265-003-0103-9; Aoki K, 2004, J PLANT RES, V117, P77, DOI 10.1007/s10265-003-0132-4; Aoki Kyoko, 2005, APG Acta Phytotaxonomica et Geobotanica, V56, P55; Aoki Kyoko, 2004, APG Acta Phytotaxonomica et Geobotanica, V55, P125; Aoki Kyoko, 2011, Insects, V2, P128, DOI 10.3390/insects2020128; Arbogast BS, 2001, J BIOGEOGR, V28, P819, DOI 10.1046/j.1365-2699.2001.00594.x; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Cornuet JM, 1996, GENETICS, V144, P2001; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fujii N, 2006, TAXON, V55, P43, DOI 10.2307/25065527; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hattori T, 2002, BIOL CONSERVATION RE, P203; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ito M, 2009, APPL ENTOMOL ZOOL, V44, P549, DOI 10.1303/aez.2009.549; Iwasaki T, 2012, J PLANT RES, V125, P207, DOI 10.1007/s10265-011-0428-8; Iwasaki Takaya, 2010, Acta Phytotaxonomica et Geobotanica, V61, P1; Kamei T., 1981, Quaternary Research (Tokyo), V20, P191; Kawamura T., 1977, KAFUN POLLEN SCI, V11, P8; Kobayashi S, 2008, VEGETATION SCI, V25, P51; Kobayashi S., 2003, J PHYTOGEOGR TAXON, V51, P63; Kobayashi S, 1998, J PHYTOGEOGR TAXON, V46, P187; KURODA T, 1998, ILLUSTRATED VEGETATI, P162; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Maeda Y, 1980, JOMON NO UMI TO MORI; MANTEL N, 1967, CANCER RES, V27, P209; MARUYAMA T, 1985, GENETICS, V111, P675; Matsuoka K., 1998, ILLUSTRATED VEGETATI, P224; Minato M., 1976, JAPANESE ARCHIPELAGO; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakamura K, 2010, J BIOGEOGR, V37, P1907, DOI 10.1111/j.1365-2699.2010.02342.x; Nakanishi Hiroki, 1996, Acta Phytotaxonomica et Geobotanica, V47, P113; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seo Akihiro, 2004, APG Acta Phytotaxonomica et Geobotanica, V55, P29; SETOGUCHI H, 1995, J PLANT RES, V108, P87, DOI 10.1007/BF02344310; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Toda M, 1997, BIOCHEM SYST ECOL, V25, P143, DOI 10.1016/S0305-1978(96)00098-1; Tsukada M, 1974, PALEOECOLOGY 2 SYNTH; Tsumura Y, 2006, TAXON, V55, P53, DOI 10.2307/25065528; Ueno S, 2008, CONSERV GENET, V9, P1083, DOI 10.1007/s10592-007-9462-4; Ueno S, 2008, GENES GENET SYST, V83, P179, DOI 10.1266/ggs.83.179; Ueno S, 2009, CONSERV GENET, V10, P1477, DOI 10.1007/s10592-008-9764-1; Ueno S, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009037; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WENDEL JF, 1985, AM J BOT, V72, P52, DOI 10.2307/2443568; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Yamanaka T., 1966, B FAC ED KOCHI U, V18, P65; YAMAZAKI T, 1987, Journal of Japanese Botany, V62, P289; YAMAZAKI T, 1987, Journal of Japanese Botany, V62, P332; Yoshida T, 2010, J PLANT RES, V123, P607, DOI 10.1007/s10265-009-0287-8; Yumoto T., 1987, Ecological Research, V2, P133, DOI 10.1007/BF02346922	70	31	33	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87429	10.1371/journal.pone.0087429	http://dx.doi.org/10.1371/journal.pone.0087429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498103	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100084
J	Wang, X; Sundquist, J; Zoller, B; Memon, AA; Palmer, K; Sundquist, K; Bennet, L				Wang, Xiao; Sundquist, Jan; Zoller, Bengt; Memon, Ashfaque A.; Palmer, Karolina; Sundquist, Kristina; Bennet, Louise			Determination of 14 Circulating microRNAs in Swedes and Iraqis with and without Diabetes Mellitus Type 2	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MIDDLE-EAST; IMMIGRANTS; PLASMA; EXPRESSION; CANCER; RISK; POPULATION; PREVALENCE; BIOMARKERS	Background: Recent reports suggest that immigrants from Middle Eastern countries are a high-risk group for type 2 diabetes (T2D) compared with Swedes, and that the pathogenesis of T2D may be ethnicity-specific. Deregulation of microRNA (miRNA) expression has been demonstrated to be associated with T2D but ethnic differences in miRNA have not been investigated. The aim of this study was to explore the ethnic specific expression (Swedish and Iraqi) of a panel of 14 previously identified miRNAs in patients without T2D (including those with prediabetes) and T2D. Methods: A total of 152 individuals were included in the study (84 Iraqis and 68 Swedes). Nineteen Iraqis and 14 Swedes were diagnosed with T2D. Expression of the 14 selected miRNAs (miR-15a, miR-20, miR-21, miR-24, miR-29b, miR-126, miR-144, miR-150, miR-197, miR-223, miR-191, miR-320a, miR-486-5p, and miR-28-3p) in plasma samples was measured by real-time PCR. Results: In the whole study population, the expression of miR-24 and miR-29b was significantly different between T2D patients and controls after adjustment for age, sex, waist circumference, family history of T2D, and a sedentary lifestyle. Interestingly, when stratifying the study population according to country of birth, we found that higher expression of miR-144 was significantly associated with T2D in Swedes (OR = 2.43, p = 0.035), but not in Iraqis (OR = 0.54, p = 0.169). The interaction test was significant (p = 0.017). Conclusion: This study suggests that the association between plasma miR-144 expression and T2D differs between Swedes and Iraqis.	[Wang, Xiao; Sundquist, Jan; Zoller, Bengt; Memon, Ashfaque A.; Palmer, Karolina; Sundquist, Kristina; Bennet, Louise] Lund Univ Reg Skane, Ctr Primary Hlth Care Res, Lund, Sweden; [Sundquist, Jan; Sundquist, Kristina] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA	Lund University; Stanford University	Wang, X (corresponding author), Lund Univ Reg Skane, Ctr Primary Hlth Care Res, Lund, Sweden.	xiao.wang@med.lu.se	Zöller, Bengt/M-3217-2019; Zöller, Bengt/H-8856-2012	Zöller, Bengt/0000-0002-8250-5613; Zöller, Bengt/0000-0002-8250-5613; Bennet, Louise/0000-0001-7101-1290; Memon, Ashfaque/0000-0002-1081-3553	Swedish Society of Medicine; Swedish Research Council; ALF; FoU from Region Skane	Swedish Society of Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF; FoU from Region Skane	This study was funded by ALF funding, FoU grants from Region Skane, and a grant from the Swedish Society of Medicine awarded to LB; grants awarded to JS and KS by the Swedish Research Council; and an ALF project grant (Drs Bennet; Jan Sundquist and Kristina Sundquist). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bener A, 2005, CROAT MED J, V46, P302; Bennet L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-303; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bovell LC, 2013, CLIN CANCER RES, V19, P3955, DOI 10.1158/1078-0432.CCR-12-3302; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Faskunger J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-304; Feng Biao, 2012, ISRN Endocrinol, V2012, P549875, DOI 10.5402/2012/549875; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Gidlof O, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-12; Glans F, 2008, DIABETIC MED, V25, P303, DOI 10.1111/j.1464-5491.2007.02366.x; Guay C, 2013, NAT REV ENDOCRINOL; Jonsson LS, 2013, J PUBLIC HEALTH-UK, V35, P270, DOI 10.1093/pubmed/fds091; Karolina DS, 2012, J CLIN ENDOCR METAB, V97, pE2271, DOI 10.1210/jc.2012-1996; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kim YJ, 2012, STEM CELLS DEV, V21, P1749, DOI 10.1089/scd.2011.0429; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Ling HY, 2012, EXP CLIN ENDOCR DIAB, V120, P553, DOI 10.1055/s-0032-1311644; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pandey AK, 2009, CELL PHYSIOL BIOCHEM, V23, P221, DOI 10.1159/000218169; Park SY, 2013, ARCH PHARM RES, V36, P154, DOI 10.1007/s12272-013-0017-6; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Radom-Aizik S, 2010, J APPL PHYSIOL, V109, P252, DOI 10.1152/japplphysiol.01291.2009; Rutanen J, 2010, DIABETES, V59, P829, DOI 10.2337/db09-1191; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Sun LL, 2011, DIABETES RES CLIN PR, V91, P94, DOI 10.1016/j.diabres.2010.11.006; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wandell PE, 2008, DIABETES METAB, V34, P328, DOI 10.1016/j.diabet.2008.01.012; Wang YL, 2009, CURR OPIN MOL THER, V11, P292; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; WMA, 2008, DECLARATION HELSINKI; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	45	58	62	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86792	10.1371/journal.pone.0086792	http://dx.doi.org/10.1371/journal.pone.0086792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497980	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100032
J	Mahapatra, S; Albrecht, M; Behrens, B; Jirmo, A; Behrens, G; Hartwig, C; Neumann, D; Raap, U; Bahre, H; Herrick, C; Dittrich, AM				Mahapatra, Subhashree; Albrecht, Melanie; Behrens, Barbara; Jirmo, Adan; Behrens, Georg; Hartwig, Christina; Neumann, Detlef; Raap, Ulrike; Baehre, Heike; Herrick, Christina; Dittrich, Anna-Maria			Delineating the Role of Histamine-1-and-4-Receptors in a Mouse Model of Th2-Dependent Antigen-Specific Skin Inflammation	PLOS ONE			English	Article							HISTAMINE H-4 RECEPTOR; ATOPIC-DERMATITIS; DENDRITIC CELLS; TH2 CELLS; T-CELLS; MURINE; ANTAGONISTS; MIGRATION; EFFECTOR	Background: Histamine drives pruritus in allergic skin diseases which clinically constitutes a most disruptive symptom. Skin pathology in allergic skin diseases is crucially influenced by different T-helper subsets. However, the contribution of different histamine-receptors to T-helper cell dependent skin pathology has not been definitively answered. Models which can specifically address the functional role of T-helper subsets and the mediators involved are therefore valuable to gain further insights into molecular pathways which contribute to allergic skin disease. They might also be helpful to probe amendable therapeutic interventions such as histamine-receptor antagonism. Objective: Establishing an adoptive transfer model for antigen-specific Th cells, we aimed to delineate the role of histamine H-1- and H-4-receptors in Th2-dependent skin inflammation. Methods: In-vitro differentiated and OVA primed Th2 cells were adoptively transferred into congenic recipient mice. In vivo treatment with specific histamine H-1- and H-4-receptor antagonists was performed to analyze the contribution of these histamine-receptors to Th2-dependent skin pathology in our model. Analysis four days after epicutaneous challenge comprised skin histology, flow cytometric detection of transferred T-helper cells and analysis of antigen-cytokine profiles in skin-draining lymph nodes. Results: Use of specific H-1- and H-4-receptor antagonists revealed a crucial role for H-1- and H-4-receptors for Th2 migration and cytokine secretion in a Th2-driven model of skin inflammation. While H-1- and H-4-receptor antagonists both reduced Th2 recruitment to the site of challenge, local cytokine responses in skin-draining lymph nodes were only reduced by the combined application of H-1- and H-4-receptor antagonists and mast cell counts remained altogether unchanged by either H1R-, H4R- or combined antagonism. Conclusion: Our model demonstrates a role for H-1- and H-4-receptors in Th2 cell infiltration and cytokine secretion in allergic skin diseases and suggests further studies to evaluate these findings for therapeutic approaches.	[Mahapatra, Subhashree; Albrecht, Melanie; Behrens, Barbara; Dittrich, Anna-Maria] Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Hannover, Germany; [Jirmo, Adan; Behrens, Georg] Hannover Med Sch, Dept Clin Immunol & Rheumatol, Hannover, Germany; [Hartwig, Christina; Neumann, Detlef; Baehre, Heike] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Raap, Ulrike] Hannover Med Sch, Dept Dermatol & Allergy, Hannover, Germany; [Herrick, Christina] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Yale University	Dittrich, AM (corresponding author), Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Hannover, Germany.	Dittrich.Anna-Maria@MH-Hannover.de	Dittrich, Anna Maria/M-5640-2013; Dittrich, Anna/GRY-6738-2022; Behrens, Georg MN/Q-4486-2016; Bähre, Heike/AAL-7873-2021; Neumann, Detlef/F-6182-2011	Neumann, Detlef/0000-0003-0145-7507; Kloth, Christina/0000-0001-6672-3808; Jirmo, Adan Chari/0000-0002-4693-0081	Hannover Biomedical Research School (HBRS); PhD program "Molecular Medicine.''; German Research Foundation (DFG);  [DFG/GRK 1441/1];  [DFG/SFB587/N0]	Hannover Biomedical Research School (HBRS); PhD program "Molecular Medicine.''; German Research Foundation (DFG)(German Research Foundation (DFG)); ; 	The project was funded by DFG/GRK 1441/1: Regulation of allergic inflammation in the lung and skin and by DFG/SFB587/N0 to Dr. Dittrich. Subhashree Mahapatra was supported by the Hannover Biomedical Research School (HBRS) and the PhD program "Molecular Medicine.'' Publication was supported by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2006, ALLERGY, V61, P969, DOI 10.1111/j.1398-9995.2006.01153.x; Albrecht M, 2011, J ALLERGY CLIN IMMUN; Baumer W, 2008, ALLERGY, V63, P1387, DOI 10.1111/j.1398-9995.2008.01720.x; Baumer W, 2011, EXP DERMATOL, V20, P577, DOI 10.1111/j.1600-0625.2011.01268.x; Beermann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030285; Bryce PJ, 2006, J CLIN INVEST, V116, P1624, DOI 10.1172/JCI26150; BUTLER JM, 1983, J ALLERGY CLIN IMMUN, V71, P490, DOI 10.1016/0091-6749(83)90467-0; Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682; Cavani A, 2001, TRENDS IMMUNOL, V22, P118, DOI 10.1016/S1471-4906(00)01815-9; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Dunford PJ, 2007, J ALLERGY CLIN IMMUN, V119, P176, DOI 10.1016/j.jaci.2006.08.034; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Gschwandtner M, 2010, ALLERGY, V65, P840, DOI 10.1111/j.1398-9995.2009.02279.x; Gutzmer R, 2009, J ALLERGY CLIN IMMUN, V123, P619, DOI 10.1016/j.jaci.2008.12.1110; Herrick CA, 2003, J IMMUNOL, V170, P2488, DOI 10.4049/jimmunol.170.5.2488; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Jin HL, 2009, J INVEST DERMATOL, V129, P31, DOI 10.1038/jid.2008.106; Jutel M, 2009, CLIN EXP ALLERGY, V39, P1786, DOI 10.1111/j.1365-2222.2009.03374.x; Lee SH, 2010, J VET SCI, V11, P35, DOI 10.4142/jvs.2010.11.1.35; Matsushita A, 2012, EXP DERMATOL, V21, P714, DOI 10.1111/j.1600-0625.2012.01559.x; Orita K, 2011, EXP DERMATOL, V20, P911, DOI 10.1111/j.1600-0625.2011.01360.x; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Qin ZH, 1997, J IMMUNOL, V159, P770; Rossbach K, 2009, EXP DERMATOL, V18, P57, DOI 10.1111/j.1600-0625.2008.00762.x; Sehra S, 2010, J IMMUNOL, V184, P3186, DOI 10.4049/jimmunol.0901860; Seike M, 2010, ALLERGY, V65, P319, DOI 10.1111/j.1398-9995.2009.02240.x; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Srivastava KD, 2005, J ALLERGY CLIN IMMUN, V115, P171, DOI 10.1016/j.jaci.2004.10.003; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8	31	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87296	10.1371/journal.pone.0087296	http://dx.doi.org/10.1371/journal.pone.0087296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503582	Green Submitted, gold, Green Published			2022-12-25	WOS:000330631800027
J	Cavalcante, A; Mansouri, A; Kacha, L; Barros, AK; Takeuchi, Y; Matsumoto, N; Ohnishi, N				Cavalcante, Andre; Mansouri, Ahmed; Kacha, Lemya; Barros, Allan Kardec; Takeuchi, Yoshinori; Matsumoto, Naoji; Ohnishi, Noboru			Measuring Streetscape Complexity Based on the Statistics of Local Contrast and Spatial Frequency	PLOS ONE			English	Article							VISUAL COMPLEXITY; RECEPTIVE-FIELDS; IMAGES; EDGE	Streetscapes are basic urban elements which play a major role in the livability of a city. The visual complexity of streetscapes is known to influence how people behave in such built spaces. However, how and which characteristics of a visual scene influence our perception of complexity have yet to be fully understood. This study proposes a method to evaluate the complexity perceived in streetscapes based on the statistics of local contrast and spatial frequency. Here, 74 streetscape images from four cities, including daytime and nighttime scenes, were ranked for complexity by 40 participants. Image processing was then used to locally segment contrast and spatial frequency in the streetscapes. The statistics of these characteristics were extracted and later combined to form a single objective measure. The direct use of statistics revealed structural or morphological patterns in streetscapes related to the perception of complexity. Furthermore, in comparison to conventional measures of visual complexity, the proposed objective measure exhibits a higher correlation with the opinion of the participants. Also, the performance of this method is more robust regarding different time scenarios.	[Cavalcante, Andre; Ohnishi, Noboru] Nagoya Univ, Dept Media Sci, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Mansouri, Ahmed; Kacha, Lemya; Matsumoto, Naoji] Nagoya Inst Technol, Dept Architecture, Nagoya, Aichi, Japan; [Barros, Allan Kardec] Univ Fed Maranhao, Dept Elect Engn & Elect, Sao Luis, Maranhao, Brazil; [Takeuchi, Yoshinori] Daido Univ, Sch Informat, Dept Informat Syst, Nagoya, Aichi, Japan	Nagoya University; Nagoya Institute of Technology; Universidade Federal do Maranhao	Cavalcante, A (corresponding author), Nagoya Univ, Dept Media Sci, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan.	andre@ohnishi.m.is.nagoya-u.ac.jp	Kacha, Lemya/GYD-8350-2022; Barros, Allan Kardec/ABD-5032-2021	Kacha, Lemya/0000-0002-2527-5356; Barros, Allan Kardec/0000-0002-1654-0955; Mansouri, Ahmed/0000-0002-4243-0426	Hori Sciences & Arts Foundation	Hori Sciences & Arts Foundation	The authors acknowledge funding from The Hori Sciences & Arts Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht DG, 1982, J NEUROPHYSIOLOGY, V43; ATTNEAVE F, 1957, J EXP PSYCHOL, V53, P221, DOI 10.1037/h0043921; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; BERLYNE DE, 1970, PERCEPT PSYCHOPHYS, V8, P279, DOI 10.3758/BF03212593; Bex PJ, 2009, J VISION, V9, DOI 10.1167/9.10.1; Blakemore CT, 1969, J PHYSL, V203; Campbell F, 1968, J PHYSL, V197; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V186, P558, DOI 10.1113/jphysiol.1966.sp008056; Cavalcante A, 2011, LECT NOTES COMPUT SC, V7062, P54, DOI 10.1007/978-3-642-24955-6_7; Chikhman V, 2012, PERCEPTION, V41, P631, DOI 10.1068/p6987; Cooper J, 2003, URBAN MORPHOL, V7, P73; DEAN AF, 1981, J PHYSIOL-LONDON, V318, P413; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Donderi DC, 2006, PERCEPTION, V35, P823, DOI 10.1068/p5249; Edquist J, 2012, ACCIDENT ANAL PREV, V45, P759, DOI 10.1016/j.aap.2011.10.001; Elsheshtawy Y, 1997, J ARCHIT PLAN RES, V14, P301; Ewing R, 2013, PEDESTRAIN TRANSIT O; Ewing Reid, 2006, J Phys Act Health, V3, pS223, DOI 10.1123/jpah.3.s1.s223; Ewing R, 2009, J URBAN DES, V14, P65, DOI 10.1080/13574800802451155; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Forsythe A, 2011, BRIT J PSYCHOL, V102, P49, DOI 10.1348/000712610X498958; Forsythe A, 2003, BEHAV RES METH INS C, V35, P334, DOI 10.3758/BF03202562; Frazor RA, 2006, VISION RES, V46, P1585, DOI 10.1016/j.visres.2005.06.038; Ginsburg A, 1986, HDB PERCEPTION HUMAN, V34; Ginsburg A, 1971, IEEE T AER EL SYST; Hecht S, 1928, J GEN PHYSIOL, V11, P255, DOI 10.1085/jgp.11.3.255; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Jahn G, 2005, TRANSPORT RES F-TRAF, V8, P255, DOI 10.1016/j.trf.2005.04.009; KAPLAN S, 1972, PERCEPT PSYCHOPHYS, V12, P354, DOI 10.3758/BF03207221; Liapis S, 1998, P EUR SIGN PROC C, P1341; Mansouri L, 2013, AIJ J ARCHITECTURE P, V78, P625; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Murray SO, 2003, CEREB CORTEX, V13, P508, DOI 10.1093/cercor/13.5.508; NASANEN R, 1993, VISION RES, V33, P903, DOI 10.1016/0042-6989(93)90073-6; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; PELI E, 1990, J OPT SOC AM A, V7, P2032, DOI 10.1364/JOSAA.7.002032; PIOTROWSKI LN, 1982, PERCEPTION, V11, P337, DOI 10.1068/p110337; Plainis S, 2002, OPHTHAL PHYSL OPT, V22, P409, DOI 10.1046/j.1475-1313.2002.00076.x; Rapoport A., 1987, PUBLIC STREETS PUBLI, P80; Rosenholtz R., 2005, P SIGCHI C HUM FACT, P761, DOI [10.1145/1054972.1055078, DOI 10.1145/1054972.1055078]; Rosenholtz R, 2007, J VISION, V7, DOI 10.1167/7.2.17; Rudin-Brown CM, 2014, SAFETY SCI, V62, P121, DOI 10.1016/j.ssci.2013.08.012; SHAPLEY RM, 1973, J PHYSIOL-LONDON, V229, P165, DOI 10.1113/jphysiol.1973.sp010133; Tolhurst DJ, 1972, VISION RES, V5; Wang JZ, 2001, IEEE T PATTERN ANAL, V23, P85, DOI 10.1109/34.899949; Wanstrom Lindh U, 2012, THESIS U GOTHENBURG; Willmore B, 2001, NETWORK, V12; Yannis G, 2013, INT J INJ CONTROL SA, V20, P111, DOI 10.1080/17457300.2012.686042	51	17	17	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87097	10.1371/journal.pone.0087097	http://dx.doi.org/10.1371/journal.pone.0087097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498292	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900038
J	Curran, J; Tang, LF; Roof, SR; Velmurugan, S; Millard, A; Shonts, S; Wang, HL; Santiago, D; Ahmad, U; Perryman, M; Bers, DM; Mohler, PJ; Ziolo, MT; Shannon, TR				Curran, Jerry; Tang, Lifei; Roof, Steve R.; Velmurugan, Sathya; Millard, Ashley; Shonts, Stephen; Wang, Honglan; Santiago, Demetrio; Ahmad, Usama; Perryman, Matthew; Bers, Donald M.; Mohler, Peter J.; Ziolo, Mark T.; Shannon, Thomas R.			Nitric Oxide-Dependent Activation of CaMKII Increases Diastolic Sarcoplasmic Reticulum Calcium Release in Cardiac Myocytes in Response to Adrenergic Stimulation	PLOS ONE			English	Article							CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; HEART-FAILURE; CA2+ LEAK; S-NITROSYLATION; SYNTHASE; PATHWAY; CONTRACTION; ENHANCEMENT; HYPERTROPHY; ARRHYTHMIA	Spontaneous calcium waves in cardiac myocytes are caused by diastolic sarcoplasmic reticulum release (SR Ca2+ leak) through ryanodine receptors. Beta-adrenergic (beta-AR) tone is known to increase this leak through the activation of Ca-calmodulin-dependent protein kinase (CaMKII) and the subsequent phosphorylation of the ryanodine receptor. When beta-AR drive is chronic, as observed in heart failure, this CaMKII-dependent effect is exaggerated and becomes potentially arrhythmogenic. Recent evidence has indicated that CaMKII activation can be regulated by cellular oxidizing agents, such as reactive oxygen species. Here, we investigate how the cellular second messenger, nitric oxide, mediates CaMKII activity downstream of the adrenergic signaling cascade and promotes the generation of arrhythmogenic spontaneous Ca2+ waves in intact cardiomyocytes. Both SCaWs and SR Ca2+ leak were measured in intact rabbit and mouse ventricular myocytes loaded with the Ca-dependent fluorescent dye, fluo-4. CaMKII activity in vitro and immunoblotting for phosphorylated residues on CaMKII, nitric oxide synthase, and Akt were measured to confirm activity of these enzymes as part of the adrenergic cascade. We demonstrate that stimulation of the beta-AR pathway by isoproterenol increased the CaMKII-dependent SR Ca2+ leak. This increased leak was prevented by inhibition of nitric oxide synthase 1 but not nitric oxide synthase 3. In ventricular myocytes isolated from wild-type mice, isoproterenol stimulation also increased the CaMKII-dependent leak. Critically, in myocytes isolated from nitric oxide synthase 1 knock-out mice this effect is ablated. We show that isoproterenol stimulation leads to an increase in nitric oxide production, and nitric oxide alone is sufficient to activate CaMKII and increase SR Ca2+ leak. Mechanistically, our data links Akt to nitric oxide synthase 1 activation downstream of beta-AR stimulation. Collectively, this evidence supports the hypothesis that CaMKII is regulated by nitric oxide as part of the adrenergic cascade leading to arrhythmogenesis.	[Curran, Jerry; Tang, Lifei; Roof, Steve R.; Wang, Honglan; Mohler, Peter J.; Ziolo, Mark T.] Ohio State Univ, Dept Physiol & Cell Biol, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Velmurugan, Sathya; Millard, Ashley; Shonts, Stephen; Santiago, Demetrio; Ahmad, Usama; Perryman, Matthew; Shannon, Thomas R.] Rush Univ, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA; [Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University System of Ohio; Ohio State University; Rush University; University of California System; University of California Davis	Ziolo, MT (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	Ziolo.1@osu.edu; tom_shannon@rush.edu	Ziolo, Mark/E-4371-2011; Santiago, Demetrio J/L-7366-2017; Santiago, Demetrio J./AAV-2525-2020; Curran, Jerry W/B-9762-2012; Velmurugan, Sathya/AAD-6646-2021	Santiago, Demetrio J/0000-0002-1541-8034; Santiago, Demetrio J./0000-0002-1541-8034; velmurugan, sathya/0000-0003-0769-8424; Bers, Donald/0000-0002-2237-9483	National Institutes of Health [HL114252, K02HL094692, HL071893]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071893, R37HL030077, R01HL030077, F32HL114252, R01HL105242, K02HL094692, P01HL080101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health [HL114252 to JC]; [K02HL094692 to MTZ]; [HL071893 to TRS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; BERS DM, 1993, CARDIOVASC RES, V27, P1772, DOI 10.1093/cvr/27.10.1772; Bers DM, 2001, CIRC RES, V89, P373, DOI 10.1161/res.89.5.373; Bovo E, 2012, J PHYSIOL-LONDON, V590, P3291, DOI 10.1113/jphysiol.2012.230748; Curran J, 2010, J MOL CELL CARDIOL; Curran J, 2007, CIRC RES, V100, P391, DOI 10.1161/01.RES.0000258172.74570.e6; Cutler MJ, 2012, P NATL ACAD SCI USA, V109, P18186, DOI 10.1073/pnas.1210565109; Dibb KM, 2007, CELL CALCIUM, V42, P503, DOI 10.1016/j.ceca.2007.04.002; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2013, NATURE; Ferrero P, 2007, J MOL CELL CARDIOL, V43, P281, DOI 10.1016/j.yjmcc.2007.05.022; Grimm M, 2010, J MOL CELL CARDIOL, V48, P322, DOI 10.1016/j.yjmcc.2009.10.016; Gutierrez DA, 2013, CARDIOVASC RES, V100, P392, DOI 10.1093/cvr/cvt201; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; Hobai IA, 2001, CIRCULATION, V103, P1577; Hoch B, 1999, CIRC RES, V84, P713, DOI 10.1161/01.RES.84.6.713; Kanai AJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1371, DOI 10.1152/ajpcell.1997.273.4.C1371; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; Li JM, 2002, HYPERTENSION, V40, P477, DOI 10.1161/01.HYP.0000032031.30374.32; Mangmool S, 2010, J CELL BIOL; Morimoto S, 2009, BIOCHEM BIOPH RES CO, V390, P87, DOI 10.1016/j.bbrc.2009.09.071; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Pereira L, 2007, J PHYSIOL-LONDON, V583, P685, DOI 10.1113/jphysiol.2007.133066; Pereira L, 2013, CIRCULATION, V127, P913, DOI 10.1161/CIRCULATIONAHA.12.148619; Salama G, 2000, ANTIOXID REDOX SIGN, V2, P5, DOI 10.1089/ars.2000.2.1-5; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Traynham CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052005; Wang H, 2008, AM J PHYSIOL-CELL PH, V294, pC1566, DOI 10.1152/ajpcell.00367.2007; Wang HL, 2010, J PHYSIOL-LONDON, V588, P2905, DOI 10.1113/jphysiol.2010.192617; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang XY, 2013, CIRC RES, V112, P498, DOI 10.1161/CIRCRESAHA.112.273896; Ziolo MT, 2008, NITRIC OXIDE-BIOL CH, V18, P153, DOI 10.1016/j.niox.2008.01.008	38	48	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87495	10.1371/journal.pone.0087495	http://dx.doi.org/10.1371/journal.pone.0087495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498331	Green Published, gold			2022-12-25	WOS:000330626900077
J	Guenthner, CJ; Luitje, ME; Pyle, LA; Molyneux, PC; Yu, JK; Li, AS; Leise, TL; Harrington, ME				Guenthner, Casey J.; Luitje, Martha E.; Pyle, Lorna A.; Molyneux, Penny C.; Yu, Jimmy K.; Li, Alexander S.; Leise, Tanya L.; Harrington, Mary E.			Circadian Rhythms of PER2::LUC in Individual Primary Mouse Hepatocytes and Cultures	PLOS ONE			English	Article							GENE-EXPRESSION; REVEALS PERSISTENT; PERIPHERAL-TISSUES; CLOCK; TIME; LIVER; MICE; TRANSCRIPTION; OSCILLATIONS; FIBROBLASTS	Background: Hepatocytes, the parenchymal cells of the liver, express core clock genes, such as Period2 and Cryptochrome2, which are involved in the transcriptional/translational feedback loop of the circadian clock. Whether or not the liver is capable of sustaining rhythms independent of a central pacemaker is controversial. Whether and how circadian information may be shared among cells in the liver in order to sustain oscillations is currently unknown. Results: In this study we isolated primary hepatocytes from transgenic Per2(Luc) mice and used bioluminescence as a read-out of the state of the circadian clock. Hepatocytes cultured in a collagen gel sandwich configuration exhibited persistent circadian rhythms for several weeks. The amplitude of the rhythms damped, but medium changes consistently reset the phase and amplitude of the cultures. Cry2(-/-) Per2(Luc) cells oscillated robustly and expressed a longer period. Co-culturing with wildtype cells did not significantly shorten the period, indicating that coupling among hepatocytes is insufficient to synchronize cells with significantly differing periods. However, spatial patterns revealed by cellular imaging of wildtype cultures provided evidence of weak local coupling among the hepatocytes. Conclusions: Our results with primary hepatocyte cultures demonstrate that cultured hepatocytes are weakly coupled. While this coupling is not sufficient to sustain global synchrony, it does increase local synchrony, which may stabilize the circadian rhythms of peripheral oscillators, such as the liver, against noise in the entraining signals.	[Guenthner, Casey J.; Luitje, Martha E.; Pyle, Lorna A.; Molyneux, Penny C.; Harrington, Mary E.] Smith Coll, Neurosci Program, Northampton, MA 01063 USA; [Yu, Jimmy K.; Li, Alexander S.; Leise, Tanya L.] Amherst Coll, Dept Math, Amherst, MA 01002 USA	Smith College; Amherst College	Harrington, ME (corresponding author), Smith Coll, Neurosci Program, Northampton, MA 01063 USA.	mharring@smith.edu		Leise, Tanya/0000-0002-7458-7604; Luitje, Martha/0000-0001-9847-9475; Yu, Jimmy/0000-0001-8536-4038	NSF [RUI: 1051716, 1129152]; Arnold and Mabel Beckman Foundation	NSF(National Science Foundation (NSF)); Arnold and Mabel Beckman Foundation	This work was supported by: NSF RUI: 1051716 (Intercellular coupling of circadian clocks in the liver) http://www.nsf.gov/, NSF 1129152 (UBM-Institutional-Collaborative Research: The Four-College Biomath Consortium) http://www.nsf.gov/, Smith College STRIDE http://www.smith.edu/, The Arnold and Mabel Beckman Foundation, Beckman Scholars Program http://www.beckman-foundation.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; EVANS J, 2011, TLS TIMES LIT S 0909, P6, DOI DOI 10.1371/J0URNAL.P0NE.0015869); Evans JA, 2013, PROG MOL BIOL TRANSL, V119, P283, DOI 10.1016/B978-0-12-396971-2.00010-5; Gachon F, 2011, EXPERT OPIN DRUG MET, V7, P147, DOI 10.1517/17425255.2011.544251; Gerber A, 2013, CELL, V152, P492, DOI 10.1016/j.cell.2012.12.027; Guo HG, 2006, J NEUROSCI, V26, P6406, DOI 10.1523/JNEUROSCI.4676-05.2006; Hughes ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002835; Kalsbeek A, 2006, CHRONOBIOL INT, V23, P201, DOI 10.1080/07420520500464528; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Koyanagi S, 2002, MOL PHARMACOL, V62, P1393, DOI 10.1124/mol.62.6.1393; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Leise TL, 2013, J BIOL RHYTHM, V28, P62, DOI 10.1177/0748730412468693; Leise TL, 2011, J BIOL RHYTHM, V26, P454, DOI 10.1177/0748730411416330; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Noguchi T, 2013, J BIOL RHYTHM, V28, P183, DOI 10.1177/0748730413487494; O'Neill John S, 2013, Handb Exp Pharmacol, P67, DOI 10.1007/978-3-642-25950-0_4; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Rougemont J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100130; SAEZ JC, 1989, AM J PHYSIOL, V257, pC1, DOI 10.1152/ajpcell.1989.257.1.C1; Saini C, 2013, GENE DEV, V27, P1526, DOI 10.1101/gad.221374.113; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shang ZX, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-23; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yamajuku D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00439; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	41	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87573	10.1371/journal.pone.0087573	http://dx.doi.org/10.1371/journal.pone.0087573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498336	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900082
J	Nunes, MC; Kuschner, Z; Rabede, Z; Madimabe, R; Van Niekerk, N; Moloi, J; Kuwanda, L; Rossen, JW; Klugman, KP; Adrian, PV; Madhi, SA				Nunes, Marta C.; Kuschner, Zachary; Rabede, Zelda; Madimabe, Richard; Van Niekerk, Nadia; Moloi, Jackie; Kuwanda, Locadiah; Rossen, John W.; Klugman, Keith P.; Adrian, Peter V.; Madhi, Shabir A.			Clinical Epidemiology of Bocavirus, Rhinovirus, Two Polyomaviruses and Four Coronaviruses in HIV-Infected and HIV-Uninfected South African Children	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; PNEUMOCOCCAL CONJUGATE VACCINE; HOSPITALIZED CHILDREN; PNEUMONIA ETIOLOGY; WU POLYOMAVIRUS; YOUNG-CHILDREN; VIRUS; DISEASE; MULTIPLE; CARE	Background: Advances in molecular diagnostics have implicated newly-discovered respiratory viruses in the pathogenesis of pneumonia. We aimed to determine the prevalence and clinical characteristics of human bocavirus (hBoV), human rhinovirus (hRV), polyomavirus-WU (WUPyV) and -KI (KIPyV) and human coronaviruses (CoV)-OC43, -NL63, -HKU1 and -229E among children hospitalized with lower respiratory tract infections (LRTI). Methods: Multiplex real-time reverse-transcriptase polymerase chain reaction was undertaken on archived nasopharyngeal aspirates from HIV-infected and -uninfected children (<2 years age) hospitalized for LRTI, who had been previously investigated for respiratory syncytial virus, human metapneumovirus, parainfluenza I-III, adenovirus and influenza A/B. Results: At least one of these viruses were identified in 274 (53.0%) of 517 and in 509 (54.0%) of 943 LRTI-episodes in HIV-infected and -uninfected children, respectively. Human rhinovirus was the most prevalent in HIV-infected (31.7%) and uninfected children (32.0%), followed by CoV-OC43 (12.2%) and hBoV (9.5%) in HIV-infected; and by hBoV (13.3%) and WUPyV (11.9%) in HIV-uninfected children. Polyomavirus-KI (8.9% vs. 4.8%; p = 0.002) and CoV-OC43 (12.2% vs. 3.6%; p < 0.001) were more prevalent in HIV-infected than -uninfected children. Combined with previously-tested viruses, respiratory viruses were identified in 60.9% of HIV-infected and 78.3% of HIV-uninfected children. The newly tested viruses were detected at high frequency in association with other respiratory viruses, including previously-investigated viruses (22.8% in HIV-infected and 28.5% in HIV-uninfected children). Conclusions: We established that combined with previously-investigated viruses, at least one respiratory virus was identified in the majority of HIV-infected and HIV-uninfected children hospitalized for LRTI. The high frequency of viral coinfections illustrates the complexities in attributing causality to specific viruses in the aetiology of LRTI and may indicate a synergetic role of viral co-infections in the pathogenesis of childhood LRTI.	[Nunes, Marta C.; Madimabe, Richard; Van Niekerk, Nadia; Kuwanda, Locadiah; Adrian, Peter V.; Madhi, Shabir A.] Natl Res Fdn Vaccine Preventable Dis, Dept Sci & Technol, Johannesburg, South Africa; [Nunes, Marta C.; Rabede, Zelda; Madimabe, Richard; Van Niekerk, Nadia; Kuwanda, Locadiah; Klugman, Keith P.; Adrian, Peter V.; Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, Resp & Meningeal Pathogens Res Unit, MRC, Johannesburg, South Africa; [Kuschner, Zachary] SUNY Stony Brook, Stony Brook Sch Med, Stony Brook, NY 11794 USA; [Moloi, Jackie] BioMerieux, Mol & Immunol Div, Johannesburg, South Africa; [Rossen, John W.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Klugman, Keith P.] Emory Univ, Sch Med, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA USA; [Klugman, Keith P.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA; [Madhi, Shabir A.] Natl Inst Communicable Dis, Johannesburg, South Africa	National Research Foundation - South Africa; University of Witwatersrand; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Groningen; Emory University; Rollins School Public Health; Emory University; National Institute for Communicable Diseases (NICD)	Madhi, SA (corresponding author), Natl Res Fdn Vaccine Preventable Dis, Dept Sci & Technol, Johannesburg, South Africa.	shabirm@nicd.ac.za	Rossen, John W/G-7564-2011	Rossen, John W/0000-0002-7167-8623; Nunes, Marta/0000-0003-3788-878X	South African Research Chairs Initiative of the Department of Science and Technology (DST); National Research Foundation (NRF) in Vaccine Preventable Diseases; National Health Laboratory Service Research Fund; Medical Research Council (Respiratory and Meningeal Pathogens Research Unit); University of the Witwatersrand	South African Research Chairs Initiative of the Department of Science and Technology (DST); National Research Foundation (NRF) in Vaccine Preventable Diseases; National Health Laboratory Service Research Fund; Medical Research Council (Respiratory and Meningeal Pathogens Research Unit); University of the Witwatersrand	This work is based upon research supported in-part by the South African Research Chairs Initiative of the Department of Science and Technology (DST) and National Research Foundation (NRF) in Vaccine Preventable Diseases. Additional funding support was received from the National Health Laboratory Service Research Fund and Medical Research Council (Respiratory and Meningeal Pathogens Research Unit). Any opinion, findings and conclusions or recommendations expressed in this material are those of the author(s) and therefore the NRF and DST do not accept any liability with regard thereto. MCN had financial support from the University of the Witwatersrand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2011, EXPERT REV RESP MED, V5, P731, DOI [10.1586/ers.11.74, 10.1586/ERS.11.74]; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bialasiewicz S, 2008, J CLIN VIROL, V41, P63, DOI 10.1016/j.jcv.2007.11.001; Bialasiewicza S, 2007, J CLIN VIROL, V40, P15, DOI 10.1016/j.jcv.2007.07.001; Choi EH, 2006, CLIN INFECT DIS, V43, P585, DOI 10.1086/506350; Christensen A, 2008, J CLIN VIROL, V41, P34, DOI 10.1016/j.jcv.2007.10.025; Dominguez SR, 2009, J MED VIROL, V81, P1597, DOI 10.1002/jmv.21541; Friedlander SL, 2005, J ALLERGY CLIN IMMUN, V116, P267, DOI 10.1016/j.jaci.2005.06.003; Garbino J, 2008, AIDS, V22, P701, DOI 10.1097/QAD.0b013e3282f470ac; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Gerna G, 2007, J CLIN VIROL, V38, P244, DOI 10.1016/j.jcv.2006.12.008; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071; HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734; Han TH, 2007, EMERG INFECT DIS, V13, P1766, DOI 10.3201/eid1311.070872; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS6, DOI 10.1097/01.inf.0000108187.63151.ea; Kaiser L, 2005, PEDIATR INFECT DIS J, V24, P1015, DOI 10.1097/01.inf.0000183773.80217.12; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kristoffersen AW, 2011, PEDIATR INFECT DIS J, V30, P279, DOI 10.1097/INF.0b013e3181fcb159; Kuypers J, 2007, PEDIATRICS, V119, pE70, DOI 10.1542/peds.2006-1406; Le BM, 2007, EMERG INFECT DIS, V13, P1936, DOI 10.3201/eid1312.070977; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Loens K, 2007, J CLIN MICROBIOL, V45, P421, DOI 10.1128/JCM.00894-06; Madhi SA, 2006, J INFECT DIS, V193, P1236, DOI 10.1086/503053; Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Madhi SA, 2001, PEDIATR INFECT DIS J, V20, P164, DOI 10.1097/00006454-200102000-00010; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; Martin ET, 2013, J INFECT DIS, V207, P982, DOI 10.1093/infdis/jis934; Martin ET, 2012, INFLUENZA OTHER RESP, V6, P71, DOI 10.1111/j.1750-2659.2011.00265.x; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; MCINTOSH K, 1967, P NATL ACAD SCI USA, V57, P933, DOI 10.1073/pnas.57.4.933; Moore DP, 2012, EXPERT REV RESP MED, V6, P451, DOI [10.1586/ers.12.32, 10.1586/ERS.12.32]; Nair H, 2013, LANCET; NUNES MC, PLOS ONE; O'Brien Linda, 2012, Morbidity and Mortality Weekly Report, V61, P289; O'Callaghan-Gordo C, 2011, TROP MED INT HEALTH, V16, P1054, DOI 10.1111/j.1365-3156.2011.02811.x; Reed C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027793; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; Techasaensiri B, 2010, PEDIATR INFECT DIS J, V29, P519, DOI 10.1097/INF.0b013e3181cdafc2; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Venter M, 2011, J MED VIROL, V83, P1458, DOI 10.1002/jmv.22120; Venter M, 2009, J CLIN VIROL, V44, P230, DOI 10.1016/j.jcv.2008.12.007; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Woo PCY, 2005, J INFECT DIS, V192, P1898, DOI 10.1086/497151; Xatzipsaiti M, 2005, AM J RESP CRIT CARE, V172, P1037, DOI 10.1164/rccm.200502-315OC	49	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86448	10.1371/journal.pone.0086448	http://dx.doi.org/10.1371/journal.pone.0086448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498274	gold, Green Submitted, Green Published			2022-12-25	WOS:000330626900020
J	Segui, N; Guino, E; Pineda, M; Navarro, M; Bellido, F; Lazaro, C; Blanco, I; Moreno, V; Capella, G; Valle, L				Segui, Nuria; Guino, Elisabet; Pineda, Marta; Navarro, Matilde; Bellido, Fernando; Lazaro, Conxi; Blanco, Ignacio; Moreno, Victor; Capella, Gabriel; Valle, Laura			Longer Telomeres Are Associated with Cancer Risk in MMR-Proficient Hereditary Non-Polyposis Colorectal Cancer	PLOS ONE			English	Article							LENGTH; CARCINOMA	Aberrant telomere length measured in blood has been associated with increased risk of several cancer types. In the field of hereditary non-polyposis colorectal cancer (CRC), and more particularly in Lynch syndrome, caused by germline mutations in the mismatch repair (MMR) genes, we recently found that cancer-affected MMR gene mutation carriers had shorter telomeres and more pronounced shortening of telomere length with age than controls and unaffected MMR gene mutation carriers. Here we evaluate blood telomere length in MMR-proficient hereditary non-polyposis CRC, i.e. familial CRC type X (fCRC-X). A total of 57 cancer-affected and 57 cancer-free individuals from 34 Amsterdam-positive fCRC-X families were analyzed and compared to the data previously published on 144 cancer-affected and 100 cancer-free MMR gene mutation carriers, and 234 controls. Relative telomere length was measured using a monochrome multiplex quantitative PCR method, following strict measures to avoid sources of bias and adjusting by age. Despite the retrospective nature of our study, the results show that longer telomeres associate with cancer risk in fCRC-X, thus identifying different patterns of telomere length according to the status of the MMR system.	[Segui, Nuria; Pineda, Marta; Navarro, Matilde; Bellido, Fernando; Lazaro, Conxi; Blanco, Ignacio; Capella, Gabriel; Valle, Laura] IDIBELL, Catalan Inst Oncol, Hereditary Canc Program, Barcelona, Spain; [Guino, Elisabet; Moreno, Victor] IDIBELL, Catalan Inst Oncol, Unit Biomarkers & Susceptibil, Barcelona, Spain; [Guino, Elisabet; Moreno, Victor] CIBERESP, Barcelona, Spain; [Moreno, Victor] Univ Barcelona, Fac Med, Dept Clin Sci, Barcelona 7, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona	Valle, L (corresponding author), IDIBELL, Catalan Inst Oncol, Hereditary Canc Program, Barcelona, Spain.	lvalle@iconcologia.net	Blanco, Ignacio/AAN-5426-2021; Capella, Gabriel/I-1879-2015; Moreno, Victor/A-1697-2010; GARCIA, CONXI LAZARO/Q-2410-2016; Riu, Marta Pineda/I-1497-2015; Blanco, Ignacio/D-2565-2013; Valle, Laura/H-8118-2012	Blanco, Ignacio/0000-0002-7414-7481; Capella, Gabriel/0000-0002-4669-7320; Moreno, Victor/0000-0002-2818-5487; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Riu, Marta Pineda/0000-0002-5403-5845; Blanco, Ignacio/0000-0002-7414-7481; Valle, Laura/0000-0003-0371-0844; Guino, Elisabet/0000-0003-0093-2652	Spanish Ministry of Economy (State Secretariat for Research, Development and Innovation) [SAF2012-38885, SAF2012-33636]; L'Oreal-UNESCO "For Women in Science"; Scientific Foundation Asociacion Espanola Contra el Cancer; Catalan Government [2009SGR290]; Carlos III Health Institute	Spanish Ministry of Economy (State Secretariat for Research, Development and Innovation); L'Oreal-UNESCO "For Women in Science"; Scientific Foundation Asociacion Espanola Contra el Cancer; Catalan Government; Carlos III Health Institute(Instituto de Salud Carlos III)	This work has been funded by the Spanish Ministry of Economy (State Secretariat for Research, Development and Innovation) (grants SAF2012-38885 to LV and SAF2012-33636 to GC; and Ramon y Cajal contract to LV); L'Oreal-UNESCO "For Women in Science"; the Scientific Foundation Asociacion Espanola Contra el Cancer; the Catalan Government (grant 2009SGR290); and Carlos III Health Institute (fellowship to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Bisoffi M, 2006, INT J CANCER, V119, P2255, DOI 10.1002/ijc.22120; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2005, EMBO J, V24, P1095, DOI 10.1038/sj.emboj.7600598; Bozzao C, 2011, CANCER-AM CANCER SOC, V117, P4325, DOI 10.1002/cncr.26022; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cui Y, 2012, CANCER EPIDEM BIOMAR, V21, P1807, DOI 10.1158/1055-9965.EPI-12-0657; Hou LF, 2012, CANCER LETT, V319, P130, DOI 10.1016/j.canlet.2012.01.028; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Jones AM, 2012, GUT, V61, P248, DOI 10.1136/gut.2011.239772; Ku CS, 2012, MODERN PATHOL, V25, P1055, DOI 10.1038/modpathol.2012.62; Lan Q, 2009, CLIN CANCER RES, V15, P7429, DOI 10.1158/1078-0432.CCR-09-0845; Lee IM, 2010, CLIN CHEM LAB MED, V48, P259, DOI 10.1515/CCLM.2010.049; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Martinez-Delgado B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002182; Maxwell F, 2011, CLIN CANCER RES, V17, P5573, DOI 10.1158/1078-0432.CCR-10-3271; Pooley KA, 2010, CANCER RES, V70, P3170, DOI 10.1158/0008-5472.CAN-09-4595; Prescott J, 2012, MUTAT RES-FUND MOL M, V730, P75, DOI 10.1016/j.mrfmmm.2011.06.009; Savage SA, 2013, JNCI-J NATL CANCER I, V105, P448, DOI 10.1093/jnci/djt041; Segui N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061286; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Zee RYL, 2009, CANCER EPIDEM BIOMAR, V18, P2280, DOI 10.1158/1055-9965.EPI-09-0360	22	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86063	10.1371/journal.pone.0086063	http://dx.doi.org/10.1371/journal.pone.0086063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498269	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900015
J	Wang, CY; Zhu, YW; Chen, JJ; Li, X; Peng, JH; Chen, JJ; Zou, Y; Zhang, ZY; Jin, H; Yang, PY; Wu, JH; Niu, LW; Gong, QG; Teng, MK; Shi, YY				Wang, Chongyuan; Zhu, Yuwei; Chen, Jiajia; Li, Xu; Peng, Junhui; Chen, Jiajing; Zou, Yang; Zhang, Zhiyong; Jin, Hong; Yang, Pengyuan; Wu, Jihui; Niu, Liwen; Gong, Qingguo; Teng, Maikun; Shi, Yunyu			Crystal Structure of Arginine Methyltransferase 6 from Trypanosoma brucei	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; PROGRAM PACKAGE; IN-VITRO; METHYLATION; PRMT6; PROTEINS; BINDING; INSIGHTS; H3K4; DNA	Arginine methylation plays vital roles in the cellular functions of the protozoan Trypanosoma brucei. The T. brucei arginine methyltransferase 6 (TbPRMT6) is a type I arginine methyltransferase homologous to human PRMT6. In this study, we report the crystal structures of apo-TbPRMT6 and its complex with the reaction product S-adenosyl-homocysteine (SAH). The structure of apo-TbPRMT6 displays several features that are different from those of type I PRMTs that were structurally characterized previously, including four stretches of insertion, the absence of strand beta 15, and a distinct dimerization arm. The comparison of the apo-TbPRMT6 and SAH-TbPRMT6 structures revealed the fine rearrangements in the active site upon SAH binding. The isothermal titration calorimetry results demonstrated that SAH binding greatly increases the affinity of TbPRMT6 to a substrate peptide derived from bovine histone H4. The western blotting and mass spectrometry results revealed that TbPRMT6 methylates bovine histone H4 tail at arginine 3 but cannot methylate several T. brucei histone tails. In summary, our results highlight the structural differences between TbPRMT6 and other type I PRMTs and reveal that the active site rearrangement upon SAH binding is important for the substrate binding of TbPRMT6.	[Wang, Chongyuan; Zhu, Yuwei; Li, Xu; Peng, Junhui; Chen, Jiajing; Zou, Yang; Zhang, Zhiyong; Wu, Jihui; Niu, Liwen; Gong, Qingguo; Teng, Maikun; Shi, Yunyu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Wang, Chongyuan; Zhu, Yuwei; Li, Xu; Peng, Junhui; Chen, Jiajing; Zou, Yang; Zhang, Zhiyong; Wu, Jihui; Niu, Liwen; Gong, Qingguo; Teng, Maikun; Shi, Yunyu] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Chen, Jiajia; Jin, Hong; Yang, Pengyuan] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China; [Chen, Jiajia; Jin, Hong; Yang, Pengyuan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Fudan University; Fudan University	Teng, MK (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China.	mkteng@ustc.edu.cn; yyshi@ustc.edu.cn	Shi, Yunyu/B-3240-2009; Peng, Junhui/ABH-7078-2020	Shi, Yunyu/0000-0002-1348-4759; Peng, Junhui/0000-0003-2855-2299; Li, Xu/0000-0001-5221-0817	Chinese Ministry of Science and Technology [2012CB917200, 2012CB917201, 2011CB911104, 2011CB966302, 2009CB825500]; Chinese National Science Foundation [31170693, 31330018, 31270782, 30830031, 31270014, 31130018, 31270760, 30900224]; Grant of Chinese Academy of Science [KJZD-EW-L05]; Anhui Nature Science Foundation [1208085MC38]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Grant of Chinese Academy of Science; Anhui Nature Science Foundation(Natural Science Foundation of Anhui Province)	Financial support for this project was provided by the Chinese Ministry of Science and Technology (Grant Nos. 2012CB917200, 2012CB917201, 2011CB911104, 2011CB966302 and 2009CB825500), Chinese National Science Foundation (Grant Nos. 31170693, 31330018, 31270782, 30830031, 31270014, 31130018, 31270760 and 30900224), Grant of Chinese Academy of Science (KJZD-EW-L05), Anhui Nature Science Foundation (Grant No. 1208085MC38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Cheng Y, 2011, J MOL BIOL, V414, P106, DOI 10.1016/j.jmb.2011.09.040; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figueiredo LM, 2009, NAT REV MICROBIOL, V7, P504, DOI 10.1038/nrmicro2149; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fisk JC, 2013, MOL CELL PROTEOMICS, V12, P302, DOI 10.1074/mcp.M112.022533; Fisk JC, 2011, EUKARYOT CELL, V10, P1013, DOI 10.1128/EC.05103-11; Fisk JC, 2010, EUKARYOT CELL, V9, P866, DOI 10.1128/EC.00018-10; Fisk JC, 2009, J BIOL CHEM, V284, P11590, DOI 10.1074/jbc.M807279200; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Ho MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057008; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Invernizzi CF, 2007, AIDS, V21, P795, DOI 10.1097/QAD.0b013e32803277ae; Invernizzi CF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-93; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lott K, 2013, J PROTEOMICS, V91, P210, DOI 10.1016/j.jprot.2013.07.010; Miranda TB, 2005, BIOCHEM BIOPH RES CO, V336, P831, DOI 10.1016/j.bbrc.2005.08.179; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pasternack DA, 2007, EUKARYOT CELL, V6, P1665, DOI 10.1128/EC.00133-07; Pelletier M, 2005, MOL BIOCHEM PARASIT, V144, P206, DOI 10.1016/j.molbiopara.2005.08.015; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sgarra R, 2006, J BIOL CHEM, V281, P3764, DOI 10.1074/jbc.M510231200; Sun LT, 2011, P NATL ACAD SCI USA, V108, P20538, DOI 10.1073/pnas.1106946108; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Waldmann T, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-11; Wang XL, 2012, INT J BIOCHEM CELL B, V44, P2333, DOI 10.1016/j.biocel.2012.09.015; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Yu WY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2304; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zou Y, 2007, BIOCHEMISTRY-US, V46, P7896, DOI 10.1021/bi6024897	50	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87267	10.1371/journal.pone.0087267	http://dx.doi.org/10.1371/journal.pone.0087267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498306	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900052
J	Yamaji, T; Hanada, K				Yamaji, Toshiyuki; Hanada, Kentaro			Establishment of HeLa Cell Mutants Deficient in Sphingolipid-Related Genes Using TALENs	PLOS ONE			English	Article							SERINE PALMITOYLTRANSFERASE; SPHINGOMYELIN SYNTHESIS; ENDOPLASMIC-RETICULUM; EFFICIENT; TRAFFICKING; CERAMIDE; LACTOSYLCERAMIDE; PROTEINS; SYNTHASE; MOTIF	Sphingolipids are essential components in eukaryotes and have various cellular functions. Recent developments in genome-editing technologies have facilitated gene disruption in various organisms and cell lines. We here show the disruption of various sphingolipid metabolic genes in human cervical carcinoma HeLa cells by using transcription activator-like effector nucleases (TALENs). A TALEN pair targeting the human CERT gene (alternative name COL4A3BP) encoding a ceramide transport protein induced a loss-of-function phenotype in more than 60% of HeLa cells even though the cell line has a pseudo-triploid karyotype. We have isolated several loss-of-function mutant clones for CERT, UGCG (encoding glucosylceramide synthase), and B4GalT5 (encoding the major lactosylceramide synthase), and also a CERT/UGCG double-deficient clone. Characterization of these clones supported previous proposals that CERT primarily contributes to the synthesis of SM but not GlcCer, and that B4GalT5 is the major LacCer synthase. These newly established sphingolipid-deficient HeLa cell mutants together with our previously established stable transfectants provide a 'sphingolipid-modified HeLa cell panel,' which will be useful to elucidate the functions of various sphingolipid species against essentially the same genomic background.	[Yamaji, Toshiyuki; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	National Institute of Infectious Diseases (NIID)	Yamaji, T (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan.	tyamaji@nih.go.jp; hanak@nih.go.jp		Hanada, Kentaro/0000-0003-1383-2781	Japan Society for the Promotion of Science [23770164, 22370054, 25670045]; Naito Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation)	This work was supported by the Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists (B), No. 23770164 to T.Y., Grant-in-Aid for Scientific Research (B), No. 22370054 to K. H., and Grant-in-Aid for Challenging Exploratory Research, No. 25670045 to K. H.), and the Naito Foundation (the 39th Subsidy for Promotion of Specific Research Projects to T.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P7276; Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Akiyama S, 1987, Methods Enzymol, V151, P38, DOI 10.1016/S0076-6879(87)51007-2; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen YF, 2010, NEUROMOL MED, V12, P306, DOI 10.1007/s12017-010-8132-8; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Funakoshi T, 2000, J BIOL CHEM, V275, P29938, DOI 10.1074/jbc.M004470200; Furukawa K, 2011, NEUROCHEM RES, V36, P1578, DOI 10.1007/s11064-011-0494-2; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; GEY GO, 1952, CANCER RES, V12, P264; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Giussani P, 2009, J BIOL CHEM, V284, P5088, DOI 10.1074/jbc.M808934200; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hanada K, 2005, JPN J INFECT DIS, V58, P131; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; HANADA K, 1992, J BIOL CHEM, V267, P23527; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; HANADA K, 2013, BIOCHIM BIOPHYS ACTA, pS1388; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; ICHIKAWA S, 1994, P NATL ACAD SCI USA, V91, P2703, DOI 10.1073/pnas.91.7.2703; Inokuchi J, 2011, P JPN ACAD B-PHYS, V87, P179, DOI 10.2183/pjab.87.179; Inokuchi J, 2010, FEBS LETT, V584, P1864, DOI 10.1016/j.febslet.2009.10.012; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Kumagai T, 2010, GLYCOCONJUGATE J, V27, P685, DOI 10.1007/s10719-010-9313-2; Kumagai T, 2009, BIOCHEM BIOPH RES CO, V379, P456, DOI 10.1016/j.bbrc.2008.12.078; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; LANNERT H, 1994, FEBS LETT, V342, P91, DOI 10.1016/0014-5793(94)80591-1; Marks DL, 2001, J BIOL CHEM, V276, P26492, DOI 10.1074/jbc.M102612200; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; MITSUI Y, 1964, SCIENCE, V145, P715, DOI 10.1126/science.145.3633.715; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nishie T, 2010, GLYCOBIOLOGY, V20, P1311, DOI 10.1093/glycob/cwq098; Nomura T, 1998, J BIOL CHEM, V273, P13570, DOI 10.1074/jbc.273.22.13570; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; PINTO WJ, 1992, J BACTERIOL, V174, P2575, DOI 10.1128/jb.174.8.2575-2581.1992; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; Russo SB, 2013, HDB EXP PHARM, V216, P373; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Tokuda N, 2013, GLYCOBIOLOGY, V23, P1175, DOI 10.1093/glycob/cwt054; TRINCHERA M, 1991, J BIOL CHEM, V266, P20907; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Yanagisawa K, 2011, J NEUROCHEM, V116, P806, DOI 10.1111/j.1471-4159.2010.07006.x; Zaima N, 2011, J OLEO SCI, V60, P93, DOI 10.5650/jos.60.93	60	51	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88124	10.1371/journal.pone.0088124	http://dx.doi.org/10.1371/journal.pone.0088124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498430	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900176
J	Yao, RQ; Yasuoka, A; Kamei, A; Ushiama, S; Kitagawa, Y; Rogi, T; Shibata, H; Abe, K; Misaka, T				Yao, Ruiqing; Yasuoka, Akihito; Kamei, Asuka; Ushiama, Shota; Kitagawa, Yoshinori; Rogi, Tomohiro; Shibata, Hiroshi; Abe, Keiko; Misaka, Takumi			Nuclear Receptor-Mediated Alleviation of Alcoholic Fatty Liver by Polyphenols Contained in Alcoholic Beverages	PLOS ONE			English	Article							EPIGENETIC REGULATION; MOLECULAR-MECHANISMS; CAR; RESVERATROL; DISEASE; GENES; ACID; TRANSCRIPTION; ISOHUMULONES; PATHOGENESIS	To elucidate the effect of the polyphenols contained in alcoholic beverages on the metabolic stress induced by ethanol consumption, four groups of mice were fed for five weeks on Lieber's diet with or without ethanol, with ethanol plus ellagic acid, and with ethanol plus trans-resveratrol. Alcoholic fatty liver was observed in the group fed the ethanol diet but not in those fed the ethanol plus polyphenol diets. Liver transcriptome analysis revealed that the addition of the polyphenols suppressed the expression of the genes related to cell stress that were up-regulated by ethanol alone. Conversely, the polyphenols up-regulated the genes involved in bile acid synthesis, unsaturated fatty acid elongation, and tetrahydrofolate synthesis that were down-regulated by ethanol alone. Because parts of these genes were known to be regulated by the constitutive androstane receptor (CAR), we performed the same experiment in the CAR-deficient mice. As a result, fatty liver was observed not only in the ethanol group but also with the ethanol plus polyphenol groups. In addition, there was no segregation of the gene expression profiles among these groups. These results provide a molecular basis for the prevention of alcohol-induced stress by the polyphenols in alcoholic beverages.	[Yao, Ruiqing; Ushiama, Shota; Abe, Keiko; Misaka, Takumi] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Yasuoka, Akihito] Maebashi Inst Technol, Dept Biol Engn, Maebashi, Gunma, Japan; [Yasuoka, Akihito; Kamei, Asuka; Abe, Keiko] Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa, Japan; [Kitagawa, Yoshinori; Rogi, Tomohiro; Shibata, Hiroshi] Suntory Wellness Ltd, Inst Hlth Care Sci, Shimamoto, Osaka, Japan	University of Tokyo; Kanagawa Academy Science & Technology; Suntory Holdings Ltd	Yasuoka, A (corresponding author), Maebashi Inst Technol, Dept Biol Engn, Maebashi, Gunma, Japan.	fp-yasuoka@newkast.or.jp; amisaka@mail.ecc.u-tokyo.ac.jp	Kamei, Asuka/GXH-4934-2022	Misaka, Takumi/0000-0002-9547-5767	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Iijima Shokuseikatu; Grants-in-Aid for Scientific Research [26242007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Iijima Shokuseikatu; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.M., to K.A.), and by the Funding Program for Next-Generation World-Leading Researchers from the Japan Society for the Promotion of Science (to T.M.) and an Iijima Shokuseikatu (to A.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Altamirano J, 2011, NAT REV GASTRO HEPAT, V8, P491, DOI 10.1038/nrgastro.2011.134; Arranz S, 2012, NUTRIENTS, V4, P759, DOI 10.3390/nu4070759; Bardag-Gorce F, 2009, ALCOHOL CLIN EXP RES, V33, P684, DOI 10.1111/j.1530-0277.2008.00885.x; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Beilke LD, 2009, DRUG METAB DISPOS, V37, P1035, DOI 10.1124/dmd.108.023317; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brufau G, 2011, ARTERIOSCL THROM VAS, V31, P1726, DOI 10.1161/ATVBAHA.108.181206; Cadoudal T, 2008, DIABETES, V57, P2272, DOI 10.2337/db08-0477; Caiozzi G, 2012, CELL BIOCHEM FUNCT, V30, P531, DOI 10.1002/cbf.2842; Cederbaum AI, 2010, WORLD J GASTROENTERO, V16, P1366, DOI 10.3748/wjg.v16.i11.1366; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Devipriya N, 2008, J BIOCHEM MOL TOXIC, V22, P101, DOI 10.1002/jbt.20226; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Ferdinandusse S, 2000, J LIPID RES, V41, P1890; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Fujieda M, 2008, J AGR FOOD CHEM, V56, P7305, DOI 10.1021/jf8012713; Gao J, 2009, J BIOL CHEM, V284, P25984, DOI 10.1074/jbc.M109.016808; Green CD, 2011, EPIGENOMICS-UK, V3, P59, DOI 10.2217/EPI.10.75; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Heuer H, 2009, ENDOCRINOLOGY, V150, P1078, DOI 10.1210/en.2008-1518; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Kato S, 2011, TRENDS BIOCHEM SCI, V36, P272, DOI 10.1016/j.tibs.2011.01.001; Kelly GS, 2010, ALTERN MED REV, V15, P313; Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8; Larrosa M, 2010, MOL ASPECTS MED, V31, P513, DOI 10.1016/j.mam.2010.09.005; Li LH, 2009, PHARM RES-DORDR, V26, P872, DOI 10.1007/s11095-008-9788-8; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mandrekar P, 2011, WORLD J GASTROENTERO, V17, P2456, DOI 10.3748/wjg.v17.i20.2456; Manzo-Avalos S, 2010, INT J ENV RES PUB HE, V7, P4281, DOI 10.3390/ijerph7124281; Matsuzaka T, 2009, J MOL MED, V87, P379, DOI 10.1007/s00109-009-0449-0; Miranda-Mendez A, 2010, INT J ENV RES PUB HE, V7, P1872, DOI 10.3390/ijerph7051872; Obara K, 2009, CLIN NUTR, V28, P278, DOI 10.1016/j.clnu.2009.03.012; Opie LH, 2007, EUR HEART J, V28, P1683, DOI 10.1093/eurheartj/ehm149; Park SH, 2008, FOOD CHEM TOXICOL, V46, P1378, DOI 10.1016/j.fct.2007.08.029; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Penumetcha M, 2012, PPAR RES, V2012, DOI 10.1155/2012/858352; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Rezen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-384; Rubins NE, 2005, MOL CELL BIOL, V25, P7069, DOI 10.1128/MCB.25.16.7069-7077.2005; Sato M, 2010, BIOL PHARM BULL, V33, P498, DOI 10.1248/bpb.33.498; Schmitz G, 2009, ARTERIOSCL THROM VAS, V29, P1718, DOI 10.1161/ATVBAHA.108.179507; Seth D, 2011, J GASTROEN HEPATOL, V26, P1089, DOI 10.1111/j.1440-1746.2011.06756.x; Shay NF, 2005, ANNU REV NUTR, V25, P297, DOI 10.1146/annurev.nutr.25.050304.092639; Song BJ, 2008, J HEPATOL, V49, P262, DOI 10.1016/j.jhep.2008.04.023; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Spanagel R, 2005, ALCOHOL CLIN EXP RES, V29, P1550, DOI 10.1097/01.alc.0000175074.70807.fd; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Timmers S, 2012, AGING-US, V4, P146, DOI 10.18632/aging.100445; Tojima H, 2012, TOXICOL LETT, V212, P288, DOI 10.1016/j.toxlet.2012.06.001; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Wang ZG, 2010, ALCOHOL CLIN EXP RES, V34, P471, DOI 10.1111/j.1530-0277.2009.01111.x; Watkins PA, 2012, BBA-MOL BASIS DIS, V1822, P1411, DOI 10.1016/j.bbadis.2012.02.010; Yajima H, 2005, INT J OBESITY, V29, P991, DOI 10.1038/sj.ijo.0802965; Yao RQ, 2011, BIOSCI BIOTECH BIOCH, V75, P1635, DOI 10.1271/bbb.110444; Yao RQ, 2010, J AGR FOOD CHEM, V58, P2168, DOI 10.1021/jf903711q; Yin HQ, 2009, TOXICOL APPL PHARM, V235, P312, DOI 10.1016/j.taap.2008.12.018	60	11	11	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87142	10.1371/journal.pone.0087142	http://dx.doi.org/10.1371/journal.pone.0087142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498295	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900041
J	Bekrater-Bodmann, R; Foell, J; Diers, M; Kamping, S; Rance, M; Kirsch, P; Trojan, J; Fuchs, X; Bach, F; Cakmak, HK; Maass, H; Flor, H				Bekrater-Bodmann, Robin; Foell, Jens; Diers, Martin; Kamping, Sandra; Rance, Mariela; Kirsch, Pinar; Trojan, Joerg; Fuchs, Xaver; Bach, Felix; Cakmak, Hueseyin Kemal; Maass, Heiko; Flor, Herta			The Importance of Synchrony and Temporal Order of Visual and Tactile Input for Illusory Limb Ownership Experiences - An fMRI Study Applying Virtual Reality	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; VENTRAL PREMOTOR CORTEX; EXTRASTRIATE BODY AREA; RUBBER HAND ILLUSION; MULTISENSORY REPRESENTATION; SOMATOSENSORY HOMUNCULUS; ATTENTIONAL MODULATION; PERIPERSONAL SPACE; SELF-ATTRIBUTION; BRAIN	In the so-called rubber hand illusion, synchronous visuotactile stimulation of a visible rubber hand together with one's own hidden hand elicits ownership experiences for the artificial limb. Recently, advanced virtual reality setups were developed to induce a virtual hand illusion (VHI). Here, we present functional imaging data from a sample of 25 healthy participants using a new device to induce the VHI in the environment of a magnetic resonance imaging (MRI) system. In order to evaluate the neuronal robustness of the illusion, we varied the degree of synchrony between visual and tactile events in five steps: in two conditions, the tactile stimulation was applied prior to visual stimulation (asynchrony of -300 ms or -600 ms), whereas in another two conditions, the tactile stimulation was applied after visual stimulation (asynchrony of +300 ms or +600 ms). In the fifth condition, tactile and visual stimulation was applied synchronously. On a subjective level, the VHI was successfully induced by synchronous visuotactile stimulation. Asynchronies between visual and tactile input of +/- 300 ms did not significantly diminish the vividness of illusion, whereas asynchronies of +/- 600 ms did. The temporal order of visual and tactile stimulation had no effect on VHI vividness. Conjunction analyses of functional MRI data across all conditions revealed significant activation in bilateral ventral premotor cortex (PMv). Further characteristic activation patterns included bilateral activity in the motion-sensitive medial superior temporal area as well as in the bilateral Rolandic operculum, suggesting their involvement in the processing of bodily awareness through the integration of visual and tactile events. A comparison of the VHI-inducing conditions with asynchronous control conditions of +/- 600 ms yielded significant PMv activity only contralateral to the stimulation site. These results underline the temporal limits of the induction of limb ownership related to multisensory body-related input.	[Bekrater-Bodmann, Robin; Foell, Jens; Diers, Martin; Kamping, Sandra; Rance, Mariela; Kirsch, Pinar; Trojan, Joerg; Fuchs, Xaver; Flor, Herta] Heidelberg Univ, Med Fac Mannheim, Dept Cognit & Clin Neurosci, Cent Inst Mental Hlth, Mannheim, Germany; [Foell, Jens] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Trojan, Joerg] Univ Koblenz Landau, Dept Psychol, Landau, Germany; [Bach, Felix; Cakmak, Hueseyin Kemal; Maass, Heiko] Karlsruhe Inst Technol, Inst Appl Comp Sci, Eggenstein Leopoldshafen, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; State University System of Florida; Florida State University; University of Koblenz & Landau; Helmholtz Association; Karlsruhe Institute of Technology	Flor, H (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Cognit & Clin Neurosci, Cent Inst Mental Hlth, Mannheim, Germany.	herta.flor@zi-mannheim.de	Fuchs, Xaver/HCI-1160-2022; Diers, Martin/M-9155-2013; Trojan, Jörg/C-1616-2009; Çakmak, Hüseyin Kemâl/G-1507-2018; Bach, Felix/AAR-4792-2020	Diers, Martin/0000-0002-3257-7299; Trojan, Jörg/0000-0003-4110-2647; Çakmak, Hüseyin Kemâl/0000-0002-1463-7606; Bach, Felix/0000-0002-5035-7978; Kamping, Sandra/0000-0001-5389-0455; Flor, Herta/0000-0003-4809-5398	'Phantom phenomena: A window to the mind and the brain (PHANTOMMIND)' project; European Community [230249]; Deutsche Forschungsgemeinschaft [KFO 256, FL 156/35-1]	'Phantom phenomena: A window to the mind and the brain (PHANTOMMIND)' project; European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the 'Phantom phenomena: A window to the mind and the brain (PHANTOMMIND)' project, which receives research funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement No. 230249 (http://erc.europa.eu/) awarded to HF, as well as the clinical research unit KFO 256 'Mechanisms of disturbed emotion processing in borderline personality disorder' funded by the Deutsche Forschungsgemeinschaft (FL 156/35-1) (http://www.dfg.de/en/research_funding/programmes/coordinated_programmes/clinical_research_units/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Arzy S, 2006, J NEUROSCI, V26, P8074, DOI 10.1523/JNEUROSCI.0745-06.2006; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Bach F, 2012, BIOMED ENG-BIOMED TE, V57, P718, DOI 10.1515/bmt-2012-4084; Beauchamp MS, 2007, J NEUROSCI, V27, P8261, DOI 10.1523/JNEUROSCI.0754-07.2007; Bekrater-Bodmann R, 2012, BRAIN RES, V1452, P130, DOI 10.1016/j.brainres.2012.03.001; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brozzoli C, 2012, J NEUROSCI, V32, P14573, DOI 10.1523/JNEUROSCI.2660-12.2012; Brozzoli C, 2011, J NEUROSCI, V31, P9023, DOI 10.1523/JNEUROSCI.1172-11.2011; Cakmak H, 2005, MINIM INVASIV THER, V14, P134, DOI 10.1080/13645700510033958; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Ebisch SJH, 2008, J COGNITIVE NEUROSCI, V20, P1611, DOI 10.1162/jocn.2008.20111; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Feinberg TE, 2010, J NEUROL NEUROSUR PS, V81, P276, DOI 10.1136/jnnp.2009.188946; Gentile G, 2013, J NEUROSCI, V33, P13350, DOI 10.1523/JNEUROSCI.1363-13.2013; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Huk AC, 2002, J NEUROSCI, V22, P7195; Inoue K, 2001, NEUROIMAGE, V14, P1469, DOI 10.1006/nimg.2001.0942; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Kida T, 2007, J NEUROPHYSIOL, V97, P3585, DOI 10.1152/jn.00007.2007; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Limanowski J, 2013, NEUROIMAGE, DOI [10.1016/j.neuro-image.2013.10.035, DOI 10.1016/J.NEUR0-IMAGE.2013.10.035.]; Lloyd D, 2006, J NEUROPHYSIOL, V95, P205, DOI 10.1152/jn.00614.2005; Lloyd DM, 2003, NAT NEUROSCI, V6, P17, DOI 10.1038/nn991; Macaluso E, 2002, CEREB CORTEX, V12, P357, DOI 10.1093/cercor/12.4.357; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Meehan SK, 2009, HUM BRAIN MAPP, V30, P484, DOI 10.1002/hbm.20520; Naito E, 2005, J NEUROPHYSIOL, V93, P1020, DOI 10.1152/jn.00637.2004; Nakashita S, 2008, BRAIN RES BULL, V75, P513, DOI 10.1016/j.brainresbull.2007.09.004; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pasalar S, 2010, EUR J NEUROSCI, V31, P1783, DOI 10.1111/j.1460-9568.2010.07193.x; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Rhee T, 2006, COMPUT GRAPH FORUM, V25, P439, DOI 10.1111/j.1467-8659.2006.00963.x; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; Schaefer M, 2007, NEUROIMAGE, V36, P700, DOI 10.1016/j.neuroimage.2007.03.046; Schaefer M, 2009, HUM BRAIN MAPP, V30, P1413, DOI 10.1002/hbm.20609; Schubotz RI, 2004, J NEUROSCI, V24, P5467, DOI 10.1523/JNEUROSCI.1169-04.2004; Shimada S, 2005, NEUROIMAGE, V24, P1225, DOI 10.1016/j.neuroimage.2004.10.039; Shimada S, 2010, EXP BRAIN RES, V201, P359, DOI 10.1007/s00221-009-2028-6; Shimada S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006185; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Spiridon M, 2006, HUM BRAIN MAPP, V27, P77, DOI 10.1002/hbm.20169; Synofzik M, 2008, CONSCIOUS COGN, V17, P411, DOI 10.1016/j.concog.2008.03.008; Tal N, 2009, EXP BRAIN RES, V198, P165, DOI 10.1007/s00221-009-1949-4; Tipper SP, 2001, EXP BRAIN RES, V139, P160, DOI 10.1007/s002210100743; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; Weber O, 2007, COMPUT GRAPH FORUM, V26, P265, DOI 10.1111/j.1467-8659.2007.01048.x; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeller D, 2011, J NEUROSCI, V31, P4852, DOI 10.1523/JNEUROSCI.5154-10.2011	63	50	51	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87013	10.1371/journal.pone.0087013	http://dx.doi.org/10.1371/journal.pone.0087013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498012	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900058
J	Che, RB; Sun, YN; Wang, RX; Xu, TJ				Che, Rongbo; Sun, Yuena; Wang, Rixin; Xu, Tianjun			Transcriptomic Analysis of Endangered Chinese Salamander: Identification of Immune, Sex and Reproduction-Related Genes and Genetic Markers	PLOS ONE			English	Article							RNA-BINDING PROTEIN; LYSOSOMAL CYSTEINE PROTEASES; MOLECULAR-CLONING; CATHEPSIN-D; EXPRESSION; ANTIGEN; ANNOTATION; EVOLUTION; SOFTWARE; GENOMICS	Background: The Chinese salamander (Hynobius chinensis), an endangered amphibian species of salamander endemic to China, has attracted much attention because of its value of studying paleontology evolutionary history and decreasing population size. Despite increasing interest in the Hynobius chinensis genome, genomic resources for the species are still very limited. A comprehensive transcriptome of Hynobius chinensis, which will provide a resource for genome annotation, candidate genes identification and molecular marker development should be generated to supplement it. Principal Findings: We performed a de novo assembly of Hynobius chinensis transcriptome by Illumina sequencing. A total of 148,510 nonredundant unigenes with an average length of approximately 580 bp were obtained. In all, 60,388 (40.66%) unigenes showed homologous matches in at least one database and 33,537 (22.58%) unigenes were annotated by all four databases. In total, 41,553 unigenes were categorized into 62 sub-categories by BLAST2GO search, and 19,468 transcripts were assigned to 140 KEGG pathways. A large number of unigenes involved in immune system, local adaptation, reproduction and sex determination were identified, as well as 31,982 simple sequence repeats (SSRs) and 460,923 putative single nucleotide polymorphisms (SNPs). Conclusion: This dataset represents the first transcriptome analysis of the Chinese salamander (Hynobius chinensis), an endangered species, to be also the first time of hynobiidae. The transcriptome will provide valuable resource for further research in discovery of new genes, protection of population, adaptive evolution and survey of various pathways, as well as development of molecule markers in Chinese salamander; and reference information for closely related species.	[Che, Rongbo; Sun, Yuena; Wang, Rixin; Xu, Tianjun] Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan, Peoples R China	Zhejiang Ocean University	Wang, RX (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan, Peoples R China.	wangrixin1123@126.com; tianjunxu@163.com			National Natural Science Foundation of China [31272661]; Zhejiang Provincial Natural Science Foundation [LY 13C 040001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This study was supported by National Natural Science Foundation of China (31272661) and Zhejiang Provincial Natural Science Foundation (LY 13C 040001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler K., 1990, Asiatic Herpetological Research, V3, P37; Akfirat FS, 2013, BIOCHEM GENET, V51, P223, DOI 10.1007/s10528-012-9557-6; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bajgain P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-370; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BOND JS, 1987, ANNU REV BIOCHEM, V56, P333, DOI 10.1146/annurev.bi.56.070187.002001; CALLEN DF, 1993, AM J HUM GENET, V52, P922; Chen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011546; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; DEDUVE C, 1983, EUR J BIOCHEM, V137, P391, DOI 10.1111/j.1432-1033.1983.tb07841.x; Dixit AK, 2008, VET PARASITOL, V154, P177, DOI 10.1016/j.vetpar.2008.03.017; Domenice S, 2004, BRAZ J MED BIOL RES, V37, P145, DOI 10.1590/S0100-879X2004000100020; Du Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-77; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu HQ, 2004, IUCN 2013 IUCN RED L; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Haerty W, 2007, GENETICS, V177, P1321, DOI 10.1534/genetics.107.078865; Han F, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-98; Hoffman JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-52; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Hu JB, 2010, SCI HORTIC-AMSTERDAM, V125, P534, DOI 10.1016/j.scienta.2010.03.021; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; JAY P, 1995, GENOMICS, V29, P541, DOI 10.1006/geno.1995.9970; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kohno S, 2010, SEX DEV, V4, P73, DOI 10.1159/000260374; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Liu XZ, 2012, FISH SHELLFISH IMMUN, V32, P464, DOI 10.1016/j.fsi.2011.11.033; Ma Xiaomei, 1999, Sichuan Journal of Zoology, V18, P107; Matsumoto K, 2000, NUCLEIC ACIDS RES, V28, P4689, DOI 10.1093/nar/28.23.4689; Mayer LP, 2002, GEN COMP ENDOCR, V127, P40, DOI 10.1016/S0016-6480(02)00019-9; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishiyama H, 1998, AM J PATHOL, V152, P289; Oshima Y, 2008, GEN COMP ENDOCR, V159, P170, DOI 10.1016/j.ygcen.2008.08.013; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; Powers TR, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-225; Pritchard VL, 2013, MOL ECOL RESOUR, V13, P276, DOI 10.1111/1755-0998.12040; Qing Li-Yan, 2009, Chinese Journal of Zoology, V44, P125; Rhen T, 2010, SEX DEV, V4, P16, DOI 10.1159/000282495; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sadamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042546; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Shibata K, 2002, GEN COMP ENDOCR, V127, P232, DOI 10.1016/S0016-6480(02)00039-4; Sugita J, 2001, GENE, V280, P67, DOI 10.1016/S0378-1119(01)00739-9; Sun YN, 2011, FISH PHYSIOL BIOCHEM, V37, P761, DOI 10.1007/s10695-011-9475-2; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang Xi, 2007, Sichuan Journal of Zoology, V26, P57; Wang XJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-716; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu TJ, 2010, FISH SHELLFISH IMMUN, V29, P1099, DOI 10.1016/j.fsi.2010.08.013; Yang WZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-588; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Zeng Xiaomao, 1997, Zoological Research, V18, P341	72	42	46	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87940	10.1371/journal.pone.0087940	http://dx.doi.org/10.1371/journal.pone.0087940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498226	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900196
J	Helvik, AS; Skancke, RH; Selbaek, G; Engedal, K				Helvik, Anne-Sofie; Skancke, Randi Helene; Selbaek, Geir; Engedal, Knut			Nursing Home Admission during the First Year after Hospitalization - The Contribution of Cognitive Impairment	PLOS ONE			English	Article							MINI-MENTAL-STATE; OLDER-PEOPLE; PREDICTORS; DEMENTIA; CARE; PREVALENCE; CRITERIA; POPULATION; PLACEMENT; SYMPTOMS	Objective: The importance of cognitive and physical functioning for nursing home admission among medically hospitalized older patients is rarely studied in a one-year follow-up perspective. This study aims to explore the association between patient characteristics and nursing home admission within one year after hospitalization in persons 65 years or more. Design: A one-year longitudinal study. Methods: We included 463 (234 women) persons aged 65 years or more from internal medical wards in a rural area of Norway. Cognitive function was assessed using the Mini Mental State Examination; physical and instrumental functional status was assessed using the physical self-maintenance scale and instrumental activities of daily living scale of Lawton and Brody. Comorbidity was measured with the Charlson index. Admission to nursing home within one year (yes versus no) was analyzed using logistic regression analysis and Cox proportional hazard regression analysis. Results: The mean age of the sample was 80.5 (SD 7.4) years, mean Mini Mental State Examination score was 24.1 (SD 3.8) (maximum score is 30). In adjusted analysis participants with cognitive impairment (a Mini Mental State Examination score,25) or impaired physical functioning at baseline had higher risk of admission to nursing home within one year (OR 3.0, 95% CI 1.5-6.2 and OR 3.5, 95% CI 1.8-9.6, respectively). The time before admission was also associated with cognitive impairment and impaired physical functioning in the adjusted analysis (HR 2.6 95% CI 1.4-4.8 and HR 3.7, 95% CI 1.5-8.9, respectively). Conclusion: Impaired cognitive and physical functioning increased the risk for nursing home admission within one year after hospitalization. However, putative regressors, such as education and social network were not included in the analysis.	[Helvik, Anne-Sofie; Skancke, Randi Helene] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Publ Hlth & Gen Practice, Trondheim, Norway; [Helvik, Anne-Sofie] St Olavs Univ Hosp, Trondheim, Norway; [Helvik, Anne-Sofie; Skancke, Randi Helene] Innlandet Hosp Trust, Div Tynset, Tynset, Norway; [Selbaek, Geir] Innlandet Hosp Trust, Ctr Old Age Psychiat Res, Ottestad, Norway; [Selbaek, Geir] Akershus Univ Hosp, Lorenskog, Norway; [Selbaek, Geir; Engedal, Knut] Oslo Univ Hosp, Norwegian Ctr Dementia Res, Ullevaal, Norway; [Engedal, Knut] Univ Oslo, Fac Med, Oslo, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Innlandet Hospital Trust; Innlandet Hospital Trust; University of Oslo; University of Oslo; University of Oslo	Helvik, AS (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Publ Hlth & Gen Practice, Trondheim, Norway.	Anne-Sofie.Helvik@ntnu.no		Selbaek, Geir/0000-0001-6511-8219	Norwegian Ministry of Health and Care Services; Innlandet Hospital Trust	Norwegian Ministry of Health and Care Services; Innlandet Hospital Trust	The research was funded by collaboration between the Norwegian Ministry of Health and Care Services, and Innlandet Hospital Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg W, 1999, Tijdschr Gerontol Geriatr, V30, P264; Alladi S, 2006, PSYCHOL MED, V36, P507, DOI 10.1017/S0033291705006744; Bilotta C, 2009, HEALTH SOC CARE COMM, V17, P543, DOI 10.1111/j.1365-2524.2009.00853.x; Brevik I, 2010, NEW HOME CARE SERVIC; Campbell SE, 2004, AGE AGEING, V33, P110, DOI 10.1093/ageing/afh036; De Saint-Hubert M, 2010, J NUTR HEALTH AGING, V14, P394, DOI 10.1007/s12603-010-0086-x; Drame M, 2011, J NUTR HEALTH AGING, V15, P399, DOI 10.1007/s12603-011-0004-x; Eaker ED, 2002, J CLIN EPIDEMIOL, V55, P462, DOI 10.1016/S0895-4356(01)00498-X; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Engedal K, 1988, Compr Gerontol A, V2, P87; Fjaertoft H, 2005, CEREBROVASC DIS, V19, P376, DOI 10.1159/000085543; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fullerton CA, 2009, PSYCHIAT SERV, V60, P965, DOI 10.1176/appi.ps.60.7.965; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Harris Y, 2006, J AM GERIATR SOC, V54, P593, DOI 10.1111/j.1532-5415.2006.00687.x; Helvik AS, 2011, NORD J PSYCHIAT, V65, P338, DOI 10.3109/08039488.2011.560684; Helvik AS, 2010, AGING MENT HEALTH, V14, P861, DOI 10.1080/13607861003801003; Helvik AS, 2010, INT J GERIATR PSYCH, V25, P150, DOI 10.1002/gps.2312; Heun R, 1998, INT J GERIATR PSYCH, V13, P368, DOI 10.1002/(SICI)1099-1166(199806)13:6<368::AID-GPS775>3.3.CO;2-0; Hirdes JP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-9; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; HUNT, 2009, HLTH STUD NORD TROND; Inouye SK, 2006, J GEN INTERN MED, V21, P1276, DOI 10.1111/j.1525-1497.2006.00613.x; Kirkevold O, 2004, SCAND J CARING SCI, V18, P281, DOI 10.1111/j.1471-6712.2004.00278.x; Kivela S L, 1985, Scand J Prim Health Care, V3, P39, DOI 10.3109/02813438509017736; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Luppa M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-186; McCusker J, 2002, J GERONTOL A-BIOL, V57, pM569, DOI 10.1093/gerona/57.9.M569; McDowell I, 1997, J CLIN EPIDEMIOL, V50, P377, DOI 10.1016/S0895-4356(97)00060-7; Mora Fernandez Jesus, 2009, Rev Esp Geriatr Gerontol, V44, P186, DOI 10.1016/j.regg.2009.03.008; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nygaard H A, 2000, Tidsskr Nor Laegeforen, V120, P3113; NYGAARD H A, 1992, Scandinavian Journal of Primary Health Care, V10, P128, DOI 10.3109/02813439209014049; Portegijs E, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.04.003; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Romoren T, 1999, PATIENTS RESIDENTS N; RUBENSTEIN LZ, 1986, HEALTH SERV RES, V20, P881; RUBENSTEIN LZ, 1984, J AM GERIATR SOC, V32, P503, DOI 10.1111/j.1532-5415.1984.tb02235.x; Satish S, 1996, J AM GERIATR SOC, V44, P914, DOI 10.1111/j.1532-5415.1996.tb01860.x; Schneeweiss S, 2003, HEALTH SERV RES, V38, P1103, DOI 10.1111/1475-6773.00165; Selbaek G, 2007, INT J GERIATR PSYCH, V22, P843, DOI 10.1002/gps.1749; Smith GE, 2001, NEUROLOGY, V57, P1467, DOI 10.1212/WNL.57.8.1467; Snaith RP., 1994, HOSP ANXIETY DEPRESS; Sorbye LW, 2010, J MULTIDISCIP HEALTH, V3, P11; Thygesen E, 2009, INT J OLDER PEOPLE N, V4, P12, DOI 10.1111/j.1748-3743.2008.00132.x; Tropea J, 2008, AUSTRALAS J AGEING, V27, P150, DOI 10.1111/j.1741-6612.2008.00301.x; Tsai ACH, 2011, ARCH GERONTOL GERIAT, V53, P298, DOI 10.1016/j.archger.2010.12.003; Tuokko H, 2000, CLIN NEUROPSYCHOL, V14, P504, DOI 10.1076/clin.14.4.504.7200; Vogels RLC, 2007, EUR J HEART FAIL, V9, P440, DOI 10.1016/j.ejheart.2006.11.001; Wilson RS, 2012, NEUROLOGY, V78, P950, DOI 10.1212/WNL.0b013e31824d5894; WINOGRAD CH, 1991, J AM GERIATR SOC, V39, P778, DOI 10.1111/j.1532-5415.1991.tb02700.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86116	10.1371/journal.pone.0086116	http://dx.doi.org/10.1371/journal.pone.0086116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302RF	24497936	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900016
J	Hensley, PJ; Desiniotis, A; Wang, C; Stromberg, A; Chen, CS; Kyprianou, N				Hensley, Patrick J.; Desiniotis, Andreas; Wang, Chi; Stromberg, Arnold; Chen, Ching-Shih; Kyprianou, Natasha			Novel Pharmacologic Targeting of Tight Junctions and Focal Adhesions in Prostate Cancer Cells	PLOS ONE			English	Article							E-CADHERIN; MESENCHYMAL TRANSITION; ANDROGEN RECEPTOR; ANOIKIS; PROGRESSION; EXPRESSION; DOXAZOSIN; APOPTOSIS; METASTASIS; INTEGRINS	Cancer cell resistance to anoikis driven by aberrant signaling sustained by the tumor microenvironment confers high invasive potential and therapeutic resistance. We recently generated a novel lead quinazoline-based Doxazosin (R) derivative, DZ-50, which impairs tumor growth and metastasis via anoikis. Genome-wide analysis in the human prostate cancer cell line DU-145 identified primary downregulated targets of DZ-50, including genes involved in focal adhesion integrity (fibronectin, integrin-alpha 6 and talin), tight junction formation (claudin-11) as well as insulin growth factor binding protein 3 (IGFBP-3) and the angiogenesis modulator thrombospondin 1 (TSP-1). Confocal microscopy demonstrated structural disruption of both focal adhesions and tight junctions by the downregulation of these gene targets, resulting in decreased cell survival, migration and adhesion to extracellular matrix (ECM) components in two androgen-independent human prostate cancer cell lines, PC-3 and DU-145. Stabilization of cell-ECM interactions by overexpression of talin-1 and/or exposing cells to a fibronectin-rich environment mitigated the effect of DZ-50. Loss of expression of the intracellular focal adhesion signaling effectors talin-1 and integrin linked kinase (ILK) sensitized human prostate cancer to anoikis. Our findings suggest that DZ-50 exerts its antitumor effect by targeting the key functional intercellular interactions, focal adhesions and tight junctions, supporting the therapeutic significance of this agent for the treatment of advanced prostate cancer.	[Hensley, Patrick J.; Desiniotis, Andreas; Kyprianou, Natasha] Univ Kentucky, Coll Med, Dept Urol, Lexington, KY 40536 USA; [Hensley, Patrick J.; Kyprianou, Natasha] Univ Kentucky, Coll Med, Dept Pathol, Lexington, KY USA; [Wang, Chi] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Lexington, KY USA; [Stromberg, Arnold] Univ Kentucky, Dept Stat, Lexington, KY USA; [Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA; [Kyprianou, Natasha] Univ Kentucky, Coll Med, Dept Toxicol, Lexington, KY USA; [Kyprianou, Natasha] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University System of Ohio; Ohio State University; University of Kentucky; University of Kentucky	Kyprianou, N (corresponding author), Univ Kentucky, Coll Med, Dept Urol, Lexington, KY 40536 USA.	nkypr2@email.uky.edu		Hensley, Patrick/0000-0002-8098-901X	National Institutes of Health [R01-GRANT00491815]; National Center for Research Resources; National Center for Advancing Translational Sciences [UL1RR033173]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the National Institutes of Health, R01-GRANT00491815 and by the National Center for Research Resources and the National Center for Advancing Translational Sciences, UL1RR033173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Chan CH, 2013, CELL, V154, P556, DOI 10.1016/j.cell.2013.06.048; Chon JK, 1999, J UROLOGY, V161, P2002, DOI 10.1016/S0022-5347(05)68873-8; Desiniotis A, 2011, INT REV CEL MOL BIO, V289, P117, DOI 10.1016/B978-0-12-386039-2.00004-3; Dominguez I, 2001, DEV BIOL, V235, P303, DOI 10.1006/dbio.2001.0317; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fornaro M, 2001, CANCER METAST REV, V20, P321, DOI 10.1023/A:1015547830323; Fouquet S, 2004, J BIOL CHEM, V279, P43061, DOI 10.1074/jbc.M405095200; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Garrison JB, 2007, CANCER RES, V67, P11344, DOI 10.1158/0008-5472.CAN-07-1662; Garrison JB, 2006, CANCER RES, V66, P464, DOI 10.1158/0008-5472.CAN-05-2039; Goel HL, 2008, ENDOCR-RELAT CANCER, V15, P657, DOI 10.1677/ERC-08-0019; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; GULLBERG D, 1992, EMBO J, V11, P3865, DOI 10.1002/j.1460-2075.1992.tb05479.x; Hall CL, 2006, CANCER RES, V66, P8648, DOI 10.1158/0008-5472.CAN-06-1544; Hensley P, 2013, BIOL CHEM, V394, P831, DOI 10.1515/hsz-2013-0128; Horbinski C, 2010, AM J PATHOL, V177, P1044, DOI 10.2353/ajpath.2010.091270; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kyprianou N, 2003, J UROLOGY, V169, P1520, DOI 10.1097/01.ju.0000033280.29453.72; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Logothetis CJ, 2013, CANCER DISCOV, V3, P849, DOI 10.1158/2159-8290.CD-12-0460; MacVicar GR, 2013, CURR OPIN ONCOL, V25, P252, DOI 10.1097/CCO.0b013e32835ff161; Matuszak EA, 2011, EXPERT REV ENDOCRINO, V6, P469, DOI 10.1586/EEM.11.32; Miloszewska J, 2013, CELL PROLIFERAT, V46, P146, DOI 10.1111/cpr.12015; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Park SH, 2013, APOPTOSIS, V18, P949, DOI 10.1007/s10495-013-0847-1; Rosen K, 2002, J BIOL CHEM, V277, P46123, DOI 10.1074/jbc.M207883200; Roy M, 2009, J CELL BIOCHEM, V106, P200, DOI 10.1002/jcb.22005; Sakamoto S, 2011, EUR UROL, V59, P734, DOI 10.1016/j.eururo.2010.12.038; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Sakamoto S, 2010, MOL ASPECTS MED, V31, P205, DOI 10.1016/j.mam.2010.02.001; Shaw YJ, 2004, J MED CHEM, V47, P4453, DOI 10.1021/jm049752k; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh AB, 2012, CARCINOGENESIS, V33, P2538, DOI 10.1093/carcin/bgs275; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Soini Y, 2012, INT J CLIN EXP PATHO, V5, P126; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Zhu ML, 2010, FASEB J, V24, P769, DOI 10.1096/fj.09-136994	40	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86238	10.1371/journal.pone.0086238	http://dx.doi.org/10.1371/journal.pone.0086238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497940	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900019
J	Liu, CP; Tsuda, Y; Shen, HL; Hu, LJ; Saito, Y; Ide, Y				Liu, Chunping; Tsuda, Yoshiaki; Shen, Hailong; Hu, Lijiang; Saito, Yoko; Ide, Yuji			Genetic Structure and Hierarchical Population Divergence History of Acer mono var. mono in South and Northeast China	PLOS ONE			English	Article							MICROSATELLITE MARKERS; EVOLUTIONARY PROCESSES; FRAXINUS-MANDSHURICA; DIVERSITY; FOREST; TREE; NUCLEAR; CONSERVATION; DIFFERENTIATION; PHYLOGEOGRAPHY	Knowledge of the genetic structure and evolutionary history of tree species across their ranges is essential for the development of effective conservation and forest management strategies. Acer mono var. mono, an economically and ecologically important maple species, is extensively distributed in Northeast China (NE), whereas it has a scattered and patchy distribution in South China (SC). In this study, the genetic structure and demographic history of 56 natural populations of A. mono var. mono were evaluated using seven nuclear microsatellite markers. Neighbor-joining tree and STRUCTURE analysis clearly separated populations into NE and SC groups with two admixed-like populations. Allelic richness significantly decreased with increasing latitude within the NE group while both allelic richness and expected heterozygosity showed significant positive correlation with latitude within the SC group. Especially in the NE region, previous studies in Quercus mongolica and Fraxinus mandshurica have also detected reductions in genetic diversity with increases in latitude, suggesting this pattern may be common for tree species in this region, probably due to expansion from single refugium following the last glacial maximum (LGM). Approximate Bayesian Computation-based analysis revealed two major features of hierarchical population divergence in the species' evolutionary history. Recent divergence between the NE group and the admixed-like group corresponded to the LGM period and ancient divergence of SC groups took place during mid-late Pleistocene period. The level of genetic differentiation was moderate (F-ST = 0.073; G(ST)' = 0.278) among all populations, but significantly higher in the SC group than the NE group, mirroring the species' more scattered distribution in SC. Conservation measures for this species are proposed, taking into account the genetic structure and past demographic history identified in this study.	[Liu, Chunping; Shen, Hailong; Hu, Lijiang] Northeast Forestry Univ, State Key Lab Forest Genet & Breeding, Harbin, Heilongjiang Pr, Peoples R China; [Liu, Chunping; Saito, Yoko; Ide, Yuji] Univ Tokyo, Lab Forest Ecosyst Studies, Dept Ecosyst Studies, Grad Sch Agr & Life Sci, Tokyo, Japan; [Tsuda, Yoshiaki] Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr, Program Plant Ecol & Evolut, Uppsala, Sweden	Northeast Forestry University - China; University of Tokyo; Uppsala University	Shen, HL (corresponding author), Northeast Forestry Univ, Sch Forestry, Harbin, Peoples R China.	shenhl-cf@nefu.edu.cn			Heilongjiang Provincial Key Technologies R D Program [GA09B202-06]; Support Plan for Distinguished Researchers in Northeast Forestry University, China	Heilongjiang Provincial Key Technologies R D Program; Support Plan for Distinguished Researchers in Northeast Forestry University, China	This study was partially supported by Heilongjiang Provincial Key Technologies R & D Program (GA09B202-06) and by the Special Funding from the Support Plan for Distinguished Researchers in Northeast Forestry University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai WN, 2010, NEW PHYTOL, V188, P892, DOI 10.1111/j.1469-8137.2010.03407.x; Baucom RS, 2005, CONSERV GENET, V6, P39, DOI 10.1007/s10592-004-7718-9; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Buiteveld J, 2007, FOREST ECOL MANAG, V247, P98, DOI 10.1016/j.foreco.2007.04.018; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dong SL, 1985, B BOT RES, V5, P97; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Escudero A, 2003, BIOL CONSERV, V113, P351, DOI 10.1016/S0006-3207(03)00122-8; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; FRANKEL OH, 1974, GENETICS, V78, P53; Fu LG, 1992, CHINA PLANT RED DATA, V1, P385; Geburek T, 1997, BIODIVERS CONSERV, V6, P1639, DOI 10.1023/A:1018330906758; Godbout J, 2005, MOL ECOL, V14, P3497, DOI 10.1111/j.1365-294X.2005.02674.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heuertz M, 2004, EVOLUTION, V58, P976; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hsu T., 1992, GUIHAIA, V12, P229; Hsu T, 1988, RESOURCE DEV MARKET, V4, P51; Hu LJ, 2008, ANN BOT-LONDON, V102, P195, DOI 10.1093/aob/mcn074; Hu LJ, 2010, CONSERV GENET, V11, P77, DOI 10.1007/s10592-009-0004-0; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ingvarsson PK, 2008, GENETICS, V180, P329, DOI 10.1534/genetics.108.090431; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kikuchi S, 2008, MOL ECOL RESOUR, V8, P339, DOI 10.1111/j.1471-8286.2007.01948.x; Kikuchi S, 2009, PLANT ECOL, V204, P43, DOI 10.1007/s11258-008-9564-1; Langella O., 2007, POPULATIONS 1 2 30 P; Lascoux M, 2008, PLANT ECOL DIVERS, V1, P209, DOI 10.1080/17550870802328439; Li WenYing, 2003, Scientia Silvae Sinicae, V39, P29; Li WH, 2004, FOREST ECOL MANAG, V201, P33, DOI 10.1016/j.foreco.2004.06.010; Lian CL, 2003, MOL ECOL, V12, P609, DOI 10.1046/j.1365-294X.2003.01756.x; Lin NF, 1999, QUATERNARY SCI, V5, P448; Liu Jian-feng, 2005, Forest Research, V18, P222; Logossa ZA, 2011, MOL ECOL, V20, P4009, DOI 10.1111/j.1365-294X.2011.05249.x; Lu ZX, 2006, PLANT SCI, V170, P407, DOI 10.1016/j.plantsci.2005.09.009; Magri D, 2007, MOL ECOL, V16, P5259, DOI 10.1111/j.1365-294X.2007.03587.x; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Matsui K, 2010, PLANT SPEC BIOL, V6, P117; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Mu Li-Qiang, 2007, Zhiwu Shengtai Xuebao, V31, P1190; Naydenov KD, 2011, NEW FOREST, V42, P179, DOI 10.1007/s11056-010-9245-5; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Newton AC, 1999, TRENDS ECOL EVOL, V14, P140, DOI 10.1016/S0169-5347(98)01555-9; Pandey M, 2004, MOL ECOL NOTES, V4, P253, DOI 10.1111/j.1471-8286.2004.00633.x; Parks DH, 2009, GENOME RES, V19, P1896, DOI 10.1101/gr.095612.109; Peakall R, 2007, GEN ANAL EXCEL POPU; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Satake G, 1993, WILD FLOWERS JAPAN W; Segarra-Moragues JG, 2008, CONSERV GENET, V9, P1059, DOI 10.1007/s10592-007-9451-7; Shibata M, 2009, ECOL RES, V24, P1, DOI 10.1007/s11284-008-0474-4; *SPSS INC, 2004, SPSS WIND REL 13 0 S; Steinitz O, 2012, MOL ECOL, V21, P300, DOI 10.1111/j.1365-294X.2011.05394.x; Terui H, 2006, MOL ECOL NOTES, V6, P77, DOI 10.1111/j.1471-8286.2005.01144.x; Tsuda Y, 2005, MOL ECOL, V14, P3929, DOI 10.1111/j.1365-294X.2005.02715.x; Tsuda Y, 2010, TREE GENET GENOMES, V6, P377, DOI 10.1007/s11295-009-0256-3; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wright S, 1943, GENETICS, V28, P114; Xia Ming, 2001, Scientia Silvae Sinicae, V37, P126; [薛祥煦 Xue Xiangxu], 2004, [第四纪研究, Quaternary Sciences], V24, P82; [薛祥煦 Xue Xiangxu], 2002, [西北大学学报. 自然科学版, Journal of Northwest University], V32, P451; Yan ZhiFeng, 2006, Biodiversity Science, V14, P488, DOI 10.1360/biodiv.060041; Yu G, 1998, J BIOGEOGR, V25, P1055, DOI 10.1046/j.1365-2699.1998.00237.x; Zhang Jie, 2007, Shengwu Duoyangxing, V15, P292, DOI 10.1360/biodiv.060133; Zhang YQ, 2003, J GEOMECH, V4, P313; Zheng W, 2004, SYLVA SINICA, V4, P4258; Zhu JJ, 2007, J FOREST RES-JPN, V12, P403, DOI 10.1007/s10310-007-0033-9	78	32	35	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87187	10.1371/journal.pone.0087187	http://dx.doi.org/10.1371/journal.pone.0087187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498039	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900075
J	Revermann, M; Neofitidou, S; Kirschning, T; Schloss, M; Brandes, RP; Hofstetter, C				Revermann, Marc; Neofitidou, Skevi; Kirschning, Thomas; Schloss, Manuel; Brandes, Ralf P.; Hofstetter, Christian			Inhalation of the BKCa-Opener NS1619 Attenuates Right Ventricular Pressure and Improves Oxygenation in the Rat Monocrotaline Model of Pulmonary Hypertension	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; DEPENDENT POTASSIUM CHANNELS; ARTERIAL SMOOTH-MUSCLE; GROWTH-FACTOR EXPRESSION; CELL-PROLIFERATION; PROTEIN-KINASE; NITRIC-OXIDE; MITOCHONDRIAL-MEMBRANE; INHIBITION; VASODILATORS	Background: Right heart failure is a fatal consequence of chronic pulmonary hypertension (PH). The development of PH is characterized by increased proliferation of vascular cells, in particular pulmonary artery smooth muscle cells (PASMCs) and pulmonary artery endothelial cells. In the course of PH, an escalated right ventricular (RV) afterload occurs, which leads to increased perioperative morbidity and mortality. BKCa channels are ubiquitously expressed in vascular smooth muscle cells and their opening induces cell membrane hyperpolarization followed by vasodilation. Moreover, BK activation induces anti-proliferative effects in a multitude of cell types. On this basis, we hypothesized that treatment with the nebulized BK channel opener NS1619 might be a therapy option for pulmonary hypertension and tested this in rats. Methods: (1) Rats received monocrotaline injection for PH induction. Twenty-four days later, rats were anesthetized and NS1619 or the solvent was administered by inhalation. Systemic hemodynamic parameters, RV hemodynamic parameters, and blood gas analyses were measured before as well as 30 and 120 minutes after inhalation. (2) Rat PASMCs were stimulated with PDGF-BB in the presence and absence of NS1619. AKT, ERK1 and ERK2 activation were investigated by western blot analyses, and relative cell number was determined 48 hours after stimulation. Results: Inhalation of a 12 mu M and 100 mu M NS1619 solution significantly reduced RV pressure without affecting systemic arterial pressure. Blood gas analyses demonstrated significantly reduced carbon dioxide and improved oxygenation in NS1619-treated animals pointing towards a considerable pulmonary shunt-reducing effect. In PASMC's, NS1619 (100 mu M) significantly attenuated PASMC proliferation by a pathway independent of AKT and ERK1/2 activation. Conclusion: NS1619 inhalation reduces RV pressure and improves oxygen supply and its application inhibits PASMC proliferation in vitro. Hence, BK opening might be a novel option for the treatment of pulmonary hypertension.	[Revermann, Marc; Neofitidou, Skevi; Kirschning, Thomas; Hofstetter, Christian] Heidelberg Univ, Dept Anesthesiol & Crit Care Med, Univ Hosp Mannheim, Fac Med, Heidelberg, Germany; [Revermann, Marc; Schloss, Manuel; Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Cardiovasc Physiol, Fac Med, D-60054 Frankfurt, Germany	Ruprecht Karls University Heidelberg; Goethe University Frankfurt	Revermann, M (corresponding author), Heidelberg Univ, Dept Anesthesiol & Crit Care Med, Univ Hosp Mannheim, Fac Med, Heidelberg, Germany.	marc.revermann@umm.de	Brandes, Ralf P/L-3058-2017	Brandes, Ralf P/0000-0002-8035-0048	Medical Faculty of Mannheim; Medical Faculty of Frankfurt; B. Braun foundation	Medical Faculty of Mannheim; Medical Faculty of Frankfurt; B. Braun foundation	The Medical Faculties of Mannheim and Frankfurt and the B. Braun foundation supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda M, 1999, ANESTH ANALG, V89, P152, DOI 10.1097/00000539-199907000-00027; Archer SL, 1998, J CLIN INVEST, V101, P2319, DOI 10.1172/JCI333; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Bae YM, 1999, J PHYSIOL-LONDON, V514, P747, DOI 10.1111/j.1469-7793.1999.747ad.x; Barman SA, 2003, AM J PHYSIOL-LUNG C, V284, pL1004, DOI 10.1152/ajplung.00295.2002; BARNES PJ, 1995, PHARMACOL REV, V47, P87; Barst RJ, 2009, J AM COLL CARDIOL, V54, pS78, DOI 10.1016/j.jacc.2009.04.017; Bentzen BH, 2009, PFLUG ARCH EUR J PHY, V457, P979, DOI 10.1007/s00424-008-0583-5; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Bonnet S, 2003, CARDIOVASC RES, V60, P326, DOI 10.1016/S0008-6363(03)00527-3; Bonnet S, 2007, PHARMACOL THERAPEUT, V115, P56, DOI 10.1016/j.pharmthera.2007.03.014; BOWRING NE, 1993, BRIT J PHARMACOL, V109, P1133, DOI 10.1111/j.1476-5381.1993.tb13740.x; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Carlino C, 2010, AM J MED SCI, V339, P55, DOI 10.1097/MAJ.0b013e3181c078d7; Chang H, 2011, J CELL PHYSIOL, V226, P1660, DOI 10.1002/jcp.22497; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; Costa RSA, 2005, NITRIC OXIDE-BIOL CH, V13, P145, DOI 10.1016/j.niox.2005.05.010; Cui B, 2009, CLIN EXP PHARMACOL P, V36, P169, DOI 10.1111/j.1440-1681.2008.05044.x; Dahal BK, 2010, AM J RESP CRIT CARE, V181, P158, DOI 10.1164/rccm.200811-1682OC; Dick GM, 2010, EXP BIOL MED, V235, P10, DOI 10.1258/ebm.2009.009201; Dimitropoulou C, 2005, AM J RESP CELL MOL, V32, P239, DOI 10.1165/rcmb.2004-0331OC; EDWARDS G, 1994, BRIT J PHARMACOL, V113, P1538, DOI 10.1111/j.1476-5381.1994.tb17171.x; Falcao-Pires I, 2009, AM J PHYSIOL-HEART C, V296, pH2007, DOI 10.1152/ajpheart.00089.2009; Ghofrani HA, 2005, NEW ENGL J MED, V353, P1412, DOI 10.1056/NEJMc051946; Han XB, 2008, BIOCHEM BIOPH RES CO, V375, P205, DOI 10.1016/j.bbrc.2008.07.161; Hoeper MM, 2013, CIRCULATION, V127, P1128, DOI 10.1161/CIRCULATIONAHA.112.000765; Humbert M, 1998, EUR RESPIR J, V11, P554; Krick S, 2001, AM J PHYSIOL-LUNG C, V281, pL887, DOI 10.1152/ajplung.2001.281.4.L887; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; Montani D, 2014, PHARMACOL THERAPEUT, V141, P172, DOI 10.1016/j.pharmthera.2013.10.002; Nagaoka T, 2005, AM J RESP CRIT CARE, V171, P494, DOI 10.1164/rccm.200405-637OC; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Pullamsetti S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-128; Redel A, 2008, ANESTH ANALG, V106, P384, DOI 10.1213/ane.0b013e318160650f; Revermann M, 2009, J HYPERTENS, V27, P322, DOI 10.1097/HJH.0b013e32831aedfa; Sandow SL, 2009, AM J PHYSIOL-HEART C, V297, pH1, DOI 10.1152/ajpheart.00042.2009; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; Tuder RM, 2009, J AM COLL CARDIOL, V54, pS3, DOI 10.1016/j.jacc.2009.04.009; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yang A, 2010, VASC PHARMACOL, V53, P122, DOI 10.1016/j.vph.2010.05.001; Yun J, 2010, SKIN PHARMACOL PHYS, V23, P91, DOI 10.1159/000265680; Zhao YJ, 1998, EXP LUNG RES, V24, P71, DOI 10.3109/01902149809046055	46	17	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86636	10.1371/journal.pone.0086636	http://dx.doi.org/10.1371/journal.pone.0086636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497961	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900030
J	Chitnis, VR; Gao, F; Yao, Z; Jordan, MC; Park, S; Ayele, BT				Chitnis, Vijaya R.; Gao, Feng; Yao, Zhen; Jordan, Mark C.; Park, Seokhoon; Ayele, Belay T.			After-Ripening Induced Transcriptional Changes of Hormonal Genes in Wheat Seeds: The Cases of Brassinosteroids, Ethylene, Cytokinin and Salicylic Acid	PLOS ONE			English	Article							ABSCISIC-ACID; DORMANCY ALLEVIATION; ARABIDOPSIS-THALIANA; GIBBERELLIC-ACID; PLANT-GROWTH; GERMINATION; EXPRESSION; RECEPTOR; DEFENSE; PROTEIN	Maintenance and release of seed dormancy is regulated by plant hormones; their levels and seed sensitivity being the critical factors. This study reports transcriptional regulation of brassinosteroids (BR), ethylene (ET), cytokinin (CK) and salicylic acid (SA) related wheat genes by after-ripening, a period of dry storage that decays dormancy. Changes in the expression of hormonal genes due to seed after-ripening did not occur in the anhydrobiotic state but rather in the hydrated state. After-ripening induced dormancy decay appears to be associated with imbibition mediated increase in the synthesis and signalling of BR, via transcriptional activation of de-etiolated2, dwarf4 and brassinosteroid signaling kinase, and repression of brassinosteroid insensitive 2. Our analysis is also suggestive of the significance of increased ET production, as reflected by enhanced transcription of 1-aminocyclopropane-1-carboxylic acid oxidase in after-ripened seeds, and tight regulation of seed response to ET in regulating dormancy decay. Differential transcriptions of lonely guy, zeatin O-glucosyltransferases and cytokinin oxidases, and pseudo-response regulator between dormant and after-ripened seeds implicate CK in the regulation of seed dormancy in wheat. Our analysis also reflects the association of dormancy decay in wheat with seed SA level and NPR independent SA signaling that appear to be regulated transcriptionally by phenylalanine ammonia lyase, and whirly and suppressor of npr1 inducible1 genes, respectively. Co-expression clustering of the hormonal genes implies the significance of synergistic and antagonistic interaction between the different plant hormones in regulating wheat seed dormancy. These results contribute to further our understanding of the molecular features controlling seed dormancy in wheat.	[Chitnis, Vijaya R.; Gao, Feng; Yao, Zhen; Park, Seokhoon; Ayele, Belay T.] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Jordan, Mark C.] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada	University of Manitoba; Agriculture & Agri Food Canada	Ayele, BT (corresponding author), Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada.	belay.ayele@umanitoba.ca			Natural Sciences and Engineering Research Council of Canada; Western Grains Research Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Western Grains Research Foundation	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada and Western Grains Research Foundation to BTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS SW, 1981, PLANT PHYSIOL, V67, P358, DOI 10.1104/pp.67.2.358; An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Bazin J, 2011, J EXP BOT, V62, P627, DOI 10.1093/jxb/erq314; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Blazejczyk M, 2007, FLEXARRAY VERSION 1; Bleecker AB, 1998, PHILOS T ROY SOC B, V353, P1405, DOI 10.1098/rstb.1998.0295; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; Chiwocha SDS, 2005, PLANT J, V42, P35, DOI 10.1111/j.1365-313X.2005.02359.x; CORBINEAU F, 1990, ISRAEL J BOT, V39, P313; Desveaux D, 2005, TRENDS PLANT SCI, V10, P95, DOI 10.1016/j.tplants.2004.12.008; Desveaux D, 2004, DEV CELL, V6, P229, DOI 10.1016/S1534-5807(04)00028-0; Dewar J, 1998, SEED SCI RES, V8, P1, DOI 10.1017/S0960258500003858; Divi UK, 2010, J PLANT GROWTH REGUL, V29, P385, DOI 10.1007/s00344-010-9150-3; EASTWOOD D, 1969, NATURE, V221, P1267, DOI 10.1038/2211267a0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; FONTAINE O, 1994, PLANT PHYSIOL BIOCH, V32, P677; Friedrichsen DM, 2002, GENETICS, V162, P1445; Gao F, 2012, PLANT BIOTECHNOL J, V10, P465, DOI 10.1111/j.1467-7652.2012.00682.x; Ghassemian M, 2000, PLANT CELL, V12, P1117, DOI 10.1105/tpc.12.7.1117; Gianinetti A, 2007, ANN BOT-LONDON, V99, P735, DOI 10.1093/aob/mcm008; GUAN LQ, 1995, P NATL ACAD SCI USA, V92, P5930, DOI 10.1073/pnas.92.13.5930; Hansen M, 2009, PLANT J, V57, P606, DOI 10.1111/j.1365-313X.2008.03711.x; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Il Je B, 2010, PLANT CELL, V22, P1777, DOI 10.1105/tpc.109.069575; Kachroo P, 2001, P NATL ACAD SCI USA, V98, P9448, DOI 10.1073/pnas.151258398; Kepczynski J, 1997, PHYSIOL PLANTARUM, V101, P720, DOI 10.1034/j.1399-3054.1997.1010407.x; KHAN AA, 1968, PLANT PHYSIOL, V43, P1463, DOI 10.1104/pp.43.9.1463; Kim HB, 2006, PLANT PHYSIOL, V140, P548, DOI 10.1104/pp.105.067918; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Lee S, 2010, PLANT SIGNAL BEHAV, V5, P1534, DOI 10.4161/psb.5.12.13159; Leubner-Metzger G, 1998, PLANT MOL BIOL, V38, P785, DOI 10.1023/A:1006040425383; Leubner-Metzger G, 2001, PLANTA, V213, P758, DOI 10.1007/s004250100542; Li QF, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002908; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Linkies A, 2009, PLANT CELL, V21, P3803, DOI 10.1105/tpc.109.070201; Liu AH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056536, 10.1371/journal.pone.0057359, 10.1371/journal.pone.0056570, 10.1371/journal.pone.0054001]; Locke JM, 2000, J EXP BOT, V51, P1843, DOI 10.1093/jexbot/51.352.1843; Ma QH, 2003, J EXP BOT, V54, P1489, DOI 10.1093/jxb/erg142; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; Nakamura S, 2011, PLANT CELL, V23, P3215, DOI 10.1105/tpc.111.088492; Nomura T, 2001, PHYTOCHEMISTRY, V57, P171, DOI 10.1016/S0031-9422(00)00440-4; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Oracz K, 2009, PLANT PHYSIOL, V150, P494, DOI 10.1104/pp.109.138107; Penfield S, 2006, CURR BIOL, V16, P2366, DOI 10.1016/j.cub.2006.10.057; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Rajjou L, 2006, PLANT PHYSIOL, V141, P910, DOI 10.1104/pp.106.082057; Resnick JS, 2006, P NATL ACAD SCI USA, V103, P7917, DOI 10.1073/pnas.0602239103; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Shakirova F. M., 2007, Salicylic acid: a plant hormone, P69, DOI 10.1007/1-4020-5184-0_4; Shakirova FM, 2003, PLANT SCI, V164, P317, DOI 10.1016/S0168-9452(02)00415-6; Shimada Y, 2003, PLANT PHYSIOL, V131, P287, DOI 10.1104/pp.013029; Steber CM, 2001, PLANT PHYSIOL, V125, P763, DOI 10.1104/pp.125.2.763; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Wang KLC, 2004, NATURE, V428, P945, DOI 10.1038/nature02516; Wang L, 2009, PLANT J, V57, P498, DOI 10.1111/j.1365-313X.2008.03707.x; Wang YH, 2011, PLANT SIGNAL BEHAV, V6, P494, DOI 10.4161/psb.6.4.14558; Wu Y, 2012, CELL REPORTS, V1, P639, DOI 10.1016/j.celrep.2012.05.008; Xi WY, 2010, PLANT SIGNAL BEHAV, V5, P1315, DOI 10.4161/psb.5.10.13161; Xie Z, 2007, PLANT MOL BIOL, V64, P293, DOI 10.1007/s11103-007-9152-0; Zhang LY, 2009, PLANT CELL, V21, P3767, DOI 10.1105/tpc.109.070441; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1	64	31	35	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87543	10.1371/journal.pone.0087543	http://dx.doi.org/10.1371/journal.pone.0087543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498132	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100093
J	Kodiha, M; Salimi, A; Wang, YM; Stochaj, U				Kodiha, Mohamed; Salimi, Ali; Wang, Yi Meng; Stochaj, Ursula			Pharmacological AMP Kinase Activators Target the Nucleolar Organization and Control Cell Proliferation	PLOS ONE			English	Article							PROTEIN-KINASE; ENERGY SENSOR; RNA; PHOSPHORYLATION; NUCLEAR; APOPTOSIS; STRESS; QUANTIFICATION; TRANSCRIPTION; MECHANISMS	Aims: Phenformin, resveratrol and AICAR stimulate the energy sensor 59-AMP activated kinase (AMPK) and inhibit the first step of ribosome biogenesis, de novo RNA synthesis in nucleoli. Nucleolar activities are relevant to human health, because ribosome production is crucial to the development of diabetic complications. Although the function of nucleoli relies on their organization, the impact of AMPK activators on nucleolar structures is not known. Here, we addressed this question by examining four nucleolar proteins that are essential for ribosome biogenesis. Methods: Kidney cells were selected as model system, because diabetic nephropathy is one of the complications associated with diabetes mellitus. To determine the impact of pharmacological agents on nucleoli, we focused on the subcellular and subnuclear distribution of B23/nucleophosmin, fibrillarin, nucleolin and RPA194. This was achieved by quantitative confocal microscopy at the single-cell level in combination with cell fractionation and quantitative Western blotting. Results: AMPK activators induced the re-organization of nucleoli, which was accompanied by changes in cell proliferation. Among the compounds tested, phenformin and resveratrol had the most pronounced impact on nucleolar organization. For B23, fibrillarin, nucleolin and RPA194, both agents (i) altered the nucleocytoplasmic distribution and nucleolar association and (ii) reduced significantly the retention in the nucleus. (iii) Phenformin and resveratrol also increased significantly the total concentration of B23 and nucleolin. Conclusions: AMPK activators have unique effects on the subcellular localization, nuclear retention and abundance of nucleolar proteins. We propose that the combination of these events inhibits de novo ribosomal RNA synthesis and modulates cell proliferation. Our studies identified nucleolin as a target that is especially sensitive to pharmacological AMPK activators. Because of its response to pharmacological agents, nucleolin represents a potential biomarker for the development of drugs that diminish diabetic renal hypertrophy.	[Kodiha, Mohamed; Salimi, Ali; Wang, Yi Meng; Stochaj, Ursula] McGill Univ, Dept Physiol, Montreal, PQ, Canada	McGill University	Stochaj, U (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	ursula.stochaj@mcgill.ca	stochaj, ursula/AAC-1865-2021; Salimi, Ali/AAG-9670-2020	Salimi, Ali/0000-0003-0016-3478	Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by the Heart and Stroke Foundation of Canada (http://www.hsf.ca/research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Abdelmohsen K, 2011, NUCLEIC ACIDS RES, V39, P8513, DOI 10.1093/nar/gkr488; Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Alazami AM, 2008, AM J HUM GENET, V83, P684, DOI 10.1016/j.ajhg.2008.10.018; Banski P, 2010, TRENDS BIOCHEM SCI, V35, P361, DOI 10.1016/j.tibs.2010.02.010; Banski P, 2010, J BIOL CHEM, V285, P21858, DOI 10.1074/jbc.M110.117291; Bierhoff H, 2008, MOL CELL BIOL, V28, P4988, DOI 10.1128/MCB.00492-08; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Cmarko D, 2008, HISTOL HISTOPATHOL, V23, P1291, DOI 10.14670/HH-23.1291; Cong R, 2014, NUCLEIC ACIDS RES, V42, P181, DOI 10.1093/nar/gkt863; Cong R, 2011, PROTEIN REV, V15, P185, DOI 10.1007/978-1-4614-0514-6_9; Cong R, 2012, NUCLEIC ACIDS RES, V40, P9441, DOI 10.1093/nar/gks720; CSERMELY P, 1993, J BIOL CHEM, V268, P9747; Detampel P, 2012, DRUG METAB REV, V44, P253, DOI 10.3109/03602532.2012.700715; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; FEUERSTEIN N, 1991, EXP CELL RES, V194, P289, DOI 10.1016/0014-4827(91)90367-4; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Goldstein M, 2013, P NATL ACAD SCI USA, V110, P16874, DOI 10.1073/pnas.1306160110; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hallows KR, 2010, AM J PHYSIOL-RENAL, V298, pF1067, DOI 10.1152/ajprenal.00005.2010; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kodiha M, 2011, MED COMPLICATIONS TY, P321; Kodiha M, 2013, CHAPERONES MULTITASK, P149; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kodiha M, 2011, AM J PHYSIOL-CELL PH, V301, pC1307, DOI 10.1152/ajpcell.00309.2011; Kodiha M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-25; Kodiha M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.137pl2; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Li DX, 1996, J BIOL CHEM, V271, P15662, DOI 10.1074/jbc.271.26.15662; Lieberthal W, 2011, AM J PHYSIOL-RENAL, V301, pF1177, DOI 10.1152/ajprenal.00034.2011; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Liu XY, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002373; Mahboubi H, 2013, MICROSC MICROANAL, V19, P617, DOI 10.1017/S1431927613000159; Mariappan MM, 2011, AM J PHYSIOL-RENAL, V300, pF219, DOI 10.1152/ajprenal.00207.2010; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nakamura M, 2009, EXP MOL MED, V41, P307, DOI 10.3858/emm.2009.41.5.034; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; Pastor-Soler NM, 2012, CURR OPIN NEPHROL HY, V21, P523, DOI 10.1097/MNH.0b013e3283562390; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Roger B, 2002, J BIOL CHEM, V277, P10209, DOI 10.1074/jbc.M106412200; Seo-Mayer PW, 2011, AM J PHYSIOL-RENAL, V301, pF1346, DOI 10.1152/ajprenal.00420.2010; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; STAUFENBIEL M, 1984, J CELL BIOL, V98, P1886, DOI 10.1083/jcb.98.5.1886; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Su HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080237; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Walle T, 2011, ANN NY ACAD SCI, V1215, P9, DOI 10.1111/j.1749-6632.2010.05842.x; Wang WG, 2004, J BIOL CHEM, V279, P48376, DOI 10.1074/jbc.M409014200; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	63	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e88087	10.1371/journal.pone.0088087	http://dx.doi.org/10.1371/journal.pone.0088087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498249	Green Submitted, gold, Green Published			2022-12-25	WOS:000330617100127
J	Lepist, EI; Gillies, H; Smith, W; Hao, J; Hubert, C; St Claire, RL; Brouwer, KR; Ray, AS				Lepist, Eve-Irene; Gillies, Hunter; Smith, William; Hao, Jia; Hubert, Cassandra; St Claire, Robert L., III; Brouwer, Kenneth R.; Ray, Adrian S.			Evaluation of the Endothelin Receptor Antagonists Ambrisentan, Bosentan, Macitentan, and Sitaxsentan as Hepatobiliary Transporter Inhibitors and Substrates in Sandwich-Cultured Human Hepatocytes	PLOS ONE			English	Article							SALT EXPORT PUMP; PULMONARY ARTERIAL-HYPERTENSION; FAMILIAL INTRAHEPATIC CHOLESTASIS; BILE-ACID TRANSPORT; P-GLYCOPROTEIN; IN-VITRO; RAT HEPATOCYTES; HEPATIC-UPTAKE; KNOCKOUT MICE; BILIARY-EXCRETION	Background: Inhibition of the transporter-mediated hepatobiliary elimination of bile salts is a putative mechanism for liver toxicity observed with some endothelin receptor antagonists (ERAs). Methods: Sandwich-cultured human hepatocytes were used to study the hepatobiliary distribution and accumulation of exogenous taurocholate, ERAs and endogenous bile acids. The molecular mechanisms for findings in hepatocytes or clinical observations were further explored using either vesicular assays (efflux transporters) or transfected cell-lines (uptake transporters). Inhibition constants (IC50) were measured for the human hepatobiliary transporters bile salt export pump (BSEP), sodium taurocholate cotransporting polypeptide (NTCP), multidrug resistance protein 2 (MRP2), P-glycoprotein (Pgp), breast cancer resistance protein (BCRP), organic anion-transporting polypeptide 1B1 (OATP1B1) and OATP1B3. Results: The ERAs showed dose-dependent reductions in exogenous taurocholate cellular accumulation in human hepatocytes, with macitentan having the greatest effect. Consistent with their effects on bile acids, the ERAs inhibited bile transporters. IC50 values for OATP1B1 and OATP1B3 ranged from 2 mu M for macitentan to 47 mu M for ambrisentan. Macitentan and bosentan also inhibited NTCP with IC50 values of 10 and 36 mu M, respectively. Similar to previously reported findings with sitaxsentan, BSEP inhibition was observed for bosentan and macitentan with IC50 values of 42 and 12 mu M, respectively. In contrast, ambrisentan showed little or no inhibition of these transporters. Other transporters tested were weakly inhibited by the ERAs. Accumulation in hepatocytes was also a factor in the effects on bile transport. Macitentan demonstrated the greatest accumulation in human hepatocytes (similar to 100x) followed by sitaxsentan (similar to 40x), bosentan (similar to 20x) and ambrisentan (similar to 2x). Conclusions: Significant differences in the inhibition of hepatic transporters were observed between the evaluated ERAs in vitro. Macitentan had the highest level of cellular accumulation and caused the greatest effects on bile acid distribution in human hepatocytes followed by sitaxsentan and bosentan. Ambrisentan showed a low potential to affect bile acids.	[Lepist, Eve-Irene; Gillies, Hunter; Hao, Jia; Ray, Adrian S.] Gilead Sci Inc, Foster City, CA 94404 USA; [Smith, William; Hubert, Cassandra; St Claire, Robert L., III; Brouwer, Kenneth R.] Qualyst Transporter Solut LLC, Durham, NC USA	Gilead Sciences	Ray, AS (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	Adrian.Ray@gilead.com		Ray, Adrian/0000-0002-3508-3008	Gilead Sciences, Inc.	Gilead Sciences, Inc.(Gilead Sciences)	This study was funded by Gilead Sciences, Inc. As employees of Gilead Sciences, Inc., EIL, HG, JH, and ASR were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ansede JH, 2010, DRUG METAB DISPOS, V38, P276, DOI 10.1124/dmd.109.028407; Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674; Barst RJ, 2006, J AM COLL CARDIOL, V47, P2049, DOI 10.1016/j.jacc.2006.01.057; Bruderer S, 2012, AAPS J, V14, P68, DOI 10.1208/s12248-011-9316-3; Chan FKL, 1997, TRANSPLANTATION, V63, P1574, DOI 10.1097/00007890-199706150-00006; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; DAVENPORT AP, 1995, J CARDIOVASC PHARM, V26, pS265; Fattinger K, 2001, CLIN PHARMACOL THER, V69, P223, DOI 10.1067/mcp.2001.114667; Fouassier L, 2002, J HEPATOL, V37, P184, DOI 10.1016/S0168-8278(02)00107-1; Funk C, 2001, MOL PHARMACOL, V59, P627, DOI 10.1124/mol.59.3.627; Galie N, 2011, EUR RESPIR J, V37, P475, DOI 10.1183/09031936.00194810; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; GIAID A, 1993, J VASC RES, V30, P333, DOI 10.1159/000159015; Hartman JC, 2010, CAN J PHYSIOL PHARM, V88, P682, DOI 10.1139/Y10-060; Hirano M, 2005, J PHARMACOL EXP THER, V314, P876, DOI 10.1124/jpet.105.084830; Humbert M, 2007, EUR RESPIR J, V30, P338, DOI 10.1183/09031936.00138706; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Jansen PLM, 1999, GASTROENTEROLOGY, V117, P1370, DOI 10.1016/S0016-5085(99)70287-8; Jara P, 2009, NEW ENGL J MED, V361, P1359, DOI 10.1056/NEJMoa0901075; Kemp DC, 2005, TOXICOL SCI, V83, P207, DOI 10.1093/toxsci/kfi020; Kim SJ, 2012, TRANSL ONCOL, V5, P39, DOI 10.1593/tlo.11286; Kostrubsky VE, 2003, TOXICOL SCI, V76, P220, DOI 10.1093/toxsci/kfg217; Lam P, 2005, BIOCHEMISTRY-US, V44, P12598, DOI 10.1021/bi050943e; Ling L, 2012, LIFE SCI, V91, P716, DOI 10.1016/j.lfs.2012.02.003; Liu XR, 1999, AM J PHYSIOL-GASTR L, V277, pG12, DOI 10.1152/ajpgi.1999.277.1.G12; Mano Y, 2007, BIOPHARM DRUG DISPOS, V28, P13, DOI 10.1002/bdd.527; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; McLaughlin VV, 2005, EUR RESPIR J, V25, P244, DOI 10.1183/09031936.05.00054804; Mizuta K, 1999, TRANSPLANT P, V31, P2755, DOI 10.1016/S0041-1345(99)00554-0; Morgan RE, 2013, TOXICOL SCI; Morgan RE, 2010, TOXICOL SCI, V118, P485, DOI 10.1093/toxsci/kfq269; Oudiz RJ, 2009, J AM COLL CARDIOL, V54, P1971, DOI 10.1016/j.jacc.2009.07.033; Ray A, 2009, ET 11 APS INT C END; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Rubin L, 2012, CHEST, V142, p1026A, DOI [DOI 10.1378/CHEST.1456207, 10.1378/chest.1456207]; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Sakurai A, 2007, EXPERT OPIN DRUG SAF, V6, P71, DOI 10.1517/14740338.6.1.71; Sidharta PN, 2011, EUR J CLIN PHARMACOL, V67, P977, DOI 10.1007/s00228-011-1043-2; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Strautnieks SS, 2008, GASTROENTEROLOGY, V134, P1203, DOI 10.1053/j.gastro.2008.01.038; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Treiber A, 2004, J PHARMACOL EXP THER, V308, P1121, DOI 10.1124/jpet.103.061614; Treiber A, 2007, DRUG METAB DISPOS, V35, P1400, DOI 10.1124/dmd.106.013615; United States Food and Drug Administration, 2008, MIRENA LEVONORGESTRE; van Giersbergen PLM, 2007, CLIN PHARMACOL THER, V81, P414, DOI 10.1038/sj.clpt.6100075; Wang RX, 2003, HEPATOLOGY, V38, P1489, DOI 10.1016/j.hep.2003.09.037; Wang RX, 2001, P NATL ACAD SCI USA, V98, P2011, DOI 10.1073/pnas.031465498; Weiss J, 2013, EUR J PHARMACOL, V701, P168, DOI 10.1016/j.ejphar.2013.01.010	49	52	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87548	10.1371/journal.pone.0087548	http://dx.doi.org/10.1371/journal.pone.0087548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498134	gold, Green Submitted, Green Published			2022-12-25	WOS:000330617100094
J	Vlach, J; Samal, AB; Saad, JS				Vlach, Jiri; Samal, Alexandra B.; Saad, Jamil S.			Solution Structure of Calmodulin Bound to the Binding Domain of the HIV-1 Matrix Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calmodulin; HIV-1; NMR; Peptides; Viral Replication; Gag; Matrix	VIRUS TYPE-1 MATRIX; PLASMA-MEMBRANE; GAG PROTEIN; TARGET RECOGNITION; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INTRACELLULAR TRAFFICKING; MYRISTATE EXPOSURE; EF-HANDS; NMR; PEPTIDE	Background: Calmodulin (CaM) binds to the matrix (MA) domain of HIV-1 Gag. Results: We present the NMR structure of CaM bound to the minimal binding domain of MA. Conclusion: Data offer a structural basis for Gag-CaM interactions during HIV-1 replication. Significance: Characterization of the MA-CaM interaction may help in understanding the functional role of CaM in HIV-1 replication. Subcellular distribution of calmodulin (CaM) in human immunodeficiency virus type-1 (HIV-1)-infected cells is distinct from that observed in uninfected cells. CaM co-localizes and interacts with the HIV-1 Gag protein in the cytosol of infected cells. Although it has been shown that binding of Gag to CaM is mediated by the matrix (MA) domain, the structural details of this interaction are not known. We have recently shown that binding of CaM to MA induces a conformational change that triggers myristate exposure, and that the CaM-binding domain of MA is confined to a region spanning residues 8-43 (MA-(8-43)). Here, we present the NMR structure of CaM bound to MA-(8-43). Our data revealed that MA-(8-43), which contains a novel CaM-binding motif, binds to CaM in an antiparallel mode with the N-terminal helix (1) anchored to the CaM C-terminal lobe, and the C-terminal helix (2) of MA-(8-43) bound to the N-terminal lobe of CaM. The CaM protein preserves a semiextended conformation. Binding of MA-(8-43) to CaM is mediated by numerous hydrophobic interactions and stabilized by favorable electrostatic contacts. Our structural data are consistent with the findings that CaM induces unfolding of the MA protein to have access to helices 1 and 2. It is noteworthy that several MA residues involved in CaM binding have been previously implicated in membrane binding, envelope incorporation, and particle production. The present findings may ultimately help in identification of the functional role of CaM in HIV-1 replication.	[Vlach, Jiri; Samal, Alexandra B.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Saad, JS (corresponding author), 845 19th St South, Birmingham, AL 35294 USA.	saad@uab.edu		Vlach, Jiri/0000-0002-0874-2055; Saad, Jamil/0000-0001-9503-6484	National Institutes of Health [1R01AI087101]; University of Albama at Birmingham Center for AIDS Research; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Albama at Birmingham Center for AIDS Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI087101 (to J. S. S.) and intramural funding from the University of Albama at Birmingham Center for AIDS Research.	Alston RW, 2004, BIOPHYS J, V87, P4036, DOI 10.1529/biophysj.104.050377; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Cao CK, 2013, J BIOL CHEM, V288, P5278, DOI 10.1074/jbc.M112.409482; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chow JYH, 2010, J MOL BIOL, V400, P702, DOI 10.1016/j.jmb.2010.05.022; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Cooper J, 2011, J BIOL CHEM, V286, P28498, DOI 10.1074/jbc.M111.239053; Coticchia CM, 2009, BREAST CANCER RES TR, V115, P545, DOI 10.1007/s10549-008-0097-z; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng W., 2013, PLOS ONE, V8; Dick RA, 2012, P NATL ACAD SCI USA, V109, P18761, DOI 10.1073/pnas.1209408109; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Engeland CE, 2011, J VIROL, V85, P13322, DOI 10.1128/JVI.00174-11; Fledderman EL, 2010, BIOCHEMISTRY-US, V49, P9551, DOI 10.1021/bi101245j; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; GIETZEN K, 1982, BIOCHEM J, V207, P541, DOI 10.1042/bj2070541; GRONENBORN AM, 1994, J BIOMOL NMR, V4, P455; Han Z, 2007, VIRUS GENES, V35, P511, DOI 10.1007/s11262-007-0125-9; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Ishida H, 2010, J BIOL CHEM, V285, P38502, DOI 10.1074/jbc.M110.131201; Ishii M, 2005, BIOCHEM J, V385, P65, DOI 10.1042/BJ20040404; Izumi Y, 2008, BIOCHEMISTRY-US, V47, P7158, DOI 10.1021/bi702416b; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Joshi A, 2008, MOL CELL, V30, P227, DOI 10.1016/j.molcel.2008.03.015; Joshi A, 2011, J BIOL CHEM, V286, P29861, DOI 10.1074/jbc.M111.241521; Joshi A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-72; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Kretsinger RH, 1996, NAT STRUCT BIOL, V3, P12, DOI 10.1038/nsb0196-12; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lohr F, 2007, J BIOMOL NMR, V37, P205, DOI 10.1007/s10858-006-9128-4; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Matsubara M, 1996, BIOCHEMISTRY-US, V35, P14651, DOI 10.1021/bi9613988; Matsubara M, 2005, PROTEIN SCI, V14, P494, DOI 10.1110/ps.04969605; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Matsubara M, 2003, J BIOL CHEM, V278, P48898, DOI 10.1074/jbc.M305488200; McQueen P, 2011, PROTEINS, V79, P2233, DOI 10.1002/prot.23048; MILLER MA, 1993, AIDS RES HUM RETROV, V9, P1057, DOI 10.1089/aid.1993.9.1057; Moorthy AK, 2001, J BIOMOL STRUCT DYN, V19, P47, DOI 10.1080/07391102.2001.10506719; Nagasaki N, 2008, FEBS J, V275, P2267, DOI 10.1111/j.1742-4658.2008.06379.x; Nishi M, 2009, FEBS LETT, V583, P1243, DOI 10.1016/j.febslet.2009.03.041; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2009, FUTURE VIROL, V4, P241, DOI 10.2217/FVL.09.4; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Radding W, 2000, AIDS RES HUM RETROV, V16, P1519, DOI 10.1089/088922200750006047; Radding W, 1996, BIOCHEM BIOPH RES CO, V218, P192, DOI 10.1006/bbrc.1996.0034; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Samal AB, 2011, J BIOL CHEM, V286, P33533, DOI 10.1074/jbc.M111.273623; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SRINIVAS SK, 1993, J BIOL CHEM, V268, P22895; Strasner AB, 2008, J IMMUNOL, V181, P3706, DOI 10.4049/jimmunol.181.5.3706; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Taylor JE, 2012, BIOPHYS J, V103, P541, DOI 10.1016/j.bpj.2012.06.042; Tomita Y, 2011, J VIROL, V85, P5618, DOI 10.1128/JVI.00846-10; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; Yuan T, 2001, BIOPOLYMERS, V58, P50, DOI 10.1002/1097-0282(200101)58:1<50::AID-BIP60>3.0.CO;2-S; Zhang MJ, 1998, BIOCHEM CELL BIOL, V76, P313, DOI 10.1139/bcb-76-2-3-313; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	92	21	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8697	8705		10.1074/jbc.M113.543694	http://dx.doi.org/10.1074/jbc.M113.543694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24500712	hybrid, Green Published			2022-12-25	WOS:000333157500058
J	Chen, C; Huang, MH; Han, ZH; Shao, LX; Xie, Y; Wu, JH; Zhang, Y; Xin, HK; Ren, AJ; Guo, Y; Wang, DL; He, Q; Ruan, D				Chen, Chun; Huang, Minghua; Han, Zhihua; Shao, Lixin; Xie, Yan; Wu, Jianhong; Zhang, Yan; Xin, Hongkui; Ren, Aijun; Guo, Yong; Wang, Deli; He, Qing; Ruan, Dike			Quantitative T2 Magnetic Resonance Imaging Compared to Morphological Grading of the Early Cervical Intervertebral Disc Degeneration: An Evaluation Approach in Asymptomatic Young Adults	PLOS ONE			English	Article							AGE-RELATED-CHANGES; LOW-BACK-PAIN; RELAXATION-TIMES; NUCLEUS PULPOSUS; WATER-CONTENT; LUMBAR; CLASSIFICATION; CARTILAGE; T1RHO; SPINE	Objective: The objective of this study was to evaluate the efficacy of quantitative T2 magnetic resonance imaging (MRI) for quantifying early cervical intervertebral disc (IVD) degeneration in asymptomatic young adults by correlating the T2 value with Pfirrmann grade, sex, and anatomic level. Methods: Seventy asymptomatic young subjects (34 men and 36 women; mean age, 22.80+/-2.11 yr; range, 18-25 years) underwent 3.0-T MRI to obtain morphological data (one T1-fast spin echo (FSE) and three-plane T2-FSE, used to assign a Pfirrmann grade (I-V)) and for T2 mapping (multi-echo spin echo). T2 values in the nucleus pulposus (NP, n = 350) and anulus fibrosus (AF, n = 700) were obtained. Differences in T2 values between sexes and anatomic level were evaluated, and linear correlation analysis of T2 values versus degenerative grade was conducted. Findings: Cervical IVDs of healthy young adults were commonly determined to be at Pfirrmann grades I and II. T2 values of NPs were significantly higher than those of AF at all anatomic levels (P<0.000). The NP, anterior AF and posterior AF values did not differ significantly between genders at the same anatomic level (P>0.05). T2 values decreased linearly with degenerative grade. Linear correlation analysis revealed a strong negative association between the Pfirrmann grade and the T2 values of the NP (P = 0.000) but not the T2 values of the AF (P = 0.854). However, non-degenerated discs (Pfirrmann grades I and II) showed a wide range of T2 relaxation time. T2 values according to disc degeneration level classification were as follows: grade I (>62.03 ms), grade II (54.60-62.03 ms), grade III (<54.60 ms). Conclusions: T2 quantitation provides a more sensitive and robust approach for detecting and characterizing the early stage of cervical IVD degeneration and to create a reliable quantitative in healthy young adults.	[Chen, Chun] Southern Med Univ, Sch Clin Med 3, Guangdong, Peoples R China; [Chen, Chun; Han, Zhihua; Wu, Jianhong; Zhang, Yan; Xin, Hongkui; Wang, Deli; He, Qing; Ruan, Dike] Navy Gen Hosp, Dept Orthoped Surg, Beijing, Peoples R China; [Huang, Minghua; Shao, Lixin; Xie, Yan; Ren, Aijun; Guo, Yong] Navy Gen Hosp, Dept Radiol, Beijing, Peoples R China	Southern Medical University - China; Sixth Medical Center of Chinese PLA General Hospital; Sixth Medical Center of Chinese PLA General Hospital	Ruan, D (corresponding author), Navy Gen Hosp, Dept Orthoped Surg, Beijing, Peoples R China.	ruandikengh@163.com	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; Han, Zhihua/0000-0003-3128-3077; chen, chun/0000-0002-7856-6405				An HS, 2004, SPINE, V29, P2677, DOI 10.1097/01.brs.0000147573.88916.c6; Binyi T, 2000, ORTHOP J CHIN, V7, P642; BOIJSEN E, 1954, ACTA RADIOL, V42, P101, DOI 10.3109/00016925409175101; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Bumenkrantz G, 2010, MAGN RESON MED, V63, P1193, DOI 10.1002/mrm.22362; Chan SCW, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13598; Chiu E J, 2001, Spine (Phila Pa 1976), V26, pE437, DOI 10.1097/00007632-200110010-00017; Chung SA, 2007, SPINE, V32, P1188, DOI 10.1097/BRS.0b013e31805471a3; Ellingson AM, 2013, SPINE, V38, pE1533, DOI 10.1097/BRS.0b013e3182a59453; Furusawa N, 2001, SPINE, V26, P1110, DOI 10.1097/00007632-200105150-00004; Haefeli M, 2006, SPINE, V31, P1522, DOI 10.1097/01.brs.0000222032.52336.8e; Hanvold TN, 2010, J ADOLESCENT HEALTH, V46, P488, DOI 10.1016/j.jadohealth.2009.11.200; Hoppe S, 2012, EUR RADIOL, V22, P2013, DOI 10.1007/s00330-012-2448-8; Karakida O, 2003, CLIN RADIOL, V58, P389, DOI 10.1016/S0009-9260(02)00583-4; Krueger EC, 2007, AM J NEURORADIOL, V28, P1237, DOI 10.3174/ajnr.A0546; Ludescher B, 2008, J MAGN RESON IMAGING, V28, P252, DOI 10.1002/jmri.21390; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Marinelli NL, 2010, AM J NEURORADIOL, V31, P1278, DOI 10.3174/ajnr.A2080; Marinelli NL, 2009, SPINE, V34, P520, DOI 10.1097/BRS.0b013e318195dd44; Matsumoto M, 2013, EUR SPINE J, V22, P708, DOI 10.1007/s00586-012-2500-z; Matsumura Y, 2009, J ORTHOP SCI, V14, P45, DOI 10.1007/s00776-008-1288-5; McGrath PA, 1994, ARCH ORAL BIOL, V39, p55S; Morishita Y, 2008, SPINE, V33, pE178, DOI 10.1097/BRS.0b013e318166f059; Nagashima M, 2012, ACTA RADIOL, V53, P1059, DOI 10.1258/ar.2012.120039; Niu G, 2011, AM J NEURORADIOL, V32, P1617, DOI 10.3174/ajnr.A2556; Okada E, 2011, EUR SPINE J, V20, P585, DOI 10.1007/s00586-010-1644-y; Perry J, 2006, AM J NEURORADIOL, V27, P337; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; SCOTT JE, 1994, J ANAT, V184, P73; Siivola SM, 2002, EUR SPINE J, V11, P358, DOI 10.1007/s00586-001-0370-x; Singh K, 2009, SPINE, V34, P10, DOI 10.1097/BRS.0b013e31818e5ddd; Sivan SS, 2006, BIOCHEM J, V399, P29, DOI 10.1042/BJ20060579; Souza RB, 2012, J ORTHOP SPORT PHYS, V42, P511, DOI 10.2519/jospt.2012.3975; Sowa G, 2008, SPINE, V33, P1821, DOI 10.1097/BRS.0b013e31817e2ce3; Stelzeneder D, 2012, EUR J RADIOL, V81, P324, DOI 10.1016/j.ejrad.2010.12.093; Stelzeneder D, 2011, EUR RADIOL, V21, P2388, DOI 10.1007/s00330-011-2198-z; Takashima H, 2012, SKELETAL RADIOL, V41, P163, DOI 10.1007/s00256-011-1144-0; Takatalo J, 2009, SPINE, V34, P1716, DOI 10.1097/BRS.0b013e3181ac5fec; Trattnig S, 2010, EUR RADIOL, V20, P2715, DOI 10.1007/s00330-010-1843-2; Trinh K, 2010, SPINE, V35, P2121, DOI 10.1097/BRS.0b013e3181edfd17; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; Wang YXJ, 2013, EUR RADIOL, V23, P228, DOI 10.1007/s00330-012-2591-2; Watanabe A, 2007, AM J ROENTGENOL, V189, P936, DOI 10.2214/AJR.07.2142; Weiler C, 2012, Eur Spine J, V21 Suppl 6, pS810, DOI 10.1007/s00586-011-1922-3; Welsch GH, 2011, SKELETAL RADIOL, V40, P543, DOI 10.1007/s00256-010-1036-8; Williams FMK, 2011, BEST PRACT RES CL RH, V25, P69, DOI 10.1016/j.berh.2011.01.007; Wu N, 2013, PLOS ONE, V8; Xin HK, 2013, TISSUE ENG PT A, V19, P143, DOI [10.1089/ten.tea.2012.0255, 10.1089/ten.TEA.2012.0255]; Xinhua J, 2009, CHIN J CT MRI, V7, P1; Yamamoto S, 2011, J MAGN RESON IMAGING, V34, P1151, DOI 10.1002/jmri.22685; Zobel BB, 2012, SPINE, V37, P1224, DOI 10.1097/BRS.0b013e31824b2450; Zou J, 2009, SPINE, V34, P2545, DOI 10.1097/BRS.0b013e3181b32998	53	18	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87856	10.1371/journal.pone.0087856	http://dx.doi.org/10.1371/journal.pone.0087856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498384	Green Submitted, gold, Green Published			2022-12-25	WOS:000330626900130
J	Hao, XQ; Du, JX; Li, Y; Li, M; Zhang, SY				Hao, Xue-Qin; Du, Jing-Xia; Li, Yan; Li, Meng; Zhang, Shou-Yan			Prenatal Exposure to Lipopolysaccharide Combined with Pre- and Postnatal High-Fat Diet Result in Lowered Blood Pressure and Insulin Resistance in Offspring Rats	PLOS ONE			English	Article							INTRAUTERINE FETAL-DEATH; DYSFUNCTION; PREGNANCY	Background: Adult metabolic syndrome may in part have origins in fetal or early life. This study was designed to explore the effect of prenatal exposure to lipopolysaccharide and high-fat diet on metabolic syndrome in offspring rats. Methods: 32 pregnant rats were randomly divided into four groups, including Control group; LPS group (pregnant rats were injected with LPS 0.4 mg/kg intraperitoneally on the 8th, 10th and 12th day of pregnancy); High-fat group (maternal rats had high-fat diet during pregnancy and lactation period, and their pups also had high-fat diet up to the third month of life); LPS + High-fat group (rats were exposed to the identical experimental scheme with LPS group and High-fat group). Results: Blood pressure elevated in LPS group and High-fat group, reduced in LPS+High-fat group, accompanied by the increase of serum leptin level in LPS and High-fat group and increase of serum IL-6, TNF-alpha in High-fat group; both serum insulin and cholesterol increased in High-fat and LPS+High-fat group, as well as insulin in LPS group. HOMA-IR value increased in LPS, High-fat and LPS+High-fat group, and QUICKI decreased in these groups; H-E staining showed morphologically pathological changes in thoracic aorta and liver tissue in the three groups. Increased serum alanine and aspartate aminotransferase suggest impaired liver function in LPS+High-fat group. Conclusion/Significance: Prenatal exposure to lipopolysaccharide combined with pre- and postnatal high-fat diet result in lowered blood pressure, insulin resistance and impaired liver function in three-month old offspring rats. The lowered blood pressure might benefit from the predictive adaptive response to prenatal inflammation.	[Hao, Xue-Qin] Henan Univ Sci & Technol, Coll Anim Sci & Technol, Dept Pharm, Luoyang, Peoples R China; [Du, Jing-Xia; Li, Yan] Henan Univ Sci & Technol, Coll Med, Dept Pharmacol, Luoyang, Peoples R China; [Li, Meng] Luoyang Entry Exit Inspect & Quarantine Bur, Luoyang, Peoples R China; [Zhang, Shou-Yan] Zhengzhou Univ, Luoyang Cent Hosp, Dept Cardiol, Luoyang, Peoples R China	Henan University of Science & Technology; Henan University of Science & Technology; Zhengzhou University	Zhang, SY (corresponding author), Zhengzhou Univ, Luoyang Cent Hosp, Dept Cardiol, Luoyang, Peoples R China.	zsydoctor@163.com		Zhang, Shouyan/0000-0003-2902-1668	Dr. Scientific Research Foundation of Henan University of Science and Technology [09001575]; Project of Henan Science and Technology [122300410234]	Dr. Scientific Research Foundation of Henan University of Science and Technology; Project of Henan Science and Technology	This research was supported by Dr. Scientific Research Foundation of Henan University of Science and Technology (No 09001575) and Project of Henan Science and Technology (No 122300410234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JA, 2005, J PHYSIOL-LONDON, V565, P171, DOI 10.1113/jphysiol.2005.084947; Blasco-Baque V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048220; de Luis DA, 2013, EUR REV MED PHARMACO, V17, P2059; Guberman C, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.023; Hao XQ, 2012, EXPT TOXICOLOGIC PAT; Hao XQ, 2010, HYPERTENS RES, V33, P76, DOI 10.1038/hr.2009.185; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Kohmura Y, 2000, MICROBIOL IMMUNOL, V44, P897, DOI 10.1111/j.1348-0421.2000.tb02581.x; Kruse M, 2013, ENDOCRINOLOGY, V154, P3565, DOI 10.1210/en.2012-1877; Lappi J, 2013, CRIT REV FOOD SCI, V53, P631, DOI 10.1080/10408398.2010.550388; Liang HY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063983, 10.1371/journal.pone.0074121]; Liu XF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-109; Makarova EN, 2013, AM J PHYSL REGUL INT; Mohammadzadeh G, 2013, INT J ENDOCRINOL MET, V11, P3, DOI 10.5812/ijem.6535; Murabayashi N, 2013, EUR J OBSTET GYN R B, V169, P39, DOI 10.1016/j.ejogrb.2013.02.003; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nilsson C, 2001, ENDOCRINOLOGY, V142, P2622, DOI 10.1210/en.142.6.2622; Ning H, 2008, TOXICOL LETT, V176, P13, DOI 10.1016/j.toxlet.2007.08.002; Rickard IJ, 2007, TRENDS ENDOCRIN MET, V18, P94, DOI 10.1016/j.tem.2007.02.004; Sanchez J, 2012, MOL NUTR FOOD RES, V56, P1715, DOI 10.1002/mnfr.201200211; Troseid M., 2013, DIABETES CARE; Xu DX, 2007, TOXICOLOGY, V234, P167, DOI 10.1016/j.tox.2007.02.010	22	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88127	10.1371/journal.pone.0088127	http://dx.doi.org/10.1371/journal.pone.0088127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498431	gold, Green Submitted, Green Published			2022-12-25	WOS:000330626900177
J	Malhotra, S; Sankar, K; Sowdhamini, R				Malhotra, Sony; Sankar, Kannan; Sowdhamini, Ramanathan			Structural Interface Parameters Are Discriminatory in Recognising Near-Native Poses of Protein-Protein Interactions	PLOS ONE			English	Article							SUBUNIT INTERFACES; LIGAND DOCKING; GAF DOMAINS; WEB SERVER; CONSERVATION; DIMERIZATION; BINDING; MODES	Interactions at the molecular level in the cellular environment play a very crucial role in maintaining the physiological functioning of the cell. These molecular interactions exist at varied levels viz. protein-protein interactions, protein-nucleic acid interactions or protein-small molecules interactions. Presently in the field, these interactions and their mechanisms mark intensively studied areas. Molecular interactions can also be studied computationally using the approach named as Molecular Docking. Molecular docking employs search algorithms to predict the possible conformations for interacting partners and then calculates interaction energies. However, docking proposes number of solutions as different docked poses and hence offers a serious challenge to identify the native (or near native) structures from the pool of these docked poses. Here, we propose a rigorous scoring scheme called DockScore which can be used to rank the docked poses and identify the best docked pose out of many as proposed by docking algorithm employed. The scoring identifies the optimal interactions between the two protein partners utilising various features of the putative interface like area, short contacts, conservation, spatial clustering and the presence of positively charged and hydrophobic residues. DockScore was first trained on a set of 30 protein-protein complexes to determine the weights for different parameters. Subsequently, we tested the scoring scheme on 30 different protein-protein complexes and native or near-native structure were assigned the top rank from a pool of docked poses in 26 of the tested cases. We tested the ability of DockScore to discriminate likely dimer interactions that differ substantially within a homologous family and also demonstrate that DOCKSCORE can distinguish correct pose for all 10 recent CAPRI targets.	[Malhotra, Sony; Sankar, Kannan; Sowdhamini, Ramanathan] Natl Ctr Biol Sci TIFR, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Sowdhamini, R (corresponding author), Natl Ctr Biol Sci TIFR, GKVK Campus, Bangalore, Karnataka, India.	mini@ncbs.res.in	Sankar, Kannan/V-3400-2019	Sankar, Kannan/0000-0002-8917-9718	Department of Biotechnology	Department of Biotechnology	SM is supported by a fellowship by Department of Biotechnology. The authors thank NCBS (The National Centre for Biological Sciences) for infrastructure and other facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva V, 2008, PROTEIN PEPTIDE LETT, V15, P33; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cui ZH, 2005, BIOINFORMATION, V1, P28, DOI 10.6026/97320630001028; Duan YH, 2005, PROTEIN SCI, V14, P316, DOI 10.1110/ps.04941505; Gottschalk KE, 2004, PROTEIN ENG DES SEL, V17, P183, DOI 10.1093/protein/gzh021; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; Garzon JI, 2009, BIOINFORMATICS, V25, P2544, DOI 10.1093/bioinformatics/btp447; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jung HJ, 2012, MOL CELLS, V33, P163, DOI 10.1007/s10059-012-2220-6; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Lobanov MY, 2009, NUCL ACIDS RES S1, V38, pD283; Makino S, 1997, J COMPUT CHEM, V18, P1812, DOI 10.1002/(SICI)1096-987X(19971115)18:14<1812::AID-JCC10>3.0.CO;2-H; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Sousa SF, 2006, PROTEINS, V65, P15, DOI 10.1002/prot.21082; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Tsai CJ, 1997, PROTEIN SCI, V6, P1426, DOI 10.1002/pro.5560060707; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Tsai CJ, 1996, CRIT REV BIOCHEM MOL, V31, P127, DOI 10.3109/10409239609106582; Xue LC, 2014, PROTEINS, V82, P250, DOI 10.1002/prot.24370; Yang YD, 2008, PROTEIN SCI, V17, P1212, DOI 10.1110/ps.033480.107	27	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e80255	10.1371/journal.pone.0080255	http://dx.doi.org/10.1371/journal.pone.0080255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498255	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900001
J	van Vugt, FT; Tillmann, B				van Vugt, Floris T.; Tillmann, Barbara			Thresholds of Auditory-Motor Coupling Measured with a Simple Task in Musicians and Non-Musicians: Was the Sound Simultaneous to the Key Press?	PLOS ONE			English	Article							TEMPORAL-ORDER; SENSORIMOTOR SYNCHRONIZATION; PERCEPTION; FEEDBACK; MOVEMENTS; SPEECH; PERFORMANCE; JUDGMENT; GENDER	The human brain is able to predict the sensory effects of its actions. But how precise are these predictions? The present research proposes a tool to measure thresholds between a simple action (keystroke) and a resulting sound. On each trial, participants were required to press a key. Upon each keystroke, a woodblock sound was presented. In some trials, the sound came immediately with the downward keystroke; at other times, it was delayed by a varying amount of time. Participants were asked to verbally report whether the sound came immediately or was delayed. Participants' delay detection thresholds (in msec) were measured with a staircase-like procedure. We hypothesised that musicians would have a lower threshold than non-musicians. Comparing pianists and brass players, we furthermore hypothesised that, as a result of a sharper attack of the timbre of their instrument, pianists might have lower thresholds than brass players. Our results show that nonmusicians exhibited higher thresholds for delay detection (180 +/- 104 ms) than the two groups of musicians (102 +/- 65 ms), but there were no differences between pianists and brass players. The variance in delay detection thresholds could be explained by variance in sensorimotor synchronisation capacities as well as variance in a purely auditory temporal irregularity detection measure. This suggests that the brain's capacity to generate temporal predictions of sensory consequences can be decomposed into general temporal prediction capacities together with auditory-motor coupling. These findings indicate that the brain has a relatively large window of integration within which an action and its resulting effect are judged as simultaneous. Furthermore, musical expertise may narrow this window down, potentially due to a more refined temporal prediction. This novel paradigm provides a simple test to estimate the temporal precision of auditory-motor action-effect coupling, and the paradigm can readily be incorporated in studies investigating both healthy and patient populations.	[van Vugt, Floris T.; Tillmann, Barbara] Univ Lyon 1, INSERM U1028, Auditory Cognit & Psychoacoust Team, Lyon Neurosci Res Ctr,CNRS UMR 5292, F-69365 Lyon, France; [van Vugt, Floris T.] Univ Mus Drama & Media, Inst Music Physiol & Musicians Med, Hannover, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	van Vugt, FT (corresponding author), Univ Lyon 1, INSERM U1028, Auditory Cognit & Psychoacoust Team, Lyon Neurosci Res Ctr,CNRS UMR 5292, F-69365 Lyon, France.	f.t.vanvugt@gmail.com	van Vugt, Floris Tijmen/GWR-1052-2022	van Vugt, Floris Tijmen/0000-0003-1739-0175	EBRAMUS, European Brain and Music ITN Grant (ITN MC FP7) [GA 238157]	EBRAMUS, European Brain and Music ITN Grant (ITN MC FP7)	This work was supported by the EBRAMUS, European Brain and Music ITN Grant (ITN MC FP7, GA 238157). The team "Auditory cognition and psychoacoustics" is part of the LabEx CeLyA ("Centre Lyonnais d'Acoustique", ANR-10-LABX-60). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011283; Aliu SO, 2009, J COGNITIVE NEUROSCI, V21, P791, DOI 10.1162/jocn.2009.21055; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Ben-Artzi E, 2005, NEUROPSYCHOLOGIA, V43, P714, DOI 10.1016/j.neuropsychologia.2004.08.004; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 1998, NEUROPSYCHOLOGIA, V36, P521, DOI 10.1016/S0028-3932(97)00145-0; Donohue SE, 2010, ATTEN PERCEPT PSYCHO, V72, P1120, DOI 10.3758/APP.72.4.1120; Drewing K, 2004, EXP BRAIN RES, V158, P50, DOI 10.1007/s00221-004-1870-9; Ehrle N, 2005, BRAIN COGNITION, V58, P133, DOI 10.1016/j.bandc.2004.09.014; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Exner S, 1875, PFLUGERS ARCH GESAMM, V11, P402; Fisher N., 1995, STAT ANAL CIRCULAR D; Fostick L, 2013, EXP PSYCHOL, V60, P432, DOI 10.1027/1618-3169/a000216; Freeman ED, 2013, CORTEX, V49, P2875, DOI 10.1016/j.cortex.2013.03.006; Frissen I, 2012, ACTA PSYCHOL, V141, P140, DOI 10.1016/j.actpsy.2012.07.010; Friston KJ, 2012, INT J PSYCHOPHYSIOL, V83, P248, DOI 10.1016/j.ijpsycho.2011.11.014; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Garcia-Perez MA, 2012, PSYCHON B REV, V19, P820, DOI 10.3758/s13423-012-0278-y; Gaser C, 2003, J NEUROSCI, V23, P9240; GATES A, 1974, PERCEPT PSYCHOPHYS, V15, P21, DOI 10.3758/BF03205822; GREEN DM, 1993, J ACOUST SOC AM, V93, P2096, DOI 10.1121/1.406696; GU X, 1994, J ACOUST SOC AM, V96, P93, DOI 10.1121/1.410378; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Helmuth LL, 1996, J EXP PSYCHOL HUMAN, V22, P278, DOI 10.1037/0096-1523.22.2.278; Herholz SC, 2012, NEURON, V76, P486, DOI 10.1016/j.neuron.2012.10.011; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Kaspar K, 2011, J SPEECH LANG HEAR R, V54, P932, DOI 10.1044/1092-4388(2010/10-0109); KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; Keetels M, 2012, EXP BRAIN RES, V219, P431, DOI 10.1007/s00221-012-3081-0; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Kuling IA, 2012, EXP BRAIN RES, V221, P403, DOI 10.1007/s00221-012-3182-9; Leek MR, 2000, J ACOUST SOC AM, V107, P2674, DOI 10.1121/1.428653; Martikainen MH, 2005, CEREB CORTEX, V15, P299, DOI 10.1093/cercor/bhh131; Pfordresher PQ, 2003, J EXP PSYCHOL HUMAN, V29, P949, DOI 10.1037/0096-1523.29.5.949; Pfordresher PQ, 2002, PSYCHOL RES-PSYCH FO, V66, P71, DOI 10.1007/s004260100075; Powers AR, 2009, J NEUROSCI, V29, P12265, DOI 10.1523/JNEUROSCI.3501-09.2009; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2004, HUM MOVEMENT SCI, V23, P389, DOI 10.1016/j.humov.2004.08.014; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Rohde M., 2013, FRONT PSYCHOL, V3, P599, DOI [10.3389/fpsyg.2012.00599, DOI 10.3389/fpsyg.2012.00599]; Saberi K, 1997, PERCEPT PSYCHOPHYS, V59, P867, DOI 10.3758/BF03205504; Stevenson RA, 2013, EXP BRAIN RES, V227, P249, DOI 10.1007/s00221-013-3507-3; Stuart A, 2002, J ACOUST SOC AM, V111, P2237, DOI 10.1121/1.1466868; Sugano Y, 2010, EXP BRAIN RES, V201, P393, DOI 10.1007/s00221-009-2047-3; Swink S, 2012, BRAIN LANG, V122, P25, DOI 10.1016/j.bandl.2012.04.007; Szymaszek A, 2006, NEUROSCI LETT, V403, P190, DOI 10.1016/j.neulet.2006.04.062; Tanaka A, 2011, NEUROREPORT, V22, P684, DOI 10.1097/WNR.0b013e32834a2724; Tillmann B, 2011, PSYCHOL RES-PSYCH FO, V75, P243, DOI 10.1007/s00426-010-0302-7; Vatakis A, 2008, EXP BRAIN RES, V185, P521, DOI 10.1007/s00221-007-1168-9; Weiss K, 2011, Q J EXP PSYCHOL, V64, P394, DOI 10.1080/17470218.2010.495783; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Yamamoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029414; Yamamoto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040379; YATES AJ, 1963, PSYCHOL BULL, V60, P213, DOI 10.1037/h0044155; YEE W, 1994, PERCEPT PSYCHOPHYS, V56, P461, DOI 10.3758/BF03206737; Zampini M, 2003, EXP BRAIN RES, V152, P198, DOI 10.1007/s00221-003-1536-z	58	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87176	10.1371/journal.pone.0087176	http://dx.doi.org/10.1371/journal.pone.0087176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302TD	24498299	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900045
J	Kicka, S; Trofimov, V; Harrison, C; Ouertatani-Sakouhi, H; McKinney, J; Scapozza, L; Hilbi, H; Cosson, P; Soldati, T				Kicka, Sebastien; Trofimov, Valentin; Harrison, Christopher; Ouertatani-Sakouhi, Hajer; McKinney, John; Scapozza, Leonardo; Hilbi, Hubert; Cosson, Pierre; Soldati, Thierry			Establishment and Validation of Whole-Cell Based Fluorescence Assays to Identify Anti-Mycobacterial Compounds Using the Acanthamoeba castellanii - Mycobacterium marinum Host-Pathogen System	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; DICTYOSTELIUM-DISCOIDEUM; DROSOPHILA-MELANOGASTER; MODEL HOST; IN-VITRO; TUBERCULOSIS; SURVIVAL; DRUG; INFECTION; VIRULENCE	Tuberculosis is considered to be one of the world's deadliest disease with 2 million deaths each year. The need for new antitubercular drugs is further exacerbated by the emergence of drug-resistance strains. Despite multiple recent efforts, the majority of the hits discovered by traditional target-based screening showed low efficiency in vivo. Therefore, there is heightened demand for whole-cell based approaches directly using host-pathogen systems. The phenotypic host-pathogen assay described here is based on the monitoring of GFP-expressing Mycobacterium marinum during infection of the amoeba Acanthamoeba castellanii. The assay showed straight-forward medium-throughput scalability, robustness and ease of manipulation, demonstrating its qualities as an efficient compound screening system. Validation with a series of known antitubercular compounds highlighted the advantages of the assay in comparison to previously published macrophage-Mycobacterium tuberculosis-based screening systems. Combination with secondary growth assays based on either GFP-expressing D. discoideum or M. marinum allowed us to further fine-tune compound characterization by distinguishing and quantifying growth inhibition, cytotoxic properties and antibiotic activities of the compounds. The simple and relatively low cost system described here is most suitable to detect anti-infective compounds, whether they present antibiotic activities or not, in which case they might exert anti-virulence or host defense boosting activities, both of which are largely overlooked by classical screening approaches.	[Kicka, Sebastien; Trofimov, Valentin; Soldati, Thierry] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Harrison, Christopher; Hilbi, Hubert] Univ Munich, Max von Pettenkofer Inst, Munich, Germany; [Ouertatani-Sakouhi, Hajer; Cosson, Pierre] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [McKinney, John] Swiss Fed Inst Technol Lausanne EPFL, Global Hlth Inst, Lausanne, Switzerland; [Scapozza, Leonardo] Univ Geneva, Pharmaceut Biochem Grp, Sch Pharmaceut Sci, EPGL, CH-1211 Geneva, Switzerland	University of Geneva; University of Munich; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Soldati, T (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.	Thierry.Soldati@unige.ch	SOLDATI, Thierry/A-2902-2009; Hilbi, Hubert/AAU-5815-2020; SOLDATI, Thierry/U-6494-2019; Trofimov, Valentin/T-3882-2019; Hill, Andrew/B-4527-2009	SOLDATI, Thierry/0000-0002-2056-7931; Hilbi, Hubert/0000-0002-5462-9301; SOLDATI, Thierry/0000-0002-2056-7931; Trofimov, Valentin/0000-0002-1823-2171; Hill, Andrew/0000-0001-5581-2354; Scapozza, Leonardo/0000-0003-1079-648X	Sinergia grant from the Swiss National Science Foundation	Sinergia grant from the Swiss National Science Foundation	The work was supported by a Sinergia grant from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Adekambi T, 2006, APPL ENVIRON MICROB, V72, P5974, DOI 10.1128/AEM.03075-05; Ahmad Z, 2012, INDIAN J MED RES, V136, P808; Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; [Anonymous], 2011, WHO REP; Arafah Sonia, 2013, Methods Mol Biol, V983, P403, DOI 10.1007/978-1-62703-302-2_22; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Baltch AL, 2005, J ANTIMICROB CHEMOTH, V56, P104, DOI 10.1093/jac/dki186; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; Ben Salah I, 2010, SURVIVING AMOEBAL EX; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Blaschke TF, 1996, CLIN INFECT DIS, V22, pS15, DOI 10.1093/clinids/22.Supplement_1.S15; Brown D, 2007, DRUG DISCOV TODAY, V12, P1007, DOI 10.1016/j.drudis.2007.10.017; Butler RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031556; Carvalho R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016779; Christophe T, 2010, FUTURE MED CHEM, V2, P1283, DOI 10.4155/FMC.10.223; Cosma CL, 2006, INFECT IMMUN, V74, P3125, DOI 10.1128/IAI.02061-05; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; El-Etr SH, 2004, INFECT IMMUN, V72, P6902, DOI 10.1128/IAI.72.12.6902-6913.2004; Escaich S, 2010, EXPERT OPIN THER PAT, V20, P1401, DOI 10.1517/13543776.2010.511176; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Feuerriegel S, 2013, J ANTIMICROB CHEMOTH, V68, P1439, DOI 10.1093/jac/dkt042; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Froquet R, 2009, NAT PROTOC, V4, P25, DOI 10.1038/nprot.2008.212; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; GLUCKMAN SJ, 1995, CLIN DERMATOL, V13, P273, DOI 10.1016/0738-081X(95)00023-9; Goldman RC, 2009, TUBERCULOSIS, V89, P331, DOI 10.1016/j.tube.2009.07.007; Golstein P, 2003, NAT REV MOL CELL BIO, V4, P798, DOI 10.1038/nrm1224; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Haagsma AC, 2009, ANTIMICROB AGENTS CH, V53, P1290, DOI 10.1128/AAC.01393-08; Hagedorn M, 2007, CELL MICROBIOL, V9, P2716, DOI 10.1111/j.1462-5822.2007.00993.x; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Hilbi H, 2011, ENV MICROBIOL REP, V3, P286, DOI 10.1111/j.1758-2229.2011.00247.x; Hurdle JG, 2008, J ANTIMICROB CHEMOTH, V62, P1037, DOI 10.1093/jac/dkn307; Jayaswal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000839; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kennedy GM, 2012, APPL ENVIRON MICROB, V78, P2049, DOI 10.1128/AEM.06965-11; Kessler A, 2013, ENVIRON MICROBIOL, V15, P646, DOI 10.1111/j.1462-2920.2012.02889.x; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Kumar V., 2007, BASIC PATHOLOGY, V8th, P516; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lelong E, 2011, CLIN MICROBIOL INFEC, V17, P1415, DOI 10.1111/j.1469-0691.2010.03431.x; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Miltner EC, 2000, ANTIMICROB AGENTS CH, V44, P1990, DOI 10.1128/AAC.44.7.1990-1994.2000; Mitchison DA, 2008, CELL HOST MICROBE, V3, P122, DOI 10.1016/j.chom.2008.02.013; Muller B, 2013, TRENDS GENET, V29, P160, DOI 10.1016/j.tig.2012.11.005; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Neufert C, 2001, J IMMUNOL, V167, P1542, DOI 10.4049/jimmunol.167.3.1542; Oh CT, 2013, J ANTIMICROB CHEMOTH, V68, P601, DOI 10.1093/jac/dks425; Ollinger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060531; Pang KM, 1998, CURR BIOL, V8, P405, DOI 10.1016/S0960-9822(98)70159-9; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Ramakrishnan L, 1997, INFECT IMMUN, V65, P767, DOI 10.1128/IAI.65.2.767-773.1997; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Salah IB, 2009, CLIN MICROBIOL INFEC, V15, P894, DOI 10.1111/j.1469-0691.2009.03011.x; Scherr N, 2009, J BACTERIOL, V191, P4546, DOI 10.1128/JB.00245-09; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Smith NH, 2008, NATURE, V456, P700, DOI 10.1038/456700a; Soldati T, 2012, TRAFFIC, V13, P1042, DOI 10.1111/j.1600-0854.2012.01358.x; Sonar VN, 2009, J ENZYM INHIB MED CH, V24, P117, DOI 10.1080/14756360801915526 ; Steinert M, 2005, CELL MICROBIOL, V7, P307, DOI 10.1111/j.1462-5822.2005.00493.x; Steinert M, 1998, APPL ENVIRON MICROB, V64, P2256; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Sundaramurthy V, 2013, CELL HOST MICROBE, V13, P129, DOI 10.1016/j.chom.2013.01.008; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; Takaki K, 2012, CELL REP, V2, P175, DOI 10.1016/j.celrep.2012.06.008; Varner TR, 2011, ANN PHARMACOTHER, V45, P967, DOI 10.1345/aph.1Q074; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Warner DF, 2007, NAT MED, V13, P282, DOI 10.1038/nm0307-282; Welin A, 2012, TUBERCULOSIS, V92, P113, DOI 10.1016/j.tube.2011.09.009; Williams KN, 2009, ANTIMICROB AGENTS CH, V53, P1314, DOI 10.1128/AAC.01182-08; Zelmer A, 2012, J ANTIMICROB CHEMOTH, V67, P1948, DOI 10.1093/jac/dks161; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2003, J ANTIMICROB CHEMOTH, V52, P790, DOI 10.1093/jac/dkg446	89	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87834	10.1371/journal.pone.0087834	http://dx.doi.org/10.1371/journal.pone.0087834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498207	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900180
J	Moore, C; Cumming, GS; Slingsby, J; Grewar, J				Moore, Christine; Cumming, Graeme S.; Slingsby, Jasper; Grewar, John			Tracking Socioeconomic Vulnerability Using Network Analysis: Insights from an Avian Influenza Outbreak in an Ostrich Production Network	PLOS ONE			English	Article							INFECTIOUS-DISEASE; CONTACT NETWORKS; MOUTH-DISEASE; MOVEMENTS; CATTLE; TRANSMISSION; EPIDEMICS; TOPOLOGY; RESOURCE; ECOLOGY	Background: The focus of management in many complex systems is shifting towards facilitation, adaptation, building resilience, and reducing vulnerability. Resilience management requires the development and application of general heuristics and methods for tracking changes in both resilience and vulnerability. We explored the emergence of vulnerability in the South African domestic ostrich industry, an animal production system which typically involves 3-4 movements of each bird during its lifetime. This system has experienced several disease outbreaks, and the aim of this study was to investigate whether these movements have contributed to the vulnerability of this system to large disease outbreaks. Methodology/Principal Findings: The ostrich production system requires numerous movements of birds between different farm types associated with growth (i.e. Hatchery to juvenile rearing farm to adult rearing farm). We used 5 years of movement records between 2005 and 2011 prior to an outbreak of Highly Pathogenic Avian Influenza (H5N2). These data were analyzed using a network analysis in which the farms were represented as nodes and the movements of birds as links. We tested the hypothesis that increasing economic efficiency in the domestic ostrich industry in South Africa made the system more vulnerable to outbreak of Highly Pathogenic Avian Influenza (H5N2). Our results indicated that as time progressed, the network became increasingly vulnerable to pathogen outbreaks. The farms that became infected during the outbreak displayed network qualities, such as significantly higher connectivity and centrality, which predisposed them to be more vulnerable to disease outbreak. Conclusions/Significance: Taken in the context of previous research, our results provide strong support for the application of network analysis to track vulnerability, while also providing useful practical implications for system monitoring and management.	[Moore, Christine; Cumming, Graeme S.] Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa; [Slingsby, Jasper] South African Environm Observat Network, Cape Town, South Africa; [Grewar, John] Govt Western Cape, Dept Agr, Elsenburg, South Africa	National Research Foundation - South Africa; University of Cape Town; National Research Foundation - South Africa; South African Environmental Observation Network (SAEON)	Moore, C (corresponding author), Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa.	christine.moore9@gmail.com	Slingsby, Jasper/AAU-7259-2021; Cumming, Graeme S./B-6551-2008	Slingsby, Jasper/0000-0003-1246-1181; Cumming, Graeme S./0000-0002-3678-1326; Grewar, John/0000-0002-4496-8051	National Research Foundation of South Africa; James S. McDonnell Foundation	National Research Foundation of South Africa(National Research Foundation - South Africa); James S. McDonnell Foundation	Funding for this project was provided by the National Research Foundation of South Africa and the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolnik C, 2012, AVIAN DIS, V56, P865, DOI 10.1637/10171-041012-Reg.1; Barabasi A. L., 2002, FORMULA UNIVERSAL LA; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2000, PHYSICA A, V281, P69, DOI 10.1016/S0378-4371(00)00018-2; Burns TE, 2011, TRANSBOUND EMERG DIS, V58, P510, DOI 10.1111/j.1865-1682.2011.01232.x; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Carpenter SR, 2002, ECOLOGY, V83, P2069, DOI 10.2307/3072038; Csardi N., 2006, INT J COMP SYST, V1695, P1; Cumming G. S., 2008, COMPLEXITY THEORY SU, P246; Cumming GS., 2008, COMPLEXITY THEORY SU, P15; Cundill G, 2012, CONSERV BIOL, V26, P13, DOI 10.1111/j.1523-1739.2011.01755.x; Danon Leon, 2011, Interdiscip Perspect Infect Dis, V2011, P284909, DOI 10.1155/2011/284909; Dube C, 2008, TRANSBOUND EMERG DIS, V55, P382, DOI 10.1111/j.1865-1682.2008.01053.x; Dube C, 2011, REV SCI TECH OIE, V30, P425; Ferrari Matthew J, 2011, Interdiscip Perspect Infect Dis, V2011, P267049, DOI 10.1155/2011/267049; Frossling J, 2012, PREV VET MED, V105, P202, DOI 10.1016/j.prevetmed.2011.12.011; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; HUTCHINGS JA, 1994, CAN J FISH AQUAT SCI, V51, P2126, DOI 10.1139/f94-214; Jeger MJ, 2007, NEW PHYTOL, V174, P279, DOI 10.1111/j.1469-8137.2007.02028.x; Jewell CP, 2009, J R SOC INTERFACE, V6, P1145, DOI 10.1098/rsif.2008.0433; Jewell CP, 2009, PREV VET MED, V91, P19, DOI 10.1016/j.prevetmed.2009.05.019; Jonkers ART, 2010, J R SOC INTERFACE, V7, P695, DOI 10.1098/rsif.2009.0304; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; LARKIN PA, 1977, T AM FISH SOC, V106, P1, DOI 10.1577/1548-8659(1977)106<1:AEFTCO>2.0.CO;2; Leibler JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009888; Mather C, 2011, AGR HUM VALUES, V28, P153, DOI 10.1007/s10460-010-9271-0; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Nickbakhsh S, 2011, BMC VET RES, V7, DOI [10.1186/1746-6148-7-66, 10.1186/1746-6148-8-51]; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; R Core Team R, 2022, R LANG ENV STAT COMP; Rautureau S, 2012, ANIMAL, V6, P1152, DOI 10.1017/S1751731111002631; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rosato V, 2008, PHYSICA A, V387, P1689, DOI 10.1016/j.physa.2007.10.065; Scheffer M, 2005, TRENDS ECOL EVOL, V20, P579, DOI 10.1016/j.tree.2005.08.018; Sharkey KJ, 2008, P ROY SOC B-BIOL SCI, V275, P19, DOI 10.1098/rspb.2007.1100; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; South Africa Department of Agriculture Forestry & Fisheries, 2011, PROF S AFR OSTR MARK; Venables W.N., 2002, MODERN APPL STAT S, V4th, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P106, DOI 10.1016/j.rse.2009.08.014; Western Cape Department of Agriculture, 2011, 1 W CAP DEP AGR; Wilcox Bruce A., 2005, Environmental Health and Preventive Medicine, V10, P263, DOI 10.1007/BF02897701; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799	49	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86973	10.1371/journal.pone.0086973	http://dx.doi.org/10.1371/journal.pone.0086973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498004	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000330621900053
J	He, YH; Cui, Y; Xu, BY; Gu, J; Wang, W; Luo, XY				He, Yinghua; Cui, Ying; Xu, Baiying; Gu, Jun; Wang, Wei; Luo, Xiaoying			Hypermethylation Leads to Bone Morphogenetic Protein 6 Downregulation in Hepatocellular Carcinoma	PLOS ONE			English	Article							PROSTATE-CANCER; IRON-METABOLISM; EXPRESSION; METHYLATION; BMP-6; CELLS; FIBROSIS; BENIGN; GENES	Background: In the liver, bone morphogenetic protein 6 (BMP-6) maintains balanced iron metabolism. However, the mechanism that underlies greater BMP-6 expression in hepatocellular carcinoma (HCC) tissue than adjacent non-cancerous tissue is unclear. This study sought to investigate the epigenetic mechanisms of BMP-6 expression by analysing the relationship between the DNA methylation status of BMP-6 and the expression of BMP-6. Methods: Methylation-specific polymerase chain reaction (PCR), bisulphite sequencing PCR, the MethyLight assay, and quantitative real-time PCR were performed to examine BMP-6 methylation and mRNA expression levels. Immunohistochemistry (IHC) was performed on tissue arrays to evaluate the BMP-6 protein level. Results: BMP-6 mRNA expression was approximately 84.09% lower in HCC tissues than in adjacent non-cancerous tissues, and this low level of expression was associated with a poor prognosis. Moreover, the hypermethylation observed in HCC cell lines and HCC tissues was correlated with the BMP-6 mRNA expression level, and this correlation was validated following treatment with 5-aza-CdR, a demethylation agent. In addition, BMP-6 DNA methylation was upregulated by 68.42% in 114 clinical HCC tissue samples compared to adjacent normal tissues, whereas the BMP-6 staining intensity was downregulated by 77.03% in 75 clinical HCC tissue samples in comparison to adjacent normal tissues. Furthermore, elevated expression of BMP-6 in HCC cell lines inhibited cell colony formation. Conclusions: Our results suggest that BMP-6 CpG island hypermethylation leads to decreased BMP-6 expression in HCC tissues.	[He, Yinghua; Gu, Jun; Wang, Wei; Luo, Xiaoying] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China; [Cui, Ying] Guangxi Canc Inst, Nanning, Guangxi, Peoples R China; [Xu, Baiying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Luo, XY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China.	lxybio@gmail.com			Natural Science Foundation of the Shanghai Science and Technology Committee [12ZR1430200]; State Key Laboratory of Oncogenes and Related Genes [91-11-05]; Young Scientists Foundation of the Shanghai Cancer Institute [SB11-10]	Natural Science Foundation of the Shanghai Science and Technology Committee; State Key Laboratory of Oncogenes and Related Genes; Young Scientists Foundation of the Shanghai Cancer Institute	This work was supported by the Natural Science Foundation of the Shanghai Science and Technology Committee (No. 12ZR1430200), the research fund of the State Key Laboratory of Oncogenes and Related Genes (91-11-05), and the Young Scientists Foundation of the Shanghai Cancer Institute (SB11-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Autzen P, 1998, BRIT J CANCER, V78, P1219, DOI 10.1038/bjc.1998.658; BENTLEY H, 1992, BRIT J CANCER, V66, P1159, DOI 10.1038/bjc.1992.427; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Darby S, 2008, J PATHOL, V214, P394, DOI 10.1002/path.2292; Dendooven A, 2011, AM J PATHOL, V178, P1069, DOI 10.1016/j.ajpath.2010.12.005; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; GITELMAN SE, 1994, J CELL BIOL, V126, P1595, DOI 10.1083/jcb.126.6.1595; HAHN GV, 1992, GENOMICS, V14, P759, DOI 10.1016/S0888-7543(05)80181-8; Hamdy FC, 1997, CANCER RES, V57, P4427; He YH, 2011, NEOPLASIA, V13, P841, DOI 10.1593/neo.11698; Jiang FX, 2002, J CELL SCI, V115, P753; Lee JH, 2013, CANC RES; Maegdefrau U, 2011, LAB INVEST, V91, P1615, DOI 10.1038/labinvest.2011.123; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020; Nomoto S, 2007, BRIT J CANCER, V97, P1260, DOI 10.1038/sj.bjc.6604016; Radpour R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016080; Rickard DJ, 1998, J CLIN INVEST, V101, P413, DOI 10.1172/JCI119880; SAUERMANN U, 1992, J NEUROSCI RES, V33, P142, DOI 10.1002/jnr.490330118; Seckinger A, 2009, ONCOGENE, V28, P3866, DOI 10.1038/onc.2009.257; Taniguchi A, 2008, INT J CANCER, V123, P1824, DOI 10.1002/ijc.23749; Wach S, 2001, ONCOGENE, V20, P7761, DOI 10.1038/sj.onc.1204962; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987	25	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87994	10.1371/journal.pone.0087994	http://dx.doi.org/10.1371/journal.pone.0087994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498236	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100124
J	Liu, P; Du, RJ; Wang, L; Han, J; Liu, L; Zhang, YL; Xia, JK; Lu, FM; Zhuang, H				Liu, Peng; Du, Ren Jie; Wang, Ling; Han, Jian; Liu, Lin; Zhang, Yu Lin; Xia, Jun Ke; Lu, Feng Min; Zhuang, Hui			Management of Hepatitis E Virus (HEV) Zoonotic Transmission: Protection of Rabbits against HEV Challenge following Immunization with HEV 239 Vaccine	PLOS ONE			English	Article							CROSS-SPECIES INFECTION; UNITED-STATES; GENOTYPES 1; CHINA; ANTIGENICITY; PREVALENCE; COUNTRIES; STRAINS; HUMANS; SWINE	Hepatitis E virus (HEV) constitutes a significant health burden worldwide, with an estimated approximately 33% of the world's population exposed to the pathogen. The recent licensed HEV 239 vaccine in China showed excellent protective efficacy against HEV of genotypes 1 and 4 in the general population and pregnant women. Because hepatitis E is a zoonosis, it is also necessary to ascertain whether this vaccine can serve to manage animal sources of human HEV infection. To test the efficacy of the HEV 239 vaccine in protecting animal reservoirs of HEV against HEV infection, twelve specific-pathogen-free (SPF) rabbits were divided randomly into two groups of 6 animals and inoculated intramuscularly with HEV 239 and placebo (PBS). All animals were challenged intravenously with swine HEV of genotype 4 or rabbit HEV seven weeks after the initial immunization. The course of infection was monitored for 10 weeks by serum ALT levels, duration of viremia and fecal virus excretion and HEV antibody responses. All rabbits immunized with HEV 239 developed high titers of anti-HEV and no signs of HEV infection were observed throughout the experiment, while rabbits inoculated with PBS developed viral hepatitis following challenge, with liver enzyme elevations, viremia, and fecal virus shedding. Our data indicated that the HEV 239 vaccine is highly immunogenic for rabbits and that it can completely protect rabbits against homologous and heterologous HEV infections. These findings could facilitate the prevention of food-borne sporadic HEV infection in both developing and industrialized countries.	[Liu, Peng; Du, Ren Jie; Wang, Ling; Han, Jian; Liu, Lin; Zhang, Yu Lin; Xia, Jun Ke; Lu, Feng Min; Zhuang, Hui] Peking Univ, Sch Basic Med Sci, Dept Microbiol, Beijing 100871, Peoples R China	Peking University	Wang, L (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Microbiol, Beijing 100871, Peoples R China.	lingwang@bjmu.edu.cn	Liu, Peng/AGH-0228-2022		National Science Foundation of China [81271827]; Specialized Research Fund for the Doctoral Program of Higher Education [20120001110098]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was partially supported by the National Science Foundation of China (grant number 81271827) and Specialized Research Fund for the Doctoral Program of Higher Education (grant number 20120001110098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang YB, 2009, HEPATOL RES, V39, P1153, DOI 10.1111/j.1872-034X.2009.00558.x; Cheng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051616; Cossaboom CM, 2012, J GEN VIROL, V93, P1687, DOI 10.1099/vir.0.041509-0; Cossaboom CM, 2011, EMERG INFECT DIS, V17, P2047, DOI 10.3201/eid1711.110428; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Dong C, 2011, J CLIN MICROBIOL, V49, P4164, DOI 10.1128/JCM.05481-11; Geng J, 2011, J VIRAL HEPATITIS, V18, P661, DOI 10.1111/j.1365-2893.2010.01341.x; Geng YS, 2011, INFECT GENET EVOL, V11, P476, DOI 10.1016/j.meegid.2010.12.012; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Izopet J, 2012, EMERG INFECT DIS, V18, P1274, DOI 10.3201/eid1808.120057; Jirintai S, 2012, VIRUS RES, V170, P126, DOI 10.1016/j.virusres.2012.09.015; Jothikumar N, 2006, J VIROL METHODS, V131, P65, DOI 10.1016/j.jviromet.2005.07.004; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Lhomme S, 2013, J CLIN VIROL; Li SW, 2005, VACCINE, V23, P2893, DOI 10.1016/j.vaccine.2004.11.064; Li TC, 2005, EMERG INFECT DIS, V11, P1958, DOI 10.3201/eid1112.051041; Liu P, 2013, EMERG INFECT DIS, V19, P559, DOI 10.3201/eid1904.120827; Liu P, 2012, INFECT GENET EVOL, V12, P428, DOI 10.1016/j.meegid.2012.01.017; Ma HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009160; Meng XJ, 2010, J VIRAL HEPATITIS, V17, P153, DOI 10.1111/j.1365-2893.2009.01257.x; Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Ollier L, 2009, ANN INTERN MED, V150, P430, DOI 10.7326/0003-4819-150-6-200903170-00026; Park SB, 2012, NATURE, V491, P21, DOI 10.1038/491021a; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Purdy MA, 2011, VIRUS RES, V161, P31, DOI 10.1016/j.virusres.2011.04.030; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Wang S, 2013, VIRUS RES, V176, P101, DOI 10.1016/j.virusres.2013.05.013; Wang S, 2013, J MED VIROL, V85, P627, DOI 10.1002/jmv.23504; Wu T, 2012, HEPATOLOGY, V55, DOI 10.1002/hep.25522; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	34	32	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87600	10.1371/journal.pone.0087600	http://dx.doi.org/10.1371/journal.pone.0087600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498149	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100099
J	Prodam, F; Savastio, S; Genoni, G; Babu, D; Giordano, M; Ricotti, R; Aimaretti, G; Bona, G; Bellone, S				Prodam, Flavia; Savastio, Silvia; Genoni, Giulia; Babu, Deepak; Giordano, Mara; Ricotti, Roberta; Aimaretti, Gianluca; Bona, Gianni; Bellone, Simonetta			Effects of Growth Hormone (GH) Therapy Withdrawal on Glucose Metabolism in Not Confirmed GH Deficient Adolescents at Final Height	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BETA-CELL FUNCTION; INSULIN SENSITIVITY; REPLACEMENT THERAPY; BODY-COMPOSITION; BASE-LINE; GH/IGF-I; IGF-I; RECEPTOR; CHILDREN	Context, objective: Growth hormone deficiency (GHD) is associated with insulin resistance and diabetes, in particular after treatment in children and adults with pre-existing metabolic risk factors. Our aims were. i) to evaluate the effect on glucose metabolism of rhGH treatment and withdrawal in not confirmed GHD adolescents at the achievement of adult height; ii) to investigate the impact of GH receptor gene genomic deletion of exon 3 (d3GHR). Design, setting: We performed a longitudinal study (1 year) in a tertiary care center. Methods: 23 GHD adolescent were followed in the last year of rhGH treatment (T0), 6 (T6) and 12 (T12) months after rhGH withdrawal with fasting and post-OGTT evaluations. 40 healthy adolescents were used as controls. HOMA-IR, HOMA%beta, insulinogenic (INS) and disposition (DI) indexes were calculated. GHR genotypes were determined by multiplex PCR. Results: In the group as a whole, fasting insulin (p<0.05), HOMA-IR (p<0.05), insulin and glucose levels during OGTT (p<0.01) progressively decreased from T0 to T12 becoming similar to controls. During rhGH, a compensatory insulin secretion with a stable DI was recorded, and, then, HOMA beta and INS decreased at T6 and T12 (p<0.05). By evaluating the GHR genotype, nDel GHD showed a decrease from T0 to T12 in HOMA-IR, HOMAb, INS (p<0.05) and DI. Del GHD showed a gradual increase in DI (p<0.05) and INS with a stable HOMA-IR and higher HDL-cholesterol (p<0.01). Conclusions: In not confirmed GHD adolescents the fasting deterioration in glucose homeostasis during rhGH is efficaciously coupled with a compensatory insulin secretion and activity at OGTT. The presence of at least one d3GHR allele is associated with lower glucose levels and higher HOMA-beta and DI after rhGH withdrawal. Screening for the d3GHR in the pediatric age may help physicians to follow and phenotype GHD patients also by a metabolic point of view.	[Prodam, Flavia; Savastio, Silvia; Genoni, Giulia; Ricotti, Roberta; Bona, Gianni; Bellone, Simonetta] Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Div Pediat, Novara, Italy; [Prodam, Flavia; Aimaretti, Gianluca; Bellone, Simonetta] Univ Piemonte Orientale, Dept Clin & Expt Med, Novara, Italy; [Prodam, Flavia; Giordano, Mara; Bona, Gianni; Bellone, Simonetta] ICOS, Novara, Italy; [Babu, Deepak; Giordano, Mara] Univ Piemonte Orientale, Dept Hlth Sci, Lab Human Genet, Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Prodam, F (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Div Pediat, Novara, Italy.	flavia.prodam@med.unipmn.it	Savastio, Silvia/AAC-6475-2022; GIORDANO, Mara/AAB-1379-2019; Bellone, Simonetta/K-2196-2016	Savastio, Silvia/0000-0002-5867-3246; GIORDANO, Mara/0000-0001-6686-4600; Prodam, Flavia/0000-0001-9660-5335; BELLONE, Simonetta/0000-0001-8521-497X	Regione Piemonte [2827]; Universita del Piemonte Orientale "A. Avogadro"; Ministero dell'Universita e della Ricerca Scientifica (MIUR) [20082P8CCE]	Regione Piemonte(Regione Piemonte); Universita del Piemonte Orientale "A. Avogadro"; Ministero dell'Universita e della Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by Regione Piemonte (grant no 2827, 2008), Universita del Piemonte Orientale "A. Avogadro", Ministero dell'Universita e della Ricerca Scientifica (MIUR, grant no 20082P8CCE, 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P1544, DOI 10.2337/dc06-1331; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; Appelman-Dijkstra NM, 2013, EUR J ENDOCRINOL, V169, pR1, DOI 10.1530/EJE-12-1088; Arafat AM, 2010, DIABETOLOGIA, V53, P1304, DOI 10.1007/s00125-010-1738-4; Bramnert M, 2003, J CLIN ENDOCR METAB, V88, P1455, DOI 10.1210/jc.2002-020542; Bulow B, 1999, CLIN ENDOCRINOL, V50, P45, DOI 10.1046/j.1365-2265.1999.00595.x; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Carroll PV, 2004, J CLIN ENDOCR METAB, V89, P3890, DOI 10.1210/jc.2003-031588; Child CJ, 2011, J CLIN ENDOCR METAB, V96, pE1025, DOI 10.1210/jc.2010-3023; Corneli G, 2007, EUR J ENDOCRINOL, V157, P701, DOI 10.1530/EJE-07-0384; Cutfield WS, 2000, LANCET, V355, P610, DOI 10.1016/S0140-6736(99)04055-6; Dominici FP, 2002, EXP BIOL MED, V227, P149, DOI 10.1177/153537020222700301; Dos Santos C, 2004, NAT GENET, V36, P720, DOI 10.1038/ng1379; Filopanti M, 2011, J ENDOCRINOL INVEST, V34, P861, DOI 10.1007/BF03346731; Gao LL, 2011, PEDIATR DIABETES, V12, P429, DOI 10.1111/j.1399-5448.2010.00747.x; Giannini C, 2012, DIABETES, V61, P606, DOI 10.2337/db11-1111; Giavoli C, 2010, EUR J ENDOCRINOL, V163, P361, DOI 10.1530/EJE-10-0317; Gungor N, 2004, J PEDIATR-US, V144, P656, DOI 10.1016/j.jpeds.2003.12.045; Heptulla RA, 1997, J CLIN ENDOCR METAB, V82, P3234, DOI 10.1210/jc.82.10.3234; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; Horan M, 2006, HUM GENET, V119, P527, DOI 10.1007/s00439-006-0166-5; JORGENSEN JOL, 1993, J CLIN ENDOCR METAB, V77, P1589, DOI 10.1210/jc.77.6.1589; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Lee SJ, 2008, J PEDIATR-US, V152, P177, DOI 10.1016/j.jpeds.2007.07.053; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MOLLER N, 1989, DIABETOLOGIA, V32, P105, DOI 10.1007/BF00505182; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Norrelund H, 2000, J CLIN ENDOCR METAB, V85, P1912, DOI 10.1210/jc.85.5.1912; Oliveira CRP, 2011, ARQ BRAS CARDIOL, V97, P434, DOI 10.1590/S0066-782X2011001400012; Pantel J, 2000, J BIOL CHEM, V275, P18664, DOI 10.1074/jbc.M001615200; Radetti G, 2004, CLIN ENDOCRINOL, V61, P473, DOI 10.1111/j.1365-2265.2004.02113.x; Rosenfalck AM, 2000, J CLIN ENDOCR METAB, V85, P4173, DOI 10.1210/jc.85.11.4173; Schneider HJ, 2011, EUR J ENDOCRINOL, V164, P223, DOI 10.1530/EJE-10-0963; Segerlantz M, 2001, J CLIN ENDOCR METAB, V86, P5813, DOI 10.1210/jc.86.12.5813; Seminara S, 1998, CLIN ENDOCRINOL, V49, P125, DOI 10.1046/j.1365-2265.1998.00502.x; Smith TR, 1997, AM J PHYSIOL-ENDOC M, V272, pE1071, DOI 10.1152/ajpendo.1997.272.6.E1071; Sorensen K, 2009, J CLIN ENDOCR METAB, V94, P2966, DOI 10.1210/jc.2009-0313; Strawbridge RJ, 2007, GROWTH HORM IGF RES, V17, P392, DOI 10.1016/j.ghir.2007.04.005; Svensson J, 2002, J CLIN ENDOCR METAB, V87, P2121, DOI 10.1210/jc.87.5.2121; Takada D, 2003, AM J MED GENET A, V121A, P136, DOI 10.1002/ajmg.a.20172; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; van der Kaay D, 2010, EUR J ENDOCRINOL, V162, P887, DOI 10.1530/EJE-09-1113; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487	46	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87157	10.1371/journal.pone.0087157	http://dx.doi.org/10.1371/journal.pone.0087157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498035	Green Submitted, gold, Green Published			2022-12-25	WOS:000330617100055
J	Hughes, LD; Rawle, RJ; Boxer, SG				Hughes, Laura D.; Rawle, Robert J.; Boxer, Steven G.			Choose Your Label Wisely: Water-Soluble Fluorophores Often Interact with Lipid Bilayers	PLOS ONE			English	Article							MEMBRANES	Water-soluble organic fluorophores are widely used as labels in biological systems. However, in many cases these fluorophores can interact strongly with lipid bilayers, influencing the interaction of the target with the bilayer and/or leading to misleading fluorescent signals. Here, we quantify the interaction of 32 common water-soluble dyes with model lipid bilayers to serve as an additional criterion when selecting a dye label.	[Hughes, Laura D.; Rawle, Robert J.; Boxer, Steven G.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Boxer, SG (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	sboxer@stanford.edu		Boxer, Steven/0000-0001-9167-4286	NSF Graduate Research Fellowship; ARCS Foundation; Althouse Family Stanford Graduate Fellowship; National Institutes of Health [GM069630]; NSF Biophysics Program; Div Of Molecular and Cellular Bioscience [0918782] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069630] Funding Source: NIH RePORTER	NSF Graduate Research Fellowship(National Science Foundation (NSF)); ARCS Foundation; Althouse Family Stanford Graduate Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Biophysics Program(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	L.D.H. was supported by an NSF Graduate Research Fellowship and by the ARCS Foundation, and R.J.R was supported by an NSF Graduate Research Fellowship and an Althouse Family Stanford Graduate Fellowship. This work was supported by National Institutes of Health grant GM069630 and the NSF Biophysics Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew B, 2007, US Patent, Patent No. [2007/0249014 A1, 20070249014A1]; [Anonymous], 2013, ATTO TECH GMBH PRODU; Boxer SG, 2003, U.S. Patent, Patent No. [6,503,452, 6503452]; Brabetz W, 2010, NOVEL COMBINATION FL, Patent No. 2010063732 A1; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Ladokhin AS, 1997, BIOPHYS J, V72, P794, DOI 10.1016/S0006-3495(97)78713-7; Loidl-Stahlhofen A, 2001, J PHARM SCI-US, V90, P599, DOI 10.1002/1520-6017(200105)90:5<599::AID-JPS1016>3.0.CO;2-N; PAULETTI GM, 1994, EUR J PHARM SCI, V1, P273, DOI 10.1016/0928-0987(94)90022-1; van de Linde S, 2011, PHOTOCH PHOTOBIO SCI, V10, P499, DOI 10.1039/c0pp00317d; van Lengerich B, 2010, LANGMUIR, V26, P8666, DOI 10.1021/la904822f; White SS, 2006, J AM CHEM SOC, V128, P11423, DOI 10.1021/ja0614870; White SH, 1998, METHOD ENZYMOL, V295, P62; Wurm C.A., 2012, OPT NANOSCOPY, V1, P1, DOI [DOI 10.1186/2192-2853-1-7, 10.1186/2192-2853-1-7]; Zanetti-Domingues LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074200; Zanetti-Domingues LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045655	15	182	184	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87649	10.1371/journal.pone.0087649	http://dx.doi.org/10.1371/journal.pone.0087649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503716	Green Published, gold, Green Submitted			2022-12-25	WOS:000330631800054
J	Bagchi, B; Al-Sabi, A; Kaza, S; Scholz, D; O'Leary, VB; Dolly, JO; Ovsepian, SV				Bagchi, Bandita; Al-Sabi, Ahmed; Kaza, Seshu; Scholz, Dimitri; O'Leary, Valerie B.; Dolly, J. Oliver; Ovsepian, Saak V.			Disruption of Myelin Leads to Ectopic Expression of K(V)1.1 Channels with Abnormal Conductivity of Optic Nerve Axons in a Cuprizone-Induced Model of Demyelination	PLOS ONE			English	Article							GATED POTASSIUM CHANNELS; MULTIPLE-SCLEROSIS; ALPHA-SUBUNITS; RAT-BRAIN; AUDITORY NEURONS; XENOPUS OOCYTES; MICE LACKING; 4-AMINOPYRIDINE; REMYELINATION; CURRENTS	The molecular determinants of abnormal propagation of action potentials along axons and ectopic conductance in demyelinating diseases of the central nervous system, like multiple sclerosis (MS), are poorly defined. Widespread interruption of myelin occurs in several mouse models of demyelination, rendering them useful for research. Herein, considerable myelin loss is shown in the optic nerves of cuprizone-treated demyelinating mice. Immuno-fluorescence confocal analysis of the expression and distribution of voltage-activated K+ channels (K(V)1.1 and 1.2 alpha subunits) revealed their spread from typical juxta-paranodal (JXP) sites to nodes in demyelinated axons, albeit with a disproportionate increase in the level of K(V)1.1 subunit. Functionally, in contrast to monophasic compound action potentials (CAPs) recorded in controls, responses derived from optic nerves of cuprizone-treated mice displayed initial synchronous waveform followed by a dispersed component. Partial restoration of CAPs by broad spectrum (4-aminopyridine) or K(V)1.1-subunit selective (dendrotoxin K) blockers of K+ currents suggest enhanced K(V)1.1-mediated conductance in the demyelinated optic nerve. Biophysical profiling of K+ currents mediated by recombinant channels comprised of different K(V)1.1 and 1.2 stoichiometries revealed that the enrichment of K(V)1 channels K(V)1.1 subunit endows a decrease in the voltage threshold and accelerates the activation kinetics. Together with the morphometric data, these findings provide important clues to a molecular basis for temporal dispersion of CAPs and reduced excitability of demyelinated optic nerves, which could be of potential relevance to the patho-physiology of MS and related disorders.	[Bagchi, Bandita; Al-Sabi, Ahmed; Kaza, Seshu; O'Leary, Valerie B.; Dolly, J. Oliver; Ovsepian, Saak V.] Dublin City Univ, Int Ctr Neurotherapeut, Dublin 9, Ireland; [Ovsepian, Saak V.] Dublin City Univ, Dept Biotechnol, Dublin 9, Ireland; [Scholz, Dimitri] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Ovsepian, Saak V.] Univ Munich, Deutsch Zentrum Neurodegenerat Erkrankungen DZNE, Zentrum Neuropathol, Munich, Germany	Dublin City University; Dublin City University; University College Dublin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Dolly, JO (corresponding author), Dublin City Univ, Int Ctr Neurotherapeut, Dublin 9, Ireland.	oliver.dolly@dcu.ie; saak.ovsepian@gmail.com	Al-Sabi, Ahmed/H-3438-2015; Dolly, Oliver/ABH-6677-2020; Al-Sabi, AHMED/AAF-9211-2020; Ovsepian, Saak/J-6207-2017; Dolly, Oliver/G-1532-2012	Dolly, Oliver/0000-0002-0861-5320; Dolly, Oliver/0000-0002-0861-5320; O'Leary, Valerie/0000-0003-1171-9830; Al-Sabi, Ahmed/0000-0002-1957-7569	Science Foundation Ireland; Neuroscience section of the Programme for Research in Third Level Institutions (PRTLI) Cycle 4; European Regional Development Fund (ERDF), part of the European Union Structural Funds Programme	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Neuroscience section of the Programme for Research in Third Level Institutions (PRTLI) Cycle 4; European Regional Development Fund (ERDF), part of the European Union Structural Funds Programme	This research was supported by a PI grant (to J.O.D.) from Science Foundation Ireland, and the Neuroscience section of the Programme for Research in Third Level Institutions (PRTLI) Cycle 4 (to S.V.O.). The PRTLI is co-funded through the European Regional Development Fund (ERDF), part of the European Union Structural Funds Programme 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2002, J BIOL CHEM, V277, P16376, DOI 10.1074/jbc.M109698200; Al-Sabi A, 2011, BIOCHEM J, V438, P389, DOI 10.1042/BJ20102169; Al-Sabi A, 2010, J GEN PHYSIOL, V136, P273, DOI 10.1085/jgp.200910398; Arnold DL, 2005, J NEUROL, V252, pV25, DOI 10.1007/s00415-005-5005-4; Bacia A, 2004, GLIA, V48, P156, DOI 10.1002/glia.20067; Bagchi B, 2013, MYELIN DISRUPTION EC; BOSTOCK H, 1981, J PHYSIOL-LONDON, V313, P301, DOI 10.1113/jphysiol.1981.sp013666; BOSTOCK H, 1985, J PHYSIOL-LONDON, V365, P239, DOI 10.1113/jphysiol.1985.sp015769; Brew HM, 2007, J NEUROPHYSIOL, V98, P1501, DOI 10.1152/jn.00640.2006; Brew HM, 2003, J PHYSIOL-LONDON, V548, P1, DOI 10.1113/jphysiol.2002.035568; Brodal P., 2004, CENTRAL NERVOUS SYST; Chiu SY, 1999, J NEUROCYTOL, V28, P349, DOI 10.1023/A:1007013731231; CHOQUET D, 1992, J GEN PHYSIOL, V99, P217, DOI 10.1085/jgp.99.2.217; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; Dutta R, 2011, ANN NEUROL, V69, P445, DOI 10.1002/ana.22337; Goodman AD, 2010, DRUG TODAY, V46, P635, DOI 10.1358/dot.2010.46.9.1499027; GORDON TR, 1988, BRAIN RES, V447, P1, DOI 10.1016/0006-8993(88)90959-6; Hopkins WF, 1998, J PHARMACOL EXP THER, V285, P1051; Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; MCDONALD WI, 1969, NATURE, V221, P182, DOI 10.1038/221182a0; MOLGO J, 1980, EUR J PHARMACOL, V61, P25, DOI 10.1016/0014-2999(80)90378-7; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Ovsepian SV, 2013, J PHYSIOL-LONDON, V591, P1771, DOI 10.1113/jphysiol.2012.249706; Ovsepian SV, 2012, J NEUROPHYSIOL, V108, P406, DOI 10.1152/jn.00642.2011; PERREAULT P, 1991, J NEUROPHYSIOL, V65, P771, DOI 10.1152/jn.1991.65.4.771; Perry VH, 2005, INFLAMATION AXON DEG; Peter A, 2012, IDEGGYOGY SZEMLE, V65, P266; Pilati N, 2008, J HISTOCHEM CYTOCHEM, V56, P539, DOI 10.1369/jhc.2008.950246; Poliak S, 2001, J NEUROSCI, V21, P7568, DOI 10.1523/JNEUROSCI.21-19-07568.2001; Rasband M, 1998, J NEUROSCI, V18, P36; Rasband MN, 2011, SEMIN CELL DEV BIOL, V22, P178, DOI 10.1016/j.semcdb.2010.09.010; Rasband MN, 1999, J NEUROCYTOL, V28, P319, DOI 10.1023/A:1007057512576; Rasband MN, 2000, J PHYSIOL-LONDON, V525, P63, DOI 10.1111/j.1469-7793.2000.00063.x; Rhodes KJ, 1996, J NEUROSCI, V16, P4846; Robertson B, 1996, FEBS LETT, V383, P26, DOI 10.1016/0014-5793(96)00211-6; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; SHERRATT RM, 1980, NATURE, V283, P570, DOI 10.1038/283570a0; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Smith KJ, 2000, BRAIN, V123, P171, DOI 10.1093/brain/123.1.171; Soderstrom M, 2001, ACTA OPHTHALMOL SCAN, V79, P223, DOI 10.1034/j.1600-0420.2001.790302.x; Sokolov MV, 2007, NEUROPHARMACOLOGY, V53, P272, DOI 10.1016/j.neuropharm.2007.05.008; Steelman AJ, 2012, NEUROSCI RES, V72, P32, DOI 10.1016/j.neures.2011.10.002; STEFOSKI D, 1987, ANN NEUROL, V21, P71, DOI 10.1002/ana.410210113; Stidworthy MF, 2003, BRAIN PATHOL, V13, P329; SWADLOW HA, 1980, ANNU REV BIOPHYS BIO, V9, P143, DOI 10.1146/annurev.bb.09.060180.001043; Torkildsen O, 2009, EXP NEUROL, V215, P160, DOI 10.1016/j.expneurol.2008.09.026; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Wang FC, 1999, EUR J BIOCHEM, V263, P230, DOI 10.1046/j.1432-1327.1999.00493.x; Wang H, 1995, NEURON, V15, P1337, DOI 10.1016/0896-6273(95)90012-8; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023; Weinstock-Guttman B, 2012, NAT REV NEUROL, V8, P66, DOI 10.1038/nrneurol.2011.213; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998	59	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87736	10.1371/journal.pone.0087736	http://dx.doi.org/10.1371/journal.pone.0087736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498366	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900112
J	Himsworth, CG; Miller, RR; Montoya, V; Hoang, L; Romney, MG; Al-Rawahi, GN; Kerr, T; Jardine, CM; Patrick, DM; Tang, P; Weese, JS				Himsworth, Chelsea G.; Miller, Ruth R.; Montoya, Vincent; Hoang, Linda; Romney, Marc G.; Al-Rawahi, Ghada N.; Kerr, Thomas; Jardine, Claire M.; Patrick, David M.; Tang, Patrick; Weese, J. Scott			Carriage of Methicillin-Resistant Staphylococcus aureus by Wild Urban Norway Rats (Rattus norvegicus)	PLOS ONE			English	Article							INJECTION-DRUG USERS; ECOLOGY; CANADA; EPIDEMIOLOGY; ALGORITHMS; INFECTION; PATHOGENS; VANCOUVER; ANIMALS; STRAINS	Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of multi-drug-resistant infections in people, particularly indigent populations. MRSA can be transmitted between people and domestic animals, but the potential for transmission between people and commensal pests, particularly rodents, had not been investigated. The objective of this study was to identify the presence and characterize the ecology of MRSA in rats (Rattus spp.) from in an impoverished, inner-city neighborhood. Oropharyngeal swabs were collected from rats trapped in 33 city blocks and one location within the adjacent port. Bacterial culture was performed and MRSA isolates were characterized using a variety of methods, including whole-genome sequencing (WGS). The ecology of MRSA in rats was described using phylogenetic analysis, geospatial analysis, and generalized linear mixed models. MRSA was identified 22 of 637 (3.5%) rats tested, although prevalence varied from 0 - 50% among blocks. Isolates belonged to 4 clusters according to WGS, with the largest cluster (n = 10) containing isolates that were genetically indistinguishable from community-acquired USA300 MRSA strains isolated from people within the study area. MRSA strains demonstrated both geographic clustering and dispersion. The odds of an individual rat carrying MRSA increased with increased body fat (OR = 2.53, 95% CI = 1.33 - 4.82), and in the winter (OR = 5.29, 95% CI = 1.04 - 26.85) and spring (OR = 5.50, 95% CI = 1.10 - 27.58) compared to the fall. The results show that urban rats carried the same MRSA lineages occurring in local human and/or animal populations, supporting recent transmission from external sources. MRSA carriage was influenced by season, most likely as a result of temporal variation in rat behavior and rat-human interactions.	[Himsworth, Chelsea G.; Patrick, David M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Himsworth, Chelsea G.; Miller, Ruth R.] British Columbia Minist Agr, Ctr Anim Hlth, Abbotsford, BC, Canada; [Montoya, Vincent; Hoang, Linda; Al-Rawahi, Ghada N.; Tang, Patrick] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Hoang, Linda; Tang, Patrick] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Romney, Marc G.; Kerr, Thomas] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Romney, Marc G.] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Al-Rawahi, Ghada N.] Childrens & Womens Hlth Ctr British Columbia, Vancouver, BC, Canada; [Kerr, Thomas] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Jardine, Claire M.; Weese, J. Scott] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	University of British Columbia; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; BC Women's Hospital & Health Centre; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of Guelph	Himsworth, CG (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	Chelsea.Himsworth@gov.bc.ca		Tang, Patrick/0000-0003-1583-5484; Al-Rawahi, Ghada N./0000-0003-2719-9112	Canadian Institutes of Health Research [MOP - 119530, CGV - 104833]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research (MOP - 119530 and CGV - 104833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rawahi GN, 2008, J CLIN MICROBIOL, V46, P477, DOI 10.1128/JCM.01596-07; Barnett S. A., 1963, RAT STUDY BEHAV; Cimolai N, 2010, CAN J MICROBIOL, V56, P89, DOI [10.1139/W09-109, 10.1139/w09-109]; Clinical and Laboratory Standards Institute, 2012, M07A9 CLIN LAB STAND; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Golubchik T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061319; Gomez-Sanz E, 2010, FOODBORNE PATHOG DIS, V7, P1269, DOI 10.1089/fpd.2010.0610; Gorwitz RJ, 2008, PEDIATR INFECT DIS J, V27, P1, DOI 10.1097/INF.0b013e31815819bb; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; He WQ, 2013, FOODBORNE PATHOG DIS, V10, P782, DOI 10.1089/fpd.2012.1452; Himsworth CG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002270; Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195; Himsworth CG, 2013, URBAN ECOSYST, V16, P341, DOI 10.1007/s11252-012-0261-4; Himsworth CG, 2013, EMERG INFECT DIS, V19, P169, DOI 10.3201/eid1901.120897; KATO Y, 1995, J VET MED SCI, V57, P499, DOI 10.1292/jvms.57.499; Kerr T, 2005, J PUBLIC HEALTH-UK, V27, P62, DOI 10.1093/pubmed/fdh189; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Lin Y, 2011, CLIN MED RES, V9, P7, DOI 10.3121/cmr.2010.944; Lloyd-Smith E, 2010, EPIDEMIOL INFECT, V138, P713, DOI 10.1017/S0950268810000464; Lowe CF, 2011, EMERG INFECT DIS, V17, P1132, DOI [10.3201/eid1706.101978, 10.3201/eid/1706.101978]; Meemken D, 2010, ZOONOSES PUBLIC HLTH, V57, pE143, DOI 10.1111/j.1863-2378.2009.01313.x; Pantosti A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00127; Rankin S, 2005, VET MICROBIOL, V108, P145, DOI 10.1016/j.vetmic.2005.02.013; Sasaki T, 2010, J CLIN MICROBIOL, V48, P765, DOI 10.1128/JCM.01232-09; Simor AE, 2010, INFECT CONT HOSP EP, V31, P348, DOI 10.1086/651313; Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13; Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; van de Giessen AW, 2009, PREV VET MED, V91, P270, DOI 10.1016/j.prevetmed.2009.05.016; Winstel V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3345; Young DM, 2004, ARCH SURG-CHICAGO, V139, P947, DOI 10.1001/archsurg.139.9.947; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	37	37	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87983	10.1371/journal.pone.0087983	http://dx.doi.org/10.1371/journal.pone.0087983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498421	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900167
J	Olafsson, K; Pampoulie, C; Hjorleifsdottir, S; Gudjonsson, S; Hreggvidsson, GO				Olafsson, Kristinn; Pampoulie, Christophe; Hjorleifsdottir, Sigridur; Gudjonsson, Sigurdur; Hreggvidsson, Gudmundur O.			Present-Day Genetic Structure of Atlantic Salmon (Salmo salar) in Icelandic Rivers and Ice-Cap Retreat Models	PLOS ONE			English	Article							WOLFFISH ANARHICHAS-LUPUS; POPULATION-STRUCTURE; MICROSATELLITE DNA; BROWN TROUT; PHYLOGENETIC TREES; PROTEIN VARIATION; FISHING GROUNDS; PLEISTOCENE; PHYLOGEOGRAPHY; L.	Due to an improved understanding of past climatological conditions, it has now become possible to study the potential concordance between former climatological models and present-day genetic structure. Genetic variability was assessed in 26 samples from different rivers of Atlantic salmon in Iceland (total of 2,352 individuals), using 15 microsatellite loci. F-statistics revealed significant differences between the majority of the populations that were sampled. Bayesian cluster analyses using both prior information and no prior information on sampling location revealed the presence of two distinguishable genetic pools - namely, the Northern (Group 1) and Southern (Group 2) regions of Iceland. Furthermore, the random permutation of different allele sizes among allelic states revealed a significant mutational component to the genetic differentiation at four microsatellite loci (SsaD144, Ssa171, SSsp2201 and SsaF3), and supported the proposition of a historical origin behind the observed variation. The estimated time of divergence, using two different ABC methods, suggested that the observed genetic pattern originated from between the Last Glacial Maximum to the Younger Dryas, which serves as additional evidence of the relative immaturity of Icelandic fish populations, on account of the recolonisation of this young environment following the Last Glacial Maximum. Additional analyses suggested the presence of several genetic entities which were likely to originate from the original groups detected.	[Olafsson, Kristinn; Hreggvidsson, Gudmundur O.] Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland; [Pampoulie, Christophe] Marine Res Inst, IS-121 Reykjavik, Iceland; [Gudjonsson, Sigurdur] Inst Freshwater Fisheries, Reykjavik, Iceland; [Olafsson, Kristinn; Hjorleifsdottir, Sigridur; Hreggvidsson, Gudmundur O.] Matis Ltd, Genet, Reykjavik, Iceland	University of Iceland; Marine & Freshwater Research Institute (MFRI)	Olafsson, K (corresponding author), Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland.	kristinn@matis.is	Dalen, Love/A-6686-2008	Dalen, Love/0000-0001-8270-7613; Hreggvidsson, Gudmundur Oli/0000-0002-4958-1673	Salmon Enhancement Fund of Iceland (Fiskraektarsjodur); Icelandic Research Fund for Graduate Students	Salmon Enhancement Fund of Iceland (Fiskraektarsjodur); Icelandic Research Fund for Graduate Students	The project was funded by the Salmon Enhancement Fund of Iceland (Fiskraektarsjodur) and The Icelandic Research Fund for Graduate Students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SM, 2006, MOL ECOL, V15, P1109, DOI 10.1111/j.1365-294X.2006.02859.x; Alleaume-Benharira M, 2006, J EVOLUTION BIOL, V19, P203, DOI 10.1111/j.1420-9101.2005.00976.x; ALLENDORF FW, 1981, CAN J FISH AQUAT SCI, V38, P1507, DOI 10.1139/f81-203; Anderson EC, 2008, MOL ECOL RESOUR, V8, P1219, DOI 10.1111/j.1755-0998.2008.02355.x; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; AVISE JC, 2001, PHYLOGEOGRAPHY HIST; Beaumont MA, 2002, GENETICS, V162, P2025; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Benn D., 2010, GLACIERS GLACIATION, DOI [10.4324/9780203785010, DOI 10.4324/9780203785010]; Bowen BW, 2005, MOL ECOL, V14, P2389, DOI 10.1111/j.1365-294X.2005.02598.x; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Burg TM, 2006, MOL ECOL, V15, P2409, DOI 10.1111/j.1365-294X.2006.02957.x; Consuegra S, 2002, MOL ECOL, V11, P2037, DOI 10.1046/j.1365-294X.2002.01592.x; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Coyer JA, 2003, MOL ECOL, V12, P1817, DOI 10.1046/j.1365-294X.2003.01850.x; Danielsdottir AK, 1997, ICES J MAR SCI, V54, P986, DOI 10.1006/jmsc.1997.0311; Dionne M, 2008, MOL ECOL, V17, P2382, DOI 10.1111/j.1365-294X.2008.03771.x; Durand JD, 2005, MOL PHYLOGENET EVOL, V36, P277, DOI 10.1016/j.ympev.2005.01.019; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Galbreath PF, 1995, AQUACULTURE, V137, P299, DOI 10.1016/0044-8486(95)01115-3; Gamache I, 2003, MOL ECOL, V12, P891, DOI 10.1046/j.1365-294X.2003.01800.x; Garant D, 2000, MOL ECOL, V9, P615, DOI 10.1046/j.1365-294x.2000.00909.x; Goldberg CS, 2010, MOL ECOL RESOUR, V10, P304, DOI 10.1111/j.1755-0998.2009.02755.x; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Griffiths AM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-31; Gudjonsson S, 1991, CLASSIFICATION ICELA; Gysels ES, 2004, MOL ECOL, V13, P403, DOI 10.1046/j.1365-294X.2003.02087.x; Hanfling B, 2002, MOL ECOL, V11, P1717, DOI 10.1046/j.1365-294X.2002.01563.x; Hansen MM, 1997, MOL ECOL, V6, P469, DOI 10.1046/j.1365-294X.1997.t01-1-00202.x; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hauksdottir H, 1999, FISKVEGIR ISLANDI FJ; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hoarau G, 2007, MOL ECOL, V16, P3606, DOI 10.1111/j.1365-294X.2007.03408.x; Hubbard A, 2006, QUATERNARY SCI REV, V25, P2283, DOI 10.1016/j.quascirev.2006.04.001; Hundertmark KJ, 2002, MOL PHYLOGENET EVOL, V22, P375, DOI 10.1006/mpev.2001.1058; Icelandic Parliament, 1994, LOG DVRAV 15; Icelandic Parliament, 2006, LOG LAX SIL 61; Ingolfsson O, 2010, GLACIAL PROCESSES SE; Johnson JA, 2008, J HERED, V99, P165, DOI 10.1093/jhered/esn002; Jonsson J, 1971, NATTURUFRAEDINGURINN, V41, P49; JORDAN WC, 1992, CAN J FISH AQUAT SCI, V49, P1863, DOI 10.1139/f92-206; King TL, 2005, MOL ECOL NOTES, V5, P130, DOI 10.1111/j.1471-8286.2005.00860.x; King TL, 2001, MOL ECOL, V10, P807, DOI 10.1046/j.1365-294X.2001.01231.x; Langella O., 1999, POPULATIONS 1 2 31; Larmuseau MHD, 2009, J BIOGEOGR, V36, P1138, DOI 10.1111/j.1365-2699.2008.02072.x; Lopes JS, 2009, BIOINFORMATICS, V25, P2747, DOI 10.1093/bioinformatics/btp487; Mathews LM, 2007, MAR BIOL, V152, P645, DOI 10.1007/s00227-007-0718-9; McCusker MR, 2010, MOL ECOL, V19, P4228, DOI 10.1111/j.1365-294X.2010.04806.x; MCELLIGOTT EA, 1991, J FISH BIOL, V39, P35, DOI 10.1111/j.1095-8649.1991.tb05065.x; Miller MP, 2006, MOL ECOL, V15, P145, DOI 10.1111/j.1365-294X.2005.02765.x; Moffett IJJ, 1996, J FISH BIOL, V48, P302, DOI 10.1111/j.1095-8649.1996.tb01123.x; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nilsson J, 2001, MOL ECOL, V10, P89, DOI 10.1046/j.1365-294X.2001.01168.x; OConnell M, 1997, REV FISH BIOL FISHER, V7, P331, DOI 10.1023/A:1018443912945; Olafsson K, 2010, MOL ECOL RESOUR, V10, P533, DOI 10.1111/j.1755-0998.2009.02781.x; Pabijan M, 2006, MOL ECOL, V15, P2397, DOI 10.1111/j.1365-294X.2006.02954.x; Palo JU, 2004, MOL ECOL, V13, P2631, DOI 10.1111/j.1365-294X.2004.02269.x; Palo JU, 2003, CONSERV GENET, V4, P117, DOI 10.1023/A:1023303109701; Pampoulie C, 2008, BIOL J LINN SOC, V94, P315, DOI 10.1111/j.1095-8312.2008.00995.x; Pampoulie C, 2008, ICES J MAR SCI, V65, P65, DOI 10.1093/icesjms/fsm181; Pampoulie C, 2012, ICES J MAR SCI, V69, P508, DOI 10.1093/icesjms/fss017; Pampoulie C, 2011, ICES J MAR SCI, V68, P20, DOI 10.1093/icesjms/fsq165; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrier C, 2011, CONSERV GENET RESOUR, V3, P131, DOI 10.1007/s12686-010-9307-1; Primmer CR, 2006, MOL ECOL, V15, P653, DOI 10.1111/j.1365-294X.2005.02844.x; Pritchard JK, 2000, GENETICS, V155, P945; Reusch TBH, 2001, MOL ECOL, V10, P2435, DOI 10.1046/j.0962-1083.2001.01366.x; Ribera I, 2004, MOL ECOL, V13, P179, DOI 10.1046/j.1365-294X.2003.02035.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schmitt T, 2005, BIOL J LINN SOC, V85, P419, DOI 10.1111/j.1095-8312.2005.00504.x; Siegert MJ, 2004, QUATERNARY SCI REV, V23, P1273, DOI 10.1016/j.quascirev.2003.12.010; Sinton J, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC001021; Spielhagen RF, 2004, QUATERNARY SCI REV, V23, P1455, DOI 10.1016/j.quascirev.2003.12.015; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Swearer SE, 2002, B MARINE SCI; Takezaki N, 2008, GENETICS, V178, P385, DOI 10.1534/genetics.107.081505; Tonteri A, 2005, ANN ZOOL FENN, V42, P1; Vaha JP, 2007, MOL ECOL, V16, P2638, DOI 10.1111/j.1365-294X.2007.03329.x; Van Vliet-Lanoe B, 2007, CR GEOSCI, V339, P1, DOI 10.1016/j.crte.2006.12.001; Verspoor E, 1999, BIOL J LINN SOC, V68, P129, DOI 10.1111/j.1095-8312.1999.tb01162.x; VERSPOOR E, 1988, J FISH BIOL, V32, P327, DOI 10.1111/j.1095-8649.1988.tb05370.x; Verspoor E., 2007, ATLANTIC SALMON GENE; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Warnock WG, 2010, CONSERV GENET, V11, P1421, DOI 10.1007/s10592-009-9969-y; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wennevik V, 2004, ENVIRON BIOL FISH, V69, P143, DOI 10.1023/B:EBFI.0000022890.15512.29; Wilson AB, 2010, MOL ECOL, V19, P4535, DOI 10.1111/j.1365-294X.2010.04811.x; YOUNGSON AF, 1994, AQUACULTURE, V121, P259, DOI 10.1016/0044-8486(94)90025-6; YOUNGSON AF, 1992, J FISH BIOL, V40, P817, DOI 10.1111/j.1095-8649.1992.tb02628.x	98	19	20	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86809	10.1371/journal.pone.0086809	http://dx.doi.org/10.1371/journal.pone.0086809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498283	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900029
J	Shien, K; Tanaka, N; Watanabe, M; Soh, J; Sakaguchi, M; Matsuo, K; Yamamoto, H; Furukawa, M; Asano, H; Tsukuda, K; Nasu, Y; Huh, NH; Miyoshi, S; Kumon, H; Toyooka, S				Shien, Kazuhiko; Tanaka, Norimitsu; Watanabe, Masami; Soh, Junichi; Sakaguchi, Masakiyo; Matsuo, Keitaro; Yamamoto, Hiromasa; Furukawa, Masashi; Asano, Hiroaki; Tsukuda, Kazunori; Nasu, Yasutomo; Huh, Nam-Ho; Miyoshi, Shinichiro; Kumon, Hiromi; Toyooka, Shinichi			Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer	PLOS ONE			English	Article							METASTATIC PLEURAL EFFUSIONS; BETA GENE-TRANSFER; DOWN-REGULATION; TUMOR-GROWTH; OVEREXPRESSION; APOPTOSIS; MESOTHELIOMA; FIBROBLASTS; INHIBITION; ACTIVATION	Objectives: REIC/Dkk-3 is down-regulated in a broad range of human cancer cells and is considered to function as a tumor suppressor. We previously reported that REIC/Dkk-3-expressing adenovirus vector (Ad-REIC) induced endoplasmic reticulum (ER) stress and cancer-specific apoptosis in human prostate cancer. In this study, we examined the therapeutic impact of Ad-REIC on non-small cell lung cancer (NSCLC). Materials and Methods: We examined the anti-tumor effect of Ad-REIC on 25 NSCLC cell lines in vitro and A549 cells in vivo. Two of these cell lines were artificially established as EGFR-tyrosine kinase inhibitor (TKI) resistant sublines. Results: Ad-REIC-treatment inhibited the cell viability by 40% or more in 13 (52%) of the 25 cell lines at multiplicity of infection (MOI) of 20 (20 MOI). These cell lines were regarded as being highly sensitive cells. The cell viability of a nonmalignant immortalized cell line, OUMS-24, was not inhibited at 200 MOI of Ad-REIC. The effects of Ad-REIC on EGFR-TKI resistant sublines were equivalent to those in the parental cell lines. Here, we demonstrated that Ad-REIC treatment activated c-Jun N-terminal kinase (JNK) in NSCLC cell lines, indicating the induction of ER stress with GRP78/BiP (GRP78) up-regulation and resulting in apoptosis. A single intratumoral injection of Ad-REIC significantly inhibited the tumorigenic growth of A549 cells in vivo. As predictive factors of sensitivity for Ad-REIC treatment in NSCLC, we examined the expression status of GRP78 and coxsackievirus and adenovirus receptor (CAR). We found that the combination of the GRP78 and CAR expressional statuses may be used as a predictive factor for Ad-REIC sensitivity in NSCLC cells. Conclusion: Ad-REIC induced JNK activation and subsequent apoptosis in NSCLC cells. Our study indicated that Ad-REIC has therapeutic potential against NSCLC and that the expression statuses of GRP78 and CAR may predict a potential therapeutic benefit of Ad-REIC.	[Shien, Kazuhiko; Toyooka, Shinichi] Okayama Univ, Dept Clin Genom Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Shien, Kazuhiko; Tanaka, Norimitsu; Soh, Junichi; Yamamoto, Hiromasa; Furukawa, Masashi; Asano, Hiroaki; Tsukuda, Kazunori; Miyoshi, Shinichiro; Toyooka, Shinichi] Okayama Univ, Dept Thorac Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Watanabe, Masami; Nasu, Yasutomo; Kumon, Hiromi] Okayama Univ, Dept Urol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Watanabe, Masami] Okayama Univ Hosp, Ctr Gene & Cell Therapy, Okayama, Japan; [Watanabe, Masami; Kumon, Hiromi] Okayama Univ, Innovat Ctr Okayama NanobioTargeted Therapy ICONT, Okayama, Japan; [Sakaguchi, Masakiyo; Huh, Nam-Ho] Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka, Japan	Okayama University; Okayama University; Okayama University; Okayama University; Okayama University; Okayama University; Kyushu University	Toyooka, S (corresponding author), Okayama Univ, Dept Clin Genom Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	toyooka@md.okayama-u.ac.jp	Soh, Junichi/AAV-1053-2020; Soh, Junichi/AAT-7095-2021; Furukawa, Masashi/ABG-5947-2021; Tsukuda, Kazunori/AAY-2985-2020; Matsuo, Keitaro/H-6758-2019; Sakaguchi, Masakiyo/B-2280-2011; Shien, Kazuhiko/B-8560-2012	Soh, Junichi/0000-0001-8532-7915; Soh, Junichi/0000-0001-8532-7915; Furukawa, Masashi/0000-0001-8102-9072; Matsuo, Keitaro/0000-0003-1761-6314; Shien, Kazuhiko/0000-0002-4959-4220; Tsukuda, Kazunori/0000-0001-6293-1693				Abarzua F, 2005, CANCER RES, V65, P9617, DOI 10.1158/0008-5472.CAN-05-0829; BAI L, 1993, INT J CANCER, V53, P451, DOI 10.1002/ijc.2910530317; Edamura K, 2007, CANCER GENE THER, V14, P765, DOI 10.1038/sj.cgt.7701071; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kashiwakura Y, 2008, CANCER RES, V68, P8333, DOI 10.1158/0008-5472.CAN-08-0080; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kawasaki K, 2009, CANCER GENE THER, V16, P65, DOI 10.1038/cgt.2008.58; Kobayashi N, 2012, LUNG CANCER, V75, P161, DOI 10.1016/j.lungcan.2011.04.022; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Larsen JE, 2011, CANCER J, V17, P512, DOI 10.1097/PPO.0b013e31823e701a; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Oxnard GR, 2011, CLIN CANCER RES, V17, P6322, DOI 10.1158/1078-0432.CCR-11-1080; Sakaguchi M, 2009, J BIOL CHEM, V284, P14236, DOI 10.1074/jbc.M808002200; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Sterman DH, 2007, CLIN CANCER RES, V13, P4456, DOI 10.1158/1078-0432.CCR-07-0403; Sterman DH, 2010, MOL THER, V18, P852, DOI 10.1038/mt.2009.309; Sugimoto M, 2012, ONCOL REP, V28, P1645, DOI 10.3892/or.2012.2001; Tanimoto R, 2007, INT J MOL MED, V19, P363; Tokumo M, 2005, CLIN CANC RES; Tsuji T, 2000, BIOCHEM BIOPH RES CO, V268, P20, DOI 10.1006/bbrc.1999.2067; Watanabe M, 2009, INT J ONCOL, V34, P657, DOI 10.3892/ijo_00000191	25	21	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87900	10.1371/journal.pone.0087900	http://dx.doi.org/10.1371/journal.pone.0087900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498395	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900141
J	Wang, LR; Wei, XL; Wang, XL; Li, JS; Li, HX; Jia, W				Wang, Lirong; Wei, Xiaoli; Wang, Xueliang; Li, Jinsong; Li, Hengxin; Jia, Wei			Long-Term Effects of Methadone Maintenance Treatment with Different Psychosocial Intervention Models	PLOS ONE			English	Article							C VIRUS-INFECTION; INJECTION-DRUG USERS; HIV RISK BEHAVIOR; CONTINGENCY MANAGEMENT; TREATMENT CLINICS; HCV INFECTION; TREATMENT MMT; ABUSE; TRANSMISSION; PREVALENCE	This study evaluated the long-term effects of different psychosocial intervention models in methadone maintenance treatment (MMT) in Xi'an China. Patients from five MMT clinics were divided into three groups receiving MMT only, MMT with counseling psychology (CP) or MMT with contingency management (CM). A five-year follow-up was carried out with daily records of medication, monthly random urine morphine tests, and tests for anti-HIV and anti-HCV every six months. Drug use behavior was recorded six months after initial recruitment using a survey. Adjusted RRs and their 95% confidence intervals (CIs) were estimated using an unconditional logistic regression model or a Cox proportional hazard model. A total of 2662 patients were recruited with 797 in MMT, 985 in MMT with CP, and 880 in MMT with CM. Following six months of treatment, the injection rates of MMT with CP and MMT with CM groups were significantly lower than that of MMT (5.1% and 6.9% vs. 16.3%, chi(2) = 47.093 and 29.908, respectively; P<0.05). HIV incidences for MMT, MMT with CP and MMT with CM at the five year follow-up were 20.09, 0.00 and 10.02 per ten thousand person-years, respectively. HCV incidences were 18.35, 4.42 and 6.61 per hundred person-years, respectively, demonstrating that CP and CM were protective factors for HCV incidence (RR = 0.209 and 0.414, with range of 0.146 - 0.300 and 0.298 - 0.574, respectively). MMT supplemented with CP or CM can reduce heroin use and related risk behaviors, thereby reducing the incidence of HIV and HCV.	[Wang, Lirong; Wei, Xiaoli; Wang, Xueliang] Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian 710049, Shaanxi, Peoples R China; [Li, Jinsong; Li, Hengxin] Xian Ctr Dis Control & Prevent, Xian, Shaanxi, Peoples R China; [Jia, Wei] Xian Mental Hlth Ctr, Methadone Maintenance Therapy Clin, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Wang, XL (corresponding author), Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian 710049, Shaanxi, Peoples R China.	wangxl@mail.xjtu.edu.cn		Li, Heng Xin/0000-0002-5547-0080				Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Bao YP, 2010, CURR OPIN PSYCHIATR, V23, P187, DOI 10.1097/YCO.0b013e328338658b; Bao Yanping, 2009, HIV Therapy, V3, P237, DOI [10.2217/hiv.09.4, 10.2217/HIV.09.4]; CALSYN DA, 1994, J ADDICT DIS, V13, P47; Chawarski MC, 2011, DRUG ALCOHOL DEPEN, V115, P237, DOI 10.1016/j.drugalcdep.2010.09.024; Chu TX, 2005, CELL RES, V15, P865, DOI 10.1038/sj.cr.7290360; Chutuape MA, 1999, J SUBST ABUSE TREAT, V16, P23, DOI 10.1016/S0740-5472(97)00318-8; Commission NNC, 2012, NAT NARC CONTR COMM; CROFTS N, 1993, MED J AUSTRALIA, V159, P237, DOI 10.5694/j.1326-5377.1993.tb137822.x; Darke S, 2005, J SUBST ABUSE TREAT, V28, P255, DOI 10.1016/j.jsat.2005.01.006; Epstein DH, 2009, DRUG ALCOHOL DEPEN, V101, P92, DOI 10.1016/j.drugalcdep.2008.11.006; Fang YX, 2006, ACTA PHARMACOL SIN, V27, P140, DOI 10.1111/j.1745-7254.2006.00270.x; Gerra G, 2003, J SUBST ABUSE TREAT, V25, P1, DOI 10.1016/S0740-5472(03)00031-X; Gibson DR, 1999, AIDS, V13, P1807, DOI 10.1097/00002030-199910010-00002; Gossop M, 2002, AIDS CARE, V14, P77, DOI 10.1080/09540120220097955; Griffith JD, 2000, DRUG ALCOHOL DEPEN, V58, P55, DOI 10.1016/S0376-8716(99)00068-X; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; Hser YI, 2011, ADDICTION, V106, P1801, DOI 10.1111/j.1360-0443.2011.03490.x; Joseph H, 2000, MT SINAI J MED, V67, P347; Li L, 2012, CUMULATIVE NUMBER RE; Liu W, 2006, ADDICTION, V101, P1493, DOI 10.1111/j.1360-0443.2006.01557.x; Marsch LA, 1998, ADDICTION, V93, P515, DOI 10.1046/j.1360-0443.1998.9345157.x; MCLELLAN AT, 1993, JAMA-J AM MED ASSOC, V269, P1953, DOI 10.1001/jama.269.15.1953; Ministry of Health People's Republic of China, 2012, 2012 CHIN AIDS RESP; Ministry of Health PRC, 2013, 2012 NAT METH MAINT; O'Brien C P, 1995, NIDA Res Monogr, V150, P5; Office SCAWC, 2007, JOINT ASS HIV AIDS P; Pang L, 2007, AIDS, V21, pS103, DOI 10.1097/01.aids.0000304704.71917.64; Piane G, 2000, J PSYCHOACTIVE DRUGS, V32, P311, DOI 10.1080/02791072.2000.10400455; Preston KL, 2002, DRUG ALCOHOL DEPEN, V67, P125, DOI 10.1016/S0376-8716(02)00023-6; Qian HZ, 2008, J SUBST ABUSE TREAT, V34, P391, DOI 10.1016/j.jsat.2007.07.002; SAXON AJ, 1993, DRUG ALCOHOL DEPEN, V31, P205, DOI 10.1016/0376-8716(93)90002-8; Shi J, 2007, J ADDICT MED, V1, P186, DOI 10.1097/ADM.0b013e318156cc19; Sullivan LE, 2005, ADDICTION, V100, P150, DOI 10.1111/j.1360-0443.2004.00963.x; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Ward J, 1999, LANCET, V353, P221, DOI 10.1016/S0140-6736(98)05356-2; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; WOODY GE, 1995, AM J PSYCHIAT, V152, P1302; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xu HF, 2012, ADDICT BEHAV, V37, P657, DOI 10.1016/j.addbeh.2012.01.020; Yao Y, 2009, INT J INFECT DIS, V13, P154, DOI 10.1016/j.ijid.2008.05.1228; Yin Lu, 2007, Harm Reduct J, V4, P6, DOI 10.1186/1477-7517-4-6; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068906; Zhang Yan-hui, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P969; Zhao CZ, 2004, ANN NY ACAD SCI, V1025, P439, DOI 10.1196/annals.1316.054; Zhuang X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-130	48	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87931	10.1371/journal.pone.0087931	http://dx.doi.org/10.1371/journal.pone.0087931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302TD	24498406	gold, Green Submitted, Green Published			2022-12-25	WOS:000330626900152
J	Brooks, AN; Choi, PS; de Waal, L; Sharifnia, T; Imielinski, M; Saksena, G; Pedamallu, CS; Sivachenko, A; Rosenberg, M; Chmielecki, J; Lawrence, MS; DeLuca, DS; Getz, G; Meyerson, M				Brooks, Angela N.; Choi, Peter S.; de Waal, Luc; Sharifnia, Tanaz; Imielinski, Marcin; Saksena, Gordon; Pedamallu, Chandra Sekhar; Sivachenko, Andrey; Rosenberg, Mara; Chmielecki, Juliann; Lawrence, Michael S.; DeLuca, David S.; Getz, Gad; Meyerson, Matthew			A Pan-Cancer Analysis of Transcriptome Changes Associated with Somatic Mutations in U2AF1 Reveals Commonly Altered Splicing Events	PLOS ONE			English	Article							SITE RECOGNITION; RNA; QUANTIFICATION; IDENTIFICATION; GENES	Although recurrent somatic mutations in the splicing factor U2AF1 (also known as U2AF35) have been identified in multiple cancer types, the effects of these mutations on the cancer transcriptome have yet to be fully elucidated. Here, we identified splicing alterations associated with U2AF1 mutations across distinct cancers using DNA and RNA sequencing data from The Cancer Genome Atlas (TCGA). Using RNA-Seq data from 182 lung adenocarcinomas and 167 acute myeloid leukemias (AML), in which U2AF1 is somatically mutated in 3-4% of cases, we identified 131 and 369 splicing alterations, respectively, that were significantly associated with U2AF1 mutation. Of these, 30 splicing alterations were statistically significant in both lung adenocarcinoma and AML, including three genes in the Cancer Gene Census, CTNNB1, CHCHD7, and PICALM. Cell line experiments expressing U2AF1 S34F in HeLa cells and in 293T cells provide further support that these altered splicing events are caused by U2AF1 mutation. Consistent with the function of U2AF1 in 3' splice site recognition, we found that S34F/Y mutations cause preferences for CAG over UAG 3' splice site sequences. This report demonstrates consistent effects of U2AF1 mutation on splicing in distinct cancer cell types.	[Brooks, Angela N.; Choi, Peter S.; de Waal, Luc; Sharifnia, Tanaz; Imielinski, Marcin; Saksena, Gordon; Pedamallu, Chandra Sekhar; Sivachenko, Andrey; Rosenberg, Mara; Chmielecki, Juliann; Lawrence, Michael S.; DeLuca, David S.; Getz, Gad; Meyerson, Matthew] Broad Inst Harvard & Massachusetts Inst Technol, Canc Program, Cambridge, MA 02141 USA; [Brooks, Angela N.; Choi, Peter S.; de Waal, Luc; Sharifnia, Tanaz; Imielinski, Marcin; Pedamallu, Chandra Sekhar; Chmielecki, Juliann; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Meyerson, M (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Canc Program, Cambridge, MA 02141 USA.	matthew_meyerson@dfci.harvard.edu	Pedamallu, Chandra Sekhar/AAV-6723-2020; Pedamallu, Chandra Sekhar/AAV-6745-2020	Choi, Peter/0000-0002-2820-3032; Rosenberg, Mara/0000-0001-6400-3161; Meyerson, Matthew/0000-0002-9133-8108	National Institutes of Health [5U24CA143867-03]; American Cancer Society AstraZeneca Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [T32CA009216, U24CA143867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society AstraZeneca Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health Grant 5U24CA143867-03. ANB is a Merck Fellow of the Damon Runyon Cancer Research Foundation (DRG-2138-12). JC is supported by an American Cancer Society AstraZeneca Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mansouri L, 2013, AM J HEMATOL, V88, P647, DOI 10.1002/ajh.23466; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Motta-Mena LB, 2010, MOL CELL; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; Tavanez JP, 2012, MOL CELL, V45, P314, DOI 10.1016/j.molcel.2011.11.033; Przychodzen B, 2013, BLOOD, V122, P999, DOI 10.1182/blood-2013-01-480970; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Team RDC, 2010, R LANG ENV STAT COMP; Thiele A, 2006, EXP CELL RES, V312, P2367, DOI 10.1016/j.yexcr.2006.03.029; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243	34	114	126	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87361	10.1371/journal.pone.0087361	http://dx.doi.org/10.1371/journal.pone.0087361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498085	Green Submitted, gold, Green Published			2022-12-25	WOS:000330621900098
J	Howard, TP; Hayward, AP; Tordillos, A; Fragoso, C; Moreno, MA; Tohme, J; Kausch, AP; Mottinger, JP; Dellaporta, SL				Howard, Thomas P., III; Hayward, Andrew P.; Tordillos, Anthony; Fragoso, Christopher; Moreno, Maria A.; Tohme, Joe; Kausch, Albert P.; Mottinger, John P.; Dellaporta, Stephen L.			Identification of the Maize Gravitropism Gene lazy plant1 by a Transposon-Tagging Genome Resequencing Strategy	PLOS ONE			English	Article							ELEMENT SYSTEM; COPY NUMBER; NUCLEOTIDE-SEQUENCE; SHOOT GRAVITROPISM; READ ALIGNMENT; CLONING; INSERTION; LAZY1; MUTAGENESIS; ALLELE	Since their initial discovery, transposons have been widely used as mutagens for forward and reverse genetic screens in a range of organisms. The problems of high copy number and sequence divergence among related transposons have often limited the efficiency at which tagged genes can be identified. A method was developed to identity the locations of Mutator (Mu) transposons in the Zea mays genome using a simple enrichment method combined with genome resequencing to identify transposon junction fragments. The sequencing library was prepared from genomic DNA by digesting with a restriction enzyme that cuts within a perfectly conserved motif of the Mu terminal inverted repeats (TIR). Paired-end reads containing Mu TIR sequences were computationally identified and chromosomal sequences flanking the transposon were mapped to the maize reference genome. This method has been used to identify Mu insertions in a number of alleles and to isolate the previously unidentified lazy plant1 (la1) gene. The la1 gene is required for the negatively gravitropic response of shoots and mutant plants lack the ability to sense gravity. Using bioinformatic and fluorescence microscopy approaches, we show that the la1 gene encodes a cell membrane and nuclear localized protein. Our Mu-Taq method is readily adaptable to identify the genomic locations of any insertion of a known sequence in any organism using any sequencing platform.	[Howard, Thomas P., III; Hayward, Andrew P.; Tordillos, Anthony; Fragoso, Christopher; Moreno, Maria A.; Dellaporta, Stephen L.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Tohme, Joe] Ctr Int Agr Trop, Cali, Colombia; [Kausch, Albert P.; Mottinger, John P.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA	Yale University; Alliance; International Center for Tropical Agriculture - CIAT; University of Rhode Island	Dellaporta, SL (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	stephen.dellaporta@yale.edu		Howard, Thomas/0000-0002-3438-2831	National Science Foundation [0965420]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007056] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded by a grant to SLD, MAM and JT from the National Science Foundation (0965420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta IF, 2009, SCIENCE, V323, P262, DOI 10.1126/science.1164645; ALLEMAN M, 1986, GENETICS, V112, P107; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARKER RF, 1984, NUCLEIC ACIDS RES, V12, P5955, DOI 10.1093/nar/12.15.5955; Benito MI, 1997, MOL CELL BIOL, V17, P5165, DOI 10.1128/MCB.17.9.5165; BENNETZEN J L, 1984, Journal of Molecular and Applied Genetics, V2, P519; Bennetzen JL, 1996, CURR TOP MICROBIOL, V204, P195; BENNETZEN JL, 1993, CRIT REV PLANT SCI, V12, P57, DOI 10.1080/713608042; BENNETZEN JL, 1984, P NATL ACAD SCI-BIOL, V81, P4125, DOI 10.1073/pnas.81.13.4125; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; CHANDLER VL, 1992, ADV GENET, V30, P77, DOI 10.1016/S0065-2660(08)60319-3; CHEN CH, 1987, GENETICS, V116, P469; Chen J., 1993, MAIZE HAND BOOK, P526; CHOMET P, 1991, GENETICS, V129, P261; CRESSE AD, 1995, GENETICS, V140, P315; Darwin C, 1880, POWER MOVEMENT PLANT; DAS L, 1995, PLANT CELL, V7, P287, DOI 10.1105/tpc.7.3.287; Dietrich CR, 2002, GENETICS, V160, P697; Dong ZB, 2013, PLANT PHYSIOL, V163, P1306, DOI 10.1104/pp.113.227314; Fernandes J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r82; FLEENOR D, 1990, NUCLEIC ACIDS RES, V18, P6725, DOI 10.1093/nar/18.22.6725; Frey M, 1998, PLANT J, V13, P717, DOI 10.1046/j.1365-313X.1998.00091.x; Hanley S, 2000, PLANT J, V23, P557, DOI 10.1046/j.1365-313x.2000.00830.x; Hayward A, 2011, METHODS MOL BIOL, V678, P55, DOI 10.1007/978-1-60761-682-5_5; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Illumina, 2010, GEN SEQ; JAMES MG, 1993, PLANT MOL BIOL, V21, P1181, DOI 10.1007/BF00023614; Jenkins M., 1931, IOWA AGIC EXP STA RE, V138, P121; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Liu SZ, 2009, GENETICS, V183, P1215, DOI 10.1534/genetics.109.108936; May BP, 2003, P NATL ACAD SCI USA, V100, P11541, DOI 10.1073/pnas.1831119100; McCarty DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077172; McCarty DR, 2005, PLANT J, V44, P52, DOI 10.1111/j.1365-313X.2005.02509.x; MCLAUGHLIN M, 1987, GENETICS, V117, P771; Moreno MA, 1997, GENE DEV, V11, P616, DOI 10.1101/gad.11.5.616; OREILLY C, 1985, EMBO J, V4, P877, DOI 10.1002/j.1460-2075.1985.tb03713.x; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Pooma W, 2002, GENETICS, V161, P793; Project TUM, 2011, PROJ DOC PROT; Raizada MN, 2001, PLANT CELL, V13, P1587, DOI 10.1105/tpc.13.7.1587; Raizada MN, 2003, METH MOL B, V236, P37; ROBERTSON DS, 1978, MUTAT RES, V51, P21, DOI 10.1016/0027-5107(78)90004-0; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SCHNABLE PS, 1989, MOL GEN GENET, V217, P459, DOI 10.1007/BF02464917; Settles AM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-116; Settles AM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh052; Shafer J, 1939, BOT GAZ, V101, P68, DOI 10.1086/334851; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; TALBERT LE, 1989, J MOL EVOL, V29, P28, DOI 10.1007/BF02106179; Tan BC, 2011, G3-GENES GENOM GENET, V1, P293, DOI 10.1534/g3.111.000398; TAYLOR LP, 1987, GENETICS, V117, P297; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Van Overbeek J, 1938, J HERED, V29, P339, DOI 10.1093/oxfordjournals.jhered.a104536; van Overbeek J, 1936, J HERED, V29, P339; WALBOT V, 1988, MOL GEN GENET, V211, P27, DOI 10.1007/BF00338389; Walbot Virginia, 2002, P533; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Yoshihara T, 2013, PLANT J, V74, P267, DOI 10.1111/tpj.12118; Zhao XX, 2007, PLANT SCI, V172, P930, DOI 10.1016/j.plantsci.2007.01.002	68	12	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87053	10.1371/journal.pone.0087053	http://dx.doi.org/10.1371/journal.pone.0087053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498020	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900064
J	Otrelo-Cardoso, AR; Schwuchow, V; Rodrigues, D; Cabrita, EJ; Leimkuhler, S; Romao, MJ; Santos-Silva, T				Otrelo-Cardoso, Ana Rita; Schwuchow, Viola; Rodrigues, David; Cabrita, Eurico J.; Leimkuehler, Silke; Romao, Maria Joao; Santos-Silva, Teresa			Biochemical, Stabilization and Crystallization Studies on a Molecular Chaperone (PaoD) Involved in the Maturation of Molybdoenzymes	PLOS ONE			English	Article							MOLYBDENUM-COFACTOR; NITRATE REDUCTASE; NMR-SPECTROSCOPY; XANTHINE-OXIDASE; SULFITE OXIDASE; LIGAND-BINDING; IONIC LIQUIDS; STD-NMR; XDHC; INSERTION	Molybdenum and tungsten enzymes require specific chaperones for folding and cofactor insertion. PaoD is the chaperone of the periplasmic aldehyde oxidoreductase PaoABC. It is the last gene in the paoABCD operon in Escherichia coli and its presence is crucial for obtaining mature enzyme. PaoD is an unstable, 35 kDa, protein. Our biochemical studies showed that it is a dimer in solution with a tendency to form large aggregates, especially after freezing/thawing cycles. In order to improve stability, PaoD was thawed in the presence of two ionic liquids [C(4)mim]Cl and [C(2)OHmim]PF6 and no protein precipitation was observed. This allowed protein concentration and crystallization using polyethylene glycol or ammonium sulfate as precipitating agents. Saturation transfer difference - nuclear magnetic resonance (STD-NMR) experiments have also been performed in order to investigate the effect of the ionic liquids in the stabilization process, showing a clear interaction between the acidic ring protons of the cation and, most likely, negatively charged residues at the protein surface. DLS assays also show a reduction of the overall size of the protein aggregates in presence of ionic liquids. Furthermore, cofactor binding studies on PaoD showed that the protein is able to discriminate between molybdenum and tungsten bound to the molybdenum cofactor, since only a Mo-MPT form of the cofactor remained bound to PaoD.	[Otrelo-Cardoso, Ana Rita; Rodrigues, David; Cabrita, Eurico J.; Romao, Maria Joao; Santos-Silva, Teresa] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, REQUIMTE, Caparica, Portugal; [Schwuchow, Viola; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Golm, Germany	Universidade Nova de Lisboa; University of Potsdam	Santos-Silva, T (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, REQUIMTE, Caparica, Portugal.	tsss@fct.unl.pt	Cabrita, Eurico/E-8053-2011; Santos-Silva, Teresa/D-2050-2013; Romao, Maria J/A-4115-2013; UCIBIO, U Cienc Biom Apl/F-7948-2017; Otrelo-Cardoso, Ana Rita/L-9116-2013; Santos-Silva, Teresa/AAE-1795-2019	Cabrita, Eurico/0000-0002-0720-2751; Santos-Silva, Teresa/0000-0003-3060-8378; Romao, Maria J/0000-0002-3004-0543; UCIBIO, U Cienc Biom Apl/0000-0002-3004-0543; Otrelo-Cardoso, Ana Rita/0000-0003-2606-9367; Santos-Silva, Teresa/0000-0003-3060-8378; Leimkuhler, Silke/0000-0003-3238-2122	Fundacao para a Ciencia e a Tecnologia [PEst-C/EQB/LA0006/2013, PTDC/BIAPRO/118377/2010]; Deutsche Forschungsgemeinschaft [Le1171/6-1]; Deutscher Akademischer Austauschdienst Programm-GRICES program; Fundacao para a Ciencia e Tecnologia [RECI/BBB-BQB/0230/2012];  [DAAD-441.00]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst Programm-GRICES program(Deutscher Akademischer Austausch Dienst (DAAD)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); 	This work has been supported by Fundacao para a Ciencia e a Tecnologia (http://www.fct.unl.pt/) through grant no. PEst-C/EQB/LA0006/2013 and project PTDC/BIAPRO/118377/2010 and Deutsche Forschungsgemeinschaft Grant (http://www.dfg.de/en/index.jsp) Le1171/6-1 (to S. L.). The exchange of researchers among laboratories involved in the work was funded by the Deutscher Akademischer Austauschdienst Programm-GRICES program (https://www.daad.de/de/index.html) and the bilateral agreement DAAD-441.00, 2013-2014. The NMR spectrometers are part of the National NMR Network (RNRMN) and are funded by Fundacao para a Ciencia e Tecnologia (RECI/BBB-BQB/0230/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brondino CD, 2006, CURR OPIN CHEM BIOL, V10, P109, DOI 10.1016/j.cbpa.2006.01.034; Byrne N, 2008, J MOL BIOL, V378, P707, DOI 10.1016/j.jmb.2008.02.050; Coelho C, 2010, J CRYST GROWTH, V312, P714, DOI 10.1016/j.jcrysgro.2009.11.060; Coughlan M. P., 1980, Molybdenum and molybdenum-containing enzymes, P119; Endres F, 2010, PHYS CHEM CHEM PHYS, V12, P1648, DOI 10.1039/c001176m; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Figueiredo AM, 2013, PHYS CHEM CHEM PHYS, V15, P19632, DOI 10.1039/c3cp53395f; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Iobbi-nivol C, 2012, BIOCH BIOPHYS ACTA; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Ji ZS, 2009, ANAL BIOCHEM, V385, P380, DOI 10.1016/j.ab.2008.11.022; JOHNSON JL, 1980, J BIOL CHEM, V255, P1783; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; Kowacz M, 2012, CRYSTENGCOMM, V14, P4912, DOI 10.1039/c2ce25129a; Leimkuhler S, 1999, J BACTERIOL, V181, P2745; Leslie A. G. W.., 1992, PROTEIN CRYSTALLOGR, V26; Mann JP, 2009, GREEN CHEM, V11, P785, DOI 10.1039/b900021f; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Neumann M, 2011, BIOCH RES INT, V2011; Neumann M, 2007, J BIOL CHEM, V282, P28493, DOI 10.1074/jbc.M704020200; Neumann M, 2007, BIOCHEMISTRY-US, V46, P9586, DOI 10.1021/bi700630p; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Neumann M, 2011, J BIOL CHEM, V286, P1400, DOI 10.1074/jbc.M110.155671; Neumann M, 2009, J BIOL CHEM, V284, P21891, DOI 10.1074/jbc.M109.008565; Neumann M, 2009, FEBS J, V276, P2762, DOI 10.1111/j.1742-4658.2009.07000.x; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Viegas A, 2011, J CHEM EDUC, V88, P990, DOI 10.1021/ed101169t; Yuan Y, 2005, BIOCHEMISTRY-US, V44, P14080, DOI 10.1021/bi0513406	32	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87295	10.1371/journal.pone.0087295	http://dx.doi.org/10.1371/journal.pone.0087295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498065	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900083
J	Xu, HG; Dong, XJ; Ai, QH; Mai, KS; Xu, W; Zhang, YJ; Zuo, RT				Xu, Houguo; Dong, Xiaojing; Ai, Qinghui; Mai, Kangsen; Xu, Wei; Zhang, Yanjiao; Zuo, Rantao			Regulation of Tissue LC-PUFA Contents, D6 Fatty Acyl Desaturase (FADS2) Gene Expression and the Methylation of the Putative FADS2 Gene Promoter by Different Dietary Fatty Acid Profiles in Japanese Seabass (Lateolabrax japonicus)	PLOS ONE			English	Article							SALMON SALMO-SALAR; PARR-SMOLT TRANSFORMATION; ATLANTIC SALMON; DICENTRARCHUS-LABRAX; FISH-OIL; DELTA-6 DESATURASE; VEGETABLE-OIL; STEARIDONIC ACID; SPARUS-AURATA; MARINE FISH	The present study was conducted to evaluate the influences of different dietary fatty acid profiles on the tissue content and biosynthesis of LC-PUFA in a euryhaline species Japanese seabass reared in seawater. Six diets were prepared, each with a characteristic fatty acid:Diet PA:Palmitic acid (C16:0); Diet SA:Stearic acid (C18:0); Diet OA:Oleic acid (C18:1n-9); Diet LNA: a-linolenic acid (C18:3n-3); Diet N-3 LC-PUFA:n-3 LC-PUFA (DHA+EPA); Diet FO:the fish oil control. A 10-week feeding trial was conducted using juvenile fish (29.5360.86 g). The results showed that Japanese seabass had limited capacity to synthesize LC-PUFA and fish fed PA, SA, OA and LNA showed significantly lower tissue n-3 LC-PUFA contents compared to fish fed N-3 LC-PUFA and FO. The putative gene promoter and full-length cDNA of FADS2 was cloned and characterized. The protein sequence was confirmed to be homologous to FADS2s of marine teleosts and possessed all the characteristic features of microsomal fatty acid desaturases. The FADS2 transcript levels in liver of fish fed N-3 LC-PUFA and FO were significantly lower than those in fish fed other diets except LNA while Diet PA significantly up-regulated the FADS2 gene expression compared to Diet LNA, N-3 LC-PUFA and FO. Inversely, fish fed N-3 LC-PUFA and FO showed significantly higher promoter methylation rates of FADS2 gene compared to fish fed the LC-PUFA deficient diets. These results suggested that Japanese seabass had low LC-PUFA synthesis capacity and LC-PUFA deficient diets caused significantly reduced tissue n-3 LC-PUFA contents. The liver gene expression of FADS2 was up-regulated in groups enriched in C16:0, C18:0 and C18:1n-9 respectively but not in the group enriched in C18:3n-3 compared to groups with high n-3 LC-PUFA contents. The FADS2 gene expression regulated by dietary fatty acids was significantly negatively correlated with the methylation rate of putative FADS2 gene promoter.	[Xu, Houguo; Dong, Xiaojing; Ai, Qinghui; Mai, Kangsen; Xu, Wei; Zhang, Yanjiao; Zuo, Rantao] Ocean Univ China, Key Lab Aquaculture Nutr & Feed, Minist Agr, Qingdao, Peoples R China; [Xu, Houguo; Dong, Xiaojing; Ai, Qinghui; Mai, Kangsen; Xu, Wei; Zhang, Yanjiao; Zuo, Rantao] Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao, Peoples R China; [Xu, Houguo] Chinese Minist Agr Sustainable Utilizat Marine Fi, Key Lab, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Zuo, Rantao] Dalian Ocean Univ, Key Lab Mariculture & Stock Enhancement North Chi, Minist Agr, Dalian, Peoples R China	Ministry of Agriculture & Rural Affairs; Ocean University of China; Ocean University of China; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Dalian Ocean University; Ministry of Agriculture & Rural Affairs	Ai, QH (corresponding author), Ocean Univ China, Key Lab Aquaculture Nutr & Feed, Minist Agr, Qingdao, Peoples R China.	qhai@ouc.edu.cn	Zhang, Yanjiao/AID-6801-2022; Xu, Houguo/AAF-3014-2019	Zhang, Yanjiao/0000-0002-7471-9021; Xu, Houguo/0000-0002-1000-9928	Program for New Century Excellent Talents in University [NCET-07-0776]; National Nature Foundation of China [31001115]; National Key Technologies R&D Program for the 11th Five-year Plan of China [2006BAD03B03]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Nature Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for the 11th Five-year Plan of China(National Key Technology R&D Program)	This work was supported by the Program for New Century Excellent Talents in University (NCET-07-0776), the National Nature Foundation of China (31001115), and the National Key Technologies R&D Program for the 11th Five-year Plan of China (2006BAD03B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaida-Pagan R, 2007, AQUACULTURE, V272, P589, DOI 10.1016/j.aquaculture.2007.08.017; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Bell JG, 2002, J NUTR, V132, P222, DOI 10.1093/jn/132.2.222; Bell JG, 1997, LIPIDS, V32, P515, DOI 10.1007/s11745-997-0066-4; Bell JG, 2001, J NUTR, V131, P1535, DOI 10.1093/jn/131.5.1535; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; Bozza PT, 2012, PLOS ONE, V7; Ceccarelli V, 2011, J BIOL CHEM, V286, P27092, DOI 10.1074/jbc.M111.253609; CHRISTIANSEN EN, 1991, BIOCHIM BIOPHYS ACTA, V1082, P57, DOI 10.1016/0005-2760(91)90299-W; Codabaccus BM, 2011, AQUACULTURE, V322, P65, DOI 10.1016/j.aquaculture.2011.09.014; Devlin AM, 2007, J BIOL CHEM, V282, P37082, DOI 10.1074/jbc.M704256200; Fonseca-Madrigal J, 2006, FISH PHYSIOL BIOCHEM, V32, P317, DOI 10.1007/s10695-006-9109-2; Francis DS, 2007, J AGR FOOD CHEM, V55, P1582, DOI 10.1021/jf062153x; Geay F, 2010, COMP BIOCHEM PHYS B, V156, P237, DOI 10.1016/j.cbpb.2010.03.008; Geay F, 2012, MAR GENOM, V5, P7, DOI 10.1016/j.margen.2011.08.003; Ghioni C, 1999, BBA-MOL CELL BIOL L, V1437, P170, DOI 10.1016/S1388-1981(99)00010-4; Gonzalez-Rovira A, 2009, AQUACULTURE, V298, P90, DOI 10.1016/j.aquaculture.2009.10.012; Hoile SP, 2013, J NUTR BIOCHEM, V24, P1213, DOI 10.1016/j.jnutbio.2012.09.005; HORROBIN DF, 1991, PROSTAG LEUKOTR ESS, V44, P127, DOI 10.1016/0952-3278(91)90196-C; Howe PRC, 2002, LIPIDS, V37, P1067, DOI 10.1007/s11745-002-1002-3; Izquierdo MS, 2008, FISH PHYSIOL BIOCHEM, V34, P117, DOI 10.1007/s10695-007-9152-7; Juliano RA, 2004, INT C, V1262, P55; Li YY, 2008, COMP BIOCHEM PHYS B, V151, P183, DOI 10.1016/j.cbpb.2008.06.013; Lindi V, 2003, MOL GENET METAB, V79, P52, DOI 10.1016/S1096-7192(03)00065-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLaren LA, 2006, DOMEST ANIM ENDOCRIN, V30, P155, DOI 10.1016/j.domaniend.2005.07.003; Miller MR, 2007, COMP BIOCHEM PHYS B, V146, P197, DOI 10.1016/j.cbpb.2006.10.099; Mourente G, 2005, AQUACULTURE, V248, P173, DOI 10.1016/j.aquaculture.2005.04.023; Mourente G, 1999, AQUACULTURE, V179, P291, DOI 10.1016/S0044-8486(99)00166-0; Moya-Falcon C, 2006, COMP BIOCHEM PHYS B, V145, P68, DOI 10.1016/j.cbpb.2006.06.004; Nakamura MT, 2002, BIOCHEM SOC T, V30, P1076, DOI 10.1042/BST0301076; Nakamura MT, 2003, PROSTAG LEUKOTR ESS, V68, P145, DOI 10.1016/S0952-3278(02)00264-8; Nara TY, 2002, BIOCHEM BIOPH RES CO, V296, P111, DOI 10.1016/S0006-291X(02)00851-3; OWEN JM, 1975, LIPIDS, V10, P528, DOI 10.1007/BF02532354; Padley F. B., 1986, LIPID HDB, P49; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Ruyter B, 1997, BBA-LIPID LIPID MET, V1348, P331, DOI 10.1016/S0005-2760(97)00080-5; Ruyter B, 2000, FISH PHYSIOL BIOCHEM, V23, P151, DOI 10.1023/A:1007893317923; Seiliez I, 2003, COMP BIOCHEM PHYS B, V135, P449, DOI 10.1016/S1096-4959(03)00111-8; Sioutis S, 2008, EUR J LIPID SCI TECH, V110, P701, DOI 10.1002/ejlt.200700253; Stubhaug I, 2005, BBA-MOL CELL BIOL L, V1734, P277, DOI 10.1016/j.bbalip.2005.04.003; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Thomassen MS, 2012, AQUACULTURE, V360, P78, DOI 10.1016/j.aquaculture.2012.07.001; Tidwell JH, 2001, EMBO REP, V2, P958, DOI 10.1093/embo-reports/kve236; Tocher DR, 2006, LIPIDS, V41, P1003, DOI 10.1007/s11745-006-5051-4; Tocher DR, 2006, COMP BIOCHEM PHYS B, V144, P245, DOI 10.1016/j.cbpb.2006.03.001; Tocher DR, 2000, FISH PHYSIOL BIOCHEM, V23, P59, DOI 10.1023/A:1007807201093; Tocher DR, 2003, FISH PHYSIOL BIOCHEM, V29, P193, DOI 10.1023/B:FISH.0000045722.44186.ee; Tocher DR, 2002, FISH PHYSIOL BIOCHEM, V26, P157, DOI 10.1023/A:1025416731014; Tocher DR, 2001, COMP BIOCHEM PHYS B, V130, P257, DOI 10.1016/S1096-4959(01)00429-8; Tocher DR, 2003, LIPIDS, V38, P723, DOI 10.1007/s11745-003-1120-y; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Tocher DR, 1999, LIPIDS, V34, P433, DOI 10.1007/s11745-999-0382-8; Tu WC, 2013, COMP BIOCHEM PHYS B, V164, P29, DOI 10.1016/j.cbpb.2012.10.001; Vagner M, 2007, AQUACULTURE, V267, P165, DOI 10.1016/j.aquaculture.2007.01.031; Vagner M, 2007, AQUACULTURE, V266, P179, DOI 10.1016/j.aquaculture.2007.02.040; Vagner M, 2011, AQUACULTURE, V315, P131, DOI 10.1016/j.aquaculture.2010.11.031; Wang SY, 2008, FISHERIES SCI, V74, P853, DOI 10.1111/j.1444-2906.2008.01599.x; Zheng XZ, 2009, COMP BIOCHEM PHYS B, V154, P255, DOI 10.1016/j.cbpb.2009.06.010; Zheng XZ, 2009, AQUACULTURE, V290, P122, DOI 10.1016/j.aquaculture.2009.02.010; Zheng XZ, 2005, BBA-MOL CELL BIOL L, V1734, P13, DOI 10.1016/j.bbalip.2005.01.006; Zheng XZ, 2005, LIPIDS, V40, P13, DOI 10.1007/s11745-005-1355-7	64	54	56	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87726	10.1371/journal.pone.0087726	http://dx.doi.org/10.1371/journal.pone.0087726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498178	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900161
J	Glouzon, JPS; Bolduc, F; Wang, SR; Najmanovich, RJ; Perreault, JP				Glouzon, Jean-Pierre Sehi; Bolduc, Francois; Wang, Shengrui; Najmanovich, Rafael J.; Perreault, Jean-Pierre			Deep-Sequencing of the Peach Latent Mosaic Viroid Reveals New Aspects of Population Heterogeneity	PLOS ONE			English	Article							RNA; CLEAVAGE; MUTATION; VIRUS	Viroids are small circular single-stranded infectious RNAs characterized by a relatively high mutation level. Knowledge of their sequence heterogeneity remains largely elusive and previous studies, using Sanger sequencing, were based on a limited number of sequences. In an attempt to address sequence heterogeneity from a population dynamics perspective, a GF305-indicator peach tree was infected with a single variant of the Avsunviroidae family member Peach latent mosaic viroid (PLMVd). Six months post-inoculation, full-length circular conformers of PLMVd were isolated and deep-sequenced. We devised an original approach to the bioinformatics refinement of our sequence libraries involving important phenotypic data, based on the systematic analysis of hammerhead self-cleavage activity. Two distinct libraries yielded a total of 3,939 different PLMVd variants. Sequence variants exhibiting up to similar to 17% of mutations relative to the inoculated viroid were retrieved, clearly illustrating the high level of divergence dynamics within a unique population. While we initially assumed that most positions of the viroid sequence would mutate, we were surprised to discover that similar to 50% of positions remained perfectly conserved, including several small stretches as well as a small motif reminiscent of a GNRA tetraloop which are the result of various selective pressures. Using a hierarchical clustering algorithm, the different variants harvested were subdivided into 7 clusters. We found that most sequences contained an average of 4.6 to 6.4 mutations compared to the variant used to initially inoculate the plant. Interestingly, it was possible to reconstitute and compare the sequence evolution of each of these clusters. In doing so, we identified several key mutations. This study provides a reliable pipeline for the treatment of viroid deep-sequencing. It also sheds new light on the extent of sequence variation that a viroid population can sustain, and which may give rise to a quasispecies.	[Glouzon, Jean-Pierre Sehi; Wang, Shengrui] Univ Sherbrooke, Fac Sci, Dept Informat, Sherbrooke, PQ J1K 2R1, Canada; [Glouzon, Jean-Pierre Sehi; Bolduc, Francois; Najmanovich, Rafael J.; Perreault, Jean-Pierre] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke	Najmanovich, RJ (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Pavillon Rech Appl Canc, Sherbrooke, PQ J1K 2R1, Canada.	Rafael.Najmanovich@usherbrooke.ca; Jean-Pierre.Perreault@usherbrooke.ca		Najmanovich, Rafael/0000-0002-6971-7224	Fonds de Recherche du Quebec en Sante (FRQ-S); Natural Sciences and Engineering Research Council of Canada [396097-2010]	Fonds de Recherche du Quebec en Sante (FRQ-S); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	R.J.N. is part of Centre de Recherche Clinique Etienne-Le Bel, a member of the Institute of Pharmacology of Sherbrooke, PROTEO(the Quebec network for research on protein function, structure and engineering), GRASP (Groupe de Recherche Axe sur la Structure des Proteines) and is the recipient of a Junior I Researcher fellowship from the Fonds de Recherche du Quebec en Sante (FRQ-S). S. W. was partly funded by the Discovery Accelerator Supplements grant of Natural Sciences and Engineering Research Council of Canada (No. 396097-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros S, 1999, J GEN VIROL, V80, P2239, DOI 10.1099/0022-1317-80-8-2239; Ambros S, 1998, J VIROL, V72, P7397; Ambros S, 1998, NUCLEIC ACIDS RES, V26, P1877, DOI 10.1093/nar/26.8.1877; Bicego M, 2003, LECT NOTES ARTIF INT, V2734, P86; Bussiere F, 2000, J VIROL, V74, P2647, DOI 10.1128/JVI.74.6.2647-2654.2000; Codoner FM, 2006, PLOS PATHOG, V2, P1187, DOI 10.1371/journal.ppat.0020136; Daros JA, 2004, P NATL ACAD SCI USA, V101, P6792, DOI 10.1073/pnas.0401090101; DIENER TO, 1971, VIROLOGY, V45, P411, DOI 10.1016/0042-6822(71)90342-4; Ding B, 2009, ANNU REV PHYTOPATHOL, V47, P105, DOI 10.1146/annurev-phyto-080508-081927; Dube A, 2011, MOL PLANT PATHOL, V12, P688, DOI 10.1111/J.1364-3703.2010.00703.X; Gago S, 2009, SCIENCE, V323, P1308, DOI 10.1126/science.1169202; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Greenacre M., 2006, MULTIPLE CORRES ANAL, DOI DOI 10.1201/9781420011319.CH1; Hassen IF, 2007, VIROLOGY, V360, P50, DOI 10.1016/j.virol.2006.10.021; HERTEL KJ, 1992, NUCLEIC ACIDS RES, V20, P3252, DOI 10.1093/nar/20.12.3252; Matousek J, 2004, VIROLOGY, V323, P9, DOI 10.1016/j.virol.2004.02.010; Navarro B, 2012, PLANT J, V70, P991, DOI 10.1111/j.1365-313X.2012.04940.x; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Pelchat M, 2002, BIOCHEMISTRY-US, V41, P6561, DOI 10.1021/bi025595k; Perreault J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002031; Przybilski R, 2007, BIOL CHEM, V388, P737, DOI 10.1515/BC.2007.065; Rocheleau L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-24; Shimura H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002021; Skums P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S6; Takeda R, 2011, PLANT CELL, V23, P258, DOI 10.1105/tpc.110.081414; Tengke Xiong, 2011, Proceedings of the 2011 IEEE 11th International Conference on Data Mining (ICDM 2011), P854, DOI 10.1109/ICDM.2011.13; Vrancken B, 2010, AIDS REV, V12, P89; Wang MB, 2004, P NATL ACAD SCI USA, V101, P3275, DOI 10.1073/pnas.0400104101; Xiong TK, 2009, IEEE DATA MINING, P1058, DOI 10.1109/ICDM.2009.118; Yang J, 2003, PROC INT CONF DATA, P101, DOI 10.1109/ICDE.2003.1260785; Yang J, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P175, DOI 10.1109/CSB.2002.1039340; Zhong XH, 2008, PLANT CELL, V20, P35, DOI 10.1105/tpc.107.056606	33	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87297	10.1371/journal.pone.0087297	http://dx.doi.org/10.1371/journal.pone.0087297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498066	gold, Green Submitted, Green Published			2022-12-25	WOS:000330617100074
J	Huang, YK; Lee, WF; Wang, MJ; Chang, YHS; Tchaou, WS; Chang, WJ; Lee, SY; Sheu, JR; Teng, NC				Huang, Yung-Kai; Lee, Wei-Fang; Wang, Meng-Jiy; Chang, Yus-Han Sophie; Tchaou, Wen-Shiun; Chang, Wei-Jen; Lee, Sheng-Yang; Sheu, Joen-Rong; Teng, Nai-Chia			Chair-Side Quantitative Oral-Microflora Screening for Assessing Familial Correlation of Periodontal Status and Caries Prevalence	PLOS ONE			English	Article							MUTANS STREPTOCOCCI; DENTAL-CARIES; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PORPHYROMONAS-GINGIVALIS; CHILDREN; PLAQUE; TRANSMISSION; SUBGINGIVAL; HEALTH; RISK	Aim: Our goal was to investigate the relationship between clinical status and the presence of carious or periodontal pathogens among parent-child familial pairs. Clinical practices of risk assessment with consideration of familial pathogen interaction might reduce the need for therapy, improve patient outcomes, and ultimately reduce oral disease burden. Materials and Methods: In this study, we enrolled 30 parent-child pairs, with the children exhibiting complete deciduous dentition or mixed dentition with only permanent first molars. Clinical statuses were evaluated using caries and periodontal disease indicators, including the sum of decay and the number of missing or filled teeth (DMFT) for adults, decay, extraction caused by dental disease, and filled teeth (deft), for children, probing depth, and plaque control record (PCR). Supra-and sub-gingival bacteria were determined based on semi-quantitative measurements of microbial infection by using data from the Dentocult (R) SM test (caries-related organisms) and the PerioCheck (R) test (periodontal disease-related organisms). Results: No statistically significant relationship was detected between the prevalence of periodontal pathogens and that of cariogenic pathogens in the oral cavity. However, the clinical status of caries (DMFT) was negatively correlated with the clinical status of periodontal disease (pocket depth) in parents who were infected with dominant periodontal pathogens (r = 20.59, p<0.01). Parents' DMFT scores were positively correlated with children's deft and PCR scores. PCR and deft scores of children appeared to decrease significantly with the parent's pocket depth. Conclusion: The study showed that the quantity of caries pathogens were not significant related to periodontal pathogens, but the caries clinical outcome is negative related with periodontal clinical outcome between familial pairs.	[Huang, Yung-Kai] Taipei Med Univ, Sch Oral Hyg, Coll Oral Med, Taipei, Taiwan; [Lee, Wei-Fang] Taipei Med Univ, Sch Dent Technol, Coll Oral Med, Taipei, Taiwan; [Wang, Meng-Jiy] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei, Taiwan; [Chang, Yus-Han Sophie; Tchaou, Wen-Shiun; Teng, Nai-Chia] Taipei Med Univ Hosp, Div Oral Rehabil, Dept Dent, Taipei, Taiwan; [Chang, Yus-Han Sophie; Tchaou, Wen-Shiun; Teng, Nai-Chia] Taipei Med Univ Hosp, Ctr Pediat Dent, Dept Dent, Taipei, Taiwan; [Chang, Wei-Jen; Lee, Sheng-Yang; Teng, Nai-Chia] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan; [Lee, Sheng-Yang] Taipei Med Univ, Dept Dent, Wan Fang Hosp, Taipei, Taiwan; [Sheu, Joen-Rong] Taipei Med Univ, Dept Pharmacol, Sch Med, Coll Med, Taipei, Taiwan; [Sheu, Joen-Rong] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; National Taiwan University of Science & Technology; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University	Teng, NC (corresponding author), Taipei Med Univ Hosp, Div Oral Rehabil, Dept Dent, Taipei, Taiwan.	dianaten@tmu.edu.tw	Huang, Yung-Kai/C-7868-2012	Huang, Yung-Kai/0000-0002-4467-0300	Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program [TMU-NTUST-100-01]	Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program	This study was supported by a research grant from the Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program (TMU-NTUST-100-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asikainen S, 1996, ORAL MICROBIOL IMMUN, V11, P387, DOI 10.1111/j.1399-302X.1996.tb00200.x; Bowen WH, 2002, CRIT REV ORAL BIOL M, V13, P126, DOI 10.1177/154411130201300203; BOWERS J E, 1989, Journal of Clinical Dentistry, V1, P106; Dalwai F, 2007, J CLIN MICROBIOL, V45, P3072, DOI 10.1128/JCM.01131-07; Dogan B, 2008, J PERIODONTOL, V79, P307, DOI [10.1902/jop.2008.070270, 10.1902/jop.2008.070270 ]; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; ELEY BM, 1995, BRIT DENT J, V178, P133, DOI 10.1038/sj.bdj.4808681; Ezzo PJ, 2003, PERIODONTOL 2000, V32, P24, DOI 10.1046/j.0906-6713.2003.03203.x; FIEHN NE, 1992, J PERIODONTAL RES, V27, P609, DOI 10.1111/j.1600-0765.1992.tb01744.x; Haffajee AD, 1994, PERIODONTOL, V5, P78, DOI DOI 10.1111/J.1600-0757.1994.TB00020.X; HASSELL TM, 1995, CRIT REV ORAL BIOL M, V6, P319, DOI 10.1177/10454411950060040401; Hemmings KW, 1997, J CLIN PERIODONTOL, V24, P110, DOI 10.1111/j.1600-051X.1997.tb00475.x; HILLMAN JD, 1985, ARCH ORAL BIOL, V30, P791, DOI 10.1016/0003-9969(85)90133-5; Iwano Y, 2010, J PERIODONTAL RES, V45, P165, DOI 10.1111/j.1600-0765.2009.01213.x; Karjalainen S, 2004, ACTA ODONTOL SCAND, V62, P153, DOI 10.1080/00016350410001559; KONONEN E, 1994, ORAL MICROBIOL IMMUN, V9, P310, DOI 10.1111/j.1399-302X.1994.tb00077.x; Kuramitsu HK, 2003, CRIT REV ORAL BIOL M, V14, P331, DOI 10.1177/154411130301400504; Lee Y, 2006, J DENT RES, V85, P182, DOI 10.1177/154405910608500213; Loesche W, 2007, INFECT DIS CLIN N AM, V21, P471, DOI 10.1016/j.idc.2007.03.006; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; LOESCHE WJ, 1985, J PERIODONTOL, V56, P447, DOI 10.1902/jop.1985.56.8.447; Morinushi T, 2000, J PERIODONTOL, V71, P403, DOI 10.1902/jop.2000.71.3.403; Olak J, 2007, INT J PAEDIATR DENT, V17, P92, DOI 10.1111/j.1365-263X.2006.00788.x; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; PIENIHAKKINEN K, 1995, EUR J ORAL SCI, V103, P61, DOI 10.1111/j.1600-0722.1995.tb00012.x; Quirynen M, 1999, J CLIN PERIODONTOL, V26, P322, DOI 10.1034/j.1600-051X.1999.260511.x; RUDNEY JD, 1994, ARCH ORAL BIOL, V39, P513, DOI 10.1016/0003-9969(94)90148-1; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Sheiham A, 2000, COMMUNITY DENT ORAL, V28, P399, DOI 10.1034/j.1600-0528.2000.028006399.x; Tanner ACR, 2006, J DENT RES, V85, P318, DOI 10.1177/154405910608500407; Thenisch NL, 2006, CARIES RES, V40, P366, DOI 10.1159/000094280; Tomas I, 2012, J CLIN PERIODONTOL, V39, P213, DOI 10.1111/j.1600-051X.2011.01784.x; van der Reijden WA, 2001, J CLIN PERIODONTOL, V28, P686, DOI 10.1034/j.1600-051x.2001.028007686.x; van Loveren C, 2000, CARIES RES, V34, P481, DOI 10.1159/000016627; WATSON MR, 1991, J DENT RES, V70, P1052, DOI 10.1177/00220345910700070701; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th	36	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87100	10.1371/journal.pone.0087100	http://dx.doi.org/10.1371/journal.pone.0087100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498022	gold, Green Published, Green Submitted			2022-12-25	WOS:000330617100048
J	Li, YW; Wang, JX; Yin, X; Qiu, SJ; Wu, H; Liao, R; Yi, Y; Xiao, YS; Zhou, J; Zhang, BH; Fan, J				Li, Yi-Wei; Wang, Jia-Xing; Yin, Xin; Qiu, Shuang-Jian; Wu, Han; Liao, Rui; Yi, Yong; Xiao, Yong-Sheng; Zhou, Jian; Zhang, Bo-Heng; Fan, Jia			Decreased Expression of GATA2 Promoted Proliferation, Migration and Invasion of HepG2 In Vitro and Correlated with Poor Prognosis of Hepatocellular Carcinoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-2; GENE-EXPRESSION; GUT ENDODERM; LEUKEMIA; CANCER; REPAIR; ERCC1; HYPERMETHYLATION; DIFFERENTIATION; OVEREXPRESSION	Background: GATA family of transcription factors are critical for organ development and associated with progression of various cancer types. However, their expression patterns and prognostic values for hepatocellular carcinoma (HCC) are still largely unknown. Methods: Expression of GATA transcription factors in HCC cell lines and tissues (n = 240) were evaluated by RT-qPCR, western blot and immunohistochemistry. Cellular proliferation, migration and invasion of HepG2 was evaluated by CCK-8 kit, scratch wound assay and transwell matrigel invasion assay, respectively. Results: GATA2 expression was decreased in HCC cell lines (p = 0.056 for mRNA, p = 0.040 for protein) and tissues (p = 1.27E-25) compared with normal hepatocytes. Decreased expression of intratumoral GATA2 protein significantly correlated with elevated alpha feto-protein (p = 2.7E-05), tumor size >5 cm (p = 0.049), absence of tumor capsule (p = 0.002), poor differentiation (p = 0.005), presence of tumor thrombi (p = 0.005) and advanced TNM stage (p = 0.001) and was associated with increased recurrence rate and decreased overall survival rate by univariate (p = 1.6E-04 for TTR, p = 1.7E-04 for OS) and multivariate analyses (HR = 0.63, 95% CI = 0.43-0.90, p = 0.012 for TTR; HR = 0.67, 95% CI = 0.47-0.95, p = 0.026 for OS). RNAi-mediated knockdown of GATA2 expression significantly enhanced proliferation, migration and invasion of HepG2 cell in vitro. Conclusions: Decreased expression of hematopoietic factor GATA2 was associated with poor prognosis of HCC following resection.	[Li, Yi-Wei; Wang, Jia-Xing; Yin, Xin; Qiu, Shuang-Jian; Wu, Han; Liao, Rui; Yi, Yong; Xiao, Yong-Sheng; Zhou, Jian; Zhang, Bo-Heng; Fan, Jia] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China; [Qiu, Shuang-Jian] Fudan Univ, Biomed Res Ctr, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Fan, Jia] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Qiu, SJ (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China.	qiu.shuangjian@zs-hospital.sh.cn; jiafan99@yahoo.com	Fan, Jia/C-6689-2017; Liao, Rui/AAC-4332-2020	Liao, Rui/0000-0002-0057-2792; Zhou, Jian/0000-0002-7650-7540	National Key Sci-Tech Project of China [2012ZX10002011-002, 2012ZX10002010-001-002]; National Natural Science Foundation of China [81071707, 81071995, 30872379, 81030038]	National Key Sci-Tech Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Sci-Tech Project of China (no. 2012ZX10002011-002 & no. 2012ZX10002010-001-002), the National Natural Science Foundation of China (no. 81071707, no. 81071995, no. 30872379 & Key Program no. 81030038).	Akiyama Y, 2003, MOL CELL BIOL, V23, P8429, DOI 10.1128/MCB.23.23.8429-8439.2003; ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Andrieux LO, 2007, CANCER RES, V67, P2114, DOI 10.1158/0008-5472.CAN-06-3821; Bohm M, 2009, ONCOGENE, V28, P3847, DOI 10.1038/onc.2009.243; Bossard P, 1998, DEVELOPMENT, V125, P4909; Cai MY, 2009, CLIN CANCER RES, V15, P4686, DOI 10.1158/1078-0432.CCR-09-0463; Capo-Chichi CD, 2003, CANCER RES, V63, P4967; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Fautrel A, 2005, J HEPATOL, V43, P288, DOI 10.1016/j.jhep.2005.02.020; Ferlay J, 2008, IARC CANCERBASE; Fu BJ, 2007, CANCER BIOL THER, V6, P1546, DOI 10.4161/cbt.6.10.4708; Furuhata A, 2009, LEUKEMIA, V23, P1270, DOI 10.1038/leu.2009.13; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Guo MZ, 2006, INT J CANCER, V119, P2078, DOI 10.1002/ijc.22092; Guo MZ, 2004, CLIN CANCER RES, V10, P7917, DOI 10.1158/1078-0432.CCR-04-1140; Hellebrekers DMEI, 2009, CLIN CANCER RES, V15, P3990, DOI 10.1158/1078-0432.CCR-09-0055; Hoene V, 2009, BRIT J CANCER, V101, P1481, DOI 10.1038/sj.bjc.6605276; Imagawa S, 1997, BLOOD, V89, P1430, DOI 10.1182/blood.V89.4.1430; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kanki Y, 2011, EMBO J, V30, P2582, DOI 10.1038/emboj.2011.173; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Kiiveri S, 1999, MOL MED, V5, P490, DOI 10.1007/bf03403542; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lee GH, 2010, ONCOGENE, V29, P2130, DOI 10.1038/onc.2009.491; Li YW, 2011, J HEPATOL, V54, P497, DOI 10.1016/j.jhep.2010.07.044; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McEachin MD, 2008, APPL IMMUNOHISTO M M, V16, P153, DOI 10.1097/PAI.0b013e31815b629c; Minegishi N, 1997, INT J HEMATOL, V65, P239; NAGAI T, 1994, BLOOD, V84, P1074, DOI 10.1182/blood.V84.4.1074.bloodjournal8441074; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Pullar CE, 2003, J BIOL CHEM, V278, P22555, DOI 10.1074/jbc.M300205200; Schneider EM, 2004, J PATHOL, V204, P538, DOI 10.1002/path.1664; Soini T, 2012, J PEDIATR GASTR NUTR, V54, P101, DOI 10.1097/MPG.0b013e31822d52cf; Stoicov C, 2009, J IMMUNOL, V183, P642, DOI 10.4049/jimmunol.0900511; Umeoka K, 2002, MODERN PATHOL, V15, P11, DOI 10.1038/modpathol.3880484; Yang M, 2008, MOL IMMUNOL, V45, P1792, DOI 10.1016/j.molimm.2007.09.027; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228; Zhang SJ, 2008, P NATL ACAD SCI USA, V105, P2076, DOI 10.1073/pnas.0711824105; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10638, DOI 10.1073/pnas.88.23.10638	44	26	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87505	10.1371/journal.pone.0087505	http://dx.doi.org/10.1371/journal.pone.0087505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498120	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100090
J	De Filette, M; Soehle, S; Ulbert, S; Richner, J; Diamond, MS; Sinigaglia, A; Barzon, L; Roels, S; Lisziewicz, J; Lorincz, O; Sanders, NN				De Filette, Marina; Soehle, Silke; Ulbert, Sebastian; Richner, Justin; Diamond, Michael S.; Sinigaglia, Alessandro; Barzon, Luisa; Roels, Stefan; Lisziewicz, Julianna; Lorincz, Orsolya; Sanders, Niek N.			Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge	PLOS ONE			English	Article							GENE DELIVERY; IN-VITRO; T-CELL; NEUTRALIZING ANTIBODIES; CLINICAL-TRIALS; DOMAIN-III; RESPONSES; IMMUNIZATION; INDUCTION; ANTIGEN	West Nile virus (WNV) is a mosquito-borne flavivirus that is endemic in Africa, the Middle East, Europe and the United States. There is currently no antiviral treatment or human vaccine available to treat or prevent WNV infection. DNA plasmid-based vaccines represent a new approach for controlling infectious diseases. In rodents, DNA vaccines have been shown to induce B cell and cytotoxic T cell responses and protect against a wide range of infections. In this study, we formulated a plasmid DNA vector expressing the ectodomain of the E-protein of WNV into nanoparticles by using linear polyethyleneimine (lPEI) covalently bound to mannose and examined the potential of this vaccine to protect against lethal WNV infection in mice. Mice were immunized twice (prime - boost regime) with the WNV DNA vaccine formulated with lPEI-mannose using different administration routes (intramuscular, intradermal and topical). In parallel a heterologous boost with purified recombinant WNV envelope (E) protein was evaluated. While no significant E-protein specific humoral response was generated after DNA immunization, protein boosting of DNA-primed mice resulted in a marked increase in total neutralizing antibody titer. In addition, E-specific IL-4 T-cell immune responses were detected by ELISPOT after protein boost and CD8(+) specific IFN-gamma expression was observed by flow cytometry. Challenge experiments using the heterologous immunization regime revealed protective immunity to homologous and virulent WNV infection.	[De Filette, Marina; Sanders, Niek N.] Univ Ghent, Fac Vet Sci, Lab Gene Therapy, Merelbeke, Belgium; [Soehle, Silke] Univ Zurich, Inst Virol, Zurich, Switzerland; [Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Leipzig, Germany; [Richner, Justin; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Richner, Justin; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Richner, Justin; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Sinigaglia, Alessandro; Barzon, Luisa] Univ Padua, Dept Mol Med, Padua, Italy; [Roels, Stefan] Vet & Agrochem Res Ctr CODA CERVA, Operat Direct Interact & Surveillance, Brussels, Belgium; [Lisziewicz, Julianna; Lorincz, Orsolya] Genet Immun, Budapest, Hungary; [Lisziewicz, Julianna; Lorincz, Orsolya] Genet Immun, Mclean, VA USA	Ghent University; University of Zurich; Fraunhofer Gesellschaft; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Padua	Sanders, NN (corresponding author), Univ Ghent, Fac Vet Sci, Lab Gene Therapy, Merelbeke, Belgium.	Niek.Sanders@UGent.be	Barzon, Luisa/K-7961-2016; Diamond, Michael/AAH-1733-2019	Barzon, Luisa/0000-0003-0720-8456; Diamond, Michael/0000-0002-8791-3165; sinigaglia, alessandro/0000-0002-2386-1757; Ulbert, Sebastian/0000-0001-5910-3643; Lisziewicz, Julianna/0000-0002-3349-4495; Sanders, Niek/0000-0003-4585-0343; Lorincz, Orsolya/0000-0003-4847-526X	European Union [261426]	European Union(European Commission)	This work was supported by the European Union under FP7, Project 261426 (WINGS-West Nile Integrated Shield Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanyan MG, 1997, AIDS RES HUM RETROV, V13, P1561, DOI 10.1089/aid.1997.13.1561; Allison; MATGWTWCRW, 2012, VET HEMATOLOGY CLIN; Balazs DA, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/326497; Barzon L, 2009, EURO SURVEILL, V14, P19384; Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; Biswal BK, 2010, MOL BIOL REP, V37, P2919, DOI 10.1007/s11033-009-9853-3; Bonsted Anette, 2008, V434, P171, DOI 10.1007/978-1-60327-248-3_11; Boyle JS, 1997, INT IMMUNOL, V9, P1897, DOI 10.1093/intimm/9.12.1897; Couissinier-Paris P, 2006, Bull Soc Pathol Exot, V99, P348; Darquet AM, 1997, GENE THER, V4, P1341, DOI 10.1038/sj.gt.3300540; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Diebold Sandra S., 2002, Somatic Cell and Molecular Genetics, V27, P65, DOI 10.1023/A:1022975705406; Diebold SS, 1999, J BIOL CHEM, V274, P19087, DOI 10.1074/jbc.274.27.19087; El Garch H, 2008, VET IMMUNOL IMMUNOP, V123, P230, DOI 10.1016/j.vetimm.2008.02.002; Fuchs A, 2011, VIROLOGY, V412, P101, DOI 10.1016/j.virol.2011.01.003; Goyal R, 2012, NANOMED-NANOTECHNOL, V8, P167, DOI 10.1016/j.nano.2011.06.001; Hartikka J, 1996, HUM GENE THER, V7, P1205, DOI 10.1089/hum.1996.7.10-1205; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Irvine KR, 1996, J IMMUNOL, V156, P238; Jones S, 2009, VACCINE, V27, P2506, DOI 10.1016/j.vaccine.2009.02.061; Kahlon R, 2003, VACCINE, V21, P2890, DOI 10.1016/S0264-410X(03)00141-5; Kim TI, 2007, BIOMATERIALS, V28, P2061, DOI 10.1016/j.biomaterials.2006.12.013; Klencke B, 2002, CLIN CANCER RES, V8, P1028; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Li M, 2013, INT J NANOMED, V8, P1843, DOI 10.2147/IJN.S43827; Lim SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074575; Limdi JK, 2003, POSTGRAD MED J, V79, P307, DOI 10.1136/pmj.79.932.307; Lisziewicz J, 2005, J INVEST DERMATOL, V124, P160, DOI 10.1111/j.0022-202X.2004.23535.x; Liu MA, 2005, ADV GENET, V55, P25, DOI 10.1016/S0065-2660(05)55002-8; Long MT, 2007, EQUINE VET J, V39, P491, DOI 10.2746/042516407X217416; Lorincz O, 2012, NANOMED-NANOTECHNOL, V8, P497, DOI 10.1016/j.nano.2011.07.013; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; May FJ, 2011, J VIROL, V85, P2964, DOI 10.1128/JVI.01963-10; Mellstedt H, 1999, Curr Opin Hematol, V6, P169, DOI 10.1097/00062752-199905000-00008; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nishijima T, 1997, J INVEST DERMATOL, V109, P175, DOI 10.1111/1523-1747.ep12319282; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Pathak A, 2007, PHARM RES-DORDR, V24, P1427, DOI 10.1007/s11095-007-9259-7; Pertmer TM, 1996, J VIROL, V70, P6119, DOI 10.1128/JVI.70.9.6119-6125.1996; Petersen LR, 2002, NEW ENGL J MED, V347, P1225, DOI 10.1056/NEJMo020128; Porgador A, 1998, J EXP MED, V188, P1075, DOI 10.1084/jem.188.6.1075; Sampathkumar P, 2003, MAYO CLIN PROC, V78, P1137, DOI 10.4065/78.9.1137; Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Smith LR, 2010, VACCINE, V28, P2565, DOI 10.1016/j.vaccine.2010.01.029; Smitha S, 2010, J HELMINTHOL, V84, P149, DOI 10.1017/S0022149X0999037X; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; Toke ER, 2010, INT J PHARMACEUT, V392, P261, DOI 10.1016/j.ijpharm.2010.03.048; Volk DE, 2004, J BIOL CHEM, V279, P38755, DOI 10.1074/jbc.M402385200; Wang RB, 2004, J IMMUNOL, V172, P5561, DOI 10.4049/jimmunol.172.9.5561; Wang S, 2008, VACCINE, V26, P3946, DOI 10.1016/j.vaccine.2008.04.025; Watson JT, 2004, ANN INTERN MED, V141, P360, DOI 10.7326/0003-4819-141-5-200409070-00010; Wilson NS, 2012, IMMUNOL CELL BIOL, V90, P540, DOI 10.1038/icb.2011.71; XIANG ZQ, 1995, VIROLOGY, V209, P569, DOI 10.1006/viro.1995.1289; Yan J, 2009, VACCINE, V27, P431, DOI 10.1016/j.vaccine.2008.10.078; Zheng C, 2006, VACCINE, V24, P4625, DOI 10.1016/j.vaccine.2005.08.046	61	19	20	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87837	10.1371/journal.pone.0087837	http://dx.doi.org/10.1371/journal.pone.0087837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24503579	Green Published, Green Submitted, gold			2022-12-25	WOS:000336971300003
J	DeVault, TL; Blackwell, BF; Seamans, TW; Lima, SL; Fernandez-Juricic, E				DeVault, Travis L.; Blackwell, Bradley F.; Seamans, Thomas W.; Lima, Steven L.; Fernandez-Juricic, Esteban			Effects of Vehicle Speed on Flight Initiation by Turkey Vultures: Implications for Bird-Vehicle Collisions	PLOS ONE			English	Article							INTERSPECIFIC VARIATION; ROAD MORTALITY; HOME RANGES; AIRCRAFT; BLACK; RISK; DISTANCES; WILDLIFE; BEHAVIOR; TIME	The avoidance of motorized vehicles is a common challenge for birds in the modern world. Birds appear to rely on antipredator behaviors to avoid vehicles, but modern vehicles (automobiles and aircraft) are faster than natural predators. Thus, birds may be relatively ill-equipped, in terms of sensory capabilities and behaviors, to avoid vehicles. We examined the idea that birds may be unable to accurately assess particularly high speeds of approaching vehicles, which could contribute to miscalculations in avoidance behaviors and ultimately cause collisions. We baited turkey vultures (Cathartes aura) to roads with animal carcasses and measured flight initiation distance and effective time-to-collision in response to a truck driving directly towards vultures from a starting distance of 1.13 km and at one of three speeds: 30, 60, or 90 kph (no vultures were struck). Flight initiation distance of vultures increased by a factor of 1.85 as speed increased from 30 to 90 kph. However, for 90-kph approaches there was no clear trend in flight initiation distance across replicates: birds appeared equally likely to initiate escape behavior at 40 m as at 220 m. Time-to-collision decreased by a factor of 0.62 with approach speeds from 30 to 90 kph. Also, at 90 kph, four vehicle approaches (17%) resulted in near collisions with vultures (time-to-collision <= 1.7 s), compared to none during 60 kph approaches and one during 30 kph approaches (4%). Our findings suggest that antipredator behaviors in turkey vultures, particularly stimulus processing and response, might not be well tuned to vehicles approaching at speeds >= 90 kph. The possible inability of turkey vultures to react appropriately to high-speed vehicles could be common among birds, and might represent an important determinant of bird-vehicle collisions.	[DeVault, Travis L.; Blackwell, Bradley F.; Seamans, Thomas W.] Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Sandusky, OH 44870 USA; [Lima, Steven L.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA; [Fernandez-Juricic, Esteban] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	United States Department of Agriculture (USDA); Indiana State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	DeVault, TL (corresponding author), Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Sandusky, OH 44870 USA.	Travis.L.DeVault@aphis.usda.gov		DeVault, Travis/0000-0001-6413-1104	U.S. Department of Agriculture	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	Funding was provided by the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Bernhardt GE, 2010, IBIS, V152, P830, DOI 10.1111/j.1474-919X.2010.01043.x; Blackwell BF, 2004, J WILDLIFE MANAGE, V68, P725, DOI 10.2193/0022-541X(2004)068[0725:EOALLI]2.0.CO;2; Blackwell BF, 2012, J APPL ECOL, V49, P758, DOI 10.1111/j.1365-2664.2012.02165.x; Blackwell BF, 2009, LANDSCAPE URBAN PLAN, V93, P1, DOI 10.1016/j.landurbplan.2009.07.005; Blackwell BF, 2009, ANIM BEHAV, V77, P673, DOI 10.1016/j.anbehav.2008.11.017; Blumstein DT, 2010, BEHAV ECOL, V21, P440, DOI 10.1093/beheco/arq030; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Blumstein DT, 2003, BIOL CONSERV, V110, P97, DOI 10.1016/S0006-3207(02)00180-5; BOUSKILA A, 1992, AM NAT, V139, P161, DOI 10.1086/285318; Cardenas YL, 2005, ANIM BEHAV, V70, P1395, DOI 10.1016/j.anbehav.2005.03.022; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; COLEMAN JS, 1989, J WILDLIFE MANAGE, V53, P782, DOI 10.2307/3809213; Cooper WE, 2005, CAN J ZOOL, V83, P1045, DOI 10.1139/Z05-104; Cooper WE, 2009, BEHAV ECOL, V20, P542, DOI 10.1093/beheco/arp029; DeLucia PR, 2003, Q J EXP PSYCHOL-A, V56, P1165, DOI 10.1080/02724980343000053; DeVault TL, 2005, J WILDLIFE MANAGE, V69, P601, DOI 10.2193/0022-541X(2005)069[0601:FBOBAT]2.0.CO;2; DeVault TL, 2004, CONDOR, V106, P706, DOI 10.1650/7461; DeVault TL, 2013, WILDL MANAGE CONSERV, P1; Devault TL, 2011, WILDLIFE SOC B, V35, P394, DOI 10.1002/wsb.75; Dolbeer RA, 2012, 18 US DEP TRANSP FED; Dolbeer RA, 2006, J WILDLIFE MANAGE, V70, P1345, DOI 10.2193/0022-541X(2006)70[1345:HDOBRB]2.0.CO;2; Dolbeer Richard A., 2011, Human-Wildlife Interactions, V5, P235; Erickson W.P., 2005, PSWGTR191 USDA FOR S; Erritzoe J, 2003, ACTA ORNITHOL, V38, P77, DOI 10.3161/068.038.0204; Fahrig L, 2009, ECOL SOC, V14; Farmer RG, 2012, J WILDLIFE MANAGE, V76, P1215, DOI 10.1002/jwmg.358; Fernandez-Juricic E, 2002, CAN J ZOOL, V80, P1212, DOI 10.1139/Z02-104; Fernandez-Juricic Esteban, 2011, Human-Wildlife Interactions, V5, P224; Frid A, 2002, CONSERV ECOL, V6; Gibson J. J., 1979, ECOLOGICAL APPROACH; Gibson J. J, 1947, 7 AAF; Gill F.B., 1998, BIRDS N AM ONLINE; Huijser M, 2007, REPORT C; Jacobson Sandra L., 2005, U S Forest Service General Technical Report PSW, V191, P1043; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Kelly NE, 2007, WILSON J ORNITHOL, V119, P267, DOI 10.1676/05-095.1; Kociolek AV, 2011, CONSERV BIOL, V25, P241, DOI 10.1111/j.1523-1739.2010.01635.x; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; Legagneux P, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0417; Li Z, 2004, P HUMAN FACTORS ERGO, P2271; LIMA SL, 1993, WILSON BULL, V105, P1; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Martin GR, 2011, IBIS, V153, P239, DOI 10.1111/j.1474-919X.2011.01117.x; Moller Anders Pape, 2011, Zoological Research, V32, P115, DOI 10.3724/SP.J.1141.2011.02115; Mumme RL, 2000, CONSERV BIOL, V14, P501, DOI 10.1046/j.1523-1739.2000.98370.x; Richardson CT, 1997, WILDLIFE SOC B, V25, P634; Runyan AM, 2004, J WILDLIFE MANAGE, V68, P1124, DOI 10.2193/0022-541X(2004)068[1124:DIDIFI]2.0.CO;2; Santos SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025383; Seiler A, 2006, ENVIRONM POLLUT SER, V10, P165, DOI 10.1007/1-4020-4504-2_8; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Teixeira FZ, 2013, BIOL CONSERV, V157, P317, DOI 10.1016/j.biocon.2012.09.006; van der Grift EA, 2013, BIODIVERS CONSERV, V22, P425, DOI 10.1007/s10531-012-0421-0; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	56	30	32	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87944	10.1371/journal.pone.0087944	http://dx.doi.org/10.1371/journal.pone.0087944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24503622	Green Published, gold			2022-12-25	WOS:000336971300020
J	Mughini-Gras, L; Enserink, R; Friesema, I; Heck, M; van Duynhoven, Y; van Pelt, W				Mughini-Gras, Lapo; Enserink, Remko; Friesema, Ingrid; Heck, Max; van Duynhoven, Yvonne; van Pelt, Wilfrid			Risk Factors for Human Salmonellosis Originating from Pigs, Cattle, Broiler Chickens and Egg Laying Hens: A Combined Case-Control and Source Attribution Analysis	PLOS ONE			English	Article							ENTERITIDIS INFECTIONS; TYPHIMURIUM DT104; FOOD-SOURCES; NETHERLANDS; SEROTYPE; OUTBREAK; GASTROENTERITIS; REGRESSION; CHILDREN; DISEASE	Several case-control studies have investigated risk factors for human salmonellosis while others have used Salmonella subtyping to attribute human infections to different food and animal reservoirs. This study combined case-control and source attribution data into a single analysis to explore risk factors at the point of exposure for human salmonellosis originating from four putative food-producing animal reservoirs (pigs, cattle, broilers and layers/eggs) in the Netherlands. We confirmed that most human cases (similar to 90%) were attributable to layers/eggs and pigs. Layers/eggs and broilers were the most likely reservoirs of salmonellosis in adults, in urban areas, and in spring/summer, whereas pigs and cattle were the most likely reservoirs of salmonellosis in children, in rural areas, and in autumn/winter. Several reservoir-specific risk factors were identified. Not using a chopping board for raw meat only and consuming raw/undercooked meat were risk factors for infection with salmonellas originating from pigs, cattle and broilers. Consuming raw/undercooked eggs and by-products were risk factors for layer/egg-associated salmonellosis. Using antibiotics was a risk factor for pig- and cattle-associated salmonellosis and using proton-pump inhibitors for salmonellosis attributable to any reservoir. Pig- and cattle-associated infections were also linked to direct contact with animals and environmental exposure (e. g. playing in sandboxes). Eating fish, meat in pastry, and several non-meat foods (fruit, vegetables and pasteurized dairy products) were protective factors. Consuming pork and occupational exposure to animals and/or raw meats were protective against layer/egg-associated salmonellosis. We concluded that individuals acquiring salmonellosis from different reservoirs have different associated risk factors, suggesting that salmonellas may infect humans through various transmission pathways depending on their original reservoirs. The outcome of classical case-control studies can be enhanced by incorporating source attribution data and vice versa.	[Mughini-Gras, Lapo; Enserink, Remko; Friesema, Ingrid; Heck, Max; van Duynhoven, Yvonne; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Mughini-Gras, L (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands.	lapo.mughini.gras@rivm.nl	Friesema, Ingrid HM/H-6601-2019	Friesema, Ingrid HM/0000-0001-9943-0518				Bassal R, 2013, EPIDEMIOL INFECT; Behravesh CB, 2010, PEDIATRICS, V126, P477, DOI 10.1542/peds.2009-3273; Bouwknegt M, 2004, SURVEILLANCE ZOONOTI; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P701; Cummings KJ, 2012, EMERG INFECT DIS, V18, P1929, DOI 10.3201/eid1812.110831; David JM, 2013, PREV VET MED, V110, P12, DOI 10.1016/j.prevetmed.2013.02.002; David JM, 2013, RISK ANAL, V33, P397, DOI 10.1111/j.1539-6924.2012.01877.x; Delarocque-Astagneau E, 2000, CLIN INFECT DIS, V31, P488, DOI 10.1086/313990; Doorduyn Y, 2006, EPIDEMIOL INFECT, V134, P617, DOI 10.1017/S0950268805005406; Dore K, 2004, EPIDEMIOL INFECT, V132, P485, DOI 10.1017/S0950268803001924; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Friesema IH, 2012, EUROSURVEILLANCE, V17, P2; Friesema IHM, 2010, EPIDEMIOL INFECT; Friesema IHM, 2012, FOODBORNE PATHOG DIS, V9, P102, DOI 10.1089/fpd.2011.0978; Gras LM, 2013, EPIDEMIOL INFECT, V141, P2526, DOI 10.1017/S0950268813000356; Gras LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042599; Graziani C, 2013, EUROSURVEILLANCE, V18, P19, DOI 10.2807/1560-7917.ES2013.18.7.20519; Guo CF, 2011, FOODBORNE PATHOG DIS, V8, P509, DOI 10.1089/fpd.2010.0714; Hald T, 2004, RISK ANAL, V24, P255, DOI 10.1111/j.0272-4332.2004.00427.x; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Hennessy TW, 2004, CLIN INFECT DIS, V38, pS237, DOI 10.1086/381593; Humphrey S, 2011, MICROBIOL-SGM, V157, P1103, DOI 10.1099/mic.0.045666-0; Kuhn KG, 2012, EPIDEMIOL INFECT; Leonard EK, 2011, ZOONOSES PUBLIC HLTH, V58, P140, DOI 10.1111/j.1863-2378.2009.01320.x; Mangen M-JJ, 2013, DIS BURDEN COST OF I; Marcus R, 2007, EPIDEMIOL INFECT, V135, P84, DOI 10.1017/S0950268806006558; Mughini-Gras L, 2013, EPIDEMIOL INFECT; Mullner P, 2010, EPIDEMIOL INFECT, V138, P1372, DOI 10.1017/S0950268809991579; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; NETHMAP MARAN, 2013, CONS ANT AG ANT RES; Nielsen LR, 2004, PREV VET MED, V65, P47, DOI 10.1016/j.prevetmed.2004.06.010; Pires SM, 2011, ESTIMATION RELATIVE; Rijksinstituut voor Volksgezondheid en Milieu (RIVM), 2012, STAAT ZOON 2011; Shah J, 2013, APPL ENVIRON MICROB, V79, P7281, DOI 10.1128/AEM.02621-13; Smid JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055029; Strachan NJC, 2009, J INFECT DIS, V199, P1205, DOI 10.1086/597417; Swift L, 2004, EUR J EPIDEMIOL, V19, P219, DOI 10.1023/B:EJEP.0000020453.84296.f6; Thompson CN, 2013, EPIDEMIOL INFECT, V141, P1604, DOI 10.1017/S0950268812002014; van den Brandhof WE, 2004, EPIDEMIOL INFECT, V132, P211, DOI 10.1017/S0950268803001559; van Duijkeren E, 2002, J CLIN MICROBIOL, V40, P3980, DOI 10.1128/JCM.40.11.3980-3985.2002; Van Duynhoven YTHP, 2009, EPIDEMIOL INFECT, V137, P1548, DOI 10.1017/S0950268809002337; van Horne P, 2007, PRODUCTION CONSUMPTI; Varga C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-866; Wahlstrom H, 2011, EPIDEMIOL INFECT, V139, P1246, DOI 10.1017/S0950268810002293; Wales A, 2007, AVIAN PATHOL, V36, P187, DOI 10.1080/03079450701338755; Whelan J, 2010, EURO SURVEILL, V15; WINSHIP C, 1994, SOCIOL METHOD RES, V23, P230, DOI 10.1177/0049124194023002004; Yang S J, 2001, J Vet Sci, V2, P181	48	83	83	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87933	10.1371/journal.pone.0087933	http://dx.doi.org/10.1371/journal.pone.0087933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24503703	Green Submitted, Green Published, gold			2022-12-25	WOS:000336971300019
J	Cox, R; Tijdens, RR; Meeter, MM; Sweegers, CCG; Talamini, LM				Cox, Roy; Tijdens, Ron R.; Meeter, Martijn M.; Sweegers, Carly C. G.; Talamini, Lucia M.			Time, Not Sleep, Unbinds Contexts from Item Memory	PLOS ONE			English	Article							NEURAL MECHANISMS; DEPENDENT MEMORY; CONSOLIDATION; HIPPOCAMPAL; SHIFT	Contextual cues are known to benefit memory retrieval, but whether and how sleep affects this context effect remains unresolved. We manipulated contextual congruence during memory retrieval in human volunteers across 12 h and 24 h intervals beginning with either sleep or wakefulness. Our data suggest that whereas contextual cues lose their potency with time, sleep does not modulate this process. Furthermore, our results are consistent with the idea that sleep's beneficial effect on memory retention depends on the amount of waking time that has passed between encoding and sleep onset. The findings are discussed in the framework of competitive consolidation theory.	[Cox, Roy; Tijdens, Ron R.; Sweegers, Carly C. G.; Talamini, Lucia M.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Cox, Roy; Sweegers, Carly C. G.; Talamini, Lucia M.] Univ Amsterdam, Amsterdam, Netherlands; [Meeter, Martijn M.] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Cox, R (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	r.cox@uva.nl	Cox, Roy/I-1753-2019; Meeter, Martijn/A-2926-2009	Cox, Roy/0000-0002-3667-9049; Meeter, Martijn/0000-0002-5112-6717	Dutch National Science Foundation (NWO) [452-08-013, 452-09-007]	Dutch National Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Dutch National Science Foundation (NWO - www.nwo.nl), grants 452-08-013 (to LMT) and 452-09-007 (to MMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCH WR, 1992, MEM COGNITION, V20, P21, DOI 10.3758/BF03208250; Bertsch S, 2005, PSYCHOL REP, V96, P879, DOI 10.2466/pr0.96.3c.879-888; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Cairney SA, 2011, EXP BRAIN RES, V214, P83, DOI 10.1007/s00221-011-2808-7; Cox R, 2012, LEARN MEMORY, V19, P264, DOI 10.1101/lm.026252.112; DALTON P, 1993, MEM COGNITION, V21, P223, DOI 10.3758/BF03202735; Deliens G, 2014, COGNITION EMOTION, V28, P698, DOI 10.1080/02699931.2013.844105; Deliens G, 2013, J SLEEP RES, V22, P656, DOI 10.1111/jsr.12065; Deliens G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068727; Deliens G, 2013, CORTEX, V49, P2221, DOI 10.1016/j.cortex.2012.11.014; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ellenbogen JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004117; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; Hayes SM, 2010, J COGNITIVE NEUROSCI, V22, P2541, DOI 10.1162/jocn.2009.21379; Inostroza M, 2013, ANNU REV NEUROSCI, V36, P79, DOI 10.1146/annurev-neuro-062012-170429; Lewis PA, 2011, NEUROPSYCHOLOGIA, V49, P2619, DOI 10.1016/j.neuropsychologia.2011.05.009; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Meeter M, 2005, COGN NEUROPSYCHOL, V22, P559, DOI 10.1080/02643290442000194; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Payne JD, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00108; Payne JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033079; Piekema C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010214; Rolls E. T., 1996, CORTICAL PLASTICITY, P223; Rolls ET, 1994, MEMORY SYSTEM BRAIN, P713; Smith SM, 2001, PSYCHON B REV, V8, P203, DOI 10.3758/BF03196157; SMITH SM, 1979, J EXP PSYCHOL-HUM L, V5, P460, DOI 10.1037/0278-7393.5.5.460; Sweegers CCG, 2014, NEUROIMAGE, V87, P138, DOI 10.1016/j.neuroimage.2013.10.063; Takashima A, 2009, J NEUROSCI, V29, P10087, DOI 10.1523/JNEUROSCI.0799-09.2009; Talamini LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062480; Talamini LM, 2012, LEARN MEMORY, V19, P239, DOI 10.1101/lm.024281.111; Talamini LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010356; Talamini LM, 2008, LEARN MEMORY, V15, P233, DOI 10.1101/lm.771608; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; van der Helm E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027421; van Dongen EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043426; Wamsley EJ, 2010, LEARN MEMORY, V17, P332, DOI 10.1101/lm.1828310; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Wiltgen BJ, 2010, CURR BIOL, V20, P1336, DOI 10.1016/j.cub.2010.06.068; Winocur G, 2009, LEARN MEMORY, V16, P722, DOI 10.1101/lm.1447209	40	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88307	10.1371/journal.pone.0088307	http://dx.doi.org/10.1371/journal.pone.0088307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302TD	24498441	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900187
J	Diaz, S; Panzera, F; Jaramillo, N; Perez, R; Fernandez, R; Vallejo, G; Saldana, A; Calzada, JE; Triana, O; Gomez-Palacio, A				Diaz, Sebastian; Panzera, Francisco; Jaramillo-O, Nicolas; Perez, Ruben; Fernandez, Rosina; Vallejo, Gustavo; Saldana, Azael; Calzada, Jose E.; Triana, Omar; Gomez-Palacio, Andres			Genetic, Cytogenetic and Morphological Trends in the Evolution of the Rhodnius (Triatominae: Rhodniini) Trans-Andean Group	PLOS ONE			English	Article							CHAGAS-DISEASE; PALLESCENS HEMIPTERA; MOLECULAR EVIDENCE; REDUVIIDAE; DIFFERENTIATION; MITOCHONDRIAL; HETEROPTERA; BIOGEOGRAPHY; PHYLOGENY; PROLIXUS	The Rhodnius Pacific group is composed of three species: Rhodnius pallescens, R. colombiensis and R. ecuadoriensis, which are considered important vectors of trypanosomes (Trypanosoma cruzi and T. rangeli) infecting humans. This group is considered as a recent trans-Andean lineage derived from the widespread distributed sister taxa R. pictipes during the later uplift of northern Andes mountain range. The widest spread species R. pallescens may be a complex of two divergent lineages with different chromosomal attributes and a particular biogeographical distribution across Central America and Colombia with several southern populations in Colombia occupying the same sylvatic habitat as its sister species R. colombiensis. Although the taxonomy of Rhodnius Pacific group has been well studied, the unresolved phylogenetic and systematic issues are the target of this paper. Here we explore the molecular phylogeography of this species group analyzing two mitochondrial (ND4 and cyt b) and one nuclear (D2 region of ribosomal 28S gene) gene sequences. The molecular analyses suggest an early divergence of the species R. ecuadoriensis and R. colombiensis, followed by a recent expansion of R. pallescens lineages. The phylogenetic relationship between sympatric R. pallescens Colombian lineage and R. colombiensis was further explored using wing morphometry, DNA genome size measurements, and by analyzing chromosomal behavior of hybrids progeny obtained from experimental crosses. Our results suggest that the diversification of the two R. pallescens lineages was mainly influenced by biogeographical events such as (i) the emergence of the Panama Isthmus, while the origin and divergence of R. colombiensis was associated with (ii) the development of particular genetic and chromosomal features that act as isolation mechanisms from its sister species R. pallescens (Colombian lineage). These findings provide new insights into the evolution of the Rhodnius Pacific group and the underlying biological processes that occurred during its divergence.	[Diaz, Sebastian; Jaramillo-O, Nicolas; Triana, Omar; Gomez-Palacio, Andres] Univ Antioquia UdeA, Grp BCEI, Medellin, Antioquia, Colombia; [Panzera, Francisco; Perez, Ruben; Fernandez, Rosina] Univ Republica, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay; [Vallejo, Gustavo] Univ Tolima, Lab Invest Parasitol Trop, Ibague, Tolima, Colombia; [Saldana, Azael; Calzada, Jose E.] ICGES, Panama City, Panama	Universidad de Antioquia; Universidad de la Republica, Uruguay; Universidad del Tolima	Gomez-Palacio, A (corresponding author), Univ Antioquia UdeA, Grp BCEI, Medellin, Antioquia, Colombia.	amgomezpa@gmail.com	Perez, Ruben/AAU-1516-2020; Jaramillo-O, Nicolas/AAU-7706-2021; Panzera, Francisco/M-9884-2015	Jaramillo-O, Nicolas/0000-0001-8885-6732; Panzera, Francisco/0000-0001-5148-957X; Saldana, Azael/0000-0002-5653-1332; Gomez-Palacio, Andres/0000-0002-1069-9199; Vallejo, Gustavo Adolfo/0000-0002-9701-9140; Perez, Ruben/0000-0003-4961-4743; Triana, Omar/0000-0001-8031-0225	Estrategia de sostenibilidad, CODI-Universidad de Antioquia, Colombia; CSIC (Udelar) from Uruguay	Estrategia de sostenibilidad, CODI-Universidad de Antioquia, Colombia; CSIC (Udelar) from Uruguay	SD, AGP, NJO, and OT received financial support from Estrategia de sostenibilidad 2013-2014, CODI-Universidad de Antioquia, Colombia. FP, RP and RF received support from CSIC (Udelar) from Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2005, AN ACAD BRAS CIENC, V77, P437, DOI 10.1590/S0001-37652005000300007; Abad-Franch F, 2007, MEM I OSWALDO CRUZ, V102, P57, DOI 10.1590/S0074-02762007005000108; Abad-Franch F, 2009, ACTA TROP, V110, P159, DOI 10.1016/j.actatropica.2008.06.005; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Martinez-Ibarra JA, 2011, MEM I OSWALDO CRUZ, V106, P293, DOI 10.1590/S0074-02762011000300007; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Ayala L Jose Manuel, 2009, Entomotropica, V24, P105; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Coates AG, 2004, GEOL SOC AM BULL, V116, P1327, DOI 10.1130/B25275.1; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Costa J, 2009, INFECT GENET EVOL, V9, P263, DOI 10.1016/j.meegid.2008.12.005; da Rosa Joao Aristeu, 2012, Zootaxa, V3478, P62; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dujardin JP, 2009, ACTA TROP, V110, P101, DOI 10.1016/j.actatropica.2008.09.026; Dujardin JP, 1999, J MED ENTOMOL, V36, P653, DOI 10.1093/jmedent/36.6.653; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; Frias-Lasserre D, 2010, NEOTROP ENTOMOL, V39, P572, DOI 10.1590/S1519-566X2010000400017; Galvao C., 2003, ZOOTAXA, V202, P1, DOI DOI 10.11646/Z00TAXA.202.1.1; Goloboff P, 2008, CLADISTICS, V24, P91; Gomez-Palacio A, 2008, MEM I OSWALDO CRUZ, V103, P160, DOI 10.1590/S0074-02762008000200006; Gomez-Palacio A, 2012, INFECT GENET EVOL, V12, P1975, DOI 10.1016/j.meegid.2012.04.003; Gottdenker NL, 2011, AM J TROP MED HYG, V84, P70, DOI 10.4269/ajtmh.2011.10-0041; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Grisales N, 2010, BIOMEDICA, V30, P207, DOI 10.7705/biomedica.v30i2.184; Guhl F, 2007, GRUP TRAB CIENT REP; Guhl F, 2007, BIOMEDICA, V27, P143, DOI 10.7705/biomedica.v27i1.258; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herrera-Aguilar M, 2009, INFECT GENET EVOL, V9, P1345, DOI 10.1016/j.meegid.2009.09.009; Hoorn C, 2010, DEV AMAZONIAN MEGAWE; Hypsa V, 2002, MOL PHYLOGENET EVOL, V23, P447, DOI 10.1016/S1055-7903(02)00023-4; Jaramillo C, 2001, MEM I OSWALDO CRUZ, V96, P1043, DOI 10.1590/S0074-02762001000800003; Jaramillo N., 2001, Research and Reviews in Parasitology, V60, P75; Jurberg José, 2009, Biota Neotrop., V9; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lyman DE, 1999, AM J TROP MED HYG, V60, P377, DOI 10.4269/ajtmh.1999.60.377; Marquez E, 2011, ACTA TROP, V120, P103, DOI 10.1016/j.actatropica.2011.06.009; Monteiro FA, 2003, MOL ECOL, V12, P997, DOI 10.1046/j.1365-294X.2003.01802.x; Monteiro FA, 2000, AM J TROP MED HYG, V62, P460, DOI 10.4269/ajtmh.2000.62.460; Moreno Mejia Jaime, 1999, Entomologia y Vectores, V6, P601; PANZERA F, 1995, CHROMOSOME RES, V3, P143, DOI 10.1007/BF00710707; Panzera F, 2010, CYTOGENET GENOME RES, V128, P77, DOI 10.1159/000298824; Panzera F, 2007, AM J TROP MED HYG, V76, P516, DOI 10.4269/ajtmh.2007.76.516; Panzera Y, 2012, CYTOGENET GENOME RES, V138, P56, DOI 10.1159/000341888; Perez R, 2005, GENETICA, V125, P261, DOI 10.1007/s10709-005-0369-z; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pita S, 2013, MEM I OSWALDO CRUZ, V108, P376, DOI 10.1590/S0074-02762013000300017; Porter CH, 1996, MOL PHYLOGENET EVOL, V6, P178, DOI 10.1006/mpev.1996.0070; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2010, FIGTREE 1 3 1; Rohlf F, 2010, TPSDIG DIGITIZE LAND; Rohlf F.J, 1997, TPSRELW VERSION 1 11; Schofield CJ, 2009, ACTA TROP, V110, P88, DOI 10.1016/j.actatropica.2009.01.010; Schofield Christopher J., 1999, Actualidades Biologicas (Medellin), V21, P183; de Paula AS, 2007, J BIOGEOGR, V34, P699, DOI 10.1111/j.1365-2699.2006.01628.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876	61	28	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87493	10.1371/journal.pone.0087493	http://dx.doi.org/10.1371/journal.pone.0087493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498330	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900076
J	Liu, YP; Keefe, K; Tang, XQ; Lin, S; Smith, GM				Liu, Yingpeng; Keefe, Kathy; Tang, Xiaoqing; Lin, Shen; Smith, George M.			Use of Self-Complementary Adeno-Associated Virus Serotype 2 as a Tracer for Labeling Axons: Implications for Axon Regeneration	PLOS ONE			English	Article							SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; GENE-THERAPY; EFFICIENT TRANSDUCTION; CORTICOSPINAL TRACT; PARKINSONS-DISEASE; FUNCTIONAL REGENERATION; TRANSGENE EXPRESSION; ALZHEIMERS-DISEASE; GROWTH-FACTOR	Various types of tracers are available for use in axon regeneration, but they require an extra operational tracer injection, time-consuming immunohistochemical analysis and cause non-specific labeling. Considerable efforts over the past years have explored other methodologies, especially the use of viral vectors, to investigate axon regeneration after injury. Recent studies have demonstrated that self-complementary Adeno-Associated Virus (scAAV) induced a high transduction efficiency and faster expression of transgenes. Here, we describe for the first time the use of scAAV2-GFP to label long-projection axons in the corticospinal tract (CST), rubrospinal tract (RST) and the central axons of dorsal root ganglion (DRG) in the normal and lesioned animal models. We found that scAAV2-GFP could efficiently transduce neurons in the sensorimotor cortex, red nucleus and DRG. Strong GFP expression could be transported anterogradely along the axon to label the numerous axon fibers from CST, RST and central axons of DRG separately. Comparison of the scAAV2 vector with single-stranded (ss) AAV2 vector in co-labeled sections showed that the scAAV2 vector induced a faster and stronger transgene expression than the ssAAV2 vector in DRG neurons and their axons. In both spinal cord lesion and dorsal root crush injury models, scAAV-GFP could efficiently label the lesioned and regenerated axons around the lesion cavity and the dorsal root entry zone (DREZ) respectively. Further, scAAV2-GFP vector could be combined with traditional tracer to specifically label sensory and motor axons after spinal cord lesion. Thus, we show that using scAAV2-GFP as a tracer is a more effective and efficient way to study axon regeneration following injury.	[Liu, Yingpeng; Keefe, Kathy; Tang, Xiaoqing; Lin, Shen; Smith, George M.] Temple Univ, Sch Med, Shriners Hosp Pediat Res Ctr, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Smith, GM (corresponding author), Temple Univ, Sch Med, Shriners Hosp Pediat Res Ctr, Philadelphia, PA 19122 USA.	george.smith@temple.edu		Lin, Shen/0000-0003-2953-7568	NIH/National Institute of Neurological Disorders and Stroke [R01 NS060784]; Shriners Hospital for Pediatric Research [SHC 84050, SHC 85200]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060784] Funding Source: NIH RePORTER	NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Shriners Hospital for Pediatric Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a grant from the NIH/National Institute of Neurological Disorders and Stroke R01 NS060784 and the Shriners Hospital for Pediatric Research, grants SHC 84050 and SHC 85200 (GMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alilain WJ, 2008, J NEUROSCI, V28, P11862, DOI 10.1523/JNEUROSCI.3378-08.2008; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Azzouz M, 2000, HUM MOL GENET, V9, P803, DOI 10.1093/hmg/9.5.803; Blackmore MG, 2012, P NATL ACAD SCI USA, V109, P7517, DOI 10.1073/pnas.1120684109; Blits B, 2010, J NEUROSCI METH, V185, P257, DOI 10.1016/j.jneumeth.2009.10.009; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Cearley CN, 2008, MOL THER, V16, P1710, DOI 10.1038/mt.2008.166; Chamberlin NL, 1998, BRAIN RES, V793, P169, DOI 10.1016/S0006-8993(98)00169-3; Depuy SD, 2011, J NEUROSCI, V31, P1981, DOI 10.1523/JNEUROSCI.4639-10.2011; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Fu H, 2002, MOL THER, V5, P42, DOI 10.1006/mthe.2001.0514; Hauck B, 2004, J VIROL, V78, P13678, DOI 10.1128/JVI.78.24.13678-13686.2004; Hu XH, 2010, EXP NEUROL, V223, P153, DOI 10.1016/j.expneurol.2009.08.025; Hutson TH, 2012, GENE THER, V19, P49, DOI 10.1038/gt.2011.71; Jin Y, 2008, EXP NEUROL, V210, P521, DOI 10.1016/j.expneurol.2007.11.030; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kells AP, 2009, P NATL ACAD SCI USA, V106, P2407, DOI 10.1073/pnas.0810682106; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Liu YP, 2008, CELL TISSUE RES, V333, P395, DOI 10.1007/s00441-008-0641-5; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Mason MRJ, 2010, MOL THER, V18, P715, DOI 10.1038/mt.2010.19; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Paterna JC, 2000, GENE THER, V7, P1304, DOI 10.1038/sj.gt.3301221; Paterna JC, 2002, METHODS, V28, P208, DOI 10.1016/S1046-2023(02)00225-6; RAJU DV, 2006, CURR PROTOC NEUROSCI, pCH1; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Romero MI, 2001, J NEUROSCI, V21, P8408, DOI 10.1523/JNEUROSCI.21-21-08408.2001; Ryan DA, 2010, MOL THER, V18, P1471, DOI 10.1038/mt.2010.111; SAMULSKI RJ, 1989, J VIROL, V63, P3822, DOI 10.1128/JVI.63.9.3822-3828.1989; Smith GM, 2012, TRENDS NEUROSCI, V35, P156, DOI 10.1016/j.tins.2011.10.006; Steward O, 2008, J NEUROSCI, V28, P6836, DOI 10.1523/JNEUROSCI.5372-07.2008; Tan CL, 2012, J NEUROSCI, V32, P7325, DOI 10.1523/JNEUROSCI.5472-11.2012; Tang XQ, 2004, J NEUROSCI, V24, P819, DOI 10.1523/JNEUROSCI.1263-03.2004; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; Wang DF, 2011, J NEUROSCI, V31, P9332, DOI 10.1523/JNEUROSCI.0983-11.2011; Wang XF, 2011, J NEUROTRAUM, V28, P635, DOI 10.1089/neu.2010.1566; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Williams RR, 2012, J GENE MED, V14, P20, DOI 10.1002/jgm.1628; Xiao X, 1997, EXP NEUROL, V144, P113, DOI 10.1006/exnr.1996.6396; Zaiss AK, 2005, CURR GENE THER, V5, P323, DOI 10.2174/1566523054065039; Zhang JH, 2012, NEUROSCI LETT, V525, P157, DOI 10.1016/j.neulet.2012.07.059	46	6	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87447	10.1371/journal.pone.0087447	http://dx.doi.org/10.1371/journal.pone.0087447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498323	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900069
J	Lopez-Hoffman, L; Wiederholt, R; Sansone, C; Bagstad, KJ; Cryan, P; Diffendorfer, JE; Goldstein, J; LaSharr, K; Loomis, J; McCracken, G; Medellin, RA; Russell, A; Semmens, D				Lopez-Hoffman, Laura; Wiederholt, Ruscena; Sansone, Chris; Bagstad, Kenneth J.; Cryan, Paul; Diffendorfer, Jay E.; Goldstein, Joshua; LaSharr, Kelsie; Loomis, John; McCracken, Gary; Medellin, Rodrigo A.; Russell, Amy; Semmens, Darius			Market Forces and Technological Substitutes Cause Fluctuations in the Value of Bat Pest-Control Services for Cotton	PLOS ONE			English	Article							FREE-TAILED BATS; FIELD-EVOLVED RESISTANCE; ECOSYSTEM SERVICES; INSECT RESISTANCE; BENEFITS TRANSFER; ECONOMIC VALUE; BT COTTON; METAANALYSIS; CHALLENGE; EXISTENCE	Critics of the market-based, ecosystem services approach to biodiversity conservation worry that volatile market conditions and technological substitutes will diminish the value of ecosystem services and obviate the "economic benefits" arguments for conservation. To explore the effects of market forces and substitutes on service values, we assessed how the value of the pest-control services provided by Mexican free-tailed bats (Tadarida brasiliensis mexicana) to cotton production in the southwestern U.S. has changed over time. We calculated service values each year from 1990 through 2008 by estimating the value of avoided crop damage and the reduced social and private costs of insecticide use in the presence of bats. Over this period, the ecosystem service value declined by 79% ($19.09 million U.S. dollars) due to the introduction and widespread adoption of Bt (Bacillus thuringiensis) cotton transgenically modified to express its own pesticide, falling global cotton prices and the reduction in the number of hectares in the U.S. planted with cotton. Our results demonstrate that fluctuations in market conditions can cause temporal variation in ecosystem service values even when ecosystem function - in this case bat population numbers - is held constant. Evidence is accumulating, however, of the evolution of pest resistance to Bt cotton, suggesting that the value of bat pest-control services may increase again. This gives rise to an economic option value argument for conserving Mexican free-tailed bat populations. We anticipate that these results will spur discussion about the role of ecosystem services in biodiversity conservation in general, and bat conservation in particular.	[Lopez-Hoffman, Laura; Wiederholt, Ruscena; LaSharr, Kelsie] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Lopez-Hoffman, Laura; Wiederholt, Ruscena] Univ Arizona, Udall Ctr Studies Publ Policy, Tucson, AZ USA; [Sansone, Chris] Bayer CropSci, Res Triangle Pk, NC USA; [Bagstad, Kenneth J.; Diffendorfer, Jay E.; Semmens, Darius] US Geol Survey, Geosci & Environm Change Sci Ctr, Denver, CO 80225 USA; [Cryan, Paul] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Goldstein, Joshua] Colorado State Univ, Dept Human Dimens Nat Resources, Ft Collins, CO 80523 USA; [Loomis, John] Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA; [McCracken, Gary] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Medellin, Rodrigo A.] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Russell, Amy] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA	University of Arizona; University of Arizona; Bayer AG; Bayer CropScience; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Colorado State University; Colorado State University; University of Tennessee System; University of Tennessee Knoxville; Universidad Nacional Autonoma de Mexico; Grand Valley State University	Lopez-Hoffman, L (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	lauralh@email.arizona.edu	Russell, Amy L/B-2222-2010	McCracken, Gary/0000-0002-2493-8103; Semmens, Darius/0000-0001-7924-6529; Bagstad, Kenneth/0000-0001-8857-5615; Diffendorfer, Jay/0000-0003-1093-6948; Cryan, Paul/0000-0002-2915-8894	National Science Foundation [DEB-1118975]; U.S. Geological Survey's John Wesley Powell Center for Analysis and Synthesis working group; Direct For Biological Sciences [1118975] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Geological Survey's John Wesley Powell Center for Analysis and Synthesis working group; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by a National Science Foundation award (DEB-1118975) to LLH. This work was supported by the U.S. Geological Survey's John Wesley Powell Center for Analysis and Synthesis working group, "Animal Migration and Spatial Subsidies: Establishing a Framework for Conservation Markets." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; [Anonymous], 2011, COST TIME INVOLVED D; [Anonymous], 2013, THE FUTURE OF NATURE, DOI DOI 10.12987/9780300188479-039; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Bagstad Kenneth J., 2013, Human Dimensions of Wildlife, V18, P307, DOI 10.1080/10871209.2013.789573; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Barbier EB, 2012, REV ENV ECON POLICY, V6, P1, DOI 10.1093/reep/rer017; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Berck P, 1996, ECOL MODEL, V92, P275, DOI 10.1016/0304-3800(95)00182-4; Bergstrom JC, 2006, ECOL ECON, V60, P351, DOI 10.1016/j.ecolecon.2006.06.015; Betke M, 2008, J MAMMAL, V89, P18, DOI 10.1644/07-MAMM-A-011.1; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; BROOKSHIRE DS, 1983, LAND ECON, V59, P1, DOI 10.2307/3145871; Brown TC, 2007, NAT RESOUR J, V47, P329; Catedra de Integracion Economica y Desarrollo Social. USDA, 2013, CAT INT EC DES SOC; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Eigenbrod F, 2010, BIOL CONSERV, V143, P2487, DOI 10.1016/j.biocon.2010.06.015; Ellison L.E., 2003, MONITORING BAT POPUL, P127; Federico P, 2008, ECOL APPL, V18, P826, DOI 10.1890/07-0556.1; Fisher B, 2011, SCIENCE, V333, P287, DOI 10.1126/science.333.6040.287-a; Gandara Fierro G, 2006, VALORACION EC SERVIC; Gassmann AJ, 2012, J INVERTEBR PATHOL, V110, P287, DOI 10.1016/j.jip.2012.04.006; Gianessi L, 2006, PESTICIDE USE US CRO; Hagerty AM, 2005, ENVIRON ENTOMOL, V34, P105, DOI 10.1603/0046-225X-34.1.105; Jackson R. E., 2003, Journal of Cotton Science, V7, P57; Kaur P, 2011, PEST MANAG SCI, V67, P1294, DOI 10.1002/ps.2185; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Kovach J., 1992, NEW YORKS FOOD LIFE, V139, P1; Kovacs K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062202; Kozak J, 2011, APPL GEOGR, V31, P303, DOI 10.1016/j.apgeog.2010.07.001; Kruger M, 2012, J APPL ENTOMOL, V136, P38, DOI 10.1111/j.1439-0418.2011.01616.x; Kruitlla J, 1976, EC NATURAL ENV; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Leach AW, 2008, ENVIRON POLLUT, V151, P139, DOI 10.1016/j.envpol.2007.02.019; Lee YF, 2005, J MAMMAL, V86, P67, DOI 10.1644/1545-1542(2005)086&lt;0067:DVOBFB&gt;2.0.CO;2; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; LOOMIS JB, 1992, WATER RESOUR RES, V28, P701, DOI 10.1029/91WR02596; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; McCauley DJ, 2006, NATURE, V443, P27, DOI 10.1038/443027a; McCracken G.F., 2003, MONITORING TRENDS BA, P21, DOI DOI 10.3996/122016-JFWM-093.S3; McCracken GF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043839; Muradian R, 2012, ECOSYST SERV, V1, P93, DOI 10.1016/j.ecoser.2012.07.009; Pagiola S., 2004, ASSESSING EC VALUE E; Peterson MJ, 2010, CONSERV BIOL, V24, P113, DOI 10.1111/j.1523-1739.2009.01305.x; PIMENTEL D, 1992, BIOSCIENCE, V42, P750, DOI 10.2307/1311994; Plummer ML, 2009, FRONT ECOL ENVIRON, V7, P38, DOI 10.1890/080091; Redford KH, 2009, CONSERV BIOL, V23, P785, DOI 10.1111/j.1523-1739.2009.01271.x; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; Rodriguez JP, 2006, ECOL SOC, V11; Sansone C, 2001, BIOL CONTROL, V30, P113; Sansone C.G., 2002, TEXAS COTTON PRODUCT; [Smithsonian Institute Smithsonian Institute], 1980, SCI TECHNOLOGY; Spash CL, 2008, ENVIRON VALUE, V17, P259, DOI 10.3197/096327108X303882; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2012, J INVERTEBR PATHOL, V110, P301, DOI 10.1016/j.jip.2012.04.008; Turner RK, 2003, ECOL ECON, V46, P493, DOI 10.1016/S0921-8009(03)00189-7; WALSH RG, 1984, LAND ECON, V60, P14, DOI 10.2307/3146089; WEISBROD BA, 1964, Q J ECON, V78, P471, DOI 10.2307/1879478; Wiedenmann RN, 2011, BIOL CONTROL, V59, P3, DOI 10.1016/j.biocontrol.2011.08.001; WILLIAMS TC, 1973, J MAMMAL, V54, P807, DOI 10.2307/1379076	62	42	45	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87912	10.1371/journal.pone.0087912	http://dx.doi.org/10.1371/journal.pone.0087912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302TD	24498400	Green Published, gold			2022-12-25	WOS:000330626900146
J	Peng, QL; Lao, XJ; Tang, WZ; Chen, ZP; Li, RL; Wang, J; Deng, Y; Li, TJ; Qin, X; Li, S				Peng, Qiliu; Lao, Xianjun; Tang, Weizhong; Chen, Zhiping; Li, Ruolin; Wang, Jian; Deng, Yan; Li, Taijie; Qin, Xue; Li, Shan			CASP8-652 6N Del Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Meta-Analysis	PLOS ONE			English	Article							PATHWAY CONFER SUSCEPTIBILITY; GENETIC-VARIANTS; ASSOCIATION; HETEROGENEITY; PROMOTER; RISK; BIAS	Objective: Caspase-8 (CASP8) plays a central role in the apoptotic pathway and aberrant regulation of this pathway may cause cancers. Previous studies investigating the association between CASP8 -652 6N ins/del polymorphism and colorectal cancer (CRC) risk showed inconclusive results. We performed a meta-analysis of all available studies to investigate this association. Methods: All studies published up to October 2013 on the association between CASP8 -652 6N ins/del polymorphism and CRC risk were identified by searching electronic databases PubMed, EMBASE, and Cochrane library. The association between CASP8 -652 6N ins/del polymorphism and CRC risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs). Results: Six studies with 6,325 cases and 6,842 controls were included in the meta-analysis. We observed that the CASP8 652 6N ins/del polymorphism was significantly correlated with CRC risk when all studies were pooled into the meta-analysis (ins/del vs. ins/ins: OR = 0.890, 95% CI 0.821-0.964, P = 0.004; del/del + ins/del vs. ins/ins: OR = 0.899, 95% CI 0.833-0.970, P = 0.006). In stratified analyses by ethnicity, source of control, and quality score, significant association was observed in Asians (ins/del vs. ins/ins: OR = 0.862, 95% CI 0.761-0.977, P = 0.020; del/del + ins/del vs. ins/ins: OR = 0.845, 95% CI 0.749-0.953, P = 0.006), population-based studies (ins/del vs. ins/ins: OR = 0.890, 95% CI 0.813-0.975, P = 0.012; del/del + ins/del vs. ins/ins: OR = 0.901, 95% CI 0.827-0.982, P = 0.018), and high quality studies. However, in subgroup analysis according to cancer location, no significant association was detected. Conclusions: The present meta-analysis suggests that the CASP8 is a candidate gene for CRC susceptibility. The CASP8 -652 6N ins/del polymorphism may play a protective role in CRC development especially among Asians. Further large and well-designed studies are needed to confirm this association.	[Peng, Qiliu; Lao, Xianjun; Wang, Jian; Deng, Yan; Li, Taijie; Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Tang, Weizhong] Guangxi Med Univ, Affiliated Hosp 1, Dept Anal & Colorectal Surg, Nanning, Guangxi, Peoples R China; [Chen, Zhiping] Guangxi Med Univ, Dept Occupat Hlth & Environm Hlth, Sch Publ Hlth, Nanning, Guangxi, Peoples R China; [Li, Ruolin] Guangxi Med Univ, Affiliated Hosp 1, Dept Med Res, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Qin, X (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	qinxue919@126.com; lis8858@126.com			National Natural Science Foundation [81260302]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The work described in this paper was supported by the National Natural Science Foundation (No. 81260302). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin O, 2012, CA-CANCER J CLIN, V62, P364, DOI 10.3322/caac.21156; Casas JP, 2004, ARCH NEUROL-CHICAGO, V61, P1652, DOI 10.1001/archneur.61.11.1652; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gangwar R, 2009, ANN SURG ONCOL, V16, P2028, DOI 10.1245/s10434-009-0488-3; Goodman JE, 2006, INT J CANCER, V118, P1790, DOI 10.1002/ijc.21523; Grenet J, 1999, GENE, V226, P225, DOI 10.1016/S0378-1119(98)00565-4; Haiman CA, 2008, NAT GENET, V40, P259, DOI 10.1038/ng0308-259; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Liu B, 2010, MOL CARCINOGEN, V49, P75, DOI 10.1002/mc.20579; MANTEL N, 1959, J NATL CANCER I, V22, P719; Pittman AM, 2008, BRIT J CANCER, V98, P1434, DOI 10.1038/sj.bjc.6604314; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Theodoropoulos GE, 2011, INT J COLORECTAL DIS, V26, P1113, DOI 10.1007/s00384-011-1217-5; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wang W, 2007, CLIN CANCER RES, V13, P5974, DOI 10.1158/1078-0432.CCR-07-0113; Wu ZW, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0565-0; Xiao MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067577; Ye YQ, 2008, CANCER-AM CANCER SOC, V112, P2467, DOI 10.1002/cncr.23472	26	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87925	10.1371/journal.pone.0087925	http://dx.doi.org/10.1371/journal.pone.0087925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498403	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900149
J	Piao, R; Chu, SH; Jiang, WZ; Yu, Y; Jin, YM; Woo, MO; Lee, J; Kim, S; Koh, HJ				Piao, Rihua; Chu, Sang-Ho; Jiang, Wenzhu; Yu, Yoye; Jin, Yongmei; Woo, Mi-Ok; Lee, Joohyun; Kim, Sunghan; Koh, Hee-Jong			Isolation and Characterization of a Dominant Dwarf Gene, D-h, in Rice	PLOS ONE			English	Article							GIBBERELLIN METABOLISM; INTERNODE ELONGATION; SEMIDWARF GENE; ALPHA-AMYLASE; ORYZA-SATIVA; MUTANT; CYTOCHROME-P450; BIOSYNTHESIS; GROWTH	Plant height is an important agronomic trait that affects grain yield. Previously, we reported a novel semi-dominant dwarfmutant, HD1, derived from chemical mutagenesis using N-methyl-N-nitrosourea (MNU) on a japonica rice cultivar, Hwacheong. In this study, we cloned the gene responsible for the dwarf mutant using a map-based approach. Fine mapping revealed that the mutant gene was located on the short arm of chromosome 1 in a 48 kb region. Sequencing of the candidate genes and rapid amplification of cDNA ends-polymerase chain reaction (RACE-PCR) analysis identified the gene, d-h, which encodes a protein of unknown function but whose sequence is conserved in other cereal crops. Real-time (RT)-PCR analysis and promoter activity assays showed that the d-h gene was primarily expressed in the nodes and the panicle. In the HD1 plant, the d-h gene was found to carry a 63-bp deletion in the ORF region that was subsequently confirmed by transgenic experiments to be directly responsible for the gain-of-function phenotype observed in the mutant. Since the mutant plants exhibit a defect in GA response, but not in the GA synthetic pathway, it appears that the d-h gene may be involved in a GA signaling pathway.	[Piao, Rihua; Chu, Sang-Ho; Yu, Yoye; Woo, Mi-Ok; Kim, Sunghan; Koh, Hee-Jong] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Plant Sci, Seoul, South Korea; [Piao, Rihua; Chu, Sang-Ho; Yu, Yoye; Woo, Mi-Ok; Kim, Sunghan; Koh, Hee-Jong] Seoul Natl Univ, Coll Agr & Life Sci, Plant Genom & Breeding Inst, Seoul, South Korea; [Jiang, Wenzhu] Jilin Univ, Coll Plant Sci, Changchun 130023, Peoples R China; [Jin, Yongmei] Jilin Acad Agr Sci, Agrobiothechnol Res Inst, Changchun, Peoples R China; [Lee, Joohyun] Konkuk Univ, Dept Appl Bio Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Jilin University; Jilin Academy of Agricultural Sciences; Konkuk University	Koh, HJ (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Plant Sci, Seoul, South Korea.	heejkoh@snu.ac.kr	Kim, Sunghan/ABH-3874-2020; Jiang, Wenzhu/AAD-7561-2022	Kim, Sunghan/0000-0002-4955-8780; Lee, Joohyun/0000-0003-4539-8342	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea [PJ008125]	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ008125), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano K, 2009, MOL GENET GENOMICS, V281, P223, DOI 10.1007/s00438-008-0406-6; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Grennan AK, 2006, PLANT PHYSIOL, V141, P524, DOI 10.1104/pp.104.900192; Hakata M, 2012, PLANT BIOTECHNOL J, V10, P1110, DOI 10.1111/j.1467-7652.2012.00741.x; HARGROVE TR, 1979, BIOSCIENCE, V29, P731, DOI 10.2307/1307667; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hiei Y, 1997, PLANT MOL BIOL, V35, P205, DOI 10.1023/A:1005847615493; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Jiang SY, 2009, PLANT PHYSIOL, V150, P1997, DOI 10.1104/pp.109.139402; Kim DY, 2013, GENE, V529, P208, DOI 10.1016/j.gene.2013.08.023; Koh HJ, 1994, KOREAN J BREED, V26, P368; KOH HJ, 1993, RICE GENET NEWS, V10, P77; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li WQ, 2010, PLANTA, V232, P1383, DOI 10.1007/s00425-010-1263-1; Liang F, 2011, J INTEGR PLANT BIOL, V53, P312, DOI 10.1111/j.1744-7909.2011.01031.x; Liu BM, 2008, PLANT BREEDING, V127, P125, DOI 10.1111/j.1439-0523.2007.01444.x; Miura K, 2009, PLANT BREEDING, V128, P63, DOI 10.1111/j.1439-0523.2008.01495.x; OKAMOTO K, 1978, AGR BIOL CHEM TOKYO, V42, P1379, DOI 10.1080/00021369.1978.10863168; Park DS, 2009, MOL BREEDING, V24, P1, DOI 10.1007/s11032-009-9300-0; Piao R, 2009, THEOR APPL GENET, V119, P1497, DOI 10.1007/s00122-009-1151-x; Qi WW, 2011, PLANT PHYSIOL, V157, P216, DOI 10.1104/pp.111.179945; Qin RZ, 2008, EUPHYTICA, V160, P379, DOI 10.1007/s10681-007-9548-6; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sunohara H, 2009, GENES GENET SYST, V84, P209, DOI 10.1266/ggs.84.209; Takada K, 1977, GAMMA FIELD S, V16, P1; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Tiwari S, 1997, COMPUT APPL BIOSCI, V13, P263; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Wang AH, 2010, PLANT J, V63, P670, DOI 10.1111/j.1365-313X.2010.04271.x; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wei LR, 2006, J INTEGR PLANT BIOL, V48, P447, DOI 10.1111/j.1744-7909.2006.00248.x; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591	34	15	18	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86210	10.1371/journal.pone.0086210	http://dx.doi.org/10.1371/journal.pone.0086210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498271	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900017
J	Szic, KSV; de Beeck, KO; Ratman, D; Wouters, A; Beck, IM; Declerck, K; Heyninck, K; Fransen, E; Bracke, M; De Bosscher, K; Lardon, F; Van Camp, G; Berghe, WV				Szic, Katarzyna Szarc vel; de Beeck, Ken Op; Ratman, Dariusz; Wouters, An; Beck, Ilse M.; Declerck, Ken; Heyninck, Karen; Fransen, Erik; Bracke, Marc; De Bosscher, Karolien; Lardon, Filip; Van Camp, Guy; Berghe, Wim Vanden			Pharmacological Levels of Withaferin A (Withania somnifera) Trigger Clinically Relevant Anticancer Effects Specific to Triple Negative Breast Cancer Cells	PLOS ONE			English	Article							HISTONE DEMETHYLASES; KAPPA-B; GROWTH; INVASION; EXPRESSION; METHYLATION; LAMININ-511; ACTIVATION; PREVENTION; REGULATORS	Withaferin A (WA) isolated from Withania somnifera (Ashwagandha) has recently become an attractive phytochemical under investigation in various preclinical studies for treatment of different cancer types. In the present study, a comparative pathway-based transcriptome analysis was applied in epithelial-like MCF-7 and triple negative mesenchymal MDA-MB-231 breast cancer cells exposed to different concentrations of WA which can be detected systemically in in vivo experiments. Whereas WA treatment demonstrated attenuation of multiple cancer hallmarks, the withanolide analogue Withanone (WN) did not exert any of the described effects at comparable concentrations. Pathway enrichment analysis revealed that WA targets specific cancer processes related to cell death, cell cycle and proliferation, which could be functionally validated by flow cytometry and real-time cell proliferation assays. WA also strongly decreased MDA-MB-231 invasion as determined by single-cell collagen invasion assay. This was further supported by decreased gene expression of extracellular matrix-degrading proteases (uPA, PLAT, ADAM8), cell adhesion molecules (integrins, laminins), pro-inflammatory mediators of the metastasis-promoting tumor microenvironment (TNFSF12, IL6, ANGPTL2, CSF1R) and concomitant increased expression of the validated breast cancer metastasis suppressor gene (BRMS1). In line with the transcriptional changes, nanomolar concentrations of WA significantly decreased protein levels and corresponding activity of uPA in MDA-MB-231 cell supernatant, further supporting its anti-metastatic properties. Finally, hierarchical clustering analysis of 84 chromatin writer-reader-eraser enzymes revealed that WA treatment of invasive mesenchymal MDA-MB-231 cells reprogrammed their transcription levels more similarly towards the pattern observed in non-invasive MCF-7 cells. In conclusion, taking into account that sub-cytotoxic concentrations of WA target multiple metastatic effectors in therapy-resistant triple negative breast cancer, WA-based therapeutic strategies targeting the uPA pathway hold promise for further (pre)clinical development to defeat aggressive metastatic breast cancer.	[Szic, Katarzyna Szarc vel; Declerck, Ken; Berghe, Wim Vanden] Univ Antwerp, Dept Biomed Sci, Lab Prot Chem Prote & Epigenet Signaling PPES, B-2020 Antwerp, Belgium; [de Beeck, Ken Op; Fransen, Erik; Van Camp, Guy] Univ Antwerp, Dept Biomed Sci, Ctr Med Genet, B-2020 Antwerp, Belgium; [de Beeck, Ken Op; Wouters, An; Lardon, Filip] Univ Antwerp, Dept Oncol, Lab Canc Res & Clin Oncol, Ctr Oncol Res CORE, B-2020 Antwerp, Belgium; [Ratman, Dariusz; De Bosscher, Karolien] Univ Ghent, VIB Dept Med Prot Res, Cytokine Receptor Lab, Nucl Receptor Signaling Unit, B-9000 Ghent, Belgium; [Beck, Ilse M.; Bracke, Marc] Univ Ghent, Dept Radiat Therapy & Expt Canc Res, Lab Expt Canc Res LECR, B-9000 Ghent, Belgium; [Heyninck, Karen] Univ Ghent, Lab Eukaryot Gene Express & Signal Transduct LEGE, B-9000 Ghent, Belgium; [Fransen, Erik] Univ Antwerp, StatUa Ctr Stat, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; University of Antwerp	Berghe, WV (corresponding author), Univ Antwerp, Dept Biomed Sci, Lab Prot Chem Prote & Epigenet Signaling PPES, B-2020 Antwerp, Belgium.	wim.vandenberghe@ua.ac.be	Van Camp, Guy/F-3386-2013; Fransen, Erik/C-4102-2015; Beck, Ilse/B-2410-2014; de Beeck, Ken Op/J-5248-2016; Wouters, An/B-5384-2017; Berghe, Wim Vanden/S-6425-2018; Vanden Berghe, Wim/HGE-4696-2022; Lardon, Filip/A-3559-2010	Van Camp, Guy/0000-0001-5105-9000; Fransen, Erik/0000-0001-7785-4790; de Beeck, Ken Op/0000-0001-5527-6838; Wouters, An/0000-0001-7771-1239; Berghe, Wim Vanden/0000-0003-0161-7355; Lardon, Filip/0000-0001-7174-4144; Beck, Ilse/0000-0002-1927-5480; De Bosscher, Karolien/0000-0001-5059-9718; Declerck, Ken/0000-0001-8104-8054	Strategic Basic Research (SBO) grant of the Agency for Innovation by Science and Technology (IWT); Special Research Fund (BOF) of The University of Antwerp, Belgium	Strategic Basic Research (SBO) grant of the Agency for Innovation by Science and Technology (IWT); Special Research Fund (BOF) of The University of Antwerp, Belgium	Research has been supported by the Strategic Basic Research (SBO) grant of the Agency for Innovation by Science and Technology (IWT) and the Special Research Fund (BOF) of The University of Antwerp, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2013, WHAT AR KEY STAT BRE; Albini A, 2012, NAT REV CLIN ONCOL, V9, P498, DOI 10.1038/nrclinonc.2012.120; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Berry WL, 2013, CANCER RES, V73, P2936, DOI 10.1158/0008-5472.CAN-12-4300; Bhat WW, 2012, GENE, V499, P25, DOI 10.1016/j.gene.2012.03.004; Blair Lauren P, 2011, Cancers (Basel), V3, P1383, DOI 10.3390/cancers3011383; Boimel PJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3108; Brown KD, 2013, BREAST CANCER RES TR, V137, P329, DOI 10.1007/s10549-012-2351-7; BRUNNER N, 1983, BRIT J CANCER, V47, P641, DOI 10.1038/bjc.1983.102; Castellana B, 2012, J CANCER, V3, P175, DOI 10.7150/jca.4120; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chia J, 2007, AM J PATHOL, V170, P2135, DOI 10.2353/ajpath.2007.060709; Chiappetta G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-17; Cock-Rada A, 2013, BIOL CELL, V105, P73, DOI 10.1111/boc.201200029; De Wever O, 2010, INT J DEV BIOL, V54, P887, DOI 10.1387/ijdb.092948ow; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Dumartin L, 2011, CANCER RES, V71, P7091, DOI 10.1158/0008-5472.CAN-11-1367; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Edmonds MD, 2009, INT J CANCER, V125, P1778, DOI 10.1002/ijc.24616; Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Floor SL, 2012, TRENDS MOL MED, V18, P509, DOI 10.1016/j.molmed.2012.06.005; GENTLEMAN RCV, 2005, BIOINFORMATICS COMPU, V19; Grigoriadis A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-619; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Hahm ER, 2012, CANC LETT; Hahm ER, 2013, JNCI-J NATL CANCER I, V105, P1111, DOI 10.1093/jnci/djt153; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He YL, 2012, ACTA BIOCH BIOPH SIN, V44, P70, DOI 10.1093/abbs/gmr109; Hurst DR, 2011, INT REV CEL MOL BIO, V286, P107, DOI 10.1016/B978-0-12-385859-7.00003-3; Jayaprakasam B, 2003, LIFE SCI, V74, P125, DOI 10.1016/j.lfs.2003.07.007; Johnson DG, 2013, CELL, V152, P685, DOI 10.1016/j.cell.2013.01.017; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Lee J, 2012, BREAST CANCER RES TR, V136, P45, DOI 10.1007/s10549-012-2239-6; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; Ma LQ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-79; Mazar AP, 2011, CURR PHARM DESIGN, V17, P1970; Mirza S, 2013, J BREAST CANCER, V16, P23, DOI 10.4048/jbc.2013.16.1.23; Mishra L C, 2000, Altern Med Rev, V5, P334; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Nanda R, 2011, SEMIN ONCOL, V38, P254, DOI 10.1053/j.seminoncol.2011.01.007; Natoli G, 2009, CURR OPIN DRUG DISC, V12, P607; Ndlovu MN, 2009, MOL CELL BIOL, V29, P5488, DOI 10.1128/MCB.01657-08; Nijwening JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025235; O'Donnell PH, 2012, INVEST NEW DRUG, V30, P604, DOI 10.1007/s10637-010-9537-9; Pereira F, 2011, HUM MOL GENET, V20, P4655, DOI 10.1093/hmg/ddr399; Pouliot N, 2013, CELL ADHES MIGR, V7, P142, DOI 10.4161/cam.22125; Ramadoss S, 2012, J BIOL CHEM, V287, P44508, DOI 10.1074/jbc.M112.424903; Rockway TW, 2003, CURR PHARM DESIGN, V9, P1483, DOI 10.2174/1381612033454649; Santana-Davila R, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-42; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Steffan JJ, 2011, CANCER LETT, V310, P109, DOI 10.1016/j.canlet.2011.06.011; Subbaram S, 2011, EXPERT OPIN THER TAR, V15, P1197, DOI 10.1517/14728222.2011.609557; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Tian MZ, 2011, CELL SIGNAL, V23, P951, DOI 10.1016/j.cellsig.2010.10.015; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Vyas A. R., 2013, AAPS J, DOI 10.1208/s12248-013-9531-1; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Yu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051239; Zambelli F, 2012, NUCLEIC ACIDS RES, V40, pW510, DOI 10.1093/nar/gks483	65	52	53	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87850	10.1371/journal.pone.0087850	http://dx.doi.org/10.1371/journal.pone.0087850			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498382	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900128
J	Tameris, M; Geldenhuys, H; Luabeya, AK; Smit, E; Hughes, JE; Vermaak, S; Hanekom, WA; Hatherill, M; Mahomed, H; McShane, H; Scriba, TJ				Tameris, Michele; Geldenhuys, Hennie; Luabeya, Angelique KanyKany; Smit, Erica; Hughes, Jane E.; Vermaak, Samantha; Hanekom, Willem A.; Hatherill, Mark; Mahomed, Hassan; McShane, Helen; Scriba, Thomas J.			The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; TUBERCULOSIS VACCINE; MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE EFFICACY; VIRUS ANKARA; SOUTH-AFRICA; BCG; IMMUNOGENICITY; SAFETY; MEMORY	Background: Vaccination against tuberculosis (TB) should provide long-term protective immunity against Mycobacterium tuberculosis (M.tb). The current TB vaccine, Bacille Calmette-Guerin (BCG), protects against disseminated childhood TB, but protection against lung TB in adolescents and adults is variable and mostly poor. One potential reason for the limited durability of protection may be waning of immunity through gradual attrition of BCG-induced T cells. We determined if a MVA85A viral-vector boost could enhance the durability of mycobacteria-specific T cell responses above those induced by BCG alone. Methods: We describe a long-term follow-up study of persons previously vaccinated with MVA85A. We performed a medical history and clinical examination, a tuberculin skin test and measured vaccine-specific T cell responses in persons previously enrolled as adults, adolescents, children or infants into three different Phase II trials, between 2005 and 2011. Results: Of 252 potential participants, 183 (72.6%) consented and completed the study visit. Vaccine-induced Ag85A-specific CD4+ T cell responses were remarkably persistent in healthy, HIV-uninfected adults, adolescents, children and infants, up to 6 years after MVA85A vaccination. Specific CD4+ T cells expressed surface markers consistent with either CD45RA-CCR7+ central memory or CD45RA-CCR7- effector memory T cells. Similarly durable Ag85A-specific CD4+ T cell responses were detected in HIV-infected persons who were on successful antiretroviral therapy when MVA85A was administered. By contrast, Ag85A-specific CD4+ T cell frequencies in untreated MVA85A-vaccinated HIV-infected persons were mostly undetectable 3-5 years after vaccination. Conclusion: MVA85A induces remarkably durable T cell responses in immunocompetent persons. However, results from a recent phase IIb trial of MVA85A, conducted in infants from the same geographic area and study population, showed no vaccine efficacy, suggesting that these durable T cell responses do not enhance BCG-induced protection against TB in infants.	[Tameris, Michele; Geldenhuys, Hennie; Luabeya, Angelique KanyKany; Smit, Erica; Hughes, Jane E.; Hanekom, Willem A.; Hatherill, Mark; Mahomed, Hassan; Scriba, Thomas J.] Univ Cape Town, Inst Infect Dis & Mol Med, South African TB Vaccine Initiat, ZA-7925 Cape Town, South Africa; [Tameris, Michele; Geldenhuys, Hennie; Luabeya, Angelique KanyKany; Smit, Erica; Hughes, Jane E.; Hanekom, Willem A.; Hatherill, Mark; Mahomed, Hassan; Scriba, Thomas J.] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [Vermaak, Samantha; McShane, Helen] Univ Oxford, Nuffield Dept Clin Med, Jenner Inst, Oxford, England	University of Cape Town; University of Cape Town; University of Oxford; Jenner Institute	Tameris, M (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, South African TB Vaccine Initiat, ZA-7925 Cape Town, South Africa.	Michele.tameris@uct.ac.za	Luabeya, Angelique Kany Kany/K-2769-2019; Tameris, Michele/AAR-6663-2021; Scriba, Thomas/GPX-2573-2022; Scriba, Thomas/AAH-9413-2020	Luabeya, Angelique Kany Kany/0000-0001-7379-2836; Tameris, Michele/0000-0002-7983-7203; Scriba, Thomas/0000-0002-0641-1359; Hanekom, Willem/0000-0003-3070-6154; Vermaak, Samantha/0000-0003-4791-8364; McShane, Helen/0000-0002-2126-5142	European Commission through University of Oxford	European Commission through University of Oxford	This clinical trial was funded by the European Commission, through grants held by the University of Oxford (PI - Helen McShane). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Brookes RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002921; Cellerai C, 2007, EUR J IMMUNOL, V37, P1129, DOI 10.1002/eji.200636885; COLDITZ GA, 1995, PEDIATRICS, V96, P29; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Dye C, 2013, LANCET, V381, P972, DOI 10.1016/S0140-6736(13)60137-3; Geldenhuys H, 2010, INT J TUBERC LUNG D, V14, P1266; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hawkridge T, 2008, J INFECT DIS, V198, P544, DOI 10.1086/590185; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Minassian AM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000223; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Odutola AA, 2012, VACCINE, V30, P5591, DOI 10.1016/j.vaccine.2012.06.054; Orme IM, 2010, TUBERCULOSIS, V90, P329, DOI 10.1016/j.tube.2010.06.002; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Scriba TJ, 2012, AM J RESP CRIT CARE, V185, P769, DOI 10.1164/rccm.201108-1548OC; Scriba TJ, 2011, J INFECT DIS, V203, P1832, DOI 10.1093/infdis/jir195; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Tameris MD, 2013, LANCET; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Whelan KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005934; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Williams A, 2005, INFECT IMMUN, V73, P3814, DOI 10.1128/IAI.73.6.3814-3816.2005; World Health Organization, 2016, CONS GUID US ANT DRU; Wrammert J, 2009, J CLIN IMMUNOL, V29, P151, DOI 10.1007/s10875-008-9267-3	37	57	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87340	10.1371/journal.pone.0087340	http://dx.doi.org/10.1371/journal.pone.0087340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498312	gold, Green Submitted, Green Published			2022-12-25	WOS:000330626900058
J	Zhang, J; Liu, XQ; Li, SY; Cheng, ZK; Li, CY				Zhang, Jie; Liu, Xiaoqiang; Li, Shuyu; Cheng, Zhukuan; Li, Chuanyou			The Rice Semi-Dwarf Mutant sd37, Caused by a Mutation in CYP96B4, Plays an Important Role in the Fine-Tuning of Plant Growth	PLOS ONE			English	Article							ORYZA-SATIVA; DWARF MUTANT; MOLECULAR-CLONING; GREEN-REVOLUTION; ALPHA-SUBUNIT; CYTOCHROME-P450; ENCODES; GENE; PROTEIN; EXPRESSION	Plant cytochrome P450 has diverse roles in developmental processes and in the response to environmental cues. Here, we characterized the rice (Oryza sativa L ssp. indica cultivar 3037) semi-dwarf mutant sd37, in which the gene CYP96B4 (Cytochrome P450 96B subfamily) was identified and confirmed as the target by map-based cloning and a complementation test. A point mutation in the SRS2 domain of CYP96B4 resulted in a threonine to lysine substitution in the sd37 mutant. Examination of the subcellular localization of the protein revealed that SD37 was ER-localized protein. And SD37 was predominantly expressed in the shoot apical meristem and developing leaf and root maturation zone but not in the root apical meristem. The sd37 leaves, panicles, and seeds were smaller than those of the wild type. Histological analysis further revealed that a decrease in cell number in the mutant, specifically in the shoots, was the main cause of the dwarf phenotype. Microarray analysis demonstrated that the expression of several cell division-related genes was disturbed in the sd37 mutant. In addition, mutation or strongly overexpression of SD37 results in dwarf plants but moderate overexpression increases plant height. These data suggest that CYP96B4 may be an important regulator of plant growth that affects plant height in rice.	[Zhang, Jie; Liu, Xiaoqiang; Li, Shuyu; Cheng, Zhukuan; Li, Chuanyou] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Genom, Beijing, Peoples R China; [Zhang, Jie] Beijing Acad Agr & Forestry Sci, Natl Engn Res Ctr Vegetables, Key Lab Biol & Genet Improvement Hort Crops North, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Beijing Academy of Agriculture & Forestry	Li, CY (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Genom, Beijing, Peoples R China.	cyli@genetics.ac.cn	Li, Chuanyou/ABF-4143-2020		National Natural Science Foundation of China [31270323, 30971544]; 973 Project from the Ministry of Sciences and Technology of China [2010CB126202]; Beijing Postdoctoral Research Foundation [2013M530548]; China Postdoctoral Science Foundation [2013M530548]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project from the Ministry of Sciences and Technology of China; Beijing Postdoctoral Research Foundation(China Postdoctoral Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (31270323 and 30971544), the 973 Project from the Ministry of Sciences and Technology of China (2010CB126202) and Beijing Postdoctoral Research and China Postdoctoral Science Foundations (2013M530548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; Asano K, 2009, MOL GENET GENOMICS, V281, P223, DOI 10.1007/s00438-008-0406-6; Asano K, 2010, P JPN ACAD B-PHYS, V86, P265, DOI 10.2183/pjab.86.265; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Benveniste I, 2006, PLANT SCI, V170, P326, DOI 10.1016/j.plantsci.2005.08.028; BORLAUG NE, 1983, SCIENCE, V219, P689, DOI 10.1126/science.219.4585.689; Butler J, 2007, CARDIOVASC RES, V74, P114, DOI 10.1016/j.cardiores.2007.01.006; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Downes BP, 1998, PLANT MOL BIOL, V37, P437, DOI 10.1023/A:1005920732211; Evans LT., 1993, CROP EVOLUTION ADAPT; Gale MD, 1985, PROGR PLANT BREEDING; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Guo J, 2010, PLANTA, V231, P293, DOI 10.1007/s00425-009-1051-y; HARGROVE TR, 1979, BIOSCIENCE, V29, P731, DOI 10.2307/1307667; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Hong Z, 2002, PLANT J, V32, P495, DOI 10.1046/j.1365-313X.2002.01438.x; Ishibashi T, 2001, GENE, V272, P335, DOI 10.1016/S0378-1119(01)00555-8; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Itoh H, 2001, P NATL ACAD SCI USA, V98, P8909, DOI 10.1073/pnas.141239398; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Katsumata T, 2011, BIOSCI BIOTECH BIOCH, V75, P331, DOI 10.1271/bbb.100759; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Khush GS, 1999, GENOME, V42, P646, DOI 10.1139/gen-42-4-646; Kimura S, 2000, PLANT SCI, V158, P33, DOI 10.1016/S0168-9452(00)00297-1; Kolesnik T, 2004, PLANT J, V37, P301, DOI 10.1046/j.1365-313X.2003.01948.x; Li JM, 2007, TRENDS PLANT SCI, V12, P37, DOI 10.1016/j.tplants.2006.11.002; Li WQ, 2010, PLANTA, V232, P1383, DOI 10.1007/s00425-010-1263-1; Magome H, 2013, P NATL ACAD SCI USA, V110, P1947, DOI 10.1073/pnas.1215788110; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Nagasawa N, 2013, PLANT J, V75, P592, DOI 10.1111/tpj.12223; Nelson David R., 2006, Phytochemistry Reviews, V5, P193, DOI 10.1007/s11101-006-9015-3; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Qi J, 2008, PLANT PHYSIOL, V147, P1947, DOI 10.1104/pp.108.118778; Ramamoorthy R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028069; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Rupasinghe Sanjeewa, 2006, Phytochemistry Reviews, V5, P473, DOI 10.1007/s11101-006-9028-y; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Sakamoto T, 2004, CURR OPIN BIOTECH, V15, P144, DOI 10.1016/j.copbio.2004.02.003; Sauter M, 1997, PLANT J, V11, P181, DOI 10.1046/j.1365-313X.1997.11020181.x; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Tuteja N, 2011, PLANT MOL BIOL, V77, P537, DOI 10.1007/s11103-011-9836-3; Ueguchi-Tanaka M, 2000, P NATL ACAD SCI USA, V97, P11638, DOI 10.1073/pnas.97.21.11638; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wang Q, 2012, PLANT PHYSIOL, V158, P1418, DOI 10.1104/pp.111.187518; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yang RF, 2011, ANN BOT-LONDON, V107, P1087, DOI 10.1093/aob/mcr057; ZHANG W, 1988, THEOR APPL GENET, V76, P835, DOI 10.1007/BF00273668; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	55	35	40	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88068	10.1371/journal.pone.0088068	http://dx.doi.org/10.1371/journal.pone.0088068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498428	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900174
J	Antunes, DA; Rigo, MM; Sinigaglia, M; de Medeiros, RM; Junqueira, DM; Almeida, SEM; Vieira, GF				Antunes, Dinler A.; Rigo, Mauricio M.; Sinigaglia, Marialva; de Medeiros, Rubia M.; Junqueira, Dennis M.; Almeida, Sabrina E. M.; Vieira, Gustavo F.			New Insights into the In Silico Prediction of HIV Protease Resistance to Nelfinavir	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-1 PROTEASE; MOLECULAR-DYNAMICS SIMULATIONS; DRUG-RESISTANCE; MUTATION D30N; SUBTYPES B; INHIBITORS; DESIGN; TARGET; BRAZIL; SITE	The Human Immunodeficiency Virus type 1 protease enzyme (HIV-1 PR) is one of the most important targets of anti-retroviral therapy used in the treatment of AIDS patients. The success of protease-inhibitors (PIs), however, is often limited by the emergence of protease mutations that can confer resistance to a specific drug, or even to multiple PIs. In the present study, we used bioinformatics tools to evaluate the impact of the unusual mutations D30V and V32E over the dynamics of the PR-Nelfinavir complex, considering that codons involved in these mutations were previously related to major drug resistance to Nelfinavir. Both studied mutations presented structural features that indicate resistance to Nelfinavir, each one with a different impact over the interaction with the drug. The D30V mutation triggered a subtle change in the PR structure, which was also observed for the well-known Nelfinavir resistance mutation D30N, while the V32E exchange presented a much more dramatic impact over the PR flap dynamics. Moreover, our in silico approach was also able to describe different binding modes of the drug when bound to different proteases, identifying specific features of HIV-1 subtype B and subtype C proteases.	[Antunes, Dinler A.; Rigo, Mauricio M.; Sinigaglia, Marialva; Vieira, Gustavo F.] Univ Fed Rio Grande do Sul, Dept Genet, NBLI, Porto Alegre, RS, Brazil; [de Medeiros, Rubia M.; Junqueira, Dennis M.; Almeida, Sabrina E. M.] State Fdn Prod & Hlth Res FEPPS, Technol & Sci Dev Ctr CDCT, Porto Alegre, RS, Brazil; [Antunes, Dinler A.; Rigo, Mauricio M.; Sinigaglia, Marialva; de Medeiros, Rubia M.; Junqueira, Dennis M.; Vieira, Gustavo F.] Univ Fed Rio Grande do Sul, PPGBM, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Vieira, GF (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, NBLI, Porto Alegre, RS, Brazil.	fioravanti.vieira@ufrgs.br	vieira, gustavo F/G-4846-2012; Junqueira, Dennis/ABC-4378-2021; Sinigaglia, Marialva/AAG-3172-2020; de Medeiros, Rúbia M/L-2761-2015; Rigo, Mauricio Menegatti/N-8532-2018; Antunes, Dinler Amaral/Z-4437-2019	vieira, gustavo F/0000-0002-2380-8059; de Medeiros, Rúbia M/0000-0001-7403-5650; Rigo, Mauricio Menegatti/0000-0002-1584-6194; Antunes, Dinler Amaral/0000-0001-7947-6455; Esteves De Matos Almeida, Sabrina/0000-0003-3599-8520; Junqueira, Dennis/0000-0003-1576-484X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora SK, 2008, AIDS RES HUM RETROV, V24, P125, DOI 10.1089/aid.2007.0156; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Batista PR, 2006, CELL BIOCHEM BIOPHYS, V44, P395, DOI 10.1385/CBB:44:3:395; Chen JZ, 2010, J MOL MODEL, V16, P459, DOI 10.1007/s00894-009-0553-7; de Medeiros RM, 2011, J MED VIROL, V83, P1682, DOI 10.1002/jmv.22188; Delano W. L., 2004, PYMOL USERS GUIDE; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Gantt S, 2013, CURR OPIN ONCOL, V25, P495, DOI 10.1097/CCO.0b013e328363dfee; Ghosh AK, 2008, ACCOUNTS CHEM RES, V41, P78, DOI 10.1021/ar7001232; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HYLAND LJ, 1991, BIOCHEMISTRY-US, V30, P8454, DOI 10.1021/bi00098a024; HYLAND LJ, 1991, BIOCHEMISTRY-US, V30, P8441, DOI 10.1021/bi00098a023; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Kar P, 2012, J COMPUT AID MOL DES, V26, P215, DOI 10.1007/s10822-012-9550-5; Kozisek M, 2007, J MOL BIOL, V374, P1005, DOI 10.1016/j.jmb.2007.09.083; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lu T, 2010, AIDS, V24, P1121, DOI 10.1097/QAD.0b013e3283383c4c; Matsuyama S, 2010, J PHYS CHEM B, V114, P521, DOI 10.1021/jp908314f; Mitsuya Y, 2006, AIDS RES HUM RETROV, V22, P1300, DOI 10.1089/aid.2006.22.1300; Naicker P, 2012, J BIOMOL STRUCT DYN; Ode H, 2007, J MOL BIOL, V370, P598, DOI 10.1016/j.jmb.2007.04.081; Perez MAS, 2007, J MOL GRAPH MODEL, V26, P634, DOI 10.1016/j.jmgm.2007.03.009; Perryman AL, 2006, BIOPOLYMERS, V82, P272, DOI 10.1002/bip.20497; Perryman AL, 2004, PROTEIN SCI, V13, P1108, DOI 10.1110/ps.03468904; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piana S, 2002, PROTEIN SCI, V11, P2393, DOI 10.1110/ps.0206702; Piana S, 2002, J MOL BIOL, V319, P567, DOI 10.1016/S0022-2836(02)00301-7; Rhee SY, 2010, ANTIMICROB AGENTS CH, V54, P4253, DOI 10.1128/AAC.00574-10; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Santos AFA, 2011, MEM I OSWALDO CRUZ, V106, P177, DOI 10.1590/S0074-02762011000200010; Soares RO, 2010, J MOL GRAPH MODEL, V29, P137, DOI 10.1016/j.jmgm.2010.05.007; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Xie L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002037	35	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87520	10.1371/journal.pone.0087520	http://dx.doi.org/10.1371/journal.pone.0087520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498124	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900125
J	Li, ZJ; Lui, EY; Wilson, JM; Ip, YK; Lin, QS; Lam, TJ; Lam, SH				Li, Zhengjun; Lui, Eei Yin; Wilson, Jonathan M.; Ip, Yuen Kwong; Lin, Qingsong; Lam, Toong Jin; Lam, Siew Hong			Expression of Key Ion Transporters in the Gill and Esophageal-Gastrointestinal Tract of Euryhaline Mozambique Tilapia Oreochromis mossambicus Acclimated to Fresh Water, Seawater and Hypersaline Water	PLOS ONE			English	Article							NA+/K+/2CL(-) COTRANSPORTER; DICENTRARCHUS-LABRAX; ANTIGEN RETRIEVAL; GLUCOSE-TRANSPORT; INTESTINAL-TRACT; RICH CELLS; TELEOST; FISH; SALINITY; ADAPTATION	The ability of euryhaline Mozambique tilapia to tolerate extreme environmental salinities makes it an excellent model for investigating iono-regulation. This study aimed to characterize and fill important information gap of the expression levels of key ion transporters for Na+ and Cl- in the gill and esophageal-gastrointestinal tract of Mozambique tilapia acclimated to freshwater (0 ppt), seawater (30 ppt) and hypersaline (70 ppt) environments. Among the seven genes studied, it was found that nkcc2, nkcc1a, cftr, nka-alpha 1 and nka-alpha 3, were more responsive to salinity challenge than nkcc1b and ncc within the investigated tissues. The ncc expression was restricted to gills of freshwater-acclimated fish while nkcc2 expression was restricted to intestinal segments irrespective of salinity challenge. Among the tissues investigated, gill and posterior intestine were found to be highly responsive to salinity changes, followed by anterior and middle intestine. Both esophagus and stomach displayed significant up-regulation of nka-alpha 1 and nka-alpha 3, but not nkcc isoforms and cftr, in hypersaline-acclimated fish suggesting a response to hypersalinity challenge and involvement of other forms of transporters in iono-regulation. Changes in gene expression levels were partly corroborated by immunohistochemical localization of transport proteins. Apical expression of Ncc was found in Nka-immunoreactive cells in freshwater-acclimated gills while Nkcc co-localized with Nka-immunoreactive cells expressing Cftr apically in seawater- and hypersaline-acclimated gills. In the intestine, Nkcc-stained apical brush border was found in Nka-immunoreactive cells at greater levels under hypersaline conditions. These findings provided new insights into the responsiveness of these genes and tissues under hypersalinity challenge, specifically the posterior intestine being vital for salt absorption and iono-osmoregulation in the Mozambique tilapia; its ability to survive in hypersalinity may be in part related to its ability to up-regulate key ion transporters in the posterior intestine. The findings pave the way for future iono-regulatory studies on the Mozambique tilapia esophageal-gastrointestinal tract.	[Li, Zhengjun; Lui, Eei Yin; Lam, Siew Hong] Natl Univ Singapore, NUS Environm Res Inst, Singapore 117548, Singapore; [Ip, Yuen Kwong; Lin, Qingsong; Lam, Toong Jin; Lam, Siew Hong] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Wilson, Jonathan M.] Univ Porto, Ctr Interdisciplinar Marine & Environm Res, P-4100 Oporto, Portugal	National University of Singapore; National University of Singapore; Universidade do Porto	Lam, SH (corresponding author), Natl Univ Singapore, NUS Environm Res Inst, Singapore 117548, Singapore.	dbslsh@nus.edu.sg	Lin, Qingsong/H-9794-2012; Quality, Aquaculture Seafood/AAD-7718-2019; Wilson, Jonathan/I-6071-2012; Lam, Siew Hong/H-8483-2012; Ip, Yuen Kwong/H-8041-2012; Wilson, Jonathan Mark/AAG-6481-2019	Lin, Qingsong/0000-0001-9117-8514; Wilson, Jonathan/0000-0003-3681-1166; Ip, Yuen Kwong/0000-0001-9124-7911; Wilson, Jonathan Mark/0000-0003-3681-1166; Li, Zhengjun/0000-0002-6997-5530	Singapore National Research Foundation [2P 10004/82]; European Regional Development Fund through the COMPETE -Operational Competitiveness Program; Portuguese Foundation for Science and Technology [PEst-C/MAR/LA0015/2011]	Singapore National Research Foundation(National Research Foundation, Singapore); European Regional Development Fund through the COMPETE -Operational Competitiveness Program; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	The research grant for this study is supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB (2P 10004/82) to S. H. Lam and Y. K. IP. J. M. Wilson was supported by the European Regional Development Fund through the COMPETE -Operational Competitiveness Program and national funds through the Portuguese Foundation for Science and Technology [PEst-C/MAR/LA0015/2011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbachano A, 2010, ONCOGENE, V29, P4800, DOI 10.1038/onc.2010.225; Bodinier C, 2009, J ANAT, V214, P318, DOI 10.1111/j.1469-7580.2009.01050.x; Brauner CJ, 2013, FISH PHYSIOL, V32, P435, DOI 10.1016/B978-0-12-396951-4.00009-8; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Fiol DF, 2007, FEBS J, V274, P5790, DOI 10.1111/j.1742-4658.2007.06099.x; Gonzalez RJ, 2012, J COMP PHYSIOL B, V182, P321, DOI 10.1007/s00360-011-0624-9; Gregorio SF, 2013, J EXP BIOL, V216, P470, DOI 10.1242/jeb.073742; Grosell M, 2006, J EXP BIOL, V209, P2813, DOI 10.1242/jeb.02345; Grosell M, 2011, FISH PHYSIOL, V30, P135, DOI 10.1016/S1546-5098(10)03004-9; Hamann S, 2005, J PHYSIOL-LONDON, V568, P123, DOI 10.1113/jphysiol.2005.093526; Hamann S, 2010, J PHYSIOL-LONDON, V588, P4089, DOI 10.1113/jphysiol.2010.194738; Hiroi J, 2008, J EXP BIOL, V211, P2584, DOI 10.1242/jeb.018663; Horng JL, 2009, AM J PHYSIOL-CELL PH, V297, pC845, DOI 10.1152/ajpcell.00218.2009; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; KULTZ D, 1993, J COMP PHYSIOL B, V163, P406; KULTZ D, 1992, COMP BIOCHEM PHYS B, V102, P293, DOI 10.1016/0305-0491(92)90125-B; KULTZ D, 1993, MAR BIOL, V117, P527; Larsen EH, 2002, J PHYSIOL-LONDON, V542, P33, DOI 10.1113/jphysiol.2001.013248; Laverty G, 2012, COMP BIOCHEM PHYS A, V163, P1, DOI 10.1016/j.cbpa.2012.05.203; Link K, 2010, MOL CELL ENDOCRINOL, V327, P40, DOI 10.1016/j.mce.2010.05.011; Loong AM, 2012, J COMP PHYSIOL B, V182, P367, DOI 10.1007/s00360-011-0626-7; Loretz CA, 2009, GEN COMP ENDOCR, V161, P216, DOI 10.1016/j.ygcen.2008.12.020; Lorin-Nebel C, 2006, J EXP BIOL, V209, P4908, DOI 10.1242/jeb.02591; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Namimatsu S, 2005, J HISTOCHEM CYTOCHEM, V53, P3, DOI 10.1369/jhc.4C6466.2005; Ouattara N, 2009, AQUACULTURE, V290, P155, DOI 10.1016/j.aquaculture.2009.01.025; RESHKIN SJ, 1987, AM J PHYSIOL, V252, pR567, DOI 10.1152/ajpregu.1987.252.3.R567; RESHKIN SJ, 1987, AM J PHYSIOL, V252, pR579, DOI 10.1152/ajpregu.1987.252.3.R579; Sardella BA, 2004, J EXP BIOL, V207, P1399, DOI 10.1242/jeb.00895; Smith BJ, 2000, CELLS TISSUES ORGANS, V166, P294, DOI 10.1159/000016743; Takahashi H, 2006, LIFE SCI, V78, P2329, DOI 10.1016/j.lfs.2005.09.050; Takahashi H, 2007, GEN COMP ENDOCR, V152, P326, DOI 10.1016/j.ygcen.2007.02.021; Taylor CR, 1996, APPL IMMUNOHISTOCHEM, V4, P144; Watanabe S, 2011, COMP BIOCHEM PHYS A, V159, P427, DOI 10.1016/j.cbpa.2011.04.009; WHITFIELD A K, 1979, Environmental Biology of Fishes, V4, P77, DOI 10.1007/BF00005931; Whittamore JM, 2012, J COMP PHYSIOL B, V182, P1, DOI 10.1007/s00360-011-0601-3; Wilson JM, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1381; Wilson JM, 2007, MAR BIOL, V151, P1633, DOI 10.1007/s00227-006-0579-7; Wood CM, 2011, FISH PHYSIOL, V30, P165, DOI 10.1016/S1546-5098(10)03005-0	39	42	42	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87591	10.1371/journal.pone.0087591	http://dx.doi.org/10.1371/journal.pone.0087591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498146	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900140
J	Mori, K; Iijima, N; Higo, S; Aikawa, S; Matsuo, I; Takumi, K; Sakamoto, A; Ozawa, H				Mori, Keisuke; Iijima, Norio; Higo, Shimpei; Aikawa, Satoko; Matsuo, Izumi; Takumi, Ken; Sakamoto, Atsuhiro; Ozawa, Hitoshi			Epigenetic Suppression of Mouse Per2 Expression in the Suprachiasmatic Nucleus by the Inhalational Anesthetic, Sevoflurane	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; IN-SITU HYBRIDIZATION; HISTONE ACETYLTRANSFERASE; GENE-EXPRESSION; MESSENGER-RNA; CPG ISLANDS; TRANSCRIPTION; GABA(A); PERIOD2; NAMPT	Background: We previously reported that sevoflurane anesthesia reversibly suppresses the expression of the clock gene, Period2 (Per2), in the mouse suprachiasmatic nucleus (SCN). However, the molecular mechanisms underlying this suppression remain unclear. In this study, we examined the possibility that sevoflurane suppresses Per2 expression via epigenetic modification of the Per2 promoter. Methods: Mice were anesthetized with a gas mixture of 2.5% sevoflurane/40% oxygen at a 6 L/min flow for 1 or 4 h. After termination, brains were removed and samples of SCN tissue were derived from frozen brain sections. Chromatin immunoprecipitation (ChIP) assays using anti-acetylated-histone antibodies were performed to investigate the effects of sevoflurane on histone acetylation of the Per2 promoter. Interaction between the E'-box (a cis-element in the Per2 promoter) and CLOCK (the Clock gene product) was also assessed by a ChIP assay using an anti-CLOCK antibody. The SCN concentration of nicotinamide adenine dinucleotide (NAD(+)), a CLOCK regulator, was assessed by liquid chromatographymass spectrometry. Results: Acetylation of histone H4 in the proximal region of the Per2 promoter was significantly reduced by sevoflurane. This change in the epigenetic profile of the Per2 gene was observed prior to suppression of Per2 expression. Simultaneously, a reduction in the CLOCK-E'-box interaction in the Per2 promoter was observed. Sevoflurane treatment did not affect the concentration of NAD(+) in the SCN. Conclusions: Independent of NAD(+) concentration in the SCN, sevoflurane decreases CLOCK binding to the Per2 promoter E'-box motif, reducing histone acetylation and leading to suppression of Per2 expression.	[Mori, Keisuke; Iijima, Norio; Higo, Shimpei; Aikawa, Satoko; Matsuo, Izumi; Takumi, Ken; Ozawa, Hitoshi] Nippon Med Sch, Grad Sch Med, Dept Anat & Neurobiol, Tokyo 113, Japan; [Mori, Keisuke; Matsuo, Izumi; Sakamoto, Atsuhiro] Nippon Med Sch, Grad Sch Med, Dept Anesthesiol & Pain Med, Tokyo 113, Japan	Nippon Medical School; Nippon Medical School	Iijima, N (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Anat & Neurobiol, 1-1-5 Sendagi, Tokyo 113, Japan.	niijima@nms.ac.jp	Ozawa, Hitoshi/AAB-1348-2020		Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; MEXT [S0801035];  [22590230];  [23659125];  [24592318];  [24790241]; Grants-in-Aid for Scientific Research [24592318] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan, the MEXT-Supported Program for Strategic Research Foundation at Private Universities (S0801035 to H.O.), and Grants-in-Aid for Scientific Research (22590230 to H.O.; 23659125 to N.I.; 24592318 to A.S.; and 24790241 to S.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2006, MOL BIOL CELL, V17, P555, DOI 10.1091/mbc.E05-05-0396; Anzai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059454; Bellet MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023982; BROWN BR, 1993, ANESTHESIOLOGY, V79, P201, DOI 10.1097/00000542-199307000-00051; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Ehlen JC, 2008, J BIOL RHYTHM, V23, P16, DOI 10.1177/0748730407310785; Ehlen JC, 2006, EUR J NEUROSCI, V23, P3328, DOI 10.1111/j.1460-9568.2006.04857.x; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; FORREST JB, 1990, ANESTHESIOLOGY, V72, P252, DOI 10.1097/00000542-199002000-00008; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Kadota K, 2012, NEUROSCI LETT, V528, P153, DOI 10.1016/j.neulet.2012.07.061; Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LEVY WJ, 1984, BRIT J ANAESTH, V56, pS101; Milagro FI, 2012, CHRONOBIOL INT, V29, P1180, DOI 10.3109/07420528.2012.719967; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Nishikawa K, 2003, ANESTHESIOLOGY, V99, P678, DOI 10.1097/00000542-200309000-00024; Nishikawa K, 2001, ANESTHESIOLOGY, V94, P340, DOI 10.1097/00000542-200102000-00025; OHARA BF, 1995, MOL BRAIN RES, V28, P239, DOI 10.1016/0169-328X(94)00212-W; Ohe Y, 2011, NEUROSCI LETT, V490, P231, DOI 10.1016/j.neulet.2010.12.059; Ohno T, 2007, NUCLEIC ACIDS RES, V35, P648, DOI 10.1093/nar/gkl868; OKAMURA H, 1989, NEUROSCI LETT, V102, P131, DOI 10.1016/0304-3940(89)90067-0; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sakamoto A, 2005, GENE, V356, P39, DOI 10.1016/j.gene.2005.03.022; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strecker GJ, 1997, J NEUROPHYSIOL, V78, P2217, DOI 10.1152/jn.1997.78.4.2217; Tanaka M, 1997, J HISTOCHEM CYTOCHEM, V45, P1231, DOI 10.1177/002215549704500906; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamajuku D, 2010, NUCLEIC ACIDS RES, V38, P7964, DOI 10.1093/nar/gkq678; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	42	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87319	10.1371/journal.pone.0087319	http://dx.doi.org/10.1371/journal.pone.0087319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498074	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900090
J	Puleston, C; Tuljapurkar, S; Winterhalder, B				Puleston, Cedric; Tuljapurkar, Shripad; Winterhalder, Bruce			The Invisible Cliff: Abrupt Imposition of Malthusian Equilibrium in a Natural-Fertility, Agrarian Society	PLOS ONE			English	Article							CLASSIC MAYA COLLAPSE; POPULATION ECOLOGY; CLIMATE; GROWTH; CIVILIZATIONS; DEMOGRAPHY; DROUGHT	Analysis of a natural fertility agrarian society with a multi-variate model of population ecology isolates three distinct phases of population growth following settlement of a new habitat: (1) a sometimes lengthy copial phase of surplus food production and constant vital rates; (2) a brief transition phase in which food shortages rapidly cause increased mortality and lessened fertility; and (3) a Malthusian phase of indefinite length in which vital rates and quality of life are depressed, sometimes strikingly so. Copial phase duration declines with increases in the size of the founding group, maximum life expectancy and fertility; it increases with habitat area and yield per hectare; and, it is unaffected by the sensitivity of vital rates to hunger. Transition phase duration is unaffected by size of founding population and area of settlement; it declines with yield, life expectancy, fertility and the sensitivity of vital rates to hunger. We characterize the transition phase as the Malthusian transition interval (MTI), in order to highlight how little time populations generally have to adjust. Under food-limited density dependence, the copial phase passes quickly to an equilibrium of grim Malthusian constraints, in the manner of a runner dashing over an invisible cliff. The three-phase pattern diverges from widely held intuitions based on standard Lotka-Verhulst approaches to population regulation, with implications for the analysis of socio-cultural evolution, agricultural intensification, bioarchaeological interpretation of food stress in prehistoric societies, and state-level collapse.	[Puleston, Cedric; Winterhalder, Bruce] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Tuljapurkar, Shripad] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of California System; University of California Davis; Stanford University	Puleston, C (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	puleston@ucdavis.edu		Tuljapurkar, Shripad/0000-0001-5549-4245	NSF (Division of Behavioral and Cognitive Sciences) [0827275]	NSF (Division of Behavioral and Cognitive Sciences)	This work is supported by the NSF (Division of Behavioral and Cognitive Sciences) Human Systems Dynamics, Collaborative Research proposal, Development and Resilience of Complex Socioeconomic Systems: A Theoretical Model and Case Study from the Maya Lowlands [Proposal# 0827275]. Website: http://www.nsf.gov/div/index.jsp?div=BCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson T., 2004, LIFE PRESSURE MORTAL, P1700; Boserup E., 1965, CONDITIONS AGR GROWT; Caswell H, 2004, MATRIX POPULATION MO; Caughley G., 1976, APPL BIOL, P183; Culbert T.P., 1988, COLLAPSE ANCIENT STA, P69; Cullen HM, 2000, GEOLOGY, V28, P379, DOI 10.1130/0091-7613(2000)28<379:CCATCO>2.0.CO;2; Diamond J, 2004, NEW YORK REV BOOKS, V51, P6; Diamond J., 2004, COLLAPSE SOC CHOOSE; Drysdale R, 2006, GEOLOGY, V34, P101, DOI 10.1130/G22103.1; Gaillard J-M, 1988, TREE, V13, P58; Gill RB, 2007, ANCIENT MESOAM, V18, P283, DOI 10.1017/S0956536107000193; HAMBLIN RL, 1980, AM ANTIQUITY, V45, P246, DOI 10.2307/279284; Holling C. S., 1959, Canadian Entomologist, V91, P385; Hunt BG, 2005, CLIMATIC CHANGE, V69, P393, DOI 10.1007/s10584-005-2794-5; Hutchinson G.E., 1978, INTRO POPULATION ECO; Johnston KJ, 2003, J ANTHROPOL ARCHAEOL, V22, P126, DOI 10.1016/S0278-4165(03)00013-8; Kennett DJ, 2012, SCIENCE, V338, P788, DOI 10.1126/science.1226299; Kirch PV, 1997, AM ANTHROPOL, V99, P30, DOI 10.1525/aa.1997.99.1.30; KOHLER TA, 2007, MODEL BASED ARCHAEOL, P00001; Lee CT, 2008, THEOR POPUL BIOL, V73, P473, DOI 10.1016/j.tpb.2008.03.001; Lee CT, 2009, THEOR POPUL BIOL, V76, P179, DOI 10.1016/j.tpb.2009.06.003; Lee R., 1986, STATE POPULATION THE, P96; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Malthus TR, 2003, ESSAY PRINCIPLE POPU; Middleton G, 2012, J ARCHAEOL RES, V20, P257, DOI 10.1007/s10814-011-9054-1; Neubert MG, 2000, J MATH BIOL, V41, P103, DOI 10.1007/s002850070001; O'Sullivan P, 2008, HOLOCENE, V18, P45, DOI 10.1177/0959683607085595; Peterson LC, 2005, AM SCI, V93, P322, DOI 10.1511/2005.54.968; Puleston CO, 2008, THEOR POPUL BIOL, V74, P147, DOI 10.1016/j.tpb.2008.05.007; Read DW, 2003, CURR ANTHROPOL, V44, P59, DOI 10.1086/344616; Scott S, 2003, DEMOGRAPHY NUTR EVID; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Staubwasser M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016822; Tainter JA, 2006, ANNU REV ANTHROPOL, V35, P59, DOI 10.1146/annurev.anthro.35.081705.123136; Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2; Turchin P, 2001, OIKOS, V94, P17, DOI 10.1034/j.1600-0706.2001.11310.x; Turchin P., 2018, HIST DYNAMICS WHY ST, DOI [10.23943/princeton/9780691180779.001.0001, DOI 10.23943/PRINCETON/9780691180779.001.0001]; Turchin P, 2008, NATURE, V454, P34, DOI 10.1038/454034a; Turchin P, 2009, ANN NY ACAD SCI, V1162, P1, DOI 10.1111/j.1749-6632.2009.04447.x; Turner BL, 2012, P NATL ACAD SCI USA, V109, P13908, DOI 10.1073/pnas.1210106109; Wang SW, 2005, PROG NAT SCI, V15, P908; WEBSTER D, 1985, J ANTHROPOL RES, V41, P375, DOI 10.1086/jar.41.4.3630571; WINTERHALDER B, 1988, J ANTHROPOL ARCHAEOL, V7, P289, DOI 10.1016/0278-4165(88)90001-3; Winterhalder B., 2002, DARWIN ARCHAEOLOGY H, P201; Winterhalder B, EXCHEQUERS GUI UNPUB; Winterhalder B, YIELD FLUCTUAT UNPUB; Wood JW, 1998, CURR ANTHROPOL, V39, P99, DOI 10.1086/204700; Wright HT, 2007, MODEL BASED ARCHAEOL, P229; Wright LE, 1996, J WORLD PREHIST, V10, P147, DOI 10.1007/BF02221075	50	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87541	10.1371/journal.pone.0087541	http://dx.doi.org/10.1371/journal.pone.0087541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	302RF	24498131	gold, Green Published			2022-12-25	WOS:000330621900130
J	Cardenas, C; Carmona, M; Gallardo, A; Labra, A; Marshall, SH				Cardenas, Constanza; Carmona, Marisela; Gallardo, Alicia; Labra, Alvaro; Marshall, Sergio H.			Coexistence in Field Samples of Two Variants of the Infectious Salmon Anemia Virus: A Putative Shift to Pathogenicity	PLOS ONE			English	Article							ATLANTIC SALMON; HEMAGGLUTININ GENE; ISAV; IDENTIFICATION; VIRULENCE; OUTBREAKS; SEQUENCE; DISEASE; NORWAY	Genetic reassortment plays an important role in the evolution of several segmented RNA viruses and in the epidemiology of their associated diseases. In particular, orthomyxoviruses show rapid fluctuation in the proportion of viral variants coexisting in an infected individual, especially under strong selective pressure. This is particularly relevant in salmon production carried out under confined and stressful conditions where one of the most feared pathogenic agents is the Infectious Salmon Anemia Virus, an orthomyxovirus family member whose biological behavior is only recently beginning to be understood. Pathogenicity of the virus has been mainly associated with deletions of the HPR region in coding segment 6 and the presence or absence of a specific insertion in a key region in coding segment 5. In this study we report, for the first time in Chile, the coexistence of two variants in fully asymptomatic fish. Of five samples analyzed, two were identified as the nonpathogenic variant, HPR0, and two as the highly pathogenic HPR7b variant, though with no clinical signs detectable in the fish. Interestingly, one of the samples unequivocally carried both variants, again without any clinical signs. Considering that in none of the samples the typical insertion in coding segment 5 was detected, it is our impression that this may represent a shift from the non-pathogenic HPR0 variant towards the highly infective HPR7b variant. If this were the case, the transition may be triggered first by deleting the corresponding sequence of the HPR region of segment 6, followed by the putative insertion in segment 5 to generate a virulent strain.	[Cardenas, Constanza; Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Nucleo Biotecnol Curauma, Valparaiso, Chile; [Labra, Alvaro; Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Nucleo Biotecnol Curauma, Lab Patogenos Acuicolas, Valparaiso, Chile; [Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Fac Ciencias, Inst Biol, Lab Genet & Inmunol Mol, Valparaiso, Chile; [Gallardo, Alicia; Labra, Alvaro] Serv Nacl Pesca & Acuicultura, Valparaiso, Chile; [Cardenas, Constanza; Carmona, Marisela; Marshall, Sergio H.] Fraunhofer Chile Res, Santiago, Chile	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso	Marshall, SH (corresponding author), Pontificia Univ Catolica Valparaiso, Nucleo Biotecnol Curauma, Valparaiso, Chile.	smarshal@ucv.cl	Cárdenas, Constanza/ABA-6477-2021	marshall, sergio/0000-0003-0438-8252				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Bouchard D, 1999, DIS AQUAT ORGAN, V35, P131, DOI 10.3354/dao035131; Bouchard DA, 2001, BULL EUR ASSN FISH P, V21, P86; Carmona M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037353; Christiansen DH, 2011, J GEN VIROL, V92, P909, DOI 10.1099/vir.0.027094-0; Cottet L, 2010, J VIROL, V84, P11916, DOI 10.1128/JVI.01202-10; Devold M, 2006, J GEN VIROL, V87, P2031, DOI 10.1099/vir.0.81687-0; Devold M, 2001, DIS AQUAT ORGAN, V47, P119, DOI 10.3354/dao047119; Godoy MG, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-28; Kawaoka Y., 2005, 8 INT COMM TAX VIR, P681; Kibenge FSB, 2007, J GEN VIROL, V88, P3100, DOI 10.1099/vir.0.83097-0; Kibenge FSB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-88; Kibenge FSB, 2001, J GEN VIROL, V82, P2869, DOI 10.1099/0022-1317-82-12-2869; Kibenge FSB, 2001, DIS AQUAT ORGAN, V45, P9, DOI 10.3354/dao045009; Krossoy B, 2001, DIS AQUAT ORGAN, V44, P1, DOI 10.3354/dao044001; Krossoy B, 2001, J GEN VIROL, V82, P1757, DOI 10.1099/0022-1317-82-7-1757; Krossoy B, 1999, J VIROL, V73, P2136; Lovely JE, 1999, DIS AQUAT ORGAN, V35, P145, DOI 10.3354/dao035145; Lyngoy C., 2003, INT RESPONSE INFECT, P97; Lyngstad TM, 2012, DIS AQUAT ORGAN, V101, P197, DOI 10.3354/dao02520; Markussen T, 2008, VIROLOGY, V374, P515, DOI 10.1016/j.virol.2008.01.019; Mjaaland S, 2002, VIROLOGY, V304, P379, DOI 10.1006/viro.2002.1658; Mullins J.E., 1998, Bulletin of the European Association of Fish Pathologists, V18, P110; Nylund A, 2003, DIS AQUAT ORGAN, V56, P11, DOI 10.3354/dao056011; Nylund A, 2007, ARCH VIROL, V152, P151, DOI 10.1007/s00705-006-0825-9; Rodger H.D., 1998, Bulletin of the European Association of Fish Pathologists, V18, P115; Sepulveda D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037265; Sernapesca, 2012, 1 SERN; Snow M, 2006, DEV BIOLOGICALS, V126, P133; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thorud K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P109; Vike S, 2009, ARCH VIROL, V154, P1, DOI 10.1007/s00705-008-0251-2	33	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87832	10.1371/journal.pone.0087832	http://dx.doi.org/10.1371/journal.pone.0087832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498206	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100118
J	Matsumura, H; Miyagi, N; Taniai, N; Fukushima, M; Tarora, K; Shudo, A; Urasaki, N				Matsumura, Hideo; Miyagi, Norimichi; Taniai, Naoki; Fukushima, Mai; Tarora, Kazuhiko; Shudo, Ayano; Urasaki, Naoya			Mapping of the Gynoecy in Bitter Gourd (Momordica charantia) Using RAD-Seq Analysis	PLOS ONE			English	Article							CUCUMIS-SATIVUS L.; SNP DISCOVERY; CUCURBITACEAE; PLANTS; INHERITANCE; EXPRESSION; MARKERS; GENES; FEMALENESS; GENETICS	Momordica charantia is a monoecious plant of the Cucurbitaceae family that has both male and female unisexual flowers. Its unique gynoecious line, OHB61-5, is essential as a maternal parent in the production of F-1 cultivars. To identify the DNA markers for this gynoecy, a RAD-seq (restriction-associated DNA tag sequencing) analysis was employed to reveal genome-wide DNA polymorphisms and to genotype the F-2 progeny from a cross between OHB61-5 and a monoecious line. Based on a RAD-seq analysis of F-2 individuals, a linkage map was constructed using 552 co-dominant markers. In addition, after analyzing the pooled genomic DNA from monoecious or gynoecious F-2 plants, several SNP loci that are genetically linked to gynoecy were identified. GTFL-1, the closest SNP locus to the putative gynoecious locus, was converted to a conventional DNA marker using invader assay technology, which is applicable to the marker-assisted selection of gynoecy in M. charantia breeding.	[Matsumura, Hideo; Fukushima, Mai] Shinshu Univ, Ctr Gene Res, Ueda, Nagano, Japan; [Miyagi, Norimichi; Taniai, Naoki; Tarora, Kazuhiko; Shudo, Ayano; Urasaki, Naoya] Okinawa Prefectural Agr Res Ctr, Itoman, Okinawa, Japan	Shinshu University	Matsumura, H (corresponding author), Shinshu Univ, Ctr Gene Res, Ueda, Nagano, Japan.	hideoma@shinshu-u.ac.jp	wang, chen/F-7230-2011	Tarora, Kazuhiko/0000-0003-1448-976X; Matsumura, Hideo/0000-0003-4849-1016	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry	This work was supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal G, 2012, PLANT SIGNAL BEHAV, V7, P827, DOI 10.4161/psb.20321; Anderson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040701; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Bharathi LK, 2011, J GENET, V90, P21, DOI 10.1007/s12041-011-0026-5; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Briggs Adrian W, 2009, J Vis Exp, P1573, DOI 10.3791/1573; Chou LS, 2010, CLIN CHEM, V56, P62, DOI 10.1373/clinchem.2009.132639; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Clepet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-252; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; GALUN E, 1961, GENETICA, V32, P134, DOI 10.1007/BF01816091; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Guo DL, 2012, AM J BOT, V99, pE182, DOI 10.3732/ajb.1100277; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Hegarty M, 2013, PLANT BIOTECHNOL J, V11, P572, DOI 10.1111/pbi.12045; Hossain MA, 1996, EUPHYTICA, V90, P121; Iwata H, 2006, BREEDING SCI, V56, P371, DOI 10.1270/jsbbs.56.371; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Kim DW, 2010, GENOME, V53, P568, DOI [10.1139/G10-025, 10.1139/g10-025]; KUBICKI B, 1969, GENET POL, V10, P69; Kwiatkowski RW, 1999, MOL DIAGN, V4, P353, DOI 10.1016/S1084-8592(99)80012-5; Li Z, 2012, J EXP BOT, V63, P4475, DOI 10.1093/jxb/ers123; Li Z, 2009, GENETICS, V182, P1381, DOI 10.1534/genetics.109.104737; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Mibus H, 2004, THEOR APPL GENET, V109, P1669, DOI 10.1007/s00122-004-1793-7; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; MITCHELL WD, 1962, SCIENCE, V136, P880, DOI 10.1126/science.136.3519.880; Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901; Olivier M, 2005, MUTAT RES-FUND MOL M, V573, P103, DOI 10.1016/j.mrfmmm.2004.08.016; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Poole CF, 1939, J HERED, V30, P21, DOI 10.1093/oxfordjournals.jhered.a104626; Ram D, 2006, J HERED, V97, P294, DOI 10.1093/jhered/esj028; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; ROBINSON RW, 1976, HORTSCIENCE, V11, P554; Schaefer H, 2010, MOL PHYLOGENET EVOL, V54, P553, DOI 10.1016/j.ympev.2009.08.006; TAKAHASHI H, 1984, PHYTON-INT J EXP BOT, V44, P81; Wang SZ, 2010, AM J BOT, V97, pE75, DOI 10.3732/ajb.1000153; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318	45	36	36	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87138	10.1371/journal.pone.0087138	http://dx.doi.org/10.1371/journal.pone.0087138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498029	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100050
J	Prommer, J; Wanek, W; Hofhansl, F; Trojan, D; Offre, P; Urich, T; Schleper, C; Sassmann, S; Kitzler, B; Soja, G; Hood-Nowotny, RC				Prommer, Judith; Wanek, Wolfgang; Hofhansl, Florian; Trojan, Daniela; Offre, Pierre; Urich, Tim; Schleper, Christa; Sassmann, Stefan; Kitzler, Barbara; Soja, Gerhard; Hood-Nowotny, Rebecca Clare			Biochar Decelerates Soil Organic Nitrogen Cycling but Stimulates Soil Nitrification in a Temperate Arable Field Trial	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; FAST-PYROLYSIS BIOCHAR; FILLED PORE-SPACE; MICROBIAL COMMUNITY; OXIDE PRODUCTION; NUMERICAL ABUNDANCE; AGRICULTURAL SOIL; PONDEROSA PINE; N2O EMISSIONS; BLACK CARBON	Biochar production and subsequent soil incorporation could provide carbon farming solutions to global climate change and escalating food demand. There is evidence that biochar amendment causes fundamental changes in soil nutrient cycles, often resulting in marked increases in crop production, particularly in acidic and in infertile soils with low soil organic matter contents, although comparable outcomes in temperate soils are variable. We offer insight into the mechanisms underlying these findings by focusing attention on the soil nitrogen (N) cycle, specifically on hitherto unmeasured processes of organic N cycling in arable soils. We here investigated the impacts of biochar addition on soil organic and inorganic N pools and on gross transformation rates of both pools in a biochar field trial on arable land (Chernozem) in Traismauer, Lower Austria. We found that biochar increased total soil organic carbon but decreased the extractable organic C pool and soil nitrate. While gross rates of organic N transformation processes were reduced by 50-80%, gross N mineralization of organic N was not affected. In contrast, biochar promoted soil ammonia-oxidizer populations (bacterial and archaeal nitrifiers) and accelerated gross nitrification rates more than two-fold. Our findings indicate a de-coupling of the soil organic and inorganic N cycles, with a build-up of organic N, and deceleration of inorganic N release from this pool. The results therefore suggest that addition of inorganic fertilizer-N in combination with biochar could compensate for the reduction in organic N mineralization, with plants and microbes drawing on fertilizer-N for growth, in turn fuelling the belowground build-up of organic N. We conclude that combined addition of biochar with fertilizer-N may increase soil organic N in turn enhancing soil carbon sequestration and thereby could play a fundamental role in future soil management strategies.	[Prommer, Judith; Wanek, Wolfgang; Hofhansl, Florian; Hood-Nowotny, Rebecca Clare] Univ Vienna, Dept Microbiol & Ecosyst Sci, Vienna, Austria; [Trojan, Daniela; Offre, Pierre; Urich, Tim; Schleper, Christa] Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria; [Sassmann, Stefan] Univ Vienna, Core Facil Cell Imaging & Ultrastruct Res, Vienna, Austria; [Kitzler, Barbara] Fed Res & Training Ctr Forests Nat Hazards & Land, Inst Forest Ecol & Soil, Vienna, Austria; [Soja, Gerhard] Austrian Inst Technol, Dept Hlth & Environm, Tulln, Austria	University of Vienna; University of Vienna; University of Vienna	Wanek, W (corresponding author), Univ Vienna, Dept Microbiol & Ecosyst Sci, Vienna, Austria.	wolfgang.wanek@univie.ac.at; rebecca.clare.hood-nowotny@univie.ac.at	Hofhansl, Florian/E-6656-2012; Urich, Tim/J-8241-2016; Wanek, Wolfgang/E-7001-2012; Kitzler, Barbara/ACM-1987-2022; Offre, Pierre/S-3382-2019; Schleper, Christa M/C-2567-2013; Soja, Gerhard/A-9657-2008; Kitzler, Barbara/HGF-0438-2022	Hofhansl, Florian/0000-0003-0073-0946; Urich, Tim/0000-0002-5718-1354; Wanek, Wolfgang/0000-0003-2178-8258; Soja, Gerhard/0000-0001-7391-4899; Hood-Nowotny, Rebecca/0000-0002-4398-3233; Kitzler, Barbara/0000-0002-1617-9186; Schleper, Christa/0000-0002-1918-2735; Trojan, Daniela/0000-0001-6748-5311	FWF Project [V138-B17]; FFG Project [825438]; Austrian Science Fund (FWF) [I 487, V 138] Funding Source: researchfish	FWF Project(Austrian Science Fund (FWF)); FFG Project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors highly appreciate the funding through FWF Project V138-B17 (to RCHN) as well as the FFG Project 825438 (to GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves RJE, 2013, ISME J, V7, P1620, DOI 10.1038/ismej.2013.35; Anderson CR, 2011, PEDOBIOLOGIA, V54, P309, DOI 10.1016/j.pedobi.2011.07.005; BAATH E, 1979, OIKOS, V33, P11, DOI 10.2307/3544505; Bailey VL, 2011, SOIL BIOL BIOCHEM, V43, P296, DOI 10.1016/j.soilbio.2010.10.014; Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; Ball PN, 2010, J ENVIRON QUAL, V39, P1243, DOI 10.2134/jeq2009.0082; BARRACLOUGH D, 1991, PLANT SOIL, V131, P89, DOI 10.1007/BF00010423; Bateman EJ, 2005, BIOL FERT SOILS, V41, P379, DOI 10.1007/s00374-005-0858-3; Bergeron SP, 2013, SOIL BIOL BIOCHEM, V58, P140, DOI 10.1016/j.soilbio.2012.11.017; Berglund LM, 2004, SOIL BIOL BIOCHEM, V36, P2067, DOI 10.1016/j.soilbio.2004.06.005; Booth MS, 2005, ECOL MONOGR, V75, P139, DOI 10.1890/04-0988; Bruun EW, 2011, EUR J SOIL SCI, V62, P581, DOI 10.1111/j.1365-2389.2011.01377.x; Bruun EW, 2012, SOIL BIOL BIOCHEM, V46, P73, DOI 10.1016/j.soilbio.2011.11.019; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; Busscher WJ, 2010, SOIL SCI, V175, P10, DOI 10.1097/SS.0b013e3181cb7f46; Case SDC, 2012, SOIL BIOL BIOCHEM, V51, P125, DOI 10.1016/j.soilbio.2012.03.017; Chen Y, 2010, AUST J SOIL RES, V48, P526, DOI 10.1071/SR10011; Cheng Y, 2012, BIOL FERT SOILS, V48, P941, DOI 10.1007/s00374-012-0687-0; Clough TJ, 2013, AGRONOMY-BASEL, V3, P275, DOI 10.3390/agronomy3020275; Clough TJ, 2010, J ENVIRON QUAL, V39, P1218, DOI 10.2134/jeq2010.0204; COLEMAN DC, 1994, MICROBIAL ECOL, V28, P245, DOI 10.1007/BF00166814; Daum M, 1998, CURR MICROBIOL, V37, P281, DOI 10.1007/s002849900379; DeLuca T.H., 2015, BIOCHAR ENV MANAGEME, P453, DOI DOI 10.4324/9781849770552; DeLuca TH, 2006, SOIL SCI SOC AM J, V70, P448, DOI 10.2136/sssaj2005.0096; Dempster DN, 2012, PLANT SOIL, V354, P311, DOI 10.1007/s11104-011-1067-5; Dempster DN, 2012, SOIL BIOL BIOCHEM, V48, P47, DOI 10.1016/j.soilbio.2012.01.013; Dempster DN, 2012, SOIL RES, V50, P216, DOI 10.1071/SR11316; Di HJ, 2000, AUST J SOIL RES, V38, P213, DOI 10.1071/SR99005; Downie A., 2009, BIOCHAR ENV MANAGEME; Doyle A, 2004, SOIL SCI SOC AM J, V68, P669, DOI 10.2136/sssaj2004.0669; Farrell M, 2013, ECOSYSTEMS, V16, P133, DOI 10.1007/s10021-012-9601-8; Finlay BJ, 2000, PROTIST, V151, P69, DOI 10.1078/1434-4610-00008; Foissner W, 1999, AGR ECOSYST ENVIRON, V74, P95, DOI 10.1016/S0167-8809(99)00032-8; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Gryc V., 2008, Journal of Forest Science (Prague), V54, P418, DOI 10.17221/59/2008-JFS; Gundale MJ, 2006, FOREST ECOL MANAG, V231, P86, DOI 10.1016/j.foreco.2006.05.004; HASLAM E, 1974, BIOCHEM J, V139, P285, DOI 10.1042/bj1390285; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Hood-Nowotny R, 2010, SOIL SCI SOC AM J, V74, P1018, DOI 10.2136/sssaj2009.0389; HYNES RK, 1982, CAN J MICROBIOL, V28, P334, DOI 10.1139/m82-049; Jeffery S, 2011, AGR ECOSYST ENVIRON, V144, P175, DOI 10.1016/j.agee.2011.08.015; Jones DL, 2012, SOIL BIOL BIOCHEM, V45, P113, DOI 10.1016/j.soilbio.2011.10.012; Jones DL, 2011, SOIL BIOL BIOCHEM, V43, P804, DOI 10.1016/j.soilbio.2010.12.015; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P413, DOI 10.1016/j.soilbio.2004.08.008; Jones DL, 2002, SOIL BIOL BIOCHEM, V34, P1893, DOI 10.1016/S0038-0717(02)00203-1; Joseph SD, 2010, AUST J SOIL RES, V48, P501, DOI 10.1071/SR10009; Kasozi GN, 2010, ENVIRON SCI TECHNOL, V44, P6189, DOI 10.1021/es1014423; Kelleher BP, 2006, GEOCHIM COSMOCHIM AC, V70, P4080, DOI 10.1016/j.gca.2006.06.012; Khan SA, 2000, SOIL SCI SOC AM J, V64, P1083, DOI 10.2136/sssaj2000.6431083x; KIRKHAM DON, 1954, SOIL SCI SOC AMER PROC, V18, P33; Knicker H, 2011, SOIL BIOL BIOCHEM, V43, P1118, DOI 10.1016/j.soilbio.2011.02.020; Kuzyakov Y, 2009, SOIL BIOL BIOCHEM, V41, P210, DOI 10.1016/j.soilbio.2008.10.016; Lachouani P, 2010, RAPID COMMUN MASS SP, V24, P3615, DOI 10.1002/rcm.4798; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; LINN DM, 1984, SOIL SCI SOC AM J, V48, P1267, DOI 10.2136/sssaj1984.03615995004800060013x; Liu XY, 2013, PLANT SOIL, V373, P583, DOI 10.1007/s11104-013-1806-x; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; Cayuela ML, 2013, SCI REP-UK, V3, DOI 10.1038/srep01732; Ma Li, 2012, Xinjiang Agricultural Sciences, V49, P589; Moore JC, 2003, ECOLOGY, V84, P846, DOI 10.1890/0012-9658(2003)084[0846:TIBDPI]2.0.CO;2; Mooshammer M, 2012, ECOLOGY, V93, P770, DOI 10.1890/11-0721.1; Mukherjee A, 2011, GEODERMA, V163, P247, DOI 10.1016/j.geoderma.2011.04.021; Mulder C, 2005, J BIOGEOGR, V32, P1775, DOI 10.1111/j.1365-2699.2005.01321.x; Mulder C, 2005, ECOL LETT, V8, P80, DOI 10.1111/j.1461-0248.2004.00704.x; Mullen CA, 2010, BIOMASS BIOENERG, V34, P67, DOI 10.1016/j.biombioe.2009.09.012; Murphy DV, 2003, ADV AGRON, V79, P69, DOI 10.1016/S0065-2113(02)79002-0; Nakajima Y, 2005, NUTR CYCL AGROECOSYS, V71, P33, DOI 10.1007/s10705-004-1196-9; Nelissen V, 2012, SOIL BIOL BIOCHEM, V55, P20, DOI 10.1016/j.soilbio.2012.05.019; Offre P, 2009, FEMS MICROBIOL ECOL, V70, P99, DOI 10.1111/j.1574-6941.2009.00725.x; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Pietikainen J, 2000, OIKOS, V89, P231, DOI 10.1034/j.1600-0706.2000.890203.x; Prosser JI, 2012, TRENDS MICROBIOL, V20, P523, DOI 10.1016/j.tim.2012.08.001; Quilliam RS, 2013, SOIL BIOL BIOCHEM, V65, P287, DOI 10.1016/j.soilbio.2013.06.004; Read D., 2000, MYCORRHIZAL SYMBIOSI; Roberts P, 2008, SOIL BIOL BIOCHEM, V40, P1485, DOI 10.1016/j.soilbio.2008.01.001; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schleper C, 2010, ISME J, V4, P1092, DOI 10.1038/ismej.2010.111; Schmidt MWI, 2000, GLOBAL BIOGEOCHEM CY, V14, P777, DOI 10.1029/1999GB001208; Singh B, 2010, AUST J SOIL RES, V48, P516, DOI 10.1071/SR10058; Singh BP, 2012, ENVIRON SCI TECHNOL, V46, P11770, DOI 10.1021/es302545b; SORENSEN P, 1991, ANAL CHIM ACTA, V252, P201, DOI 10.1016/0003-2670(91)87215-S; STIENSTRA AW, 1994, FEMS MICROBIOL ECOL, V14, P45, DOI 10.1111/j.1574-6941.1994.tb00089.x; Strong DT, 1998, AUST J SOIL RES, V36, P855, DOI 10.1071/S97103; Taghizadeh-Toosi A, 2012, PLANT SOIL, V353, P73, DOI 10.1007/s11104-011-1010-9; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Vaccari FP, 2011, EUR J AGRON, V34, P231, DOI 10.1016/j.eja.2011.01.006; van Zwieten L, 2010, AUST J SOIL RES, V48, P555, DOI 10.1071/SR10004; Ventura M, 2013, J ENVIRON QUAL, V42, P76, DOI 10.2134/jeq2012.0250; Wanek W, 2010, SOIL BIOL BIOCHEM, V42, P1293, DOI 10.1016/j.soilbio.2010.04.001; Wang JY, 2012, PLANT SOIL, V360, P287, DOI 10.1007/s11104-012-1250-3; Wang LF, 2008, SOIL SCI PLANT NUTR, V54, P786, DOI 10.1111/j.1747-0765.2008.00297.x; Wang T, 2012, ORG GEOCHEM, V51, P45, DOI 10.1016/j.orggeochem.2012.07.009; Warnock DD, 2007, PLANT SOIL, V300, P9, DOI 10.1007/s11104-007-9391-5; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Zheng H, 2013, GEODERMA, V206, P32, DOI 10.1016/j.geoderma.2013.04.018; Zimmerman AR, 2004, ENVIRON SCI TECHNOL, V38, P4542, DOI 10.1021/es035340+	101	186	202	27	317	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86388	10.1371/journal.pone.0086388	http://dx.doi.org/10.1371/journal.pone.0086388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497947	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100015
J	Welschoff, J; Matthey, M; Wenzel, D				Welschoff, Julia; Matthey, Michaela; Wenzel, Daniela			RGD peptides induce relaxation of pulmonary arteries and airways via beta 3-integrins	FASEB JOURNAL			English	Article						endothelial nitric oxide synthase; hypoxia; pulmonary vascular tone	ARG-GLY-ASP; SOLUBLE GUANYLATE-CYCLASE; SMOOTH-MUSCLE; POTASSIUM CHANNELS; K-V; ALPHA(V)BETA(3); INHIBITION; INTEGRINS; BINDING; RECEPTORS	Novel relaxants of pulmonary arteries and airways are of special interest to obtain insights into pulmonary signaling pathways and to develop treatment strategies for lung diseases. Herein, we demonstrate that Arg-Gly-Asp (RGD) peptides induce a dose-dependent relaxation of pulmonary arteries and airways in mouse. The relaxing effect was specific because it was strongly reduced using the control peptides RGE or RAD (P<0.001). Longer peptide sequences containing RGD and its flanking amino acids found in fibronectin showed a similar effect even at a 10-fold lower concentration. The relevance of RGD-induced pulmonary vasorelaxation was demonstrated in isometric force measurements, lung slices, and the isolated perfused lung model under normoxia and hypoxia and in vivo. As cell surface receptor we identified 3- but not 1-integrin subunits. Moreover, vasorelaxation by RGD peptides was strongly diminished after removal of the endothelium in endothelial nitric oxide synthase-deficient (eNOS(-/-) mice; P<0.01) and after pharmacological inhibition of the NO/sGC pathway (P<0.05). Additionally, several potassium channels like K-v, K-ir, and K-ATP played a role. In airways the response was mediated by K-v and K-Ca channels. Thus, RGD peptides are relaxants of pulmonary arteries and airways. These findings may help to establish novel therapeutic approaches for pulmonary hypertension and obstructive lung disease.Welschoff, J., Matthey, M., Wenzel, D. RGD peptides induce relaxation of pulmonary arteries and airways via 3-integrins.	[Welschoff, Julia; Matthey, Michaela; Wenzel, Daniela] Univ Bonn, Inst Physiol 1, D-53127 Bonn, Germany	University of Bonn	Wenzel, D (corresponding author), Univ Bonn, Inst Physiol 1, Sigmund Freud Str 25, D-53127 Bonn, Germany.	dwenzel@uni-bonn.de	Wenzel, Daniela/B-7613-2014	Wenzel, Daniela/0000-0003-1100-6363; Matthey, Michaela/0000-0002-1841-2906	BONFOR program of the University of Bonn; Ministry of Innovation, Science, Research, and Technology of the State of North Rhine, Westphalia, Germany	BONFOR program of the University of Bonn; Ministry of Innovation, Science, Research, and Technology of the State of North Rhine, Westphalia, Germany	The authors thank T. Baum for excellent technical assistance and A. Godecke (Heinrich-Heine-Universitat Dusseldorf, Dusseldorf, Germany) for providing eNOS<SUP>-/-</SUP> mice. The project was supported by the BONFOR program of the University of Bonn and a junior research group to D.W. funded by the Ministry of Innovation, Science, Research, and Technology of the State of North Rhine, Westphalia, Germany.	Arcangeli A, 2006, TRENDS CELL BIOL, V16, P631, DOI 10.1016/j.tcb.2006.10.003; Archer S, 2002, NEWS PHYSIOL SCI, V17, P131, DOI 10.1152/nips.01388.2002; AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D; Bhattacharya S, 2000, CIRC RES, V86, P456, DOI 10.1161/01.RES.86.4.456; Borron P, 1998, AM J PHYSIOL-LUNG C, V275, pL679, DOI 10.1152/ajplung.1998.275.4.L679; BOTNEY MD, 1992, AM J PATHOL, V140, P357; Buerkle MA, 2002, BRIT J CANCER, V86, P788, DOI 10.1038/sj.bjc.6600141; Burgel PR, 2011, EUR RESPIR REV, V20, P23, DOI 10.1183/09059180.00010410; Chan WL, 2001, AM J PHYSIOL-CELL PH, V280, pC593, DOI 10.1152/ajpcell.2001.280.3.C593; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; CURTIS TM, 1995, AM J PHYSIOL-LUNG C, V269, pL248, DOI 10.1152/ajplung.1995.269.2.L248; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; Dekkers BGJ, 2010, AM J RESP CRIT CARE, V181, P556, DOI 10.1164/rccm.200907-1065OC; Diez-Marques ML, 2006, CARDIOVASC RES, V69, P359, DOI 10.1016/j.cardiores.2005.10.011; Godecke A, 1998, CIRC RES, V82, P186; Hein TW, 2001, AM J PHYSIOL-HEART C, V281, pH2378, DOI 10.1152/ajpheart.2001.281.6.H2378; Herz K, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0257-5; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S; IGNARRO LJ, 1989, FASEB J, V3, P31, DOI 10.1096/fasebj.3.1.2642868; Irvine JC, 2003, HYPERTENSION, V41, P1301, DOI 10.1161/01.HYP.0000072010.54901.DE; Kawaguchi M, 2001, BIOCHEM BIOPH RES CO, V288, P711, DOI 10.1006/bbrc.2001.5809; Kawasaki J, 2004, J BIOL CHEM, V279, P12959, DOI 10.1074/jbc.M313791200; Konig P, 2005, J HISTOCHEM CYTOCHEM, V53, P155, DOI 10.1369/jhc.4A6453.2005; Levine DJ, 2006, RESP CARE, V51, P368; Lipke DW, 1996, REGUL PEPTIDES, V63, P23, DOI 10.1016/0167-0115(96)00020-1; Malan D, 2010, DEVELOPMENT, V137, P993, DOI 10.1242/dev.045377; Martinez-Lemus LA, 2003, J VASC RES, V40, P211, DOI 10.1159/000071886; MATSUNO H, 1994, CIRCULATION, V90, P2203, DOI 10.1161/01.CIR.90.5.2203; Mogford JE, 1997, J CLIN INVEST, V100, P1647, DOI 10.1172/JCI119689; Mogford JE, 1996, CIRC RES, V79, P821, DOI 10.1161/01.RES.79.4.821; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; NICOSIA RF, 1991, AM J PATHOL, V138, P829; PFAFF M, 1994, EUR J BIOCHEM, V225, P975, DOI 10.1111/j.1432-1033.1994.0975b.x; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Platts SH, 1998, AM J PHYSIOL-HEART C, V275, pH1449; PLOW EF, 1985, P NATL ACAD SCI USA, V82, P8057, DOI 10.1073/pnas.82.23.8057; QIAO RL, 1995, AM J PHYSIOL-CELL PH, V269, pC110, DOI 10.1152/ajpcell.1995.269.1.C110; Reardon DA, 2011, FUTURE ONCOL, V7, P339, DOI [10.2217/fon.11.8, 10.2217/FON.11.8]; SCHWARTZ MA, 1993, J CELL BIOL, V120, P1003, DOI 10.1083/jcb.120.4.1003; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Singh B, 2000, AM J PHYSIOL-LUNG C, V278, pL217, DOI 10.1152/ajplung.2000.278.1.L217; Sweeney M, 2000, Respir Res, V1, P40, DOI 10.1186/rr11; Thirstrup S, 2000, RESP MED, V94, P328, DOI 10.1053/rmed.1999.0737; Tsikaris V, 2004, J PEPT SCI, V10, P589, DOI 10.1002/psc.603; Umesh A, 2006, J BIOL CHEM, V281, P34312, DOI 10.1074/jbc.M606765200; Wenzel D, 2006, CIRC RES, V98, P1203, DOI 10.1161/01.RES.0000219899.93384.ed; Wenzel D, 2013, P NATL ACAD SCI USA, V110, P18710, DOI 10.1073/pnas.1308130110; Wenzel D, 2012, HYPERTENSION, V59, P1256, DOI 10.1161/HYPERTENSIONAHA.111.188367; Wenzel D, 2012, PHARM RES-DORDR, V29, P1242, DOI 10.1007/s11095-011-0657-5; Wenzel D, 2009, HYPERTENSION, V54, P157, DOI 10.1161/HYPERTENSIONAHA.109.130468; Wu X, 1998, J CELL BIOL, V143, P241, DOI 10.1083/jcb.143.1.241; Zhao YJ, 1997, AM J PHYSIOL-HEART C, V272, pH904, DOI 10.1152/ajpheart.1997.272.2.H904	52	12	12	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2281	2292		10.1096/fj.13-246348	http://dx.doi.org/10.1096/fj.13-246348			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24500921				2022-12-25	WOS:000335336000030
J	Lui, S; Jones, RL; Robinson, NJ; Greenwood, SL; Aplin, JD; Tower, CL				Lui, Sylvia; Jones, Rebecca L.; Robinson, Nathalie J.; Greenwood, Susan L.; Aplin, John D.; Tower, Clare L.			Detrimental Effects of Ethanol and Its Metabolite Acetaldehyde, on First Trimester Human Placental Cell Turnover and Function	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; SELECTIVE FETAL MALNUTRITION; PRENATAL ALCOHOL EXPOSURE; AMINO-ACID-TRANSPORT; LOW-BIRTH-WEIGHT; BEWO CELLS; TAURINE TRANSPORTER; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT PLACENTA	Fetal alcohol spectrum disorder (FASD) describes developmental issues from high maternal alcohol intake, which commonly results in fetal growth restriction and long term morbidity. We aimed to investigate the effect of alcohol and acetaldehyde, on the first trimester placenta, the period essential for normal fetal organogenesis. Normal invasion and establishment of the placenta during this time are essential for sustaining fetal viability to term. We hypothesise that alcohol (ethanol) and acetaldehyde have detrimental effects on cytotrophoblast invasion, turnover and placental function. Taurine is an important amino acid for neuronal and physiological development, and so, its uptake was assayed in cells and placental explants exposed to alcohol or acetaldehyde. First trimester villous explants and BeWo cells were treated with 0, 10, 20, 40 mM ethanol or 0, 10, 20, 40 mu M acetaldehyde. The invasive capacity of SGHPL4, a first trimester extravillous cytotrophoblast cell line, was unaffected by ethanol or acetaldehyde (p > 0.05; N = 6). The cells in-cycle were estimated using immunostaining for Ki67. Proliferating trophoblast cells treated with ethanol were decreased in both experiments (explants: 40% at 20 mM and 40 mM, p < 0.05, N = 8-9) (cell line: 5% at 20 mM and 40 mM, p < 0.05, N = 6). Acetaldehyde also reduced Ki67-positive cells in both experiments (explants at 40 mu M p > 0.05; N = 6) (cell line at 10 mu M and 40 mu M; p < 0.05; N = 7). Only in the cell line at 20 mu M acetaldehyde demonstrated increased apoptosis (p < 0.05; N = 6). Alcohol inhibited taurine transport in BeWo cells at 10 mu M and 40 mM (p < 0.05; N = 6), and in placenta at 40 mu M (p < 0.05; N = 7). Acetaldehyde did not affect taurine transport in either model (P < 0.05; N = 6). Interestingly, system A amino acid transport in placental explants was increased at 10 mu M and 40 mu M acetaldehyde exposure (p < 0.05; N = 6). Our results demonstrate that exposure to both genotoxins may contribute to the pathogenesis of FASD by reducing placental growth. Alcohol also reduces the transport of taurine, which is vital for developmental neurogenesis.	[Lui, Sylvia; Jones, Rebecca L.; Robinson, Nathalie J.; Greenwood, Susan L.; Aplin, John D.; Tower, Clare L.] Univ Manchester, St Marys Hosp, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester M13 0JH, Lancs, England; [Jones, Rebecca L.; Robinson, Nathalie J.; Greenwood, Susan L.; Aplin, John D.; Tower, Clare L.] Manchester Acad Hlth Sci Ctr, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England	University of Manchester; University of Manchester	Lui, S (corresponding author), Univ Manchester, St Marys Hosp, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester M13 0JH, Lancs, England.	sylvia.lui@manchester.ac.uk	Jones, Rebecca/E-4481-2011; Aplin, John/AET-4363-2022	Jones, Rebecca/0000-0002-8871-0589; Aplin, John/0000-0001-8777-9261; Tower, Clare/0000-0001-8532-5354; Greenwood, Susan/0000-0003-2867-4368; Lui, Sylvia/0000-0002-9185-3564	British Medical Association; Tommy's the Baby Charity; Action Research Endowment Fund; Manchester Biomedical Research Centre; Greater Manchester Comprehensive Local Research Network	British Medical Association; Tommy's the Baby Charity; Action Research Endowment Fund; Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Greater Manchester Comprehensive Local Research Network	This research was funded by the British Medical Association, Harper Research Grant (www.bma.org.uk). The Maternal and Fetal Health Research Centre is supported by funding from Tommy's the Baby Charity (www.tommys.org), an Action Research Endowment Fund, the Manchester Biomedical Research Centre and the Greater Manchester Comprehensive Local Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adde-Michel C, 2005, NEUROSCI LETT, V374, P109, DOI 10.1016/j.neulet.2004.10.037; Aerts L, 2002, J PERINAT MED, V30, P281, DOI 10.1515/JPM.2002.040; AHLUWALIA B, 1992, ALCOHOL, V9, P395, DOI 10.1016/0741-8329(92)90038-C; Akay MT, 2005, CELL BIOCHEM FUNCT, V23, P435, DOI 10.1027/cbf.1175; ALI F, 1988, EXP PATHOL-JENA, V33, P17, DOI 10.1016/S0232-1513(88)80048-3; Ali Shaukat, 2011, PLoS One, V6, pe20037, DOI 10.1371/journal.pone.0020037; Anthony B, 2010, ALCOHOL, V44, P659, DOI 10.1016/j.alcohol.2010.04.002; APLIN JD, 1992, J CELL SCI, V103, P435; APLIN JD, 1991, J CELL SCI, V99, P681; Araujo JR, 2013, REPROD TOXICOL, V40, P76, DOI 10.1016/j.reprotox.2013.06.073; ASAI M, 1985, EXPERIENTIA, V41, P1566, DOI 10.1007/BF01964810; Bakker R, 2010, INT J EPIDEMIOL, V39, P777, DOI 10.1093/ije/dyq047; BALDWIN VJ, 1982, BIRTH DEFECTS-ORIG, V18, P89; Boujendar S, 2003, J NUTR, V133, P2820, DOI 10.1093/jn/133.9.2820; British Medical Association, 2007, FET ALC SPECTR DIS G; Burd L, 2012, J PERINATOL, V32, P652, DOI 10.1038/jp.2012.57; Chen CP, 2002, AM J OBSTET GYNECOL, V187, P764, DOI 10.1067/mob.2002.125243; Church HJ, 1998, BIOCHEM J, V332, P491, DOI 10.1042/bj3320491; Desforges M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.81; Desforges M, 2013, ADV EXP MED BIOL, V776, P81, DOI 10.1007/978-1-4614-6093-0_9; Eriksson J, 2000, HYPERTENSION, V36, P790, DOI 10.1161/01.HYP.36.5.790; ESPINET C, 1984, ARCH INT PHYSIOL BIO, V92, P339, DOI 10.3109/13813458409080609; Fisher S E, 1981, Prog Biochem Pharmacol, V18, P216; FISHER SE, 1981, LIFE SCI, V29, P1283, DOI 10.1016/0024-3205(81)90235-6; FISHER SE, 1985, J PEDIATR GASTR NUTR, V4, P645, DOI 10.1097/00005176-198508000-00026; FISHER SE, 1984, DEV PHARMACOL THERAP, V7, P229, DOI 10.1159/000457169; Forbes K, 2012, CELL MOL LIFE SCI; Forbes K, 2010, ENDOCRINOLOGY, V151, P1723, DOI 10.1210/en.2009-0896; Forbes K, 2009, ENDOCRINOLOGY, V150, P4744, DOI 10.1210/en.2009-0166; Forbes K, 2008, J CELL MOL MED, V12, P2295, DOI 10.1111/j.1582-4934.2008.00466.x; GHISOLFI J, 1989, BIOL NEONATE, V56, P181, DOI 10.1159/000243120; Greenwood SL, 2006, METH MOLEC MED, V122, P253; GUERRI C, 1985, ALCOHOL, V2, P267, DOI 10.1016/0741-8329(85)90057-6; Gundogan F, 2008, PLACENTA, V29, P148, DOI 10.1016/j.placenta.2007.10.002; Gundogan F, 2010, ALCOHOL CLIN EXP RES, V34, P415, DOI 10.1111/j.1530-0277.2009.01106.x; Hard ML, 2001, THER DRUG MONIT, V23, P427, DOI 10.1097/00007691-200108000-00018; Harris LK, 2010, AM J PATHOL, V177, P2103, DOI 10.2353/ajpath.2010.100182; Hayashi M, 1991, Arukoru Kenkyuto Yakubutsu Ison, V26, P89; Hayward CE, 2011, PLACENTA, V32, P990, DOI 10.1016/j.placenta.2011.09.016; HENDERSON GI, 1981, J PHARMACOL EXP THER, V216, P465; Holder BS, 2012, IMMUNOLOGY, V136, P184, DOI 10.1111/j.1365-2567.2012.03568.x; HOLLSTEDT C, 1983, ACTA PSYCHIAT SCAND, V67, P236, DOI 10.1111/j.1600-0447.1983.tb06737.x; Huang FD, 2009, PLACENTA, V30, P187, DOI 10.1016/j.placenta.2008.11.016; Hultman K, 2007, J PHYSIOL-LONDON, V579, P823, DOI 10.1113/jphysiol.2006.124610; Jaddoe VWV, 2007, ANN EPIDEMIOL, V17, P834, DOI 10.1016/j.annepidem.2007.04.001; Jones CJP, 2009, GLYCOCONJUGATE J, V26, P359, DOI 10.1007/s10719-008-9152-6; KALMUS GW, 1989, EXPERIENTIA, V45, P484, DOI 10.1007/BF01952040; KARL PI, 1994, ALCOHOL CLIN EXP RES, V18, P942, DOI 10.1111/j.1530-0277.1994.tb00063.x; Karl PI, 1996, ALCOHOL CLIN EXP RES, V20, P1269, DOI 10.1111/j.1530-0277.1996.tb01122.x; Kay HH, 2006, J SOC GYNECOL INVEST, V13, P118, DOI 10.1016/j.jsgi.2005.11.007; Kayani MA, 2010, TOXICOL IN VITRO, V24, P56, DOI 10.1016/j.tiv.2009.09.003; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; KORSTEN MA, 1975, NEW ENGL J MED, V292, P386, DOI 10.1056/NEJM197502202920802; Kuntsche E, 2004, SOC SCI MED, V59, P113, DOI 10.1016/j.socscimed.2003.10.009; Lambert IH, 2004, NEUROCHEM RES, V29, P27, DOI 10.1023/B:NERE.0000010433.08577.96; Lang F, 1999, HERZ, V24, P232, DOI 10.1007/BF03044966; Martyn C N, 1994, Health Rep, V6, P45; Maulik D, 2006, CLIN OBSTET GYNECOL, V49, P228, DOI 10.1097/00003081-200606000-00006; Menegola E, 2001, ALCOHOL, V23, P35, DOI 10.1016/S0741-8329(00)00132-4; NHS Information Centre Lifestyles and statistics, 2012, STAT ALC ENGL; Norberg S, 1998, PEDIATR RES, V44, P233, DOI 10.1203/00006450-199808000-00016; Peadon E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-584; PHILIPPS AF, 1978, AM J OBSTET GYNECOL, V131, P881, DOI 10.1016/S0002-9378(16)33136-2; PIJNENBORG R, 1983, PLACENTA, V4, P397, DOI 10.1016/S0143-4004(83)80043-5; Probyn ME, 2012, REPROD FERT DEVELOP, V24, P859, DOI 10.1071/RD11200; Roos S, 2004, AM J PHYSIOL-REG I, V287, pR886, DOI 10.1152/ajpregu.00232.2004; Rout UK, 2010, INT J ENV RES PUB HE, V7, P4023, DOI 10.3390/ijerph7114023; Rout UK, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-44; Salihu HM, 2011, ALCOHOL, V45, P73, DOI 10.1016/j.alcohol.2010.05.010; SANCHIS R, 1986, ALCOHOL CLIN EXP RES, V10, P39, DOI 10.1111/j.1530-0277.1986.tb05611.x; SANCHIS R, 1987, TERATOLOGY, V36, P199, DOI 10.1002/tera.1420360207; SASTRY BVR, 1991, REPROD FERT DEVELOP, V3, P355, DOI 10.1071/RD9910355; Shivaraj MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042935; Sibley CP, 2009, J PHYSIOL-LONDON, V587, P3431, DOI 10.1113/jphysiol.2009.172403; Sibley CP, 2005, PEDIATR RES, V58, P827, DOI 10.1203/01.PDR.0000181381.82856.23; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; STURMAN JA, 1985, J NEUROSCI RES, V13, P405, DOI 10.1002/jnr.490130307; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; STURMAN JA, 1991, J NUTR, V121, pS166, DOI 10.1093/jn/121.suppl_11.S166; Ugele B, 1999, J STEROID BIOCHEM, V71, P203, DOI 10.1016/S0960-0760(99)00138-7; Utoguchi N, 2000, REPROD TOXICOL, V14, P217, DOI 10.1016/S0890-6238(00)00071-X; Vedmedovska N, 2011, EUR J OBSTET GYN R B, V155, P36, DOI 10.1016/j.ejogrb.2010.11.017; Verlohren S, 2010, HYPERTENSION, V56, P304, DOI 10.1161/HYPERTENSIONAHA.110.153163; Warskulat U, 2007, METHOD ENZYMOL, V428, P439, DOI 10.1016/S0076-6879(07)28025-5; WATERSON EJ, 1989, BRIT J ADDICT, V84, P323; Way BA, 1998, PLACENTA, V19, P323, DOI 10.1016/S0143-4004(98)90065-0; Wolff GS, 2007, BIOL REPROD, V77, P53, DOI 10.1095/biolreprod.106.057984; Xu Ya-jun, 2005, Beijing Da Xue Xue Bao Yi Xue Ban, V37, P346; Zhao HY, 2000, BIOCHEM BIOPH RES CO, V274, P43, DOI 10.1006/bbrc.2000.3099	89	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87328	10.1371/journal.pone.0087328	http://dx.doi.org/10.1371/journal.pone.0087328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503565	Green Published, gold, Green Submitted			2022-12-25	WOS:000330631800028
J	Beck, D; Foster, JA				Beck, Daniel; Foster, James A.			Machine Learning Techniques Accurately Classify Microbial Communities by Bacterial Vaginosis Characteristics	PLOS ONE			English	Article							VAGINAL MICROBIOME; INFECTIONS; SEQUENCES	Microbial communities are important to human health. Bacterial vaginosis (BV) is a disease associated with the vagina microbiome. While the causes of BV are unknown, the microbial community in the vagina appears to play a role. We use three different machine-learning techniques to classify microbial communities into BV categories. These three techniques include genetic programming (GP), random forests (RF), and logistic regression (LR). We evaluate the classification accuracy of each of these techniques on two different datasets. We then deconstruct the classification models to identify important features of the microbial community. We found that the classification models produced by the machine learning techniques obtained accuracies above 90% for Nugent score BV and above 80% for Amsel criteria BV. While the classification models identify largely different sets of important features, the shared features often agree with past research.	[Beck, Daniel] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho	Beck, D (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	danlbek@gmail.com		Foster, James/0000-0002-6770-6521	NIH [P20 RR016454, P20 GM103408]; NIH COBRE award [P20GM16448]; National Science Foundation [DBI-0939454]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH COBRE award; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was made possible by the INBRE Program, NIH Grant Nos. P20 RR016454 (National Center for Research Resources) and P20 GM103408 (National Institute of General Medical Sciences). Computational support provided by NIH COBRE award P20GM16448. This material is based in part upon work supported by the National Science Foundation under Cooperative Agreement No. DBI-0939454. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172; Eiben AE, 2007, INTRO EVOLUTIONARY C; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Hastie T., 2009, UNSUPERVISED LEARNIN; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Moore JH, 2007, HUM HERED, V63, P120, DOI 10.1159/000099184; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Srinivasan S, 2008, INTERDISCIPLINARY PE, V2008; Srinivasan S, 2012, PLOS ONE, V7, P6, DOI DOI 10.1371/J0URNAL.P0NE.0037818; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TK Ho, 1995, P 3 INT C DOC AN REC, V3, P278; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0	25	37	39	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87830	10.1371/journal.pone.0087830	http://dx.doi.org/10.1371/journal.pone.0087830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498380	Green Submitted, gold, Green Published			2022-12-25	WOS:000330626900126
J	Chetan, N; Praveen, KK; Vasudeva, GK				Chetan, Nag; Praveen, Karanth K.; Vasudeva, Gururaja Kotambylu			Delineating Ecological Boundaries of Hanuman Langur Species Complex in Peninsular India Using MaxEnt Modeling Approach	PLOS ONE			English	Article							SEMNOPITHECUS-ENTELLUS; ENVIRONMENTAL NICHE; NATIONAL-PARK; CLIMATE-CHANGE; WESTERN-GHATS; CONSERVATION; DISTRIBUTIONS; DELIMITATION; FORESTS; PERFORMANCE	Hanuman langur is one of the widely distributed and extensively studied non-human diurnal primates in India. Until recently it was believed to be a single species - Semnopithecus entellus. Recent molecular and morphological studies suggest that the Hanuman langurs consists of at least three species S. entellus, S. hypoleucos and S. priam. Furthermore, morphological studies suggested that both S. hypoleucos and S. priam have at least three subspecies in each. We explored the use of ecological niche modeling (ENM) to confirm the validity of these seven taxa and an additional taxon S. johnii belonging to the same genus. MaxEnt modeling tool was used with 19 bioclimatic, 12 vegetation and 6 hydrological environmental layers. We reduced total environmental variables to 14 layers after testing for collinearity and an independent test for model prediction was done using ENMTools. A total of 196 non-overlapping data points from primary and secondary sources were used as inputs for ENM. Results showed eight distinct ecological boundaries, corroborating the eight taxa mentioned above thereby confirming validity of these eight taxa. The study, for the first time provided ecological variables that determined the ecological requirements and distribution of members of the Hanuman langur species complex in the Indian peninsula.	[Chetan, Nag] Indian Inst Sci, Undergrad Program, Dept Biol, Bangalore 560012, Karnataka, India; [Praveen, Karanth K.] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Vasudeva, Gururaja Kotambylu] Indian Inst Sci, Ctr Infrastruct Sustainable Transportat & Urban P, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Vasudeva, GK (corresponding author), Indian Inst Sci, Ctr Infrastruct Sustainable Transportat & Urban P, Bangalore 560012, Karnataka, India.	gururaj@cistup.iisc.ernet.in		Gururaja, KV/0000-0001-6907-9907; Nag, Chetan/0000-0002-7545-8556	Department of Biotechnology, Government of India [BT/PR-7127/BCE/08/445/2006]; Ministry of Environment and Forest	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Ministry of Environment and Forest	The study was financially supported by the Department of Biotechnology, Government of India (BT/PR-7127/BCE/08/445/2006) and Ministry of Environment and Forest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan M. Farid, 2006, University Journal of Zoology Rajshahi University, V25, P3; Alroy J, 2002, P NATL ACAD SCI USA, V99, P3706, DOI 10.1073/pnas.062691099; [Anonymous], 2010, WORLDS MOST ENDANGER; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Austin MP, 1996, FOREST ECOL MANAG, V85, P95, DOI 10.1016/S0378-1127(96)03753-X; AVISE JC, 1989, TREE, V9, P279; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Barve N., 2008, TOOL PARTIAL ROC BIO; Bauer JT, 2005, DIVERS DISTRIB, V11, P275, DOI 10.1111/j.1366-9516.2005.00173.x; BERNSTEIN IS, 1967, FOLIA PRIMATOL, V7, P198, DOI 10.1159/000155119; Bett NN, 2012, INT J PRIMATOL, V33, P972, DOI 10.1007/s10764-012-9622-3; BISHOP NH, 1979, J HUM EVOL, V8, P251, DOI 10.1016/0047-2484(79)90092-7; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Boubli J, 2009, INT J PRIMATOL, V30, P217, DOI 10.1007/s10764-009-9335-4; Brandon-Jones Douglas, 2004, Zoos' Print Journal, V19, P1552; Burton F. D., 1996, P389; Chaudhuri S., 2004, Records of the Zoological Survey of India, V103, P47; Chellam R, 1995, BLACKBUCK, V1, P20; Chhangani A. K., 2004, PRIMATE REP, V69, P35; Chhangani Anil Kumar, 2002, Zoos' Print Journal, V17, P848; Choudhury Anwaruddin, 2007, Journal of the Bombay Natural History Society, V104, P199; CURTIN RA, 1982, FOLIA PRIMATOL, V38, P1, DOI 10.1159/000156041; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Diekotter T, 2006, BIODIVERS CONSERV, V15, P57, DOI 10.1007/s10531-004-2932-9; Dupin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020957; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Ellerman, 1966, CHECKLIST PALAEARCTI, P810; Ganesh T, 2001, CURR SCI INDIA, V80, P394; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Groves CP, 2001, PRIMATE TAXONOMY; Grueter Cyril C., 2010, Zoological Research, V31, P516, DOI 10.3724/SP.J.1141.2010.05516; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harrison RG, 1998, ENDLESS FORMS, P19; HEANEY LR, 1991, CLIMATIC CHANGE, V19, P53, DOI 10.1007/BF00142213; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill W. C. O., 1939, Spolia Zeylanica, V21, P277; Hladik C. M., 1977, P323; HOHMANN G, 1991, FOLIA PRIMATOL, V56, P133, DOI 10.1159/000156538; HOHMANN G, 1989, INT J PRIMATOL, V10, P441, DOI 10.1007/BF02736370; Hrdy S. B., 1977, LANGURS ABU FEMALE M; Jathanna D, 2003, J ZOOL, V261, P285, DOI 10.1017/S0952836903004278; Karanth KP, 2010, J GENET, V89, P393, DOI 10.1007/s12041-010-0057-3; Khanum R, 2013, ACTA OECOL, V49, P23, DOI 10.1016/j.actao.2013.02.007; KIRKPATRICK RC, 2007, PRIMATES PERSPECTIVE, P186; Koenig A, 1997, J ZOOL, V243, P215, DOI 10.1111/j.1469-7998.1997.tb02778.x; Kumara HN, 2004, INT J PRIMATOL, V25, P1001, DOI 10.1023/B:IJOP.0000043348.06255.7f; Kumara Honnavalli N., 2009, Endangered Species Research, V7, P29, DOI 10.3354/esr00185; Kunz W, 2001, PARASITOL RES, V87, P413, DOI 10.1007/s004360000372; KURUP G U, 1984, Proceedings of the Indian National Science Academy Part B Biological Sciences, V50, P245; Legendre P, 1998, NUMERICAL ECOLOGY, P451; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Luoto M, 2006, J BIOGEOGR, V33, P1764, DOI 10.1111/j.1365-2699.2005.01395.x; MacKinnon J. R., 1980, MALAYAN FOREST PRIMA, P167, DOI DOI 10.1007/978-1-4757-0878-3_6; Manel S, 2000, J APPL ECOL, V37, P756, DOI 10.1046/j.1365-2664.2000.00537.x; Mayden R.L., 1997, Systematics Association Special Volume Series, V54, P381; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Minhas RA, 2010, PAK J ZOOL, V42, P143; Mittermeier RA, 2012, PRIMATES PERIL WORLD, P40; Nag KSC, 2011, INT J PRIMATOL, V32, P830, DOI 10.1007/s10764-011-9504-0; Oates John F., 1994, P45; Oppenheimer JR, 1977, RAINIER 3 GRIMALDI P, V1977, P469; Ortiz-Martinez T, 2008, PRIMATES, V49, P186, DOI 10.1007/s10329-008-0088-z; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pigliucci M, 2003, BIOESSAYS, V25, P596, DOI 10.1002/bies.10284; Pirta RS, 1997, BIOL CONSERV, V79, P97, DOI 10.1016/0006-3207(95)00131-X; Pocock RI, 1939, PRIMATES CARNIVORA, P97; Prasad S, 2004, CURR SCI INDIA, V87, P1188; Punekar, 2002, ZOOS PRINT J, V17, P797, DOI [10.11609/JoTT.ZPJ.17.6.797-801, DOI 10.11609/JOTT.ZPJ.17.6.797-801]; Ramachandran K. K., 2001, Journal of the Bombay Natural History Society, V98, P191; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Rebelo H, 2010, J APPL ECOL, V47, P410, DOI 10.1111/j.1365-2664.2009.01765.x; Reeves PA, 2011, SYST BIOL, V60, P45, DOI 10.1093/sysbio/syq056; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Roonwal M.L., 1984, P93; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Roy Kuladeep, 2010, Journal of Threatened Taxa, V2, P930; Steinberg ER, 2009, INT J PRIMATOL, V30, P29, DOI 10.1007/s10764-008-9328-8; Sayers K, 2008, INT J PRIMATOL, V29, P509, DOI 10.1007/s10764-008-9245-x; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Schulke O, 2001, AM J PRIMATOL, V55, P57, DOI 10.1002/ajp.1039; Sharma Satish Kumar, 2001, Zoos' Print Journal, V16, P669; Singh M., 2000, Primate Report, V58, P5; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Smith SA, 2010, SYST BIOL, V59, P322, DOI 10.1093/sysbio/syq011; Sugiyama Y., 1965, Primates, V6, P381, DOI 10.1007/BF01730356; Sushma HS, 2006, BEHAV ECOL, V17, P479, DOI 10.1093/beheco/arj058; Thorn JS, 2009, DIVERS DISTRIB, V15, P289, DOI 10.1111/j.1472-4642.2008.00535.x; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Torres J, 2010, BIOL CONSERV, V143, P416, DOI 10.1016/j.biocon.2009.11.007; Vasudev D, 2008, AM J PRIMATOL, V70, P680, DOI 10.1002/ajp.20549; Vidal-Garcia F, 2011, PRIMATES, V52, P261, DOI 10.1007/s10329-011-0246-6; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106	104	35	37	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87804	10.1371/journal.pone.0087804	http://dx.doi.org/10.1371/journal.pone.0087804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498377	Green Accepted, Green Published, gold			2022-12-25	WOS:000330626900123
J	Kollmar, M; Hatje, K				Kollmar, Martin; Hatje, Klas			Shared Gene Structures and Clusters of Mutually Exclusive Spliced Exons within the Metazoan Muscle Myosin Heavy Chain Genes	PLOS ONE			English	Article							SMOOTH-MUSCLE; BINDING SITE; ISOFORMS; PROTEIN; LOOP; MODULATE; CLONING; DOMAIN; MOTOR; SUBSTITUTIONS	Multicellular animals possess two to three different types of muscle tissues. Striated muscles have considerable ultrastructural similarity and contain a core set of proteins including the muscle myosin heavy chain (Mhc) protein. The ATPase activity of this myosin motor protein largely dictates muscle performance at the molecular level. Two different solutions to adjusting myosin properties to different muscle subtypes have been identified so far: Vertebrates and nematodes contain many independent differentially expressed Mhc genes while arthropods have single Mhc genes with clusters of mutually exclusive spliced exons (MXEs). The availability of hundreds of metazoan genomes now allowed us to study whether the ancient bilateria already contained MXEs, how MXE complexity subsequently evolved, and whether additional scenarios to control contractile properties in different muscles could be proposed, By reconstructing the Mhc genes from 116 metazoans we showed that all intron positions within the motor domain coding regions are conserved in all bilateria analysed. The last common ancestor of the bilateria already contained a cluster of MXEs coding for part of the loop-2 actin-binding sequence. Subsequently the protostomes and later the arthropods gained many further clusters while MXEs got completely lost independently in several branches (vertebrates and nematodes) and species (for example the annelid Helobdella robusta and the salmon louse Lepeophtheirus salmonis). Several bilateria have been found to encode multiple Mhc genes that might all or in part contain clusters of MXEs. Notable examples are a cluster of six tandemly arrayed Mhc genes, of which two contain MXEs, in the owl limpet Lottia gigantea and four Mhc genes with three encoding MXEs in the predatory mite Metaseiulus occidentalis. Our analysis showed that similar solutions to provide different myosin isoforms (multiple genes or clusters of MXEs or both) have independently been developed several times within bilaterian evolution.	[Kollmar, Martin; Hatje, Klas] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Grp Syst Biol Motor Prot, D-37077 Gottingen, Germany	Max Planck Society	Kollmar, M (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Grp Syst Biol Motor Prot, D-37077 Gottingen, Germany.	mako@nmr.mpibpc.mpg.de	Hatje, Klas/D-1076-2014; Kollmar, Martin/AAF-4966-2020	Kollmar, Martin/0000-0002-9768-1855	DFG [KO2251/6-1]	DFG(German Research Foundation (DFG))	This research was supported by DFG grant KO2251/6-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bernstein SI, 1997, J MOL BIOL, V271, P1, DOI 10.1006/jmbi.1997.1160; Bloemink MJ, 2009, J MOL BIOL, V389, P707, DOI 10.1016/j.jmb.2009.04.036; Cruz-Rivera M, 2006, CELL BIOL INT, V30, P598, DOI 10.1016/j.cellbi.2006.02.010; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dayraud C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-107; Decarreau JA, 2011, J MUSCLE RES CELL M, V32, P49, DOI 10.1007/s10974-011-9251-z; Dimmic MW, 2002, J MOL EVOL, V55, P65, DOI 10.1007/s00239-001-2304-y; Eddinger TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC493, DOI 10.1152/ajpcell.00131.2007; England J, 2013, CELL MOL LIFE SCI, V70, P1221, DOI 10.1007/s00018-012-1131-1; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Gonzalez-Malerva L, 2004, CELL BIOL INT, V28, P885, DOI 10.1016/j.cellbi.2004.09.008; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Hammesfahr B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-77; Hatje K, 2011, GENE DUPLICATION, P59; Hatje K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3460; Hatje Klas, 2011, BMC Res Notes, V4, P265, DOI 10.1186/1756-0500-4-265; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Joel PB, 2001, J BIOL CHEM, V276, P2998, DOI 10.1074/jbc.M006930200; Kliche W, 2001, EMBO J, V20, P40, DOI 10.1093/emboj/20.1.40; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Koyama H, 2013, J EXP ZOOL PART A, V319A, P268, DOI 10.1002/jez.1791; Koyama H, 2012, J EXP ZOOL PART A, V317A, P608, DOI 10.1002/jez.1752; Koyama H, 2012, J EXP BIOL, V215, P14, DOI 10.1242/jeb.058206; Kronert WA, 2012, J MOL BIOL, V416, P543, DOI 10.1016/j.jmb.2011.12.044; Kurzawa-Goertz SE, 1998, BIOCHEMISTRY-US, V37, P7517, DOI 10.1021/bi972844+; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Miller BM, 2007, J MOL BIOL, V368, P1051, DOI 10.1016/j.jmb.2007.02.042; Murphy CT, 1998, BIOCHEMISTRY-US, V37, P6738, DOI 10.1021/bi972903j; NYITRAY L, 1994, P NATL ACAD SCI USA, V91, P12686, DOI 10.1073/pnas.91.26.12686; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Odronitz Florian, 2008, BMC Genomics, V9, P422, DOI 10.1186/1471-2164-9-422; Odronitz F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-300; Odronitz F, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-21; Paps J, 2009, MOL BIOL EVOL, V26, P2397, DOI 10.1093/molbev/msp150; PerreaultMicale CL, 1996, J MUSCLE RES CELL M, V17, P543, DOI 10.1007/BF00124354; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pillmann H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-270; Pohl M, 2013, BIOSYSTEMS, V114, P31, DOI 10.1016/j.biosystems.2013.07.003; Rambaut A., FIGTREE V1 3 1; Riutort M, 2012, INT J DEV BIOL, V56, P5, DOI 10.1387/ijdb.113441mr; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shaffer JF, 2012, J EXP BIOL, V215, P239, DOI 10.1242/jeb.064055; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Smerdu V, 2013, CELLS TISSUES ORGANS, V198, P75, DOI 10.1159/000351293; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Standiford DM, 1997, J MOL BIOL, V265, P40, DOI 10.1006/jmbi.1996.0710; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Suggs JA, 2007, J MOL BIOL, V367, P1312, DOI 10.1016/j.jmb.2007.01.045; Swank DM, 2006, BIOPHYS J, V90, P2427, DOI 10.1529/biophysj.105.075184; Swank DM, 2004, BIOPHYS J, V87, P1805, DOI 10.1529/biophysj.103.032078; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; UYEDA TQP, 1994, NATURE, V368, P567, DOI 10.1038/368567a0; WESTON D, 1993, MOL BIOCHEM PARASIT, V58, P161, DOI 10.1016/0166-6851(93)90100-C; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whiteley NM, 2010, COMP BIOCHEM PHYS A, V157, P116, DOI 10.1016/j.cbpa.2010.05.014; Yamada A, 2000, J MOL BIOL, V295, P169, DOI 10.1006/jmbi.1999.3349; Zhu JG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-117	59	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88111	10.1371/journal.pone.0088111	http://dx.doi.org/10.1371/journal.pone.0088111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498429	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900175
J	Martianov, I; Cler, E; Duluc, I; Vicaire, S; Philipps, M; Freund, JN; Davidson, I				Martianov, Igor; Cler, Emilie; Duluc, Isabelle; Vicaire, Serge; Philipps, Muriel; Freund, Jean-Noel; Davidson, Irwin			TAF4 Inactivation Reveals the 3 Dimensional Growth Promoting Activities of Collagen 6A3	PLOS ONE			English	Article							RETINOIC ACID RECEPTOR; ACUTE PROMYELOCYTIC LEUKEMIA; HIPPO PATHWAY; CELL-DIFFERENTIATION; RNA-SEQ; GENES; YAP; PROTEIN; PROLIFERATION; TUMORIGENESIS	Collagen 6A3 (Col6a3), a component of extracellular matrix, is often up-regulated in tumours and is believed to play a pro-oncogenic role. However the mechanisms of its tumorigenic activity are poorly understood. We show here that Col6a3 is highly expressed in densely growing mouse embryonic fibroblasts (MEFs). In MEFs where the TAF4 subunit of general transcription factor IID (TFIID) has been inactivated, elevated Col6a3 expression prevents contact inhibition promoting their 3 dimensional growth as foci and fibrospheres. Analyses of gene expression in densely growing Taf4(-/-) MEFs revealed repression of the Hippo pathway and activation of Wnt signalling. The Hippo activator Kibra/Wwc1 is repressed under dense conditions in Taf4(-/-) MEFs, leading to nuclear accumulation of the proliferation factor YAP1 in the cells forming 3D foci. At the same time, Wnt9a is activated and the Sfrp2 antagonist of Wnt signalling is repressed. Surprisingly, treatment of Taf4(-/-) MEFs with all-trans retinoic acid (ATRA) restores contact inhibition suppressing 3D growth. ATRA represses Col6a3 expression independently of TAF4 expression and Col6a3 silencing is sufficient to restore contact inhibition in Taf4(-/-) MEFs and to suppress 3D growth by reactivating Kibra expression to induce Hippo signalling and by inducing Sfrp2 expression to antagonize Wnt signalling. All together, these results reveal a critical role for Col6a3 in regulating both Hippo and Wnt signalling to promote 3D growth, and show that the TFIID subunit TAF4 is essential to restrain the growth promoting properties of Col6a3. Our data provide new insight into the role of extra cellular matrix components in regulating cell growth.	[Martianov, Igor; Cler, Emilie; Vicaire, Serge; Philipps, Muriel; Davidson, Irwin] CNRS INSERM UDS, Inst Genet & Biol Mol & Cellulaire, Dept Funct Genom & Canc, Illkirch Graffenstaden, France; [Duluc, Isabelle; Freund, Jean-Noel] Inserm U1113 Dev & Physiopathol Intestin & Pancre, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Martianov, I (corresponding author), CNRS INSERM UDS, Inst Genet & Biol Mol & Cellulaire, Dept Funct Genom & Canc, Illkirch Graffenstaden, France.	irwin@igbmc.fr; martiano@igbmc.fr	Freund, Jean-Noel/R-4383-2016; DULUC, Isabelle/AAA-7062-2022; Duluc, Isabelle/O-1972-2017	Freund, Jean-Noel/0000-0002-0971-3774; DULUC, Isabelle/0000-0001-8396-6385; Duluc, Isabelle/0000-0001-8396-6385; Martiyanov, Igor/0000-0001-6108-2036; Davidson, Irwin/0000-0001-5533-1171	CNRS; INSERM; Association pour la Recherche contre le Cancer; Ligue Nationale et Departementale Region Alsace contre le Cancer; Institut National du Cancer (INCa); Fondation pour la Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale et Departementale Region Alsace contre le Cancer(Region Grand-Est); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants from the CNRS, the INSERM, the Association pour la Recherche contre le Cancer, the Ligue Nationale et Departementale Region Alsace contre le Cancer and in Institut National du Cancer (INCa). ID is an 'equipe labellisee' of the Ligue Nationale contre le Cancer. EC was supported by a fellowship from the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7; Benhaddou A, 2012, CELL DEATH DIFFER, V19, P220, DOI 10.1038/cdd.2011.87; Cioce M, 2010, CELL CYCLE, V9, P2878, DOI 10.4161/cc.9.14.12371; Donato LJ, 2007, CANCER RES, V67, P609, DOI 10.1158/0008-5472.CAN-06-0989; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Fadloun A, 2007, DEVELOPMENT, V134, P2947, DOI 10.1242/dev.005041; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Howell SJ, 1998, EXP CELL RES, V241, P230, DOI 10.1006/excr.1998.4051; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Licht JD, 2006, CANCER CELL, V9, P73, DOI 10.1016/j.ccr.2006.01.024; Licht JD, 2009, NEW ENGL J MED, V360, P928, DOI 10.1056/NEJMcibr0810371; Mao YP, 2011, DEVELOPMENT, V138, P947, DOI 10.1242/dev.057166; Mauviel A, 2012, ONCOGENE, V31, P1743, DOI 10.1038/onc.2011.363; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Ruhl M, 1999, J BIOL CHEM, V274, P34361, DOI 10.1074/jbc.274.48.34361; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sherman-Baust CA, 2003, CANCER CELL, V3, P377, DOI 10.1016/S1535-6108(03)00058-8; St Croix B, 2000, SCIENCE, V289, P1197; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varelas X, 2012, TRENDS CELL BIOL, V22, P88, DOI 10.1016/j.tcb.2011.10.002; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	36	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87365	10.1371/journal.pone.0087365	http://dx.doi.org/10.1371/journal.pone.0087365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498316	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900062
J	Yoshida, S; Lee, JO; Nakamura, K; Suzuki, S; Hendon, DN; Kobayashi, M; Suzuki, F				Yoshida, Shohei; Lee, Jong O.; Nakamura, Kiwamu; Suzuki, Sumihiro; Hendon, David N.; Kobayashi, Makiko; Suzuki, Fujio			Lineage(-)CD34(+)CD31(+) Cells That Appear in Association with Severe Burn Injury Are Inhibitory on the Production of Antimicrobial Peptides by Epidermal Keratinocytes	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BETA-DEFENSIN; MACROPHAGES; SUPPRESSOR; EXPRESSION; INFECTION; SEPSIS; MICE; SKIN; PHAGOCYTOSIS	Antimicrobial peptides are major host defense effectors against Pseudomonas aeruginosa skin infections. Due to the lack of such peptide production, severely burned hosts are greatly susceptible to P. aeruginosa burn wound infection. beta-Defensin (HBD) production by normal human epidermal keratinocytes (NHEK) was inhibited by lineage(-)CD34(+) cells isolated from peripheral blood of severely burned patients. Lineage(-)CD34(+) cells obtained from severely burned patients were characterized as CD31(+), while healthy donor lineage(-)CD34(+) cells were shown to be CD31 2 cells. Lineage(-)CD34(+)CD31(-) cells did not show any inhibitory activities on HBD-1 production by NHEK. CCL2 and IL-10 released from lineage(-)CD34(+)CD31(+) cells were shown to be inhibitory on the peptide production by NHEK, while these soluble factors were not produced by lineage(-)CD34(+)CD31(-) cells. After treatment with a mixture of mAbs for CCL2 and IL-10, the culture fluids of lineage(-)CD34(+)CD31(+) cells did not show any inhibitory activities on HBD-1 production by NHEK. Lineage(-)CD34(+)CD31(+) cells that appear in association with burn injuries play a role on the inhibition of antimicrobial peptide production by skin keratinocytes through the production of CCL2 and IL-10.	[Yoshida, Shohei; Nakamura, Kiwamu; Kobayashi, Makiko; Suzuki, Fujio] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Lee, Jong O.; Hendon, David N.; Kobayashi, Makiko; Suzuki, Fujio] Shriners Hosp Children, Galveston, TX 77550 USA; [Suzuki, Sumihiro] Univ N Texas, Hlth Sci Ctr, Dept Biostat, Ft Worth, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of North Texas System; University of North Texas Health Science Center	Suzuki, F (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	fsuzuki@utmb.edu			Shriners Hospitals for Children Grant [85110]	Shriners Hospitals for Children Grant	This work was supported by the Shriners Hospitals for Children Grant #85110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 2007, J IMMUNOL, V179, P984, DOI 10.4049/jimmunol.179.2.984; Baniyash M, 2006, SEMIN CANCER BIOL, V16, P80, DOI 10.1016/j.semcancer.2005.12.002; Ben-Baruch A, 2006, SEMIN CANCER BIOL, V16, P38, DOI 10.1016/j.semcancer.2005.07.006; Braff MH, 2006, CURR TOP MICROBIOL, V306, P91; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Brudecki L, 2012, INFECT IMMUN, V80, P2026, DOI 10.1128/IAI.00239-12; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Davey V, 2002, EMERGING INFECTIOUS DISEASES: TRENDS AND ISSUES, P303; Ganz T, 2003, INFEC DIS S, P287; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Heggers JP., 2002, TOTAL BURN CARE, P120, DOI DOI 10.1038/SREP41441; Herndon DN., 2017, TOTAL BURN CARE, V5th; Howell MD, 2006, CLIN IMMUNOL, V121, P332, DOI 10.1016/j.clim.2006.08.008; Hunsicker LM, 2001, CLINICAL MANAGEMENT OF INFECTIONS IN IMMUNOCOMPROMISED INFANTS AND CHILDREN, P327; Inatsu A, 2011, J IMMUNOL, V187, P2155, DOI 10.4049/jimmunol.1003235; Kobayashi M, 2008, J LEUKOCYTE BIOL, V83, P1354, DOI 10.1189/jlb.0807541; Kobayashi M, 2010, J IMMUNOL, V185, P7174, DOI 10.4049/jimmunol.0903935; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Maree AFM, 2008, J APPL PHYSIOL, V104, P157, DOI 10.1152/japplphysiol.00514.2007; Milner SM, 1999, BURNS, V25, P411, DOI 10.1016/S0305-4179(98)00192-2; Morrison VA, 2000, INFEC DIS S, P315; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; O'Brien BA, 2002, DIABETES, V51, P2481, DOI 10.2337/diabetes.51.8.2481; Ortega MR, 2000, BURNS, V26, P724, DOI 10.1016/S0305-4179(00)00052-8; Piganelli JD, 1998, DIABETES, V47, P1212, DOI 10.2337/diabetes.47.8.1212; Sawamura D, 2005, GENE THER, V12, P857, DOI 10.1038/sj.gt.3302472; Shigematsu K, 2012, EUR J IMMUNOL, V42, P158, DOI 10.1002/eji.201141572; Shigematsu K, 2009, J LEUKOCYTE BIOL, V86, P999, DOI 10.1189/jlb.0409235; STIERITZ DD, 1975, J INFECT DIS, V131, P688, DOI 10.1093/infdis/131.6.688; TORIMOTO Y, 1992, J IMMUNOL, V148, P388; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Tsuda Y, 2008, J IMMUNOL, V180, P4133, DOI 10.4049/jimmunol.180.6.4133; Yoshida S, 2010, J IMMUNOL, V184, P8930; Yoshida T, 2010, J LEUKOCYTE BIOL, V87, P35, DOI 10.1189/jlb.1208760	39	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e82926	10.1371/journal.pone.0082926	http://dx.doi.org/10.1371/journal.pone.0082926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498256	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900002
J	Awad, WA; Ghareeb, K; Dadak, A; Hess, M; Bohm, J				Awad, Wageha A.; Ghareeb, Khaled; Dadak, Agnes; Hess, Michael; Boehm, Josef			Single and Combined Effects of Deoxynivalenol Mycotoxin and a Microbial Feed Additive on Lymphocyte DNA Damage and Oxidative Stress in Broiler Chickens	PLOS ONE			English	Article							BLOOD PHAGOCYTIC-ACTIVITY; T-2 TOXIN; LIPID-PEROXIDATION; FUSARIUM MYCOTOXIN; CELL-LINE; IN-VIVO; PERFORMANCE; TRICHOTHECENES; IMMUNOTOXICITY; ANTIOXIDANT	The immune and intestinal epithelial cells are particularly sensitive to the toxic effects of deoxynivalenol (DON). The aim of this experiment was to study the effects of DON and/or a microbial feed additive on the DNA damage of blood lymphocytes and on the level of thiobarbituric acid reactive substance (TBARS) as an indicator of lipid peroxidation and oxidative stress in broilers. A total of forty 1-d-old broiler chicks were randomly assigned to 1 of 4 dietary treatments (10 birds per group) for 5 wk. The dietary treatments were 1) basal diet; 2) basal diet contaminated with 10 mg DON/kg feed; 3) basal diet contaminated with 10 mg DON/kg feed and supplemented with 2.5 kg/ton of feed of Mycofix Select; 4) basal diet supplemented with Mycofix Select (2.5 kg/ton of feed). At the end of the feeding trial, blood were collected for measuring the level of lymphocyte DNA damage of blood and the TBARS level was measured in plasma, heart, kidney, duodenum and jejunum. The dietary exposure of DON caused a significant increase (P = 0.001) of DNA damage in blood lymphocytes (31.99 +/- 0.89%) as indicated in the tail of comet assay. Interestingly addition of Mycofix Select to DON contaminated diet decreased (P = 0.001) the DNA damage (19.82 +/- 1.75%) induced by DON. In order to clarify the involvement of lipid peroxidation in the DNA damage of DON, TBARS levels was measured. A significant increase (P = 0.001) in the level of TBARS (23 +/- 2 nmol/mg) was observed in the jejunal tissue suggesting that the lipid peroxidation might be involved in the DNA damage. The results indicate that DON is cytotoxic and genotoxic to the chicken intestinal and immune cells and the feed additive have potential ability to prevent DNA damage induced by DON.	[Awad, Wageha A.; Hess, Michael] Univ Vet Med, Dept Farm Animals & Vet Publ Hlth, Clin Avian Reptile & Fish Med, Vienna, Austria; [Awad, Wageha A.; Ghareeb, Khaled; Boehm, Josef] South Valley Univ, Dept Anim Hyg Behav & Management, Fac Vet Med, Qena, Egypt; [Ghareeb, Khaled] Univ Vet Med, Dept Farm Animals & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Dadak, Agnes] Univ Vet Med, Inst Pharmacol & Toxicol, Dept Biomed Sci, Vienna, Austria	University of Veterinary Medicine Vienna; Egyptian Knowledge Bank (EKB); South Valley University Egypt; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Awad, WA (corresponding author), Univ Vet Med, Dept Farm Animals & Vet Publ Hlth, Clin Avian Reptile & Fish Med, Vienna, Austria.	wageha.awad@vetmeduni.ac.at	Awad, Wageha/R-1705-2016	Awad, Wageha/0000-0003-0843-2089; Hess, Michael/0000-0002-6991-0120; Dadak, Agnes/0000-0002-0948-4764; Ghareeb, Khaled/0000-0001-6191-6344	Biomin GTI GmbH, Herzogenburg, Austria	Biomin GTI GmbH, Herzogenburg, Austria	This work received the financial support from Biomin GTI GmbH, Herzogenburg, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atroshi F, 1997, MOL ASPECTS MED, V18, pS255; Awad WA, 2007, POULTRY SCI, V86, P15, DOI 10.1093/ps/86.1.15; Awad WA, 2006, POULTRY SCI, V85, P974, DOI 10.1093/ps/85.6.974; Awad WA, 2012, WORLD POULTRY SCI J, V68, P651, DOI 10.1017/S0043933912000797; Awad WA, 2012, J ANIM PHYSIOL AN N, V96, P717, DOI 10.1111/j.1439-0396.2011.01199.x; Awad WA, 2012, POULTRY SCI, V91, P550, DOI 10.3382/ps.2011-01742; Awad W, 2013, TOXINS, V5, P912, DOI 10.3390/toxins5050912; Awad WA, 2011, INT J MOL SCI, V12, P7996, DOI 10.3390/ijms12117996; Awad WA, 2011, LIVEST SCI, V140, P72, DOI 10.1016/j.livsci.2011.02.014; Borutova R, 2008, ARCH ANIM NUTR, V62, P303, DOI 10.1080/17450390802190292; Danicke S, 2003, BRIT POULTRY SCI, V44, P113, DOI 10.1080/0007166031000085300; Dvorska JE, 2007, COMP BIOCHEM PHYS C, V145, P582, DOI 10.1016/j.cbpc.2007.02.005; Eriksen GS, 2004, ANIM FEED SCI TECH, V114, P205, DOI 10.1016/j.anifeedsci.2003.08.008; Feldman E., 2004, ANIMAL MODELS DIABET; Frankic T, 2006, FOOD CHEM TOXICOL, V44, P1838, DOI 10.1016/j.fct.2006.06.002; Ghareeb K, 2012, POULTRY SCI, V91, P800, DOI 10.3382/ps.2011-01741; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; Kouadio JH, 2005, TOXICOLOGY, V213, P56, DOI 10.1016/j.tox.2005.05.010; Leal M, 1999, TOXICOL LETT, V109, P1, DOI 10.1016/S0378-4274(99)00062-4; Minervini F, 2005, TOXICOLOGY, V210, P81, DOI 10.1016/j.tox.2005.01.007; Minervini F, 2004, TOXICOL IN VITRO, V18, P21, DOI 10.1016/S0887-2333(03)00130-9; Pestka JJ, 2004, TOXICOL LETT, V153, P61, DOI 10.1016/j.toxlet.2004.04.023; Placha I, 2009, J ANIM PHYSIOL AN N, V93, P695, DOI 10.1111/j.1439-0396.2008.00857.x; Rizzo A., 1998, PATHOPHYSIOLOGY, V1001, P81; RIZZO AF, 1994, J VET MED A, V41, P81, DOI 10.1111/j.1439-0442.1994.tb00070.x; Schatzmayr G, 2006, MOL NUTR FOOD RES, V50, P543, DOI 10.1002/mnfr.200500181; Steenkamp V, 2005, MUTAT RES-GEN TOX EN, V581, P35, DOI 10.1016/j.mrgentox.2004.10.009; Vila B, 2002, FOOD CHEM TOXICOL, V40, P479, DOI 10.1016/S0278-6915(01)00122-3; Zhang XO, 2009, TOXICON, V54, P513, DOI 10.1016/j.toxicon.2009.05.021	29	52	53	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e88028	10.1371/journal.pone.0088028	http://dx.doi.org/10.1371/journal.pone.0088028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498242	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900208
J	Cruz, NM; Yuan, Y; Leehy, BD; Baid, R; Kompella, U; DeAngelis, MM; Escher, P; Haider, NB				Cruz, Nelly M.; Yuan, Yang; Leehy, Barrett D.; Baid, Rinku; Kompella, Uday; DeAngelis, Margaret M.; Escher, Pascal; Haider, Neena B.			Modifier Genes as Therapeutics: The Nuclear Hormone Receptor Rev Erb Alpha (Nr1d1) Rescues Nr2e3 Associated Retinal Disease	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; DOMINANT RETINITIS-PIGMENTOSA; S-CONE SYNDROME; PHOTORECEPTOR DEVELOPMENT; HUNTINGTONS-DISEASE; CIRCADIAN CLOCK; CYSTIC-FIBROSIS; IN-VIVO; MUTATION; DEGENERATION	Nuclear hormone receptors play a major role in many important biological processes. Most nuclear hormone receptors are ubiquitously expressed and regulate processes such as metabolism, circadian function, and development. They function in these processes to maintain homeostasis through modulation of transcriptional gene networks. In this study we evaluate the effectiveness of a nuclear hormone receptor gene to modulate retinal degeneration and restore the integrity of the retina. Currently, there are no effective treatment options for retinal degenerative diseases leading to progressive and irreversible blindness. In this study we demonstrate that the nuclear hormone receptor gene Nr1d1 (Rev-Erba) rescues Nr2e3-associated retinal degeneration in the rd7 mouse, which lacks a functional Nr2e3 gene. Mutations in human NR2E3 are associated with several retinal degenerations including enhanced S cone syndrome and retinitis pigmentosa. The rd7 mouse, lacking Nr2e3, exhibits an increase in S cones and slow, progressive retinal degeneration. A traditional genetic mapping approach previously identified candidate modifier loci. Here, we demonstrate that in vivo delivery of the candidate modifier gene, Nr1d1 rescues Nr2e3 associated retinal degeneration. We observed clinical, histological, functional, and molecular restoration of the rd7 retina. Furthermore, we demonstrate that the mechanism of rescue at the molecular and functional level is through the re-regulation of key genes within the Nr2e3-directed transcriptional network. Together, these findings reveal the potency of nuclear receptors as modulators of disease and specifically of NR1D1 as a novel therapeutic for retinal degenerations.	[Cruz, Nelly M.; Leehy, Barrett D.; Haider, Neena B.] Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA; [Cruz, Nelly M.; Haider, Neena B.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Yuan, Yang] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Baid, Rinku; Kompella, Uday] Univ Colorado, Nanomed & Drug Delivery Lab, Dept Pharmaceut Sci, Aurora, CO USA; [Kompella, Uday] Univ Colorado, Dept Ophthalmol, Aurora, CO USA; [DeAngelis, Margaret M.] Univ Utah, Ctr Translat Med, John A Moran Eye Ctr, Salt Lake City, UT USA; [Escher, Pascal] Inst Res Ophthalmol, Grand Champsec Sion, Switzerland	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; University of Nebraska System; University of Nebraska Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Utah System of Higher Education; University of Utah	Haider, NB (corresponding author), Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA.	neena_haider@meei.harvard.edu	DeAngelis, e/J-7863-2015	Cruz, Nelly/0000-0002-9040-6957	NIH-NCRR [P20-RRO18788-03]; NIH-NEI [RO1EY017653, RO1EY017653-01A2S1, T32EY007145-14]; Hope for Vision; Edward N. & Della L. Thome Memorial Foundation; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE [R01EY017653, T32EY007145] Funding Source: NIH RePORTER	NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH-NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Hope for Vision; Edward N. & Della L. Thome Memorial Foundation; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the following funding agencies: NIH-NCRR P20-RRO18788-03 (NBH), NIH-NEI RO1EY017653 (NBH), NIH-NEI RO1EY017653-01A2S1 (NBH), NIH-NEI T32EY007145-14 (NMC), Hope for Vision (NBH), Edward N. & Della L. Thome Memorial Foundation (NBH, MMD), Massachusetts Lions Eye Research Fund (NBH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Bandah D, 2009, ARCH OPHTHALMOL-CHIC, V127, P297, DOI 10.1001/archophthalmol.2008.615; Bergren SK, 2009, MAMM GENOME, V20, P359, DOI 10.1007/s00335-009-9193-6; Bergren SK, 2005, MAMM GENOME, V16, P683, DOI 10.1007/s00335-005-0049-4; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Chen F, 1999, P NATL ACAD SCI USA, V96, P15149, DOI 10.1073/pnas.96.26.15149; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Collaco JM, 2008, CURR OPIN PULM MED, V14, P559, DOI 10.1097/MCP.0b013e3283121cdc; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Djousse L, 2004, NEUROGENETICS, V5, P109, DOI 10.1007/s10048-004-0175-2; Escher P, 2009, HUM MUTAT, V30, P342, DOI 10.1002/humu.20858; Fahim AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023021; Forrest D, 2012, MOL ENDOCRINOL, V26, P905, DOI 10.1210/me.2012-1010; Gerber S, 2000, HUM GENET, V107, P276, DOI 10.1007/s004390000350; Gire AI, 2007, MOL VIS, V13, P1970; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2002, HUM MOL GENET, V11, P1195, DOI 10.1093/hmg/11.10.1195; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Haider NB, 2008, MAMM GENOME, V19, P145, DOI 10.1007/s00335-008-9092-2; Haider NB, 2006, VISUAL NEUROSCI, V23, P917, DOI 10.1017/S095252380623027X; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Hamilton BA, 2012, PLOS GENET, V8, P326, DOI 10.1371/journal.pgen.1002644; Houlston RS, 1998, EUR J HUM GENET, V6, P80, DOI 10.1038/sj.ejhg.5200156; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kakizawa T, 2007, J MOL ENDOCRINOL, V38, P555, DOI 10.1677/JME-06-0063; Kearney JA, 2011, CURR OPIN GENET DEV, V21, P349, DOI 10.1016/j.gde.2010.12.007; Li JL, 2003, AM J HUM GENET, V73, P682, DOI 10.1086/378133; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Metzger S, 2006, NEUROGENETICS, V7, P27, DOI 10.1007/s10048-005-0023-z; Metzger S, 2006, HUM GENET, V120, P285, DOI 10.1007/s00439-006-0221-2; Mollema N, 2010, EXP EYE RES, V91, P116, DOI 10.1016/j.exer.2010.04.013; Mollema NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017494; Passerini I, 2007, EUR J OPHTHALMOL, V17, P1000, DOI 10.1177/112067210701700624; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Schorderet DF, 2009, HUM MUTAT, V30, P1475, DOI 10.1002/humu.21096; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; Simonelli F, MOL THER, V18, P643; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Walia S, 2008, ARCH OPHTHALMOL-CHIC, V126, P379, DOI 10.1001/archophthalmol.2007.72; Webber AL, 2008, EXP EYE RES, V87, P35, DOI 10.1016/j.exer.2008.04.006; Wolf U, 1997, HUM GENET, V100, P305, DOI 10.1007/s004390050509; Yan D, 2010, CURR GENOMICS, V11, P269, DOI 10.2174/138920210791233054; Yanagi Y, 2002, INVEST OPHTH VIS SCI, V43, P3489; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yin L, 2010, NUCL RECEP SIGNAL, V8, DOI [10.1621/nrs.08001, DOI 10.1621/NRS.08001]; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zernant J, 2005, INVEST OPHTH VIS SCI, V46, P3052, DOI 10.1167/iovs.05-0111	56	30	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87942	10.1371/journal.pone.0087942	http://dx.doi.org/10.1371/journal.pone.0087942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498227	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900197
J	Gong, L; Wei, LX; Ren, P; Zhang, WD; Liu, XY; Han, XJ; Yao, L; Zhu, SJ; Lan, M; Li, YH; Zhang, W				Gong, Li; Wei, Long-Xiao; Ren, Pin; Zhang, Wen-Dong; Liu, Xiao-Yan; Han, Xiu-Juan; Yao, Li; Zhu, Shao-Jun; Lan, Miao; Li, Yan-Hong; Zhang, Wei			Dysplastic Nodules with Glypican-3 Positive Immunostaining: A Risk for Early Hepatocellular Carcinoma	PLOS ONE			English	Article							LIVER-CELL DYSPLASIA; DIAGNOSTIC-VALUE; CD34 IMMUNOHISTOCHEMISTRY; ONCOFETAL PROTEIN; LESIONS; MARKER; EXPRESSION; CIRRHOSIS; UTILITY; BENIGN	Glypican-3 (GPC3) has been reported to be a novel serum and histochemical marker for HCC. The positivity or negativity for GPC3 in hepatic precancerous lesions, such as dysplastic nodules (DN), has also been described. Moreover, our previous studies have demonstrated that some DN in liver cirrhosis represent monoclonal hyperplasia, and confirmed their neoplastic nature. However, additional studies must be performed to investigate further the relationship between DN with GPC3 positivity and HCC. Thus, we first investigated the expression of GPC3 in 136 HCC and 103 small DN (less than 1 cm in diameter) by immunohistochemical staining and determined the clonality of 81 DN from female patients using X-chromosome inactivation mosaicism and polymorphism of androgen receptor (AR) gene. Then we examined these samples for chromosomal loss of heterozygosity (LOH) at 11 microsatellite polymorphism sites. The results demonstrated that GPC3 immunoreactivity was detected in 103 of 136 HCC (75.7%) and 19 of 103 DN (18.4%), and the positive ratio correlated with HBsAg positivity. Clonality assays showed that 15 GPC3-positive DN from female patients, including 12 high-grade DN (HGDN), and 28 (42.4%) of 66 GPC3-negative DN, were monoclonal. In addition, among 19 GPC3-positive DN, chromosomal LOH was found at loci D6S1008 (100%, 19/19), D8S262 (52.6%, 10/19) and D11S1301 (57.9%, 11/19). However, the LOH frequency in GPC3-negative DN was 5.95% (5/84), 23.8% (20/84), and 4.76% (4/84) in three loci, respectively. Thus, we concluded that GPC3-positive DN, especially GPC3-positive HGDN, was really a late premalignant lesion of HCC.	[Gong, Li; Ren, Pin; Zhang, Wen-Dong; Liu, Xiao-Yan; Han, Xiu-Juan; Yao, Li; Zhu, Shao-Jun; Lan, Miao; Li, Yan-Hong; Zhang, Wei] Fourth Mil Med Univ, Tangdu Hosp, Dept Pathol, Helmholtz Sino German Lab Canc Res, Xian 710032, Peoples R China; [Wei, Long-Xiao] Fourth Mil Med Univ, Tangdu Hosp, Dept Nucl Med, Xian 710032, Peoples R China; [Li, Yan-Hong] Fourth Mil Med Univ, Tangdu Hosp, Dept Gynaecol & Obstet, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Li, YH (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Pathol, Helmholtz Sino German Lab Canc Res, Xian 710032, Peoples R China.	lyhzhw@fmmu.edu.cn; zhwlyh@fmmu.edu.cn	li, yan/GTI-4638-2022		National Natural Science Foundation of China [30800417, 30672013, 81372226]; National Basic Research Program (973 Program) of China [2009CB521705]; Shaanxi Province [2011KTCL03-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program) of China(National Basic Research Program of China); Shaanxi Province	The study was supported by the National Natural Science Foundation of China (No. 30800417; 30672013; 81372226), the National Basic Research Program (973 Program) of China (No. 2009CB521705), and Shaanxi Province Innovation Project Co-ordinator (No. 2011KTCL03-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anatelli F, 2008, AM J CLIN PATHOL, V130, P219, DOI 10.1309/WMB5PX57Y4P8QCTY; ANTHONY PP, 1973, J CLIN PATHOL, V26, P217, DOI 10.1136/jcp.26.3.217; Baumhoer D, 2008, AM J CLIN PATHOL, V129, P899, DOI 10.1309/HCQWPWD50XHD2DW6; Coston WMP, 2008, AM J SURG PATHOL, V32, P433, DOI 10.1097/PAS.0b013e318158142f; Di Tommaso L, 2007, HEPATOLOGY, V45, P725, DOI 10.1002/hep.21531; Du Jing-li, 2011, Chinese Journal of Pathology, V40, P11, DOI 10.3760/cma.j.issn.0529-5807.2011.01.004; Ferenci P, 2010, J CLIN GASTROENTEROL, V44, P239, DOI 10.1097/MCG.0b013e3181d46ef2; Filmus J, 2001, J CLIN INVEST, V108, P497, DOI 10.1172/JCI13712; Gong L, 2008, PATHOLOGY, V40, P392, DOI 10.1080/00313020801911496; Gong L, 2010, HISTOPATHOLOGY, V56, P589, DOI 10.1111/j.1365-2559.2010.03523.x; Grozdanov PN, 2006, LAB INVEST, V86, P1272, DOI 10.1038/labinvest.3700479; Hippo Y, 2004, CANCER RES, V64, P2418, DOI 10.1158/0008-5472.CAN-03-2191; Hirohashi S, 2000, PATHOLOGY GENETICS T, P159; Kojiro M, 2006, PATHOLOGY HEPATOCELL, P105; Libbrecht L, 2006, AM J SURG PATHOL, V30, P1405, DOI 10.1097/01.pas.0000213323.97294.9a; Ligato S, 2008, MODERN PATHOL, V21, P626, DOI 10.1038/modpathol.2008.26; Liu H, 2010, WORLD J GASTROENTERO, V16, P4410, DOI 10.3748/wjg.v16.i35.4410; Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014; Park YN, 2011, ARCH PATHOL LAB MED, V135, P704, DOI 10.1043/2010-0524-RA.1; Plentz RR, 2007, HEPATOLOGY, V45, P968, DOI 10.1002/hep.21552; Shafizadeh N, 2008, MODERN PATHOL, V21, P1011, DOI 10.1038/modpathol.2008.85; Su N, 2011, MOL BIOL REP, V15, P162; Tangkijvanich P, 2010, J GASTROEN HEPATOL, V25, P129, DOI 10.1111/j.1440-1746.2009.05988.x; Tatrai P, 2009, AM J SURG PATHOL, V33, P874, DOI 10.1097/PAS.0b013e318194b3ea; Wang XY, 2006, HUM PATHOL, V37, P1435, DOI 10.1016/j.humpath.2006.05.016; WATANABE S, 1983, CANCER, V51, P2197, DOI 10.1002/1097-0142(19830615)51:12<2197::AID-CNCR2820511208>3.0.CO;2-5; Yamauchi N, 2005, MODERN PATHOL, V18, P1591, DOI 10.1038/modpathol.3800436; Yan B, 2011, ANN DIAGN PATHOL, V15, P162, DOI 10.1016/j.anndiagpath.2010.10.004; Yao M, 2011, HEPATOB PANCREAT DIS, V10, P289, DOI 10.1016/S1499-3872(11)60048-9; Zhang LJ, 2012, ACTA HISTOCHEM, V114, P547, DOI 10.1016/j.acthis.2011.10.003	30	8	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87120	10.1371/journal.pone.0087120	http://dx.doi.org/10.1371/journal.pone.0087120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498024	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900067
J	Ko, JH; Spetsieris, P; Ma, YL; Dhawan, V; Eidelberg, D				Ko, Ji Hyun; Spetsieris, Phoebe; Ma, Yilong; Dhawan, Vijay; Eidelberg, David			Quantifying Significance of Topographical Similarities of Disease-Related Brain Metabolic Patterns	PLOS ONE			English	Article							PARKINSONS-DISEASE; NETWORK ACTIVITY; MULTIVARIATE	Multivariate analytical routines have become increasingly popular in the study of cerebral function in health and in disease states. Spatial covariance analysis of functional neuroimaging data has been used to identify and validate characteristic topographies associated with specific brain disorders. Voxel-wise correlations can be used to assess similarities and differences that exist between covariance topographies. While the magnitude of the resulting topographical correlations is critical, statistical significance can be difficult to determine in the setting of large data vectors (comprised of over 100,000 voxel weights) and substantial autocorrelation effects. Here, we propose a novel method to determine the p-value of such correlations using pseudo-random network simulations.	[Ko, Ji Hyun; Spetsieris, Phoebe; Ma, Yilong; Dhawan, Vijay; Eidelberg, David] North Shore Long Isl Jewish Hlth Syst, Ctr Neurosci, Feinstein Inst Med Res, Manhasset, NY 11030 USA	Northwell Health	Ko, JH (corresponding author), North Shore Long Isl Jewish Hlth Syst, Ctr Neurosci, Feinstein Inst Med Res, Manhasset, NY 11030 USA.	jko1@nshs.edu	Ko, Ji Hyun/E-5150-2011; Ma, Yilong/AAF-2571-2020	Ko, Ji Hyun/0000-0002-9700-7692; Ma, Yilong/0000-0002-8383-6748; Spetsieris, Phoebe/0000-0001-7368-2354; Eidelberg, David/0000-0002-0854-864X; Dhawan, Vijay/0000-0002-2418-5674	National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01 NS 35069, P50 NS 071675]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035069, P50NS071675] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health/National Institute of Neurological Disorders and Stroke Grants R01 NS 35069 and P50 NS 071675 (Morris K. Udall Center of Excellence in Parkinson's Disease Research at The Feinstein Institute for Medical Research) (D. E.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Carbon M, 2010, BRAIN, V133, P690, DOI 10.1093/brain/awq017; Eckert T, 2008, MOVEMENT DISORD, V23, P727, DOI 10.1002/mds.21933; Eidelberg D, 2009, TRENDS NEUROSCI, V32, P548, DOI 10.1016/j.tins.2009.06.003; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Habeck C, 2008, NEUROIMAGE, V40, P1503, DOI 10.1016/j.neuroimage.2008.01.056; Habeck C, 2011, BRAIN CONNECT, V1, P99, DOI 10.1089/brain.2011.0021; Hirano S, 2008, J NEUROSCI, V28, P4201, DOI 10.1523/JNEUROSCI.0582-08.2008; Ko JH, 2013, J NEUROSCI, V33, P4540, DOI 10.1523/JNEUROSCI.5024-12.2013; Liebhold A.M., 1998, P111; Ma YL, 2007, J CEREBR BLOOD F MET, V27, P597, DOI 10.1038/sj.jcbfm.9600358; MOELLER JR, 1991, J CEREBR BLOOD F MET, V11, pA121, DOI 10.1038/jcbfm.1991.47; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Mure H, 2012, J NEUROSCI, V32, P2804, DOI 10.1523/JNEUROSCI.4331-11.2012; Mure H, 2011, NEUROIMAGE, V54, P1244, DOI 10.1016/j.neuroimage.2010.09.028; Niethammer M., 2012, ANN NEUROL; Poston KL, 2012, NEUROLOGY, V78, P1237, DOI 10.1212/WNL.0b013e318250d7fd; Spetsieris P, 2013, JOVE-J VIS EXP, DOI 10.3791/50319; Spetsieris PG, 2011, NEUROIMAGE, V54, P2899, DOI 10.1016/j.neuroimage.2010.10.025; Spetsieris PG, 2010, IEEE ENG MED BIO, P2906, DOI 10.1109/IEMBS.2010.5626327; Spetsieris PG, 2009, NEUROIMAGE, V45, P1241, DOI 10.1016/j.neuroimage.2008.12.063; Tang CC, 2010, LANCET NEUROL, V9, P149, DOI 10.1016/S1474-4422(10)70002-8; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978	24	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e88119	10.1371/journal.pone.0088119	http://dx.doi.org/10.1371/journal.pone.0088119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498250	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900214
J	McGaughran, A; Morgan, K; Sommer, RJ				McGaughran, Angela; Morgan, Katy; Sommer, Ralf J.			Environmental Variables Explain Genetic Structure in a Beetle-Associated Nematode	PLOS ONE			English	Article							PRISTIONCHUS-PACIFICUS; POPULATION-STRUCTURE; EVOLUTIONARY HISTORY; LANDSCAPE GENETICS; INDIAN-OCEAN; DIVERSITY; CLIMATE; REUNION; ECOLOGY; DIVERSIFICATION	The distribution of a species is a complex expression of its ecological and evolutionary history and integrating population genetic, environmental, and ecological data can provide new insights into the effects of the environment on the population structure of species. Previous work demonstrated strong patterns of genetic differentiation in natural populations of the hermaphroditic nematode Pristionchus pacificus in its La Reunion Island habitat, but gave no clear understanding of the role of the environment in structuring this variation. Here, we present what is to our knowledge the first study to statistically evaluate the role of the environment in shaping the structure and distribution of nematode populations. We test the hypothesis that genetic structure in P. pacificus is influenced by environmental variables, by combining population genetic analyses of microsatellite data from 18 populations and 370 strains, with multivariate statistics on environmental data, and species distribution modelling. We assess and quantify the relative importance of environmental factors (geographic distance, altitude, temperature, precipitation, and beetle host) on genetic variation among populations. Despite the fact that geographic populations of P. pacificus comprise vast genetic diversity sourced from multiple ancestral lineages, we find strong evidence for local associations between environment and genetic variation. Further, we show that significantly more genetic variation in P. pacificus populations is explained by environmental variation than by geographic distances. This supports a strong role for environmental heterogeneity vs. genetic drift in the divergence of populations, which we suggest may be influenced by adaptive forces.	[McGaughran, Angela; Morgan, Katy; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany	Max Planck Society	McGaughran, A (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany.	ang.mcgaughran@gmail.com	McGaughran, Angela/C-5916-2014	McGaughran, Angela/0000-0002-3429-8699	Max-Planck Society; Alexander von Humboldt Foundation	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by the Max-Planck Society and the Alexander von Humboldt Foundation (Research Fellowship for Post-doctoral Researchers to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Avise John C., 1994, pi; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Blair C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057433; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111; Dionne M, 2008, MOL ECOL, V17, P2382, DOI 10.1111/j.1365-294X.2008.03771.x; Dionne M, 2007, EVOLUTION, V61, P2154, DOI 10.1111/j.1558-5646.2007.00178.x; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; EPPERSON BK, 1993, EVOL BIOL, V27, P95; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Gomez-Uchida D, 2009, MOL ECOL, V18, P4854, DOI 10.1111/j.1365-294X.2009.04409.x; Gould S.J., 1972, Annual Rev Ecol Syst, V3, P457, DOI 10.1146/annurev.es.03.110172.002325; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Gugger P. F., 2012, REDUNDANCY ANAL TUTO; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hanfling B, 2006, GENETICS, V173, P1487, DOI 10.1534/genetics.105.054296; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Herrmann M, 2006, ZOOLOGY, V109, P96, DOI 10.1016/j.zool.2006.03.001; Herrmann M, 2010, BIOL J LINN SOC, V100, P170, DOI 10.1111/j.1095-8312.2010.01410.x; Hijmans R.J., 2001, PLANT GENETIC RESOUR, V127, P15, DOI DOI 10.1016/j.compositesa.2008.10.018; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jumaux G., 2011, ATLAS CLIMATIQUE REU; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Lee CR, 2011, MOL ECOL, V20, P4631, DOI 10.1111/j.1365-294X.2011.05310.x; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046761; Liu QH, 1997, ENVIRONMETRICS, V8, P75, DOI 10.1002/(SICI)1099-095X(199703)8:2<75::AID-ENV250>3.0.CO;2-N; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Mayr E., 1982, GROWTH BIOL THOUGHT; McGaughran A, 2013, ECOL EVOL, V3, P5209, DOI 10.1002/ece3.902; McGaughran A, 2013, ECOL EVOL, V3, P667, DOI 10.1002/ece3.495; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Morgan K, 2012, MOL ECOL, V21, P250, DOI 10.1111/j.1365-294X.2011.05382.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Orsini L, 2013, MOL ECOL, V22, P583, DOI 10.1111/mec.12117; Peterman WE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062184; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pritchard JK, 2000, GENETICS, V155, P945; R Core Development Team, 2013, R LANG ENV STAT COMP; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Rodelsperger C, 2013, P NATL ACAD IN PRESS; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SOKAL RR, 1989, GENETICS, V121, P845; Sommer RJ, 2013, MOL ECOL, V22, P2380, DOI 10.1111/mec.12286; Sork VL, 2010, MOL ECOL, V19, P3806, DOI 10.1111/j.1365-294X.2010.04726.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Strasberg D, 2005, BIODIVERS CONSERV, V14, P3015, DOI 10.1007/s10531-004-0258-2; Temunovic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042764; Wright S, 1943, GENETICS, V28, P114	61	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87317	10.1371/journal.pone.0087317	http://dx.doi.org/10.1371/journal.pone.0087317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498073	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900089
J	Vater, SM; Weisse, S; Maleschlijski, S; Lotz, C; Koschitzki, F; Schwartz, T; Obst, U; Rosenhahn, A				Vater, Svenja M.; Weisse, Sebastian; Maleschlijski, Stojan; Lotz, Carmen; Koschitzki, Florian; Schwartz, Thomas; Obst, Ursula; Rosenhahn, Axel			Swimming Behavior of Pseudomonas aeruginosa Studied by Holographic 3D Tracking	PLOS ONE			English	Article							IN-LINE HOLOGRAPHY; ESCHERICHIA-COLI; FLAGELLAR ROTATION; MOTILITY; CHEMOTAXIS; BACTERIA; MOTION; STRATEGIES; ORGANISMS; VELOCITY	Holographic 3D tracking was applied to record and analyze the swimming behavior of Pseudomonas aeruginosa. The obtained trajectories allow to qualitatively and quantitatively analyze the free swimming behavior of the bacterium. This can be classified into five distinct swimming patterns. In addition to the previously reported smooth and oscillatory swimming motions, three additional patterns are distinguished. We show that Pseudomonas aeruginosa performs helical movements which were so far only described for larger microorganisms. Occurrence of the swimming patterns was determined and transitions between the patterns were analyzed.	[Vater, Svenja M.; Weisse, Sebastian; Maleschlijski, Stojan; Koschitzki, Florian] Heidelberg Univ, Heidelberg, Germany; [Vater, Svenja M.; Weisse, Sebastian; Maleschlijski, Stojan; Lotz, Carmen; Schwartz, Thomas; Obst, Ursula; Rosenhahn, Axel] Karlsruhe Inst Technol, Inst Funct Interfaces, IFG, D-76021 Karlsruhe, Germany; [Maleschlijski, Stojan; Rosenhahn, Axel] Ruhr Univ Bochum, Bochum, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; Ruhr University Bochum	Rosenhahn, A (corresponding author), Karlsruhe Inst Technol, Inst Funct Interfaces, IFG, D-76021 Karlsruhe, Germany.	axel.rosenhahn@rub.de	Schwartz, Thomas/H-2920-2013; Rosenhahn, Axel/F-7319-2011	Rosenhahn, Axel/0000-0001-9393-7190; Maleschlijski, Stojan/0000-0002-1711-4712	Office of Naval Research [N00014-12-1-0498]; DFG [RO 2524/2-2, Graduiertenkolleg 1114]; Biointerfaces Programme of the Helmholtz Society	Office of Naval Research(Office of Naval Research); DFG(German Research Foundation (DFG)); Biointerfaces Programme of the Helmholtz Society	The authors acknowledge the Office of Naval Research (grant number N00014-12-1-0498), the DFG project RO 2524/2-2, the DFG Graduiertenkolleg 1114, and the Biointerfaces Programme of the Helmholtz Society for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; BERG HC, 1971, REV SCI INSTRUM, V42, P868, DOI 10.1063/1.1685246; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BERG HC, 1975, ANNU REV BIOPHYS BIO, V4, P119, DOI 10.1146/annurev.bb.04.060175.001003; BERG HC, 1990, BIOPHYS J, V58, P919, DOI 10.1016/S0006-3495(90)82436-X; Conrad JC, 2011, BIOPHYS J, V100, P1608, DOI 10.1016/j.bpj.2011.02.020; Crenshaw HC, 2000, J EXP BIOL, V203, P961; Crenshaw HC, 1995, NEW LOOK LOCOMOTION, P608; De Kerchove AJ, 2008, ENVIRON SCI TECHNOL, V42, P4371, DOI 10.1021/es703028u; DRAKE D, 1988, J GEN MICROBIOL, V134, P43; Fenchel T, 2001, PROTIST, V152, P329, DOI 10.1078/1434-4610-00071; FRYMIER PD, 1995, P NATL ACAD SCI USA, V92, P6195, DOI 10.1073/pnas.92.13.6195; Garcia-Sucerquia J, 2006, APPL OPTICS, V45, P836, DOI 10.1364/AO.45.000836; HARWOOD CS, 1989, J BACTERIOL, V171, P4063, DOI 10.1128/jb.171.7.4063-4066.1989; Heydt M, 2007, J ADHESION, V83, P417, DOI 10.1080/00218460701377388; Heydt M, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0033-y; Heydt M, 2009, EUR PHYS J E, V30, P141, DOI 10.1140/epje/i2009-10459-9; Homma M, 1996, MICROBIOL-UK, V142, P2777, DOI 10.1099/13500872-142-10-2777; Hsu CY, 2009, B MATH BIOL, V71, P1228, DOI 10.1007/s11538-009-9400-3; Jericho MH, 2012, APPL OPTICS, V51, P1503, DOI 10.1364/AO.51.001503; Jericho SK, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2193827; Karim QN, 1998, J CLIN PATHOL, V51, P623, DOI 10.1136/jcp.51.8.623; KODAKA H, 1982, J CLIN MICROBIOL, V16, P948, DOI 10.1128/JCM.16.5.948-952.1982; Kreuzer HJ, 2001, J PHYS-CONDENS MAT, V13, P10729, DOI 10.1088/0953-8984/13/47/313; Kudo S, 2005, FEMS MICROBIOL LETT, V242, P221, DOI 10.1016/j.femsle.2004.11.007; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; Lauga E, 2006, BIOPHYS J, V90, P400, DOI 10.1529/biophysj.105.069401; Lewis NI, 2006, PHYCOLOGIA, V45, P61, DOI 10.2216/04-59.1; Li GL, 2008, P NATL ACAD SCI USA, V105, P18355, DOI 10.1073/pnas.0807305105; Luchsinger RH, 1999, BIOPHYS J, V77, P2377, DOI 10.1016/S0006-3495(99)77075-X; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; MACNAB RM, 1977, P NATL ACAD SCI USA, V74, P221, DOI 10.1073/pnas.74.1.221; Magariyama Y, 2005, BIOPHYS J, V88, P3648, DOI [10.1529/biophysj.104.054049, 10.1529/biophsj.104.054049]; Mitchell JG, 2002, AM NAT, V160, P727, DOI 10.1086/343874; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Riccio ML, 2005, ANTIMICROB AGENTS CH, V49, P104, DOI 10.1128/AAC.49.1.104-110.2005; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sendra GH, 2012, APPL OPTICS, V51, P3416, DOI 10.1364/AO.51.003416; Sheng J, 2007, P NATL ACAD SCI USA, V104, P17512, DOI 10.1073/pnas.0704658104; Sheng J, 2010, P NATL ACAD SCI USA, V107, P2082, DOI 10.1073/pnas.0912254107; SHIGEMATSU M, 1995, MICROBIOL IMMUNOL, V39, P741, DOI 10.1111/j.1348-0421.1995.tb03260.x; Sohn MH, 2011, MAR BIOL, V158, P561, DOI 10.1007/s00227-010-1581-7; Stocker R, 2011, P NATL ACAD SCI USA, V108, P2635, DOI 10.1073/pnas.1019199108; Su TW, 2012, P NATL ACAD SCI USA, V109, P16018, DOI 10.1073/pnas.1212506109; TAYLOR BL, 1974, J BACTERIOL, V119, P640, DOI 10.1128/JB.119.2.640-642.1974; Tremblay J, 2007, ENVIRON MICROBIOL, V9, P2622, DOI 10.1111/j.1462-2920.2007.01396.x; Vigeant MAS, 1997, APPL ENVIRON MICROB, V63, P3474, DOI 10.1128/AEM.63.9.3474-3479.1997; Weisse S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037296; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108; Xu W, 2003, OPT LETT, V28, P164, DOI 10.1364/OL.28.000164	51	33	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87765	10.1371/journal.pone.0087765	http://dx.doi.org/10.1371/journal.pone.0087765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498187	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900166
J	Jimenez, AG; Van Brocklyn, J; Wortman, M; Williams, JB				Jimenez, Ana Gabriela; Van Brocklyn, James; Wortman, Matthew; Williams, Joseph B.			Cellular Metabolic Rate Is Influenced by Life-History Traits in Tropical and Temperate Birds	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MITOCHONDRIAL PROTON LEAK; OXIDATIVE STRESS; SKELETAL-MUSCLE; HEXAVALENT CHROMIUM; SKIN FIBROBLASTS; MULTIPLE FORMS; TRADE-OFFS; SLOW PACE; RESPIRATION	In general, tropical birds have a "slow pace of life," lower rates of whole-animal metabolism and higher survival rates, than temperate species. A fundamental challenge facing physiological ecologists is the understanding of how variation in life-history at the whole-organism level might be linked to cellular function. Because tropical birds have lower rates of whole-animal metabolism, we hypothesized that cells from tropical species would also have lower rates of cellular metabolism than cells from temperate species of similar body size and common phylogenetic history. We cultured primary dermal fibroblasts from 17 tropical and 17 temperate phylogenetically-paired species of birds in a common nutritive and thermal environment and then examined basal, uncoupled, and non-mitochondrial cellular O-2 consumption (OCR), proton leak, and anaerobic glycolysis (extracellular acidification rates [ECAR]), using an XF24 Seahorse Analyzer. We found that multiple measures of metabolism in cells from tropical birds were significantly lower than their temperate counterparts. Basal and uncoupled cellular metabolism were 29% and 35% lower in cells from tropical birds, respectively, a decrease closely aligned with differences in whole-animal metabolism between tropical and temperate birds. Proton leak was significantly lower in cells from tropical birds compared with cells from temperate birds. Our results offer compelling evidence that whole-animal metabolism is linked to cellular respiration as a function of an animal's life-history evolution. These findings are consistent with the idea that natural selection has uniquely fashioned cells of long-lived tropical bird species to have lower rates of metabolism than cells from shorter-lived temperate species.	[Jimenez, Ana Gabriela; Van Brocklyn, James; Williams, Joseph B.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Wortman, Matthew] Univ Cincinnati, Inst Canc, Cincinnati, OH USA	University System of Ohio; Ohio State University; University System of Ohio; University of Cincinnati	Jimenez, AG (corresponding author), Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA.	jimenez.102@osu.edu		Wortman, Matthew/0000-0002-1263-4145	NSF IBN [0212587]; Smithsonian Tropical Research Institute; Direct For Biological Sciences [1036914] Funding Source: National Science Foundation	NSF IBN(National Science Foundation (NSF)); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by NSF IBN 0212587 (JBW), and a Smithsonian Tropical Research Institute post-doctoral fellowship (AGJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agutter Paul S, 2004, Theor Biol Med Model, V1, P13, DOI 10.1186/1742-4682-1-13; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Bartholomew GA, 1972, ANIMAL PHYSL PRINCIP, P63; Boyd J. H., 2011, AVES TAXONOMY FLUX V; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Brawn JD, 1999, P INT ORN C, V22, P297; BROWN GC, 1986, BIOCHEM J, V234, P75, DOI 10.1042/bj2340075; BROWN GC, 1990, EUR J BIOCHEM, V192, P355, DOI 10.1111/j.1432-1033.1990.tb19234.x; Brown MF, 2007, AM J PHYSIOL-REG I, V292, pR2115, DOI 10.1152/ajpregu.00568.2006; Calder WA., 1984, SIZE FUNCTION LIFE H; Calhoon EA, 2013, PHYS BIOCH IN PRESS; Charnov Eric L., 1993, P1; Chen TL, 2009, ENVIRON MOL MUTAGEN, V50, P387, DOI 10.1002/em.20471; Cheng YR, 2012, AM NAT, V180, P285, DOI 10.1086/667214; COULSON RA, 1977, COMP BIOCHEM PHYS A, V56, P251, DOI 10.1016/0300-9629(77)90232-8; Csiszar A, 2012, J GERONTOL A-BIOL, V67, P841, DOI 10.1093/gerona/glr216; Demetrius L, 2006, J THEOR BIOL, V243, P455, DOI 10.1016/j.jtbi.2006.05.031; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fisher RA, 1930, GENETICAL THEORY NAT, pxiv; Francis CM, 1999, INT ORNITHOL C, P326; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GARLAND T, 1994, PHYSIOL ZOOL, V67, P797, DOI 10.1086/physzool.67.4.30163866; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Ghalambor CK, 2001, SCIENCE, V292, P494, DOI 10.1126/science.1059379; Gonda TA, 2010, SEMIN CELL DEV BIOL, V21, P2, DOI 10.1016/j.semcdb.2009.10.001; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Harper JM, 2011, J EXP BIOL, V214, P1902, DOI 10.1242/jeb.054643; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Holmes DJ, 2001, EXP GERONTOL, V36, P869, DOI 10.1016/S0531-5565(00)00247-3; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jimenez AG, 2013, J EXP BIOL, V216, P1373, DOI 10.1242/jeb.079889; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Klicka J, 2000, AUK, V117, P321, DOI 10.1642/0004-8038(2000)117[0321:NWNPOR]2.0.CO;2; KREBS HA, 1950, BIOCHIM BIOPHYS ACTA, V4, P249, DOI 10.1016/0006-3002(50)90032-1; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lima CF, 2011, MOL NUTR FOOD RES, V55, P430, DOI 10.1002/mnfr.201000221; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Marsh T., 2012, BIOCHIM BIOPHYS ACTA, V1832, P1070; Mueller P, 2001, P NATL ACAD SCI USA, V98, P12550, DOI 10.1073/pnas.221456698; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; ONIKI Y, 1981, IBIS, V123, P349, DOI 10.1111/j.1474-919X.1981.tb04038.x; Petrosillo G, 2008, NEUROCHEM INT, V53, P126, DOI 10.1016/j.neuint.2008.07.001; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR226, DOI 10.1152/ajpregu.1995.269.1.R226; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Ricklefs RE, 1997, ECOL MONOGR, V67, P23, DOI 10.1890/0012-9615(1997)067[0023:CDONWP]2.0.CO;2; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Ricklefs RE, 2000, CONDOR, V102, P9, DOI 10.1650/0010-5422(2000)102[0009:DDEOAT]2.0.CO;2; Roff Derek A., 1992; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rolfe DFS, 1996, AM J PHYSIOL-CELL PH, V271, pC1380, DOI 10.1152/ajpcell.1996.271.4.C1380; Rolfe DFS, 1999, AM J PHYSIOL-CELL PH, V276, pC692, DOI 10.1152/ajpcell.1999.276.3.C692; Rubner M, 1908, PROBLEM LEBENSDAUER; SAETHER BE, 1988, NATURE, V331, P616, DOI 10.1038/331616a0; Salmon AB, 2008, J GERONTOL A-BIOL, V63, P232, DOI 10.1093/gerona/63.3.232; Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Selvaraj V, 2011, NAT METHODS, V8, P805, DOI 10.1038/nmeth.1715; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Stearns S.C., 1992, pi; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P501, DOI 10.1093/gerona/glr004; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; Walker DW, 2004, P NATL ACAD SCI USA, V101, P10290, DOI 10.1073/pnas.0403767101; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; Wheatley DN, 2007, AM J PHYSIOL-REG I, V292, pR2113, DOI 10.1152/ajpregu.00102.2007; Wiersma P, 2004, P ROY SOC B-BIOL SCI, V271, pS360, DOI 10.1098/rsbl.2004.0171; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P20866, DOI 10.1073/pnas.0707683104; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P9340, DOI 10.1073/pnas.0702212104; Wiersma P, 2012, J EXP BIOL, V215, P1662, DOI 10.1242/jeb.065144; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams JB, 2010, INTEGR COMP BIOL, V50, P855, DOI 10.1093/icb/icq024; Wise JP, 2010, COMP BIOCHEM PHYS C, V152, P91, DOI 10.1016/j.cbpc.2010.03.001; Yuri T, 2002, MOL PHYLOGENET EVOL, V23, P229, DOI 10.1016/S1055-7903(02)00012-X; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	86	24	24	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87349	10.1371/journal.pone.0087349	http://dx.doi.org/10.1371/journal.pone.0087349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498080	Green Submitted, gold, Green Published			2022-12-25	WOS:000330617100076
J	Ramachandran, H; Schafer, T; Kim, Y; Herfurth, K; Hoff, S; Lienkamp, SS; Kramer-Zucker, A; Walz, G				Ramachandran, Haribaskar; Schaefer, Tobias; Kim, Yunhee; Herfurth, Konstantin; Hoff, Sylvia; Lienkamp, Soeren S.; Kramer-Zucker, Albrecht; Walz, Gerd			Interaction with the Bardet-Biedl Gene Product TRIM32/BBS11 Modifies the Half-life and Localization of Glis2/NPHP7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Genetic Diseases; Protein Degradation; Protein Stability; Transcription Regulation; Ubiquitylation; Bardet-Biedl Syndrome; Ciliopathies; Nephronophthisis	FINGER PROTEIN GLIS2; E3 UBIQUITIN LIGASE; DYSTROPHY TYPE 2H; ACUTE MEGAKARYOBLASTIC LEUKEMIA; TRANSCRIPTION FACTOR; KIDNEY-DISEASE; NEPHRONOPHTHISIS; CILIOPATHY; MUTATIONS; APOPTOSIS	Background: NPHP and BBS are closely related syndromes, but the underlying mechanisms are unclear. Results: BBS11 promotes accumulation of NPHP7, changing the properties of NPHP7. Conclusion: NPHP and BBS gene products may be involved in similar signaling pathways. Significance: These findings may help to explain the clinical overlap between certain ciliopathies. Although the two ciliopathies Bardet-Biedl syndrome and nephronophthisis share multiple clinical manifestations, the molecular basis for this overlap remains largely unknown. Both BBS11 and NPHP7 are unusual members of their respective gene families. Although BBS11/TRIM32 represents a RING finger E3 ubiquitin ligase also involved in hereditary forms of muscular dystrophy, NPHP7/Glis2 is a Gli-like transcriptional repressor that localizes to the nucleus, deviating from the ciliary localization of most other ciliopathy-associated gene products. We found that BBS11/TRIM32 and NPHP7/Glis2 can physically interact with each other, suggesting that both proteins form a functionally relevant protein complex in vivo. This hypothesis was further supported by the genetic interaction and synergist cyst formation in the zebrafish pronephros model. However, contrary to our expectation, the E3 ubiquitin ligase BBS11/TRIM32 was not responsible for the short half-life of NPHP7/Glis2 but instead promoted the accumulation of mixed Lys(48)/Lys(63)-polyubiquitylated NPHP7/Glis2 species. This modification not only prolonged the half-life of NPHP7/Glis2, but also altered the subnuclear localization and the transcriptional activity of NPHP7/Glis2. Thus, physical and functional interactions between NPHP and Bardet-Biedl syndrome gene products, demonstrated for Glis2 and TRIM32, may help to explain the phenotypic similarities between these two syndromes.	[Ramachandran, Haribaskar; Schaefer, Tobias; Kim, Yunhee; Herfurth, Konstantin; Hoff, Sylvia; Lienkamp, Soeren S.; Kramer-Zucker, Albrecht; Walz, Gerd] Univ Freiburg, Med Ctr, Dept Med, Div Renal, D-79106 Freiburg, Germany; [Kim, Yunhee; Hoff, Sylvia] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79085 Freiburg, Germany; [Kim, Yunhee; Hoff, Sylvia] Univ Freiburg, Fac Biol, D-79085 Freiburg, Germany; [Walz, Gerd] BIOSS Ctr Biol Signaling Studies, D-79108 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Walz, G (corresponding author), Div Renal, Hugstetter Str 55, D-79106 Freiburg, Germany.	gerd.walz@uniklinik-freiburg.de/	Lienkamp, Soeren/AAH-6296-2020	Lienkamp, Soeren/0000-0003-2963-6865	Deutsche Forschungsgemeinschaft [KFO 201]; European Community [241955];  [Sonderforschungsbereich 746]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission); 	This work was supported by Deutsche Forschungsgemeinschaft Grant KFO 201 (to S. S. L. and A. K.-Z.), Sonderforschungsbereich 746 (to T. S. and G. W.), and the European Community's Seventh Framework Program Grant Agreement 241955 (SYSCILIA; to G. W.).	Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Cammas F, 2012, ADV EXP MED BIOL, V770, P59; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Cohen S, 2012, J CELL BIOL, V198, P575, DOI 10.1083/jcb.201110067; Cossee M, 2009, NEUROMUSCULAR DISORD, V19, P255, DOI 10.1016/j.nmd.2009.02.003; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Gonzalez-Cano L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.224; Gruber TA, 2012, CANCER CELL, V22, P683, DOI 10.1016/j.ccr.2012.10.007; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Haribaskar R, 2009, BIOCHEM BIOPH RES CO, V387, P212, DOI 10.1016/j.bbrc.2009.07.012; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hosking CR, 2007, MOL BIOL CELL, V18, P1918, DOI 10.1091/mbc.E06-10-0941; Jauregui AR, 2008, J CELL BIOL, V180, P973, DOI 10.1083/jcb.200707090; Kang HS, 2010, HISTOL HISTOPATHOL, V25, P1481, DOI 10.14670/HH-25.1481; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kim SC, 2005, NUCLEIC ACIDS RES, V33, P6805, DOI 10.1093/nar/gki985; KIM YH, 2013, PLOS ONE, V8; Kim YS, 2008, MOL CELL BIOL, V28, P2358, DOI 10.1128/MCB.01722-07; Kim YS, 2007, FEBS LETT, V581, P858, DOI 10.1016/j.febslet.2007.01.058; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Kudryashova E, 2011, HUM MOL GENET, V20, P3925, DOI 10.1093/hmg/ddr311; Kudryashova E, 2009, HUM MOL GENET, V18, P1353, DOI 10.1093/hmg/ddp036; LaBeau-DiMenna EM, 2012, P NATL ACAD SCI USA, V109, P17983, DOI 10.1073/pnas.1208408109; Li B, 2011, HUM MOL GENET, V20, P4155, DOI 10.1093/hmg/ddr339; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Masetti R, 2013, BLOOD, V121, P3469, DOI 10.1182/blood-2012-11-469825; Micale L, 2012, ADV EXP MED BIOL, V770, P11; Muller J, 2010, HUM GENET, V127, P583, DOI 10.1007/s00439-010-0804-9; Mund T, 2010, P NATL ACAD SCI USA, V107, P11429, DOI 10.1073/pnas.0911714107; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Ryu YS, 2011, J BIOL CHEM, V286, P25729, DOI 10.1074/jbc.M111.241893; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Thiollier C, 2012, J EXP MED, V209, P2017, DOI 10.1084/jem.20121343; Vasanth S, 2011, J BIOL CHEM, V286, P4749, DOI 10.1074/jbc.M110.165951; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Williams CL, 2010, J AM SOC NEPHROL, V21, P782, DOI 10.1681/ASN.2009060597; Wolf MTF, 2011, PEDIATR NEPHROL, V26, P181, DOI 10.1007/s00467-010-1585-z; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhang F, 2002, J BIOL CHEM, V277, P10139, DOI 10.1074/jbc.M108062200; Zhang F, 2001, GENE, V280, P49, DOI 10.1016/S0378-1119(01)00764-8; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608	51	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8390	8401		10.1074/jbc.M113.534024	http://dx.doi.org/10.1074/jbc.M113.534024			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24500717	Green Published, hybrid			2022-12-25	WOS:000333157500031
J	Hino, K; Saito, A; Asada, R; Kanemoto, S; Imaizumi, K				Hino, Kenta; Saito, Atsushi; Asada, Rie; Kanemoto, Soshi; Imaizumi, Kazunori			Increased Susceptibility to Dextran Sulfate Sodium-Induced Colitis in the Endoplasmic Reticulum Stress Transducer OASIS Deficient Mice	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; NITRIC-OXIDE SYNTHASE; INFLAMMATORY-BOWEL-DISEASE; ER STRESS; TRANSCRIPTION FACTOR; INTESTINAL INFLAMMATION; CREB/ATF-FAMILY; KAPPA-B; TNF-ALPHA; ACTIVATION	OASIS is a basic leucine zipper (bZIP) transmembrane transcription factor that is activated in response to endoplasmic reticulum (ER) stress. Previously, we showed that OASIS regulates final maturation of goblet cells in the large intestine. In the present study, to elucidate the roles of OASIS under pathophysiological conditions, we examined the stress response and inflammatory responses in Oasis deficient (Oasis-/-) mice exposed to dextran sulfate sodium (DSS) to induce colitis. A significant loss of body weight and an increase of mortality were observed in Oasis-/- mice with DSS-induced colitis compared with those in WT mice. The mucosa of the large intestine in Oasis-/- mice exhibited severe damage involving inflammatory cell infiltration. The expression levels of ER stress and apoptosis markers in intestinal epithelial cells were upregulated in Oasis-/- mice. These abnormalities were improved by treatment with tauroursodeoxycholic acid, a chemical chaperone that facilitates protein folding. Taken together, our findings demonstrate that OASIS plays important roles in protection of the large intestinal mucosa in DSS-induced colitis through attenuation of ER stress and inflammation.	[Hino, Kenta; Saito, Atsushi; Asada, Rie; Kanemoto, Soshi; Imaizumi, Kazunori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biochem, Minami Ku, Hiroshima, Japan	Hiroshima University	Imaizumi, K (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima, Japan.	imaizumi@hiroshima-u.ac.jp		Kitamura, Rie/0000-0001-8347-6909	Japan Society for the Promotion of Science KAKENHI [25251014, 25650069, 24689058, 25861324]; Takeda Science Foundation; SEI Group CSR Foundation; INAMORI FOUNDATION; Uehara Memorial Foundation; Princess Takamatsu Cancer Research Fund; Cell Science Research Foundation; Grants-in-Aid for Scientific Research [25650069] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); SEI Group CSR Foundation; INAMORI FOUNDATION; Uehara Memorial Foundation(Uehara Memorial Foundation); Princess Takamatsu Cancer Research Fund; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by grants from the Japan Society for the Promotion of Science KAKENHI (25251014, 25650069, 24689058, and 25861324), Takeda Science Foundation, SEI Group CSR Foundation, INAMORI FOUNDATION, and The Uehara Memorial Foundation, and a Research Grant of the Princess Takamatsu Cancer Research Fund and The Cell Science Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham IM, 2005, MOL CELL BIOL, V25, P7657, DOI 10.1128/MCB.25.17.7657-7664.2005; Asada R, 2012, J BIOL CHEM, V287, P8144, DOI 10.1074/jbc.M111.332593; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Beck PL, 2007, GASTROENTEROLOGY, V132, P1778, DOI 10.1053/j.gastro.2007.01.032; Beck PL, 2004, AM J PHYSIOL-GASTR L, V286, pG137, DOI 10.1152/ajpgi.00309.2003; Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Eleveld-Trancikova D, 2010, MOL IMMUNOL, V47, P1963, DOI 10.1016/j.molimm.2010.04.019; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Hu S, 2007, GASTROENTEROLOGY, V133, P1893, DOI 10.1053/j.gastro.2007.09.026; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Ko J, 2004, FASEB J, V18, P890, DOI 10.1096/fj.03-0867fje; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; LI WWF, 1993, J BIOL CHEM, V268, P12003; Lu R, 1997, MOL CELL BIOL, V17, P5117, DOI 10.1128/MCB.17.9.5117; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nagamori I, 2006, GENES CELLS, V11, P1161, DOI 10.1111/j.1365-2443.2006.01013.x; Naito Y, 2003, J GASTROEN HEPATOL, V18, P560, DOI 10.1046/j.1440-1746.2003.03034.x; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Saito A, 2013, MOL CELL IN PRESS, DOI [10.1016/j.molcel.2013.11.008, DOI 10.1016/J.M0LCEL.2013.11.008.IN]; Saito A, 2007, ANTIOXID REDOX SIGN, V9, P563, DOI 10.1089/ars.2006.1520; Saito A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1971; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Stelzer G, 2002, ENDOCRINOLOGY, V143, P1578, DOI 10.1210/en.143.5.1578; Storlazzi CT, 2003, HUM MOL GENET, V12, P2349, DOI 10.1093/hmg/ddg237; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; TSUJINO M, 1994, CIRCULATION, V90, P375, DOI 10.1161/01.CIR.90.1.375; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yamazaki H, 2009, J IMMUNOL, V183, P1480, DOI 10.4049/jimmunol.0900017; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zheng W, 2006, GENES IMMUN, V7, P11, DOI 10.1038/sj.gene.6364263	54	29	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88048	10.1371/journal.pone.0088048	http://dx.doi.org/10.1371/journal.pone.0088048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498426	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900172
J	Lamkowski, A; Forcheron, F; Agay, D; Ahmed, EA; Drouet, M; Meineke, V; Scherthan, H				Lamkowski, Andreas; Forcheron, Fabien; Agay, Diane; Ahmed, Emad A.; Drouet, Michel; Meineke, Viktor; Scherthan, Harry			DNA Damage Focus Analysis in Blood Samples of Minipigs Reveals Acute Partial Body Irradiation	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; IN-VIVO FORMATION; RADIATION-EXPOSURE; 53BP1/GAMMA-H2AX FOCI; COMPUTED-TOMOGRAPHY; HUMAN-LYMPHOCYTES; GAMMA-H2AX ASSAY; HISTONE H2AX; REPAIR; DOSIMETRY	Radiation accidents frequently involve acute high dose partial body irradiation leading to victims with radiation sickness and cutaneous radiation syndrome that implements radiation-induced cell death. Cells that are not lethally hit seek to repair ionizing radiation (IR) induced damage, albeit at the expense of an increased risk of mutation and tumor formation due to misrepair of IR-induced DNA double strand breaks (DSBs). The response to DNA damage includes phosphorylation of histone H2AX in the vicinity of DSBs, creating foci in the nucleus whose enumeration can serve as a radiation biodosimeter. Here, we investigated gamma H2AX and DNA repair foci in peripheral blood lymphocytes of Gottingen minipigs that experienced acute partial body irradiation (PBI) with 49 Gy (+/- 6%) Co-60 gamma-rays of the upper lumbar region. Blood samples taken 4, 24 and 168 hours post PBI were subjected to gamma-H2AX, 53BP1 and MRE11 focus enumeration. Peripheral blood lymphocytes (PBL) of 49 Gy partial body irradiated minipigs were found to display 1-8 DNA damage foci/cell. These PBL values significantly deceed the high foci numbers observed in keratinocyte nuclei of the directly gamma-irradiated minipig skin regions, indicating a limited resident time of PBL in the exposed tissue volume. Nonetheless, PBL samples obtained 4 h post IR in average contained 2.2% of cells displaying a pan-gamma H2AX signal, suggesting that these received a higher IR dose. Moreover, dispersion analysis indicated partial body irradiation for all 13 minipigs at 4 h post IR. While dose reconstruction using gamma H2AX DNA repair foci in lymphocytes after in vivo PBI represents a challenge, the DNA damage focus assay may serve as a rapid, first line indicator of radiation exposure. The occurrence of PBLs with pan-gamma H2AX staining and of cells with relatively high foci numbers that skew a Poisson distribution may be taken as indicator of acute high dose partial body irradiation, particularly when samples are available early after IR exposure.	[Lamkowski, Andreas; Ahmed, Emad A.; Meineke, Viktor; Scherthan, Harry] Univ Ulm, Inst Radiobiol Bundeswehr Verb, Munich, Germany; [Forcheron, Fabien; Agay, Diane; Drouet, Michel] IRBA, Bretigny Sur Orge, France	Ulm University	Scherthan, H (corresponding author), Univ Ulm, Inst Radiobiol Bundeswehr Verb, Munich, Germany.	scherth@web.de	Ahmed, Emad/O-9188-2016; Ahmed, Emad A/ABD-6691-2021	Ahmed, Emad/0000-0002-5289-2966; Ahmed, Emad A/0000-0002-5289-2966	German Ministry of Defense; French Ministry of Defense	German Ministry of Defense; French Ministry of Defense	The work was supported by the German Ministry of Defense and the French Ministry of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agay D, 2010, EXP HEMATOL, V38, P945, DOI 10.1016/j.exphem.2010.06.008; Ahmed EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039521; Ainsbury EA, 2011, RADIAT PROT DOSIM, V147, P573, DOI 10.1093/rpd/ncq499; Beels L, 2010, INT J RADIAT BIOL, V86, P760, DOI 10.3109/09553002.2010.484479; Beels L, 2009, CIRCULATION, V120, P1903, DOI 10.1161/CIRCULATIONAHA.109.880385; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Belyaev IY, 2010, MUTAT RES-REV MUTAT, V704, P132, DOI 10.1016/j.mrrev.2010.01.011; Bonner WM, 2003, P NATL ACAD SCI USA, V100, P4973, DOI 10.1073/pnas.1031538100; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Carvalho O, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3394261; Di Giorgio M, 2000, BIOL DOSE ESTIMATION, P1; Dickey JS, 2012, NUCLEIC ACIDS RES, V40, P10274, DOI 10.1093/nar/gks795; Dickey JS, 2009, CARCINOGENESIS, V30, P1686, DOI 10.1093/carcin/bgp192; Dolphin GW, 1969, STIPUB229 IAEA, P215; Fleckenstein J, 2011, INT J RADIAT ONCOL, V81, P1465, DOI 10.1016/j.ijrobp.2010.08.004; Forand A, 2004, BIOL REPROD, V71, P643, DOI 10.1095/biolreprod.104.027466; Forcheron F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031694; Horn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025113; Hudson D, 2011, AGING-US, V3, P609, DOI 10.18632/aging.100340; Kolanko CJ, 2000, BIOTECH HISTOCHEM, V75, P91, DOI 10.3109/10520290009064153; Lassmann M, 2010, J NUCL MED, V51, P1318, DOI 10.2967/jnumed.109.071357; LLOYD DC, 1973, PHYS MED BIOL, V18, P421, DOI 10.1088/0031-9155/18/3/007; LLOYD DC, 1987, MUTAT RES, V179, P197, DOI 10.1016/0027-5107(87)90310-1; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; Markova E, 2007, INT J RADIAT BIOL, V83, P319, DOI 10.1080/09553000601170469; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Moroni M, 2013, INT J MOL SCI, V14, P14119, DOI 10.3390/ijms140714119; Moroni M, 2011, RADIAT RES, V176, P89, DOI 10.1667/RR2481.1; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; Nenot JC, 2009, J RADIOL PROT, V29, P301, DOI 10.1088/0952-4746/29/3/R01; Olive PL, 2011, RADIOTHER ONCOL, V101, P18, DOI 10.1016/j.radonc.2011.05.055; Prasanna Pataje G S, 2010, Radiat Res, V173, P245, DOI 10.1667/RR1993.1; Redon CE, 2011, RADIAT MEAS, V46, P877, DOI 10.1016/j.radmeas.2011.02.017; Redon CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015544; Roch-Lefevre S, 2010, RADIAT RES, V174, P185, DOI 10.1667/RR1775.1; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2013, RAD RES; Rothkamm K, 2007, RADIOLOGY, V242, P244, DOI 10.1148/radiol.2421060171; Scherthan H, 2008, BIOCHEM BIOPH RES CO, V371, P694, DOI 10.1016/j.bbrc.2008.04.127; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Sorokina S, 2013, INT J RADIAT BIOL, V89, P716, DOI 10.3109/09553002.2013.797619; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Turner HC, 2011, RADIAT RES, V175, P282, DOI 10.1667/RR2125.1; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001	48	29	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87458	10.1371/journal.pone.0087458	http://dx.doi.org/10.1371/journal.pone.0087458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498326	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900072
J	Ramos, RAN; Giannelli, A; Lia, RP; Brianti, E; Tarallo, VD; Breitshwerdt, EB; Dantas-Torres, F; Stanneck, D; Otranto, D				Ramos, Rafael Antonio Nascimento; Giannelli, Alessio; Lia, Riccardo Paolo; Brianti, Emanuele; Tarallo, Viviana Domenica; Breitshwerdt, Edward B.; Dantas-Torres, Filipe; Stanneck, Dorothee; Otranto, Domenico			Incidence of Cercopithifilaria bainae in Dogs and Probability of Co-Infection with Other Tick-Borne Pathogens	PLOS ONE			English	Article							SANGUINEUS-SENSU-LATO; RHIPICEPHALUS-SANGUINEUS; MICROFILARIAE	Background: Cercopithifilaria bainae is a filarioid parasite that infects dogs, being transmitted by Rhipicephalus sanguineus group ticks in many countries of the Mediterranean basin. This study assessed the incidence density rate (IDR) of infection by C. bainae in dogs and the probability of co-infection with other tick-borne pathogens (i.e., Anaplasma platys, Babesia vogeli and Hepatozoon canis), in an area of high endemicity in southern Italy. Methodology/Principal Findings: From March 2011 to October 2012, a field study involving 58 young dogs naturally exposed to tick infestation was conducted. Skin and blood samples obtained from each dog six times during an 18-month period were tested for C. bainae by parasite detection within skin snip sediments, with subsequent confirmation through PCR and DNA sequencing. Dogs examined monthly for ticks and A. platys, B. vogeli and H. canis were microscopically and/or molecularly diagnosed and after the first and the second summer seasons, the IDR for positive animal-month at risk was 3.8% and 1.7% in November 2011 and October 2012, respectively. All 58 C. bainae-infected dogs were simultaneously infected with at least one other tick-borne pathogen. After the first summer season (assessment in November 2011), a C. bainae-infected dog had a 33% probability of being infected with H. canis or A. platys, whereas after the second tick season (assessment in October 2012) the probability of co-infection was 78%, 22% and 11% for H. canis, A. platys and B. vogeli, respectively. Conclusions: Our data indicate that tick-infested dogs are at risk of acquiring infection by C. bainae. In addition, the detection of C. bainae microfilariae indicates a prior tick exposure and, should stimulate testing for other tick-borne disease causing pathogens.	[Ramos, Rafael Antonio Nascimento; Giannelli, Alessio; Lia, Riccardo Paolo; Tarallo, Viviana Domenica; Dantas-Torres, Filipe; Otranto, Domenico] Univ Bari, Dipartimento Med Vet, Valenzano, Italy; [Brianti, Emanuele] Univ Messina, Fac Med Vet, Dipartimento Sanita Pubbl Vet, Messina, Italy; [Breitshwerdt, Edward B.] N Carolina State Univ, Coll Vet Med, Intracellular Pathogens Res Lab, Raleigh, NC USA; [Dantas-Torres, Filipe] Ctr Pesquisas Aggeu Magalhaes Fiocruz PE, Dept Imunol, Recife, PE, Brazil; [Stanneck, Dorothee] Bayer Anim Hlth GmbH, Leverkusen, Germany	Universita degli Studi di Bari Aldo Moro; University of Messina; University of North Carolina; North Carolina State University; Fundacao Oswaldo Cruz; Bayer AG	Otranto, D (corresponding author), Univ Bari, Dipartimento Med Vet, Valenzano, Italy.	domenico.otranto@uniba.it	Dantas-Torres, Filipe/AAC-5982-2020; Otranto, Domenico/Y-3249-2019; Dantas-Torres, Filipe/G-1617-2012	Dantas-Torres, Filipe/0000-0002-1496-6274; Giannelli, Alessio/0000-0001-5855-2906; Breitschwerdt, Edward/0000-0002-3506-0279; Lia, Riccardo Paolo/0000-0001-7239-1694; Otranto, Domenico/0000-0002-7518-476X	Bayer Animal Health (Germany)	Bayer Animal Health (Germany)(Bayer AG)	This work was supported by Bayer Animal Health (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain O, 2002, PROCEEDINGS OF THE 10TH INTERNATIONAL CONGRESS OF PARASITOLOGY-ICOPA X: SYMPOSIA, WORKSHOPS AND CONTRIBUTED PAPERS, P365; Brianti E, 2012, VET PARASITOL, V183, P330, DOI 10.1016/j.vetpar.2011.07.031; Dantas-Torres F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-245; Dantas-Torres F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-213; Dantas-Torres F, 2011, EXP APPL ACAROL, V53, P389, DOI 10.1007/s10493-010-9406-4; De Tommasi AS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-97; Lorusso V, 2010, MED VET ENTOMOL, V24, P309, DOI 10.1111/j.1365-2915.2010.00885.x; Otranto D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056374; Otranto D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-132; Otranto D, 2013, PARASITOLOGY, V140, P99, DOI 10.1017/S0031182012001357; Otranto D, 2012, VET PARASITOL, V190, P143, DOI 10.1016/j.vetpar.2012.05.016; Otranto D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-1; Otranto D, 2011, VET PARASITOL, V182, P221, DOI 10.1016/j.vetpar.2011.05.043; R Core Team, 2012, R LANG ENV STAT COMP; Ramos RA, 2013, TICKS TICK IN PRESS; Ramos RAN, 2013, PARASITOL RES, V112, P3013, DOI 10.1007/s00436-013-3474-4; Walker J. B., 2000, GENUS RHIPICEPHALUS; WINKHARDT HJ, 1980, TROPENMED PARASITOL, V31, P21	18	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88198	10.1371/journal.pone.0088198	http://dx.doi.org/10.1371/journal.pone.0088198			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498437	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900183
J	Tetard-Jones, C; Gatehouse, AMR; Cooper, J; Leifert, C; Rushton, S				Tetard-Jones, Catherine; Gatehouse, Angharad M. R.; Cooper, Julia; Leifert, Carlo; Rushton, Steven			Modelling Pathways to Rubisco Degradation: A Structural Equation Network Modelling Approach	PLOS ONE			English	Article							CONTRASTING FERTILIZATION REGIMES; QUANTITATIVE PROTEOMICS; TRANSCRIPTOME ANALYSIS; GENE-EXPRESSION; POTATO-TUBERS; WHEAT LEAVES; ARABIDOPSIS; SENESCENCE; LEAF; ELECTROPHORESIS	'Omics analysis (transcriptomics, proteomics) quantifies changes in gene/protein expression, providing a snapshot of changes in biochemical pathways over time. Although tools such as modelling that are needed to investigate the relationships between genes/proteins already exist, they are rarely utilised. We consider the potential for using Structural Equation Modelling to investigate protein-protein interactions in a proposed Rubisco protein degradation pathway using previously published data from 2D electrophoresis and mass spectrometry proteome analysis. These informed the development of a prior model that hypothesised a pathway of Rubisco Large Subunit and Small Subunit degradation, producing both primary and secondary degradation products. While some of the putative pathways were confirmed by the modelling approach, the model also demonstrated features that had not been originally hypothesised. We used Bayesian analysis based on Markov Chain Monte Carlo simulation to generate output statistics suggesting that the model had replicated the variation in the observed data due to protein-protein interactions. This study represents an early step in the development of approaches that seek to enable the full utilisation of information regarding the dynamics of biochemical pathways contained within proteomics data. As these approaches gain attention, they will guide the design and conduct of experiments that enable 'Omics modelling to become a common place practice within molecular biology.	[Tetard-Jones, Catherine; Cooper, Julia; Leifert, Carlo] Newcastle Univ, Mol Agr Grp, Nafferton Ecol Farming Grp, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gatehouse, Angharad M. R.] Newcastle Univ, Mol Agr Grp, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Rushton, Steven] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Tetard-Jones, C (corresponding author), Newcastle Univ, Mol Agr Grp, Nafferton Ecol Farming Grp, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Catherine.tetard-jones@ncl.ac.uk	Tétard-Jones, Catherine/H-5509-2019	Tétard-Jones, Catherine/0000-0001-7121-2236; Gatehouse, Angharad/0000-0002-6406-2927; Leifert, Carlo/0000-0002-2974-3612	NERC [NE/K011138/1]; European Community [NUE-CROPS FP7-CP-IP 222645]; Natural Environment Research Council [NE/K011138/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Community(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by NERC under the Discipline Hopping Scheme (NE/K011138/1) awarded to S.R. and C.T.-J., and the European Community financial participation under the Seventh Framework Program for Research, Technological Development and Demonstration Activities, for the Integrated Project NUE-CROPS FP7-CP-IP 222645. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrman N, 2004, PROTEOMICS, V4, P709, DOI 10.1002/pmic.200300571; Barraclough PB, 2010, EUR J AGRON, V33, P1, DOI 10.1016/j.eja.2010.01.005; Caruso G, 2008, ANAL BIOANAL CHEM, V391, P381, DOI 10.1007/s00216-008-2008-x; Chiba A, 2003, PLANT CELL PHYSIOL, V44, P914, DOI 10.1093/pcp/pcg118; Crafts-Brandner SJ, 1998, PHYSIOL PLANTARUM, V102, P192, DOI 10.1034/j.1399-3054.1998.1020206.x; Elmhagen B, 2010, J ANIM ECOL, V79, P785, DOI 10.1111/j.1365-2656.2010.01678.x; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; Ferry N, 2011, PROTEOMICS, V11, P1985, DOI 10.1002/pmic.200900801; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gregersen PL, 2007, PLANT BIOTECHNOL J, V5, P192, DOI 10.1111/j.1467-7652.2006.00232.x; Hill SM, 2012, BIOINFORMATICS, V28, P2804, DOI 10.1093/bioinformatics/bts514; Irving LJ, 2006, NEW PHYTOL, V169, P493, DOI 10.1111/j.1469-8137.2005.01584.x; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kline RB, 2005, PRINCIPLES PRACTICE; Lee S.-Y., 2007, STRUCTURAL EQUATION; Lee SY, 2004, MULTIVAR BEHAV RES, V39, P653, DOI 10.1207/s15327906mbr3904_4; Lehesranta SJ, 2006, PROTEOMICS, V6, P6042, DOI 10.1002/pmic.200600383; Liu B, 2008, GENETICS, V178, P1763, DOI 10.1534/genetics.107.080069; MAE T, 1983, PLANT CELL PHYSIOL, V24, P1079; Malviya A, 2012, ARTHRITIS RHEUMATOLO, V64; Mill AC, 2012, EPIDEMIOL INFECT, V140, P219, DOI 10.1017/S0950268811000434; Parry MAJ, 2003, J EXP BOT, V54, P1321, DOI 10.1093/jxb/erg141; Peng ZY, 2009, MOL CELL PROTEOMICS, V8, P2676, DOI 10.1074/mcp.M900052-MCP200; Plummer M., 2012, JAGS; Rempelos L, 2013, MOL BREEDING, V31, P363, DOI 10.1007/s11032-012-9795-7; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Rodermel S, 1999, PHOTOSYNTH RES, V59, P105, DOI 10.1023/A:1006122619851; Rushton SP, 2010, EPIDEMIOL INFECT, V138, P915, DOI 10.1017/S095026880999094X; SCHNEIDER G, 1992, ANNU REV BIOPH BIOM, V21, P119, DOI 10.1146/annurev.bb.21.060192.001003; Song XY, 2012, J MATH PSYCHOL, V56, P135, DOI 10.1016/j.jmp.2012.02.001; Tetard-Jones C, 2013, AGRONOMY-BASEL, V3, P59, DOI 10.3390/agronomy3010059; Tetard-Jones C, 2013, MOL BREEDING, V31, P379, DOI 10.1007/s11032-012-9796-6; Thoenen M, 2007, ACTA PHYSIOL PLANT, V29, P339, DOI 10.1007/s11738-007-0043-4; Tian TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042230; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; van Dijk JP, 2012, J AGR FOOD CHEM, V60, P2090, DOI 10.1021/jf204696w; van Dijk JP, 2009, J AGR FOOD CHEM, V57, P1612, DOI 10.1021/jf802815d; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509	39	4	4	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87597	10.1371/journal.pone.0087597	http://dx.doi.org/10.1371/journal.pone.0087597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498339	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900085
J	Zheng, LW; Wang, WC; Ni, JD; Li, ZH; Xiao, T				Zheng, Liwen; Wang, Wanchun; Ni, Jiangdon; Li, Zhihong; Xiao, Tao			The Association of eNOS Gene Polymorphism with Avascular Necrosis of Femoral Head	PLOS ONE			English	Article							OXIDE SYNTHASE GENE; IDIOPATHIC OSTEONECROSIS; HYPOFIBRINOLYSIS; HIP	Objectives: Necrosis of femoral head is a severe pathological state with multiple etiologies. This study investigated the association of the 27-bp repeat polymorphism in intron 4 and G894T polymorphism in exon 7 of the endothelial nitric oxide synthase (eNOS) gene with the pathogenesis of avascular necrosis of femoral head (ANFH). Methods: A total of 125 non-traumatic ANFH patients and 126 healthy controls were recruited for this study. The 27-bp repeat polymorphisms in intron 4 were analyzed by polymerase chain reaction (PCR) and sequencing. The G894T polymorphisms in exon 7 were analyzed by PCR-restriction fragment length polymorphism (PCR-RFLP) analysis. Results: All alleles were observed in non-traumatic ANFH patients and control subjects. Both ANFH patients and idiopathic subgroup of ANFH patients showed higher frequency of the 4a/b genotype than controls (p = 0.001 and p = 0.020, respectively). Significantly higher frequency of G/T genotype was observed in ANFH patients and idiopathic subgroup of ANFH patients compared to controls (p = 0.009 and p = 0.035, respectively). Conclusion: eNOS gene polymorphisms may be a risk factor for ANFH. The 27-bp repeat polymorphism in intron 4, G894T polymorphism in exon 7, and subsequently reduced eNOS activity may be involved in the etiology of idiopathic ANFH.	[Zheng, Liwen; Wang, Wanchun; Ni, Jiangdon; Li, Zhihong; Xiao, Tao] Cent S Univ, Xiangya Hosp 2, Dept Orthoped, Changsha, Hunan, Peoples R China	Central South University	Wang, WC (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Orthoped, Changsha, Hunan, Peoples R China.	wangwanchun@yahoo.com						Albrecht EWJA, 2003, J PATHOL, V199, P8, DOI 10.1002/path.1250; Asano Takeshi, 2003, Pharmacogenetics, V13, P675, DOI 10.1097/00008571-200311000-00003; Babis GC, 2011, ORTHOPEDICS, V34, P39, DOI 10.3928/01477447-20101123-19; Bachiller FGC, 2002, CLIN ORTHOP RELAT R, P87; Calder JDF, 2004, J BONE JOINT SURG BR, V86B, P1209, DOI 10.1302/0301-620X.86B8.14834; Chao YC, 2003, ALCOHOL ALCOHOLISM, V38, P431, DOI 10.1093/alcalc/agg106; Cheras PA, 1997, CLIN ORTHOP RELAT R, P57; FELSON DT, 1987, LANCET, V1, P902; FICAT RP, 1985, J BONE JOINT SURG BR, V67, P3, DOI 10.1302/0301-620X.67B1.3155745; Glueck CJ, 2007, J BONE JOINT SURG AM, V89A, P2460, DOI 10.2106/JBJS.F.01421; GLUECK CJ, 1994, THROMB HAEMOSTASIS, V71, P195; Kaushik AP, 2012, WORLD J ORTHOP, V3, P49, DOI 10.5312/wjo.v3.i5.49; Koo KH, 2002, CLIN RHEUMATOL, V21, P299, DOI 10.1007/s100670200078; Koo KH, 2006, J ORTHOP RES, V24, P1722, DOI 10.1002/jor.20164; Li RL, 2004, AM J HYPERTENS, V17, P560, DOI 10.1016/j.amjhyper.2004.02.013; MATSUO K, 1988, CLIN ORTHOP RELAT R, P115; Mombouli JV, 1999, J MOL CELL CARDIOL, V31, P61, DOI 10.1006/jmcc.1998.0844; Philip I, 1999, CIRCULATION, V99, P3096, DOI 10.1161/01.CIR.99.24.3096; Rossi GP, 2003, J AM COLL CARDIOL, V41, P930, DOI 10.1016/S0735-1097(02)03012-7; Silva Pâmela Souza, 2011, Arq. Bras. Cardiol., V96, pe27, DOI 10.1590/S0066-782X2011000200017; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Tsukada T, 1998, BIOCHEM BIOPH RES CO, V245, P190, DOI 10.1006/bbrc.1998.8267; Wattanapitayakul SK, 2001, TRENDS PHARMACOL SCI, V22, P361, DOI 10.1016/S0165-6147(00)01692-8; Wong GKC, 2005, ANZ J SURG, V75, P409, DOI 10.1111/j.1445-2197.2005.03389.x	24	19	21	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87583	10.1371/journal.pone.0087583	http://dx.doi.org/10.1371/journal.pone.0087583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498338	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900084
J	Han, D; Kang, I; Ha, HK; Kim, HC; Kim, OS; Lee, BY; Cho, JC; Hur, HG; Lee, YK				Han, Dukki; Kang, Ilnam; Ha, Ho Kyung; Kim, Hyun Cheol; Kim, Ok-Sun; Lee, Bang Yong; Cho, Jang-Cheon; Hur, Hor-Gil; Lee, Yoo Kyung			Bacterial Communities of Surface Mixed Layer in the Pacific Sector of the Western Arctic Ocean during Sea-Ice Melting	PLOS ONE			English	Article							BIOMASS PRODUCTION; HETEROTROPHIC PRODUCTION; ARCHAEAL COMMUNITIES; DIVERSITY; BIOGEOGRAPHY; ASSEMBLAGES; ECOSYSTEM; SALINITY; LINEAGES; WATERS	From July to August 2010, the IBRV ARAON journeyed to the Pacific sector of the Arctic Ocean to monitor bacterial variation in Arctic summer surface-waters, and temperature, salinity, fluorescence, and nutrient concentrations were determined during the ice-melting season. Among the measured physicochemical parameters, we observed a strong negative correlation between temperature and salinity, and consequently hypothesized that the melting ice decreased water salinity. The bacterial community compositions of 15 samples, includicng seawater, sea-ice, and melting pond water, were determined using a pyrosequencing approach and were categorized into three habitats: (1) surface seawater, (2) ice core, and (3) melting pond. Analysis of these samples indicated the presence of local bacterial communities; a deduction that was further corroborated by the discovery of seawater- and ice-specific bacterial phylotypes. In all samples, the Alphaproteobacteria, Flavobacteria, and Gammaproteobacteria taxa composed the majority of the bacterial communities. Among these, Alphaproteobacteria was the most abundant and present in all samples, and its variation differed among the habitats studied. Linear regression analysis suggested that changes in salinity could affect the relative proportion of Alphaproteobacteria in the surface water. In addition, the species-sorting model was applied to evaluate the population dynamics and environmental heterogeneity in the bacterial communities of surface mixed layer in the Arctic Ocean during sea-ice melting.	[Han, Dukki; Ha, Ho Kyung; Kim, Hyun Cheol; Kim, Ok-Sun; Lee, Bang Yong; Lee, Yoo Kyung] KIOST, Korea Polar Res Inst, Inchon, South Korea; [Han, Dukki; Hur, Hor-Gil] Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Kwangju, South Korea; [Kang, Ilnam; Cho, Jang-Cheon] Inha Univ, Div Biol & Ocean Sci, Inchon, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Gwangju Institute of Science & Technology (GIST); Inha University	Lee, YK (corresponding author), KIOST, Korea Polar Res Inst, Inchon, South Korea.	yklee@kopri.re.kr	Kim, Hyun-Cheol/AAP-1250-2020; Ha, Ho Kyung/HCH-4138-2022	Kim, Hyun-Cheol/0000-0002-6831-9291; Cho, Jang-Cheon/0000-0002-0666-3791; Lee, Yoo Kyung/0000-0002-1271-5738	Korea Polar Research Institute (KOPRI) [PP10090, PP11020, PM11050, PD12010]; Gwanju Institute of Science and Technology; Inha University, Korea	Korea Polar Research Institute (KOPRI); Gwanju Institute of Science and Technology; Inha University, Korea	This research was supported by a grant from the Korea Polar Research Institute (KOPRI; http://www.kopri.re.kr) as K-Polar projects (PP10090; PP11020; PM11050). This study was also supported by the Polar Academic Program (PD12010) of the KOPRI, Gwanju Institute of Science and Technology and Inha University, Korea, 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; Barbeyron T, 2011, INT J SYST EVOL MICR, V61, P1899, DOI 10.1099/ijs.0.024489-0; Bates NR, 2009, BIOGEOSCIENCES, V6, P2433, DOI 10.5194/bg-6-2433-2009; Bowman JS, 2012, ISME J, V6, P11, DOI 10.1038/ismej.2011.76; Cai WJ, 2010, SCIENCE, V329, P556, DOI 10.1126/science.1189338; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Carmack EC, 2002, ARCTIC, V55, P29; Collins RE, 2010, ENVIRON MICROBIOL, V12, P1828, DOI 10.1111/j.1462-2920.2010.02179.x; Cooper LW, 1997, J GEOPHYS RES-OCEANS, V102, P12563, DOI 10.1029/97JC00015; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cottrell MT, 2003, LIMNOL OCEANOGR, V48, P168, DOI 10.4319/lo.2003.48.1.0168; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Galand PE, 2008, LIMNOL OCEANOGR, V53, P813, DOI 10.4319/lo.2008.53.2.0813; Galand PE, 2010, ISME J, V4, P564, DOI 10.1038/ismej.2009.134; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Galand PE, 2009, ENVIRON MICROBIOL, V11, P971, DOI 10.1111/j.1462-2920.2008.01822.x; Garneau ME, 2006, AQUAT MICROB ECOL, V42, P27, DOI 10.3354/ame042027; Gosink JJ, 1997, SYST APPL MICROBIOL, V20, P356, DOI 10.1016/S0723-2020(97)80003-3; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Hamilton AK, 2008, LIMNOL OCEANOGR, V53, P922, DOI 10.4319/lo.2008.53.3.0922; Harding T, 2011, APPL ENVIRON MICROB, V77, P3234, DOI 10.1128/AEM.02611-10; Kellogg CTE, 2009, AQUAT MICROB ECOL, V57, P1, DOI 10.3354/ame01317; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Kirchman DL, 2005, DEEP-SEA RES PT II, V52, P3386, DOI 10.1016/j.dsr2.2005.09.005; Langenheder S, 2007, ECOLOGY, V88, P2154, DOI 10.1890/06-2098.1; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Larose C, 2010, EXTREMOPHILES, V14, P205, DOI 10.1007/s00792-009-0299-2; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Li LN, 1999, BIODIVERS CONSERV, V8, P659, DOI 10.1023/A:1008848203739; Lim GE, 2004, APPL ENVIRON MICROB, V70, P4921, DOI 10.1128/AEM.70.8.4921-4929.2004; Logares R, 2010, MOL BIOL EVOL, V27, P347, DOI 10.1093/molbev/msp239; Logue JB, 2010, ISME J, V4, P729, DOI 10.1038/ismej.2009.156; Malmstrom RR, 2007, AQUAT MICROB ECOL, V47, P45, DOI 10.3354/ame047045; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; Nishino S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004666; Palacios C, 2009, MICROB ECOL, V58, P737, DOI 10.1007/s00248-009-9538-4; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Proshutinsky A.Y., 2009, J GEOPHYS RES, V114; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Trosvik P, 2010, ISME J, V4, P151, DOI 10.1038/ismej.2009.96; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Wilkins D, 2013, FEMS MICROBIOL REV, V37, P303, DOI 10.1111/1574-6976.12007; Zhang Y, 2006, AQUAT MICROB ECOL, V43, P233, DOI 10.3354/ame043233	51	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86887	10.1371/journal.pone.0086887	http://dx.doi.org/10.1371/journal.pone.0086887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497990	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900044
J	Mukai, H; Hironaka, M; Tojo, S; Nomakuchi, S				Mukai, Hiromi; Hironaka, Mantaro; Tojo, Sumio; Nomakuchi, Shintaro			Maternal Vibration: An Important Cue for Embryo Hatching in a Subsocial Shield Bug	PLOS ONE			English	Article							PARASTRACHIA-JAPONENSIS HEMIPTERA; TROPHIC EGG-PRODUCTION; ADAPTIVE PLASTICITY; BURROWER BUG; RELEASE; RISK; HETEROPTERA; RESPONSES; CYDNIDAE; CRABS	Hatching care has been reported for many taxonomic groups, from invertebrates to vertebrates. The sophisticated care that occurs around hatching time is expected to have an adaptive function supporting the feeble young. However, details of the characteristics of the adaptive function of hatching care remain unclear. This study investigated the hatching care of the subsocial shield bug, Parastrachia japonensis (Heteroptera: Parastrachiidae) to verify its function. Results show that the P. japonensis mothers vibrated the egg mass intermittently while maintaining an egg-guarding posture. Then embryos started to emerge from their shells synchronously. Unlike such behaviors of closely related species, this vibrating behavior was faint, but lasted more than 6 h. To investigate the effect of this behavior on hatching synchrony and hatching success, we observed the hatching pattern and the hatching rate in control, mother-removed, and two artificial vibration groups. Control broods experienced continuous guarding from the mother. Intermittent artificial vibration broods were exposed to vibrations that matched the temporal pattern of maternal vibration produced by a motor. They showed synchronous hatching patterns and high hatching rates. However, for mother-removed broods, which were isolated from the mother, and when we provided continuous artificial vibration that did not match the temporal pattern of the maternal vibration, embryo hatching was not only asynchronous: some embryos failed to emerge from their shells. These results lead us to infer that hatching care in P. japonensis has two functions: hatching regulation and hatching assistance. Nevertheless, several points of observational and circumstantial evidence clearly contraindicate hatching assistance. A reduction in the hatching rate might result from dependence on maternal hatching care as a strong cue in P. japonensis. We conclude that the hatching care of P. japonensis regulates the hatching pattern and serves as an important cue to induce embryo hatching.	[Mukai, Hiromi] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Hironaka, Mantaro] Hamamatsu Univ, Sch Med, Dept Biol, Fac Med, Hamamatsu, Shizuoka 4312102, Japan; [Tojo, Sumio; Nomakuchi, Shintaro] Saga Univ, Fac Agr, Dept Appl Biol Sci, Saga 840, Japan	Kagoshima University; Hamamatsu University School of Medicine; Saga University	Mukai, H (corresponding author), Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan.	mh.isa.8088@gmail.com	Hironaka, Mantaro/HGC-7443-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan [21370011, 236923, 22770067]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for JSPS Fellows and Young Scientists (B) (21370011), and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (236923, 22770067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott SE, 2002, ECOL APPL, V12, P138; Birmelin I, 1986, BARRONS ED SERIES; BOND GM, 1988, BIOL REV, V63, P395, DOI 10.1111/j.1469-185X.1988.tb00723.x; BRANFORD JR, 1978, J MAR BIOL ASSOC UK, V58, P639, DOI 10.1017/S0025315400041291; Christy JH, 2011, INTEGR COMP BIOL, V51, P62, DOI 10.1093/icb/icr013; DEVRIES MC, 1991, J CRUSTACEAN BIOL, V11, P29, DOI 10.2307/1548542; DEVRIES MC, 1991, BIOL BULL, V180, P1, DOI 10.2307/1542424; DEVRIES MC, 1991, MAR BIOL, V110, P281, DOI 10.1007/BF01313715; Doody JS, 2012, ANIM BEHAV, V83, P645, DOI 10.1016/j.anbehav.2011.12.006; Ewert M.A., 1991, P173, DOI 10.1017/CBO9780511585739.012; Filippi L, 2001, POPUL ECOL, V43, P41, DOI 10.1007/PL00012014; Filippi L, 2009, NATURWISSENSCHAFTEN, V96, P201, DOI 10.1007/s00114-008-0463-z; FORWARD RB, 1983, BIOL BULL, V165, P154, DOI 10.2307/1541361; Gomez-Mestre I, 2008, ECOL MONOGR, V78, P205, DOI 10.1890/07-0529.1; HERZOG H A JR, 1975, Herpetologica, V31, P446; Hironaka M, 2005, ETHOLOGY, V111, P1089, DOI 10.1111/j.1439-0310.2005.01112.x; Hosokawa T, 2012, ANIM BEHAV, V83, P293, DOI 10.1016/j.anbehav.2011.11.006; Hosokawa T, 2010, APPL ENVIRON MICROB, V76, P4130, DOI 10.1128/AEM.00616-10; Jantschke Barbara, 2001, Bulletin of the British Arachnological Society, V12, P12; Kashima T, 2006, J INSECT PHYSIOL, V52, P816, DOI 10.1016/j.jinsphys.2006.05.003; Li DQ, 2002, P ROY SOC B-BIOL SCI, V269, P2155, DOI 10.1098/rspb.2002.2140; Mukai H, 2012, ANIM BEHAV, V84, P1443, DOI 10.1016/j.anbehav.2012.09.012; Mukai H, 2010, CAN ENTOMOL, V142, P52, DOI 10.4039/n09-045; NAKAHIRA T, 1994, NATURWISSENSCHAFTEN, V81, P413, DOI 10.1007/s001140050097; Newton I., 1986, SPARROWHAWK; Nomakuchi S, 2005, ANN ENTOMOL SOC AM, V98, P143, DOI 10.1603/0013-8746(2005)098[0143:VITSON]2.0.CO;2; Ohba Shinya, 2002, Japanese Journal of Entomology (New Series), V5, P157; POOLEY AC, 1977, J ZOOL, V182, P17; Randall JB, 1977, PSYCHE, V84, P286; Saifur RGM, 2010, J AM MOSQUITO CONTR, V26, P373, DOI 10.2987/10-6003.1; SITES RW, 1982, ANN ENTOMOL SOC AM, V75, P210, DOI 10.1093/aesa/75.2.210; TACHIKAWA S, 1985, ANN ENTOMOL SOC AM, V78, P387, DOI 10.1093/aesa/78.3.387; Toyama M, 1999, J ETHOL, V17, P33, DOI 10.1007/BF02769295; TREMAINE MM, 1974, WILSON BULL, V86, P77; TSUKAMOTO L, 1992, J ETHOL, V10, P21, DOI 10.1007/BF02350183; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P14, DOI 10.1093/icb/icr017; WARKENTIN KM, 1995, P NATL ACAD SCI USA, V92, P3507, DOI 10.1073/pnas.92.8.3507	37	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87932	10.1371/journal.pone.0087932	http://dx.doi.org/10.1371/journal.pone.0087932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498224	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900195
J	Vriet, C; Smith, AM; Wang, TL				Vriet, Cecile; Smith, Alison M.; Wang, Trevor L.			Root Starch Reserves Are Necessary for Vigorous Re-Growth following Cutting Back in Lotus japonicus	PLOS ONE			English	Article							MEDICAGO-SATIVA L; NITROGEN RESERVES; ALFALFA; ARABIDOPSIS; CARBON	Perenniality and vegetative re-growth vigour represent key agronomic traits in forage legume (Fabaceae) species. The known determinants of perenniality include the conservation of the vegetative meristem during and after the flowering phase, and the separation of flowering from senescence. The ability of the plants to store nutrient resources in perennial organs and remobilize them may also play an important role in the perennial growth habit, and in determining the capacity of the plant to re-grow following grazing or from one season to the next. To examine the importance of stored starch, we examined the vegetative re-growth vigour following cutting back of a unique collection of Lotus japonicus mutants impaired in their ability to synthesize or degrade starch. Our results establish that starch stored in the roots is important for re-growth vigour in Lotus japonicus. We extended this analysis to a collection of Lotus ( trefoil) species and two ecotypes of Lotus japonicus displaying a large variation in their carbohydrate resource allocation. There was a positive correlation between root starch content and re-growth vigour in these natural variants, and a good general correlation between high re-growth vigour and the perennial life-form. We discuss the relationship between perenniality and the availability of root carbohydrates for re-growth.	[Vriet, Cecile; Smith, Alison M.; Wang, Trevor L.] John Innes Ctr Plant Sci Res, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Wang, TL (corresponding author), John Innes Ctr Plant Sci Res, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England.	trevor.wang@jic.ac.uk		Vriet, cecile/0000-0001-6625-268X	Marie Curie studentship (EU EST Programme) [019727]; Biotechnology and Biological Sciences Research Council, UK [BB/J004561/1]; John Innes Foundation; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000020, BBS/E/J/00000150] Funding Source: researchfish	Marie Curie studentship (EU EST Programme); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Marie Curie studentship (EU EST Programme 019727) to C.V., and by Institute Strategic Programme grant BB/J004561/1 from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) UK and the John Innes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avice JC, 1996, PLANT PHYSIOL, V112, P281, DOI 10.1104/pp.112.1.281; BOYCE PJ, 1992, CROP SCI, V32, P757, DOI 10.2135/cropsci1992.0011183X003200030036x; Degtjareva GV, 2008, WULFENIA, V15, P35; Deng WW, 2011, P NATL ACAD SCI USA, V108, P6680, DOI 10.1073/pnas.1103175108; DESOUZA JG, 1987, J EXP BOT, V38, P1211, DOI 10.1093/jxb/38.7.1211; Dhont C, 2006, ANN BOT-LONDON, V97, P109, DOI 10.1093/aob/mcj006; Dhont C, 2004, CROP SCI, V44, P144, DOI 10.2135/cropsci2004.0144; Dhont C, 2002, CROP SCI, V42, P754, DOI 10.2135/cropsci2002.0754; Diaz P, 2005, LOTUS JAPONICUS HANDBOOK, P25, DOI 10.1007/1-4020-3735-X_2; Escaray FJ, 2012, PLANT SCI, V182, P121, DOI 10.1016/j.plantsci.2011.03.016; HANDBERG K, 1992, PLANT J, V2, P487, DOI 10.1111/j.1365-313X.1992.00487.x; Kawaguchi M, 2000, J PLANT RES, V113, P507, DOI 10.1007/PL00013961; KIM TH, 1993, J EXP BOT, V44, P555, DOI 10.1093/jxb/44.3.555; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253; OURRY A, 1994, PLANT PHYSIOL, V105, P831, DOI 10.1104/pp.105.3.831; Seo E, 2009, PLANT CELL, V21, P3185, DOI 10.1105/tpc.108.063883; SZ-BORSOS O, 1972, Canadian Journal of Botany, V50, P1865, DOI 10.1139/b72-235; TA TC, 1990, PLANT SOIL, V127, P231, DOI 10.1007/BF00014430; Taliercio EW, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-11; Vriet C, 2010, PLANT PHYSIOL, V154, P643, DOI 10.1104/pp.110.161844; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988	22	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87333	10.1371/journal.pone.0087333	http://dx.doi.org/10.1371/journal.pone.0087333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498076	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900092
J	Xi, JX; Si, XHA; Gaide, R				Xi, Jinxiang; Si, Xiuhua A.; Gaide, Rachel			Electrophoretic Particle Guidance Significantly Enhances Olfactory Drug Delivery: A Feasibility Study	PLOS ONE			English	Article							SUBMICROMETER AEROSOL DEPOSITION; NASAL; AIRWAYS; VENTILATION; DYNAMICS; FLOW	Background: Intranasal olfactory drug delivery provides a non-invasive method that bypasses the Blood-Brain-Barrier and directly delivers medication to the brain and spinal cord. However, a device designed specifically for olfactory delivery has not yet been found. Methods: In this study, a new delivery method was proposed that utilized electrophoretic forces to guide drug particles to the olfactory region. The feasibility of this method was numerically evaluated in both idealized 2-D and anatomically accurate 3-D nose models. The influence of nasal airflow, electrode strength, and drug release position were also studied on the olfactory delivery efficiency. Findings: Results showed that by applying electrophoretic forces, the dosage to the olfactory region was significantly enhanced. In both 2-D and 3-D cases, electrophoretic-guided delivery achieved olfactory dosages nearly two orders of magnitude higher than that without electrophoretic forces. Furthermore, releasing drugs into the upper half of the nostril (i.e., partial release) led to olfactory dosages two times higher than releasing drugs over the entire area of the nostril. By combining the advantages of pointed drug release and appropriate electrophoretic guidance, olfactory dosages of more than 90% were observed as compared to the extremely low olfactory dosage (<1%) with conventional inhaler devices. Conclusion: Results of this study have important implications in developing personalized olfactory delivery protocols for the treatment of neurological disorders. Moreover, a high sensitivity of olfactory dosage was observed in relation to different pointed release positions, indicating the importance of precise particle guidance for effective olfactory delivery.	[Xi, Jinxiang] Cent Michigan Univ, Dept Mech & Biomed Engn, Mt Pleasant, MI 48859 USA; [Si, Xiuhua A.; Gaide, Rachel] Calvin Coll, Dept Engn, Grand Rapids, MI 49506 USA	Central Michigan University; Calvin University	Xi, JX (corresponding author), Cent Michigan Univ, Dept Mech & Biomed Engn, Mt Pleasant, MI 48859 USA.	xi1j@cmich.edu	Xi, Jinxiang/Y-1161-2019		Central Michigan University [P421071, P622911]; Calvin Summer Research Grant	Central Michigan University; Calvin Summer Research Grant	This work was funded by Central Michigan University Innovative Research Grant P421071 and Central Michigan University Early Career Grant P622911. RG was supported by Calvin Summer Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2012, INT J NANOMED, V7, P5705, DOI 10.2147/IJN.S35329; [Anonymous], 2009, J AEROSOL MED, DOI DOI 10.1089/JAM.1989.2.365; Bagger M, 2004, INT J PHARMACEUT, V269, P311, DOI 10.1016/j.ijpharm.2003.09.017; Chan T. L., 1978, Journal of Aerosol Science, V9, P463, DOI 10.1016/0021-8502(78)90009-5; CHEN YK, 1993, AEROSOL SCI TECH, V19, P389, DOI 10.1080/02786829308959646; CHENG KH, 1995, AEROSOL SCI TECH, V23, P465, DOI 10.1080/02786829508965329; CHENG YS, 1993, AEROSOL SCI TECH, V18, P359, DOI 10.1080/02786829308959610; COHEN BS, 1995, J AEROSOL SCI, V26, P1149, DOI 10.1016/0021-8502(95)00039-F; Covert D, 1997, AEROSOL SCI TECH, V27, P206, DOI 10.1080/02786829708965467; Dahlem MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005007; Dhand R, 2012, J AEROSOL MED PULM D, V25, P63, DOI 10.1089/jamp.2011.0929; Fry FA, 1970, J AEROSOL SCI, V1, P135; Geller David E, 2005, Respir Care, V50, P1313; Hanson LR, 2007, J NEUROIMMUNE PHARM, V2, P81, DOI 10.1007/s11481-006-9039-x; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Illum L, 2002, DRUG DISCOV TODAY, V7, P1184, DOI 10.1016/S1359-6446(02)02529-1; Karner S, 2011, J AEROSOL SCI, V42, P428, DOI 10.1016/j.jaerosci.2011.02.010; Kelly JT, 2004, AEROSOL SCI TECH, V38, P1063, DOI 10.1080/027868290883360; Kwok PCL, 2005, J PHARM SCI-US, V94, P2789, DOI 10.1002/jps.20395; Kwok PCL, 2008, J AEROSOL SCI, V39, P211, DOI 10.1016/j.jaerosci.2007.11.004; Mancuso G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036337; Misra A, 2012, CURR PHARM BIOTECHNO, V13, P2355, DOI 10.2174/138920112803341752; Mistry A, 2009, INT J PHARMACEUT, V379, P146, DOI 10.1016/j.ijpharm.2009.06.019; MORSI SA, 1972, J FLUID MECH, V55, P193, DOI 10.1017/S0022112072001806; Nava S, 2001, INTENS CARE MED, V27, P1627, DOI 10.1007/s001340101062; Petitot F, 2013, TOXICOL LETT, V217, P217, DOI 10.1016/j.toxlet.2012.12.022; Ribeiro P, 2012, ELECTRON ENG, P21; Schroeter JD, 2006, J AEROSOL MED, V19, P301, DOI 10.1089/jam.2006.19.301; Shi H, 2006, J BIOMECH ENG-T ASME, V128, P697, DOI 10.1115/1.2244574; Si XHA, 2013, RESP PHYSIOL NEUROBI, V186, P22, DOI 10.1016/j.resp.2012.12.005; Tao XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049304; Turker S, 2004, PHARM WORLD SCI, V26, P137, DOI 10.1023/B:PHAR.0000026823.82950.ff; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Willis LD, 2012, RESP CARE, V57, P1234, DOI 10.4187/respcare.01518; Xi JX, 2008, INT J HEAT MASS TRAN, V51, P5562, DOI 10.1016/j.ijheatmasstransfer.2008.04.037; Xi JX, 2007, ANN BIOMED ENG, V35, P560, DOI 10.1007/s10439-006-9245-y; Xi JX, 2012, ANN BIOMED ENG, V40, P2579, DOI 10.1007/s10439-012-0603-7; Xi JX, 2010, SURFACTANT SCI SER, V148, P501; Xi JX, 2009, AEROSOL SCI TECH, V43, P808, DOI 10.1080/02786820902950887; Xi JX, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838039; Yaakov Y, 2007, CHEST, V132, P1219, DOI 10.1378/chest.06-2975; YU CP, 1977, B MATH BIOL, V39, P471, DOI 10.1007/BF02462925; Zeng Y, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/46/464125; Zhang L, 2002, BIOELECTROCHEMISTRY, V56, P233, DOI 10.1016/S1567-5394(02)00057-9	44	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86593	10.1371/journal.pone.0086593	http://dx.doi.org/10.1371/journal.pone.0086593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497957	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900028
J	Cai, YH; Vega-Sanchez, ME; Park, CH; Bellizzi, M; Guo, ZJ; Wang, GL				Cai, Yuhui; Vega-Sanchez, Miguel E.; Park, Chan Ho; Bellizzi, Maria; Guo, Zejian; Wang, Guo-Liang			RBS1, an RNA Binding Protein, Interacts with SPIN1 and Is Involved in Flowering Time Control in Rice	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; ARABIDOPSIS; HD3A; ENCODES; DEFENSE; HD1; REGULATOR; CONSTANS; MUTANT	The rice U-box/ARM E3 ubiquitin ligase SPL11 negatively regulates programmed cell death (PCD) and disease resistance, and controls flowering time through interacting with the novel RNA/DNA binding KH domain protein SPIN1. Overexpression of Spin1 causes late flowering in transgenic rice under short-day (SD) and long-day (LD) conditions. In this study, we characterized the function of the RNA-binding and SPIN1-interacting 1 (RBS1) protein in flowering time regulation. Rbs1was identified in a yeast-two-hybrid screen using the full-length Spin1 cDNA as a bait and encodes an RNA binding protein with three RNA recognition motifs. The protein binds RNA in vitro and interacts with SPIN1 in the nucleus. Rbs1 overexpression causes delayed flowering under SD and LD conditions in rice. Expression analyses of flowering marker genes show that Rbs1 overexpression represses the expression of Hd3a under SD and LD conditions. Rbs1 is upregulated in both Spin1 overexpression plants and in the spl11 mutant. Interestingly, Spin1 expression is increased but Spl11 expression is repressed in the Rbs1 overexpression plants. Western blot analysis revealed that the SPIN1 protein level is increased in the Rbs1 overexpression plants and that the RBS1 protein level is also up-regulated in the Spin1 overexpression plants. These results suggest that RBS1 is a new negative regulator of flowering time that itself is positively regulated by SPIN1 but negatively regulated by SPL11 in rice.	[Cai, Yuhui; Wang, Guo-Liang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Cai, Yuhui; Guo, Zejian] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Vega-Sanchez, Miguel E.; Park, Chan Ho; Bellizzi, Maria; Wang, Guo-Liang] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; China Agricultural University; University System of Ohio; Ohio State University	Wang, GL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	wang.620@osu.edu		Wang, Guo-Liang/0000-0001-8877-3064	State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection	State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection	The authors thank the State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection for grant support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasino RM, 2010, PLANT PHYSIOL, V154, P516, DOI 10.1104/pp.110.161653; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Cai XN, 2006, J EXP BOT, V57, P2563, DOI 10.1093/jxb/erl022; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Fedoroff NV, 2002, CURR OPIN PLANT BIOL, V5, P452, DOI 10.1016/S1369-5266(02)00280-7; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Huang J, 2008, CELL MOL BIOL LETT, V13, P303, DOI 10.2478/s11658-008-0002-0; Jeong DH, 2002, PLANT PHYSIOL, V130, P1636, DOI 10.1104/pp.014357; Kim TD, 2005, MOL CELL BIOL, V25, P3232, DOI 10.1128/MCB.25.8.3232-3246.2005; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Latrasse D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016592; Lim MH, 2004, PLANT CELL, V16, P731, DOI 10.1105/tpc.019331; Liu JL, 2012, PLANT PHYSIOL, V160, P28, DOI 10.1104/pp.112.199430; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Morris RT, 2011, PLANT SCI, V180, P204, DOI 10.1016/j.plantsci.2010.08.004; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Vega-Sanchez ME, 2008, PLANT CELL, V20, P1456, DOI 10.1105/tpc.108.058610; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Yin ZC, 2000, MOL PLANT MICROBE IN, V13, P869, DOI 10.1094/MPMI.2000.13.8.869; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171	33	2	5	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87258	10.1371/journal.pone.0087258	http://dx.doi.org/10.1371/journal.pone.0087258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498057	Green Submitted, gold, Green Published			2022-12-25	WOS:000330617100069
J	Capitini, C; Conti, S; Perni, M; Guidi, F; Cascella, R; De Poli, A; Penco, A; Relini, A; Cecchi, C; Chiti, F				Capitini, Claudia; Conti, Simona; Perni, Michele; Guidi, Francesca; Cascella, Roberta; De Poli, Angela; Penco, Amanda; Relini, Annalisa; Cecchi, Cristina; Chiti, Fabrizio			TDP-43 Inclusion Bodies Formed in Bacteria Are Structurally Amorphous, Non-Amyloid and Inherently Toxic to Neuroblastoma Cells	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; C-TERMINAL FRAGMENTS; PROTEIN AGGREGATION; ESCHERICHIA-COLI; NEURONAL INCLUSIONS; SECONDARY STRUCTURE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; ALS	Accumulation of ubiquitin-positive, tau-and a-synuclein-negative intracellular inclusions of TDP-43 in the central nervous system represents the major hallmark correlated to amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin-positive inclusions. Such inclusions have variably been described as amorphous aggregates or more structured deposits having an amyloid structure. Following the observations that bacterial inclusion bodies generally consist of amyloid aggregates, we have overexpressed full-length TDP-43 and C-terminal TDP-43 in E. coli, purified the resulting full-length and C-terminal TDP-43 containing inclusion bodies (FL and Ct TDP-43 IBs) and subjected them to biophysical analyses to assess their structure/morphology. We show that both FL and Ct TDP-43 aggregates contained in the bacterial IBs do not bind amyloid dyes such as thioflavin T and Congo red, possess a disordered secondary structure, as inferred using circular dichroism and infrared spectroscopies, and are susceptible to proteinase K digestion, thus possessing none of the hallmarks for amyloid. Moreover, atomic force microscopy revealed an irregular structure for both types of TDP-43 IBs and confirmed the absence of amyloid-like species after proteinase K treatment. Cell biology experiments showed that FL TDP-43 IBs were able to impair the viability of cultured neuroblastoma cells when added to their extracellular medium and, more markedly, when transfected into their cytosol, where they are at least in part ubiquitinated and phosphorylated. These data reveal an inherently high propensity of TDP-43 to form amorphous aggregates, which possess, however, an inherently high ability to cause cell dysfunction. This indicates that a gain of toxic function caused by TDP-43 deposits is effective in TDP-43 pathologies, in addition to possible loss of function mechanisms originating from the cellular mistrafficking of the protein.	[Capitini, Claudia; Conti, Simona; Perni, Michele; Guidi, Francesca; Cascella, Roberta; De Poli, Angela; Cecchi, Cristina; Chiti, Fabrizio] Univ Florence, Biochem Sect, Dept Biomed Expt & Clin Sci, Florence, Italy; [Penco, Amanda; Relini, Annalisa] Univ Genoa, Dept Phys, Genoa, Italy	University of Florence; University of Genoa	Chiti, F (corresponding author), Univ Florence, Biochem Sect, Dept Biomed Expt & Clin Sci, Florence, Italy.	fabrizio.chiti@unifi.it	Relini, Annalisa/AHC-3105-2022; Cascella, Roberta/K-5122-2016	Cecchi, Cristina/0000-0001-8387-7737; RELINI, ANNALISA/0000-0002-4040-9279; Capitini, Claudia/0000-0003-2834-1424; Cascella, Roberta/0000-0001-9856-6843	Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA); "fondi di Ateneo" of the University of Genoa; Istituto Nazionale di Biostrutture e Biosistemi (INBB)	Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA); "fondi di Ateneo" of the University of Genoa; Istituto Nazionale di Biostrutture e Biosistemi (INBB)	This work was supported by a pilot grant from the Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA) and by "fondi di Ateneo" of the University of Genoa. RC was supported by the Istituto Nazionale di Biostrutture e Biosistemi (INBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Ami D, 2003, BBA-GEN SUBJECTS, V1624, P6, DOI 10.1016/j.bbagen.2003.09.008; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Baloh RH, 2011, FEBS J, V278, P3539, DOI 10.1111/j.1742-4658.2011.08256.x; Bigio EH, 2013, ACTA NEUROPATHOL, V125, P463, DOI 10.1007/s00401-013-1089-6; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009; Duan W, 2010, NEUROSCIENCE, V169, P1621, DOI 10.1016/j.neuroscience.2010.06.018; Evangelisti E, 2013, CURR ALZHEIMER RES, V10, P143, DOI 10.2174/1567205011310020004; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Garcia-Fruitos E, 2011, FEBS J, V278, P2419, DOI 10.1111/j.1742-4658.2011.08165.x; Gatti-Lafranconi P, 2011, FEBS J, V278, P2408, DOI 10.1111/j.1742-4658.2011.08163.x; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Jiang LL, 2013, J BIOL CHEM, V288, P19614, DOI 10.1074/jbc.M113.463828; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Jurgen B, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-41; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Kwong LK, 2008, NEUROSIGNALS, V16, P41, DOI 10.1159/000109758; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Lin WL, 2008, ACTA NEUROPATHOL, V116, P205, DOI 10.1007/s00401-008-0408-9; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; MaachupalliReddy J, 1997, BIOTECHNOL PROGR, V13, P144, DOI 10.1021/bp970008l; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nyrkova IA, 2000, EUR PHYS J B, V17, P499, DOI 10.1007/s100510070128; OBERG K, 1994, BIOCHEMISTRY-US, V33, P2628, DOI 10.1021/bi00175a035; PRZYBYCIEN TM, 1994, PROTEIN ENG, V7, P131, DOI 10.1093/protein/7.1.131; Ramshini H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016075; Robinson JL, 2013, ACTA NEUROPATHOL, V125, P121, DOI 10.1007/s00401-012-1055-8; Sabate R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-56; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Sicorello A, 2009, BIOPHYS J, V96, P2289, DOI 10.1016/j.bpj.2008.11.042; Soldi G, 2005, BIOPHYS J, V89, P4234, DOI 10.1529/biophysj.105.067538; Thorpe J, 2008, J NEURAL TRANSM, V115, P1661, DOI 10.1007/s00702-008-0137-1; Umetsu M, 2004, FEBS LETT, V557, P49, DOI 10.1016/S0014-5793(03)01441-8; VALAX P, 1993, BIOTECHNOL PROGR, V9, P539, DOI 10.1021/bp00023a014; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007; Wang L, 2009, PRION, V3, P139, DOI 10.4161/pri.3.3.9922; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; Wasmer C, 2009, ANGEW CHEM INT EDIT, V48, P4858, DOI 10.1002/anie.200806100; Wright D, 2013, PHOTOCHEM PHOTOBIOL, V89, P442, DOI 10.1111/j.1751-1097.2012.01231.x; Zampagni M, 2011, J CELL MOL MED, V15, P2106, DOI 10.1111/j.1582-4934.2010.01239.x	49	56	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86720	10.1371/journal.pone.0086720	http://dx.doi.org/10.1371/journal.pone.0086720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497973	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100027
J	Da, Y; Wang, CK; Wang, SW; Hu, G				Da, Yang; Wang, Chunkao; Wang, Shengwen; Hu, Guo			Mixed Model Methods for Genomic Prediction and Variance Component Estimation of Additive and Dominance Effects Using SNP Markers	PLOS ONE			English	Article							LINEAR UNBIASED PREDICTION; MISSING HERITABILITY; MAXIMUM-LIKELIHOOD; WIDE ASSOCIATION; SELECTION; INFORMATION; MATRIX; PLANT	We established a genomic model of quantitative trait with genomic additive and dominance relationships that parallels the traditional quantitative genetics model, which partitions a genotypic value as breeding value plus dominance deviation and calculates additive and dominance relationships using pedigree information. Based on this genomic model, two sets of computationally complementary but mathematically identical mixed model methods were developed for genomic best linear unbiased prediction (GBLUP) and genomic restricted maximum likelihood estimation (GREML) of additive and dominance effects using SNP markers. These two sets are referred to as the CE and QM sets, where the CE set was designed for large numbers of markers and the QM set was designed for large numbers of individuals. GBLUP and associated accuracy formulations for individuals in training and validation data sets were derived for breeding values, dominance deviations and genotypic values. Simulation study showed that GREML and GBLUP generally were able to capture small additive and dominance effects that each accounted for 0.00005-0.0003 of the phenotypic variance and GREML was able to differentiate true additive and dominance heritability levels. GBLUP of the total genetic value as the summation of additive and dominance effects had higher prediction accuracy than either additive or dominance GBLUP, causal variants had the highest accuracy of GREML and GBLUP, and predicted accuracies were in agreement with observed accuracies. Genomic additive and dominance relationship matrices using SNP markers were consistent with theoretical expectations. The GREML and GBLUP methods can be an effective tool for assessing the type and magnitude of genetic effects affecting a phenotype and for predicting the total genetic value at the whole genome level.	[Da, Yang; Wang, Chunkao; Wang, Shengwen; Hu, Guo] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Da, Y (corresponding author), Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA.	yda@umn.edu	Hu, Guo/K-7879-2012	Hu, Guo/0000-0002-4437-0797	USDA National Institute of Food and Agriculture Grant [2011-67015-30333]; Agricultural Experiment Station at the University of Minnesota [MN-16-043]; National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2008-35205-18846]; Holstein Association USA; Heilongjiang River Fishery Research Institute of Chinese Academy of Fishery Sciences, Harbin, China	USDA National Institute of Food and Agriculture Grant; Agricultural Experiment Station at the University of Minnesota(University of Minnesota System); National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; Holstein Association USA; Heilongjiang River Fishery Research Institute of Chinese Academy of Fishery Sciences, Harbin, China	This research was supported by USDA National Institute of Food and Agriculture Grant no. 2011-67015-30333 and by project MN-16-043 of the Agricultural Experiment Station at the University of Minnesota. The Holstein SNP data were supported by National Research Initiative Competitive Grant no. 2008-35205-18846 from the USDA National Institute of Food and Agriculture and by a financial contribution from Holstein Association USA. Supercomputer computing time was provided by the Minnesota Supercomputer Institute at the University of Minnesota. Guo Hu was supported by Heilongjiang River Fishery Research Institute of Chinese Academy of Fishery Sciences, Harbin, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cleveland MA, 2012, G3-GENES GENOM GENET, V2, P429, DOI 10.1534/g3.111.001453; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Falconer D. S, 1996, INTRO QUANTITATIVE G; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes B, 2010, GENOME, V53, P876, DOI 10.1139/G10-076; HENDERSON CR, 1985, J ANIM SCI, V60, P111, DOI 10.2527/jas1985.601111x; Hickey JM, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-9; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; JOHNSON DL, 1995, J DAIRY SCI, V78, P449, DOI 10.3168/jds.S0022-0302(95)76654-1; Lee SH, 2006, GENET SEL EVOL, V38, P25, DOI 10.1051/gse:2005025; Ma L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-536; Meuwissen THE, 2001, GENETICS, V157, P1819; Misztal I, 1997, J DAIRY SCI, V80, P975, DOI 10.3168/jds.S0022-0302(97)76022-3; Ober U, 2011, GENETICS, V188, P695, DOI 10.1534/genetics.111.128694; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; Sun C, 2013, J DAIRY SCI, V96, P8014, DOI 10.3168/jds.2013-6969; Toro MA, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-33; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vineis P, 2010, NAT REV GENET, V11, DOI 10.1038/nrg2809-c2; Wang C., 2013, GVCBLUP COMPUTER PAC; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zeng J, 2012, GENOMIC BREEDING VAL, pS7; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	33	59	62	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87666	10.1371/journal.pone.0087666	http://dx.doi.org/10.1371/journal.pone.0087666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498162	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100106
J	Drovetski, SV; Rakovic, M; Semenov, G; Fadeev, IV; Red'kin, YA				Drovetski, Sergei V.; Rakovic, Marko; Semenov, Georgy; Fadeev, Igor V.; Red'kin, Yaroslav A.			Limited Phylogeographic Signal in Sex-Linked and Autosomal Loci Despite Geographically, Ecologically, and Phenotypically Concordant Structure of mtDNA Variation in the Holarctic Avian Genus Eremophila	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; MULTILOCUS PHYLOGEOGRAPHY; MAXIMUM-LIKELIHOOD; PHYLOGENY; DIVERGENCE; PASSERINE; HISTORY; BIRDS; RATES; SPECIATION	Phylogeographic studies of Holarctic birds are challenging because they involve vast geographic scale, complex glacial history, extensive phenotypic variation, and heterogeneous taxonomic treatment across countries, all of which require large sample sizes. Knowledge about the quality of phylogeographic information provided by different loci is crucial for study design. We use sequences of one mtDNA gene, one sex-linked intron, and one autosomal intron to elucidate large scale phylogeographic patterns in the Holarctic lark genus Eremophila. The mtDNA ND2 gene identified six geographically, ecologically, and phenotypically concordant clades in the Palearctic that diverged in the Early - Middle Pleistocene and suggested paraphyly of the horned lark (E. alpestris) with respect to the Temminck's lark (E. bilopha). In the Nearctic, ND2 identified five subclades which diverged in the Late Pleistocene. They overlapped geographically and were not concordant phenotypically or ecologically. Nuclear alleles provided little information on geographic structuring of genetic variation in horned larks beyond supporting the monophyly of Eremophila and paraphyly of the horned lark. Multilocus species trees based on two nuclear or all three loci provided poor support for haplogroups identified by mtDNA. The node ages calculated using mtDNA were consistent with the available paleontological data, whereas individual nuclear loci and multilocus species trees appeared to underestimate node ages. We argue that mtDNA is capable of discovering independent evolutionary units within avian taxa and can provide a reasonable phylogeographic hypothesis when geographic scale, geologic history, and phenotypic variation in the study system are too complex for proposing reasonable a priori hypotheses required for multilocus methods. Finally, we suggest splitting the currently recognized horned lark into five Palearctic and one Nearctic species.	[Drovetski, Sergei V.] Univ Tromso, Tromso Univ Museum, Dept Nat Hist, Tromso, Norway; [Rakovic, Marko] Nat Hist Museum Belgrade, Dept Vertebrate Zool, Belgrade, Serbia; [Semenov, Georgy] Russian Acad Sci, Siberian Branch, Themat Grp Bird Ecol, Inst Systemat & Ecol Anim, Novosibirsk, Russia; [Fadeev, Igor V.] State Darwin Museum, Dept Collect, Moscow, Russia; [Red'kin, Yaroslav A.] Moscow MV Lomonosov State Univ, Zool Museum, Dept Ornithol, Moscow, Russia	UiT The Arctic University of Tromso; Russian Academy of Sciences; Lomonosov Moscow State University	Drovetski, SV (corresponding author), Univ Tromso, Tromso Univ Museum, Dept Nat Hist, Tromso, Norway.	sdrovetski@gmail.com	Drovetski, Sergei/A-6002-2011; Red'kin, Yaroslav/AAE-4218-2021	Drovetski, Sergei/0000-0002-1832-5597; Rakovic, Marko/0000-0002-3658-3362	Fundacao para a Ciencia e a Tecnologia [PTDC/BIA-BEC/103435/2008]; Fundacao Calouste Gulbenkian, Portugal	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Calouste Gulbenkian, Portugal	This study was supported by Fundacao para a Ciencia e a Tecnologia (http://www.fct.pt/) grant PTDC/BIA-BEC/103435/2008 and Fundacao Calouste Gulbenkian (http://www.gulbenkian.pt/Institucional/en/Homepage), Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom P, 2013, MOL PHYLOGENETICS EV; Arbelaez-Cortes E, 2014, MOL PHYLOGENET EVOL, V70, P362, DOI 10.1016/j.ympev.2013.10.006; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Beason RC, 1995, BIRDS N AM ONLINE; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; Chesser RT, 2010, AUK, V127, P726, DOI 10.1525/auk.2010.127.3.726; Christie D.A, 2004, HDB BIRDS WORLD, P496; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clements JF, 2007, CLEMENTS CHECKLIST B; Cramp S., 1985, HDB BIRDS EUROPE MID; Dickinson EC., 2003, HOWARD MOORE COMPLET; Dove C, 2013, CONSERV GENET, P1; Drovetski SV, 2010, J BIOGEOGR, V37, P696, DOI 10.1111/j.1365-2699.2009.02234.x; Drovetski SV, 2009, MOL PHYLOGENET EVOL, V50, P437, DOI 10.1016/j.ympev.2008.12.002; Drovetski SV, 2005, CONSERV GENET, V6, P875, DOI 10.1007/s10592-005-9074-9; Drovetski SV, 2004, P ROY SOC B-BIOL SCI, V271, P545, DOI 10.1098/rspb.2003.2638; Drovetski SV, 2002, SYST BIOL, V51, P930, DOI 10.1080/10635150290156033; Drovetski SV, 2004, J AVIAN BIOL, V35, P105; Drovetski SV, 2013, ECOLOGY EVOLUTION; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ducey James, 1992, Transactions of the Nebraska Academy of Sciences, V19, P83; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Edwards SV, 2005, P NATL ACAD SCI USA, V102, P6550, DOI 10.1073/pnas.0501846102; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Hung CM, 2013, J ORNITHOL, V154, P1105, DOI 10.1007/s10336-013-0980-1; Hung CM, 2012, EVOLUTION, V66, P2850, DOI 10.1111/j.1558-5646.2012.01657.x; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; Kimball RT, 2009, MOL PHYLOGENET EVOL, V50, P654, DOI 10.1016/j.ympev.2008.11.018; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krosby M, 2009, P ROY SOC B-BIOL SCI, V276, P615, DOI 10.1098/rspb.2008.1310; Lee JY, 2008, EVOLUTION, V62, P3117, DOI 10.1111/j.1558-5646.2008.00543.x; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; McKay BD, 2009, MOL PHYLOGENETICS EV; Mullarney K., 2006, BIRD GUIDE MOST COMP; Pavlova A, 2008, MOL PHYLOGENET EVOL, V48, P61, DOI 10.1016/j.ympev.2008.03.030; Peters JL, 2008, EVOLUTION, V62, P1469, DOI 10.1111/j.1558-5646.2008.00372.x; Peters JL, 2012, MOL ECOL, V21, P4563, DOI 10.1111/j.1365-294X.2012.05711.x; Primmer CR, 2002, MOL ECOL, V11, P603, DOI 10.1046/j.0962-1083.2001.01452.x; Smith BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055161; Stepanyan L. S., 2003, CONSPECTUS ORNITHOLO; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Toews DPL, 2008, MOL ECOL, V17, P2691, DOI 10.1111/j.1365-294X.2008.03769.x; Tyrberg T., 1998, PLEISTOCENE BIRDS PA; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zink RM, 2009, MOL ECOL, V18, P1; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	54	27	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87570	10.1371/journal.pone.0087570	http://dx.doi.org/10.1371/journal.pone.0087570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498139	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100096
J	Linz, B; Vololonantenainab, CRR; Seck, A; Carod, JF; Dia, D; Garin, B; Ramanampamonjy, RM; Thiberge, JM; Raymond, J; Breurec, S				Linz, Bodo; Vololonantenainab, Clairette Romaine Raharisolo; Seck, Abdoulaye; Carod, Jean-Francois; Dia, Daouda; Garin, Benoit; Ramanampamonjy, Rado Manitrala; Thiberge, Jean-Michel; Raymond, Josette; Breurec, Sebastien			Population Genetic Structure and Isolation by Distance of Helicobacter pylori in Senegal and Madagascar	PLOS ONE			English	Article							ETHNIC-GROUPS; SEQUENCES; INFERENCE; PACIFIC; ORIGIN	Helicobacter pylori has probably infected the human stomach since our origins and subsequently diversified in parallel with their human hosts. The genetic population history of H. pylori can therefore be used as a marker for human migration. We analysed seven housekeeping gene sequences of H. pylori strains isolated from 78 Senegalese and 24 Malagasy patients and compared them with the sequences of strains from other geographical locations. H. pylori from Senegal and Madagascar can be placed in the previously described HpAfrica1 genetic population, subpopulations hspWAfrica and hspSAfrica, respectively. These 2 subpopulations correspond to the distribution of Niger-Congo speakers in West and most of subequatorial Africa (due to Bantu migrations), respectively. H. pylori appears as a single population in Senegal, indicating a long common history between ethnicities as well as frequent local admixtures. The lack of differentiation between these isolates and an increasing genetic differentiation with geographical distance between sampling locations in Africa was evidence for genetic isolation by distance. The Austronesian expansion that started from Taiwan 5000 years ago dispersed one of the 10 subgroups of the Austronesian language family via insular Southeast Asia into the Pacific and Madagascar, and hspMaori is a marker for the entire Austronesian expansion. Strain competition and replacement of hspMaori by hpAfrica1 strains from Bantu migrants are the probable reasons for the presence of hspSAfrica strains in Malagasy of Southeast Asian descent. hpAfrica1 strains appear to be generalist strains that have the necessary genetic diversity to efficiently colonise a wide host spectrum.	[Linz, Bodo] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Vololonantenainab, Clairette Romaine Raharisolo] Inst Pasteur, Lab Anat & Cytol Pathol, Antananarivo, Madagascar; [Seck, Abdoulaye; Garin, Benoit; Breurec, Sebastien] Inst Pasteur, Med Biol Lab, Dakar, Senegal; [Carod, Jean-Francois] Inst Pasteur, Ctr Biol Clin, Antananarivo, Madagascar; [Dia, Daouda] Ctr Hosp Le Dantec, Dakar, Senegal; [Garin, Benoit] Inst Pasteur, Lab Bacteriol Expt, Antananarivo, Madagascar; [Ramanampamonjy, Rado Manitrala] Ctr Hosp Univ Joseph Ravoahangy Befelatana, Dept Gastroenterol, Antananarivo, Madagascar; [Thiberge, Jean-Michel] Inst Pasteur, Plate Forme Genotypage Pathogenes & Sante Publ, Paris, France; [Raymond, Josette] Inst Pasteur, Unite Postulante Pathogenese Helicobacter, Paris, France; [Breurec, Sebastien] Inst Pasteur, Med Biol Lab, Bangui, Cent Afr Republ	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Breurec, S (corresponding author), Inst Pasteur, Med Biol Lab, Dakar, Senegal.	sbreurec@pasteur.sn			Institut Pasteur (ACIP Helicobacter pylori); ERA-NET PathoGenoMics (project HELDIVNET) [ANR-06-PATHO-007-01]	Institut Pasteur (ACIP Helicobacter pylori); ERA-NET PathoGenoMics (project HELDIVNET)(Academy of Finland)	This study was supported by grants from Institut Pasteur (ACIP Helicobacter pylori) and the ERA-NET PathoGenoMics (project HELDIVNET, decision noANR-06-PATHO-007-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breurec S, 2012, CLIN MICROBIOL INFEC, V18, P153, DOI 10.1111/j.1469-0691.2011.03524.x; Breurec S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022058; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cox MP, 2012, P ROY SOC B-BIOL SCI, V279, P2761, DOI 10.1098/rspb.2012.0012; de Filippo C, 2012, P ROY SOC B-BIOL SCI, V279, P3256, DOI 10.1098/rspb.2012.0318; Delport W, 2006, GENETICS, V174, P2107, DOI 10.1534/genetics.106.057703; Devi SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-184; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dominguez-Bello MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003307; Ehret C, 1983, ARCHEOLOGICAL LINGUI; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fenoglio-Preiser CM, 1999, GASTROINTESTINAL PAT; Fernando N, 2001, J CLIN MICROBIOL, V39, P1323, DOI 10.1128/JCM.39.4.1323-1327.2001; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Hurles ME, 2005, AM J HUM GENET, V76, P894, DOI 10.1086/430051; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Latifi-Navid S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009645; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Liao YL, 2009, CURR MICROBIOL, V59, P123, DOI 10.1007/s00284-009-9407-x; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Momynaliev K T, 2005, Genetika, V41, P1434; Moodley Y, 2009, GENOME DYNAM, V6, P62, DOI 10.1159/000235763; Moodley Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002693; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Nell S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003775; Oppenheimer SJ, 2001, NATURE, V410, P166, DOI 10.1038/35065520; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Schwarz S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000180; SOODYALL H, 1995, NAT GENET, V10, P377, DOI 10.1038/ng0895-377; Spriggs M, 1996, WHAT IS SE ASIAN LAP, P322; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tay CY, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-126; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; Wright D. R., 2010, WORLD VERY SMALL PLA; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0	41	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87355	10.1371/journal.pone.0087355	http://dx.doi.org/10.1371/journal.pone.0087355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498084	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100078
J	Paul, NA; Svensson, CJ; de Nys, R; Steinberg, PD				Paul, Nicholas A.; Svensson, Carl Johan; de Nys, Rocky; Steinberg, Peter D.			Simple Growth Patterns Can Create Complex Trajectories for the Ontogeny of Constitutive Chemical Defences in Seaweeds	PLOS ONE			English	Article							ALGA ASPARAGOPSIS-ARMATA; LONG-DISTANCE TRANSPORT; NUTRIENT AVAILABILITY; PHLOROTANNIN PRODUCTION; HERBIVORY; RESISTANCE; ALLOCATION; CHEMISTRY; SELECTION; COSTS	All of the theory and most of the data on the ecology and evolution of chemical defences derive from terrestrial plants, which have considerable capacity for internal movement of resources. In contrast, most macroalgae - seaweeds - have no or very limited capacity for resource translocation, meaning that trade-offs between growth and defence, for example, should be localised rather than systemic. This may change the predictions of chemical defence theories for seaweeds. We developed a model that mimicked the simple growth pattern of the red seaweed Asparagopsis armata which is composed of repeating clusters of somatic cells and cells which contain deterrent secondary chemicals (gland cells). To do this we created a distinct growth curve for the somatic cells and another for the gland cells using empirical data. The somatic growth function was linked to the growth function for defence via differential equations modelling, which effectively generated a trade-off between growth and defence as these neighbouring cells develop. By treating growth and defence as separate functions we were also able to model a trade-off in growth of 2-3% under most circumstances. However, we found contrasting evidence for this trade-off in the empirical relationships between growth and defence, depending on the light level under which the alga was cultured. After developing a model that incorporated both branching and cell division rates, we formally demonstrated that positive correlations between growth and defence are predicted in many circumstances and also that allocation costs, if they exist, will be constrained by the intrinsic growth patterns of the seaweed. Growth patterns could therefore explain contrasting evidence for cost of constitutive chemical defence in many studies, highlighting the need to consider the fundamental biology and ontogeny of organisms when assessing the allocation theories for defence.	[Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Svensson, Carl Johan] Univ Gothenburg, Dept Marine Ecol, Gothenburg, Sweden; [Steinberg, Peter D.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Steinberg, Peter D.] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia	James Cook University; University of Gothenburg; University of New South Wales Sydney; University of New South Wales Sydney	Paul, NA (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	nicholas.paul@jcu.edu.au	de Nys, Rocky/D-6741-2012; Paul, Nicholas/B-6496-2009	de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535; Svensson, Carl Johan/0000-0002-8265-9313; Steinberg, Peter/0000-0002-1781-0726	Australian Research Council; Swedish research council FORMAS [2007-449]	Australian Research Council(Australian Research Council); Swedish research council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This study was jointly funded by the Australian Research Council ( P. D. S) and the Swedish research council FORMAS, project No. 2007-449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Arnold TM, 2003, OIKOS, V100, P406, DOI 10.1034/j.1600-0706.2003.11680.x; Barton KE, 2007, AM J BOT, V94, P56, DOI 10.3732/ajb.94.1.56; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; BJORKMAN C, 1991, OECOLOGIA, V86, P202, DOI 10.1007/BF00317532; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; BRYANT JP, 1995, J CHEM ECOL, V21, P883, DOI 10.1007/BF02033796; Cronin G, 1996, OIKOS, V77, P93, DOI 10.2307/3545589; Cronin G, 2001, CRC MAR SCI, P325; Cronin G, 1996, OECOLOGIA, V105, P361, DOI 10.1007/BF00328739; DIOURIS M, 1984, MAR BIOL, V78, P199, DOI 10.1007/BF00394701; Dworjanyn SA, 2006, OIKOS, V113, P13; Elger A, 2009, OIKOS, V118, P767, DOI 10.1111/j.1600-0706.2009.17206.x; GERSHENZON J, 1994, J CHEM ECOL, V20, P1281, DOI 10.1007/BF02059810; Hay KB, 2011, J ECOL, V99, P1540, DOI 10.1111/j.1365-2745.2011.01874.x; HERMS DA, 1992, Q REV BIOL, V67, P478; Jasienski M, 1999, OIKOS, V84, P321, DOI 10.2307/3546729; Jormalainen V, 2004, J EVOLUTION BIOL, V17, P807, DOI 10.1111/j.1420-9101.2004.00715.x; Jormalainen V, 2009, OIKOS, V118, P713, DOI 10.1111/j.1600-0706.2008.17178.x; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Koricheva J, 1999, OECOLOGIA, V119, P467, DOI 10.1007/s004420050809; Luning K, 1981, BIOL SEAWEEDS, P326; Lynch M., 1998, GENETICS ANAL QUANTI; Mata L, 2006, AQUACULTURE, V252, P12, DOI 10.1016/j.aquaculture.2005.11.045; Mata L, 2010, J APPL PHYCOL, V22, P639, DOI 10.1007/s10811-010-9504-z; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; MCCONNELL O, 1977, PHYTOCHEMISTRY, V16, P367, DOI 10.1016/0031-9422(77)80067-8; McKey D., 1979, HERBIVORES THEIR INT, P55; Monro K, 2007, EVOL ECOL, V21, P765, DOI 10.1007/s10682-006-9150-8; Nylund GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061291; Orians CM, 2010, OECOLOGIA, V163, P283, DOI 10.1007/s00442-009-1521-8; Paul NA, 2006, J PHYCOL, V42, P637, DOI 10.1111/j.1529-8817.2006.00226.x; Paul NA, 2006, MAR ECOL PROG SER, V306, P87, DOI 10.3354/meps306087; Paul NA, 2006, MAR ECOL PROG SER, V323, P1, DOI 10.3354/meps323001; Pavia H, 1999, J ECOL, V87, P761, DOI 10.1046/j.1365-2745.1999.00397.x; Pavia H, 2002, ECOLOGY, V83, P891; Powers SJ, 2003, J THEOR BIOL, V222, P219, DOI 10.1016/S0022-5193(03)00030-4; Provasoli L., 1968, CULTURES COLLECTIONS, P63; Raven JA, 2003, PLANT CELL ENVIRON, V26, P73, DOI 10.1046/j.1365-3040.2003.00920.x; Simms E. L., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P392; STEINBERG PD, 1984, SCIENCE, V223, P405, DOI 10.1126/science.223.4634.405; STEINBERG PD, 1995, OECOLOGIA, V102, P169, DOI 10.1007/BF00333248; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Toth GB, 2005, ECOLOGY, V86, P612, DOI 10.1890/04-0484; Verges A, 2008, ECOLOGY, V89, P1334, DOI 10.1890/07-0248.1; Wright JT, 2004, ECOLOGY, V85, P2946, DOI 10.1890/03-4041; YATES JL, 1993, ECOLOGY, V74, P1757, DOI 10.2307/1939934	48	5	5	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86893	10.1371/journal.pone.0086893	http://dx.doi.org/10.1371/journal.pone.0086893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497991	Green Accepted, Green Published, gold			2022-12-25	WOS:000330617100038
J	Pulcu, E; Lythe, K; Elliott, R; Green, S; Moll, J; Deakin, JFW; Zahn, R				Pulcu, Erdem; Lythe, Karen; Elliott, Rebecca; Green, Sophie; Moll, Jorge; Deakin, John F. W.; Zahn, Roland			Increased Amygdala Response to Shame in Remitted Major Depressive Disorder	PLOS ONE			English	Article							NEURAL RESPONSE; ANTIDEPRESSANT TREATMENT; MORAL COGNITION; INSULAR CORTEX; MOOD STATE; GUILT; SELF; METAANALYSIS; BEHAVIOR; FACES	Proneness to self-blaming moral emotions such as shame and guilt is increased in major depressive disorder (MDD), and may play an important role in vulnerability even after symptoms have subsided. Social psychologists have argued that shame-proneness is relevant for depression vulnerability and is distinct from guilt. Shame depends on the imagined critical perception of others, whereas guilt results from one's own judgement. The neuroanatomy of shame in MDD is unknown. Using fMRI, we compared 21 participants with MDD remitted from symptoms with no current co-morbid axis-I disorders, and 18 control participants with no personal or family history of MDD. The MDD group exhibited higher activation of the right amygdala and posterior insula for shame relative to guilt (SPM8). This neural difference was observed despite equal levels of rated negative emotional valence and frequencies of induced shame and guilt experience across groups. These same results were found in the medication-free MDD subgroup (N = 15). Increased amygdala and posterior insula activations, known to be related to sensory perception of emotional stimuli, distinguish shame from guilt responses in remitted MDD. People with MDD thus exhibit changes in the neural response to shame after symptoms have subsided. This supports the hypothesis that shame and guilt play at least partly distinct roles in vulnerability to MDD. Shame-induction may be a more sensitive probe of residual amygdala hypersensitivity in MDD compared with facial emotion-evoked responses previously found to normalize on remission.	[Pulcu, Erdem; Lythe, Karen; Elliott, Rebecca; Green, Sophie; Deakin, John F. W.; Zahn, Roland] Univ Manchester, Manchester, Lancs, England; [Pulcu, Erdem; Lythe, Karen; Elliott, Rebecca; Deakin, John F. W.] Manchester Acad Hlth Sci Ctr, Sch Med, Neurosci & Psychiat Unit, Manchester, Lancs, England; [Lythe, Karen; Green, Sophie; Zahn, Roland] Manchester Acad Hlth Sci Ctr, Sch Psychol Sci, Neurosci & Aphasia Res Unit, Manchester, Lancs, England; [Moll, Jorge] DOr Inst Res & Educ IDOR, Cognit & Behav Neurosci Unit, Rio De Janeiro, Brazil; [Zahn, Roland] Kings Coll London, Inst Psychiat, Dept Psychol Med, Ctr Affect Disorders, London WC2R 2LS, England	University of Manchester; University of Manchester; University of Manchester; IDOR - Instituto D'Or de Ensino e Pesquisa; University of London; King's College London	Zahn, R (corresponding author), Univ Manchester, Manchester, Lancs, England.	roland.zahn@kcl.ac.uk	Moll, Jorge/AAF-8388-2021; Zahn, Roland/C-4665-2008; Zahn, Roland/O-8944-2019	Moll, Jorge/0000-0002-4297-591X; Zahn, Roland/0000-0002-8447-1453; Zahn, Roland/0000-0002-8447-1453; Elliott, Rebecca/0000-0002-7602-010X; Deakin, John/0000-0002-2750-962X; Pulcu, Erdem/0000-0002-2170-0677	Medical Research Council Clinician Scientist Fellowship [G0902304]; MRC [G0902304] Funding Source: UKRI; Medical Research Council [G0902304] Funding Source: researchfish	Medical Research Council Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study has been funded by a Medical Research Council Clinician Scientist Fellowship to RZ (G0902304). http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arnone D, 2012, AM J PSYCHIAT, V169, P841, DOI 10.1176/appi.ajp.2012.11121774; Basile B, 2011, HUM BRAIN MAPP, V32, P229, DOI 10.1002/hbm.21009; Berthoz S, 2006, NEUROIMAGE, V31, P945, DOI 10.1016/j.neuroimage.2005.12.039; Bhagwagar Z, 2008, PSYCHOL MED, V38, P307, DOI 10.1017/S0033291707001250; Bjornsdotter M, 2009, J NEUROSCI, V29, P9314, DOI 10.1523/JNEUROSCI.0400-09.2009; Brett M., 2002, 8 INT C FUNCT MAPP H; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Delvecchio G, 2012, EUR NEUROPSYCHOPHARM, V22, P100, DOI 10.1016/j.euroneuro.2011.07.003; Diener C, 2012, NEUROIMAGE, V61, P677, DOI 10.1016/j.neuroimage.2012.04.005; Eaton WW, 2008, ARCH GEN PSYCHIAT, V65, P513, DOI 10.1001/archpsyc.65.5.513; Ellison RH, 2010, NEW HISTORY OF THE SERMON: THE NINETEENTH CENTURY, P1, DOI 10.1163/ej.9789004185722.i-571.7; Fessler D. M. T., 1999, NATURE NURTURE BIOCU, P75; First MB, 2002, STRUCTURED CLIN INTE; Freud S, 1918, INT Z ARZTL PSYCHOAN, V4, P288; Fu CHY, 2004, ARCH GEN PSYCHIAT, V61, P877, DOI 10.1001/archpsyc.61.9.877; Gilbert P, 2009, PSYCHOL PSYCHOTHER-T, V82, P123, DOI 10.1348/147608308X379806; Green S, 2012, ARCH GEN PSYCHIAT, V173; Green S, 2013, PSYCHOPATHOLOGY; Green S, 2010, NEUROIMAGE, V52, P1720, DOI 10.1016/j.neuroimage.2010.05.038; Grimm S, 2009, HUM BRAIN MAPP, V30, P2617, DOI 10.1002/hbm.20693; Groenewold NA, 2013, NEUROSCI BIOBEHAV R, V37, P152, DOI 10.1016/j.neubiorev.2012.11.015; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; Kayhan G, 2002, J AFFECT DISORDERS, V68, P307, DOI 10.1016/S0165-0327(01)00335-4; Kedia G, 2008, J COGNITIVE NEUROSCI, V20, P1788, DOI 10.1162/jocn.2008.20070; Kosslyn SM, 2005, COGN NEUROPSYCHOL, V22, P333, DOI 10.1080/02643290442000130; KOSSLYN SM, 1993, J COGNITIVE NEUROSCI, V5, P263, DOI 10.1162/jocn.1993.5.3.263; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; Michl P, 2012, SOC COGN AFFECT NEUR; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moll J, 2008, ANN NY ACAD SCI, V1124, P161, DOI 10.1196/annals.1440.005; Moll J, 2007, SOC NEUROSCI-UK, V2, P336, DOI 10.1080/17470910701392024; Morey RA, 2012, NEUROIMAGE, V60, P683, DOI 10.1016/j.neuroimage.2011.12.069; Nagai M, 2007, EUR PSYCHIAT, V22, P387, DOI 10.1016/j.eurpsy.2007.02.006; Neumeister A, 2006, NEUROPSYCHOPHARMACOL, V31, P1750, DOI 10.1038/sj.npp.1301010; Norbury R, 2010, PSYCHOL MED, V40, P425, DOI 10.1017/S0033291709990596; Northoff G, 2007, J AFFECT DISORDERS, V104, P1, DOI 10.1016/j.jad.2007.02.012; Nummenmaa L, 2009, TRENDS COGN SCI, V13, P135, DOI 10.1016/j.tics.2008.12.006; O'Connor LE, 2002, J AFFECT DISORDERS, V71, P19, DOI 10.1016/S0165-0327(01)00408-6; O'Connor LE, 2000, BRIT J MED PSYCHOL, V73, P519, DOI 10.1348/000711200160705; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Ramel W, 2007, BIOL PSYCHIAT, V61, P231, DOI 10.1016/j.biopsych.2006.05.004; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; SROUFE LA, 1977, CHILD DEV, V48, P1184, DOI 10.1111/j.1467-8624.1977.tb03922.x; Takahashi H, 2004, NEUROIMAGE, V23, P967, DOI 10.1016/j.neuroimage.2004.07.054; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Thompson RJ, 2006, COGNITIVE THER RES, V30, P415, DOI 10.1007/s10608-006-9056-3; Tracy JL, 2006, PERS SOC PSYCHOL B, V32, P1339, DOI 10.1177/0146167206290212; Victor TA, 2010, ARCH GEN PSYCHIAT, V67, P1128, DOI 10.1001/archgenpsychiatry.2010.144; Wagner U, 2011, CEREB CORTEX, V21, P2461, DOI 10.1093/cercor/bhr016; Wichers M, 2010, PSYCHOL MED, V40, P359, DOI 10.1017/S0033291709990420; Zahn R, 2011, HDB HUMAN AFFECTIVE; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104; Zahn R, 2009, NEUROSCI LETT, V457, P107, DOI 10.1016/j.neulet.2009.03.090; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080	67	33	34	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86900	10.1371/journal.pone.0086900	http://dx.doi.org/10.1371/journal.pone.0086900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497992	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100039
J	Weis, J; Bruvold, M; Ortiz-Nieto, F; Ahlstrom, H				Weis, Jan; Bruvold, Morten; Ortiz-Nieto, Francisco; Ahlstrom, Hakan			High-Resolution Echo-Planar Spectroscopic Imaging of the Human Calf	PLOS ONE			English	Article							INTRAMYOCELLULAR LIPID-CONTENT; PROTON MR; CHEMICAL-SHIFT; HUMAN MUSCLE; HUMAN BRAIN; INSULIN SENSITIVITY; ACQUISITION; H-1-NMR; ORIENTATION; GRADIENT	Background: This study exploits the speed benefits of echo-planar spectroscopic imaging (EPSI) to acquire lipid spectra of skeletal muscle. The main purpose was to develop a high-resolution EPSI technique for clinical MR scanner, to visualise the bulk magnetic susceptibility (BMS) shifts of extra-myocellular lipid (EMCL) spectral lines, and to investigate the feasibility of this method for the assessment of intra-myocellular (IMCL) lipids. Methods: The study group consisted of six healthy volunteers. A two dimensional EPSI sequence with point-resolved spectroscopy (PRESS) spatial localization was implemented on a 3T clinical MR scanner. Measurements were performed by means of 64664 spatial matrix and nominal voxel size 363615 mm(3). The total net measurement time was 3 min 12 sec for non-water-suppressed (1 acquisition) and 12 min 48 sec for water-suppressed scans (4 acquisitions). Results: Spectra of the human calf had a very good signal-to-noise ratio and linewidths sufficient to differentiate IMCL resonances from EMCL. The use of a large spatial matrix reduces inter-voxel signal contamination of the strong EMCL signals. Small voxels enabled visualisation of the methylene EMCL spectral line splitting and their BMS shifts up to 0.5 ppm relative to the correspondent IMCL line. The mean soleus muscle IMCL content of our six volunteers was 0.30 +/- 0.10 vol% (range 0.18-0.46) or 3.6 +/- 1.2 mmol/kg wet weight (range: 2.1-5.4). Conclusion: This study demonstrates that high-spatial resolution PRESS EPSI of the muscle lipids is feasible on standard clinical scanners.	[Weis, Jan; Ortiz-Nieto, Francisco; Ahlstrom, Hakan] Univ Uppsala Hosp, Dept Radiol, Uppsala, Sweden; [Bruvold, Morten] Philips Healthcare, Best, Netherlands	Uppsala University; Uppsala University Hospital; Philips; Philips Healthcare	Weis, J (corresponding author), Univ Uppsala Hosp, Dept Radiol, Uppsala, Sweden.	jan.weis@radiol.uu.se			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The grant for this study was sponsored by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesch C, 1997, MAGN RESON MED, V37, P484, DOI 10.1002/mrm.1910370403; Boesch C, 2006, NMR BIOMED, V19, P968, DOI 10.1002/nbm.1096; Chen AP, 2007, J MAGN RESON IMAGING, V25, P1288, DOI 10.1002/jmri.20916; CHU SCK, 1990, MAGN RESON MED, V13, P239, DOI 10.1002/mrm.1910130207; Cunningham CH, 2005, MAGN RESON MED, V54, P1286, DOI 10.1002/mrm.20663; Ebel A, 2001, MAGNET RESON MED, V46, P1072, DOI 10.1002/mrm.1301; ERICSSON A, 1995, MAGNET RESON MED, V33, P171, DOI 10.1002/mrm.1910330205; Furuyama JK, 2012, MAGN RESON MED, V67, P1515, DOI 10.1002/mrm.23184; Guimaraes AR, 1999, MAGNET RESON MED, V41, P877, DOI 10.1002/(SICI)1522-2594(199905)41:5<877::AID-MRM4>3.0.CO;2-3; Hu J, 1997, J MAGN RESON, V126, P187, DOI 10.1006/jmre.1997.1163; Hu JN, 2005, MAGN RESON IMAGING, V23, P97, DOI 10.1016/j.mri.2004.09.009; Hwang JH, 2001, J APPL PHYSIOL, V90, P1267, DOI 10.1152/jappl.2001.90.4.1267; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Khuu A, 2009, MAGN RESON MED, V61, P16, DOI 10.1002/mrm.21831; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Larson-Meyer DE, 2002, AM J PHYSIOL-ENDOC M, V282, pE95, DOI 10.1152/ajpendo.2002.282.1.E95; Lipnick S, 2010, MAGN RESON MED, V64, P947, DOI 10.1002/mrm.22499; MANSFIELD P, 1984, MAGNET RESON MED, V1, P370, DOI 10.1002/mrm.1910010308; Mathiesen HK, 2005, MAGN RESON MED, V53, P750, DOI 10.1002/mrm.20407; MATSUI S, 1985, J AM CHEM SOC, V107, P2817, DOI 10.1021/ja00295a050; Maudsley AA, 2006, NMR BIOMED, V19, P492, DOI 10.1002/nbm.1025; Mulkern RV, 2001, CONCEPT MAGNETIC RES, V13, P213, DOI 10.1002/cmr.1011; Newcomer BR, 2007, MAGN RESON MED, V57, P848, DOI 10.1002/mrm.21209; Otazo R, 2006, MAGN RESON MED, V56, P1200, DOI 10.1002/mrm.21067; Pohmann R, 2001, MAGN RESON MED, V45, P817, DOI 10.1002/mrm.1110; POSSE S, 1995, MAGN RESON MED, V33, P34, DOI 10.1002/mrm.1910330106; Posse S, 2007, MAGN RESON MED, V58, P236, DOI 10.1002/mrm.21287; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Ren JM, 2008, J LIPID RES, V49, P2055, DOI 10.1194/jlr.D800010-JLR200; Scheenen TWJ, 2004, MAGN RESON MED, V52, P80, DOI 10.1002/mrm.20103; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Steidle G, 2002, J MAGN RESON, V154, P228, DOI 10.1006/jmre.2001.2481; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Szczepaniak LS, 2002, MAGN RESON MED, V47, P607, DOI 10.1002/mrm.10086; Vermathen P, 2004, MAGNET RESON MED, V51, P253, DOI 10.1002/mrm.10721; Vermathen P, 2003, MAGN RESON MED, V49, P424, DOI 10.1002/mrm.10396; Vermathen P, 2012, MAGN RESON MED, V68, P1357, DOI 10.1002/mrm.24168; Weis J, 2007, MAGN RESON MED, V57, P22, DOI 10.1002/mrm.21085; Weis J, 1997, MAGN RESON MATER PHY, V5, P201, DOI 10.1007/BF02594583; Weis J, 1999, MAGNET RESON MED, V41, P904, DOI 10.1002/(SICI)1522-2594(199905)41:5<904::AID-MRM8>3.0.CO;2-4; Weis J, 2012, P 19 ANN M ISMRM MEL	41	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87533	10.1371/journal.pone.0087533	http://dx.doi.org/10.1371/journal.pone.0087533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498129	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100091
J	Zheng, H; Lan, RT; Zheng, X; Cui, ZG; Liu, ZJ; Bai, XM; Ji, SB; Gottschalk, M; Xu, JG				Zheng, Han; Lan, Ruiting; Zheng, Xiao; Cui, Zhigang; Liu, Zhijie; Bai, Xuemei; Ji, Shaobo; Gottschalk, Marcelo; Xu, Jianguo			Comparative Genomic Hybridization Identifies Virulence Differences in Streptococcus suis	PLOS ONE			English	Article							SEQUENCE TYPE-7; ZOONOTIC AGENT; NORTH-AMERICA; SEROTYPE-2; PATHOGENESIS; MENINGITIS; ACTIVATION; EXPRESSION; INFECTION; CHINA	Streptococcus suis is an important zoonotic pathogen. However, identification of virulent S. suis strains is complicated because of the high diversity of the species. Here we evaluated the genetic difference among S. suis strains using comparative genomic hybridization (CGH) and virulence variation in vivo and in vitro. We showed that different clades differed in their ability to activate TLR2/6 in vitro and their capacity to induce cytokine production in vivo as well as their resistance to phagocytosis and survival in vivo. Our data showed the S. suis strains tested can be classified into three groups having differing levels of virulence: epidemic and highly virulent strains were clustered into clade Ia (epidemic and highly virulent group, E/HV group), virulent strains were clustered into clade Ib (virulent group, V group), and intermediately or weakly virulent strains were clustered into other clades (intermediately or weakly virulent group, I/WV group). Our study provided further insight into the genomic and virulence variation of S. suis.	[Zheng, Han; Zheng, Xiao; Cui, Zhigang; Liu, Zhijie; Bai, Xuemei; Ji, Shaobo; Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Gottschalk, Marcelo] Univ Montreal, Grp Rech Malad Infect Porc, Fac Med Vet, Montreal, PQ, Canada	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of New South Wales Sydney; Universite de Montreal	Xu, JG (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China.	xujianguo@icdc.cn	Gottschalk, Marcelo/I-8116-2012; Zheng, Han/AAH-6977-2019	Lan, Ruiting/0000-0001-9834-5258	State Key Laboratory for Infectious Disease Prevention and Control [50153-3]; Ministry of Science and Technology, PR China [2011ZX10004-001, 2013ZX10004221, 2013ZX10004216-001-002, 81261120559]	State Key Laboratory for Infectious Disease Prevention and Control; Ministry of Science and Technology, PR China(Ministry of Science and Technology, China)	This work was supported by a grant (50153-3) from the State Key Laboratory for Infectious Disease Prevention and Control (to H.Z) and grants (2011ZX10004-001, 2013ZX10004221, 2013ZX10004216-001-002, 81261120559) from the Ministry of Science and Technology, PR China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, BIOSCI BIOTECH BIOCH, V74, P1564, DOI 10.1271/bbb.100135; Baums CG, 2007, APPL ENVIRON MICROB, V73, P711, DOI 10.1128/AEM.01800-06; Benga L, 2008, VET MICROBIOL, V132, P211, DOI 10.1016/j.vetmic.2008.05.005; Berthelot-Herault F, 2005, CAN J VET RES, V69, P236; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Chen C, 2013, J CLIN MICROBIOL, V51, P2582, DOI 10.1128/JCM.00535-13; de GA, 2011, BMC MICROBIOL, V11, P161; Dominguez-Punaro MD, 2010, INFECT IMMUN, V78, P5074, DOI 10.1128/IAI.00698-10; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; Fittipaldi N, 2009, VET MICROBIOL, V139, P310, DOI 10.1016/j.vetmic.2009.06.024; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; He X, 2006, MICROB PATHOGENESIS, V41, P199, DOI 10.1016/j.micpath.2006.07.001; Hu P, 2011, J BACTERIOL, V193, P3428, DOI 10.1128/JB.05018-11; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Meijerink M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035849; Rasmussen SR, 1999, J CLIN MICROBIOL, V37, P404, DOI 10.1128/JCM.37.2.404-408.1999; Schreur PJW, 2010, VET MICROBIOL, V143, P363, DOI 10.1016/j.vetmic.2009.12.010; Segura M, 2004, INFECT IMMUN, V72, P5322, DOI 10.1128/IAI.72.9.5322-5330.2004; Takamatsu D, 2009, VET MICROBIOL, V138, P132, DOI 10.1016/j.vetmic.2009.02.013; Vecht U, 1996, VET MICROBIOL, V51, P125, DOI 10.1016/0378-1135(96)00028-4; Wu ZW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-219; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Ye CY, 2006, EMERG INFECT DIS, V12, P1203, DOI 10.3201/eid1708.060232; Ye CY, 2009, J INFECT DIS, V199, P97, DOI 10.1086/594370; Zheng H, 2008, CLIN EXP IMMUNOL, V153, P385, DOI 10.1111/j.1365-2249.2008.03722.x; Zheng H, 2013, J MED MICROBIOL, V62, P360, DOI 10.1099/jmm.0.046698-0; Zheng H, 2012, VET MICROBIOL, V156, P147, DOI 10.1016/j.vetmic.2011.10.014; Zheng H, 2011, J NEUROIMMUNOL, V234, P71, DOI 10.1016/j.jneuroim.2011.02.005; Zheng X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017987	30	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87866	10.1371/journal.pone.0087866	http://dx.doi.org/10.1371/journal.pone.0087866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24503649	Green Published, gold, Green Submitted			2022-12-25	WOS:000336971300008
J	Chen, ZG; Wang, JC; Cai, L; Zhong, BL; Luo, HH; Hao, YT; Yu, WH; Wang, BC; Su, CH; Lei, YY; Bella, AE; Xiang, AP; Wang, T				Chen, Zhenguang; Wang, Jiancheng; Cai, Lie; Zhong, Beilong; Luo, Honghe; Hao, Yuantao; Yu, Weihua; Wang, Binchao; Su, Chunhua; Lei, Yiyan; Bella, Amos Ela; Xiang, Andy Peng; Wang, Tao			Role of the Stem Cell-Associated Intermediate Filament Nestin in Malignant Proliferation of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							FORTHCOMING 7TH EDITION; TNM CLASSIFICATION; STAGE GROUPINGS; MARKER NESTIN; CYCLIN D1; EXPRESSION; TUMOR; AKT; STATISTICS; PROPOSALS	Background: Nestin is associated with neoplastic transformation, but the mechanisms by which nestin contributes to invasion and malignancy of lung cancer remain unknown. Considering that proliferation is necessary for malignant behavior, we investigated the mechanism of nestin action in association with the proliferative properties of non-small cell lung cancer (NSCLC). Methods: Nestin expression was examined in NSCLC specimens and cell lines. Associations with clinicopathological features, including prognosis and proliferative markers, were evaluated. Effects of nestin knockdown on proliferation and the signaling pathways involved were further investigated. Results: Nestin was expressed in most cancer specimens and all the tumor cell lines analyzed. High nestin expression in malignant tissue was associated with high Ki-67 or PCNA levels and poor patient outcomes. Conversely, knockdown of nestin expression led to significant inhibition of tumor cell proliferation, decreased colony forming ability, and cell cycle G1 arrest. Furthermore, nestin knockdown resulted in inhibition of Akt and GSK3 beta activation. Conclusions: Our data demonstrate that nestin expression in NSCLC cells is associated with poor prognosis of patients and tumor cell proliferation pathway. Downregulation of nestin efficiently inhibited lung cancer cell proliferation, which might be through affecting cell cycle arrest and Akt-GSK3 beta-Rb signaling pathway.	[Chen, Zhenguang; Luo, Honghe; Su, Chunhua; Lei, Yiyan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Zhenguang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Huangpu Div, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Zhenguang; Luo, Honghe; Su, Chunhua; Lei, Yiyan; Bella, Amos Ela] Sun Yat Sen Univ, Lung Canc Res Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Jiancheng; Yu, Weihua; Xiang, Andy Peng; Wang, Tao] Sun Yat Sen Univ, Ctr Stem Cell Biol & Tissue Engn, Minist Educ, Key Lab Stem Cells & Tissue Engn, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Lie] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Rehabil, Guangzhou 510275, Guangdong, Peoples R China; [Zhong, Beilong] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Thorac Surg, Zhuhai, Guangdong, Peoples R China; [Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Binchao] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [Wang, Binchao] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Bella, Amos Ela] Sun Yat Sen Univ, Ctr Canc, Dept Thorac Surg, Guangzhou 510275, Guangdong, Peoples R China; [Xiang, Andy Peng] Sun Yat Sen Univ, Zhongshan Med Sch, Dept Biochem, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University; Sun Yat Sen University	Chen, ZG (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou 510275, Guangdong, Peoples R China.	chenzhenguang@yahoo.com; wangt69@mail.sysu.edu.cn	Yu, Wei/GZL-3831-2022		National Basic Research Program of China [2009CB522100, 2010CB945400]; National Natural Science Foundation of China [30971675, 30900729, 31171398]; Key Scientific and Technological Projects of Guangdong Province [2007A032100003]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific and Technological Projects of Guangdong Province	This study was supported by grants from the National Basic Research Program of China (No. 2009CB522100 and 2010CB945400), the National Natural Science Foundation of China (No. 30971675, 30900729, and 31171398), and the Key Scientific and Technological Projects of Guangdong Province (No. 2007A032100003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Amoh Y, 2005, CANCER RES, V65, P5352, DOI 10.1158/0008-5472.CAN-05-0821; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Brychtova S, 2007, J CUTAN PATHOL, V34, P370, DOI 10.1111/j.1600-0560.2006.00627.x; Chen ZG, 2010, HUM PATHOL, V41, P737, DOI 10.1016/j.humpath.2009.10.018; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; D'Addario G, 2009, ANN ONCOL, V20, P68, DOI 10.1093/annonc/mdp132; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; FLORENES VA, 1994, CANCER RES, V54, P354; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Groome PA, 2007, J THORAC ONCOL, V2, P694, DOI 10.1097/JTO.0b013e31812d05d5; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kleeberger W, 2007, CANCER RES, V67, P9199, DOI 10.1158/0008-5472.CAN-07-0806; Klein WM, 2007, MODERN PATHOL, V20, P102, DOI 10.1038/modpathol.3800720; Li H, 2007, CANCER RES, V67, P501, DOI 10.1158/0008-5472.CAN-05-4571; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Lodish H., 2008, MOL CELL BIOL, V6th ed.; Mangiola A, 2007, CLIN CANCER RES, V13, P6970, DOI 10.1158/1078-0432.CCR-07-1229; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsuda Y, 2011, CANCER BIOL THER, V11, P1; Mokry J, 2004, STEM CELLS DEV, V13, P658, DOI 10.1089/scd.2004.13.658; Ohike N, 2007, PATHOL INT, V57, P589, DOI 10.1111/j.1440-1827.2007.02143.x; Pallari HM, 2006, SCI STKE, V2006, ppe53; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rani SB, 2006, INDIAN J MED RES, V124, P269; Ryuge S, 2011, CHEST, V139, P862, DOI 10.1378/chest.10-1121; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; SEJERSEN T, 1993, J CELL SCI, V106, P1291; Shimizu T, 2006, NEUROL MED-CHIR, V46, P111, DOI 10.2176/nmc.46.111; Suzuki S, 2010, J HISTOCHEM CYTOCHEM, V58, P721, DOI 10.1369/jhc.2010.955609; Thomas SK, 2004, J BIOL CHEM, V279, P27994, DOI 10.1074/jbc.M312663200; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Wei LC, 2008, BRAIN RES, V1196, P103, DOI 10.1016/j.brainres.2007.11.026; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Yan SC, 2001, J CELL PHYSIOL, V186, P338, DOI 10.1002/1097-4652(2000)9999:9999<000::AID-JCP1032>3.0.CO;2-B; Yang H, 2006, INT J CANCER, V119, P2304, DOI 10.1002/ijc.22154; Yang XH, 2008, J CLIN PATHOL, V61, P467, DOI 10.1136/jcp.2007.047605; You H, 2005, J NEURO-ONCOL, V74, P1, DOI 10.1007/s11060-004-2354-2	42	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e85584	10.1371/journal.pone.0085584	http://dx.doi.org/10.1371/journal.pone.0085584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498263	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900009
J	Jafree, HA; Imtiaz, M; Inayatullah, S; Khan, FH; Nizami, T				Jafree, Hafsa Athar; Imtiaz, Muhammad; Inayatullah, Syed; Khan, Fozia Hanif; Nizami, Tajuddin			A Space Efficient Flexible Pivot Selection Approach to Evaluate Determinant and Inverse of a Matrix (Publication with Expression of Concern. See vol. 11, 2016)	PLOS ONE			English	Article; Publication with Expression of Concern								This paper presents new simple approaches for evaluating determinant and inverse of a matrix. The choice of pivot selection has been kept arbitrary thus they reduce the error while solving an ill conditioned system. Computation of determinant of a matrix has been made more efficient by saving unnecessary data storage and also by reducing the order of the matrix at each iteration, while dictionary notation [1] has been incorporated for computing the matrix inverse thereby saving unnecessary calculations. These algorithms are highly class room oriented, easy to use and implemented by students. By taking the advantage of flexibility in pivot selection, one may easily avoid development of the fractions by most. Unlike the matrix inversion method [2] and [3], the presented algorithms obviate the use of permutations and inverse permutations.	[Jafree, Hafsa Athar; Imtiaz, Muhammad; Inayatullah, Syed] Univ Karachi, Dept Math Sci, Karachi, Pakistan; [Khan, Fozia Hanif] Sir Syed Univ Engn & Technol, Dept Math, Karachi, Pakistan; [Nizami, Tajuddin] Iqra Univ, Dept Math, Karachi, Pakistan	University of Karachi; Sir Syed University of Engineering & Technology; Iqra University	Jafree, HA (corresponding author), Univ Karachi, Dept Math Sci, Karachi, Pakistan.	hajafree@uok.edu.pk		Inayatullah, Syed/0000-0002-8576-4653				Anton H., 2005, ELEMENTARY LINEAR AL, V9th ed.; Augustin CL, 1815, MEMOIRE FONCTIONS QU; Chvatal V., 1983, LINEAR PROGRAMMING; Cramer G, 1750, INTRO ANAL ALGEBRAIC; Farooq Ahmad, 2010, International Journal of Technology Diffusion, V1, P36, DOI 10.4018/jtd.2010040102; Farooq Ahmad, 2010, International Journal of Technology Diffusion, V1, P20, DOI 10.4018/jtd.2010010102; GREENBERG BG, 1959, J AM STAT ASSOC, V54, P755; Higham NJ, 2011, GAUSSIAN ELIMINATION, P230; Kuttler K, 2013, LINEAR ALGEBRA THEOR; Maclaurin C, 1748, TREATISE ALGEBRA; Rice A, 2006, MATH HORIZONS, P12; Vellaikannan B, 2010, INT J COMP TECH APPL, P78	12	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87219	10.1371/journal.pone.0087219	http://dx.doi.org/10.1371/journal.pone.0087219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498300	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900046
J	Kilic, G; Alvarez-Mercado, AI; Zarrouki, B; Opland, D; Liew, CW; Alonso, LC; Myers, MG; Jonas, JC; Poitout, V; Kulkarni, RN; Mauvais-Jarvis, F				Kilic, Gamze; Alvarez-Mercado, Ana I.; Zarrouki, Bader; Opland, Darren; Liew, Chong Wee; Alonso, Laura C.; Myers, Martin G., Jr.; Jonas, Jean-Christophe; Poitout, Vincent; Kulkarni, Rohit N.; Mauvais-Jarvis, Franck			The Islet Estrogen Receptor-alpha Is Induced by Hyperglycemia and Protects Against Oxidative Stress-Induced Insulin-Deficient Diabetes	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; GLUCOSE-HOMEOSTASIS; INDUCED APOPTOSIS; ACTIVATION; MICE; MECHANISMS; EXPRESSION; SURVIVAL; ENERGY; MODEL	The female steroid, 17 beta-estradiol (E2), is important for pancreatic beta-cell function and acts via at least three estrogen receptors (ER), ER alpha, ER beta, and the G-protein coupled ER (GPER). Using a pancreas-specific ER alpha knockout mouse generated using the Cre-lox-P system and a Pdx1-Cre transgenic line (PER alpha KO-/-), we previously reported that islet ER alpha suppresses islet glucolipotoxicity and prevents beta-cell dysfunction induced by high fat feeding. We also showed that E2 acts via ER alpha to prevent beta-cell apoptosis in vivo. However, the contribution of the islet ER alpha to beta-cell survival in vivo, without the contribution of ER alpha in other tissues is still unclear. Using the PER alpha KO-/- mouse, we show that ER alpha mRNA expression is only decreased by 20% in the arcuate nucleus of the hypothalamus, without a parallel decrease in the VMH, making it a reliable model of pancreas-specific ER alpha elimination. Following exposure to alloxan-induced oxidative stress in vivo, female and male PER alpha KO-/- mice exhibited a predisposition to beta-cell destruction and insulin deficient diabetes. In male PER alpha KO-/- mice, exposure to E2 partially prevented alloxan-induced beta-cell destruction and diabetes. ER alpha mRNA expression was induced by hyperglycemia in vivo in islets from young mice as well as in cultured rat islets. The induction of ER alpha mRNA by hyperglycemia was retained in insulin receptor-deficient beta-cells, demonstrating independence from direct insulin regulation. These findings suggest that induction of ER alpha expression acts to naturally protect beta-cells against oxidative injury.	[Kilic, Gamze; Mauvais-Jarvis, Franck] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Alvarez-Mercado, Ana I.; Mauvais-Jarvis, Franck] Tulane Univ, Sch Med, Dept Med, Div Endocrinol & Metab,Hlth Sci Ctr, New Orleans, LA 70112 USA; [Zarrouki, Bader; Poitout, Vincent] Univ Montreal, CRCHUM, Montreal Diabet Res Ctr, Montreal, PQ, Canada; [Zarrouki, Bader; Poitout, Vincent] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Opland, Darren; Myers, Martin G., Jr.] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Liew, Chong Wee; Kulkarni, Rohit N.] Joslin Diabet Ctr, Sect Islet Cell Biol & Regenerat Med, Boston, MA 02215 USA; [Liew, Chong Wee; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Boston, MA USA; [Alonso, Laura C.] Univ Massachusetts, Sch Med, Dept Med, Div Diabet, Worcester, MA USA; [Jonas, Jean-Christophe] Catholic Univ Louvain, Inst Clin & Expt Res, Brussels, Belgium	Northwestern University; Feinberg School of Medicine; Tulane University; Universite de Montreal; Universite de Montreal; University of Michigan System; University of Michigan; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Universite Catholique Louvain	Mauvais-Jarvis, F (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA.	fmauvais@tulane.edu	Jonas, Jean-Christophe/C-6766-2011; Álvarez Mercado, Ana/C-3466-2019	Jonas, Jean-Christophe/0000-0001-9882-5438; Álvarez Mercado, Ana/0000-0002-8476-9970; Poitout, Vincent/0000-0002-6555-5053; Liew, Chong Wee/0000-0001-9904-0958	National Institutes of Health [RO1 DK074970]; Canadian Institutes of Health Research [MOP 77686]; Eli Lilly; Fonds de la Recherche Scientifique-FNRS, Belgium;  [R01DK58096];  [RO1DK095140];  [RO1DK67536]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074970, R01DK058096, R01DK067536, R01DK095140, P30DK020572, R00DK090210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Eli Lilly(Eli Lilly); Fonds de la Recherche Scientifique-FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS); ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by National Institutes of Health (RO1 DK074970) to FMJ. Fig. 5A was funded by R01DK58096 to VP and the Canadian Institutes of Health Research (MOP 77686 to VP) and a postdoctoral fellowship from Eli Lilly to BZ. Fig. 5 C was supported by the Fonds de la Recherche Scientifique-FNRS, Belgium to JCJ. Fig. 5B was supported by RO1DK095140 to LCA. Fig. 5D was supported by RO1DK67536 to RNK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Balhuizen A, 2010, MOL CELL ENDOCRINOL, V320, P16, DOI 10.1016/j.mce.2010.01.030; Baquie M, 2011, HUM MOL GENET, V20, P2823, DOI 10.1093/hmg/ddr193; Brendel A, 2013, RESTOR NEUROL NEUROS, V31, P199, DOI 10.3233/RNN-120272; Chuang JC, 2008, MOL ENDOCRINOL, V22, P2353, DOI 10.1210/me.2007-0568; Clegg DJ, 2012, MOL ENDOCRINOL, V26, P1957, DOI 10.1210/me.2012-1284; Contreras JL, 2002, TRANSPLANTATION, V74, P1252, DOI 10.1097/00007890-200211150-00010; Duprez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046831; Ferriere F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069081; Fontes G, 2010, DIABETOLOGIA, V53, P2369, DOI 10.1007/s00125-010-1850-5; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Liu S, 2013, DIABETOLOGIA, V56, P370, DOI 10.1007/s00125-012-2764-1; Liu SH, 2009, ISLETS, V1, P273, DOI 10.4161/isl.1.3.9781; Liu SH, 2009, DIABETES, V58, P2292, DOI 10.2337/db09-0257; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Munzberg H, 2007, J NEUROSCI, V27, P69, DOI 10.1523/JNEUROSCI.3168-06.2007; Ropero AB, 2008, STEROIDS, V73, P874, DOI 10.1016/j.steroids.2007.12.018; Tiano JP, 2012, NAT REV ENDOCRINOL, V8, P342, DOI 10.1038/nrendo.2011.242; Tiano JP, 2011, J CLIN INVEST, V121, P3331, DOI 10.1172/JCI44564; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107	25	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87941	10.1371/journal.pone.0087941	http://dx.doi.org/10.1371/journal.pone.0087941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498408	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900154
J	Oh, SI; Park, A; Kim, HJ; Oh, KW; Choi, H; Kwon, MJ; Ki, CS; Kim, HT; Kim, SH				Oh, Seong-il; Park, Aram; Kim, Hee-Jin; Oh, Ki-Wook; Choi, Hojin; Kwon, Min-Jung; Ki, Chang-Seok; Kim, Hee-Tae; Kim, Seung Hyun			Spectrum of Cognitive Impairment in Korean ALS Patients without Known Genetic Mutations	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL DEMENTIA; HEXANUCLEOTIDE REPEAT; ALZHEIMERS-DISEASE; BEHAVIORAL-CHANGES; NORMATIVE DATA; DYSFUNCTION; DIAGNOSIS; C9ORF72; VERSION	Background: Cognitive impairment is associated with a negative prognosis in amyotrophic lateral sclerosis (ALS), as well as with clinical specificity. We investigate neuropsychological function in ALS patients without known genetic mutations in a Korean tertiary clinic. Methods: Three hundred and eighteen patients were enrolled in a prospective longitudinal cohort from September 2008 to February 2012. At the time of diagnosis of sporadic ALS, we carried out genetic and comprehensive neuropsychological tests on all patients, and collected demographic and clinical characteristics. Six cognitive domains, namely executive function, attention, language, calculation, visuospatial function and memory were evaluated. ANOVA and t-tests were used to assess differences in clinical characteristics and neuropsychological parameters between sporadic ALS patients. The Kaplan-Meier method and Cox proportional hazard model were used for survival analysis. Results: One hundred and sixty-six patients were categorized into five subtypes: normal cognition (ALS pure), cognitive impairment (ALSci), behavioral impairment (ALSbi), frontotemporal dementia (ALS-FTD), and other types of dementia. Seventy patients (70/166, 42.2%) were cognitively or behaviorally impaired. Among the impaired patients, eight (8/166, 4.8%) had FTD-type dementia and one (1/166, 0.6%) was Alzheimer's disease-type. The ALS patients with cognitive impairment (ALSci) and with FTD (ALS-FTD) were more severely impaired in executive function, attention, language and memory than the cognitively intact ALS patients (ALS pure). In a survival analysis, ALSci (beta = 1.925, p = 0.025) and ALS-FTD groups (beta = 4.150, p = 0.019) tended to have shorter survival than the ALS pure group. Conclusions: About half of ALS patients without known genetic variation have cognitive or behavioral impairment. ALS patients with cognitive abnormalities, especially FTD, have a poorer prognosis than those without cognitive impairment. In neuropsychological profiling, executive tasks were effective in identifying cognitive impairment in the ALS patients. It would be useful for clinicians to classify ALS according to neuropsychological profiles, and screen for subtle cognitive impairment.	[Oh, Seong-il; Park, Aram; Kim, Hee-Jin; Oh, Ki-Wook; Choi, Hojin; Kim, Hee-Tae; Kim, Seung Hyun] Hanyang Univ, Coll Med, Dept Neurol, Seoul 133791, South Korea; [Kwon, Min-Jung] Univ Sch Med, Kangbuk Samsung Hosp, Dept Lab Med, Seoul, South Korea; [Ki, Chang-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea	Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, SH (corresponding author), Hanyang Univ, Coll Med, Dept Neurol, Seoul 133791, South Korea.	kimsh1@hanyang.ac.kr	Ki, Chang-Seok/G-7559-2014; Kim, Seung Hyun/T-5133-2017; Oh, Seong-il/A-8790-2019; ki, cs/O-5931-2014; Oh, Ki-wook/E-6996-2017	Ki, Chang-Seok/0000-0001-7679-8731; Kim, Seung Hyun/0000-0001-9644-9598; Oh, Seong-il/0000-0002-8067-2135; Oh, Ki-wook/0000-0001-6011-629X	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A120182]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A120182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SW, 2011, CAN J NEUROL SCI, V38, P242, DOI 10.1017/S0317167100011409; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Bae JS, 2012, J CLIN NEUROL, V8, P293, DOI 10.3988/jcn.2012.8.4.293; Barson FP, 2000, J NEUROL SCI, V180, P107, DOI 10.1016/S0022-510X(00)00413-5; Benton A.L., 1994, CONTRIBUTIONS NEUROP; Brandt J, 2001, HOPKINS VERBAL LEARN, Vv; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Byrne S, 2012, LANCET NEUROL, V11, P232, DOI 10.1016/S1474-4422(12)70014-5; Chin J, 2012, CLIN NEUROPSYCHOL, V26, P224, DOI 10.1080/13854046.2012.658865; Chio A, 2010, EUR J NEUROL, V17, P1298, DOI 10.1111/j.1468-1331.2010.03016.x; Chio A, 2012, NEUROLOGY, V79, P1983, DOI 10.1212/WNL.0b013e3182735d36; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Floris G, 2012, AMYOTROPH LATERAL SC, V13, P95, DOI 10.3109/17482968.2011.605453; Gibbons ZC, 2008, AMYOTROPH LATERAL SC, V9, P67, DOI 10.1080/17482960701642437; Gordon PH, 2011, AMYOTROPH LATERAL SC, V12, P372, DOI 10.3109/17482968.2011.580847; Gordon PH, 2010, AMYOTROPH LATERAL SC, V11, P312, DOI 10.3109/17482961003622585; Gordon PH, 2004, AMYOTROPH LATERAL SC, V5, P90, DOI 10.1080/17434470410019906; Hamilton RL, 2004, ACTA NEUROPATHOL, V107, P515, DOI 10.1007/s00401-004-0843-1; Hu WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057584; Jang JH, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.09.004; Kang SJ, 2004, J GERIATR PSYCH NEUR, V17, P32, DOI 10.1177/089198873258818; Kang Y, 2012, SEOUL NEUROPSYCHOLOG, V2nd; Kang Yeonwook, 2006, [Korean Journal of Psychology: General, 한국심리학회지:일반], V25, P1; Kawamura Mitsuru, 2007, Brain and Nerve (Tokyo), V59, P1083; Kim H, 2004, J CLIN EXP NEUROPSYC, V26, P1011, DOI 10.1080/13803390490515397; Kim HH, 1999, J CLIN EXP NEUROPSYC, V21, P127, DOI 10.1076/jcen.21.1.127.942; 백원기, 2011, [Journal of the Korean Neurological Association, 대한신경과학회지], V29, P16; Kim JY, 2008, PSYCHIAT INVEST, V5, P232, DOI 10.4306/pi.2008.5.4.232; Kim JK, 1999, CLIN NEUROPSYCHOL, V13, P365, DOI 10.1076/clin.13.3.365.1740; Kimura F, 2006, NEUROLOGY, V66, P265, DOI 10.1212/01.wnl.0000194316.91908.8a; Kwon MJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.003; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Merrilees J, 2010, AMYOTROPH LATERAL SC, V11, P298, DOI 10.3109/17482961003605788; Meyers J E, 1996, Appl Neuropsychol, V3, P89, DOI 10.1207/s15324826an0302_8; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Olney RK, 2005, NEUROLOGY, V65, P1774, DOI 10.1212/01.wnl.0000188759.87240.8b; Park HK, 2011, J NEUROL SCI, V301, P12, DOI 10.1016/j.jns.2010.11.017; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Raaphorst J, 2012, AMYOTROPH LATERAL SC, V13, P493, DOI 10.3109/17482968.2012.656652; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Rippon GA, 2006, ARCH NEUROL-CHICAGO, V63, P345, DOI 10.1001/archneur.63.3.345; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rusina R, 2007, EUR J NEUROL, V14, P815, DOI 10.1111/j.1468-1331.2007.01759.x; Schreiber H, 2005, J NEUROL, V252, P772, DOI 10.1007/s00415-005-0739-6; Seo EH, 2008, INT J GERIATR PSYCH, V23, P1020, DOI 10.1002/gps.2027; Sha SJ, 2012, NEUROLOGY, V79, P1002, DOI 10.1212/WNL.0b013e318268452e; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Taylor LJ, 2013, J NEUROL NEUROSUR PS, V84, P494, DOI 10.1136/jnnp-2012-303526; Terada T, 2011, J NEUROL SCI, V309, P136, DOI 10.1016/j.jns.2011.06.049; Tsermentseli S, 2012, CORTEX, V48, P166, DOI 10.1016/j.cortex.2011.02.004; Tsuji-Akimoto S, 2010, J NEUROL, V257, P2071, DOI 10.1007/s00415-010-5662-9; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Varnum MEW, 2010, CURR DIR PSYCHOL SCI, V19, P9, DOI 10.1177/0963721409359301; Wilson RS, 2009, NEUROLOGY, V72, P460, DOI 10.1212/01.wnl.0000341782.71418.6c; Zago S, 2011, ARCH ITAL BIOL, V149, P39, DOI 10.4449/aib.v149i1.1263	61	34	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87163	10.1371/journal.pone.0087163	http://dx.doi.org/10.1371/journal.pone.0087163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498297	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900043
J	Zhu, LY; Xu, Q; Jiang, L; Huang, H; Li, S				Zhu, Lingyan; Xu, Qing; Jiang, Ling; Huang, He; Li, Shuang			Polydiacetylene-Based High-Throughput Screen for Surfactin Producing Strains of Bacillus subtilis	PLOS ONE			English	Article							COLORIMETRIC DETECTION; BIOSURFACTANT PRODUCTION; POTENTIAL APPLICATIONS; MICROBIAL SURFACTANTS; PDA LIPOSOMES; VESICLES; MICROORGANISMS; TEMPERATURE; ISOFORMS; ROLES	Although traditional mutation is still an attractive approach for strain improvement, it is tedious, time-consuming, and inefficient to screen for surfactin producing strains. To overcome this, we developed a high-throughput screening method for surfactin producing mutants by applying polydiacetylene (PDA) vesicles as sensors with visible chromatic change from blue to red, detected as colorimetric response (CR%) signal, which can even semi-quantify the yields of surfactin. Bacillus subtilis 723 was used as parent strain and multiply mutated with atmospheric and room temperature plasma (ARTP). Mutants were cultured in MicroFlask by Duetz (24 square deepwell plates, Applikon Biotechnology) and surfactin titers were tested in 96-well plates with PDA vesicles. Mutants with surfactin titers above 150 mg/L (CR% value above 26%) were selected as high-yield strains and further quantified by HPLC. By integrating MicroFlask cultivation and the PDA vesicles detection, we screened 27,000 mutants and found 37 high-yield strains. From these, one mutant produced 473.6 mg/L surfactin (including 353.1 mg/L C-15 surfactin), which was 5.4-fold than that of the parent strain. This method is efficient, cost-effective and provides wider application in screening for various surfactants.	[Zhu, Lingyan; Xu, Qing; Huang, He; Li, Shuang] Nanjing Univ Technol, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Jiang, Ling] Nanjing Univ Technol, Coll Food Sci & Light Ind, Nanjing, Jiangsu, Peoples R China	Nanjing Tech University; Nanjing Tech University	Huang, H (corresponding author), Nanjing Univ Technol, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China.	biotech@njtech.edu.cn; lishuang@njtech.end.cn			National Basic Research Program of China (973 Plan) [2011CB710800]; National High Technology Research and Development Program of China (863 Plan) [2012AA021700]; National Science Foundation for Distinguished Young Scholars of China [21225626]	National Basic Research Program of China (973 Plan)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Plan)(National High Technology Research and Development Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the National Basic Research Program of China (973 Plan) (Grant No. 2011CB710800), the National High Technology Research and Development Program of China (863 Plan) (No. 2012AA021700), National Science Foundation for Distinguished Young Scholars of China (No. 21225626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Banat IM, 2000, APPL MICROBIOL BIOT, V53, P495, DOI 10.1007/s002530051648; Bodour AA, 1998, J MICROBIOL METH, V32, P273, DOI 10.1016/S0167-7012(98)00031-1; Burch AY, 2010, APPL ENVIRON MICROB, V76, P5363, DOI 10.1128/AEM.00592-10; Cameotra SS, 2004, CURR OPIN MICROBIOL, V7, P262, DOI 10.1016/j.mib.2004.04.006; Charoenthai N, 2011, J COLLOID INTERF SCI, V360, P565, DOI 10.1016/j.jcis.2011.04.109; CHARYCH DH, 1993, SCIENCE, V261, P585, DOI 10.1126/science.8342021; Chen CY, 2007, J MICROBIOL METH, V70, P503, DOI 10.1016/j.mimet.2007.06.006; Chen X, 2009, CHEM COMMUN, P1356, DOI 10.1039/b820894h; Deleu M, 2003, LANGMUIR, V19, P3377, DOI 10.1021/la026543z; Haddad NIA, 2008, PROTEIN PEPTIDE LETT, V15, P265, DOI 10.2174/092986608783744225; Jung YK, 2008, ADV FUNCT MATER, V18, P701, DOI 10.1002/adfm.200700929; Jung YK, 2010, ADV FUNCT MATER, V20, P3092, DOI 10.1002/adfm.201001008; JungaJou M, 2009, CHEM COMMUN, P3434; Kew SJ, 2006, ANAL CHEM, V78, P2231, DOI 10.1021/ac0517794; Kracht M, 1999, J ANTIBIOT, V52, P613, DOI 10.7164/antibiotics.52.613; Lee HY, 2011, SOFT MATTER, V7, P3273, DOI 10.1039/c0sm01243b; Lee NY, 2006, BIOCHEM ENG J, V29, P103, DOI 10.1016/j.bej.2005.02.025; Lee S, 2013, ACS APPL MATER INTER, V5, P4521, DOI 10.1021/am3030245; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034430; Lu Y, 2011, BIOCHEM ENG J, V55, P17, DOI 10.1016/j.bej.2011.02.020; MULLIGAN CN, 1989, APPL MICROBIOL BIOT, V31, P486, DOI 10.1007/BF00270781; Pecci Y, 2010, J MASS SPECTROM, V45, P772, DOI 10.1002/jms.1767; PEYPOUX F, 1991, EUR J BIOCHEM, V202, P101, DOI 10.1111/j.1432-1033.1991.tb16349.x; Potisatityuenyong A, 2008, LANGMUIR, V24, P4461, DOI 10.1021/la800354q; Razafindralambo H, 2004, J SURFACTANTS DETERG, V7, P41, DOI 10.1007/s11743-004-0286-x; Rodrigues L, 2006, J ANTIMICROB CHEMOTH, V57, P609, DOI 10.1093/jac/dkl024; Ron EZ, 2001, ENVIRON MICROBIOL, V3, P229, DOI 10.1046/j.1462-2920.2001.00190.x; Singh P, 2004, TRENDS BIOTECHNOL, V22, P142, DOI 10.1016/j.tibtech.2004.01.010; Su YL, 2004, COLLOID SURFACE B, V38, P29, DOI 10.1016/j.colsurfb.2004.08.010; Thongmalai W, 2011, J MATER CHEM, V21, P16391, DOI 10.1039/c1jm12795k; WILSON TE, 1994, LANGMUIR, V10, P1512, DOI 10.1021/la00017a031; Yoneda T, 2001, J COSMET SCI, V52, P153; Yoon B, 2009, CHEM SOC REV, V38, P1958, DOI 10.1039/b819539k; Youssef NH, 2004, J MICROBIOL METH, V56, P339, DOI 10.1016/j.mimet.2003.11.001	35	11	14	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88207	10.1371/journal.pone.0088207	http://dx.doi.org/10.1371/journal.pone.0088207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498439	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900185
J	Bandyopadhyay, D; Cyphersmith, A; Zapata, JA; Kim, YJ; Payne, CK				Bandyopadhyay, Debjyoti; Cyphersmith, Austin; Zapata, Jairo A.; Kim, Y. Joseph; Payne, Christine K.			Lysosome Transport as a Function of Lysosome Diameter	PLOS ONE			English	Article							CARGO TRANSPORT; LIVING CELLS; LIVE-CELL; IN-VIVO; MOTORS; CYTOPLASM; POLARIZATION; MICROTUBULES; TRAFFICKING; VISCOSITY	Lysosomes are membrane-bound organelles responsible for the transport and degradation of intracellular and extracellular cargo. The intracellular motion of lysosomes is both diffusive and active, mediated by motor proteins moving lysosomes along microtubules. We sought to determine how lysosome diameter influences lysosome transport. We used osmotic swelling to double the diameter of lysosomes, creating a population of enlarged lysosomes. This allowed us to directly examine the intracellular transport of the same organelle as a function of diameter. Lysosome transport was measured using live cell fluorescence microscopy and single particle tracking. We find, as expected, the diffusive component of intracellular transport is decreased proportional to the increased lysosome diameter. Active transport of the enlarged lysosomes is not affected by the increased lysosome diameter.	[Payne, Christine K.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Payne, CK (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	christine.payne@chemistry.gatech.edu			National Institutes of Health (NIH) [1DP2OD006470]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006470] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a National Institutes of Health (NIH) Director's New Innovator Award (to CKP, 1DP2OD006470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 1994, MOL BIOL CELL; ALLEN RD, 1982, SCIENCE, V218, P1127, DOI 10.1126/science.6183744; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Bakker AC, 1997, J CELL SCI, V110, P2227; Balint S, 2013, P NATL ACAD SCI USA, V110, P3375, DOI 10.1073/pnas.1219206110; Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; COHN ZA, 1969, J EXP MED, V129, P201, DOI 10.1084/jem.129.1.201; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; DECOURCY K, 1991, EXP CELL RES, V192, P52, DOI 10.1016/0014-4827(91)90156-O; FERRIS AL, 1987, J CELL BIOL, V105, P2703, DOI 10.1083/jcb.105.6.2703; FUSHIMI K, 1991, J CELL BIOL, V112, P719, DOI 10.1083/jcb.112.4.719; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Hill DB, 2004, EUR BIOPHYS J BIOPHY, V33, P623, DOI 10.1007/s00249-004-0403-6; Humphries WH, 2010, INTEGR BIOL-UK, V2, P536, DOI 10.1039/c0ib00035c; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Kole TP, 2004, MOL BIOL CELL, V15, P3475, DOI 10.1091/mbc.E04-03-0218; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Leduc C, 2011, ACS NANO, V5, P2587, DOI 10.1021/nn1023285; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Leijnse N, 2012, EUR PHYS J-SPEC TOP, V204, P75, DOI 10.1140/epjst/e2012-01553-y; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; LUBYPHELPS K, 1993, BIOPHYS J, V65, P236, DOI 10.1016/S0006-3495(93)81075-0; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Martinez JE, 2007, BIOCHEM BIOPH RES CO, V353, P835, DOI 10.1016/j.bbrc.2006.12.120; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Selhuber-Unkel C, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025015; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; STEINMAN RM, 1976, J CELL BIOL, V68, P665, DOI 10.1083/jcb.68.3.665; Szymanski CJ, 2011, ANALYST, V136, P3527, DOI 10.1039/c0an00855a; Yum K, 2009, NANO LETT, V9, P2193, DOI 10.1021/nl901047u	35	82	84	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86847	10.1371/journal.pone.0086847	http://dx.doi.org/10.1371/journal.pone.0086847			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497985	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900042
J	Hermant, P; Demarez, C; Mahlakoiv, T; Staeheli, P; Meuleman, P; Michiels, T				Hermant, Pascale; Demarez, Celine; Mahlakoiv, Tanel; Staeheli, Peter; Meuleman, Philip; Michiels, Thomas			Human but Not Mouse Hepatocytes Respond to Interferon-Lambda In Vivo	PLOS ONE			English	Article							HEPATITIS-C VIRUS; IFN-LAMBDA; GENE-EXPRESSION; INFLUENZA-VIRUS; K-RAS; MICE; REPLICATION; CELLS; ACTIVATION; PROTEINS	The type III interferon (IFN) receptor is preferentially expressed by epithelial cells. It is made of two subunits: IFNLR1, which is specific to IFN-lambda (IFN-lambda) and IL10RB, which is shared by other cytokine receptors. Human hepatocytes express IFNLR1 and respond to IFN-lambda. In contrast, the IFN-lambda response of the mouse liver is very weak and IFNLR1 expression is hardly detectable in this organ. Here we investigated the IFN-lambda response at the cellular level in the mouse liver and we tested whether human and mouse hepatocytes truly differ in responsiveness to IFN-lambda. When monitoring expression of the IFN-responsive Mx genes by immunohistofluorescence, we observed that the IFN-lambda response in mouse livers was restricted to cholangiocytes, which form the bile ducts, and that mouse hepatocytes were indeed not responsive to IFN-lambda. The lack of mouse hepatocyte response to IFN-lambda was observed in different experimental settings, including the infection with a hepatotropic strain of influenza A virus which triggered a strong local production of IFN-lambda. With the help of chimeric mice containing transplanted human hepatocytes, we show that hepatocytes of human origin readily responded to IFN-lambda in a murine environment. Thus, our data suggest that human but not mouse hepatocytes are responsive to IFN-lambda in vivo. The non-responsiveness is an intrinsic property of mouse hepatocytes and is not due to the mouse liver micro-environment.	[Hermant, Pascale; Demarez, Celine; Michiels, Thomas] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Mahlakoiv, Tanel; Staeheli, Peter] Univ Med Ctr Freiburg, Inst Virol, Freiburg, Germany; [Mahlakoiv, Tanel] Univ Med Ctr Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany; [Meuleman, Philip] Ghent Univ & Hosp, Dept Clin Chem Microbiol & Immunol, Ctr Vaccinol, Ghent, Belgium	Universite Catholique Louvain; University of Freiburg; University of Freiburg; Ghent University; Ghent University Hospital	Michiels, T (corresponding author), Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium.	thomas.michiels@uclouvain.be	Michiels, Thomas/ABE-3203-2021; Meuleman, Philip/H-2899-2013	Michiels, Thomas/0000-0001-9615-8053; Meuleman, Philip/0000-0001-6821-234X; Mahlakoiv, Tanel/0000-0001-9059-0486	National Fund for Scientific Research (FNRS-FRSM); Research Foundation Flanders (FWO) [3G052112]; Ghent University (GOA) [01G01712]; Action de Recherche Concertee (ARC) of the French Community of Belgium; Interuniversitary Attraction Poles programme; Belgian Science Policy Office [PAI-P7/45 BELVIR, IAP-P7/47-HEPRO2]; Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School)	National Fund for Scientific Research (FNRS-FRSM)(Fonds de la Recherche Scientifique - FNRS); Research Foundation Flanders (FWO)(FWO); Ghent University (GOA)(Ghent University); Action de Recherche Concertee (ARC) of the French Community of Belgium; Interuniversitary Attraction Poles programme; Belgian Science Policy Office(Belgian Federal Science Policy Office); Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School)	P.H. was a research assistant with the Universite catholique de Louvain (UCL). This work was supported by the National Fund for Scientific Research (FNRS-FRSM), by the Research Foundation Flanders (FWO project #3G052112), by the Ghent University (GOA #01G01712), by the Action de Recherche Concertee (ARC) of the French Community of Belgium and by the Interuniversitary Attraction Poles programme initiated by the Belgian Science Policy Office (PAI-P7/45 BELVIR and IAP-P7/47-HEPRO2). TaM was supported in part by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Dickensheets H, 2013, J LEUKOCYTE BIOL, V93, P377, DOI 10.1189/jlb.0812395; Diegelmann J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015200; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Dumoutier L, 2003, BIOCHEM J, V370, P391, DOI 10.1042/BJ20021935; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; HALLER O, 1975, ARCH VIROL, V49, P99, DOI 10.1007/BF01317530; HECKEL JL, 1990, CELL, V62, P447, DOI 10.1016/0092-8674(90)90010-C; HORISBERGER MA, 1987, J GEN VIROL, V68, P945, DOI 10.1099/0022-1317-68-3-945; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; MEIER E, 1988, J VIROL, V62, P2386, DOI 10.1128/JVI.62.7.2386-2393.1988; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; Nakagawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059611; O'Connor KA, 2006, CLIN IMMUNOL, V120, P319, DOI 10.1016/j.clim.2006.05.011; Pagliaccetti NE, 2010, VIROLOGY, V401, P197, DOI 10.1016/j.virol.2010.02.022; Paul S, 2006, J GEN VIROL, V87, P1237, DOI 10.1099/vir.0.81642-0; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; Tyrrell DA, 1959, NATURE S7, P452; van Pesch V, 2004, J VIROL, V78, P8219, DOI 10.1128/JVI.78.15.8219-8228.2004; VEOMETT MJ, 1979, J VIROL, V31, P785, DOI 10.1128/JVI.31.3.785-794.1979; Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	34	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87906	10.1371/journal.pone.0087906	http://dx.doi.org/10.1371/journal.pone.0087906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498220	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900191
J	Hotop, SK; Abd El Wahed, A; Beutling, U; Jentsch, D; Motzkus, D; Frank, R; Hunsmann, G; Stahl-Hennig, C; Fritz, HJ				Hotop, Sven-Kevin; Abd El Wahed, Ahmed; Beutling, Ulrike; Jentsch, Dieter; Motzkus, Dirk; Frank, Ronald; Hunsmann, Gerhard; Stahl-Hennig, Christiane; Fritz, Hans-Joachim			Multiple Antibody Targets on Herpes B Glycoproteins B and D Identified by Screening Sera of Infected Rhesus Macaques with Peptide Microarrays	PLOS ONE			English	Article							C-TERMINAL TAIL; VIRUS CERCOPITHECINE-HERPESVIRUS-1; DOMAIN; MONKEY; SEQUENCE; PROTEIN; REVEAL	Herpes B virus (or Herpesvirus simiae or Macacine herpesvirus 1) is endemic in many populations of macaques, both in the wild and in captivity. The virus elicits only mild clinical symptoms (if any) in monkeys, but can be transmitted by various routes, most commonly via bites, to humans where it causes viral encephalitis with a high mortality rate. Hence, herpes B constitutes a considerable occupational hazard for animal caretakers, veterinarians and laboratory personnel. Efforts are therefore being made to reduce the risk of zoonotic infection and to improve prognosis after accidental exposure. Among the measures envisaged are serological surveillance of monkey colonies and specific diagnosis of herpes B zoonosis against a background of antibodies recognizing the closely related human herpes simplex virus (HSV). 422 pentadecapeptides covering, in an overlapping fashion, the entire amino acid sequences of herpes B proteins gB and gD were synthesized and immobilized on glass slides. Antibodies present in monkey sera that bind to subsets of the peptide collection were detected by microserological techniques. With 42 different rhesus macaque sera, 114 individual responses to 18 different antibody target regions (ATRs) were recorded, 17 of which had not been described earlier. This finding may pave the way for a peptide-based, herpes B specific serological diagnostic test.	[Hotop, Sven-Kevin; Jentsch, Dieter; Motzkus, Dirk; Stahl-Hennig, Christiane] German Primate Ctr, Unit Infect Models, Gottingen, Germany; [Abd El Wahed, Ahmed; Hunsmann, Gerhard] Univ Gottingen, Univ Med Ctr, Dept Virol, D-37073 Gottingen, Germany; [Beutling, Ulrike; Frank, Ronald] Helmholtz Ctr Infect Res, Dept Chem Biol, Braunschweig, Germany; [Fritz, Hans-Joachim] Courant Res Ctr Geobiol, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Gottingen; Helmholtz Association; Helmholtz-Center for Infection Research	Stahl-Hennig, C (corresponding author), German Primate Ctr, Unit Infect Models, Gottingen, Germany.	stahlh@dpz.eu		Abd El Wahed, Ahmed/0000-0003-3347-6075	EUPRIM-Net under the EU [262443]	EUPRIM-Net under the EU	The screening of monkey sera with ELISA was funded by EUPRIM-Net under the EU grant agreement 262443 of the 7th Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender FC, 2007, J VIROL, V81, P3827, DOI 10.1128/JVI.02710-06; Bruss V, 2007, WORLD J GASTROENTERO, V13, P65, DOI 10.3748/wjg.v13.i1.65; Coulibaly C, 2004, LAB ANIM-UK, V38, P432, DOI 10.1258/0023677041958891; Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277; Dikmans A, 2006, QSAR COMB SCI, V25, P1069, DOI 10.1002/qsar.200640130; Elmore D, 2008, COMPARATIVE MED, V58, P11; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; GILBERT R, 1994, J VIROL, V68, P2272, DOI 10.1128/JVI.68.4.2272-2285.1994; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Hollier MJ, 2005, VIROLOGY, V337, P284, DOI 10.1016/j.virol.2005.04.015; Jainkittivong A, 1998, ORAL SURG ORAL MED O, V85, P399, DOI 10.1016/S1079-2104(98)90064-6; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Lazear E, 2012, J VIROL, V86, P1563, DOI 10.1128/JVI.06480-11; Morton WR, 2008, ILAR J, V49, P137, DOI 10.1093/ilar.49.2.137; Perelygina L, 2005, J CLIN MICROBIOL, V43, P620, DOI 10.1128/JCM.43.2.620-628.2005; Perelygina L, 2003, J VIROL, V77, P6167, DOI 10.1128/JVI.77.11.6167-6177.2003; Perelygina L, 2002, J INFECT DIS, V186, P453, DOI 10.1086/341834; Perelygina L, 2002, ARCH VIROL, V147, P2057, DOI 10.1007/s00705-002-0889-0; Postler TS, 2012, J VIROL, V86, P1145, DOI 10.1128/JVI.06463-11; Sabin AB, 1934, J EXP MED, V59, P115, DOI 10.1084/jem.59.2.115; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SODORA DL, 1989, J VIROL, V63, P5184, DOI 10.1128/JVI.63.12.5184-5193.1989; Steckbeck JD, 2013, J GEN VIROL, V94, P1, DOI 10.1099/vir.0.046508-0; Steckbeck JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015261; Timmerman P, 2005, CHEMBIOCHEM, V6, P821, DOI 10.1002/cbic.200400374; Timmerman P, 2004, MOL DIVERS, V8, P61, DOI 10.1023/B:MODI.0000025650.94399.bb; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wang J, 2009, J VIROL, V83, P13042, DOI 10.1128/JVI.00792-09	28	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86857	10.1371/journal.pone.0086857	http://dx.doi.org/10.1371/journal.pone.0086857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497986	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900043
J	Yang, LP; Chen, Y; Zhang, BL; Chen, CX; Yue, M; Du, J; Yu, CH; Li, YM				Yang, Liping; Chen, Yu; Zhang, Bingling; Chen, Chunxiao; Yue, Min; Du, Juan; Yu, Chaohui; Li, Youming			Increased Diagnostic Yield of Capsule Endoscopy in Patients with Chronic Abdominal Pain	PLOS ONE			English	Article							BOWEL CROHNS-DISEASE; HENOCH-SCHONLEIN PURPURA; PUSH ENTEROSCOPY; VIDEO CAPSULE; CELIAC-DISEASE; ENTEROCLYSIS; BARIUM; TUMORS	Background and Study Aims: Chronic abdominal pain is one of the most common chief complaints, but the underlying pathophysiology often remains unknown after routine clinical evaluation. Capsule endoscopy (CE) is a new technique for the visualization of the entire small bowel. The aim of this study was to evaluate the diagnostic efficacy of CE in patients with chronic abdominal pain of obscure origin. Patients and Methods: Two hundred forty three patients with chronic abdominal pain with no significant lesions were enrolled in this study. CE was performed in all patients. Results: A diagnosis was made in 23.0% of patients screened with CE. Of the 243 patients, 19 (7.8%) were diagnosed with Crohn's disease, 15 (6.2%) with enteritis, 11 (4.5%) with idiopathic intestinal lymphangiectasia, 5 (2.1%) with uncinariasis, and a number of other diagnoses including small bowel tumor, ascariasis, and anaphylactoid purpura. Five patients had abnormal transit time, and capsule retention occurred in two patients. Conclusions: In contrast to other previous studies, we found that CE is an effective diagnostic tool for patients with abdominal pain.	[Yang, Liping; Chen, Yu; Zhang, Bingling; Chen, Chunxiao; Yue, Min; Du, Juan; Yu, Chaohui; Li, Youming] Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Li, YM (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	zlym@zju.edu.cn	Chen, Yu/Y-3292-2019	Ma, Han/0000-0001-9985-3035				Adler DG, 2004, GASTROINTEST ENDOSC, V59, P492, DOI 10.1016/S0016-5107(03)02862-1; Appleyard M, 2000, GASTROENTEROLOGY, V119, P1431, DOI 10.1053/gast.2000.20844; Bailey AA, 2006, AM J GASTROENTEROL, V101, P2237, DOI 10.1111/j.1572-0241.2006.00749.x; Bardan E, 2003, ENDOSCOPY, V35, P688; Chong AKH, 2005, GASTROINTEST ENDOSC, V61, P255, DOI 10.1016/S0016-5107(04)02571-4; Cobrin GM, 2006, CANCER-AM CANCER SOC, V107, P22, DOI 10.1002/cncr.21975; Cobrin GM, 2004, GASTROENTEROLOGY S2, V26; Costamagna G, 2002, GASTROENTEROLOGY, V123, P999, DOI 10.1053/gast.2002.35988; Culliford A, 2005, GASTROINTEST ENDOSC, V62, P55, DOI 10.1016/S0016-5107(05)01566-X; De Bona M, 2006, DIGEST LIVER DIS, V38, P331, DOI 10.1016/j.dld.2006.02.004; Dubcenco E, 2005, GASTROINTEST ENDOSC, V62, P538, DOI 10.1016/j.gie.2005.06.026; Ell C, 2002, ENDOSCOPY, V34, P685, DOI 10.1055/s-2002-33446; Fireman Z, 2003, GUT, V52, P390, DOI 10.1136/gut.52.3.390; Fry LC, 2006, ENDOSCOPY, V38, P498, DOI 10.1055/s-2006-925340; Ginsberg GG, 2002, GASTROINTEST ENDOSC, V56, P621, DOI 10.1016/S0016-5107(02)70106-5; Hara AK, 2004, RADIOLOGY, V230, P260, DOI 10.1148/radiol.2301021535; Herrerias JM, 2003, ENDOSCOPY, V35, P564; Ichikawa R, 2011, ENDOSCOPY, V43, pE162, DOI 10.1055/s-0030-1256266; Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Lewis BS, 2002, GASTROINTEST ENDOSC, V56, P349, DOI 10.1067/mge.2002.126906; Mata A, 2005, GASTROINTEST ENDOSC, V61, P721, DOI 10.1016/S0016-5107(05)00289-0; Mylonaki M, 2003, GUT, V52, P1122, DOI 10.1136/gut.52.8.1122; Nakamura M, 2006, ENDOSCOPY, V38, P59, DOI 10.1055/s-2005-870446; Petroniene R, 2005, AM J GASTROENTEROL, V100, P685, DOI 10.1111/j.1572-0241.2005.41069.x; Preud'Homme DL, 2006, PEDIATRICS, V118, pE904, DOI 10.1542/peds.2005-3111; Rey JF, 2006, ENDOSCOPY, V38, P1047, DOI 10.1055/s-2006-944874; Skogestad E, 2005, Endoscopy, V37, P189, DOI 10.1055/s-2004-826188; Voderholzer WA, 2005, GUT, V54, P369, DOI 10.1136/gut.2004.040055	28	11	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87396	10.1371/journal.pone.0087396	http://dx.doi.org/10.1371/journal.pone.0087396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498097	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900106
J	Yang, XF; Gao, L; Guo, XL; Shi, XH; Wu, H; Song, F; Wang, BB				Yang, Xiaofei; Gao, Lin; Guo, Xingli; Shi, Xinghua; Wu, Hao; Song, Fei; Wang, Bingbo			A Network Based Method for Analysis of IncRNA-Disease Associations and Prediction of IncRNAs Implicated in Diseases	PLOS ONE			English	Article							LONG NONCODING RNAS; ALZHEIMER-DISEASE; X-CHROMOSOME; EXPRESSION; GENE; METASTASIS; H19	Increasing evidence has indicated that long non-coding RNAs (lncRNAs) are implicated in and associated with many complex human diseases. Despite of the accumulation of lncRNA-disease associations, only a few studies had studied the roles of these associations in pathogenesis. In this paper, we investigated lncRNA-disease associations from a network view to understand the contribution of these lncRNAs to complex diseases. Specifically, we studied both the properties of the diseases in which the lncRNAs were implicated, and that of the lncRNAs associated with complex diseases. Regarding the fact that protein coding genes and lncRNAs are involved in human diseases, we constructed a coding-non-coding gene-disease bipartite network based on known associations between diseases and disease-causing genes. We then applied a propagation algorithm to uncover the hidden lncRNA-disease associations in this network. The algorithm was evaluated by leave-one-out cross validation on 103 diseases in which at least two genes were known to be involved, and achieved an AUC of 0.7881. Our algorithm successfully predicted 768 potential lncRNA-disease associations between 66 lncRNAs and 193 diseases. Furthermore, our results for Alzheimer's disease, pancreatic cancer, and gastric cancer were verified by other independent studies.	[Yang, Xiaofei; Gao, Lin; Guo, Xingli; Wu, Hao; Song, Fei; Wang, Bingbo] Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China; [Shi, Xinghua] Univ N Carolina, Dept Bioinformat & Genom, Coll Comp & Informat, Charlotte, NC 28223 USA	Xidian University; University of North Carolina; University of North Carolina Charlotte	Gao, L (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China.	lgao@mail.xidian.edu.cn		Yang, Xiaofei/0000-0002-5118-7755	National Natural Science Foundation of China [60933009, 61070137, 91130006, 61303118, 61303122]; Fundamental Research Funds for the Central Universities (XIDIAN UNIVERSITY) [K50512230005, K50512230003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities (XIDIAN UNIVERSITY)	This work was supported by the National Natural Science Foundation of China (Grant No. 60933009, 61070137, 91130006, 61303118, & 61303122), the website is http://www.nsfc.gov.cn/publish/portal1/ the Fundamental Research Funds for the Central Universities (XIDIAN UNIVERSITY, No. K50512230005 & K50512230003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bartholdi D, 2009, J MED GENET, V46, P192, DOI 10.1136/jmg.2008.061820; Bevan S, 1999, QJM-MON J ASSOC PHYS, V92, P5, DOI 10.1093/qjmed/92.1.5; Bjornsson HT, 2007, JNCI-J NATL CANCER I, V99, P1270, DOI 10.1093/jnci/djm069; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Cui ZL, 2013, UROL ONCOL-SEMIN ORI, V31, P1117, DOI 10.1016/j.urolonc.2011.11.030; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Eggermann Thomas, 2010, Pediatr Endocrinol Rev, V8, P86; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Gibb EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025915; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guo XL, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks967; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman R, 1999, ARCH FAM MED, V8, P347, DOI 10.1001/archfami.8.4.347; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kaneko K, 2011, J PEDIATR GASTR NUTR, V52, P744, DOI 10.1097/MPG.0b013e318214bd30; Kawakami T, 2003, J UROLOGY, V169, P1546, DOI 10.1097/01.ju.0000044927.23323.5a; Li J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1033; Looijenga LHJ, 1997, MOL REPROD DEV, V46, P419; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Sun BK, 2008, J INVEST DERMATOL, V128, P2753, DOI 10.1038/jid.2008.145; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Vincent-Salomon A, 2007, CANCER RES, V67, P5134, DOI 10.1158/0008-5472.CAN-07-0465; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weakley SM, 2011, WORLD J SURG, V35, P1751, DOI 10.1007/s00268-010-0951-0; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Zhang XQ, 2012, NEUROBIOL DIS, V48, P1, DOI 10.1016/j.nbd.2012.06.004; Zhou DY, 2004, ADV NEUR IN, V16, P321; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	42	73	80	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87797	10.1371/journal.pone.0087797	http://dx.doi.org/10.1371/journal.pone.0087797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498199	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900175
J	Ghareeb, K; Awad, WA; Sid-Ahmed, OE; Bohm, J				Ghareeb, Khaled; Awad, Wageha A.; Sid-Ahmed, Omer E.; Boehm, Josef			Insights on the Host Stress, Fear and Growth Responses to the Deoxynivalenol Feed Contaminant in Broiler Chickens	PLOS ONE			English	Article							TONIC IMMOBILITY REACTION; LAYING HENS; PHYSIOLOGICAL STRESS; FUSARIUM MYCOTOXINS; LYMPHOCYTE RATIO; DOMESTIC-FOWL; IMMUNOLOGICAL PARAMETERS; HOUSING CONDITIONS; DETOXIFYING AGENT; FEATHER PECKING	Mycotoxins pose an important danger to human and animal health. Poultry feeds are frequently contaminated with deoxynivalenol (DON) mycotoxin. It is thus of great importance to evaluate the effects of DON on the welfare related parameters in poultry industry. In the present study, the effects of contamination of broiler diet with 10 mg DON/kg feed on plasma corticosterone and heterophil to lymphocyte (H/L) ratio as indicators of stress, tonic immobility duration as an index for fear response and growth performance of broiler chickens were studied. In addition, the effect of a microbial feed additive either alone or in combination with DON contamination on these different aspects was also evaluated. The results showed that DON feeding significantly affected the welfare related parameters of broiler chickens. The feeding of DON contaminated diet resulted in an elevation of plasma corticosterone, higher H/L ratio and increased the fear levels as indicated by longer duration of tonic immobility reaction. Furthermore, DON reduced the body weight and body weight gain during the starter phase definitely at the second and third week. However, during grower phase, feeding of DON decreased the body weight at the fourth week and reduced the body gain at the fifth week. Addition of the microbial feed additive, a commercial antidote for DON mycotoxin, was able to overcome DON effects on stress index (H/L ratio), fearfulness and growth parameters of broilers. In conclusion, we showed for the first time that the DON feeding increased the underlying fearfulness and physiological stress responses of broilers and resulted in a reduction in the welfare status as indicated by higher plasma corticosterone, higher H/L ratio and higher fearfulness. Additionally, feeding the microbial feed additive was effective in reducing the adverse effects of DON on the bird's welfare and can improve the performance of broiler chickens.	[Ghareeb, Khaled; Boehm, Josef] Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Ghareeb, Khaled; Awad, Wageha A.] South Valley Univ, Dept Anim Hyg Behav & Management, Fac Vet Med, Qena, Egypt; [Awad, Wageha A.] Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Clin Avian Reptile & Fish Med, Vienna, Austria; [Sid-Ahmed, Omer E.] Univ Vet Med, Dept Biomed Sci, Inst Med Biochem, Vienna, Austria	University of Veterinary Medicine Vienna; Egyptian Knowledge Bank (EKB); South Valley University Egypt; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Ghareeb, K (corresponding author), Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria.	khaled.ghareeb@vetmeduni.ac.at	Awad, Wageha/R-1705-2016	Awad, Wageha/0000-0003-0843-2089; Ghareeb, Khaled/0000-0001-6191-6344	Biomin GTI GmbH, Herzogenburg, Austria	Biomin GTI GmbH, Herzogenburg, Austria	This work received the financial support from Biomin GTI GmbH, Herzogenburg, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad WA, 2006, POULTRY SCI, V85, P974, DOI 10.1093/ps/85.6.974; Awad WA, 2012, POULTRY SCI, V91, P550, DOI 10.3382/ps.2011-01742; Awad W. A., 2008, International Journal of Poultry Science, V7, P827; Awad WA, 2004, POULTRY SCI, V83, P1964, DOI 10.1093/ps/83.12.1964; Awad W, 2013, TOXINS, V5, P912, DOI 10.3390/toxins5050912; Awad WA, 2011, INT J MOL SCI, V12, P7996, DOI 10.3390/ijms12117996; Binder EM, 2007, ANIM FEED SCI TECH, V137, P265, DOI 10.1016/j.anifeedsci.2007.06.005; Campo JL, 2005, POULTRY SCI, V84, P1004, DOI 10.1093/ps/84.7.1004; CAMPO JL, 1994, ARCH GEFLUGELKD, V58, P75; Carsia R.V., 2000, P489, DOI 10.1016/B978-012747605-6/50020-1; Cheng HW, 2004, PSYCHONEUROENDOCRINO, V29, P961, DOI 10.1016/j.psyneuen.2003.09.002; Chowdhury SR, 2004, POULTRY SCI, V83, P1849, DOI 10.1093/ps/83.11.1849; CURTIS MJ, 1980, RES VET SCI, V28, P123, DOI 10.1016/S0034-5288(18)32785-1; Danicke S, 2003, BRIT POULTRY SCI, V44, P113, DOI 10.1080/0007166031000085300; Danicke S, 2002, POULTRY SCI, V81, P1671, DOI 10.1093/ps/81.11.1671; Deo P, 1998, P AUSTR POULT SCI S, V10, P172; DONKER RA, 1989, BRIT POULTRY SCI, V30, P361, DOI 10.1080/00071668908417157; El-Lethey H, 2003, VET IMMUNOL IMMUNOP, V95, P91, DOI 10.1016/S0165-2427(02)00308-2; El-Lethey H, 2000, BRIT POULTRY SCI, V41, P22, DOI 10.1080/00071660086358; El-lethey H, 2001, PHYSIOL BEHAV, V73, P243, DOI 10.1016/S0031-9384(01)00475-9; Elrom K, 2000, ISREAL J VET MED, V56, P41; European Food Safety Authority, 2004, EFSA J, V73, P1, DOI DOI 10.2903/J.EFSA.2004.73; FREEMAN BM, 1984, VET REC, V114, P286, DOI 10.1136/vr.114.12.286; GALLUP GG, 1979, ANIM BEHAV, V27, P316, DOI 10.1016/0003-3472(79)90159-3; Ghareeb K, 2008, BRIT POULTRY SCI, V49, P502, DOI 10.1080/00071660802290390; Ghareeb K, 2012, POULTRY SCI, V91, P800, DOI 10.3382/ps.2011-01741; Ghareeb K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071492; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; GROVE JF, 2000, PROG CHEM ORG NAT PR, V69, P1; Hangalapura BN, 2005, POULTRY SCI, V84, P1520, DOI 10.1093/ps/84.10.1520; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; JONES RB, 1986, WORLD POULTRY SCI J, V42, P82, DOI 10.1079/WPS19860008; JONES RB, 1988, APPL ANIM BEHAV SCI, V19, P297, DOI 10.1016/0168-1591(88)90011-1; Lin H, 2006, COMP BIOCHEM PHYS A, V143, P400, DOI 10.1016/j.cbpa.2005.12.030; Magnoli AP, 2012, POULTRY SCI, V91, P354, DOI 10.3382/ps.2011-01763; Maresca M, 2013, TOXINS, V5, P784, DOI 10.3390/toxins5040784; Maresca M, 2010, TOXICON, V56, P282, DOI 10.1016/j.toxicon.2010.04.016; Mashaly MM, 2004, POULTRY SCI, V83, P889, DOI 10.1093/ps/83.6.889; MENCH JA, 1986, POULTRY SCI, V65, P1058, DOI 10.3382/ps.0651058; Mumma JO, 2006, POULTRY SCI, V85, P761, DOI 10.1093/ps/85.4.761; Nazar FN, 2012, POULTRY SCI, V91, P47, DOI 10.3382/ps.2011-01658; Onbasilar EE, 2005, LIVEST PROD SCI, V95, P255, DOI 10.1016/j.livprodsci.2005.01.006; Osselaere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069014; Palme R, 1997, Z SAUGETIERKD, V62, P192; Pestka JJ, 2010, TOXINS, V2, P1300, DOI 10.3390/toxins2061300; Post J, 2003, POULTRY SCI, V82, P1313, DOI 10.1093/ps/82.8.1313; Roll V.F.B., 2010, Arch. zootec., V59, P93, DOI 10.4321/s0004-05922010000100010; Shini S, 2009, Stress, V12, P388, DOI 10.1080/10253890802526894; SIEGEL HS, 1995, BRIT POULTRY SCI, V36, P3, DOI 10.1080/00071669508417748; SIEGEL HS, 1980, BIOSCIENCE, V30, P529, DOI 10.2307/1307973; Smith T. K., 2009, World Poultry, V25, P16; Streit E, 2012, TOXINS, V4, P788, DOI 10.3390/toxins4100788; Swamy HVLN, 2002, POULTRY SCI, V81, P966, DOI 10.1093/ps/81.7.966; Swamy HVLN, 2004, POULTRY SCI, V83, P533, DOI 10.1093/ps/83.4.533; VALENTA H, 2002, VDLUFA SCHRIFTENREIH, V158, P680; Xu L, 2011, POULTRY SCI, V90, P2766, DOI 10.3382/ps.2011-01654; Yunus AW, 2012, POULTRY SCI, V91, P844, DOI 10.3382/ps.2011-01873; Zulkifli I, 2000, POULTRY SCI, V79, P402, DOI 10.1093/ps/79.3.402	58	28	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87727	10.1371/journal.pone.0087727	http://dx.doi.org/10.1371/journal.pone.0087727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498179	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100109
J	Konda, VR; Desai, A; Darland, G; Grayson, N; Bland, JS				Konda, Veera R.; Desai, Anuradha; Darland, Gary; Grayson, Neile; Bland, Jeffrey S.			KDT501, a Derivative from Hops, Normalizes Glucose Metabolism and Body Weight in Rodent Models of Diabetes	PLOS ONE			English	Article							RECEPTOR-GAMMA MODULATOR; INSULIN-RESISTANCE; PPAR-GAMMA; ADIPOSE-TISSUE; ANGIOTENSIN-II; SELECTIVE MODULATOR; DB/DB MICE; OBESITY; INFLAMMATION; ACTIVATION	Aims/Hypothesis: We developed KDT501, a novel substituted 1,3-cyclopentadione chemically derived from hop extracts, and evaluated it in various in vitro and in vivo models of diabetes and insulin sensitivity. Methods: KDT501 was evaluated for anti-inflammatory effects in monocyte/macrophage cells; agonistic activity for peroxisome proliferator-activated receptors (PPAR); lipogenesis and gene expression profile in human subcutaneous adipocytes. Body composition, glucose, insulin sensitivity, and lipids were assessed in diet-induced obesity (DIO) mice and Zucker Diabetic Fatty (ZDF) rats after oral administration. Results: KDT501 mediated lipogenesis in 3T3L1 and human subcutaneous adipocytes; however, the gene expression profile of KDT501 differed from that of the full PPAR gamma agonist rosiglitazone, suggesting that KDT501 has pleiotropic biological activities. In addition, KDT501 showed only modest, partial PPAR gamma agonist activity and exhibited anti-inflammatory effects in monocytes/macrophages that were not observed with rosiglitazone. In a DIO mouse model, oral administration of KDT501 significantly reduced fed blood glucose, glucose/insulin AUC following an oral glucose bolus, and body fat. In ZDF rats, oral administration of KDT501 significantly reduced fed glucose, fasting plasma glucose, and glucose AUC after an oral glucose bolus. Significant, dose-dependent reductions of plasma hemoglobin A1c, weight gain, total cholesterol, and triglycerides were also observed in animals receiving KDT501. Conclusion: These results indicate that KDT501 produces a unique anti-diabetic profile that is distinct in its spectrum of pharmacological effects and biological mechanism from both metformin and pioglitazone. KDT501 may thus constitute a novel therapeutic agent for the treatment of Type 2 diabetes and associated conditions.	[Konda, Veera R.; Desai, Anuradha; Darland, Gary; Grayson, Neile; Bland, Jeffrey S.] KinDex Therapeut LLC, Seattle, WA 98104 USA		Konda, VR (corresponding author), KinDex Therapeut LLC, Seattle, WA 98104 USA.	veerakonda@kindextherapeutics.com			KinDex Therapeutics	KinDex Therapeutics	All authors were employees of KinDex Therapeutics and research presented was funded by KinDex Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton JJ, 2005, BIOORG MED CHEM LETT, V15, P357, DOI 10.1016/j.bmcl.2004.10.068; Acton JJ, 2009, J MED CHEM, V52, P3846, DOI 10.1021/jm900097m; Babish JG, 2010, J MED FOOD, V13, P535, DOI 10.1089/jmf.2009.0110; Bassaganya-Riera J, 2011, J BIOL CHEM, V286, P2504, DOI 10.1074/jbc.M110.160077; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; Brun RP, 1997, J ENDOCRINOL, V155, P217, DOI 10.1677/joe.0.1550217; Castrillo A, 2001, J BIOL CHEM, V276, P34082, DOI 10.1074/jbc.M102472200; Chang CH, 2008, EUR J PHARMACOL, V584, P192, DOI 10.1016/j.ejphar.2007.12.036; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Desai A, 2009, INFLAMM RES, V58, P229, DOI 10.1007/s00011-008-8162-y; Desai A, 2012, ATHEROSCLEROSIS, V223, P130, DOI 10.1016/j.atherosclerosis.2012.05.004; Everard A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033858; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Guasch L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050816; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Hirai S, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/367838; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Konda VR, 2010, ARTHRITIS RHEUM-US, V62, P1683, DOI 10.1002/art.27441; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Motani A, 2009, J MOL BIOL, V386, P1301, DOI 10.1016/j.jmb.2009.01.025; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nio Y, 2012, DIABETOLOGIA, V55, P3350, DOI 10.1007/s00125-012-2710-2; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohshima K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048387; Olivares-Reyes JA, 2009, MOL CELL ENDOCRINOL, V302, P128, DOI 10.1016/j.mce.2008.12.011; Pang T, 2012, J HYPERTENS, V30, P87, DOI 10.1097/HJH.0b013e32834dde5f; Peraza MA, 2006, TOXICOL SCI, V90, P269, DOI 10.1093/toxsci/kfj062; Siriwardhana N, 2013, J NUTR BIOCHEM, V24, P613, DOI 10.1016/j.jnutbio.2012.12.013; Tan YJ, 2012, MOL PHARMACOL, V82, P68, DOI 10.1124/mol.111.076679; Urban J, 2013, ANGEW CHEM INT EDIT, V52, P1553, DOI 10.1002/anie.201208450; Vroegrijk IOCM, 2013, NUTRITION, V29, P276, DOI 10.1016/j.nut.2012.05.004; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yajima H, 2004, J BIOL CHEM, V279, P33456, DOI 10.1074/jbc.M403456200	37	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87848	10.1371/journal.pone.0087848	http://dx.doi.org/10.1371/journal.pone.0087848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498211	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100119
J	Zbinden, C; Stephan, R; Johler, S; Borel, N; Bunter, J; Bruckmaier, RM; Wellnitz, O				Zbinden, Christina; Stephan, Roger; Johler, Sophia; Borel, Nicole; Buenter, Julia; Bruckmaier, Rupert M.; Wellnitz, Olga			The Inflammatory Response of Primary Bovine Mammary Epithelial Cells to Staphylococcus aureus Strains Is Linked to the Bacterial Phenotype	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; SERUM AMYLOID A3; ESCHERICHIA-COLI; GENE-EXPRESSION; MASTITIS; ACID; CYTOKINE; GLAND; MILK; LIPOPOLYSACCHARIDE	Staphylococcus aureus is a major mastitis-causing pathogen in dairy cows. The latex agglutination-based Staphaurex test allows bovine S. aureus strains to be grouped into Staphaurex latex agglutination test (SLAT)-negative [SLAT(-)] and SLAT-positive [SLAT(+)] isolates. Virulence and resistance gene profiles within SLAT(-) isolates are highly similar, but differ largely from those of SLAT(+) isolates. Notably, specific genetic changes in important virulence factors were detected in SLAT(-) isolates. Based on the molecular data, it is assumed that SLAT(+) strains are more virulent than SLAT(-) strains. The objective of this study was to investigate if SLAT(-) and SLAT(+) strains can differentially induce an immune response with regard to their adhesive capacity to epithelial cells in the mammary gland and in turn, could play a role in the course of mastitis. Primary bovine mammary epithelial cells (bMEC) were challenged with suspensions of heat inactivated SLAT(+) (n = 3) and SLAT(-) (n = 3) strains isolated from clinical bovine mastitis cases. After 1, 6, and 24 h, cells were harvested and mRNA expression of inflammatory mediators (TNF-alpha, IL-1 beta, IL-8, RANTES, SAA, lactoferrin, GM-CSF, COX-2, and TLR-2) was evaluated by reverse transcription and quantitative PCR. Transcription (Delta Delta CT) of most measured factors was induced in challenged bMEC for 6 and 24 h. Interestingly, relative mRNA levels were higher (P<0.05) in response to SLAT(+) compared to SLAT(-) strains. In addition, adhesion assays on bMEC also showed significant differences between SLAT(+) and SLAT(-) strains. The present study clearly shows that these two S. aureus strain types cause a differential immune response of bMEC and exhibit differences in their adhesion capacity in vitro. This could reflect differences in the severity of mastitis that the different strain types may induce.	[Zbinden, Christina; Bruckmaier, Rupert M.; Wellnitz, Olga] Univ Bern, Vetsuisse Fac, Bern, Switzerland; [Stephan, Roger; Johler, Sophia] Univ Zurich, Vetsuisse Fac, Inst Food Safety & Hyg, Zurich, Switzerland; [Borel, Nicole; Buenter, Julia] Univ Zurich, Inst Vet Pathol, Vetsuisse Fac, Zurich, Switzerland; [Zbinden, Christina] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland	University of Bern; University of Zurich; University of Zurich; University of Bern	Wellnitz, O (corresponding author), Univ Bern, Vetsuisse Fac, Bern, Switzerland.	olga.wellnitz@vetsuisse.unibe.ch	Stephan, Roger/AAP-8501-2020; Johler, Sophia/ABC-9349-2020; Borel, Nicole/M-6204-2016; Wellnitz, Olga/GRY-4518-2022; Borel, Nicole/GPP-1073-2022	Johler, Sophia/0000-0003-4299-5651; Borel, Nicole/0000-0002-1556-9262; Wellnitz, Olga/0000-0002-5817-3428; Borel, Nicole/0000-0002-1556-9262	Swiss Federal Veterinary Office (BVET)	Swiss Federal Veterinary Office (BVET)	This work was financially supported by the Swiss Federal Veterinary Office (BVET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alluwaimi AM, 2003, J VET MED B, V50, P105, DOI 10.1046/j.1439-0450.2003.00628.x; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Bannerman DD, 2009, J ANIM SCI, V87, P10, DOI 10.2527/jas.2008-1187; Bannerman DD, 2004, CLIN DIAGN LAB IMMUN, V11, P463, DOI 10.1128/CDLI.11.3.463-472.2004; CRAVEN N, 1986, COMP IMMUNOL MICROB, V9, P29, DOI 10.1016/0147-9571(86)90072-X; Crofford LJ, 1997, J RHEUMATOL, V24, P15; Dego OK, 2002, VET QUART, V24, P181, DOI 10.1080/01652176.2002.9695135; Goldammer T, 2004, CLIN DIAGN LAB IMMUN, V11, P174, DOI 10.1128/CDLI.11.1.174-185.2004; Griesbeck-Zilch B, 2008, J DAIRY SCI, V91, P2215, DOI 10.3168/jds.2007-0752; Griesbeck-Zilch B, 2009, J DAIRY SCI, V92, P4621, DOI 10.3168/jds.2008-1954; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Hensen SM, 2000, J DAIRY SCI, V83, P418, DOI 10.3168/jds.S0022-0302(00)74898-3; Hogan J, 2003, VET RES, V34, P507, DOI 10.1051/vetres:2003022; KEHRLI ME, 1991, J DAIRY SCI, V74, P4399, DOI 10.3168/jds.S0022-0302(91)78636-0; Lahouassa H, 2007, CYTOKINE, V38, P12, DOI 10.1016/j.cyto.2007.04.006; Le Marechal C, 2011, DAIRY SCI TECHNOL, V91, P247, DOI 10.1007/s13594-011-0009-6; Lee JW, 2006, VET RES, V37, P219, DOI 10.1051/vetres:2005051; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Molenaar AJ, 2009, BIOMARKERS, V14, P26, DOI 10.1080/13547500902730714; Moser A, 2013, J DAIRY SCI, V96, P329, DOI 10.3168/jds.2012-5944; Oviedo-Boyso J, 2007, J INFECTION, V54, P399, DOI 10.1016/j.jinf.2006.06.010; Petzl W, 2008, VET RES, V39, DOI 10.1051/vetres:2007057; Pfaffl MW, 2003, J DAIRY SCI, V86, P538, DOI 10.3168/jds.S0022-0302(03)73632-7; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Strandberg Y, 2005, CYTOKINE, V31, P72, DOI 10.1016/j.cyto.2005.02.010; Stutz K, 2011, J CLIN MICROBIOL, V49, P638, DOI 10.1128/JCM.01148-10; Takagi M, 2008, VET J, V177, P398, DOI 10.1016/j.tvjl.2007.05.017; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Weber A, 2006, VET IMMUNOL IMMUNOP, V109, P79, DOI 10.1016/j.vetimm.2005.07.023; Wellnitz O, 2006, VET MED-CZECH, V51, P125, DOI 10.17221/5531-VETMED; Wellnitz O, 2004, VET IMMUNOL IMMUNOP, V101, P191, DOI 10.1016/j.vetimm.2004.04.019; Wellnitz O, 2012, SCHWEIZ ARCH TIERH, V154, P317, DOI 10.1024/0036-7281/a000355; Wellnitz O, 2011, J DAIRY SCI, V94, P5405, DOI 10.3168/jds.2010-3931; Wellnitz O, 2012, VET J, V192, P148, DOI 10.1016/j.tvjl.2011.09.013; Zecconi A, 2006, MICROB PATHOGENESIS, V40, P177, DOI 10.1016/j.micpath.2006.01.001	36	38	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87374	10.1371/journal.pone.0087374	http://dx.doi.org/10.1371/journal.pone.0087374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498088	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000330617100079
J	Li, SC; Chang, HH; Niewolik, D; Hedrick, MP; Pinkerton, AB; Hassig, CA; Schwarz, K; Lieber, MR				Li, Sicong; Chang, Howard H.; Niewolik, Doris; Hedrick, Michael P.; Pinkerton, Anthony B.; Hassig, Christian A.; Schwarz, Klaus; Lieber, Michael R.			Evidence That the DNA Endonuclease ARTEMIS also Has Intrinsic 5 '-Exonuclease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Repair; Nucleic Acid; Nucleic Acid Enzymology; Nucleic Acid Structure; Protein DNA-Interaction; Nonhomologous DNA End Joining	POLYADENYLATION FACTOR CPSF-73; DEPENDENT PROTEIN-KINASE; V(D)J RECOMBINATION; BREAK REPAIR; NUCLEASE; MECHANISM; PATHWAY	Background: DNA-PKcs stimulates the endonucleolytic activities of ARTEMIS but not the 5-exonuclease activity. Results: Point mutagenesis, small molecule inhibitors, and modulation of divalent cation concentrations all affect both the endonuclease and 5-exonuclease activities in parallel. Conclusion: ARTEMIS has intrinsic 5-exonuclease activity, in addition to its known endonuclease activity. Significance: ARTEMIS may use both its endo- and its 5-exonuclease activity in NHEJ. ARTEMIS is a member of the metallo--lactamase protein family. ARTEMIS has endonuclease activity at DNA hairpins and at 5- and 3-DNA overhangs of duplex DNA, and this endonucleolytic activity is dependent upon DNA-PKcs. There has been uncertainty about whether ARTEMIS also has 5-exonuclease activity on single-stranded DNA and 5-overhangs, because this 5-exonuclease is not dependent upon DNA-PKcs. Here, we show that the 5-exonuclease and the endonuclease activities co-purify. Second, we show that a point mutant of ARTEMIS at a putative active site residue (H115A) markedly reduces both the endonuclease activity and the 5-exonuclease activity. Third, divalent cation effects on the 5-exonuclease and the endonuclease parallel one another. Fourth, both the endonuclease activity and 5-exonuclease activity of ARTEMIS can be blocked in parallel by small molecule inhibitors, which do not block unrelated nucleases. We conclude that the 5-exonuclease is intrinsic to ARTEMIS, making it relevant to the role of ARTEMIS in nonhomologous DNA end joining.	[Li, Sicong; Chang, Howard H.; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90089 USA; [Li, Sicong; Chang, Howard H.; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Li, Sicong; Chang, Howard H.; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biol Sci, Los Angeles, CA 90089 USA; [Li, Sicong; Chang, Howard H.; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA; [Niewolik, Doris; Schwarz, Klaus] Univ Hosp, Inst Transfus Med, D-89081 Ulm, Germany; [Hedrick, Michael P.; Pinkerton, Anthony B.; Hassig, Christian A.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Ulm University; Sanford Burnham Prebys Medical Discovery Institute	Lieber, MR (corresponding author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90089 USA.	lieber@usc.edu		Lieber, Michael/0000-0003-3700-6345; Pinkerton, Anthony/0000-0003-4571-152X; Lieber, Michael/0000-0001-8809-0909	National Institutes of Health [R01 CA100504, R01 CA51105]; BMBF (German Federal Ministry of Education Research) [01GM1111F]; NATIONAL CANCER INSTITUTE [R01CA051105, R01CA100504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BMBF (German Federal Ministry of Education Research)(Federal Ministry of Education & Research (BMBF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health Grants R01 CA100504 and R01 CA51105 (to M. R. L.) and the BMBF (German Federal Ministry of Education & Research) Grant 01GM1111F (to K. S.).	Aravind L, 1999, In Silico Biol, V1, P69; Chan DW, 1996, BIOCHEM CELL BIOL, V74, P67, DOI 10.1139/o96-007; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Dronkert MLG, 2000, MOL CELL BIOL, V20, P4553, DOI 10.1128/MCB.20.13.4553-4561.2000; Gu JF, 2010, DNA REPAIR, V9, P429, DOI 10.1016/j.dnarep.2010.01.001; Kurosawa A, 2008, DNA CELL BIOL, V27, P55, DOI 10.1089/dna.2007.0649; LARSEN KS, 1989, BIOCHEMISTRY-US, V28, P9620, DOI 10.1021/bi00451a012; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lu H, 2008, MOL CELL, V31, P485, DOI 10.1016/j.molcel.2008.05.029; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pawelczak KS, 2010, DNA REPAIR, V9, P670, DOI 10.1016/j.dnarep.2010.03.002; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; Sengerova B, 2012, J BIOL CHEM, V287, P26254, DOI 10.1074/jbc.M112.367243; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; Yannone SM, 2008, NUCLEIC ACIDS RES, V36, P3354, DOI 10.1093/nar/gkn205	21	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7825	7834		10.1074/jbc.M113.544874	http://dx.doi.org/10.1074/jbc.M113.544874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24500713	hybrid, Green Published			2022-12-25	WOS:000332761500048
J	Behrens, S; Widder, S; Mannala, GK; Qing, XX; Madhugiri, R; Kefer, N; Abu Mraheil, M; Rattei, T; Hain, T				Behrens, Sebastian; Widder, Stefanie; Mannala, Gopala Krishna; Qing, Xiaoxing; Madhugiri, Ramakanth; Kefer, Nathalie; Abu Mraheil, Mobarak; Rattei, Thomas; Hain, Torsten			Ultra Deep Sequencing of Listeria monocytogenes sRNA Transcriptome Revealed New Antisense RNAs	PLOS ONE			English	Article							REGULATORY RNAS; COMPARATIVE GENOMICS; METABOLISM; IDENTIFICATION; LANDSCAPE; BACTERIA; GROWTH; PHASE; HFQ	Listeria monocytogenes, a gram-positive pathogen, and causative agent of listeriosis, has become a widely used model organism for intracellular infections. Recent studies have identified small non-coding RNAs (sRNAs) as important factors for regulating gene expression and pathogenicity of L. monocytogenes. Increased speed and reduced costs of high throughput sequencing (HTS) techniques have made RNA sequencing (RNA-Seq) the state-of-the-art method to study bacterial transcriptomes. We created a large transcriptome dataset of L. monocytogenes containing a total of 21 million reads, using the SOLiD sequencing technology. The dataset contained cDNA sequences generated from L. monocytogenes RNA collected under intracellular and extracellular condition and additionally was size fractioned into three different size ranges from <40 nt, 40-150 nt and >150 nt. We report here, the identification of nine new sRNAs candidates of L. monocytogenes and a reevaluation of known sRNAs of L. monocytogenes EGD-e. Automatic comparison to known sRNAs revealed a high recovery rate of 55%, which was increased to 90% by manual revision of the data. Moreover, thorough classification of known sRNAs shed further light on their possible biological functions. Interestingly among the newly identified sRNA candidates are antisense RNAs (asRNAs) associated to the housekeeping genes purA, fumC and pgi and potentially their regulation, emphasizing the significance of sRNAs for metabolic adaptation in L. monocytogenes.	[Behrens, Sebastian; Widder, Stefanie; Rattei, Thomas] Univ Vienna, Dept Computat Syst Biol, Vienna, Austria; [Madhugiri, Ramakanth] Univ Giessen, Inst Med Virol, D-35390 Giessen, Germany; [Kefer, Nathalie] Febit Biomed GmbH, Heidelberg, Germany; [Kefer, Nathalie] Life Technol GmbH, Darmstadt, Germany; [Behrens, Sebastian; Mannala, Gopala Krishna; Qing, Xiaoxing; Abu Mraheil, Mobarak; Hain, Torsten] Univ Giessen, Inst Med Mikrobiol, D-35390 Giessen, Germany	University of Vienna; Justus Liebig University Giessen; Thermo Fisher Scientific; Justus Liebig University Giessen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hain, T (corresponding author), Univ Giessen, Inst Med Mikrobiol, D-35390 Giessen, Germany.	Torsten.Hain@mikrobio.med.uni-giessen.de	Rattei, Thomas/F-1366-2011; Mannala, Gopala Krishna/ABF-2325-2020; Widder, Stefanie/B-9584-2014	Rattei, Thomas/0000-0002-0592-7791; Widder, Stefanie/0000-0003-0733-5666; Madhugiri, Ramakanth/0000-0002-9306-4155	German Federal Ministry of Education and Research (BMBF ERA-NET Pathogenomics Network) [62080061]; German Centre for Infection Research; Justus-Liebig University Giessen	German Federal Ministry of Education and Research (BMBF ERA-NET Pathogenomics Network)(Federal Ministry of Education & Research (BMBF)); German Centre for Infection Research; Justus-Liebig University Giessen	This work was supported by grants from the German Federal Ministry of Education and Research (BMBF ERA-NET Pathogenomics Network to the sncRNAomics project (62080061) to T. H. as well as the German Centre for Infection Research, Justus-Liebig University Giessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r98; Basineni SR, 2009, RNA BIOL, V6, P584, DOI 10.4161/rna.6.5.10082; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Faith NG, 2012, FOODBORNE PATHOG DIS, V9, P480, DOI 10.1089/fpd.2011.1013; Fuchs TM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00023; Garcia-del Portillo F, 2011, J BIOL CHEM, V286, P34675, DOI 10.1074/jbc.M111.230441; Georg J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.63; Glaser P, 2001, SCIENCE, V294, P849; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Guell M, 2011, NAT REV MICROBIOL, V9, P658, DOI 10.1038/nrmicro2620; Hain T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-144; Huynen MA, 1999, TRENDS MICROBIOL, V7, P281, DOI 10.1016/S0966-842X(99)01539-5; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Livny J, 2010, NUCLEIC ACIDS RES, V38, P1504, DOI 10.1093/nar/gkp1121; Loessner MJ, 2000, MOL MICROBIOL, V35, P324, DOI 10.1046/j.1365-2958.2000.01720.x; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Pischimarov J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-384; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schauer K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-573; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Siezen RJ, 2010, MICROB BIOTECHNOL, V3, P125, DOI 10.1111/j.1751-7915.2010.00166.x; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wurtzel O, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.11; Xiao B, 2009, CURR MICROBIOL, V58, P258, DOI 10.1007/s00284-008-9318-2	38	26	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e83979	10.1371/journal.pone.0083979	http://dx.doi.org/10.1371/journal.pone.0083979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498259	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900005
J	Gomez-Marcos, MA; Recio-Rodriguez, JI; Patino-Alonso, MC; Martinez-Vizcaino, V; Martin-Borras, C; de-la-Cal-dela-Fuente, A; Sauras-Llera, I; Sanchez-Perez, A; Agudo-Conde, C; Garcia-Ortiz, L				Gomez-Marcos, Manuel A.; Recio-Rodriguez, Jose I.; Patino-Alonso, Maria C.; Martinez-Vizcaino, Vicente; Martin-Borras, Carme; de-la-Cal-dela-Fuente, Aventina; Sauras-Llera, Ines; Sanchez-Perez, Alvaro; Agudo-Conde, Cristina; Garcia-Ortiz, Luis		EVIDENT Study Investigators	Relationship between Physical Activity and Plasma Fibrinogen Concentrations in Adults without Chronic Diseases	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INFLAMMATORY MARKERS; COMPUTER-SCIENCE; RISK; MEN; MORTALITY; VALIDITY; WOMEN; EXERCISE; HEALTH	Objective: To analyze the relationship between regular physical activity, as assessed by accelerometer and 7-day physical activity recall (PAR), and plasma fibrinogen concentrations. Methods: A cross-sectional study in a previously established cohort of healthy subjects was performed. This study analyzed 1284 subjects who were included in the EVIDENT study (mean age 55.0 +/- 13.6 years; 60.90% women). Fibrinogen concentrations were measured in blood plasma. Physical activity was assessed with a 7-day PAR (metabolic equivalents (METs)/hour/week) and GT3X ActiGraph accelerometer (counts/minute) for 7 days. Results: Physical exercise, which was evaluated with both an accelerometer (Median: 237.28 counts/minute) and 7-day PAR (Median: 8 METs/hour/week). Physical activity was negatively correlated with plasma fibrinogen concentrations, which was evaluated by counts/min (r=-0.100; p<0.001) and METs/hour/week (r=-0.162; p<0.001). In a multiple linear regression analysis, fibrinogen concentrations of the subjects who performed more physical activity (third tertile of count/minute and METs/hour/week) respect to subjects who performed less (first tertile), maintained statistical significance after adjustments for age and others confounders (beta = -0.03; p = 0.046 and beta = -0.06; p<0.001, respectively). Conclusions: Physical activity, as assessed by accelerometer and 7-day PAR, was negatively associated with plasma fibrinogen concentrations. This relation is maintained in subjects who performed more exercise even after adjusting for age and other confounders.	[Gomez-Marcos, Manuel A.; Garcia-Ortiz, Luis] Univ Salamanca, Castilla & Leon Hlth Serv SACYL, IBSAL, Primary Care Res Unit,Alamedilla Hlth Ctr, E-37008 Salamanca, Spain; [Gomez-Marcos, Manuel A.; Garcia-Ortiz, Luis] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain; [Recio-Rodriguez, Jose I.; Agudo-Conde, Cristina] Castilla & Leon Hlth Serv SACYL, Alamedilla Hlth Ctr, Primary Care Res Unit, Salamanca, Spain; [Patino-Alonso, Maria C.] Univ Salamanca, Stadist Dept, E-37008 Salamanca, Spain; [Patino-Alonso, Maria C.] Alamedilla Hlth Ctr, Primary Care Res Unit, Salamanca, Spain; [Martinez-Vizcaino, Vicente] Univ Castilla La Mancha, Social & Hlth Care Res Ctr, Cuenca, Spain; [Martin-Borras, Carme] Ciencies Educ & Esport FPCEE Univ Ramon Llull, DEA, Barcelona, Spain; [de-la-Cal-dela-Fuente, Aventina] Castilla & Leon Hlth Serv SACYL, Casa Barco Hlth Ctr, Valladolid, Spain; [Sauras-Llera, Ines] Aragon Hlth Serv Salud, Torre Ramona Hlth Ctr, Zaragoza, Spain; [Sanchez-Perez, Alvaro] Basque Hlth Serv Osakidetza, Primary Care Res Unit Bizkaia, Bilbao, Spain	University of Salamanca; University of Salamanca; University of Salamanca; Universidad de Castilla-La Mancha; Universitat Ramon Llull	Gomez-Marcos, MA (corresponding author), Univ Salamanca, Castilla & Leon Hlth Serv SACYL, IBSAL, Primary Care Res Unit,Alamedilla Hlth Ctr, E-37008 Salamanca, Spain.	magomez@usal.es	Recio-Rodriguez, Jose I/AAA-8588-2020; VIZCAINO, VICENTE MARTINEZ/R-4336-2017; Rodríguez-Sánchez, Emiliano/N-5582-2014; VIZCAINO, VICENTE MARTINEZ/AAZ-9034-2021; Martin Cantera, Carlos/D-2693-2011; Patino-Alonso, Carmen/I-4608-2014; Maderuelo-Fernandez, Jose-Angel/R-8868-2018	VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Rodríguez-Sánchez, Emiliano/0000-0003-3667-7155; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Martin Cantera, Carlos/0000-0003-0656-8126; Patino-Alonso, Carmen/0000-0001-8232-6685; Gomez-Marcos, Manuel A/0000-0003-0133-6123; Garcia-Ortiz, Luis/0000-0001-6555-8302; Recio-Rodriguez, Jose I/0000-0002-3772-8746; Maderuelo-Fernandez, Jose-Angel/0000-0001-7544-8684; DE CABO-LASO, ANGELA/0000-0003-1449-282X	Carlos III Health Institute of the Ministry of Health in Spain [FIS: PS09/00233, PS09/01057, PS09/01972, PS09/01376, PS09/0164, PS09/01458, RETICS D06/0018]; Autonomous Government of Castile and Leon [SAN/1778/2009]	Carlos III Health Institute of the Ministry of Health in Spain; Autonomous Government of Castile and Leon	This project was financed by the Carlos III Health Institute of the Ministry of Health in Spain (FIS: PS09/00233, PS09/01057, PS09/01972, PS09/01376, PS09/0164, PS09/01458, RETICS D06/0018) and the Autonomous Government of Castile and Leon (SAN/1778/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autenrieth CS, 2011, EUR J EPIDEMIOL, V26, P91, DOI 10.1007/s10654-010-9517-6; Colbert LH, 2004, J AM GERIATR SOC, V52, P1098, DOI 10.1111/j.1532-5415.2004.52307.x; Deurenberg P, 2001, EUR J CLIN NUTR, V55, P973, DOI 10.1038/sj.ejcn.1601254; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Garcia-Ortiz L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-233; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Germano G, 2012, EUR HEART J, V33, P137; Hamer M, 2012, CIRCULATION, V126, P928, DOI 10.1161/CIRCULATIONAHA.112.103879; Hamer M, 2009, MED SCI SPORT EXER, V41, P1206, DOI 10.1249/MSS.0b013e3181971247; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Kaptoge S, 2007, AM J EPIDEMIOL, V166, P867, DOI 10.1093/aje/kwm191; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; King DE, 2003, MED SCI SPORT EXER, V35, P575, DOI 10.1249/01.MSS.0000058440.28108.CC; Kirk A, 2003, DIABETES CARE, V26, P1186, DOI 10.2337/diacare.26.4.1186; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MELANSON EL, 1995, MED SCI SPORT EXER, V27, P934; Myint PK, 2008, ATHEROSCLEROSIS, V198, P419, DOI 10.1016/j.atherosclerosis.2007.09.021; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; Rana JS, 2011, EUR HEART J, V32, P336, DOI 10.1093/eurheartj/ehp010; Sabia S, 2012, AM J PUBLIC HEALTH, V102, P698, DOI 10.2105/AJPH.2011.300257; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Talbot LA, 2007, PREV MED, V45, P169, DOI 10.1016/j.ypmed.2007.05.014; Wannamethee SG, 2002, CIRCULATION, V105, P1785, DOI 10.1161/01.CIR.0000016346.14762.71; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Washburn RA, 2003, MED SCI SPORT EXER, V35, P1374, DOI 10.1249/01.MSS.0000079081.08476.EA	25	10	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87954	10.1371/journal.pone.0087954	http://dx.doi.org/10.1371/journal.pone.0087954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498413	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900159
J	Miller, GS; Zoratti, GL; Murray, AS; Bergum, C; Tanabe, LM; List, K				Miller, Gregory S.; Zoratti, Gina L.; Murray, Andrew S.; Bergum, Christopher; Tanabe, Lauren M.; List, Karin			HATL5: A Cell Surface Serine Protease Differentially Expressed in Epithelial Cancers	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; BARRIER FUNCTION; MATRIPTASE; ICHTHYOSIS; ACTIVATION; SURVIVAL; RELEASE	Over the last two decades, cell surface proteases belonging to the type II transmembrane serine protease (TTSP) family have emerged as important enzymes in the mammalian degradome, playing critical roles in epithelial biology, regulation of metabolic homeostasis, and cancer. Human airway trypsin-like protease 5 (HATL5) is one of the few family members that remains uncharacterized. Here we demonstrate that HATL5 is a catalytically active serine protease that is inhibited by the two Kunitz type serine protease inhibitors, hepatocyte growth factor activator inhibitor (HAI)-1 and 2, as well as by serpinA1. Full-length HATL5 is localized on the cell surface of cultured mammalian cells as demonstrated by confocal microscopy. HATL5 displays a relatively restricted tissue expression profile, with both transcript and protein present in the cervix, esophagus, and oral cavity. Immunohistochemical analysis revealed an expression pattern where HATL5 is localized on the cell surface of differentiated epithelial cells in the stratified squamous epithelia of all three of these tissues. Interestingly, HATL5 is significantly decreased in cervical, esophageal, and head and neck carcinomas as compared to normal tissue. Analysis of cervical and esophageal cancer tissue arrays demonstrated that the squamous epithelial cells lose their expression of HATL5 protein upon malignant transformation.	[Miller, Gregory S.; Bergum, Christopher; Tanabe, Lauren M.; List, Karin] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Miller, Gregory S.; Zoratti, Gina L.; Murray, Andrew S.; Bergum, Christopher; Tanabe, Lauren M.; List, Karin] Barbara Ann Karmanos Canc Inst, Detroit, MI USA; [Zoratti, Gina L.; Murray, Andrew S.; List, Karin] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	List, K (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	klist@med.wayne.edu		Murray, Andrew/0000-0002-2899-4970; Tanabe, Lauren/0000-0003-1760-3468	Wayne State School of Medicine; Barbara Ann Karmanos Cancer Institute, Detroit, MI; NATIONAL CANCER INSTITUTE [R01CA160565] Funding Source: NIH RePORTER	Wayne State School of Medicine; Barbara Ann Karmanos Cancer Institute, Detroit, MI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by start-up funds from Wayne State School of Medicine and Barbara Ann Karmanos Cancer Institute, Detroit, MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Baron J, 2013, J VIROL, V87, P1811, DOI 10.1128/JVI.02320-12; Beaufort N, 2007, AM J PHYSIOL-LUNG C, V292, pL1263, DOI 10.1152/ajplung.00191.2006; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Chokki M, 2005, FEBS J, V272, P6387, DOI 10.1111/j.1742-4658.2005.05035.x; Hashimoto T, 2010, FEBS J, V277, P4888, DOI 10.1111/j.1742-4658.2010.07894.x; Hobson JP, 2004, J BIOL CHEM, V279, P46981, DOI 10.1074/jbc.M403299200; Iwakiri K, 2004, J INVEST DERMATOL, V122, P937, DOI 10.1111/j.0022-202X.2004.22415.x; Kato M, 2011, J BIOCH, V2, P179; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2000, BIOCHEMISTRY-US, V39, P508, DOI 10.1021/bi991701f; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Matsushima R, 2006, AM J PHYSIOL-LUNG C, V290, pL385, DOI 10.1152/ajplung.00098.2005; Maurer E, 2013, BIOCHEM J, V450, P583, DOI 10.1042/BJ20121518; Nygaard RM, 2012, J VIROL, V86, P1238, DOI 10.1128/JVI.06429-11; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sales KU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023261; Somoza JR, 2003, STRUCTURE, V11, P1123, DOI 10.1016/S0969-2126(03)00148-5; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tsai CH, 2013, ONCOGENE; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Yoshinaga Sumiko, 1998, Journal of Medical Investigation, V45, P77	33	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87675	10.1371/journal.pone.0087675	http://dx.doi.org/10.1371/journal.pone.0087675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498351	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900097
J	Hu, YW; Zhang, P; Yang, JY; Huang, JL; Ma, X; Li, SF; Zhao, JY; Hu, YR; Wang, YC; Gao, JJ; Sha, YH; Zheng, L; Wang, Q				Hu, Yan-Wei; Zhang, Peng; Yang, Jun-Yao; Huang, Jin-Lan; Ma, Xin; Li, Shu-Fen; Zhao, Jia-Yi; Hu, Ya-Rong; Wang, Yan-Chao; Gao, Ji-Juan; Sha, Yan-Hua; Zheng, Lei; Wang, Qian			Nur77 Decreases Atherosclerosis Progression in apoE(-/-) Mice Fed a High-Fat/High-Cholesterol Diet	PLOS ONE			English	Article							NUCLEAR RECEPTOR NUR77; APOLIPOPROTEIN-B; LIPID-METABOLISM; ORPHAN RECEPTOR; MUSCLE-CELLS; DEFICIENT; TRANSPORTERS; LIPOPROTEIN; ABSORPTION; EXPRESSION	Rationale: It is clear that lipid disorder and inflammation are associated with cardiovascular diseases and underlying atherosclerosis. Nur77 has been shown to be involved in inflammatory response and lipid metabolism. Objective: Here, we explored the role of Nur77 in atherosclerotic plaque progression in apoE(-/-) mice fed a high-fat/high cholesterol diet. Methods and Results: The Nur77 gene, a nuclear hormone receptor, was highly induced by treatment with Cytosporone B (Csn-B, specific Nur77 agonist), recombinant plasmid over-expressing Nur77 (pcDNA-Nur77), while inhibited by treatment with siRNAs against Nur77 (si-Nur77) in THP-1 macrophage-derived foam cells, HepG2 cells and Caco-2 cells, respectively. In addition, the expression of Nur77 was highly induced by Nur77 agonist Csn-B, lentivirus encoding Nur77 (LV-Nur77), while silenced by lentivirus encoding siRNA against Nur77 (si-Nur77) in apoE(-/-) mice fed a high-fat/high cholesterol diet, respectively. We found that increased expression of Nur77 reduced macrophage-derived foam cells formation and hepatic lipid deposition, downregulated gene levels of inflammatory molecules, adhesion molecules and intestinal lipid absorption, and decreases atherosclerotic plaque formation. Conclusion: These observations provide direct evidence that Nur77 is an important nuclear hormone receptor in regulation of atherosclerotic plaque formation and thus represents a promising target for the treatment of atherosclerosis.	[Hu, Yan-Wei; Zhang, Peng; Yang, Jun-Yao; Huang, Jin-Lan; Li, Shu-Fen; Zhao, Jia-Yi; Hu, Ya-Rong; Wang, Yan-Chao; Gao, Ji-Juan; Sha, Yan-Hua; Zheng, Lei; Wang, Qian] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China; [Ma, Xin] Southern Med Univ, Nanfang Hosp, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Wang, Q (corresponding author), Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China.	nfyyzl@163.com; nfyywangqian@163.com			National Natural Sciences Foundation of China [81071416, 81271905, 81301489]; Guangdong Provincial Natural Sciences Foundation of China [S2012020010920]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Sciences Foundation of China	The authors gratefully acknowledge financial support from the National Natural Sciences Foundation of China (81071416, 81271905, 81301489), and Guangdong Provincial Natural Sciences Foundation of China (S2012020010920). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Babaev VR, 2000, ARTERIOSCL THROM VAS, V20, P2593, DOI 10.1161/01.ATV.20.12.2593; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Chao LC, 2009, DIABETES, V58, P2788, DOI 10.2337/db09-0763; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Davis RA, 2001, ARTERIOSCL THROM VAS, V21, P887, DOI 10.1161/01.ATV.21.6.887; de Waard V, 2006, AM J PATHOL, V168, P2027, DOI 10.2353/ajpath.2006.050932; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Febbraio M, 2004, ARTERIOSCL THROM VAS, V24, P2333, DOI 10.1161/01.ATV.0000148007.06370.68; Gargalovic P, 2003, J LIPID RES, V44, P11, DOI 10.1194/jlr.R200005-JLR200; Ghosh S, 2011, EXPERT REV CARDIOVAS, V9, P329, DOI [10.1586/erc.11.16, 10.1586/ERC.11.16]; Hamers AAJ, 2012, CIRC RES, V110, P428, DOI 10.1161/CIRCRESAHA.111.260760; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hu YW, 2010, CLIN CHIM ACTA, V411, P617, DOI 10.1016/j.cca.2009.12.027; Hui DY, 2008, AM J PHYSIOL-GASTR L, V294, pG839, DOI 10.1152/ajpgi.00061.2008; KANE JP, 1983, ANNU REV PHYSIOL, V45, P637, DOI 10.1146/annurev.ph.45.030183.003225; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Liu YW, 2010, J LIPID RES, V51, P2253, DOI 10.1194/jlr.M005371; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Maxwell MA, 2005, J BIOL CHEM, V280, P12573, DOI 10.1074/jbc.M409580200; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Olofsson SO, 1999, CURR OPIN LIPIDOL, V10, P341, DOI 10.1097/00041433-199908000-00008; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Pedersen Terje R, 2006, Diab Vasc Dis Res, V3, pS1; Pires NMM, 2007, CIRCULATION, V115, P493, DOI 10.1161/CIRCULATIONAHA.106.626838; PITTMAN RC, 1982, J BIOL CHEM, V257, P7994; Pols TWH, 2008, BIOCHEM BIOPH RES CO, V366, P910, DOI 10.1016/j.bbrc.2007.12.039; Pols TWH, 2007, CURR OPIN LIPIDOL, V18, P515, DOI 10.1097/MOL.0b013e3282ef77d1; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saggini A, 2011, INT J IMMUNOPATH PH, V24, P567, DOI 10.1177/039463201102400303; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shi YG, 2009, AM J PHYSIOL-ENDOC M, V297, pE10, DOI 10.1152/ajpendo.90949.2008; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	41	33	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87313	10.1371/journal.pone.0087313	http://dx.doi.org/10.1371/journal.pone.0087313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498071	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900087
J	Ooi, JLS; Van Niel, KP; Kendrick, GA; Holmes, KW				Ooi, Jillian L. S.; Van Niel, Kimberly P.; Kendrick, Gary A.; Holmes, Karen W.			Spatial Structure of Seagrass Suggests That Size-Dependent Plant Traits Have a Strong Influence on the Distribution and Maintenance of Tropical Multispecies Meadows	PLOS ONE			English	Article							SE ASIAN SEAGRASSES; POSIDONIA-OCEANICA; SOIL PROPERTIES; GEOSTATISTICAL TOOLS; THALASSIA-HEMPRICHII; LANDSCAPE PATTERN; GROWTH DYNAMICS; PRODUCTIVITY; AUTOCORRELATION; PHOTOSYNTHESIS	Background: Seagrass species in the tropics occur in multispecies meadows. How these meadows are maintained through species co-existence and what their ecological drivers may be has been an overarching question in seagrass biogeography. In this study, we quantify the spatial structure of four co-existing species and infer potential ecological processes from these structures. Methods and Results: Species presence/absence data were collected using underwater towed and dropped video cameras in Pulau Tinggi, Malaysia. The geostatistical method, utilizing semivariograms, was used to describe the spatial structure of Halophila spp, Halodule uninervis, Syringodium isoetifolium and Cymodocea serrulata. Species had spatial patterns that were oriented in the along-shore and across-shore directions, nested with larger species in meadow interiors, and consisted of multiple structures that indicate the influence of 2-3 underlying processes. The Linear Model of Coregionalization (LMC) was used to estimate the amount of variance contributing to the presence of a species at specific spatial scales. These distances were <2.5 m (micro-scale), 2.5-50 m (fine-scale) and >50 m (broad-scale) in the along-shore; and <2.5 m (micro-scale), 2.5-140 m (fine-scale) and >140 m (broad-scale) in the across-shore. The LMC suggests that smaller species (Halophila spp and H. uninervis) were most influenced by broad-scale processes such as hydrodynamics and water depth whereas large, localised species (S. isoetifolium and C. serrulata) were more influenced by finer-scale processes such as sediment burial, seagrass colonization and growth, and physical disturbance. Conclusion: In this study, we provide evidence that spatial structure is distinct even when species occur in well-mixed multispecies meadows, and we suggest that size-dependent plant traits have a strong influence on the distribution and maintenance of tropical marine plant communities. This study offers a contrast from previous spatial models of seagrasses which have largely focused on monospecific temperate meadows.	[Ooi, Jillian L. S.; Kendrick, Gary A.] Univ Western Australia, Sch Plant Biol, Fac Nat & Agr Sci, Perth, WA 6009, Australia; [Ooi, Jillian L. S.; Van Niel, Kimberly P.; Holmes, Karen W.] Univ Western Australia, Sch Earth & Environm, Fac Nat & Agr Sci, Perth, WA 6009, Australia; [Ooi, Jillian L. S.; Van Niel, Kimberly P.; Kendrick, Gary A.] Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia; [Ooi, Jillian L. S.] Univ Malaya, Dept Geog, Fac Arts & Social Sci, Kuala Lumpur, Malaysia; [Holmes, Karen W.] Univ Western Australia, Ctr Ecohydrol, Sch Environm Engn, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia; Universiti Malaya; University of Western Australia	Ooi, JLS (corresponding author), Univ Western Australia, Sch Plant Biol, Fac Nat & Agr Sci, Perth, WA 6009, Australia.	jillian_03@um.edu.my	OOI, JILLIAN/B-5252-2010; Holmes, karen/AAS-6809-2021; Kendrick, Gary Andrew/B-3460-2011	OOI, JILLIAN/0000-0002-1764-6495; Kendrick, Gary Andrew/0000-0002-0276-6064	MOSTI [04-01-03-SF0177]; Grant for Research Student Training (GRST, UWA); Endeavour International Postgraduate Research Scholarship; University Postgraduate Award; University of Western Australia; Universiti Malaya	MOSTI(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Grant for Research Student Training (GRST, UWA); Endeavour International Postgraduate Research Scholarship(Australian Government); University Postgraduate Award; University of Western Australia; Universiti Malaya(Universiti Malaya)	Fieldtrips were partly funded by the MOSTI E-Science grant (04-01-03-SF0177) and the Grant for Research Student Training (GRST, UWA) awarded to JLSO. JLSO was supported by the Endeavour International Postgraduate Research Scholarship, the University Postgraduate Award, the PhD Completion Scholarship (University of Western Australia) and the Hadiah Cuti Belajar program (Universiti Malaya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOVERRO T, 1995, MAR ECOL PROG SER, V120, P203, DOI 10.3354/meps120203; Balestri E, 2003, MAR ECOL PROG SER, V250, P51, DOI 10.3354/meps250051; BIRCH WR, 1984, AQUAT BOT, V19, P343, DOI 10.1016/0304-3770(84)90048-2; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borg JA, 2005, ESTUAR COAST SHELF S, V62, P667, DOI 10.1016/j.ecss.2004.10.003; Bostrom C, 2011, MAR ECOL PROG SER, V427, P191, DOI 10.3354/meps09051; BURGESS TM, 1980, J SOIL SCI, V31, P315, DOI 10.1111/j.1365-2389.1980.tb02084.x; DENNISON WC, 1987, AQUAT BOT, V27, P15, DOI 10.1016/0304-3770(87)90083-0; DOBERMANN A, 1995, GEODERMA, V68, P173, DOI 10.1016/0016-7061(95)00035-M; Duarte CM, 1997, MAR ECOL PROG SER, V147, P285, DOI 10.3354/meps147285; Duarte CM, 2000, MAR ECOL PROG SER, V197, P231, DOI 10.3354/meps197231; DUARTE CM, 1991, AQUAT BOT, V40, P363, DOI 10.1016/0304-3770(91)90081-F; DUARTE CM, 1991, MAR ECOL PROG SER, V77, P289, DOI 10.3354/meps077289; Fonseca M, 2002, ECOL APPL, V12, P218, DOI 10.1890/1051-0761(2002)012[0218:MSLPAA]2.0.CO;2; Fonseca MS, 2008, ESTUAR COAST SHELF S, V76, P163, DOI 10.1016/j.ecss.2007.06.014; Fonseca MS, 1998, MAR ECOL PROG SER, V171, P109, DOI 10.3354/meps171109; FONSECA MS, 1987, AQUAT BOT, V27, P59, DOI 10.1016/0304-3770(87)90086-6; Gobert S, 2003, OCEANOL ACTA, V26, P199, DOI 10.1016/S0399-1784(02)00009-9; GOOVAERTS P, 1992, J SOIL SCI, V43, P597, DOI 10.1111/j.1365-2389.1992.tb00163.x; Goovaerts P, 1998, BIOL FERT SOILS, V27, P315, DOI 10.1007/s003740050439; Hammerli A, 2003, HEREDITY, V91, P448, DOI 10.1038/sj.hdy.6800310; Holmes KW, 2007, AQUAT CONSERV, V17, P385, DOI 10.1002/aqc.772; Holmes KW, 2005, BIOGEOCHEMISTRY, V74, P173, DOI 10.1007/s10533-004-3544-x; Japar Sidik B, 2006, AQUAT ECOSYST HEALTH, V9, P1; Kendrick GA, 2005, MAR ECOL PROG SER, V290, P291, DOI 10.3354/meps290291; Kendrick GA, 2008, ECOGRAPHY, V31, P191, DOI 10.1111/j.0906-7590.2008.5252.x; Lacap CDA, 2002, MAR ECOL PROG SER, V235, P75, DOI 10.3354/meps235075; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Marba N, 1996, MAR ECOL PROG SER, V133, P203, DOI 10.3354/meps133203; Marba N, 2002, MAR ECOL PROG SER, V226, P287, DOI 10.3354/meps226287; Marba N, 1998, MAR ECOL PROG SER, V174, P269, DOI 10.3354/meps174269; Marba N, 2006, OECOLOGIA, V150, P362, DOI 10.1007/s00442-006-0524-y; MCBRATNEY AB, 1986, J SOIL SCI, V37, P617, DOI 10.1111/j.1365-2389.1986.tb00392.x; Meadows PS, 2012, GEOMORPHOLOGY, V157, P31, DOI 10.1016/j.geomorph.2011.07.007; Migliaccio M, 2005, MAR ECOL PROG SER, V304, P55, DOI 10.3354/meps304055; Miller CJ, 2005, MAR ECOL PROG SER, V304, P45, DOI 10.3354/meps304045; NACORDA HM, 2008, BURROWING SHRIMPS SE; Nakaoka M, 2005, POPUL ECOL, V47, P167, DOI 10.1007/s10144-005-0226-z; Nakaoka M, 2000, ECOL RES, V15, P415, DOI 10.1046/j.1440-1703.2000.00362.x; OLIVER M, 1989, T I BRIT GEOGR, V14, P259, DOI 10.2307/622687; Ooi JLS, 2011, CONT SHELF RES, V31, P1945, DOI 10.1016/j.csr.2011.09.005; Ooi JLS, 2011, ESTUAR COAST SHELF S, V92, P118, DOI 10.1016/j.ecss.2010.12.021; PREEN A, 1995, MAR ECOL PROG SER, V124, P201, DOI 10.3354/meps124201; Ralph PJ, 2007, J EXP MAR BIOL ECOL, V350, P176, DOI 10.1016/j.jembe.2007.06.017; Rasheed MA, 2004, J EXP MAR BIOL ECOL, V310, P13, DOI 10.1016/j.jembe.2004.03.022; ROSSI RE, 1992, ECOL MONOGR, V62, P277, DOI 10.2307/2937096; Terrados J, 1998, ESTUAR COAST SHELF S, V46, P757, DOI 10.1006/ecss.1997.0304; Vermaat JE, 2009, PERSPECT PLANT ECOL, V11, P137, DOI 10.1016/j.ppees.2009.01.002; VERMAAT JE, 1995, MAR ECOL PROG SER, V124, P215, DOI 10.3354/meps124215; Wagner HH, 2003, ECOLOGY, V84, P1045, DOI 10.1890/0012-9658(2003)084[1045:SCIPCI]2.0.CO;2	51	21	21	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86782	10.1371/journal.pone.0086782	http://dx.doi.org/10.1371/journal.pone.0086782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497978	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900039
J	Soubeyrand, S; Tollenaere, C; Haon-Lasportes, E; Laine, AL				Soubeyrand, Samuel; Tollenaere, Charlotte; Haon-Lasportes, Emilie; Laine, Anna-Liisa			Regression-Based Ranking of Pathogen Strains with Respect to Their Contribution to Natural Epidemics	PLOS ONE			English	Article							PLANT-PATHOGEN; FITNESS; AGGRESSIVENESS; ADAPTATION; GENETICS; ECOLOGY	Genetic variation in pathogen populations may be an important factor driving heterogeneity in disease dynamics within their host populations. However, to date, we understand poorly how genetic diversity in diseases impact on epidemiological dynamics because data and tools required to answer this questions are lacking. Here, we combine pathogen genetic data with epidemiological monitoring of disease progression, and introduce a statistical exploratory method to investigate differences among pathogen strains in their performance in the field. The method exploits epidemiological data providing a measure of disease progress in time and space, and genetic data indicating the relative spatial patterns of the sampled pathogen strains. Applying this method allows to assign ranks to the pathogen strains with respect to their contributions to natural epidemics and to assess the significance of the ranking. This method was first tested on simulated data, including data obtained from an original, stochastic, multi-strain epidemic model. It was then applied to epidemiological and genetic data collected during one natural epidemic of powdery mildew occurring in its wild host population. Based on the simulation study, we conclude that the method can achieve its aim of ranking pathogen strains if the sampling effort is sufficient. For powdery mildew data, the method indicated that one of the sampled strains tends to have a higher fitness than the four other sampled strains, highlighting the importance of strain diversity for disease dynamics. Our approach allowing the comparison of pathogen strains in natural epidemic is complementary to the classical practice of using experimental infections in controlled conditions to estimate fitness of different pathogen strains. Our statistical tool, implemented in the R package StrainRanking, is mainly based on regression and does not rely on mechanistic assumptions on the pathogen dynamics. Thus, the method can be applied to a wide range of pathogens.	[Soubeyrand, Samuel; Haon-Lasportes, Emilie] INRA, Biostat & Spatial Proc UR546, Avignon, France; [Tollenaere, Charlotte; Laine, Anna-Liisa] Univ Helsinki, Metapopulat Res Grp, Dept Biosci, Helsinki, Finland	INRAE; University of Helsinki	Soubeyrand, S (corresponding author), INRA, Biostat & Spatial Proc UR546, Avignon, France.	Samuel.Soubeyrand@avignon.inra.fr	Tollenaere, Charlotte/ABB-6175-2020; Laine, Anna-Liisa/B-1398-2016	Tollenaere, Charlotte/0000-0003-2045-2824; Laine, Anna-Liisa/0000-0002-0703-5850; Soubeyrand, Samuel/0000-0003-2447-3067	Academy of Finland [250444, 136393, 133499]; European Research Council (PATHEVOL) [281517]; French National Research Agency (EMILE project); European Union Seventh Framework Programme (PLANTFOODSEC) [261752]	Academy of Finland(Academy of Finland); European Research Council (PATHEVOL); French National Research Agency (EMILE project)(French National Research Agency (ANR)); European Union Seventh Framework Programme (PLANTFOODSEC)	A-L Laine acknowledges funding from the Academy of Finland (Grant numbers 250444, 136393, 133499) and European Research Council (PATHEVOL; 281517). S Soubeyrand acknowledges funding from the French National Research Agency (EMILE project) and the European Union Seventh Framework Programme (PLANTFOODSEC, 261752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Archie EA, 2009, TRENDS ECOL EVOL, V24, P21, DOI 10.1016/j.tree.2008.08.008; Bruns E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-135; Carroll R., 2006, MEASUREMENT ERROR NO, V105; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Frenkel O, 2012, PLANT PATHOL, V61, P106, DOI 10.1111/j.1365-3059.2011.02502.x; Gibson GJ, 1999, P ROY SOC B-BIOL SCI, V266, P1743, DOI 10.1098/rspb.1999.0841; Gilligan CA, 2002, ADV BOT RES, V38, P1, DOI 10.1016/S0065-2296(02)38027-3; Giraud T, 2008, PARASITE, V15, P449, DOI 10.1051/parasite/2008153449; Grech K, 2006, J EVOLUTION BIOL, V19, P1620, DOI 10.1111/j.1420-9101.2006.01116.x; Laine AL, 2007, J EVOLUTION BIOL, V20, P2371, DOI 10.1111/j.1420-9101.2007.01406.x; Laine AL, 2006, J ECOL, V94, P217, DOI 10.1111/j.1365-2745.2005.01075.x; Luijckx P, 2011, ECOL LETT, V14, P125, DOI 10.1111/j.1461-0248.2010.01561.x; Manly BFJ, 1997, RANDOMIZATION BOOTST; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Ovaskainen O, 2006, ECOLOGY, V87, P880, DOI 10.1890/0012-9658(2006)87[880:IESFED]2.0.CO;2; Pariaud B, 2009, PLANT PATHOL, V58, P409, DOI 10.1111/j.1365-3059.2009.02039.x; Pullan RL, 2012, PARASITOLOGY, V139, P1870, DOI 10.1017/S0031182012000698; Qi WH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000580; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Salvaudon L, 2005, EVOLUTION, V59, P2518, DOI 10.1111/j.0014-3820.2005.tb00965.x; Shaw MW., 2002, PLANT PATHOLOGISTS P, P252; Silverman B.W., 1986, DENSITY ESTIMATION S; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Soubeyrand S, 2009, AM NAT, V174, P308, DOI 10.1086/603624; Soubeyrand S, 2006, STAT METHODOL, V3, P464, DOI DOI 10.1016/J4.STAMET.2005.12.005; Soubeyrand S, 2007, COMPUT STAT DATA AN, V51, P6404, DOI 10.1016/j.csda.2007.02.008; Tack AJM, 2012, J EVOLUTION BIOL, V25, P1918, DOI 10.1111/j.1420-9101.2012.02588.x; Thrall PH, 2002, EVOLUTION, V56, P1340; Tollenaere C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052492; Vale PF, 2009, HEREDITY, V103, P102, DOI 10.1038/hdy.2009.54; Vojvodic S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025035; Wolinska J, 2009, TRENDS PARASITOL, V25, P236, DOI 10.1016/j.pt.2009.02.004	36	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86591	10.1371/journal.pone.0086591	http://dx.doi.org/10.1371/journal.pone.0086591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497956	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900027
J	Tugizimana, F; Steenkamp, PA; Piater, LA; Dubery, IA				Tugizimana, Fidele; Steenkamp, Paul A.; Piater, Lizelle A.; Dubery, Ian A.			Multi-Platform Metabolomic Analyses of Ergosterol-Induced Dynamic Changes in Nicotiana tabacum Cells	PLOS ONE			English	Article							2-DIMENSIONAL GAS-CHROMATOGRAPHY; VARIABLE SELECTION METHODS; ABSCISIC-ACID; PLANT METABOLOMICS; SESQUITERPENOID BIOSYNTHESIS; SUSPENSION-CULTURES; SPECIALIZED METABOLISM; SECONDARY METABOLITES; DISEASE RESISTANCE; TERPENE SYNTHASES	Metabolomics is providing new dimensions into understanding the intracellular adaptive responses in plants to external stimuli. In this study, a multi-technology-metabolomic approach was used to investigate the effect of the fungal sterol, ergosterol, on the metabolome of cultured tobacco cells. Cell suspensions were treated with different concentrations (0-1000 nM) of ergosterol and incubated for different time periods (0-24 h). Intracellular metabolites were extracted with two methods: a selective dispersive liquid-liquid micro-extraction and a general methanol extraction. Chromatographic techniques (GC-FID, GC-MS, GCxGC-TOF-MS, UHPLC-MS) and H-1 NMR spectroscopy were used for quantitative and qualitative analyses. Multivariate data analyses (PCA and OPLS-DA models) were used to extract interpretable information from the multidimensional data generated from the analytical techniques. The results showed that ergosterol triggered differential changes in the metabolome of the cells, leading to variation in the biosynthesis of secondary metabolites. PCA scores plots revealed dose-and time-dependent metabolic variations, with optimal treatment conditions being found to be 300 nM ergosterol and an 18 h incubation period. The observed ergosterol-induced metabolic changes were correlated with changes in defence-related metabolites. The 'defensome' involved increases in terpenoid metabolites with five antimicrobial compounds (the bicyclic sesquiterpenoid phytoalexins: phytuberin, solavetivone, capsidiol, lubimin and rishitin) and other metabolites (abscisic acid and phytosterols) putatively identified. In addition, various phenylpropanoid precursors, cinnamic acid derivatives and - conjugates, coumarins and lignin monomers were annotated. These annotated metabolites revealed a dynamic reprogramming of metabolic networks that are functionally correlated, with a high complexity in their regulation.	[Tugizimana, Fidele; Steenkamp, Paul A.; Piater, Lizelle A.; Dubery, Ian A.] Univ Johannesburg, Dept Biochem, Johannesburg, South Africa; [Steenkamp, Paul A.] CSIR Biosci, Drug Discovery & Dev, Pretoria, South Africa	University of Johannesburg; Council for Scientific & Industrial Research (CSIR) - South Africa	Dubery, IA (corresponding author), Univ Johannesburg, Dept Biochem, Auckland Pk, Johannesburg, South Africa.	idubery@uj.ac.za	Tugizimana, Fidele/I-2952-2014; Dubery, Ian/A-6346-2013	Tugizimana, Fidele/0000-0001-8172-6599; Dubery, Ian/0000-0002-9079-4769; Piater, Lizelle/0000-0002-9526-0109	South African National Research Foundation (NRF) [IPRR2011032400055]	South African National Research Foundation (NRF)(National Research Foundation - South Africa)	The research was funded by the South African National Research Foundation (NRF), grant no. IPRR2011032400055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliferis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042576; Allwood JW, 2008, PHYSIOL PLANTARUM, V132, P117, DOI 10.1111/j.1399-3054.2007.01001.x; Allwood JW, 2010, PHYTOCHEM ANALYSIS, V21, P33, DOI 10.1002/pca.1187; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bateman KP, 2007, RAPID COMMUN MASS SP, V21, P1485, DOI 10.1002/rcm.2996; Bhalla R, 2005, PLANT CELL REP, V24, P562, DOI 10.1007/s00299-005-0054-9; Bino RJ, 2004, TRENDS PLANT SCI, V9, P418, DOI 10.1016/j.tplants.2004.07.004; Blumberg LM, 2003, J CHROMATOGR A, V985, P29, DOI 10.1016/S0021-9673(02)01416-4; Blumberg LM, 2001, J CHROMATOGR A, V933, P13, DOI 10.1016/S0021-9673(01)01276-6; Brown M, 2009, ANALYST, V134, P1322, DOI 10.1039/b901179j; Brown M, 2011, BIOINFORMATICS, V27, P1108, DOI 10.1093/bioinformatics/btr079; Bylesjo M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-207; Camacho D, 2005, METABOLOMICS, V1, P53, DOI 10.1007/s11306-005-1107-3; Cane DE, 1999, BIOORG MED CHEM LETT, V9, P1127, DOI 10.1016/S0960-894X(99)00149-3; Canellas E, 2010, ANAL CHIM ACTA, V666, P62, DOI 10.1016/j.aca.2010.03.032; Castello G, 2009, J CHROMATOGR A, V1216, P1607, DOI 10.1016/j.chroma.2008.11.049; CHAPPELL J, 1989, PLANT CELL REP, V8, P48, DOI 10.1007/BF00735777; CHAPPELL J, 1987, PLANT PHYSIOL, V85, P469, DOI 10.1104/pp.85.2.469; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Choi HK, 2007, PROCESS BIOCHEM, V42, P271, DOI 10.1016/j.procbio.2006.07.007; Choi YH, 2004, J NAT PROD, V67, P953, DOI 10.1021/np049919c; Choi YH, 2006, J NAT PROD, V69, P742, DOI 10.1021/np050535b; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Fernie AR, 2012, PLANT PHYSIOL, V158, P1139, DOI 10.1104/pp.112.193235; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Finkelstein Ruth R, 2002, Arabidopsis Book, V1, pe0058, DOI 10.1199/tab.0058; Fischer Regina, 1994, Current Opinion in Biotechnology, V5, P125, DOI 10.1016/S0958-1669(05)80024-2; Flores-Sanchez IJ, 2009, J BIOTECHNOL, V143, P157, DOI 10.1016/j.jbiotec.2009.05.006; Fukusaki E, 2005, J BIOSCI BIOENG, V100, P347, DOI 10.1263/jbb.100.347; Garcia-Mata C, 2007, NITRIC OXIDE-BIOL CH, V17, P143, DOI 10.1016/j.niox.2007.08.001; Gerber IB, 2004, PHYTOCHEMISTRY, V65, P2957, DOI 10.1016/j.phytochem.2004.09.005; GIDDINGS JC, 1995, J CHROMATOGR A, V703, P3, DOI 10.1016/0021-9673(95)00249-M; GRANADO J, 1995, PLANT PHYSIOL, V107, P485, DOI 10.1104/pp.107.2.485; Grata E, 2008, J CHROMATOGR B, V871, P261, DOI 10.1016/j.jchromb.2008.04.021; Grebenstein C, 2011, PHYTOCHEMISTRY, V72, P1341, DOI 10.1016/j.phytochem.2011.04.008; Griebel T, 2010, PLANT J, V63, P254, DOI 10.1111/j.1365-313X.2010.04235.x; Hammerschmidt R, 1999, ANNU REV PHYTOPATHOL, V37, P285, DOI 10.1146/annurev.phyto.37.1.285; Homayoun S.B., 2011, SCI RES ESSAYS, V6, P4369, DOI [10.5897/SRE10.1147, DOI 10.5897/SRE10.1147]; INGHAM JL, 1972, BOT REV, V38, P343, DOI 10.1007/BF02860009; Jackson AO, 1996, PLANT CELL, V8, P1651, DOI 10.1105/tpc.8.10.1651; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kaal E, 2008, J CHROMATOGR A, V1184, P43, DOI 10.1016/j.chroma.2007.11.114; Kachroo A, 2003, PLANT CELL, V15, P2952, DOI 10.1105/tpc.017301; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Kanani H, 2008, J CHROMATOGR B, V871, P191, DOI 10.1016/j.jchromb.2008.04.049; Kanani HH, 2007, METAB ENG, V9, P39, DOI 10.1016/j.ymben.2006.08.001; Kasparovsky T, 2003, PLANT PHYSIOL BIOCH, V41, P495, DOI 10.1016/S0981-9428(03)00058-5; Kasparovsky T, 2004, PLANT PHYSIOL BIOCH, V42, P429, DOI 10.1016/j.plaphy.2004.04.003; Keller H, 1998, PLANTA, V205, P467, DOI 10.1007/s004250050345; Kim HK, 2011, TRENDS BIOTECHNOL, V29, P267, DOI 10.1016/j.tibtech.2011.02.001; Kim HK, 2010, NAT PROTOC, V5, P536, DOI 10.1038/nprot.2009.237; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Koek MM, 2011, METABOLOMICS, V7, P1, DOI 10.1007/s11306-010-0219-6; KUC J, 1985, ARCH BIOCHEM BIOPHYS, V236, P455; Lochman J, 2006, PLANT MOL BIOL, V62, P43, DOI 10.1007/s11103-006-9002-5; Madala NE, 2012, INNATE IMMUN-LONDON, V18, P140, DOI 10.1177/1753425910392609; Marriott P, 2002, TRAC-TREND ANAL CHEM, V21, P573, DOI 10.1016/S0165-9936(02)00814-2; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; MCGARVEY DJ, 1995, PLANT CELL, V7, P1015, DOI 10.1105/tpc.7.7.1015; Mehmood T, 2012, CHEMOMETR INTELL LAB, V118, P62, DOI 10.1016/j.chemolab.2012.07.010; Mert-Turk Figen, 2002, Journal of Cell and Molecular Biology, V1, P1; Mialoundama AS, 2009, PLANT PHYSIOL, V150, P1556, DOI 10.1104/pp.109.138420; Milborrow BV, 2001, J EXP BOT, V52, P1145, DOI 10.1093/jexbot/52.359.1145; Moco S, 2007, TRAC-TREND ANAL CHEM, V26, P855, DOI 10.1016/j.trac.2007.08.003; Newman MA, 2001, MOL PLANT MICROBE IN, V14, P785, DOI 10.1094/MPMI.2001.14.6.785; Ni Y, 2008, FEBS LETT, V582, P2627, DOI 10.1016/j.febslet.2008.06.040; Nugroho LH, 2002, PLANT SCI, V162, P989, DOI 10.1016/S0168-9452(02)00049-3; Oh C, 2008, J CHROMATOGR A, V1179, P205, DOI 10.1016/j.chroma.2007.11.101; Peters RJB, 2009, J CHROMATOGR A, V1216, P8206, DOI 10.1016/j.chroma.2009.04.027; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Lopez-Gresa MP, 2010, PHYTOCHEM ANALYSIS, V21, P89, DOI 10.1002/pca.1179; Pritchard L, 2011, PLANT SCI, V180, P584, DOI 10.1016/j.plantsci.2010.12.008; Ralston-Hooper K, 2008, AQUAT TOXICOL, V88, P48, DOI 10.1016/j.aquatox.2008.03.002; Sanabria N, 2008, NEW PHYTOL, V178, P503, DOI 10.1111/j.1469-8137.2008.02403.x; Sanabria NM, 2006, BIOCHEM BIOPH RES CO, V344, P1001, DOI 10.1016/j.bbrc.2006.03.216; Sanabria Natasha M, 2010, Self Nonself, V1, P40; Sanchez-Sampedro A, 2007, J BIOTECHNOL, V130, P133, DOI 10.1016/j.jbiotec.2007.03.007; Schilmiller AL, 2012, CURR OPIN PLANT BIOL, V15, P338, DOI 10.1016/j.pbi.2011.12.005; Schnee C, 2002, PLANT PHYSIOL, V130, P2049, DOI 10.1104/pp.008326; Schure MR, 2011, J CHROMATOGR A, V1218, P293, DOI 10.1016/j.chroma.2010.11.016; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; Shellie RA, 2005, J CHROMATOGR A, V1086, P83, DOI 10.1016/j.chroma.2005.05.088; Smith CJ, 1996, NEW PHYTOL, V132, P1, DOI 10.1111/j.1469-8137.1996.tb04506.x; Song WW, 2011, PLANT PHYSIOL BIOCH, V49, P693, DOI 10.1016/j.plaphy.2011.03.018; STOESSL A, 1976, PHYTOCHEMISTRY, V15, P855, DOI 10.1016/S0031-9422(00)84361-7; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Sumner LW, 2003, PHYTOCHEMISTRY, V62, P817, DOI 10.1016/S0031-9422(02)00708-2; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Toumi I, 2010, J PLANT PHYSIOL, V167, P519, DOI 10.1016/j.jplph.2009.10.022; TOWILL LE, 1975, CAN J BOT, V53, P1097, DOI 10.1139/b75-129; Trivedi D. K., 2012, J CHROMATOGR SEP TEC, V3, P1, DOI DOI 10.4172/2157-7064.1000145; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Tugizimana Fidele, 2013, S. Afr. j. sci., V109, P01; Tugizimana F, 2012, MOLECULES, V17, P1698, DOI 10.3390/molecules17021698; Tulipani S, 2011, J PROTEOME RES, V10, P5047, DOI 10.1021/pr200514h; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; van Gulik WM, 2001, ENZYME MICROB TECH, V28, P796, DOI 10.1016/S0141-0229(01)00331-3; Vasconsuelo A, 2007, PLANT SCI, V172, P861, DOI 10.1016/j.plantsci.2007.01.006; Vatsa P, 2011, PLANT PHYSIOL BIOCH, V49, P764, DOI 10.1016/j.plaphy.2011.04.002; Verpoorte R., 2007, Phytochemistry Reviews, V6, P3, DOI 10.1007/s11101-006-9031-3; Verpoorte R., 2008, Phytochemistry Reviews, V7, P525, DOI 10.1007/s11101-008-9091-7; Vichi M, 2009, COMPUT STAT DATA AN, V53, P3194, DOI 10.1016/j.csda.2008.05.028; VOGELI U, 1990, PLANT PHYSIOL, V93, P182, DOI 10.1104/pp.93.1.182; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang KR, 2012, PLANT PHYSIOL, V158, P1789, DOI 10.1104/pp.111.189217; Weckwerth W, 2004, P NATL ACAD SCI USA, V101, P7809, DOI 10.1073/pnas.0303415101; Weckwerth W, 2002, CURR OPIN BIOTECH, V13, P156, DOI 10.1016/S0958-1669(02)00299-9; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wilson RB, 2011, J CHROMATOGR A, V1218, P3130, DOI 10.1016/j.chroma.2010.12.108; WINK M, 1988, THEOR APPL GENET, V75, P225, DOI 10.1007/BF00303957; Xiao JF, 2012, TRAC-TREND ANAL CHEM, V32, P1, DOI 10.1016/j.trac.2011.08.009; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Zang XH, 2009, CHINESE J ANAL CHEM, V37, P161, DOI 10.1016/S1872-2040(08)60082-1; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhao CX, 2005, J CHROMATOGR A, V1096, P76, DOI 10.1016/j.chroma.2005.09.067; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zook M, 1996, PLANT PHYSIOL, V112, P311, DOI 10.1104/pp.112.1.311	124	44	45	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87846	10.1371/journal.pone.0087846	http://dx.doi.org/10.1371/journal.pone.0087846			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498209	gold, Green Published			2022-12-25	WOS:000330621900182
J	VanBavel, E; Tuna, BG				VanBavel, Ed; Tuna, Bilge Guvenc			Integrative Modeling of Small Artery Structure and Function Uncovers Critical Parameters for Diameter Regulation	PLOS ONE			English	Article							MESENTERIC SMALL ARTERIES; RESISTANCE ARTERIES; BLOOD-FLOW; WALL TENSION; ACTIVATION; MUTATIONS; PRESSURE; VASOCONSTRICTION; BIOMECHANICS; DISSECTIONS	Organ perfusion is regulated by vasoactivity and structural adaptation of small arteries and arterioles. These resistance vessels are sensitive to pressure, flow and a range of vasoactive stimuli. Several strongly interacting control loops exist. As an example, the myogenic response to a change of pressure influences the endothelial shear stress, thereby altering the contribution of shear-dependent dilation to the vascular tone. In addition, acute responses change the stimulus for structural adaptation and vice versa. Such control loops are able to maintain resistance vessels in a functional and stable state, characterized by regulated wall stress, shear stress, matched active and passive biomechanics and presence of vascular reserve. In this modeling study, four adaptation processes are identified that together with biomechanical properties effectuate such integrated regulation: control of tone, smooth muscle cell length adaptation, eutrophic matrix rearrangement and trophic responses. Their combined action maintains arteries in their optimal state, ready to cope with new challenges, allowing continuous long-term vasoregulation. The exclusion of any of these processes results in a poorly regulated state and in some cases instability of vascular structure.	[VanBavel, Ed; Tuna, Bilge Guvenc] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	VanBavel, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.vanbavel@amc.uva.nl	Tuna, Bilge Guvenc/AAB-5827-2020; Tuna, Bilge Güvenç/O-2215-2014	Tuna, Bilge Guvenc/0000-0003-1348-1336; Tuna, Bilge Güvenç/0000-0003-1348-1336; van Bavel, Ed/0000-0001-8654-986X	European Commission [235711]	European Commission(European CommissionEuropean Commission Joint Research Centre)	BGT is supported by grant 235711 (Small Artery remodeling) of the Marie Curie program of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Bakker ENTP, 2002, J VASC RES, V39, P12, DOI 10.1159/000048989; Bakker ENTP, 2008, CARDIOVASC RES, V78, P341, DOI 10.1093/cvr/cvn050; Bakker ENTP, 2008, J VASC RES, V45, P271, DOI 10.1159/000113599; Bakker ENTP, 2006, CIRC RES, V99, P86, DOI 10.1161/01.RES.0000229657.83816.a7; BURROWS ME, 1981, AM J PHYSIOL, V241, pH829, DOI 10.1152/ajpheart.1981.241.6.H829; Buus CL, 2001, CIRC RES, V89, P180, DOI 10.1161/hh1401.093575; Chilian WM, 2012, J MOL CELL CARDIOL, V52, P905, DOI 10.1016/j.yjmcc.2011.12.006; Cornelissen AJM, 2002, AM J PHYSIOL-HEART C, V282, pH2224, DOI 10.1152/ajpheart.00491.2001; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; Eftekhari A, 2011, J HYPERTENS, V29, P896, DOI 10.1097/HJH.0b013e3283447a1c; Fung Y.C., 1984, BIODYNAMICS CIRCULAT; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Hacking WJG, 1996, AM J PHYSIOL-HEART C, V270, pH364, DOI 10.1152/ajpheart.1996.270.1.H364; Heeneman S, 2007, CIRC RES, V101, P441, DOI 10.1161/CIRCRESAHA.107.148338; Jacobsen JCB, 2008, AM J PHYSIOL-REG I, V294, pR1379, DOI 10.1152/ajpregu.00407.2007; KUO L, 1991, AM J PHYSIOL, V261, pH1706, DOI 10.1152/ajpheart.1991.261.6.H1706; Martinez-Lemus LA, 2004, FASEB J, V18, P708, DOI 10.1096/fj.03-0634fje; Martinez-Lemus LA, 2011, AM J PHYSIOL-HEART C, V300, pH2005, DOI 10.1152/ajpheart.01066.2010; Martinez-Lemus LA, 2009, PHYSIOLOGY, V24, P45, DOI 10.1152/physiol.00029.2008; McGrath JC, 2005, EXP PHYSIOL, V90, P469, DOI 10.1113/expphysiol.2005.030130; Mulvany MJ, 2012, BASIC CLIN PHARMACOL, V110, P49, DOI 10.1111/j.1742-7843.2011.00758.x; Osol G, 2009, PHYSIOLOGY, V24, P58, DOI 10.1152/physiol.00033.2008; Pourageaud F, 1997, AM J PHYSIOL-HEART C, V273, pH1699, DOI 10.1152/ajpheart.1997.273.4.H1699; Prewitt RL, 2002, MICROCIRCULATION, V9, P295, DOI 10.1038/sj.mn.7800143; PRIES AR, 1995, CIRC RES, V77, P1017, DOI 10.1161/01.RES.77.5.1017; Smith N, 2011, PROG BIOPHYS MOL BIO, V104, P1, DOI 10.1016/j.pbiomolbio.2010.12.006; Sonoyama Kazuhiko, 2007, Ther Adv Cardiovasc Dis, V1, P129, DOI 10.1177/1753944707086358; Sorop O, 2003, CIRC RES, V92, P1344, DOI 10.1161/01.RES.0000078604.47063.2B; Sorop O, 2006, AM J PHYSIOL-HEART C, V291, pH1236, DOI 10.1152/ajpheart.00838.2005; Tuna BG, 2013, J VASCULAR IN PRESS; Tuna BG, 2013, J BIOMECH, V46, P1420, DOI 10.1016/j.jbiomech.2013.03.010; Tuna BG, 2012, BASIC CLIN PHARMACOL, V110, P35, DOI 10.1111/j.1742-7843.2011.00794.x; van den Akker J, 2010, J VASC RES, V47, P183, DOI 10.1159/000255962; VanBavel E, 1998, CIRC RES, V82, P210; VANBAVEL E, 1994, J PHYSIOL-LONDON, V477, P103, DOI 10.1113/jphysiol.1994.sp020175; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	38	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86901	10.1371/journal.pone.0086901	http://dx.doi.org/10.1371/journal.pone.0086901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497993	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900045
J	Xu, HX; Yang, Y; Xie, L; Li, XY; Feng, C; Chen, JW; Xu, CJ				Xu, Hongxia; Yang, Yong; Xie, Li; Li, Xiaoying; Feng, Chao; Chen, Junwei; Xu, Changjie			Involvement of Multiple Types of Dehydrins in the Freezing Response in Loquat (Eriobotrya japonica)	PLOS ONE			English	Article							COLD-ACCLIMATION; LIPID-PEROXIDATION; PLANT DEHYDRINS; CITRUS DEHYDRIN; ACIDIC DEHYDRIN; GENE FAMILY; EXPRESSION; STRESS; ACCUMULATION; MEMBRANE	Dehydrins (DHNs) are a family of plant proteins typically induced in response to stress conditions that cause cellular dehydration, such as low temperatures, high salinity, and drought. Loquat (Eriobotrya japonica) is a perennial fruit crop that blossoms during winter. Loquat fruitlets are frequently injured by freezing. To evaluate the role of the EjDHNs in freezing resistance in loquat fruitlets, two cultivars of loquat, the freezing-sensitive 'Ninghaibai' (FS-NHB) and the freezing-tolerant 'Jiajiao' (FT-JJ), were analyzed under induced freezing stress. Freezing stress led to obvious accumulation of reactive oxygen species and considerable lipid peroxidation in membranes during the treatment period. Both these phenomena were more pronounced in 'FS-NHB' than in 'FS-JJ.' Immunogold labeling of dehydrin protein was performed. DHN proteins were found to be concentrated mainly in the vicinity of the plasma membrane, and the density of the immunogold labeling was significantly higher after freezing treatment, especially in the more freezing-tolerant cultivar 'FT-JJ.' Seven DHNs, showing four different structure types, were obtained from loquat fruitlets and used to study the characteristics of different EjDHN proteins. These DHN proteins are all highly hydrophilic, but they differ significantly in size, ranging from 188 to 475 amino acids, and in biochemical properties, such as theoretical pI, aliphatic index, and instability index. Freezing treatment resulted in up-regulation of the expression levels of all seven EjDHNs, regardless of structure type. The accumulation of the transcripts of these EjDHN genes was much more pronounced in 'FT-JJ' than in 'FS-NHB.' Altogether, this study provides evidence that EjDHNs are involved in the cryoprotection of the plasma membrane during freeze-induced dehydration in loquat fruitlets.	[Xu, Hongxia; Feng, Chao; Xu, Changjie] Zhejiang Univ, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Lab Fruit Qual Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Xu, Hongxia; Li, Xiaoying; Chen, Junwei] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China; [Yang, Yong; Xie, Li] Zhejiang Acad Agr Sci, MOA, Inst Virol & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Yang, Yong; Xie, Li] Zhejiang Acad Agr Sci, Zhejiang Prov Key Lab Plant Virol, Inst Virol & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences	Xu, CJ (corresponding author), Zhejiang Univ, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Lab Fruit Qual Biol, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China.	chjxu@zju.edu.cn	Xu, Changjie/D-2656-2009		National Science Foundation of China [31101530]; Natural Science Foundation of Zhejiang Province [Y306128]; Program for Zhejiang Leading Team of Scientific and Technology Innovation [2009R50033]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Program for Zhejiang Leading Team of Scientific and Technology Innovation	This study was supported by the National Science Foundation of China (Grant No. 31101530), the Natural Science Foundation of Zhejiang Province (Grant No. Y306128), and the Program for Zhejiang Leading Team of Scientific and Technology Innovation (Grant No. 2009R50033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARCLAY KD, 1994, LIPIDS, V29, P877, DOI 10.1007/BF02536256; Beauchamp C. O., 1981, ANAL BIOCHEM, V44, P867; Borovskii GB, 2000, J PLANT PHYSIOL, V156, P797, DOI 10.1016/S0176-1617(00)80250-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen LA, 2011, PLANT CELL REP, V30, P463, DOI 10.1007/s00299-010-0952-3; Cheng HY, 2008, J INTEGR PLANT BIOL, V50, P1549, DOI 10.1111/j.1744-7909.2008.00723.x; Choi DW, 2000, THEOR APPL GENET, V100, P1274, DOI 10.1007/s001220051434; Choi DW, 1999, THEOR APPL GENET, V98, P1234, DOI 10.1007/s001220051189; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Danyluk J, 1998, PLANT CELL, V10, P623, DOI 10.1105/tpc.10.4.623; DANYLUK J, 1994, FEBS LETT, V344, P20, DOI 10.1016/0014-5793(94)00353-X; Dhanaraj AL, 2005, PLANT SCI, V168, P949, DOI 10.1016/j.plantsci.2004.11.007; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; Eriksson SK, 2011, PLANT CELL, V23, P2391, DOI 10.1105/tpc.111.085183; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Fernandez M, 2012, TREE GENET GENOMES, V8, P149, DOI 10.1007/s11295-011-0429-8; Garcia-Banuelos ML, 2009, PLANT MOL BIOL REP, V27, P476, DOI 10.1007/s11105-009-0110-7; GILMOUR SJ, 1992, PLANT MOL BIOL, V18, P13, DOI 10.1007/BF00018452; Hara M, 2005, J EXP BOT, V56, P2695, DOI 10.1093/jxb/eri262; Hara M, 2004, PLANT PHYSIOL BIOCH, V42, P657, DOI 10.1016/j.plaphy.2004.06.004; Hara M, 2003, PLANTA, V217, P290, DOI 10.1007/s00425-003-0986-7; Hara M, 1999, BIOSCI BIOTECH BIOCH, V63, P433, DOI 10.1271/bbb.63.433; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171; KOSTER KL, 1992, PLANT PHYSIOL, V98, P108, DOI 10.1104/pp.98.1.108; Liang D, 2012, MOL BIOL REP, V39, P10759, DOI 10.1007/s11033-012-1968-2; Liu CC, 2012, PLANT MOL BIOL REP, V30, P848, DOI 10.1007/s11105-011-0395-1; MORTIMER JA, 1987, COPEIA, P103, DOI 10.2307/1446043; MUTHALIF MM, 1994, PLANT PHYSIOL, V104, P1439, DOI 10.1104/pp.104.4.1439; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Rampino P, 2006, PLANT CELL ENVIRON, V29, P2143, DOI 10.1111/j.1365-3040.2006.01588.x; Rodriguez EM, 2005, THEOR APPL GENET, V110, P852, DOI 10.1007/s00122-004-1877-4; Rorat T, 2006, CELL MOL BIOL LETT, V11, P536, DOI 10.2478/s11658-006-0044-0; Shan LL, 2008, PLANTA, V227, P1243, DOI 10.1007/s00425-008-0696-2; SUKUMARAN N P, 1972, Hortscience, V7, P467; Sun X, 2010, BIOLOGIA, V65, P755, DOI 10.2478/s11756-010-0090-y; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao DL, 1998, CRYOBIOLOGY, V37, P38, DOI 10.1006/cryo.1998.2096; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; THOMPSON JE, 1987, NEW PHYTOL, V105, P317, DOI 10.1111/j.1469-8137.1987.tb00871.x; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Wisniewski ME, 2006, TREE PHYSIOL, V26, P575, DOI 10.1093/treephys/26.5.575; Xu HongXia, 2011, Acta Horticulturae Sinica, V38, P1071; Yang YZ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-140; Yang Y, 2011, J PLANT PHYSIOL, V168, P1701, DOI 10.1016/j.jplph.2011.02.012	49	24	28	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87575	10.1371/journal.pone.0087575	http://dx.doi.org/10.1371/journal.pone.0087575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498141	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900136
J	Tobin, SJ; Cacao, EE; Hong, DWW; Terenius, L; Vukojevic, V; Jovanovic-Talisman, T				Tobin, Steven J.; Cacao, Eliedonna E.; Hong, Daniel Wing Wo; Terenius, Lars; Vukojevic, Vladana; Jovanovic-Talisman, Tijana			Nanoscale Effects of Ethanol and Naltrexone on Protein Organization in the Plasma Membrane Studied by Photoactivated Localization Microscopy (PALM)	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; NUCLEUS-ACCUMBENS; ACTIN CYTOSKELETON; ALCOHOL; CHOLESTEROL; MICE; HETEROGENEITY; STIMULATION; ANESTHETICS; ACTIVATION	Background: Ethanol affects the signaling of several important neurotransmitter and neuromodulator systems in the CNS. It has been recently proposed that ethanol alters the dynamic lateral organization of proteins and lipids in the plasma membrane, thereby affecting surface receptor-mediated cellular signaling. Our aims are to establish whether pharmacologically relevant levels of ethanol can affect the lateral organization of plasma membrane and cytoskeletal proteins at the nanoscopic level, and investigate the relevance of such perturbations for mu-opioid receptor (MOP) function. Methodology/Principal Findings: We used Photoactivated Localization Microscopy with pair-correlation analysis (pcPALM), a quantitative fluorescence imaging technique with high spatial resolution (15-25 nm) and single-molecule sensitivity, to study ethanol effects on protein organization in the plasma membrane. We observed that short (20 min) exposure to 20 and 40 mM ethanol alters protein organization in the plasma membrane of cells that harbor endogenous MOPs, causing a rearrangement of the lipid raft marker glycosylphosphatidylinositol (GPI). These effects could be largely occluded by pretreating the cells with the MOP antagonist naltrexone (200 nM for 3 hours). In addition, ethanol induced pronounced actin polymerization, leading to its partial co-localization with GPI. Conclusions/Significance: Pharmacologically relevant levels of ethanol alter the lateral organization of GPI-linked proteins and induce actin cytoskeleton reorganization. Pretreatment with the MOP antagonist naltrexone is protective against ethanol action and significantly reduces the extent to which ethanol remodels the lateral organization of lipid-rafts-associated proteins in the plasma membrane. Super-resolution pcPALM reveals details of ethanol action at the nanoscale level, giving new mechanistic insight on the cellular and molecular mechanisms of its action.	[Tobin, Steven J.; Cacao, Eliedonna E.; Jovanovic-Talisman, Tijana] City Hope Comprehens Canc Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Tobin, Steven J.; Cacao, Eliedonna E.; Hong, Daniel Wing Wo; Jovanovic-Talisman, Tijana] Univ Hawaii Manoa, Dept Chem, Honolulu, HI 96822 USA; [Terenius, Lars; Vukojevic, Vladana] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	City of Hope; Beckman Research Institute of City of Hope; University of Hawaii System; University of Hawaii Manoa; Karolinska Institutet	Jovanovic-Talisman, T (corresponding author), City Hope Comprehens Canc Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA.	ttalisman@coh.org	Vukojevic, Vladana B/AAY-3144-2021	Vukojevic, Vladana/0000-0003-0873-5653; Jovanovic-Talisman, Tijana/0000-0003-1928-4763	University of Hawaii at Manoa; Undergraduate Research Opportunities program, UH Manoa; Beckman Research Institute of the City of Hope; Karolinska Institutet; NIAAA [R21 AA017272]	University of Hawaii at Manoa; Undergraduate Research Opportunities program, UH Manoa; Beckman Research Institute of the City of Hope; Karolinska Institutet(Karolinska Institutet); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding sources include University of Hawaii at Manoa; The Undergraduate Research Opportunities program, UH Manoa; Beckman Research Institute of the City of Hope; Karolinska Institutet; and NIAAA (grant R21 AA017272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo GI, 1996, ALCOHOL, V13, P597, DOI 10.1016/S0741-8329(96)00074-2; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Coltharp C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051725; Dai Q, 2005, BIOCHEM BIOPH RES CO, V332, P37, DOI 10.1016/j.bbrc.2005.04.088; Dai Q, 2006, ALCOHOL CLIN EXP RES, V30, P1436, DOI 10.1111/j.1530-0277.2006.00172.x; Drell TL, 2003, BREAST CANCER RES TR, V80, P63, DOI 10.1023/A:1024491219366; Entschladen F, 2004, ANN NY ACAD SCI, V1028, P320, DOI 10.1196/annals.1322.036; Fernandez-Lizarbe S, 2013, J NEUROCHEM; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Georgoussi Z, 2012, CURR DRUG TARGETS, V13, P80, DOI 10.2174/138945012798868470; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Grahame NJ, 1998, ALCOHOL CLIN EXP RES, V22, P1093, DOI 10.1111/j.1530-0277.1998.tb03706.x; Grisel JE, 1999, BRAIN RES, V835, P62, DOI 10.1016/S0006-8993(99)01384-0; Guizzetti M, 2007, HUM EXP TOXICOL, V26, P355, DOI 10.1177/0960327107078412; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hulse GK, 2009, ARCH GEN PSYCHIAT, V66, P1108, DOI 10.1001/archgenpsychiatry.2009.130; Jayaram-Lindstrom N, 2008, NEUROPSYCHOPHARMACOL, V33, P1856, DOI 10.1038/sj.npp.1301572; Jung SW, 2005, J BIOL CHEM, V280, P308, DOI 10.1074/jbc.M409871200; Koenig HN, 2002, NEUROSCI LETT, V325, P75, DOI 10.1016/S0304-3940(02)00242-2; Lam M, 2008, PSYCHOPHARMACOLOGY, V201, P261, DOI 10.1007/s00213-008-1267-8; Lamberts JT, 2013, CURR PHARM DES; Lando D, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120078; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Lee MW, 2009, EXPERT OPIN PHARMACO, V10, P1841, DOI 10.1517/14656560903048959; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Malkusch S, 2013, HISTOCHEM CELL BIOL, V139, P173, DOI 10.1007/s00418-012-1014-4; Mann K, 2010, EUR ARCH PSY CLIN N, V260, pS116, DOI 10.1007/s00406-010-0153-7; Marinelli PW, 2004, ALCOHOL CLIN EXP RES, V28, p55A; Milligan G, 2005, NEUROMOL MED, V7, P51, DOI 10.1385/NMM:7:1-2:051; Nourissat P, 2008, HEPATOLOGY, V47, P59, DOI 10.1002/hep.21958; Olive MF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0002.2001; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Petrovic P, 2008, J NEUROSCI, V28, P10509, DOI 10.1523/JNEUROSCI.2807-08.2008; Roberts AJ, 2000, J PHARMACOL EXP THER, V293, P1002; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sanchis-Segura C, 2005, ALCOHOL CLIN EXP RES, V29, P1522, DOI 10.1097/01.alc.0000174913.60384.e8; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Scarselli M, 2012, J BIOL CHEM, V287, P16768, DOI 10.1074/jbc.M111.329912; SEEMAN P, 1972, PHARMACOL REV, V24, P583; Sengupta P, 2013, NAT PROTOC, V8, P345, DOI 10.1038/nprot.2013.005; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Simon EJ, 2010, NEUROCHEM RES, V35, P1859, DOI 10.1007/s11064-010-0261-9; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; Terama E, 2008, J PHYS CHEM B, V112, P4131, DOI 10.1021/jp0750811; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Vukojevic V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004008; Wang HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001893; Wang HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004282; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; YAMADA S, 1984, J CLIN INVEST, V74, P2285, DOI 10.1172/JCI111656; Zangen A, 2003, EUR J NEUROSCI, V17, P1067, DOI 10.1046/j.1460-9568.2003.02509.x	57	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87225	10.1371/journal.pone.0087225	http://dx.doi.org/10.1371/journal.pone.0087225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503624	Green Published, Green Submitted, gold			2022-12-25	WOS:000330631800023
J	Yang, J; Farioli, A; Korre, M; Kales, SN				Yang, Justin; Farioli, Andrea; Korre, Maria; Kales, Stefanos N.			Modified Mediterranean Diet Score and Cardiovascular Risk in a North American Working Population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SUGAR-SWEETENED BEVERAGES; METABOLIC SYNDROME; WEIGHT-GAIN; CARDIORESPIRATORY FITNESS; LIFE-STYLE; FOOD; PREDICTION; MORTALITY; HEALTH	Introduction: Greater adherence to a Mediterranean diet is linked to lower risk for cardiovascular morbidity/mortality in studies of Mediterranean cohorts, older subjects, and/or those with existing health conditions. No studies have examined the effects of this dietary pattern in younger working populations in the United States. We investigated the effects of Mediterranean diet adherence on cardiovascular disease (CVD) biomarkers, metabolic syndrome and body composition in an occupationally active, non-Mediterranean cohort. Methods: A cross-sectional study in a cohort of 780 career male firefighters, ages 18 years or older, from the United States Midwest. No dietary intervention was performed. A modified Mediterranean diet score (mMDS) was developed for assessment of adherence to a Mediterranean dietary pattern from a previously administered life-style questionnaire that examined pre-existing dietary habits. Clinical data from fire department medical examinations were extracted and analyzed. Results: Obese subjects had significantly lower mMDS, and they reported greater fast/take-out food consumption (p < 0.001) and intake of sweetened drinks during meals (p = 0.002). After multivariate adjustment, higher mMDS was inversely related to risk of weight gain over the past 5 years (odds ratio [OR]: 0.57, 95% confidence interval [CI]: 0.39-0.84, p for trend across score quartiles: 0.01); as well as the presence of metabolic syndrome components (OR: 0.65, 95% CI: 0.44-0.94, p for trend across score quartiles: 0.04). Higher HDL-cholesterol (p = 0.008) and lower LDL-cholesterol (p = 0.04) were observed in those with higher mMDS in linear regression after multivariate adjustment for age, BMI and physical activity. Conclusions: In a cohort of young and active US adults, greater adherence to a Mediterranean-style dietary pattern had significant inverse associations with metabolic syndrome, LDL-cholesterol and reported weight gain, and was significantly and independently associated with higher HDL-cholesterol. Our results support the potential effectiveness of this diet in young, non-Mediterranean working cohorts, and justify future intervention studies.	[Yang, Justin; Farioli, Andrea; Korre, Maria; Kales, Stefanos N.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth Environm & Occupat Med & Epide, Boston, MA 02115 USA; [Yang, Justin; Korre, Maria; Kales, Stefanos N.] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Cambridge, MA 02138 USA; [Farioli, Andrea] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Cambridge Health Alliance; University of Bologna	Kales, SN (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth Environm & Occupat Med & Epide, 665 Huntington Ave, Boston, MA 02115 USA.	skales@hsph.harvard.edu	Farioli, Andrea/K-9256-2016	Farioli, Andrea/0000-0003-2001-2140; Yang, Justin/0000-0002-9743-2074	U.S. Department of Homeland Security [EMW-2006-FP-01493, EMW-2009-FP-00835]	U.S. Department of Homeland Security(United States Department of Homeland Security (DHS))	Supported in part by grants from the U.S. Department of Homeland Security (EMW-2006-FP-01493 and EMW-2009-FP-00835 to Dr. Kales). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alcacera MA, 2008, EUR J CLIN NUTR, V62, P1178, DOI 10.1038/sj.ejcn.1602833; Martinez-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043134; Babio N, 2009, PUBLIC HEALTH NUTR, V12, P1607, DOI 10.1017/S1368980009990449; Barrington WE, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120001; Baur DM, 2012, J OBES, V2012, DOI 10.1155/2012/710903; Baur DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-480; Baur DM, 2012, J STRENGTH COND RES, V26, P2331, DOI 10.1519/JSC.0b013e31823e9b19; Baur DM, 2011, J OCCUP ENVIRON MED, V53, P1155, DOI 10.1097/JOM.0b013e31822c9e47; Biener L, 1999, HEALTH EDUC BEHAV, V26, P478, DOI 10.1177/109019819902600407; Binkley JK, 2000, INT J OBESITY, V24, P1032, DOI 10.1038/sj.ijo.0801356; Blanck HM, 2009, HEALTH EDUC BEHAV, V36, P289, DOI 10.1177/1090198107303308; Bonaccio M, 2013, APPETITE, V68, P139, DOI 10.1016/j.appet.2013.04.026; Di Daniele N, 2013, ACTA DIABETOL, V50, P409, DOI 10.1007/s00592-012-0445-7; Duffey KJ, 2012, AM J CLIN NUTR, V95, P909, DOI 10.3945/ajcn.111.026682; Durand G, 2011, MED SCI SPORT EXER, V43, P1752, DOI 10.1249/MSS.0b013e318215cf25; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3; Kafatos A, 1997, AM J CLIN NUTR, V65, P1882, DOI 10.1093/ajcn/65.6.1882; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Leiba A, 2013, J AM SOC HYPERTENS, V7, P40, DOI 10.1016/j.jash.2012.11.002; Leighton F, 2009, PUBLIC HEALTH NUTR, V12, P1635, DOI 10.1017/S1368980009990486; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Martinez-Gonzalez MA, 2011, NUTR METAB CARDIOVAS, V21, P237, DOI 10.1016/j.numecd.2009.10.005; Mitrou PN, 2007, ARCH INTERN MED, V167, P2461, DOI 10.1001/archinte.167.22.2461; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Nadtochiy SM, 2011, NUTRITION, V27, P733, DOI 10.1016/j.nut.2010.12.006; Nagler EM, 2013, CANCER CAUSE CONTROL, V24, P637, DOI 10.1007/s10552-012-9998-6; Nettleton JA, 2009, AM J CLIN NUTR, V90, P647, DOI 10.3945/ajcn.2009.27597; Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005; Odegaard AO, 2012, CIRCULATION, V126, P182, DOI 10.1161/CIRCULATIONAHA.111.084004; Panagiotakos DB, 2003, J HYPERTENS, V21, P1483, DOI 10.1097/00004872-200308000-00011; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; ROYSTON P, 1991, STATA TECHNICAL B RE, P110; Schwarzfuchs D, 2012, NEW ENGL J MED, V367, P1373, DOI 10.1056/NEJMc1204792; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Trichopoulou A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2337; Urquiaga I, 2010, ATHEROSCLEROSIS, V211, P694, DOI 10.1016/j.atherosclerosis.2010.04.020; Vincent-Baudry S, 2005, AM J CLIN NUTR, V82, P964, DOI 10.1093/ajcn/82.5.964; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodward-Lopez G, 2011, PUBLIC HEALTH NUTR, V14, P499, DOI 10.1017/S1368980010002375	49	59	60	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87539	10.1371/journal.pone.0087539	http://dx.doi.org/10.1371/journal.pone.0087539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503596	Green Published, gold			2022-12-25	WOS:000330631800044
J	Dornas, FP; Silva, LCF; de Almeida, GM; Campos, RK; Boratto, PVM; Franco-Luiz, APM; La Scola, B; Ferreira, PCP; Kroon, EG; Abrahao, JS				Dornas, Fabio P.; Silva, Lorena C. F.; de Almeida, Gabriel M.; Campos, Rafael K.; Boratto, Paulo V. M.; Franco-Luiz, Ana P. M.; La Scola, Bernard; Ferreira, Paulo C. P.; Kroon, Erna G.; Abrahao, Jonatas S.			Acanthamoeba polyphaga mimivirus Stability in Environmental and Clinical Substrates: Implications for Virus Detection and Isolation	PLOS ONE			English	Article							PUTATIVE PNEUMONIA AGENT; GIANT VIRUSES; MARINE; SEQUENCES; VIROPHAGE; RELATIVES; SEAWATER	Viruses are extremely diverse and abundant and are present in countless environments. Giant viruses of the Megavirales order have emerged as a fascinating research topic for virologists around the world. As evidence of their ubiquity and ecological impact, mimiviruses have been found in multiple environmental samples. However, isolation of these viruses from environmental samples is inefficient, mainly due to methodological limitations and lack of information regarding the interactions between viruses and substrates. In this work, we demonstrate the long-lasting stability of mimivirus in environmental (freshwater and saline water) and hospital (ventilator plastic device tube) substrates, showing the detection of infectious particles after more than 9 months. In addition, an enrichment protocol was implemented that remarkably increased mimivirus detection from all tested substrates, including field tests. Moreover, biological, morphological and genetic tests revealed that the enrichment protocol maintained mimivirus particle integrity. In conclusion, our work demonstrated the stability of APMV in samples of environmental and health interest and proposed a reliable and easy protocol to improve giant virus isolation. The data presented here can guide future giant virus detection and isolation studies.	[Dornas, Fabio P.; Silva, Lorena C. F.; de Almeida, Gabriel M.; Campos, Rafael K.; Boratto, Paulo V. M.; Franco-Luiz, Ana P. M.; Ferreira, Paulo C. P.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil; [La Scola, Bernard] Aix Marseille Univ, URMITE, CNRS, IRD 3R198,UMR 6236, Marseille, France	Universidade Federal de Minas Gerais; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil.	jonatas.abrahao@gmail.com	Campos, Rafael Kroon/AAB-5135-2020; LA SCOLA, Bernard/P-6477-2016; Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Dornas, Fabio/AAI-3582-2020; Almeida, Gabriel MF/I-8910-2012; Abrahão, Jônatas/B-3895-2015	Campos, Rafael Kroon/0000-0002-4852-0449; LA SCOLA, Bernard/0000-0001-8006-7704; Kroon, Erna Geessien/0000-0003-2721-3826; Dornas, Fabio/0000-0001-7926-5551; Almeida, Gabriel MF/0000-0003-2317-5092; Abrahão, Jônatas/0000-0001-9420-1791; Boratto, Paulo/0000-0001-7531-888X				Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Boughalmi M., 2012, ENV MICROBIOL; Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108; Breitbart M, 2004, FEMS MICROBIOL LETT, V236, P249, DOI 10.1016/j.femsle.2004.05.042; Campos RK, 2012, J CLIN VIROL, V55, P323, DOI 10.1016/j.jcv.2012.08.009; Desnues C, 2010, INTERVIROLOGY, V53, P293, DOI 10.1159/000312914; Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109; GERBA CP, 1975, J WATER POLLUT CON F, V47, P93; Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62; Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; La Scola B, 2005, EMERG INFECT DIS, V11, P449, DOI 10.3201/eid1103.040538; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919; Monier A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-12; Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Raoult D, 2007, CLIN INFECT DIS, V45, P95, DOI 10.1086/518608; Rohwer F, 2009, ENVIRON MICROBIOL, V11, P2771, DOI 10.1111/j.1462-2920.2009.02101.x; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6; Van Etten JL, 2010, ANNU REV MICROBIOL, V64, P83, DOI 10.1146/annurev.micro.112408.134338; Wetz JJ, 2004, MAR POLLUT BULL, V48, P698, DOI 10.1016/j.marpolbul.2003.09.008; Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109	25	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87811	10.1371/journal.pone.0087811	http://dx.doi.org/10.1371/journal.pone.0087811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498379	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900125
J	Hoeke, MO; Heegsma, J; Hoekstra, M; Moshage, H; Faber, KN				Hoeke, Martijn O.; Heegsma, Janette; Hoekstra, Mark; Moshage, Han; Faber, Klaas Nico			Human FXR Regulates SHP Expression through Direct Binding to an LRH-1 Binding Site, Independent of an IR-1 and LRH-1	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; FARNESOID-X-RECEPTOR; SALT EXPORT PUMP; CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; BILE-ACID BIOSYNTHESIS; LIVER RECEPTOR; FEEDBACK-REGULATION; MOLECULAR-BASIS; DNA-BINDING; ACTIVATION	Background: Farnesoid X receptor/retinoid X receptor-alpha (FXR/RXR alpha) is the master transcriptional regulator of bile salt synthesis and transport in liver and intestine. FXR is activated by bile acids, RXR alpha by the vitamin A-derivative 9-cis retinoic acid (9cRA). Remarkably, 9cRA inhibits binding of FXR/RXR alpha to its response element, an inverted repeat-1 (IR-1). Still, most FXR/RXR alpha target genes are maximally expressed in the presence of both ligands, including the small heterodimer partner (SHP). Here, we revisited the FXR/RXR alpha-mediated regulation of human SHP. Methods: A 579-bp hSHP promoter element was analyzed to locate FXR/chenodeoxycholic acid (CDCA)-and RXR alpha/9cRA-responsive elements. hSHP promoter constructs were analyzed in FXR/RXR alpha-transfected DLD-1, HEK293 and HepG2 cells exposed to CDCA, GW4064 (synthetic FXR ligand) and/or 9cRA. FXR-DNA interactions were analyzed by in vitro pull down assays. Results: hSHP promoter elements lacking the previously identified IR-1 (-291/-279) largely maintained their activation by FXR/CDCA, but were unresponsive to 9cRA. FXR-mediated activation of the hSHP promoter was primarily dependent on the -122/-69 region. Pull down assays revealed a direct binding of FXR to the -122/-69 sequence, which was abrogated by site-specific mutations in a binding site for the liver receptor homolog-1 (LRH-1) at -78/-70. These mutations strongly impaired the FXR/CDCA-mediated activation, even in the context of a hSHP promoter containing the IR-1. LRH-1 did not increase FXR/RXR alpha-mediated activation of hSHP promoter activity. Conclusion: FXR/CDCA-activated expression of SHP is primarily mediated through direct binding to an LRH-1 binding site, which is not modulated by LRH-1 and unresponsive to 9cRA. 9cRA-induced expression of SHP requires the IR-1 that overlaps with a direct repeat-2 (DR-2) and DR-4. This establishes for the first time a co-stimulatory, but independent, action of FXR and RXR alpha agonists.	[Hoeke, Martijn O.; Heegsma, Janette; Hoekstra, Mark; Moshage, Han; Faber, Klaas Nico] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands	University of Groningen	Faber, KN (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.	k.n.faber@umcg.nl		Moshage, Han/0000-0002-4764-0246	Dutch Digestive Diseases Foundation [MLDS WS 03-38, MLDS MWO 08-70]	Dutch Digestive Diseases Foundation	This work was supported by grants from the Dutch Digestive Diseases Foundation (MLDS WS 03-38 to MOH and MLDS MWO 08-70 to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Blokzijl H, 2007, INFLAMM BOWEL DIS, V13, P710, DOI 10.1002/ibd.20088; Cai SY, 2010, J LIPID RES; Castelein H, 1996, MOL CELL ENDOCRINOL, V119, P11, DOI 10.1016/0303-7207(96)03794-X; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Chen WL, 2001, J LIPID RES, V42, P1402; Chong HK, 2010, NUCLEIC ACIDS RES, V38, P6007, DOI 10.1093/nar/gkq397; Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503; Dijkstra G, 2004, J PATHOL, V204, P296, DOI 10.1002/path.1656; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Frankenberg T, 2006, AM J PHYSIOL-GASTR L, V290, pG912, DOI 10.1152/ajpgi.00479.2005; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246; Hoeke MO, 2009, HEPATOLOGY, V49, P151, DOI 10.1002/hep.22661; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Kassam A, 2003, J BIOL CHEM, V278, P10028, DOI 10.1074/jbc.M208312200; Kim HI, 2007, BIOCHEM BIOPH RES CO, V360, P301, DOI 10.1016/j.bbrc.2007.05.171; Kullak-Ublick GA, 2000, CYTOTECHNOLOGY, V34, pB1, DOI 10.1023/A:1008152729133; Lee J, 2012, HEPATOLOGY; Lee YK, 1999, J BIOL CHEM, V274, P20869, DOI 10.1074/jbc.274.30.20869; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Matsukuma KE, 2007, J BIOL CHEM, V282, P20164, DOI 10.1074/jbc.M702895200; Matsukuma KE, 2006, J LIPID RES, V47, P2754, DOI 10.1194/jlr.M600342-JLR200; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Out C, 2011, HEPATOLOGY, V53, P2075, DOI 10.1002/hep.24286; Plass JRM, 2002, HEPATOLOGY, V35, P589, DOI 10.1053/jhep.2002.31724; Song CS, 2001, J BIOL CHEM, V276, P42549, DOI 10.1074/jbc.M107557200; Song KH, 2008, HEPATOLOGY; Song XL, 2008, J LIPID RES, V49, P973, DOI 10.1194/jlr.M700417-JLR200; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; UEDA H, 1992, MOL CELL BIOL, V12, P5667, DOI 10.1128/MCB.12.12.5667; Urizar NL, 2000, J BIOL CHEM, V275, P39313, DOI 10.1074/jbc.M007998200; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289	35	29	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88011	10.1371/journal.pone.0088011	http://dx.doi.org/10.1371/journal.pone.0088011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498423	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900169
J	Patel, V; Adya, R; Chen, J; Ramanjaneya, M; Bari, MF; Bhudia, SK; Hillhouse, EW; Tan, BK; Randeva, HS				Patel, Vanlata; Adya, Raghu; Chen, Jing; Ramanjaneya, Manjunath; Bari, Muhammad F.; Bhudia, Sunil K.; Hillhouse, Edward W.; Tan, Bee K.; Randeva, Harpal S.			Novel Insights into the Cardio-Protective Effects of FGF21 in Lean and Obese Rat Hearts	PLOS ONE			English	Article							GROWTH-FACTOR 21; EXPERIMENTAL MYOCARDIAL-ISCHEMIA; BETA-KLOTHO; CROSS-TALK; INFARCTION; EXPRESSION; LIVER; ASSOCIATION; REPERFUSION; REGULATOR	Aims: Fibroblast growth factor 21 (FGF21) is a hepatic metabolic regulator with pleotropic actions. Its plasma concentrations are increased in obesity and diabetes; states associated with an increased incidence of cardiovascular disease. We therefore investigated the direct effect of FGF21 on cardio-protection in obese and lean hearts in response to ischemia. Methods and Results: FGF21, FGF21-receptor 1 (FGFR1) and beta-Klotho (beta Klotho) were expressed in rodent, human hearts and primary rat cardiomyocytes. Cardiac FGF21 was expressed and secreted (real time RT-PCR/western blot and ELISA) in an autocrine-paracrine manner, in response to obesity and hypoxia, involving FGFR1-beta Klotho components. Cardiac-FGF21 expression and secretion were increased in response to global ischemia. In contrast beta Klotho was reduced in obese hearts. In isolated adult rat cardiomyocytes, FGF21 activated PI3K/Akt (phosphatidylinositol 3-kinase/Akt), ERK1/2(extracellular signal-regulated kinase) and AMPK (AMP-activated protein kinase) pathways. In Langendorff perfused rat [adult male wild-type wistar] hearts, FGF21 administration induced significant cardio-protection and restoration of function following global ischemia. Inhibition of PI3K/Akt, AMPK, ERK1/2 and ROR-alpha (retinoic-acid receptor alpha) pathway led to significant decrease of FGF21 induced cardio-protection and restoration of cardiac function in response to global ischemia. More importantly, this cardio-protective response induced by FGF21 was reduced in obesity, although the cardiac expression profiles and circulating FGF21 levels were increased. Conclusion: In an ex vivo Langendorff system, we show that FGF21 induced cardiac protection and restoration of cardiac function involving autocrine-paracrine pathways, with reduced effect in obesity. Collectively, our findings provide novel insights into FGF21-induced cardiac effects in obesity and ischemia.	[Patel, Vanlata; Adya, Raghu; Chen, Jing; Ramanjaneya, Manjunath; Bari, Muhammad F.; Tan, Bee K.; Randeva, Harpal S.] Univ Warwick, Warwick Med Sch, Div Metab & Vasc Hlth, Coventry CV4 7AL, W Midlands, England; [Bari, Muhammad F.] Dow Int Med Coll, Dept Pathol, Karachi, Pakistan; [Bhudia, Sunil K.] UHCW NHS Trust, Dept Cardiothorac Surg, Coventry, W Midlands, England; [Hillhouse, Edward W.] Hamad Med Corp, Doha, Qatar; [Hillhouse, Edward W.] Weill Cornell Med Sch, Doha, Qatar	University of Warwick; Dow University of Health Sciences; University of Warwick; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Randeva, HS (corresponding author), Univ Warwick, Warwick Med Sch, Div Metab & Vasc Hlth, Coventry CV4 7AL, W Midlands, England.	Harpal.Randeva@warwick.ac.uk	Bhudia, Sunil K/A-3150-2011; Bhudia, Sunil/AAF-8325-2020	Bhudia, Sunil K/0000-0002-6660-3141; 				Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bertinchant JP, 1999, CLIN CHIM ACTA, V283, P43, DOI 10.1016/S0009-8981(99)00029-7; Bose AK, 2005, DIABETES, V54, P146, DOI 10.2337/diabetes.54.1.146; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Clavijo LC, 2006, CARDIOVASC REVASCULA, V7, P7, DOI 10.1016/j.carrev.2005.10.007; Diaz-Delfin J, 2012, ENDOCRINOLOGY, V153, P4238, DOI 10.1210/en.2012-1193; Doroudgar S, 2013, J MOL CELL CARDIOL, V55, P85, DOI 10.1016/j.yjmcc.2012.10.006; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Hausenloy DJ, 2004, CARDIOVASC RES, V63, P305, DOI 10.1016/j.cardiores.2004.04.011; Jiao H, 2011, J CLIN ENDOCR METAB, V96, pE962, DOI 10.1210/jc.2010-2639; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Lionetti V, 2010, HEART FAIL REV, V15, P531, DOI 10.1007/s10741-010-9165-7; Liu SQ, 2012, AM J PHYSIOL-HEART C, V303, pH1446, DOI 10.1152/ajpheart.00362.2012; Liu SQ, 2011, CELL MOL BIOENG, V4, P693, DOI 10.1007/s12195-011-0197-4; Liu Shu Q, 2010, Front Biosci (Elite Ed), V2, P711, DOI 10.2741/e131; Lopaschuk GD, 1997, AM J CARDIOL, V80, pA11, DOI 10.1016/S0002-9149(97)00453-0; Mair J, 1999, CLIN CHEM LAB MED, V37, P1077, DOI 10.1515/CCLM.1999.157; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; MITRA R, 1985, AM J PHYSIOL, V249, P1056, DOI 10.1152/ajpheart.1985.249.5.H1056; Morabito D, 2002, INT J OBESITY, V26, P327, DOI 10.1038/sj.ijo.0801881; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; Nanayakkara G, 2012, AM J CARDIOVASC DIS, V2, P253; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Planavila A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3019; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; RODRIGO GC, 1991, J PHYSIOL-LONDON, V434, P627, DOI 10.1113/jphysiol.1991.sp018490; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; SHAH PK, 1991, AM J CARDIOL, V68, pC16; Sharma A, 2000, MOL CELL BIOCHEM, V214, P31, DOI 10.1023/A:1007167519596; Shimizu N, 1998, CARDIOVASC RES, V38, P116, DOI 10.1016/S0008-6363(97)00327-1; Tan BK, 2011, DIABETES, V60, P2758, DOI 10.2337/db11-0672; Thim T, 2006, CLIN SCI, V110, P665, DOI 10.1042/CS20050326; Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018; Uebanso T, 2012, J NUTR BIOCHEM, V23, P785, DOI 10.1016/j.jnutbio.2011.03.023; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Yang CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033870; Yie JM, 2012, CHEM BIOL DRUG DES, V79, P398, DOI 10.1111/j.1747-0285.2012.01325.x; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	46	81	86	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87102	10.1371/journal.pone.0087102	http://dx.doi.org/10.1371/journal.pone.0087102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498293	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900039
J	De Spiegeleer, A; Wynendaele, E; Vandekerckhove, M; Stalmans, S; Boucart, M; Van den Noortgate, N; Venken, K; Van Calenbergh, S; Aspeslagh, S; Elewaut, D				De Spiegeleer, Anton; Wynendaele, Evelien; Vandekerckhove, Matthias; Stalmans, Sofie; Boucart, Maxime; Van den Noortgate, Nele; Venken, Koen; Van Calenbergh, Serge; Aspeslagh, Sandrine; Elewaut, Dirk			An In Silico Approach for Modelling T-Helper Polarizing iNKT Cell Agonists	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ALPHA-GALACTOSYLCERAMIDE; IMMUNE-SYSTEM; NKT CELLS; POLARIZATION; RECOGNITION; ACTIVATION; VARIANTS; PEPTIDES; ANTIGENS	Many analogues of the glycolipid alpha-galactosylceramide (alpha-GalCer) are known to activate iNKT cells through their interaction with CD1d-expressing antigen-presenting cells, inducing the release of Th1 and Th2 cytokines. Because of iNKT cell involvement and associated Th1/Th2 cytokine changes in a broad spectrum of human diseases, the design of iNKT cell ligands with selective Th1 and Th2 properties has been the subject of extensive research. This search for novel iNKT cell ligands requires refined structural insights. Here we will visualize the chemical space of 333 currently known iNKT cell activators, including several newly tested analogues, by more than 3000 chemical descriptors which were calculated for each individual analogue. To evaluate the immunological responses we analyzed five different cytokines in five different test-systems. We linked the chemical space to the immunological space using a system biology computational approach resulting in highly sensitive and specific predictive models. Moreover, these models correspond with the current insights of iNKT cell activation by alpha-GalCer analogues, explaining the Th1 and Th2 biased responses, downstream of iNKT cell activation. We anticipate that such models will be of great value for the future design of iNKT cell agonists.	[De Spiegeleer, Anton; Vandekerckhove, Matthias; Venken, Koen; Aspeslagh, Sandrine; Elewaut, Dirk] Univ Ghent, Lab Mol Immunol & Inflammat, Dept Rheumatol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Wynendaele, Evelien; Stalmans, Sofie; Boucart, Maxime] Univ Ghent, Drug Qual & Registrat DruQuaR Grp, Dept Pharmaceut Anal, Fac Pharmaceut Sci, B-9000 Ghent, Belgium; [Van den Noortgate, Nele] Univ Ghent, Geriatr Unit, Dept Internal Med, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Van Calenbergh, Serge] Univ Ghent, Med Chem Lab, Dept Pharmaceut, Fac Pharmaceut Sci, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	Elewaut, D (corresponding author), Univ Ghent, Lab Mol Immunol & Inflammat, Dept Rheumatol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	Dirk.Elewaut@ugent.be	Van Calenbergh, Serge/A-3167-2008; Elewaut, Dirk/K-6831-2014; De Spiegeleer, Anton/V-5417-2019	Van Calenbergh, Serge/0000-0002-4201-1264; De Spiegeleer, Anton/0000-0002-3681-2807; Elewaut, Dirk/0000-0002-7468-974X; Venken, Koen/0000-0002-4950-386X				Alberti S, 2006, MECH AGEING DEV, V127, P560, DOI 10.1016/j.mad.2006.01.014; Aspeslagh S, 2013, J IMMUNOL, V191, P2916, DOI 10.4049/jimmunol.1203134; Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; Bai L, 2012, J IMMUNOL, V188, P3053, DOI 10.4049/jimmunol.1102414; Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; Berkers CR, 2005, TRENDS PHARMACOL SCI, V26, P252, DOI 10.1016/j.tips.2005.03.005; Chiba A, 2004, ARTHRITIS RHEUM, V50, P305, DOI 10.1002/art.11489; DERRINGER G, 1980, J QUAL TECHNOL, V12, P214, DOI 10.1080/00224065.1980.11980968; DERRINGER GC, 1994, QUAL PROG, V27, P51; Drennan MB, 2010, NAT REV RHEUMATOL, V6, P90, DOI 10.1038/nrrheum.2009.261; Eriksson L., 2006, MULTI MEGAVARIATE 1; Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Jervis PJ, 2012, BIOORG MED CHEM LETT, V22, P4348, DOI 10.1016/j.bmcl.2012.05.009; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Schiefner A, 2009, J MOL BIOL, V394, P71, DOI 10.1016/j.jmb.2009.08.061; Smyth MJ, 2002, BLOOD, V99, P1259, DOI 10.1182/blood.V99.4.1259; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Van Dorpe S, 2010, J SEP SCI, V33, P728, DOI 10.1002/jssc.200900476; Van Dorpe S, 2011, J PEPT SCI, V17, P398, DOI 10.1002/psc.1323; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wu TN, 2011, P NATL ACAD SCI USA, V108, P17275, DOI 10.1073/pnas.1114255108; Yu ED, 2011, J IMMUNOL, V187, P2079, DOI 10.4049/jimmunol.1101636	30	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87000	10.1371/journal.pone.0087000	http://dx.doi.org/10.1371/journal.pone.0087000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498010	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900057
J	Feng, P; Wei, PP; Shuai, CJ; Peng, SP				Feng, Pei; Wei, Pingpin; Shuai, Cijun; Peng, Shuping			Characterization of Mechanical and Biological Properties of 3-D Scaffolds Reinforced with Zinc Oxide for Bone Tissue Engineering	PLOS ONE			English	Article							BETA-TRICALCIUM PHOSPHATE; ZNO; PROLIFERATION; COMPONENTS; CERAMICS; BEHAVIOR; MGO	A scaffold for bone tissue engineering should have highly interconnected porous structure, appropriate mechanical and biological properties. In this work, we fabricated well-interconnected porous beta-tricalcium phosphate (beta-TCP) scaffolds via selective laser sintering (SLS). We found that the mechanical and biological properties of the scaffolds were improved by doping of zinc oxide (ZnO). Our data showed that the fracture toughness increased from 1.09 to 1.40 MPam 1/2, and the compressive strength increased from 3.01 to 17.89 MPa when the content of ZnO increased from 0 to 2.5 wt%. It is hypothesized that the increase of ZnO would lead to a reduction in grain size and an increase in density of the strut. However, the fracture toughness and compressive strength decreased with further increasing of ZnO content, which may be due to the sharp increase in grain size. The biocompatibility of the scaffolds was investigated by analyzing the adhesion and the morphology of human osteoblast-like MG-63 cells cultured on the surfaces of the scaffolds. The scaffolds exhibited better and better ability to support cell attachment and proliferation when the content of ZnO increased from 0 to 2.5 wt%. Moreover, a bone like apatite layer formed on the surfaces of the scaffolds after incubation in simulated body fluid (SBF), indicating an ability of osteoinduction and osteoconduction. In summary, interconnected porous b-TCP scaffolds doped with ZnO were successfully fabricated and revealed good mechanical and biological properties, which may be used for bone repair and replacement potentially.	[Feng, Pei; Shuai, Cijun] Cent S Univ, State Key Lab High Performance Complex Mfg, Changsha, Hunan, Peoples R China; [Shuai, Cijun] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Wei, Pingpin; Peng, Shuping] Cent S Univ, Canc Res Inst, Changsha, Hunan, Peoples R China; [Peng, Shuping] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA	Central South University; Medical University of South Carolina; Central South University; Yale University	Shuai, CJ (corresponding author), Cent S Univ, State Key Lab High Performance Complex Mfg, Changsha, Hunan, Peoples R China.	shuai@csu.edu.cn; shuping@csu.edu.cn	Shuai, Cijun/AAC-9740-2019	Shuai, Cijun/0000-0002-2029-5112	Natural Science Foundation of China [51222506, 81000972]; foundation for the author of national excellent doctoral dissertation of PR China [201032]; Program for New Century Excellent Talents in University [NCET-12-0544]; Fundamental Research Funds for the Central Universities [2011JQ005, 2012QNZT015]; Fok Ying-Tong Education Foundation, China [131050]; Open-End Fund for the Valuable and Precision Instruments of Central South University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); foundation for the author of national excellent doctoral dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fok Ying-Tong Education Foundation, China(Fok Ying Tung Education Foundation); Open-End Fund for the Valuable and Precision Instruments of Central South University	This work was supported by the following funds: (1) the Natural Science Foundation of China (51222506, 81000972); (2) The foundation for the author of national excellent doctoral dissertation of PR China (201032); (3) Program for New Century Excellent Talents in University (NCET-12-0544); (4) The Fundamental Research Funds for the Central Universities (2011JQ005, 2012QNZT015); (5) Project supported by the Fok Ying-Tong Education Foundation, China (131050); (6) The Open-End Fund for the Valuable and Precision Instruments of Central South University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034117; Bae CJ, 2006, J MATER SCI-MATER M, V17, P517, DOI 10.1007/s10856-006-8934-2; Bandyopadhyay A, 2007, MAT SCI ENG C-BIO S, V27, P14, DOI 10.1016/j.msec.2005.11.004; Bandyopadhyay A, 2006, J AM CERAM SOC, V89, P2675, DOI 10.1111/j.1551-2916.2006.01207.x; BETTGER WJ, 1993, J NUTR BIOCHEM, V4, P194, DOI 10.1016/0955-2863(93)90052-X; Bhatt HA, 2007, J MATER SCI-MATER M, V18, P883, DOI 10.1007/s10856-006-0091-0; Bose S, 2003, MAT SCI ENG C-BIO S, V23, P479, DOI 10.1016/S0928-4931(02)00129-7; Bose S, 2011, BONE, V48, P1282, DOI 10.1016/j.bone.2011.03.685; Cai X, 2012, TISSUE ENG PART C-ME, V18, P310, DOI [10.1089/ten.tec.2011.0519, 10.1089/ten.TEC.2011.0519]; Campbell M, 2008, J MATER SCI-MATER M, V19, P683, DOI 10.1007/s10856-007-3073-y; Carbajal L, 2012, J EUR CERAM SOC, V32, P569, DOI 10.1016/j.jeurceramsoc.2011.09.025; Santos EC, 2006, INT J MACH TOOL MANU, V46, P1459, DOI 10.1016/j.ijmachtools.2005.09.005; Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399; Espalin D, 2010, RAPID PROTOTYPING J, V16, P164, DOI 10.1108/13552541011034825; Fielding GA, 2012, DENT MATER, V28, P113, DOI 10.1016/j.dental.2011.09.010; Fujibayashi S, 2003, BIOMATERIALS, V24, P1349, DOI 10.1016/S0142-9612(02)00511-2; HASHIZUME M, 1993, MOL CELL BIOCHEM, V122, P59, DOI 10.1007/BF00925737; Hernandez CJ, 2001, BONE, V29, P74, DOI 10.1016/S8756-3282(01)00467-7; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; Jin HB, 2011, J COMPOS MATER, V45, P1435, DOI 10.1177/0021998310383728; Kalita S. J., 2006, AM J BIOCH BIOTECHNO, V2, P57; Kannan S, 2011, J AM CERAM SOC, V94, P231, DOI 10.1111/j.1551-2916.2010.04070.x; Kannan S, 2009, J AM CERAM SOC, V92, P1592, DOI 10.1111/j.1551-2916.2009.03093.x; KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F; Leoni L, 2004, ADV DRUG DELIVER REV, V56, P211, DOI 10.1016/j.addr.2003.08.014; Lin FH, 2001, BIOMATERIALS, V22, P2981, DOI 10.1016/S0142-9612(01)00044-8; MOONGA BS, 1995, J BONE MINER RES, V10, P453; Ni GX, 2006, BIOMATERIALS, V27, P1963, DOI 10.1016/j.biomaterials.2005.09.044; Oh S., 2006, AM J BIOCH BIOTECHNO, V2, P49, DOI [10.3844/ajbbsp.2006.49.562, DOI 10.3844/AJBBSP.2006.49.56]; Park JH, 2012, MATER CHARACT, V71, P103, DOI 10.1016/j.matchar.2012.06.012; Ragel CV, 2002, BIOMATERIALS, V23, P1865, DOI 10.1016/S0142-9612(01)00313-1; Ramesh S, 2007, SCI TECHNOL ADV MAT, V8, P124, DOI 10.1016/j.stam.2006.11.002; Rho JY, 1999, J BIOMED MATER RES, V45, P48, DOI 10.1002/(SICI)1097-4636(199904)45:1<48::AID-JBM7>3.0.CO;2-5; Shi XT, 2010, J BIOMED MATER RES A, V92A, P963, DOI 10.1002/jbm.a.32423; Shuai CJ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285703; Soman P, 2012, BIOMED MICRODEVICES, V14, P829, DOI 10.1007/s10544-012-9662-7; Terrier A, 2005, CLIN BIOMECH, V20, P998, DOI 10.1016/j.clinbiomech.2005.06.008; van Noort R, 2012, DENT MATER, V28, P3, DOI 10.1016/j.dental.2011.10.014; Vaz CM, 2003, J BIOMED MATER RES A, V65A, P60, DOI 10.1002/jbm.a.10416; Viswanath B, 2008, ACTA BIOMATER, V4, P1448, DOI 10.1016/j.actbio.2008.02.031; Wang MD, 2011, TISSUE ENG PART B-RE, V17, P177, DOI 10.1089/ten.teb.2010.0648; Wei X, 2005, KEY ENG MATER, V284-286, P83, DOI 10.4028/www.scientific.net/KEM.284-286.83; Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019; Wust S, 2011, J FUNCT BIOMATER, V2, P119, DOI 10.3390/jfb2030119; Xue WC, 2008, J MATER SCI-MATER M, V19, P2669, DOI 10.1007/s10856-008-3395-4; Zhang FM, 2008, J EUR CERAM SOC, V28, P539, DOI 10.1016/j.jeurceramsoc.2007.07.012; Zhang WB, 2011, J BIOMED MATER RES A, V97A, P414, DOI 10.1002/jbm.a.33062	47	78	80	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87755	10.1371/journal.pone.0087755	http://dx.doi.org/10.1371/journal.pone.0087755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498185	Green Submitted, gold, Green Published			2022-12-25	WOS:000330621900165
J	Rolland-Debord, C; Lair, D; Roussey-Bihouee, T; Hassoun, D; Evrard, J; Cheminant, MA; Chesne, J; Braza, F; Mahay, G; Portero, V; Sagan, C; Pitard, B; Magnan, A				Rolland-Debord, Camille; Lair, David; Roussey-Bihouee, Tiphaine; Hassoun, Dorian; Evrard, Justine; Cheminant, Marie-Aude; Chesne, Julie; Braza, Faouzi; Mahay, Guillaume; Portero, Vincent; Sagan, Christine; Pitard, Bruno; Magnan, Antoine			Block Copolymer/DNA Vaccination Induces a Strong Allergen-Specific Local Response in a Mouse Model of House Dust Mite Asthma	PLOS ONE			English	Article							IN-VIVO; IMMUNOTHERAPY; NANOSPHERES; MECHANISMS; CELLS	Background: Allergic asthma is caused by abnormal immunoreactivity against allergens such as house dust mites among which Dermatophagoides farinae (Der f) is a common species. Currently, immunotherapy is based on allergen administration, which has variable effect from patient to patient and may cause serious side effects, principally the sustained risk of anaphylaxis. DNA vaccination is a promising approach by triggering a specific immune response with reduced allergenicity. Objective: The aim of the study is to evaluate the effects of DNA immunization with Der f1 allergen specific DNA on allergic sensitization, inflammation and respiratory function in mice. Methods: Mice were vaccinated 28 and 7 days before allergen exposure with a Der f1-encoding plasmid formulated with a block copolymer. Asthma was induced by skin sensitization followed by intra-nasal challenges with Der f extract. Total lung, broncho-alveolar lavage (BAL) and spleen cells were analyzed by flow cytometry for their surface antigen and cytokine expression. Splenocytes and lung cell IFN-gamma production by CD8+ cells in response to Der f CMH1-restricted peptides was assessed by ELISPOT. IgE, IgG1 and IgG2a were measured in serum by ELISA. Specific bronchial hyperresponsiveness was assessed by direct resistance measurements. Results: Compared to animals vaccinated with an irrelevant plasmid, pVAX-Der f1 vaccination induced an increase of B cells in BAL, and an elevation of IL-10 and IFN-gamma but also of IL-4, IL-13 and IL-17 producing CD4+ lymphocytes in lungs and of IL-4 and IL-5 in spleen. In response to CD8-restricted peptides an increase of IFN-gamma was observed among lung cells. IgG2a levels non-specifically increased following block copolymer/DNA vaccination although IgE, IgG1 levels and airways resistances were not impacted. Conclusions & Clinical Relevance: DNA vaccination using a plasmid coding for Der f1 formulated with the block copolymer 704 induces a specific immune response in the model of asthma used herein.	[Rolland-Debord, Camille; Lair, David; Roussey-Bihouee, Tiphaine; Hassoun, Dorian; Evrard, Justine; Cheminant, Marie-Aude; Chesne, Julie; Braza, Faouzi; Mahay, Guillaume; Portero, Vincent; Pitard, Bruno; Magnan, Antoine] Ctr Natl Rech Sci 6291, INSERM, U1087, Unite Mixte Rech, Nantes, France; [Rolland-Debord, Camille; Lair, David; Roussey-Bihouee, Tiphaine; Hassoun, Dorian; Cheminant, Marie-Aude; Chesne, Julie; Braza, Faouzi; Mahay, Guillaume; Portero, Vincent; Magnan, Antoine] Univ Nantes, Nantes, France; [Sagan, Christine] Ctr Hosp Univ, Serv Anat & Cytol Pathol, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes	Magnan, A (corresponding author), Ctr Natl Rech Sci 6291, INSERM, U1087, Unite Mixte Rech, Nantes, France.	Antoine.Magnan@univ-nantes.fr	MAGNAN, ANTOINE/GVT-4308-2022; Magnan, Antoine/D-4100-2015; Pitard, Bruno F/K-9270-2015	Braza, Faouzi/0000-0003-1182-1413; Hassoun, Dorian/0000-0002-2154-0474; Chesne, Julie/0000-0001-8831-4386; Portero, Vincent/0000-0002-7221-859X	Societe Francaise d'Allergologie; Societe de Pneumologie de Langue Francaise; Fondation Recherche Medicale; Fondation Genavie (Nantes, France); Region Pays de La Loire	Societe Francaise d'Allergologie; Societe de Pneumologie de Langue Francaise; Fondation Recherche Medicale; Fondation Genavie (Nantes, France); Region Pays de La Loire(Region Pays de la Loire)	This work was supported by grants from the Societe Francaise d'Allergologie, Societe de Pneumologie de Langue Francaise, Fondation Recherche Medicale, Fondation Genavie (Nantes, France), and Region Pays de La Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2010, CLIN VACCINE IMMUNOL, V17, P36, DOI 10.1128/CVI.00275-09; Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Beilvert F, 2012, HUM GENE THER, V23, P597, DOI 10.1089/hum.2012.024; Biliczki P, 2009, HEART RHYTHM, V6, P1792, DOI 10.1016/j.hrthm.2009.08.009; Fonseca DM, 2012, CLIN EXP ALLERGY, V42, P131, DOI 10.1111/j.1365-2222.2011.03845.x; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Jarman ER, 2004, IMMUNOLOGY, V112, P631, DOI 10.1111/j.1365-2567.2004.01927.x; Jin HL, 2008, EUR J IMMUNOL, V38, P2451, DOI 10.1002/eji.200737899; Jutel M, 2011, ALLERGY, V66, P725, DOI 10.1111/j.1398-9995.2011.02589.x; Kim CH, 2006, J ASTHMA, V43, P345, DOI 10.1080/02770900600701424; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Mamessier E, 2006, CLIN EXP ALLERGY, V36, P704, DOI 10.1111/j.1365-2222.2006.02487.x; McIlroy D, 2009, MOL THER, V17, P1473, DOI 10.1038/mt.2009.84; Peng HJ, 2002, VACCINE, V20, P1761, DOI 10.1016/S0264-410X(02)00029-4; Pipe A, 2009, RESP MED, V103, P800, DOI 10.1016/j.rmed.2009.01.008; Pitard B, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh153; Richard P, 2005, J GENE MED, V7, P80, DOI 10.1002/jgm.631; Richard P, 2005, HUM GENE THER, V16, P1318, DOI 10.1089/hum.2005.16.1318; SECRIST H, 1993, J EXP MED, V178, P2123, DOI 10.1084/jem.178.6.2123	20	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e85976	10.1371/journal.pone.0085976	http://dx.doi.org/10.1371/journal.pone.0085976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497934	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900014
J	Saleh, MC; Connell, BJ; Rajagopal, D; Khan, BV; Abd-El-Aziz, AS; Kucukkaya, I; Saleh, TM				Saleh, Monique C.; Connell, Barry J.; Rajagopal, Desikan; Khan, Bobby V.; Abd-El-Aziz, Alaa S.; Kucukkaya, Inan; Saleh, Tarek M.			Co-Administration of Resveratrol and Lipoic Acid, or Their Synthetic Combination, Enhances Neuroprotection in a Rat Model of Ischemia/Reperfusion	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; NEUROLOGICAL DEFICIT; CEREBRAL-ISCHEMIA; VITAMIN-E; ALPHA; PROTECTS	The present study demonstrates the benefits of combinatorial antioxidant therapy in the treatment of ischemic stroke. Male Sprague-Dawley rats were anaesthetised and the middle cerebral artery (MCA) was occluded for 30 minutes followed by 5.5 hours of reperfusion. Pretreatment with resveratrol 30 minutes prior to MCA occlusion resulted in a significant, dose-dependent decrease in infarct volume (p<0.05) compared to vehicle-treated animals. Neuroprotection was also observed when resveratrol (2x10(-3) mg/kg; iv) was administered within 60 minutes following the return of blood flow (reperfusion). Pretreatment with non-neuroprotective doses of resveratrol (2x10(-6) mg/kg) and lipoic acid (LA; 0.005 mg/kg) in combination produced significant neuroprotection as well. This neuroprotection was also observed when resveratrol and LA were administered 15 minutes following the onset of MCA occlusion. Subsequently, we synthetically combined resveratrol and LA in both a 1:3 (UPEI-200) and 1:1 (UPEI-201) ratio, and screened these new chemical entities in both permanent and transient ischemia models. UPEI-200 was ineffective, while UPEI-201 demonstrated significant, dose-dependent neuroprotection. These results demonstrate that combining subthreshold doses of resveratrol and LA prior to ischemia-reperfusion can provide significant neuroprotection likely resulting from concurrent effects on multiple pathways. The additional protection observed in the novel compound UPEI 201 may present opportunities for addressing ischemia-induced damage in patients presenting with transient ischemic episodes.	[Saleh, Monique C.; Connell, Barry J.; Khan, Bobby V.; Saleh, Tarek M.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Biomed Sci, Charlottetown, PE C1A 4P3, Canada; [Abd-El-Aziz, Alaa S.; Kucukkaya, Inan] Univ Prince Edward Isl, Dept Chem, Charlottetown, PE C1A 4P3, Canada; [Rajagopal, Desikan; Khan, Bobby V.] Carmel BioSci Inc, Atlanta, GA USA	University of Prince Edward Island; University of Prince Edward Island	Saleh, TM (corresponding author), Univ Prince Edward Isl, Atlantic Vet Coll, Dept Biomed Sci, Charlottetown, PE C1A 4P3, Canada.	tsaleh@upei.ca	Saleh, Tarek M/G-7231-2018; Rajagopal, Desikan/AAA-6549-2019	Saleh, Tarek M/0000-0003-2502-2380; Abd-El-Aziz, Alaa/0000-0002-2808-1151	Atlantic Canada Opportunities Agency Atlantic Innovation fund (AIF) [1999294]	Atlantic Canada Opportunities Agency Atlantic Innovation fund (AIF)	This work was supported by the Atlantic Canada Opportunities Agency Atlantic Innovation fund (AIF; file #1999294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2000, CANCER LETT, V154, P29, DOI 10.1016/S0304-3835(00)00351-7; Biewenga GP, 1997, GEN PHARMACOL, V29, P315, DOI 10.1016/S0306-3623(96)00474-0; Bilska A, 2005, PHARMACOL REP, V57, P570; Candelario-Jalil E, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-25; CAO XH, 1995, FREE RADICAL RES, V23, P365, DOI 10.3109/10715769509065257; Chun YJ, 1999, BIOCHEM BIOPH RES CO, V262, P20, DOI 10.1006/bbrc.1999.1152; Clark WM, 2001, STROKE, V32, P1000, DOI 10.1161/01.STR.32.4.1000; Connell BJ, 2012, NEUROSCI LETT, V507, P43, DOI 10.1016/j.neulet.2011.11.047; Connell BJ, 2011, BRAIN RES, V1375, P128, DOI 10.1016/j.brainres.2010.12.045; Connell BJ, 2010, J NEUROSCI METH, V190, P28, DOI 10.1016/j.jneumeth.2010.04.021; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Delmas D, 2005, MOL NUTR FOOD RES, V49, P377, DOI 10.1002/mnfr.200400098; Fava A, 2013, J NEURODEGEN DIS, V2013; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Garcia-Estrada J, 2003, NEUROSCI RES, V47, P219, DOI 10.1016/S0168-0102(03)00200-1; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; Gonzalez-Perez O, 2002, NEUROSCI LETT, V321, P100, DOI 10.1016/S0304-3940(02)00056-3; Gulcin I, 2010, INNOV FOOD SCI EMERG, V11, P210, DOI 10.1016/j.ifset.2009.07.002; He L, 2012, EUR J PHARMACOL, V678, P32, DOI 10.1016/j.ejphar.2011.12.042; Ibrahimpasic Kanita, 2013, Med Arch, V67, P7; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Kang OH, 2009, PHARMACOL RES, V59, P330, DOI 10.1016/j.phrs.2009.01.009; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Michikoshi H, 2013, CANCER LETT, V335, P472, DOI 10.1016/j.canlet.2013.03.008; Mukherjee R, 2011, CARDIOVASC TOXICOL, V11, P78, DOI 10.1007/s12012-010-9092-9; Panigrahi M, 1996, BRAIN RES, V717, P184, DOI 10.1016/0006-8993(96)00009-1; Valdecantos MP, 2010, REDOX REP, V15, P207, DOI 10.1179/135100010X12826446921464; Richard MJP, 2011, NEUROSCI RES, V69, P299, DOI 10.1016/j.neures.2010.12.011; Rocha KKR, 2009, FOOD CHEM TOXICOL, V47, P1362, DOI 10.1016/j.fct.2009.03.010; Saleh MC, 2013, NEUROSCI LETT, V548, P217, DOI 10.1016/j.neulet.2013.05.057; Shotton HR, 2004, AUTON NEUROSCI-BASIC, V111, P57, DOI 10.1016/j.autneu.2004.02.004; Smith AR, 2004, CURR MED CHEM, V11, P1135, DOI 10.2174/0929867043365387; Sola S, 2005, CIRCULATION, V111, P343, DOI 10.1161/01.CIR.0000153272.48711.B9; Wang MH, 2012, J NEUROSCI, V32, P17948, DOI 10.1523/JNEUROSCI.1860-12.2012; Wolz P, 1996, NEUROPHARMACOLOGY, V35, P369, DOI 10.1016/0028-3908(95)00172-7; Yan Y, 2011, MUTAT RES-GEN TOX EN, V721, P171, DOI 10.1016/j.mrgentox.2011.01.012	37	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87865	10.1371/journal.pone.0087865	http://dx.doi.org/10.1371/journal.pone.0087865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498217	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900189
J	Sanchez-Mir, L; Soto, T; Franco, A; Madrid, M; Viana, RA; Vicente, J; Gacto, M; Perez, P; Cansado, J				Sanchez-Mir, Laura; Soto, Teresa; Franco, Alejandro; Madrid, Marisa; Viana, Raul A.; Vicente, Jero; Gacto, Mariano; Perez, Pilar; Cansado, Jose			Rho1 GTPase and PKC Ortholog Pck1 Are Upstream Activators of the Cell Integrity MAPK Pathway in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; REGULATES MORPHOGENESIS; WALL INTEGRITY; S-POMBE; KINASE; PROTEIN; STRESS; LOCALIZATION; ENCODES	In the fission yeast Schizosaccharomyces pombe the cell integrity pathway (CIP) orchestrates multiple biological processes like cell wall maintenance and ionic homeostasis by fine tuning activation of MAPK Pmk1 in response to various environmental conditions. The small GTPase Rho2 positively regulates the CIP through protein kinase C ortholog Pck2. However, Pmk1 retains some function in mutants lacking either Rho2 or Pck2, suggesting the existence of additional upstream regulatory elements to modulate its activity depending on the nature of the environmental stimulus. The essential GTPase Rho1 is a candidate to control the activity of the CIP by acting upstream of Pck2, whereas Pck1, a second PKC ortholog, appears to negatively regulate Pmk1 activity. However, the exact regulatory nature of these two proteins within the CIP has remained elusive. By exhaustive characterization of strains expressing a hypomorphic Rho1 allele (rho1-596) in different genetic backgrounds we show that both Rho1 and Pck1 are positive upstream regulatory members of the CIP in addition to Rho2 and Pck2. In this new model Rho1 and Rho2 control Pmk1 basal activity during vegetative growth mainly through Pck2. Notably, whereas Rho2-Pck2 elicit Pmk1 activation in response to most environmental stimuli, Rho1 drives Pmk1 activation through either Pck2 or Pck1 exclusively in response to cell wall damage. Our study reveals the intricate and complex functional architecture of the upstream elements participating in this signaling pathway as compared to similar routes from other simple eukaryotic organisms.	[Sanchez-Mir, Laura; Soto, Teresa; Franco, Alejandro; Madrid, Marisa; Vicente, Jero; Gacto, Mariano; Cansado, Jose] Univ Murcia, Fac Biol, Yeast Physiol Grp, Dept Genet & Microbiol, Murcia, Spain; [Viana, Raul A.; Perez, Pilar] Univ Salamanca, Inst Biol Func & Genom, CSIC, Dept Genet & Microbiol, E-37008 Salamanca, Spain	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Cansado, J (corresponding author), Univ Murcia, Fac Biol, Yeast Physiol Grp, Dept Genet & Microbiol, Murcia, Spain.	jcansado@um.es	Madrid, Marisa/AAV-2154-2020; Franco, Alejandro/ABG-6823-2020; Vicente-Soler, Jerónima/ABF-6293-2020; Pino, Teresa Soto/AAC-6096-2020; Cansado, Jose/K-5212-2014; Perez, Pilar/B-4948-2010; Mir, Laura Sanchez/H-5409-2015; Madrid, Marisa/K-7755-2014; Cansado, Jose/ABC-6872-2020	Madrid, Marisa/0000-0002-7970-2587; Franco, Alejandro/0000-0001-7461-3414; Vicente-Soler, Jerónima/0000-0001-8759-6545; Pino, Teresa Soto/0000-0003-2965-318X; Perez, Pilar/0000-0003-3557-2247; Mir, Laura Sanchez/0000-0002-3898-5840; Madrid, Marisa/0000-0002-7970-2587; Cansado, Jose/0000-0002-2342-8152	Ministerio de Economia y Competitividad [BFU2011-22517, BFU2010-15641]; (Fundacion Seneca, Region de Murcia), Spain [15280/PI/10]; EU	Ministerio de Economia y Competitividad(Spanish Government); (Fundacion Seneca, Region de Murcia), Spain(Fundacion Seneca); EU(European Commission)	This work was supported by grants BFU2011-22517 (Ministerio de Economia y Competitividad) and 15280/PI/10 (Fundacion Seneca, Region de Murcia), Spain to J.C., and BFU2010-15641 (Ministerio de Economia y Competitividad) to P. P. ERDF (European Regional Development Fund) co-funding was received from the EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Villar-Tajadura MA, 2008, MOL MICROBIOL, V70, P867, DOI 10.1111/j.1365-2958.2008.06447.x; Arellano M, 1999, J CELL SCI, V112, P3569; Arellano M, 1997, J CELL SCI, V110, P2547; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barba G, 2008, CELL SIGNAL, V20, P748, DOI 10.1016/j.cellsig.2007.12.017; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Calonge TM, 2000, MOL BIOL CELL, V11, P4393, DOI 10.1091/mbc.11.12.4393; Cruz S, 2013, MICROBIOLOGYOPEN JUL, DOI [10.1002/mbo3.113, DOI 10.1002/MBO3.113]; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Gacto M, 2003, INT MICROBIOL, V6, P211, DOI 10.1007/s10123-003-0136-x; Garcia P, 2009, MOL BIOL CELL, V20, P721, DOI 10.1091/mbc.E08-07-0673; Hirata D, 1998, J CELL SCI, V111, P149; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewith R, 2000, J CELL SCI, V113, P153; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Madrid M, 2007, MOL BIOL CELL, V18, P4405, DOI 10.1091/mbc.E07-05-0484; Madrid M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-34; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Perez P, 2010, CURR PROTEIN PEPT SC, V11, P680, DOI 10.2174/138920310794557718; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sengar AS, 1997, MOL CELL BIOL, V17, P3508, DOI 10.1128/MCB.17.7.3508; Soto T, 2002, EUR J BIOCHEM, V269, P5056, DOI 10.1046/j.1432-1033.2002.03214.x; Soto T, 2010, J BIOL CHEM, V285, P11516, DOI 10.1074/jbc.M109.071027; Sugiura R, 1999, NATURE, V399, P479, DOI 10.1038/20951; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Toda T, 1996, MOL CELL BIOL, V16, P6752; Viana RA, 2013, GENETICS, V195, P421, DOI 10.1534/genetics.113.154807; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; ZaitsevskayaCarter T, 1997, EMBO J, V16, P1318, DOI 10.1093/emboj/16.6.1318	31	26	28	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e88020	10.1371/journal.pone.0088020	http://dx.doi.org/10.1371/journal.pone.0088020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498240	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900206
J	Schecklmann, M; Landgrebe, M; Langguth, B				Schecklmann, Martin; Landgrebe, Michael; Langguth, Berthold		TRI Database Study Grp	Phenotypic Characteristics of Hyperacusis in Tinnitus	PLOS ONE			English	Article							GENERALIZED HYPERVIGILANCE; DISORDERS; SOUND; NOISE; HYPERSENSITIVITY; INDIVIDUALS; ASSOCIATION; PREVALENCE	Background: Many people with tinnitus also suffer from hyperacusis. Both clinical and basic scientific data indicate an overlap in pathophysiologic mechanisms. In order to further elucidate the interplay between tinnitus and hyperacusis we compared clinical and demographic characteristics of tinnitus patients with and without hyperacusis by analyzing a large sample from an international tinnitus patient database. Materials: The default dataset import [November 1st, 2012] from the Tinnitus Research Initiative [TRI] Database was used for analyses. Hyperacusis was defined by the question "Do sounds cause you pain or physical discomfort?" of the Tinnitus Sample Case History Questionnaire. Patients who answered this question with "yes" were contrasted with "no"-responders with respect to 41 variables. Results: 935 [55%] out of 1713 patients were characterized as hyperacusis patients. Hyperacusis in tinnitus was associated with younger age, higher tinnitus-related, mental and general distress; and higher rates of pain disorders and vertigo. In relation to objective audiological assessment patients with hyperacusis rated their subjective hearing function worse than those without hyperacusis. Similarly the tinnitus pitch was rated higher by hyperacusis patients in relation to the audiometrically determined tinnitus pitch. Among patients with tinnitus and hyperacusis the tinnitus was more frequently modulated by external noise and somatic maneuvers, i.e., exposure to environmental sounds and head and neck movements change the tinnitus percept. Conclusions: Our findings suggest that the comorbidity of hyperacusis is a useful criterion for defining a sub-type of tinnitus which is characterized by greater need of treatment. The higher sensitivity to auditory, somatosensory and vestibular input confirms the notion of an overactivation of an unspecific hypervigilance network in tinnitus patients with hyperacusis.	[Schecklmann, Martin; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [Landgrebe, Michael] Social Fdn Bamberg, Dept Psychiat & Psychotherapy, Bamberg, Germany	University of Regensburg	Schecklmann, M (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany.	martin.schecklmann@medbo.de	Coelho, Claudia/J-6250-2016; Langguth, Berthold/AAP-2638-2021; Kleinjung, Tobias/AAJ-3141-2020; Heyning, Paul H Vande/I-8278-2017	Coelho, Claudia/0000-0002-2441-0739; Kleinjung, Tobias/0000-0003-3867-234X; Heyning, Paul H Vande/0000-0002-8424-3717; Vanneste, Sven/0000-0003-1513-5752	Tinnitus Research Initiative (TRI)	Tinnitus Research Initiative (TRI)	The study was supported by the Tinnitus Research Initiative (TRI; www.tinnitusresearch.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley DM, 2003, J ROY SOC MED, V96, P582, DOI 10.1258/jrsm.96.12.582; Basura GJ, 2012, BRAIN RES, V1485, P95, DOI 10.1016/j.brainres.2012.08.037; Blasing L, 2010, INT J AUDIOL, V49, P518, DOI 10.3109/14992021003724996; Chen G, 2013, JARO-J ASSOC RES OTO, V14, P413, DOI 10.1007/s10162-013-0375-2; Cima RFF, 2012, LANCET, V379, P1951, DOI 10.1016/S0140-6736(12)60469-3; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; De Ridder D, NEUROSCI BI IN PRESS; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Saldanha ADD, 2012, CRANIO, V30, P166, DOI 10.1179/crn.2012.026; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Falkenberg Eva-Signe, 2012, Int J Otolaryngol, V2012, P375460, DOI 10.1155/2012/375460; Fioretti AB, 2013, NOISE HEALTH, V15, P91, DOI 10.4103/1463-1741.110287; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Hebert S, 2013, J NEUROSCI, V33, P2356, DOI 10.1523/JNEUROSCI.3461-12.2013; Hollins M, 2009, PAIN, V141, P215, DOI 10.1016/j.pain.2008.10.003; Hwang JH, 2009, AM J OTOLARYNG, V30, P432, DOI 10.1016/j.amjoto.2008.08.005; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; JASTREBOFF PJ, 1993, BRIT J AUDIOL, V27, P7, DOI 10.3109/03005369309077884; Juris L, 2013, INT J AUDIOL, V52, P230, DOI 10.3109/14992027.2012.743043; Katzenell U, 2001, OTOL NEUROTOL, V22, P321, DOI 10.1097/00129492-200105000-00009; KLEIN AJ, 1990, J SPEECH HEAR DISORD, V55, P339, DOI 10.1044/jshd.5502.339; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Landgrebe M, 2008, NEUROIMAGE, V41, P1336, DOI 10.1016/j.neuroimage.2008.04.171; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Landgrebe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005026; Langguth B, 2011, CURR MED RES OPIN, V27, P1635, DOI 10.1185/03007995.2011.595781; McDermid AJ, 1996, PAIN, V66, P133, DOI 10.1016/0304-3959(96)03059-X; Meeus OM, 2010, INT J AUDIOL, V49, P7, DOI 10.3109/14992020903160868; Nelson Jeffrey J, 2004, Ear Nose Throat J, V83, P472; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Schecklmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034878; Sereda M, 2013, HEARING RES, V302, P50, DOI 10.1016/j.heares.2013.04.006; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Song JJ, BRAIN STRUC IN PRESS; Turner J, 2012, J NEUROSCI RES, V90, P1480, DOI 10.1002/jnr.22827; Tuz HH, 2003, AM J ORTHOD DENTOFAC, V123, P620, DOI 10.1016/S0889-5406(03)00153-7; Vielsmeier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038887; Vielsmeier V, 2011, OTOLARYNG HEAD NECK, V145, P748, DOI 10.1177/0194599811413376; Zeman F, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-128; Zeng FG, 2013, HEARING RES, V295, P172, DOI 10.1016/j.heares.2012.05.009	42	114	117	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86944	10.1371/journal.pone.0086944	http://dx.doi.org/10.1371/journal.pone.0086944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498000	gold, Green Published			2022-12-25	WOS:000330621900050
J	Wijayalath, W; Majji, S; Kleschenko, Y; Pow-Sang, L; Brumeanu, TD; Villasante, EF; Vasta, GR; Fernandez-Robledo, JA; Casares, S				Wijayalath, Wathsala; Majji, Sai; Kleschenko, Yuliya; Pow-Sang, Luis; Brumeanu, Teodor D.; Villasante, Eileen Franke; Vasta, Gerardo R.; Fernandez-Robledo, Jose-Antonio; Casares, Sofia			Humanized HLA-DR4 Mice Fed with the Protozoan Pathogen of Oysters Perkinsus Marinus (Dermo) Do Not Develop Noticeable Pathology but Elicit Systemic Immunity	PLOS ONE			English	Article							SUBUNIT RIBOSOMAL-RNA; CRASSOSTREA-VIRGINICA; EASTERN OYSTER; RAW OYSTERS; PHYLUM APICOMPLEXA; CHESAPEAKE BAY; PARASITE; CELLS; GENE; TRANSMISSION	Perkinsus marinus (Phylum Perkinsozoa) is a marine protozoan parasite responsible for "Dermo" disease in oysters, which has caused extensive damage to the shellfish industry and estuarine environment. The infection prevalence has been estimated in some areas to be as high as 100%, often causing death of infected oysters within 1-2 years post-infection. Human consumption of the parasites via infected oysters is thus likely to occur, but to our knowledge the effect of oral consumption of P. marinus has not been investigated in humans or other mammals. To address the question we used humanized mice expressing HLA-DR4 molecules and lacking expression of mouse MHC-class II molecules (DR4.EA(0)) in such a way that CD4 T cell responses are solely restricted by the human HLA-DR4 molecule. The DR4.EA(0) mice did not develop diarrhea or any detectable pathology in the gastrointestinal tract or lungs following single or repeated feedings with live P. marinus parasites. Furthermore, lymphocyte populations in the gut associated lymphoid tissue and spleen were unaltered in the parasite-fed mice ruling out local or systemic inflammation. Notably, naive DR4.EA(0) mice had antibodies (IgM and IgG) reacting against P. marinus parasites whereas parasite specific T cell responses were undetectable. Feeding with P. marinus boosted the antibody responses and stimulated specific cellular (IFN gamma) immunity to the oyster parasite. Our data indicate the ability of P. marinus parasites to induce systemic immunity in DR4.EA(0) mice without causing noticeable pathology, and support rationale grounds for using genetically engineered P. marinus as a new oral vaccine platform to induce systemic immunity against infectious agents.	[Wijayalath, Wathsala; Majji, Sai; Kleschenko, Yuliya; Villasante, Eileen Franke; Casares, Sofia] Naval Med Res Ctr, Walter Reed Army Inst Res, US Mil Malaria Vaccine Program, Silver Spring, MD 20910 USA; [Pow-Sang, Luis; Brumeanu, Teodor D.; Casares, Sofia] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA; [Vasta, Gerardo R.; Fernandez-Robledo, Jose-Antonio] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Naval Medical Research Center (NMRC); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Uniformed Services University of the Health Sciences - USA; University System of Maryland; University of Maryland Baltimore	Casares, S (corresponding author), Naval Med Res Ctr, Walter Reed Army Inst Res, US Mil Malaria Vaccine Program, Silver Spring, MD 20910 USA.	sofia.casares@med.navy.mil	Brumeanu, Teodor/AAB-1965-2020		work unit number 6000.RAD1.F. under Military Infectious Diseases Research Program (MDRIP) [F0338_13_NM]; National Science Foundation (NSF) [IOS 1063729, IOS 1050518, IOS 0958016]; National Institutes of Health (NIH) [1R21AI076797-01A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076797] Funding Source: NIH RePORTER; Direct For Biological Sciences [1050518] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0958016] Funding Source: National Science Foundation	work unit number 6000.RAD1.F. under Military Infectious Diseases Research Program (MDRIP); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by work unit number 6000.RAD1.F. under grants from the Military Infectious Diseases Research Program (MDRIP, #F0338_13_NM)to SC, National Science Foundation (NSF, #IOS 1063729, #IOS 1050518, #IOS 0958016) to GRV, and National Institutes of Health (NIH, #1R21AI076797-01A2) to JAFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam B, 2013, J INVERTEBR PATHOL, V113, P26, DOI 10.1016/j.jip.2012.12.011; Bachvaroff TR, 2011, J EUKARYOT MICROBIOL, V58, P223, DOI 10.1111/j.1550-7408.2011.00555.x; Brugerolle G, 2002, EUR J PROTISTOL, V37, P379, DOI 10.1078/0932-4739-00837; Bushek D, 2002, DIS AQUAT ORGAN, V51, P217, DOI 10.3354/dao051217; Caceres-Martinez J, 2008, J INVERTEBR PATHOL, V99, P66, DOI 10.1016/j.jip.2008.03.005; Caceres-Martinez J, 2012, J INVERTEBR PATHOL, V110, P321, DOI 10.1016/j.jip.2012.03.019; Calvo LMR, 2003, DIS AQUAT ORGAN, V56, P75, DOI 10.3354/dao056075; Cardoso CR, 2009, AM J PHYSIOL-GASTR L, V296, pG593, DOI 10.1152/ajpgi.90431.2008; Casares S, 2002, NAT IMMUNOL, V3, P383, DOI 10.1038/ni770; den Hertog AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057997; DESENCLOS JCA, 1991, AM J PUBLIC HEALTH, V81, P1268, DOI 10.2105/AJPH.81.10.1268; Dungan CF, 2006, J EUKARYOT MICROBIOL, V53, P316, DOI 10.1111/j.1550-7408.2006.00120.x; Dungan Christopher F., 1996, Journal of Shellfish Research, V15, P500; Feng CG, 2013, J BIOL CHEM, V288, P24394, DOI 10.1074/jbc.M113.476531; Fernandez-Robledo JA, 2008, MOL BIOCHEM PARASIT, V157, P44, DOI 10.1016/j.molbiopara.2007.09.007; Fernandez-Robledo JA, 2010, TRENDS PARASITOL, V26, P244, DOI 10.1016/j.pt.2010.02.004; Ford SE, 1996, J SHELLFISH RES, V15, P45; Ford SE, 2006, J EXP MAR BIOL ECOL, V339, P226, DOI 10.1016/j.jembe.2006.08.004; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; Fyfe M, 1997, RELEVE MALADIES TRAN, V23, P145; GAUTHIER JD, 1995, J INVERTEBR PATHOL, V66, P156, DOI 10.1006/jipa.1995.1079; Gile GH, 2006, PROTIST, V157, P435, DOI 10.1016/j.protis.2006.06.002; GOGGIN CL, 1993, MOL BIOCHEM PARASIT, V60, P65, DOI 10.1016/0166-6851(93)90029-W; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; Hur EM, 2012, BLOOD, V120, P4571, DOI 10.1182/blood-2012-04-422303; Ito K, 1996, J EXP MED, V183, P2635, DOI 10.1084/jem.183.6.2635; James KJ, 2010, EPIDEMIOL INFECT, V138, P927, DOI 10.1017/S0950268810000853; Joseph SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-228; Kelly GS, 1997, ALTERN MED REV, V2, P116; Khansa S, 2012, GENE, V506, P396, DOI 10.1016/j.gene.2012.06.063; KOHN MA, 1995, JAMA-J AM MED ASSOC, V273, P466, DOI 10.1001/jama.273.6.466; Kurz S, 2013, J BIOL CHEM, V288, P24410, DOI 10.1074/jbc.M113.478933; Kuvardina ON, 2002, J EUKARYOT MICROBIOL, V49, P498, DOI 10.1111/j.1550-7408.2002.tb00235.x; LEVINE ND, 1978, J PARASITOL, V64, P549, DOI 10.2307/3279807; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; MacKenzie CL, 1996, E OYSTER CRASSOSTREA, P1; MACKIN J. G., 1951, BULL MARINE SCI GULF AND CARIBBEAN, V1, P72; MACKIN JG, 1950, SCIENCE, V111, P328, DOI 10.1126/science.111.2883.328; MACKIN JG, 1966, J INVERTEBR PATHOL, V8, P544, DOI 10.1016/0022-2011(66)90088-7; MARSH AG, 1995, J PARASITOL, V81, P577, DOI 10.2307/3283856; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Moss JA, 2008, J EUKARYOT MICROBIOL, V55, P117, DOI 10.1111/j.1550-7408.2008.00314.x; Noren F, 1999, EUR J PROTISTOL, V35, P233, DOI 10.1016/S0932-4739(99)80001-7; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Pecher WT, 2008, J PARASITOL, V94, P410, DOI 10.1645/GE-1282.1; PERKINS FO, 1976, J PARASITOL, V62, P959, DOI 10.2307/3279192; Perkins FO, 1996, J SHELLFISH RES, V15, P67; POWELL EN, 1992, MAR ECOL-P S Z N I, V13, P243, DOI 10.1111/j.1439-0485.1992.tb00354.x; REEVE G, 1989, NEW ENGL J MED, V321, P224, DOI 10.1056/NEJM198907273210404; Robledo JAF, 1998, J PARASITOL, V84, P1237, DOI 10.2307/3284680; Robledo JAF, 2011, INT J PARASITOL, V41, P1217, DOI 10.1016/j.ijpara.2011.07.008; ROTHBARD JB, 1991, ANNU REV IMMUNOL, V9, P527, DOI 10.1146/annurev.iy.09.040191.002523; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; Sanchez V, 2006, VACCINE, V24, P4914, DOI 10.1016/j.vaccine.2006.03.066; Schott EJ, 2003, EXP PARASITOL, V105, P232, DOI 10.1016/j.exppara.2003.12.012; Schott EJ, 2003, GENE, V309, P1, DOI 10.1016/S0378-1119(03)00469-4; Schott EJ, 2003, MOL BIOCHEM PARASIT, V126, P81, DOI 10.1016/S0166-6851(02)00271-2; Shridhar S, 2013, INT J PARASITOL-DRUG, V3, P85, DOI 10.1016/j.ijpddr.2013.03.001; Siddall ME, 1997, PARASITOLOGY, V115, P165, DOI 10.1017/S0031182097001157; Slavik T, 2012, ARCH PATHOL LAB MED, V136, P305, DOI 10.5858/arpa.2011-0332-RA; Smith JL, 2003, J FOOD PROTECT, V66, P1292, DOI 10.4315/0362-028X-66.7.1292; STETLER HC, 1985, PEDIATRICS, V75, P299; Surls J, 2010, VACCINE, V28, P7319, DOI 10.1016/j.vaccine.2010.08.074; Taneja V, 2010, IMMUNOL REV, V233, P62, DOI 10.1111/j.0105-2896.2009.00858.x; Tasumi S, 2007, J IMMUNOL, V179, P3086, DOI 10.4049/jimmunol.179.5.3086; Villalba A, 2004, AQUAT LIVING RESOUR, V17, P411, DOI 10.1051/alr:2004050; Wang L, 2008, EXPERT REV VACCINES, V7, P729, DOI 10.1586/14760584.7.6.729; Wijayalath W, 2014, INFECT IMMUN, V82, P286, DOI 10.1128/IAI.00272-13; Wilberg MJ, 2011, MAR ECOL PROG SER, V436, P131, DOI 10.3354/meps09161	69	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87435	10.1371/journal.pone.0087435	http://dx.doi.org/10.1371/journal.pone.0087435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498105	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900112
J	Xu, JS; Calhoun, VD; Pearlson, GD; Potenza, MN				Xu, Jiansong; Calhoun, Vince D.; Pearlson, Godfrey D.; Potenza, Marc N.			Opposite Modulation of Brain Functional Networks Implicated at Low vs. High Demand of Attention and Working Memory	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; PREFRONTAL CORTEX AREA-10; DEFAULT-MODE; VENTRAL ATTENTION; RESPONSE FUNCTIONS; BLIND SEPARATION; FMRI; CONNECTIVITY; SCHIZOPHRENIA; ACTIVATION	Background: Functional magnetic resonance imaging (fMRI) studies indicate that the brain organizes its activity into multiple functional networks (FNs) during either resting condition or task-performance. However, the functions of these FNs are not fully understood yet. Methodology/Principal Findings: To investigate the operation of these FNs, spatial independent component analysis (sICA) was used to extract FNs from fMRI data acquired from healthy participants performing a visual task with two levels of attention and working memory load. The task-related modulations of extracted FNs were assessed. A group of FNs showed increased activity at low-load conditions and reduced activity at high-load conditions. These FNs together involve the left lateral frontoparietal cortex, insula, and ventromedial prefrontal cortex. A second group of FNs showed increased activity at high-load conditions and reduced activity at low-load conditions. These FNs together involve the intraparietal sulcus, frontal eye field, lateral frontoparietal cortex, insula, and dorsal anterior cingulate, bilaterally. Though the two groups of FNs showed opposite task-related modulations, they overlapped extensively at both the lateral and medial frontoparietal cortex and insula. Such an overlap of FNs would not likely be revealed using standard general-linear-model-based analyses. Conclusions: By assessing task-related modulations, this study differentiated the functional roles of overlapping FNs. Several FNs including the left frontoparietal network are implicated in task conditions of low attentional load, while another set of FNs including the dorsal attentional network is implicated in task conditions involving high attentional demands.	[Xu, Jiansong; Calhoun, Vince D.; Pearlson, Godfrey D.; Potenza, Marc N.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Potenza, Marc N.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Pearlson, Godfrey D.; Potenza, Marc N.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [Pearlson, Godfrey D.] Inst Living, Olin Neuropsychiat Res Ctr, Hartford, CT USA; [Calhoun, Vince D.] Univ New Mexico, Dept ECE, Albuquerque, NM 87131 USA	Yale University; Yale University; Yale University; Lovelace Respiratory Research Institute; University of New Mexico	Xu, JS (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	Jiansong.xu@yale.edu	Calhoun, Vince D./ACN-9399-2022	Calhoun, Vince D./0000-0001-9058-0747	National Institute On Drug Abuse (NIDA) grants [K01 DA027750, P20 DA027844]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA027750, P20DA027844] Funding Source: NIH RePORTER	National Institute On Drug Abuse (NIDA) grants; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the following grants: National Institute On Drug Abuse (NIDA) grants K01 DA027750 (Xu) and P20 DA027844 (Potenza). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Amedi A, 2005, NEURON, V48, P859, DOI 10.1016/j.neuron.2005.10.032; Asplund CL, 2010, J EXP PSYCHOL HUMAN, V36, P1372, DOI 10.1037/a0020551; Asplund CL, 2010, NAT NEUROSCI, V13, P507, DOI 10.1038/nn.2509; Assaf M, 2009, BRAIN COGNITION, V70, P238, DOI 10.1016/j.bandc.2009.02.007; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Beldzik E, 2013, NEUROIMAGE, V76, P304, DOI 10.1016/j.neuroimage.2013.03.014; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Braga RM, 2013, J NEUROSCI, V33, P14031, DOI 10.1523/JNEUROSCI.0570-13.2013; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Calhoun Vince D, 2012, IEEE Rev Biomed Eng, V5, P60, DOI 10.1109/RBME.2012.2211076; Calhoun VD, 2012, TRENDS COGN SCI, V16, P255, DOI 10.1016/j.tics.2012.03.008; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Daselaar SM, 2010, NEUROIMAGE, V52, P677, DOI 10.1016/j.neuroimage.2010.04.239; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Domagalik A, 2012, NEUROIMAGE, V62, P1325, DOI 10.1016/j.neuroimage.2012.06.006; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Esposito F, 2009, ARCH ITAL BIOL, V147, P11; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Esposito F, 2011, CURR OPIN NEUROL, V24, P378, DOI 10.1097/WCO.0b013e32834897a5; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gilbert SJ, 2006, J EXP PSYCHOL HUMAN, V32, P45, DOI 10.1037/0096-1523.32.1.45; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Hahn B, 2006, NEUROIMAGE, V32, P842, DOI 10.1016/j.neuroimage.2006.04.177; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Juarez M, 2012, HUM BRAIN MAPP; Kalcher K, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00301; Kim DI, 2009, HUM BRAIN MAPP, V30, P3795, DOI 10.1002/hbm.20807; Kim DI, 2009, SCHIZOPHRENIA BULL, V35, P67, DOI 10.1093/schbul/sbn133; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Laird AR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00154; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Leung HC, 2007, NEUROIMAGE, V35, P368, DOI 10.1016/j.neuroimage.2006.12.012; Linden DEJ, 2003, NEUROIMAGE, V20, P1518, DOI 10.1016/j.neuroimage.2003.07.021; Majerus S, 2012, CEREB CORTEX, V22, P1086, DOI 10.1093/cercor/bhr174; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Meda SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007911; Menz MM, 2009, HUM BRAIN MAPP, V30, P3339, DOI 10.1002/hbm.20756; Nagel IE, 2011, J COGNITIVE NEUROSCI, V23, P2030, DOI 10.1162/jocn.2010.21560; Nygard M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00149; Peelen MV, 2004, NEUROIMAGE, V22, P822, DOI 10.1016/j.neuroimage.2004.01.044; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; St Jacques PL, 2011, NEUROIMAGE, V57, P608, DOI 10.1016/j.neuroimage.2011.04.039; Stevens MC, 2009, HUM BRAIN MAPP, V30, P24, DOI 10.1002/hbm.20478; Tomasi D, 2007, BRAIN RES, V1132, P158, DOI 10.1016/j.brainres.2006.11.030; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; van Wageningen H, 2009, HUM BRAIN MAPP, V30, P3616, DOI 10.1002/hbm.20789; Verduzco-Flores S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006399; Vossel S, 2013, NEUROSCIENTIST; Weissman DH, 2012, NEUROIMAGE, V61, P798, DOI 10.1016/j.neuroimage.2012.03.032; White TP, 2010, SCHIZOPHR RES, V123, P105, DOI 10.1016/j.schres.2010.07.020; Wu X, 2009, NEUROIMAGE, V45, P1347, DOI 10.1016/j.neuroimage.2008.12.050; Xu JS, 2013, NEUROIMAGE, V79, P62, DOI 10.1016/j.neuroimage.2013.04.038; Xu JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014552; Yan XD, 2011, J NEUROSCI METH, V199, P108, DOI 10.1016/j.jneumeth.2011.05.001; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang S, 2012, HUM BRAIN MAPP, V33, P89, DOI 10.1002/hbm.21197; Zsigmond TK, 2008, IDEGGYOGY SZEMLE, V61, P280; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	76	39	39	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87078	10.1371/journal.pone.0087078	http://dx.doi.org/10.1371/journal.pone.0087078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498021	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900065
J	Banerjee, D; Burkard, L; Panepinto, JC				Banerjee, Dithi; Burkard, Lauren; Panepinto, John C.			Inhibition of Nucleotide Biosynthesis Potentiates the Antifungal Activity of Amphotericin B	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; IN-VITRO; CANDIDA-ALBICANS; PYRIMIDINE BIOSYNTHESIS; 5-FLUOROCYTOSINE; COMBINATION; FLUCYTOSINE; MENINGITIS; AGENTS; ASPERGILLUS	The polyene antifungal agent Amphotericin B exhibits potent and broad spectrum fungicidal activity. However, high nephrotoxicity can hinder its administration in resource poor settings. Quantification of early fungicidal activity in studies of HIV patients with cryptococcosis demonstrate that 5-Fluorocytosine therapy in combination with Amphotericin B results in faster clearance than with Amphotericin B alone. In vitro synergy between the two drugs has also been reported but the mechanism by which 5-Fluorocytosine synergizes with Amphotericin B has not been delineated. In this study we set out to investigate the effect of genetic mutation or pharmacologic repression of de novo pyrimidine and purine biosynthesis pathways on the Amphotericin B susceptibility of Cryptococcus neoformans. We demonstrate that a ura- derivative of wild type Cryptococcus neoformans strain H99 is hypersensitive to Amphotericin B. This sensitivity is remediated by reintroduction of a wild type URA5 gene, but not by addition of exogenous uracil to supplement the auxotrophy. Repression of guanine biosynthesis by treatment with the inosine monophosphate dehydrogenase inhibitor, mycophenolic acid, was synergistic with Amphotericin B as determined by checkerboard analysis. As in Cryptococcus neoformans, a ura(-) derivative of Candida albicans was also hypersensitive to Amphotericin B, and treatment of Candida albicans with mycophenolic acid was likewise synergistic with Amphotericin B. In contrast, neither mycophenolic acid nor 5-FC had an effect on the Amphotericin B susceptibility of Aspergillus fumigatus. These studies suggest that pharmacological targeting of nucleotide biosynthesis pathways has potential to lower the effective dose of Amphotericin B for both C. neoformans and C. albicans. Given the requirement of nucleotide and nucleotide sugars for growth and pathogenesis of Cryptococcus neoformans, disrupting nucleotide metabolic pathways might thus be an effective mechanism for the development of novel antifungal drugs.	[Banerjee, Dithi; Burkard, Lauren; Panepinto, John C.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Dept Microbiol & Immunol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Panepinto, JC (corresponding author), SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	jcp25@buffalo.edu			Public Health Service (PHS) [1R01 AI089920]; University at Buffalo, the State University of New York; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089920] Funding Source: NIH RePORTER	Public Health Service (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); University at Buffalo, the State University of New York; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Public Health Service (PHS) Grant 1R01 AI089920 to JCP and Startup Funds from the University at Buffalo, the State University of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriole VT, 1999, J ANTIMICROB CHEMOTH, V44, P151, DOI 10.1093/jac/44.2.151; Aoun M, 2000, INT J ANTIMICROB AG, V16, P143, DOI 10.1016/S0924-8579(00)00220-X; Balish E, 2009, J MED MICROBIOL, V58, P290, DOI 10.1099/jmm.0.004846-0; BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Cassera MB, 2011, CURR TOP MED CHEM, V11, P2103; CHESNEY PJ, 1976, J PEDIATR-US, V89, P1017, DOI 10.1016/S0022-3476(76)80624-5; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; DENISDUPHIL M, 1989, BIOCHEM CELL BIOL, V67, P612, DOI 10.1139/o89-094; Deray G, 2002, J ANTIMICROB CHEMOTH, V49, P37, DOI 10.1093/jac/49.suppl_1.37; DiDomenico B, 1999, CURR OPIN MICROBIOL, V2, P509, DOI 10.1016/S1369-5274(99)00009-0; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Dromer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002870; EDMAN JC, 1990, MOL CELL BIOL, V10, P4538, DOI 10.1128/MCB.10.9.4538; Engl T, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-4; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; GHANNOUM MA, 1995, ANTIMICROB AGENTS CH, V39, P2459, DOI 10.1128/AAC.39.11.2459; HUGHES CE, 1984, ANTIMICROB AGENTS CH, V25, P560, DOI 10.1128/AAC.25.5.560; Hyde JE, 2007, CURR DRUG TARGETS, V8, P31, DOI 10.2174/138945007779315524; ITTARAT I, 1995, ANTIMICROB AGENTS CH, V39, P325, DOI 10.1128/AAC.39.2.325; Kagan S, 2012, ANTIMICROB AGENTS CH, V56, P5603, DOI 10.1128/AAC.00612-12; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; LAUER BA, 1978, J ANTIMICROB CHEMOTH, V4, P375, DOI 10.1093/jac/4.4.375; Low Chian-Yong, 2011, F1000 Med Rep, V3, P14, DOI 10.3410/M3-14; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Morrow CA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002957; Moyrand F, 2004, EUKARYOT CELL, V3, P1601, DOI 10.1128/EC.3.6.1601-1608.2004; Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x; ODDS FC, 1982, ANTIMICROB AGENTS CH, V22, P763, DOI 10.1128/AAC.22.5.763; Panepinto JC, 2007, INFECT IMMUN, V75, P4769, DOI 10.1128/IAI.00536-07; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pfaller MA, 2002, ANTIMICROB AGENTS CH, V46, P3518, DOI 10.1128/AAC.46.11.3518-3521.2002; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Schwarz P, 2003, ANTIMICROB AGENTS CH, V47, P3361, DOI 10.1128/AAC.47.10.3361-3364.2003; SNELLER MR, 1977, ANTIMICROB AGENTS CH, V12, P390, DOI 10.1128/AAC.12.3.390; Steinbach WJ, 2003, CLIN INFECT DIS, V37, pS188, DOI 10.1086/376524; Thompson GR, 2009, CLIN CHEST MED, V30, P203, DOI 10.1016/j.ccm.2009.02.001; TITSWORTH E, 1973, ANTIMICROB AGENTS CH, V4, P306, DOI 10.1128/AAC.4.3.306; VARMA A, 1992, INFECT IMMUN, V60, P1101, DOI 10.1128/IAI.60.3.1101-1108.1992; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Walsh T J, 1999, Transpl Infect Dis, V1, P247, DOI 10.1034/j.1399-3062.1999.010404.x; Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10; White RL, 1996, ANTIMICROB AGENTS CH, V40, P1914, DOI 10.1128/AAC.40.8.1914; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68	45	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87246	10.1371/journal.pone.0087246	http://dx.doi.org/10.1371/journal.pone.0087246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498052	gold, Green Published, Green Submitted			2022-12-25	WOS:000330617100066
J	Low, ETL; Rosli, R; Jayanthi, N; Mohd-Amin, A; Azizi, N; Chan, KL; Maqbool, NJ; Maclean, P; Brauning, R; McCulloch, A; Moraga, R; Ong-Abdullah, M; Singh, R				Low, Eng-Ti L.; Rosli, Rozana; Jayanthi, Nagappan; Mohd-Amin, Ab Halim; Azizi, Norazah; Chan, Kuang-Lim; Maqbool, Nauman J.; Maclean, Paul; Brauning, Rudi; McCulloch, Alan; Moraga, Roger; Ong-Abdullah, Meilina; Singh, Rajinder			Analyses of Hypomethylated Oil Palm Gene Space	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; ELAEIS-GUINEENSIS JACQ.; DISEASE RESISTANCE GENES; EXPRESSED SEQUENCE TAGS; SSR MARKERS; DIFFERENTIAL METHYLATION; TRANSCRIPTOME ANALYSIS; ARABIDOPSIS-THALIANA; GENOME SEQUENCE; DRAFT SEQUENCE	Demand for palm oil has been increasing by an average of similar to 8% the past decade and currently accounts for about 59% of the world's vegetable oil market. This drives the need to increase palm oil production. Nevertheless, due to the increasing need for sustainable production, it is imperative to increase productivity rather than the area cultivated. Studies on the oil palm genome are essential to help identify genes or markers that are associated with important processes or traits, such as flowering, yield and disease resistance. To achieve this, 294,115 and 150,744 sequences from the hypomethylated or gene-rich regions of Elaeis guineensis and E. oleifera genome were sequenced and assembled into contigs. An additional 16,427 shot-gun sequences and 176 bacterial artificial chromosomes (BAC) were also generated to check the quality of libraries constructed. Comparison of these sequences revealed that although the methylation-filtered libraries were sequenced at low coverage, they still tagged at least 66% of the RefSeq supported genes in the BAC and had a filtration power of at least 2.0. A total 33,752 microsatellites and 40,820 high-quality single nucleotide polymorphism (SNP) markers were identified. These represent the most comprehensive collection of microsatellites and SNPs to date and would be an important resource for genetic mapping and association studies. The gene models predicted from the assembled contigs were mined for genes of interest, and 242, 65 and 14 oil palm transcription factors, resistance genes and miRNAs were identified respectively. Examples of the transcriptional factors tagged include those associated with floral development and tissue culture, such as homeodomain proteins, MADS, Squamosa and Apetala2. The E. guineensis and E. oleifera hypomethylated sequences provide an important resource to understand the molecular mechanisms associated with important agronomic traits in oil palm.	[Low, Eng-Ti L.; Rosli, Rozana; Jayanthi, Nagappan; Mohd-Amin, Ab Halim; Azizi, Norazah; Chan, Kuang-Lim; Ong-Abdullah, Meilina; Singh, Rajinder] Malaysian Palm Oil Board, Adv Biotechnol & Breeding Ctr, Kajang, Selangor, Malaysia; [Maqbool, Nauman J.; Maclean, Paul] AgRes Ruakura Res Ctr, Hamilton, New Zealand; [Brauning, Rudi; McCulloch, Alan] AgRes Invermay Agr Ctr, Mosgiel, New Zealand; [Moraga, Roger] AgRes Grasslands Res Ctr, Palmerston North, New Zealand	Malaysian Palm Oil Board; AgResearch - New Zealand; AgResearch - New Zealand; AgResearch - New Zealand	Singh, R (corresponding author), Malaysian Palm Oil Board, Adv Biotechnol & Breeding Ctr, Kajang, Selangor, Malaysia.	rajinder@mpob.gov.my	Low, Eng Ti Leslie/AHD-7011-2022; Singh, Rajinder/P-9179-2015; Moraga, Roger/AAW-2660-2021	Low, Eng Ti Leslie/0000-0003-3414-8401; Singh, Rajinder/0000-0001-9933-4884; Azizi, Norazah/0000-0001-5023-9763; Chan, Kuang-Lim/0000-0002-8419-0432; Maqbool, Nauman/0000-0002-9404-3647; Brauning, Rudiger/0000-0001-5068-9166; Maclean, Paul/0000-0001-8898-8276; Ong-Abdullah, Meilina/0000-0003-4825-5021	MPOB [R001702000-RB01-J]	MPOB	This work was supported by special MPOB grant (R001702000-RB01-J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alwee SS, 2006, PLANT CELL TISS ORG, V85, P331, DOI 10.1007/s11240-006-9084-4; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Barbosa-Da-Silva A, 2005, GENET MOL BIOL, V28, P562, DOI 10.1590/S1415-47572005000400011; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batley J, 2003, PLANT PHYSIOL, V132, P84, DOI 10.1104/pp.102.019422; Bedell JA, 2005, PLOS BIOL, V3, P103, DOI 10.1371/journal.pbio.0030013; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Bent AF, 1996, PLANT CELL, V8, P1757, DOI 10.1105/tpc.8.10.1757; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Billotte N, 2005, THEOR APPL GENET, V110, P754, DOI 10.1007/s00122-004-1901-8; Billotte N, 2001, GENOME, V44, P413, DOI 10.1139/g01-017; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Budiman M. A., 2005, P 2005 PIPOC INT PAL, P628; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cardle L, 2000, GENETICS, V156, P847; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chan PL, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue1-fulltext-14; Chandrasekar A, 2009, BIOINFORMATION, V4, P119, DOI 10.6026/97320630004119; Corley R., 2003, OIL PALM; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dransfield J, 2008, GENERA PALMARUM EVOL; Feng SP, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/373768; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gao G, 2006, BIOINFORMATICS, V22, P1286, DOI 10.1093/bioinformatics/btl107; Giorgetti L, 2007, CARYOLOGIA, V60, P279, DOI 10.1080/00087114.2007.10797949; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Ho CL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-381; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Irish VF, 1999, DEV BIOL, V209, P211, DOI 10.1006/dbio.1999.9226; Itaya A, 2008, BBA-GENE REGUL MECH, V1779, P99, DOI 10.1016/j.bbagrm.2007.09.003; Jaligot E, 2000, PLANT CELL REP, V19, P684, DOI 10.1007/s002999900177; Jaligot E, 2011, ANN BOT-LONDON, V108, P1453, DOI 10.1093/aob/mcq266; Joslyn CA, 2004, BIOINFORMATICS, V20, P169, DOI 10.1093/bioinformatics/bth921; Jouannic S, 2005, FEBS LETT, V579, P2709, DOI 10.1016/j.febslet.2005.03.093; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LANDER E S, 1988, Genomics, V2, P231; Latiff A., 2000, ADV OIL PALM RES, V1, P19; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Lin HC, 2009, PLANT MOL BIOL, V70, P173, DOI 10.1007/s11103-009-9464-3; Lorang JM, 2007, P NATL ACAD SCI USA, V104, P14861, DOI 10.1073/pnas.0702572104; Low ETL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-62; Ma QH, 2007, J PLANT GROWTH REGUL, V26, P369, DOI 10.1007/s00344-007-9022-7; Martienssen RA, 2004, CURR OPIN PLANT BIOL, V7, P102, DOI 10.1016/j.pbi.2004.01.010; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Matthes M, 2001, THEOR APPL GENET, V102, P971, DOI 10.1007/s001220000491; McDowell JM, 2003, TRENDS BIOTECHNOL, V21, P178, DOI 10.1016/S0167-7799(03)00053-2; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Mitsuda N, 2009, PLANT CELL PHYSIOL, V50, P1232, DOI 10.1093/pcp/pcp075; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Molesini B, 2012, TRENDS BIOTECHNOL, V30, P80, DOI 10.1016/j.tibtech.2011.07.005; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Ooi LCL, 2007, INT PLANT AN GEN 15, P177; Opdam FJM, 2000, EUR J CELL BIOL, V79, P308, DOI 10.1078/S0171-9335(04)70034-5; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Peraza-Echeverria S, 2007, MOL GENET GENOMICS, V278, P443, DOI 10.1007/s00438-007-0262-9; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Rabinowicz PD, 2005, GENOME RES, V15, P1431, DOI 10.1101/gr.4100405; Ragupathy R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-217; Riju A, 2009, NATURE PRECEDINGS; Riju A, 2009, J GENET, V88, P217, DOI 10.1007/s12041-009-0030-1; Riju A, 2007, BIOINFORMATION, V2, P128, DOI 10.6026/97320630002128; Rival A, 1997, PLANT CELL REP, V16, P884, DOI 10.1007/s002990050339; Sakai H, 2011, PLANT J, V66, P796, DOI 10.1111/j.1365-313X.2011.04539.x; Sanseverino W, 2013, NUCLEIC ACIDS RES, V41, pD1167, DOI 10.1093/nar/gks1183; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shearman JR, 2013, GENOMICS, V101, P306, DOI 10.1016/j.ygeno.2013.02.012; Singh R, 2008, BIOLOGIA, V63, P227, DOI 10.2478/s11756-008-0041-z; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Singh R, 2013, NATURE, V500, P340, DOI 10.1038/nature12356; Singhal D, 2011, AFR J BIOTECHNOL, V10, P580; Soleimani VD, 2003, PLANT MOL BIOL REP, V21, P281, DOI 10.1007/BF02772803; Song WY, 1997, PLANT CELL, V9, P1279, DOI 10.1105/tpc.9.8.1279; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tameling WIL, 2008, EUR J PLANT PATHOL, V121, P243, DOI 10.1007/s10658-007-9187-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarr D Ellen K, 2009, BMC Res Notes, V2, P197, DOI 10.1186/1756-0500-2-197; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timko MP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-103; Ting NC, 2010, J GENET, V89, P135, DOI 10.1007/s12041-010-0053-7; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Tranbarger TJ, 2011, PLANT PHYSIOL, V156, P564, DOI 10.1104/pp.111.175141; Tranbarger TJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-1; van der Linden CG, 2004, THEOR APPL GENET, V109, P384, DOI 10.1007/s00122-004-1642-8; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Vijayraghavan U, 2001, CURR SCI INDIA, V80, P233; Wanderley-Nogueira AC, 2007, GENET MOL RES, V6, P866; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047; Xu ZS, 2011, J INTEGR PLANT BIOL, V53, P570, DOI 10.1111/j.1744-7909.2011.01062.x; Yonemaru J, 2009, DNA RES, V16, P187, DOI 10.1093/dnares/dsp005; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan DaoJun, 2012, African Journal of Biotechnology, V11, P13269; Yun ChoongHyo, 1999, Plant Pathology Journal, V15, P105; Zaki NM, 2012, INT J MOL SCI, V13, P4069, DOI 10.3390/ijms13044069; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang HY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-401; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang LD, 2004, BIOINFORMATICS, V20, P1081, DOI 10.1093/bioinformatics/bth043; Zhang XH, 2011, FEBS LETT, V585, P435, DOI 10.1016/j.febslet.2010.12.036	116	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86728	10.1371/journal.pone.0086728	http://dx.doi.org/10.1371/journal.pone.0086728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497974	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100028
J	Nikitin, PA; Price, AM; McFadden, K; Yan, CM; Luftig, MA				Nikitin, Pavel A.; Price, Alexander M.; McFadden, Karyn; Yan, Christopher M.; Luftig, Micah A.			Mitogen-Induced B-Cell Proliferation Activates Chk2-Dependent G1/S Cell Cycle Arrest	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; DNA-DAMAGE RESPONSE; ONCOGENE-INDUCED SENESCENCE; NF-KAPPA-B; CANCER; CHK2; CHECKPOINT; EXPRESSION; KINASE; AID	B-cell activation and proliferation can be induced by a variety of extracellular stimuli. The fate of an activated B cell following mitogen stimulation can be dictated by the strength or duration of the signal, the expression of downstream signaling components necessary to promote proliferation, and the cell intrinsic sensors and regulators of the proliferative program. Previously we have identified the DNA damage response (DDR) signaling pathway as a cell intrinsic sensor that is activated upon latent infection of primary human B cells by Epstein-Barr virus (EBV). Here we have assessed the role of the DDR as a limiting factor in the proliferative response to non-viral B-cell mitogens. We report that TLR9 activation through CpG-rich oligonucleotides induced B-cell hyper-proliferation and an ATM/Chk2 downstream signaling pathway. However, B-cell activation through the CD40 pathway coupled with interleukin-4 (IL-4) promoted proliferation less robustly and only a modest DDR. These two mitogens, but not EBV, modestly induced intrinsic apoptosis that was independent from the DDR. However, all three mitogens triggered a DDR-dependent G1/S phase cell cycle arrest preventing B-cell proliferation. The extent of G1/S arrest, as evidenced by release through Chk2 inhibition, correlated with B-cell proliferation rates. These findings have implications for the regulation of extra-follicular B-cell activation as it may pertain to the development of auto-immune diseases or lymphoma.	[Nikitin, Pavel A.; Price, Alexander M.; McFadden, Karyn; Yan, Christopher M.; Luftig, Micah A.] Duke Univ, Sch Med, Ctr Virol, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Luftig, MA (corresponding author), Duke Univ, Sch Med, Ctr Virol, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	micah.luftig@duke.edu	Luftig, Micah/AAY-7567-2021	Luftig, Micah/0000-0002-2964-1907; Nikitin, Pavel/0000-0003-4930-3814	NIH [R01 CA140337, 5P30 AI064518, T32 CA009111, F31 CA180451]; American Cancer Society [RSG-13-228-01-MPC]; Duke CFAR; NATIONAL CANCER INSTITUTE [T32CA009111, F31CA180451, R01CA140337, P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Duke CFAR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 CA140337 (M. A. L.) and American Cancer Society grant RSG-13-228-01-MPC (M. A. L.) as well as the Duke CFAR, an NIH funded program (5P30 AI064518). A. M. P. and K. M. were both supported by the NIH training grant T32 CA009111. Additionally, A. M. P. was supported by NIH fellowship F31 CA180451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Arienti KL, 2005, J MED CHEM, V48, P1873, DOI 10.1021/jm0495935; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Cunningham-Rundles C, 2006, J IMMUNOL, V176, P1978, DOI 10.4049/jimmunol.176.3.1978; Daniel JA, 2013, MOL CELL, V50, P309, DOI 10.1016/j.molcel.2013.04.017; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kolar GR, 2007, BLOOD, V109, P2545, DOI 10.1182/blood-2006-07-037150; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Markham JF, 2010, J R SOC INTERFACE, V7, P1049, DOI 10.1098/rsif.2009.0488; Maruo S, 2011, P NATL ACAD SCI USA, V108, P1919, DOI 10.1073/pnas.1019599108; McFarland EDC, 1999, ONCOGENE, V18, P6959, DOI 10.1038/sj.onc.1203217; McPherson JP, 2004, GENE DEV, V18, P1144, DOI 10.1101/gad.1192704; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nikitin PA, 2010, CELL HOST MICROBE, V8, P510, DOI 10.1016/j.chom.2010.11.004; O'Nions J, 2004, J GEN VIROL, V85, P881, DOI 10.1099/vir.0.19704-0; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Price AM, 2012, J VIROL, V86, P11096, DOI 10.1128/JVI.01069-12; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Sato K, 2010, NAT CELL BIOL, V12, P424, DOI 10.1038/ncb0510-424; Skalska L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003187; Skalska L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000951; Toellner KM, 1996, J EXP MED, V183, P2303, DOI 10.1084/jem.183.5.2303; Tort F, 2002, BLOOD, V100, P4602, DOI 10.1182/blood-2002-04-1078; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430	42	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87299	10.1371/journal.pone.0087299	http://dx.doi.org/10.1371/journal.pone.0087299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498068	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100075
J	Osler, M; Martensson, S; Prescott, E; Carlsen, K				Osler, Merete; Martensson, Solvej; Prescott, Eva; Carlsen, Kathrine			Impact of Gender, Co-Morbidity and Social Factors on Labour Market Affiliation after First Admission for Acute Coronary Syndrome. A Cohort Study of Danish Patients 2001-2009	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; FOLLOW-UP; BYPASS-SURGERY; RETURN; WORK; MORTALITY; REGISTRY; DISEASE; ANGIOPLASTY; COMORBIDITY	Background: Over the last decades survival after acute coronary syndrome (ACS) has improved, leading to an increasing number of patients returning to work, but little is known about factors that may influence their labour market affiliation. This study examines the impact of gender, co-morbidity and socio-economic position on subsequent labour market affiliation and transition between various social services in patients admitted for the first time with ACS. Methods: From 2001 to 2009 all first-time hospitalisations for ACS were identified in the Danish National Patient Registry (n = 79,714). For this population, data on sick leave, unemployment and retirement were obtained from an administrative register covering all citizens. The 21,926 patients, aged 18-63 years, who had survived 30 days and were part of the workforce at the time of diagnosis were included in the analyses where subsequent transition between the above labour market states was examined using Kaplan-Meier estimates and Cox proportional hazards models. Findings: A total of 37% of patients were in work 30 days after first ACS diagnosis, while 55% were on sick leave and 8% were unemployed. Seventy-nine per cent returned to work once during follow-up. This probability was highest among males, those below 50 years, living with a partner, the highest educated, with higher occupations, having specific events (NSTEMI, and percutaneous coronary intervention) and with no co-morbidity. During five years follow-up, 43% retired due to disability or voluntary early pension. Female gender, low education, basic occupation, co-morbidity and having a severer event (invasive procedures) and receiving sickness benefits or being unemployed 30 days after admission were associated with increased probability of early retirement. Conclusion: About half of patients with first-time ACS stay in or return to work shortly after the event. Women, the socially disadvantaged, those with presumed severer events and co-morbidity have lower rates of return.	[Osler, Merete; Martensson, Solvej; Carlsen, Kathrine] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Prescott, Eva] Bispebjerg Hosp, Dept Cardiol Y, DK-2400 Copenhagen, Denmark; [Osler, Merete] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Osler, M (corresponding author), Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.	merete.osler@regionh.dk	Osler, Merete/AAF-7885-2019; Prescott, Eva/AAJ-7441-2020	Prescott, Eva/0000-0002-4134-0349; Osler, Merete/0000-0002-6921-220X	Danish Heart Association [1104-R83-A3441-22623]	Danish Heart Association	The study was funded by the Danish Heart Association (jr nr. 1104-R83-A3441-22623). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman EL, 1997, JAMA-J AM MED ASSOC, V277, P715; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; [Anonymous], 2006, IDA INT DAT LAB MARK; Boudrez H, 2000, ACTA CARDIOL, V55, P341, DOI 10.2143/AC.55.6.2005765; Hallberg V, 2009, SCAND CARDIOVASC J, V43, P277, DOI 10.1080/14017430802506601; Hamalainen H, 2004, EUR J PUBLIC HEALTH, V14, P350, DOI 10.1093/eurpub/14.4.350; Hjollund NH, 2007, SCAND J PUBLIC HEALT, V35, P497, DOI 10.1080/14034940701271882; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; MARK DB, 1992, CIRCULATION, V86, P1485, DOI 10.1161/01.CIR.86.5.1485; Mital Anil, 2004, J Cardiopulm Rehabil, V24, P365, DOI 10.1097/00008483-200411000-00001; Mittag O, 2001, SOC SCI MED, V52, P1441, DOI 10.1016/S0277-9536(00)00250-1; Nielsen FE, 2004, J CLIN EPIDEMIOL, V57, P837, DOI 10.1016/j.jclinepi.2003.12.022; Pedersen J, 2012, SCAND J WORK ENV HEA, V38, P516, DOI 10.5271/sjweh.3293; Perk J, 2004, SCAND J PUBLIC HEALT, V32, P181, DOI 10.1080/14034950410021880; Pinto Nigel, 2012, Asian Cardiovasc Thorac Ann, V20, P387, DOI 10.1177/0218492312437881; Pocock SJ, 1996, CIRCULATION, V94, P135, DOI 10.1161/01.CIR.94.2.135; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Rasmussen JN, 2006, J EPIDEMIOL COMMUN H, V60, P351, DOI 10.1136/jech.200X.040972; Schmidt M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e356; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; Voss M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040952	23	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86758	10.1371/journal.pone.0086758	http://dx.doi.org/10.1371/journal.pone.0086758			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302PJ	24497976	gold, Green Submitted, Green Published			2022-12-25	WOS:000330617100030
J	Rogers, AJ; McGeachie, M; Baron, RM; Gazourian, L; Haspel, JA; Nakahira, K; Fredenburgh, LE; Hunninghake, GM; Raby, BA; Matthay, MA; Otero, RM; Fowler, VG; Rivers, EP; Woods, CW; Kingsmore, S; Langley, RJ; Choi, AMK				Rogers, Angela J.; McGeachie, Michael; Baron, Rebecca M.; Gazourian, Lee; Haspel, Jeffrey A.; Nakahira, Kiichi; Fredenburgh, Laura E.; Hunninghake, Gary M.; Raby, Benjamin A.; Matthay, Michael A.; Otero, Ronny M.; Fowler, Vance G.; Rivers, Emanuel P.; Woods, Christopher W.; Kingsmore, Stephen; Langley, Ray J.; Choi, Augustine M. K.			Metabolomic Derangements Are Associated with Mortality in Critically Ill Adult Patients	PLOS ONE			English	Article							OPERATING CHARACTERISTIC CURVES; BAYESIAN NETWORKS; SEPTIC SHOCK; CORTISOL; PROFILES; SEARCH; SEPSIS	Objective: To identify metabolomic biomarkers predictive of Intensive Care Unit (ICU) mortality in adults. Rationale: Comprehensive metabolomic profiling of plasma at ICU admission to identify biomarkers associated with mortality has recently become feasible. Methods: We performed metabolomic profiling of plasma from 90 ICU subjects enrolled in the BWH Registry of Critical Illness (RoCI). We tested individual metabolites and a Bayesian Network of metabolites for association with 28-day mortality, using logistic regression in R, and the CGBayesNets Package in MATLAB. Both individual metabolites and the network were tested for replication in an independent cohort of 149 adults enrolled in the Community Acquired Pneumonia and Sepsis Outcome Diagnostics (CAPSOD) study. Results: We tested variable metabolites for association with 28-day mortality. In RoCI, nearly one third of metabolites differed among ICU survivors versus those who died by day 28 (N = 57 metabolites, p<.05). Associations with 28-day mortality replicated for 31 of these metabolites (with p<.05) in the CAPSOD population. Replicating metabolites included lipids (N = 14), amino acids or amino acid breakdown products (N = 12), carbohydrates (N = 1), nucleotides (N = 3), and 1 peptide. Among 31 replicated metabolites, 25 were higher in subjects who progressed to die; all 6 metabolites that are lower in those who die are lipids. We used Bayesian modeling to form a metabolomic network of 7 metabolites associated with death (gamma-glutamylphenylalanine, gamma-glutamyltyrosine, 1-arachidonoylGPC(20: 4), taurochenodeoxycholate, 3-(4-hydroxyphenyl) lactate, sucrose, kynurenine). This network achieved a 91% AUC predicting 28-day mortality in RoCI, and 74% of the AUC in CAPSOD (p<.001 in both populations). Conclusion: Both individual metabolites and a metabolomic network were associated with 28-day mortality in two independent cohorts. Metabolomic profiling represents a valuable new approach for identifying novel biomarkers in critically ill patients.	[Rogers, Angela J.; McGeachie, Michael; Raby, Benjamin A.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Rogers, Angela J.; Baron, Rebecca M.; Gazourian, Lee; Haspel, Jeffrey A.; Nakahira, Kiichi; Fredenburgh, Laura E.; Hunninghake, Gary M.; Raby, Benjamin A.; Choi, Augustine M. K.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Rogers, Angela J.] Stanford Univ, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Matthay, Michael A.] Univ Calif San Francisco, Dept Med & Anesthesia, San Francisco, CA 94143 USA; [Otero, Ronny M.; Rivers, Emanuel P.] Henry Ford Hosp, Dept Emergency Med, Detroit, MI 48202 USA; [Fowler, Vance G.; Woods, Christopher W.] Duke Univ, Sch Med, Duke Inst Genome Sci & Policy, Durham, NC USA; [Fowler, Vance G.; Woods, Christopher W.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Kingsmore, Stephen; Langley, Ray J.] Natl Ctr Genome Resources, Santa Fe, NM USA; [Langley, Ray J.] Lovelace Resp Res Inst, Santa Fe, NM USA; [Nakahira, Kiichi; Choi, Augustine M. K.] Weill Cornell Med Coll, Dept Med, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Stanford University; University of California System; University of California San Francisco; Henry Ford Health System; Henry Ford Hospital; Duke University; Duke University; National Center for Genome Resources (NCGR); Lovelace Respiratory Research Institute; Cornell University	Choi, AMK (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.	amchoi@med.cornell.edu	Raby, Benjamin/AAK-3866-2021; Haspel, J./K-3563-2019; Fowler, Vance/AAW-2017-2021	kingsmore, stephen/0000-0002-3758-4631; Rogers, Angela/0000-0001-6969-6200; Kingsmore, Stephen/0000-0001-7180-2527	Parker B. Francis foundation; NIH [K08 HL092222, U01AI066569, P20RR016480, HHSN266200400064C]; NHLBI [R37 HL51856, HL51854]; Pfizer Inc.; Roche Diagnostics Inc.;  [K12 HL089990];  [T32 HL7118];  [T32 HL007680];  [K08 GM083207];  [R01 HL091957];  [R01 HL112747];  [P01 108801];  [P01 HL108801];  [R01 HL079904]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111024, K12HL089990, R01HL051854, R01HL112747, R01HL091957, R37HL051856, R01HL055330, T32HL007118, T32HL007680, R01HL079904, P01HL108801, K08HL092222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM083207] Funding Source: NIH RePORTER	Parker B. Francis foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pfizer Inc.(Pfizer); Roche Diagnostics Inc.; ; ; ; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Rogers is supported by a grant from the Parker B. Francis foundation (http://www.francisfellowships.org/). Dr. McGeachie is supported by K12 HL089990; Dr. Gazourian is supported by T32 HL7118 and T32 HL007680; Dr. Fredenburgh is supported by K08 GM083207; Dr. Baron is supported by R01 HL091957, R01 HL112747, and P01 108801; Dr. Hunninghake is supported by NIH grant: K08 HL092222; and Dr. Choi is supported by P01 HL108801, R01 HL079904, and R01 HL112747. Dr. Matthay is supported by NHLBI R37 HL51856 and HL51854. The CAPSOD study was supported by grants from NIH (U01AI066569, P20RR016480, HHSN266200400064C), Pfizer Inc. (www.pfizer.com) and Roche Diagnostics Inc. (www.roche-diagnostics.us). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Boonen E, 2013, NEW ENGL J MED, V368, P1477, DOI 10.1056/NEJMoa1214969; Calfee CS, 2012, AM J RESP CRIT CARE, V186, P2, DOI 10.1164/rccm.201205-0854ED; Chang HH, 2011, IEEE ENG MED BIO, P6849, DOI 10.1109/IEMBS.2011.6091689; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; Focker M, 2012, J PSYCHIATR RES, V46, P1600, DOI 10.1016/j.jpsychires.2012.08.015; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; Gibney MJ, 2005, AM J CLIN NUTR, V82, P497, DOI 10.1093/ajcn/82.3.497; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Joint Commission Resources, 2004, IMPR CAR ICU; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Li GX, 2011, AM J RESP CRIT CARE, V183, P59, DOI 10.1164/rccm.201003-0436OC; McGeachie M, 2011, MULTIMODAL CONDITION; Mickiewicz B, 2013, AM J RESP CRIT CARE, V187, P967, DOI 10.1164/rccm.201209-1726OC; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rodin AS, 2005, BIOINFORMATICS, V21, P3273, DOI 10.1093/bioinformatics/bti505; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tsalik EL, 2012, J EMERG MED, V43, P97, DOI 10.1016/j.jemermed.2011.05.072; Tsalik EL, 2010, J CLIN MICROBIOL, V48, P26, DOI 10.1128/JCM.01447-09; Veenstra TD, 2012, GENOME MED, V4, DOI 10.1186/gm339; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695	29	93	97	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87538	10.1371/journal.pone.0087538	http://dx.doi.org/10.1371/journal.pone.0087538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498130	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100092
J	Wang, XT; Dai, Y; Zhao, S; Tang, JX; Li, HJ; Xing, YT; Qu, GL; Li, XS; Dai, JR; Zhu, YC; Zhang, XG				Wang, Xiaoting; Dai, Yang; Zhao, Song; Tang, Jianxia; Li, Hongjun; Xing, Yuntian; Qu, Guoli; Li, Xinsong; Dai, Jianrong; Zhu, Yinchang; Zhang, Xueguang			PAMAM-Lys, a Novel Vaccine Delivery Vector, Enhances the Protective Effects of the SjC23 DNA Vaccine against Schistosoma japonicum Infection	PLOS ONE			English	Article							PLASMID DNA; GENE DELIVERY; MOUSE MUSCLE; CHINA; EXPRESSION; PIGS; EXPERIENCES; PARAMYOSIN; CHALLENGE; DENDRIMER	Background: Schistosomiasis japonica remains a major public-health concern in China. Praziquantel-based chemotherapy effectively reduces both infections and intensity; however, it can not prevent re-infection. Furthermore, there is an increasing concern about praziquantel resistance following long-term repeated use of the drug in endemic areas. Therefore, development of a schistosomiasis vaccine, as a strategy to prevent and control schistosomiasis japonica, has been given high priority. The present study was conducted to develop PAMAM dendrimers as a novel vaccine delivery vector for a schistosomiasis japonica DNA vaccine and evaluate its ability to enhance protective effects against Schistosoma japonicum infection. Methodology/Principal Findings: Lysine was used to modify 4.0G PAMAM, and the modified product PAMAM-Lys was synthesized. PAMAM-Lys showed both high transfection and low cytotocity for gene delivery in vitro. DNA vaccines combined with PAMAM-Lys produced higher level of protection compare with naked DNA vaccines against S. japonicum infection in a mouse model. Futhermore, antibodies from mice immunized with PAMAM-Lys combined DNA vaccines were significantly higher than those of mice immunized with the naked DNA vaccines. The PAMAM-Lys vector elicited a predominantly IgG2a antibody response and a tremendously increase in the production of IL-2 and IFN-gamma. Conclusion/Significance: Lysine-modified PAMAM-Lys is an excellent vector. PAMAM-Lys may enhance the immunoreactivity of DNA vaccine and increase the protective effect of the SjC23 DNA vaccine against S. japonicum infection.	[Wang, Xiaoting; Zhang, Xueguang] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Clin Immunol,Med Coll, Jiangsu Stem Cell Key Lab,Inst Med Biotechnol, Suzhou, Peoples R China; [Wang, Xiaoting; Dai, Yang; Zhao, Song; Tang, Jianxia; Li, Hongjun; Xing, Yuntian; Qu, Guoli; Dai, Jianrong; Zhu, Yinchang] Jiangsu Prov Key Lab Mol Biol Parasites, Minist Hlth, Jiangsu Inst Parasit Dis, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China; [Li, Xinsong] Southeast Univ, Sch Chem & Chem Engn, Biomat & Drug Delivery Labs, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Southeast University - China	Zhu, YC (corresponding author), Jiangsu Prov Key Lab Mol Biol Parasites, Minist Hlth, Jiangsu Inst Parasit Dis, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China.	yczhu2006@aliyun.com; xueguangzh@126.com.cn	Wang, Xiaoting/AAI-3159-2020		National Program on Key Basic Research Project(973 Program) [2013CB530501]; Chinese National Natural Science Foundation of China [81000749, 81000748]; Jiangsu Provincial Nature Science Foundation [BK2010152]; Chinese Ministry of Health [LW201005]; Jiangsu Province's Outstanding Medical Academic Leader program [LJ201132]	National Program on Key Basic Research Project(973 Program)(National Basic Research Program of China); Chinese National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Nature Science Foundation; Chinese Ministry of Health; Jiangsu Province's Outstanding Medical Academic Leader program	The study has been financially supported by the following grants: National Program on Key Basic Research Project(973 Program, Grant No. 2013CB530501); Chinese National Natural Science Foundation of China (No: 81000749 and 81000748); Jiangsu Provincial Nature Science Foundation (BK2010152); Scientific Research Project from Chinese Ministry of Health (LW201005); and Jiangsu Province's Outstanding Medical Academic Leader program (LJ201132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickle QD, 2001, VET PARASITOL, V100, P51, DOI 10.1016/S0304-4017(01)00483-6; Choi JS, 2004, J CONTROL RELEASE, V99, P445, DOI 10.1016/j.jconrel.2004.07.027; Da'Dara AA, 2008, VACCINE, V26, P3617, DOI 10.1016/j.vaccine.2008.04.080; Dai Y, 2009, CLIN VACCINE IMMUNOL, V16, P1796, DOI 10.1128/CVI.00231-09; Dennig Jorg, 2002, J Biotechnol, V90, P339; Doenhoff Michael J, 2006, Expert Rev Anti Infect Ther, V4, P199, DOI 10.1586/14787210.4.2.199; Eberl M, 2001, INFECT IMMUN, V69, P5352, DOI 10.1128/IAI.69.9.5352-5362.2001; Fenwick A, 2006, CURR OPIN INFECT DIS, V19, P577, DOI 10.1097/01.qco.0000247591.13671.6a; Gao Q, 2007, CHEM RES, V18, P41; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hao Yang, 2008, Chinese Journal of Schistosomiasis Control, V20, P401; Hogg KG, 2003, INFECT IMMUN, V71, P3563, DOI 10.1128/IAI.71.6.3563-3571.2003; Hu Y, 2007, EXP PARASITOL, V115, P379, DOI 10.1016/j.exppara.2006.09.022; Jain K, 2010, INT J PHARMACEUT, V394, P122, DOI 10.1016/j.ijpharm.2010.04.027; Kamimura Kenya, 2011, Pharmaceut Med, V25, P293; Li CY, 2006, CELL MOL BIOL LETT, V11, P449, DOI 10.2478/s11658-006-0036-0; LIU SX, 1995, VACCINE, V13, P603, DOI 10.1016/0264-410X(94)00045-O; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; McManus DP, 2000, INT J PARASITOL, V30, P265, DOI 10.1016/S0020-7519(99)00200-3; McManus DP, 1998, INT J PARASITOL, V28, P1739, DOI 10.1016/S0020-7519(98)00151-9; Ren JianGong, 2002, Chinese Journal of Schistosomiasis Control, V14, P98; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; SHI YE, 1990, EXP PARASITOL, V71, P100, DOI 10.1016/0014-4894(90)90012-2; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Sun WY, 1999, PROTEIN EXPRES PURIF, V17, P410, DOI 10.1006/prep.1999.1140; Sun XL, 2010, MINI-REV MED CHEM, V10, P108, DOI 10.2174/138955710791185109; Taylor MG, 1998, VACCINE, V16, P1290, DOI 10.1016/S0264-410X(98)00055-3; Wang LD, 2009, TROP MED INT HEALTH, V14, P1475, DOI 10.1111/j.1365-3156.2009.02403.x; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang Shi-Ping, 2009, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V27, P402; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Wolff JA, 2005, ADV GENET, V54, P3, DOI 10.1016/S0065-2660(05)54001-X; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; Zheng Hao, 2012, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V24, P621; Zhou SH, 2000, VACCINE, V18, P3196, DOI 10.1016/S0264-410X(99)00555-1; Zhu Y, 2006, PARASITOLOGY, V132, P67, DOI 10.1017/S0031182005008644; Zhu YC, 2004, VACCINE, V23, P78, DOI 10.1016/j.vaccine.2004.04.031; Zhu Yinchang, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P518; Zhu Yinchang, 2002, Southeast Asian J Trop Med Public Health, V33, P207; Zhu Yingchang, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P697	41	11	12	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86578	10.1371/journal.pone.0086578	http://dx.doi.org/10.1371/journal.pone.0086578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497955	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100020
J	Farsani, SF; Souverein, PC; van der Vorst, MMJ; Mantel-Teeuwisse, AK; Knibbe, CAJ; de Boer, A				Farsani, Soulmaz Fazeli; Souverein, Patrick C.; van der Vorst, Marja M. J.; Mantel-Teeuwisse, Aukje K.; Knibbe, Catherijne A. J.; de Boer, Anthonius			Disease History and Medication Use as Risk Factors for the Clinical Manifestation of Type 1 Diabetes in Children and Young Adults: An Explorative Case Control Study	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; CHILDHOOD; EPIDEMIOLOGY; PATHOGENESIS; POPULATION; PREVALENCE; MELLITUS	Background: There is a highly variable asymptomatic period of beta cell destruction prior to the clinical presentation of type1 diabetes. It is not well known what triggers type 1 diabetes to become a clinically overt disease. This explorative study aimed to identify the association between disease history/medication use and the clinical manifestation of type 1 diabetes. Methodology/Principal Findings: An explorative case control study was conducted in the Dutch PHARMO Record Linkage System. Cases (n = 1,107) were younger than 25 years and had at least 2 insulin prescriptions between 1999 and 2009. For each case, up to 4 controls (without any prescription for the glucose lowering medications (n = 4,424)) were matched by age and sex. Conditional logistic regression analysis was used to evaluate the association between disease history/medication use in the year prior to the diagnosis of type1 diabetes and clinical manifestation of this disease. Type1 diabetes was significantly associated with a history of mental disorder (odds ratio (OR) 8.0, 95% confidence interval (CI) 1.5-43.7), anemia (OR 5.1, 95% CI 1.1-22.9), and disease of digestive system (OR 2.6, 95% CI 1.2-5.5). The following drug exposures were significantly associated with the clinical manifestation of type 1 diabetes: "systemic hormonal preparations'' (OR 1.7, 95% CI 1.1-2.6), medications for "blood and blood forming organs'' (OR 1.6, 95% CI 1.1-2.6), "alimentary tract and metabolism'' (OR 1.3, 95% CI 1.1-1.6), and "anti-infectives for systemic use'' (OR 1.2, 95% CI 1.01-1.4). Conclusions: Our explorative study demonstrated that in the year prior to the presentation of type1 diabetes in children and young adults, hospitalization for a diverse group of diseases and drug exposures were significantly more prevalent compared with age-and sex-matched diabetes-free controls.	[Farsani, Soulmaz Fazeli; Souverein, Patrick C.; Mantel-Teeuwisse, Aukje K.; de Boer, Anthonius] Univ Utrecht, UIPS, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [van der Vorst, Marja M. J.] St Antonius Hosp, Dept Pediat, Nieuwegein, Netherlands; [Knibbe, Catherijne A. J.] St Antonius Hosp, Dept Clin Pharm, Nieuwegein, Netherlands; [Knibbe, Catherijne A. J.] Leiden Univ, Leiden Acad Ctr Drug Res, Div Pharmacol, Leiden, Netherlands	Utrecht University; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Leiden University; Leiden University - Excl LUMC	de Boer, A (corresponding author), Univ Utrecht, UIPS, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	a.deboer@uu.nl	Mantel-Teeuwisse, Aukje/I-8902-2016; Farsani, Soulmaz Fazeli/AAG-9598-2020	Souverein, Patrick/0000-0002-7452-0477	department of Pharmaceutical Sciences, Utrecht University	department of Pharmaceutical Sciences, Utrecht University	This project was funded by the department of Pharmaceutical Sciences, Utrecht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerblom HK, 2002, AM J MED GENET, V115, P18, DOI 10.1002/ajmg.10340; Akerblom HK, 1998, DIABETES METAB REV, V14, P31, DOI 10.1002/(SICI)1099-0895(199803)14:1&lt;31::AID-; Aronsson CA, 2013, PUBLIC HEALTH NUTR, V16, P1390, DOI 10.1017/S1368980013000293; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Blackburn DF, 2006, CAN J CARDIOL, V22, P229, DOI 10.1016/S0828-282X(06)70902-3; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; De Block CEM, 2008, J CLIN ENDOCR METAB, V93, P363, DOI 10.1210/jc.2007-2134; De Bruin ML, 2005, J CLIN EPIDEMIOL, V58, P1325, DOI 10.1016/j.jclinepi.2005.04.009; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Green A, 2000, LANCET, V355, P873; Guglielmi C, 2012, DIABETES-METAB RES, V28, P40, DOI 10.1002/dmrr.2345; HAGGLOF B, 1991, DIABETOLOGIA, V34, P579, DOI 10.1007/BF00400277; Haynes A, 2007, DIABETIC MED, V24, P564, DOI 10.1111/j.1464-5491.2007.02149.x; Herings RMC, 1996, J CLIN EPIDEMIOL, V49, P115, DOI 10.1016/0895-4356(95)00552-8; HERINGS RMC, 1995, PHARM WORLD SCI, V17, P17, DOI 10.1007/BF01875553; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Houweling LMA, 2013, J PEDIATR-US, V163, P61, DOI 10.1016/j.jpeds.2012.12.014; Hsia YF, 2009, BRIT J CLIN PHARMACO, V67, P242, DOI 10.1111/j.1365-2125.2008.03347.x; Izzedine Hassane, 2005, Expert Opin Drug Saf, V4, P1097, DOI 10.1517/14740338.4.6.1097; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Knip M, 2002, HORM RES, V57, P6, DOI 10.1159/000053305; Krischer J, 2007, PEDIATR DIABETES, V8, P286; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; Luna B, 2001, JAMA-J AM MED ASSOC, V286, P1945, DOI 10.1001/jama.286.16.1945; Ma RCW, 2009, NAT REV ENDOCRINOL, V5, P529, DOI 10.1038/nrendo.2009.180; Malcova H, 2006, EUR J PEDIATR, V165, P114, DOI 10.1007/s00431-005-0008-9; Martikainen MH, 2013, ACTA DIABETOL, V50, P737, DOI 10.1007/s00592-012-0393-2; Overbeek Jetty A, 2011, BMC Res Notes, V4, P402, DOI 10.1186/1756-0500-4-402; PANDIT MK, 1993, ANN INTERN MED, V118, P529, DOI 10.7326/0003-4819-118-7-199304010-00008; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Svensson J, 2005, EUR J EPIDEMIOL, V20, P429, DOI 10.1007/s10654-005-0878-1; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Vehik K, 2011, DIABETES-METAB RES, V27, P3, DOI 10.1002/dmrr.1141; Visalli N, 2003, ARCH DIS CHILD, V88, P695, DOI 10.1136/adc.88.8.695; Ziegler AG, 2003, JAMA-J AM MED ASSOC, V290, P1721, DOI 10.1001/jama.290.13.1721	35	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87408	10.1371/journal.pone.0087408	http://dx.doi.org/10.1371/journal.pone.0087408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498320	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900066
J	Lu, J; Huang, GH; Li, HP; Feng, KY; Chen, L; Zheng, MY; Cai, YD				Lu, Jing; Huang, Guohua; Li, Hai-Peng; Feng, Kai-Yan; Chen, Lei; Zheng, Ming-Yue; Cai, Yu-Dong			Prediction of Cancer Drugs by Chemical-Chemical Interactions	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; KILLER (NK)/T-CELL LYMPHOMA; MULTICENTER PHASE-II; SMILE CHEMOTHERAPY; RESISTANT LYMPHOMA; RANDOMIZED-TRIAL; HODGKIN-LYMPHOMA; PROTEIN FUNCTION; CLINICAL-TRIAL; L-ASPARAGINASE	Cancer, which is a leading cause of death worldwide, places a big burden on health-care system. In this study, an order-prediction model was built to predict a series of cancer drug indications based on chemical-chemical interactions. According to the confidence scores of their interactions, the order from the most likely cancer to the least one was obtained for each query drug. The 1st order prediction accuracy of the training dataset was 55.93%, evaluated by Jackknife test, while it was 55.56% and 59.09% on a validation test dataset and an independent test dataset, respectively. The proposed method outperformed a popular method based on molecular descriptors. Moreover, it was verified that some drugs were effective to the 'wrong' predicted indications, indicating that some 'wrong' drug indications were actually correct indications. Encouraged by the promising results, the method may become a useful tool to the prediction of drugs indications.	[Lu, Jing] Yantai Univ, Sch Pharm, Dept Med Chem, Yantai, Shandong, Peoples R China; [Huang, Guohua; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Guohua] Shaoyang Univ, Dept Math, Shaoyang, Hunan, Peoples R China; [Li, Hai-Peng] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Feng, Kai-Yan] Shenzhen Beishan Ind Zone, Beijing Genom Inst, Shenzhen, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Zheng, Ming-Yue] Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China	Yantai University; Shanghai University; Shaoyang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Beijing Genomics Institute (BGI); Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Chen, L (corresponding author), Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China.	chen_lei1@163.com; myzheng@mail.shcnc.ac.cn; cai_yud@126.com	Zheng, Mingyue/AAJ-8027-2020; Zheng, Mingyue/B-4860-2010; Huang, Guohua/A-2215-2019; Zheng, Mingyue/HHZ-4062-2022; Zheng, Mingyue/Z-3582-2019; Chen, Lei/A-2275-2011	Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Huang, Guohua/0000-0001-6954-3933; Zheng, Mingyue/0000-0002-3323-3092; Chen, Lei/0000-0003-3068-1583; Lu, Jing/0000-0001-9195-7470; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510101, 2011CB510102]; National Science Foundation of China [61202021, 31371335, 61373028]; Shanghai Municipal Education Commission [12ZZ087, 12YZ120]; Shanghai Educational Development Foundation [12CG55]; Hunan Provincial Science and Technology Department [2011FJ3197]; Hunan National Science Foundation [11JJ5001]; Hunan Provincial Education Department [11C1125]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Educational Development Foundation; Hunan Provincial Science and Technology Department; Hunan National Science Foundation; Hunan Provincial Education Department(Hunan Provincial Education Department)	This study was funded by the National Basic Research Program of China (2011CB510101, 2011CB510102), the National Science Foundation of China (61202021, 31371335, 61373028), the Innovation Program of Shanghai Municipal Education Commission (12ZZ087, 12YZ120), the grant of "The First-class Discipline of Universities in Shanghai", Shanghai Educational Development Foundation (12CG55), the Scientific Research Fund of Hunan Provincial Science and Technology Department (2011FJ3197), the Hunan National Science Foundation (Grand: 11JJ5001), and the Scientific Research Fund of Hunan Provincial Education Department (Grant: 11C1125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro M, 2012, CANCER TREAT REV, V38, P120, DOI 10.1016/j.ctrv.2011.05.005; Agerholm-Larsen B, 2011, CANCER RES, V71, P3753, DOI 10.1158/0008-5472.CAN-11-0451; Ajani JA, 2006, INVEST NEW DRUG, V24, P441, DOI 10.1007/s10637-006-7304-8; Andersen SM, 2010, CARCINOGENESIS, V31, P1483, DOI 10.1093/carcin/bgq122; [Anonymous], COMPR DESCR STRUCT S; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; BAI GZ, 1984, EXP HEMATOL, V12, P171; Bajetta E, 2003, ANN ONCOL, V14, P1543, DOI 10.1093/annonc/mdg406; BAKER TR, 1991, AM J CLIN ONCOL-CANC, V14, P246, DOI 10.1097/00000421-199106000-00012; Blum JL, 1999, ONCOLOGY-BASEL, V57, P16, DOI 10.1159/000055264; Blumenschein GR, 2009, J CLIN ONCOL, V27, P4274, DOI 10.1200/JCO.2009.22.0541; Boguski MS, 2009, SCIENCE, V324, P1394, DOI 10.1126/science.1169920; Burstein HJ, 2008, J CLIN ONCOL, V26, P1810, DOI 10.1200/JCO.2007.14.5375; Chen L, 2013, CURR BIOINFORM, V8, P200, DOI 10.2174/1574893611308020008; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056517; Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Chortis V, 2013, J CLIN ENDOCR METAB, V98, P161, DOI 10.1210/jc.2012-2851; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; DIMONACO M, 1993, INT J ONCOL, V2, P653; Du PF, 2011, EXPERT REV PROTEOMIC, V8, P391, DOI [10.1586/EPR.11.20, 10.1586/epr.11.20]; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Ershler WB, 2006, ONCOLOGIST, V11, P325, DOI 10.1634/theoncologist.11-4-325; Flory AB, 2008, J VET INTERN MED, V22, P164, DOI 10.1111/j.1939-1676.2007.0005.x; Galetta F, 2005, BIOMED PHARMACOTHER, V59, P541, DOI 10.1016/j.biopha.2004.12.003; Gao P, 2012, PROTEIN PEPTIDE LETT, V19, P910, DOI 10.2174/092986612802084528; Gao YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045944; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gopal AK, 2010, LEUKEMIA LYMPHOMA, V51, P1523, DOI 10.3109/10428194.2010.491137; Hackshaw A, 2009, JNCI-J NATL CANCER I, V101, P341, DOI 10.1093/jnci/djn498; Hahner Stefanie, 2005, Curr Opin Investig Drugs, V6, P386; Halbsguth TV, 2010, BLOOD, V116, P2026, DOI 10.1182/blood-2009-11-253211; Hayashi H, 2013, BREAST CANCER-TOKYO, V20, P131, DOI 10.1007/s12282-011-0316-z; Heading KL, 2011, AUST VET J, V89, P109, DOI 10.1111/j.1751-0813.2011.00690.x; Hensing TA, 2003, CANCER-AM CANCER SOC, V98, P779, DOI 10.1002/cncr.11548; Hermann TW, 2005, LUNG CANCER, V50, P9, DOI 10.1016/j.lungcan.2005.05.008; HOHN DC, 1989, J CLIN ONCOL, V7, P1646, DOI 10.1200/JCO.1989.7.11.1646; Hu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017668; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; IMAI R, 1983, J ANTIBIOT, V36, P559, DOI 10.7164/antibiotics.36.559; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; JAMES DH, 1966, J AMER MED ASSOC, V197, P1043, DOI 10.1001/jama.197.12.1043; JARABAK J, 1981, JAMA-J AM MED ASSOC, V246, P1706, DOI 10.1001/jama.246.15.1706; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kanazawa K, 1996, Gan To Kagaku Ryoho, V23, P1925; Kim YH, 2012, CANCER CHEMOTH PHARM, V70, P583, DOI 10.1007/s00280-012-1943-6; Kolb EA, 2003, LEUKEMIA, V17, P1967, DOI 10.1038/sj.leu.2403097; Kozloff M, 2010, ANN ONCOL, V21, P1436, DOI 10.1093/annonc/mdp565; KREDENTSER DC, 1991, GYNECOL ONCOL, V43, P145, DOI 10.1016/0090-8258(91)90061-9; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Kuhn M, 2010, NUCLEIC ACIDS RES, V38, pD552, DOI 10.1093/nar/gkp937; Leibl S, 2005, J CLIN PATHOL, V58, P700, DOI 10.1136/jcp.2004.025163; Lian FR, 1999, NUTR CANCER, V33, P125, DOI 10.1207/S15327914NC330202; Lipshultz SE, 2004, NEW ENGL J MED, V351, P145, DOI 10.1056/NEJMoa035153; LUTON JP, 1990, NEW ENGL J MED, V322, P1195, DOI 10.1056/NEJM199004263221705; Majolino I, 2007, LEUKEMIA LYMPHOMA, V48, P759, DOI 10.1080/10428190601186150; Massuti B, 2012, LUNG CANCER, V76, P354, DOI 10.1016/j.lungcan.2011.12.002; Matsuta Y, 2013, BIOINFORMATICS, V29, P365, DOI 10.1093/bioinformatics/bts700; Moore AS, 1999, J VET INTERN MED, V13, P395, DOI 10.1892/0891-6640(1999)013&lt;0395:LFTTOR&gt;2.3.CO;2; Moskowitz CH, 1999, J CLIN ONCOL, V17, P3776, DOI 10.1200/JCO.1999.17.12.3776; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Peethambaram PP, 1999, BREAST CANCER RES TR, V54, P117, DOI 10.1023/A:1006185805079; Perez EA, 2004, J CLIN ONCOL, V22, P2849, DOI 10.1200/JCO.2004.10.047; Poplin EA, 1999, GYNECOL ONCOL, V74, P432, DOI 10.1006/gyno.1999.5461; Prasad S. B., 1994, Indian Journal of Experimental Biology, V32, P155; Pratap J, 2010, MOL CANCER THER, V9, P3210, DOI 10.1158/1535-7163.MCT-10-0572; Ramani RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055401; Reni M, 2007, BRIT J CANCER, V96, P864, DOI 10.1038/sj.bjc.6603660; REPETTO L, 1994, BREAST CANCER RES TR, V30, P133, DOI 10.1007/BF00666056; Rivera E, 2012, 35 ANN CTRC AACR SAN; Rummel MJ, 1999, ANN ONCOL, V10, P183, DOI 10.1023/A:1008312432416; Saba CF, 2007, J VET INTERN MED, V21, P127, DOI 10.1892/0891-6640(2007)21[127:CCWLLA]2.0.CO;2; SARTORELLI AC, 1965, CANCER RES, V25, P1393; SCHWARTZ HS, 1981, CANCER LETT, V13, P309, DOI 10.1016/0304-3835(81)90059-8; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sirota M, 2011, SCI TRANSL MED, V3; Stathopoulos GP, 2005, CANCER CHEMOTH PHARM, V56, P487, DOI 10.1007/s00280-005-1006-3; Steinman RA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3223; SWAFFAR DS, 1989, CANCER RES, V49, P2442; Takeno Atsushi, 2010, Gan To Kagaku Ryoho, V37, P2382; TAKEUCHI K, 1975, INT J CLIN PHARM BI, V12, P419; Terzolo M, 2007, NEW ENGL J MED, V356, P2372, DOI 10.1056/NEJMoa063360; Villanueva C, 2011, EUR J CANCER, V47, P1037, DOI 10.1016/j.ejca.2011.01.001; Vogel C, 1999, ANN ONCOL, V10, P397, DOI 10.1023/A:1008364222793; Vrooman LM, 2011, EUR J CANCER, V47, P1373, DOI 10.1016/j.ejca.2011.03.022; Walters WP, 2011, J MED CHEM, V54, P6405, DOI 10.1021/jm200504p; Wang Y, 2006, ONCOGENE, V25, P1320, DOI 10.1038/sj.onc.1209180; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Williams LE, 2006, J VET INTERN MED, V20, P136, DOI 10.1892/0891-6640(2006)20[136:CITTOC]2.0.CO;2; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yamaguchi M, 2008, CANCER SCI, V99, P1016, DOI 10.1111/j.1349-7006.2008.00768.x; Yamaguchi M, 2011, J CLIN ONCOL, V29, P4410, DOI 10.1200/JCO.2011.35.6287; Yu Carol S., 2008, International Ophthalmology, V28, P51, DOI 10.1007/s10792-007-9102-5	96	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87791	10.1371/journal.pone.0087791	http://dx.doi.org/10.1371/journal.pone.0087791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498372	Green Submitted, gold, Green Published			2022-12-25	WOS:000330626900118
J	Yang, Y; Wong, SE; Lightstone, FC				Yang, Yue; Wong, Sergio E.; Lightstone, Felice C.			Understanding a Substrate's Product Regioselectivity in a Family of Enzymes: A Case Study of Acetaminophen Binding in Cytochrome P450s	PLOS ONE			English	Article							DRUG-DRUG INTERACTIONS; TOXIC METABOLITE; LIVER-MICROSOMES; ACCURATE DOCKING; IN-VITRO; ACTIVATION; OXIDATION; CYP2E1; HYDROXYLATION; DYNAMICS	Product regioselectivity as influenced by molecular recognition is a key aspect of enzyme catalysis. We applied large-scale two-dimensional (2D) umbrella sampling (USP) simulations to characterize acetaminophen (APAP) binding in the active sites of the family of Cytochrome P450 (CYP) enzymes as a case study to show the different regioselectivity exhibited by a single substrate in comparative enzymes. Our results successfully explain the experimentally observed product regioselectivity for all five human CYPs included in this study, demonstrating that binding events play an important role in determining regioselectivity. In CYP2C9 and CYP3A4, weak interactions in an overall large active site cavity result in a fairly small binding free energy difference between APAP reactive binding states, consistent with experimental results that show little preference for resulting metabolites. In contrast, in CYP1A2 and CYP2E1, APAP is strongly restrained by a compact binding pocket, leading to a preferred binding conformation. The calculated binding equilibrium of APAP within the compact active site of CYP2A6 is able to predict the experimentally documented product ratios and is also applied to explain APAP regioselectivity in CYP1A2 and CYP2C9. APAP regioselectivity seems to be related to the selectivity for one binding conformation over another binding conformation as dictated by the size and shape of the active site. Additionally, unlike docking and molecular dynamics (MD), our free energy calculations successfully reproduced a unique APAP pose in CYP3A4 that had been reported experimentally, suggesting this approach is well suited to find the realistic binding pose and the lowest-energy starting structure for studying the chemical reaction step in the future.	[Yang, Yue; Wong, Sergio E.; Lightstone, Felice C.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Lightstone, FC (corresponding author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA.	Lightstone1@llnl.gov		Yang, Yue/0000-0001-5670-9551	Laboratory Directed Research and Development fund [12-SI-004]	Laboratory Directed Research and Development fund	This work was funded by Laboratory Directed Research and Development fund, 12-SI-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allameh A, 2002, TOXICOL IN VITRO, V16, P637, DOI 10.1016/S0887-2333(02)00087-5; Allen MP., 1989, COMPUTER SIMULATION; [Anonymous], 2011, SUIT 2011 PRIM VERS; [Anonymous], 2008, AMBER 10; [Anonymous], 2011, SUIT 2011 GLID VERS; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Bruice TC, 1999, ACCOUNTS CHEM RES, V32, P127, DOI 10.1021/ar960131y; Cameron MD, 2007, CHEM RES TOXICOL, V20, P1434, DOI 10.1021/tx7000702; Carey F.A., 1984, ADV ORGANIC CHEM A, V2nd; Case D. A., 2012, AMBER 12; Chaker L, 2012, J PHYS ORG CHEM, V25, P894, DOI 10.1002/poc.2943; Chen WQ, 1998, CHEM RES TOXICOL, V11, P295, DOI 10.1021/tx9701687; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; CORCORAN GB, 1980, MOL PHARMACOL, V18, P536; Cui GL, 2007, BIOCHEMISTRY-US, V46, P1303, DOI 10.1021/bi062076z; DAHLIN DC, 1982, J MED CHEM, V25, P885, DOI 10.1021/jm00350a001; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVIDSON DG, 1966, BRIT MED J, V2, P497, DOI 10.1136/bmj.2.5512.497; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Domingo LR, 2013, TETRAHEDRON, V69, P107, DOI 10.1016/j.tet.2012.10.056; Dowers TS, 2004, DRUG METAB DISPOS, V32, P328, DOI 10.1124/dmd.32.3.328; Feenstra KA, 2007, PROTEIN SCI, V16, P420, DOI 10.1110/ps.062224407; Feig M., 2001, MMTSB TOOL SET; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GOLDSTEIN JA, 1994, PHARMACOGENETICS, V4, P285, DOI 10.1097/00008571-199412000-00001; Griffin JL, 2012, P NATL ACAD SCI USA, V109, P6910, DOI 10.1073/pnas.1116855109; Grossfield A., WHAM WEIGHTED HISTOG; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hazai E, 2002, BIOCHEM BIOPH RES CO, V291, P1089, DOI 10.1006/bbrc.2002.6541; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hummel MA, 2005, MOL PHARMACOL, V68, P644, DOI 10.1124/mol.105.013763; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Johnston JB, 2012, BIOORGAN MED CHEM, V20, P4064, DOI 10.1016/j.bmc.2012.05.003; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalsi SS, 2011, OPEN ACCESS EMERG M, V3, P69, DOI 10.2147/OAEM.S24962; KOOP DR, 1983, FED PROC, V42, P910; Kuhn H, 2000, PROSTAG OTH LIPID M, V62, P255, DOI 10.1016/S0090-6980(00)00084-8; KUMAR S, 1995, J COMPUT CHEM, V16, P1339, DOI 10.1002/jcc.540161104; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lee CR, 2002, PHARMACOGENETICS, V12, P251, DOI 10.1097/00008571-200204000-00010; Lewis DFV, 1998, CHEM-BIOL INTERACT, V115, P175, DOI 10.1016/S0009-2797(98)00068-4; LI Y, 1994, DRUG METAB DISPOS, V22, P566; Lonsdale R, 2013, J AM CHEM SOC ASAP; Lonsdale R, 2011, J AM CHEM SOC, V133, P15464, DOI 10.1021/ja203157u; Manyike PT, 2000, CLIN PHARMACOL THER, V67, P275, DOI 10.1067/mcp.2000.104736; MERZ KM, 1991, J AM CHEM SOC, V113, P406, DOI 10.1021/ja00002a004; Nelson SD, 2003, DRUG METAB DISPOS, V31, P1481, DOI 10.1124/dmd.31.12.1481; Nic M, 2006, CURTIN HAMMETT PRINC; Olah J, 2011, P NATL ACAD SCI USA, V108, P6050, DOI 10.1073/pnas.1010194108; Park HG, 2003, BIOTECHNOL BIOPROC E, V8, P1, DOI 10.1007/BF02932891; PATTEN CJ, 1993, CHEM RES TOXICOL, V6, P511, DOI 10.1021/tx00034a019; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; POTTER WZ, 1973, J PHARMACOL EXP THER, V187, P203; R Core Team, 2012, R LANG ENV STAT COMP; RAUCY JL, 1989, ARCH BIOCHEM BIOPHYS, V271, P270, DOI 10.1016/0003-9861(89)90278-6; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Rydberg P, 2010, BIOINFORMATICS, V26, P2988, DOI 10.1093/bioinformatics/btq584; Sarich T, 1997, CLIN PHARMACOL THER, V62, P21, DOI 10.1016/S0009-9236(97)90148-X; Schmidt LE, 2003, ALIMENT PHARM THER, V18, P979, DOI 10.1046/j.1365-2036.2003.01789.x; Seo KW, 2000, J APPL TOXICOL, V20, P427, DOI 10.1002/1099-1263(200011/12)20:6<427::AID-JAT707>3.0.CO;2-#; Shahrokh K, 2012, J COMPUT CHEM, V33, P119, DOI 10.1002/jcc.21922; Shaik S, 2010, CHEM REV, V110, P949, DOI 10.1021/cr900121s; Sheng X, 2008, J AM CHEM SOC, V130, P13310, DOI 10.1021/ja802652b; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Sindhikara DJ, 2009, J CHEM THEORY COMPUT, V5, P1624, DOI 10.1021/ct800573m; SNAWDER JE, 1994, BIOCHEM BIOPH RES CO, V203, P532, DOI 10.1006/bbrc.1994.2215; SZABO A, 1978, P NATL ACAD SCI USA, V75, P2108, DOI 10.1073/pnas.75.5.2108; THOMSON JS, 1966, BRIT MED J, V2, P506, DOI 10.1136/bmj.2.5512.506; THUMMEL KE, 1993, BIOCHEM PHARMACOL, V45, P1563, DOI 10.1016/0006-2952(93)90295-8; Uberuaga BP, 2004, J CHEM PHYS, V120, P6363, DOI 10.1063/1.1667473; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WERCKREICHHART D, 2000, GENOME BIOL, V1; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Wolf KK, 2007, DRUG METAB DISPOS, V35, P1223, DOI 10.1124/dmd.107.014738; Wuensch C, 2012, ORG LETT, V14, P1974, DOI 10.1021/ol300385k; Yang Y, 2012, BIOCHEMISTRY-US, V51, P2606, DOI 10.1021/bi201800m; Yang Y, 2012, J AM CHEM SOC, V134, P820, DOI 10.1021/ja209650h; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501; Zhou LX, 1997, J PHARMACOL EXP THER, V281, P785	86	11	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87058	10.1371/journal.pone.0087058	http://dx.doi.org/10.1371/journal.pone.0087058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498291	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900037
J	Al-Salam, S; Hashmi, S				Al-Salam, Suhail; Hashmi, Satwat			Galectin-1 in Early Acute Myocardial Infarction	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; DIFFERENTIAL EXPRESSION; CELL-PROLIFERATION; BINDING PROTEIN; HYPOXIA; ISCHEMIA; FAMILY; MICE; HIF-1-ALPHA; ROLES	Myocardial infarction (MI) is the most serious manifestation of coronary artery disease and the cause of significant mortality and morbidity worldwide. Galectin-1(GAL-1), a divalent 14.5-kDa protein, is present both inside and outside cells, and has both intracellular and extracellular functions. Hypoxia inducible factor-1 alpha (HIF-1 alpha) is a transcription factor mediating early and late responses to myocardial ischemia. Identification of the pattern of expression of GAL-1 and HIF-1 alpha in the heart during the first 24 hours following acute MI will help in understanding early molecular changes in this event and may provide methods to overcome serious complications. Mouse model of MI was used and heart samples were processed for immunohistochemical and immunofluorescent labeling and Enzyme linked immunosorbent assay to identify GAL-1 and HIF 1 alpha levels in the heart during the first 24 hours following MI. There was significant increase in left ventricular GAL-1 at 20 (p = 0.001) and 30 minutes (p = 0.004) following MI. There was also a significant increase in plasma GAL-1 at 4 hours (p = 0.012) and 24 hours (p = 0.001) following MI. A significant increase in left ventricular HIF-1 alpha was seen at 20 minutes (p = 0.047) following MI. In conclusion, we show for the first time that GAL-1 level in the left ventricle is increased in early ischemic period. We also report for the first time that HIF-1 alpha is significantly increased at 20 minutes following MI. In addition we report for the first time that mouse plasma GAL-1 level is significantly raised as early as 4 hours following MI.	[Al-Salam, Suhail; Hashmi, Satwat] United Arab Emirates Univ, Dept Pathol, Coll Med & Hlth Sci, Abu Dhabi, U Arab Emirates	United Arab Emirates University	Al-Salam, S (corresponding author), United Arab Emirates Univ, Dept Pathol, Coll Med & Hlth Sci, Abu Dhabi, U Arab Emirates.	suhaila@uaeu.ac.ae		Al-Salam, Suhail/0000-0003-0109-5964	UAEU-National Research Foundation [21MO73]	UAEU-National Research Foundation	This work was supported by UAEU-National Research Foundation grant 21MO73. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H, 2009, GLYCOCONJUGATE J, V26, P277, DOI 10.1007/s10719-008-9178-9; Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Case D, 2007, AM J PHYSIOL-LUNG C, V292, pL154, DOI 10.1152/ajplung.00192.2006; Chan J, 2006, STEM CELLS, V24, P1879, DOI 10.1634/stemcells.2005-0564; Colnot C, 1996, BIOCHEM SOC T, V24, P141, DOI 10.1042/bst0240141; Dias-Baruffi M, 2010, GLYCOBIOLOGY, V20, P507, DOI 10.1093/glycob/cwp203; Georgiadis V, 2007, DEV DYNAM, V236, P1014, DOI 10.1002/dvdy.21123; Giordanengo L, 2001, CLIN EXP IMMUNOL, V124, P266, DOI 10.1046/j.1365-2249.2001.01512.x; Hashmi S, 2013, INT J CLIN EXP PATHO, V6, P249; Hashmi S, 2012, CARDIOL REV, V20, P268, DOI 10.1097/CRD.0b013e31826287f6; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; HUGHES RC, 1994, GLYCOBIOLOGY, V4, P5, DOI 10.1093/glycob/4.1.5; Iwamoto M, 2010, GLYCOCONJUGATE J, V27, P419, DOI 10.1007/s10719-010-9288-z; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Kasai K, 1996, J BIOCHEM-TOKYO, V119, P1; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; Kumar Aka V., 2007, BASIC PATHOLOGY, V8th edn; Le QT, 2005, J CLIN ONCOL, V23, P8932, DOI 10.1200/JCO.2005.02.0206; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; LIPKE DW, 1993, AM J RESP CELL MOL, V9, P418, DOI 10.1165/ajrcmb/9.4.418; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Merklinger SL, 2005, CIRC RES, V97, P596, DOI 10.1161/01.RES.0000182425.49768.8a; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Michael LH, 1999, AM J PHYSIOL-HEART C, V277, pH660, DOI 10.1152/ajpheart.1999.277.2.H660; Mitani Y, 2001, EUR RESPIR J, V17, P316, DOI 10.1183/09031936.01.17203160; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; OFFNER H, 1990, J NEUROIMMUNOL, V28, P177, DOI 10.1016/0165-5728(90)90032-I; Parisi Q, 2005, INT J CARDIOL, V99, P337, DOI 10.1016/j.ijcard.2003.11.038; Park JW, 2001, NUCLEIC ACIDS RES, V29, P3595, DOI 10.1093/nar/29.17.3595; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; POIRIER F, 1993, DEVELOPMENT, V119, P1229; POIRIER F, 1992, DEVELOPMENT, V115, P143; Poirier F, 2002, BIOCHEM SOC SYMP, V69, P95; Qu WS, 2011, J NEUROCHEM, V116, P217, DOI 10.1111/j.1471-4159.2010.07095.x; Qu WS, 2010, NEUROCHEM RES, V35, P1716, DOI 10.1007/s11064-010-0234-z; Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385; Scott Ken, 2004, Glycoconjugate Journal, V19, P467; Seropian IM, 2013, AM J PATHOL, V182, P29, DOI 10.1016/j.ajpath.2012.09.022; Shao HF, 2009, BIOCHEM BIOPH RES CO, V378, P750, DOI 10.1016/j.bbrc.2008.11.134; Stillman BN, 2005, BRAIN PATHOL, V15, P124; Vansthertem D, 2010, HISTOL HISTOPATHOL, V25, P1417, DOI 10.14670/HH-25.1417; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Xue WL, 2010, AM J PATHOL, V177, P97, DOI 10.2353/ajpath.2010.091091; Zhao XY, 2010, CARCINOGENESIS, V31, P1367, DOI 10.1093/carcin/bgq116	52	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86994	10.1371/journal.pone.0086994	http://dx.doi.org/10.1371/journal.pone.0086994			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498007	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900055
J	Mukonzo, JK; Owen, JS; Ogwal-Okeng, J; Kuteesa, RB; Nanzigu, S; Sewankambo, N; Thabane, L; Gustafsson, LL; Ross, C; Aklillu, E				Mukonzo, Jackson K.; Owen, Joel S.; Ogwal-Okeng, Jasper; Kuteesa, Ronald B.; Nanzigu, Sarah; Sewankambo, Nelson; Thabane, Lehana; Gustafsson, Lars L.; Ross, Colin; Aklillu, Eleni			Pharmacogenetic-Based Efavirenz Dose Modification: Suggestions for an African Population and the Different CYP2B6 Genotypes	PLOS ONE			English	Article							PHARMACOKINETICS; THERAPY; PLASMA; INDIVIDUALS; FAILURE	Background: Pharmacogenetics contributes to inter-individual variability in pharmacokinetics (PK) of efavirenz (EFV), leading to variations in both efficacy and toxicity. The purpose of this study was to assess the effect of genetic factors on EFV pharmacokinetics, treatment outcomes and genotype based EFV dose recommendations for adult HIV-1 infected Ugandans. Methods: In total, 556 steady-state plasma EFV concentrations from 99 HIV infected patients (64 female) treated with EFV/lamivudine/zidovidine were analyzed. Patient genotypes for CYP2B6 (*6 & *11), CYP3A5 (*3,*6 & *7) and ABCB1 c.4046A>G, baseline biochemistries and CD4 and viral load change from baseline were determined. A one-compartment population PK model with first-order absorption (NONMEM) was used to estimate genotype effects on EFV pharmacokinetics. PK simulations were performed based upon population genotype frequencies. Predicted AUCs were compared between the product label and simulations for doses of 300 mg, 450 mg, and 600 mg. Results: EFV apparent clearance (CL/F) was 2.2 and 1.74 fold higher in CYP2B6*6 (*1/*1) and CYP2B6*6 (*1/*6) compared CYP2B6*6 (*6/*6) carriers, while a 22% increase in F1 was observed for carriers of ABCB1 c.4046A>G variant allele. Higher mean AUC was attained in CYP2B6 *6/*6 genotypes compared to CYP2B6 *1/*1 (p < 0.0001). Simulation based AUCs for 600 mg doses were 1.25 and 2.10 times the product label mean AUC for the Ugandan population in general and CYP2B6*6/*6 genotypes respectively. Simulated exposures for EFV daily doses of 300 mg and 450 mg are comparable to the product label. Viral load fell precipitously on treatment, with only six patients having HIV RNA >40 copies/mL after 84 days of treatment. No trend with exposure was noted for these six patients. Conclusion: Results of this study suggest that daily doses of 450 mg and 300 mg might meet the EFV treatment needs of HIV-1 infected Ugandans in general and individuals homozygous for CYP2B6*6 mutation, respectively.	[Mukonzo, Jackson K.; Ogwal-Okeng, Jasper; Kuteesa, Ronald B.; Nanzigu, Sarah; Sewankambo, Nelson] Makerere Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, Kampala, Uganda; [Mukonzo, Jackson K.] Canadian HIV Trials Network, CIHR, Vancouver, BC, Canada; [Owen, Joel S.] Union Univ, Sch Pharm, Jackson, TN 38305 USA; [Thabane, Lehana] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Thabane, Lehana] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Thabane, Lehana] McMaster Univ, Dept Anaesthesia, Hamilton, ON, Canada; [Gustafsson, Lars L.; Aklillu, Eleni] Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Ross, Colin] Univ British Columbia, Div Translat Therapeut, Vancouver, BC V5Z 1M9, Canada; [Thabane, Lehana] St Josephs Healthcare Hamilton, Biostat Unit, Hamilton, ON, Canada	Makerere University; McMaster University; McMaster University; McMaster University; Karolinska Institutet; Karolinska University Hospital; University of British Columbia; McMaster University	Mukonzo, JK (corresponding author), Makerere Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, Kampala, Uganda.	mukojack@yahoo.co.uk	Nanzigu, Sarah/HGA-3602-2022; Aklillu, Eleni/ABG-3461-2021	Ross, Colin/0000-0003-1476-7037; Bisaso, Kuteesa R/0000-0001-7721-4005; Gustafsson, Lars Lennart/0000-0002-0063-552X; Mukonzo, Jackson/0000-0002-0573-1908; Aklillu, Eleni/0000-0002-9788-0790; Sewankambo, Nelson/0000-0001-9362-053X	CIHR Canadian HIV Trials Network (Clinical Trials Network); SIDA/SAREC [SWE 2007-270]	CIHR Canadian HIV Trials Network (Clinical Trials Network)(Canadian Institutes of Health Research (CIHR)); SIDA/SAREC	This study was funded in-part through a CIHR Canadian HIV Trials Network (Clinical Trials Network) international HIV postdoctoral grant and through a SIDA/SAREC, grant No. SWE 2007-270 to Makerere University-Karolinska Institutet research collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; Arab-Alameddine M, 2009, CLIN PHARMACOL THER, V85, P485, DOI 10.1038/clpt.2008.271; Burger D, 2006, BRIT J CLIN PHARMACO, V61, P148, DOI 10.1111/j.1365-2125.2005.02536.x; Csajka C, 2003, CLIN PHARMACOL THER, V73, P20, DOI 10.1067/mcp.2003.22; Elens L, 2010, PHARMACOGENOMICS, V11, P1223, DOI 10.2217/PGS.10.94; Ford N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010460; Gatanaga H, 2007, CLIN INFECT DIS, V45, P1230, DOI 10.1086/522175; Haas DW, 2004, AIDS, V18, P2391; Habtewold A, 2011, J ANTIMICROB CHEMOTH, V66, P2350, DOI 10.1093/jac/dkr304; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Leutscher PD, 2013, SCAND J INFECT DIS; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Mello AF, 2011, ANTIVIR THER, V16, P189, DOI 10.3851/IMP1742; Mukonzo JK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-261; Mukonzo JK, 2009, BRIT J CLIN PHARMACO, V68, P690, DOI 10.1111/j.1365-2125.2009.03516.x; Ngaimisi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067946; Nyakutira C, 2008, EUR J CLIN PHARMACOL, V64, P357, DOI 10.1007/s00228-007-0412-3; Puls R, 2013, IAS 2013; Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470; Rotger Margalida, 2006, Curr HIV/AIDS Rep, V3, P118, DOI 10.1007/BF02696655; Sanchez A, 2011, ANTIMICROB AGENTS CH, V55, P5314, DOI 10.1128/AAC.00194-11; Solas C, 2011, THERAPIE, V66, P197, DOI 10.2515/therapie/2011033; Stohr W, 2008, ANTIVIR THER, V13, P675; Torno MS, 2008, PHARMACOTHERAPY, V28, P782, DOI 10.1592/phco.28.6.782; WADE JR, 1993, J PHARMACOKINET BIOP, V21, P209, DOI 10.1007/BF01059771; Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601; World Health Organization (WHO), 2009, WHOHTMTB2009420; Yimer G, 2012, PHARMACOGENOMICS J, V12, P499, DOI 10.1038/tpj.2011.34	28	52	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86919	10.1371/journal.pone.0086919	http://dx.doi.org/10.1371/journal.pone.0086919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497997	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900048
J	Oh, E; Jeon, B				Oh, Euna; Jeon, Byeonghwa			Role of Alkyl Hydroperoxide Reductase (AhpC) in the Biofilm Formation of Campylobacter jejuni	PLOS ONE			English	Article							OXIDATIVE STRESS; ESCHERICHIA-COLI; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; RESISTANCE; SURVIVAL; CATALASE; IRON; COLONIZATION; REGULATOR	Biofilm formation of Campylobacter jejuni, a major cause of human gastroenteritis, contributes to the survival of this pathogenic bacterium in different environmental niches; however, molecular mechanisms for its biofilm formation have not been fully understood yet. In this study, the role of oxidative stress resistance in biofilm formation was investigated using mutants defective in catalase (KatA), superoxide dismutase (SodB), and alkyl hydroperoxide reductase (AhpC). Biofilm formation was substantially increased in an ahpC mutant compared to the wild type, and katA and sodB mutants. In contrast to the augmented biofilm formation of the ahpC mutant, a strain overexpressing ahpC exhibited reduced biofilm formation. A perR mutant and a CosR-overexpression strain, both of which upregulate ahpC, also displayed decreased biofilms. However, the introduction of the ahpC mutation to the perR mutant and the CosR-overexpression strain substantially enhanced biofilm formation. The ahpC mutant accumulated more total reactive oxygen species and lipid hydroperoxides than the wild type, and the treatment of the ahpC mutant with antioxidants reduced biofilm formation to the wild-type level. Confocal microscopy analysis showed more microcolonies were developed in the ahpC mutant than the wild type. These results successfully demonstrate that AhpC plays an important role in the biofilm formation of C. jejuni.	[Oh, Euna; Jeon, Byeonghwa] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	University of Alberta	Jeon, B (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	bjeon@ualberta.ca	Jeon, Byeonghwa/AAB-6806-2020	Jeon, Byeonghwa/0000-0002-6665-5558				Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Atack JM, 2009, FUTURE MICROBIOL, V4, P677, DOI 10.2217/FMB.09.44; Baillon MLA, 1999, J BACTERIOL, V181, P4798, DOI 10.1128/JB.181.16.4798-4804.1999; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Butcher J, 2012, P NATL ACAD SCI USA, V109, P10047, DOI 10.1073/pnas.1118321109; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Day WA, 2000, INFECT IMMUN, V68, P6337, DOI 10.1128/IAI.68.11.6337-6345.2000; DePas WH, 2013, P NATL ACAD SCI USA, V110, P2629, DOI 10.1073/pnas.1218703110; Fields JA, 2008, J BACTERIOL, V190, P3411, DOI 10.1128/JB.01928-07; Frirdich E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002602; Garenaux A, 2009, CURR MICROBIOL, V58, P134, DOI 10.1007/s00284-008-9289-3; Garenaux A, 2008, RES MICROBIOL, V159, P718, DOI 10.1016/j.resmic.2008.08.001; Gaynor EC, 2005, MOL MICROBIOL, V56, P8, DOI 10.1111/j.1365-2958.2005.04525.x; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; Haddock G, 2010, MICROBIOL-SGM, V156, P3079, DOI 10.1099/mic.0.039867-0; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hwang S, 2013, J ANTIBIOT, V66, P351, DOI 10.1038/ja.2013.20; Hwang S, 2012, J BACTERIOL, V194, P6883, DOI 10.1128/JB.01636-12; Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022300; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; Jokinen C, 2011, WATER RES, V45, P1247, DOI 10.1016/j.watres.2010.10.001; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Jung IL, 2003, BIOCHEM BIOPH RES CO, V301, P915, DOI 10.1016/S0006-291X(03)00064-0; Kalmokoff M, 2006, J BACTERIOL, V188, P4312, DOI 10.1128/JB.01975-05; Karlyshev AV, 2005, APPL ENVIRON MICROB, V71, P4004, DOI 10.1128/AEM.71.7.4004-4013.2005; Kim M, 2011, J BACTERIOL, V193, P6171, DOI 10.1128/JB.05493-11; Kim YH, 2006, PROTEOMICS, V6, P6181, DOI 10.1002/pmic.200600320; Kulkarni R, 2012, INFECT IMMUN, V80, P3804, DOI 10.1128/IAI.00689-12; Maal-Bared R, 2012, INT J HYG ENVIR HEAL, V215, P270, DOI 10.1016/j.ijheh.2011.12.004; McLennan MK, 2008, J BACTERIOL, V190, P1097, DOI 10.1128/JB.00516-07; Mikkelsen H, 2007, J BACTERIOL, V189, P2411, DOI 10.1128/JB.01687-06; Monroe D, 2007, PLOS BIOL, V5, P2458, DOI 10.1371/journal.pbio.0050307; Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012; MORGAN RW, 1986, P NATL ACAD SCI USA, V83, P8059, DOI 10.1073/pnas.83.21.8059; Murphy C, 2006, J APPL MICROBIOL, V100, P623, DOI 10.1111/j.1365-2672.2006.02903.x; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; Palyada K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-481; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Parsonage D, 2008, P NATL ACAD SCI USA, V105, P8209, DOI 10.1073/pnas.0708308105; Purdy D, 1999, APPL ENVIRON MICROB, V65, P2540; Raphael BH, 2005, J BACTERIOL, V187, P3662, DOI 10.1128/JB.187.11.3662-3670.2005; Reeser RJ, 2007, APPL ENVIRON MICROB, V73, P1908, DOI 10.1128/AEM.00740-06; Reuter M, 2010, APPL ENVIRON MICROB, V76, P2122, DOI 10.1128/AEM.01878-09; Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936; Ryder VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047695; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Snelling WJ, 2005, LETT APPL MICROBIOL, V41, P297, DOI 10.1111/j.1472-765X.2005.01788.x; Stead D, 2000, APPL ENVIRON MICROB, V66, P3110, DOI 10.1128/AEM.66.7.3110-3112.2000; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Svensson SL, 2009, MOL MICROBIOL, V71, P253, DOI 10.1111/j.1365-2958.2008.06534.x; van Vliet AHM, 1999, J BACTERIOL, V181, P6371, DOI 10.1128/JB.181.20.6371-6376.1999; Wood TK, 2009, ENVIRON MICROBIOL, V11, P1, DOI 10.1111/j.1462-2920.2008.01768.x; Wosten MMSM, 1998, J BACTERIOL, V180, P594; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	57	55	57	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87312	10.1371/journal.pone.0087312	http://dx.doi.org/10.1371/journal.pone.0087312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498070	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900086
J	Okahashi, N; Sumitomo, T; Nakata, M; Sakurai, A; Kuwata, H; Kawabata, S				Okahashi, Nobuo; Sumitomo, Tomoko; Nakata, Masanobu; Sakurai, Atsuo; Kuwata, Hirotaka; Kawabata, Shigetada			Hydrogen Peroxide Contributes to the Epithelial Cell Death Induced by the Oral Mitis Group of Streptococci	PLOS ONE			English	Article							IDENTIFICATION; OXYGEN; INTERLEUKIN-6; APOPTOSIS; SANGUINIS; VIRULENCE; RESPONSES; PEPTIDES; GORDONII; BIOLOGY	Members of the mitis group of streptococci are normal inhabitants of the commensal flora of the oral cavity and upper respiratory tract of humans. Some mitis group species, such as Streptococcus oralis and Streptococcus sanguinis, are primary colonizers of the human oral cavity. Recently, we found that hydrogen peroxide (H2O2) produced by S. oralis is cytotoxic to human macrophages, suggesting that streptococcus-derived H2O2 may act as a cytotoxin. Since epithelial cells provide a physical barrier against pathogenic microbes, we investigated their susceptibility to infection by H2O2-producing streptococci in this study. Infection by S. oralis and S. sanguinis was found to stimulate cell death of Detroit 562, Calu-3 and HeLa epithelial cell lines at a multiplicity of infection greater than 100. Catalase, an enzyme that catalyzes the decomposition of H2O2, inhibited S. oralis cytotoxicity, and H2O2 alone was capable of eliciting epithelial cell death. Moreover, S. oralis mutants lacking the spxB gene encoding pyruvate oxidase, which are deficient in H2O2 production, exhibited reduced cytotoxicity toward Detroit 562 epithelial cells. In addition, enzyme-linked immunosorbent assays revealed that both S. oralis and H2O2 induced interleukin-6 production in Detroit 562 epithelial cells. These results suggest that streptococcal H2O2 is cytotoxic to epithelial cells, and promotes bacterial evasion of the host defense systems in the oral cavity and upper respiratory tracts.	[Okahashi, Nobuo] Osaka Univ, Dept Oral Frontier Biol, Grad Sch Dent, Suita, Osaka, Japan; [Sumitomo, Tomoko; Nakata, Masanobu; Kawabata, Shigetada] Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, Suita, Osaka, Japan; [Sakurai, Atsuo] Tokyo Dent Coll, Dept Pediat Dent, Chiba, Japan; [Sakurai, Atsuo] Tokyo Dent Coll, Hlth Sci Ctr Hrc8, Chiba, Japan; [Kuwata, Hirotaka] Showa Univ, Sch Dent, Dept Oral Microbiol & Immunol, Tokyo 142, Japan	Osaka University; Osaka University; Tokyo Dental College; Tokyo Dental College; Showa University	Okahashi, N (corresponding author), Osaka Univ, Dept Oral Frontier Biol, Grad Sch Dent, Suita, Osaka, Japan.	okahashi@dent.osaka-u.ac.jp	okahashi, nobuo/A-4032-2010; Kuwata, Hiro/N-2023-2019	okahashi, nobuo/0000-0002-8045-7021; Kuwata, Hiro/0000-0002-5023-1777; Nakata, Masanobu/0000-0003-1686-5415	Japan Society for the Promotion of Science [23593027, 23592700, 23593043]; Grants-in-Aid for Scientific Research [24659812, 26463112, 23592700] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) (# 23593027, # 23592700, # 23593043) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Boardman KC, 2004, J CELL PHYSIOL, V199, P57, DOI 10.1002/jcp.10451; Braun JS, 2002, J CLIN INVEST, V109, P19; BRIDGE PD, 1982, INT J SYST BACTERIOL, V32, P410, DOI 10.1099/00207713-32-4-410; Chen L, 2011, MICROBIOL-SGM, V157, P13, DOI 10.1099/mic.0.039669-0; Chiu B, 1999, AM HEART J, V138, pS534, DOI 10.1016/S0002-8703(99)70294-2; COYKENDALL AL, 1989, CLIN MICROBIOL REV, V2, P315, DOI 10.1128/CMR.2.3.315-328.1989; Diamond G, 2008, J DENT RES, V87, P915, DOI 10.1177/154405910808701011; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; Dyson C, 1999, J INFECTION, V38, P87, DOI 10.1016/S0163-4453(99)90074-9; Eisele NA, 2011, J PATHOG, V2011, DOI 10.4061/2011/249802; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; GUGGENHEIM B, 1968, Caries Research, V2, P147; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Hasegawa Y, 2007, INFECT IMMUN, V75, P2540, DOI 10.1128/IAI.01957-06; Health Protection Agency, 2012, HLTH PROT AG HLTH PR, V6; Hirano T, 1998, Int Rev Immunol, V16, P249; Ji S, 2007, J PERIODONTAL RES, V42, P503, DOI 10.1111/j.1600-0765.2007.00974.x; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; McCormick TS, 2010, PERIODONTOL 2000, V54, P195, DOI 10.1111/j.1600-0757.2010.00373.x; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nakano K, 2006, J CLIN MICROBIOL, V44, P3313, DOI 10.1128/JCM.00377-06; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; OKAHASHI N, 1984, INFECT IMMUN, V44, P617, DOI 10.1128/IAI.44.3.617-622.1984; Okahashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062563; Okahashi N, 2011, FEMS MICROBIOL LETT, V323, P164, DOI 10.1111/j.1574-6968.2011.02375.x; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Pelaia G, 2004, J CELL BIOCHEM, V93, P142, DOI 10.1002/jcb.20124; Sliepen I, 2009, J DENT RES, V88, P1026, DOI 10.1177/0022034509347296; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Waters CM, 1997, AM J PHYSIOL-LUNG C, V272, pL681, DOI 10.1152/ajplung.1997.272.4.L681; Watt Barbara E, 2004, Toxicol Rev, V23, P51, DOI 10.2165/00139709-200423010-00006; Wu WC, 2010, MOL VIS, V16, P1864; Yoshida Y, 1999, AM J PHYSIOL-LUNG C, V276, pL900, DOI 10.1152/ajplung.1999.276.6.L900; Zhu L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/717843	48	27	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e88136	10.1371/journal.pone.0088136	http://dx.doi.org/10.1371/journal.pone.0088136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498253	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900217
J	Seddon, JM; Reynolds, R; Yu, Y; Rosner, B				Seddon, Johanna M.; Reynolds, Robyn; Yu, Yi; Rosner, Bernard			Three New Genetic Loci (R1210C in CFH, Variants in COL8A1 and RAD51B) Are Independently Related to Progression to Advanced Macular Degeneration	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK PREDICTION MODELS; COMPLEMENT FACTOR-H; APOLIPOPROTEIN-E; SUSCEPTIBILITY; POLYMORPHISM; ROLES	Objectives: To assess the independent impact of new genetic variants on conversion to advanced stages of AMD, controlling for established risk factors, and to determine the contribution of genes in predictive models. Methods: In this prospective longitudinal study of 2765 individuals, 777 subjects progressed to neovascular disease (NV) or geographic atrophy (GA) in either eye over 12 years. Recently reported genetic loci were assessed for their independent effects on incident advanced AMD after controlling for 6 established loci in 5 genes, and demographic, behavioral, and macular characteristics. New variants which remained significantly related to progression were then added to a final multivariate model to assess their independent effects. The contribution of genes to risk models was assessed using reclassification tables by determining risk within cross-classified quintiles for alternative models. Results: Three new genetic variants were significantly related to progression: rare variant R1210C in CFH (hazard ratio (HR) 2.5, 95% confidence interval [CI] 1.2-5.3, P = 0.01), and common variants in genes COL8A1 (HR 2.0, 95% CI 1.1-3.5, P = 0.02) and RAD51B (HR 0.8, 95% CI 0.60-0.97, P = 0.03). The area under the curve statistic (AUC) was significantly higher for the 9 gene model (. 884) vs the 0 gene model (. 873), P = .01. AUC's for the 9 vs 6 gene models were not significantly different, but reclassification analyses indicated significant added information for more genes, with adjusted odds ratios (OR) for progression within 5 years per one quintile increase in risk score of 2.7, P<0.001 for the 9 vs 6 loci model, and OR 3.5, P<0.001 for the 9 vs. 0 gene model. Similar results were seen for NV and GA. Conclusions: Rare variant CFH R1210C and common variants in COL8A1 and RAD51B plus six genes in previous models contribute additional predictive information for advanced AMD beyond macular and behavioral phenotypes.	[Seddon, Johanna M.; Reynolds, Robyn; Yu, Yi] Tufts Univ, Sch Med, Ophthalm Epidemiol & Genet Serv, Boston, MA 02111 USA; [Seddon, Johanna M.; Reynolds, Robyn; Yu, Yi] New England Eye Ctr, Tufts Med Ctr, Boston, MA USA; [Seddon, Johanna M.] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA; [Rosner, Bernard] Harvard Univ, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Rosner, Bernard] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Tufts University; Tufts Medical Center; Tufts University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Seddon, JM (corresponding author), Tufts Univ, Sch Med, Ophthalm Epidemiol & Genet Serv, Boston, MA 02111 USA.	jseddon@tuftsmedicalcenter.org			National Institutes of Health [RO1-EY11309]; Massachusetts Lions Eye Research Fund; Foundation Fighting Blindness; Research to Prevent Blindness; American Macular Degeneration Foundation; Macula Vision Research Foundation; Macular Degeneration Research Fund, Ophthalmic Epidemiology and Genetics Service, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA; NATIONAL EYE INSTITUTE [R01EY011309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research Fund; Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); American Macular Degeneration Foundation; Macula Vision Research Foundation; Macular Degeneration Research Fund, Ophthalmic Epidemiology and Genetics Service, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by grant RO1-EY11309 from the National Institutes of Health; Massachusetts Lions Eye Research Fund; Foundation Fighting Blindness; unrestricted grants from Research to Prevent Blindness; American Macular Degeneration Foundation; Macula Vision Research Foundation; and the Macular Degeneration Research Fund, Ophthalmic Epidemiology and Genetics Service, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosner B, 2009, BIOMETRICS, V65, P188, DOI 10.1111/j.1541-0420.2008.01062.x; Rosner B, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2110; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Seddon JM, 2013, JAMA OPHTHALMOL, V131, P448, DOI 10.1001/jamaophthalmol.2013.2578; Seddon JM, 2011, OPHTHALMOLOGY, V118, P2203, DOI 10.1016/j.ophtha.2011.04.029; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Seddon JM, 2013, FARADAY DISCUSS, V161, P9, DOI 10.1039/c2fd90045a; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; TAMURA Y, 1991, INVEST OPHTH VIS SCI, V32, P2636; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yu Y, 2012, INVEST OPHTH VIS SCI, V53, P1548, DOI 10.1167/iovs.11-8657; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270	34	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87047	10.1371/journal.pone.0087047	http://dx.doi.org/10.1371/journal.pone.0087047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498017	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900062
J	Xiang, XG; Jin, WT; Li, DZ; Schuiteman, A; Huang, WC; Li, JW; Jin, XH; Li, ZY				Xiang, Xiao-Guo; Jin, Wei-Tao; Li, De-Zhu; Schuiteman, Andre; Huang, Wei-Chang; Li, Jian-Wu; Jin, Xiao-Hua; Li, Zhen-Yu			Phylogenetics of Tribe Collabieae (Orchidaceae, Epidendroideae) Based on Four Chloroplast Genes with Morphological Appraisal	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; DNA; EVOLUTION; NUCLEAR	Collabieae (Orchidaceae) is a long neglected tribe with confusing tribal and generic delimitation and little-understood phylogenetic relationships. Using plastid matK, psaB, rbcL, and trnH-psbA DNA sequences and morphological evidence, the phylogenetic relationships within the tribe Collabieae were assessed as a basis for revising their tribal and generic delimitation. Collabieae (including the previously misplaced mycoheterotrophic Risleya) is supported as monophyletic and nested within a superclade that also includes Epidendreae, Podochileae, Cymbidieae and Vandeae. Risleya is nested in Collabiinae and sister to Chrysoglossum, a relationship which, despite their great vegetative differences, is supported by floral characters. Ania is a distinct genus supported by both morphological and molecular evidence, while redefined Tainia includes Nephelaphyllum and Mischobulbum. Calanthe is paraphyletic and consists four clades; the genera Gastrorchis, Phaius and Cephalantheropsis should be subsumed within Calanthe. Calanthe sect. Ghiesbreghtia is nested within sect. Calanthe, to which the disputed Calanthe delavayi belongs as well. Our results indicate that, in Collabieae, habit evolved from being epiphytic to terrestrial.	[Xiang, Xiao-Guo; Jin, Wei-Tao; Jin, Xiao-Hua; Li, Zhen-Yu] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Schuiteman, Andre] Royal Bot Gardens, Herbarium, Lib Art & Arch Directorate, Richmond, Surrey, England; [Huang, Wei-Chang] Shanghai Chenshan Bot Garden, Shanghai, Peoples R China; [Li, Jian-Wu] Chinese Acad Sci, Herbarium, Xishuanbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Royal Botanic Gardens, Kew; Chinese Academy of Sciences; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Jin, XH (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	orchid@ibcas.ac.cn; lizy@ibcas.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X	National Natural Science Foundation of China [31107176]; Knowledge Innovation Program of the Chinese Academy of Sciences [13214G1014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	Funds were provided by a grant from the National Natural Science Foundation of China (Grant No. 31107176) and the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. 13214G1014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GENERA ORCHIDACEARUM; Bateman R. M., 2012, New Journal of Botany, V2, P110, DOI 10.1179/2042349712Y.0000000013; Batista JAN, 2013, MOL PHYLOGENET EVOL, V67, P95, DOI 10.1016/j.ympev.2013.01.008; Cameron KM, 1999, AM J BOT, V86, P208, DOI 10.2307/2656938; CHASE MW, 2003, ORCHID CONSERVATION, P69; Chen S-C., 1999, FLORA REPUBLICAE POP; Chen SC, 1999, ACTA PHYTOTAXONOMICA, V37, P113; Chen SC, 2009, FLORA CHINA, P280; Dresser R, 1993, PHYLOGENY CLASSIFICA; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Dressler RL, 1981, ORCHIDS NATURAL HIST; DRESSLER ROBERT L., 1960, ANN MISSOURI BOT GARDEN, V47, P25, DOI 10.2307/2394615; Freudenstein JV, 2004, AM J BOT, V91, P149, DOI 10.3732/ajb.91.1.149; Gagnepain F, 1932, B MUSEUM HIST NATU 2, V2, P708; GARAY L. A., 1960, BOT MUS LEAFLETS HARVARD UNIV, V19, P57; Goldman DH, 2001, SYST BOT, V26, P670; Gorniak M, 2010, MOL PHYLOGENET EVOL, V56, P784, DOI 10.1016/j.ympev.2010.03.003; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Holttum RE, 1964, REVISED FLORA MALAYA, V1; Inda LA, 2012, ANN BOT-LONDON, V110, P71, DOI 10.1093/aob/mcs083; Li L, 2009, SYSTEMATICS TAINIA S; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Monteiro SHN, 2010, SYST BOT, V35, P476, DOI 10.1600/036364410792495944; Pearce N.P., 2002, FLORA BHUTAN, V3, P195; Perner H., 2002, ALP GARD, V70, P285; Pfitzer E. H. H., 1887, ENTWURF NATURLICHEN; Rakotoarivelo FP, 2012, TAXON, V61, P534, DOI 10.1002/tax.613004; Rasmussen FN, 1985, FAMLIES MONOCOTYLEDO; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schlechter R, 1919, REPERT SP NOV REGIN, V4, P176; Schlechter R., 1915, HDB ORCHIDEENLIEBHAB; Seidenfaden G, 1986, OPERA BOT, V89, P24; Smith JJ, 1912, B JARD BOT BUITENZ 2, V8, P5; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turner H, 1992, ORCHID MONOGRAPHS, V6, P43; van den Berg C, 2005, AM J BOT, V92, P613, DOI 10.3732/ajb.92.4.613; Xiang X, 2012, PLOS ONE, V7; Xiang XG, 2012, TAXON, V61, P45, DOI 10.1002/tax.611003	39	22	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87625	10.1371/journal.pone.0087625	http://dx.doi.org/10.1371/journal.pone.0087625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498156	Green Submitted, gold, Green Published			2022-12-25	WOS:000330621900145
J	Kanai, T; Seki, S; Jenks, JA; Kohli, A; Kawli, T; Martin, DP; Snyder, M; Bacchetta, R; Nadeau, KC				Kanai, Takahiro; Seki, Scott; Jenks, Jennifer A.; Kohli, Arunima; Kawli, Trupti; Martin, Dorrelyn Patacsil; Snyder, Michael; Bacchetta, Rosa; Nadeau, Kari C.			Identification of STAT5A and STAT5B Target Genes in Human T Cells	PLOS ONE			English	Article							GROWTH-HORMONE; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; FAMILY CYTOKINES; MESSENGER-RNA; ALPHA-CHAIN; EXPRESSION; MUTATION; IMMUNODEFICIENCY; DEFICIENCY	Signal transducer and activator of transcription (STAT) comprises a family of universal transcription factors that help cells sense and respond to environmental signals. STAT5 refers to two highly related proteins, STAT5A and STAT5B, with critical function: their complete deficiency is lethal in mice; in humans, STAT5B deficiency alone leads to endocrine and immunological problems, while STAT5A deficiency has not been reported. STAT5A and STAT5B show peptide sequence similarities greater than 90%, but subtle structural differences suggest possible non-redundant roles in gene regulation. However, these roles remain unclear in humans. We applied chromatin immunoprecipitation followed by DNA sequencing using human CD4(+) T cells to detect candidate genes regulated by STAT5A and/or STAT5B, and quantitative-PCR in STAT5A or STAT5B knock-down (KD) human CD4(+) T cells to validate the findings. Our data show STAT5A and STAT5B play redundant roles in cell proliferation and apoptosis via SGK1 interaction. Interestingly, we found a novel, unique role for STAT5A in binding to genes involved in neural development and function (NDRG1, DNAJC6, and SSH2), while STAT5B appears to play a distinct role in T cell development and function via DOCK8, SNX9, FOXP3 and IL2RA binding. Our results also suggest that one or more co-activators for STAT5A and/or STAT5B may play important roles in establishing different binding abilities and gene regulation behaviors. The new identification of these genes regulated by STAT5A and/or STAT5B has major implications for understanding the pathophysiology of cancer progression, neural disorders, and immune abnormalities.	[Kanai, Takahiro; Seki, Scott; Jenks, Jennifer A.; Kohli, Arunima; Bacchetta, Rosa; Nadeau, Kari C.] Stanford Univ, Dept Pediat, Sch Med, Div Immunol & Allergy, Stanford, CA 94305 USA; [Kawli, Trupti; Martin, Dorrelyn Patacsil; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Bacchetta, Rosa] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy HSR TIGET, I-20132 Milan, Italy	Stanford University; Stanford University; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Kanai, T (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Div Immunol & Allergy, Stanford, CA 94305 USA.	tkanai@jichi.ac.jp		Bacchetta, Rosa/0000-0002-0606-6268; Snyder, Michael/0000-0003-0784-7987; Jenks, Jennifer/0000-0002-6865-5615	Clinical Immunological Society Jr. Faculty Award; Fondazione Telethon Funding Source: Custom	Clinical Immunological Society Jr. Faculty Award; Fondazione Telethon(Fondazione Telethon)	Clinical Immunological Society Jr. Faculty Award funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-4; Badour K, 2007, P NATL ACAD SCI USA, V104, P1593, DOI 10.1073/pnas.0610543104; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Bernasconi A, 2006, PEDIATRICS, V118, pE1584, DOI 10.1542/peds.2005-2882; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Ferbeyre G, 2011, BBA-REV CANCER, V1815, P104, DOI 10.1016/j.bbcan.2010.10.004; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Goudy K, 2013, CLIN IMMUNOL, V146, P248, DOI 10.1016/j.clim.2013.01.004; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Jenks JA, 2013, CLIN IMMUNOL, V148, P227, DOI 10.1016/j.clim.2013.04.014; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kanai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00234; Kelly J, 2003, J IMMUNOL, V170, P210, DOI 10.4049/jimmunol.170.1.210; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Laloraya M, 2006, DIABETES, V55, P734, DOI 10.2337/diabetes.55.03.06.db05-1059; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Lin FR, 2012, BLOOD, V120, P1039, DOI 10.1182/blood-2011-12-399808; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Liu YY, 2011, CANCER RES, V71, P2276, DOI 10.1158/0008-5472.CAN-10-3107; Lu N, 2009, J EXP MED, V206, P2111, DOI 10.1084/jem.20090153; Markham K, 2007, MOL CELL NEUROSCI, V35, P272, DOI 10.1016/j.mcn.2007.03.001; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Messner MC, 2010, ADV EXP MED BIOL, V688, P156; Nadeau K, 2011, J PEDIATR-US, V158, P701, DOI 10.1016/j.jpeds.2010.12.042; Nelson EA, 2006, J BIOL CHEM, V281, P26216, DOI 10.1074/jbc.M605001200; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; Nomura S, 2007, TRANSPL IMMUNOL, V18, P115, DOI 10.1016/j.trim.2007.05.012; NUNEZ G, 1994, IMMUNOL TODAY, V15, P582, DOI 10.1016/0167-5699(94)90221-6; Pathipati P, 2011, NEUROSCIENCE, V190, P409, DOI 10.1016/j.neuroscience.2011.05.029; Peng B, 2002, MOL ENDOCRINOL, V16, P2019, DOI 10.1210/me.2002-0108; Pugliese-Pires PN, 2010, EUR J ENDOCRINOL, V163, P349, DOI 10.1530/EJE-10-0272; Randall KL, 2011, J EXP MED, V208, P2305, DOI 10.1084/jem.20110345; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Ronchi CL, 2012, J CLIN ENDOCR METAB, V97, pE2251, DOI 10.1210/jc.2012-2669; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Tran TH, 2010, CANCER RES, V70, P1711, DOI 10.1158/0008-5472.CAN-09-2314; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Van Dyken SJ, 2007, MOL CELL BIOL, V27, P1096, DOI 10.1128/MCB.01750-06; Vauthier V, 2012, MOL GENET METAB, V106, P345, DOI 10.1016/j.ymgme.2012.04.026; Baez MV, 2011, J CELL BIOL, V195, P1141, DOI 10.1083/jcb.201108159; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Yamaji D, 2013, NUCLEIC ACIDS RES, V41, P1622, DOI 10.1093/nar/gks1310; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zhu BM, 2012, NUCLEIC ACIDS RES, V40, P4461, DOI 10.1093/nar/gks056	55	47	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86790	10.1371/journal.pone.0086790	http://dx.doi.org/10.1371/journal.pone.0086790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497979	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100031
J	Lin, SP; Li, CY; Suzuki, K; Chang, CK; Chou, KM; Fang, SH				Lin, Shiuan-Pey; Li, Chia-Yang; Suzuki, Katsuhiko; Chang, Chen-Kang; Chou, Kuei-Ming; Fang, Shih-Hua			Green Tea Consumption after Intense Taekwondo Training Enhances Salivary Defense Factors and Antibacterial Capacity	PLOS ONE			English	Article							RADICAL-SCAVENGING ACTIVITY; ALPHA-AMYLASE; ANTIMICROBIAL PEPTIDES; PROLONGED EXERCISE; ACUTE DEHYDRATION; OXIDATIVE STRESS; MUCOSAL IMMUNITY; IMMUNOGLOBULIN-A; HYDRATION STATUS; ANTIOXIDANT	The aim of this study was to investigate the short-term effects of green tea consumption on selected salivary defense proteins, antibacterial capacity and anti-oxidation activity in taekwondo (TKD) athletes, following intensive training. Twenty-two TKD athletes performed a 2-hr TKD training session. After training, participants ingested green tea (T, caffeine 6 mg/kg and catechins 22 mg/kg) or an equal volume of water (W). Saliva samples were collected at three time points: before training (BT-T; BT-W), immediately after training (AT-T; AT-W), and 30 min after drinking green tea or water (Rec-T; Rec-W). Salivary total protein, immunoglobulin A (SIgA), lactoferrin, a-amylase activity, free radical scavenger activity (FRSA) and antibacterial capacity were measured. Salivary total protein, lactoferrin, SIgA concentrations and a-amylase activity increased significantly immediately after intensive TKD training. After tea drinking and 30 min rest, a-amylase activity and the ratio of a-amylase to total protein were significantly higher than before and after training. In addition, salivary antibacterial capacity was not affected by intense training, but green tea consumption after training enhanced salivary antibacterial capacity. Additionally, we observed that salivary FRSA was markedly suppressed immediately after training and quickly returned to pre-exercise values, regardless of which fluid was consumed. Our results show that green tea consumption significantly enhances the activity of a-amylase and salivary antibacterial capacity.	[Lin, Shiuan-Pey] China Med Univ, Sch Pharm, Taichung, Taiwan; [Li, Chia-Yang] Kaohsiung Med Univ, Coll Med, Dept Genome Med, Kaohsiung, Taiwan; [Suzuki, Katsuhiko] Waseda Univ, Fac Sport Sci, Saitama, Japan; [Chang, Chen-Kang] Natl Taiwan Univ Phys Educ & Sport, Sport Sci Res Ctr, Taichung, Taiwan; [Chou, Kuei-Ming] Natl Taiwan Univ Phys Educ & Sport, Dept Combat Sports, Taichung, Taiwan; [Fang, Shih-Hua] Natl Taiwan Univ Phys Educ & Sport, Inst Athlet, Taichung, Taiwan	China Medical University Taiwan; Kaohsiung Medical University; Waseda University	Fang, SH (corresponding author), Natl Taiwan Univ Phys Educ & Sport, Inst Athlet, Taichung, Taiwan.	shfang@ntupes.edu.tw	Suzuki, Katsuhiko/AAI-2197-2019; Chang, Chen-Kang/C-3501-2008	Suzuki, Katsuhiko/0000-0002-6572-5809; Chang, Chen-Kang/0000-0001-8335-6595; LI, CHIA-YANG/0000-0001-5689-9850; Lin, Shiuan-Pey/0000-0002-6186-2101	NSC [101-2628-H-028-002-MY3]; National Science Council, R. O. C.; Ministry of Education, Culture, Sports Science and Technology of Japan [23240097]	NSC(Ministry of Science and Technology, Taiwan); National Science Council, R. O. C.(Ministry of Science and Technology, Taiwan); Ministry of Education, Culture, Sports Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by NSC 101-2628-H-028-002-MY3 granted by National Science Council, R. O. C. and the Scientific Research (A) 23240097 from the Ministry of Education, Culture, Sports Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgrove JE, 2008, J SPORT SCI, V26, P653, DOI 10.1080/02640410701716790; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Atsumi T, 2008, ORAL DIS, V14, P490, DOI 10.1111/j.1601-0825.2007.01406.x; Atsumi T, 1999, ANTIOXID REDOX SIGN, V1, P537, DOI 10.1089/ars.1999.1.4-537; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Battino M, 2002, J CLIN PERIODONTOL, V29, P189, DOI 10.1034/j.1600-051X.2002.290301x.x; BORTNER CA, 1983, INFECT IMMUN, V41, P44, DOI 10.1128/IAI.41.1.44-49.1983; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Chicharro JL, 1998, SPORTS MED, V26, P17, DOI 10.2165/00007256-199826010-00002; Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000; Davison G, 2009, EUR J APPL PHYSIOL, V106, P277, DOI 10.1007/s00421-009-1020-y; ELLISON RT, 1988, INFECT IMMUN, V56, P2774, DOI 10.1128/IAI.56.11.2774-2781.1988; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; He CS, 2010, EUR J APPL PHYSIOL, V110, P989, DOI 10.1007/s00421-010-1574-8; Jankun J, 1997, NATURE, V387, P561, DOI 10.1038/42381; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; Jespersgaard C, 2002, INFECT IMMUN, V70, P1136, DOI 10.1128/IAI.70.3.1136-1142.2002; Katiyar Santosh K., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P234, DOI 10.2174/1568008033340171; Laing SJ, 2005, EUR J APPL PHYSIOL, V93, P665, DOI 10.1007/s00421-004-1270-7; Li H, 2011, SCI RES ESSAYS, V13, P2624; Marcotte H, 1998, MICROBIOL MOL BIOL R, V62, P71, DOI 10.1128/MMBR.62.1.71-109.1998; Murakami S, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-23; Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005; Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Panza VSP, 2008, NUTRITION, V24, P433, DOI 10.1016/j.nut.2008.01.009; Sabu MC, 2002, J ETHNOPHARMACOL, V83, P109; Serafini M, 1996, EUR J CLIN NUTR, V50, P28; SJODIN B, 1990, SPORTS MED, V10, P236; THRANE PS, 1991, CLIN EXP IMMUNOL, V86, P342; Tipoe George L., 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P135; Tsai ML, 2011, SCAND J MED SCI SPOR, V21, P758, DOI 10.1111/j.1600-0838.2010.01099.x; Tsai ML, 2011, BRIT J SPORT MED, V45, P729, DOI 10.1136/bjsm.2009.062497; Walsh NP, 2004, MED SCI SPORT EXER, V36, P1535, DOI 10.1249/01.MSS.0000139797.26760.06; Walsh NP, 2004, ARCH ORAL BIOL, V49, P149, DOI 10.1016/j.archoralbio.2003.08.001; West NP, 2006, FEMS IMMUNOL MED MIC, V48, P293, DOI 10.1111/j.1574-695X.2006.00132.x; Yang DJ, 2007, J CHROMATOGR A, V1156, P312, DOI 10.1016/j.chroma.2006.11.088; ZAKOWSKI JJ, 1985, CRC CR REV CL LAB SC, V21, P283, DOI 10.3109/10408368509165786	38	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87580	10.1371/journal.pone.0087580	http://dx.doi.org/10.1371/journal.pone.0087580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498143	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100097
J	Pohlmeyer, EA; Mahmoudi, B; Geng, SJ; Prins, NW; Sanchez, JC				Pohlmeyer, Eric A.; Mahmoudi, Babak; Geng, Shijia; Prins, Noeline W.; Sanchez, Justin C.			Using Reinforcement Learning to Provide Stable Brain-Machine Interface Control Despite Neural Input Reorganization	PLOS ONE			English	Article							COMPUTER INTERFACE; CORTICAL-NEURONS; FIELD POTENTIALS; MOVEMENT; PERFORMANCE; MONKEY; ARM; INFORMATION; ADAPTATION; PREDICTION	Brain-machine interface (BMI) systems give users direct neural control of robotic, communication, or functional electrical stimulation systems. As BMI systems begin transitioning from laboratory settings into activities of daily living, an important goal is to develop neural decoding algorithms that can be calibrated with a minimal burden on the user, provide stable control for long periods of time, and can be responsive to fluctuations in the decoder's neural input space (e. g. neurons appearing or being lost amongst electrode recordings). These are significant challenges for static neural decoding algorithms that assume stationary input/output relationships. Here we use an actor-critic reinforcement learning architecture to provide an adaptive BMI controller that can successfully adapt to dramatic neural reorganizations, can maintain its performance over long time periods, and which does not require the user to produce specific kinetic or kinematic activities to calibrate the BMI. Two marmoset monkeys used the Reinforcement Learning BMI (RLBMI) to successfully control a robotic arm during a two-target reaching task. The RLBMI was initialized using random initial conditions, and it quickly learned to control the robot from brain states using only a binary evaluative feedback regarding whether previously chosen robot actions were good or bad. The RLBMI was able to maintain control over the system throughout sessions spanning multiple weeks. Furthermore, the RLBMI was able to quickly adapt and maintain control of the robot despite dramatic perturbations to the neural inputs, including a series of tests in which the neuron input space was deliberately halved or doubled.	[Pohlmeyer, Eric A.; Geng, Shijia; Prins, Noeline W.; Sanchez, Justin C.] Univ Miami, Dept Biomed Engn, Coral Gables, FL 33124 USA; [Mahmoudi, Babak] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; [Sanchez, Justin C.] Univ Miami, Dept Neurosci, Miami, FL USA; [Sanchez, Justin C.] Univ Miami, Miami Project Cure Paralysis, Miami, FL USA	University of Miami; Emory University; University of Miami; University of Miami	Sanchez, JC (corresponding author), Univ Miami, Dept Biomed Engn, Coral Gables, FL 33124 USA.	jcsanchez@miami.edu	Mahmoudi, Babak/HHY-7302-2022	Prins, Noeline/0000-0002-6452-5733	Defense Advanced Research Projects Agency (DARPA) [N66001-1O-C-2008]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was funded under the Defense Advanced Research Projects Agency (DARPA, www.darpa.mil) Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) project N66001-1O-C-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burish MJ, 2008, J COMP NEUROL, V507, P1151, DOI 10.1002/cne.21596; Burman KJ, 2008, J COMP NEUROL, V506, P860, DOI 10.1002/cne.21580; Carmena JM, 2005, J NEUROSCI, V25, P10712, DOI 10.1523/JNEUROSCI.2772-05.2005; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chase SM, 2012, J NEUROPHYSIOL, V108, P624, DOI 10.1152/jn.00371.2011; Chestek CA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045005; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Dickey AS, 2009, J NEUROPHYSIOL, V102, P1331, DOI 10.1152/jn.90920.2008; DiGiovanna J, 2009, IEEE T BIO-MED ENG, V56, P54, DOI 10.1109/TBME.2008.926699; Fraser GW, 2012, J NEUROPHYSIOL, V107, P1970, DOI 10.1152/jn.01012.2010; Fraser GW, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055004; Gage GJ, 2005, J NEURAL ENG, V2, P52, DOI 10.1088/1741-2560/2/2/006; Ganguly K, 2011, NAT NEUROSCI, V14, P662, DOI 10.1038/nn.2797; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Geng S, 2013, 6 INT IEEE EMB UNPUB; Gilja V, 2012, NAT NEUROSCI, V15, P1752, DOI 10.1038/nn.3265; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hoffmann S, 2012, INT J PSYCHOPHYSIOL, V83, P208, DOI 10.1016/j.ijpsycho.2011.11.015; Iturrate I, 2010, IEEE INT CONF ROBOT, P4822, DOI 10.1109/ROBOT.2010.5509734; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Kreilinger A, 2012, MED BIOL ENG COMPUT, V50, P223, DOI 10.1007/s11517-011-0858-4; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Li Z, 2011, NEURAL COMPUT, V23, P3162, DOI 10.1162/NECO_a_00207; Li Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006243; Llera A, 2011, NEURAL NETWORKS, V24, P1120, DOI 10.1016/j.neunet.2011.05.006; Long JY, 2011, COGN NEURODYNAMICS, V5, P387, DOI 10.1007/s11571-011-9167-8; Lu SJ, 2009, IEEE T NEUR SYS REH, V17, P135, DOI 10.1109/TNSRE.2009.2015197; Ludwig KA, 2009, J NEUROPHYSIOL, V101, P1679, DOI 10.1152/jn.90989.2008; Mahmoudi B, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066005; Mahmoudi B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014760; Matsuzaki S, 2011, LECT NOTES COMPUT SC, V7062, P360, DOI 10.1007/978-3-642-24955-6_44; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; Mehring C, 2004, J PHYSIOL-PARIS, V98, P498, DOI 10.1016/j.jphysparis.2005.09.016; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Milekovic T, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026007; Newman JD, 2009, BRAIN RES REV, V62, P1, DOI 10.1016/j.brainresrev.2009.09.001; Orsborn AL, 2012, IEEE T NEUR SYS REH, V20, P468, DOI 10.1109/TNSRE.2012.2185066; Palazzi X., 2008, MARMOSET BRAIN STERE; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Pilarski P. M., 2011, IEEE INT C REH ROB I, P1; Pohlmeyer EA, 2007, J NEURAL ENG, V4, P369, DOI 10.1088/1741-2560/4/4/003; Pohlmeyer EA, 2012, IEEE ENG MED BIO, P4108, DOI 10.1109/EMBC.2012.6346870; Pohlmeyer EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005924; Prasad A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056015; Prins NW, 2013, 2013 ANN IN IN PRESS; Qin Jianzhao, 2007, Comput Intell Neurosci, P94397, DOI 10.1155/2007/94397; Sanchez JC, 2004, IEEE T BIO-MED ENG, V51, P943, DOI 10.1109/TBME.2004.827061; Santhanam G, 2007, IEEE T BIO-MED ENG, V54, P2037, DOI 10.1109/TBME.2007.895753; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Simeral JD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025027; Spuler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051077; Sussillo D, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026027; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Thomas MC, 2006, ELEMENTS INFORM THEO; Tokuno H, 2009, NEUROSCI RES, V65, P312, DOI 10.1016/j.neures.2009.08.004; Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Vidaurre C, 2011, IEEE T BIO-MED ENG, V58, P587, DOI 10.1109/TBME.2010.2093133; Vidaurre C, 2010, NEURAL COMPUT; Vidaurre C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025009; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wu W, 2008, IEEE T NEUR SYS REH, V16, P213, DOI 10.1109/TNSRE.2008.922679	68	44	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87253	10.1371/journal.pone.0087253	http://dx.doi.org/10.1371/journal.pone.0087253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498055	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100067
J	Sciancalepore, AG; Sallustio, F; Girardo, S; Passione, LG; Camposeo, A; Mele, E; Di Lorenzo, M; Costantino, V; Schena, FP; Pisignano, D				Sciancalepore, Anna Giovanna; Sallustio, Fabio; Girardo, Salvatore; Passione, Laura Gioia; Camposeo, Andrea; Mele, Elisa; Di Lorenzo, Mirella; Costantino, Vincenzo; Schena, Francesco Paolo; Pisignano, Dario			A Bioartificial Renal Tubule Device Embedding Human Renal Stem/Progenitor Cells	PLOS ONE			English	Article							PROGENITOR CELLS; STEM-CELLS; CULTURE MODELS; KIDNEY REPAIR; TRANSPORT; MEMBRANES; SYSTEM; PHENOTYPE; GROWTH; RAT	We present a bio-inspired renal microdevice that resembles the in vivo structure of a kidney proximal tubule. For the first time, a population of tubular adult renal stem/progenitor cells (ARPCs) was embedded into a microsystem to create a bioengineered renal tubule. These cells have both multipotent differentiation abilities and an extraordinary capacity for injured renal cell regeneration. Therefore, ARPCs may be considered a promising tool for promoting regenerative processes in the kidney to treat acute and chronic renal injury. Here ARPCs were grown to confluence and exposed to a laminar fluid shear stress into the chip, in order to induce a functional cell polarization. Exposing ARPCs to fluid shear stress in the chip led the aquaporin-2 transporter to localize at their apical region and the Na+K+ ATPase pump at their basolateral portion, in contrast to statically cultured ARPCs. A recovery of urea and creatinine of (20 +/- 5)% and (13 +/- 5)%, respectively, was obtained by the device. The microengineered biochip here-proposed might be an innovative "lab-on-a-chip" platform to investigate in vitro ARPCs behaviour or to test drugs for therapeutic and toxicological responses.	[Sciancalepore, Anna Giovanna; Passione, Laura Gioia; Camposeo, Andrea; Mele, Elisa; Pisignano, Dario] Ist Italiano Tecnol, Ctr Biomol Nanotechnol, Arnesano, Italy; [Sallustio, Fabio; Costantino, Vincenzo; Schena, Francesco Paolo] Univ Bari, Dept Emergency & Organ Transplantat, Nephrol Dialysis & Transplantat Unit, Bari, Italy; [Sallustio, Fabio; Schena, Francesco Paolo] Ctr Addestramento Ric Sci Oncol CARSO Consortium, Valenzano, Italy; [Sallustio, Fabio] Univ Salento, Dept Sci Biol & Environm Sci & Technol, Lecce, Italy; [Girardo, Salvatore; Passione, Laura Gioia; Camposeo, Andrea; Di Lorenzo, Mirella; Pisignano, Dario] CNR, Ist Nanosci, Natl Nanotechnol Lab, Lecce, Italy; [Passione, Laura Gioia; Pisignano, Dario] Univ Salento, Dipartimento Matemat & Fis Ennio De Giorgi, Lecce, Italy	Istituto Italiano di Tecnologia - IIT; Universita degli Studi di Bari Aldo Moro; University of Salento; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); University of Salento	Sciancalepore, AG (corresponding author), Ist Italiano Tecnol, Ctr Biomol Nanotechnol, Arnesano, Italy.	anna.sciancalepore@iit.it; dario.pisignano@unisalento.it	girardo, salvatore/O-7354-2017; zhou, ke/A-2345-2019; Sallustio, Fabio/AFP-7212-2022; Camposeo, Andrea/O-2338-2015; Mele, Elisa/D-5426-2011; Pisignano, Dario/M-8309-2015; Schena, Francesco P/K-6982-2016; Sallustio, Fabio/D-2326-2011	girardo, salvatore/0000-0002-5350-0186; Sallustio, Fabio/0000-0002-5132-6532; Camposeo, Andrea/0000-0002-3533-7389; Pisignano, Dario/0000-0003-3758-5199; Schena, Francesco P/0000-0001-7927-5207; Sallustio, Fabio/0000-0002-5132-6532; Sciancalepore, Anna Giovanna/0000-0002-4839-8041; Mele, Elisa/0000-0003-3574-7684; Di Lorenzo, Mirella/0000-0002-1332-6347	Regione Puglia [Progetti strategici 44/09 BISIMANE, PS 144/06]; Italian Ministry of University and Research through FIRB [RBNE08BNL7]	Regione Puglia(Regione Puglia); Italian Ministry of University and Research through FIRB	This study was supported by grants from "Regione Puglia" (Progetti strategici 44/09 BISIMANE and PS 144/06). Authors at the National Nanotechnology Laboratory of CNR-NANO also acknowledge the support of the Italian Ministry of University and Research through the FIRB Contract RBNE08BNL7 (MERIT Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelotti ML, 2012, STEM CELLS, V30, P1714, DOI 10.1002/stem.1130; BARACNIETO M, 1988, PEDIATR NEPHROL, V2, P356, DOI 10.1007/BF00858693; Baudoin R, 2007, BIOTECHNOL PROGR, V23, P1245, DOI 10.1021/bp0603513; Brodie JC, 2005, PHARMACOL REV, V57, P299, DOI 10.1124/pr.57.3.3; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Bussolati B, 2008, AM J NEPHROL, V28, P813, DOI 10.1159/000137681; Carraro A, 2008, BIOMED MICRODEVICES, V10, P795, DOI 10.1007/s10544-008-9194-3; Chueh BH, 2007, ANAL CHEM, V79, P3504, DOI 10.1021/ac062118p; Dankers PYW, 2010, MACROMOL BIOSCI, V10, P1345, DOI 10.1002/mabi.201000146; Duan Y, 2008, P NATL ACAD SCI USA, V105, P11418, DOI 10.1073/pnas.0804954105; Essig M, 2001, AM J PHYSIOL-RENAL, V281, pF751, DOI 10.1152/ajprenal.2001.281.4.F751; Frohlich EM, 2012, INTEGR BIOL-UK, V4, P75, DOI 10.1039/c1ib00096a; Gugala Z, 2004, BIOMATERIALS, V25, P2341, DOI 10.1016/j.biomaterials.2003.09.013; Hsieh YC, 2005, SENSOR ACTUAT B-CHEM, V107, P649, DOI 10.1016/j.snb.2004.11.039; Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Humes HD, 1999, KIDNEY INT, V55, P2502, DOI 10.1046/j.1523-1755.1999.00486.x; Inamdar NK, 2011, CURR OPIN BIOTECH, V22, P681, DOI 10.1016/j.copbio.2011.05.512; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; Jang KJ, 2011, INTEGR BIOL-UK, V3, P134, DOI 10.1039/c0ib00018c; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Kim SM, 2008, LAB CHIP, V8, P1015, DOI 10.1039/b800835c; Lazzeri E, 2007, J AM SOC NEPHROL, V18, P3128, DOI 10.1681/ASN.2007020210; Lechleitner T, 2008, BIOMATERIALS, V29, P4275, DOI 10.1016/j.biomaterials.2008.07.023; Mahler GJ, 2009, BIOTECHNOL BIOENG, V104, P193, DOI 10.1002/bit.22366; Meyvantsson I, 2008, ANNU REV ANAL CHEM, V1, P423, DOI 10.1146/annurev.anchem.1.031207.113042; Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001; Ozgen N, 2004, NEPHROL DIAL TRANSPL, V19, P2198, DOI 10.1093/ndt/gfh399; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Pereira BJG, 2000, COMPLICATIONS DIALYS; Poulsom R, 2002, J PATHOL, V197, P441, DOI 10.1002/path.1176; Procino G, 2011, CELL PHYSIOL BIOCHEM, V28, P683, DOI 10.1159/000335762; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sagrinati C, 2008, TRENDS MOL MED, V14, P277, DOI 10.1016/j.molmed.2008.05.005; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Sallustio F, 2013, KIDNEY INT, V83, P392, DOI 10.1038/ki.2012.413; Sallustio F, 2010, FASEB J, V24, P514, DOI 10.1096/fj.09-136481; Sanechika N, 2011, NEPHROL DIAL TRANSPL, V26, P2761, DOI 10.1093/ndt/gfr066; Sheng YX, 2012, ANALYST, V137, P1144, DOI 10.1039/c2an15966j; Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27; Simone S, 2012, AM J PHYSIOL-RENAL, V303, pF23, DOI 10.1152/ajprenal.00328.2011; Song JW, 2005, ANAL CHEM, V77, P3993, DOI 10.1021/ac050131o; Sonntag F, 2010, J BIOTECHNOL, V148, P70, DOI 10.1016/j.jbiotec.2010.02.001; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Sung JH, 2009, BIOMED MICRODEVICES, V11, P731, DOI 10.1007/s10544-009-9286-8; Tiranathanagul K, 2006, NEPHROLOGY, V11, P285, DOI 10.1111/j.1440-1797.2006.00588.x; Tzoneva R, 2007, BBA-GEN SUBJECTS, V1770, P1538, DOI 10.1016/j.bbagen.2007.07.008; van der Meer AD, 2012, INTEGR BIOL-UK, V4, P461, DOI 10.1039/c2ib00176d; van Noort D, 2009, BIOTECHNOL PROGR, V25, P52, DOI 10.1002/btpr.171; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Webster A, 2011, J CHEM TECHNOL BIOT, V86, P10, DOI 10.1002/jctb.2482; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Wieser M, 2008, AM J PHYSIOL-RENAL, V295, pF1365, DOI 10.1152/ajprenal.90405.2008; Yokoo T, 2008, KIDNEY INT, V74, P847, DOI 10.1038/ki.2008.327	56	42	43	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87496	10.1371/journal.pone.0087496	http://dx.doi.org/10.1371/journal.pone.0087496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498117	Green Published, gold			2022-12-25	WOS:000330617100088
J	Stoczynska-Fidelus, E; Piaskowski, S; Bienkowski, M; Banaszczyk, M; Hulas-Bigoszewska, K; Winiecka-Klimek, M; Radomiak-Zaluska, A; Och, W; Borowiec, M; Zieba, J; Treda, C; Rieske, P				Stoczynska-Fidelus, Ewelina; Piaskowski, Sylwester; Bienkowski, Michal; Banaszczyk, Mateusz; Hulas-Bigoszewska, Krystyna; Winiecka-Klimek, Marta; Radomiak-Zaluska, Anna; Och, Waldemar; Borowiec, Maciej; Zieba, Jolanta; Treda, Cezary; Rieske, Piotr			The Failure in the Stabilization of Glioblastoma-Derived Cell Lines: Spontaneous In Vitro Senescence as the Main Culprit	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; INTEGRATED GENOMIC ANALYSIS; HUMAN GLIOMA-CELLS; MITOTIC CATASTROPHE; SELF-RENEWAL; STEM-CELLS; CANCER; EGFR; EXPRESSION; MULTIFORME	Cell line analysis is an important element of cancer research. Despite the progress in glioblastoma cell culturing, the cells isolated from the majority of specimens cannot be propagated infinitely in vitro. The aim of this study was to identify the processes responsible for the stabilization failure. Therefore, we analyzed 56 primary GB cultures, 7 of which were stabilized. Our results indicate that senescence is primarily responsible for the glioblastoma cell line stabilization failure, while mitotic catastrophe and apoptosis play a minor role. Moreover, a new technical approach allowed for a more profound analysis of the senescent cells in primary cultures, including the distinction between tumor and normal cells. In addition, we observed that glioblastoma cells in primary cultures have a varied potential to undergo spontaneous in vitro senescence, which is often higher than that of the normal cells infiltrating the tumor. Thus, this is the first report of GB cells in primary cell cultures (including both monolayer and spheroid conditions) rapidly and spontaneously becoming senescent. Intriguingly, our data also suggest that nearly half of GB cell lines have a combination of TP53 mutation and CDKN2A homozygous deletion, which are considered as mutually exclusive in glioblastoma. Moreover, recognition of the mechanisms of senescence and mitotic catastrophe in glioblastoma cells may be a step towards a potential new therapeutic approach.	[Stoczynska-Fidelus, Ewelina; Piaskowski, Sylwester; Banaszczyk, Mateusz; Winiecka-Klimek, Marta; Zieba, Jolanta; Treda, Cezary; Rieske, Piotr] Med Univ Lodz, Dept Tumor Biol, Lodz, Poland; [Bienkowski, Michal; Hulas-Bigoszewska, Krystyna] Med Univ Lodz, Dept Mol Pathol & Neuropathol, Chair Oncol, Lodz, Poland; [Radomiak-Zaluska, Anna] Maria Sklodowska Curie Reg Specialist Hosp Zgierz, Lodz, Poland; [Och, Waldemar] Voivodal Specialist Hosp Olsztyn, Clin Dept Neurosurg, Olsztyn, Warmia, Poland; [Och, Waldemar] Voivodal Specialist Hosp Olsztyn, Clin Dept Neurosurg, Olsztyn, Masuria, Poland; [Borowiec, Maciej] Med Univ Lodz, Dept Paediat Oncol Haematol & Diabetol, Lodz, Poland	Medical University Lodz; Medical University Lodz; Medical University Lodz	Stoczynska-Fidelus, E (corresponding author), Med Univ Lodz, Dept Tumor Biol, Lodz, Poland.	ewelina.stoczynska-fidelus@umed.lodz.pl	Stoczynska-Fidelus, Ewelina/S-9948-2016; Bieńkowski, Michał/H-3046-2019; Rieske, Piotr/M-4821-2015; Borowiec, Maciej/S-9220-2016; Stoczynska-Fidelus, Ewelina/M-4871-2015	Bieńkowski, Michał/0000-0002-9291-3928; Rieske, Piotr/0000-0002-2970-0970; Borowiec, Maciej/0000-0003-2812-5676; Stoczynska-Fidelus, Ewelina/0000-0002-7779-3075; Och, Waldemar/0000-0001-7006-872X	National Science Centre [2011/03/N/NZ1/06534]; Polpharma Science Foundation	National Science Centre(National Science Centre, Poland); Polpharma Science Foundation	This study was sponsored by National Science Centre Grant No. 2011/03/N/NZ1/06534 (analyses of senescence) and by Polpharma Science Foundation (other analyses). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; [Anonymous], 2008, NATURE, V455, P1061; Bienkowski M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065444; BIGNER SH, 1990, CANCER RES, V50, P8017; Bottger K, 2012, MATH MODEL NAT PHENO, V7, P105, DOI 10.1051/mmnp/20127106; Chang BD, 1999, CANCER RES, V59, P3761; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Clavreul A, 2012, J NEURO-ONCOL, V106, P493, DOI 10.1007/s11060-011-0701-7; Clement V, 2009, INT J CANCER, V125, P244, DOI 10.1002/ijc.24352; Angelini PD, 2013, CANCER RES, V73, P450, DOI 10.1158/0008-5472.CAN-12-2301; Del Vecchio CA, 2013, ONCOGENE, V32, P2670, DOI 10.1038/onc.2012.280; Dhruv HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072134; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Firat E, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-71; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Fulci G, 2000, ONCOGENE, V19, P3816, DOI 10.1038/sj.onc.1203700; Garay T, 2013, EXP CELL RES, V319, P3094, DOI 10.1016/j.yexcr.2013.08.018; Golebiewska A, 2013, BRAIN, V136, P1462, DOI 10.1093/brain/awt025; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Hirose Y, 2001, CANCER RES, V61, P5843; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Knizhnik AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055665; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Layfield LJ, 2006, APPL IMMUNOHISTO M M, V14, P91, DOI 10.1097/01.pai.0000159772.73775.2e; Le Mercier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045475; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Nomura M, 2004, J CELL PHYSIOL, V201, P374, DOI 10.1002/jcp.20090; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piaskowski S, 2011, BRIT J CANCER, V104, P968, DOI 10.1038/bjc.2011.27; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rajaraman R, 2005, CELL BIOL INT, V29, P1084, DOI 10.1016/j.cellbi.2005.10.003; Rajaraman R, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-25; Rieske P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-54; SAUTER G, 1994, INT J CANCER, V57, P508, DOI 10.1002/ijc.2910570412; Schulte A, 2012, CLIN CANCER RES, V18, P1901, DOI 10.1158/1078-0432.CCR-11-3084; Stockhausen MT, 2011, EXP CELL RES, V317, P1513, DOI 10.1016/j.yexcr.2011.04.001; Sundaram M, 2004, CANCER BIOL THER, V3, P207, DOI 10.4161/cbt.3.2.663; Svensson S, 2003, CANCER RES, V63, P1737; Ueki K, 2002, CLIN CANCER RES, V8, P196; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Villalonga-Planells R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018588; Witusik-Perkowska M, 2011, J NEURO-ONCOL, V102, P395, DOI 10.1007/s11060-010-0352-0; Yoshimoto K, 2008, CLIN CANCER RES, V14, P488, DOI 10.1158/1078-0432.CCR-07-1966; Zupanska A, 2005, NEUROCHEM INT, V47, P430, DOI 10.1016/j.neuint.2005.05.010	50	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87136	10.1371/journal.pone.0087136	http://dx.doi.org/10.1371/journal.pone.0087136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498027	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100049
J	Xiong, XL; Qi, Y; Jiao, J; Gong, WP; Duan, CS; Wen, BH				Xiong, Xiaolu; Qi, Yong; Jiao, Jun; Gong, Wenping; Duan, Changsong; Wen, Bohai			Exploratory Study on Th1 Epitope-Induced Protective Immunity against Coxiella burnetii Infection	PLOS ONE			English	Article							Q-FEVER; BACTERIAL CLEARANCE; PROTEIN MICROARRAY; BALB/C MICE; T-CELLS; VACCINE; INTERFERON; MATURATION; RESPONSES; PATHOGEN	Coxiella burnetii is a Gram-negative bacterium that causes Q fever in humans. In the present study, 131 candidate peptides were selected from the major immunodominant proteins (MIPs) of C. burnetii due to their high-affinity binding capacity for the MHC class II molecule H2 I-A(b) based on bioinformatic analyses. Twenty-two of the candidate peptides with distinct MIP epitopes were well recognized by the IFN-gamma recall responses of CD4(+) T cells from mice immunized with parental proteins in an ELISPOT assay. In addition, 7 of the 22 peptides could efficiently induce CD4(+) T cells from mice immunized with C. burnetii to rapidly proliferate and significantly increase IFN-gamma production. Significantly higher levels of IL-2, IL-12p70, IFN-gamma, and TNF-alpha were also detected in serum from mice immunized with a pool of the 7 peptides. Immunization with the pool of 7 peptides, but not the individual peptides, conferred a significant protection against C. burnetii infection in mice, suggesting that these Th1 peptides could work together to efficiently activate CD4(+) T cells to produce the Th1-type immune response against C. burnetii infection. These observations could contribute to the rational design of molecular vaccines for Q fever.	[Xiong, Xiaolu; Qi, Yong; Jiao, Jun; Gong, Wenping; Duan, Changsong; Wen, Bohai] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Xiong, XL (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	xiongxiaolu624@sohu.com; wenbohai@yahoo.com	Jiao, Jun/ABE-7519-2021; Qi, Yong/AAK-8798-2021; Gong, Wenping/B-8183-2018	Qi, Yong/0000-0001-6186-9023; Gong, Wenping/0000-0002-0333-890X	National Natural Science Foundation of China [81371767, 31170161]; National Basic Research Program of China [2010CB530200/2010CB530205]; National Science and Technology Major Project of China [2013ZX10004803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project of China	This research was supported by grants (81371767 and 31170161) from the National Natural Science Foundation of China, a grant (2010CB530200/2010CB530205) from the National Basic Research Program of China, and a grant (2013ZX10004803) from the National Science and Technology Major Project of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh M, 2007, INFECT IMMUN, V75, P3245, DOI 10.1128/IAI.01767-06; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017712; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Ghigo E, 2002, J IMMUNOL, V169, P4488, DOI 10.4049/jimmunol.169.8.4488; Gidding HF, 2009, VACCINE, V27, P2037, DOI 10.1016/j.vaccine.2009.02.007; HACKSTADT T, 1985, INFECT IMMUN, V48, P359, DOI 10.1128/IAI.48.2.359-365.1985; Hendrix LR, 2012, ADV EXP MED BIOL, V984, P299, DOI 10.1007/978-94-007-4315-1_16; Howe D, 2002, INFECT IMMUN, V70, P5140, DOI 10.1128/IAI.70.9.5140-5147.2002; Lockhart M, 2012, FEMS IMMUNOL MED MIC, V64, P61, DOI 10.1111/j.1574-695X.2011.00898.x; MARMION BP, 1984, LANCET, V2, P1411; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Maybeno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043481; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Peng Y, 2012, J IMMUNOL, V189, P4909, DOI 10.4049/jimmunol.1201622; Qi Y, 2013, VACCINE; Qi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070440; Read AJ, 2010, INFECT IMMUN, V78, P3019, DOI 10.1128/IAI.00101-10; Sarchielli P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068428; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Shannon JG, 2009, IMMUNOL RES, V43, P138, DOI 10.1007/s12026-008-8059-4; TURCO J, 1984, INFECT IMMUN, V45, P781, DOI 10.1128/IAI.45.3.781-783.1984; Vigil A, 2010, PROTEOMICS, V10, P2259, DOI 10.1002/pmic.201000064; Wei Y, 2011, J INFECT DIS, V203, P283, DOI 10.1093/infdis/jiq037; WEN BH, 1991, ACTA VIROL, V35, P538; WILLIAMS JC, 1981, INFECT IMMUN, V32, P840, DOI 10.1128/IAI.32.2.840-851.1981; Xiong XL, 2012, VACCINE, V30, P6809, DOI 10.1016/j.vaccine.2012.09.017; Xiong XL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-35; Zhang GQ, 2004, INFECT IMMUN, V72, P844, DOI 10.1128/IAI.72.2.844-852.2004; Zhang GQ, 2007, J IMMUNOL, V179, P8372, DOI 10.4049/jimmunol.179.12.8372; Zhang Guoquan, 2004, Expert Rev Vaccines, V3, P577, DOI 10.1586/14760584.3.5.577; Zhang GQ, 2012, ADV EXP MED BIOL, V984, P91, DOI 10.1007/978-94-007-4315-1_5	32	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87206	10.1371/journal.pone.0087206	http://dx.doi.org/10.1371/journal.pone.0087206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498044	gold, Green Published, Green Submitted			2022-12-25	WOS:000330617100059
J	Yu, Y; Wei, JK; Zhang, XJ; Liu, JW; Liu, CZ; Li, FH; Xiang, JH				Yu, Yang; Wei, Jiankai; Zhang, Xiaojun; Liu, Jingwen; Liu, Chengzhang; Li, Fuhua; Xiang, Jianhai			SNP Discovery in the Transcriptome of White Pacific Shrimp Litopenaeus vannamei by Next Generation Sequencing	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; LINKAGE MAP; ATLANTIC COD; MICROSATELLITE; IDENTIFICATION; MARKERS; SUSCEPTIBILITY; ANNOTATION; RESOURCE	The application of next generation sequencing technology has greatly facilitated high throughput single nucleotide polymorphism (SNP) discovery and genotyping in genetic research. In the present study, SNPs were discovered based on two transcriptomes of Litopenaeus vannamei (L. vannamei) generated from Illumina sequencing platform HiSeq 2000. One transcriptome of L. vannamei was obtained through sequencing on the RNA from larvae at mysis stage and its reference sequence was de novo assembled. The data from another transcriptome were downloaded from NCBI and the reads of the two transcriptomes were mapped separately to the assembled reference by BWA. SNP calling was performed using SAMtools. A total of 58,717 and 36,277 SNPs with high quality were predicted from the two transcriptomes, respectively. SNP calling was also performed using the reads of two transcriptomes together, and a total of 96,040 SNPs with high quality were predicted. Among these 96,040 SNPs, 5,242 and 29,129 were predicted as non-synonymous and synonymous SNPs respectively. Characterization analysis of the predicted SNPs in L. vannamei showed that the estimated SNP frequency was 0.21% (one SNP per 476 bp) and the estimated ratio for transition to transversion was 2.0. Fifty SNPs were randomly selected for validation by Sanger sequencing after PCR amplification and 76% of SNPs were confirmed, which indicated that the SNPs predicted in this study were reliable. These SNPs will be very useful for genetic study in L. vannamei, especially for the high density linkage map construction and genome-wide association studies.	[Yu, Yang; Wei, Jiankai; Zhang, Xiaojun; Liu, Jingwen; Liu, Chengzhang; Li, Fuhua; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Yu, Yang; Wei, Jiankai; Liu, Jingwen] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, FH (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	fhli@qdio.ac.cn	zhang, jin/GXV-9154-2022; jingwen, liu/B-5167-2014; xiang, jianhai/A-4767-2012	jingwen, liu/0000-0002-9863-1235; xiang, jianhai/0000-0001-5395-7787	National High Technology Research and Development Program (863 Program) of China [2012AA10A404, 2012AA092205]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China)	This work is supported by National High Technology Research and Development Program (863 Program) of China (2012AA10A404, 2012AA092205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcivar-Warren A, 2007, J SHELLFISH RES, V26, P1259, DOI 10.2983/0730-8000(2007)26[1259:SALMLM]2.0.CO;2; An HS, 2011, INT J MOL SCI, V12, P9189, DOI 10.3390/ijms12129189; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Ciobanu DC, 2010, ANIM GENET, V41, P39, DOI 10.1111/j.1365-2052.2009.01961.x; Du ZQ, 2010, ANIM GENET, V41, P286, DOI 10.1111/j.1365-2052.2009.02002.x; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; Glenn KL, 2005, ANIM GENET, V36, P235, DOI 10.1111/j.1365-2052.2005.01274.x; Gorbach DM, 2009, ANIM GENET, V40, P106, DOI 10.1111/j.1365-2052.2008.01792.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Helyar SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042089; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Leu JH, 2011, MAR BIOTECHNOL, V13, P608, DOI 10.1007/s10126-010-9286-y; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Liu CZ, 2012, CHIN J OCEANOL LIMN, V30, P713, DOI 10.1007/s00343-012-1252-2; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Matsunaga E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025272; Miller NJ, 2012, ENVIRON ENTOMOL, V41, P997, DOI 10.1603/EN11216; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Moen T, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-18; Moen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-223; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nguyen MT, 2010, AQUACULTURE, V301, P7, DOI 10.1016/j.aquaculture.2010.02.001; Perez F, 2004, AQUACULTURE, V242, P105, DOI 10.1016/j.aquaculture.2004.09.002; Prudence M, 2006, ANIM GENET, V37, P348, DOI 10.1111/j.1365-2052.2006.01481.x; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058815; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sha Z, 2010, J FISH BIOL, V76, P1190, DOI 10.1111/j.1095-8649.2010.02592.x; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tseng MC, 2012, INT J MOL SCI, V13, P4281, DOI 10.3390/ijms13044281; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Vera M, 2013, INT J MOL SCI, V14, P5694, DOI 10.3390/ijms14035694; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Zakas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031613; Zeng DG, 2013, PLOS ONE, V8; Zhang LS, 2007, GENETICA, V131, P37, DOI 10.1007/s10709-006-9111-8; Zhang LS, 2010, AQUACULTURE, V302, P124, DOI 10.1016/j.aquaculture.2010.02.012; Zhang X, 2010, 7 INT CRUST C QINGD, pP361	46	40	53	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87218	10.1371/journal.pone.0087218	http://dx.doi.org/10.1371/journal.pone.0087218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498047	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100062
J	Nunes, PM; Wright, AJ; Veltien, A; van Asten, JJA; Tack, CJ; Jones, JG; Heerschap, A				Nunes, Patricia M.; Wright, Alan J.; Veltien, Andor; van Asten, Jack J. A.; Tack, Cees J.; Jones, John G.; Heerschap, Arend			Dietary lipids do not contribute to the higher hepatic triglyceride levels of fructose- compared to glucose-fed mice	FASEB JOURNAL			English	Article						in vivo hepatic lipid metabolism; magnetic resonance spectroscopy; de novo lipogenesis	FATTY LIVER-DISEASE; DE-NOVO LIPOGENESIS; INSULIN-RESISTANCE; MAGNETIC-RESONANCE; LIPOPROTEIN OVERPRODUCTION; SWEETENED BEVERAGES; RATS; CONSUMPTION; METABOLISM; HAMSTER	Fructose consumption has been associated with the surge in obesity and dyslipidemia. This may be mediated by the fructose effects on hepatic lipids and ATP levels. Fructose metabolism provides carbons for de novo lipogenesis (DNL) and stimulates enterocyte secretion of apoB48. Thus, fructose-induced hepatic triglyceride (HTG) accumulation can be attributed to both DNL stimulation and dietary lipid absorption. The aim of this study was to assess the effects of fructose diet on HTG and ATP content and the contributions of dietary lipids and DNL to HTG. Measurements were performed in vivo in mice by magnetic resonance imaging (MRI) and novel magnetic resonance spectroscopy (MRS) approaches. Abdominal adipose tissue volume and intramyocellular lipid levels were comparable between 8-wk fructose- and glucose-fed mice. HTG levels were approximate to 1.5-fold higher in fructose-fed than in glucose-fed mice (P<0.05). Metabolic flux analysis by C-13 and H-2 MRS showed that this was not due to dietary lipid absorption, but due to DNL stimulation. The contribution of oral lipids to HTG was, after 5 h, 1.60 +/- 0.23% for fructose and 2.16 +/- 0.35% for glucose diets (P=0.26), whereas that of DNL was higher in fructose than in glucose diets (2.55 +/- 0.51 vs.1.13 +/- 0.24%, P=0.01). Hepatic energy status, assessed by P-31 MRS, was similar for fructose- and glucose-fed mice. Fructose-induced HTG accumulation is better explained by DNL and not by dietary lipid uptake, while not compromising ATP homeostasis.Nunes, P. M., Wright, A. J., Veltien, A., van Asten, J. J. A., Tack, C. J., Jones, J. G., Heerschap, A. Dietary lipids do not contribute to the higher hepatic triglyceride levels of fructose- compared to glucose-fed mice.	[Nunes, Patricia M.; Wright, Alan J.; Veltien, Andor; van Asten, Jack J. A.; Heerschap, Arend] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands; [Tack, Cees J.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Jones, John G.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal	Radboud University Nijmegen; Radboud University Nijmegen; Universidade de Coimbra	Nunes, PM (corresponding author), Natl Inst Med Res, Dept Physiol & Metab, Mill Hill, London NW7 1AA, England.	pnunes@nimr.mrc.ac.uk	van Asten, Jack/C-6559-2013; Jones, John/A-8684-2010; Veltien, Andor/E-2834-2016; Tack, Cees J/A-2368-2014; Heerschap, Arend/G-5228-2010	van Asten, Jack/0000-0002-2135-5682; Jones, John/0000-0002-3745-3885; Veltien, Andor/0000-0002-8090-5445; Nunes, Patricia/0000-0003-4740-8268	project PREDICCt [01C-104]; Dutch Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Portuguese Foundation of Science and Technology project [PTDC/SAU-MET/111398/2009]	project PREDICCt; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Portuguese Foundation of Science and Technology project	This research was performed within the framework of the Netherlands Center for Translational Molecular Medicine (CTMM; http://www.ctmm.nl), project PREDICCt (grant 01C-104), and supported by the Dutch Heart Foundation, Dutch Diabetes Research Foundation, and Dutch Kidney Foundation. Additional support was obtained from the Portuguese Foundation of Science and Technology project PTDC/SAU-MET/111398/2009.	Abdelmalek MF, 2012, HEPATOLOGY, V56, P952, DOI 10.1002/hep.25741; Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Assy N, 2008, CAN J GASTROENTEROL, V22, P811, DOI 10.1155/2008/810961; Bray George A, 2010, J Diabetes Sci Technol, V4, P1003; Chemlik M., 2012, P INT SOC MAG RESON, V20, P1704; Delgado TC, 2009, NMR BIOMED, V22, P310, DOI 10.1002/nbm.1327; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; FOLCH J, 1957, J BIOL CHEM, V226, P497; Griffiths JR, 1980, BIOCHEM SOC T, V8, P641, DOI 10.1042/bst0080641; Haidari M, 2002, J BIOL CHEM, V277, P31646, DOI 10.1074/jbc.M200544200; Hellerstein MK, 1996, ANNU REV NUTR, V16, P523, DOI 10.1146/annurev.nu.16.070196.002515; HIGUCHI K, 1992, J LIPID RES, V33, P1753; Jones JG, 2001, MAGN RESON MED, V45, P156, DOI 10.1002/1522-2594(200101)45:1<156::AID-MRM1020>3.0.CO;2-Z; Jonkers R. A., 2013, DIABETOLOGIA, V56; Jonkers RAM, 2012, MAGN RESON MED, V68, P997, DOI 10.1002/mrm.23321; KasimKarakas SE, 1996, J LAB CLIN MED, V128, P208, DOI 10.1016/S0022-2143(96)90013-X; Koo HY, 2008, BBA-MOL BASIS DIS, V1782, P341, DOI 10.1016/j.bbadis.2008.02.007; Le KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336; Lewis GF, 2005, ENDOCRINOLOGY, V146, P247, DOI 10.1210/en.2004-1143; MOON RB, 1973, J BIOL CHEM, V248, P7276; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Nunes PM, 2012, AM J PHYSIOL-ENDOC M, V303, pE71, DOI 10.1152/ajpendo.00597.2011; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Pfeuffer J, 1999, MAGNET RESON MED, V41, P1077, DOI 10.1002/(SICI)1522-2594(199906)41:6<1077::AID-MRM1>3.0.CO;2-#; RIZKALLA SW, 1992, MOL CELL BIOCHEM, V109, P127, DOI 10.1007/BF00229766; Roglans N, 2007, HEPATOLOGY, V45, P778, DOI 10.1002/hep.21499; Sevastianova K, 2010, RADIOLOGY, V256, P466, DOI 10.1148/radiol.10091351; Sock ETN, 2010, BRIT J NUTR, V103, P939, DOI 10.1017/S0007114509992819; STAEWEN RS, 1990, INVEST RADIOL, V25, P559, DOI 10.1097/00004424-199005000-00015; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Swarbrick MM, 2008, BRIT J NUTR, V100, P947, DOI 10.1017/S0007114508968252; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Teff KL, 2009, J CLIN ENDOCR METAB, V94, P1562, DOI 10.1210/jc.2008-2192; THORBURN AW, 1989, AM J CLIN NUTR, V49, P1155, DOI 10.1093/ajcn/49.6.1155; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vila L, 2011, J NUTR BIOCHEM, V22, P741, DOI 10.1016/j.jnutbio.2010.06.005	37	24	24	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					1988	1997		10.1096/fj.13-241208	http://dx.doi.org/10.1096/fj.13-241208			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24500922				2022-12-25	WOS:000335336000004
J	Angin, M; Klarenbeek, PL; King, M; Sharma, SM; Moodley, ES; Rezai, A; Piechocka-Trocha, A; Toth, I; Chan, AT; Goulder, PJ; Ndung'u, T; Kwon, DS; Addo, MM				Angin, Mathieu; Klarenbeek, Paul L.; King, Melanie; Sharma, Siddhartha M.; Moodley, Eshia S.; Rezai, Ashley; Piechocka-Trocha, Alicja; Toth, Ildiko; Chan, Andrew T.; Goulder, Philip J.; Ndung'u, Thumbi; Kwon, Douglas S.; Addo, Marylyn M.			Regulatory T Cells Expanded from HIV-1-Infected Individuals Maintain Phenotype, TCR Repertoire and Suppressive Capacity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; HIV-1 INFECTION; DNA METHYLATION; DENDRITIC CELLS; MURINE MODEL; FOXP3; EXPRESSION; MECHANISMS; EXPANSION; IMMUNOTHERAPY	While modulation of regulatory T cell (Treg) function and adoptive Treg transfer are being explored as therapeutic modalities in the context of autoimmune diseases, transplantation and cancer, their role in HIV-1 pathogenesis remains less well defined. Controversy persists regarding their beneficial or detrimental effects in HIV-1 disease, which warrants further detailed exploration. Our objectives were to investigate if functional CD4(+) Tregs can be isolated and expanded from HIV-1-infected individuals for experimental or potential future therapeutic use and to determine phenotype and suppressive capacity of expanded Tregs from HIV-1 positive blood and tissue. Tregs and conventional T cell controls were isolated from blood and gut-associated lymphoid tissue of individuals with HIV-1 infection and healthy donors using flow-based cell-sorting. The phenotype of expanded Tregs was assessed by flow-cytometry and quantitative PCR. T-cell receptor beta-chain (TCR-beta) repertoire diversity was investigated by deep sequencing. Flow-based T-cell proliferation and chromium release cytotoxicity assays were used to determine Treg suppressive function. Tregs from HIV-1 positive individuals, including infants, were successfully expanded from PBMC and GALT. Expanded Tregs expressed high levels of FOXP3, CTLA4, CD39 and HELIOS and exhibited a highly demethylated TSDR (Treg-specific demethylated region), characteristic of Treg lineage. The TCR beta repertoire was maintained following Treg expansion and expanded Tregs remained highly suppressive in vitro. Our data demonstrate that Tregs can be expanded from blood and tissue compartments of HIV-1+ donors with preservation of Treg phenotype, function and TCR repertoire. These results are highly relevant for the investigation of potential future therapeutic use, as currently investigated for other disease states and hold great promise for detailed studies on the role of Tregs in HIV-1 infection.	[Angin, Mathieu; King, Melanie; Sharma, Siddhartha M.; Rezai, Ashley; Piechocka-Trocha, Alicja; Toth, Ildiko; Ndung'u, Thumbi; Kwon, Douglas S.; Addo, Marylyn M.] Ragon Inst MGH MIT & Harvard, Boston, MA USA; [Klarenbeek, Paul L.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Moodley, Eshia S.; Goulder, Philip J.; Ndung'u, Thumbi] Univ KwaZulu Natal, HIV Pathogenesis Programme, Doris Duke Med Res Inst, Durban, South Africa; [Moodley, Eshia S.; Goulder, Philip J.; Ndung'u, Thumbi] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Chan, Andrew T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Goulder, Philip J.] Univ Oxford, Dept Paediat, Oxford, England; [Kwon, Douglas S.; Addo, Marylyn M.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Addo, Marylyn M.] Univ Med Ctr Hamburg Eppendorf, Dept Med, Hamburg, Germany	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Kwazulu Natal; University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; University of Oxford; Harvard University; Massachusetts General Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Addo, MM (corresponding author), Ragon Inst MGH MIT & Harvard, Boston, MA USA.	maddo@partners.org	Addo, Marylyn M./GNP-2548-2022; Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767; Angin, Mathieu/0000-0002-6867-4680; Addo, Marylyn/0000-0003-2836-9224; Ndung'u, Thumbi/0000-0003-2962-3992	Elisabeth Glaser Pediatric AIDS Foundation (Pediatric HIV Vaccine Program Award) [MV-00-9-900-1429-0-00]; MGH/ECOR (Physician Scientist Development Award); NIH NIAID [KO8 AI074405, AI074405-03S1]; Milton Fund; Bill & Melinda Gates Foundation; Terry and Susan Ragon Foundation; Harvard University Center for AIDS Research (CFAR); NIH [5P30AI060354-09]; NIH; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; NCCAM; FIC; OAR; International Early Career Scientist award from the Howard Hughes Medical Institute; South African Department of Science and Technology/National Research Foundation Research Chairs Initiative; MGH Center for the Study Inflammatory Bowel Disease [P30DK043351]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, K08AI074405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Elisabeth Glaser Pediatric AIDS Foundation (Pediatric HIV Vaccine Program Award); MGH/ECOR (Physician Scientist Development Award); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Milton Fund; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Terry and Susan Ragon Foundation; Harvard University Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); FIC; OAR; International Early Career Scientist award from the Howard Hughes Medical Institute; South African Department of Science and Technology/National Research Foundation Research Chairs Initiative; MGH Center for the Study Inflammatory Bowel Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by research funding from the Elisabeth Glaser Pediatric AIDS Foundation (Pediatric HIV Vaccine Program Award MV-00-9-900-1429-0-00 to MMA), MGH/ECOR (Physician Scientist Development Award to MMA), NIH NIAID (KO8 AI074405 and AI074405-03S1 to MMA) and the Milton Fund (MMA). The studies were furthermore supported by the Bill & Melinda Gates Foundation and the Terry and Susan Ragon Foundation. This publication resulted in part from research supported by the Harvard University Center for AIDS Research (CFAR) (including a CFAR scholar award to MA), an NIH funded program (5P30AI060354-09), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, NCCAM, FIC, and OAR. The research of TN and EM was supported in part by an International Early Career Scientist award from the Howard Hughes Medical Institute and by the South African Department of Science and Technology/National Research Foundation Research Chairs Initiative. ATC was supported by funding from MGH Center for the Study Inflammatory Bowel Disease (P30DK043351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Addo MM, 2001, P NATL ACAD SCI USA, V98, P1781, DOI 10.1073/pnas.98.4.1781; Akdis CA, 2001, IMMUNOLOGY, V103, P131, DOI 10.1046/j.1365-2567.2001.01235.x; Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; Angin M, 2012, AIDS, V26, P2112, DOI 10.1097/QAD.0b013e328358cc75; Angin M, 2012, J INFECT DIS, V205, P1495, DOI 10.1093/infdis/jis236; Aricha R, 2008, J IMMUNOL, V180, P2132, DOI 10.4049/jimmunol.180.4.2132; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Barron L, 2010, J IMMUNOL, V185, P6426, DOI 10.4049/jimmunol.0903940; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Chevalier MF, 2013, BLOOD, V121, P29, DOI 10.1182/blood-2012-07-409755; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Garibal J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-220; Guo XM, 2012, HUM IMMUNOL, V73, P1061, DOI 10.1016/j.humimm.2012.08.014; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Imamichi H, 2012, J INFECT DIS, V205, P1479, DOI 10.1093/infdis/jis238; Jenabian MA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/908314; Kared H, 2008, AIDS, V22, P2451, DOI 10.1097/QAD.0b013e328319edc0; Kim YC, 2012, BLOOD, V119, P2810, DOI 10.1182/blood-2011-09-377895; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Klarenbeek PL, 2012, ANN RHEUM DIS, V71, P1088, DOI 10.1136/annrheumdis-2011-200612; Klarenbeek PL, 2010, IMMUNOL LETT, V133, P42, DOI 10.1016/j.imlet.2010.06.011; Lapierre P, 2013, HEPATOLOGY, V57, P217, DOI 10.1002/hep.26023; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Liu JU, 2009, J IMMUNOL, V182, P3855, DOI 10.4049/jimmunol.0803330; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lundsgaard D, 2005, DIABETES, V54, P1040, DOI 10.2337/diabetes.54.4.1040; Ma AL, 2011, INT IMMUNOPHARMACOL, V11, P618, DOI 10.1016/j.intimp.2010.11.001; Macatangay Bernard J. C., 2010, HIV Therapy, V4, P639, DOI [10.2217/hiv.10.51, 10.2217/HIV.10.51]; McMurchy AN, 2013, BLOOD, V121, P1265, DOI 10.1182/blood-2012-05-431023; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mizrahi M, 2009, CURR PHARM DESIGN, V15, P1191, DOI 10.2174/138161209787846784; Moreno-Fernandez ME, 2011, BLOOD, V117, P5372, DOI 10.1182/blood-2010-12-323162; Moreno-Fernandez ME, 2012, J VIROL; O'Brien M, 2013, ADV EXP MED BIOL, V762, P71, DOI 10.1007/978-1-4614-4433-6_3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pion M, 2013, AIDS, V27, P2019, DOI 10.1097/QAD.0b013e32836253fd; Presicce P, 2012, AIDS, V26, P263, DOI 10.1097/QAD.0b013e32834ed8df; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rozen S, 2000, Methods Mol Biol, V132, P365; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shacklett BL, 2003, J IMMUNOL METHODS, V279, P17, DOI 10.1016/S0022-1759(03)00255-2; Shaw JM, 2011, J VIROL, V85, P11422, DOI 10.1128/JVI.05608-11; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tran TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003305; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Weiss L, 2010, P NATL ACAD SCI USA, V107, P10632, DOI 10.1073/pnas.1000027107; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Xia GL, 2006, TRANSPLANTATION, V82, P1749, DOI 10.1097/01.tp.0000250731.44913.ee; zur Wiesch JS, 2011, J VIROL, V85, P1287, DOI 10.1128/JVI.01758-10	65	5	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86920	10.1371/journal.pone.0086920	http://dx.doi.org/10.1371/journal.pone.0086920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498287	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900033
J	Robbins, WD; Peddemors, VM; Kennelly, SJ; Ives, MC				Robbins, William D.; Peddemors, Victor M.; Kennelly, Steven J.; Ives, Matthew C.			Experimental Evaluation of Shark Detection Rates by Aerial Observers	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; SIGHTABILITY MODEL; BASKING SHARKS; SOUTH-AFRICA; HABITAT USE; ABUNDANCE; PATTERNS; DUGONGS; WATERS; BIAS	Aerial surveys are a recognised technique to identify the presence and abundance of marine animals. However, the capability of aerial observers to reliably sight coastal sharks has not been previously assessed, nor have differences in sighting rates between aircraft types been examined. In this study we investigated the ability of observers in fixed-wing and helicopter aircraft to sight 2.5 m artificial shark analogues placed at known depths and positions. Initial tests revealed that the shark analogues could only be detected at shallow depths, averaging only 2.5 m and 2.7 m below the water surface for observers in fixed-wing and helicopter aircraft, respectively. We then deployed analogues at shallower depths along a 5 km-long grid, and assessed their sightability to aircraft observers through a series of transects flown within 500 m. Analogues were seen infrequently from all distances, with overall sighting rates of only 12.5% and 17.1% for fixed-wing and helicopter observers, respectively. Although helicopter observers had consistently higher success rates of sighting analogues within 250 m of their flight path, neither aircraft observers sighted more than 9% of analogues deployed over 300 m from their flight paths. Modelling of sighting rates against environmental and experimental variables indicated that observations were affected by distance, aircraft type, sun glare and sea conditions, while the range of water turbidities observed had no effect. We conclude that aerial observers have limited ability to detect the presence of submerged animals such as sharks, particularly when the sharks are deeper than similar to 2.6 m, or over 300 m distant from the aircraft's flight path, especially during sunny or windy days. The low rates of detections found in this study cast serious doubts on the use of aerial beach patrols as an effective early-warning system to prevent shark attacks.	[Robbins, William D.; Peddemors, Victor M.; Kennelly, Steven J.; Ives, Matthew C.] New South Wales Dept Primary Ind, Cronulla Fisheries Res Ctr Excellence, Cronulla, NSW, Australia; [Robbins, William D.] Wildlife Marine, Perth, WA, Australia	NSW Department of Primary Industries	Robbins, WD (corresponding author), New South Wales Dept Primary Ind, Cronulla Fisheries Res Ctr Excellence, Cronulla, NSW, Australia.	will.robbins@wildlifemarine.com.au	Ives, Matthew/H-7647-2019; Peddemors, Victor M/Q-4281-2016	Robbins, William/0000-0003-1106-1733; Peddemors, Victor/0000-0002-8743-9782; Ives, Matthew/0000-0002-3536-2787	New South Wales Department of Primary Industries Shark Meshing (Bather Protection) Program	New South Wales Department of Primary Industries Shark Meshing (Bather Protection) Program	This project was funded through New South Wales Department of Primary Industries Shark Meshing (Bather Protection) Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 1996, WILDLIFE SOC B, V24, P247; [Anonymous], 2010, PREVENTING COASTAL D; [Anonymous], 2006, P SCI SHARK PROT SUM; Ayers LW, 1999, J WILDLIFE MANAGE, V63, P85, DOI 10.2307/3802489; BARLOW J, 1988, FISH B-NOAA, V86, P433; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bruce BD, 1992, MARINE FRESHWATER RE, V43, P1; Burks CM, 2005, FISH B, V104, P579; Cairns SC, 2008, WILDLIFE RES, V35, P331, DOI 10.1071/WR07079; Cardona L, 2005, MAR BIOL, V147, P583, DOI 10.1007/s00227-005-1578-9; Chapman DD, 2007, MAR ECOL PROG SER, V344, P271, DOI 10.3354/meps06941; Clark CW, 2010, MAR MAMMAL SCI, V26, P837, DOI 10.1111/j.1748-7692.2010.00376.x; Cliff G, 2007, FISH RES, V84, P41, DOI 10.1016/j.fishres.2006.11.012; COCKCROFT VG, 1992, S AFR J WILDL RES, V22, P102; Cunningham L, 2010, J MAR BIOL ASSOC UK, V90, P1659, DOI 10.1017/S002531540999155X; Dawson MJ, 2008, WILDLIFE RES, V35, P365, DOI 10.1071/WR07075; Freddy DJ, 2004, WILDLIFE SOC B, V32, P916, DOI 10.2193/0091-7648(2004)032[0916:HMMDAT]2.0.CO;2; Gales N, 2004, WILDLIFE RES, V31, P283, DOI 10.1071/WR02073; Gilbert BA, 2008, NORTHWEST SCI, V82, P222, DOI 10.3955/0029-344X-82.3.222; GRAHAM A, 1989, J WILDLIFE MANAGE, V53, P1009, DOI 10.2307/3809603; Green M, 2009, REPORT NSW SHARK MES; Harvey-Clark CJ, 1999, COPEIA, P780, DOI 10.2307/1447614; Hodgson AJ, 2004, THESIS J COOK U TOWN; Hodgson AJ, 2007, J EXP MAR BIOL ECOL, V340, P50, DOI 10.1016/j.jembe.2006.08.006; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; HONE J, 1988, AUST WILDLIFE RES, V15, P647; Johnson R, 2000, ENVIRON BIOL FISH, V85, P189; KENNEY RD, 1985, COPEIA, P220, DOI 10.2307/1444813; Kock AA, 2012, GLOBAL PERSPECTIVES, P447; Krueger B, 2007, S AFR J WILDL RES, V37, P133, DOI 10.3957/0379-4369-37.2.133; Lowry MS, 2005, FISH B-NOAA, V103, P331; MARSH H, 1989, AUST WILDLIFE RES, V16, P639; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; McIntosh TE, 2009, J WILDLIFE MANAGE, V73, P580, DOI 10.2193/2007-550; Motta PJ, 2010, ZOOLOGY, V113, P199, DOI 10.1016/j.zool.2009.12.001; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; Nakano H, 2003, MAR ECOL PROG SER, V265, P255, DOI 10.3354/meps265255; O'Donoghue SH, 2010, AFR J MAR SCI, V32, P279, DOI 10.2989/1814232X.2010.501584; Parker G, 2011, AFR J ECOL, V49, P56, DOI 10.1111/j.1365-2028.2010.01232.x; Parrish FA, 1997, B MAR SCI, V61, P763; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; R Development Core Team, 2012, R LANG ENV STAT COMP; Rice CG, 2009, J WILDLIFE MANAGE, V73, P468, DOI 10.2193/2008-196; ROSS GJB, 1989, S AFR J MARINE SCI, V8, P119, DOI 10.2989/02577618909504555; Rowat D, 2009, J EXP MAR BIOL ECOL, V368, P1, DOI 10.1016/j.jembe.2008.09.001; Vrtiska MP, 2011, WATERBIRDS, V34, P96, DOI 10.1675/063.034.0112; West JG, 2011, MAR FRESHWATER RES, V62, P744, DOI 10.1071/MF10181; Wilson SG, 2004, FISH OCEANOGR, V13, P283, DOI 10.1111/j.1365-2419.2004.00292.x; Zuur AF, 2009, STAT BIOL HLTH, P269	49	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e83456	10.1371/journal.pone.0083456	http://dx.doi.org/10.1371/journal.pone.0083456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498258	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900004
J	Annweiler, C; Beauchet, O; Bartha, R; Hachinski, V; Montero-Odasso, M				Annweiler, Cedric; Beauchet, Olivier; Bartha, Robert; Hachinski, Vladimir; Montero-Odasso, Manuel		WALK Team Working Grp	Vitamin D and Caudal Primary Motor Cortex: A Magnetic Resonance Spectroscopy Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; OLDER-ADULTS; D DEFICIENCY; GAIT; PREVENTION	Background: Vitamin D is involved in brain physiology and lower-extremity function. We investigated spectroscopy in a cohort of older adults to explore the hypothesis that lower vitamin D status was associated with impaired neuronal function in caudal primary motor cortex (cPMC) measured by proton magnetic resonance spectroscopic imaging. Methods: Twenty Caucasian community-dwellers (mean +/- standard deviation, 74.6 +/- 6.2 years; 35.0% female) from the 'Gait and Brain Study' were included in this analysis. Ratio of N-acetyl-aspartate to creatine (NAA/Cr), a marker of neuronal function, was calculated in cPMC. Participants were categorized according to mean NAA/Cr. Lower vitamin D status was defined as serum 25-hydroxyvitamin D (25OHD) concentration <75 nmol/L. Age, gender, number of comorbidities, vascular risk, cognition, gait performance, vitamin D supplements, undernourishment, cPMC thickness, white matter hyperintensities grade, serum parathyroid hormone concentration, and season of evaluation were used as potential confounders. Results: Compared to participants with high NAA/Cr (n = 11), those with low NAA/Cr (i.e., reduced neuronal function) had lower serum 25OHD concentration (P = 0.044) and more frequently lower vitamin D status (P = 0.038). Lower vitamin D status was cross-sectionally associated with a decrease in NAA/Cr after adjustment for clinical characteristics (beta = -0.41, P = 0.047), neuroimaging measures (beta = -0.47, P = 0.032) and serum measures (beta = -0.45, P = 0.046). Conclusions: Lower vitamin D status was associated with reduced neuronal function in cPMC. These novel findings need to be replicated in larger and preferably longitudinal cohorts. They contribute to explain the pathophysiology of gait disorders in older adults with lower vitamin D status, and provide a scientific base for vitamin D replacement trials.	[Annweiler, Cedric; Montero-Odasso, Manuel] Univ Western Ontario, Parkwood Hosp, Lawson Hlth Res Inst, Gait & Brain Lab, London, ON, Canada; [Annweiler, Cedric; Beauchet, Olivier] Univ Angers, UPRES EA 4638, Mem Clin, Div Geriatr Med,Univ Hosp, Angers, France; [Annweiler, Cedric; Bartha, Robert] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Hachinski, Vladimir] Univ Western Ontario, Univ Hosp, Dept Clin Neurol Sci, London, ON, Canada	Western University (University of Western Ontario); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Western University (University of Western Ontario); Western University (University of Western Ontario)	Annweiler, C (corresponding author), Univ Western Ontario, Parkwood Hosp, Lawson Hlth Res Inst, Gait & Brain Lab, London, ON, Canada.	Cedric.Annweiler@sjhc.london.on.ca	Beauchet, Olivier/AAP-8108-2020; Montero-Odasso, Manuel/G-3335-2011; Bartha, Robert/K-3611-2013	Montero-Odasso, Manuel/0000-0002-5796-2361; Bartha, Robert/0000-0002-7118-9096; Annweiler, Cedric/0000-0002-7199-8109	Canadian Institute of Health and Research (CIHR) [211220]; Canadian Institutes for Health and Research - Institute of Aging (CIHR-IA); Servier Institute in France; CIHR-IA; Drummond Foundation; Physician Services Incorporated Foundation of Canada (PSI); Ontario Ministry of Research and Innovation; Western University Department of Medicine Program of Experimental Medicine (POEM) Research Award; Schulich Clinician-Scientist Award; CIHR	Canadian Institute of Health and Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health and Research - Institute of Aging (CIHR-IA)(Canadian Institutes of Health Research (CIHR)); Servier Institute in France; CIHR-IA(Canadian Institutes of Health Research (CIHR)); Drummond Foundation; Physician Services Incorporated Foundation of Canada (PSI); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Western University Department of Medicine Program of Experimental Medicine (POEM) Research Award; Schulich Clinician-Scientist Award; CIHR(Canadian Institutes of Health Research (CIHR))	This project was supported by the Canadian Institute of Health and Research (CIHR) (Principal investigator: Manuel Montero-Odasso; grant number 211220). Dr. Annweiler is supported by a grant from the Canadian Institutes for Health and Research - Institute of Aging (CIHR-IA), and holds a research grant from Servier Institute in France. Dr Montero-Odasso is supported by grants from CIHR-IA; Drummond Foundation; Physician Services Incorporated Foundation of Canada (PSI); Ontario Ministry of Research and Innovation; and by Western University Department of Medicine Program of Experimental Medicine (POEM) Research Award. He is the first recipient of Schulich Clinician-Scientist Award and of CIHR New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annweiler C, 2013, BRAIN, V136, P859, DOI 10.1093/brain/aws373; Annweiler C, 2013, MOL NUTR FOOD RES, V57, P267, DOI 10.1002/mnfr.201200418; Annweiler Cedric, 2012, Open Neuroimag J, V6, P16, DOI 10.2174/1874440001206010016; Annweiler C, 2011, GERIATR PSYCHOL NEUR, V9, P259, DOI 10.1684/pnv.2011.0288; Annweiler C, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-50; Annweiler C, 2010, NEUROPSYCHOBIOLOGY, V62, P139, DOI 10.1159/000318570; [Anonymous], MAN STRAT PROT EN MA; Bartha R, 1999, NMR BIOMED, V12, P205, DOI 10.1002/(SICI)1099-1492(199906)12:4<205::AID-NBM558>3.0.CO;2-1; Beauchet O, 2011, NEUROLOGY, V76, P1617, DOI 10.1212/WNL.0b013e318219fb08; BONNARD M, 2008, BRAIN STIMUL, V1, P274; Burne THJ, 2006, BRAIN RES BULL, V69, P74, DOI 10.1016/j.brainresbull.2005.10.014; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Kalueff AV, 2007, CURR OPIN CLIN NUTR, V10, P12, DOI 10.1097/MCO.0b013e328010ca18; MANOLIO TA, 1994, STROKE, V25, P318, DOI 10.1161/01.STR.25.2.318; Meier JD, 2008, J NEUROPHYSIOL, V100, P1800, DOI 10.1152/jn.90531.2008; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Montero-Odasso M, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-35; Muir SW, 2011, J AM GERIATR SOC, V59, P2291, DOI 10.1111/j.1532-5415.2011.03733.x; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Villeneuve S, 2009, DEMENT GERIATR COGN, V27, P375, DOI 10.1159/000209965; Wozniak JR, 2006, NEUROSCI BIOBEHAV R, V30, P762, DOI 10.1016/j.neubiorev.2006.06.003	23	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87314	10.1371/journal.pone.0087314	http://dx.doi.org/10.1371/journal.pone.0087314			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498072	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900088
J	Dufour, E; Goepfert, N; Leon, BG; Chauchat, C; Jordan, RF; Sanchez, SV				Dufour, Elise; Goepfert, Nicolas; Leon, Belkys Gutierrez; Chauchat, Claude; Jordan, Regulo Franco; Sanchez, Segundo Vasquez			Pastoralism in Northern Peru during Pre-Hispanic Times: Insights from the Mochica Period (100-800 AD) Based on Stable Isotopic Analysis of Domestic Camelids	PLOS ONE			English	Article							HUMAN TOOTH ENAMEL; BONE-COLLAGEN; OXYGEN ISOTOPES; GEOGRAPHIC ORIGINS; NITROGEN ISOTOPES; MAIZE AGRICULTURE; DELTA-N-15 VALUES; CARBON ISOTOPES; DIET; APATITE	Llama (Lama glama) and alpaca (Vicugna pacos) are the only large domesticated animals indigenous to the Americas. Pastoralism occupies a fundamental economic, social and religious role in Andean life. Today, camelid livestock are confined to the ecozone of the puna (above 3,500 masl), while their presence on the Pacific coast during pre-Hispanic times is attested by archaeological skeletal remains. This study aims to document herding practices on the northern Peruvian coast during the Early Intermediate Period (200 BC-600 AD) by gaining insights into diet, location of breeding and mobility of archaeological camelids from the funerary and ritual contexts of two Mochica sites, Uhle Platform in Huacas de Moche and El Brujo. The three first early years and the long-term life histories of the animals were documented by the combined bulk analysis of bone collagen (delta C-13(col) and delta N-15(col)) and bone structural carbonate (delta C-13(bone) and delta O-18(bone)) and the serial analysis of structural carbonate of molar tooth enamel (delta C-13(enamel) and delta O-18(enamel)). Mochica camelids were bred in the low and/or middle valleys, unlike their modern counterparts, who are restricted to highland puna C-3 pastures. Archaeological camelids had diverse and complex life histories, usually with substantial maize foddering. An ontogenetic switch in diet and possible residential mobility during the course of life were identified for some specimens. Although the inference of geographic origin from delta O-18(bone) and delta O-18(enamel) values was limited because of the lack of understanding of the influence of environmental and biological factors, tooth enamel analysis has great potential for exploring camelid herding practices and Andean pastoralism. Our study suggested that Mochica herders adapted their practices to the difficult lowland environment and that herding practices were varied and not restricted to breeding at higher altitudes. The role of maize in different aspects of the economic life of the Mochicas is also underlined.	[Dufour, Elise] Museum Natl Hist Nat, CNRS, UMR Archeozool Archeobot Soc Prat & Environm 7209, Dept Ecol & Gest Biodivers, Paris, France; [Goepfert, Nicolas; Chauchat, Claude] CNRS Paris 1, UMR Archeol Amer 8096, Nanterre, France; [Leon, Belkys Gutierrez; Sanchez, Segundo Vasquez] Univ Nacl Trujillo, Trujillo, Peru; [Jordan, Regulo Franco] Museo Cao Fdn Wiese, Lima, Peru	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Universidad Nacional de Trujillo	Dufour, E (corresponding author), Museum Natl Hist Nat, CNRS, UMR Archeozool Archeobot Soc Prat & Environm 7209, Dept Ecol & Gest Biodivers, Paris, France.	edufour@mnhn.fr			Action Thematique du Museum BIOMINERALIZATION; Action Thematique du Museum Biodiversite actuelle et fossile (MNHN); Universidad Nacional de Trujillo (UNT)	Action Thematique du Museum BIOMINERALIZATION; Action Thematique du Museum Biodiversite actuelle et fossile (MNHN); Universidad Nacional de Trujillo (UNT)	This research was supported by the Action Thematique du Museum BIOMINERALIZATION and the Action Thematique du Museum Biodiversite actuelle et fossile (MNHN) and the Universidad Nacional de Trujillo (UNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose S.H., 1993, PREHISTORIC HUMAN BO, P1, DOI 10.1007/978-3-662-02894-0_1; AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; AMBROSE SH, 1987, NATURE, V325, P201, DOI 10.1038/325201a0; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Amiot R, 2004, EARTH PLANET SC LETT, V226, P255, DOI 10.1016/j.epsl.2004.07.015; [Anonymous], 1979, GEOGRAFIA PERU OCHO; Balasse M, 2005, J ZOOL, V266, P283, DOI 10.1017/S0952836905006916; Balasse M, 2002, J ARCHAEOL SCI, V29, P917, DOI 10.1006/jasc.2001.0787; Balasse M, 2002, INT J OSTEOARCHAEOL, V12, P155, DOI 10.1002/oa.601; Billman BR, 2002, LAT AM ANTIQ, V13, P371, DOI 10.2307/972222; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; BOCHERENS H, 1991, J HUM EVOL, V20, P481, DOI 10.1016/0047-2484(91)90021-M; Bonavia D., 2008, MAIZ ORIGEN DOMESTIC; Bonavia D., 1996, CAMELIDOS SUDAMERICA; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; BROWMAN DL, 1974, CURR ANTHROPOL, V15, P188, DOI 10.1086/201455; BURGER RL, 1990, AM ANTHROPOL, V92, P85, DOI 10.1525/aa.1990.92.1.02a00060; Buzon MR, 2011, INT J OSTEOARCHAEOL, V21, P446, DOI 10.1002/oa.1151; Castillo L.J., 2010, NEW PERSPECTIVES MOC, P1; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Chauchat C, 2008, INVESTIGACIONES HUAC, P63; Chauchat C., 2009, REV MUSEO ARQUEOLOGI, V11, P85; Chauchat C, 2006, INVESTIGACIONES HUAC, P103; CHAUCHAT C., 2008, NOUVELLES ARCHEOLOGI, V111-112, P116; Clementz MT, 2009, GEOL J, V44, P605, DOI 10.1002/gj.1173; Collin Delavaud C, 1968, REGIONS COTIERES PER; DANSGAARD W, 1964, TELLUS, V16, P436; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; DeNiro MJ, 1988, BRIT ARCHAEOLOGICAL, V427, P119; Dobberstein RC, 2009, ARCHAEOL ANTHROP SCI, V1, P31, DOI 10.1007/s12520-009-0002-7; Dollfus O, 1978, ANN ESC EC SOC CIVIL, V5-6, P895; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; EVANS RD, 1994, J ARID ENVIRON, V28, P189, DOI 10.1016/S0140-1963(05)80056-4; Falabella F, 2008, LAT AM ANTIQ, V19, P25, DOI 10.2307/25478207; Fernandes R, 2012, ARCHAEOL ANTHROP SCI, V4, P291, DOI 10.1007/s12520-012-0102-7; Finucane B, 2006, J ARCHAEOL SCI, V33, P1766, DOI 10.1016/j.jas.2006.03.012; Finucane BC, 2009, CURR ANTHROPOL, V50, P534, DOI 10.1086/599860; Flores Ochoa J.A., 1994, ORO ANDES LLAMAS ALP; Franco R, 2005, BRUJO PASADO MILENAR; Franco R, 2001, DESENTIERRO REENTERR; Franco R, 2003, MOCHE HACIA FINAL MI, V2, P125; Franco R, 1999, TUMBAS CAMARA MOCHE; Franco R, 1994, MOCHE PROPUESTAS PER, P147; Franklin W. L., 1982, MAMMALIAN BIOL S AM, P457; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P45, DOI 10.1002/ajpa.20244; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Goepfert N., 2011, BRIT ARCHAEOLOGICAL, V2278; Goepfert N, 2012, J FIELD ARCHAEOL, V37, P104, DOI 10.1179/0093469012Z.00000000010; Goepfert Nicolas, 2013, B LINSTITUT FRANCAIS, V42, P25, DOI DOI 10.4000/BIFEA.869; Gumerman G, 1991, SUBSISTENCE COMPLEX; Gumerman G, 1997, PACATNAMU PAPERS, V2, P243; Gumerman G. IV, 1994, Corn and culture in the prehistoric New World., P399; Haas J, 2013, P NATL ACAD SCI USA, V110, P4945, DOI 10.1073/pnas.1219425110; HASTORF CA, 1990, AM ANTIQUITY, V55, P262, DOI 10.2307/281647; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Henton E, 2010, ARCHAEOMETRY, V52, P429, DOI 10.1111/j.1475-4754.2009.00492.x; Hillson, 1986, TEETH; IAEA/WMO, 2020, GLOB NETW IS PREC GN; Izeta AD, 2009, INT J OSTEOARCHAEOL, V19, P204, DOI 10.1002/oa.1066; Jim S, 2004, GEOCHIM COSMOCHIM AC, V68, P61, DOI 10.1016/S0016-7037(03)00216-3; Johannessen S., 1994, CORN CULTURE PREHIST; Katzenberg MA, 1999, INT J OSTEOARCHAEOL, V9, P316, DOI 10.1002/(SICI)1099-1212(199909/10)9:5<316::AID-OA500>3.0.CO;2-D; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Kent JD, 1982, DOMESTICATION EXPLOI; Knudson KJ, 2009, INT J OSTEOARCHAEOL, V19, P171, DOI 10.1002/oa.1042; Knudson KJ, 2012, J ARCHAEOL SCI, V39, P479, DOI 10.1016/j.jas.2011.10.003; Knudson KJ, 2009, J ANTHROPOL ARCHAEOL, V28, P244, DOI 10.1016/j.jaa.2008.10.006; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Lambert PM, 2012, LAT AM ANTIQ, V23, P144, DOI 10.7183/1045-6635.23.2.144; Larco Hoyle R, 1948, CRONOLOGIA ARQUEOLOG; Lecoq Patrice, 1987, B LINSTITUT FRANCAIS, V16, P1; Lecuyer C, 2010, GEOCHIM COSMOCHIM AC, V74, P2072, DOI 10.1016/j.gca.2009.12.024; LEETHORP JA, 1989, J ARCHAEOL SCI, V16, P585, DOI 10.1016/0305-4403(89)90024-1; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; Lozada M.C., 2009, ANDEAN CIVILIZATION, P351; LUZ B, 1985, EARTH PLANET SC LETT, V75, P29, DOI 10.1016/0012-821X(85)90047-0; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; MARINO BD, 1991, NATURE, V349, P127, DOI 10.1038/349127a0; McCorkle C. M., 1987, Arid land use strategies and risk management in the Andes. A regional anthropological perspective, P57; Mekota AM, 2006, RAPID COMMUN MASS SP, V20, P1604, DOI 10.1002/rcm.2477; Mengoni Gonalons Guillermo Luis, 2007, Anthropozoologica, V42, P129; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Murra John, 1975, FORMACIONES EC Y POL, P59; Nunez Lautaro, 1978, MOVILIDAD GIRATORIA; O'Connell TC, 2001, J ARCHAEOL SCI, V28, P1247, DOI 10.1006/jasc.2001.0698; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; Penaherrera Del Aguila C, 1986, GRAN GEOGRAFIA PERU, VI; Pillsbury J, 2001, MOCHE ART ARCHAEOLOG; POZORSKI S, 1979, Annals of Carnegie Museum, V48, P139; Pozorski S., 1979, J FIELD ARCHAEOL, V6, P413; Pozorski SG, 1976, PREHISTORIC SUBSISTE; Quilter J., 2010, NEW PERSPECTIVES MOC; RANSON SL, 1960, ANNU REV PLANT PHYS, V11, P81, DOI 10.1146/annurev.pp.11.060160.000501; ROBERTS SB, 1988, AM J PHYSIOL, V254, pR622, DOI 10.1152/ajpregu.1988.254.4.R622; SCHOENINGER MJ, 1983, SCIENCE, V220, P1381, DOI 10.1126/science.6344217; SCHOENINGER MJ, 1982, NATURE, V297, P577, DOI 10.1038/297577a0; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Sharp Z., 2007, PRINCIPLES STABLE IS; SHIMADA M, 1985, AM ANTIQUITY, V50, P3, DOI 10.2307/280631; Shimada M, 1981, REV MUSEO NACL, V45, P19; Shin JY, 2012, J ARCHAEOL SCI, V39, P1123, DOI 10.1016/j.jas.2011.12.016; Skrzypek G, 2011, EARTH PLANET SC LETT, V307, P298, DOI 10.1016/j.epsl.2011.05.002; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Szpak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053763; Szpak P, 2012, J ARCHAEOL SCI, V39, P3721, DOI 10.1016/j.jas.2012.06.035; Thornton EK, 2011, INT J OSTEOARCHAEOL, V21, P544, DOI 10.1002/oa.1157; Tieszen Larry, 1992, P 1 WORLD C MUMMY ST, P409; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; TOPIC TL, 1987, AM ANTIQUITY, V52, P832, DOI 10.2307/281392; Trueman CN, 2005, RAPID COMMUN MASS SP, V19, P3239, DOI 10.1002/rcm.2199; Turner BL, 2009, J ARCHAEOL SCI, V36, P317, DOI 10.1016/j.jas.2008.09.018; Tykot RH, 2002, CURR ANTHROPOL, V43, P666, DOI 10.1086/342433; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; VanBuren M, 1996, AM ANTHROPOL, V98, P338; Vasquez Sanchez VF, 2001, USO CAMELIDOS TRAVES, P241; VERANO JW, 1993, INVESTIGATIONS ANCIE, P361; WANG Y, 1994, PALAEOGEOGR PALAEOCL, V107, P281, DOI 10.1016/0031-0182(94)90100-7; Warinner C, 2009, J ARCHAEOL SCI, V36, P1690, DOI 10.1016/j.jas.2009.03.034; Webb EC, 2013, INT J OSTEOARCHAEOL, V23, P698, DOI 10.1002/oa.1298; WEINREB MM, 1964, AM J VET RES, V25, P891; Wheeler J. C., 1991, AVANCES PERSPECTIVAS, P11; Wheeler Jane, 1982, LLAMA WORLD, P12; White CD, 2009, J ARCHAEOL SCI, V36, P1527, DOI 10.1016/j.jas.2009.03.008; White CD, 2002, LAT AM ANTIQ, V13, P217, DOI 10.2307/971915; White CD, 1998, J ARCHAEOL SCI, V25, P643, DOI 10.1006/jasc.1997.0259; White CD, 2000, J ANTHROPOL RES, V56, P535, DOI 10.1086/jar.56.4.3630930; Williams AR, 2006, NATL GEOGR, V19, P2; Wright LE, 1999, J ARCHAEOL SCI, V26, P1159, DOI 10.1006/jasc.1998.0351; Wright LE, 1998, AM J PHYS ANTHROPOL, V106, P1; Yacobaccio HD, 2009, INT J OSTEOARCHAEOL, V19, P144, DOI 10.1002/oa.1050; Yesner DR, 2003, J ANTHROPOL ARCHAEOL, V22, P279, DOI 10.1016/S0278-4165(03)00040-0; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P1, DOI 10.1016/S0016-7037(03)00278-3; Zazzo A, 2010, GEOCHIM COSMOCHIM AC, V74, P3571, DOI 10.1016/j.gca.2010.03.017	138	41	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87559	10.1371/journal.pone.0087559	http://dx.doi.org/10.1371/journal.pone.0087559			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	302RF	24498136	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900133
J	Li, XH; Qu, JQ; Yi, H; Zhang, PF; Yi, HM; Wan, XX; He, QY; Ye, X; Yuan, L; Zhu, JF; Li, JY; Xiao, ZQ				Li, Xin-Hui; Qu, Jia-Quan; Yi, Hong; Zhang, Peng-Fei; Yi, Hong-Mei; Wan, Xun-Xun; He, Qiu-Yan; Ye, Xu; Yuan, Li; Zhu, Jing-Feng; Li, Jiao-Yang; Xiao, Zhi-Qiang			Integrated Analysis of Differential miRNA and mRNA Expression Profiles in Human Radioresistant and Radiosensitive Nasopharyngeal Carcinoma Cells	PLOS ONE			English	Article							IONIZING-RADIATION; DOWN-REGULATION; UP-REGULATION; DRUG-RESISTANCE; TUMOR-CELLS; APOPTOSIS; MICRORNA; PATHWAYS; IDENTIFICATION; RADIOTHERAPY	Background: The purpose of this study was to identify miRNAs and genes involved in nasopharyngeal carcinoma (NPC) radioresistance, and explore the underlying mechanisms in the development of radioresistance. Methods: We used microarrays to compare the differences of both miRNA and mRNA expression profiles in the radioresistant NPC CNE2-IR and radiosensitive NPC CNE2 cells, applied qRT-PCR to confirm the reliability of microarray data, adopted databases prediction and anticorrelated analysis of miRNA and mRNA expression to identify the miRNA target genes, and employed bioinformatics tools to examine the functions and pathways in which miRNA target genes are involved, and construct a miRNA-target gene regulatory network. We further investigated the roles of miRNA-23a and its target gene IL-8 in the NPC radioresistance. Results: The main findings were fourfold: (1) fifteen differential miRNAs and 372 differential mRNAs were identified, and the reliability of microarray data was validated for randomly selected eight miRNAs and nine genes; (2) 174 miRNA target were identified, and most of their functions and regulating pathways were related to tumor therapeutic resistance; (3) a posttranscriptional regulatory network including 375 miRNA-target gene pairs was constructed, in which the ten genes were coregulated by the six miRNAs; (4) IL-8 was a direct target of miRNA-23a, the expression levels of IL-8 were elevated in the radioresistant NPC tissues and showed inverse correlation with miRNA-23a expression, and genetic upregulation of miRNA-23a and antibody neutralization of secretory IL-8 could reduce NPC cells radioresistance. Conclusions: We identified fifteen differential miRNAs and 372 differential mRNAs in the radioresistant NPC cells, constructed a posttranscriptional regulatory network including 375 miRNA-target gene pairs, discovered the ten target genes coregulated by the six miRNAs, and validated that downregulated miRNA-23a was involved in NPC radioresistance through directly targeting IL-8. Our data form a basis for further investigating the mechanisms of NPC radioresistance.	[Li, Xin-Hui; Qu, Jia-Quan; Yi, Hong; Zhang, Peng-Fei; Yi, Hong-Mei; Wan, Xun-Xun; He, Qiu-Yan; Ye, Xu; Yuan, Li; Zhu, Jing-Feng; Li, Jiao-Yang; Xiao, Zhi-Qiang] Cent S Univ, Key Lab Canc Prote, Chinese Minist Hlth, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Qu, Jia-Quan] Jishou Univ, Dept Pathol, Coll Med, Jishou, Hunan, Peoples R China	Central South University; Jishou University	Xiao, ZQ (corresponding author), Cent S Univ, Key Lab Canc Prote, Chinese Minist Hlth, Xiangya Hosp, Changsha, Hunan, Peoples R China.	zqxiao2001@hotmail.com			National Natural Science Foundation of China [81230053, 81172559, 81272959]; National Basic Research Program of China [2013CB910502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This research program was supported by National Natural Science Foundation of China (81230053, 81172559, 81272959), National Basic Research Program of China (2013CB910502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Bonovich M, 2002, CANCER GENE THER, V9, P62, DOI 10.1038/sj/cgt/7700409; Chang JTC, 2007, MOL CANCER THER, V6, P2271, DOI 10.1158/1535-7163.MCT-06-0801; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Chen HL, 1999, P NATL ACAD SCI USA, V96, P9339, DOI 10.1073/pnas.96.16.9339; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; De Vito C, 2012, CANCER CELL, V21, P807, DOI 10.1016/j.ccr.2012.04.023; Deng Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041493, 10.1371/journal.pone.0038737]; Deorukhkar A, 2010, BIOCHEM PHARMACOL, V80, P1904, DOI 10.1016/j.bcp.2010.06.039; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; Efimova EV, 2009, INT J RADIAT BIOL, V85, P421, DOI 10.1080/09553000902838566; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Feng XP, 2010, CANCER RES, V70, P3450, DOI 10.1158/0008-5472.CAN-09-4099; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo Y, 2012, INT J ONCOL, V40, P85, DOI 10.3892/ijo.2011.1172; Gwak HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047449; Hardee ME, 2012, CANCER RES, V72, P4119, DOI 10.1158/0008-5472.CAN-12-0546; Husbeck B, 2005, FREE RADICAL BIO MED, V38, P50, DOI 10.1016/j.freeradbiomed.2004.09.022; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jayasurya A, 2000, BRIT J CANCER, V82, P1198; Kim AH, 2003, INT J ONCOL, V23, P1593; Kristensen CA, 2007, ACTA ONCOL, V46, P214, DOI 10.1080/02841860600635862; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Li JA, 2011, CANCER LETT, V304, P52, DOI 10.1016/j.canlet.2011.02.003; Li T, 2011, ONCOL REP, V25, P1353, DOI 10.3892/or.2011.1204; Li XJ, 2012, CARCINOGENESIS, V33, P1302, DOI 10.1093/carcin/bgs181; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Liu XF, 2006, CELL BIOL INT, V30, P283, DOI 10.1016/j.cellbi.2005.11.010; Luo ZH, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-3; Lynam-Lennon N, 2012, J MOL MED, V90, P1449, DOI 10.1007/s00109-012-0924-x; Ma XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024647; MAITY A, 1994, RADIOTHER ONCOL, V31, P1, DOI 10.1016/0167-8140(94)90408-1; Mansour WY, 2013, RADIOTHER ONCOL, V106, P147, DOI 10.1016/j.radonc.2012.10.020; Qu CJ, 2012, CELL CYCLE, V11, P785, DOI 10.4161/cc.11.4.19228; Ren Y, 2013, MOL CELL PROTEOMICS, V12, P485, DOI 10.1074/mcp.M112.018325; Shi QL, 2011, J NEUROCHEM, V118, P440, DOI 10.1111/j.1471-4159.2011.07333.x; Shi RZ, 2013, J CELL BIOCHEM, V114, P1890, DOI 10.1002/jcb.24533; Shin S, 2009, INT J ONCOL, V35, P81, DOI 10.3892/ijo_00000315; Tan GY, 2012, J BIOL CHEM, V287, P33036, DOI 10.1074/jbc.M112.383273; Tang HL, 2013, CURR CANCER DRUG TAR, V13, P221, DOI 10.2174/1568009611313020010; Wang XC, 2011, LUNG CANCER, V72, P92, DOI 10.1016/j.lungcan.2010.07.014; Wu Y, 2012, J RADIAT RES, V53, P516, DOI 10.1093/jrr/rrs002; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Yang S, 2010, CURR CANCER DRUG TAR, V10, P611, DOI 10.2174/156800910791859506; Yang W, 2012, EXP CELL RES, V318, P944, DOI 10.1016/j.yexcr.2012.02.010; Zeng GQ, 2011, J PROTEOMICS, V74, P2723, DOI 10.1016/j.jprot.2011.02.012; Zeng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046367; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang ZH, 2011, CANCER BIOL THER, V11, P690, DOI 10.4161/cbt.11.7.15060; Zhao LQ, 2013, CELL SIGNAL, V25, P1625, DOI 10.1016/j.cellsig.2013.04.004; Zhao LQ, 2012, CARCINOGENESIS, V33, P2220, DOI 10.1093/carcin/bgs235; Zhivotovsky B, 1999, EXP CELL RES, V248, P10, DOI 10.1006/excr.1999.4452; Zhou H, 2007, CLIN CANCER RES, V13, P2344, DOI 10.1158/1078-0432.CCR-06-2303; Ziliak D, 2012, MOL CANCER THER, V11, P2054, DOI 10.1158/1535-7163.MCT-12-0221; Zou ZY, 2012, J BIOL CHEM, V287, P4148, DOI 10.1074/jbc.M111.307405	60	31	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87767	10.1371/journal.pone.0087767	http://dx.doi.org/10.1371/journal.pone.0087767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498188	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900167
J	Marinho, FA; Goncalves, KCS; Oliveira, SSC; Goncalves, DS; Matteoli, FP; Seabra, SH; Oliveira, ACS; Bellio, M; Oliveira, SS; Souto-Padron, T; d'Avila-Levy, CM; Santos, ALS; Branquinha, MH				Marinho, Fernanda A.; Goncalves, Keyla C. S.; Oliveira, Simone S. C.; Goncalves, Diego S.; Matteoli, Filipe P.; Seabra, Sergio H.; Oliveira, Ana Carolina S.; Bellio, Maria; Oliveira, Selma S.; Souto-Padron, Thais; d'Avila-Levy, Claudia M.; Santos, Andre L. S.; Branquinha, Marta H.			The Calpain Inhibitor MDL28170 Induces the Expression of Apoptotic Markers in Leishmania amazonensis Promastigotes	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; TARGETING ESSENTIAL PATHWAYS; DNA FRAGMENTATION; TRYPANOSOMA-CRUZI; DONOVANI PROMASTIGOTES; PROTOZOAN MECHANISMS; INSIGHTS; LOCALIZATION; PENTAMIDINE; DISRUPTION	Background: Human cutaneous leishmaniasis is caused by distinct species, including Leishmania amazonensis. Treatment of cutaneous leishmaniasis is far from satisfactory due to increases in drug resistance and relapses, and toxicity of compounds to the host. As a consequence for this situation, the development of new leishmanicidal drugs and the search of new targets in the parasite biology are important goals. Methodology/Principal Findings: In this study, we investigated the mechanism of death pathway induced by the calpain inhibitor MDL28170 on Leishmania amazonensis promastigote forms. The combined use of different techniques was applied to contemplate this goal. MDL28170 treatment with IC50 (15 mu M) and two times the IC50 doses induced loss of parasite viability, as verified by resazurin assay, as well as depolarization of the mitochondrial membrane, which was quantified by JC-1 staining. Scanning and transmission electron microscopic images revealed drastic alterations on the parasite morphology, some of them resembling apoptotic-like death, including cell shrinking, surface membrane blebs and altered chromatin condensation pattern. The lipid rearrangement of the plasma membrane was detected by Annexin-V labeling. The inhibitor also induced a significant increase in the proportion of cells in the sub-G(0)/G(1) phase, as quantified by propidium iodide staining, as well as genomic DNA fragmentation, detected by TUNEL assay. In cells treated with MDL28170 at two times the IC50 dose, it was also possible to observe an oligonucleossomal DNA fragmentation by agarose gel electrophoresis. Conclusions/Significance: The data presented in the current study suggest that MDL28170 induces apoptotic marker expression in promastigotes of L. amazonensis. Altogether, the results described in the present work not only provide a rationale for further exploration of the mechanism of action of calpain inhibitors against trypanosomatids, but may also widen the investigation of the potential clinical utility of calpain inhibitors in the chemotherapy of leishmaniases.	[Marinho, Fernanda A.; Oliveira, Simone S. C.; Goncalves, Diego S.; Matteoli, Filipe P.; Oliveira, Selma S.; Souto-Padron, Thais; Santos, Andre L. S.; Branquinha, Marta H.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes IMPG, Dept Microbiol Geral, Rio De Janeiro, Brazil; [Goncalves, Keyla C. S.; d'Avila-Levy, Claudia M.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, Rio De Janeiro, Brazil; [Seabra, Sergio H.] Ctr Univ Estadual Zona Oeste UEZO, Lab Tecnol Cultura Celulas, Rio De Janeiro, Brazil; [Oliveira, Ana Carolina S.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Imunol Mol, BR-21941 Rio De Janeiro, Brazil; [Bellio, Maria] Univ Fed Rio de Janeiro, IMPG, Dept Imunol, Rio De Janeiro, Brazil; [Souto-Padron, Thais] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Centro Universitario Estadual da Zona Oeste; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Branquinha, MH (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes IMPG, Dept Microbiol Geral, Rio De Janeiro, Brazil.	mbranquinha@micro.ufrj.br	Bellio, Maria/N-8525-2018; Santos, André/Z-5853-2019; Branquinha, Marta/AAA-3084-2019; aquino, thiago/B-5443-2017; de Souza Gonçalves, Diego/AAA-7872-2021; Oliveira, Ana Carolina/O-6791-2014; Oliveira, Ana Carolina/GRF-1435-2022; Matteoli, Filipe/CAF-3979-2022; d'Avila-Levy, Claudia M/O-7192-2014	Bellio, Maria/0000-0002-3360-2740; Santos, André/0000-0003-0821-8592; aquino, thiago/0000-0001-9138-8466; de Souza Gonçalves, Diego/0000-0002-1697-0760; Oliveira, Ana Carolina/0000-0002-0036-3720; Matteoli, Filipe/0000-0003-4981-100X; d'Avila-Levy, Claudia M/0000-0001-8042-4695; Da Silva Goncalves, Keyla Cristiny/0000-0002-8965-0776	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Oswaldo Cruz (FIOCRUZ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz (FIOCRUZ)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Fundacao Oswaldo Cruz (FIOCRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORTNER CD, 1995, TRENDS CELL BIOL, V5, P21, DOI 10.1016/S0962-8924(00)88932-1; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Constantinou C, 2009, CURR CANCER DRUG TAR, V9, P717, DOI 10.2174/156800909789271512; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; d'Avila-Levy CM, 2006, INT J ANTIMICROB AG, V28, P138, DOI 10.1016/j.ijantimicag.2006.03.021; den Boer M, 2011, CLIN MICROBIOL INFEC, V17, P1471, DOI 10.1111/j.1469-0691.2011.03635.x; Dutta A, 2007, J MED MICROBIOL, V56, P1196, DOI 10.1099/jmm.0.47114-0; El-Fadili AK, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.51; Ennes-Vidal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018371; Ennes-Vidal V, 2010, J ANTIMICROB CHEMOTH, V65, P1395, DOI 10.1093/jac/dkq154; Feinstein-Rotkopf Y, 2009, APOPTOSIS, V14, P980, DOI 10.1007/s10495-009-0346-6; Foucher AL, 2013, ANTIMICROB AGENTS CH, V57, P1252, DOI 10.1128/AAC.01983-12; Galetovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027634; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]; GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230, DOI 10.1128/CMR.6.3.230-250.1993; Hertz-Fowler C, 2001, MOL BIOCHEM PARASIT, V116, P25, DOI 10.1016/S0166-6851(01)00296-1; Holzmuller P, 2002, INFECT IMMUN, V70, P3727, DOI 10.1128/IAI.70.7.3727-3735.2002; Imbert L, 2012, ANAL BIOANAL CHEM, V402, P1169, DOI 10.1007/s00216-011-5520-3; Jayanarayan KG, 2005, PARASITOLOGY, V131, P215, DOI 10.1017/S0031182005007687; Kidd JF, 2002, J BIOL CHEM, V277, P6504, DOI 10.1074/jbc.M106802200; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; Kumar P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000642; LAINSON R, 1987, Memorias do Instituto Oswaldo Cruz, V82, P421, DOI 10.1590/S0074-02761987000300015; Lee N, 2002, CELL DEATH DIFFER, V9, P53, DOI 10.1038/sj.cdd.4400952; Macedo-Silva ST, 2011, MOL BIOL INT, DOI [10.4061/2011/876021, DOI 10.4061/2011/876021]; Marinho FD, 2011, MEM I OSWALDO CRUZ, V106, P507, DOI 10.1590/S0074-02762011000400021; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Mottram JC, 1996, P NATL ACAD SCI USA, V93, P6008, DOI 10.1073/pnas.93.12.6008; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Olego-Fernandez S, 2009, PROTIST, V160, P576, DOI 10.1016/j.protis.2009.05.003; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Polonio T, 2008, INT J MOL MED, V22, P277, DOI 10.3892/ijmm_00000020; Portes JD, 2012, VET PARASITOL, V186, P261, DOI 10.1016/j.vetpar.2011.11.008; Proto WR, 2013, NAT REV MICROBIOL, V11, P58, DOI 10.1038/nrmicro2929; Rami A, 1997, NEUROSCI RES, V27, P93, DOI 10.1016/S0168-0102(96)01123-6; Sangenito LS, 2009, PARASITOLOGY, V136, P433, DOI 10.1017/S0031182009005629; Selvapandiyan A, 2004, J BIOL CHEM, V279, P25703, DOI 10.1074/jbc.M402794200; Sereno D, 2001, ANTIMICROB AGENTS CH, V45, P2064, DOI 10.1128/AAC.45.7.2064-2069.2001; Singh G, 2007, ACTA TROP, V103, P172, DOI 10.1016/j.actatropica.2007.06.004; Smirlis D, 2011, VIRULENCE, V2, P253, DOI 10.4161/viru.2.3.16278; Smirlis D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-107; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Sorimachi H, 2011, J BIOCHEM, V150, P23, DOI 10.1093/jb/mvr070; SOUTOPADRON T, 1990, J CELL SCI, V96, P485; Tote K, 2009, J APPL MICROBIOL, V107, P606, DOI 10.1111/j.1365-2672.2009.04228.x; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Vannier-Santos MA, 2009, CURR DRUG TARGETS, V10, P246, DOI 10.2174/138945009787581168; Verma NK, 2007, EXP PARASITOL, V116, P1, DOI 10.1016/j.exppara.2006.10.007; Wanderley JLM, 2006, J IMMUNOL, V176, P1834, DOI 10.4049/jimmunol.176.3.1834; Weingartner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042070; World Health Organization (WHO, 2013, LEISHMANIASIS	56	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87659	10.1371/journal.pone.0087659	http://dx.doi.org/10.1371/journal.pone.0087659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498160	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900147
J	Seifert, J; Hammer, CM; Rheinlaender, J; Sel, S; Scholz, M; Paulsen, F; Schaffer, TE				Seifert, Jan; Hammer, Christian M.; Rheinlaender, Johannes; Sel, Saadettin; Scholz, Michael; Paulsen, Friedrich; Schaeffer, Tilman E.			Distribution of Young's Modulus in Porcine Corneas after Riboflavin/UVA-Induced Collagen Cross-Linking as Measured by Atomic Force Microscopy	PLOS ONE			English	Article							ULTRAVIOLET-A; BIOMECHANICAL PROPERTIES; KERATOCONUS; IRRADIATION; LIGHT	Riboflavin/UVA-induced corneal collagen cross-linking has become an effective clinical application to treat keratoconus and other ectatic disorders of the cornea. Its beneficial effects are attributed to a marked stiffening of the unphysiologically weak stroma. Previous studies located the stiffening effect predominantly within the anterior cornea. In this study, we present an atomic force microscopy-derived analysis of the depth-dependent distribution of the Young's modulus with a depth resolution of 5 mu m in 8 cross-linked porcine corneas and 8 contralateral controls. Sagittal cryosections were fabricated from every specimen and subjected to force mapping. The mean stromal depth of the zone with effective cross-linking was found to be 219 +/- 67 mu m. Within this cross-linked zone, the mean Young's modulus declined from 49 +/- 18 kPa at the corneal surface to 46 +/- 17 kPa, 33 +/- 11 kPa, 17 +/- 5 kPa, 10 +/- 4 kPa and 10 +/- 4 kPa at stromal depth intervals of 0-50 mu m, 50-100 mu m, 100-150 mu m, 150-200 mu m and 200-250 mu m, respectively. This corresponded to a stiffening by a factor of 8.1 (corneal surface), 7.6 (0-50 mu m), 5.4 (50-100 mu m), 3.0 (100-150 mu m), 1.6 (150-200 mu m), and 1.5 (200-250 mu m), when compared to the Young's modulus of the posterior 100 mu m. The mean Young's modulus within the cross-linked zone was 20 +/- 8 kPa (2.9-fold stiffening), while it was 11 +/- 4 kPa (1.7-fold stiffening) for the entire stroma. Both values were significantly distinct from the mean Young's modulus obtained from the posterior 100 mu m of the cross-linked corneas and from the contralateral controls. In conclusion, we were able to specify the depth-dependent distribution of the stiffening effect elicited by standard collagen cross-linking in porcine corneas. Apart from determining the depth of the zone with effective corneal cross-linking, we also developed a method that allows for atomic force microscopy-based measurements of gradients of Young's modulus in soft tissues in general.	[Seifert, Jan; Rheinlaender, Johannes; Schaeffer, Tilman E.] Univ Tubingen, Dept Appl Phys, Tubingen, Germany; [Seifert, Jan; Rheinlaender, Johannes; Schaeffer, Tilman E.] Univ Tubingen, LISA, Tubingen, Germany; [Hammer, Christian M.; Scholz, Michael; Paulsen, Friedrich] Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany; [Sel, Saadettin] Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg	Hammer, CM (corresponding author), Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany.	c.m.hammer@t-online.de	Schäffer, Tilman E/Q-7995-2017	Schäffer, Tilman E/0000-0001-5643-8384; Paulsen, Friedrich/0000-0002-0527-0953; Rheinlaender, Johannes/0000-0002-1976-9245; Scholz, Michael/0000-0001-8440-6785; Sel, Prof. Dr. med. Saadettin/0000-0003-3307-3305				Ambekar R, 2011, J MECH BEHAV BIOMED, V4, P223, DOI 10.1016/j.jmbbm.2010.09.014; ANDREASSEN TT, 1980, EXP EYE RES, V31, P435, DOI 10.1016/S0014-4835(80)80027-3; Braunsmann C, 2012, INVEST OPHTH VIS SCI, V53, P2960, DOI 10.1167/iovs.11-8409; Chai D, 2011, INVEST OPHTH VIS SCI, V52, P4231, DOI 10.1167/iovs.10-7105; Clavert P, 2001, SURG RADIOL ANAT, V23, P259, DOI 10.1007/s00276-001-0259-8; Cook S, 2006, NANOTECHNOLOGY, V17, P2135, DOI 10.1088/0957-4484/17/9/010; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Dias J, 2013, EXPT EYE RES; Galletti JG, 2012, J REFRACT SURG, V28, P202, DOI 10.3928/1081597X-20120103-03; Goldich Y, 2012, CORNEA, V31, P609, DOI 10.1097/ICO.0b013e318226bf4a; Hafezi F, 2007, J CATARACT REFR SURG, V33, P2035, DOI 10.1016/j.jcrs.2007.07.028; Hatami-Marbini H, 2013, EXPT EYE RES; Hayenga HN, 2011, J VASC RES, V48, P495, DOI 10.1159/000329586; Hayes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052860; Hertz H, 1882, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRLL.1882.92.156; Jinabhai A, 2011, CONTACT LENS ANTERIO, V34, P56, DOI 10.1016/j.clae.2010.11.007; Kamaev P, 2012, INVEST OPHTH VIS SCI, V53, P2360, DOI 10.1167/iovs.11-9385; Kampik D, 2010, INVEST OPHTH VIS SCI, V51, P3929, DOI 10.1167/iovs.09-4524; Kling S, 2010, INVEST OPHTH VIS SCI, V51, P3961, DOI 10.1167/iovs.09-4536; Kohlhaas M, 2006, J CATARACT REFR SURG, V32, P279, DOI 10.1016/j.jcrs.2005.12.092; Kymes SM, 2004, AM J OPHTHALMOL, V138, P527, DOI 10.1016/j.ajo.2004.04.031; Labiris G, 2012, CORNEA, V31, P734, DOI 10.1097/ICO.0b013e31823cbe85; Last JA, 2012, MICRON, V43, P1293, DOI 10.1016/j.micron.2012.02.014; McCall AS, 2010, INVEST OPHTH VIS SCI, V51, P129, DOI 10.1167/iovs.09-3738; Meek KM, 2013, OPHTHAL PHYSL OPT, V33, P78, DOI 10.1111/opo.12032; Ortiz D, 2007, J CATARACT REFR SURG, V33, P1371, DOI 10.1016/j.jcrs.2007.04.021; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9; Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039; Randleman JB, 2008, J REFRACT SURG, V24, P85; Romero-Jimenez M, 2010, CONTACT LENS ANTERIO, V33, P157, DOI 10.1016/j.clae.2010.04.006; Scarcelli G, 2013, INVEST OPHTH VIS SCI, V54, P1418, DOI 10.1167/iovs.12-11387; Scarcelli G, 2012, INVEST OPHTH VIS SCI, V53, P185, DOI 10.1167/iovs.11-8281; Schumacher S, 2012, INVEST OPHTH VIS SCI, V53, P762, DOI 10.1167/iovs.11-8059; Shimizu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034305; Sondergaard AP, 2010, CURR EYE RES, V35, P116, DOI 10.3109/02713680903431847; Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410; Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78; Spoerl E, 2010, CURR EYE RES, V35, P1040, DOI 10.3109/02713683.2010.506969; Weeber HA, 2005, EXP EYE RES, V80, P425, DOI 10.1016/j.exer.2004.10.010; Wittig-Silva C, 2008, J REFRACT SURG, V24; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2009, ACTA OPHTHALMOL, V87, P48, DOI 10.1111/j.1755-3768.2008.01190.x; Zhang Y, 2013, J BIOL CHEM, V286, P13011	45	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e88186	10.1371/journal.pone.0088186	http://dx.doi.org/10.1371/journal.pone.0088186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498254	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900218
J	Townsend, AK; Barker, CM				Townsend, Andrea K.; Barker, Christopher M.			Plastic and the Nest Entanglement of Urban and Agricultural Crows	PLOS ONE			English	Article							ECOLOGICAL TRAPS; LAND-USE; DEBRIS; BIRDS; ACCUMULATION; ENVIRONMENT; INGESTION; MORTALITY; DESERT	Much attention has been paid to the impacts of plastics and other debris on marine organisms, but the effects of plastic on terrestrial organisms have been largely ignored. Detrimental effects of terrestrial plastic could be most pronounced in intensively human-modified landscapes (e. g., urban and agricultural areas), which are a source of much anthropogenic debris. Here, we examine the occurrence, types, landscape associations, and consequences of anthropogenic nest material in the American crow (Corvus brachyrhynchos), a North American species that breeds in both urban and agricultural landscapes. We monitored 195 nestlings in 106 nests across an urban and agricultural gradient in the Sacramento Valley, California, USA. We found that 85.2% of crow nests contained anthropogenic material, and 11 of 195 nestlings (5.6%) were entangled in their nests. The length of the material was greater in nests in agricultural territories than in urban territories, and the odds of entanglement increased 7.55 times for each meter of anthropogenic material in the nest. Fledging success was significantly lower for entangled than for unentangled nestlings. In all environments, particularly urban, agricultural, and marine, careful disposal of potential hazards (string, packing and hay bale twine, balloon ribbon, wire, fishing line) could reduce the occurrence of entanglement of nestling birds.	[Townsend, Andrea K.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Barker, Christopher M.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Townsend, AK (corresponding author), Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA.	aktownsend@ucdavis.edu			University of California at Davis	University of California at Davis(University of California System)	This work was funded by the University of California at Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 2010, URBAN WILDLIFE MANAG; Badyaev AV, 2012, BIRDS N AM ONLINE; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Benedict L, 2011, BIRDS N AM ONLINE; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; BEST L B, 1986, Wildlife Society Bulletin, V14, P308; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Blem CR, 2002, WILSON BULL, V114, P528, DOI 10.1676/0043-5643(2002)114[0528:TCSMIN]2.0.CO;2; Boal CW, 1999, J WILDLIFE MANAGE, V63, P77, DOI 10.2307/3802488; Boutin C, 1999, AGR ECOSYST ENVIRON, V72, P239, DOI 10.1016/S0167-8809(98)00181-9; Cabe P. R., 1993, BIRDS N AM ONLINE; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Clark CJ, 2012, BIRDS N AM ONLINE; Coelho IP, 2012, J ENVIRON MANAGE, V112, P17, DOI 10.1016/j.jenvman.2012.07.004; Collins C.T., 1983, Western Birds, V13, P25; Dahlsten D. L., 2002, BIRDS N AM ONLINE; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Farnsworth G, 2011, BIRDS N AM ONLINE; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Gaston K. J., 2010, URBAN ECOLOGY; Gaylor MO, 2012, CHEMOSPHERE, V86, P500, DOI 10.1016/j.chemosphere.2011.10.014; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; HALKIN S. L., 1999, BIRDS N AM ONLINE; Herrington B., 1985, Herpetological Review, V16, P113; Jackson BJ., 2000, BIRDS N AM ONLINE; Kokko H, 2001, EVOL ECOL RES, V3, P537; Laist David W., 1997, P99; LAIST DW, 1987, MAR POLLUT BULL, V18, P319, DOI 10.1016/S0025-326X(87)80019-X; Leston LFV, 2006, BIOL CONSERV, V131, P566, DOI 10.1016/j.biocon.2006.03.003; Lowther P.E., 2006, BIRDS N AM ONLINE, DOI 10.2173/bna.12; Mato Y, 2001, ENVIRON SCI TECHNOL, V35, P318, DOI 10.1021/es0010498; Mcdonald RI, 2009, LANDSCAPE URBAN PLAN, V93, P63, DOI 10.1016/j.landurbplan.2009.06.002; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Mee A, 2007, BIRD CONSERV INT, V17, P119, DOI 10.1017/S095927090700069X; MONTEVECCHI WA, 1991, CAN J ZOOL, V69, P295, DOI 10.1139/z91-047; Parker GH, 2007, CAN FIELD NAT, V121, P436, DOI 10.22621/cfn.v121i4.522; R Core Team, 2021, R LANG ENV STAT COMP; Roux KE, 2007, ARCH ENVIRON CON TOX, V53, P261, DOI 10.1007/s00244-006-0174-4; Ryan TP, 2000, BIRDS N AM ONLINE; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schuyler Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040884; Suarez-Rodriguez M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0931; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thompson RC, 2009, PHILOS T R SOC B, V364, P1973, DOI 10.1098/rstb.2009.0054; Walde AD, 2007, WEST N AM NATURALIST, V67, P147, DOI 10.3398/1527-0904(2007)67[147:ATTTDT]2.0.CO;2; Wang YP, 2009, ACTA ORNITHOL, V44, P185, DOI 10.3161/000164509X482768; Zylstra ER, 2013, J ARID ENVIRON, V89, P13, DOI 10.1016/j.jaridenv.2012.10.004; [No title captured]	48	49	51	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e88006	10.1371/journal.pone.0088006	http://dx.doi.org/10.1371/journal.pone.0088006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498238	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900205
J	Jurgensen, HJ; Johansson, K; Madsen, DH; Porse, A; Melander, MC; Sorensen, KR; Nielsen, C; Bugge, TH; Behrendt, N; Engelholm, LH				Juergensen, Henrik J.; Johansson, Kristina; Madsen, Daniel H.; Porse, Astrid; Melander, Maria C.; Sorensen, Kristine R.; Nielsen, Christoffer; Bugge, Thomas H.; Behrendt, Niels; Engelholm, Lars H.			Complex Determinants in Specific Members of the Mannose Receptor Family Govern Collagen Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Endocytosis; Extracellular Matrix; Protein Chimeras; Receptor Structure-Function; Intracellular Collagen Degradation; Mannose Receptor; Cancer Invasion; Mannose Receptor Family; uPARAP; Endo180	GELATIN-BINDING SITE; PHOSPHOLIPASE A(2); ENDOTHELIAL-CELLS; MEMBRANE-RECEPTOR; DENDRITIC CELLS; ENDO180; DEGRADATION; FIBRONECTIN; ANTIGEN; PROTEIN	Background: Mannose receptor family members are candidate mediators of intracellular collagen degradation. Results: Despite common candidate collagen-binding domains and endocytic capacity throughout the family, only uPARAP/Endo180 and MR internalize collagens. Conclusion: A multi-domain interplay in the active receptors governs collagen endocytosis. Significance: Identification of the principal collagen receptors allows elucidation of the biological importance of intracellular collagen degradation. Members of the well-conserved mannose receptor (MR) protein family have been functionally implicated in diverse biological and pathological processes. Importantly, a proposed common function is the internalization of collagen for intracellular degradation occurring during bone development, cancer invasion, and fibrosis protection. This functional relationship is suggested by a common endocytic capability and a candidate collagen-binding domain. Here we conducted a comparative investigation of each member's ability to facilitate intracellular collagen degradation. As expected, the family members uPARAP/Endo180 and MR bound collagens in a purified system and internalized collagens for degradation in cellular settings. In contrast, the remaining family members, PLA(2)R and DEC-205, showed no collagen binding activity and were unable to mediate collagen internalization. To pinpoint the structural elements discriminating collagen from non-collagen receptors, we constructed a series of receptor chimeras and loss- and gain-of-function mutants. Using this approach we identified a critical collagen binding loop in the suggested collagen binding region (an FN-II domain) in uPARAP/Endo180 and MR, which was different in PLA(2)R or DEC-205. However, we also found that an active FN-II domain was not a sufficient determinant to allow collagen internalization through these receptors. Nevertheless, this ability could be acquired by the transfer of a larger segment of uPARAP/Endo180 (the Cys-rich domain, the FN-II domain and two CTLDs) to DEC-205. These data underscore the importance of the FN-II domain in uPARAP/Endo180 and MR-mediated collagen internalization but at the same time uncover a critical interplay with flanking domains.	[Juergensen, Henrik J.; Johansson, Kristina; Madsen, Daniel H.; Porse, Astrid; Melander, Maria C.; Sorensen, Kristine R.; Nielsen, Christoffer; Behrendt, Niels; Engelholm, Lars H.] Rigshosp, Finsen Lab, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Juergensen, Henrik J.; Madsen, Daniel H.; Bugge, Thomas H.] NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA	Rigshospitalet; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Engelholm, LH (corresponding author), Rigshosp, Finsen Lab, Copenhagen Bioctr, BRIC, Ole Maaloesvej 5, DK-2200 Copenhagen N, Denmark.	lhe@finsenlab.dk		Behrendt, Niels/0000-0003-1833-3922; Madsen, Daniel Hargboel/0000-0002-3183-6201; Engelholm, Lars/0000-0002-6616-1232	NIDCR Intramural Research Program; Danish Cancer Society; Danish Medical Research Council; Danish Cancer Research Foundation; Novo Nordisk Foundation; Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer); European Community [201279]; Lundbeck Foundation; "Grosserer Alfred Nielsen og Hustrus" foundation; Rigshospitalet/Copenhagen University Hospital; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER; Lundbeck Foundation [R118-2012-11578] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0002353] Funding Source: researchfish	NIDCR Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer)(Danmarks Grundforskningsfond); European Community(European Commission); Lundbeck Foundation(Lundbeckfonden); "Grosserer Alfred Nielsen og Hustrus" foundation; Rigshospitalet/Copenhagen University Hospital; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the NIDCR Intramural Research Program (D. M. and T. H. B.), the Danish Cancer Society, the Danish Medical Research Council, the Danish Cancer Research Foundation, the Novo Nordisk Foundation, the Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer) and the European Community's Seventh Framework Programme FP7/2007-2011 under Grant agreement no 201279 (to M. C. M. and N. B.), by the Lundbeck Foundation (to D. H. M. and L. H. E.), the "Grosserer Alfred Nielsen og Hustrus" foundation (to L. H. E.). The work was also supported by personal grants from Rigshospitalet/Copenhagen University Hospital (to H. J. J. and A. P.).	ANCIAN P, 1995, BIOCHEMISTRY-US, V34, P13146, DOI 10.1021/bi00040a028; BANYAI L, 1994, BIOCHEM J, V298, P403, DOI 10.1042/bj2980403; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Behrendt N, 2000, J BIOL CHEM, V275, P1993, DOI 10.1074/jbc.275.3.1993; Boskovic J, 2006, J BIOL CHEM, V281, P8780, DOI 10.1074/jbc.M513277200; Briknarova K, 1999, STRUCTURE, V7, P1235, DOI 10.1016/S0969-2126(00)80057-X; Bugge TH, 2011, BIOL EXTRACELL MATR, P53, DOI 10.1007/978-3-642-16861-1_3; Bundesmann MM, 2012, AM J RESP CELL MOL, V46, P233, DOI 10.1165/rcmb.2010-0485OC; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; East L, 2002, J BIOL CHEM, V277, P50469, DOI 10.1074/jbc.M208985200; East L, 2003, EMBO REP, V4, P710, DOI 10.1038/sj.embor.embor882; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Fasquelle C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000666; Gardsvoll H, 2007, PROTEIN EXPRES PURIF, V52, P384, DOI 10.1016/j.pep.2006.11.013; Gravallese EM, 2002, ANN RHEUM DIS, V61, P84, DOI 10.1136/ard.61.suppl_2.ii84; Hanasaki K, 2002, PROSTAG OTH LIPID M, V68-9, P71, DOI 10.1016/S0090-6980(02)00022-9; Hanasaki K, 1997, J BIOL CHEM, V272, P32792, DOI 10.1074/jbc.272.52.32792; Holmbeck Kenn, 2006, Birth Defects Research, V78, P11, DOI 10.1002/bdrc.20064; Howard MJ, 2002, J BIOL CHEM, V277, P32320, DOI 10.1074/jbc.M203631200; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Jurgensen HJ, 2011, J BIOL CHEM, V286, P32736, DOI 10.1074/jbc.M111.266692; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; Kjoller L, 2004, EXP CELL RES, V293, P106, DOI 10.1016/j.yexcr.2003.10.008; Kogianni G, 2009, EUR J CANCER, V45, P685, DOI 10.1016/j.ejca.2008.11.023; Kundu GC, 1997, J BIOL CHEM, V272, P2346; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Llorca O, 2008, CELL MOL LIFE SCI, V65, P1302, DOI 10.1007/s00018-007-7497-9; Lopez-Guisa JM, 2012, J AM SOC NEPHROL, V23, P236, DOI 10.1681/ASN.2011030310; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Madsen DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071261; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Madsen DH, 2012, J PATHOL, V227, P94, DOI 10.1002/path.3981; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639; Martinez-Pomares L, 2006, EUR J IMMUNOL, V36, P1074, DOI 10.1002/eji.200535685; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Nielsen BS, 2002, INT J CANCER, V98, P656, DOI 10.1002/ijc.10227; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Pickford AR, 1997, STRUCTURE, V5, P359, DOI 10.1016/S0969-2126(97)00193-7; Rivera-Calzada A, 2003, EMBO REP, V4, P807, DOI 10.1038/sj.embor.embor898; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Schweizer A, 2000, J BIOL CHEM, V275, P29694, DOI 10.1074/jbc.M000571200; Segal G, 2001, J CELL SCI, V114, P119; Sheikh H, 2000, J CELL SCI, V113, P1021; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Sulek J, 2007, J HISTOCHEM CYTOCHEM, V55, P347, DOI 10.1369/jhc.6A7133.2006; Tamaru S, 2013, J IMMUNOL, V191, P1021, DOI 10.4049/jimmunol.1300738; Tordai H, 1999, EUR J BIOCHEM, V259, P513, DOI 10.1046/j.1432-1327.1999.00070.x; Wagenaar-Miller RA, 2007, MOL CELL BIOL, V27, P6309, DOI 10.1128/MCB.00291-07; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Wienke D, 2007, CANCER RES, V67, P10230, DOI 10.1158/0008-5472.CAN-06-3496; Wu K, 1996, J BIOL CHEM, V271, P21323, DOI 10.1074/jbc.271.35.21323; Xu XP, 2009, BIOCHEMISTRY-US, V48, P5822, DOI 10.1021/bi900513h; Yamaguchi T., 2013, ORAL DIS, DOI 10.1111/odi.12140; Zvaritch E, 1996, J BIOL CHEM, V271, P250, DOI 10.1074/jbc.271.1.250	67	40	43	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7935	7947		10.1074/jbc.M113.512780	http://dx.doi.org/10.1074/jbc.M113.512780			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24500714	Green Published, hybrid			2022-12-25	WOS:000332761500058
J	Issouf, M; Guegnard, F; Koch, C; Le Vern, Y; Blanchard-Letort, A; Che, H; Beech, RN; Kerboeuf, D; Neveu, C				Issouf, Mohamed; Guegnard, Fabrice; Koch, Christine; Le Vern, Yves; Blanchard-Letort, Alexandra; Che, Hua; Beech, Robin N.; Kerboeuf, Dominique; Neveu, Cedric			Haemonchus contortus P-Glycoproteins Interact with Host Eosinophil Granules: A Novel Insight into the Role of ABC Transporters in Host-Parasite Interaction	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MULTIDRUG-RESISTANCE; DRUG TRANSPORT; IVERMECTIN RESISTANCE; EXPRESSION; CELLS; INVOLVEMENT; TRANSITION; MECHANISMS; INFECTION	Eosinophils are one of the major mammalian effector cells encountered by helminths during infection. In the present study, we investigated the effects of eosinophil granule exposure on the sheep parasitic nematode Haemonchus contortus as a model. H. contortus eggs exposed to eosinophil granule products showed increased rhodamine 123 efflux and this effect was not due to loss of egg integrity. Rh123 is known to be a specific P-glycoprotein (Pgp) substrate and led to the hypothesis that in addition to their critical role in xenobiotic resistance, helminth ABC transporters such as Pgp may also be involved in the detoxification of host cytotoxic products. We showed by quantitative RT-PCR that, among nine different H. contortus Pgp genes, Hco-pgp-3, Hco-pgp-9.2, Hco-pgp-11 and, Hco-pgp-16 were specifically up-regulated in parasitic life stages suggesting a potential involvement of these Pgps in the detoxification of eosinophil granule products. Using exsheathed L3 larvae that mimic the first life stage in contact with the host, we demonstrated that eosinophil granules induced a dose dependent overexpression of Hco-pgp-3 and the closely related Hco-pgp-16. Taken together, our results provide the first evidence that a subset of helminth Pgps interact with, and could be involved in the detoxification of, host products. This opens the way for further studies aiming to explore the role of helminth Pgps in the host-parasite interaction, including evasion of the host immune response.	[Issouf, Mohamed; Guegnard, Fabrice; Koch, Christine; Le Vern, Yves; Blanchard-Letort, Alexandra; Beech, Robin N.; Kerboeuf, Dominique; Neveu, Cedric] INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France; [Issouf, Mohamed; Guegnard, Fabrice; Koch, Christine; Le Vern, Yves; Blanchard-Letort, Alexandra; Kerboeuf, Dominique; Neveu, Cedric] Univ Tours, Infectiol & Sante Publ UMR1282, Tours, France; [Che, Hua; Beech, Robin N.] McGill Univ, Inst Parasitol, Quebec City, PQ, Canada	INRAE; Universite de Tours; McGill University	Neveu, C (corresponding author), INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France.	cedric.neveu@tours.inra.fr	Issouf, Mohamed/I-7327-2016; Beech, Robin/U-7759-2019; Blanchard, Alexandra/AAM-5138-2020	Issouf, Mohamed/0000-0003-4964-8492; neveu, cedric/0000-0003-4314-1850	French department of Mayotte	French department of Mayotte	MI is a grateful recipient of a PhD grant from the French department of Mayotte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Ardelli BF, 2013, VET PARASITOL, V191, P264, DOI 10.1016/j.vetpar.2012.09.021; Balic A, 2000, VET IMMUNOL IMMUNOP, V75, P109, DOI 10.1016/S0165-2427(00)00189-6; Beech RN, 2010, TRENDS PARASITOL, V26, P334, DOI 10.1016/j.pt.2010.04.003; BROEKS A, 1995, EMBO J, V14, P1858, DOI 10.1002/j.1460-2075.1995.tb07178.x; Burse A, 2004, MOL PLANT MICROBE IN, V17, P43, DOI 10.1094/MPMI.2004.17.1.43; Chan MS, 1996, AM J TROP MED HYG, V55, P52, DOI 10.4269/ajtmh.1996.55.52; Christian P, 2004, LANCET, V364, P981, DOI 10.1016/S0140-6736(04)17023-2; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; De Graef J, 2013, PARASITOLOGY, V140, P499, DOI 10.1017/S0031182012001849; de Silva NR, 2003, ACTA TROP, V86, P197, DOI 10.1016/S0001-706X(03)00035-4; Delannoy-Normand A, 2010, VET PARASITOL, V174, P106, DOI 10.1016/j.vetpar.2010.07.017; Dicker AJ, 2011, INT J PARASITOL, V41, P935, DOI 10.1016/j.ijpara.2011.03.015; Drach J, 1996, BLOOD, V88, P1747, DOI 10.1182/blood.V88.5.1747.bloodjournal8851747; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Frank MH, 2001, J IMMUNOL, V166, P2451, DOI 10.4049/jimmunol.166.4.2451; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; HAMANN KJ, 1987, J PARASITOL, V73, P523, DOI 10.2307/3282130; HAMANN KJ, 1991, INT ARCH ALLER A IMM, V94, P202, DOI 10.1159/000235362; Haslam IS, 2008, BIOCHEM PHARMACOL, V76, P850, DOI 10.1016/j.bcp.2008.07.020; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janssen IJI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061635; Kerboeuf D, 1999, PARASITOL RES, V85, P118, DOI 10.1007/s004360050519; Kerboeuf D, 2011, ANTIMICROB AGENTS CH, V55, P2224, DOI 10.1128/AAC.01477-10; Kerboeuf Dominique, 2010, Anti-Infective Agents in Medicinal Chemistry, V9, P113; Ludescher C, 1998, BRIT J HAEMATOL, V101, P722, DOI 10.1046/j.1365-2141.1998.00751.x; Makepeace BL, 2012, CURR MED CHEM, V19, P1567; Meeusen ENT, 2005, VET IMMUNOL IMMUNOP, V108, P121, DOI 10.1016/j.vetimm.2005.07.002; Moser JM, 2005, MOL BIOCHEM PARASIT, V143, P39, DOI 10.1016/j.molbiopara.2005.04.012; Nobmann S, 2001, BRIT J PHARMACOL, V132, P722, DOI 10.1038/sj.bjp.0703762; Ohnuki LE, 2005, J IMMUNOL METHODS, V307, P54, DOI 10.1016/j.jim.2005.09.006; Pawlik A, 2005, EUR J PHARMACOL, V528, P27, DOI 10.1016/j.ejphar.2005.10.068; Pendse SS, 2006, AM J TRANSPLANT, V6, P2884, DOI 10.1111/j.1600-6143.2006.01561.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pouliot JF, 1997, BIOCHEM PHARMACOL, V53, P17, DOI 10.1016/S0006-2952(96)00656-9; Raghu G, 1996, EXP HEMATOL, V24, P1258; Randolph GJ, 1998, P NATL ACAD SCI USA, V95, P6924, DOI 10.1073/pnas.95.12.6924; Raso G, 2004, INT J EPIDEMIOL, V33, P1092, DOI 10.1093/ije/dyh241; Rossanigo CE, 1995, J HELMINTHOL, V69, P357, DOI 10.1017/S0022149X00014954; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Shamri R, 2011, CELL TISSUE RES, V343, P57, DOI 10.1007/s00441-010-1049-6; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; SLIFMAN NR, 1986, J IMMUNOL, V137, P2913; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; Terefe G, 2007, VET RES, V38, P647, DOI 10.1051/vetres:2007019; WALLER PJ, 2005, TROPBIOMED, V222, P131; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Williamson SM, 2012, J HELMINTHOL, V86, P202, DOI 10.1017/S0022149X11000216; Xu M, 1998, MOL BIOCHEM PARASIT, V91, P327, DOI 10.1016/S0166-6851(97)00215-6	53	16	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87802	10.1371/journal.pone.0087802	http://dx.doi.org/10.1371/journal.pone.0087802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498376	gold, Green Submitted, Green Published			2022-12-25	WOS:000330626900122
J	Karataeva, AR; Klaassen, RV; Stroder, J; Ruiperez-Alonso, M; Hjorth, JJJ; van Nierop, P; Spijker, S; Mansvelder, HD; Smit, AB				Karataeva, Anna R.; Klaassen, Remco V.; Stroder, Jasper; Ruiperez-Alonso, Marta; Hjorth, Johannes J. J.; van Nierop, Pim; Spijker, Sabine; Mansvelder, Huibert D.; Smit, August B.			C-Terminal Interactors of the AMPA Receptor Auxiliary Subunit Shisa9	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; NETWORK OSCILLATIONS; GLUTAMATE RECEPTORS; IN-VITRO; PROTEINS; TRAFFICKING; HIPPOCAMPUS; ENDOCYTOSIS; STARGAZIN; DIVERSITY	Shisa9 (initially named CKAMP44) has been identified as auxiliary subunit of the AMPA-type glutamate receptors and was shown to modulate its physiological properties. Shisa9 is a type-I transmembrane protein and contains a C-terminal PDZ domain that potentially interacts with cytosolic proteins. In this study, we performed a yeast two-hybrid screening that yielded eight PDZ domain-containing interactors of Shisa9, which were independently validated. The identified interactors are known scaffolding proteins residing in the neuronal postsynaptic density. To test whether C-terminal scaffolding interactions of Shisa9 affect synaptic AMPA receptor function in the hippocampus, we disrupted these interactions using a Shisa9 C-terminal mimetic peptide. In the absence of scaffolding interactions of Shisa9, glutamatergic AMPA receptor-mediated synaptic currents in the lateral perforant path of the mouse hippocampus had a faster decay time, and paired-pulse facilitation was reduced. Furthermore, disruption of the PDZ interactions between Shisa9 and its binding partners affected hippocampal network activity. Taken together, our data identifies novel interaction partners of Shisa9, and shows that the C-terminal interactions of Shisa9 through its PDZ domain interaction motif are important for AMPA receptor synaptic and network functions.	[Karataeva, Anna R.; Klaassen, Remco V.; Stroder, Jasper; van Nierop, Pim; Spijker, Sabine; Smit, August B.] Vrije Univ Univ, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, Amsterdam, Netherlands; [Stroder, Jasper; Ruiperez-Alonso, Marta; Hjorth, Johannes J. J.; Mansvelder, Huibert D.] Vrije Univ Univ, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Smit, AB (corresponding author), Vrije Univ Univ, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	guus.smit@vu.nl	Hjorth, Johannes/A-2043-2009; Mansvelder, Huibert/N-6138-2018	Hjorth, Johannes/0000-0002-9302-0750; Mansvelder, Huibert/0000-0003-1365-5340; Spijker, Sabine/0000-0002-6814-2019	EU [HEALTH-F2-2009-242167, ITN 238686]; Dutch Fund for Economic Structure Reinforcement (FES) [0908]; ERC StG (EBrainSignals); NWO-ALW [ALW2PJ/12048]	EU(European Commission); Dutch Fund for Economic Structure Reinforcement (FES); ERC StG (EBrainSignals); NWO-ALW(Netherlands Organization for Scientific Research (NWO))	ABS, HDM and AK received funding from the EU 7th Framework Programme (HEALTH-F2-2009-242167 'SynSys'). ABS, SS and HDM received funding from the Dutch Fund for Economic Structure Reinforcement (FES, 0908 "NeuroBasic PharmaPhenomics project'') and HDM received funding from the ERC StG (EBrainSignals). RVK received funding from NWO-ALW (ALW2PJ/12048). JS received funding from the EU 7th Framework ITN 238686 'CEREBNET'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heine M, 2012, ADV EXP MED BIOL, V970, P197, DOI 10.1007/978-3-7091-0932-8_9; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Iwamoto T, 2004, J NEUROCHEM, V89, P100, DOI 10.1046/j.1471-4159.2003.02293.x; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Kalashnikova E, 2010, NEURON, V65, P80, DOI 10.1016/j.neuron.2009.12.021; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Li SP, 2011, METHODS MOL BIOL, V756, P381, DOI 10.1007/978-1-61779-160-4_24; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Mao LF, 2010, P NATL ACAD SCI USA, V107, P19038, DOI 10.1073/pnas.1013494107; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Oren I, 2006, J NEUROSCI, V26, P9923, DOI 10.1523/JNEUROSCI.1580-06.2006; Palhalmi J, 2004, NEUROPHARMACOLOGY, V47, P381, DOI 10.1016/j.neuropharm.2004.04.010; Pei JM, 2012, CELL SIGNAL, V24, P758, DOI 10.1016/j.cellsig.2011.11.011; Rao-Ruiz P, 2011, NAT NEUROSCI, V14, P1302, DOI 10.1038/nn.2907; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Steiner P, 2005, EMBO J, V24, P2873, DOI 10.1038/sj.emboj.7600755; Sumioka A, 2010, NEURON, V66, P755, DOI 10.1016/j.neuron.2010.04.035; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Zhang JP, 2005, MOL BRAIN RES, V135, P204, DOI 10.1016/j.molbrainres.2004.12.023	38	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87360	10.1371/journal.pone.0087360	http://dx.doi.org/10.1371/journal.pone.0087360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498314	Green Submitted, gold, Green Published			2022-12-25	WOS:000330626900060
J	Li, JQ; Li, L; Zuo, HX; Ke, CJ; Yan, B; Wen, HX; Zhang, YP; Yang, X				Li, Jinquan; Li, Li; Zuo, Haoxiao; Ke, Chenjuan; Yan, Biao; Wen, Huaxiao; Zhang, Yinping; Yang, Xu			T-Helper Type-2 Contact Hypersensitivity of Balb/c Mice Aggravated by Dibutyl Phthalate via Long-Term Dermal Exposure	PLOS ONE			English	Article							ATOPIC-DERMATITIS; FLUORESCEIN ISOTHIOCYANATE; DI(2-ETHYLHEXYL) PHTHALATE; SEXUAL-DIFFERENTIATION; DEVELOPMENTAL TOXICITY; EXPERIMENTAL ASTHMA; MALE-RAT; SKIN; INFLAMMATION; MOUSE	Objective: During the last few decades, the prevalence of allergic skin diseases, asthma and rhinitis, has increased worldwide. Introduction of environmental chemicals with aggravation effects may play a part in this increase. The artificial chemical product dibutyl phthalate (DBP) is used in many products used in daily life. Dermal exposure to DBP is a common (but easily neglected) exposure pattern. Methodology/Principal Findings: In this study, we examined the aggravation effect of long-term dermal exposure to DBP in a T-helper type 2 (Th2) model of contact hypersensitivity (CHS) in mice, and sought the potential molecular mechanisms. Experimental tests were conducted after 40-day dermal exposure to saline or three concentrations of DBP and subsequent three times of sensitization with 0.5% fluorescein isothiocyanate (FITC) or vehicle. The results of immunological and inflammatory biomarkers (total-immunoglobulin (Ig)E and Th cytokines) as well as histopathological examination and measurement of ear swelling supported the notion that high doses of DBP may promote and aggravate atopic dermatitis. Increased expression of thymic stromal lymphopoietin (TSLP) in this mouse model suggested that TSLP might be one of the molecular mechanisms of the aggravation effect induced by DBP. Conclusions/Significance: Together, these results indicated that long-term dermal exposure to types of environmental toxins such as phthalates may endow an atopic predisposition in animals or humans. In addition, the high expression of TSLP in the mouse model demonstrated that TSLP might have an important role in the aggravation effect. This result could help to provide effective prevention strategies against atopic diseases such as atopic dermatitis (AD).	[Li, Jinquan; Li, Li; Zuo, Haoxiao; Ke, Chenjuan; Yan, Biao; Wen, Huaxiao; Yang, Xu] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Sect Environm Biomed, Wuhan, Peoples R China; [Zhang, Yinping] Tsinghua Univ, Dept Bldg Sci, Beijing 100084, Peoples R China	Central China Normal University; Tsinghua University	Yang, X (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Sect Environm Biomed, Wuhan, Peoples R China.	yangxu@mail.ccnu.edu.cn	Zhang, Yinping/B-5187-2012; Yan, Biao/B-5880-2018	Zhang, Yinping/0000-0001-9175-7890; li, jinquan/0000-0003-0498-5399; Yan, Biao/0000-0002-9692-4966	National Natural Science Foundation of China [51136002]; 12th Five-Year Key Program for Science and Technology Development of China [2012BAJ02B0301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-Year Key Program for Science and Technology Development of China	This work was supported by the National Natural Science Foundation of China (grant number 51136002) and the 12th Five-Year Key Program for Science and Technology Development of China (2012BAJ02B0301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1; Boehme SA, 2009, INT IMMUNOL, V21, P81, DOI 10.1093/intimm/dxn127; Boeniger MF, 2003, ANN OCCUP HYG, V47, P591, DOI 10.1093/annhyg/meg095; Bogiatzi SI, 2007, J IMMUNOL, V178, P3373, DOI 10.4049/jimmunol.178.6.3373; Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Bystrom J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-10; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664; Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350; Guttman-Yassky Emma, 2007, Curr Probl Dermatol, V35, P154, DOI 10.1159/000106422; Hahn EL, 2005, IMMUNOL ALLERGY CLIN, V25, P231, DOI 10.1016/j.iac.2005.02.004; Han H, 2012, MUCOSAL IMMUNOL, V5, P342, DOI 10.1038/mi.2012.14; Heinisch IVWM, 2001, J ALLERGY CLIN IMMUN, V108, P21, DOI 10.1067/mai.2001.116864; Imai Y, 2006, CLIN EXP ALLERGY, V36, P1462, DOI 10.1111/j.1365-2222.2006.02574.x; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jaakkola JJK, 2000, AM J PUBLIC HEALTH, V90, P797, DOI 10.2105/AJPH.90.5.797; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P560, DOI 10.2105/AJPH.94.4.560; Jaakkola JJK, 2008, ENVIRON HEALTH PERSP, V116, P845, DOI 10.1289/ehp.10846; Kavlock R, 2002, REPROD TOXICOL, V16, P721, DOI 10.1016/S0890-6238(02)00031-X; Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007; Larsen JM, 2009, J ALLERGY CLIN IMMUN, V123, P486, DOI 10.1016/j.jaci.2008.09.036; Larson RP, 2010, J IMMUNOL, V184, P2974, DOI 10.4049/jimmunol.0803478; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Leyva-Castillo JM, 2013, J INVEST DERMATOL, V133, P154, DOI 10.1038/jid.2012.239; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690; Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Novak N, 2003, J ALLERGY CLIN IMMUN, V112, P252, DOI 10.1067/mai.2003.1595; Shiba T, 2012, TOXICOL APPL PHARM, V264, P370, DOI 10.1016/j.taap.2012.08.012; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Takano H, 2006, ENVIRON HEALTH PERSP, V114, P1266, DOI 10.1289/ehp.8985; Takeshita K, 2004, INT IMMUNOL, V16, P685, DOI 10.1093/intimm/dxh073; Tang AM, 1996, J IMMUNOL, V157, P117; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Tuomainen A, 2006, ENVIRON HEALTH PERSP, V114, P1409, DOI 10.1289/ehp.8965; VANREIJSEN FC, 1992, J ALLERGY CLIN IMMUN, V90, P184, DOI 10.1016/0091-6749(92)90070-I; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zeng Q, 2013, FOOD CHEM TOXICOL, V56, P18, DOI 10.1016/j.fct.2013.01.045; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P1536, DOI 10.1073/pnas.0812668106	45	13	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87887	10.1371/journal.pone.0087887	http://dx.doi.org/10.1371/journal.pone.0087887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498391	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900137
J	Li, PC; Yang, YC; Hwang, GY; Kao, LS; Lin, CY				Li, Ping-Chun; Yang, Ya-Chi; Hwang, Guang-Yuh; Kao, Lung-Sen; Lin, Ching-Yuang			Inhibition of Reverse-Mode Sodium-Calcium Exchanger Activity and Apoptosis by Levosimendan in Human Cardiomyocyte Progenitor Cell-Derived Cardiomyocytes after Anoxia and Reoxygenation	PLOS ONE			English	Article							MYOCARDIAL INFARCT SIZE; CARDIAC STEM-CELLS; REPERFUSION INJURY; BLOOD-FLOW; HEART; HEMODYNAMICS; PROTECTION; ISCHEMIA; CHANNELS; CORONARY	Levosimendan, a known calcium sensitizer with positive inotropic and vasodilating properties, might also be cardioprotective during ischemia-reperfusion (I/R) insult. Its effects on calcium homeostasis and apoptosis in I/R injury remain unclear. Na+/Ca2+ exchanger (NCX) is a critical mediator of calcium homeostasis in cardiomyocytes, with reverse-mode NCX activity responsible for intracellular calcium overload and apoptosis of cardiomyocytes during I/R. We probed effects and underlying mechanisms of levosimendan on apoptosis and NCX activity in cultured human cardiomyocyte progenitor cells (CPC)-derived cardiomyocytes undergoing anoxia-reoxygenation (A/R), simulating I/R in vivo. Administration of levosimendan decreased apoptosis of CPC-derived cardiomyocytes induced by A/R. The increase in reverse-mode NCX activity after A/R was curtailed by levosimendan, and NCX1 was translocated away from the cell membrane. Concomitantly, endoplasmic reticulum (ER) stress response induced by A/R was attenuated in CPC-derived cardiomycytes treated with NCX-targeted siRNA or levosimendan, with no synergistic effect between treatments. Results indicated levosimendan inhibited reverse-mode NCX activity to protect CPC-derived cardiomyocytes from A/R-induced ER stress and cell death.	[Li, Ping-Chun] China Med Univ Hosp, Dept Surg, Div Cardiovasc Surg, Taichung, Taiwan; [Li, Ping-Chun; Hwang, Guang-Yuh] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Yang, Ya-Chi; Kao, Lung-Sen] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Yang, Ya-Chi; Kao, Lung-Sen] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Lin, Ching-Yuang] China Med Univ Hosp, Clin Immunol Ctr, Taichung, Taiwan; [Lin, Ching-Yuang] China Med Univ, Coll Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; Tunghai University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Lin, CY (corresponding author), China Med Univ Hosp, Clin Immunol Ctr, Taichung, Taiwan.	cylin@mail.cmuh.org.tw						Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Busk M, 2006, CARDIOVASC DRUG THER, V20, P335, DOI 10.1007/s10557-006-0294-0; Chang KC, 2008, P NATL ACAD SCI USA, V105, P4477, DOI 10.1073/pnas.0709118105; du Toit E, 2001, HEART, V86, P81, DOI 10.1136/heart.86.1.81; Eriksson O, 2004, J CARDIOVASC PHARM, V44, P316, DOI 10.1097/01.fjc.0000137163.22359.17; Garcia-Gonzalez M J, 2007, Minerva Cardioangiol, V55, P625; Grossini E, 2010, CARDIOVASC DRUG THER, V24, P5, DOI 10.1007/s10557-010-6217-0; Hu D, 1999, CELL IMMUNOL, V195, P43, DOI 10.1006/cimm.1999.1513; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Kersten JR, 2000, ANESTH ANALG, V90, P5, DOI 10.1097/00000539-200001000-00003; KORCHAK HM, 1982, BIOCHEM BIOPH RES CO, V108, P1495, DOI 10.1016/S0006-291X(82)80076-4; KUSUOKA H, 1993, J AM COLL CARDIOL, V21, P240, DOI 10.1016/0735-1097(93)90743-K; Lilleberg J, 1998, EUR HEART J, V19, P660, DOI 10.1053/euhj.1997.0806; Mattiello JA, 1998, CARDIOVASC RES, V37, P424, DOI 10.1016/S0008-6363(97)00271-X; Maytin M, 2005, AM J CARDIOL, V96, p26G, DOI 10.1016/j.amjcard.2005.07.018; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Papp Z, 2012, INT J CARDIOL, V159, P82, DOI 10.1016/j.ijcard.2011.07.022; Scheiermann P, 2011, CARDIOVASCULAR DRUG, V6, P20; Shintani-Ishida K, 2006, BIOCHEM BIOPH RES CO, V345, P1600, DOI 10.1016/j.bbrc.2006.05.077; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Verma S, 2002, CIRCULATION, V105, P2332, DOI 10.1161/01.CIR.0000016602.96363.36; Wang HH, 2011, J CELL PHYSIOL, V226, P94, DOI 10.1002/jcp.22309; Yamada M, 2010, J PHYSIOL-LONDON, V588, P283, DOI 10.1113/jphysiol.2009.179028; Yang YC, 2010, J BIOL CHEM, V285, P28275, DOI 10.1074/jbc.M110.141424; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	27	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e85909	10.1371/journal.pone.0085909	http://dx.doi.org/10.1371/journal.pone.0085909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498266	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900012
J	Lin, CJ; Chang, CC; Liu, BS				Lin, Chiuhsiang Joe; Chang, Chi-Chan; Liu, Bor-Shong			Developing and Evaluating a Target-Background Similarity Metric for Camouflage Detection	PLOS ONE			English	Article								Background: Measurement of camouflage performance is of fundamental importance for military stealth applications. The goal of camouflage assessment algorithms is to automatically assess the effect of camouflage in agreement with human detection responses. In a previous study, we found that the Universal Image Quality Index (UIQI) correlated well with the psychophysical measures, and it could be a potentially camouflage assessment tool. Methodology: In this study, we want to quantify the camouflage similarity index and psychophysical results. We compare several image quality indexes for computational evaluation of camouflage effectiveness, and present the results of an extensive human visual experiment conducted to evaluate the performance of several camouflage assessment algorithms and analyze the strengths and weaknesses of these algorithms. Significance: The experimental data demonstrates the effectiveness of the approach, and the correlation coefficient result of the UIQI was higher than those of other methods. This approach was highly correlated with the human target-searching results. It also showed that this method is an objective and effective camouflage performance evaluation method because it considers the human visual system and image structure, which makes it consistent with the subjective evaluation results.	[Lin, Chiuhsiang Joe; Chang, Chi-Chan] Natl Taiwan Univ Sci & Technol, Dept Ind Management, Taipei, Taiwan; [Liu, Bor-Shong] St Johns Univ, Dept Ind Engn & Management, New Taipei City, Taiwan	National Taiwan University of Science & Technology	Lin, CJ (corresponding author), Natl Taiwan Univ Sci & Technol, Dept Ind Management, Taipei, Taiwan.	cjoelin@mail.ntust.edu.tw		Liu, Bor-Shong/0000-0002-9318-1335	National Taiwan University of Science and Technology	National Taiwan University of Science and Technology	This study was funded by the National Taiwan University of Science and Technology, where the authors work and study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYCE SJ, 1992, J EXP PSYCHOL LEARN, V18, P531, DOI 10.1037/0278-7393.18.3.531; Cadik M, 2004, IEEE INFOR VIS, P513, DOI 10.1109/IV.2004.1320193; Chang CC, 2012, PERCEPT MOTOR SKILL, V114, P1; Copeland AC, 2001, OPT ENG, V40, P1885, DOI 10.1117/1.1390297; Doll TJ, 1999, NATO RES TECHNOLOGY, V45, P1; Doll TJ, 1993, P SPIE INT; Ehmke C, 2007, BRIT COMP SOC C HUM; Engeldrum P. G., 1999, IS TS 1999 PICS C SA, P251; Farrell J.E., 1999, COLOUR IMAGING VISIO, P285; Findlay JM, 1997, VISION RES, V37, P617, DOI 10.1016/S0042-6989(96)00218-0; Goldberg JH, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P493, DOI 10.1016/B978-044451020-4/50027-X; Hogervorst MA, 2010, SPIE, V7662, P1; Hore Alain, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2366, DOI 10.1109/ICPR.2010.579; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; KILIAN JC, 1992, P SOC PHOTO-OPT INS, V1687, P358, DOI 10.1117/12.137864; Kreis R, 2004, NMR BIOMEDECINE, P17361; Li L, 2008, 2008 INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY APPLICATION, VOL II, PROCEEDINGS, P181, DOI 10.1109/IITA.2008.215; Lin CJ, 2013, APPL ERGONO IN PRESS, DOI DOI 10.1016/J.APERG0.2013.09.012); Muller T, 2007, P SOC PHOTO-OPT INS, V6543, P701; O'Neill T, 1977, FIELD EVALUATION DUA; O'Neill T, 1977, PSYCHOMETRIC CORRELA; Piella G, 2003, 2003 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL 3, PROCEEDINGS, P173; Poole A., 2005, ENCY HUMAN COMPUTER, P211, DOI DOI 10.4018/978-1-59140-562-7; Research and Technology Organisation (RTO) of NATO, 2006, NATO PUBL; Santos LDM, 2004, US patent, Patent No. [6 805 957 B1, 6805957, 6,805,957]; Toet A., 2000, RTO MP 045; U.S. Army Natick Soldier Research Development and Engineering Center Natick, 2009, US ARM NAT SOLD RES; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823; Watson AB, 1997, SPATIAL VISION, V10, P447, DOI 10.1163/156856897X00384; Williams Stefan B., 2009, 2009 IEEE International Conference on Robotics and Automation (ICRA), P214, DOI 10.1109/ROBOT.2009.5152868	32	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87310	10.1371/journal.pone.0087310	http://dx.doi.org/10.1371/journal.pone.0087310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498310	Green Submitted, gold, Green Published			2022-12-25	WOS:000330626900056
J	Shen, M; Lu, J; Cheng, P; Lin, CL; Dai, WQ; Wang, F; Wang, CF; Zhang, Y; Chen, K; Xu, L; Zhou, YQ; Guo, CY				Shen, Miao; Lu, Jie; Cheng, Ping; Lin, Chunlei; Dai, Weiqi; Wang, Fan; Wang, Chengfen; Zhang, Yan; Chen, Kan; Xu, Ling; Zhou, Yinqun; Guo, Chuanyong			Ethyl Pyruvate Pretreatment Attenuates Concanavalin A-Induced Autoimmune Hepatitis in Mice	PLOS ONE			English	Article							SEVERE ACUTE-PANCREATITIS; CHRONIC LIVER-FAILURE; GROUP BOX 1; HUMAN MONOCYTES; LETHAL SEPSIS; RECEPTOR 4; INJURY; PROTEIN; EXPRESSION; HMGB1	Pharmacological Relevance: Ethyl pyruvate (EP), a potent reactive oxygen species scavenger, has been reported to contribute to the inflammatory process. However, the protective effect of ethyl pyruvate on Concanavalin A (Con A)-induced autoimmune hepatitis have not been explored. Thus, the aims of this study are to investigate both the effects of ethyl pyruvate and its mechanism of protection on Con A-induced autoimmune hepatitis in mice. Materials and Methods: Acute autoimmune hepatitis was induced by Con A (20 mg/kg) in Balb/C mice; ethyl pyruvate (40 mg/kg and 80 mg/kg) was administrated 1h prior to the Con A injection. At 3h, 6h and 24h post Con A injection, histological grading, proinflammatory cytokine levels and nuclear factor kappa B (NF-kappa B) activity were determined. Results: Following Con A challenge, cytokines TNF-alpha, IL-2, IL-1 beta and IL-6 were expressed at 3h and 6h, and the level of HMGB1 significantly increased by 24h. Pretreatment with ethyl pyruvate ameliorated the pathological effects of Con A-induced autoimmune hepatitis and significantly decreased the levels of TNF-alpha, IL-2, IL-6 and IL-1 beta at 3h and 6h and the level of HMGB1 at 6h and 24h post injection. Ethyl pyruvate blocked the degradation of I kappa B alpha and I kappa B beta and decreased the expression of NF-kappa B at 24h. Conclusion: Taken together, these results indicated that ethyl pyruvate protected against Con A-induced autoimmune hepatitis by decreasing both early (TNF-alpha, IL-2, IL-1 beta and IL-6) and late (HMGB1) cytokine expression in mice. The reduction of HMGB1 may correlate with the amelioration of NF-kappa B activity.	[Shen, Miao; Lu, Jie; Cheng, Ping; Lin, Chunlei; Dai, Weiqi; Wang, Fan; Wang, Chengfen; Zhang, Yan; Chen, Kan; Xu, Ling; Zhou, Yinqun; Guo, Chuanyong] Tongji Univ Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai, Peoples R China	Tongji University	Zhou, YQ (corresponding author), Tongji Univ Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai, Peoples R China.	yqzh02@163.com; guochuanyong@hotmail.com		Guo, Chuanyong/0000-0002-6527-4673	National Natural Science Foundation of China [81101579, 81270515]; Shanghai Science and Technology Innovation Plan of Action for international cooperation projects [11430702400]; China Foundation for Hepatitis Prevention and Control WBN Liver Disease Research Fund [20100021, 20120005]; Shanghai Health Bureau issues [2011287, 2012107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Innovation Plan of Action for international cooperation projects; China Foundation for Hepatitis Prevention and Control WBN Liver Disease Research Fund; Shanghai Health Bureau issues	This work was supported by the National Natural Science Foundation of China (No. 81101579 and 81270515), the Shanghai Science and Technology Innovation Plan of Action for international cooperation projects (No. 11430702400), the China Foundation for Hepatitis Prevention and Control WBN Liver Disease Research Fund (No. 20100021 and 20120005), and the Shanghai Health Bureau issues (No. 2011287 and 2012107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Andrassy M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052081; BEASLEY RP, 1982, HEPATOLOGY, V2, P553; Fink MP, 2007, J INTERN MED, V261, P349, DOI 10.1111/j.1365-2796.2007.01789.x; Gong QA, 2010, J MOL MED, V88, P1289, DOI 10.1007/s00109-010-0681-7; Huang JM, 2013, J CRIT CARE, V28, P792, DOI 10.1016/j.jcrc.2012.10.003; Kang R, 2013, ONCOGENE; Kim S, 2013, MOL MED, V19, P88, DOI 10.2119/molmed.2012.00306; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Li W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001153; Luan ZG, 2012, PANCREAS, V41, P729, DOI 10.1097/MPA.0b013e31823cd3ef; Nakamura K, 2001, J HEPATOL, V35, P217, DOI 10.1016/S0168-8278(01)00109-X; Nogueira-Machado JA, 2012, RECENT PATENTS ENDOC, V6, P201, DOI 10.2174/187221412802481784; Pisetsky DS, 2013, ANTIOXID REDOX SIGNA, DOI 10.1089/ars.2012.5143; Rosas-Ballina M, 2009, MOL MED, V15, P195, DOI 10.2119/molmed.2009.00039; Sass G, 2002, CYTOKINE, V19, P115, DOI 10.1006/cyto.2002.1948; Sawa H, 2006, WORLD J GASTROENTERO, V12, P7666, DOI 10.3748/wjg.v12.i47.7666; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tang DL, 2009, AM J RESP CELL MOL, V41, P651, DOI 10.1165/rcmb.2008-0119OC; Tiegs G, 2007, Z GASTROENTEROL, V45, P63, DOI 10.1055/s-2006-927397; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tong HS, 2013, J TRAUMA ACUTE CARE, V74, P801, DOI 10.1097/TA.0b013e31827e9a65; Tu CT, 2012, FOOD CHEM TOXICOL, V50, P3343, DOI 10.1016/j.fct.2012.05.050; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Wang CM, 2013, MOL MED REP, V7, P499, DOI 10.3892/mmr.2012.1181; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang LW, 2012, WORLD J GASTROENTERO, V18, P5709, DOI 10.3748/wjg.v18.i40.5709; Watanabe T, 2005, J SURG RES, V124, P59, DOI 10.1016/j.jss.2004.10.019; Wolf D, 2001, J IMMUNOL, V166, P1300, DOI 10.4049/jimmunol.166.2.1300; Xu Xin-hui, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P750; Yasuda T, 2007, PANCREAS, V34, P487, DOI 10.1097/MPA.0b013e31804154e4; Zhang XA, 2010, HEPATOL INT, V4, P641, DOI 10.1007/s12072-010-9196-0; Zhou RR, 2012, EXP MOL PATHOL, V93, P213, DOI 10.1016/j.yexmp.2012.05.006; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2	36	71	76	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87977	10.1371/journal.pone.0087977	http://dx.doi.org/10.1371/journal.pone.0087977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498418	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900164
J	Sripriyalakshmi, S; Anjali, CH; Doss, CGP; Rajith, B; Ravindran, A				Sripriyalakshmi, S.; Anjali, C. H.; Doss, George Priya C.; Rajith, B.; Ravindran, Aswathy			BSA Nanoparticle Loaded Atorvastatin Calcium - A New Facet for an Old Drug	PLOS ONE			English	Article							SERUM-ALBUMIN; BOVINE; DELIVERY; CYTOTOXICITY; APOPTOSIS; DOCKING	Background: Currently, the discovery of effective chemotherapeutic agents poses a major challenge to the field of cancer biology. The present study focuses on enhancing the therapeutic and anti cancer properties of atorvastatin calcium loaded BSA (ATV-BSA) nanoparticles in vitro. Methodology/Results: BSA-ATV nanoparticles were prepared using desolvation technique. The process parameters were optimized based on the amount of desolvating agent, stabilization conditions as well as the concentration of the cross linker. The anti cancer properties of the protein coated ATV nanoparticles were tested on MiaPaCa-2 cell lines. In vitro release behavior of the drug from the carrier suggests that about 85% of the drug gets released after 72 hrs. Our studies show that ATV-BSA nanoparticles showed specific targeting and enhanced cytotoxicity to MiaPaCa-2 cells when compared to the bare ATV. Conclusion: We hereby propose that the possible mechanism of cellular uptake of albumin bound ATV could be through caveolin mediated endocytosis. Hence our studies open up new facet for an existing cholesterol drug as a potent anticancer agent.	[Sripriyalakshmi, S.; Anjali, C. H.; Ravindran, Aswathy] SASTRA Univ, Sch Chem & Biotechnol, Ctr Nanotechnol & Adv Biomat CeNTAB, Tirumalaisamudram, Thanjavur, India; [Doss, George Priya C.; Rajith, B.] VIT Univ, Sch Biosci & Technol, Med Biotechnol Div, Vellore, Tamil Nadu, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Vellore Institute of Technology	Ravindran, A (corresponding author), SASTRA Univ, Sch Chem & Biotechnol, Ctr Nanotechnol & Adv Biomat CeNTAB, Tirumalaisamudram, Thanjavur, India.	aswathy85@gmail.com	C, George/ABE-4676-2021; Alizadeh/AAK-1398-2021	C, George Priya Doss/0000-0002-5971-8290				Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Brigger I, 2009, ADV DRUG DELIV REV, V54, P631; CARTER DC, 1990, SCIENCE, V249, P302, DOI 10.1126/science.2374930; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doshi N, 2009, ADV FUNCT MATER, V19, P3843, DOI 10.1002/adfm.200901538; Eom HJ, 2010, ENVIRON SCI TECHNOL, V44, P8337, DOI 10.1021/es1020668; Fromigue O, 2006, CELL DEATH DIFFER, V13, P1845, DOI 10.1038/sj.cdd.4401873; Fromigue O, 2008, J PHARMACOL EXP THER, V325, P595, DOI 10.1124/jpet.108.136127; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Irache JM, 2005, MINI-REV MED CHEM, V5, P293, DOI 10.2174/1389557053175335; Jana S, 2002, PHOTOCH PHOTOBIO SCI, V1, P323, DOI 10.1039/c1pp05180f; Jhonsi MA, 2009, COLLOID SURFACE B, V72, P167, DOI 10.1016/j.colsurfb.2009.03.030; Jiang W, 2007, EXPERT OPIN DRUG DEL, V4, P621, DOI 10.1517/17425247.4.6.621; Jithan AV, 2011, INT J PHARM INVESTIG, V1, P119, DOI 10.4103/2230-973X.82432; Joshi P, 2011, J COLLOID INTERF SCI, V355, P402, DOI 10.1016/j.jcis.2010.12.032; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0; Lin W, 1993, J DRUG TARGET, V1, P237, DOI 10.3109/10611869308996081; Majorek KA, 2012, MOL IMMUNOL, V52, P174, DOI 10.1016/j.molimm.2012.05.011; MARTY JJ, 1978, PHARM ACTA HELV, V53, P17; Merodio M, 2001, EUR J PHARM SCI, V12, P251, DOI 10.1016/S0928-0987(00)00169-X; Moriyama Y, 1996, J PROTEIN CHEM, V15, P265, DOI 10.1007/BF01887115; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Ruizendaal L, 2009, NANOTOXICOLOGY, V3, P339, DOI 10.3109/17435390903288896; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sardar PS, 2008, J PHYS CHEM B, V112, P3451, DOI 10.1021/jp074598+; Sieczkowski E, 2010, INT J CANCER, V126, P2025, DOI 10.1002/ijc.24885; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; [王耀普 WANG Yao-pu], 2010, [介入放射学杂志, Journal of Interventional Radiology], V19, P214; Weber C, 2000, INT J PHARM, V194, P91, DOI 10.1016/S0378-5173(99)00370-1	32	43	44	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86317	10.1371/journal.pone.0086317	http://dx.doi.org/10.1371/journal.pone.0086317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498272	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900018
J	Zhao, YY; Miao, G; Li, Y; Isaji, T; Gu, JG; Li, J; Qi, RM				Zhao, Yanyang; Miao, Gang; Li, Yao; Isaji, Tomoya; Gu, Jianguo; Li, Jian; Qi, Ruomei			Microrna 130b Suppresses Migration and Invasion of Colorectal Cancer Cells through Downregulation of Integrin beta 1	PLOS ONE			English	Article							KINASE EXPRESSION INCREASES; FOCAL ADHESION KINASE; MALIGNANT PHENOTYPE; TUMOR; METASTASIS; CARCINOMA; BREAST; GROWTH; ROLES; PROLIFERATION	MicroRNA 130b (miR-130b) is significantly dysregulated in various human tumor types. In this study, using a microarray assay, we characterized the upregulation of miR-130b expression in colorectal cancer (CRC) specimens. However, there is limited knowledge about the roles of aberrant miR-130b expression in CRC. Our studies in CRC cells demonstrated that miR-130b significantly decreases cell migration and invasion, but it has no evidently effects on cell proliferation and apoptosis. In the overexpression miR-130b CRC cells and the CRC specimens, we observed a decreased level of integrin beta 1 protein, which is considered as a key molecule involved in cell motility. The targeting of the 3'-UTR region of integrin beta 1 gene by miR-130b was revealed using a luciferase reporter assay. The regulation of integrin beta 1 by miR-130b was further shown using the miR130b mimics and the inhibitor of miR-130b. The impaired motility of the miR-130b overexpression cells is recovered partly by the expression of integrin beta 1 lacking the 3'-UTR. Additionally, the knockdown of integrin beta 1 also gives rise to a decrease in cell migration and invasion, which is similar to the impeded motility due to overexpression of miR-130b in CRC cells. Furthermore, the inverse expressions of miR-130b and integrin beta 1 were observed in CRC specimens. In summary, these data demonstrate that miR-130b downregulates its target-integrin beta 1, leading to the impaired migration and invasion of CRC cells.	[Zhao, Yanyang; Li, Jian; Qi, Ruomei] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Zhao, Yanyang; Li, Jian; Qi, Ruomei] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Miao, Gang; Li, Yao] Beijing Hosp, Minist Hlth, Dept Surg, Beijing, Peoples R China; [Isaji, Tomoya; Gu, Jianguo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi, Japan	Beijing Hospital; Beijing Hospital; Tohoku Medical & Pharmaceutical University	Zhao, YY (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China.	yanyangzhaobj@gmail.com; miaogang72@hotmail.com	Isaji, Tomoya/ABC-9285-2021; Gu, Jianguo/ABC-9257-2020	Miao, Gang/0000-0003-1826-3733	National Natural Science Foundation of China [81101859, 81270379, 81070231]; Beijing Natural Science Foundation [5102039]; Grants-in-Aid for Scientific Research [24570169] Funding Source: KAKEN	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Natural Science Foundation of China Grant 81101859, National Natural Science Foundation of China Grant 81270379, National Natural Science Foundation of China Grant 81070231 and Beijing Natural Science Foundation 5102039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2003, J PATHOL, V201, P229, DOI 10.1002/path.1441; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Brockbank EC, 2005, BRIT J CANCER, V92, P102, DOI 10.1038/sj.bjc.6602255; CANNISTRA SA, 1995, GYNECOL ONCOL, V58, P216, DOI 10.1006/gyno.1995.1214; Casey RC, 2000, CLIN EXP METASTAS, V18, P67, DOI 10.1023/A:1026519016213; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Dong P, 2012, ONCOGENE IN PRESS; Felding-Habermann B, 2003, CLIN EXP METASTAS, V20, P203, DOI 10.1023/A:1022983000355; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Graff JR, 2001, CLIN CANCER RES, V7, P1987; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hur K., 2012, GUT IN PRESS; Hynes RO, 2002, COLD SPRING HARB SYM, V67, P143, DOI 10.1101/sqb.2002.67.143; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; KEMPERMAN H, 1994, INVAS METAST, V14, P98; Kim BH, 2013, J SURG ONCOL, V107, P505, DOI 10.1002/jso.23271; Lai KW, 2010, EUR J CANCER, V46, P1456, DOI 10.1016/j.ejca.2010.01.036; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li S, 2009, HEPATOLOGY, V49, P1194, DOI 10.1002/hep.22757; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Marotta A, 2001, ONCOGENE, V20, P6250, DOI 10.1038/sj.onc.1204791; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Oktay MH, 2003, HUM PATHOL, V34, P240, DOI 10.1053/hupa.2003.40; Ramsay AG, 2007, CANCER METAST REV, V26, P567, DOI 10.1007/s10555-007-9078-7; Sand M, 2013, CELL TISSUE RES, V351, P85, DOI 10.1007/s00441-012-1514-5; Scheffer AR, 2012, WORLD J URO IN PRESS; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wennerberg K, 2000, MOL CELL BIOL, V20, P5758, DOI 10.1128/MCB.20.15.5758-5765.2000; White DE, 2007, J MAMMARY GLAND BIOL, V12, P135, DOI 10.1007/s10911-007-9045-5; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Yang C, 2011, GYNECOL ONCOL, V124, P325; Yip L, 2011, ANN SURG ONCOL, V18, P2035, DOI 10.1245/s10434-011-1733-0; Zhao G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073803; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	48	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87938	10.1371/journal.pone.0087938	http://dx.doi.org/10.1371/journal.pone.0087938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498407	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900153
J	Komolka, K; Albrecht, E; Schering, L; Brenmoehl, J; Hoeflich, A; Maak, S				Komolka, Katrin; Albrecht, Elke; Schering, Lisa; Brenmoehl, Julia; Hoeflich, Andreas; Maak, Steffen			Locus Characterization and Gene Expression of Bovine FNDC5: Is the Myokine Irisin Relevant in Cattle?	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; CIRCULATING LEVELS; ADIPOSE-TISSUE; EXERCISE; MUSCLE; DIFFERENTIATION; MUTATIONS; PROTEIN; HUMANS; PLASMA	The transmembrane protein FNDC5 was recently characterized as precursor of an exercise induced myokine named irisin. Previous studies found a relationship between circulating irisin levels and muscle mass in humans. Consequently, we tested the hypothesis whether FNDC5/irisin is involved in the modulation of body composition in cattle. Since information on the bovine FNDC5 locus was scarce, we characterized the gene experimentally as prerequisite for these investigations. We provide here a revised and extended gene model for bovine FNDC5. Although similarly organized like the human and murine loci, a higher variability was observed at transcript level in the bovine locus. FNDC5 mRNA was abundant in bovine skeletal muscle and was detected at lower levels in adipose tissue and liver. There were no expression differences between two groups of bulls highly different in muscularity and adiposity. Full-length FNDC5 protein (25 kDa) was present in bovine skeletal muscle independent of muscularity. Neither FNDC5 nor its putatively secreted peptide irisin were found in circulation of bulls. In contrast, we demonstrated that FNDC5 (25 kDa) and irisin (12 kDa) were present in murine skeletal muscle and that irisin was circulating in murine serum. This indicates fundamental differences in the regulation of FNDC5 and irisin between rodents and cattle.	[Komolka, Katrin; Albrecht, Elke; Schering, Lisa; Maak, Steffen] Leibniz Inst Farm Anim Biol FBN Dummerstorf, Inst Muscle Biol & Growth, Dummerstorf, Germany; [Brenmoehl, Julia; Hoeflich, Andreas] Leibniz Inst Farm Anim Biol FBN Dummerstorf, Inst Genome Biol, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Maak, S (corresponding author), Leibniz Inst Farm Anim Biol FBN Dummerstorf, Inst Muscle Biol & Growth, Dummerstorf, Germany.	maak@fbn-dummerstorf.de	Albrecht, Elke/ABB-6155-2021	Albrecht, Elke/0000-0001-5974-1514; Hoeflich, Andreas/0000-0003-2018-2836	Leibniz Association [SAW-2013-FBN-3]	Leibniz Association	This work was supported in part by the Leibniz Association (grant no. SAW-2013-FBN-3). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035282; Bostrom P, 2012, NATURE, V488, pE10, DOI 10.1038/nature11365; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; Dun SL, 2013, NEUROSCIENCE, V240, P155, DOI 10.1016/j.neuroscience.2013.02.050; Erickson HP, 2013, ADIPOCYTE, V2, P289, DOI 10.4161/adip.26082; Fain JN, 2013, METABOLISM, V62, P1503, DOI 10.1016/j.metabol.2013.05.021; Ferrer-Martinez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099; Gouni-Berthold I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072858; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Hashemi MS, 2013, NEUROSCIENCE, V231, P296, DOI 10.1016/j.neuroscience.2012.11.041; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Karim L, 2000, ANIM GENET, V31, P396, DOI 10.1046/j.1365-2052.2000.00684.x; Komolka K, 2013, J GENOMICS, V2, P31; Kraemer RR, 2013, HORM METAB IN PRESS; Kuhn C, 2002, ARCH TIERZUCHT, V45, P317; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Moraes C, 2013, HORM METAB RES, V45, P900, DOI 10.1055/s-0033-1354402; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Pekkala S, 2013, J PHYSIOL-LONDON, V591, P5393, DOI 10.1113/jphysiol.2013.263707; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfuhl R, 2007, ARCH TIERZUCHT, V50, P59, DOI 10.5194/aab-50-59-2007; Polyzos SA, 2013, METABOLISM IN PRESS; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073680; Raschke S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/320724; Roberts MD, 2013, METABOLISM, V62, P1052, DOI 10.1016/j.metabol.2013.02.002; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Sanchez J, 2013, MOL NUTR FOOD RES, V57, P1456, DOI 10.1002/mnfr.201300126; Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; Sharma N, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-90; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Stephenson EJ, 2012, J APPL PHYSIOL, V113, P1403, DOI 10.1152/japplphysiol.00788.2012; Swick AG, 2013, METABOLISM, V62, P1070, DOI 10.1016/j.metabol.2013.02.012; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Vamvini MT, 2013, EUR J ENDOCRINOL, V169, P829, DOI 10.1530/EJE-13-0276; Vaughan RA, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-142; Weikard R, 2010, PHYSIOL GENOMICS, V42A, P79, DOI 10.1152/physiolgenomics.00120.2010; Wen MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064025; Zhang HJ, 2013, J HEPATOL, V59, P557, DOI 10.1016/j.jhep.2013.04.030	44	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e88060	10.1371/journal.pone.0088060	http://dx.doi.org/10.1371/journal.pone.0088060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498244	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900210
J	Patel, HK; Ferrante, P; Covaceuszach, S; Lamba, D; Scortichini, M; Venturi, V				Patel, Hitendra Kumar; Ferrante, Patrizia; Covaceuszach, Sonia; Lamba, Doriano; Scortichini, Marco; Venturi, Vittorio			The Kiwifruit Emerging Pathogen Pseudomonas syringae pv. actinidiae Does Not Produce AHLs but Possesses Three LuxR Solos	PLOS ONE			English	Article							QUORUM-SENSING SYSTEM; LACTONE SIGNAL MOLECULES; TO-CELL COMMUNICATION; BACTERIAL CANKER; XANTHOMONAS-ORYZAE; ESCHERICHIA-COLI; GENE-EXPRESSION; 1ST REPORT; AUREOFACIENS 30-84; CRYSTAL-STRUCTURE	Pseudomonas syringae pv. actinidiae (Psa) is an emerging phytopathogen causing bacterial canker disease in kiwifruit plants worldwide. Quorum sensing (QS) gene regulation plays important roles in many different bacterial plant pathogens. In this study we analyzed the presence and possible role of N-acyl homoserine lactone (AHL) quorum sensing in Psa. It was established that Psa does not produce AHLs and that a typical complete LuxI/R QS system is absent in Psa strains. Psa however possesses three putative luxR solos designated here as PsaR1, PsaR2 and PsaR3. PsaR2 belongs to the sub-family of LuxR solos present in many plant associated bacteria (PAB) that binds and responds to yet unknown plant signal molecules. PsaR1 and PsaR3 are highly similar to LuxRs which bind AHLs and are part of the canonical LuxI/R AHL QS systems. Mutation in all the three luxR solos of Psa showed reduction of in planta survival and also showed additive effect if more than one solo was inactivated in double mutants. Gene promoter analysis revealed that the three solos are not auto-regulated and investigated their possible role in several bacterial phenotypes.	[Patel, Hitendra Kumar; Venturi, Vittorio] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Ferrante, Patrizia; Scortichini, Marco] Agr Res Council, Res Ctr Fruit Crops, Rome, Italy; [Scortichini, Marco] Agr Res Council, Res Unit Fruit Trees, Caserta, Italy; [Covaceuszach, Sonia; Lamba, Doriano] UOS Trieste, Consiglio Nazl Ric, Ist Cristallog, Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR)	Venturi, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	venturi@icgeb.org	Lamba, Doriano/B-2961-2011; Lamba, Doriano/L-9808-2018; Venturi, Vittorio/AAO-3069-2021; Covaceuszach, Sonia/AAA-4116-2021	Lamba, Doriano/0000-0001-6859-7868; Lamba, Doriano/0000-0001-6859-7868; FERRANTE, PATRIZIA/0000-0001-7577-9096; Venturi, Vittorio/0000-0003-4307-5697; Scortichini, Marco/0000-0003-1565-9097	ICGEB	ICGEB	HKP was funded by an ICGEB Pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2011, PLANT DIS, V95, P1583, DOI 10.1094/PDIS-06-11-0537; Ahmer BMM, 1998, J BACTERIOL, V180, P1185, DOI 10.1128/JB.180.5.1185-1193.1998; Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Australia B, 2011, PEST RISK ANAL REPOR; Balestra GM, 2010, NEW DIS REPORTS, V22; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Bastas KK, 2012, PLANT DIS, V96, P452, DOI 10.1094/PDIS-08-11-0675; Bertani I, 2004, APPL ENVIRON MICROB, V70, P5493, DOI 10.1128/AEM.70.9.5493-5502.2004; BETTER M, 1983, CELL, V35, P479, DOI 10.1016/0092-8674(83)90181-2; BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Butler MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057464; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Case RJ, 2008, ISME J, V2, P345, DOI 10.1038/ismej.2008.13; Chatnaparat T, 2012, MOL PLANT MICROBE IN, V25, P1104, DOI 10.1094/MPMI-01-12-0008-R; Chen GZ, 2007, P NATL ACAD SCI USA, V104, P16474, DOI 10.1073/pnas.0704843104; CHOI SH, 1992, J BACTERIOL, V174, P4064, DOI 10.1128/jb.174.12.4064-4069.1992; CHOI SH, 1991, P NATL ACAD SCI USA, V88, P11115, DOI 10.1073/pnas.88.24.11115; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Covaceuszach S, 2013, INT J MOL SCI, V14, P20578, DOI 10.3390/ijms141020578; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEVINE JH, 1989, P NATL ACAD SCI USA, V86, P5688, DOI 10.1073/pnas.86.15.5688; Dumenyo CK, 1998, EUR J PLANT PATHOL, V104, P569, DOI 10.1023/A:1008651300599; El-Sayed AK, 2001, MICROBIOL-SGM, V147, P2127, DOI 10.1099/00221287-147-8-2127; Everett KR, 2011, AUSTRALAS PLANT DIS, V6, P67, DOI 10.1007/s13314-011-0023-9; Farrand SK, 2002, METHOD ENZYMOL, V358, P452; Ferluga S, 2009, J BACTERIOL, V191, P890, DOI 10.1128/JB.01507-08; Ferluga S, 2007, MOL PLANT PATHOL, V8, P529, DOI [10.1111/j.1364-3703.2007.00415.x, 10.1111/J.1364-3703.2007.00415.X]; Ferrante P, 2010, PLANT PATHOL, V59, P954, DOI 10.1111/j.1365-3059.2010.02304.x; Ferrante P, 2009, J PHYTOPATHOL, V157, P768, DOI 10.1111/j.1439-0434.2009.01550.x; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Fuqua C, 2006, J BACTERIOL, V188, P3169, DOI 10.1128/JB.188.9.3169-3171.2006; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gonzalez JF, 2013, TRENDS PLANT SCI, V18, P167, DOI 10.1016/j.tplants.2012.09.007; Gonzalez JF, 2013, MOL PLANT PATHOL, V14, P211, DOI 10.1111/j.1364-3703.2012.00843.x; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Koh Y., 1994, KOREAN J PLANT PATHO, V10, P68; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lequette Y, 2006, J BACTERIOL, V188, P3365, DOI 10.1128/JB.188.9.3365-3370.2006; Licciardello G, 2007, FEMS MICROBIOL ECOL, V61, P222, DOI 10.1111/j.1574-6941.2007.00338.x; Lintz MJ, 2011, P NATL ACAD SCI USA, V108, P15763, DOI 10.1073/pnas.1112398108; Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297; Mattiuzzo M, 2011, ENVIRON MICROBIOL, V13, P145, DOI 10.1111/j.1462-2920.2010.02316.x; Mazzaglia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036518; McCann HC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003503; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Mereghetti P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-66; Michael B, 2001, J BACTERIOL, V183, P5733, DOI 10.1128/JB.183.19.5733-5742.2001; Patankar AV, 2009, APPL ENVIRON MICROB, V75, P946, DOI 10.1128/AEM.01692-08; Quinones B, 2004, MOL PLANT MICROBE IN, V17, P521, DOI 10.1094/MPMI.2004.17.5.521; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCORTICHINI M, 1994, PLANT PATHOL, V43, P1035, DOI 10.1111/j.1365-3059.1994.tb01654.x; Scortichini M, 2012, MOL PLANT PATHOL, V13, P631, DOI 10.1111/j.1364-3703.2012.00788.x; Service E, 2011, 1 REPORT PSEUDOMONAS; SHADEL GS, 1990, J BIOLUM CHEMILUM, V5, P99, DOI 10.1002/bio.1170050205; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; SLOCK J, 1990, J BACTERIOL, V172, P3974, DOI 10.1128/jb.172.7.3974-3979.1990; SMELTZER MS, 1992, APPL ENVIRON MICROB, V58, P2815, DOI 10.1128/AEM.58.9.2815-2819.1992; Smith RS, 2003, J CLIN INVEST, V112, P1460, DOI 10.1172/JCI200320364; STACHEL SE, 1985, EMBO J, V4, P891, DOI 10.1002/j.1460-2075.1985.tb03715.x; STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987; Steidle A, 2002, APPL ENVIRON MICROB, V68, P6371, DOI 10.1128/AEM.68.12.6371-6382.2002; Steindler L, 2008, J MICROBIOL METH, V73, P273, DOI 10.1016/j.mimet.2008.02.022; Steindler L, 2009, APPL ENVIRON MICROB, V75, P5131, DOI 10.1128/AEM.02914-08; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Stevens AM, 1997, J BACTERIOL, V179, P557, DOI 10.1128/jb.179.2.557-562.1997; Subramoni S, 2011, APPL ENVIRON MICROB, V77, P4579, DOI 10.1128/AEM.00183-11; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; TAKIKAWA Y, 1989, Annals of the Phytopathological Society of Japan, V55, P437, DOI 10.3186/jjphytopath.55.437; Taylor WR, 2000, METH MOL B, V143, P19; Vanneste JL, 2011, PLANT DIS, V95, P1311, DOI 10.1094/PDIS-03-11-0195; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Venturi V, 2013, ANNU REV PHYTOPATHOL, V51, P17, DOI 10.1146/annurev-phyto-082712-102239; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Wood DW, 1996, GENE, V168, P49, DOI 10.1016/0378-1119(95)00754-7; Wood DW, 1997, J BACTERIOL, V179, P7663, DOI 10.1128/jb.179.24.7663-7670.1997; Yao Y, 2006, J MOL BIOL, V355, P262, DOI 10.1016/j.jmb.2005.10.041; Zhang LL, 2007, MOL MICROBIOL, V65, P121, DOI 10.1111/j.1365-2958.2007.05775.x; Zhang RG, 2002, NATURE, V417, P971, DOI 10.1038/nature00833; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang ZG, 2001, APPL ENVIRON MICROB, V67, P4305, DOI 10.1128/AEM.67.9.4305-4315.2001	93	28	30	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87862	10.1371/journal.pone.0087862	http://dx.doi.org/10.1371/journal.pone.0087862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498215	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900187
J	Theisen, LL; Erdelmeier, CAJ; Spoden, GA; Boukhallouk, F; Sausy, A; Florin, L; Muller, CP				Theisen, Linda L.; Erdelmeier, Clemens A. J.; Spoden, Gilles A.; Boukhallouk, Fatima; Sausy, Aurelie; Florin, Luise; Muller, Claude P.			Tannins from Hamamelis virginiana Bark Extract: Characterization and Improvement of the Antiviral Efficacy against Influenza A Virus and Human Papillomavirus	PLOS ONE			English	Article							GREEN TEA; CONDOM USE; EPIGALLOCATECHIN GALLATE; VEGETABLE TANNINS; GENITAL WARTS; GALLIC ACID; IN-VITRO; CATECHINS; PROANTHOCYANIDINS; POLYPHENOL	Antiviral activity has been demonstrated for different tannin-rich plant extracts. Since tannins of different classes and molecular weights are often found together in plant extracts and may differ in their antiviral activity, we have compared the effect against influenza A virus (IAV) of Hamamelis virginiana L. bark extract, fractions enriched in tannins of different molecular weights and individual tannins of defined structures, including pseudotannins. We demonstrate antiviral activity of the bark extract against different IAV strains, including the recently emerged H7N9, and show for the first time that a tannin-rich extract inhibits human papillomavirus (HPV) type 16 infection. As the best performing antiviral candidate, we identified a highly potent fraction against both IAV and HPV, enriched in high molecular weight condensed tannins by ultrafiltration, a simple, reproducible and easily upscalable method. This ultrafiltration concentrate and the bark extract inhibited early and, to a minor extent, later steps in the IAV life cycle and tannin-dependently inhibited HPV attachment. We observed interesting mechanistic differences between tannin structures: High molecular weight tannin containing extracts and tannic acid (1702 g/mol) inhibited both IAV receptor binding and neuraminidase activity. In contrast, low molecular weight compounds (<500 g/mol) such as gallic acid, epigallocatechin gallate or hamamelitannin inhibited neuraminidase but not hemagglutination. Average molecular weight of the compounds seemed to positively correlate with receptor binding (but not neuraminidase) inhibition. In general, neuraminidase inhibition seemed to contribute little to the antiviral activity. Importantly, antiviral use of the ultrafiltration fraction enriched in high molecular weight condensed tannins and, to a lesser extent, the unfractionated bark extract was preferable over individual isolated compounds. These results are of interest for developing and improving plant-based antivirals.	[Theisen, Linda L.; Sausy, Aurelie; Muller, Claude P.] Ctr Rech Publ Sante, Inst Immunol, Lab Natl Sante, Luxembourg, Luxembourg; [Erdelmeier, Clemens A. J.] Dr Willmar Schwabe GmbH & Co KG, Dept Preclin Res, Karlsruhe, Germany; [Spoden, Gilles A.; Boukhallouk, Fatima; Florin, Luise] Johannes Gutenberg Univ Mainz, Dept Med Microbiol & Hyg, Univ Med Ctr, D-55122 Mainz, Germany	Luxembourg Institute of Health; Dr. Willmar Schwabe GmbH & Co. KG; Johannes Gutenberg University of Mainz	Muller, CP (corresponding author), Ctr Rech Publ Sante, Inst Immunol, Lab Natl Sante, Luxembourg, Luxembourg.	Claude.Muller@crp-sante.lu		Sausy, Aurelie/0000-0003-2090-7198	Dr. Willmar Schwabe GmbH Co. KG; AFR PhD grant of the Fonds National de la Recherche, Luxembourg [2903120]	Dr. Willmar Schwabe GmbH Co. KG; AFR PhD grant of the Fonds National de la Recherche, Luxembourg(Luxembourg National Research Fund)	The study was in part financially supported by Dr. Willmar Schwabe GmbH & Co. KG (http://www.schwabepharma.com/international). Linda L. Theisen was supported by an AFR PhD grant (Nr 2903120) of the Fonds National de la Recherche, Luxembourg (http://www.fnr.lu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102; [Anonymous], FACT SHEET INFL SEAS; BATESMITH EC, 1975, PHYTOCHEMISTRY, V14, P1107, DOI 10.1016/0031-9422(75)85197-1; Baz M, 2009, NEW ENGL J MED, V361, P2296, DOI 10.1056/NEJMc0910060; Betts JW, 2011, INT J ANTIMICROB AG, V38, P421, DOI 10.1016/j.ijantimicag.2011.07.006; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; CARSON RS, 1953, J BACTERIOL, V66, P572, DOI 10.1002/path.1700660233; Cerqueira C, 2013, CELL MICROBIOL, V15, P1818, DOI 10.1111/cmi.12150; Chelimo C, 2013, J INFECTION, V66, P207, DOI 10.1016/j.jinf.2012.10.024; Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; da Silva AP, 2000, PHYTOTHER RES, V14, P612, DOI 10.1002/1099-1573(200012)14:8&lt;612::AID-PTR677&gt;3.0.CO;2-T; Dauer A, 1998, PLANTA MED, V64, P324, DOI 10.1055/s-2006-957443; Dauer A, 2003, PLANTA MED, V69, P89, DOI 10.1055/s-2003-37022; Deters A, 2001, PHYTOCHEMISTRY, V58, P949, DOI 10.1016/S0031-9422(01)00361-2; Ehrhardt C, 2007, ANTIVIR RES, V76, P38, DOI 10.1016/j.antiviral.2007.05.002; Erdelmeier CAJ, 1996, PLANTA MED, V62, P241, DOI 10.1055/s-2006-957868; European Directorate for the Quality of Medicines & Healthcare, 2008, EUROPEAN PHARMACOPOE, P328; European Food Safety Authority, 2009, EFSA J, V954, P1; Florin L, 2012, MED MICROBIOL IMMUN, V201, P437, DOI 10.1007/s00430-012-0270-1; Frazier RA, 2010, J PHARMACEUT BIOMED, V51, P490, DOI 10.1016/j.jpba.2009.05.035; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Gaur AH, 2010, NEW ENGL J MED, V362, P88, DOI 10.1056/NEJMc0910893; Gescher K, 2011, ANTIVIR RES, V89, P9, DOI 10.1016/j.antiviral.2010.10.007; HAGERMAN AE, 1992, ACS SYM SER, V506, P236; Haidari M, 2009, PHYTOMEDICINE, V16, P1127, DOI 10.1016/j.phymed.2009.06.002; Hamilton BS, 2012, VIRUSES-BASEL, V4, P1144, DOI 10.3390/v4071144; Hashimoto T, 1999, BIOSCI BIOTECH BIOCH, V63, P2252, DOI 10.1271/bbb.63.2252; Haslam E, 1996, J NAT PROD, V59, P205, DOI 10.1021/np960040+; Haslam E, 2007, PHYTOCHEMISTRY, V68, P2713, DOI 10.1016/j.phytochem.2007.09.009; Hull Vance Stacy, 2011, Biomed Sci Instrum, V47, P177; Hurt AC, 2011, NEW ENGL J MED, V365, P2541, DOI 10.1056/NEJMc1111078; IKIGAI H, 1993, BIOCHIM BIOPHYS ACTA, V1147, P132, DOI 10.1016/0005-2736(93)90323-R; Imanishi N, 2002, MICROBIOL IMMUNOL, V46, P491, DOI 10.1111/j.1348-0421.2002.tb02724.x; Ishii T, 2011, BIOSCI BIOTECH BIOCH, V75, P100, DOI 10.1271/bbb.100600; Janecki A, 2011, J ETHNOPHARMACOL, V133, P147, DOI 10.1016/j.jep.2010.09.018; Gonzalez MJ, 2010, J AGR FOOD CHEM, V58, P4274, DOI 10.1021/jf904032y; Jobstl E, 2006, J AGR FOOD CHEM, V54, P4077, DOI 10.1021/jf053259f; Kimmel EM, 2011, ANTIVIR RES, V90, P80, DOI 10.1016/j.antiviral.2011.02.011; Kittel C, 2004, VIROLOGY, V324, P67, DOI 10.1016/j.virol.2004.03.035; Knappe M, 2007, J BIOL CHEM, V282, P27913, DOI 10.1074/jbc.M705127200; Kratz JM, 2008, MEM I OSWALDO CRUZ, V103, P437, DOI 10.1590/S0074-02762008000500005; Lackenby A, 2011, EUROSURVEILLANCE, V16, P10; Laux P, 1993, Z PHYTOTHER, V14, P155; Li M, 2013, CURR DRUG METAB, V14, P432, DOI 10.2174/1389200211314040006; Lin LT, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-187; Lin LT, 2011, J VIROL, V85, P4386, DOI 10.1128/JVI.01492-10; Liu G, 2011, ARCH VIROL, V156, P1359, DOI 10.1007/s00705-011-0989-9; MacKay D, 2001, Altern Med Rev, V6, P126; Manhart LE, 2002, SEX TRANSM DIS, V29, P725, DOI 10.1097/00007435-200211000-00018; Mantani N, 1999, ANTIVIR RES, V44, P193, DOI 10.1016/S0166-3542(99)00067-4; Mi X, 2011, PHOTODERMATOL PHOTO, V27, P176, DOI 10.1111/j.1600-0781.2011.00592.x; Minoda K, 2010, J NUTR SCI VITAMINOL, V56, P331, DOI 10.3177/jnsv.56.331; Mistrangelo M, 2010, COLORECTAL DIS, V12, P799, DOI 10.1111/j.1463-1318.2009.01960.x; NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7; Nance CL, 2003, J ALLERGY CLIN IMMUN, V112, P851, DOI 10.1016/j.jaci.2003.08.048; Nielson CM, 2010, J INFECT DIS, V202, P445, DOI 10.1086/653708; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Raff AB, 2013, J VIROL, V87, P6062, DOI 10.1128/JVI.00330-13; Repp KK, 2012, J INFECT DIS, V205, P1287, DOI 10.1093/infdis/jis181; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Sanchez-Tena S, 2012, J NAT PROD, V75, P26, DOI 10.1021/np200426k; SAPP M, 1994, J GEN VIROL, V75, P3375, DOI 10.1099/0022-1317-75-12-3375; Sarni-Manchado P, 1999, J AGR FOOD CHEM, V47, P42, DOI 10.1021/jf9805146; Sasaki H, 2004, CARIES RES, V38, P2, DOI 10.1159/000073913; Scheffer KD, 2013, J VIROL, V87, P3435, DOI 10.1128/JVI.02906-12; Schneider MA, 2011, CELL MICROBIOL, V13, P32, DOI 10.1111/j.1462-5822.2010.01515.x; Selinka HC, 2007, J VIROL, V81, P10970, DOI 10.1128/JVI.00998-07; SETO JT, 1966, VIROLOGY, V30, P731, DOI 10.1016/0042-6822(66)90178-4; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; Spoden GA, 2012, ANTIMICROB AGENTS CH, V56, P75, DOI 10.1128/AAC.05147-11; Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009; TAKECHI M, 1985, PHYTOCHEMISTRY, V24, P2245, DOI 10.1016/S0031-9422(00)83018-6; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; Theisen LL, 2012, ANTIVIR RES, V94, P147, DOI 10.1016/j.antiviral.2012.03.006; Tourino S, 2008, CHEM RES TOXICOL, V21, P696, DOI 10.1021/tx700425n; Ueda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055343; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; VENNAT B, 1988, PLANTA MED, P454, DOI 10.1055/s-2006-962499; Wagner H, 1999, PHARMAZEUTISCHE BIOL, V2; Wang HF, 2003, J PHARMACEUT BIOMED, V33, P539, DOI 10.1016/S0731-7085(03)00303-0; Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; Wolff HH, 2007, EUR J PEDIATR, V166, P943, DOI 10.1007/s00431-006-0363-1	87	50	59	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e88062	10.1371/journal.pone.0088062	http://dx.doi.org/10.1371/journal.pone.0088062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498245	gold, Green Submitted, Green Published			2022-12-25	WOS:000330621900211
J	Wadford, DA; Kauffman, RC; Deere, JD; Aoki, ST; Stanton, RA; Higgins, J; Van Rompay, KKA; Villalobos, A; Nettles, JH; Schinazi, RF; Pedersen, NC; North, TW				Wadford, Debra A.; Kauffman, Robert C.; Deere, Jesse D.; Aoki, Scott T.; Stanton, Richard A.; Higgins, Joanne; Van Rompay, Koen K. A.; Villalobos, Andradi; Nettles, James H.; Schinazi, Raymond F.; Pedersen, Niels C.; North, Thomas W.			Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV	PLOS ONE			English	Article							HIV-1 NUCLEOCAPSID PROTEIN; ACTIVE ANTIRETROVIRAL THERAPY; RHESUS MACAQUES; SEQUENCE VARIATION; DRUG-RESISTANCE; VIRAL DYNAMICS; IN-VITRO; INFECTED MACAQUES; STRAND TRANSFER; M184V MUTATION	RT-SHIV is a chimera of simian immunodeficiency virus (SIV) containing the reverse transcriptase (RT)-encoding region of human immunodeficiency virus type 1 (HIV-1) within the backbone of SIVmac239. It has been used in a non-human primate model for studies of non-nucleoside RT inhibitors (NNRTI) and highly active antiretroviral therapy (HAART). We and others have identified several mutations that arise in the "foreign" HIV-1 RT of RT-SHIV during in vivo replication. In this study we catalogued amino acid substitutions in the HIV-1 RT and in regions of the SIV backbone with which RT interacts that emerged 30 weeks post-infection from seven RT-SHIV-infected rhesus macaques. The virus set points varied from relatively high virus load, moderate virus load, to undetectable virus load. The G196R substitution in RT was detected from 6 of 7 animals at week 4 post-infection and remained in virus from 4 of 6 animals at week 30. Virus from four high virus load animals showed several common mutations within RT, including L74V or V75L, G196R, L214F, and K275R. The foreign RT from high virus load isolates exhibited as much variation as that of the highly variable envelope surface glycoprotein, and 10-fold higher than that of the native RT of SIVmac239. Isolates from moderate virus load animals showed much less variation in the foreign RT than the high virus load isolates. No variation was found in SIVmac239 genes known to interact with RT. Our results demonstrate substantial adaptation of the foreign HIV-1 RT in RT-SHIV-infected macaques, which most likely reflects selective pressure upon the foreign RT to attain optimal activity within the context of the chimeric RT-SHIV and the rhesus macaque host.	[Wadford, Debra A.; Kauffman, Robert C.; Deere, Jesse D.; Aoki, Scott T.; Higgins, Joanne; Villalobos, Andradi; North, Thomas W.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Stanton, Richard A.; Nettles, James H.] Emory Univ, Sch Med, Dept Pediat, Childrens Ctr Drug Discovery CDD, Atlanta, GA USA; [Stanton, Richard A.; Nettles, James H.] Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA USA; [Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Schinazi, Raymond F.] Emory Univ, Sch Med, Vet Affairs Med Ctr, Decatur, GA 30033 USA; [Pedersen, Niels C.] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA; [North, Thomas W.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; Emory University; Emory University; University of California System; University of California Davis; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Davis; University of California System; University of California Davis	North, TW (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	twnorth@ucdavis.edu	Deere, Jesse Dee/ABH-7940-2020; Schinazi, Raymond F/B-6777-2017	Deere, Jesse/0000-0002-2539-0338; Wadford, Debra/0000-0002-8630-427X	NIH-IMSD Fellowship [R25 GM 56765]; NIH R01 grants [AI47070, RR13967]; NIH [P01 AI058708]; National Center for Research Resources [P51RR000169]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169, R01RR013967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058708, R01AI047070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056765] Funding Source: NIH RePORTER	NIH-IMSD Fellowship; NIH R01 grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DAW was supported in part by the NIH-IMSD Fellowship R25 GM 56765. This work was supported by NIH R01 grants AI47070 and RR13967 to TWN, by NIH Program Project grant P01 AI058708, and the National Center for Research Resources grant P51RR000169 to CNPRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose Z, 2004, J VIROL, V78, P13553, DOI 10.1128/JVI.78.24.13553-13561.2004; Ambrose Z, 2007, J VIROL, V81, P12145, DOI 10.1128/JVI.01301-07; Arts EJ, 1996, P NATL ACAD SCI USA, V93, P10063, DOI 10.1073/pnas.93.19.10063; Balzarini J, 1997, J ACQ IMMUN DEF SYND, V15, P1, DOI 10.1097/00042560-199705010-00001; BARAT C, 1993, J MOL BIOL, V231, P185, DOI 10.1006/jmbi.1993.1273; BARAT C, 1989, EMBO J, V8, P3279, DOI 10.1002/j.1460-2075.1989.tb08488.x; Beerens N, 2000, NUCLEIC ACIDS RES, V28, P4130, DOI 10.1093/nar/28.21.4130; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Berkhout B, 1996, J VIROL, V70, P6723, DOI 10.1128/JVI.70.10.6723-6732.1996; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boyer PL, 1998, ANTIMICROB AGENTS CH, V42, P447; Buckley KA, 2003, VIROLOGY, V312, P470, DOI 10.1016/S0042-6822(03)00262-9; Burns D P, 1994, Curr Top Microbiol Immunol, V188, P185; BURNS DPW, 1991, J VIROL, V65, P1843, DOI 10.1128/JVI.65.4.1843-1854.1991; Cameron CE, 1997, P NATL ACAD SCI USA, V94, P6700, DOI 10.1073/pnas.94.13.6700; CAMPBELL BJ, 1994, J VIROL, V68, P3129, DOI 10.1128/JVI.68.5.3129-3137.1994; Capetti AF, 2005, AIDS, V19, P633, DOI 10.1097/01.aids.0000163943.31682.c8; Cen S, 1999, J VIROL, V73, P4485, DOI 10.1128/JVI.73.5.4485-4488.1999; Cen Shan, 2004, Retrovirology, V1, P33, DOI 10.1186/1742-4690-1-33; CHENGMAYER C, 1988, SCIENCE, V240, P80, DOI 10.1126/science.2832945; CHOI WS, 1994, J VIROL, V68, P5395, DOI 10.1128/JVI.68.9.5395-5402.1994; Clever JL, 1999, J VIROL, V73, P101, DOI 10.1128/JVI.73.1.101-109.1999; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Das AT, 1997, J GEN VIROL, V78, P837, DOI 10.1099/0022-1317-78-4-837; DECLERCQ E, 1992, AIDS RES HUM RETROV, V8, P119, DOI 10.1089/aid.1992.8.119; Deere JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011640; DESROSIERS RC, 1990, ANNU REV IMMUNOL, V8, P557, DOI 10.1146/annurev.iy.08.040190.003013; Druillennec S, 1999, J BIOL CHEM, V274, P11283, DOI 10.1074/jbc.274.16.11283; ESSINK BBO, 1995, J BIOL CHEM, V270, P23867, DOI 10.1074/jbc.270.40.23867; Finzi D, 1998, CELL, V93, P665, DOI 10.1016/S0092-8674(00)81427-0; GARDNER MB, 2004, AIDS OTHER MANIFESTA, P195; HAHN BH, 1985, P NATL ACAD SCI USA, V82, P4813, DOI 10.1073/pnas.82.14.4813; Harrich D, 1997, EMBO J, V16, P1224, DOI 10.1093/emboj/16.6.1224; Harrich D, 1996, J VIROL, V70, P4017, DOI 10.1128/JVI.70.6.4017-4027.1996; Havlir DV, 1996, ANN INTERN MED, V124, P984, DOI 10.7326/0003-4819-124-11-199606010-00006; Hofman MJ, 2004, ANTIMICROB AGENTS CH, V48, P3483, DOI 10.1128/AAC.48.9.3483-3490.2004; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Ji XD, 1996, BIOCHEMISTRY-US, V35, P132, DOI 10.1021/bi951707e; JIANG M, 1993, J VIROL, V67, P3246, DOI 10.1128/JVI.67.6.3246-3253.1993; Joly V, 2004, ANTIMICROB AGENTS CH, V48, P172, DOI 10.1128/AAC.48.1.172-175.2004; Kameoka M, 2001, J VIROL, V75, P2675, DOI 10.1128/JVI.75.6.2675-2683.2001; Kearney M, 2011, J VIROL, V85, P1067, DOI 10.1128/JVI.01701-10; Knapp LA, 1997, TISSUE ANTIGENS, V50, P657, DOI 10.1111/j.1399-0039.1997.tb02927.x; KODAMA T, 1993, J VIROL, V67, P6522, DOI 10.1128/JVI.67.11.6522-6534.1993; KODAMA T, 1991, J VIROL, V65, P2010, DOI 10.1128/JVI.65.4.2010-2018.1991; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; LapadatTapolsky M, 1997, J MOL BIOL, V268, P250, DOI 10.1006/jmbi.1997.0978; Leutenegger CM, 2001, AIDS RES HUM RETROV, V17, P243, DOI 10.1089/088922201750063160; LOHMAN BL, 1991, J CLIN MICROBIOL, V29, P2187, DOI 10.1128/JCM.29.10.2187-2192.1991; MILLER MA, 1992, AIDS RES HUM RETROV, V8, P1153, DOI 10.1089/aid.1992.8.1153; Miller V, 1998, ANTIMICROB AGENTS CH, V42, P3123, DOI 10.1128/AAC.42.12.3123; MORI K, 1992, J VIROL, V66, P2067, DOI 10.1128/JVI.66.4.2067-2075.1992; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Murry JP, 2003, J VIROL, V77, P1120, DOI 10.1128/JVI.77.2.1120-1130.2003; NAJERA I, 1995, J VIROL, V69, P23; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; North TW, 2005, J VIROL, V79, P7349, DOI 10.1128/JVI.79.12.7349-7354.2005; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Pata JD, 2004, P NATL ACAD SCI USA, V101, P10548, DOI 10.1073/pnas.0404151101; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; QuinonesMateu M, 1996, AIDS RES HUM RETROV, V12, P1117, DOI 10.1089/aid.1996.12.1117; Riddler SA, 1997, AIDS, V11, pS141; RIZVI TA, 1993, J VIROL, V67, P2681, DOI 10.1128/JVI.67.5.2681-2688.1993; RODRIGUEZRODRIGUEZ L, 1995, J BIOL CHEM, V270, P15005, DOI 10.1074/jbc.270.25.15005; Rong LW, 2001, J BIOL CHEM, V276, P47725, DOI 10.1074/jbc.M105124200; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Ryzhova E, 2002, J VIROL, V76, P7903, DOI 10.1128/JVI.76.15.7903-7909.2002; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Shao W, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-101; Sharma PL, 1997, J VIROL, V71, P8846, DOI 10.1128/JVI.71.11.8846-8851.1997; SIMMONDS P, 1991, J VIROL, V65, P6266, DOI 10.1128/JVI.65.11.6266-6276.1991; Soderberg K, 2002, J VIROL, V76, P5803, DOI 10.1128/JVI.76.11.5803-5806.2002; Svicher V, 2006, J VIROL, V80, P7186, DOI 10.1128/JVI.02084-05; Tisne C, 2004, J BIOL CHEM, V279, P3588, DOI 10.1074/jbc.M310368200; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Van Rompay KKA, 2002, J VIROL, V76, P6083, DOI 10.1128/JVI.76.12.6083-6092.2002; Van Rompay KKA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-25; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wrobel JA, 1998, P NATL ACAD SCI USA, V95, P638, DOI 10.1073/pnas.95.2.638; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	81	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86997	10.1371/journal.pone.0086997	http://dx.doi.org/10.1371/journal.pone.0086997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498008	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900056
J	Zhu, FC; Huang, SJ; Wu, T; Zhang, XF; Wang, ZZ; Ai, X; Yan, Q; Yang, CL; Cai, JP; Jiang, HM; Wang, YJ; Ng, MH; Zhang, J; Xia, NS				Zhu, Feng-Cai; Huang, Shou-Jie; Wu, Ting; Zhang, Xue-Feng; Wang, Zhong-Ze; Ai, Xing; Yan, Qiang; Yang, Chang-Lin; Cai, Jia-Ping; Jiang, Han-Min; Wang, Yi-Jun; Ng, Mun-Hon; Zhang, Jun; Xia, Ning-Shao			Epidemiology of Zoonotic Hepatitis E: A Community-Based Surveillance Study in a Rural Population in China	PLOS ONE			English	Article							E VIRUS-INFECTION; NON-B HEPATITIS; BLOOD-DONORS; UNITED-STATES; NON-A; ANTIBODIES; ASSAYS; PREVALENCE; OUTBREAK; TRANSMISSION	Background: Hepatitis E is caused by two viral genotype groups: human types and zoonotic types. Current understanding of the epidemiology of the zoonotic hepatitis E disease is founded largely on hospital-based studies. Methods: The epidemiology of hepatitis E was investigated in a community-based surveillance study conducted over one year in a rural city in eastern China with a registered population of 400,162. Results: The seroprevalence of hepatitis E in the cohort was 38%. The incidence of hepatitis E was 2.8/10,000 person-years. Totally 93.5% of the infections were attributed to genotype 4 and the rest, to genotype 1. Hepatitis E accounted for 28.4% (102/359) of the acute hepatitis cases and 68.9% (102/148) of the acute viral hepatitis cases in this area of China. The disease occurred sporadically with a higher prevalence during the cold season and in men, with the male-to-female ratio of 3:1. Additionally, the incidence of hepatitis E increased with age. Hepatitis B virus carriers have an increased risk of contracting hepatitis E than the general population (OR = 2.5, 95% CI 1.5-4.2). Pre-existing immunity to hepatitis E lowered the risk (relative risk = 0.34, 95% CI 0.21-0.55) and reduced the severity of the disease. Conclusions: Hepatitis E in the rural population of China is essentially that of a zoonosis due to the genotype 4 virus, the epidemiology of which is similar to that due to the other zoonotic genotype 3 virus.	[Zhu, Feng-Cai; Zhang, Xue-Feng; Ai, Xing] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Huang, Shou-Jie; Wu, Ting; Yan, Qiang; Ng, Mun-Hon; Zhang, Jun; Xia, Ning-Shao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Publ Hlth, Xiamen, Peoples R China; [Wang, Zhong-Ze; Yang, Chang-Lin; Cai, Jia-Ping; Jiang, Han-Min; Wang, Yi-Jun] Dongtai Ctr Dis Control & Prevent, Dongtai, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Xiamen University	Zhang, J (corresponding author), Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Publ Hlth, Xiamen, Peoples R China.	zhangj@xmu.edu.cn	Zhang, Jun/G-4598-2010; Wang, Yixuan/GZK-6559-2022; wang, yi/GVT-8516-2022; Wang, Yijun/GXW-1763-2022; wang, yixuan/GXW-2866-2022	Zhang, Jun/0000-0002-6601-9180; Wu, Ting/0000-0002-1806-3056; Xia, Ningshao/0000-0003-0179-5266	National Major Scientific and Technological Special Project for "Significant New Drugs Development'' [2013ZX09101017]; National High-tech Research & Development Program (863 Program) [2012AA02A408]; National Major Scientific and Technological Special Project for "Prevention and Control of important infectious diseases'' [2012ZX10002001, 2011ZX10004-903]; Fujian Provincial Science Fund for Distinguished Young Scholars [2011J06015]; Jiangsu science and technology support plan project [BE2013723]	National Major Scientific and Technological Special Project for "Significant New Drugs Development''; National High-tech Research & Development Program (863 Program); National Major Scientific and Technological Special Project for "Prevention and Control of important infectious diseases''; Fujian Provincial Science Fund for Distinguished Young Scholars; Jiangsu science and technology support plan project	The work was supported by National Major Scientific and Technological Special Project for "Significant New Drugs Development'' (2013ZX09101017); National High-tech Research & Development Program (863 Program) (2012AA02A408); National Major Scientific and Technological Special Project for "Prevention and Control of important infectious diseases'' (2012ZX10002001, 2011ZX10004-903) (http://www.most.gov.cn/); Fujian Provincial Science Fund for Distinguished Young Scholars (2011J06015) (http://www.fjkjt.gov.cn/) and Jiangsu science and technology support plan project (BE2013723). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Kenji, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P90; Acharya SK, 2007, J HEPATOL, V46, P387, DOI 10.1016/j.jhep.2006.09.016; Boutrouille A, 2007, J CLIN MICROBIOL, V45, P2009, DOI 10.1128/JCM.00235-07; Buti M, 2006, CLIN VACCINE IMMUNOL, V13, P1328, DOI 10.1128/CVI.00255-06; Chen HY, 2005, CLIN DIAGN LAB IMMUN, V12, P593, DOI 10.1128/CDLI.12.5.593-598.2005; Christensen PB, 2008, CLIN INFECT DIS, V47, P1026, DOI 10.1086/591970; Cooper K, 2005, J CLIN MICROBIOL, V43, P1684, DOI 10.1128/JCM.43.4.1684-1688.2005; Corwin AL, 1996, AM J TROP MED HYG, V54, P559, DOI 10.4269/ajtmh.1996.54.559; Dalton HR, 2007, LANCET, V369, P1260, DOI 10.1016/S0140-6736(07)60595-9; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dalton HR, 2007, J GASTROEN HEPATOL, V22, P1236, DOI 10.1111/j.1440-1746.2007.04894.x; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Herremans M, 2007, CLIN VACCINE IMMUNOL, V14, P562, DOI 10.1128/CVI.00231-06; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Huang SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013560; Ijaz S, 2005, J INFECT DIS, V192, P1166, DOI 10.1086/444396; Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Legrand-Abravanel F, 2009, CLIN VACCINE IMMUNOL, V16, P772, DOI 10.1128/CVI.00438-08; Li RC, 2006, EMERG INFECT DIS, V12, P1682, DOI 10.3201/eid1211.060332; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Mansuy JM, 2009, J CLIN VIROL, V44, P74, DOI 10.1016/j.jcv.2008.09.010; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002; Myint KSA, 2006, J CLIN MICROBIOL, V44, P1581, DOI 10.1128/JCM.44.4.1581-1583.2006; Myint KSA, 2005, AM J TROP MED HYG, V73, P942, DOI 10.4269/ajtmh.2005.73.942; NAIK SR, 1992, B WORLD HEALTH ORGAN, V70, P597; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Purcell RH, 2005, VIRAL HEPATITIS, 3RD EDITION, P635, DOI 10.1002/9780470987131.ch42; Said B, 2009, EMERG INFECT DIS, V15, P1738, DOI 10.3201/eid1511.091094; Seriwatana J, 2002, CLIN DIAGN LAB IMMUN, V9, P1072, DOI 10.1128/CDLI.9.5.1072-1078.2002; Taniguchi M, 2009, J INFECTION, V58, P232, DOI 10.1016/j.jinf.2009.01.011; Teshale EH, 2010, CLIN INFECT DIS, V51, P328, DOI 10.1086/653943; Teshale EH, 2010, EMERG INFECT DIS, V16, P126, DOI 10.3201/eid1601.090764; VELAZQUEZ O, 1990, JAMA-J AM MED ASSOC, V263, P3281, DOI 10.1001/jama.263.24.3281; Wedemeyer H, 2013, SEMIN LIVER DIS, V33, P71, DOI 10.1055/s-0033-1338118; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhang J, 2013, CLIN MICROBIOL INFEC; Zheng YJ, 2006, J INFECT DIS, V193, P1643, DOI 10.1086/504293; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6; Zhuang H, 1999, CHIN MED SCI J, V14, P47	43	35	41	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87154	10.1371/journal.pone.0087154	http://dx.doi.org/10.1371/journal.pone.0087154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498033	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900071
J	Zomer-Kooijker, K; van der Ent, CK; Ermers, MJJ; Uiterwaal, CSPM; Rovers, MM; Bont, LJ				Zomer-Kooijker, Kim; van der Ent, Cornelis K.; Ermers, Marieke J. J.; Uiterwaal, Cuno S. P. M.; Rovers, Maroeska M.; Bont, Louis J.		RSV Corticosteroid Study Grp	Increased Risk of Wheeze and Decreased Lung Function after Respiratory Syncytial Virus Infection	PLOS ONE			English	Article							BRONCHIOLITIS; ASTHMA; ALLERGY; AGE; INFANCY; INTERLEUKIN-10; PREVENTION; RATIONALE; SYMPTOMS; DESIGN	Background: A relationship between hospitalization for respiratory syncytial virus (RSV) bronchiolitis and asthma development has been suggested in case-control studies. Objective: The aim of this study was to assess the risk of current wheeze, asthma, and lung function at school age in infants previously hospitalized for RSV bronchiolitis compared to non-hospitalized children. Methods: For this study, data from a prospective birth cohort of unselected, term-born infants (n = 553), of whom 4 (0.7%) were hospitalized for RSV bronchiolitis, and a prospective patient cohort of 155 term infants hospitalized for RSV bronchiolitis were used. Respiratory outcomes at age 6 in children hospitalized for RSV bronchiolitis were compared to non-hospitalized children. Results: The risk of current wheeze was higher in hospitalized patients (n = 159) compared to non-hospitalized children (n = 549) (adjusted odds ratio (OR) 3.2 (95% CI 1.2-8.1). Similarly, the risk of current asthma, defined as a doctor's diagnosis of asthma plus current symptoms or medication use, was higher in hospitalized patients (adjusted OR 3.1 (95% CI 1.3-7.5). Compared to non-hospitalized children, RSV bronchiolitis hospitalization was associated with lower lung function (mean difference FEV1% predicted -6.8 l (95% CI (-10.2 to -3.4). Conclusions and Clinical Relevance: This is the first study showing that hospitalization for RSV bronchiolitis during infancy is associated with increased risk of wheezing, current asthma, and impaired lung function as compared to an unselected birth cohort at age 6.	[Zomer-Kooijker, Kim; van der Ent, Cornelis K.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Pulmonol & Allergol, Utrecht, Netherlands; [Ermers, Marieke J. J.] Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands; [Uiterwaal, Cuno S. P. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen, Med Ctr Nijmegen, Dept Epidemiol Biostat & HTA & Operating Rooms, NL-6525 ED Nijmegen, Netherlands; [Bont, Louis J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Immunol & Infect Dis, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Bont, LJ (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Immunol & Infect Dis, Utrecht, Netherlands.	l.bont@umcutrecht.nl	Rovers, Maroeska/F-2969-2014; Bont, Louis/J-6370-2014	Rovers, Maroeska/0000-0002-3095-170X; Van der Ent, Cornelis/0000-0002-2501-4121	Teva Pharmaceutical industries inc.; Dutch Asthma Foundation; Abbott	Teva Pharmaceutical industries inc.; Dutch Asthma Foundation; Abbott(Abbott Laboratories)	LB received a grant for this study from Teva Pharmaceutical industries inc., and from the Dutch Asthma Foundation. MR received an educational grant from Abbott, to provide financial support without restrictions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher MI, 1998, EUR RESPIR J, V12, P315; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Bont L, 2000, AM J RESP CRIT CARE, V161, P1518, DOI 10.1164/ajrccm.161.5.9904078; Empey KM, 2010, CLIN INFECT DIS, V50, P1258, DOI 10.1086/651603; Ermers MJJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b897; Fjaerli Hans-Olav, 2005, BMC Pediatr, V5, P31, DOI 10.1186/1471-2431-5-31; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Hoebee B, 2004, J INFECT DIS, V189, P239, DOI 10.1086/380908; Juntti H, 2003, ALLERGY, V58, P878, DOI 10.1034/j.1398-9995.2003.00233.x; Katier N, 2004, EUR J EPIDEMIOL, V19, P895, DOI 10.1023/B:EJEP.0000040530.98310.0c; Koopman M, 2011, RESP MED, V105, P15, DOI 10.1016/j.rmed.2010.07.020; Korppi M, 2004, PEDIATR PULM, V38, P155, DOI 10.1002/ppul.20058; Mikalsen IB, 2012, PEDIAT ALLERG IMM-UK, V23, P391, DOI 10.1111/j.1399-3038.2012.01283.x; Mohapatra SS, 2008, CLIN MICROBIOL REV, V21, P495, DOI 10.1128/CMR.00054-07; MURRAY M, 1992, ARCH DIS CHILD, V67, P482, DOI 10.1136/adc.67.4.482; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; PULLAN CR, 1982, BRIT MED J, V284, P1665, DOI 10.1136/bmj.284.6330.1665; Regnier S, 2013, PEDIATR INFECT DIS J, P3; Schuurhof A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-121; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6284; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stein RT, 2010, THORAX, V65, P1033, DOI 10.1136/thx.2009.133967; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Szabo SM, 2012, PAEDIATR RESPIR REV, V13, pS9; van der Zalm MM, 2011, AM J RESP CRIT CARE, V183, P262, DOI 10.1164/rccm.200905-0716OC; Verbeke M, 2006, STUD HLTH TECHNOL IN, V124; Zomer-Kooijker K, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-9	29	76	81	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87162	10.1371/journal.pone.0087162	http://dx.doi.org/10.1371/journal.pone.0087162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498037	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900073
J	Laabei, M; Jamieson, WD; Massey, RC; Jenkins, ATA				Laabei, Maisem; Jamieson, W. David; Massey, Ruth C.; Jenkins, A. Tobias A.			Staphylococcus aureus Interaction with Phospholipid Vesicles - A New Method to Accurately Determine Accessory Gene Regulator (agr) Activity	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; PHENOL-SOLUBLE MODULINS; QUORUM-SENSING SYSTEM; ALPHA-TOXIN; VIRULENCE; EXPRESSION; IDENTIFICATION; DYSFUNCTION; MUTANT; LOCUS	The staphylococcal accessory gene regulatory (agr) operon is a well-characterised global regulatory element that is important in the control of virulence gene expression for Staphylococcus aureus, a major human pathogen. Hence, accurate and sensitive measurement of Agr activity is central in understanding the virulence potential of Staphylococcus aureus, especially in the context of Agr dysfunction, which has been linked with persistent bacteraemia and reduced susceptibility to glycopeptide antibiotics. Agr function is typically measured using a synergistic haemolysis CAMP assay, which is believe to report on the level of expression of one of the translated products of the agr locus, delta toxin. In this study we develop a vesicle lysis test (VLT) that is specific to small amphipathic peptides, most notably delta and Phenol Soluble Modulin (PSM) toxins. To determine the accuracy of this VLT method in assaying Agr activity, we compared it to the CAMP assay using 89 clinical Staphylococcus aureus isolates. Of the 89 isolates, 16 were designated as having dysfunctional Agr systems by the CAMP assay, whereas only three were designated as such by VLT. Molecular analysis demonstrated that of these 16 isolates, the 13 designated as having a functional Agr system by VLT transcribed rnaIII and secreted delta toxin, demonstrating they have a functional Agr system despite the results of the CAMP assay. The agr locus of all 16 isolates was sequenced, and only the 3 designated as having a dysfunctional Agr system contained mutations, explaining their Agr dysfunction. Given the potentially important link between Agr dysfunction and clinical outcome, we have developed an assay that determines this more accurately than the conventional CAMP assay.	[Laabei, Maisem; Jamieson, W. David; Jenkins, A. Tobias A.] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England; [Laabei, Maisem; Massey, Ruth C.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath; University of Bath	Jenkins, ATA (corresponding author), Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England.	a.t.a.jenkins@bath.ac.uk	Massey, Ruth/AAT-6415-2021; Jenkins, Toby/C-2124-2009; Laabei, Maisem/AAH-6383-2021; Jamieson, David/F-9534-2016	Massey, Ruth/0000-0002-8154-4039; Jenkins, Toby/0000-0002-8981-3029; Laabei, Maisem/0000-0002-8425-3704; Jamieson, David/0000-0001-8260-5211	European Commission [245500]; Biotechnology and Biological Sciences Research Council [1360189, 1096378, APG20594] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I027602/1] Funding Source: researchfish; EPSRC [EP/I027602/1] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors acknowledge funding from the European Commission 7th Framework programme, for grant #245500, Bacteriosafe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Bhattacharya S, 2000, BBA-BIOMEMBRANES, V1467, P39, DOI 10.1016/S0005-2736(00)00196-6; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; BUNCE C, 1992, INFECT IMMUN, V60, P2636, DOI 10.1128/IAI.60.7.2636-2640.1992; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Cheung GYC, 2012, MICROBES INFECT, V14, P380, DOI 10.1016/j.micinf.2011.11.013; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Collins J, 2008, J CLIN MICROBIOL, V46, P2112, DOI 10.1128/JCM.00156-08; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; DOERY HM, 1965, J GEN MICROBIOL, V40, P283, DOI 10.1099/00221287-40-2-283; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; Duong AC, 2012, PATHOGENS, V1, P3, DOI 10.3390/pathogens1010003; ELEK SD, 1950, J PATHOL BACTERIOL, V62, P541, DOI 10.1002/path.1700620405; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; Fournier B, 2001, MOL MICROBIOL, V41, P247, DOI 10.1046/j.1365-2958.2001.02515.x; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; GAGNAIRE J, 2012, PLOS ONE, V6, P7; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; GEMMELL CG, 1982, INFECT IMMUN, V38, P981, DOI 10.1128/IAI.38.3.981-985.1982; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Karp G, 2009, STRUCTURE FUNCTION P, P126; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lowy FD, 1998, NEW ENGL J MED, V339, P2026; Nicholas RO, 1999, INFECT IMMUN, V67, P3667, DOI 10.1128/IAI.67.7.3667-3669.1999; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; OREILLY M, 1986, MICROB PATHOGENESIS, V1, P125, DOI 10.1016/0882-4010(86)90015-X; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Petti CA, 2002, INFECT DIS CLIN N AM, V16, P413, DOI 10.1016/S0891-5520(01)00003-4; Potrich C, 2009, J MEMBRANE BIOL, V227, P13, DOI 10.1007/s00232-008-9140-6; Pratt DA, 2011, ACCOUNTS CHEM RES, V44, P458, DOI 10.1021/ar200024c; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; Sakoulas G, 2009, J INFECT DIS, V199, P1558, DOI 10.1086/598607; Schweizer ML, 2011, ANTIMICROB AGENTS CH, V55, P1082, DOI 10.1128/AAC.00918-10; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Shopsin B, 2008, J INFECT DIS, V198, P1171, DOI 10.1086/592051; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Supersac G, 1998, MICROB PATHOGENESIS, V24, P241, DOI 10.1006/mpat.1997.0192; Thet NT, 2012, BIOSENSORS BIOELECTR; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; Traikia M, 2000, EUR BIOPHYS J BIOPHY, V29, P184, DOI 10.1007/s002490000077; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; Verdon J, 2009, PEPTIDES, V30, P817, DOI 10.1016/j.peptides.2008.12.017; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; WATANABE M, 1987, BIOCHIM BIOPHYS ACTA, V898, P257, DOI 10.1016/0005-2736(87)90065-4; Yarwood JM, 2003, J CLIN INVEST, V112, P1620, DOI 10.1172/JCI200320442; Zhou J, 2011, BIOSENS BIOELECTRON, V30, P67, DOI 10.1016/j.bios.2011.08.028; Zhou J, 2010, J AM CHEM SOC, V132, P6566, DOI 10.1021/ja101554a	64	27	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87270	10.1371/journal.pone.0087270	http://dx.doi.org/10.1371/journal.pone.0087270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498061	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100071
J	Oliveira, BM; Barrio, E; Querol, A; Perez-Torrado, R				Oliveira, Bruno M.; Barrio, Eladio; Querol, Amparo; Perez-Torrado, Roberto			Enhanced Enzymatic Activity of Glycerol-3-Phosphate Dehydrogenase from the Cryophilic Saccharomyces kudriavzevii	PLOS ONE			English	Article							NATURAL HYBRIDS; GLYCEROL PRODUCTION; FREEZE STRESS; HOG PATHWAY; CEREVISIAE; GPD1; STRAINS; POPULATIONS; GROWTH	During the evolution of the different species classified within the Saccharomyces genus, each one has adapted to live in different environments. One of the most important parameters that have influenced the evolution of Saccharomyces species is the temperature. Here we have focused on the study of the ability of certain species as Saccharomyces kudriavzevii to grow at low temperatures, in contrast to Saccharomyces cerevisiae. We observed that S. kudriavzevii strains isolated from several regions are able to synthesize higher amounts of glycerol, a molecule that has been shown to accumulate in response to freeze and cold stress. To explain this observation at the molecular level we studied the expression of glycerol biosynthetic pathway genes and we observed a higher expression of GPD1 gene in S. kudriavzevii compared to S. cerevisiae in micro-vinification conditions. We observed higher enzymatic activity of Gpd1p in S. kudriavzevii in response to osmotic and cold stress. Also, we determined that S. kudriavzevii Gpd1p enzyme presents increased catalytic properties that will contribute to increase glycerol production. Finally, we evaluated the glycerol production with S. cerevisiae, S. kudriavzevii or a recombinant Gpd1p variant in the same background and observed that the S. kudriavzevii enzyme produced increased glycerol levels at 12 or 28 degrees C. This suggests that glycerol is increased in S. kudriavzevii mainly due to increased V-max of the Gpd1p enzyme. All these differences indicate that S. kudriavzevii has changed the metabolism to promote the branch of the glycolytic pathway involved in glycerol production to adapt to low temperature environments and maintain the NAD(+)/NADH ratio in alcoholic fermentations. This knowledge is industrially relevant due to the potential use, for example, of S. cerevisiae-S. kudriavzevii hybrids in the wine industry where glycerol content is an important quality parameter.	[Oliveira, Bruno M.; Barrio, Eladio; Querol, Amparo; Perez-Torrado, Roberto] CSIC, IATA, E-46980 Paterna, Valencia, Spain; [Barrio, Eladio] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Valencia	Perez-Torrado, R (corresponding author), CSIC, IATA, E-46980 Paterna, Valencia, Spain.	rober@iata.csic.es	Barrio, Eladio/G-8969-2015; Querol, Amparo/AAW-7469-2020; Querol, Amparo/H-3782-2012; Perez Torrado, Roberto/E-7613-2012	Barrio, Eladio/0000-0003-1024-954X; Querol, Amparo/0000-0002-6478-6845; Querol, Amparo/0000-0002-6478-6845; MOTTA OLIVEIRA, BRUNO/0000-0002-1646-0410; Perez Torrado, Roberto/0000-0002-3118-6755	Brazilian Federal Agency for the Support and Evaluation of Graduate Education (Brazilian Ministry of Education); JAEDOC postdoctoral program (CSIC); ESF; CICYT from Ministerio de Educacion y Ciencia [AGL2009-12673-CO2-01, AGL2009-12673-C02-01, AGL2009-12673-C02-02, AGL2012-39937-C02-01, AGL2012-39937-C02-02]; Generalitat Valenciana [2009/019]	Brazilian Federal Agency for the Support and Evaluation of Graduate Education (Brazilian Ministry of Education); JAEDOC postdoctoral program (CSIC); ESF(European Commission); CICYT from Ministerio de Educacion y Ciencia; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	BMO was supported by the Brazilian Federal Agency for the Support and Evaluation of Graduate Education (Brazilian Ministry of Education). R. P. T. was supported from JAEDOC postdoctoral program (CSIC) co-funded by ESF. This work was supported by CICYT grants (refs. AGL2009-12673-CO2-01, AGL2009-12673-C02-01, AGL2009-12673-C02-02, AGL2012-39937-C02-01 and AGL2012-39937-C02-02) from Ministerio de Educacion y Ciencia and by grant PROMETEO (2009/019) from Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera J, 2007, FEMS MICROBIOL REV, V31, P327, DOI 10.1111/j.1574-6976.2007.00066.x; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Bely M, 2003, J BIOSCI BIOENG, V96, P507, DOI 10.1016/S1389-1723(04)70141-3; Cambon B, 2006, APPL ENVIRON MICROB, V72, P4688, DOI 10.1128/AEM.02975-05; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Cronwright GR, 2002, APPL ENVIRON MICROB, V68, P4448, DOI 10.1128/AEM.68.9.4448-4456.2002; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eglinton JM, 2002, YEAST, V19, P295, DOI 10.1002/yea.834; Ehsani M, 2009, APPL ENVIRON MICROB, V75, P3196, DOI 10.1128/AEM.02157-08; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Gonzalez SS, 2007, INT J FOOD MICROBIOL, V116, P11, DOI 10.1016/j.ijfoodmicro.2006.10.047; Hayashi M, 2006, J BIOCHEM, V139, P797, DOI 10.1093/jb/mvj089; Hubmann G, 2011, APPL ENVIRON MICROB, V77, P5857, DOI 10.1128/AEM.05338-11; Izawa S, 2004, APPL MICROBIOL BIOT, V66, P108, DOI 10.1007/s00253-004-1624-4; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Kinclova-Zimmermannova O, 2006, CURR GENET, V49, P229, DOI 10.1007/s00294-005-0050-1; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; Michnick S, 1997, YEAST, V13, P783, DOI 10.1002/(SICI)1097-0061(199707)13:9<783::AID-YEA128>3.0.CO;2-W; Nass R, 1999, MICROBIOL-SGM, V145, P3221, DOI 10.1099/00221287-145-11-3221; Naumov GI, 2000, INT J SYST EVOL MICR, V50, P1931, DOI 10.1099/00207713-50-5-1931; Nevoigt E, 1996, YEAST, V12, P1331, DOI 10.1002/(SICI)1097-0061(199610)12:13<1331::AID-YEA28>3.3.CO;2-S; Arroyo-Lopez FN, 2010, FOOD MICROBIOL, V27, P628, DOI 10.1016/j.fm.2010.02.001; Norbeck J, 1997, J BIOL CHEM, V272, P5544, DOI 10.1074/jbc.272.9.5544; Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200; Panadero J, 2006, J BIOL CHEM, V281, P4638, DOI 10.1074/jbc.M512736200; Perez-Torrado R, 2009, APPL MICROBIOL BIOT, V81, P951, DOI 10.1007/s00253-008-1722-9; QUEROL A, 1994, INT J FOOD MICROBIOL, V21, P315, DOI 10.1016/0168-1605(94)90061-2; Remize F, 2001, METAB ENG, V3, P301, DOI 10.1006/mben.2001.0197; Ribereau-Gayon P., 2006, HDB ENOLOGY MICROBIO, V1; Salvado Z, 2011, APPL ENVIRON MICROB, V77, P2292, DOI 10.1128/AEM.01861-10; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Tronchoni J, 2009, INT J FOOD MICROBIOL, V134, P237, DOI 10.1016/j.ijfoodmicro.2009.07.004; Tulha J, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-82	38	43	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87290	10.1371/journal.pone.0087290	http://dx.doi.org/10.1371/journal.pone.0087290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498063	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100072
J	Yang, N; Lei, Z; Li, XY; Zhao, JH; Liu, TJ; Ning, NN; Xiao, AL; Xu, LL; Li, JX				Yang, Ning; Lei, Zhen; Li, Xiaoyu; Zhao, Junhan; Liu, Tianjian; Ning, Nannan; Xiao, Ailin; Xu, Linlin; Li, Jingxin			Chloroquine Stimulates Cl- Secretion by Ca2+ Activated Cl- Channels in Rat Ileum	PLOS ONE			English	Article							BITTER TASTE RECEPTORS; ALPHA-GUSTDUCIN; ANTIMALARIAL PROPHYLAXIS; GASTROINTESTINAL-TRACT; ADVERSE EVENTS; EAST-AFRICA; GUT; EXPRESSION; CELLS; MEFLOQUINE	Chloroquine (CQ), a bitter tasting drug widely used in treatment of malaria, is associated gastrointestinal side effects including nausea or diarrhea. In the present study, we investigated the effect of CQ on electrolyte transport in rat ileum using the Ussing chamber technique. The results showed that CQ evoked an increase in short circuit current (I-SC) in rat ileum at lower concentration (<= 5x10(-4) M) but induced a decrease at higher concentrations (>= 10(-3) M). These responses were not affected by tetrodotoxin (TTX). Other bitter compounds, such as denatoniumbenzoate and quinine, exhibited similar effects. CQ-evoked increase in I-SC was partly reduced by amiloride(10(-4) M), a blocker of epithelial Na+ channels. Furosemide (10(-4) M), an inhibitor of Na+-K+ -2Cl(-) co-transporter, also inhibited the increased I-SC response to CQ, whereas another Cl- channel inhibitor, CFTR(inh)-172(10(-5) M), had no effect. Intriguingly, CQ-evoked increases were almost completely abolished by niflumic acid (10(-4) M), a relatively specific Ca2+-activated Cl- channel (CaCC) inhibitor. Furthermore, other CaCC inhibitors, such as DIDS and NPPB, also exhibited similar effects. CQ-induced increases in I-SC were also abolished by thapsigargin(10(-6) M), a Ca2+ pump inhibitor and in the absence of either Cl- or Ca2+ from bathing solutions. Further studies demonstrated that T2R and CaCC-TMEM16A were colocalized in small intestinal epithelial cells and the T2R agonist CQ evoked an increase of intracelluar Ca2+ in small intestinal epithelial cells. Taken together, these results demonstrate that CQ induces Cl- secretion in rat ileum through CaCC at low concentrations, suggesting a novel explanation for CQ-associated gastrointestinal side-effects during the treatment of malaria.	[Yang, Ning; Li, Xiaoyu; Zhao, Junhan; Liu, Tianjian; Ning, Nannan; Xiao, Ailin; Xu, Linlin; Li, Jingxin] Shandong Univ, Sch Med, Dept Physiol, Jinan 250100, Peoples R China; [Lei, Zhen] Shandong Univ, Qilu Hosp, Dept Anesthesiol, Jinan 250100, Peoples R China	Shandong University; Shandong University	Li, JX (corresponding author), Shandong Univ, Sch Med, Dept Physiol, Jinan 250100, Peoples R China.	ljingxin@sdu.edu.cn			National Natural Science Foundation of China [31171108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants to Jingxin Li from the National Natural Science Foundation of China (grant no. 31171108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett PJ, 1996, BRIT MED J, V313, P525, DOI 10.1136/bmj.313.7056.525; Basavappa S, 2005, J CELL PHYSIOL, V202, P21, DOI 10.1002/jcp.20085; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Deshpande DA, NAT MED, V16, P1299; Durrheim DN, 1999, S AFR MED J, V89, P170; FOGEL R, 1982, AM J PHYSIOL, V243, pG117, DOI 10.1152/ajpgi.1982.243.2.G117; FOGH S, 1988, BMJ-BRIT MED J, V296, P820, DOI 10.1136/bmj.296.6625.820; Furness JB, 1999, AM J PHYSIOL-GASTR L, V277, pG922, DOI 10.1152/ajpgi.1999.277.5.G922; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Isenring P, 1997, J BIOL CHEM, V272, P24556, DOI 10.1074/jbc.272.39.24556; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Jing F, J PHARM PHARM, V65, P847; Kaji I, 2009, AM J PHYSIOL-GASTR L, V296, pG971, DOI 10.1152/ajpgi.90514.2008; Li Y, EUR J PHARM, V656, P94; Ogura T, 2002, J NEUROPHYSIOL, V87, P3152, DOI 10.1152/jn.2002.87.6.3152; Ogura T, 1997, J NEUROSCI, V17, P3580; Rozengurt E, 2006, AM J PHYSIOL-GASTR L, V291, pG171, DOI 10.1152/ajpgi.00073.2006; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; STEFFEN R, 1993, LANCET, V341, P1299, DOI 10.1016/0140-6736(93)90814-W; Thiagarajah JR, 2003, CURR OPIN PHARMACOL, V3, P594, DOI 10.1016/j.coph.2003.06.012; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Xu J, MOL HUM REPROD, V19, P17; Yan WT, 2001, AM J PHYSIOL-CELL PH, V280, pC742, DOI 10.1152/ajpcell.2001.280.4.C742	24	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87627	10.1371/journal.pone.0087627	http://dx.doi.org/10.1371/journal.pone.0087627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498157	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100103
J	Uchino, J; Curiel, DT; Ugai, H				Uchino, Junji; Curiel, David T.; Ugai, Hideyo			Species D Human Adenovirus Type 9 Exhibits Better Virus-Spread Ability for Antitumor Efficacy among Alternative Serotypes	PLOS ONE			English	Article							CONDITIONALLY REPLICATIVE ADENOVIRUS; SELECTIVE ONCOLYTIC ADENOVIRUS; RECURRENT PROSTATE-CANCER; MALIGNANT GLIOMA-CELLS; SUICIDE GENE-THERAPY; WILD-TYPE ADENOVIRUS; HUMAN BLADDER-CANCER; CORE PROTEIN-V; PHASE-I TRIAL; RECOMBINANT ADENOVIRUS	Species C human adenovirus serotype 5 (HAdV-C5) is widely used as a vector for cancer gene therapy, because it efficiently transduces target cells. A variety of HAdV-C5 vectors have been developed and tested in vitro and in vivo for cancer gene therapy. While clinical trials with HAdV-C5 vectors resulted in effective responses in many cancer patients, administration of HAdV-C5 vectors to solid tumors showed responses in a limited area. A biological barrier in tumor mass is considered to hinder viral spread of HAdV-C5 vectors from infected cells. Therefore, efficient virus-spread from an infected tumor cell to surrounding tumor cells is required for successful cancer gene therapy. In this study, we compared HAdV-C5 to sixteen other HAdV serotypes selected from species A to G for virus-spread ability in vitro. HAdV-D9 showed better virus-spread ability than other serotypes, and its viral progeny were efficiently released from infected cells during viral replication. Although the HAdV-D9 fiber protein contains a binding site for coxsackie B virus and adenovirus receptor (CAR), HAdV-D9 showed expanded tropism for infection due to human CAR (hCAR)-independent attachment to target cells. HAdV-D9 infection effectively killed hCAR-negative cancer cells as well as hCAR-positive cancer cells. These results suggest that HADV-D9, with its better virus-spread ability, could have improved therapeutic efficacy in solid tumors compared to HAdV-C5.	[Uchino, Junji; Curiel, David T.; Ugai, Hideyo] Washington Univ, Sch Med, Div Canc Biol, St Louis, MO 63130 USA; [Curiel, David T.] Washington Univ, Sch Med, Dept Radiat Oncol, Biol Therapeut Ctr, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Ugai, H (corresponding author), Washington Univ, Sch Med, Div Canc Biol, St Louis, MO 63130 USA.	hugai@radonc.wustl.edu	Ugai, Hideyo/K-4920-2017	Ugai, Hideyo/0000-0002-9121-8480; Uchino, Junji/0000-0003-0651-7767	Susan G. Komen for the Cure [KG100194]; National Institutes of Health [5R01CA154697]; NATIONAL CANCER INSTITUTE [R01CA154697] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from Susan G. Komen for the Cure KG100194 (Drs. David T. Curiel and Hideyo Ugai), and the National Institutes of Health 5R01CA154697 (Drs. David T. Curiel and Michael J. Mathis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Adachi Y, 2001, CANCER RES, V61, P7882; Alemany R, 2000, NAT BIOTECHNOL, V18, P723, DOI 10.1038/77283; Anders M, 2009, BRIT J CANCER, V100, P352, DOI 10.1038/sj.bjc.6604876; Arnberg N, 2000, J VIROL, V74, P7691, DOI 10.1128/JVI.74.16.7691-7693.2000; Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; Arnberg N, 2002, VIROLOGY, V302, P33, DOI 10.1006/viro.2002.1503; Arnberg N, 2009, REV MED VIROL, V19, P165, DOI 10.1002/rmv.612; Asaoka K, 2000, J NEUROSURG, V92, P1002, DOI 10.3171/jns.2000.92.6.1002; Auer D, 2009, BREAST CANCER RES TR, V116, P103, DOI 10.1007/s10549-008-0108-0; Beatty MS, 2012, ADV CANCER RES, V115, P39, DOI [10.1016/B978-0-12-3983,12-8.00002-1, 10.1016/B978-0-12-398342-8.00002-1]; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Blusch JH, 2002, VIROLOGY, V296, P94, DOI 10.1006/viro.2002.1404; Cascallo M, 2007, MOL THER, V15, P1607, DOI 10.1038/sj.mt.6300239; Cerullo V, 2010, CANCER RES, V70, P4297, DOI 10.1158/0008-5472.CAN-09-3567; Chen CY, 2011, CANCER GENE THER, V18, P744, DOI 10.1038/cgt.2011.47; Chiocca EA, 2002, NAT REV CANCER, V2, P938, DOI 10.1038/nrc948; Curiel DT, 2000, CLIN CANCER RES, V6, P3395; De Jong JC, 1999, J CLIN MICROBIOL, V37, P3940, DOI 10.1128/JCM.37.12.3940-3945.1999; DeWeese TL, 2001, CANCER RES, V61, P7464; Dey SK, 2009, INFECT GENET EVOL, V9, P518, DOI 10.1016/j.meegid.2009.02.001; Fields B. N., 2007, FIELDS VIROLOGY; FORD E, 1987, EPIDEMIOL REV, V9, P244, DOI 10.1093/oxfordjournals.epirev.a036304; Freytag SO, 2002, CANCER RES, V62, P4968; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; Glasgow JN, 2004, CURR GENE THER, V4, P1, DOI 10.2174/1566523044577997; GREEN M, 1967, VIROLOGY, V31, P562, DOI 10.1016/0042-6822(67)90241-3; Gros A, 2008, CANCER RES, V68, P8928, DOI 10.1158/0008-5472.CAN-08-1145; Harrison D, 2001, HUM GENE THER, V12, P1323, DOI 10.1089/104303401750270977; Havenga MJE, 2002, J VIROL, V76, P4612, DOI 10.1128/JVI.76.9.4612-4620.2002; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; HSU KHL, 1988, J VIROL, V62, P1647, DOI 10.1128/JVI.62.5.1647-1652.1988; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; KEMP MC, 1983, J INFECT DIS, V148, P24, DOI 10.1093/infdis/148.1.24; KHOO SH, 1995, J INFECT DIS, V172, P629, DOI 10.1093/infdis/172.3.629; KIBRICK S, 1957, ANN NY ACAD SCI, V67, P311, DOI 10.1111/j.1749-6632.1957.tb46055.x; Kim KH, 2013, GYNECOL ONCOL; Kim M, 2003, BRIT J CANCER, V88, P1411, DOI 10.1038/sj.bjc.6600932; Kimball KJ, 2010, CLIN CANCER RES, V16, P5277, DOI 10.1158/1078-0432.CCR-10-0791; Kirby I, 2001, J VIROL, V75, P7210, DOI 10.1128/JVI.75.15.7210-7214.2001; Kirn D, 2001, GENE THER, V8, P89, DOI 10.1038/sj.gt.3301377; Korn WM, 2006, CANCER GENE THER, V13, P792, DOI 10.1038/sj.cgt.7700947; Koski A, 2010, MOL THER, V18, P1874, DOI 10.1038/mt.2010.161; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; Kuhn I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002409; Li JL, 2009, GENE THER, V16, P376, DOI 10.1038/gt.2008.179; Li YM, 1999, CANCER RES, V59, P325; Lichtenstein DL, 2009, CANCER GENE THER, V16, P644, DOI 10.1038/cgt.2009.5; Liu EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033212; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; McCormick F, 2001, NAT REV CANCER, V1, P130, DOI 10.1038/35101008; Murakami M, 2010, PROSTATE, V70, P362, DOI 10.1002/pros.21070; Nemunaitis J, 2010, MOL THER, V18, P429, DOI 10.1038/mt.2009.262; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nokisalmi P, 2010, CLIN CANCER RES, V16, P3035, DOI 10.1158/1078-0432.CCR-09-3167; Okegawa T, 2001, CANCER RES, V61, P6592; PRAGE L, 1972, VIROLOGY, V49, P745, DOI 10.1016/0042-6822(72)90531-4; Ramesh N, 2006, CLIN CANCER RES, V12, P305, DOI 10.1158/1078-0432.CCR-05-1059; Ramirez PJ, 2008, AM J SURG, V195, P481, DOI 10.1016/j.amjsurg.2007.04.014; Rauen KA, 2002, CANCER RES, V62, P3812; Roelvink PW, 1996, J VIROL, V70, P7614, DOI 10.1128/JVI.70.11.7614-7621.1996; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Russell SJ, 2007, TRENDS PHARMACOL SCI, V28, P326, DOI 10.1016/j.tips.2007.05.005; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sachs MD, 2002, UROLOGY, V60, P531, DOI 10.1016/S0090-4295(02)01748-X; SAITO I, 1985, J VIROL, V54, P711, DOI 10.1128/JVI.54.3.711-719.1985; Sambrook J., 2002, MOL CLONING LAB MANU; Sauthoff H, 2003, HUM GENE THER, V14, P425, DOI 10.1089/104303403321467199; Sauthoff H, 2000, HUM GENE THER, V11, P379, DOI 10.1089/10430340050015851; Shenk TE, 2001, ADENOVIRIDAE VIRUSES, P1053; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Subramanian T, 2006, J VIROL, V80, P2000, DOI 10.1128/JVI.80.4.2000-2012.2006; Tang YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008526; TIEMESSEN CT, 1994, J VIROL, V68, P1239, DOI 10.1128/JVI.68.2.1239-1244.1994; Ugai H, 2003, BIOCHEM BIOPH RES CO, V300, P448, DOI 10.1016/S0006-291X(02)02852-8; Ugai H, 2007, J MOL BIOL, V366, P1142, DOI 10.1016/j.jmb.2006.11.090; Ugai H, 2012, VIROLOGY, V432, P283, DOI 10.1016/j.virol.2012.05.028; Ugai H, 2010, J MOL BIOL, V395, P55, DOI 10.1016/j.jmb.2009.10.034; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Yamamoto M, 2001, MOL THER, V3, P385, DOI 10.1006/mthe.2001.0275; Yamasaki S, 2010, ARCH VIROL, V155, P1059, DOI 10.1007/s00705-010-0683-3; Yan W, 2003, J VIROL, V77, P2640, DOI 10.1128/JVI.77.4.2640-2650.2003; Zeimet AG, 2002, GENE THER, V9, P1093, DOI 10.1038/sj.gt.3301775; Zhang YM, 2005, J VIROL, V79, P12125, DOI 10.1128/JVI.79.19.12125-12131.2005	87	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87342	10.1371/journal.pone.0087342	http://dx.doi.org/10.1371/journal.pone.0087342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503714	Green Published, Green Submitted, gold			2022-12-25	WOS:000330631800029
J	Chen, X; Chen, Z; Zhao, HL; Zhao, Y; Cheng, BJ; Xiang, Y				Chen, Xue; Chen, Zhu; Zhao, Hualin; Zhao, Yang; Cheng, Beijiu; Xiang, Yan			Genome-Wide Analysis of Soybean HD-Zip Gene Family and Expression Profiling under Salinity and Drought Treatments	PLOS ONE			English	Article							IV TRANSCRIPTION FACTOR; PHYLOGENETIC ANALYSIS; EVOLUTIONARY FATE; DNA-BINDING; ARABIDOPSIS; PROTEIN; RICE; DOMAIN; AUXIN; DUPLICATION	Background: Homeodomain-leucine zipper (HD-Zip) proteins, a group of homeobox transcription factors, participate in various aspects of normal plant growth and developmental processes as well as environmental responses. To date, no overall analysis or expression profiling of the HD-Zip gene family in soybean (Glycine max) has been reported. Methods and Findings: An investigation of the soybean genome revealed 88 putative HD-Zip genes. These genes were classified into four subfamilies, I to IV, based on phylogenetic analysis. In each subfamily, the constituent parts of gene structure and motif were relatively conserved. A total of 87 out of 88 genes were distributed unequally on 20 chromosomes with 36 segmental duplication events, indicating that segmental duplication is important for the expansion of the HD-Zip family. Analysis of the Ka/Ks ratios showed that the duplicated genes of the HD-Zip family basically underwent purifying selection with restrictive functional divergence after the duplication events. Analysis of expression profiles showed that 80 genes differentially expressed across 14 tissues, and 59 HD-Zip genes are differentially expressed under salinity and drought stress, with 20 paralogous pairs showing nearly identical expression patterns and three paralogous pairs diversifying significantly under drought stress. Quantitative real-time RT-PCR (qRT-PCR) analysis of six paralogous pairs of 12 selected soybean HD-Zip genes under both drought and salinity stress confirmed their stress-inducible expression patterns. Conclusions: This study presents a thorough overview of the soybean HD-Zip gene family and provides a new perspective on the evolution of this gene family. The results indicate that HD-Zip family genes may be involved in many plant responses to stress conditions. Additionally, this study provides a solid foundation for uncovering the biological roles of HD-Zip genes in soybean growth and development.	[Chen, Xue; Chen, Zhu; Zhao, Hualin; Xiang, Yan] Anhui Agr Univ, Sch Forestry & Landscape Architecture, Lab Modern Biotechnol, Hefei, Peoples R China; [Zhao, Yang; Cheng, Beijiu] Anhui Agr Univ, Key Lab Crop Biol, Hefei, Peoples R China	Anhui Agricultural University; Anhui Agricultural University	Xiang, Y (corresponding author), Anhui Agr Univ, Sch Forestry & Landscape Architecture, Lab Modern Biotechnol, Hefei, Peoples R China.	xiangyan@ahau.edu.cn			National Natural Science Foundation of China [31370561]; Anhui Provincial Natural Science Foundation [1308085MC36]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	This work was supported by grants from the National Natural Science Foundation of China (No. 31370561) and Anhui Provincial Natural Science Foundation (No. 1308085MC36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, DEVELOPMENT, V130, P635, DOI 10.1242/dev.00292; Agalou A, 2008, PLANT MOL BIOL, V66, P87, DOI 10.1007/s11103-007-9255-7; Ariel F, 2010, PLANT CELL, V22, P2171, DOI 10.1105/tpc.110.074823; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Byrne ME, 2006, PLOS GENET, V2, P785, DOI 10.1371/journal.pgen.0020089; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; Chan RL, 1998, BBA-GENE STRUCT EXPR, V1442, P1, DOI 10.1016/S0167-4781(98)00119-5; Chen Q, 2011, PLANTA, V233, P583, DOI 10.1007/s00425-010-1322-7; Ciarbelli AR, 2008, PLANT MOL BIOL, V68, P465, DOI 10.1007/s11103-008-9383-8; Crespi M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.149re11; Delarue M, 1998, PLANT J, V14, P603, DOI 10.1046/j.1365-313X.1998.00163.x; Depege-Fargeix N, 2011, J EXP BOT, V62, P293, DOI 10.1093/jxb/erq267; Dezar CA, 2011, J EXP BOT, V62, P1061, DOI 10.1093/jxb/erq339; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; Dolan L, 2013, US Patent, Patent No. [20,130,081,153, 20130081153]; Du H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-106; Du QL, 2010, MOL BIOL REP, V37, P685, DOI 10.1007/s11033-009-9535-1; Fan CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062288; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frank W, 1998, PLANT J, V15, P413, DOI 10.1046/j.1365-313X.1998.00222.x; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Harris JC, 2011, NEW PHYTOL, V190, P823, DOI 10.1111/j.1469-8137.2011.03733.x; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Hu RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031149; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Hyun TK, 2013, IND CROP PROD, V49, P864, DOI 10.1016/j.indcrop.2013.06.046; Ilegems M, 2010, DEVELOPMENT, V137, P975, DOI 10.1242/dev.047662; Ingram GC, 2000, PLANT J, V22, P401, DOI 10.1046/j.1365-313X.2000.00755.x; Ito M, 2003, BREEDING SCI, V53, P245, DOI 10.1270/jsbbs.53.245; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Johannesson H, 2001, PLANT MOL BIOL, V45, P63, DOI 10.1023/A:1006423324025; Juretic N, 2005, GENOME RES, V15, P1292, DOI 10.1101/gr.4064205; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; Meijer AH, 1997, PLANT J, V11, P263, DOI 10.1046/j.1365-313X.1997.11020263.x; Morelli G, 2000, PLANT PHYSIOL, V122, P621, DOI 10.1104/pp.122.3.621; Mukherjee K, 2006, PLANT PHYSIOL, V140, P1142, DOI 10.1104/pp.105.073833; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Nuccio ML, 1999, CURR OPIN PLANT BIOL, V2, P128, DOI 10.1016/S1369-5266(99)80026-0; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Prigge MJ, 2006, EVOL DEV, V8, P350, DOI 10.1111/j.1525-142X.2006.00107.x; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rhoades J. D., 1990, Agronomy, P1089; Robischon M, 2011, PLANT PHYSIOL, V155, P1214, DOI 10.1104/pp.110.167007; Rueda EC, 2005, PLANT CELL PHYSIOL, V46, P1954, DOI 10.1093/pcp/pci210; Sawa S, 2002, PLANT J, V32, P1011, DOI 10.1046/j.1365-313X.2002.01488.x; SCHENA M, 1992, P NATL ACAD SCI USA, V89, P3894, DOI 10.1073/pnas.89.9.3894; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sessa G, 2005, GENE DEV, V19, P2811, DOI 10.1101/gad.364005; Sessa G, 1998, PLANT MOL BIOL, V38, P609, DOI 10.1023/A:1006016319613; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; Sessa G., 1994, PLANT MOL BIO, V81, P411; Skirycz A, 2010, CURR OPIN BIOTECH, V21, P197, DOI 10.1016/j.copbio.2010.03.002; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tardieu F, 1998, J EXP BOT, V49, P419, DOI 10.1093/jexbot/49.suppl_1.419; Tron AE, 2002, J BIOL CHEM, V277, P34800, DOI 10.1074/jbc.M203297200; Valdes AE, 2012, PLANT MOL BIOL, V80, P405, DOI 10.1007/s11103-012-9956-4; Vollbrecht E, 1991, DEV GENE KNOTTED 1 I; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wei Q, 2012, PLANT CELL TISS ORG, V110, P299, DOI 10.1007/s11240-012-0151-8; Wen BQ, 2011, J INTEGR PLANT BIOL, V53, P869, DOI 10.1111/j.1744-7909.2011.01075.x; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6; Xu HL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-197; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yin GJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-148; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488	96	79	95	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87156	10.1371/journal.pone.0087156	http://dx.doi.org/10.1371/journal.pone.0087156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498296	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900042
J	Emery, P; Rigby, W; Tak, PP; Dorner, T; Olech, E; Martin, C; Millar, L; Travers, H; Fisheleva, E				Emery, Paul; Rigby, William; Tak, Paul P.; Doerner, Thomas; Olech, Ewa; Martin, Carmen; Millar, Laurie; Travers, Helen; Fisheleva, Elena			Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program	PLOS ONE			English	Article							DOUBLE-BLIND; INADEQUATE RESPONSE; B-CELLS; EFFICACY; TRIAL; RITUXIMAB; METHOTREXATE; MULTICENTER; THERAPY; NAIVE	Objective: The objective was to determine the safety of ocrelizumab (OCR) in patients with rheumatoid arthritis (RA). Methods: This was an analysis of the double-blind, placebo-controlled periods and long-term follow-up of 4 OCR phase III trials in RA (SCRIPT, STAGE, FILM and FEATURE). Safety data per study and the results of a meta-analysis of serious infectious events (SIEs) are presented. Results: Overall, 868 patients received placebo, 1064 patients OCR 200 mgx2 (or 400 mgx1) (OCR200), and 827 patients OCR 500 mgx2 (OCR500) plus background methotrexate (MTX) at baseline and 24 weeks. During the double-blind, placebo-controlled periods, the incidence of adverse events and serious adverse events was comparable between the OCR+ MTX and placebo +MTX groups. Infusion-related reactions were more common with OCR+ MTX and decreased in frequency with subsequent infusions. Serious infusion-related reactions were rare (0.1%). Serious infections occurred more frequently with OCR500+MTX. In the meta-analysis, a statistically significant difference from placebo +MTX in incidence of SIEs per 100 patient-years of 2.4 (95% CI, 0.3-4.5) was observed with OCR500+MTX, but not with OCR200+MTX (0.6; 95% CI, -1.3 to 2.4). Patients recruited in Asia exhibited a higher risk of serious infections (hazard ratio, 1.78; 95% CI, 1.03-3.06). The incidence of human anti-human antibodies was <5%. Long-term follow-up indicated no differences in malignancy rates between the treatment groups. There was no apparent difference in time to B-cell repletion between the OCR dose groups. Conclusions: In placebo-controlled clinical trials of RA, OCR500+MTX was associated with a higher risk of serious infections compared with placebo +MTX. The safety profile of OCR 200+MTX was comparable with placebo+MTX.	[Emery, Paul] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Emery, Paul] Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Rigby, William] Geisel Sch Med Darthmouth, Lebanon, NH USA; [Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Doerner, Thomas] Charite, Berlin, Germany; [Doerner, Thomas] DRFZ, Berlin, Germany; [Olech, Ewa] Univ Nevada, Sch Med, Las Vegas, NV 89154 USA; [Martin, Carmen; Millar, Laurie; Travers, Helen; Fisheleva, Elena] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England	University of Leeds; Leeds Biomedical Research Centre; University of Leeds; University of Amsterdam; Academic Medical Center Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Roche Holding	Emery, P (corresponding author), Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England.	p.emery@leeds.ac.uk	emery, paul/B-3560-2013		F. Hoffmann-La Roche; Abbvie; Genentech; Pfizer; UCB; Vertex; National Institute for Health Research [NF-SI-0513-10139] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	F. Hoffmann-La Roche(Hoffmann-La Roche); Abbvie(AbbVie); Genentech(Roche HoldingGenentech); Pfizer(Pfizer); UCB(UCB Pharma SA); Vertex(Vertex Pharmaceuticals); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by F. Hoffmann-La Roche, the employer of Carmen Martin, Laurie Millar, Helen Travers, and Elena Fisheleva. EO has received research funding from Abbvie, Genentech, Pfizer, UCB and Vertex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Dorner T, 2010, PHARMACOL THERAPEUT, V125, P464, DOI 10.1016/j.pharmthera.2010.01.001; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Emery P, 2010, ANN RHEUM DIS, V69, P1629, DOI 10.1136/ard.2009.119933; Huffstutter JE, 2011, INT J CLIN RHEUMATOL, V6, P689, DOI DOI 10.2217/IJR.11.55; Kappos L, 2011, LANCET, V378, P1779, DOI 10.1016/S0140-6736(11)61649-8; Rigby W, 2012, ARTHRITIS RHEUM-US, V64, P350, DOI 10.1002/art.33317; Rubbert-Roth A, 2010, RHEUMATOLOGY, V49, P1683, DOI 10.1093/rheumatology/keq116; Silverman GJ, 2003, ARTHRITIS RES THER, V5, pS1, DOI 10.1186/ar1010; Stohl W, 2012, ANN RHEUM DIS, V71, P1289, DOI 10.1136/annrheumdis-2011-200706; Tak PP, 2012, ARTHRITIS RHEUM-US, V64, P360, DOI 10.1002/art.33353; van Vollenhoven RF, 2012, ANN RHEUM DIS; van Vollenhoven RF, 2010, J RHEUMATOL, V37, P558, DOI 10.3899/jrheum.090856	14	63	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87379	10.1371/journal.pone.0087379	http://dx.doi.org/10.1371/journal.pone.0087379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498318	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900064
J	Komatsu, H; Tanji, E; Sakata, N; Aoki, T; Motoi, F; Naitoh, T; Katayose, Y; Egawa, S; Unno, M; Furukawa, T				Komatsu, Hirotake; Tanji, Etsuko; Sakata, Naoaki; Aoki, Takeshi; Motoi, Fuyuhiko; Naitoh, Takeshi; Katayose, Yu; Egawa, Shinichi; Unno, Michiaki; Furukawa, Toru			A GNAS Mutation Found in Pancreatic Intraductal Papillary Mucinous Neoplasms Induces Drastic Alterations of Gene Expression Profiles with Upregulation of Mucin Genes	PLOS ONE			English	Article							ACTIVATING MUTATION; TUMOR-SUPPRESSOR; CELL-LINES; CANCER; PATHWAY; ALPHA; MAPK; PHOSPHORYLATION; INHIBITOR; CARCINOMA	GNAS, a gene encoding G protein stimulating a subunit, is frequently mutated in intraductal papillary mucinous neoplasms (IPMNs), which are indolent and slow-growing pancreatic tumors that secrete abundant mucin. The GNAS mutation is not observed in conventional ductal adenocarcinomas of the pancreas. To determine the functional significance of the GNAS mutation in pancreatic ductal lineage cells, we examined in vitro phenotypes of cells of pancreatic ductal lineage, HPDE, PK-8, PCI-35, and MIA PaCa-2, with exogenous expression of either wild-type or mutated (R201H) GNAS. We found that exogenous GNAS upregulated intracellular cyclic adenine monophosphate (cAMP), particularly in mutated GNAS transfectants, and upregulated expression of MUC2 and MUC5AC in HPDE and PK-8 cells. By contrast, exogenous GNAS inhibited expression of mucin genes in PCI-35 and MIA PaCa-2 cells, despite upregulation of cAMP. We examined global gene expression profiles of some of the cells transfected with exogenous mutated GNAS (PK-8, PCI-35, and MIA PaCa-2), and found that PK-8 cells exhibited drastic alterations of the gene expression profile, which contrasted with modest alterations in PCI-35 and MIA PaCa-2 cells. To identify a cause of these different effects of exogenous mutated GNAS on phenotypes of the cells, we examined effects of interactions of the signaling pathways of G protein-coupled receptor (GPCR), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K) on expression of mucin genes. The MAPK and PI3K pathways significantly influenced the expression of mucin genes. Exogenous GNAS did not promote cell growth but suppressed it in some of the cells. In conclusion, mutated GNAS found in IPMNs may extensively alter gene expression profiles, including expression of mucin genes, through the interaction with MAPK and PI3K pathways in pancreatic ductal cells; these changes may determine the characteristic phenotype of IPMN. PK-8 cells expressing exogenous mutated GNAS may be an ideal in vitro model of IPMN.	[Komatsu, Hirotake; Tanji, Etsuko; Furukawa, Toru] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan; [Komatsu, Hirotake; Sakata, Naoaki; Aoki, Takeshi; Motoi, Fuyuhiko; Naitoh, Takeshi; Katayose, Yu; Egawa, Shinichi; Unno, Michiaki] Tohoku Univ, Dept Surg, Grad Sch Med, Sendai, Miyagi 980, Japan; [Katayose, Yu] Tohoku Univ, Grad Sch Med, Div Integrated Surg & Oncol, Sendai, Miyagi 980, Japan	Tokyo Women's Medical University; Tohoku University; Tohoku University	Furukawa, T (corresponding author), Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan.	furukawa.toru@twmu.ac.jp	Sakata, Naoaki/H-4738-2019; Unno, Michiaki/AAX-5246-2020; Egawa, Shinichi/S-4055-2019; Furukawa, Toru/AAF-5596-2021; KOMATSU, HIROTAKE/R-7234-2019; Naitoh, Takeshi/K-1693-2014	Sakata, Naoaki/0000-0002-3495-4270; Unno, Michiaki/0000-0002-2145-6416; Egawa, Shinichi/0000-0002-1115-4932; Furukawa, Toru/0000-0002-1083-2324; KOMATSU, HIROTAKE/0000-0003-0876-4809; Naitoh, Takeshi/0000-0003-4169-6334	Japan Society for the Promotion of Science [24659167]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by the Grant-in-Aid for Challenging Exploratory Research (Grant number 24659167), Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt S, 2006, INT J CANCER, V119, P2812, DOI 10.1002/ijc.22242; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Basturk O, 2010, AM J SURG PATHOL, V34, P364, DOI 10.1097/PAS.0b013e3181cf8bb6; Cardenas-Navia LI, 2010, CANCER BIOL THER, V10, P33, DOI 10.4161/cbt.10.1.11949; Chung WC, 2009, J IMMUNOL, V182, P2349, DOI 10.4049/jimmunol.0713637; Cui WJ, 2012, FEBS LETT, V586, P766, DOI 10.1016/j.febslet.2012.01.039; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Delaney D, 2009, MODERN PATHOL, V22, P718, DOI 10.1038/modpathol.2009.32; DHANASEKARAN DN, 2006, SCI STKE, V2006, pE31; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fragoso MCBV, 1998, J CLIN ENDOCR METAB, V83, P2074, DOI 10.1210/jc.83.6.2074; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; Furukawa T, 1996, AM J PATHOL, V148, P1763; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Furukawa T, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-88; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Furukawa T, 2011, GUT, V60, P509, DOI 10.1136/gut.2010.210567; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hruban RH, 2007, TUMORS PANCREAS, P75; Ideno N, 2013, ANN SURG, V258, P141, DOI 10.1097/SLA.0b013e31828cd008; Jin HO, 2011, ONCOGENE, V30, P3792, DOI 10.1038/onc.2011.102; Jung M, 2012, MOL CELL BIOL, V32, P3938, DOI 10.1128/MCB.00413-12; Kadota K, 2012, ALGORITHM MOL BIOL, V7, DOI 10.1186/1748-7188-7-5; Kalfa N, 2006, J UROLOGY, V176, P891, DOI 10.1016/j.juro.2006.04.023; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Katsuno Y, 2012, J PATHOL, V228, P391, DOI 10.1002/path.4020; Kim YO, 2011, MOL CELLS, V32, P359, DOI 10.1007/s10059-011-0118-3; KOBARI M, 1986, TOHOKU J EXP MED, V150, P231, DOI 10.1620/tjem.150.231; Kohno T, 2012, DNA CELL BIOL, V31, P1636, DOI 10.1089/dna.2012.1666; Kucejova B, 2011, MOL CANCER RES, V9, P1255, DOI 10.1158/1541-7786.MCR-11-0302; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Luttges J, 2001, AM J SURG PATHOL, V25, P942; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Raz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019287; Schonleben F, 2006, CLIN CANCER RES, V12, P3851, DOI 10.1158/1078-0432.CCR-06-0292; Song KS, 2003, J BIOL CHEM, V278, P23243, DOI 10.1074/jbc.M300096200; SUGIURA H, 1994, PATHOL INT, V44, P688; Tan BK, 2009, DIABETES CARE, V32, P129, DOI 10.2337/dc08-1236; Terris B, 2002, AM J PATHOL, V160, P1745, DOI 10.1016/S0002-9440(10)61121-2; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wilson CH, 2010, ONCOGENE, V29, P4567, DOI 10.1038/onc.2010.202; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yamada M, 2012, J PATHOL, V228, P113, DOI 10.1002/path.4012; Yamanaka S, 2004, LAB INVEST, V84, P1339, DOI 10.1038/labinvest.3700160; Yonezawa S, 2008, PROTEOMICS, V8, P3329, DOI 10.1002/pmic.200800040; Yonezawa S, 2010, J HEPATO-BIL-PAN SCI, V17, P108, DOI 10.1007/s00534-009-0174-7; YUNIS AA, 1977, INT J CANCER, V19, P128, DOI 10.1002/ijc.2910190118	53	43	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87875	10.1371/journal.pone.0087875	http://dx.doi.org/10.1371/journal.pone.0087875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498386	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900132
J	Lin, PF; Lo, MT; Tsao, JH; Chang, YC; Lin, C; Ho, YL				Lin, Pei-Feng; Lo, Men-Tzung; Tsao, Jenho; Chang, Yi-Chung; Lin, Chen; Ho, Yi-Lwun			Correlations between the Signal Complexity of Cerebral and Cardiac Electrical Activity: A Multiscale Entropy Analysis	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; TIME-SERIES ANALYSIS; EMPIRICAL MODE DECOMPOSITION; ALZHEIMERS-DISEASE; PHOTIC-STIMULATION; VASCULAR DEMENTIA; SAMPLE ENTROPY; BLOOD-PRESSURE; PHASE-LOCKING; EEG	The heart begins to beat before the brain is formed. Whether conventional hierarchical central commands sent by the brain to the heart alone explain all the interplay between these two organs should be reconsidered. Here, we demonstrate correlations between the signal complexity of brain and cardiac activity. Eighty-seven geriatric outpatients with healthy hearts and varied cognitive abilities each provided a 24-hour electrocardiography (ECG) and a 19-channel eye-closed routine electroencephalography (EEG). Multiscale entropy (MSE) analysis was applied to three epochs (resting-awake state, photic stimulation of fast frequencies (fast-PS), and photic stimulation of slow frequencies (slow-PS)) of EEG in the 1-58 Hz frequency range, and three RR interval (RRI) time series (awake-state, sleep and that concomitant with the EEG) for each subject. The low-to-high frequency power (LF/HF) ratio of RRI was calculated to represent sympatho-vagal balance. With statistics after Bonferroni corrections, we found that: (a) the summed MSE value on coarse scales of the awake RRI (scales 11-20, RRI-MSE-coarse) were inversely correlated with the summed MSE value on coarse scales of the resting-awake EEG (scales 6-20, EEG-MSE-coarse) at Fp2, C4, T6 and T4; (b) the awake RRI-MSE-coarse was inversely correlated with the fast-PS EEG-MSE-coarse at O1, O2 and C4; (c) the sleep RRI-MSE-coarse was inversely correlated with the slow-PS EEG-MSE-coarse at Fp2; (d) the RRI-MSE-coarse and LF/HF ratio of the awake RRI were correlated positively to each other; (e) the EEG-MSE-coarse at F8 was proportional to the cognitive test score; (f) the results conform to the cholinergic hypothesis which states that cognitive impairment causes reduction in vagal cardiac modulation; (g) fast-PS significantly lowered the EEG-MSE-coarse globally. Whether these heart-brain correlations could be fully explained by the central autonomic network is unknown and needs further exploration.	[Lin, Pei-Feng] Tainan Hosp, Minist Hlth & Welf, Dept Geriatr, Tainan, Taiwan; [Lin, Pei-Feng; Tsao, Jenho] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lo, Men-Tzung; Lin, Chen] Natl Cent Univ, Res Ctr Adapt Data Anal, Jongli, Taiwan; [Chang, Yi-Chung] Natl Taiwan Univ, Grad Inst Commun Engn, Taipei 10764, Taiwan; [Lin, Chen] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jongli, Taiwan; [Ho, Yi-Lwun] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Ho, Yi-Lwun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Central University; National Taiwan University; National Central University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lin, PF (corresponding author), Tainan Hosp, Minist Hlth & Welf, Dept Geriatr, Tainan, Taiwan.	pflin@hotmail.com	huang, yuting/T-4341-2019; Wang, Pa-Chun/AAD-4094-2019	Lin, Chen/0000-0001-6261-8509; HO, YI-LWUN/0000-0002-8936-9570	National Science Council of Taiwan [100-2221-E-008-008-MY2, NSC 100-2911-I-008-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study is supported by the grants from the National Science Council of Taiwan (grants number: 100-2221-E-008-008-MY2 and NSC 100-2911-I-008-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo D, 2007, P ANN INT IEEE EMBS, P6192; AIHARA K, 1986, PHYS LETT A, V116, P313, DOI 10.1016/0375-9601(86)90578-5; Allan LM, 2005, DEMENT GERIATR COGN, V19, P140, DOI 10.1159/000082885; Armour JA, 2011, HEART RHYTHM, V8, P739, DOI 10.1016/j.hrthm.2011.01.033; Baumert M, 2012, COMPUT BIOL MED, V42, P347, DOI 10.1016/j.compbiomed.2011.03.019; Beekwilder JP, 2010, J CLIN NEUROPHYSIOL, V27, P130, DOI 10.1097/WNP.0b013e3181d64d8a; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Bhattacharya J, 2005, NEUROSCIENCE, V131, P547, DOI 10.1016/j.neuroscience.2004.11.013; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Dufey M, 2011, SOC NEUROSCI-UK, V6, P48, DOI 10.1080/17470911003691402; Escudero J, 2006, PHYSIOL MEAS, V27, P1091, DOI 10.1088/0967-3334/27/11/004; Fingelkurts Al A, 2010, Open Neuroimag J, V4, P130, DOI 10.2174/1874440001004010130; GLASS L, 1983, PHYSICA D, V7, P89, DOI 10.1016/0167-2789(83)90119-7; Goldberger AL, 1997, PERSPECT BIOL MED, V40, P543; GUEVARA MR, 1981, SCIENCE, V214, P1350, DOI 10.1126/science.7313693; HARTMAN ML, 1994, J CLIN INVEST, V94, P1277, DOI 10.1172/JCI117446; Hornero R, 2009, PHILOS T R SOC A, V367, P317, DOI 10.1098/rsta.2008.0197; Hu K, 2008, CARDIOVASC ENG, V8, P60, DOI 10.1007/s10558-007-9045-5; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kikuchi M, 2002, CLIN NEUROPHYSIOL, V113, P1045, DOI 10.1016/S1388-2457(02)00129-3; Leppanen PHT, 2004, EXP NEUROL, V190, pS91, DOI 10.1016/j.expneurol.2004.06.002; Lin DC, 2010, CHAOS, V20, DOI 10.1063/1.3427639; Lippe S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.048.2009; McIntosh AR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000106; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Misic B, 2010, J NEUROPHYSIOL, V104, P2667, DOI 10.1152/jn.00648.2010; Murakami Shogo, 2002, Nihon Ronen Igakkai Zasshi, V39, P520; Park JH, 2007, FRACTALS, V15, P399, DOI 10.1142/S0218348X07003691; Paskaski M, 2008, NEUROCHEM INT, V53, P103, DOI 10.1016/j.neuint.2008.06.005; Pavlov AN, 2005, CHAOS SOLITON FRACT, V24, P57, DOI 10.1016/j.chaos.2004.09.025; Peng CK, 2009, ADV DATA SCI ADAPT, V1, P61, DOI 10.1142/S1793536909000035; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; PETRILLO GA, 1984, AM J PHYSIOL, V246, pR311, DOI 10.1152/ajpregu.1984.246.3.R311; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355; Plochl M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00278; Popivanov D, 2005, SIGNAL PROCESS, V85, P2112, DOI 10.1016/j.sigpro.2005.07.005; Porta A, 1996, BIOL CYBERN, V75, P163, DOI 10.1007/s004220050284; Poupard L, 2001, BIOL CYBERN, V85, P19, DOI 10.1007/PL00007993; Protzner AB, 2010, ARCH ITAL BIOL, V148, P289; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Safieddine D, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-127; Sinnreich R, 1998, HEART, V80, P156, DOI 10.1136/hrt.80.2.156; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Takahashi T, 2010, NEUROIMAGE, V51, P173, DOI 10.1016/j.neuroimage.2010.02.009; Takahashi T, 2009, CLIN NEUROPHYSIOL, V120, P476, DOI 10.1016/j.clinph.2008.12.043; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Thuraisingham RA, 2006, PHYSICA A, V366, P323, DOI 10.1016/j.physa.2005.10.008; Tsai PH, 2012, J NEUROSCI METH, V210, P230, DOI 10.1016/j.jneumeth.2012.07.002; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; vandenBerg G, 1997, EUR J ENDOCRINOL, V136, P394, DOI 10.1530/eje.0.1360394; WINKEL K, 1953, PFLUG ARCH GES PHYS, V258, P22, DOI 10.1007/BF00364084	60	54	54	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87798	10.1371/journal.pone.0087798	http://dx.doi.org/10.1371/journal.pone.0087798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498375	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900121
J	Pradhan, AB; Haque, L; Roy, S; Das, S				Pradhan, Ankur Bikash; Haque, Lucy; Roy, Snigdha; Das, Suman			Binding of Phenazinium Dye Safranin T to Polyriboadenylic Acid: Spectroscopic and Thermodynamic Study	PLOS ONE			English	Article							SELF-STRUCTURE INDUCTION; RNA-PROCESSING ENZYME; MOLECULAR RECOGNITION; NUCLEIC-ACIDS; POLY(A)-BINDING PROTEIN; DEOXYRIBONUCLEIC-ACID; BIOLOGICAL STAINS; DNA; POLY(A); LIGANDS	Here, we report results from experiments designed to explore the association of the phenazinium dye safranin T (ST, 3,7-diamino-2,8-dimethyl-5-phenylphenazinium chloride) with single and double stranded form of polyriboadenylic acid (hereafter poly-A) using several spectroscopic techniques. We demonstrate that the dye binds to single stranded polyriboadenylic acid (hereafter ss poly-A) with high affinity while it does not interact at all with the double stranded (ds) form of the polynucleotide. Fluorescence and absorption spectral studies reveal the molecular aspects of binding of ST to single stranded form of the polynucleotide. This observation is also supported by the circular dichroism study. Thermodynamic data obtained from temperature dependence of binding constant reveals that association is driven by negative enthalpy change and opposed by negative entropy change. Ferrocyanide quenching studies have shown intercalative binding of ST to ss poly-A. Experiments on viscosity measurements confirm the binding mode of the dye to be intercalative. The effect of [Na+] ion concentration on the binding process suggests the role of electrostatic forces in the complexation. Present studies reveal the utility of the dye in probing nucleic acid structure.	[Pradhan, Ankur Bikash; Haque, Lucy; Roy, Snigdha; Das, Suman] Jadavpur Univ, Dept Chem, Kolkata, India	Jadavpur University	Das, S (corresponding author), Jadavpur Univ, Dept Chem, Kolkata, India.	sumandas10@yahoo.com	Pradhan, Ankur/L-8503-2019		University Grant Commission, Government of India	University Grant Commission, Government of India(University Grants Commission, India)	ABP and LH acknowledge University Grant Commission, Government of India, for Junior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Bose D, 2010, CHEM PHYS LIPIDS, V163, P94, DOI 10.1016/j.chemphyslip.2009.10.003; Cao Y, 1998, SPECTROCHIM ACTA A, V54, P883, DOI 10.1016/S1386-1425(97)00277-1; Cetinkol OP, 2009, NUCLEIC ACIDS RES, V37, P611, DOI 10.1093/nar/gkn977; Chaires JB, 2005, TOP CURR CHEM, V253, P33, DOI 10.1007/b100441; Das P, 2007, J PHYS CHEM B, V111, P7401, DOI 10.1021/jp072142m; Das S, 2008, J MOL STRUCT, V872, P56, DOI 10.1016/j.molstruc.2007.02.016; Das S, 2014, SPECTROCHIM ACTA A, V118, P356, DOI 10.1016/j.saa.2013.08.106; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Dower K, 2004, RNA, V10, P1888, DOI 10.1261/rna.7166704; Foloppe N, 2006, DRUG DISCOV TODAY, V11, P1019, DOI 10.1016/j.drudis.2006.09.001; FRESCO JR, 1957, J AM CHEM SOC, V79, P3928, DOI 10.1021/ja01571a089; Fulle S, 2010, J MOL RECOGNIT, V23, P220, DOI 10.1002/jmr.1000; Giri P, 2008, ARCH BIOCHEM BIOPHYS, V474, P183, DOI 10.1016/j.abb.2008.03.013; Giri P, 2007, BBA-GEN SUBJECTS, V1770, P1419, DOI 10.1016/j.bbagen.2007.05.005; HOLCOMB DN, 1965, BIOPOLYMERS, V3, P121, DOI 10.1002/bip.360030203; Hossain M, 2012, DYES PIGMENTS, V92, P1376, DOI 10.1016/j.dyepig.2011.09.016; Huang CZ, 1998, ANAL CHIM ACTA, V375, P89; Ihmels H, 2005, TOP CURR CHEM, V258, P161, DOI 10.1007/b135804; Krings M, 2000, REV PALAEOBOT PALYNO, V108, P143, DOI 10.1016/S0034-6667(99)00040-8; KUMAR GS, 1993, BIOCHEM PHARMACOL, V46, P1666, DOI 10.1016/0006-2952(93)90337-V; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE; LERMAN LS, 1961, J MOL BIOL, V3, P18, DOI 10.1016/S0022-2836(61)80004-1; Liu Z, 2008, INT J MOL SCI, V9, P978, DOI 10.3390/ijms9060978; Maiti M, 2007, MED RES REV, V27, P649, DOI 10.1002/med.20087; MCDEVITT MA, 1986, EMBO J, V5, P2907, DOI 10.1002/j.1460-2075.1986.tb04586.x; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; MULLER W, 1968, J MOL BIOL, V35, P251, DOI 10.1016/S0022-2836(68)80024-5; MUNROE D, 1990, MOL CELL BIOL, V10, P3441, DOI 10.1128/MCB.10.7.3441; NANDI R, 1985, PHOTOCHEM PHOTOBIOL, V42, P497, DOI 10.1111/j.1751-1097.1985.tb01600.x; Palchaudhuri R, 2007, CURR OPIN BIOTECH, V18, P497, DOI 10.1016/j.copbio.2007.09.006; Penney DP, 2002, BIOTECH HISTOCHEM, V77, P237, DOI 10.1080/714028210; Petrovic AG, 2005, J PHYS CHEM B, V109, P23698, DOI 10.1021/jp054280m; Proevska LI, 1998, DYES PIGMENTS, V36, P177, DOI 10.1016/S0143-7208(97)00011-9; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RICH A, 1961, J MOL BIOL, V3, P71, DOI 10.1016/S0022-2836(61)80009-0; Saenger W., 1984, PRINCIPLES NUCL ACID; Saha I, 2011, J FLUORESC, V21, P247, DOI 10.1007/s10895-010-0712-3; Sarkar D, 2008, J PHYS CHEM B, V112, P9243, DOI 10.1021/jp801659d; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Svitkin Yuri V., 2004, V257, P155; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Topalian SL, 2002, CANCER RES, V62, P5505; Topalian SL, 2001, MOL CELL BIOL, V21, P5614, DOI 10.1128/MCB.21.16.5614-5623.2001; VENNERSTROM JL, 1995, ANTIMICROB AGENTS CH, V39, P2671, DOI 10.1128/AAC.39.12.2671; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; WILSON WD, 1979, BIOPOLYMERS, V18, P3025, DOI 10.1002/bip.1979.360181210; Xi HJ, 2009, FEBS LETT, V583, P2269, DOI 10.1016/j.febslet.2009.06.007; Xing FF, 2005, FEBS LETT, V579, P5035, DOI 10.1016/j.febslet.2005.07.091; Yadav RC, 2005, BIOORGAN MED CHEM, V13, P165, DOI 10.1016/j.bmc.2004.09.045; Zaghbani N, 2008, DESALINATION, V222, P348, DOI 10.1016/j.desal.2007.01.148; Zarudnaya MI, 1999, IUBMB LIFE, V48, P581	54	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87992	10.1371/journal.pone.0087992	http://dx.doi.org/10.1371/journal.pone.0087992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498422	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900168
J	Shanmughapriya, V; Meenakshi, S; Munavar, MH				Shanmughapriya, Vinod; Meenakshi, Shanmugaraja; Munavar, M. Hussain			Selective Alleviation of Mitomycin C Sensitivity in lexA3 Strains of Escherichia coli Demands Allele Specificity of rif-nal Mutations: A Pivotal Role for rpoB87-gyrA87 Mutations	PLOS ONE			English	Article							RNA-POLYMERASE MUTANTS; COUPLED DNA-REPAIR; TERMINATION; RESISTANCE; GENE; SULA; ANTIBIOTICS; STIMULATE; SUBUNIT; K-12	Very recently, we have reported about an unconventional mode of elicitation of Mitomycin C (MMC) specific resistance in lexA3 (SOS repair deficient) mutants due to a combination of Rif-Nal mutations (rpoB87-gyrA87). We have clearly shown that UvrB is mandatory for this unconventional MMC resistance in rpoB87-gyrA87-lexA3 strains and uvrB is expressed more even without DNA damage induction from its LexA dependent promoter despite the uncleavable LexA3 repressor. The rpoB87 allele is same as the rpoB3595 which is known to give rise to a fast moving RNA Polymerase and gyrA87 is a hitherto unreported Nal(R) allele. Thus, it is proposed that the RNA Polymerase with higher elongation rate with the mutant DNA Gyrase is able to overcome the repressional hurdle posed by LexA3 to express uvrB. In this study we have systematically analysed the effect of three other rpoB (rif) mutations-two known to give rise to fast moving RNAP (rpoB2 and rpoB111) and one to a slow moving RNAP (rpoB8) and four different alleles of gyrA Nal(R) mutations (gyrA199, gyrA247, gyrA250, gyrA259) isolated spontaneously, on elicitation of MMC resistance in lexA3 strains. Our results indicate that in order to acquire resistance to 0.5 mu g/ml MMC cells require both rpoB87 and gyrA87 but resistance to 0.25 mu g/ml of MMC can be brought about by either rpoB87, gyrA87, fast moving rpoB mutations or other nal mutations also. We have also depicted increased constitutive uvrB expression in strains carrying fast moving RNAP (rpoB2 and rpoB111) with gyrA87 and another nal mutation with rpoB87 and expression level in these strains is lesser than rpoB87-gyrA87 strain. These results evidently suggest an allele specific role for the rif-nal mutations to acquire MMC resistance in lexA3 strains via increased constitutive uvrB expression and a pivotal role for rpoB87-gyrA87 combination to elicit higher levels of resistance.	[Shanmughapriya, Vinod; Meenakshi, Shanmugaraja; Munavar, M. Hussain] Madurai Kamaraj Univ, Sch Biol Sci, Dept Mol Biol, Madurai 625021, Tamil Nadu, India	Madurai Kamaraj University	Munavar, MH (corresponding author), Madurai Kamaraj Univ, Sch Biol Sci, Dept Mol Biol, Madurai 625021, Tamil Nadu, India.	munavar61@gmail.com	Shanmugaraja, Meenakshi/HDN-1904-2022	Shanmugaraja, Meenakshi/0000-0002-7944-5840	Centre for Excellence in Genomic Sciences; Centre for Advanced Studies in Functional and Organismal Genomics of School of Biological Sciences, Madurai Kamaraj University; University Grants Commission, Government of India; Department of Science and Technology, Government of India; Council for Scientific and Industrial Research, Government of India	Centre for Excellence in Genomic Sciences; Centre for Advanced Studies in Functional and Organismal Genomics of School of Biological Sciences, Madurai Kamaraj University; University Grants Commission, Government of India(University Grants Commission, India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by common grants especially Centre for Excellence in Genomic Sciences and Centre for Advanced Studies in Functional and Organismal Genomics of School of Biological Sciences, Madurai Kamaraj University originally funded by University Grants Commission, Government of India and PURSE program funded by Department of Science and Technology, Government of India to Madurai Kamaraj University. VS thanks, Council for Scientific and Industrial Research, Government of India for providing Junior and Senior Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BI E, 1990, J BACTERIOL, V172, P5602, DOI 10.1128/jb.172.10.5602-5609.1990; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; DEMEREC M, 1966, GENETICS, V54, P61; FISHER RF, 1983, J BIOL CHEM, V258, P8146; Ganesan AK, 2007, DNA REPAIR, V6, P1434, DOI 10.1016/j.dnarep.2007.04.002; GOTTESMAN S, 1981, J BACTERIOL, V148, P265, DOI 10.1128/JB.148.1.265-273.1981; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Janion C, 2008, INT J BIOL SCI, V4, P338; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; JIN DJ, 1988, J MOL BIOL, V202, P245, DOI 10.1016/0022-2836(88)90455-X; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; JIN DJ, 1988, J MOL BIOL, V204, P247, DOI 10.1016/0022-2836(88)90573-6; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; KOGOMA T, 1994, J BACTERIOL, V176, P1521, DOI 10.1128/jb.176.5.1521-1523.1994; KUMARESAN KR, 1988, MUTAT RES, V194, P109, DOI 10.1016/0167-8817(88)90013-2; Miller J.H., 1972, EXPT MOL GENETICS; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MIZUSAWA S, 1983, P NATL ACAD SCI-BIOL, V80, P358, DOI 10.1073/pnas.80.2.358; MOUNT DW, 1972, J BACTERIOL, V112, P886, DOI 10.1128/JB.112.2.886-893.1972; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Reckinger AR, 2007, NUCLEIC ACIDS RES, V35, P79, DOI 10.1093/nar/gkl981; Shanmughapriya V, 2012, DNA REPAIR, V11, P915, DOI 10.1016/j.dnarep.2012.09.005; Smith AJ, 2005, NUCLEIC ACIDS RES, V33, P755, DOI 10.1093/nar/gki225; SZYBALSKI W, 1964, FED PROC, V23, P946; Truong QC, 1997, ANTIMICROB AGENTS CH, V41, P85, DOI 10.1128/AAC.41.1.85; Vidal LS, 2006, CHEM RES TOXICOL, V19, P1351, DOI 10.1021/tx060035y	27	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87702	10.1371/journal.pone.0087702	http://dx.doi.org/10.1371/journal.pone.0087702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498357	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900103
J	Askautrud, HA; Gjernes, E; Gunnes, G; Sletten, M; Ross, DT; Borresen-Dale, AL; Iversen, N; Tranulis, MA; Frengen, E				Askautrud, Hanne A.; Gjernes, Elisabet; Gunnes, Gjermund; Sletten, Marit; Ross, Douglas T.; Borresen-Dale, Anne Lise; Iversen, Nina; Tranulis, Michael A.; Frengen, Eirik			Global Gene Expression Analysis Reveals a Link between NDRG1 and Vesicle Transport	PLOS ONE			English	Article							DIFFERENTIATION-RELATED GENE; NUCLEOTIDE EXCHANGE FACTOR; N-MYC; TUMOR-METASTASIS; SUPPRESSOR GENE; SENSORY NEUROPATHY; REGULATED GENE-1; HEREDITARY MOTOR; DRG-1; IDENTIFICATION	N-myc downstream-regulated gene 1 (NDRG1) is induced by cellular stress such as hypoxia and DNA damage, and in humans, germ line mutations cause Charcot-Marie-Tooth disease. However, the cellular roles of NDRG1 are not fully understood. Previously, NDRG1 was shown to mediate doxorubicin resistance under hypoxia, suggesting a role for NDRG1 in cell survival under these conditions. We found decreased apoptosis in doxorubicin-treated cells expressing NDRG1 shRNAs under normoxia, demonstrating a requirement for NDRG1 in apoptosis in breast epithelial cells under normal oxygen pressure. Also, different cellular stress regimens, such as hypoxia and doxorubicin treatment, induced NDRG1 through different stress signalling pathways. We further compared expression profiles in human breast epithelial cells ectopically over-expressing NDRG1 with cells expressing NDRG1 shRNAs in order to identify biological pathways where NDRG1 is involved. The results suggest that NDRG1 may have roles connected to vesicle transport.	[Askautrud, Hanne A.; Gjernes, Elisabet; Sletten, Marit; Iversen, Nina; Frengen, Eirik] Univ Oslo, Dept Med Genet, Oslo, Norway; [Askautrud, Hanne A.; Gjernes, Elisabet; Sletten, Marit; Iversen, Nina; Frengen, Eirik] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Gunnes, Gjermund; Tranulis, Michael A.] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Ross, Douglas T.] Clarient Diagnost Serv, Aliso Viejo, CA USA; [Borresen-Dale, Anne Lise] Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Genet, Oslo, Norway	University of Oslo; University of Oslo; Norwegian University of Life Sciences; University of Oslo	Frengen, E (corresponding author), Univ Oslo, Dept Med Genet, Oslo, Norway.	eirik.frengen@medisin.uio.no		Askautrud, Hanne/0000-0002-4404-3622; Frengen, Eirik/0000-0002-8387-2247	Research Council of Norway [151882, 160698/V40]; Southeastern Regional Health Authorities [2007060]; University of Oslo Research Fund (UNIFOR); Ulleval University Hospital Research Fund (VIRUUS)	Research Council of Norway(Research Council of Norway); Southeastern Regional Health Authorities; University of Oslo Research Fund (UNIFOR); Ulleval University Hospital Research Fund (VIRUUS)	This work was supported by The Research Council of Norway through grants from the Functional Genomics Program (FUGE, grant number 151882) and project support (grant number 160698/V40), and from Southeastern Regional Health Authorities (grant number 2007060). EF and HAA were supported by "University of Oslo Research Fund (UNIFOR)" and Ulleval University Hospital Research Fund (VIRUUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst E, 2011, SURGERY, V149, P614, DOI 10.1016/j.surg.2010.11.002; Bandyopadhyay S, 2004, CANCER RES, V64, P7655, DOI 10.1158/0008-5472.CAN-04-1623; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386; Blanke S, 2006, FASEB J, V20, P683, DOI 10.1096/fj.05-5376com; Bruun CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054547; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chi XJ, 2013, INT J MOL SCI, V14, P7089, DOI 10.3390/ijms14047089; Curtin JF, 2003, CELL SIGNAL, V15, P983, DOI 10.1016/S0898-6568(03)00093-7; Degli Esposti M, 2009, MOL BIOL CELL, V20, P600, DOI 10.1091/mbc.E08-09-0925; Delague V, 2007, AM J HUM GENET, V81, P1, DOI 10.1086/518428; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Gomez-Casero E, 2001, MOL CARCINOGEN, V32, P100, DOI 10.1002/mc.1069; Guang RJ, 2000, CANCER RES, V60, P749; Hampson L, 2009, BRIT J CANCER, V101, P829, DOI 10.1038/sj.bjc.6605208; Hirsch DS, 2001, J BIOL CHEM, V276, P875, DOI 10.1074/jbc.M007039200; Hu ZY, 2005, BIOTECHNIQUES, V38, P121, DOI 10.2144/05381MT02; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Jung EU, 2010, CANCER LETT, V298, P9, DOI 10.1016/j.canlet.2010.05.020; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kalaydjieva L, 1998, BRAIN, V121, P399, DOI 10.1093/brain/121.3.399; King RHM, 2011, NEUROBIOL DIS, V42, P368, DOI 10.1016/j.nbd.2011.01.030; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Kurdistani SK, 1998, CANCER RES, V58, P4439; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Landry MC, 2009, MOL BIOL CELL, V20, P4091, DOI 10.1091/mbc.E09-01-0057; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Li J, 2003, MOL CELL BIOCHEM, V250, P91, DOI 10.1023/A:1024918328162; Lin Q, 2006, J BIOL CHEM, V281, P35253, DOI 10.1074/jbc.M606248200; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Murshid A, 2006, J NEUROCHEM, V98, P1746, DOI 10.1111/j.1471-4159.2006.04066.x; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Park MY, 2008, CLIN CHIM ACTA, V387, P84, DOI 10.1016/j.cca.2007.09.010; Salnikow K, 2000, CANCER RES, V60, P3375; Salnikow K, 2000, CANCER RES, V60, P38; Shaw E, 2002, PROTEINS, V47, P163, DOI 10.1002/prot.10083; Shi XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075473; Sick E, 2009, CELL MOL LIFE SCI, V66, P1271, DOI 10.1007/s00018-009-8778-2; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; Stein S, 2004, J BIOL CHEM, V279, P48930, DOI 10.1074/jbc.M400386200; Storvold GL, 2007, MOL BIOTECHNOL, V35, P275, DOI 10.1007/BF02686013; Sugiki T, 2004, BIOL PHARM BULL, V27, P624, DOI 10.1248/bpb.27.624; Taketomi Y, 2003, BIOCHEM BIOPH RES CO, V306, P339, DOI 10.1016/S0006-291X(03)00942-2; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; Troester MA, 2004, CANCER RES, V64, P4218, DOI 10.1158/0008-5472.CAN-04-0107; Tu LC, 2007, MOL CELL PROTEOMICS, V6, P575, DOI 10.1074/mcp.M600249-MCP200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; vanBelzen N, 1997, LAB INVEST, V77, P85; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhang AH, 2007, AM J PHYSIOL-CELL PH, V293, pC379, DOI 10.1152/ajpcell.00547.2006; Zhou DJ, 1998, CANCER RES, V58, P2182; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	60	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87268	10.1371/journal.pone.0087268	http://dx.doi.org/10.1371/journal.pone.0087268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498060	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000330621900081
J	Botelho, AL; Shin, Y; Liu, JK; Lin, X				Botelho, Andre Leitao; Shin, Yongwoo; Liu, Jiakai; Lin, Xi			Structure and Optical Bandgap Relationship of pi-Conjugated Systems	PLOS ONE			English	Article							ABSORPTION-SPECTRA; ISOTHIANAPHTHENE OLIGOMERS; POLYMER; GAP; SOLITONS; DESIGN; ALTERNATION; CELLS; CHAIN	In bulk heterojunction photovoltaic systems both the open-circuit voltage as well as the short-circuit current, and hence the power conversion efficiency, are dependent on the optical bandgap of the electron-donor material. While first-principles methods are computationally intensive, simpler model Hamiltonian approaches typically suffer from one or more flaws: inability to optimize the geometries for their own input; absence of general, transferable parameters; and poor performance for non-planar systems. We introduce a set of new and revised parameters for the adapted Su-Schrieffer-Heeger (aSSH) Hamiltonian, which is capable of optimizing geometries, along with rules for applying them to any pi-conjugated system containing C, N, O, or S, including non-planar systems. The predicted optical bandgaps show excellent agreement to UV-vis spectroscopy data points from literature, with a coefficient of determination R-2 = 0.95, a mean error of -0.05 eV, and a mean absolute deviation of 0.16 eV. We use the model to gain insights from PEDOT, fused thiophene polymers, poly-isothianaphthene, copolymers, and pentacene as sources of design rules in the search for low bandgap materials. Using the model as an in-silico design tool, a copolymer of benzodithiophenes along with a small-molecule derivative of pentacene are proposed as optimal donor materials for organic photovoltaics.	[Lin, Xi] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA; Boston Univ, Div Mat Sci & Engn, Boston, MA 02215 USA	Boston University; Boston University	Lin, X (corresponding author), Boston Univ, Dept Mech Engn, Boston, MA 02215 USA.	linx@bu.edu	Lin, Xi/D-5321-2011; Liu, Jiakai/AGO-2094-2022; lin, xi/GZL-4959-2022; Shin, Yongwoo/G-5838-2011; Botelho, Andre/M-5369-2013	Shin, Yongwoo/0000-0001-7760-9883; Botelho, Andre/0000-0002-5246-8161	Honda RD Co., Ltd; Idaho National Laboratory; Nenter Co., Inc; NSF XSEDE [DMR-090073]	Honda RD Co., Ltd; Idaho National Laboratory(United States Department of Energy (DOE)); Nenter Co., Inc; NSF XSEDE(National Science Foundation (NSF))	This work is partially supported by Honda R&D Co., Ltd, Idaho National Laboratory, Nenter & Co., Inc, and NSF XSEDE under Grant No. DMR-090073. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS L, 1982, J PHYS CHEM-US, V86, P2916, DOI 10.1021/j100212a023; BECKER RS, 1963, J CHEM PHYS, V38, P2144, DOI 10.1063/1.1733946; Bendikov M, 2004, J AM CHEM SOC, V126, P7416, DOI 10.1021/ja048919w; Blouin N, 2008, J AM CHEM SOC, V130, P732, DOI 10.1021/ja0771989; Botelho AL, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/45/455501; BURROUGHES JH, 1988, NATURE, V335, P137, DOI 10.1038/335137a0; CHANDROSS EA, 1966, J CHEM PHYS, V45, P3546, DOI 10.1063/1.1727371; Cohen AJ, 2008, SCIENCE, V321, P792, DOI 10.1126/science.1158722; Davis WB, 1998, NATURE, V396, P60, DOI 10.1038/23912; DIAZ AF, 1981, J ELECTROANAL CHEM, V121, P355, DOI 10.1016/0368-1874(81)80028-7; ECKHARDT H, 1989, J CHEM PHYS, V91, P1303, DOI 10.1063/1.457153; Gidron O, 2010, J AM CHEM SOC, V132, P2148, DOI 10.1021/ja9093346; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; Guo XG, 2011, J AM CHEM SOC, V133, P13685, DOI 10.1021/ja205398u; HEEGER AJ, 1988, REV MOD PHYS, V60, P781, DOI 10.1103/RevModPhys.60.781; Hellstrom S, 2009, DALTON T, P10032, DOI 10.1039/b913769f; Hinderhofer A, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2786992; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; HONG SY, 1992, J CHEM PHYS, V96, P5497, DOI 10.1063/1.462705; Kaur I, 2010, J AM CHEM SOC, V132, P1261, DOI 10.1021/ja9095472; Kertesz M, 2005, CHEM REV, V105, P3448, DOI 10.1021/cr990357p; KHAN ZH, 1973, J CHEM PHYS, V59, P3015, DOI 10.1063/1.1680437; Kohn W, 1999, REV MOD PHYS, V71, P1253, DOI 10.1103/RevModPhys.71.1253; KURTI J, 1991, PHYS REV B, V44, P597, DOI 10.1103/PhysRevB.44.597; Kuzmany H, 1989, SPRINGER SERIES SOLI, V91; LEE YS, 1988, J CHEM PHYS, V88, P2609, DOI 10.1063/1.454040; Li G, 2012, NAT PHOTONICS, V6, P153, DOI [10.1038/NPHOTON.2012.11, 10.1038/nphoton.2012.11]; Li MH, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.155141; Li MH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.153102; Lin X, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.198303; Lin X, 2005, INT J QUANTUM CHEM, V102, P980, DOI 10.1002/qua.20433; Lin X, 2006, P NATL ACAD SCI USA, V103, P8943, DOI 10.1073/pnas.0601314103; LONGUETHIGGINS HC, 1959, PROC R SOC LON SER-A, V251, P172, DOI 10.1098/rspa.1959.0100; Mattuck R.D., 1976, GUIDE FEYNMAN DIAGRA; Parr RG, 1989, INT SERIES MONOGRAPH, V16; Payne MM, 2005, J AM CHEM SOC, V127, P8028, DOI 10.1021/ja051798v; Peierls R. E., 1955, INT SERIES MONOGRAPH; POMERANTZ M, 1993, SYNTHETIC MET, V55, P960, DOI 10.1016/0379-6779(93)90182-V; POPLE JA, 1987, J CHEM PHYS, V87, P5968, DOI 10.1063/1.453520; Price SC, 2010, MACROMOLECULES, V43, P4609, DOI 10.1021/ma100051v; QUATTROCCHI C, 1993, MACROMOLECULES, V26, P1260, DOI 10.1021/ma00058a010; QUATTROCCHI C, 1995, J PHYS CHEM-US, V99, P3932, DOI 10.1021/j100012a011; Rang Z, 2001, APPL PHYS LETT, V79, P2731, DOI 10.1063/1.1410878; RICE MJ, 1982, PHYS REV LETT, V49, P1455, DOI 10.1103/PhysRevLett.49.1455; Risko C, 2011, CHEM SCI, V2, P1200, DOI 10.1039/c0sc00642d; Roncali J, 2007, MACROMOL RAPID COMM, V28, P1761, DOI 10.1002/marc.200700345; RUNGE E, 1984, PHYS REV LETT, V52, P997, DOI 10.1103/PhysRevLett.52.997; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Scharber MC, 2006, ADV MATER, V18, P789, DOI 10.1002/adma.200501717; Shimizu Y, 2002, TETRAHEDRON LETT, V43, P8485, DOI 10.1016/S0040-4039(02)02054-3; Shin YW, 2013, J PHYS CHEM C, V117, P12432, DOI 10.1021/jp402137b; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; SU WP, 1979, PHYS REV LETT, V42, P1698, DOI 10.1103/PhysRevLett.42.1698; SUBBASWAMY KR, 1981, PHYS REV B, V24, P2168, DOI 10.1103/PhysRevB.24.2168; Tonshoff C, 2010, ANGEW CHEM INT EDIT, V49, P4125, DOI 10.1002/anie.200906355; van Faassen M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186401; WALKER IC, 1990, CHEM PHYS, V141, P365, DOI 10.1016/0301-0104(90)87070-R; WUDL F, 1984, J ORG CHEM, V49, P3382, DOI 10.1021/jo00192a027; Yang F, 2005, NAT MATER, V4, P37, DOI 10.1038/nmat1285; Yang SJ, 2004, SYNTHETIC MET, V141, P171, DOI 10.1016/j.synthmet.2003.08.019; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Zhou HX, 2011, ANGEW CHEM INT EDIT, V50, P2995, DOI 10.1002/anie.201005451	62	29	29	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86370	10.1371/journal.pone.0086370	http://dx.doi.org/10.1371/journal.pone.0086370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497944	gold, Green Submitted, Green Published			2022-12-25	WOS:000330621900022
J	Williamson, VJ; Liikkanen, LA; Jakubowski, K; Stewart, L				Williamson, Victoria J.; Liikkanen, Lassi A.; Jakubowski, Kelly; Stewart, Lauren			Sticky Tunes: How Do People React to Involuntary Musical Imagery?	PLOS ONE			English	Article							WORKING-MEMORY; MIND; ATTENTION; SPEECH; STUCK	The vast majority of people experience involuntary musical imagery (INMI) or 'earworms'; perceptions of spontaneous, repetitive musical sound in the absence of an external source. The majority of INMI episodes are not bothersome, while some cause disruption ranging from distraction to anxiety and distress. To date, little is known about how the majority of people react to INMI, in particular whether evaluation of the experience impacts on chosen response behaviours or if attempts at controlling INMI are successful or not. The present study classified 1046 reports of how people react to INMI episodes. Two laboratories in Finland and the UK conducted an identical qualitative analysis protocol on reports of INMI reactions and derived visual descriptive models of the outcomes using grounded theory techniques. Combined analysis carried out across the two studies confirmed that many INMI episodes were considered neutral or pleasant, with passive acceptance and enjoyment being among the most popular response behaviours. A significant number of people, however, reported on attempts to cope with unwanted INMI. The most popular and effective behaviours in response to INMI were seeking out the tune in question, and musical or verbal distraction. The outcomes of this study contribute to our understanding of the aetiology of INMI, in particular within the framework of memory theory, and present testable hypotheses for future research on successful INMI coping strategies.	[Williamson, Victoria J.] Lucerne Univ Appl Sci & Arts, Hsch Luzern Mus, Luzern, Switzerland; [Williamson, Victoria J.] Univ Sheffield, Dept Mus, Sheffield, S Yorkshire, England; [Liikkanen, Lassi A.] Aalto Univ, Helsinki Inst Informat Technol, Espoo, Finland; [Jakubowski, Kelly; Stewart, Lauren] Univ London, Dept Psychol, London, England	University of Sheffield; Aalto University; University of Helsinki; University of London	Williamson, VJ (corresponding author), Lucerne Univ Appl Sci & Arts, Hsch Luzern Mus, Luzern, Switzerland.	v.williamson@sheffield.ac.uk	Stewart, Lauren/HHC-2911-2022	Jakubowski, Kelly/0000-0002-4954-7117; stewart, lauren/0000-0002-6221-6064	Leverhulme Trust [RPG - 297]	Leverhulme Trust(Leverhulme Trust)	This research was funded by a Leverhulme Trust grant (http://www.leverhulme.ac.uk/) to LS (RPG - 297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Beaman CP, 2010, BRIT J PSYCHOL, V101, P637, DOI 10.1348/000712609X479636; Berntsen D, 2010, CURR DIR PSYCHOL SCI, V19, P138, DOI 10.1177/0963721410370301; Brown S, 2006, J CONSCIOUSNESS STUD, V13, P43; Charmaz K., 2008, HDB EMERGENT METHODS, P155, DOI DOI 10.1080/15332691.2013.779094; FLORIDOU G, 2012, P ICMPC ESCOM 12 THE, P302; Halpern AR, 2011, MUSIC PERCEPT, V28, P425, DOI 10.1525/mp.2011.28.4.425; Hemming J., 2009, MUSIKPSYCHOLOGIE, V20, P184; Hyman IE, 2013, APPL COGNITIVE PSYCH, V27, P204, DOI 10.1002/acp.2897; Jones D, 1999, J EXP PSYCHOL LEARN, V25, P464, DOI 10.1037/0278-7393.25.2.464; Jones DM., 1996, MODELS SHORT TERM ME, P209; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kvavilashvili L, 2004, COGNITIVE PSYCHOL, V48, P47, DOI 10.1016/S0010-0285(03)00115-4; Liikkanen LA, 2012, MUSIC SCI, V16, P217, DOI 10.1177/1029864912440770; Liikkanen LA, 2012, PSYCHOL MUSIC, V40, P236, DOI 10.1177/0305735611406578; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McVay JC, 2009, PSYCHON B REV, V16, P857, DOI 10.3758/PBR.16.5.857; Mullensiefen D, 2014, MUSIC PERCE IN PRESS; Neath I, 2000, PSYCHON B REV, V7, P403, DOI 10.3758/BF03214356; Payne S, 2007, ANAL QUALITATIVE DAT, P65, DOI [DOI 10.4135/9781446207536, 10.4135/9781446207536.d12, DOI 10.4135/9781446207536.D12]; Sacks O, 2007, MUSICOPHILIA TALES M; Schulze K, 2012, ANN NY ACAD SCI, V1252, P229, DOI 10.1111/j.1749-6632.2012.06447.x; Schulze K, 2011, HUM BRAIN MAPP, V32, P771, DOI 10.1002/hbm.21060; Smallwood J, 2008, MEM COGNITION, V36, P1144, DOI 10.3758/MC.36.6.1144; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2007, PSYCHON B REV, V14, P527, DOI 10.3758/BF03194102; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smith JD, 1992, AUDITORY IMAGERY, P95; Strauss A., 1990, BASICS QUALITATIVE R; Urquhart, 2013, GROUNDED THEORY QUAL; Wammes M, 2009, J CONSCIOUSNESS STUD, V16, P37; Williamson V. J., 2012, P 12 INT C MUS PERC, P1124; Williamson VJ, 2014, PSYCHOL MUSIC, V42, P653, DOI 10.1177/0305735613483848; Williamson VJ, 2012, PSYCHOL MUSIC, V40, P259, DOI 10.1177/0305735611418553; Williamson VJ, 2010, MEM COGNITION, V38, P163, DOI 10.3758/MC.38.2.163; Zeigarnik B., 1967, SOURCEBOOK GESTALT P, P300	37	36	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86170	10.1371/journal.pone.0086170	http://dx.doi.org/10.1371/journal.pone.0086170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302RF	24497938	Green Accepted, Green Published, gold			2022-12-25	WOS:000330621900018
J	Yao, YX; Lu, YH; Chen, WC; Jiang, YP; Cheng, T; Ma, YP; Lu, L; Dai, W				Yao, Yixin; Lu, Yinghua; Chen, Wen-chi; Jiang, Yongping; Cheng, Tao; Ma, Yupo; Lu, Lou; Dai, Wei			Cobalt and Nickel Stabilize Stem Cell Transcription Factor OCT4 through Modulating Its Sumoylation and Ubiquitination	PLOS ONE			English	Article							SELF-RENEWAL; INDUCED PLURIPOTENT; EXPRESSION; PROMOTES; GENE; DIFFERENTIATION; LIVER; MICE; AKT	Stem cell research can lead to the development of treatments for a wide range of ailments including diabetes, heart disease, aging, neurodegenerative diseases, spinal cord injury, and cancer. OCT4 is a master regulator of self-renewal of undifferentiated embryonic stem cells. OCT4 also plays a crucial role in reprogramming of somatic cells into induced pluripotent stem (iPS) cells. Given known vivo reproductive toxicity of cobalt and nickel metals, we examined the effect of these metals on expression of several stem cell factors in embryonic Tera-1 cells, as well as stem cells. Cobalt and nickel induced a concentration-dependent increase of OCT4 and HIF-1 alpha, but not NANOG or KLF4. OCT4 induced by cobalt and nickel was due primarily to protein stabilization because MG132 stabilized OCT4 in cells treated with either metals and because neither nickel nor cobalt significantly modulated its steady-state mRNA level. OCT4 stabilization by cobalt and nickel was mediated largely through reactive oxygen species (ROS) as co-treatment with ascorbic acid abolished OCT4 increase. Moreover, nickel and cobalt treatment increased sumoylation and mono-ubiquitination of OCT4 and K123 was crucial for mediating these modifications. Combined, our observations suggest that nickel and cobalt may exert their reproductive toxicity through perturbing OCT4 activity in the stem cell compartment.	[Yao, Yixin; Lu, Yinghua; Chen, Wen-chi; Dai, Wei] NYU, Dept Environm Med, Langone Med Ctr, Tuxedo Pk, NY USA; [Jiang, Yongping] Chinese Acad Med Sci, Biopharmaceut Res Ctr, Suzhou, Peoples R China; [Jiang, Yongping] Peking Union Med Coll, Suzhou, Peoples R China; [Cheng, Tao] Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China; [Cheng, Tao] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Cheng, Tao] Peking Union Med Coll, Tianjin, Peoples R China; [Ma, Yupo] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Lu, Lou] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA USA; [Dai, Wei] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, Tuxedo Pk, NY USA	New York University; NYU Langone Medical Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University; NYU Langone Medical Center	Dai, W (corresponding author), NYU, Dept Environm Med, Langone Med Ctr, Tuxedo Pk, NY USA.	wei.dai@nyumc.org		Dai, Wei/0000-0003-0169-8327; Jiang, Yongping/0000-0001-6024-4187; Cheng, Tao/0000-0002-5925-2769; Yao, Yixin/0000-0003-1891-7186	US Public Service [CA090658, ES019929]; NIEHS Center grant Nickel and cobalt stabilize [ES000260]; key State project of China on iPS and stem cell research [2011ZX09102-010-04]; NATIONAL CANCER INSTITUTE [R01CA090658, P30CA016087] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, R03ES019929] Funding Source: NIH RePORTER	US Public Service; NIEHS Center grant Nickel and cobalt stabilize; key State project of China on iPS and stem cell research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported in part by US Public Service Awards to WD (CA090658 and ES019929), an NIEHS Center grant Nickel and cobalt stabilize (ES000260) and a key State project of China on iPS and stem cell research (2011ZX09102-010-04). The funders had no role in study design, data collection and analysis, and decision to publish, or preparation of the manuscript.	Bae D, 2012, STEM CELLS DEV, V21, P1344, DOI 10.1089/scd.2011.0225; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Campbell PA, 2013, STEM CELLS, V31, P1107, DOI 10.1002/stem.1365; Cangul H, 2002, TOXICOL LETT, V127, P69, DOI 10.1016/S0378-4274(01)00485-4; Clarson LH, 2003, J PHYSIOL-LONDON, V550, P515, DOI 10.1113/jphysiol.2003.044149; Dhodapkar KM, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25205; Forgacs Z, 2012, J ENVIRON SCI HEAL A, V47, P1249, DOI 10.1080/10934529.2012.672114; Forristal CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062507; HANNA PM, 1992, CHEM RES TOXICOL, V5, P109, DOI 10.1021/tx00025a019; Harvey AJ, 2004, BIOL REPROD, V71, P1108, DOI 10.1095/biolreprod.104.028639; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Jungwirth U, 2011, ANTIOXID REDOX SIGN, V15, P1085, DOI 10.1089/ars.2010.3663; Li QY, 2013, FEBS LETT, V587, P2105, DOI 10.1016/j.febslet.2013.05.027; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065095; Liao B, 2010, CELL RES, V20, P332, DOI 10.1038/cr.2009.136; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Liu CM, 2013, J AGR FOOD CHEM, V61, P1146, DOI 10.1021/jf304562b; Liu LM, 1996, J BIOL CHEM, V271, P16683, DOI 10.1074/jbc.271.28.16683; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma W, 2013, CELL CYCLE, V12, P88, DOI 10.4161/cc.23028; Mathieu J, 2013, STEM CELLS; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oda M, 2006, METHOD ENZYMOL, V419, P387, DOI 10.1016/S0076-6879(06)19015-1; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Paksy K, 1999, ENVIRON RES, V80, P340, DOI 10.1006/enrs.1998.3933; Pantazis P, 2012, CELL CYCLE, V11, P2055, DOI 10.4161/cc.20118; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; RODRIGUEZ RE, 1991, TOXICOL LETT, V57, P269, DOI 10.1016/0378-4274(91)90201-G; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Salnikow K, 2000, CANCER RES, V60, P3375; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; STORENG R, 1981, TOXICOLOGY, V20, P45, DOI 10.1016/0300-483X(81)90104-9; STORENG R, 1980, TOXICOLOGY, V17, P183, DOI 10.1016/0300-483X(80)90092-X; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan MH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.65; Vaktskjold Arild, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P327, DOI 10.2478/v10001-0070034-0; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wu YH, 2012, DERMATOL SIN, V30, P1, DOI 10.1016/j.dsi.2012.02.004; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Yang JC, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-38; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhang ZH, 2007, FASEB J, V21, P3042, DOI 10.1096/fj.06-6914com; Zhang ZN, 2013, STEM CELLS; Zhao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064503; Zhao XM, 2012, MOL REPROD DEV, V79, P445, DOI 10.1002/mrd.22052	47	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86620	10.1371/journal.pone.0086620	http://dx.doi.org/10.1371/journal.pone.0086620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497960	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900029
J	Zeindl-Eberhart, E; Brandl, L; Liebmann, S; Ormanns, S; Scheel, SK; Brabletz, T; Kirchner, T; Jung, A				Zeindl-Eberhart, Evelyn; Brandl, Lydia; Liebmann, Sibylle; Ormanns, Steffen; Scheel, Silvio K.; Brabletz, Thomas; Kirchner, Thomas; Jung, Andreas			Epithelial-Mesenchymal Transition Induces Endoplasmic-Reticulum-Stress Response in Human Colorectal Tumor Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; HYPOXIA-INDUCIBLE FACTOR; E-CADHERIN EXPRESSION; CANCER STEM-CELLS; BETA-CATENIN; COLON-CANCER; TARGET GENE; ER STRESS; GRP78; OVEREXPRESSION	Tumor cells are stressed by unfavorable environmental conditions like hypoxia or starvation. Driven by the resulting cellular stress tumor cells undergo epithelial-mesenchymal transition. Additionally, cellular stress is accompanied by endoplasmic reticulum-stress which induces an unfolded protein response. It is unknown if epithelial-mesenchymal transition and endoplasmic reticulum-stress are occurring as independent parallel events or if an interrelationship exists between both of them. Here, we show that in colorectal cancer cells endoplasmic reticulum-stress depends on the induction of ZEB-1, which is a main factor of epithelial-mesenchymal transition. In the absence of ZEB-1 colorectal cancer cells cannot mount endoplasmic reticulum-stress as a reaction on cellular stress situations like hypoxia or starvation. Thus, our data suggest that there is a hierarchy in the development of cellular stress which starts with the presence of environmental stress that induces epithelial-mesenchymal transition which allows finally endoplasmic reticulum-stress. This finding highlights the central role of epithelial-mesenchymal transition during the process of tumorigenesis as epithelial-mesenchymal transition is also associated with chemoresistance and cancer stemness. Consequently, endoplasmic reticulum-stress might be a well suited target for chemotherapy of colorectal cancers.	[Zeindl-Eberhart, Evelyn; Brandl, Lydia; Liebmann, Sibylle; Ormanns, Steffen; Scheel, Silvio K.; Kirchner, Thomas; Jung, Andreas] Univ Munich, Inst Pathol, D-80539 Munich, Germany; [Brabletz, Thomas] Univ Freiburg, Dept Visceral Surg, D-79106 Freiburg, Germany	University of Munich; University of Freiburg	Brandl, L (corresponding author), Univ Munich, Inst Pathol, Thalkirchner Str 36, D-80539 Munich, Germany.	lydia.kriegl@med.uni-muenchen.de						Acloque H, 2008, EMBO REP, V9, P322, DOI 10.1038/embor.2008.30; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Al-Rawashdeh FY, 2010, EUR J GASTROEN HEPAT, V22, P1099, DOI 10.1097/MEG.0b013e3283378405; Bai ZG, 2011, INT J ONCOL, V38, P375, DOI 10.3892/ijo.2010.873; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cattaneo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017206; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Garber K, 2006, J NATL CANCER I, V98, P512, DOI 10.1093/jnci/djj174; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Horst D, 2008, BRIT J CANCER, V99, P1285, DOI 10.1038/sj.bjc.6604664; Jaitner S, 2012, CELL CYCLE, V11, P3331, DOI 10.4161/cc.21790; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jun Eun Jung, 2007, Korean J Ophthalmol, V21, P244, DOI 10.3341/kjo.2007.21.4.244; Karovic O, 2007, BIOCHEM PHARMACOL, V73, P694, DOI 10.1016/j.bcp.2006.11.008; Klose J, 1999, METH MOL B, V112, P67; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Krishnamachary B, 2003, CANCER RES, V63, P1138; Langer R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-70; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee JY, 2011, AM J PHYSIOL-RENAL, V300, pF1214, DOI 10.1152/ajprenal.00710.2010; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Ma J, 1997, CANCER RES, V57, P1098; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Peng Y, 2012, MOL BIOSYST, V8, P3077, DOI 10.1039/c2mb25286d; Pirot P, 2007, DIABETOLOGIA, V50, P1006, DOI 10.1007/s00125-007-0609-0; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Takahashi H, 2011, HISTOL HISTOPATHOL, V26, P663, DOI 10.14670/HH-26.663; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wang Q, 2005, CANCER DETECT PREV, V29, P544, DOI 10.1016/j.cdp.2005.09.010; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wu MJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-283; Xing XM, 2006, CLIN CHIM ACTA, V364, P308, DOI 10.1016/j.cca.2005.07.016; Yang L, 2005, J BIOL CHEM, V280, P31156, DOI 10.1074/jbc.M501069200; Zeindl-Eberhart E, 2004, HEPATOLOGY, V39, P540, DOI 10.1002/hep.20060; Zeindl-Eberhart E, 2011, AMINO ACIDS, V41, P415, DOI 10.1007/s00726-010-0733-x; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zhang LH, 2010, J CELL BIOCHEM, V110, P1299, DOI 10.1002/jcb.22679; Zheng HC, 2008, HUM PATHOL, V39, P1042, DOI 10.1016/j.humpath.2007.11.009; Zhong H, 1999, CANCER RES, V59, P5830; Zhong Q, 2011, AM J RESP CELL MOL, V45, P498, DOI 10.1165/rcmb.2010-0347OC	58	16	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87386	10.1371/journal.pone.0087386	http://dx.doi.org/10.1371/journal.pone.0087386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498091	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900102
J	Havelka, D; Kucera, O; Deriu, MA; Cifra, M				Havelka, Daniel; Kucera, Ondrej; Deriu, Marco A.; Cifra, Michal			Electro-Acoustic Behavior of the Mitotic Spindle: A Semi-Classical Coarse-Grained Model	PLOS ONE			English	Article							HIGH MAGNETIC-FIELDS; ELECTRIC-FIELDS; ELECTROMAGNETIC-FIELD; VIBRATION ANALYSIS; DIPOLE-MOMENT; MICROTUBULES; TUBULIN; FREQUENCY; DYNAMICS; CHROMOSOMES	The regulation of chromosome separation during mitosis is not fully understood yet. Microtubules forming mitotic spindles are targets of treatment strategies which are aimed at (i) the triggering of the apoptosis or (ii) the interruption of uncontrolled cell division. Despite these facts, only few physical models relating to the dynamics of mitotic spindles exist up to now. In this paper, we present the first electromechanical model which enables calculation of the electromagnetic field coupled to acoustic vibrations of the mitotic spindle. This electromagnetic field originates from the electrical polarity of microtubules which form the mitotic spindle. The model is based on the approximation of resonantly vibrating microtubules by a network of oscillating electric dipoles. Our computational results predict the existence of a rapidly changing electric field which is generated by either driven or endogenous vibrations of the mitotic spindle. For certain values of parameters, the intensity of the electric field and its gradient reach values which may exert a not-inconsiderable force on chromosomes which are aligned in the spindle midzone. Our model may describe possible mechanisms of the effects of ultra-short electrical and mechanical pulses on dividing cells-a strategy used in novel methods for cancer treatment.	[Havelka, Daniel; Kucera, Ondrej; Cifra, Michal] Acad Sci Czech Republ, Inst Photon & Elect, Prague, Czech Republic; [Havelka, Daniel] Czech Tech Univ, Fac Elect Engn, Dept Electromagnet Field, CR-16635 Prague, Czech Republic; [Deriu, Marco A.] Univ Appl Sci & Arts Southern Switzerland SUPSI, Inst Comp Integrated Mfg Sustainable Innovat, Dept Innovat Technol, Manno, Switzerland	Czech Academy of Sciences; Institute of Photonics & Electronics of the Czech Academy of Sciences; Czech Technical University Prague	Havelka, D (corresponding author), Acad Sci Czech Republ, Inst Photon & Elect, Prague, Czech Republic.	havelka@ufe.cz	Deriu, Marco Agostino Agostino/GPW-8179-2022; Kucera, Ondrej/F-6806-2014; Deriu, Marco Agostino/M-5161-2016; Havelka, Daniel/F-6807-2014; Cifra, Michal/D-4416-2013	Deriu, Marco Agostino Agostino/0000-0003-1918-1772; Kucera, Ondrej/0000-0002-9559-1717; Deriu, Marco Agostino/0000-0003-1918-1772; Havelka, Daniel/0000-0001-5695-168X; Cifra, Michal/0000-0002-8853-9523	Czech Science Foundation; GA CR [P102/11/0649]; Grant Agency of the Czech Technical University in Prague [SGS13/077/OHK3/1T/13]	Czech Science Foundation(Grant Agency of the Czech Republic); GA CR(Grant Agency of the Czech Republic); Grant Agency of the Czech Technical University in Prague	Research presented in this paper was supported by the Czech Science Foundation, GA CR, grant no. P102/11/0649, and the Grant Agency of the Czech Technical University in Prague, grant no. SGS13/077/OHK3/1T/13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm KJ, 2005, ELECTROMAGN BIOL MED, V24, P319, DOI 10.1080/15368370500380010; Bras W, 1998, BIOPHYS J, V74, P1509, DOI 10.1016/S0006-3495(98)77863-4; Breton M, 2012, BIOELECTROMAGNETICS, V33, P106, DOI 10.1002/bem.20692; Cifra M, 2010, BIOSYSTEMS, V100, P122, DOI 10.1016/j.biosystems.2010.02.007; Daneshmand F, 2012, J BIOL PHYS, V38, P429, DOI 10.1007/s10867-012-9263-y; Deriu MA, 2010, BIOPHYS J, V99, P2190, DOI 10.1016/j.bpj.2010.06.070; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Foster KR, 2000, J BIOL PHYS, V26, P255, DOI 10.1023/A:1010306216654; FRICKEL RH, 1988, CAN J CHEM, V66, P2161, DOI 10.1139/v88-343; Ghavanloo E, 2010, PHYSICA E, V43, P192, DOI 10.1016/j.physe.2010.07.016; Glade N, 2005, BIOPHYS CHEM, V115, P29, DOI 10.1016/j.bpc.2004.12.048; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; HAMEROFF SR, 1986, BIOPHYS J, V49, pA58; Havelka D, 2011, J PHYS CONF SER, V329, DOI 10.1088/1742-6596/329/1/012014; Havelka D, 2011, J THEOR BIOL, V286, P31, DOI 10.1016/j.jtbi.2011.07.007; Holzel R, 2009, IET NANOBIOTECHNOL, V3, P28, DOI 10.1049/iet-nbt.2008.0014; Ibrahim B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001555; Kaatze U, 2003, MEAS SCI TECHNOL, V14, pN55, DOI 10.1088/0957-0233/14/9/401; Kasas S, 2004, BIOL CELL, V96, P697, DOI 10.1016/j.biolcel.2004.09.002; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Kucera O, 2012, BIOSYSTEMS, V109, P346, DOI 10.1016/j.biosystems.2012.04.009; Kucera O, 2010, EUR BIOPHYS J BIOPHY, V39, P1465, DOI 10.1007/s00249-010-0597-8; Li HB, 2013, EUR J MECH A-SOLID, V39, P11, DOI 10.1016/j.euromechsol.2012.10.007; Liu YF, 2006, P NATL ACAD SCI USA, V103, P10654, DOI 10.1073/pnas.0510381103; Mallakzadeh M, 2013, COMMUN NONLINEAR SCI, V18, P2240, DOI 10.1016/j.cnsns.2012.12.014; Mershin A, 2004, BIOSYSTEMS, V77, P73, DOI 10.1016/j.biosystems.2004.04.003; Minoura I, 2006, BIOPHYS J, V90, P3739, DOI 10.1529/biophysj.105.071324; Mohrbach H, 2012, EUR BIOPHYS J BIOPHY, V41, P217, DOI 10.1007/s00249-011-0778-0; Naruse Y, 2002, BIOSYSTEMS, V66, P55, DOI 10.1016/S0303-2647(02)00033-3; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Pavicic I, 2008, TOXICOL IN VITRO, V22, P1344, DOI 10.1016/j.tiv.2008.04.014; Pellegrini F, 2005, CANCER INVEST, V23, P264, DOI 10.1081/CNV-200055970; Pelling AE, 2004, SCIENCE, V305, P1147, DOI 10.1126/science.1097640; Pokorny J, 2003, ELECTROMAGN BIOL MED, V22, P15, DOI 10.1081/JBC-120020349; Pokorny J, 2001, ELECTRO MAGNETOBIOL, V20, P59, DOI 10.1081/JBC-100103160; Portet S, 2005, EUR BIOPHYS J BIOPHY, V34, P912, DOI 10.1007/s00249-005-0461-4; Postnikoff SDL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00183; Preto J, 2013, PHYS LETT A, V377, P587, DOI 10.1016/j.physleta.2012.12.034; Preto J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041904; Priel A, 2005, ELECTROMAGN BIOL MED, V24, P221, DOI 10.1080/15368370500379590; Qian XS, 2007, J APPL PHYS, V101, DOI 10.1063/1.2717573; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ramalho RR, 2007, MAT SCI ENG C-BIO S, V27, P1207, DOI 10.1016/j.msec.2006.09.045; Samarbakhsh A, 2011, EUR BIOPHYS J BIOPHY, V40, P937, DOI 10.1007/s00249-011-0709-0; Samsonov A, 2013, BIOELECTROMAGNETICS, V34, P133, DOI 10.1002/bem.21760; Shen HS, 2011, CURR APPL PHYS, V11, P812, DOI 10.1016/j.cap.2010.11.116; Simonson T, 2003, REP PROG PHYS, V66, P737, DOI 10.1088/0034-4885/66/5/202; Stracke R, 2002, BIOCHEM BIOPH RES CO, V293, P602, DOI 10.1016/S0006-291X(02)00251-6; Taj M, 2012, BIOCHEM BIOPH RES CO, V424, P89, DOI 10.1016/j.bbrc.2012.06.072; Tuszynski JA, 2005, EUR PHYS J E, V17, P29, DOI 10.1140/epje/i2004-10102-5; Tuszynski JA, 2005, MATH COMPUT MODEL, V41, P1055, DOI 10.1016/j.mcm.2005.05.002; Tyner KM, 2007, BIOPHYS J, V93, P1163, DOI 10.1529/biophysj.106.092452; Uppalapati M, 2011, INTEGR BIOL-UK, V3, P57, DOI 10.1039/c0ib00065e; van den Heuvel MGL, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.118301; VASSILEV PM, 1982, BIOSCIENCE REP, V2, P1025, DOI 10.1007/BF01122171; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Wang CY, 2008, J BIOMECH, V41, P1892, DOI 10.1016/j.jbiomech.2008.03.029; Wang CY, 2006, PHYSICA E, V35, P48, DOI 10.1016/j.physe.2006.05.008; Xiang P, 2012, J SOUND VIB, V331, P213, DOI 10.1016/j.jsv.2011.08.024; Zhao Y, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-26	60	26	26	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86501	10.1371/journal.pone.0086501	http://dx.doi.org/10.1371/journal.pone.0086501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497952	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100018
J	Huang, EYK; Tsui, PF; Kuo, TT; Tsai, JJ; Chou, YC; Ma, HI; Chiang, YH; Chen, YH				Huang, Eagle Yi-Kung; Tsui, Pi-Fen; Kuo, Tung-Tai; Tsai, Jing-Jr; Chou, Yu-Ching; Ma, Hsin-I; Chiang, Yung-Hsiao; Chen, Yuan-Hao			Amantadine Ameliorates Dopamine-Releasing Deficits and Behavioral Deficits in Rats after Fluid Percussion Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; PLACEBO-CONTROLLED TRIAL; WATER MAZE PERFORMANCE; OXIDATIVE STRESS; BASAL GANGLIA; HEAD-INJURY; STRIATUM; METHYLPHENIDATE; TRANSPORTER	Aims: To investigate the role of dopamine in cognitive and motor learning skill deficits after a traumatic brain injury (TBI), we investigated dopamine release and behavioral changes at a series of time points after fluid percussion injury, and explored the potential of amantadine hydrochloride as a chronic treatment to provide behavioral recovery. Materials and Methods: In this study, we sequentially investigated dopamine release at the striatum and behavioral changes at 1, 2, 4, 6, and 8 weeks after fluid percussion injury. Rats subjected to 6-Pa cerebral cortical fluid percussion injury were treated by using subcutaneous infusion pumps filled with either saline (sham group) or amantadine hydrochloride, with a releasing rate of 3.6mg/kg/hour for 8 weeks. The dopamine-releasing conditions and metabolism were analyzed sequentially by fast scan cyclic voltammetry (FSCV) and high-pressure liquid chromatography (HPLC). Novel object recognition (NOR) and fixed-speed rotarod (FSRR) behavioral tests were used to determine treatment effects on cognitive and motor deficits after injury. Results: Sequential dopamine-release deficits were revealed in 6-Pa-fluid-percussion cerebral cortical injured animals. The reuptake rate (tau value) of dopamine in injured animals was prolonged, but the tau value became close to the value for the control group after amantadine therapy. Cognitive and motor learning impairments were shown evidenced by the NOR and FSRR behavioral tests after injury. Chronic amantadine therapy reversed dopamine-release deficits, and behavioral impairment after fluid percussion injuries were ameliorated in the rats treated by using amantadine-pumping infusion. Conclusion: Chronic treatment with amantadine hydrochloride can ameliorate dopamine-release deficits as well as cognitive and motor deficits caused by cerebral fluid-percussion injury.	[Huang, Eagle Yi-Kung; Tsui, Pi-Fen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Kuo, Tung-Tai] Natl Taipei Univ Technol, Grad Inst Comp & Commun Engn, Taipei 106, Taiwan; [Tsai, Jing-Jr; Ma, Hsin-I; Chen, Yuan-Hao] Triserv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, Taipei, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Taipei Med Univ Hosp, PhD Program Neural Regenerat Med, Dept Neurosurg,Grad Inst Neural Regenerat Med, Taipei, Taiwan	National Defense Medical Center; National Taipei University of Technology; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital	Chen, YH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, Taipei, Taiwan.	nova.chenyuanhao@gmail.com	Chen, Yuan-Hao/U-6870-2019	Chen, Yuan-Hao/0000-0002-0570-4328	National Science Council of Taiwan [NSC 101-2314-B-016-008]; Tri-Service General Hospital of Taiwan [TSGH-C101-084, TSGH-C100-033]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital of Taiwan	This work was supported by the National Science Council of Taiwan under grant NSC 101-2314-B-016-008, and by Medical Research Project grants TSGH-C101-084, and TSGH-C100-033 from the Tri-Service General Hospital of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI FY, 1988, CLIN PHARMACOKINET, V14, P35, DOI 10.2165/00003088-198814010-00003; Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bates G, 2006, DEV MED CHILD NEUROL, V48, P697, DOI 10.1017/S0012162206001472; Berman SB, 1996, J NEUROCHEM, V67, P593; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; CHAPMAN AG, 1989, NEUROSCI LETT, V107, P256, DOI 10.1016/0304-3940(89)90827-6; Chen YH, 2008, FASEB J, V22, P261, DOI 10.1096/fj.07-8797com; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Crosson B, 2003, J INT NEUROPSYCH SOC, V9, P1061, DOI 10.1017/S135561770397010X; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; FILLOUX F, 1991, SYNAPSE, V8, P281, DOI 10.1002/syn.890080406; FRITSCHY JM, 1992, J COMP NEUROL, V321, P421, DOI 10.1002/cne.903210309; Furman CA, 2009, J NEUROSCI, V29, P3328, DOI 10.1523/JNEUROSCI.5386-08.2009; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HEIKKILA RE, 1972, EUR J PHARMACOL, V20, P156, DOI 10.1016/0014-2999(72)90144-6; Huang EYK, 2003, N-S ARCH PHARMACOL, V368, P386, DOI 10.1007/s00210-003-0803-7; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KLINE AE, 1994, PHARMACOL BIOCHEM BE, V48, P773, DOI 10.1016/0091-3057(94)90345-X; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; MIZOGUCHI K, 1994, BRAIN RES, V662, P255, DOI 10.1016/0006-8993(94)90821-4; OLNEY JW, 1990, EXP NEUROL, V108, P269, DOI 10.1016/0014-4886(90)90134-E; ONN SP, 1986, BRAIN RES, V376, P8, DOI 10.1016/0006-8993(86)90894-2; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Pristupa ZB, 1998, SYNAPSE, V30, P79, DOI 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.3.CO;2-I; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Sabeti J, 2002, J NEUROSCI METH, V121, P41, DOI 10.1016/S0165-0270(02)00229-7; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Takahashi T, 1996, BRAIN RES BULL, V41, P363, DOI 10.1016/S0361-9230(96)00211-0; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Von Voigtlander P F, 1971, Science, V174, P408, DOI 10.1126/science.174.4007.408; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wang T, 2013, J NEUROTRAUMA; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Williams SE, 2007, BRAIN INJURY, V21, P885, DOI 10.1080/02699050701553213; Wilson MS, 2005, J NEUROSCI RES, V80, P85, DOI 10.1002/jnr.20419; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	63	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86354	10.1371/journal.pone.0086354	http://dx.doi.org/10.1371/journal.pone.0086354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497943	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100013
J	Klawitter, J; Klawitter, J; Schmitz, V; Shokati, T; Epshtein, E; Thurman, JM; Christians, U				Klawitter, Jelena; Klawitter, Jost; Schmitz, Volker; Shokati, Touraj; Epshtein, Ekaterina; Thurman, Joshua M.; Christians, Uwe			Mycophenolate Mofetil Enhances the Negative Effects of Sirolimus and Tacrolimus on Rat Kidney Cell Metabolism	PLOS ONE			English	Article							CARDIOVASCULAR RISK PROFILE; RENAL-ALLOGRAFT REJECTION; TRANSPLANT RECIPIENTS; NMR-SPECTROSCOPY; RANDOMIZED-TRIAL; IN-VIVO; MAINTENANCE IMMUNOSUPPRESSION; CYCLOSPORINE NEPHROTOXICITY; ACID PHARMACOKINETICS; ORGAN-TRANSPLANTATION	Background and Purpose: Mycophenolate mofetil (MMF) per se is not known to have negative effects on the kidney. MMF alone or in combination with sirolimus, can be the basis of calcineurin inhibitor (CNI)-free, kidney sparing drug protocols. However, long-term outcomes in patients on MMF/SRL seem to be inferior to those treated with regimens that include the CNI tacrolimus (TAC) due to an increased risk of allo-immune reactions. Interestingly, potential enhancement of the negative effects of SRL and TAC on the kidney by MMF has never been considered. Experimental Approach: It was our aim to study the effects of TAC, SRL and MMF alone and evaluate their interactions when combined on the rat kidney. For this purpose we used a comprehensive molecular marker approach including measurements of urinary 8-isoprostane concentrations (oxidative stress marker) and changes of urinary metabolite patterns (H-1-NMR spectroscopy) and comparing these markers to renal function (glomerular filtration rate (GFR)) and morphologic alterations (histology). Key Results: While MMF alone did not impact GFR, its interaction with SRL and TAC led to a significant decrease of rats' renal function. The decline went in parallel with a significant increase in urinary isoprostane concentrations and an enhancement of negative effects on urinary metabolite patterns. Conclusions: In broad summary, the present study showed that MMF may enhance the negative effects of TAC on kidney function and may even display nephrotoxic properties when combined with SRL.	[Klawitter, Jelena; Klawitter, Jost; Schmitz, Volker; Shokati, Touraj; Epshtein, Ekaterina; Christians, Uwe] Univ Colorado, Dept Anesthesiol, Aurora, CO 80045 USA; [Klawitter, Jelena; Thurman, Joshua M.] Univ Colorado, Div Renal Dis & Hypertens, Aurora, CO USA; [Schmitz, Volker] Charite, Dept Gen Visceral & Transplantat Surg, Berlin, Germany	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Klawitter, J (corresponding author), Univ Colorado, Dept Anesthesiol, Aurora, CO 80045 USA.	jelena.klawitter@ucdenver.edu	Klawitter, Jost/F-3976-2015	Klawitter, Jost/0000-0002-6413-4820; Thurman, Joshua Michael/0000-0002-3476-9956	United States National Institutes of Health [R01 DK065094]; University of Colorado Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065094] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by the United States National Institutes of Health grant R01 DK065094. The NMR experiments were performed at the University of Colorado NMR core facility, funded by the University of Colorado Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2004, TRANSPLANTATION, V77, P686, DOI 10.1097/01.TP.0000113850.34945.DC; Akira K, 2008, J PHARMACEUT BIOMED, V46, P550, DOI 10.1016/j.jpba.2007.11.017; Artz MA, 2004, AM J TRANSPLANT, V4, P937, DOI 10.1111/j.1600-6143.2004.00427.x; Augustine JJ, 2004, AM J TRANSPLANT, V4, P2001, DOI 10.1111/j.1600-6143.2004.00612.x; Augustine JJ, 2006, TRANSPLANTATION, V81, P1004, DOI 10.1097/01.tp.0000202880.78509.b4; Bairaktari E, 1998, CLIN CHEM, V44, P1256; CALNE RY, 1978, LANCET, V2, P1323; Campistol JM, 2001, TRANSPLANTATION, V71, pSS42; Cattaneo D, 2005, AM J TRANSPLANT, V5, P2937, DOI 10.1111/j.1600-6143.2005.01107.x; Christians U, 2004, BRIT J PHARMACOL, V143, P388, DOI 10.1038/sj.bjp.0705939; Christians U, 2008, THER DRUG MONIT, V30, P151, DOI 10.1097/FTD.0b013e31816b9063; Ciancio G, 2006, TRANSPLANTATION, V81, P845, DOI 10.1097/01.tp.0000203894.53714.27; Cravedi P, 2010, KIDNEY INT, V78, P1068, DOI 10.1038/ki.2010.268; Crescioli C, 2008, EXP CELL RES, V314, P1337, DOI 10.1016/j.yexcr.2007.12.016; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Filler G, 2000, PEDIATR NEPHROL, V14, P100, DOI 10.1007/s004670050021; Fleck C, 1999, PHYSIOL RES, V48, P267; FOXALL PJD, 1993, KIDNEY INT, V43, P234, DOI 10.1038/ki.1993.37; Fung J J, 1990, Clin Transpl, P115; Gallon L, 2006, AM J TRANSPLANT, V6, P1617, DOI 10.1111/j.1600-6143.2006.01340.x; GARTLAND KPR, 1989, MOL PHARMACOL, V35, P242; Guerra G, 2011, J AM SOC NEPHROL, V22, P1758, DOI 10.1681/ASN.2011010006; Halloran PF, 2000, LANCET, V356, P179, DOI 10.1016/S0140-6736(00)02473-9; Haschke M, 2007, CLIN CHEM, V53, P489, DOI 10.1373/clinchem.2006.078972; Hauet T, 2000, CRYOBIOLOGY, V41, P280, DOI 10.1006/cryo.2000.2291; Holt DW, 2003, TRANSPL P, V35, p157S, DOI 10.1016/S0041-1345(03)00214-8; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Johnston A, 1999, BRIT J CLIN PHARMACO, V47, P339, DOI 10.1046/j.1365-2125.1999.00911.x; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Klawitter J, 2012, J PROTEOME RES, V11, P5135, DOI 10.1021/pr300260e; Klawitter J, 2011, RAPID COMMUN MASS SP, V25, P463, DOI 10.1002/rcm.4871; Klawitter J, 2010, BRIT J CLIN PHARMACO, V70, P241, DOI 10.1111/j.1365-2125.2010.03689.x; Klawitter J, 2010, J PROTEOME RES, V9, P865, DOI 10.1021/pr900761m; Klawitter J, 2009, CHEM RES TOXICOL, V22, P118, DOI 10.1021/tx800253x; Klein IHHT, 2002, TRANSPLANTATION, V73, P732, DOI 10.1097/00007890-200203150-00012; Kovarik JM, 2004, THER DRUG MONIT, V26, P499, DOI 10.1097/00007691-200410000-00007; Kuypers DRJ, 2010, CLIN J AM SOC NEPHRO, V5, P341, DOI 10.2215/CJN.07111009; Kuypers DRJ, 2005, TRANSPL INT, V18, P140, DOI 10.1111/j.1432-2277.2004.00041.x; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; Lee RA, 2012, AM J HEALTH-SYST PH, V69, P1961, DOI 10.2146/ajhp110624; Ligtenberg G, 2001, J AM SOC NEPHROL, V12, P368, DOI 10.1681/ASN.V122368; Lorenz JN, 1999, AM J PHYSIOL-RENAL, V276, pF172, DOI 10.1152/ajprenal.1999.276.1.F172; Lucey MR, 2005, AM J TRANSPLANT, V5, P1111, DOI 10.1111/j.1600-6143.2005.00808.x; MacDonald AS, 2001, TRANSPLANTATION, V71, P271, DOI 10.1097/00007890-200101270-00019; Mayer AD, 1997, TRANSPLANTATION, V64, P436, DOI 10.1097/00007890-199708150-00012; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1289, DOI 10.1111/j.1600-6143.2004.00515.x; Meier-Kriesche HU, 2006, AM J TRANSPLANT, V6, P1111, DOI 10.1111/j.1600-6143.2006.01270.x; Meier-Kriesche HU, 2005, AM J TRANSPLANT, V5, P2273, DOI 10.1111/j.1600-6143.2005.01019.x; Mendez R, 2005, TRANSPLANTATION, V80, P303, DOI 10.1097/01.tp.0000167757.63922.42; MIHATSCH MJ, 1988, TRANSPLANT P, V20, P759; Moore J, 2009, TRANSPLANTATION, V87, P591, DOI 10.1097/TP.0b013e318195a421; Morales JM, 2005, J HYPERTENS, V23, P1609, DOI 10.1097/01.hjh.0000180159.81640.2f; Neild GH, 1997, NEPHROL DIAL TRANSPL, V12, P404, DOI 10.1093/ndt/12.3.404; Opelz G, 2008, TRANSPLANTATION, V86, P371, DOI 10.1097/TP.0b013e31817fdddb; Perry TW, 2007, CLIN TRANSPLANT, V21, P413, DOI 10.1111/j.1399-0012.2007.00662.x; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Podder H, 2001, J AM SOC NEPHROL, V12, P1059, DOI 10.1681/ASN.V1251059; Roberts LJ, 2000, FREE RADICAL BIO MED, V28, P505, DOI 10.1016/S0891-5849(99)00264-6; Robertson DG, 2000, TOXICOL SCI, V57, P326, DOI 10.1093/toxsci/57.2.326; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Sagrinati C, 2010, TRANSPL INT, V23, P914, DOI 10.1111/j.1432-2277.2010.01078.x; Schmitz V, 2009, NEPHRON EXP NEPHROL, V111, pE80, DOI 10.1159/000209208; Shockcor John P., 2002, Current Topics in Medicinal Chemistry, V2, P35, DOI 10.2174/1568026023394498; Smith KD, 2003, J AM SOC NEPHROL, V14, P1037, DOI 10.1097/01.ASN.0000057542.86377.5A; Sottili M, 2009, EXP CELL RES, V315, P264, DOI 10.1016/j.yexcr.2008.10.025; Srinivas TR, 2007, AM J TRANSPLANT, V7, P586, DOI 10.1111/j.1600-6143.2006.01658.x; STEPKOWSKI SM, 1991, TRANSPLANT P, V23, P3262; Taylor DO, 2006, J HEART LUNG TRANSPL, V25, P869, DOI 10.1016/j.healun.2006.05.002; Tyagi R, 2013, J APPL TOXICOL, V33, P134, DOI 10.1002/jat.1730; van Leuven SI, 2012, ANN RHEUM DIS, V71, P408, DOI 10.1136/annrheumdis-2011-200071; Vicenti F, 2002, TRANSPLANTATION, V73, P775, DOI 10.1097/00007890-200203150-00021; Vincenti F, 2003, J AM SOC NEPHROL, V14, P1940, DOI 10.1097/01.ASN.0000076844.59963.CF; Zucker K, 1999, THER DRUG MONIT, V21, P35, DOI 10.1097/00007691-199902000-00006; Zucker K, 1997, TRANSPL IMMUNOL, V5, P225, DOI 10.1016/S0966-3274(97)80042-1	74	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86202	10.1371/journal.pone.0086202	http://dx.doi.org/10.1371/journal.pone.0086202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497939	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100012
J	van Sijl, AM; Boers, M; Voskuyl, AE; Nurmohamed, MT				van Sijl, Alper M.; Boers, Maarten; Voskuyl, Alexandre E.; Nurmohamed, Michael T.			Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study	PLOS ONE			English	Article							GLUCOCORTICOIDS; RECOMMENDATIONS; MANAGEMENT; RISK	Objective: To evaluate the risk of cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids. Methods: Retrospective analysis of exposure to glucocorticoids in a prospective cohort of 353 patients with rheumatoid arthritis followed from June 2001 up to November 2011 for incident cardiovascular disease in a hospital-based outpatient cohort in the Netherlands. Hazard ratios with 95%-confidence intervals were calculated for the association between different types of exposure to glucocorticoids and incident cardiovascular disease. Associations were adjusted for demographics, cardiovascular risk factors and disease related parameters. Results: Recent and current exposure to glucocorticoids were associated with incident cardiovascular disease, as was a longer duration of exposure and cumulative exposure to glucocorticoids. Adjustment for disease activity and severity negated the association. Conclusion: In observational studies the finding of incident cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids is strongly confounded by indication due to high disease activity. The adverse cardiovascular effects of glucocorticoids might be balanced by positive effects working through inflammation control.	[van Sijl, Alper M.; Boers, Maarten; Voskuyl, Alexandre E.; Nurmohamed, Michael T.] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Sijl, AM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, Amsterdam, Netherlands.	Alper.vanSijl@vumc.nl		Voskuyl, Alexandre/0000-0002-9699-1827; Nurmohamed, Michael/0000-0002-6274-1934				Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; Davis JM, 2007, ARTHRITIS RHEUM-US, V56, P820, DOI 10.1002/art.22418; Duru N, 2013, ANN RHEUM DIS, V72, P1905, DOI 10.1136/annrheumdis-2013-203249; Gorter SL, 2010, ANN RHEUM DIS, V69, P1010, DOI 10.1136/ard.2009.127332; Mazzantini M, 2010, J RHEUMATOL, V37, P2232, DOI 10.3899/jrheum.100461; Peters MJL, 2009, ARTHRIT RHEUM-ARTHR, V61, P1571, DOI 10.1002/art.24836; Souverein PC, 2004, HEART, V90, P859, DOI 10.1136/hrt.2003.020180	8	39	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87965	10.1371/journal.pone.0087965	http://dx.doi.org/10.1371/journal.pone.0087965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498229	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100122
J	Hsieh, V; Kim, MJ; Gelissen, IC; Brown, AJ; Sandoval, C; Hallab, JC; Kockx, M; Traini, M; Jessup, W; Kritharides, L				Hsieh, Victar; Kim, Mi-Jurng; Gelissen, Ingrid C.; Brown, Andrew J.; Sandoval, Cecilia; Hallab, Jeannette C.; Kockx, Maaike; Traini, Mathew; Jessup, Wendy; Kritharides, Leonard			Cellular Cholesterol Regulates Ubiquitination and Degradation of the Cholesterol Export Proteins ABCA1 and ABCG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Cholesterol; Proteasome; Protein Degradation; Ubiquitination; ABCA1; ABCG1	CASSETTE TRANSPORTER A1; ATHEROSCLEROTIC LESION DEVELOPMENT; DENSITY-LIPOPROTEIN RECEPTOR; LDL RECEPTOR; HELICAL APOLIPOPROTEINS; LYSOSOMAL DEGRADATION; ENDOPLASMIC-RETICULUM; LOADED MACROPHAGES; PROTEASOME PATHWAY; FOAM CELLS	Background: Cholesterol transporters ABCA1 and ABCG1 export excess cellular cholesterol and protect against atherosclerosis. Results: Cholesterol loading decreases cellular degradation of ABCA1 and ABCG1 and also their ubiquitination. Conclusion: Cholesterol-dependent suppression of ABCA1 and ABCG1 ubiquitination decreases their proteasomal degradation. Significance: This mechanism enhances the capacity of cholesterol-loaded cells to export their excess cholesterol. The objective of this study was to examine the influence of cholesterol in post-translational control of ABCA1 and ABCG1 protein expression. Using CHO cell lines stably expressing human ABCA1 or ABCG1, we observed that the abundance of these proteins is increased by cell cholesterol loading. The response to increased cholesterol is rapid, is independent of transcription, and appears to be specific for these membrane proteins. The effect is mediated through cholesterol-dependent inhibition of transporter protein degradation. Cell cholesterol loading similarly regulates degradation of endogenously expressed ABCA1 and ABCG1 in human THP-1 macrophages. Turnover of ABCA1 and ABCG1 is strongly inhibited by proteasomal inhibitors and is unresponsive to inhibitors of lysosomal proteolysis. Furthermore, cell cholesterol loading inhibits ubiquitination of ABCA1 and ABCG1. Our findings provide evidence for a rapid, cholesterol-dependent, post-translational control of ABCA1 and ABCG1 protein levels, mediated through a specific and sterol-sensitive mechanism for suppression of transporter protein ubiquitination, which in turn decreases proteasomal degradation. This provides a mechanism for acute fine-tuning of cholesterol transporter activity in response to fluctuations in cell cholesterol levels, in addition to the longer term cholesterol-dependent transcriptional regulation of these genes.	[Kockx, Maaike; Traini, Mathew; Jessup, Wendy; Kritharides, Leonard] Concord Hosp, ANZAC Res Inst, Atherosclerosis Lab, Concord, NSW 2139, Australia; [Kritharides, Leonard] Concord Hosp, Dept Cardiol, Concord, NSW 2139, Australia; [Gelissen, Ingrid C.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Hsieh, Victar; Kim, Mi-Jurng; Sandoval, Cecilia; Hallab, Jeannette C.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia	Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Jessup, W (corresponding author), Concord Hosp, ANZAC Res Inst, Atherosclerosis Lab, Hosp Rd, Concord, NSW 2139, Australia.	wendy.jessup@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Kritharides, Leonard/AAQ-2720-2020; Ekanayake, Kanchana/P-8817-2016	Hsieh, Victar/0000-0003-0085-5933; Traini, Mathew/0000-0002-9423-5294	Pfizer CardioVascular Lipid grant; National Health and Medical Research Council of Australia; Principal Research Fellowship	Pfizer CardioVascular Lipid grant; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Principal Research Fellowship	This work was supported by a Pfizer CardioVascular Lipid grant (to V. H.), National Health and Medical Research Council of Australia Program grants (to W. J. and L. K.), and a Principal Research Fellowship (to W. J.).	Arakawa R, 2004, J BIOL CHEM, V279, P6217, DOI 10.1074/jbc.C300553200; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Azuma Y, 2009, BIOCHEM BIOPH RES CO, V382, P145, DOI 10.1016/j.bbrc.2009.02.161; Bowden K, 2008, J BIOL CHEM, V283, P18210, DOI 10.1074/jbc.M800918200; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Burns V, 2013, ATHEROSCLEROSIS, V226, P408, DOI 10.1016/j.atherosclerosis.2012.12.009; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Feng B, 2002, J BIOL CHEM, V277, P43271, DOI 10.1074/jbc.M207532200; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; Garner B, 1997, ATHEROSCLEROSIS, V128, P47, DOI 10.1016/S0021-9150(96)05979-5; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Gelissen IC, 1996, J BIOL CHEM, V271, P17852, DOI 10.1074/jbc.271.30.17852; Gelissen IC, 2012, J LIPID RES, V53, P2133, DOI 10.1194/jlr.M028795; Gelissen IC, 2010, ATHEROSCLEROSIS, V208, P75, DOI 10.1016/j.atherosclerosis.2009.06.028; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Hori N, 2011, ATHEROSCLEROSIS, V215, P383, DOI 10.1016/j.atherosclerosis.2010.12.033; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Kobayashi A, 2006, J LIPID RES, V47, P1791, DOI 10.1194/jlr.M500546-JLR200; Kockx M, 2012, BIOCHEM J, V447, P51, DOI 10.1042/BJ20111891; KRITHARIDES L, 1995, ARTERIOSCL THROM VAS, V15, P276, DOI 10.1161/01.ATV.15.2.276; Larrede S, 2009, ARTERIOSCL THROM VAS, V29, P1930, DOI 10.1161/ATVBAHA.109.194548; Lee JP, 2010, MOL CANCER RES, V8, P93, DOI 10.1158/1541-7786.MCR-08-0491; Mizuno T, 2011, HEPATOLOGY, V54, P631, DOI 10.1002/hep.24387; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Nagelin MH, 2008, ARTERIOSCL THROM VAS, V28, P1811, DOI 10.1161/ATVBAHA.108.167908; Nagelin MH, 2009, J BIOL CHEM, V284, P31303, DOI 10.1074/jbc.M109.028910; Nakagawa H, 2008, BIOCHEM J, V411, P623, DOI 10.1042/BJ20071229; Ogura M, 2011, ARTERIOSCL THROM VAS, V31, P1980, DOI 10.1161/ATVBAHA.111.228478; Out R, 2008, CIRC RES, V102, P113, DOI 10.1161/CIRCRESAHA.107.161711; Out R, 2007, ARTERIOSCL THROM VAS, V27, P594, DOI 10.1161/01.ATV.0000257136.24308.0c; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Scotti E, 2013, MOL CELL BIOL, V33, P1503, DOI 10.1128/MCB.01716-12; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Tanaka N, 2010, J LIPID RES, V51, P2591, DOI 10.1194/jlr.M006049; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang YT, 2002, J BIOL CHEM, V277, P5692, DOI 10.1074/jbc.M109977200; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Yokoyama S, 2012, BBA-MOL CELL BIOL L, V1821, P547, DOI 10.1016/j.bbalip.2011.07.017; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	54	50	51	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7524	7536		10.1074/jbc.M113.515890	http://dx.doi.org/10.1074/jbc.M113.515890			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24500716	hybrid, Green Published			2022-12-25	WOS:000332761500023
J	Pieroh, P; Koch, M; Wagner, DC; Boltze, J; Ehrlich, A; Ghadban, C; Hobusch, C; Birkenmeier, G; Dehghani, F				Pieroh, Philipp; Koch, Marco; Wagner, Daniel-Christoph; Boltze, Johannes; Ehrlich, Angela; Ghadban, Chalid; Hobusch, Constance; Birkenmeier, Gerd; Dehghani, Faramarz			Temporal Dynamics of Glyoxalase 1 in Secondary Neuronal Injury	PLOS ONE			English	Article							METHYL-D-ASPARTATE; RAT HIPPOCAMPAL-NEURONS; ACUTE ISCHEMIC-STROKE; NITRIC-OXIDE; GLUCOSE-METABOLISM; CEREBRAL-ISCHEMIA; INDUCED APOPTOSIS; CORTICAL-NEURONS; OXIDATIVE STRESS; S-NITROSYLATION	Background: Enhanced glycolysis leads to elevated levels of the toxic metabolite methylglyoxal which contributes to loss of protein-function, metabolic imbalance and cell death. Neurons were shown being highly susceptible to methylglyoxal toxicity. Glyoxalase 1 as an ubiquitous enzyme reflects the main detoxifying enzyme of methylglyoxal and underlies changes during aging and neurodegeneration. However, little is known about dynamics of Glyoxalase 1 following neuronal lesions so far. Methods: To determine a possible involvement of Glyoxalase 1 in acute brain injury, we analysed the temporal dynamics of Glyoxalase 1 distribution and expression by immunohistochemistry and Western Blot analysis. Organotypic hippocampal slice cultures were excitotoxically (N-methyl-D-aspartate, 50 mu M for 4 hours) lesioned in vitro (5 minutes to 72 hours). Additionally, permanent middle cerebral artery occlusion was performed (75 minutes to 60 days). Results: We found (i) a predominant localisation of Glyoxalase 1 in endothelial cells in non-lesioned brains (ii) a time-dependent up-regulation and re-distribution of Glyoxalase 1 in neurons and astrocytes and (iii) a strong increase in Glyoxalase 1 dimers after neuronal injury (24 hours to 72 hours) when compared to monomers of the protein. Conclusions: The high dynamics of Glyoxalase 1 expression and distribution following neuronal injury may indicate a novel role of Glyoxalase 1.	[Pieroh, Philipp; Ghadban, Chalid; Dehghani, Faramarz] Univ Halle Wittenberg, Dept Anat & Cell Biol, D-06108 Halle, Saale, Germany; [Pieroh, Philipp; Koch, Marco; Ehrlich, Angela; Ghadban, Chalid; Hobusch, Constance; Dehghani, Faramarz] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Wagner, Daniel-Christoph; Boltze, Johannes] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany; [Wagner, Daniel-Christoph; Boltze, Johannes] Translat Ctr Regenerat Med, Leipzig, Germany; [Boltze, Johannes] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Boltze, Johannes] Harvard Univ, Sch Med, Boston, MA USA; [Birkenmeier, Gerd] Univ Leipzig, Inst Biochem, D-04109 Leipzig, Germany	Martin Luther University Halle Wittenberg; Leipzig University; Fraunhofer Gesellschaft; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Leipzig University	Dehghani, F (corresponding author), Univ Halle Wittenberg, Dept Anat & Cell Biol, D-06108 Halle, Saale, Germany.	Dehghani@medizin.uni-halle.de		Pieroh, Philipp/0000-0003-0906-5479; Boltze, Johannes/0000-0003-3956-4164				Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Ahmed N, 2003, BBA-MOL BASIS DIS, V1639, P121, DOI 10.1016/j.bbadis.2003.08.002; Amicarelli F, 2003, FREE RADICAL BIO MED, V35, P856, DOI 10.1016/S0891-5849(03)00438-6; Belanger M, 2011, J NEUROSCI, V31, P18338, DOI 10.1523/JNEUROSCI.1249-11.2011; Birkenmeier G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010399; Candelario-Jalil E, 2009, CURR OPIN INVEST DR, V10, P644; Dave KR, 2011, NEUROSCI LETT, V496, P25, DOI 10.1016/j.neulet.2011.03.079; de Arriba SG, 2006, FREE RADICAL BIO MED, V40, P779, DOI 10.1016/j.freeradbiomed.2005.09.038; de Arriba SG, 2007, NEUROBIOL AGING, V28, P1044, DOI 10.1016/j.neurobiolaging.2006.05.007; de Hemptinne V, 2009, MOL CELL BIOCHEM, V325, P169, DOI 10.1007/s11010-009-0031-7; Di Loreto S, 1997, NEUROIMMUNOMODULAT, V4, P195, DOI 10.1159/000097338; Di Loreto S, 2004, BRAIN RES, V1006, P157, DOI 10.1016/j.brainres.2004.01.066; Di Loreto S, 2008, INT J BIOCHEM CELL B, V40, P245, DOI 10.1016/j.biocel.2007.07.019; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DUGAN LL, 1995, J NEUROSCI, V15, P6377; DYKENS JA, 1994, J NEUROCHEM, V63, P584; Ebrahimi F, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-89; Grabiec U, 2012, NEUROPHARMACOLOGY, V62, P1797, DOI 10.1016/j.neuropharm.2011.11.023; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Ientile R, 2002, NEUROSCIENCE, V115, P723, DOI 10.1016/S0306-4522(02)00482-7; Ito G, 2006, BIOCHEM BIOPH RES CO, V339, P667, DOI 10.1016/j.bbrc.2005.11.058; Kallendrusch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033537; Kang JH, 2003, TOXICOL LETT, V145, P181, DOI 10.1016/S0378-4274(03)00305-9; Kikuchi S, 1999, J NEUROSCI RES, V57, P280, DOI 10.1002/(SICI)1097-4547(19990715)57:2<280::AID-JNR14>3.0.CO;2-U; Kreutz S, 2009, GLIA, V57, P286, DOI 10.1002/glia.20756; Kuhla B, 2006, J NEUROSCI RES, V83, P1591, DOI 10.1002/jnr.20838; Kuhla B, 2007, NEUROBIOL AGING, V28, P29, DOI 10.1016/j.neurobiolaging.2005.11.007; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lee HK, 2009, J NEUROCHEM, V108, P273, DOI 10.1111/j.1471-4159.2008.05764.x; Lee KH, 2011, J NEUROSCI RES, V89, P96, DOI 10.1002/jnr.22525; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Mannervik Bengt, 2008, Drug Metabolism and Drug Interactions, V23, P13; Mitsumoto A, 2000, J BIOCHEM, V128, P647, DOI 10.1093/oxfordjournals.jbchem.a022797; Mitsumoto A, 1999, BIOCHEM J, V344, P837, DOI 10.1042/0264-6021:3440837; Okouchi M, 2005, CURR NEUROVASC RES, V2, P13, DOI 10.2174/1567202052773535; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Park JW, 2011, BIOCHEMISTRY-US, V50, P3204, DOI 10.1021/bi101373h; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; RACKER E, 1951, J BIOL CHEM, V190, P685; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; SELKOE DJ, 1982, P NATL ACAD SCI-BIOL, V79, P6070, DOI 10.1073/pnas.79.19.6070; Shi ZQ, 2013, P NATL ACAD SCI USA, V110, P3137, DOI 10.1073/pnas.1215501110; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Tenneti L, 1998, J NEUROCHEM, V71, P946; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Wagner DC, 2012, NEUROIMAGE, V61, P780, DOI 10.1016/j.neuroimage.2012.04.023; Wang GJ, 1996, J NEUROPHYSIOL, V76, P1611, DOI 10.1152/jn.1996.76.3.1611; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200	54	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87364	10.1371/journal.pone.0087364	http://dx.doi.org/10.1371/journal.pone.0087364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498315	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900061
J	Ebrahimi, D; Alinejad-Rokny, H; Davenport, MP				Ebrahimi, Diako; Alinejad-Rokny, Hamid; Davenport, Miles P.			Insights into the Motif Preference of APOBEC3 Enzymes	PLOS ONE			English	Article							HIV-1 REVERSE TRANSCRIPTION; CYTIDINE DEAMINATION; HYPERMUTATION; INHIBITION; DNA; RESTRICTION; INFECTION	We used a multivariate data analysis approach to identify motifs associated with HIV hypermutation by different APOBEC3 enzymes. The analysis showed that APOBEC3G targets G mainly within GG, TG, TGG, GGG, TGGG and also GGGT. The G nucleotides flanked by a C at the 39 end (in + 1 and + 2 positions) were indicated as disfavoured targets by APOBEC3G. The G nucleotides within GGGG were found to be targeted at a frequency much less than what is expected. We found that the infrequent G-to-A mutation within GGGG is not limited to the inaccessibility, to APOBEC3, of poly Gs in the central and 3'polypurine tracts (PPTs) which remain double stranded during the HIV reverse transcription. GGGG motifs outside the PPTs were also disfavoured. The motifs GGAG and GAGG were also found to be disfavoured targets for APOBEC3. The motif-dependent mutation of G within the HIV genome by members of the APOBEC3 family other than APOBEC3G was limited to GA -> AA changes. The results did not show evidence of other types of context dependent G-to-A changes in the HIV genome.	[Ebrahimi, Diako; Alinejad-Rokny, Hamid; Davenport, Miles P.] Univ New S Wales, Fac Med, Ctr Vasc Res, Complex Syst Biol Grp, Sydney, NSW, Australia	University of New South Wales Sydney	Davenport, MP (corresponding author), Univ New S Wales, Fac Med, Ctr Vasc Res, Complex Syst Biol Grp, Sydney, NSW, Australia.	m.davenport@unsw.edu.au	Ebrahimi, Diako/B-4367-2008	Ebrahimi, Diako/0000-0002-8577-0420; Davenport, Miles/0000-0002-4751-1831	Australian National Health and Medical Research Council (NHMRC); NHMRC	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work is funded by the Australian National Health and Medical Research Council (NHMRC). DE is funded by an Early Career Fellowship from NHMRC. MPD is a senior Research Fellow funded by NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage AE, 2008, J VIROL, V82, P8743, DOI 10.1128/JVI.00584-08; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Brereton RG, 2009, CHEMOMETRICS PATTERN, pxvii; Ebrahimi D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-113; Ebrahimi D, 2011, J VIROL, V85, P9139, DOI 10.1128/JVI.00658-11; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Kijak GH, 2008, VIROLOGY, V376, P101, DOI 10.1016/j.virol.2008.03.017; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Ma SG, 2011, BRIEF BIOINFORM, V12, P714, DOI 10.1093/bib/bbq090; MacMillan AL, 2013, J VIROL, V87, P4808, DOI 10.1128/JVI.00112-13; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Strebel K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-37; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758	24	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87679	10.1371/journal.pone.0087679	http://dx.doi.org/10.1371/journal.pone.0087679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498164	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900149
J	Gadave, KS; Panda, S; Singh, S; Kalra, S; Malakar, D; Mohanty, AK; Kaushik, JK				Gadave, Kaustubh S.; Panda, Santanu; Singh, Surender; Kalra, Shalini; Malakar, Dhruba; Mohanty, Ashok K.; Kaushik, Jai K.			Structural and Functional Insights into the Catalytic Inactivity of the Major Fraction of Buffalo Milk Xanthine Oxidoreductase	PLOS ONE			English	Article							BOVINE-MILK; GROSSLY DEFICIENT; OXIDASE; MOLYBDENUM; MECHANISM; SULFUR; ENZYME; DEHYDROGENASE; ACTIVATION; SECRETION	Background: Xanthine oxidoreductase (XOR) existing in two interconvertible forms, xanthine dehydrogenase (XDH) and xanthine oxidase (XO), catabolises xanthine to uric acid that is further broken down to antioxidative agent allantoin. XOR also produces free radicals serving as second messenger and microbicidal agent. Large variation in the XO activity has been observed among various species. Both hypo and hyper activity of XOR leads to pathophysiological conditions. Given the important nutritional role of buffalo milk in human health especially in south Asia, it is crucial to understand the functional properties of buffalo XOR and the underlying structural basis of variations in comparison to other species. Methods and Findings: Buffalo XO activity of 0.75 U/mg was almost half of cattle XO activity. Enzymatic efficiency (k(cat)/K-m) of 0.11 sec(-1) mu M-1 of buffalo XO was 8-10 times smaller than that of cattle XO. Buffalo XOR also showed lower antibacterial activity than cattle XOR. A CD value (Delta epsilon(430) (nm)) of 46,000 M-1 cm(-1) suggested occupancy of 77.4% at Fe/S I centre. Buffalo XOR contained 0.31 molybdenum atom/subunit of which 48% existed in active sulfo form. The active form of XO in buffalo was only 16% in comparison to similar to 30% in cattle. Sequencing revealed 97.4% similarity between buffalo and cattle XOR. FAD domain was least conserved, while metal binding domains (Fe/S and Molybdenum) were highly conserved. Homology modelling of buffalo XOR showed several variations occurring in clusters, especially close to FAD binding pocket which could affect NAD(+) entry in the FAD centre. The difference in XO activity seems to be originating from cofactor deficiency, especially molybdenum. Conclusion: A major fraction of buffalo milk XOR exists in a catalytically inactive form due to high content of demolybdo and desulfo forms. Lower Fe/S content and structural factors might be contributing to lower enzymatic efficiency of buffalo XOR in a minor way.	[Gadave, Kaustubh S.; Panda, Santanu; Singh, Surender; Kalra, Shalini; Malakar, Dhruba; Mohanty, Ashok K.; Kaushik, Jai K.] Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal 132001, Haryana, India; [Kaushik, Jai K.] Natl Dairy Res Inst, BTIS Subctr, Karnal 132001, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute	Kaushik, JK (corresponding author), Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal 132001, Haryana, India.	jaikr1@gmail.com		Kaushik, Jai/0000-0002-8872-0066	Institutional Fellowship Program for master students; Council of Scientific and Industrial Research, India	Institutional Fellowship Program for master students; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	KSG was supported by Institutional Fellowship Program for master students, while SK was supported by Senior Research Fellowship of Council of Scientific and Industrial Research, India. The research was carried out under the Institute's broader area of research on "Genetic improvement of milch animals through identification and dissemination of superior germplasm by application of emerging reproductive and molecular technologies." The running departmental grant was used for purchase of consumables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmani D, 2004, J DAIRY RES, V71, P7, DOI 10.1017/S0022029903006514; AVIS PG, 1956, J CHEM SOC, P1219, DOI 10.1039/jr9560001219; Beaucamp K., 1974, METHOD ENZYMAT AN, P523; Benboubetra M, 2004, J DAIRY SCI, V87, P1580, DOI 10.3168/jds.S0022-0302(04)73311-1; BHAVADASAN MK, 1980, J DAIRY SCI, V63, P362, DOI 10.3168/jds.S0022-0302(80)82940-7; Boueiz A, 2008, AM J PHYSIOL-LUNG C, V294, pL830, DOI 10.1152/ajplung.00007.2008; Bray RC., 1975, ENZYMES, V12, P299, DOI DOI 10.1016/S1874-6047(08)60229-2; BROWN AM, 1995, BBA-GEN SUBJECTS, V1245, P248, DOI 10.1016/0304-4165(95)00093-Q; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; DENT CE, 1954, LANCET, V1, P182, DOI 10.1016/S0140-6736(54)91257-X; Desco MC, 2002, DIABETES, V51, P1118, DOI 10.2337/diabetes.51.4.1118; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; GANDHI MPS, 1979, ZBL VET MED A, V26, P765; Geroge J, 2009, VASC HLTH RISK MANAG, V5, P265; Godber BLJ, 2000, J BIOL CHEM, V275, P7757, DOI 10.1074/jbc.275.11.7757; Godber BLJ, 2005, BIOCHEM J, V388, P501, DOI 10.1042/BJ20041984; Gus'kov E P, 2002, Dokl Biochem Biophys, V383, P105, DOI 10.1023/A:1015331601169; GUTTERIDGE S, 1978, BIOCHEM J, V175, P887, DOI 10.1042/bj1750887; Hancock JT, 2002, ANTIMICROB AGENTS CH, V46, P3308, DOI 10.1128/AAC.46.10.3308-3310.2002; Harris CM, 1997, J BIOL CHEM, V272, P28335, DOI 10.1074/jbc.272.45.28335; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; HART L I, 1970, Biochemical Journal, V116, P851; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; HORECKER BL, 1948, J BIOL CHEM, V175, P385; HUNT J, 1992, J BIOL CHEM, V267, P21479; Iwasaki T, 2000, J BIOCHEM, V127, P771, DOI 10.1093/oxfordjournals.jbchem.a022669; Kanawjia SK, 2008, DAIRY YB 2008, V2008, P71; Kaushik JK, 2006, BIOCHEMISTRY-US, V45, P7100, DOI 10.1021/bi052610n; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linder N, 2005, CLIN CANCER RES, V11, P4372, DOI 10.1158/1078-0432.CCR-04-2280; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin HM, 2004, INFECT IMMUN, V72, P4933, DOI 10.1128/IAI.72.9.4933-4939.2004; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; McManaman JL, 2002, J PHYSIOL-LONDON, V545, P567, DOI 10.1113/jphysiol.2002.027185; Millar TM, 2002, REDOX REP, V7, P65, DOI 10.1179/135100002125000280; Ohtsubo T, 2005, CIRC RES, V95, P1118; Okamoto K, 2003, J BIOL CHEM, V278, P1848, DOI 10.1074/jbc.M208307200; OKAMOTO K, 1995, J BIOL CHEM, V270, P7816, DOI 10.1074/jbc.270.14.7816; Oster K. A. J. B., 1974, AM LAB, V6, P41; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; PATTON S, 1975, BIOCHIM BIOPHYS ACTA, V415, P273, DOI 10.1016/0304-4157(75)90011-8; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; RZUCIDLO SJ, 1979, P SOC EXP BIOL MED, V160, P477, DOI 10.3181/00379727-160-40474; Seymour KJ, 2006, J BIOL CHEM, V281, P8545, DOI 10.1074/jbc.M507349200; Stevens CR, 2000, LANCET, V356, P829, DOI 10.1016/S0140-6736(00)02660-X; Suzuki H, 1998, P NATL ACAD SCI USA, V95, P4754, DOI 10.1073/pnas.95.8.4754; TERADA LS, 1992, P NATL ACAD SCI USA, V89, P3362, DOI 10.1073/pnas.89.8.3362; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; WAHL RC, 1982, J BIOL CHEM, V257, P1354	51	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87618	10.1371/journal.pone.0087618	http://dx.doi.org/10.1371/journal.pone.0087618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498153	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900144
J	Santos, ARC; Dvoriantchikova, G; Li, YW; Mohammad, G; Abu El-Asrar, AM; Wen, R; Ivanov, D				Santos, Andrea Rachelle C.; Dvoriantchikova, Galina; Li, Yiwen; Mohammad, Ghulam; Abu El-Asrar, Ahmed M.; Wen, Rong; Ivanov, Dmitry			Cellular Mechanisms of High Mobility Group 1 (HMGB-1) Protein Action in the Diabetic Retinopathy	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION; SIGNALING PATHWAY; RETINA; CELLS; INJURY; INFLAMMATION; PERICYTES; RAGE; NEOVASCULARIZATION; RECEPTOR	Diabetic retinopathy is one of the main microvascular complications of diabetes and remains one of the leading causes of blindness worldwide. Recent studies have revealed an important role of inflammatory and proangiogenic high mobility group 1 (HMGB-1) cytokine in diabetic retinopathy. To elucidate cellular mechanisms of HMGB-1 activity in the retina, we performed this study. The histological features of diabetic retinopathy include loss of blood-vessel pericytes and endothelial cells, as well as abnormal new blood vessel growth. To establish the role of HMGB-1 in vulnerability of endothelial cells and pericytes, cultures of these cells, or co-cultures with glial cells, were treated with HMGB-1 and assessed for survival after 24 hours. The expression levels of the cytokines, chemokines, and cell adhesion molecules in glial and endothelial cells were tested by quantitative RT-PCR to evaluate changes in these cells after HMGB-1 treatment. Animal models of neovascularization were also used to study the role of HMGB-1 in the retina. We report that pericyte death is mediated by HMGB-1-induced cytotoxic activity of glial cells, while HMGB-1 can directly mediate death of endothelial cells. We also found that HMGB-1 affects endothelial cell activity. However, we did not observe a difference in the levels of neovascularization between HMGB-1-treated eyes compared to the control eyes, nor in the levels of proangiogenic cytokine VEGF-A expression between glial cells treated with HMGB-1 and control cells. Our data also indicate that HMGB-1 is not involved in retinal neovascularization in the oxygen-induced retinopathy model. Thus, our data suggest that retinal pericyte and endothelial injury and death in diabetic retinopathy may be due to HMGB-1-induced cytotoxic activity of glial cells as well as the direct effect of HMGB-1 on endothelial cells. At the same time, our findings indicate that HMGB-1 plays an insignificant role in retinal and choroidal neovascularization.	[Santos, Andrea Rachelle C.; Dvoriantchikova, Galina; Li, Yiwen; Wen, Rong; Ivanov, Dmitry] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Mohammad, Ghulam; Abu El-Asrar, Ahmed M.] King Saud Univ, Coll Med, Dept Ophthalmol, King Abdul Aziz Univ Hosp, Riyadh 11461, Saudi Arabia; [Ivanov, Dmitry] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami; King Abdulaziz University; King Saud University; University of Miami	Ivanov, D (corresponding author), Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	divanov@med.miami.edu	Abu El-Asrar, Ahmed/AAX-5055-2021; Mohammad, Ghulam/F-5623-2011	Mohammad, Ghulam/0000-0002-6418-4772; Ivanov, Dmitry/0000-0002-5573-4402	National Eye Institute/National Institutes of Health (NIH) [R01 EY022348]; James and Esther King Biomedical Research Program Bridge Grant [3KB01-50988]; King Saud University; Bascom Palmer Research collaboration agreement; Hope for Vision; NIH Center [P30EY014801]; NATIONAL EYE INSTITUTE [R01EY022348, P30EY014801] Funding Source: NIH RePORTER	National Eye Institute/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); James and Esther King Biomedical Research Program Bridge Grant; King Saud University(King Saud University); Bascom Palmer Research collaboration agreement; Hope for Vision; NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by National Eye Institute/National Institutes of Health (NIH) Grant R01 EY022348 (DI), James and Esther King Biomedical Research Program Bridge Grant 3KB01-50988 (DI), the King Saud University and Bascom Palmer Research collaboration agreement (DI and RW), Hope for Vision (RW) and NIH Center Core Grant P30EY014801 to the University of Miami Department of Ophthalmology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Eye Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/697489; ABUELASRAR AM, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/863036; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Biscetti F, 2010, DIABETES, V59, P1496, DOI 10.2337/db09-1507; Cao JT, 2010, INVEST OPHTH VIS SCI, V51, P6009, DOI 10.1167/iovs.09-4956; Chen XL, 2013, BRIT J OPHTHALMOL, V97, P1598, DOI 10.1136/bjophthalmol-2013-303736; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Dvoriantchikova G, 2011, INVEST OPHTH VIS SCI, V52, P7187, DOI 10.1167/iovs.11-7793; Dvoriantchikova G, 2010, MOL VIS, V16, P2882; Dvoriantchikova G, 2010, MOL VIS, V16, P1907; Edelman DA, 2007, AM J SURG, V193, P730, DOI 10.1016/j.amjsurg.2006.08.086; El-Asrar Ahmed M Abu, 2011, Mol Vis, V17, P1829; El-Asrar AM, 2011, MOL VIS, V17, P508; Favard C, 1996, DIABETES METAB, V22, P268; Fernandez DC, 2011, AM J PATHOL, V178, P2264, DOI 10.1016/j.ajpath.2011.01.040; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Ivanov D, 2008, J NEUROSCI METH, V174, P10, DOI 10.1016/j.jneumeth.2008.06.016; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Lin Q, 2011, ARTERIOSCL THROM VAS, V31, P1024, DOI 10.1161/ATVBAHA.111.224048; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Mohammad G, 2013, EXP EYE RES, V107, P101, DOI 10.1016/j.exer.2012.12.009; Neely KA, 1998, MED CLIN N AM, V82, P847, DOI 10.1016/S0025-7125(05)70027-4; Noda K, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/279037; Santos AM, 2008, J COMP NEUROL, V506, P224, DOI 10.1002/cne.21538; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sim DA, 2013, INVEST OPHTH VIS SCI, V54, P2353, DOI 10.1167/iovs.12-11103; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Yamagishi S, 2005, FEBS LETT, V579, P4265, DOI 10.1016/j.febslet.2005.06.058	34	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87574	10.1371/journal.pone.0087574	http://dx.doi.org/10.1371/journal.pone.0087574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498140	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900135
J	Li, L; Liu, C; Wang, F; Miao, W; Zhang, J; Kang, ZQ; Chen, YH; Peng, LY				Li, Li; Liu, Chang; Wang, Fang; Miao, Wei; Zhang, Jie; Kang, Zhiqian; Chen, Yihan; Peng, Luying			Unraveling the Hidden Heterogeneities of Breast Cancer Based on Functional miRNA Cluster	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; INTEGRATIVE ANALYSIS; EXPRESSION DATA; MICRORNA; TUMOR; PATTERNS	It has become increasingly clear that the current taxonomy of clinical phenotypes is mixed with molecular heterogeneity, which potentially affects the treatment effect for involved patients. Defining the hidden molecular-distinct diseases using modern large-scale genomic approaches is therefore useful for refining clinical practice and improving intervention strategies. Given that microRNA expression profiling has provided a powerful way to dissect hidden genetic heterogeneity for complex diseases, the aim of the study was to develop a bioinformatics approach that identifies microRNA features leading to the hidden subtyping of complex clinical phenotypes. The basic strategy of the proposed method was to identify optimal miRNA clusters by iteratively partitioning the sample and feature space using the two-ways super-paramagnetic clustering technique. We evaluated the obtained optimal miRNA cluster by determining the consistency of co-expression and the chromosome location among the within-cluster microRNAs, and concluded that the optimal miRNA cluster could lead to a natural partition of disease samples. We applied the proposed method to a publicly available microarray dataset of breast cancer patients that have notoriously heterogeneous phenotypes. We obtained a feature subset of 13 microRNAs that could classify the 71 breast cancer patients into five subtypes with significantly different five-year overall survival rates (45%, 82.4%, 70.6%, 100% and 60% respectively; p = 0.008). By building a multivariate Cox proportional-hazards prediction model for the feature subset, we identified has-miR-146b as one of the most significant predictor (p = 0.045; hazard ratios = 0.39). The proposed algorithm is a promising computational strategy for dissecting hidden genetic heterogeneity for complex diseases, and will be of value for improving cancer diagnosis and treatment.	[Li, Li; Liu, Chang; Wang, Fang; Miao, Wei; Zhang, Jie; Kang, Zhiqian; Peng, Luying] Tongji Univ, Sch Med, Div Med Genet, Shanghai 200092, Peoples R China; [Li, Li; Liu, Chang; Wang, Fang; Miao, Wei; Zhang, Jie; Kang, Zhiqian; Chen, Yihan; Peng, Luying] Tongji Univ, Minist Educ, Key Lab Arrhythmias, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Chen, YH (corresponding author), Tongji Univ, Minist Educ, Key Lab Arrhythmias, Shanghai 200092, Peoples R China.	yihanchen@tongji.edu.cn; luyingpeng@tongji.edu.cn			National Basic Research Program of China (973 Program) [2012CB9668003, 2010CB945500]; National Natural Science Foundation of China [81270231, 31170791, 81370298]; International Science & Technology Cooperation Program of China [2011DFB30010]; Shanghai Committee of Science and Technology [12140903600]; Fundamental Research Funds for the Central Universities; Shanghai Municipal Health Bureau Project	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shanghai Municipal Health Bureau Project	This work was supported by the National Basic Research Program of China (973 Program) (2012CB9668003 and 2010CB945500); National Natural Science Foundation of China (81270231, 31170791, and 81370298); International Science & Technology Cooperation Program of China (2011DFB30010); Shanghai Committee of Science and Technology(12140903600); the Fundamental Research Funds for the Central Universities to L. L.; and Shanghai Municipal Health Bureau Project to L. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; COX DR, 1972, J R STAT SOC B, V34, P187; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Getz G, 2003, BIOINFORMATICS, V19, P1079, DOI 10.1093/bioinformatics/btf876; Getz G, 2003, BIOINFORMATICS, V19, P1153, DOI 10.1093/bioinformatics/btg143; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Kopycka-Kedzierawski DT, 2004, COMMUNITY DENT ORAL, V32, P201, DOI 10.1111/j.1600-0528.2004.00153.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu ZD, 2012, ONCOL LETT, V4, P1027, DOI 10.3892/ol.2012.841; McLachlan GJ, 2002, BIOINFORMATICS, V18, P413, DOI 10.1093/bioinformatics/18.3.413; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Tetko IV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-82; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Zhang W, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-332; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200	27	1	1	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87601	10.1371/journal.pone.0087601	http://dx.doi.org/10.1371/journal.pone.0087601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498150	gold, Green Published, Green Submitted			2022-12-25	WOS:000330617100100
J	Lou, PH; Lucchinetti, E; Zhang, LY; Affolter, A; Schaub, MC; Gandhi, M; Hersberger, M; Warren, BE; Lemieux, H; Sobhi, HF; Clanachan, AS; Zaugg, M				Lou, Phing-How; Lucchinetti, Eliana; Zhang, Liyan; Affolter, Andreas; Schaub, Marcus C.; Gandhi, Manoj; Hersberger, Martin; Warren, Blair E.; Lemieux, Helene; Sobhi, Hany F.; Clanachan, Alexander S.; Zaugg, Michael			The Mechanism of Intralipid (R)-Mediated Cardioprotection Complex IV Inhibition by the Active Metabolite, Palmitoylcarnitine, Generates Reactive Oxygen Species and Activates Reperfusion Injury Salvage Kinases	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; FATTY-ACID OXIDATION; UNCOUPLING PROTEIN-3; LIPID EMULSION; IN-VIVO; ISCHEMIA; HEARTS; CARNITINE; RECOVERY; PROTECTS	Background: Intralipid (R) administration at reperfusion elicits protection against myocardial ischemia-reperfusion injury. However, the underlying mechanisms are not fully understood. Methods: Sprague-Dawley rat hearts were exposed to 15 min of ischemia and 30 min of reperfusion in the absence or presence of Intralipid (R) 1% administered at the onset of reperfusion. In separate experiments, the reactive oxygen species (ROS) scavenger N-(2-mercaptopropionyl)-glycine was added either alone or with Intralipid (R). Left ventricular work and activation of Akt, STAT3, and ERK1/2 were used to evaluate cardioprotection. ROS production was assessed by measuring the loss of aconitase activity and the release of hydrogen peroxide using Amplex Red. Electron transport chain complex activities and proton leak were measured by high-resolution respirometry in permeabilized cardiac fibers. Titration experiments using the fatty acid intermediates of Intralipid (R) palmitoyl-, oleoyl- and linoleoylcarnitine served to determine concentration-dependent inhibition of complex IV activity and mitochondrial ROS release. Results: Intralipid (R) enhanced postischemic recovery and activated Akt and Erk1/2, effects that were abolished by the ROS scavenger N-(2-mercaptopropionyl) glycine. Palmitoylcarnitine and linoleoylcarnitine, but not oleoylcarnitine concentration-dependently inhibited complex IV. Only palmitoylcarnitine reached high tissue concentrations during early reperfusion and generated significant ROS by complex IV inhibition. Palmitoylcarnitine (1 mu M), administered at reperfusion, also fully mimicked Intralipid (R)-mediated protection in an N-(2-mercaptopropionyl)-glycine -dependent manner. Conclusions: Our data describe a new mechanism of postconditioning cardioprotection by the clinically available fat emulsion, Intralipid (R). Protection is elicited by the fatty acid intermediate palmitoylcarnitine, and involves inhibition of complex IV, an increase in ROS production and activation of the RISK pathway.	[Lou, Phing-How] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Lucchinetti, Eliana; Zhang, Liyan; Zaugg, Michael] Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB, Canada; [Affolter, Andreas; Hersberger, Martin] Univ Childrens Hosp Zurich, Dept Clin Chem, Zurich, Switzerland; [Schaub, Marcus C.] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Gandhi, Manoj; Clanachan, Alexander S.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Warren, Blair E.; Lemieux, Helene] Univ Alberta, Edmonton, AB, Canada; [Sobhi, Hany F.] Coppin State Univ, Coppin Ctr Organ Synth, Baltimore, MD USA	University of Alberta; University of Alberta; University Children's Hospital Zurich; University of Zurich; University of Alberta; University of Alberta; University System of Maryland; Coppin State University	Zaugg, M (corresponding author), Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB, Canada.	michael.zaugg@ualberta.ca	Zhang, Li/GWM-7501-2022; Zaugg, Michael/G-4287-2016	Lucchinetti, Eliana/0000-0003-3338-1279; lemieux, Helene/0000-0002-8864-6062; Zaugg, Michael/0000-0002-2016-8973; Hersberger, Martin/0000-0002-4472-329X	Heart and Stroke Foundation of Alberta; Northwest Territories; Nunavut (Canada); Canadian Institutes of Health Research [MOP115055]; Natural Sciences and Engineering Research Council of Canada; Mazankowski Alberta Heart Institute, Edmonton, Canada; Campus Saint-Jean of the University of Alberta, Edmonton, Canada	Heart and Stroke Foundation of Alberta; Northwest Territories; Nunavut (Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Mazankowski Alberta Heart Institute, Edmonton, Canada; Campus Saint-Jean of the University of Alberta, Edmonton, Canada	This work was supported by the Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut (Canada), and the Canadian Institutes of Health Research (MOP115055), a discovery grant from the Natural Sciences and Engineering Research Council of Canada, and a grant from the Mazankowski Alberta Heart Institute, Edmonton, Canada. BEW was supported by a "Bourse pour apprentis-chercheurs" from the Campus Saint-Jean of the University of Alberta, Edmonton, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Arnold S, 2012, MITOCHONDRION, V12, P46, DOI 10.1016/j.mito.2011.05.003; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Burwell LS, 2009, J MOL CELL CARDIOL, V46, P804, DOI 10.1016/j.yjmcc.2009.02.026; Cave G, 2009, ACAD EMERG MED, V16, P815, DOI 10.1111/j.1553-2712.2009.00499.x; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Hausenloy DJ, 2011, ANTIOXID REDOX SIGN, V14, P893, DOI 10.1089/ars.2010.3360; HEATHERS GP, 1993, J CARDIOVASC PHARM, V22, P857; Hiser C, 2013, BIOCHEMISTRY-US, V52, P1385, DOI 10.1021/bi3014505; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; HULSMANN WC, 1985, BIOCHIM BIOPHYS ACTA, V847, P62, DOI 10.1016/0167-4889(85)90153-3; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Ito M, 2010, AM J PHYSIOL-HEART C, V298, pH1426, DOI 10.1152/ajpheart.00284.2009; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Kudej RK, 2011, CARDIOVASC RES, V92, P394, DOI 10.1093/cvr/cvr215; LETELLIER T, 1994, BIOCHEM J, V302, P171, DOI 10.1042/bj3020171; Li JY, 2012, ANESTHESIOLOGY, V117, P836, DOI 10.1097/ALN.0b013e3182655e73; Lou PH, 2013, CARDIOVASC RES, V97, P251, DOI 10.1093/cvr/cvs323; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lucchinetti E, 2011, BRIT J ANAESTH, V106, P792, DOI 10.1093/bja/aer065; Mirtallo JM, 2010, ANN PHARMACOTHER, V44, P688, DOI 10.1345/aph.1M626; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; MURTHY MSR, 1985, BIOCHEM J, V230, P657, DOI 10.1042/bj2300657; ORAM JF, 1973, J BIOL CHEM, V248, P5299; Ozcan C, 2013, AM J PHYSIOL-HEART C, V304, pH1192, DOI 10.1152/ajpheart.00592.2012; Partownavid P, 2012, CRIT CARE MED, V40, P2431, DOI 10.1097/CCM.0b013e3182544f48; Penna C, 2006, BASIC RES CARDIOL, V101, P180, DOI 10.1007/s00395-006-0584-5; Penna C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0371-z; Penna C, 2009, BBA-BIOENERGETICS, V1787, P781, DOI 10.1016/j.bbabio.2009.02.008; Pillutla P, 2005, AM J PHYSIOL-ENDOC M, V288, pE1229, DOI 10.1152/ajpendo.00273.2004; Rahman S, 2011, ANESTHESIOLOGY, V115, P242, DOI 10.1097/ALN.0b013e318223b8b9; Saotome M, 2009, AM J PHYSIOL-HEART C, V296, pH1125, DOI 10.1152/ajpheart.00436.2008; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Stanley WC, 2012, CIRC RES, V110, P764, DOI [10.1161/CIRCRESAHA.111.253104, 10.1161/circresaha.111.253104]; TAKEUCHI Y, 1991, ARCH BIOCHEM BIOPHYS, V289, P33, DOI 10.1016/0003-9861(91)90438-O; Tominaga H, 2008, AM J PHYSIOL-HEART C, V295, pH105, DOI 10.1152/ajpheart.01307.2007; Tsutsumi YM, 2007, LIFE SCI, V81, P1223, DOI 10.1016/j.lfs.2007.08.031; Tullio F, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0392-7; Van de Velde M, 2000, CARDIOVASC RES, V48, P129, DOI 10.1016/S0008-6363(00)00151-6; VandeVelde M, 1996, CARDIOVASC RES, V32, P1008, DOI 10.1016/S0008-6363(96)00165-4; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; Wang LG, 2010, ANESTHESIOLOGY, V113, P541, DOI 10.1097/ALN.0b013e3181e2c1a1; Xie NL, 2011, ARCH MED RES, V42, P171, DOI 10.1016/j.arcmed.2011.04.008; Yue TL, 2003, CIRCULATION, V108, P2393, DOI 10.1161/01.CIR.0000093187.42015.6C; Zaugg M, 2012, ANESTHESIOLOGY, V116, P648, DOI 10.1097/ALN.0b013e318247225a; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	52	39	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87205	10.1371/journal.pone.0087205	http://dx.doi.org/10.1371/journal.pone.0087205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498043	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000330617100058
J	Sharp, AN; Heazell, AEP; Baczyk, D; Dunk, CE; Lacey, HA; Jones, CJP; Perkins, JE; Kingdom, JCP; Baker, PN; Crocker, IP				Sharp, Andrew N.; Heazell, Alexander E. P.; Baczyk, Dora; Dunk, Caroline E.; Lacey, Helen A.; Jones, Carolyn J. P.; Perkins, Jonathan E.; Kingdom, John C. P.; Baker, Philip N.; Crocker, Ian P.			Preeclampsia Is Associated with Alterations in the p53-Pathway in Villous Trophoblast	PLOS ONE			English	Article							PLACENTAL APOPTOSIS; ANTAGONIST NUTLIN-3; MEDIATED APOPTOSIS; P53 PATHWAY; EXPRESSION; BAX; PREGNANCIES; HYPOXIA; OXYGEN; ACTIVATION	Background: Preeclampsia (PE) is characterized by exaggerated apoptosis of the villous trophoblast of placental villi. Since p53 is a critical regulator of apoptosis we hypothesized that excessive apoptosis in PE is mediated by abnormal expression of proteins participating in the p53 pathway and that modulation of the p53 pathway alters trophoblast apoptosis in vitro. Methods: Fresh placental villous tissue was collected from normal pregnancies and pregnancies complicated by PE; Western blotting and real-time PCR were performed on tissue lysate for protein and mRNA expression of p53 and downstream effector proteins, p21, Bax and caspases 3 and 8. To further assess the ability of p53 to modulate apoptosis within trophoblast, BeWo cells and placental villous tissue were exposed to the p53-activator, Nutlin-3, alone or in combination with the p53-inhibitor, Pifithrin-alpha (PFT- alpha). Equally, Mdm2 was knocked-down with siRNA. Results: Protein expression of p53, p21 and Bax was significantly increased in pregnancies complicated by PE. Conversely, Mdm2 protein levels were significantly depleted in PE; immunohistochemistry showed these changes to be confined to trophoblast. Reduction in the negative feedback of p53 by Mdm2, using siRNA and Nutlin-3, caused an imbalance between p53 and Mdm2 that triggered apoptosis in term villous explants. In the case of Nutlin, this was attenuated by Pifithrin-alpha. Conclusions: These data illustrate the potential for an imbalance in p53 and Mdm2 expression to promote excessive apoptosis in villous trophoblast. The upstream regulation of p53 and Mdm2, with regard to exaggerated apoptosis and autophagy in PE, merits further investigation.	[Sharp, Andrew N.; Heazell, Alexander E. P.; Lacey, Helen A.; Baker, Philip N.; Crocker, Ian P.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Baczyk, Dora; Dunk, Caroline E.; Jones, Carolyn J. P.; Perkins, Jonathan E.; Kingdom, John C. P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Baker, Philip N.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Manchester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Auckland	Sharp, AN (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.	asharp@liv.ac.uk	Kingdom, John/AAF-2145-2020; Kingdom, John/A-3247-2013; Dunk, Caroline/AAF-7423-2021	Dunk, Caroline/0000-0002-4146-099X; Jones, Carolyn/0000-0002-0026-9494; sharp, andrew/0000-0003-3396-7464; Heazell, Alexander/0000-0002-4303-7845; Baker, Philip/0000-0002-4592-6427	Tommy's-The Baby Charity; Wellcome Trust [R107500]; Castang Foundation; Boehringher Ingelheim Fonds Travel Award	Tommy's-The Baby Charity; Wellcome Trust(Wellcome TrustEuropean Commission); Castang Foundation; Boehringher Ingelheim Fonds Travel Award	This work was supported by Tommy's-The Baby Charity, The Wellcome Trust (Grant code: R107500), The Castang Foundation and a Boehringher Ingelheim Fonds Travel Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire AD, 2000, OBSTET GYNECOL, V96, P271, DOI 10.1016/S0029-7844(00)00895-4; Askelund KJ, 2011, PLACENTA, V32, P716, DOI 10.1016/j.placenta.2011.07.081; Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Baczyk D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051837; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; CAMPBELL DM, 1985, BRIT J OBSTET GYNAEC, V92, P131, DOI 10.1111/j.1471-0528.1985.tb01064.x; Chen BS, 2010, AM J PHYSIOL-CELL PH, V299, pC968, DOI 10.1152/ajpcell.00154.2010; CHEUNG ANY, 1994, J CLIN PATHOL, V47, P601, DOI 10.1136/jcp.47.7.601; Chua CC, 2006, AM J PHYSIOL-HEART C, V290, pH2606, DOI 10.1152/ajpheart.01138.2005; Cobellis L, 2007, IN VIVO, V21, P777; Coleman SJ, 2013, PLACENTA, V34, P449, DOI 10.1016/j.placenta.2013.02.007; Coll-Mulet L, 2006, BLOOD, V107, P4109, DOI 10.1182/blood-2005-08-3273; Crocker IP, 2004, J HISTOCHEM CYTOCHEM, V52, P749, DOI 10.1369/jhc.3A6176.2004; Daayana S, 2004, J SOC GYNECOL INVEST, V11, P545, DOI 10.1016/j.jsgi.2004.06.009; DAVEY DA, 1988, AM J OBSTET GYNECOL, V158, P892, DOI 10.1016/0002-9378(88)90090-7; DiFederico E, 1999, AM J PATHOL, V155, P293, DOI 10.1016/S0002-9440(10)65123-1; Ding HF, 2000, J BIOL CHEM, V275, P38905, DOI 10.1074/jbc.M004714200; Drakos E, 2009, LEUKEMIA, V23, P2290, DOI 10.1038/leu.2009.180; Drakos E, 2007, CLIN CANCER RES, V13, P3380, DOI 10.1158/1078-0432.CCR-06-2581; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ellery PM, 2009, PLACENTA, V30, P329, DOI 10.1016/j.placenta.2009.01.002; Fulop V, 1998, J REPROD MED, V43, P119; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Heazell AEP, 2008, PLACENTA, V29, P772, DOI 10.1016/j.placenta.2008.07.003; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Heazell AEP, 2011, APOPTOSIS, V16, P135, DOI 10.1007/s10495-010-0551-3; Heazell AEP, 2008, REPROD SCI, V15, P1034, DOI 10.1177/1933719108322438; Hung TH, 2008, PLACENTA, V29, P565, DOI 10.1016/j.placenta.2008.03.005; Hung Tai-Ho, 2006, Taiwan J Obstet Gynecol, V45, P189; Hung TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040957; Huppertz B, 2004, J SOC GYNECOL INVEST, V11, P353, DOI 10.1016/j.jsgi.2004.06.002; Huppertz B, 1999, LAB INVEST, V79, P1687; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; JONES CJP, 1980, PLACENTA, V1, P61, DOI 10.1016/S0143-4004(80)80016-6; JONES CJP, 1987, HISTOCHEM J, V19, P264, DOI 10.1007/BF01675685; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Ka H, 2003, AM J PATHOL, V163, P413, DOI 10.1016/S0002-9440(10)63671-1; Kadyrov M, 2001, PLACENTA, V22, P44, DOI 10.1053/plac.2000.0616; Kannan K, 2001, ONCOGENE, V20, P3449, DOI 10.1038/sj.onc.1204446; Kilani RT, 2003, PLACENTA, V24, P826, DOI 10.1016/S0143-4004(03)00129-2; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komarova EA, 1998, SEMIN CANCER BIOL, V8, P389, DOI 10.1006/scbi.1998.0101; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lacey HA, 2005, PLACENTA, V26, P93, DOI 10.1016/j.placenta.2004.05.005; Lau LMS, 2008, ONCOGENE, V27, P997, DOI 10.1038/sj.onc.1210707; Leung DN, 2001, AM J OBSTET GYNECOL, V184, P1249, DOI 10.1067/mob.2001.112906; Levy R, 2002, AM J OBSTET GYNECOL, V186, P1056, DOI 10.1067/mob.2002.122250; Logan IR, 2007, PROSTATE, V67, P900, DOI 10.1002/pros.20568; Longtine MS, 2012, REPRODUCTION, V143, P107, DOI 10.1530/REP-11-0340; Lorenzo E, 2002, J BIOL CHEM, V277, P10883, DOI 10.1074/jbc.M107442200; Martinez LA, 2002, P NATL ACAD SCI USA, V99, P14849, DOI 10.1073/pnas.222406899; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; MIYASHITA T, 1995, CELL, V80, P293; Myers JE, 2002, CURR OPIN OBSTET GYN, V14, P119, DOI 10.1097/00001703-200204000-00004; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oh SY, 2008, REPROD SCI, V15, P912, DOI 10.1177/1933719108319159; OREN M, 1981, MOL CELL BIOL, V1, P101, DOI 10.1128/MCB.1.2.101; Pan Y, 1999, CANCER RES, V59, P2064; Park JK, 2008, PLACENTA, V29, P584, DOI 10.1016/j.placenta.2008.03.007; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Prives C, 1999, J PATHOL, V187, P112; Qiao S, 1998, PLACENTA, V19, P361, DOI 10.1016/S0143-4004(98)90075-3; Ratts VS, 2000, PLACENTA, V21, P361, DOI 10.1053/plac.1999.0486; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Rodriguez D, 2011, BBA-MOL CELL RES, V1813, P564, DOI 10.1016/j.bbamcr.2010.11.012; Sharp AN, 2010, AM J REPROD IMMUNOL, V64, P159, DOI 10.1111/j.1600-0897.2010.00837.x; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P57, DOI 10.1016/S0002-9378(97)70438-1; Soleymanlou N, 2007, AM J PATHOL, V171, P496, DOI 10.2353/ajpath.2007.070094; Steele AJ, 2008, BLOOD, V112, P3827, DOI 10.1182/blood-2008-05-156380; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Stuhmer T, 2005, BLOOD, V106, P3609, DOI 10.1182/blood-2005-04-1489; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Vaseva AV, 2009, CELL CYCLE, V8, P1711, DOI 10.4161/cc.8.11.8596; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Xiong X, 2002, AM J OBSTET GYNECOL, V187, P1013, DOI 10.1067/mob.2002.126282; Zeng Y, 2002, RNA, V8, P855, DOI 10.1017/S1355838202020071	85	66	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87621	10.1371/journal.pone.0087621	http://dx.doi.org/10.1371/journal.pone.0087621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498154	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100101
J	Wang, B; Dai, S; Dong, ZJ; Sun, Y; Song, XG; Guo, C; Zhu, FL; Wang, Q; Zhang, LN				Wang, Bo; Dai, Shen; Dong, Zhaojing; Sun, Yue; Song, Xingguo; Guo, Chun; Zhu, Faliang; Wang, Qun; Zhang, Lining			The Modulation of Endoplasmic Reticulum Stress by Chemical Chaperone Upregulates Immune Negative Cytokine IL-35 in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; VIRUS-INDUCED GENE-3; T-CELLS; ATHEROSCLEROSIS; INFLAMMATION; INTERLEUKIN-35; SUPPRESSION; INDUCTION; RESPONSES; DISEASE	Interleukin (IL)-35 is a newly identified immune negative molecule which is secreted by CD4(+)Foxp3(+) T regulatory cells (Tregs) and contributes to their suppressive capacity. Early data have shown that IL-35 inhibits development of several autoimmune diseases. However, the role of IL-35 in atherosclerosis, a lipid-driven chronic inflammatory disease in arterial wall, remains to be investigated. Here, we found that IL-35 was involved in atherosclerosis in apolipoprotein E-deficient (ApoE(-/-)) mice. ApoE(-/-) mice with established atherosclerotic lesion displayed a lower level of IL-35 compared to age-matched wild type C57BL/6 mice without plaque. However, IL-35 expression increased significantly in ApoE(-/-) mice with attenuated plaque. More importantly, we found that modulation of ER stress treated by chemical chaperone, 4-Phenyl butyric acid (PBA) in vivo, mainly upregulated immune negative regulating molecule IL-35, as well as IL-10 and Foxp3, accompanied by increased Tregs. However, no obvious impact on pro-inflammatory molecules such as TNF-alpha, IFN-gamma, IL-17 and IL-23 was observed, which provides new insight into the benefit of ER stress recovery from attenuated plaque. Our results suggest that IL-35 might have a potential value for atherosclerotic therapy.	[Wang, Bo; Dai, Shen; Dong, Zhaojing; Sun, Yue; Song, Xingguo; Guo, Chun; Zhu, Faliang; Wang, Qun; Zhang, Lining] Shandong Univ, Sch Med, Dept Immunol, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhang, LN (corresponding author), Shandong Univ, Sch Med, Dept Immunol, Jinan 250100, Shandong, Peoples R China.	zhanglining@sdu.edu.cn			National "973'' program of China [2011CB503906]; National Natural Science Foundation of China [81172863, 81128013, 81202069, 81072407]; Natural Science foundation of Shandong [Z2008C02]	National "973'' program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science foundation of Shandong(Natural Science Foundation of Shandong Province)	This research was supported by the National "973'' program of China (2011CB503906), the National Natural Science Foundation of China (81172863, 81128013, 81202069 and 81072407). Natural Science foundation of Shandong (Z2008C02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mosbah I, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.29; Bettini M, 2012, DIABETES, V61, P1519, DOI 10.2337/db11-0784; Chaturvedi V, 2011, J IMMUNOL, V186, P6661, DOI 10.4049/jimmunol.1100315; Christen V, 2013, ENVIRON SCI TECHNOL, V47, P3378, DOI 10.1021/es304886y; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gotoh T, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/259462; Huang CH, 2011, J IMMUNOL, V187, P462, DOI 10.4049/jimmunol.1100259; Jia L, 2013, ATHEROSCLEROSIS, V228, P346, DOI 10.1016/j.atherosclerosis.2013.01.027; Kempe S, 2009, AM J PATHOL, V175, P440, DOI 10.2353/ajpath.2009.080752; Kim HJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01142; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Lenin R, 2012, EXP DIABETES RES, DOI 10.1155/2012/356487; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033628; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Lin YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052490; Liu JQ, 2012, J IMMUNOL, V188, P3099, DOI 10.4049/jimmunol.1100106; Lu CX, 2013, ATHEROSCLEROSIS, V229, P263, DOI 10.1016/j.atherosclerosis.2013.05.007; Luoma PV, 2013, ANN MED, V45, P194, DOI 10.3109/07853890.2012.700116; McAlpine CS, 2012, ARTERIOSCL THROM VAS, V32, P82, DOI 10.1161/ATVBAHA.111.237941; Meng X, 2012, MOL MED, V18, P598, DOI 10.2119/molmed.2011.00471; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Ning-Wei Z, 2010, REV MED CHILE, V138, P758; Scull CM, 2011, ARTERIOSCL THROM VAS, V31, P2792, DOI 10.1161/ATVBAHA.111.224881; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Wirtz S, 2011, GASTROENTEROLOGY, V141, P1875, DOI 10.1053/j.gastro.2011.07.040; Wu ZH, 2013, BIOCHEM BIOPH RES CO, V432, P365, DOI 10.1016/j.bbrc.2013.01.094; Yang JF, 2008, EUR J IMMUNOL, V38, P1204, DOI 10.1002/eji.200838145; Zhou AX, 2013, SEMIN IMMUNOPATHOL, V35, P321, DOI 10.1007/s00281-013-0372-x	35	32	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87787	10.1371/journal.pone.0087787	http://dx.doi.org/10.1371/journal.pone.0087787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498194	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100114
J	Altonsy, MO; Sasse, SK; Phang, TL; Gerber, AN				Altonsy, Mohammed O.; Sasse, Sarah K.; Phang, Tzu L.; Gerber, Anthony N.			Context-dependent Cooperation between Nuclear Factor kappa B (NF-kappa B) and the Glucocorticoid Receptor at a TNFAIP3 Intronic Enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Immunoprecipitation (ChiP); Cooperativity; Glucocorticoid Receptor; NF-kappa B (NF-KB); Transcription Enhancers; TNFAIP3; Negative Feedback	CHROMATIN ACCESSIBILITY; GENE; MECHANISMS; ALPHA; A20; PHOSPHORYLATION; RECRUITMENT; REPRESSION; INHIBITOR; DYNAMICS	Background: The effects of glucocorticoids on the expression of negative feedback regulators of NF-B are not well understood. Results: A novel intronic enhancer for TNFAIP3 was synergistically induced by the glucocorticoid receptor and NF-B. Conclusion: The glucocorticoid receptor can cooperate with NF-B to enhance the expression of anti-inflammatory genes such as TNFAIP3. Significance: These results establish a novel mechanism for anti-inflammatory effects of glucocorticoids. TNF expression is elevated in asthma and other inflammatory airway diseases that are commonly treated with glucocorticoid-based therapies, but the impact of glucocorticoids on negative feedback control of TNF is not well understood. We analyzed the effect of dexamethasone, a potent synthetic glucocorticoid, on TNF-regulated gene expression in cultured airway epithelial cells. Although dexamethasone-mediated activation of the glucocorticoid receptor (GR) potently repressed expression of IL1, IL8, and several other pro-inflammatory TNF targets, the expression of anti-inflammatory TNF targets such as TNFAIP3 (A20) and NFKBIA was selectively spared or augmented by dexamethasone treatment. Despite divergent effects on gene expression, GR and NF-B occupancy at the TNFAIP3 locus and GR-repressed targets was similar. A co-occupied intronic TNFAIP3 regulatory element mediated cooperative enhancement of transcription by GR and NF-B that required the presence of a functional GR binding site (GBS). GBS exchanges between reporters for TNFAIP3 and FKBP5, a canonical GR-induced target, revealed substantial latitude in the GBS sequence requirements for GR/NF-B cooperation, suggesting that the TNFAIP3 GBS acts primarily as a docking site in this context. Supporting this notion, a selective GR ligand with only weak agonist activity for induction of FKBP5 enabled robust GR/NF-B cooperative induction of a mutant TNFAIP3 reporter harboring the FKBP5 GBS. Taken together, our data support a model in which the expression of anti-inflammatory targets of TNF is maintained during treatment with glucocorticoids through context-dependent cooperation between GR and NF-B.	[Altonsy, Mohammed O.; Sasse, Sarah K.; Gerber, Anthony N.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Altonsy, Mohammed O.] Sohag Univ, Dept Zool, Sohag 285224, Egypt; [Phang, Tzu L.; Gerber, Anthony N.] Univ Colorado, Dept Med, Denver, CO 80045 USA	National Jewish Health; Egyptian Knowledge Bank (EKB); Sohag University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gerber, AN (corresponding author), Natl Jewish Hlth, Dept Med, Rm K621,1400 Jackson St, Denver, CO 80206 USA.	gerbera@njhealth.org			National Institutes of Health [R01HL109557]; National Jewish Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Jewish Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant R01HL109557 (to A. N. G.) and with institutional funds from National Jewish Health.	Bain DL, 2012, J MOL BIOL, V422, P18, DOI 10.1016/j.jmb.2012.06.005; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bungard CJ, 2011, BIOORGAN MED CHEM, V19, P7374, DOI 10.1016/j.bmc.2011.10.054; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chinenov Y, 2012, P NATL ACAD SCI USA, V109, P11776, DOI 10.1073/pnas.1206059109; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; De Bosscher K, 2008, EUR J PHARMACOL, V583, P290, DOI 10.1016/j.ejphar.2007.11.076; De Bosscher K, 2010, CURR OPIN PHARMACOL, V10, P497, DOI 10.1016/j.coph.2010.04.007; Flammer JR, 2011, MOL ENDOCRINOL, V25, P1075, DOI 10.1210/me.2011-0068; Galliher-Beckley AJ, 2008, MOL CELL BIOL, V28, P7309, DOI 10.1128/MCB.00808-08; Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106; Hofmann TG, 2002, BIOL CHEM, V383, P1947, DOI 10.1515/BC.2002.219; Hu A., 2013, PLOS ONE, V8; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Hudson WH, 2013, NAT STRUCT MOL BIOL, V20, P53, DOI 10.1038/nsmb.2456; Joanny E, 2012, BRIT J PHARMACOL, V165, P1124, DOI 10.1111/j.1476-5381.2011.01574.x; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; McMaster A, 2008, NAT CLIN PRACT ENDOC, V4, P91, DOI 10.1038/ncpendmet0745; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Morjaria Jaymin B, 2007, Expert Rev Respir Med, V1, P51, DOI 10.1586/17476348.1.1.51; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Sasse SK, 2013, MOL CELL BIOL, V33, P2104, DOI 10.1128/MCB.01474-12; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Vandevyver S, 2013, ENDOCRINOLOGY, V154, P993, DOI 10.1210/en.2012-2045; Wang SK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003302; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Weber A., 2010, SCI SIGNAL, V3; Webster JC, 2002, ENDOCRINOLOGY, V143, P3866, DOI 10.1210/en.2002-220188; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708	41	49	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8231	8239		10.1074/jbc.M113.545178	http://dx.doi.org/10.1074/jbc.M113.545178			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24500711	Green Published, hybrid			2022-12-25	WOS:000333157500018
J	Dai, ZM; Guo, X; Yin, HQ; Liang, YL; Cong, J; Liu, XD				Dai, Zhimin; Guo, Xue; Yin, Huaqun; Liang, Yili; Cong, Jing; Liu, Xueduan			Identification of Nitrogen-Fixing Genes and Gene Clusters from Metagenomic Library of Acid Mine Drainage	PLOS ONE			English	Article							NIF GENES; STRUCTURAL ORGANIZATION; MICROBIAL COMMUNITIES; FIXATION; BACTERIA	Biological nitrogen fixation is an essential function of acid mine drainage (AMD) microbial communities. However, most acidophiles in AMD environments are uncultured microorganisms and little is known about the diversity of nitrogen-fixing genes and structure of nif gene cluster in AMD microbial communities. In this study, we used metagenomic sequencing to isolate nif genes in the AMD microbial community from Dexing Copper Mine, China. Meanwhile, a metagenome microarray containing 7,776 large-insertion fosmids was constructed to screen novel nif gene clusters. Metagenomic analyses revealed that 742 sequences were identified as nif genes including structural subunit genes nifH, nifD, nifK and various additional genes. The AMD community is massively dominated by the genus Acidithiobacillus. However, the phylogenetic diversity of nitrogen-fixing microorganisms is much higher than previously thought in the AMD community. Furthermore, a 32.5-kb genomic sequence harboring nif, fix and associated genes was screened by metagenome microarray. Comparative genome analysis indicated that most nif genes in this cluster are most similar to those of Herbaspirillum seropedicae, but the organization of the nif gene cluster had significant differences from H. seropedicae. Sequence analysis and reverse transcription PCR also suggested that distinct transcription units of nif genes exist in this gene cluster. nifQ gene falls into the same transcription unit with fixABCX genes, which have not been reported in other diazotrophs before. All of these results indicated that more novel diazotrophs survive in the AMD community.	[Dai, Zhimin; Guo, Xue; Yin, Huaqun; Liang, Yili; Cong, Jing; Liu, Xueduan] Cent South Univ, Sch Minerals Proc & Bioengn, Changsha, Hunan, Peoples R China; [Yin, Huaqun; Liang, Yili; Cong, Jing; Liu, Xueduan] Cent South Univ, Minist Educ, Key Lab Biomet, Changsha, Hunan, Peoples R China	Central South University; Central South University	Liu, XD (corresponding author), Cent South Univ, Sch Minerals Proc & Bioengn, Changsha, Hunan, Peoples R China.	xueduanliu@yahoo.com	Guo, Xue/GLR-8229-2022	Guo, Xue/0000-0002-4309-6140	National Basic Research Program [2010CB630901]; National Natural Science Foundation of China [30770051]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program (No. 2010CB630901) and the National Natural Science Foundation of China (No. 30770051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1984, J BACTERIOL, V159, P857, DOI 10.1128/JB.159.3.857-862.1984; Agar JN, 2000, J BIOL INORG CHEM, V5, P167, DOI 10.1007/s007750050361; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARNOLD W, 1988, J MOL BIOL, V203, P715, DOI 10.1016/0022-2836(88)90205-7; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; CORBIN D, 1982, J BACTERIOL, V149, P221, DOI 10.1128/JB.149.1.221-228.1982; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; EARL CD, 1987, J BACTERIOL, V169, P1127, DOI 10.1128/jb.169.3.1127-1136.1987; Eddy SR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000069; Edgren T, 2004, J BACTERIOL, V186, P2052, DOI 10.1128/JB.186.7.2052-2060.2004; Ferrandez A, 2002, J BACTERIOL, V184, P4374, DOI 10.1128/JB.184.16.4374-4383.2002; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; Guo X, 2013, APPL ENVIRON MICROB, V79, P2019, DOI 10.1128/AEM.03400-12; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jutabha P, 2001, BIOCH GENETIC CHARAC; KALLAS T, 1985, PLANT MOL BIOL, V5, P321, DOI 10.1007/BF00020630; Lee S, 2000, J BACTERIOL, V182, P7088, DOI 10.1128/JB.182.24.7088-7091.2000; Levican G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-581; LIANG YY, 1991, MOL MICROBIOL, V5, P2735, DOI 10.1111/j.1365-2958.1991.tb01982.x; Machado IMP, 1996, BRAZ J MED BIOL RES, V29, P1599; Masepohl B, 2002, J MOL MICROB BIOTECH, V4, P243; Cardenas JP, 2010, APPL MICROBIOL BIOT, V88, P605, DOI 10.1007/s00253-010-2795-9; PAWLOWSKI K, 1991, MOL GEN GENET, V231, P124, DOI 10.1007/BF00293830; Pedrosa FO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002064; Pedrosa FO, 2001, J BIOTECHNOL, V91, P189, DOI 10.1016/S0168-1656(01)00343-1; Pedrosa FO, 1997, SOIL BIOL BIOCHEM, V29, P843, DOI 10.1016/S0038-0717(96)00206-4; Rhee SK, 2004, APPL ENVIRON MICROB, V70, P4303, DOI 10.1128/AEM.70.7.4303-4317.2004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Young J. P. W., 1992, BIOL NITROGEN FIXATI, V1544, P43; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	38	19	22	6	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87976	10.1371/journal.pone.0087976	http://dx.doi.org/10.1371/journal.pone.0087976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498417	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900163
J	Favreau-Peigne, A; Calandreau, L; Constantin, P; Gaultier, B; Bertin, A; Arnould, C; Laurence, A; Richard-Yris, MA; Houdelier, C; Lumineau, S; Boissy, A; Leterrier, C				Favreau-Peigne, Angelique; Calandreau, Ludovic; Constantin, Paul; Gaultier, Bernard; Bertin, Aline; Arnould, Cecile; Laurence, Agathe; Richard-Yris, Marie-Annick; Houdelier, Cecilia; Lumineau, Sophie; Boissy, Alain; Leterrier, Christine			Emotionality Modulates the Effect of Chronic Stress on Feeding Behaviour in Birds	PLOS ONE			English	Article							CHRONIC MILD STRESS; COTURNIX-COTURNIX-JAPONICA; JAPANESE-QUAIL CHICKS; CHRONIC PSYCHOLOGICAL STRESS; MEAT-TYPE CHICKENS; EUROPEAN STARLINGS; TONIC IMMOBILITY; FLAVOR PREFERENCE; COMFORT FOOD; CORTICOSTERONE	Chronic stress is a long-lasting negative emotional state that induces negative consequences on animals' psychophysiological state. This study aimed at assessing whether unpredictable and repeated negative stimuli (URNS) influence feeding behaviour in quail. Sixty-four quail were exposed to URNS from day 17 to 40, while 64 quail were undisturbed. Two lines divergently selected on their inherent emotionality were used to assess the effect of genetic factors on the sensitivity to URNS. All quail were submitted to a sequential feeding procedure (using two diets of different energetic values) which placed them in a contrasting situation. Behavioural tests were performed to assess the emotional reactivity of the two lines. Results confirmed that differences exist between them and that their emotional reactivity was enhanced by URNS. Diet preferences, motivation and daily intake were also measured. URNS did not change the preferences for the hypercaloric diet compared to the hypocaloric diet in choice tests, but they reduced daily intakes in both lines. Motivations for each diet were differently affected by URNS: they decreased the motivation to eat the hypercaloric diet in quail selected for their low inherent fearfulness whereas they increased the motivation to eat the hypocaloric diet in quail selected for their high inherent fearfulness, which suggested a devaluation process in the former and a compensatory behaviour in the later. Growth was furthermore reduced and laying delayed by URNS in both lines. In conclusion, the exposure to URNS induced interesting changes in feeding behaviour added with an increase in emotional reactivity and an alteration of production parameters. This confirms that both lines of quail experienced a chronic stress state. However differences in feed motivation and emotional reactivity between lines under chronic stress suggested that they experienced different emotional state and use different ways to cope with it depending on their genetic background.	[Favreau-Peigne, Angelique] AgroParisTech, UMR Modelisat Syst Appl Ruminants 791, Paris, France; [Favreau-Peigne, Angelique] INRA, UMR Modelisat Syst Appl Ruminants 791, Paris, France; [Calandreau, Ludovic; Constantin, Paul; Bertin, Aline; Arnould, Cecile; Leterrier, Christine] INRA, UMR Physiol Reprod & Comportements 85, F-37380 Nouzilly, France; [Calandreau, Ludovic; Constantin, Paul; Bertin, Aline; Arnould, Cecile; Leterrier, Christine] CNRS, UMR 6175, Nouzilly, France; [Calandreau, Ludovic; Constantin, Paul; Bertin, Aline; Arnould, Cecile; Leterrier, Christine] Univ Tours, Tours, France; [Calandreau, Ludovic; Constantin, Paul; Bertin, Aline; Arnould, Cecile; Leterrier, Christine] IFCE, Nouzilly, France; [Gaultier, Bernard] INRA, UE Expt Avicole Tours 1295, F-37380 Nouzilly, France; [Laurence, Agathe; Richard-Yris, Marie-Annick; Houdelier, Cecilia; Lumineau, Sophie] Univ Rennes 1, Ethos UMR 6552, CNRS, Rennes, France; [Boissy, Alain] INRA, UMR Herbivores 1213, F-63122 St Genes Champanelle, France	AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; INRAE; VetAgro Sup	Favreau-Peigne, A (corresponding author), AgroParisTech, UMR Modelisat Syst Appl Ruminants 791, Paris, France.	angelique.favreau@agroparistech.fr	Leterrier, Christine/AAY-7201-2020	Favreau-Peigne, Angelique/0000-0002-6707-7825; Lumineau, Sophie/0000-0002-2076-9947	French National Research Agency, Emofarm Program [ANR-09BLAN-0339]	French National Research Agency, Emofarm Program(French National Research Agency (ANR))	This work was supported by the French National Research Agency, Emofarm Program (ANR-09BLAN-0339). See website: http://www.agence-nationale-recherche.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; Anisman H, 2008, NEUROSCI BIOBEHAV R, V32, P1185, DOI 10.1016/j.neubiorev.2008.03.001; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Awerman JL, 2010, COMP BIOCHEM PHYS A, V156, P136, DOI 10.1016/j.cbpa.2010.01.010; Baker SL, 2006, PHYSIOL BEHAV, V87, P314, DOI 10.1016/j.physbeh.2005.10.019; Baumont R, 1996, ANN ZOOTECH, V45, P385, DOI 10.1051/animres:19960501; Bizeray D, 2002, POULTRY SCI, V81, P1798, DOI 10.1093/ps/81.12.1798; Blache D, 2008, REPROD DOMEST ANIM, V43, P8, DOI 10.1111/j.1439-0531.2008.01137.x; Boulay J, 2013, BEHAV BRAIN RES, V237, P124, DOI 10.1016/j.bbr.2012.09.026; Bouvarel I, 2008, ANIMAL, V2, P1674, DOI 10.1017/S1751731108002954; Bowman RE, 2006, BRAIN RES, V1126, P156, DOI 10.1016/j.brainres.2006.07.047; Calandreau L, 2011, BEHAV BRAIN RES, V225, P505, DOI 10.1016/j.bbr.2011.08.010; Calandreau L, 2011, BEHAV BRAIN RES, V217, P104, DOI 10.1016/j.bbr.2010.10.004; Clouard C, 2012, APPL ANIM BEHAV SCI, V136, P26, DOI 10.1016/j.applanim.2011.11.007; Cremaschi GA, 2000, LIFE SCI, V67, P3171, DOI 10.1016/S0024-3205(00)00909-7; Cyr NE, 2007, GEN COMP ENDOCR, V154, P59, DOI 10.1016/j.ygcen.2007.06.016; Cyr NE, 2007, GEN COMP ENDOCR, V151, P82, DOI 10.1016/j.ygcen.2006.12.003; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; Destrez A, 2013, ANIMAL FIRSTVIEW, P1; Driscoll P, 1998, ANN NY ACAD SCI, V851, P501, DOI 10.1111/j.1749-6632.1998.tb09029.x; Dwyer CM, 2004, ANIM WELFARE, V13, P293; Eiland L, 2013, NEUROSCIENCE, V249, P162, DOI 10.1016/j.neuroscience.2012.10.048; Faure JM, 2006, ARCH GEFLUGELKD, V70, P216; Favreau A, 2010, J ANIM SCI, V88, P1535, DOI 10.2527/jas.2009-2455; Forbes NF, 1996, PHYSIOL BEHAV, V60, P1481, DOI 10.1016/S0031-9384(96)00305-8; Gard DE, 2007, SCHIZOPHR RES, V93, P253, DOI 10.1016/j.schres.2007.03.008; Hart K, 2008, REPROD DOMEST ANIM, V43, P88; Hazard D, 2008, HORM BEHAV, V54, P645, DOI 10.1016/j.yhbeh.2008.07.002; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; Laurence A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047475; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Lin H, 2006, COMP BIOCHEM PHYS A, V143, P400, DOI 10.1016/j.cbpa.2005.12.030; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; Nazar FN, 2011, STRESS, V14, P166, DOI 10.3109/10253890.2010.523093; Oliver G, 1999, PHYSIOL BEHAV, V66, P511, DOI 10.1016/S0031-9384(98)00322-9; Ortolani D, 2011, PHYSIOL BEHAV, V103, P487, DOI 10.1016/j.physbeh.2011.03.028; Pecoraro N, 2004, ENDOCRINOLOGY, V145, P3754, DOI 10.1210/en.2004-0305; Pijiman FTA, 2003, BEHAV BRAIN RES, V139, P131, DOI 10.1016/S0166-4328(02)00124-9; Ramos A, 1998, NEUROSCI BIOBEHAV R, V22, P33; Rich EL, 2005, AM J PHYSIOL-REG I, V288, pR1628, DOI 10.1152/ajpregu.00484.2004; Richard S, 2000, BEHAV PROCESS, V48, P165, DOI 10.1016/S0376-6357(99)00082-0; Richard-Yris MA, 2005, DEV PSYCHOBIOL, V46, P1, DOI 10.1002/dev.20040; ROVEECOLLIER C, 1993, PHYSIOL BEHAV, V53, P353, DOI 10.1016/0031-9384(93)90217-4; Schmidt MV, 2008, EUR NEUROPSYCHOPHARM, V18, pS161, DOI 10.1016/S0924-977X(08)70131-7; Schweitzer C, 2010, APPL ANIM BEHAV SCI, V125, P143, DOI 10.1016/j.applanim.2010.04.005; Sclafani A, 2006, PHYSIOL BEHAV, V88, P88, DOI 10.1016/j.physbeh.2006.03.009; Shini S, 2009, PHYSIOL BEHAV, V98, P73, DOI 10.1016/j.physbeh.2009.04.012; Tannenbaum B, 2003, BIOL PSYCHIAT, V53, P292, DOI 10.1016/S0006-3223(02)01487-7; Wang S, 2012, COMP BIOCH PHYSL A; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Wood GE, 2004, P NATL ACAD SCI USA, V101, P3973, DOI 10.1073/pnas.0400208101; Wu HAH, 2010, BEHAV BRAIN RES, V213, P94, DOI 10.1016/j.bbr.2010.04.041	53	13	13	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87249	10.1371/journal.pone.0087249	http://dx.doi.org/10.1371/journal.pone.0087249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498302	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900048
J	Huttenlocker, AK				Huttenlocker, Adam K.			Body Size Reductions in Nonmammalian Eutheriodont Therapsids (Synapsida) during the End-Permian Mass Extinction	PLOS ONE			English	Article							SOUTH-AFRICA; KAROO-BASIN; COPES RULE; CLADISTIC RELATIONSHIPS; VERTEBRATE DIVERSITY; TRIASSIC BOUNDARY; BEAUFORT-GROUP; EVOLUTION; PATTERNS; RECOVERY	The extent to which mass extinctions influence body size evolution in major tetrapod clades is inadequately understood. For example, the 'Lilliput effect,' a common feature of mass extinctions, describes a temporary decrease in body sizes of survivor taxa in post-extinction faunas. However, its signature on existing patterns of body size evolution in tetrapods and the persistence of its impacts during post-extinction recoveries are virtually unknown, and rarely compared in both geologic and phylogenetic contexts. Here, I evaluate temporal and phylogenetic distributions of body size in Permo-Triassic therocephalian and cynodont therapsids (eutheriodonts) using a museum collections-based approach and time series model fitting on a regional stratigraphic sequence from the Karoo Basin, South Africa. I further employed rank order correlation tests on global age and clade rank data from an expanded phylogenetic dataset, and performed evolutionary model testing using Brownian (passive diffusion) models. Results support significant size reductions in the immediate aftermath of the end-Permian mass extinction (ca. 252.3 Ma) consistent with some definitions of Lilliput effects. However, this temporal succession reflects a pattern that was underscored largely by Brownian processes and constructive selectivity. Results also support two recent contentions about body size evolution and mass extinctions: 1) active, directional evolution in size traits is rare over macroevolutionary time scales and 2) geologically brief size reductions may be accomplished by the ecological removal of large-bodied species without rapid originations of new small-bodied clades or shifts from long-term evolutionary patterns.	[Huttenlocker, Adam K.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Huttenlocker, Adam K.] Univ Washington, Museum Nat Hist & Culture, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Huttenlocker, AK (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	ahuttenlocker@gmail.com			National Science Foundation Doctoral Dissertation Improvement Grant Program [1209018]; Evolving Earth Foundation; University of Washington Department of Biology WRF-Hall Fellowship; Burke Museum of Natural History and Culture Vertebrate Paleontology Fellowship; Society of Vertebrate Paleontology Richard Estes Memorial Grant; Division Of Environmental Biology [1209018] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1309040] Funding Source: National Science Foundation	National Science Foundation Doctoral Dissertation Improvement Grant Program; Evolving Earth Foundation; University of Washington Department of Biology WRF-Hall Fellowship; Burke Museum of Natural History and Culture Vertebrate Paleontology Fellowship; Society of Vertebrate Paleontology Richard Estes Memorial Grant; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Science Foundation Doctoral Dissertation Improvement Grant Program (1209018), Evolving Earth Foundation, University of Washington Department of Biology WRF-Hall Fellowship, Burke Museum of Natural History and Culture Vertebrate Paleontology Fellowship, and the Society of Vertebrate Paleontology Richard Estes Memorial Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2006, ZOOL J LINN SOC-LOND, V147, P383, DOI 10.1111/j.1096-3642.2006.00224.x; Abdala F, 2010, PALAEOGEOGR PALAEOCL, V286, P202, DOI 10.1016/j.palaeo.2010.01.011; Botha J, 2006, J AFR EARTH SCI, V45, P502, DOI 10.1016/j.jafrearsci.2006.04.006; Botha J, 2007, LETHAIA, V40, P125, DOI 10.1111/j.1502-3931.2007.00011.x; Botha-Brink J, 2010, ZOOL J LINN SOC-LOND, V160, P341, DOI 10.1111/j.1096-3642.2009.00601.x; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Calder WA., 1984, SIZE FUNCTION LIFE H; Cardillo M, 2001, CONSERV BIOL, V15, P1435, DOI 10.1046/j.1523-1739.2001.00286.x; Carrano Matthew T., 2006, P225; Carrano MT, 2000, PALEOBIOLOGY, V26, P489, DOI 10.1666/0094-8373(2000)026<0489:HATEOD>2.0.CO;2; Chan KMA, 2005, BIOINFORMATICS, V21, P1709, DOI 10.1093/bioinformatics/bti175; Cope E.D., 1896, PRIMARY FACTORS ORGA, DOI DOI 10.5962/BHL.TITLE.2068; Cope ED., 1887, ORIGIN FITTEST; De Oliveira TV, 2010, ZOOTAXA, P1; Erwin DH, 2002, GEOL SOC AM SPEC PAP, V356, P363; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; Evans AR, 2012, P NATL ACAD SCI USA, V109, P4187, DOI 10.1073/pnas.1120774109; Frobisch J, 2014, VERTEBR PALEOBIOL PA, P305, DOI 10.1007/978-94-007-6841-3_18; Frobisch J, 2013, PALAEOGEOGR PALAEOCL, V372, P50, DOI 10.1016/j.palaeo.2012.10.036; Gotthard K, 2001, EXPTL BIOL REV, P287; Gould SJ, 1997, NATURE, V385, P199, DOI 10.1038/385199a0; Harries PJ, 2009, PALAEOGEOGR PALAEOCL, V284, P4, DOI 10.1016/j.palaeo.2009.08.021; Hone DWE, 2005, TRENDS ECOL EVOL, V20, P4, DOI 10.1016/j.tree.2004.10.012; Hopson James A., 2001, Bulletin of the Museum of Comparative Zoology, V156, P5; Hunt G., 2010, PALEONTOLOGICAL SOC, V16, P245, DOI DOI 10.1017/S1089332600001893; Hunt G, 2007, P NATL ACAD SCI USA, V104, P18404, DOI 10.1073/pnas.0704088104; Huttenlocker A.K., 2013, THESIS U WASHINGTON; Huttenlocker A, 2009, ZOOL J LINN SOC-LOND, V157, P865, DOI 10.1111/j.1096-3642.2009.00538.x; Huttenlocker AK, 2013, PALEOBIOLOGY, V39, P253, DOI 10.1666/12020; Huttenlocker AK, 2011, J VERTEBR PALEONTOL, V31, P405, DOI 10.1080/02724634.2011.546720; Irmis RB, 2013, PALAEOGEOGR PALAEOCL, V372, P62, DOI 10.1016/j.palaeo.2012.07.014; Irmis Randall B., 2010, Albertiana, V38, P40; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Kingsolver JG, 2004, EVOLUTION, V58, P1608; Laurin M, 2004, SYST BIOL, V53, P594, DOI 10.1080/10635150490445706; Liow LH, 2008, P NATL ACAD SCI USA, V105, P6097, DOI 10.1073/pnas.0709763105; Liow LH, 2009, AM NAT, V173, P264, DOI 10.1086/595756; Liu J, 2010, J MAMM EVOL, V17, P151, DOI 10.1007/s10914-010-9136-8; Luo GM, 2008, PALAEOGEOGR PALAEOCL, V264, P176, DOI 10.1016/j.palaeo.2008.04.015; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Matthews LJ, 2011, P ROY SOC B-BIOL SCI, V278, P1256, DOI 10.1098/rspb.2010.1489; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; Metcalfe B, 2011, PALAEOGEOGR PALAEOCL, V308, P171, DOI 10.1016/j.palaeo.2010.09.011; NORELL MA, 1992, SCIENCE, V255, P1690, DOI 10.1126/science.255.5052.1690; Payne JL, 2005, PALEOBIOLOGY, V31, P269, DOI 10.1666/0094-8373(2005)031[0269:EDOGSA]2.0.CO;2; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Ranivoharimanana L, 2011, J VERTEBR PALEONTOL, V31, P1292, DOI 10.1080/02724634.2011.618154; Rego BL, 2012, PALEOBIOLOGY, V38, P627, DOI 10.1666/11040.1; Retallack GJ, 2013, GONDWANA RES, V24, P90, DOI 10.1016/j.gr.2012.03.003; Rubidge B.S., 1995, GEOLOGICAL SURVEY S, V1, P1; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Ruta M, 2007, P ROY SOC B-BIOL SCI, V274, P3087, DOI 10.1098/rspb.2007.1250; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; Sidor CA, 2001, EVOLUTION, V55, P1419; Sidor CA, 2006, J PALEONTOL, V80, P333, DOI 10.1666/0022-3360(2006)080[0333:EKANTF]2.0.CO;2; Sidor CA, 1998, PALEOBIOLOGY, V24, P254; Sidor CA, 2003, PALEOBIOLOGY, V29, P605, DOI 10.1666/0094-8373(2003)029<0605:ETATOO>2.0.CO;2; Sigurdsen T, 2012, J VERTEBR PALEONTOL, V32, P1113, DOI 10.1080/02724634.2012.688693; Smith R, 2005, CR PALEVOL, V4, P623, DOI 10.1016/j.crpv.2005.07.005; SMITH RMH, 1995, PALAEOGEOGR PALAEOCL, V117, P81, DOI 10.1016/0031-0182(94)00119-S; Song HJ, 2011, PALAEOGEOGR PALAEOCL, V308, P98, DOI 10.1016/j.palaeo.2010.10.036; Sookias RB, 2012, BIOL LETTERS, V8, P674, DOI 10.1098/rsbl.2012.0060; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; Stearns S.C., 1992, pi; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Urbanek Adam, 1993, Historical Biology, V7, P29; Walther M, 2013, CR PALEVOL, V12, P495, DOI 10.1016/j.crpv.2013.07.007; Wilson GP, 2013, PALEOBIOLOGY, V39, P429, DOI 10.1666/12041; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880	71	53	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87553	10.1371/journal.pone.0087553	http://dx.doi.org/10.1371/journal.pone.0087553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498335	Green Submitted, gold, Green Published			2022-12-25	WOS:000330626900081
J	Ikeda, Y; Morioka, S; Matsumoto, K; Ninomiya-Tsuji, J				Ikeda, Yuka; Morioka, Sho; Matsumoto, Kunihiro; Ninomiya-Tsuji, Jun			TAK1 Binding Protein 2 Is Essential for Liver Protection from Stressors	PLOS ONE			English	Article							ACTIVATED KINASE 1; INDUCED CELL-DEATH; KAPPA-B; CHEMICAL HEPATOCARCINOGENESIS; POLYUBIQUITIN CHAINS; SIGNALING PATHWAY; DUAL ROLES; IKK; CANCER; TAB2	The liver is the first line of defense from environmental stressors in that hepatocytes respond to and metabolize them. Hence, hepatocytes can be damaged by stressors. Protection against hepatic cell damage and cell death is important for liver function and homeostasis. TAK1 (MAP3K7) is an intermediate of stressors such as bacterial moieties-induced signal transduction pathways in several cell types. Tak1 deficiency has been reported to induce spontaneous hepatocellular carcinoma. However, the regulatory mechanism of TAK1 activity in liver stress response has not yet been defined. Here we report that activation of TAK1 through TAK1 binding protein 2 (TAB2) is required for liver protection from stressors. We found that a bacterial moiety, lipopolysaccharides (LPS), activated TAK1 in primary hepatocytes, which was diminished by deletion of TAB2. Mice having hepatocyte-specific deletion of the Tab2 gene exhibited only late-onset moderate liver lesions but were hypersensitive to LPS-induced liver injury. Furthermore, we show that a chemical stressor induced greatly exaggerated liver injury in hepatocyte-specific Tab2-deficient mice. These results demonstrate that TAB2 is a sensor of stress conditions in the liver and functions to protect the liver by activating the TAK1 pathway.	[Ikeda, Yuka; Morioka, Sho; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648601, Japan	University of North Carolina; North Carolina State University; Nagoya University	Ninomiya-Tsuji, J (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	Jun_Tsuji@ncsu.edu	Morioka, Sho/I-2074-2019	Morioka, Sho/0000-0002-1153-4919; Ikeda-Iwabu, Yuka/0000-0003-3550-7891; Ninomiya-Tsuji, Jun/0000-0002-5584-0176	National Institutes of Health [GM068812]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM068812 (to JN-T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea TC, 2003, J NEUROSCI, V23, P2314; Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Broglie P, 2010, J BIOL CHEM, V285, P2333, DOI 10.1074/jbc.M109.090522; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Chowdhury G, 2010, J BIOL CHEM, V285, P8031, DOI 10.1074/jbc.M109.088039; Das M, 2011, GENE DEV, V25, P634, DOI 10.1101/gad.1989311; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Inagaki M, 2008, GENESIS, V46, P431, DOI 10.1002/dvg.20418; Inagaki M, 2008, J BIOL CHEM, V283, P33080, DOI 10.1074/jbc.M807574200; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Kajino-Sakamoto R, 2010, J IMMUNOL, V185, P4729, DOI 10.4049/jimmunol.0903587; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Ma YY, 2005, J BIOL CHEM, V280, P41827, DOI 10.1074/jbc.M510849200; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Morioka S, 2009, ONCOGENE, V28, P2257, DOI 10.1038/onc.2009.110; Morioka S, 2012, BLOOD, V120, P3846, DOI 10.1182/blood-2012-03-416198; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Omori E, 2012, P NATL ACAD SCI USA, V109, P3365, DOI 10.1073/pnas.1116188109; Omori E, 2010, CANCER RES, V70, P8417, DOI 10.1158/0008-5472.CAN-10-1227; Ori D, 2013, J IMMUNOL, V190, P4037, DOI 10.4049/jimmunol.1300173; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Sanjo H, 2003, MOL CELL BIOL, V23, P1231, DOI 10.1128/MCB.23.4.1231-1238.2003; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Szabo G, 2006, HEPATOLOGY, V44, P287, DOI 10.1002/hep.21308; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051073; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	42	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88037	10.1371/journal.pone.0088037	http://dx.doi.org/10.1371/journal.pone.0088037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498425	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900171
J	Meng, QH; Jin, C; Chen, YL; Chen, J; Medvedovic, M; Xia, Y				Meng, Qinghang; Jin, Chang; Chen, Yinglei; Chen, Jing; Medvedovic, Mario; Xia, Ying			Expression of Signaling Components in Embryonic Eyelid Epithelium	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; NEURAL-TUBE DEFECTS; VENTRAL BODY-WALL; CELL POLARITY; SOMITE SEGMENTATION; MEMBRANE-PROTEINS; WNT/BETA-CATENIN; PLANAR POLARITY; BIRTH PHENOTYPE; FETAL MICE	Closure of an epithelium opening is a critical morphogenetic event for development. An excellent example for this process is the transient closure of embryonic eyelid. Eyelid closure requires shape change and migration of epithelial cells at the tip of the developing eyelids, and is dictated by numerous signaling pathways. Here we evaluated gene expression in epithelial cells isolated from the tip (leading edge, LE) and inner surface epithelium (IE) of the eyelid from E15.5 mouse fetuses by laser capture microdissection (LCM). We showed that the LE and IE cells are different at E15.5, such that IE had higher expression of muscle specific genes, while LE acquired epithelium identities. Despite their distinct destinies, these cells were overall similar in expression of signaling components for the "eyelid closure pathways". However, while the LE cells had more abundant expression of Fgfr2, Erbb2, Shh, Ptch1 and 2, Smo and Gli2, and Jag1 and Notch1, the IE cells had more abundant expression of Bmp5 and Bmpr1a. In addition, the LE cells had more abundant expression of adenomatosis polyposis coli down-regulated 1 (Apcdd1), but the IE cells had high expression of Dkk2. Our results suggest that the functionally distinct LE and IE cells have also differential expression of signaling molecules that may contribute to the cell-specific responses to morphogenetic signals. The expression pattern suggests that the EGF, Shh and NOTCH pathways are preferentially active in LE cells, the BMP pathways are effective in IE cells, and the Wnt pathway may be repressed in LE and IE cells via different mechanisms.	[Meng, Qinghang; Jin, Chang; Chen, Yinglei; Chen, Jing; Medvedovic, Mario; Xia, Ying] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Xia, Y (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	ying.xia@uc.edu		Xia, Ying/0000-0001-9532-9527; Chen, Jing/0000-0002-6227-7393	National Institutes of Health, National Eye Institute [R01EY15227]; National Institute of Environmental Health Sciences [P30 ES006096]; NATIONAL EYE INSTITUTE [R01EY015227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported in part by funding from National Institutes of Health, National Eye Institute R01EY15227 and National Institute of Environmental Health Sciences P30 ES006096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Al Alam D, 2012, DEV BIOL, V369, P340, DOI 10.1016/j.ydbio.2012.07.008; Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Bailon-Plaza A, 1999, BONE, V24, P211, DOI 10.1016/S8756-3282(98)00171-9; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Byun TH, 2011, ANAT REC, V294, P789, DOI 10.1002/ar.21366; Christov M, 2011, ENDOCRINOLOGY, V152, P2031, DOI 10.1210/en.2010-1351; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dhomen Nathalie S., 2012, Critical Reviews in Oncogenesis, V17, P31; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; FINDLATER GS, 1993, J ANAT, V183, P121; Freudenberg JM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-234; Gage PJ, 2008, DEV BIOL, V317, P310, DOI 10.1016/j.ydbio.2008.02.030; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; HARRIS MJ, 1982, ANAT EMBRYOL, V164, P207, DOI 10.1007/BF00318505; HARRIS MJ, 1986, J EMBRYOL EXP MORPH, V91, P1; Harris MJ, 2007, BIRTH DEFECTS RES A, V79, P187, DOI 10.1002/bdra.20333; Hassemer EL, 2012, INVEST OPHTHALMOL VI; He W, 2002, EMBO J, V21, P2580, DOI 10.1093/emboj/21.11.2580; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Heasley Lynn E., 2008, V468, P187, DOI 10.1007/978-1-59745-249-6_14; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jin C, 2012, DEV BIOL; JURILOFF DM, 1989, TERATOLOGY, V40, P59, DOI 10.1002/tera.1420400108; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kato S, 2007, FEBS LETT, V581, P4685, DOI 10.1016/j.febslet.2007.08.064; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Knop E, 2010, DEV OPHTHALMOL, V45, P108, DOI 10.1159/000315024; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kumar S, 2010, DEV BIOL, V340, P67, DOI 10.1016/j.ydbio.2010.01.027; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Li CL, 2001, DEV DYNAM, V222, P471, DOI 10.1002/dvdy.1205; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Matsumoto Y, 2012, MOL CELL ENDOCRINOL, V350, P78, DOI 10.1016/j.mce.2011.11.023; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mohamed YH, 2003, EXP EYE RES, V76, P115, DOI 10.1016/S0014-4835(02)00269-5; Molotkov A, 2006, DEVELOPMENT, V133, P1901, DOI 10.1242/dev.02328; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Okada K, 2013, ZOOL SCI, V30, P1, DOI 10.2108/zsj.30.1; PEARSON AA, 1980, J ANAT, V130, P33; Pirvola U, 2004, DEV BIOL, V273, P350, DOI 10.1016/j.ydbio.2004.06.010; Qu CK, 1999, P NATL ACAD SCI USA, V96, P8528, DOI 10.1073/pnas.96.15.8528; Ranheim EA, 2005, BLOOD, V105, P2487, DOI 10.1182/blood-2004-06-2334; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Riau A, 2008, CURR EYE RES, V33, P912, DOI 10.1080/02713680802485147; Rice DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047168; Rivera C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054410; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Saravanamuthu SS, 2012, DEV BIOL, V362, P219, DOI 10.1016/j.ydbio.2011.11.011; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Schaeper U, 2007, P NATL ACAD SCI USA, V104, P15376, DOI 10.1073/pnas.0702555104; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schnekenburger M, 2007, BBA-GENE STRUCT EXPR, V1769, P569, DOI 10.1016/j.bbaexp.2007.07.002; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Takatori A, 2008, DEVELOPMENT, V135, P23, DOI 10.1242/dev.007120; Tao H, 2006, DEV GROWTH DIFFER, V48, P339, DOI 10.1111/j.1440-169x.2006.00869.x; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VASSALLI A, 1994, GENE DEV, V8, P414, DOI 10.1101/gad.8.4.414; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YS, 2002, J NEUROSCI, V22, P8563; Wang ZL, 2010, FEBS LETT, V584, P4057, DOI 10.1016/j.febslet.2010.08.028; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Weston CR, 2003, GENE DEV, V17, P1271, DOI 10.1101/gad.1087303; Wojnowski L, 1998, MECH DEVELOP, V76, P141, DOI 10.1016/S0925-4773(98)00111-7; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440; Zhang YJ, 2013, DEVELOPMENT, V140, P594, DOI 10.1242/dev.082842; Zhang YJ, 2011, J CELL SCI, V124, P2561, DOI 10.1242/jcs.085001; Zhao RB, 1999, DEV BIOL, V212, P68, DOI 10.1006/dbio.1999.9326; Zhou CJ, 2008, DEV DYNAM, V237, P3681, DOI 10.1002/dvdy.21770; Zhou CJ, 2010, DEV DYNAM, V239, P318, DOI 10.1002/dvdy.22054	106	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87038	10.1371/journal.pone.0087038	http://dx.doi.org/10.1371/journal.pone.0087038			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498290	Green Published, gold			2022-12-25	WOS:000330626900036
J	Philbin, MM; Zhang, FJ				Philbin, Morgan M.; Zhang FuJie			Exploring Stakeholder Perceptions of Facilitators and Barriers to Using Needle Exchange Programs in Yunnan Province, China	PLOS ONE			English	Article							METHADONE-MAINTENANCE TREATMENT; INJECTING DRUG-USERS; HARM REDUCTION; ADDICTION TREATMENT; SYRINGE EXCHANGE; HIV/AIDS; RISK; TRANSMISSION; PREVENTION; STRATEGIES	Injection drug use is an ongoing urban health crisis in China and one of the largest drivers of the transmission of HIV/AIDS. Sentinel surveillance sites in Yunnan province show upwards of 20% of injection drug users (IDUs) are HIV positive. Though the Ministry of Health has scaled-up needle exchange programs (NEPs), they have not received official government recognition nor have they been extensively evaluated to explore factors influencing their acceptability and feasibility. Using in-depth qualitative interviews conducted from February to July 2008 with 35 participants consisting of IDUs and other key stakeholders, we explored facilitators and barriers to accessing needle exchange programs in Kunming, the capital of Yunnan province. Content analysis was conducted to identify themes including attitudes toward NEPs and harm reduction, barriers to access, and suggestions for improvement. Themes that emerged included fears of breached confidentiality and police interference at the exchange sites and tensions between the public health and law enforcement perspective. Low levels of NEP-related knowledge and awareness were uniformly reported among interviewees. Suggestions to facilitate an increase in NEP acceptance included raising awareness of harm reduction and HIV more generally, offering services such as psychological counseling, job training and behavioral therapy at NEPs, and increasing communication between police, government, and public health officials. High rates of HIV infection among injection drug users in China have prompted rapid scale up of NEPs. Additional adaptations are necessary, however, to increase needle exchange use among injection drug users. This study finds that an urgent need to raise awareness of NEPs among policy makers and IDUs and act upon identified steps for developing social-structural interventions to create enabling environments that facilitate increased access to NEPs among injection drug users in Kunming.	[Philbin, Morgan M.] Columbia Univ, HIV Ctr Clin & Behav Studies, New York, NY 10027 USA; [Philbin, Morgan M.] NY State Psychiat Inst, New York, NY USA; [Zhang FuJie] Chinese Ctr Dis Control & Prevent, Care Div, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Columbia University; New York State Psychiatry Institute; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Philbin, MM (corresponding author), Columbia Univ, HIV Ctr Clin & Behav Studies, New York, NY 10027 USA.	mp3243@columbia.edu			Institute for International Education; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019139, P30MH043520] Funding Source: NIH RePORTER	Institute for International Education; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded through the first author's Fulbright Grant through the Institute for International Education, and by institutional support from the Chinese Center for Disease Control: National Center for AIDS and STDs. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Chinese Center for Disease Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett N, 2006, OVERVIEW DRUG TREATM; (CCM) Coordinating Country Mechanism, 2004, CHINA ROUND 4 HIV AI; Chen H, 2007, GRIM SITUATION YUNNA; Chu TX, 2005, CELL RES, V15, P865, DOI 10.1038/sj.cr.7290360; Cooper H, 2005, SOC SCI MED, V61, P673, DOI 10.1016/j.socscimed.2004.12.030; Davis S, 2004, HUMAN RIGHTS WATCH, V17, P1; Deng QJ, 2012, ADDICTION, V107, P610, DOI 10.1111/j.1360-0443.2011.03648.x; Des Jarlais D, 1995, REGULATING CONTROVER, P1577; Firestone-Cruz M, 2006, AIDS BEHAV, V11, P253; Fu ZH, 2011, AIDS BEHAV, V15, P1017, DOI 10.1007/s10461-010-9797-6; Hagan H, 2000, J SUBST ABUSE TREAT, V19, P247, DOI 10.1016/S0740-5472(00)00104-5; Hammett TM, 2008, ADDICTION, V103, P137, DOI 10.1111/j.1360-0443.2007.02053.x; Hammett TM, 2005, J URBAN HEALTH, V82, pIV34, DOI 10.1093/jurban/jti106; Henderson LA, 2003, JAIDS-J ACQ IMM DEF, V32, P229, DOI 10.1097/00126334-200302010-00017; Hilton BA, 2001, J ADV NURS, V33, P357, DOI 10.1046/j.1365-2648.2001.01672.x; (HRW) HRW, 2003, HUMAN RIGHTS WATCH, V15, P1; Joseph H, 2000, MT SINAI J MED, V67, P347; Khoshnood K, 2003, YALE CHINA HLTH J, V4, P37; Kulsudjarit K, 2004, ANN NY ACAD SCI, V1025, P446, DOI 10.1196/annals.1316.055; Kuo I, 2003, J SUBST ABUSE TREAT, V24, P67, DOI 10.1016/S0740-5472(02)00343-4; Liu B, 2007, AIDS, V21, pS123, DOI 10.1097/01.aids.0000304707.56670.cf; Liu Z, 2003, ZHONGGUO YAO WU YI L, V12, P204; Lu L, 2008, AM J DRUG ALCOHOL AB, V34, P127, DOI 10.1080/00952990701876989; Malcolm SE, 2003, AIDS CARE, V15, P251, DOI 10.1080/0954012031000068399; Miller CL, 2002, J URBAN HEALTH, V79, P257, DOI 10.1093/jurban/79.2.257; MOH WHO, 2011, 2011 EST HIV AIDS EP; Moore E, 2012, AM J PUBLIC HEALTH, V102, P1833, DOI 10.2105/AJPH.2012.300842; Muhr T, 2004, USERS MANUAL ATLAS T; NEEDLE R, 2010, CLOSING COVERAGE GAP; *NNCC, 2006, ANN REP DRUG CONTR C; (NNCC) BNCC, 2010, ANN REP DRUG CONTR C; NORMAND J, 1995, PREVENTING HIV TRANS; Pang L, 2007, AIDS, V21, pS103, DOI 10.1097/01.aids.0000304704.71917.64; Philbin M, 2008, INT J DRUG POLICY; Powell-Cope GM, 2003, AIDS CARE, V15, P239, DOI 10.1080/0954012031000068380; Power R, 1998, AIDS, V12, P687, DOI 10.1097/00002030-199807000-00004; Project C-UHAPnC, 2004, BEST PRACT CAS STUD; Qian Han-Zhu, 2006, Harm Reduct J, V3, P4, DOI 10.1186/1477-7517-3-4; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Reid G., 2002, REVISITING HIDDEN EP; Reid G, 2009, INT J DRUG POLICY, V20, P365, DOI 10.1016/j.drugpo.2008.10.004; Rhodes T, 2003, SOC SCI MED, V57, P39, DOI 10.1016/S0277-9536(02)00521-X; Shannon K, 2008, INT J DRUG POLICY, V19, P140, DOI 10.1016/j.drugpo.2007.11.024; Smith M, 2010, IJDP UNPUB; Strathdee SA., 2001, AIDSCIENCE, V1, P1; Sullivan LE, 2005, ADDICTION, V100, P150, DOI 10.1111/j.1360-0443.2004.00963.x; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Tang YL, 2007, ADDICTION, V102, P1057, DOI 10.1111/j.1360-0443.2007.01849.x; Tashima N, 1996, QUAL HEALTH RES, V6, P23, DOI 10.1177/104973239600600103; Tkatchenko-Schmidt E, 2008, HEALTH POLICY, V85, P162, DOI 10.1016/j.healthpol.2007.07.005; (UNTG) UNETG, 2007, HIV AIDS CHIN TIT PE; (UNTG) United Nations Theme Group, 2007, RES JOINT ASS HIV AI; Wang S, 2004, YU FANG YI XUE XING, V20, P611; Williams CT, 2011, AIDS BEHAV, V15, P1011, DOI 10.1007/s10461-010-9764-2; Wodak Alex, 2006, HIV AIDS Policy Law Rev, V11, P77; Wood E, 2003, J URBAN HEALTH, V80, P455, DOI 10.1093/jurban/jtg052; Wood E, 2007, ADDICTION, V102, P1503, DOI 10.1111/j.1360-0443.2007.01975.x; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Yang LJ, 2008, AM J DRUG ALCOHOL AB, V34, P5, DOI 10.1080/00952990701653867; Zhang L, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-8; Zhao Y, 2012, CHINESE MED J-PEKING, V125, P1331, DOI 10.3760/cma.j.issn.0366-6999.2012.07.025; ZHENG X, 1997, CHINESE J EPIDEMIOLO, V18, P259	62	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86873	10.1371/journal.pone.0086873	http://dx.doi.org/10.1371/journal.pone.0086873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302TD	24498286	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900032
J	Ren, XY; He, L; Cheng, JW; Chang, JM				Ren, Xueyong; He, Liang; Cheng, Junwen; Chang, Jianmin			Optimization of the Solid-state Fermentation and Properties of a Polysaccharide from Paecilomyces cicadae (Miquel) Samson and Its Antioxidant Activities In Vitro	PLOS ONE			English	Article							WATER-SOLUBLE POLYSACCHARIDE; MYCELIAL CULTURE; EXOPOLYSACCHARIDES; PURIFICATION; KINETICS; BODIES	The culture conditions for the yield of a polysaccharide (PCPS) produced by Paecilomyces cicadae (Miquel) Samson on solid-state fermentation were investigated using response surface methodology (RSM). Plackett-Burman design (PBD) was applied to screen out significant factors, followed by the paths of steepest ascent to move to the nearest region of maximum response. Then Box-Behnken design (BBD) was conducted to optimize the final levels of the culture conditions. After analyzing the regression equation and the response surface contour plots, relative humidity 56.07%, inoculum 13.51 mL/100 g and temperature 27.09 degrees C were found to be the optimal key parameters for PCPS production. The maximum predicted yield of PCPS was 10.76 mg/g under the optimized conditions. The resulting PCPS (FPCPS) generated at optimal conditions was purified by chromatography column and found to be composed of mannose (43.2%), rhamnose (32.1%), xylose (14.5%) and arabinose (10.2%). Based on the size exclusion chromatography combined with multi-angle laser light scattering (SEC-MALLS) analysis, FPCPS adopted a Gaussian coil conformation in 0.1 M NaNO3 solution with 3.75x10(6) g/mol of the weight-average molar mass (M-w) and 41.1 nm of the root-mean square radius (Rg(2))(z)(1/2). Furthermore, both of the polysaccharides were revealed to have strong antioxidant activities by evaluating in DPPH radical, superoxide radicals and hydroxyl radical assay. These data suggest the polysaccharides of Paecilomyces cicadae (Miquel) Samson produced by solid-state fermentation could be explored as potential natural antioxidants.	[Ren, Xueyong; Chang, Jianmin] Beijing Forestry Univ, Coll Mat Sci & Technol, Beijing, Peoples R China; [He, Liang; Cheng, Junwen] Zhejiang Forestry Acad, Inst Biol Technol, Key Lab Biol & Chem Utilizat Zhejiang Forest Reso, Hangzhou, Zhejiang, Peoples R China	Beijing Forestry University	He, L (corresponding author), Zhejiang Forestry Acad, Inst Biol Technol, Key Lab Biol & Chem Utilizat Zhejiang Forest Reso, Hangzhou, Zhejiang, Peoples R China.	hekite006@126.com; cjianmin@bjfu.edu.cn			key laboratory of biochemical utilization of Zhejiang province (KLBUZJ); National Natural Science Foundation of China [31000281]; Key Project of Science and Technology of Zhejiang [2012C12004-4]; State Forestry Administration of China [2008-4-64]; National High Technology Research and Development Program of China ("863" Program) [2012AA101808-06]	key laboratory of biochemical utilization of Zhejiang province (KLBUZJ); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology of Zhejiang; State Forestry Administration of China; National High Technology Research and Development Program of China ("863" Program)(National High Technology Research and Development Program of China)	This work was supported by the research fellowship from the key laboratory of biochemical utilization of Zhejiang province (KLBUZJ) and financial grants from the National Natural Science Foundation of China (No. 31000281, the Key Project of Science and Technology of Zhejiang (No. 2012C12004-4), the State Forestry Administration of China (2008-4-64) and the National High Technology Research and Development Program of China ("863" Program, 2012AA101808-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asker MMS, 2009, CARBOHYD POLYM, V77, P563, DOI 10.1016/j.carbpol.2009.01.037; Balusu R, 2005, PROCESS BIOCHEM, V40, P3025, DOI 10.1016/j.procbio.2005.02.003; Bi HT, 2013, FOOD CHEM, V138, P1470, DOI 10.1016/j.foodchem.2012.11.039; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Chen XY, 2009, CARBOHYD POLYM, V78, P581, DOI 10.1016/j.carbpol.2009.05.019; Chen Y, 2008, FOOD CHEM, V107, P231, DOI 10.1016/j.foodchem.2007.08.021; Cheng JW, 2012, WORLD J MICROB BIOT, V28, P3293, DOI 10.1007/s11274-012-1140-0; Cui J, 2007, J IND MICROBIOL BIOT, V34, P393, DOI 10.1007/s10295-007-0209-5; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fukatsu T, 1997, J INVERTEBR PATHOL, V70, P203, DOI 10.1006/jipa.1997.4696; Gandhi HP, 1997, CARBOHYD POLYM, V34, P323, DOI 10.1016/S0144-8617(97)00132-X; Gao H, 2009, BIORESOURCE TECHNOL, V100, P4012, DOI 10.1016/j.biortech.2009.03.013; Goh KKT, 2011, FOOD HYDROCOLLOID, V25, P286, DOI 10.1016/j.foodhyd.2010.06.005; Han Q, 2011, CARBOHYD POLYM, V86, P797, DOI 10.1016/j.carbpol.2011.05.039; He L, 2008, BIOTECHNOL BIOENG, V100, P250, DOI 10.1002/bit.21767; He L, 2010, INT J MED MUSHROOMS, V12, P51, DOI 10.1615/IntJMedMushr.v12.i1.50; He Z.S., 2004, AM J CHINESE MED, V243, P236; KOJIMA T, 1986, AGR BIOL CHEM TOKYO, V50, P231, DOI 10.1080/00021369.1986.10867365; Leung PH, 2009, FOOD CHEM, V114, P1251, DOI 10.1016/j.foodchem.2008.10.081; Li QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071968; Lin RS, 2012, INT J BIOL MACROMOL, V51, P153, DOI 10.1016/j.ijbiomac.2012.04.011; Liu RS, 2008, PROCESS BIOCHEM, V43, P868, DOI 10.1016/j.procbio.2008.04.009; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lv Y, 2009, FOOD CHEM, V112, P742, DOI 10.1016/j.foodchem.2008.06.042; Mohammadifar MA, 2006, INT J BIOL MACROMOL, V38, P31, DOI 10.1016/j.ijbiomac.2005.12.015; MORAINE RA, 1966, BIOTECHNOL BIOENG, V8, P511, DOI 10.1002/bit.260080405; Papagianni M, 2004, BIOTECHNOL ADV, V22, P189, DOI 10.1016/j.biotechadv.2003.09.005; Peng YF, 2003, CHINESE J POLYM SCI, V21, P309; PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI DOI 10.1093/BIOMET/33.4.305; Robak J, 1988, J ETHNOPHARMACOL, V23, P345, DOI DOI 10.1016/0378-8741(88)90046-3; Takano F, 2005, INT IMMUNOPHARMACOL, V5, P903, DOI 10.1016/j.intimp.2005.01.005; Vinderola G, 2006, CYTOKINE, V36, P254, DOI 10.1016/j.cyto.2007.01.003; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Xu SQ, 2012, J AGR FOOD CHEM, V60, P3498, DOI 10.1021/jf300423z; Yamada T, 1997, CARBOHYD POLYM, V32, P51, DOI 10.1016/S0144-8617(96)00128-2	35	34	40	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87578	10.1371/journal.pone.0087578	http://dx.doi.org/10.1371/journal.pone.0087578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498337	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900083
J	Sasaki, T; Lorkovic, ZJ; Liang, SC; Matzke, AJM; Matzke, M				Sasaki, Taku; Lorkovic, Zdravko J.; Liang, Shih-Chieh; Matzke, Antonius J. M.; Matzke, Marjori			The Ability to Form Homodimers Is Essential for RDM1 to Function in RNA-Directed DNA Methylation	PLOS ONE			English	Article							NONCODING RNA; PLANTS; PROTEIN; PATHWAY; TRANSCRIPTION; LOCUS; IV	RDM1 (RNA-DIRECTED DNA METHYLATION1) is a small plant-specific protein required for RNA-directed DNA methylation (RdDM). RDM1 interacts with RNA polymerase II (Pol II), ARGONAUTE4 (AGO4), and the de novo DNA methyltransferase DOMAINS REARRANGED METHYLTRANSFERASE2 (DRM2) and binds to methylated single stranded DNA. As the only protein identified so far that interacts directly with DRM2, RDM1 plays a pivotal role in the RdDM mechanism by linking the de novo DNA methyltransferase activity to AGO4, which binds short interfering RNAs (siRNAs) that presumably base-pair with Pol II or Pol V scaffold transcripts synthesized at target loci. RDM1 also acts together with the chromatin remodeler DEFECTIVE IN RNA-DIRECTED DNA METHYLATION1 (DRD1) and the structural-maintenance-of-chromosomes solo hinge protein DEFECTIVE IN MERISTEM SILENCING3 (DMS3) to form the DDR complex, which facilitates synthesis of Pol V scaffold transcripts. The manner in which RDM1 acts in both the DDR complex and as a factor bridging DRM2 and AGO4 remains unclear. RDM1 contains no known protein domains but a prior structural analysis suggested distinct regions that create a hydrophobic pocket and promote homodimer formation, respectively. We have tested several mutated forms of RDM1 altered in the predicted pocket and dimerization regions for their ability to complement defects in RdDM and transcriptional gene silencing, support synthesis of Pol V transcripts, form homodimers, and interact with DMS3. Our results indicate that the ability to form homodimers is essential for RDM1 to function fully in the RdDM pathway and may be particularly important during the de novo methylation step.	[Sasaki, Taku; Liang, Shih-Chieh; Matzke, Antonius J. M.; Matzke, Marjori] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Sasaki, Taku; Lorkovic, Zdravko J.] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1010 Vienna, Austria	Academia Sinica - Taiwan; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Matzke, M (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	marjorimatzke@gate.sinica.edu.tw	Matzke, Antonius/H-8698-2015; Matzke, Marjori/H-8689-2015	Lorkovic, Zdravko/0000-0002-3074-7258	Gregor Mendel Institute; Austrian Academy of Sciences; Academia Sinica; Japan Society for the Promotion of Science (JSPS)	Gregor Mendel Institute; Austrian Academy of Sciences; Academia Sinica(Academia Sinica - Taiwan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank the Gregor Mendel Institute, Austrian Academy of Sciences, and Academia Sinica for financial support. TS is supported by the Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship for Research Abroad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard STM, 2005, ACTA CRYSTALLOGR F, V61, P647, DOI 10.1107/S1744309105019743; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Eun C, 2012, Cold Spring Harb Symp Quant Biol, V77, P195, DOI 10.1101/sqb.2012.77.015099; Gao ZH, 2010, NATURE, V465, P106, DOI 10.1038/nature09025; Gohlke J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003267; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Kanno T, 2008, NAT GENET, V40, P670, DOI 10.1038/ng.119; Law JA, 2010, CURR BIOL, V20, P951, DOI 10.1016/j.cub.2010.03.062; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lopez A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002434; Lorkovic ZJ, 2012, CURR BIOL, V22, P933, DOI 10.1016/j.cub.2012.03.061; Matzke AJM, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-2; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Popova OV, 2013, MOL PLANT, V6, P396, DOI 10.1093/mp/sst023; Sasaki T, 2012, GENETICS, V192, P1271, DOI 10.1534/genetics.112.144634; Shultz RW, 2007, PLANT PHYSIOL, V144, P1697, DOI 10.1104/pp.107.101105; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wierzbicki AT, 2012, CURR OPIN PLANT BIOL, V15, P517, DOI 10.1016/j.pbi.2012.08.008; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; You WH, 2013, PLANT MOL BIOL, V82, P85, DOI 10.1007/s11103-013-0041-4; Yu A, 2013, P NATL ACAD SCI USA, V110, P2389, DOI 10.1073/pnas.1211757110; Zheng BL, 2009, GENE DEV, V23, P2850, DOI 10.1101/gad.1868009	28	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88190	10.1371/journal.pone.0088190	http://dx.doi.org/10.1371/journal.pone.0088190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498436	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900182
J	Thornton, IM; Bulthoff, HH; Horowitz, TS; Rynning, A; Lee, SW				Thornton, Ian M.; Buelthoff, Heinrich H.; Horowitz, Todd S.; Rynning, Aksel; Lee, Seong-Whan			Interactive Multiple Object Tracking (iMOT)	PLOS ONE			English	Article							DIVIDED ATTENTION; VISUAL-ATTENTION; PERCEPTION; INFORMATION; LOCATION; MODEL; DISTRACTION; SELECTION; DRIVEN; SPEED	We introduce a new task for exploring the relationship between action and attention. In this interactive multiple object tracking (iMOT) task, implemented as an iPad app, participants were presented with a display of multiple, visually identical disks which moved independently. The task was to prevent any collisions during a fixed duration. Participants could perturb object trajectories via the touchscreen. In Experiment 1, we used a staircase procedure to measure the ability to control moving objects. Object speed was set to 1 degrees/s. On average participants could control 8.4 items without collision. Individual control strategies were quite variable, but did not predict overall performance. In Experiment 2, we compared iMOT with standard MOT performance using identical displays. Object speed was set to 2 degrees/s. Participants could reliably control more objects (M = 6.6) than they could track (M = 4.0), but performance in the two tasks was positively correlated. In Experiment 3, we used a dual-task design. Compared to single-task baseline, iMOT performance decreased and MOT performance increased when the two tasks had to be completed together. Overall, these findings suggest: 1) There is a clear limit to the number of items that can be simultaneously controlled, for a given speed and display density; 2) participants can control more items than they can track; 3) task-relevant action appears not to disrupt MOT performance in the current experimental context.	[Thornton, Ian M.] Univ Malta, Dept Cognit Sci, Msida, Malta; [Thornton, Ian M.; Rynning, Aksel] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Buelthoff, Heinrich H.; Lee, Seong-Whan] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Horowitz, Todd S.] Brigham & Womens Hosp, Visual Attent Lab, Boston, MA 02115 USA; [Horowitz, Todd S.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA	University of Malta; Swansea University; Max Planck Society; Korea University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Thornton, IM (corresponding author), Univ Malta, Dept Cognit Sci, Msida, Malta.	ian.thornton@um.edu.mt; heinrich.buelthoff@tuebingen.mpg.de	Bülthoff, Heinrich/AAC-8818-2019; Bülthoff, Heinrich H/J-6579-2012	Bülthoff, Heinrich H/0000-0003-2568-0607; Horowitz, Todd/0000-0001-5571-6266; Thornton, Ian/0000-0001-6328-3536	National Research Foundation; Ministry of Science, ICT and Future Planning of Korea [2012-005741]; WCU (World Class University) program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R31 10008]; Brain Korea 21 PLUS Program through the National Research Foundation of Korea; Ministry of Education; NIMH Grant [R01 65576]	National Research Foundation; Ministry of Science, ICT and Future Planning of Korea; WCU (World Class University) program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 PLUS Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education; NIMH Grant	This work was supported by a National Research Foundation grant funded by the Ministry of Science, ICT and Future Planning of Korea (No. 2012-005741), the WCU (World Class University) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31 10008), the Brain Korea 21 PLUS Program through the National Research Foundation of Korea funded by the Ministry of Education, and NIMH Grant R01 65576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport D. A., 1987, PERSPECTIVES PERCEPT, V15, P395; Alvarez GA, 2007, J VISION, V7, DOI 10.1167/7.13.14; Atmaca S, 2013, BRAIN BEHAV, V3, P683, DOI 10.1002/brb3.180; Bae GY, 2012, ATTEN PERCEPT PSYCHO, V74, P703, DOI 10.3758/s13414-011-0260-1; Bekkering H, 2002, PSYCHOL SCI, V13, P370, DOI 10.1111/1467-9280.00466; Bettencourt KC, 2009, J VISION, V9, DOI 10.1167/9.7.9; Boduroglu A, 2009, J CROSS CULT PSYCHOL, V40, P349, DOI 10.1177/0022022108331005; CURRAN T, 1993, J EXP PSYCHOL LEARN, V19, P189, DOI 10.1037/0278-7393.19.1.189; Deubel H, 1998, VIS COGN, V5, P81, DOI 10.1080/713756776; Doran MM, 2010, ATTEN PERCEPT PSYCHO, V72, P33, DOI 10.3758/APP.72.1.33; Durso FT, 2009, REV HUMAN FACTORS ER, P195; Fencsik DE, 2007, PERCEPT PSYCHOPHYS, V69, P567, DOI 10.3758/BF03193914; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Feria CS, 2012, PERCEPTION, V41, P287, DOI 10.1068/p7053; Franconeri SL, 2010, PSYCHOL SCI, V21, P920, DOI 10.1177/0956797610373935; Hommel B, 2010, EFFORTLESS ATTENTION, P121, DOI DOI 10.7551/MITPRESS/9780262013840.003.0006; Howard CJ., 2009, HUM FACTORS, P1; Howe PDL, 2010, J VISION, V10, DOI 10.1167/10.8.11; Hulleman J, 2005, VISION RES, V45, P2298, DOI 10.1016/j.visres.2005.02.016; Humphreys GW, 2010, BRIT J PSYCHOL, V101, P185, DOI 10.1348/000712609X458927; Hylan JP, 1903, PSYCHOL REV, V10, P373, DOI 10.1037/h0070820; Iordanescu L, 2009, J VISION, V9, DOI 10.1167/9.4.1; James W., 1890, PRINCIPLES PSYCHOL; Kahneman D., 1973, ATTENTION EFFORT; Kazanovich Y, 2006, NEURAL COMPUT, V18, P1413, DOI 10.1162/neco.2006.18.6.1413; Kimura Doreen, 1999, SEX COGNITION; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Oksama L, 2008, COGNITIVE PSYCHOL, V56, P237, DOI 10.1016/j.cogpsych.2007.03.001; PASHLER H, 1989, COGNITIVE PSYCHOL, V21, P469, DOI 10.1016/0010-0285(89)90016-9; Proctor KJ, 2011, PERCEPTION, V40, P206; PYLYSHYN Z, 1989, COGNITION, V32, P65, DOI 10.1016/0010-0277(89)90014-0; Pylyshyn Z., 2009, COMPOSITIONALITY CON, P255; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Pylyshyn ZW, 2006, VIS COGN, V14, P175, DOI 10.1080/13506280544000200; Riddoch MJ, 2003, NAT NEUROSCI, V6, P82, DOI 10.1038/nn984; Schneider WX, 2002, ATTENTION PERFORM, V19, P609; Scholl BJ, 2009, COMPUTATION, COGNITION, AND PYLYSHYN, P49; Strayer DL, 2007, CURR DIR PSYCHOL SCI, V16, P128, DOI 10.1111/j.1467-8721.2007.00489.x; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Symes E, 2008, J EXP PSYCHOL HUMAN, V34, P854, DOI 10.1037/0096-1523.34.4.854; Taylor JA, 2007, J NEUROPHYSIOL, V98, P317, DOI 10.1152/jn.01070.2006; Valdes AL, 2004, J VIS, DOI [10.1167/4.8.372, DOI 10.1167/4.8.372]; Vogel EK, 2008, CURR DIR PSYCHOL SCI, V17, P171, DOI 10.1111/j.1467-8721.2008.00569.x; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Vul E, 2010, ADV NEURAL INFORM PR, V22, P1955; Wickens C.D., 1980, ATTENTION PERFORM, VVIII, P239; Yoon EY, 2005, MEM COGNITION, V33, P1131, DOI 10.3758/BF03193218; Zelinsky GJ, 2010, J VISION, V10, DOI 10.1167/10.14.29	49	18	18	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86974	10.1371/journal.pone.0086974	http://dx.doi.org/10.1371/journal.pone.0086974			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302TD	24498288	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900034
J	Bitar, A; Selej, M; Bolad, I; Lahm, T				Bitar, Abbas; Selej, Mona; Bolad, Islam; Lahm, Tim			Poor Agreement between Pulmonary Capillary Wedge Pressure and Left Ventricular End-Diastolic Pressure in a Veteran Population	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; HEART-FAILURE; TASK-FORCE; DIAGNOSIS; ASSOCIATION; MANAGEMENT; DISEASE; SEX	Background: Accurate determination of left ventricular filling pressure is essential for differentiation of pre-capillary pulmonary hypertension (PH) from pulmonary venous hypertension (PVH). Previous data suggest only a poor correlation between left ventricular end-diastolic pressure (LVEDP) and its commonly used surrogate, the pulmonary capillary wedge pressure (PCWP). However, no data exist on the diagnostic accuracy of PCWP in veterans. Furthermore, the effects of age and comorbidities on the PCWP-LVEDP relationship remain unknown. Methods: We investigated the PCWP-LVEDP relationship in 101 patients undergoing simultaneous right and left heart catherization at a large VA hospital. PCWP performance was evaluated using correlation and Bland-Altman analyses. Area under Receiver Operating Characteristics curves (AUROC) for PCWP were determined. Results: PCWP-LVEDP correlation was moderate (r = 0.57). PCWP-LVEDP calibration was poor (Bland-Altman limits of agreement -17.2 to 11.4 mmHg; mean bias -2.87 mmHg). 59 patients (58.4%) had pulmonary hypertension; 15 (25.4%) of those met pre-capillary PH criteria based on PCWP. However, if LVEDP was used instead of PCWP, 7/15 patients (46.6%) met criteria for PVH rather than pre-capillary PH. When restricting analysis to patients with a mean pulmonary artery pressure of >= 25 mmHg and pulmonary vascular resistance of >3 Wood units (n = 22), 10 patients (45.4%) were classified as precapillary PH based on PCWP <= 15 mmHg. However, if LVEDP was used, 4/10 patients (40%) were reclassified as PVH. Among patients with any type of pulmonary hypertension, PCWP discriminated moderately between high and normal LVEDP (AUROC, 0.81; 95% CI 0.69-0.94). PCWP-LVEDP correlation was particularly poor in patients with COPD or obesity. Conclusion: Reliance on PCWP rather than LVEDP results in misclassification of veterans as having pre-capillary PH rather than PVH in almost 50% of cases. This is clinically relevant, as misclassification may lead to inappropriate therapies and adverse events.	[Bitar, Abbas] Indiana Univ, Dept Med, Internal Med Residency Program, Krannert Inst Cardiol, Indianapolis, IN USA; [Selej, Mona; Lahm, Tim] Indiana Univ, Dept Med, Krannert Inst Cardiol, Div Pulm Allergy Crit Care Occupat & Sleep Med, Indianapolis, IN 46204 USA; [Bolad, Islam] Indiana Univ, Dept Med, Krannert Inst Cardiol, Indianapolis, IN USA; [Bolad, Islam; Lahm, Tim] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Lahm, T (corresponding author), Indiana Univ, Dept Med, Krannert Inst Cardiol, Div Pulm Allergy Crit Care Occupat & Sleep Med, Indianapolis, IN 46204 USA.	tlahm@iu.edu	Lahm, Tim/AAF-7162-2020; Bitar, Abbas/K-9653-2019		Indiana University; Richard L. Roudebush Veterans Affairs Medical Center	Indiana University; Richard L. Roudebush Veterans Affairs Medical Center(US Department of Veterans Affairs)	This research was funded by Indiana University and the Richard L. Roudebush Veterans Affairs Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Califf RM, 1997, AM HEART J, V134, P44, DOI 10.1016/S0002-8703(97)70105-4; CALVIN JE, 1981, CRIT CARE MED, V9, P437, DOI 10.1097/00003246-198106000-00001; Champion HC, 2009, CIRCULATION, V120, P992, DOI 10.1161/CIRCULATIONAHA.106.674028; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Gerges C, 2013, CHEST, V143, P758, DOI 10.1378/chest.12-1653; Guazzi M, 2012, CIRCULATION, V126, P975, DOI 10.1161/CIRCULATIONAHA.111.085761; Halpern SD, 2009, CHEST, V136, P37, DOI 10.1378/chest.08-2784; Hoeper MM, 2009, J AM COLL CARDIOL, V54, pS85, DOI 10.1016/j.jacc.2009.04.008; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Kaboli PJ, 2012, ANN INTERN MED, V157, P837, DOI 10.7326/0003-4819-157-12-201212180-00003; Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515; Kovacs G, 2009, EUR RESPIR J, V34, P888, DOI 10.1183/09031936.00145608; Maron BA, 2013, CIRC-HEART FAIL, V6, P906, DOI 10.1161/CIRCHEARTFAILURE.112.000091; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Packer M, 2005, J CARD FAIL, V11, P12, DOI 10.1016/j.cardfail.2004.05.006; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; RAHIMTOOLA SH, 1972, CIRCULATION, V46, P283, DOI 10.1161/01.CIR.46.2.283; Ryan JJ, 2012, AM HEART J, V163, P589, DOI 10.1016/j.ahj.2012.01.024; Shapiro S, 2012, CHEST, V141, P363, DOI 10.1378/chest.10-3114; Sharkey S W, 1997, GUIDE INTERPRETATION; Shure D, 2006, NEW ENGL J MED, V354, P2273, DOI 10.1056/NEJMe068099; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213	24	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87304	10.1371/journal.pone.0087304	http://dx.doi.org/10.1371/journal.pone.0087304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498069	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900085
J	Erttmann, SF; Gekara, NO; Fallman, M				Erttmann, Saskia F.; Gekara, Nelson O.; Fallman, Maria			Bacteria Induce Prolonged PMN Survival via a Phosphatidylcholine-Specific Phospholipase C- and Protein Kinase C-Dependent Mechanism	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TOLL-LIKE RECEPTORS; NEUTROPHIL APOPTOSIS; SIGNAL-TRANSDUCTION; PKC-EPSILON; POLYMORPHONUCLEAR LEUKOCYTES; YERSINIA-PSEUDOTUBERCULOSIS; SELECTIVE-INHIBITION; CELL-DEATH; MEMBRANE	Polymorphonuclear leukocytes (PMNs) are essential for the human innate immune defense, limiting expansion of invading microorganisms. PMN turnover is controlled by apoptosis, but the regulating signaling pathways remain elusive, largely due to inherent differences between mice and humans that undermine use of mouse models for understanding human PMN biology. Here, we aim to elucidate signal transduction mediating survival of human peripheral blood PMNs in response to bacteria, such as Yersinia pseudotuberculosis, an enteropathogen that causes the gastro-intestinal disease yersiniosis, as well as Escherichia coli and Staphylococcus aureus. Determinations of cell death reveal that uninfected control cells undergo apoptosis, while PMNs infected with either Gram-positive or -negative bacteria show profoundly increased survival. Infected cells exhibit decreased caspase 3 and 8 activities, increased mitochondrial integrity and are resistant to apoptosis induced by a death receptor ligand. This bacteria-induced response is accompanied by pro-inflammatory cytokine production including interleukin-8 and tumor necrosis factor-a competent to attract additional PMNs. Using agonists and pharmacological inhibitors, we show participation of Toll-like receptor 2 and 4, and interestingly, that protein kinase C (PKC) and phosphatidylcholine-specific phospholipase C (PC-PLC), but not tyrosine kinases or phosphatidylinositol-specific phospholipase C (PI-PLC) are key players in this dual PMN response. Our findings indicate the importance of prolonged PMN survival in response to bacteria, where general signaling pathways ensure complete exploitation of PMN anti-microbial capacity.	[Erttmann, Saskia F.; Gekara, Nelson O.; Fallman, Maria] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea Ctr Microbial Res UCMR, Dept Mol Biol, Umea, Sweden	Umea University	Fallman, M (corresponding author), Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea Ctr Microbial Res UCMR, Dept Mol Biol, Umea, Sweden.	maria.fallman@molbiol.umu.se	Gekara, Nelson/P-9208-2019; Gekara, Nelson/AAG-7944-2020	Gekara, Nelson O./0000-0002-1269-8288; Erttmann, Saskia Friederike/0000-0003-2398-8405	Swedish Research Council VR-M [K2008-58X-11222-14-3]; Laboratory for Molecular Infection Medicine Sweden	Swedish Research Council VR-M(Swedish Research Council); Laboratory for Molecular Infection Medicine Sweden	This work was supported by grants from the Swedish Research Council VR-M (K2008-58X-11222-14-3 [M.F.]) and grants from Laboratory for Molecular Infection Medicine Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul C, 2003, CELL MOL LIFE SCI, V60, P2402, DOI 10.1007/s00018-003-3110-z; Akita Y, 2002, J BIOCHEM, V132, P847, DOI 10.1093/oxfordjournals.jbchem.a003296; Aksoy E, 2002, EUR J IMMUNOL, V32, P3040, DOI 10.1002/1521-4141(200211)32:11<3040::AID-IMMU3040>3.0.CO;2-M; BAZZONI F, 1991, J EXP MED, V173, P771, DOI 10.1084/jem.173.3.771; Bertolotto M, 2009, CLIN EXP PHARMACOL P, V36, P1132, DOI 10.1111/j.1440-1681.2009.05215.x; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; BOLIN I, 1982, INFECT IMMUN, V37, P506; BOLIN I, 1984, INFECT IMMUN, V43, P72; BUDWORTH J, 1995, FEBS LETT, V362, P139, DOI 10.1016/0014-5793(95)00227-Z; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Chen A, 2011, INFECT IMMUN, V79, P4447, DOI 10.1128/IAI.01267-10; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Couto D, 2010, REDOX REP, V15, P259, DOI 10.1179/135100010X12826446921707; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Durgan J, 2008, BIOCHEM J, V411, P319, DOI [10.1042/BJ20071348, 10.1042/bj20071348]; Eyster KM, 2007, ADV PHYSIOL EDUC, V31, P5, DOI 10.1152/advan.00088.2006; Faisal A, 2008, J BIOL CHEM, V283, P18591, DOI 10.1074/jbc.M710330200; Gajate C, 2002, CURR DRUG METAB, V3, P491, DOI 10.2174/1389200023337225; Gonzalez-Roura A, 2002, LIPIDS, V37, P401, DOI 10.1007/s1145-002-0908-0; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Haselmayer P, 2009, J INNATE IMMUN, V1, P582, DOI 10.1159/000231973; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; KISS Z, 1995, BBA-MOL CELL RES, V1265, P93, DOI 10.1016/0167-4889(94)00242-7; Klein JB, 2000, J IMMUNOL, V164, P4286, DOI 10.4049/jimmunol.164.8.4286; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Kouroedov A, 2004, CIRCULATION, V110, P91, DOI 10.1161/01.CIR.0000133384.38551.A8; LINDEMANN A, 1989, J CLIN INVEST, V83, P1308, DOI 10.1172/JCI114016; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Murphy BM, 2003, J EXP MED, V197, P625, DOI 10.1084/jem.20021862; OMURA S, 1977, J ANTIBIOT, V30, P275, DOI 10.7164/antibiotics.30.275; Perskvist N, 2002, J IMMUNOL, V168, P6358, DOI 10.4049/jimmunol.168.12.6358; Rolan HG, 2013, CELL HOST MICROBE, V14, P306, DOI 10.1016/j.chom.2013.08.013; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; TSUCHIDA H, 1995, J IMMUNOL, V154, P2403; Valledor AF, 2000, J IMMUNOL, V164, P29, DOI 10.4049/jimmunol.164.1.29; Voss OH, 2005, J BIOL CHEM, V280, P17371, DOI 10.1074/jbc.M412449200; Watson RWG, 1999, FEBS LETT, V453, P67, DOI 10.1016/S0014-5793(99)00688-2; Wei S, 1996, J IMMUNOL, V157, P5155; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; William R, 1997, BLOOD, V89, P4175, DOI 10.1182/blood.V89.11.4175	51	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87859	10.1371/journal.pone.0087859	http://dx.doi.org/10.1371/journal.pone.0087859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498214	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900186
J	Hermans, M; Schrauwen, B; Bienstman, P; Dambre, J				Hermans, Michiel; Schrauwen, Benjamin; Bienstman, Peter; Dambre, Joni			Automated Design of Complex Dynamic Systems	PLOS ONE			English	Article							ROBOTS	Several fields of study are concerned with uniting the concept of computation with that of the design of physical systems. For example, a recent trend in robotics is to design robots in such a way that they require a minimal control effort. Another example is found in the domain of photonics, where recent efforts try to benefit directly from the complex nonlinear dynamics to achieve more efficient signal processing. The underlying goal of these and similar research efforts is to internalize a large part of the necessary computations within the physical system itself by exploiting its inherent non-linear dynamics. This, however, often requires the optimization of large numbers of system parameters, related to both the system's structure as well as its material properties. In addition, many of these parameters are subject to fabrication variability or to variations through time. In this paper we apply a machine learning algorithm to optimize physical dynamic systems. We show that such algorithms, which are normally applied on abstract computational entities, can be extended to the field of differential equations and used to optimize an associated set of parameters which determine their behavior. We show that machine learning training methodologies are highly useful in designing robust systems, and we provide a set of both simple and complex examples using models of physical dynamical systems. Interestingly, the derived optimization method is intimately related to direct collocation a method known in the field of optimal control. Our work suggests that the application domains of both machine learning and optimal control have a largely unexplored overlapping area which envelopes a novel design methodology of smart and highly complex physical systems.	[Hermans, Michiel; Schrauwen, Benjamin; Dambre, Joni] Univ Ghent, ELIS Dept, B-9000 Ghent, Belgium; [Bienstman, Peter] Univ Ghent, INTEC Dept, B-9000 Ghent, Belgium	Ghent University; Ghent University	Hermans, M (corresponding author), Univ Ghent, ELIS Dept, B-9000 Ghent, Belgium.	michiel.hermans@ugent.be	Dambre, Joni/C-2926-2013	Dambre, Joni/0000-0002-9373-1210	interuniversity attraction pole (IAP) Photonics@be of the Belgian Science Policy Office; ERC	interuniversity attraction pole (IAP) Photonics@be of the Belgian Science Policy Office; ERC(European Research Council (ERC)European Commission)	This work is supported by the interuniversity attraction pole (IAP) Photonics@be of the Belgian Science Policy Office and the ERC NaResCo Starting grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamatzky A., 2005, REACTION DIFFUSION C; AGRAWAL GP, 1989, IEEE J QUANTUM ELECT, V25, P2297, DOI 10.1109/3.42059; [Anonymous], 2007, BODY SHAPES WAY WE T; Arena P, 2004, IEEE T SYST MAN CY B, V34, P1823, DOI 10.1109/TSMCB.2004.828593; Becker R, 2000, SIAM J CONTROL OPTIM, V39, P113, DOI 10.1137/S0363012999351097; Bertsekas DP, 1995, DYNAMIC PROGRAMMING; Boltyanskii VG, 1960, THEORY OPTIMAL PROCE; Bongard J, 2006, SCIENCE, V314, P1118, DOI 10.1126/science.1133687; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; Brunner D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2368; Dale K, 2010, ARTIF LIFE, V16, P1, DOI 10.1162/artl.2009.16.1.16100; DOYA K, 1992, 1992 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-6, P2777, DOI 10.1109/ISCAS.1992.230622; Fiers M, 2012, J OPT SOC AM B, V29, P896, DOI 10.1364/JOSAB.29.000896; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; Hansen N, 2001, EVOL COMPUT, V9, P159, DOI 10.1162/106365601750190398; Hastie T, 1996, J ROY STAT SOC B MET, V58, P155; Hawkes PW, 1966, QUADRUPOLE OPTICS; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; Larger L, 2012, OPT EXPRESS, V20, P3241, DOI 10.1364/OE.20.003241; LeCun Y., 1988, P 1988 CONNECTIONIST, DOI DOI 10.3168/JDS.S0022-0302(88)79586-7; Lipson H, 2000, NATURE, V406, P974, DOI 10.1038/35023115; Liu L, 2010, NAT PHOTONICS, V4, P182, DOI 10.1038/NPHOTON.2009.268; Mozer M.C., 1995, BACKPROPAGATION THEO, P137; Oden T, 2014, COMPUTATIONAL SCI 3; OLSSON NA, 1989, J LIGHTWAVE TECHNOL, V7, P1071, DOI 10.1109/50.29634; Paquot Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00287; Paul C, 2006, IEEE T ROBOT, V22, P944, DOI 10.1109/TRO.2006.878980; Pearlmutter BA, 1989, NEURAL COMPUT, V1, P263, DOI 10.1162/neco.1989.1.2.263; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Robinson A.J, 1987, CUEDFINFENGTR1; Rumelhart D. E., 1986, LEARNING INTERNAL RE; Shinya A, 2006, OPT EXPRESS, V14, P1230, DOI 10.1364/OE.14.001230; Sutskever I., 2011, P 28 INT C MACH LEAR; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vandoorne K, 2008, OPT EXPRESS, V16, P11182, DOI 10.1364/OE.16.011182; Vandoorne K, 2011, IEEE T NEURAL NETWOR, V22, P1469, DOI 10.1109/TNN.2011.2161771; Vinh NX, 1981, OPTIMAL TRAJECTORIES; von Neumann J., 1951, GEN LOGICAL THEORY A; Werbos P.J., 1994, ROOTS BACKPROPAGATIO, V1; Werbos P.J., 2006, AUTOMATIC DIFFERENTI, P15; WERBOS PJ, 1988, NEURAL NETWORKS, V1, P339, DOI 10.1016/0893-6080(88)90007-X; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270	42	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86696	10.1371/journal.pone.0086696	http://dx.doi.org/10.1371/journal.pone.0086696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497969	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900035
J	Huang, SC; Chiou, TH; Marshall, J; Reinhard, J				Huang, Shao-chang; Chiou, Tsyr-huei; Marshall, Justin; Reinhard, Judith			Spectral Sensitivities and Color Signals in a Polymorphic Damselfly	PLOS ONE			English	Article							ENALLAGMA DAMSELFLIES; MATE RECOGNITION; RECEPTOR NOISE; ODONATA; COENAGRIONIDAE; CUES; PHOTORECEPTORS; THRESHOLDS; EXPERIENCE; PREFERENCE	Animal communication relies on conspicuous signals and compatible signal perception abilities. Good signal perception abilities are particularly important for polymorphic animals where mate choice can be a challenge. Behavioral studies suggest that polymorphic damselflies use their varying body colorations and/or color patterns as communication signal for mate choice and to control mating frequencies. However, solid evidence for this hypothesis combining physiological with spectral and behavioral data is scarce. We investigated this question in the Australian common blue tail damselfly, Ischnura heterosticta, which has pronounced female-limited polymorphism: andromorphs have a male-like blue coloration and gynomorphs display green/grey colors. We measured body color reflectance and investigated the visual capacities of each morph, showing that I. heterosticta have at least three types of photoreceptors sensitive to UV, blue, and green wavelength, and that this visual perception ability enables them to detect the spectral properties of the color signals emitted from the various color morphs in both males and females. We further demonstrate that different color morphs can be discriminated against each other and the vegetation based on color contrast. Finally, these findings were supported by field observations of natural mating pairs showing that mating partners are indeed chosen based on their body coloration. Our study provides the first comprehensive evidence for the function of body coloration on mate choice in polymorphic damselflies.	[Huang, Shao-chang; Marshall, Justin; Reinhard, Judith] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Chiou, Tsyr-huei] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan	University of Queensland; National Cheng Kung University	Huang, SC (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	shaochang.huang@uqconnect.edu.au		Marshall, Justin/0000-0001-9006-6713; Chiou, Tsyr-Huei/0000-0003-3504-5113	International Postgraduate Research Scholarship fellowship; Asian Office of Aerospace Research Development AFOSR; ARC	International Postgraduate Research Scholarship fellowship; Asian Office of Aerospace Research Development AFOSR; ARC(Australian Research Council)	This work was supported in part by an International Postgraduate Research Scholarship fellowship to S-CH, Asian Office of Aerospace Research Development AFOSR grant to JM and T-HC, and an ARC grant to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Bybee SM, 2012, ORG DIVERS EVOL, V12, P241, DOI 10.1007/s13127-012-0090-6; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; FINCKE O M, 1987, Odonatologica, V16, P129; Fincke Ola M., 2005, International Journal of Odonatology, V8, P183; Fincke OM, 2007, BEHAV ECOL SOCIOBIOL, V61, P1121, DOI 10.1007/s00265-006-0345-3; FINCKE OM, 1994, EVOL ECOL, V8, P328, DOI 10.1007/BF01238282; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; Gorb SN, 1998, J INSECT BEHAV, V11, P73, DOI 10.1023/A:1020818617066; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Henze MJ, 2012, AVA C AUG 2012; Huang SC, 2012, ODONATOLOGICA, V41, P99; Huang SC, 2012, BEHAV ECOL, V23, P1269, DOI 10.1093/beheco/ars112; Iserbyt A, 2009, ANIM BEHAV, V78, P1463, DOI 10.1016/j.anbehav.2009.09.031; Joop G, 2006, EVOL ECOL, V20, P259, DOI 10.1007/s10682-006-0001-4; LAVOIE-DORNIK J, 1988, Odonatologica, V17, P337; MEINERTZHAGEN IA, 1983, J COMP PHYSIOL, V151, P295, DOI 10.1007/BF00623906; MENZEL R, 1986, J COMP PHYSIOL A, V158, P165, DOI 10.1007/BF01338560; Miller MN, 1999, J INSECT BEHAV, V12, P801, DOI 10.1023/A:1020957110842; Osorio D, 2008, VISION RES, V48, P2042, DOI 10.1016/j.visres.2008.06.018; PARR M J, 1973, Odonatologica, V2, P159; Plaistow SJ, 2000, P ROY SOC B-BIOL SCI, V267, P969, DOI 10.1098/rspb.2000.1098; Sanchez-Guillen RA, 2005, BIOL J LINN SOC, V85, P471, DOI 10.1111/j.1095-8312.2005.00506.x; Schultz TD, 2008, ANIM BEHAV, V76, P1357, DOI 10.1016/j.anbehav.2008.04.024; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; SRINIVASAN MV, 1985, VISION RES, V25, P997, DOI 10.1016/0042-6989(85)90210-X; STAVENGA DG, 1993, VISION RES, V33, P1011, DOI 10.1016/0042-6989(93)90237-Q; Takahashi Y, 2011, J ETHOL, V29, P293, DOI 10.1007/s10164-010-0257-6; Takahashi Yuma, 2008, Japanese Journal of Entomology (New Series), V11, P13; Ting JJ, 2009, BEHAV ECOL SOCIOBIOL, V64, P225, DOI 10.1007/s00265-009-0839-x; UBUKATA H, 1983, Odonatologica, V12, P71; van Gossum H, 2001, P ROY SOC B-BIOL SCI, V268, P83; Van Gossum H, 2011, EVOL ECOL, V25, P139, DOI 10.1007/s10682-010-9388-z; Van Gossum Hans, 2008, P219; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Vorobyev M, 2001, VISION RES, V41, P639, DOI 10.1016/S0042-6989(00)00288-1; WATANABE M, 1990, J ETHOL, V8, P129, DOI 10.1007/BF02350283; YANG EC, 1991, J COMP PHYSIOL A, V169, P663	39	24	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87972	10.1371/journal.pone.0087972	http://dx.doi.org/10.1371/journal.pone.0087972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498233	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900201
J	Li, X; Jiang, XY; Ge, J; Wang, J; Chen, GJ; Xu, L; Xie, DY; Yuan, TY; Zhang, DS; Zhang, H; Chen, YH				Li, Xiang; Jiang, Xiao-Yan; Ge, Jin; Wang, Jing; Chen, Guo-Jun; Xu, Liang; Xie, Duan-Yang; Yuan, Tian-You; Zhang, Da-Sheng; Zhang, Hong; Chen, Yi-Han			Aberrantly Expressed lncRNAs in Primary Varicose Great Saphenous Veins	PLOS ONE			English	Article							LONG NONCODING RNAS; VENOUS REFLUX; RISK; IDENTIFICATION; PATHOGENESIS; TRANSCRIPTS; DYSFUNCTION; METABOLISM; MECHANISMS; PERIOSTIN	Long non-coding RNAs (lncRNAs) are key regulatory molecules involved in a variety of biological processes and human diseases. However, the pathological effects of lncRNAs on primary varicose great saphenous veins (GSVs) remain unclear. The purpose of the present study was to identify aberrantly expressed lncRNAs involved in the prevalence of GSV varicosities and predict their potential functions. Using microarray with 33,045 lncRNA and 30,215 mRNA probes, 557 lncRNAs and 980 mRNAs that differed significantly in expression between the varicose great saphenous veins and control veins were identified in six pairs of samples. These lncRNAs were sub-grouped and mRNAs expressed at different levels were clustered into several pathways with six focused on metabolic pathways. Quantitative real-time PCR replication of nine lncRNAs was performed in 32 subjects, validating six lncRNAs (AF119885, AK021444, NR_027830, G36810, NR_027927, uc.345). A coding-non-coding gene co-expression network revealed that four of these six lncRNAs may be correlated with 11 mRNAs and pathway analysis revealed that they may be correlated with another 8 mRNAs associated with metabolic pathways. In conclusion, aberrantly expressed lncRNAs for GSV varicosities were here systematically screened and validated and their functions were predicted. These findings provide novel insight into the physiology of lncRNAs and the pathogenesis of varicose veins for further investigation. These aberrantly expressed lncRNAs may serve as new therapeutic targets for varicose veins. The Human Ethnics Committee of Shanghai East Hospital, Tongji University School of Medicine approved the study (NO.: 2011-DF-53).	[Li, Xiang; Jiang, Xiao-Yan; Wang, Jing; Xu, Liang; Xie, Duan-Yang; Yuan, Tian-You; Zhang, Da-Sheng; Zhang, Hong; Chen, Yi-Han] Tongji Univ, Sch Med, Key Lab Arrhythmia, Minist Educ China,East Hosp, Shanghai 200092, Peoples R China; [Li, Xiang; Jiang, Xiao-Yan; Wang, Jing; Xie, Duan-Yang; Yuan, Tian-You; Zhang, Da-Sheng; Zhang, Hong; Chen, Yi-Han] Tongji Univ, Inst Med Genet, Shanghai 200092, Peoples R China; [Li, Xiang; Jiang, Xiao-Yan; Xie, Duan-Yang; Yuan, Tian-You; Chen, Yi-Han] Tongji Univ, Sch Med, Dept Pathol & Pathophysiol, Shanghai 200092, Peoples R China; [Ge, Jin; Chen, Guo-Jun] Tongji Univ, Sch Med, Dept Vasc Surg, East Hosp, Shanghai 200092, Peoples R China	Ministry of Education, China; Tongji University; Tongji University; Tongji University; Tongji University	Chen, YH (corresponding author), Tongji Univ, Sch Med, Key Lab Arrhythmia, Minist Educ China,East Hosp, Shanghai 200092, Peoples R China.	yihanchen@tongji.edu.cn			Major International Joint Research Program Fund of China [81120108004]; Foundation for Innovative Research Groups of China [81221001]; National Key Basic Research Program of China [2013CB531100]; National Natural Science Foundation of China [31271214, 81100551]; Shanghai Natural Science Fund [10JC1414700]; Shanghai Municipal Natural Science Foundation [11ZR1438600]; Fundamental Research Funds for the Central Universities [1500219042]	Major International Joint Research Program Fund of China; Foundation for Innovative Research Groups of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Fund; Shanghai Municipal Natural Science Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Major International Joint Research Program Fund of China (81120108004), the Foundation for Innovative Research Groups of China (81221001), the National Key Basic Research Program of China (2013CB531100), the National Natural Science Foundation of China (31271214, 81100551), the Shanghai Natural Science Fund (10JC1414700), the grant from Shanghai Municipal Natural Science Foundation (11ZR1438600), and the Fundamental Research Funds for the Central Universities (1500219042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascher E, 2001, J VASC SURG, V33, P1080, DOI 10.1067/mva.2001.113976; Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Eklof B, 2004, J VASC SURG, V40, P1248, DOI 10.1016/j.jvs.2004.09.027; EXTON J H, 1987, Diabetes Metabolism Reviews, V3, P163; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Fowkes FGR, 2001, INT J EPIDEMIOL, V30, P846, DOI 10.1093/ije/30.4.846; Friedrichs F, 2009, GENOME RES, V19, P395, DOI 10.1101/gr.076653.108; Furuno M, 2006, PLOS GENET, V2, P537, DOI 10.1371/journal.pgen.0020037; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Ishii N, 2006, J HUM GENET, V51, P1087, DOI 10.1007/s10038-006-0070-9; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Labropoulos N, 2003, J VASC SURG, V38, P793, DOI 10.1016/S0741-5214(03)00424-5; Lee JD, 2012, PHLEBOLOGY, V27, P409, DOI 10.1258/phleb.2011.011051; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Lim CS, 2009, BRIT J SURG, V96, P1231, DOI 10.1002/bjs.6798; Lindner V, 2005, ARTERIOSCL THROM VAS, V25, P77, DOI 10.1161/01.ATV.0000149141.81230.c6; Lorenzen JM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0245-9; Meissner MH, 2007, J VASC SURG, V46, p54S, DOI 10.1016/j.jvs.2007.08.038; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pan YF, 2011, CHINESE MED J-PEKING, V124, P2378, DOI 10.3760/cma.j.issn.0366-6999.2011.15.023; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Raffetto JD, 2008, PHLEBOLOGY, V23, P85, DOI 10.1258/phleb.2007.007027; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schleithoff C, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-7; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Somers P, 2006, ANGIOLOGY, V57, P546, DOI 10.1177/0003319706293115; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Takase S, 2000, ANN VASC SURG, V14, P427, DOI 10.1007/s100169910092; van Groenendael L, 2009, J VASC SURG, V50, P1106, DOI 10.1016/j.jvs.2009.06.057; Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563	43	20	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86156	10.1371/journal.pone.0086156	http://dx.doi.org/10.1371/journal.pone.0086156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497937	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900017
J	Robertson, T; Benzeval, M				Robertson, Tony; Benzeval, Michaela			Do Mismatches between Pre- and Post-Natal Environments Influence Adult Physiological Functioning?	PLOS ONE			English	Article							BRITISH WOMENS HEART; LOW-BIRTH-WEIGHT; DEPENDENT DIABETES-MELLITUS; FETAL ORIGINS; BLOOD-PRESSURE; CHILDHOOD GROWTH; LUNG-FUNCTION; CARDIOVASCULAR-DISEASE; RESPIRATORY-FUNCTION; INFANT GROWTH	Purpose: Mismatches between pre- and post-natal environments have implications for disease in adulthood. However, less is known about how this mismatch can affect physiological systems more generally, especially at younger ages. We hypothesised that mismatches between pre- and post-natal environments, as measured by the measures of birthweight and adult leg length, would be associated with poorer biomarker levels across five key physiological systems in young adults. Methods: Data were collected from 923, 36 year-old respondents from the West of Scotland Twenty-07 Study. The biomarkers were: systolic blood pressure (sBP); forced expiratory volume (FEV1); glycated haemoglobin (HbA(1c)); glomerular filtration rate (eGFR); and gamma-glutamyltransferase (GGT). These biomarkers were regressed against pre-natal conditions (birthweight), post-natal conditions (leg length) and the interaction between pre- and post-natal measures. Sex, childhood socioeconomic position and adult lifestyle characteristics were adjusted for as potential effect modifiers and confounders, respectively. Results: There were no associations between birthweight and leg length and sBP, FEV1, HbA(1c), or GGT. Higher birthweight and longer leg length were associated with better kidney function (eGFR). However, there was no evidence for mismatches between birthweight and leg length to be associated with worse sBP, FEV1, HbA(1c), eGFR or GGT levels (P>0.05). Conclusions: Our hypothesis that early signs of physiological damage would be present in young adults given mismatches in childhood environments, as measured by growth markers, was not proven. This lack of association could be because age 36 is too young to identify significant trends for future health, or the associations simply not being present.	[Robertson, Tony] Univ Edinburgh, Scottish Collaborat Publ Hlth Res & Policy, Edinburgh, Midlothian, Scotland; [Benzeval, Michaela] Univ Essex, Inst Social & Econ Res, Colchester CO4 3SQ, Essex, England	University of Edinburgh; University of Essex	Robertson, T (corresponding author), Univ Edinburgh, Scottish Collaborat Publ Hlth Res & Policy, Edinburgh, Midlothian, Scotland.	tony.robertson@ed.ac.uk	Benzeval, Michaela/J-3163-2015; Robertson, Tony/L-5062-2015	Benzeval, Michaela/0000-0002-0372-2098; Robertson, Tony/0000-0002-1962-5874	Scottish Collaboration for Public Health Research and Policy from the UK Medical Research Council (MRC); Chief Scientist Office of Scotland; UK Economic and Social Research Council; University of Essex; MRC; MRC/CSO Social and Public Health Sciences Unit, Glasgow as part of the Social Patterning of Health over the Lifecourse programme [MC_UU_12017/7]; Medical Research Council [MC_UU_12017/7, MC_UP_A540_1021, MR/K023209/1] Funding Source: researchfish; MRC [MC_UU_12017/7, MR/K023209/1, MC_UP_A540_1021] Funding Source: UKRI	Scottish Collaboration for Public Health Research and Policy from the UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of Scotland; UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); University of Essex; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC/CSO Social and Public Health Sciences Unit, Glasgow as part of the Social Patterning of Health over the Lifecourse programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr. Tony Robertson is funded by a grant awarded to the Scottish Collaboration for Public Health Research and Policy from the UK Medical Research Council (MRC) and the Chief Scientist Office of Scotland. Professor Michaela Benzeval is funded by the UK Economic and Social Research Council and the University of Essex. The Twenty-07 Study is funded by the MRC. At the time the work for this project was conducted, both authors were employed by the MRC and based at the MRC/CSO Social and Public Health Sciences Unit, Glasgow as part of the Social Patterning of Health over the Lifecourse programme (grant number: MC_UU_12017/7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1992, BMJ-BRIT MED J, V304, P148, DOI 10.1136/bmj.304.6820.148; Barker DJP, 2004, J EPIDEMIOL COMMUN H, V58, P114, DOI 10.1136/jech.58.2.114; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; BARKER DJP, 1993, BRIT HEART J, V69, P195; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bateson P, 2012, INT J EPIDEMIOL, V41, P219, DOI 10.1093/ije/dyr240; Benzeval M, 2009, INT J EPIDEMIOL, V38, P1215, DOI 10.1093/ije/dyn213; Bonellie S, 2005, NEW CENTILE CHARTS B; Boubred F, 2009, AM J PHYSIOL-RENAL, V297, pF943, DOI 10.1152/ajprenal.90704.2008; Byrne CD, 2000, J CLIN PATHOL, V53, P822, DOI 10.1136/jcp.53.11.822; Canoy D, 2007, THORAX, V62, P396, DOI 10.1136/thx.2006.066241; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; COLE TJ, 1975, J R STAT SOC A STAT, V138, P297, DOI 10.2307/2344580; Eriksson JG, 2003, DIABETES CARE, V26, P3006, DOI 10.2337/diacare.26.11.3006; FALL C, 1992, EUR J CLIN NUTR, V46, pS57; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Glassock Richard J, 2009, Trans Am Clin Climatol Assoc, V120, P419; Gunnell DJ, 1998, PAEDIATR PERINAT EP, V12, P96, DOI 10.1046/j.1365-3016.1998.0120s1096.x; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hancox RJ, 2009, THORAX, V64, P228, DOI 10.1136/thx.2008.103978; Higgins Trefor, 2009, J Diabetes Sci Technol, V3, P644; Horta BL, 2003, J EPIDEMIOL COMMUN H, V57, P226, DOI 10.1136/jech.57.3.226; Howe LD, 2012, J EPIDEMIOL COMMUN H, V66, P143, DOI 10.1136/jech.2010.113068; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; Kerstjens HAM, 1997, THORAX, V52, P820, DOI 10.1136/thx.52.9.820; Kinshuck D, 2011, CONTROL TYPE 2 DIABE; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Langenberg C, 2005, AM J PUBLIC HEALTH, V95, P628, DOI 10.2105/2004.046219; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lawlor DA, 2005, THORAX, V60, P851, DOI 10.1136/thx.2005.042408; Lawlor DA, 2005, CURR OPIN NEPHROL HY, V14, P259, DOI 10.1097/01.mnh.0000165893.13620.2b; Lawlor DA, 2003, DIABETES CARE, V26, P97, DOI 10.2337/diacare.26.1.97; Lawlor DA, 2003, PAEDIATR PERINAT EP, V17, P148, DOI 10.1046/j.1365-3016.2003.00479.x; Lawlor DA, 2007, COMPREHENSIVE HYPERT, P41; Leon DA, 2004, INT J EPIDEMIOL, V33, P1167, DOI 10.1093/ije/dyh389; Lewit EM, 1997, FUTURE CHILD, V7, P149, DOI 10.2307/1602393; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Luyckx VA, 2013, LANCET, V382, P273, DOI 10.1016/S0140-6736(13)60311-6; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; NHLBI, 2012, US NAT HEART LUNG BL; Orfei L, 2008, ARCH DIS CHILD, V93, P570, DOI 10.1136/adc.2006.112201; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Pike KC, 2008, BJOG-INT J OBSTET GY, V115, P149, DOI 10.1111/j.1471-0528.2007.01603.x; Puukka K, 2006, ALCOHOL ALCOHOLISM, V41, P522, DOI 10.1093/alcalc/agl052; Robinson R, 2001, BMJ, P322; SCHIELE F, 1977, CLIN CHEM, V23, P1023; Schmidt IM, 2005, KIDNEY INT, V68, P731, DOI 10.1111/j.1523-1755.2005.00451.x; ScottishGovernment, 2012, SCOTT HLTH SURV 2011, V1; Seaman S, 2011, 27 MRCCSO SOC PUBL H; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; Silva LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037356; Singh GR, 2004, AM J KIDNEY DIS, V43, P254, DOI 10.1053/j.ajkd.2003.10.015; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Spencer J, 2001, AM J KIDNEY DIS, V37, P915, DOI 10.1016/S0272-6386(05)80006-X; Stein CE, 1997, THORAX, V52, P895, DOI 10.1136/thx.52.10.895; Tate AR, 2005, INT J EPIDEMIOL, V34, P688, DOI 10.1093/ije/dyi029; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Wills AK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000440	66	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86953	10.1371/journal.pone.0086953	http://dx.doi.org/10.1371/journal.pone.0086953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498001	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000330621900051
J	Sorensen, MR; Pedersen, SR; Lindkvist, A; Christensen, JP; Thomsen, AR				Sorensen, Maria R.; Pedersen, Sara R.; Lindkvist, Annika; Christensen, Jan P.; Thomsen, Allan R.			Quantification of B16 Melanoma Cells in Lungs Using Triplex Q-PCR - A New Approach to Evaluate Melanoma Cell Metastasis and Tumor Control	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; VESICULAR STOMATITIS-VIRUS; T-CELLS; NK-CELL; MICE; ADENOVIRUS; IMMUNITY; SURGERY; DISSEMINATION; ANTIGENS	Skin cancer is the most common type of all cancers. However, it comprises several different types of cancers, one of which is malignant melanoma. Even though melanomas only make up about 5% of skin cancers, they are responsible for the majority of skin cancer deaths due to the poor chance of survival once the tumor has metastasized. In the present study, we have developed a new assay for quantitative analysis of B16 melanoma metastasis in the lungs. We have used a triplex Q-PCR to determine the expression of the melanoma genes GP100/Pmel and tyrosinase-related protein 2 (TRP-2), and found that B16.F10gp cells were detectable in the lungs as early as 2 hours after intravenous challenge with >= 10(4) tumor cells. When investigating the gene expression as a function of time, we observed a gradual decrease from 2-24 hours post tumor challenge followed by an increase of approximately 2 log(10) on day 11. The early decrease was accelerated in the presence of activated NK cells. To further evaluate our assay, we also investigated the level of metastasis in the context of vaccination with replication defective adenoviral vectors, Ad-Ii-GP and Ad-GP, previously found to significantly delay the outgrowth of subcutaneous melanomas. Results obtained using Q-PCR were compared to conventional counting of metastatic foci under a dissection microscope. A marked reduction in gene expression was observed in the lungs after vaccination with both vectors; however, Ad-Ii-GP showed the highest protection, and matching results were obtained by enumeration of visible tumor nodules on the lung surfaces. Finally, we could show that inhibition of tumor metastasis required antigen-specific CD8 T cells and IFN gamma, but not perforin. In conclusion, the presented results validate triplex Q-PCR as a fast, objective, and quantitative method for analysis of melanoma metastasis in the lungs.	[Sorensen, Maria R.; Pedersen, Sara R.; Lindkvist, Annika; Christensen, Jan P.; Thomsen, Allan R.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark	University of Copenhagen	Thomsen, AR (corresponding author), Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	athomsen@sund.ku.dk	Christensen, Jan Pravsgaard/I-4782-2017	Christensen, Jan Pravsgaard/0000-0002-4299-9479; Sorensen, Maria Rathmann/0000-0002-8384-4481; Thomsen, Allan Randrup/0000-0002-2392-9803	Danish Cancer Society; Dansk Kraeftforskningsfond	Danish Cancer Society(Danish Cancer Society); Dansk Kraeftforskningsfond	This project was funded in part by The Danish Cancer Society and Dansk Kraeftforskningsfond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG 2012; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Ben-Eliyahu S, 2003, BRAIN BEHAV IMMUN, V17, pS27; Diebold SS, 2001, GENE THER, V8, P487, DOI 10.1038/sj.gt.3301433; ESCHWEGE P, 1995, LANCET, V346, P1528, DOI 10.1016/S0140-6736(95)92054-4; FIDLER IJ, 1975, CANCER RES, V35, P218; GREEN EL, 1962, HDB GENETICALLY STAN; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hangalapura BN, 2011, VACCINE, V29, P2313, DOI 10.1016/j.vaccine.2011.01.022; HERBERMAN RB, 1979, IMMUNOL REV, V44, P43, DOI 10.1111/j.1600-065X.1979.tb00267.x; Holst PJ, 2007, J GEN VIROL, V88, P1708, DOI 10.1099/vir.0.82727-0; Holst PJ, 2008, J IMMUNOL, V180, P3339, DOI 10.4049/jimmunol.180.5.3339; Howlader N, 2012, SEER CANC STAT REV; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; KIESSLING R, 1979, IMMUNOL REV, V44, P165, DOI 10.1111/j.1600-065X.1979.tb00270.x; MCKINNON KP, 1981, INFECT IMMUN, V32, P204, DOI 10.1128/IAI.32.1.204-210.1981; Miyazono F, 2001, ANN SURG, V233, P189, DOI 10.1097/00000658-200102000-00007; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; Raso A, 2010, DIAGN MOL PATHOL, V19, P78, DOI 10.1097/PDM.0b013e3181b6a546; Ren CC, 2008, STEM CELLS, V26, P2332, DOI 10.1634/stemcells.2008-0084; Sauer KA, 2008, J IMMUNOL, V181, P6148, DOI 10.4049/jimmunol.181.9.6148; Singh S, 2009, CANCER RES, V69, P411, DOI 10.1158/0008-5472.CAN-08-3378; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Sorensen MR, 2009, EUR J IMMUNOL, V39, P2725, DOI 10.1002/eji.200939543; Steitz J, 2002, GENE THER, V9, P208, DOI 10.1038/sj.gt.3301634; STITZ L, 1985, J IMMUNOL, V134, P598; Thomsen AR, 1997, INT IMMUNOL, V9, P1757, DOI 10.1093/intimm/9.11.1757; World Health Organization, 2013, COMM IS SKIN CANC; Yamashita J, 2000, J THORAC CARDIOV SUR, V119, P899, DOI 10.1016/S0022-5223(00)70084-5	29	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87831	10.1371/journal.pone.0087831	http://dx.doi.org/10.1371/journal.pone.0087831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498205	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900179
J	Verma, SS; Rahman, MH; Deyholos, MK; Basu, U; Kav, NNV				Verma, Shiv S.; Rahman, Muhammad H.; Deyholos, Michael K.; Basu, Urmila; Kav, Nat N. V.			Differential Expression of miRNAs in Brassica napus Root following Infection with Plasmodiophora brassicae	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; MICROARRAY-BASED ANALYSIS; CLUBROOT RESISTANCE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; SMALL RNAS; ARABIDOPSIS; PLANT; AUXIN; IDENTIFICATION	Canola (oilseed rape, Brassica napus L.) is susceptible to infection by the biotrophic protist Plasmodiophora brassicae, the causal agent of clubroot. To understand the roles of microRNAs (miRNAs) during the post-transcriptional regulation of disease initiation and progression, we have characterized the changes in miRNA expression profiles in canola roots during clubroot disease development and have compared these to uninfected roots. Two different stages of clubroot development were targeted in this miRNA profiling study: an early time of 10-dpi for disease initiation and a later 20-dpi, by which time the pathogen had colonized the roots (as evident by visible gall formation and histological observations). P. brassicae responsive miRNAs were identified and validated by qRT-PCR of miRNAs and the subsequent validation of the target mRNAs through starBase degradome analysis, and through 5' RLM-RACE. This study identifies putative miRNA-regulated genes with roles during clubroot disease initiation and development. Putative target genes identified in this study included: transcription factors (TFs), hormone-related genes, as well as genes associated with plant stress response regulation such as cytokinin, auxin/ethylene response elements. The results of our study may assist in elucidating the role of miRNAs in post-transcriptional regulation of target genes during disease development and may contribute to the development of strategies to engineer durable resistance to this important phytopathogen.	[Verma, Shiv S.; Rahman, Muhammad H.; Basu, Urmila; Kav, Nat N. V.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Deyholos, Michael K.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta	Kav, NNV (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	nat@ualberta.ca	Verma, Shiv Shankar/AAI-6913-2021; Verma, Shiv Shankar/N-3726-2016		Natural Sciences and Engineering Research Council (NSERC) of Canada; Agriculture Funding Consortium; Alberta Canola Producers Commission; Alberta Crop Industry Development Fund	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Agriculture Funding Consortium; Alberta Canola Producers Commission; Alberta Crop Industry Development Fund	Funding from the Natural Sciences and Engineering Research Council (NSERC) of Canada, Agriculture Funding Consortium, Alberta Canola Producers Commission, and Alberta Crop Industry Development Fund is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Agarwal A, 2011, FUNCT PLANT BIOL, V38, P462, DOI 10.1071/FP11026; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Bulman S, 2007, PROTIST, V158, P423, DOI 10.1016/j.protis.2007.04.005; Cao T, 2008, PLANT SCI, V174, P97, DOI 10.1016/j.plantsci.2007.10.002; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen XB, 2010, J INTEGR PLANT BIOL, V52, P946, DOI 10.1111/j.1744-7909.2010.00987.x; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Czimmerer Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055168; Dastidar MG, 2012, WIRES DEV BIOL, V1, P329, DOI 10.1002/wdev.17; Devos S, 2006, MOL PLANT MICROBE IN, V19, P1431, DOI 10.1094/MPMI-19-1431; Diederichsen E, 2009, J PLANT GROWTH REGUL, V28, P265, DOI 10.1007/s00344-009-9100-0; Ding YF, 2011, J EXP BOT, V62, P3563, DOI 10.1093/jxb/err046; Dixon GR, 2009, J PLANT GROWTH REGUL, V28, P194, DOI 10.1007/s00344-009-9090-y; Dougherty WJ, 1981, STAINING PROCEDURES, P27; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gravot A, 2012, PLANT CELL PHYSIOL, V53, P901, DOI 10.1093/pcp/pcs037; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hatakeyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054745; Hawker NP, 2004, PLANT PHYSIOL, V135, P2261, DOI 10.1104/pp.104.040196; Hirai M, 2004, THEOR APPL GENET, V108, P639, DOI 10.1007/s00122-003-1475-x; Hwang SF, 2012, CAN J PLANT SCI, V92, P1175, DOI [10.4141/cjps2011-149, 10.4141/CJPS2011-149]; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kato T, 2013, BREEDING SCI, V63, P116, DOI 10.1270/jsbbs.63.116; Kramer Martha F, 2011, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1510s95; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Linder P, 2009, TRENDS PLANT SCI, V14, P344, DOI 10.1016/j.tplants.2009.03.007; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2010, METHODS MOL BIOL, V592, P107, DOI 10.1007/978-1-60327-005-2_8; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Ludwig-Muller J, 2009, NEW PHYTOL, V181, P323, DOI 10.1111/j.1469-8137.2008.02677.x; Malinowski R, 2012, PLANT J, V71, P226, DOI 10.1111/j.1365-313X.2012.04983.x; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Moldovan D, 2010, J EXP BOT, V61, P165, DOI 10.1093/jxb/erp296; Naqvi AR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-281; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Pande S, 2005, AUST J AGR RES, V56, P317, DOI 10.1071/AR04143; Peng G, 2011, PLANT PATHOL, V60, P566, DOI 10.1111/j.1365-3059.2010.02400.x; SACRISTAN MD, 1979, THEOR APPL GENET, V54, P129, DOI 10.1007/BF01159467; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Siemens J, 2009, PLANT PATHOL, V58, P130, DOI 10.1111/j.1365-3059.2008.01943.x; Siemens J, 2006, MOL PLANT MICROBE IN, V19, P480, DOI 10.1094/MPMI-19-0480; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; Strelkov SE, 2007, J PHYTOPATHOL, V155, P706, DOI 10.1111/j.1439-0434.2007.01303.x; Strelkov SE, 2006, CAN J PLANT PATHOL, V28, P467, DOI 10.1080/07060660609507321; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sundelin T, 2011, J EUKARYOT MICROBIOL, V58, P310, DOI 10.1111/j.1550-7408.2011.00551.x; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2008, BMC PLANT BIOL, V8, P1471; Testa A, 2005, J BIOL CHEM, V280, P13606, DOI 10.1074/jbc.M414039200; Tewari JP, 2005, CAN J PLANT PATHOL, V27, P143; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; Ueno H, 2012, PLANT MOL BIOL, V80, P621, DOI 10.1007/s11103-012-9971-5; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xin M, 2010, BMC PLANT BIOL, V10, P1471; Yang JH, 2011, NUCLEIC ACIDS RES, V39, P30; Yeung Edward C., 2005, V77, P517; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143	76	34	38	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86648	10.1371/journal.pone.0086648	http://dx.doi.org/10.1371/journal.pone.0086648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497962	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900031
J	Colli, L; Joost, S; Negrini, R; Nicoloso, L; Crepaldi, P; Ajmone-Marsan, P				Colli, Licia; Joost, Stephane; Negrini, Riccardo; Nicoloso, Letizia; Crepaldi, Paola; Ajmone-Marsan, Paolo		ECONOGENE Consortium	Assessing The Spatial Dependence of Adaptive Loci in 43 European and Western Asian Goat Breeds Using AFLP Markers	PLOS ONE			English	Article							DETECT CANDIDATE LOCI; LANDSCAPE GENOMICS; POPULATION GENOMICS; POSITIVE SELECTION; ADAPTATION; GENETICS; POLYMORPHISM; DIVERSITY; DOMINANT; PROMISE	Background: During the past decades, neutral DNA markers have been extensively employed to study demography, population genetics and structure in livestock, but less interest has been devoted to the evaluation of livestock adaptive potential through the identification of genomic regions likely to be under natural selection. Methodology/Principal findings: Landscape genomics can greatly benefit the entire livestock system through the identification of genotypes better adapted to specific or extreme environmental conditions. Therefore we analyzed 101 AFLP markers in 43 European and Western Asian goat breeds both with MATSAM software, based on a correlative approach (SAM), and with MCHEZA and BAYESCAN, two F-ST based software able to detect markers carrying signatures of natural selection. MATSAM identified four loci possibly under natural selection - also confirmed by F-ST-outlier methods - and significantly associated with environmental variables such as diurnal temperature range, frequency of precipitation, relative humidity and solar radiation. Conclusions/Significance: These results show that landscape genomics can provide useful information on the environmental factors affecting the adaptive potential of livestock living in specific climatic conditions. Besides adding conservation value to livestock genetic resources, this knowledge may lead to the development of novel molecular tools useful to preserve the adaptive potential of local breeds during genetic improvement programs, and to increase the adaptability of industrial breeds to changing environments.	[Colli, Licia; Negrini, Riccardo; Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Ist Zootecn, Lab Genet Anim, Piacenza, Italy; [Colli, Licia; Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, BioDNA Res Ctr, Piacenza, Italy; [Joost, Stephane] Ecole Polytech Fed Lausanne, Lab Geog Informat Syst LASIG, Sch Architecture Civil & Environm Engn ENAC, Lausanne, Switzerland; [Negrini, Riccardo] Assoc Italiana Allevatori, Rome, Italy; [Nicoloso, Letizia; Crepaldi, Paola] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy	Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Milan	Colli, L (corresponding author), Univ Cattolica Sacro Cuore, Ist Zootecn, Lab Genet Anim, Piacenza, Italy.	licia.colli@unicatt.it	Bruford, Michael W/D-3750-2009; Bruford, Michael/Y-7463-2019; Colli, Licia/AAC-2985-2021; Crepaldi, Paola/L-4681-2017; Beja-Pereira, Albano/B-3681-2008; D'Andrea, Mariasilvia/E-5760-2012; D'ANDREA, Mariasilvia/AAQ-9396-2020; Pérez, Trinidad/AAC-6729-2019; Hoda, Anila/GRY-7191-2022; Joost, Stéphane/B-4152-2010; AJMONE MARSAN, Paolo/M-2466-2018; Canon Ferreras, Francisco Javier/M-5704-2018; Cortes Gardyn, Oscar/K-7545-2014; valentini, alessio/L-3970-2013	Bruford, Michael W/0000-0001-6357-6080; Bruford, Michael/0000-0001-6357-6080; Crepaldi, Paola/0000-0002-6526-2162; Beja-Pereira, Albano/0000-0002-1607-7382; D'Andrea, Mariasilvia/0000-0002-8932-4057; Pérez, Trinidad/0000-0003-1216-5593; Hoda, Anila/0000-0003-0906-2550; Joost, Stéphane/0000-0002-1184-7501; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Ibeagha-Awemu, Eveline/0000-0001-8810-9294; Marletta, Donata/0000-0002-8408-7443; CANALI, Gabriele/0000-0001-9244-8184; Canon Ferreras, Francisco Javier/0000-0003-1137-0958; PILLA, Fabio/0000-0002-1781-994X; Cortes Gardyn, Oscar/0000-0001-7685-3980; Dobi, Petrit/0000-0002-6101-0101; LIGDA, CHRISTINA/0000-0003-4980-3026; NEGRINI, Riccardo/0000-0002-8735-0286; Baret, Philippe/0000-0002-6189-666X; Carta, Antonello/0000-0003-0534-4876; valentini, alessio/0000-0003-4733-7519	EU ECONOGENE [QLK5-CT-2001-02461]	EU ECONOGENE	This work has been supported by the EU ECONOGENE contract QLK5-CT-2001-02461. The content of the publication does not represent necessarily the views of the European Commission or its services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Marsan P, 1997, ANIM GENET, V28, P418, DOI 10.1111/j.1365-2052.1997.00204.x; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; Avise J.C., 2004, MOL MARKERS NATURAL; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Buitkamp J, 1996, PARASITOL RES, V82, P693, DOI 10.1007/s004360050187; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Canon J, 2006, ANIM GENET, V37, P327, DOI 10.1111/j.1365-2052.2006.01461.x; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Goodchild MF., 1996, ANTHR SPACE GEOGRAPH, P214; Hahn MW, 2008, EVOLUTION, V62, P255, DOI 10.1111/j.1558-5646.2007.00308.x; Hanotte O, 2010, SCIENCE, V328, P1640, DOI 10.1126/science.1186254; Hedrick PW, 2006, ANNU REV ECOL EVOL S, V37, P67, DOI 10.1146/annurev.ecolsys.37.091305.110132; Jeffreys H., 1961, THEORY PROBABILITY, V3rd ed.; Jones MR, 2013, EVOLUTION, V67, P3455, DOI 10.1111/evo.12237; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Joost S, 2008, MOL ECOL RESOUR, V8, P957, DOI 10.1111/j.1755-0998.2008.02162.x; Joost S, 2013, MOL ECOL, V22, P3659, DOI 10.1111/mec.12352; Joost S, 2011, CONSERV GENET RESOUR, V3, P785, DOI 10.1007/s12686-011-9457-9; Lampkin NH, 2001, ORGANIC FARM MANAGEM; LEWONTIN RC, 1973, GENETICS, V74, P175; Li HP, 2011, MOL BIOL EVOL, V28, P365, DOI 10.1093/molbev/msq211; Li JR, 2012, MOL ECOL, V21, P28, DOI 10.1111/j.1365-294X.2011.05308.x; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MacEachern S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-181; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Manel S, 2010, MOL ECOL, V19, P3760, DOI 10.1111/j.1365-294X.2010.04717.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Neigel JE, 2002, CONSERV GENET, V3, P167, DOI 10.1023/A:1015213626922; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nielsen EE, 2005, CAN J FISH AQUAT SCI, V62, P2219, DOI 10.1139/F05-139; ORGANIZACION DE LAS NACIONES UNIDAS PARA LA AGRICULTURA Y LA ALIMENTACION (FAO), 2010, 6 SESS INT TECHN WOR; Pariset L, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-7; Phillips PC, 2005, GENETICA, V123, P15, DOI 10.1007/s10709-004-2704-1; Riebler A, 2008, GENETICS, V178, P1817, DOI 10.1534/genetics.107.081281; SanCristobal M, 2006, ANIM GENET, V37, P232, DOI 10.1111/j.1365-2052.2006.01440.x; Schlotterer C, 2005, MOL B INT U, P55, DOI 10.1007/0-387-27651-3_5; Scholtz MM, 2011, LIVEST SCI, V142, P195, DOI 10.1016/j.livsci.2011.07.014; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Storz JF, 2005, HEREDITY, V95, P3, DOI 10.1038/sj.hdy.6800683; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	52	13	14	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86668	10.1371/journal.pone.0086668	http://dx.doi.org/10.1371/journal.pone.0086668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497965	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000330617100024
J	Filtjens, J; Foquet, L; Taveirne, S; Van Ammel, E; Vanhees, M; Van Acker, A; Kerre, T; Taghon, T; Vandekerckhove, B; Plum, J; Van den Steen, PE; Leclercq, G				Filtjens, Jessica; Foquet, Lander; Taveirne, Sylvie; Van Ammel, Els; Vanhees, Mandy; Van Acker, Aline; Kerre, Tessa; Taghon, Tom; Vandekerckhove, Bart; Plum, Jean; Van den Steen, Philippe E.; Leclercq, Georges			Contribution of the Ly49E Natural Killer Receptor in the Immune Response to Plasmodium berghei Infection and Control of Hepatic Parasite Development	PLOS ONE			English	Article							MURINE CEREBRAL MALARIA; NK CELL RECOGNITION; T-CELLS; MISSING SELF; PROTECTIVE IMMUNITY; INTERFERON-GAMMA; LIVER-STAGE; PATHOGENESIS; EXPRESSION; MHC	Natural killer (NK) cells have different roles in the host response against Plasmodium-induced malaria depending on the stage of infection. Liver NK cells have a protective role during the initial hepatic stage of infection by production of the T(H)1-type cytokines IFN-gamma and TNF-alpha. In the subsequent erythrocytic stage of infection, NK cells also induce protection through Th1-type cytokines but, in addition, may also promote development of cerebral malaria via CXCR3-induction on CD8(+) T cells resulting in migration of these cells to the brain. We have recently shown that the regulatory Ly49E NK receptor is expressed on liver NK cells in particular. The main objective of this study was therefore to examine the role of Ly49E expression in the immune response upon Plasmodium berghei ANKA infection, for which we compared wild type (WT) to Ly49E knockout (KO) mice. We show that the parasitemia was higher at the early stage, i.e. at days 6-7 of Plasmodium berghei ANKA infection in Ly49E KO mice, which correlated with lower induction of CD69, IFN-gamma and TNF-alpha in DX5(-) liver NK cells at day 5 post-infection. At later stages, these differences faded. There was also no difference in the kinetics and the percentage of cerebral malaria development and in lymphocyte CXCR3 expression in WT versus Ly49E KO mice. Collectively, we show that the immune response against Plasmodium berghei ANKA infection is not drastically affected in Ly49E KO mice. Although NK cells play a crucial role in Plasmodium infection and Ly49E is highly expressed on liver NK cells, the Ly49E NK receptor only has a temporarily role in the immune control of this parasite.	[Filtjens, Jessica; Foquet, Lander; Taveirne, Sylvie; Van Ammel, Els; Vanhees, Mandy; Van Acker, Aline; Kerre, Tessa; Taghon, Tom; Vandekerckhove, Bart; Plum, Jean; Leclercq, Georges] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Van den Steen, Philippe E.] Katholieke Univ Leuven, Rega Inst Med Res, Immunobiol Lab, Louvain, Belgium	Ghent University; KU Leuven	Leclercq, G (corresponding author), Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium.	georges.leclercq@ugent.be	Van den Steen, Philippe E/K-5132-2012; Leclercq, Georges/H-9659-2017; Taghon, Tom/M-9111-2018; Plum, Jean/A-4357-2008; Kerre, Tessa CC/C-3226-2016; Foquet, Lander/P-1586-2016	Van den Steen, Philippe E/0000-0002-7334-9145; Leclercq, Georges/0000-0002-1691-5294; Foquet, Lander/0000-0001-9235-0814; Taghon, Tom/0000-0002-5781-0288; Vandekerckhove, Bart/0000-0003-3828-4195	Foundation against Cancer; foundation of public interest; Fund for Scientific Research Flanders (FWO); Institute for the Promotion of Innovation through Science and Technology Flanders (IWT-Vlaanderen); BOF Ghent University; FWO; KU Leuven	Foundation against Cancer; foundation of public interest; Fund for Scientific Research Flanders (FWO)(FWO); Institute for the Promotion of Innovation through Science and Technology Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); BOF Ghent University(Ghent University); FWO(FWO); KU Leuven(KU Leuven)	This work was supported by the Foundation against Cancer, a foundation of public interest, and by the Fund for Scientific Research Flanders (FWO). J.F., L. F., M. V. and A. V. A. are supported by the Institute for the Promotion of Innovation through Science and Technology Flanders (IWT-Vlaanderen), S. T. is supported by the BOF Ghent University, T. K. and T. T. are supported by the FWO. P.E.V.d.S. holds a Research Professorship of the KU Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2013, NAT MED, V19, P150, DOI 10.1038/nm.3077; ANDERSON P, 1989, NATURE, V341, P159, DOI 10.1038/341159a0; Arase H, 1996, J EXP MED, V183, P2391, DOI 10.1084/jem.183.5.2391; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Filtjens J, 2013, J LEUKOCYTE BIOL, V93, P699, DOI 10.1189/jlb.0812378; Fraser KP, 2002, EUR J IMMUNOL, V32, P868, DOI 10.1002/1521-4141(200203)32:3<868::AID-IMMU868>3.0.CO;2-A; Gays F, 2005, J IMMUNOL, V175, P2938, DOI 10.4049/jimmunol.175.5.2938; Gonzalez-Aseguinolaza G, 2000, P NATL ACAD SCI USA, V97, P8461, DOI 10.1073/pnas.97.15.8461; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hansen DS, 2003, IMMUNITY, V18, P391, DOI 10.1016/S1074-7613(03)00052-9; Hansen DS, 2005, INFECT IMMUN, V73, P2288, DOI 10.1128/IAI.73.4.2288-2297.2005; Hermsen CC, 2003, CLIN EXP IMMUNOL, V132, P467, DOI 10.1046/j.1365-2249.2003.02160.x; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Karre K, 2008, NAT IMMUNOL, V9, P477, DOI 10.1038/ni0508-477; Krzych U, 2000, IMMUNOL REV, V174, P123, DOI 10.1034/j.1600-0528.2002.00013h.x; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Mohan K, 1997, J IMMUNOL, V159, P4990; Piguet PF, 2000, INFECT IMMUN, V68, P3822, DOI 10.1128/IAI.68.7.3822-3829.2000; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; Proteau MF, 2004, GENOMICS, V84, P669, DOI 10.1016/j.ygeno.2004.05.004; Riley EM, 2013, NAT MED, V19, P168, DOI 10.1038/nm.3083; Roland J, 2006, J IMMUNOL, V177, P1229, DOI 10.4049/jimmunol.177.2.1229; Roth C, 2000, IMMUNITY, V13, P143, DOI 10.1016/S1074-7613(00)00015-7; Stevenaert F, 2003, J LEUKOCYTE BIOL, V73, P731, DOI 10.1189/jlb.0902443; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Taveirne S, 2011, BLOOD, V118, P339, DOI 10.1182/blood-2011-01-331124; Van Beneden K, 2002, J IMMUNOL, V168, P3295, DOI 10.4049/jimmunol.168.7.3295; Van Beneden K, 2001, J IMMUNOL, V166, P4302, DOI 10.4049/jimmunol.166.7.4302; Van den Broeck T, 2013, J IMMUNOL, V190, P1982, DOI 10.4049/jimmunol.1200354; Van Den Broeck T, 2008, BLOOD, V112, P5046, DOI 10.1182/blood-2008-06-164350; Yanez DM, 1996, J IMMUNOL, V157, P1620; Yanez DM, 1999, INFECT IMMUN, V67, P446	40	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87463	10.1371/journal.pone.0087463	http://dx.doi.org/10.1371/journal.pone.0087463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498110	gold, Green Published, Green Submitted			2022-12-25	WOS:000330617100086
J	Schmidt, AH; Sauter, J; Pingel, J; Ehninger, G				Schmidt, Alexander H.; Sauter, Juergen; Pingel, Julia; Ehninger, Gerhard			Toward an Optimal Global Stem Cell Donor Recruitment Strategy	PLOS ONE			English	Article							HLA HAPLOTYPE FREQUENCIES; HIGH-RESOLUTION; NATIONAL REGISTRY; TRANSPLANTATION; POPULATION; ALLELES; ANTIGEN; IMPACT; PROBABILITY; PROGRAM	Population-specific matching probabilities (MP) are a key parameter to assess the benefits of unrelated stem cell donor registries and the need for further donor recruitment efforts. In this study, we describe a general framework for MP estimations of specific and mixed patient populations under consideration of international stem cell donor exchange. Calculations were based on population-specific 4-locus (HLA-A, -B, -C, -DRB1) high-resolution haplotype frequencies (HF) of up to 21 populations. In various scenarios, we calculated several quantities of high practical relevance, including the maximal MP that can be reached by recruiting a fixed number of donors, the corresponding optimal composition by population of new registrants, and the minimal number of donors who need to be recruited to reach a defined MP. Starting at current donor numbers, the largest MP increases due to n = 500,000 additional same-population donors were observed for patients from Bosnia-Herzegovina (+0.25), Greece (+0.21) and Romania (+0.20). Especially small MP increases occurred for European Americans (+0.004), Germans (+0.01) and Hispanic Americans (+0.01). Due to the large Chinese population, the optimal distribution of n = 5,000,000 new donors worldwide included 3.9 million Chinese donors. As a general result of our calculations, we observed a need for same-population donor recruitment in order to increase population-specific MP efficiently. This result was robust despite limitations of our input data, including the use of HF derived from relatively small samples ranging from n = 1028 (Bosnia-Herzegovina) to n = 33,083 (Turkey) individuals. National strategies that neglect domestic donor recruitment should therefore be critically re-assessed, especially if only few donors have been recruited so far.	[Schmidt, Alexander H.; Sauter, Juergen; Pingel, Julia] DKMS German Bone Marrow Donor Ctr, Tubingen, Germany; [Ehninger, Gerhard] Univ Hosp Carl Gustav Carus, Dresden, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Schmidt, AH (corresponding author), DKMS German Bone Marrow Donor Ctr, Tubingen, Germany.	schmidt@dkms.de; sauter@dkms.de			DKMS German Bone Marrow Donor Center	DKMS German Bone Marrow Donor Center	This work was funded by DKMS German Bone Marrow Donor Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum FR, 2007, NEW ENGL J MED, V357, P1472, DOI 10.1056/NEJMp078166; BEATTY PG, 1995, TRANSPLANTATION, V60, P778, DOI 10.1097/00007890-199510270-00003; Bergstrom TC, 2009, AM ECON REV, V99, P1309, DOI 10.1257/aer.99.4.1309; Bray RA, 2008, BIOL BLOOD MARROW TR, V14, P45, DOI 10.1016/j.bbmt.2008.06.014; Buhler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041400; Castelli EC, 2010, TISSUE ANTIGENS, V76, P459, DOI 10.1111/j.1399-0039.2010.01539.x; Confer DL, 2001, CANCER, V91, P274, DOI 10.1002/1097-0142(20010101)91:1+<274::AID-CNCR18>3.0.CO;2-E; Dehn J, 2011, BIOL BLOOD MARROW TR, V17, pS170, DOI 10.1016/j.bbmt.2010.12.059; Eberhard HP, 2010, TISSUE ANTIGENS, V76, P352, DOI 10.1111/j.1399-0039.2010.01518.x; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Gratwohl A, 2007, BONE MARROW TRANSPL, V39, P71, DOI 10.1038/sj.bmt.1705555; Gratwohl A, 2010, JAMA-J AM MED ASSOC, V303, P1617, DOI 10.1001/jama.2010.491; Hwang WYK, 2009, ANN ACAD MED SINGAP, V38, P340; Kollman C, 2004, TRANSPLANTATION, V78, P89, DOI 10.1097/01.TP.0000132327.40702.97; Kollman C, 2007, HUM IMMUNOL, V68, P950, DOI 10.1016/j.humimm.2007.10.009; Lange V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-63; Lazaro AM, 2011, TISSUE ANTIGENS, V77, P54, DOI 10.1111/j.1399-0039.2010.01558.x; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; LONJOU C, 1995, TRANSPLANTATION, V60, P375, DOI 10.1097/00007890-199508270-00013; Mack SJ, 2009, TISSUE ANTIGENS, V73, P17, DOI 10.1111/j.1399-0039.2008.01151.x; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Mueller CR, 2012, HUM IMMUNOL, V73, P121, DOI 10.1016/j.humimm.2012.07.240; Muller CR, 2003, HUM IMMUNOL, V64, P137, DOI 10.1016/S0198-8859(02)00706-1; Pingel J, 2013, HUM IMMUNOL, V74, P330, DOI 10.1016/j.humimm.2012.10.029; Qin PQ, 2011, INT J IMMUNOGENET, V38, P475, DOI 10.1111/j.1744-313X.2011.01029.x; Rendine S, 1998, TISSUE ANTIGENS, V52, P135, DOI 10.1111/j.1399-0039.1998.tb02277.x; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Schmidt AH, 2010, TISSUE ANTIGENS, V76, P362, DOI 10.1111/j.1399-0039.2010.01520.x; Schmidt AH, 2009, BONE MARROW TRANSPL, V44, P405, DOI 10.1038/bmt.2009.55; Schmidt AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073835; Schmidt AH, 2013, TISSUE ANTIGENS, V81, P270; Schmidt AH, 2011, HUM IMMUNOL, V72, P558, DOI 10.1016/j.humimm.2011.03.010; Schmidt AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020268; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Shaw BE, 2010, BRIT J HAEMATOL, V150, P251, DOI 10.1111/j.1365-2141.2010.08224.x; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; SONNENBERG FA, 1989, BLOOD, V74, P2569; Spellman SR, 2012, BLOOD, V120, P259, DOI 10.1182/blood-2012-03-379032; Switzer GE, 2013, BLOOD, V121, P1469, DOI 10.1182/blood-2012-06-437343; Tu B, 2013, TISSUE ANTIGENS, V81, P150, DOI 10.1111/tan.12072; World Marrow Donor Association, WORLD MARR DON ASS A	44	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86605	10.1371/journal.pone.0086605	http://dx.doi.org/10.1371/journal.pone.0086605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497958	gold, Green Submitted, Green Published			2022-12-25	WOS:000330617100021
J	Ambriz-Pena, X; Garcia-Zepeda, EA; Meza, I; Soldevila, G				Ambriz-Pena, Xochitl; Alberto Garcia-Zepeda, Eduardo; Meza, Isaura; Soldevila, Gloria			Jak3 Enables Chemokine-Dependent Actin Cytoskeleton Reorganization by Regulating Cofilin and Rac/Rhoa GTPases Activation	PLOS ONE			English	Article							JANUS KINASE 3; TYROSINE PHOSPHORYLATION; LIM-KINASE; SIGNAL-TRANSDUCTION; RHO GTPASES; MIGRATION; PROTEINS; RAC; PHOSPHATASE; CHEMOTAXIS	We have previously shown that Jak3 is involved in the signaling pathways of CCR7, CCR9 and CXCR4 in murine T lymphocytes and that Jak3(-/-) lymphocytes display an intrinsic defect in homing to peripheral lymph nodes. However, the molecular mechanism underlying the defective migration observed in Jak3(-/-) lymphocytes remains elusive. Here, it is demonstrated for the first time, that Jak3 is required for the actin cytoskeleton reorganization in T lymphocytes responding to chemokines. It was found that Jak3 regulates actin polymerization by controlling cofilin inactivation in response to CCL21 and CXCL12. Interestingly, cofilin inactivation was not precluded in PTX- treated cells despite their impaired actin polymerization. Additionally, Jak3 was required for small GTPases Rac1 and RhoA activation, which are indispensable for acquisition of the migratory cell phenotype and the generation of a functional leading edge and uropod, respectively. This defect correlates with data obtained by time-lapse video-microscopy showing an incompetent uropod formation and impaired motility in Jak3-pharmacologically inhibited T lymphocytes. Our data support a new model in which Jak3 and heterotrimeric G proteins can use independent, but complementary, signaling pathways to regulate actin cytoskeleton dynamics during cell migration in response to chemokines.	[Ambriz-Pena, Xochitl; Alberto Garcia-Zepeda, Eduardo; Soldevila, Gloria] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico; [Meza, Isaura] IPN, Ctr Invest & Estudios Avanzados CINVESTAV, Dept Biomed Mol, Mexico City 07738, DF, Mexico	Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Soldevila, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico.	soldevi@servidor.unam.mx		Soldevila, Gloria/0000-0003-1539-2548; Ambriz, Xochitl/0000-0003-3596-9682	Conacyt (Mexico) [79573]; DGAPA (UNAM, Mexico) [214411]; Conacyt [166462, 23543/220705]	Conacyt (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA (UNAM, Mexico)(Universidad Nacional Autonoma de Mexico); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Work in GS laboratory was supported by Grant # 79573 from Conacyt (Mexico) and DGAPA (UNAM, Mexico) Grant # 214411. Work in IM laboratory was supported by Conacyt grant # 166462. Xochilt Ambriz-Pena was a student of the PhD program: Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico and was a recipient of a doctoral fellowship from CONACyT 23543/220705. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alferink J, 1998, SCIENCE, V282, P1338, DOI 10.1126/science.282.5392.1338; Arcaro A, 1998, J BIOL CHEM, V273, P805, DOI 10.1074/jbc.273.2.805; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bardi G, 2003, FEBS LETT, V542, P79, DOI 10.1016/S0014-5793(03)00351-X; Barreiro O, 2007, IMMUNOL REV, V218, P147, DOI 10.1111/j.1600-065X.2007.00529.x; BENGTSSON T, 1986, EUR J CELL BIOL, V42, P338; Biswas SK, 2002, INT IMMUNOPHARMACOL, V2, P1095, DOI 10.1016/S1567-5769(02)00055-3; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Disanza A, 2005, CELL MOL LIFE SCI, V62, P955, DOI 10.1007/s00018-004-4472-6; Faroudi M, 2010, BLOOD, V116, P5536, DOI 10.1182/blood-2010-08-299438; Filippi MD, 2007, BLOOD, V109, P1257, DOI 10.1182/blood-2006-04-017731; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Freeman SN, 2011, J IMMUNOL, V187, P5887, DOI 10.4049/jimmunol.1102233; Garcia-Zepeda EA, 2007, IMMUNOLOGY, V122, P247, DOI 10.1111/j.1365-2567.2007.02634.x; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Gutjahr MC, 2005, EXP CELL RES, V308, P422, DOI 10.1016/j.yexcr.2005.05.001; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hirayama A, 2007, J LEUKOCYTE BIOL, V81, P720, DOI 10.1189/jlb.0506314; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jovceva E, 2007, J CELL SCI, V120, P1888, DOI 10.1242/jcs.004366; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kumar N, 2007, J BIOL CHEM, V282, P30341, DOI 10.1074/jbc.C600319200; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; Mahankali M, 2012, J BIOL CHEM, V287, P41417, DOI 10.1074/jbc.M112.383596; Mishra J, 2012, J BIOL CHEM, V287, P41386, DOI 10.1074/jbc.C112.363507; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Mueller A, 2004, FEBS LETT, V570, P126, DOI 10.1016/j.febslet.2004.04.100; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita Michiru, 2006, Tanpakushitsu Kakusan Koso, V51, P516; Oleinik NV, 2010, ONCOGENE, V29, P6233, DOI 10.1038/onc.2010.356; Perez-Rivero G, 2013, EUROPEAN J IMMUNOLOG; Pestonjamasp KN, 2006, BLOOD, V108, P2814, DOI 10.1182/blood-2006-01-010363; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Roa NS, 2013, BIOCHEM BIOPH RES CO, V432, P52, DOI 10.1016/j.bbrc.2013.01.086; Soldevila G, 2004, IMMUNOLOGY, V112, P191, DOI 10.1111/j.1365-2567.2004.01863.x; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Soriano SF, 2003, EUR J IMMUNOL, V33, P1328, DOI 10.1002/eji.200323897; Soriano SF, 2011, J IMMUNOL, V187, P2356, DOI 10.4049/jimmunol.1100935; Stein JV, 2003, BLOOD, V101, P38, DOI 10.1182/blood-2002-03-0841; Steindler C, 2004, J BIOL CHEM, V279, P43168, DOI 10.1074/jbc.M401915200; Sudbeck EA, 1999, CLIN CANCER RES, V5, P1569; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wong MM, 2003, SEMIN IMMUNOL, V15, P5, DOI 10.1016/S1044-5323(02)00123-9; Yoo Y, 2010, ONCOGENE, V29, P263, DOI 10.1038/onc.2009.319; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	52	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e88014	10.1371/journal.pone.0088014	http://dx.doi.org/10.1371/journal.pone.0088014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498424	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900170
J	Bouktif, S; Hanna, EM; Zaki, N; Abu Khousa, E				Bouktif, Salah; Hanna, Eileen Marie; Zaki, Nazar; Abu Khousa, Eman			Ant Colony Optimization Algorithm for Interpretable Bayesian Classifiers Combination: Application to Medical Predictions	PLOS ONE			English	Article							HEART-DISEASE; MODELS; DIAGNOSIS	Prediction and classification techniques have been well studied by machine learning researchers and developed for several real-word problems. However, the level of acceptance and success of prediction models are still below expectation due to some difficulties such as the low performance of prediction models when they are applied in different environments. Such a problem has been addressed by many researchers, mainly from the machine learning community. A second problem, principally raised by model users in different communities, such as managers, economists, engineers, biologists, and medical practitioners, etc., is the prediction models' interpretability. The latter is the ability of a model to explain its predictions and exhibit the causality relationships between the inputs and the outputs. In the case of classification, a successful way to alleviate the low performance is to use ensemble classiers. It is an intuitive strategy to activate collaboration between different classifiers towards a better performance than individual classier. Unfortunately, ensemble classifiers method do not take into account the interpretability of the final classification outcome. It even worsens the original interpretability of the individual classifiers. In this paper we propose a novel implementation of classifiers combination approach that does not only promote the overall performance but also preserves the interpretability of the resulting model. We propose a solution based on Ant Colony Optimization and tailored for the case of Bayesian classifiers. We validate our proposed solution with case studies from medical domain namely, heart disease and Cardiotography-based predictions, problems where interpretability is critical to make appropriate clinical decisions.	[Bouktif, Salah; Hanna, Eileen Marie; Zaki, Nazar; Abu Khousa, Eman] United Arab Emirates Univ, Coll Informat Technol, Al Ain, U Arab Emirates	United Arab Emirates University	Bouktif, S (corresponding author), United Arab Emirates Univ, Coll Informat Technol, Al Ain, U Arab Emirates.	salahb@uaeu.ac.ae	Zaki, Nazar/ABC-1680-2020; Bouktif, Salah/AAD-6537-2021; Zaki, Nazar M/F-1972-2013	Zaki, Nazar M/0000-0002-6259-9843; Hanna, Eileen Marie/0000-0002-2093-4586				Adriaenssens V, 2004, SCI TOTAL ENVIRON, V319, P1, DOI 10.1016/S0048-9697(03)00433-9; Alkoot FM, 1999, PATTERN RECOGN LETT, V20, P1361, DOI 10.1016/S0167-8655(99)00107-5; Ayari K, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P1074; Ayres-de Campos D, 2000, J Matern Fetal Med, V9, P311; BOUKTIF S, 2005, THESIS MONTREAL U; BOUKTIF S, 2006, GEN EV COMP C GECCO; Bouktif S, 2010, INFORM SOFTWARE TECH, V52, P1298, DOI 10.1016/j.infsof.2010.07.003; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; BRIAND LC, 1993, IEEE T SOFTWARE ENG, V19, P1028, DOI 10.1109/32.256851; Chen JN, 2009, EXPERT SYST APPL, V36, P5432, DOI 10.1016/j.eswa.2008.06.054; Cook T.C., 1979, QUASIEXPERIMENTATION; Das R, 2009, EXPERT SYST APPL, V36, P7675, DOI 10.1016/j.eswa.2008.09.013; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; DETRANO R, 1989, AM J CARDIOL, V64, P304, DOI 10.1016/0002-9149(89)90524-9; Dorigo M, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.329691; Fenton N, 2002, IEEE SOFTWARE, V19, P116, DOI 10.1109/MS.2002.1020298; Fenton NE, 2000, IEEE T SOFTWARE ENG, V26, P797, DOI 10.1109/32.879815; Fenton NE, 1999, IEEE T SOFTWARE ENG, V25, P675, DOI 10.1109/32.815326; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Fu G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S3; Galar M, 2012, IEEE T SYST MAN CY C, V42, P463, DOI 10.1109/TSMCC.2011.2161285; GENNARI JH, 1989, ARTIF INTELL, V40, P11, DOI 10.1016/0004-3702(89)90046-5; Gray A, 1997, INFORM SOFTWARE TECH, V39, P425, DOI 10.1016/S0950-5849(96)00006-7; John GHG, 1995, P 11 C UNC ART INT, P338, DOI [DOI 10.1109/TGRS.2004.834800, 10.1.1.8. 3257.]; Lee D, 1996, CONTROL ENG PRACT, V4, P1511, DOI 10.1016/0967-0661(96)00165-7; Lounis H, 2004, QSIC 2004: PROCEEDINGS OF THE FOURTH INTERNATIONAL CONFERENCE ON QUALITY SOFTWARE, P102; Meir R., 2000, P 13 ANN C COMP LEAR, P190; MERZ C, 1998, THESIS U CALIFORNIA; Moerland P., 1999, TECHNICAL REPORT; *ORG HW, 2011, TOP 10 CAUS DEATH; Oza NC, 2008, INFORM FUSION, V9, P4, DOI 10.1016/j.inffus.2007.07.002; Perrone MP, 1993, NEURAL NETWORKS SPEE; Quinlan J.R, 2014, C4 5 PROGRAMS MACHIN; Ramoni R., 1999, TECHNICAL REPORT; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Tsipouras MG, 2008, IEEE T INF TECHNOL B, V12, P447, DOI 10.1109/TITB.2007.907985; Van Belle VMCA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034312; van Gerven MAJ, 2007, ARTIF INTELL MED, V40, P45, DOI 10.1016/j.artmed.2006.09.003; World Health Organization, 2013, COMM BAS EFF RED BLO; Youden W. J., 1961, MAT RES STANDARDS; Zaki N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-217; Zhou ZH, 2004, IEEE T KNOWL DATA EN, V16, P770, DOI 10.1109/TKDE.2004.11	42	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86456	10.1371/journal.pone.0086456	http://dx.doi.org/10.1371/journal.pone.0086456			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498276	gold, Green Published			2022-12-25	WOS:000330626900022
J	Fathinajafabadi, A; Perez-Jimenez, E; Riera, M; Knecht, E; Gonzalez-Duarte, R				Fathinajafabadi, Alihamze; Perez-Jimenez, Eva; Riera, Marina; Knecht, Erwin; Gonzalez-Duarte, Roser			CERKL, a Retinal Disease Gene, Encodes an mRNA-Binding Protein That Localizes in Compact and Untranslated mRNPs Associated with Microtubules	PLOS ONE			English	Article							CERAMIDE KINASE-LIKE; RETINITIS-PIGMENTOSA; STRESS GRANULES; EXPRESSION; KNOCKDOWN; DYSTROPHY; AUTOPHAGY; MUTATION; SIGNAL	The function of CERKL (CERamide Kinase Like), a causative gene of retinitis pigmentosa and cone-rod dystrophy, still awaits characterization. To approach its cellular role we have investigated the subcellular localization and interaction partners of the full length CERKL isoform, CERKLa of 532 amino acids, in different cell lines, including a photoreceptor-derived cell line. We demonstrate that CERKLa is a main component of compact and untranslated mRNPs and that associates with other RNP complexes such as stress granules, P-bodies and polysomes. CERKLa is a protein that binds through its N-terminus to mRNAs and interacts with other mRNA-binding proteins like eIF3B, PABP, HSP70 and RPS3. Except for eIF3B, these interactions depend on the integrity of mRNAs but not of ribosomes. Interestingly, the C125W CERKLa pathological mutant does not interact with eIF3B and is absent from these complexes. Compact mRNPs containing CERKLa also associate with microtubules and are found in neurites of neural differentiated cells. These localizations had not been reported previously for any member of the retinal disorders gene family and should be considered when investigating the pathogenic mechanisms and therapeutical approaches in these diseases.	[Fathinajafabadi, Alihamze; Perez-Jimenez, Eva; Knecht, Erwin] Ctr Investigac Principe Felipe, Lab Biol Celular, Valencia, Spain; [Riera, Marina; Gonzalez-Duarte, Roser] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Riera, Marina; Knecht, Erwin; Gonzalez-Duarte, Roser] CIBERER, Madrid, Spain	Prince Felipe Research Center; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Knecht, E (corresponding author), Ctr Investigac Principe Felipe, Lab Biol Celular, Valencia, Spain.	knecht@cipf.es	Pérez-Jiménez, Eva/K-4345-2014; Knecht, Erwin/K-2432-2014; Knecht, Erwin/A-9366-2014	Pérez-Jiménez, Eva/0000-0001-7076-9577; Knecht, Erwin/0000-0002-7208-3832; 	Ministerio de Ciencia e Innovacion [BFU2011-22630, SAF2009-08079]; Generalitat Valenciana [PROMETEO/2012/061, 2009SGR-1427]; Fundacio Marato TV3 [100130]; CIBERER [U718]; Retina Asturias; ONCE; fellowship BES [2009-16033]; fellowship FPU [AP2007-00805]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Fundacio Marato TV3; CIBERER; Retina Asturias; ONCE; fellowship BES; fellowship FPU	This study was supported by grants BFU2011-22630 (Ministerio de Ciencia e Innovacion), PROMETEO/2012/061 (Generalitat Valenciana) and Fundacio Marato TV3 (Grant number 100130) to E.K. and SAF2009-08079 (Ministerio de Ciencia e Innovacion), 2009SGR-1427 (Generalitat de Catalunya), CIBERER (U718), Retina Asturias and ONCE to R.G.-D. A.F. and M.R. were in receipt of the fellowships BES 2009-16033 and FPU AP2007-00805, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman TS, 2009, INVEST OPHTH VIS SCI, V50, P5944, DOI 10.1167/iovs.09-3982; Ali M, 2008, MOL VIS, V14, P1960; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arhzaouy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052956; Bornancin FR, 2005, BBA-MOL CELL BIOL L, V1687, P31, DOI 10.1016/j.bbalip.2004.11.012; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Esposito AM, 2010, JOVE-J VIS EXP, V40; Moruno-Manchon JF, 2013, BIOCHEM J, V449, P497, DOI 10.1042/BJ20121122; Fitzgerald JB, 2008, ADV EXP MED BIOL, V613, P327, DOI 10.1007/978-0-387-74904-4_38; Garanto A, 2013, EXP EYE RES, V110, P96, DOI 10.1016/j.exer.2013.03.003; Garanto A, 2012, BBA-MOL BASIS DIS, V1822, P1258, DOI 10.1016/j.bbadis.2012.04.004; Garanto A, 2011, INVEST OPHTH VIS SCI, V52, P5202, DOI 10.1167/iovs.10-7101; Ghislat G, 2012, J CELL SCI, V125, P92, DOI 10.1242/jcs.086728; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Hammarskjold M. L., 2006, PROTOCOL EXCHANGE, DOI [DOI 10.1038/NPROT.2006.216, 10.1038/nprot.2006.216]; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Inagaki Y, 2006, BIOCHEM BIOPH RES CO, V343, P982, DOI 10.1016/j.bbrc.2006.03.056; Karunakaran DKP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075964; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Libonati M, 2004, BIOCHEM J, V380, P311, DOI 10.1042/BJ20031922; Mandal NA, 2013, EXP EYE RES, V106, P24, DOI 10.1016/j.exer.2012.10.014; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Naarmann IS, 2010, RNA, V16, P2189, DOI 10.1261/rna.2211110; Nevet MJ, 2012, INVEST OPHTH VIS SCI, V53, P4565, DOI 10.1167/iovs.12-9770; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Riera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064048; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stoecklin G, 2013, ADV EXP MED BIOL, V768, P197, DOI 10.1007/978-1-4614-5107-5_12; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Tuson M, 2004, AM J HUM GENET, V74, P128, DOI 10.1086/381055; Tuson M, 2009, MOL VIS, V15, P168; Vekslin S, 2010, MOL VIS, V16, P2539; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511	39	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87898	10.1371/journal.pone.0087898	http://dx.doi.org/10.1371/journal.pone.0087898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498393	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900139
J	Johnson, KA; Ve, T; Larsen, O; Pedersen, RB; Lillehaug, JR; Jensen, HB; Helland, R; Karlsen, OA				Johnson, Kenneth A.; Ve, Thomas; Larsen, Oivind; Pedersen, Rolf B.; Lillehaug, Johan R.; Jensen, Harald B.; Helland, Ronny; Karlsen, Odd A.			CorA Is a Copper Repressible Surface-Associated Copper(I)-Binding Protein Produced in Methylomicrobium album BG8	PLOS ONE			English	Article							METHYLOCOCCUS-CAPSULATUS BATH; PARTICULATE METHANE MONOOXYGENASE; METHYLOSINUS-TRICHOSPORIUM OB3B; CYTOCHROME-C PEROXIDASE; FORMALDEHYDE DEHYDROGENASE; SECONDARY-STRUCTURE; GENOME SEQUENCE; BINDING-SITES; METAL SITES; METHANOTROPH	CorA is a copper repressible protein previously identified in the methanotrophic bacterium Methylomicrobium album BG8. In this work, we demonstrate that CorA is located on the cell surface and binds one copper ion per protein molecule, which, based on X-ray Absorption Near Edge Structure analysis, is in the reduced state (Cu(I)). The structure of endogenously expressed CorA was solved using X-ray crystallography. The 1.6 angstrom three-dimensional structure confirmed the binding of copper and revealed that the copper atom was coordinated in a mononuclear binding site defined by two histidines, one water molecule, and the tryptophan metabolite, kynurenine. This arrangement of the copper-binding site is similar to that of its homologous protein MopE* from Metylococcus capsulatus Bath, confirming the importance of kynurenine for copper binding in these proteins. Our findings show that CorA has an overall fold similar to MopE, including the unique copper(I)-binding site and most of the secondary structure elements. We suggest that CorA plays a role in the M. album BG8 copper acquisition.	[Johnson, Kenneth A.; Helland, Ronny] Univ Tromso, Fac Sci, Norwegian Struct Biol Ctr, Tromso, Norway; [Ve, Thomas; Larsen, Oivind; Lillehaug, Johan R.; Jensen, Harald B.; Karlsen, Odd A.] Univ Bergen, Dept Mol Biol, Bergen, Norway; [Pedersen, Rolf B.] Univ Bergen, Ctr Geobiol, Dept Earth Sci, Bergen, Norway	UiT The Arctic University of Tromso; University of Bergen; University of Bergen	Karlsen, OA (corresponding author), Univ Bergen, Dept Mol Biol, Bergen, Norway.	odd.karlsen@mbi.uib.no	Ve, Thomas/AEK-1006-2022	Ve, Thomas/0000-0002-0113-1905	Research Council of Norway [101742]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway (grant no. 101742, www.forskningsradet.no). Provision of beamtime at the MX beamlines at the European Synchrotron Radiation Facility (ESRF), Grenoble, France, and travel support from the Synchrotron programme of RCN are greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berson O, 1997, FEMS MICROBIOL LETT, V148, P169, DOI 10.1016/S0378-1097(97)00029-3; BIOL C, J BIOL CHEM, V283, P9753, DOI DOI 10.1107/S0907444904026460; Burmeister WP, 2000, ACTA CRYSTALLOGR D, V56, P328, DOI 10.1107/S0907444999016261; Choi DW, 2010, J INORG BIOCHEM, V104, P1240, DOI 10.1016/j.jinorgbio.2010.08.002; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; Choi DW, 2006, BIOCHEMISTRY-US, V45, P1442, DOI 10.1021/bi051815t; Dalton H, 1984, MICROBIOLOGY, P75; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fjellbirkeland A, 2001, ARCH MICROBIOL, V176, P197, DOI 10.1007/s002030100307; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hatcher LQ, 2008, J PHYS CHEM B, V112, P8160, DOI 10.1021/jp710806s; Helland R, 2008, J BIOL CHEM, V283, P13897, DOI 10.1074/jbc.M800340200; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kao WC, 2004, J BIOL CHEM, V279, P51554, DOI 10.1074/jbc.M408013200; Karlsen OA, 2008, MOL MICROBIOL, V70, P15, DOI 10.1111/j.1365-2958.2008.06380.x; Karlsen OA, 2010, MICROBIOL-SGM, V156, P2682, DOI 10.1099/mic.0.037119-0; Karlsen OA, 2005, FEBS J, V272, P2428, DOI 10.1111/j.1742-4658.2005.04663.x; Karlsen OA, 2005, FEBS J, V272, P6324, DOI 10.1111/j.1742-4658.2005.05020.x; Karlsen OA, 2003, APPL ENVIRON MICROB, V69, P2386, DOI 10.1128/AEM.69.4.2386-2388.2003; Karlsen OA, 2011, FEMS MICROBIOL LETT, V323, P97, DOI 10.1111/j.1574-6968.2011.02365.x; Karlsen OA, 2011, METHOD ENZYMOL, P167, DOI 10.1016/B978-0-12-386905-0.00011-5; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Kenney GE, 2012, ACS CHEM BIOL, V7, pA, DOI 10.1021/cb2003913; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laugesen S, 2003, J AM SOC MASS SPECTR, V14, P992, DOI 10.1016/S1044-0305(03)00262-9; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; Lloyd JS, 1999, ARCH MICROBIOL, V171, P364, DOI 10.1007/s002030050723; Lontoh S, 1998, APPL ENVIRON MICROB, V64, P1106; Martell AE, 1974, SCIENCE; MARTELL AE, 1974, CRITICAL STABILITY C, DOI DOI 10.1074/JBC.M110.213074; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen AK, 1996, MICROBIOL-UK, V142, P1289, DOI 10.1099/13500872-142-5-1289; Nielsen AK, 1997, MOL MICROBIOL, V25, P399, DOI 10.1046/j.1365-2958.1997.4801846.x; Pearson AR, 2004, BIOCHEMISTRY-US, V43, P5494, DOI 10.1021/bi049863l; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, P25; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PRIOR SD, 1985, J GEN MICROBIOL, V131, P155; Rupp B, 2003, J STRUCT BIOL, V142, P162, DOI 10.1016/S1047-8477(03)00047-9; Semrau JD, 2010, FEMS MICROBIOL REV, V34, P496, DOI 10.1111/j.1574-6976.2010.00212.x; Shchukin VN, 2011, MICROBIOLOGY+, V80, P608, DOI 10.1134/S0026261711050122; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STANLEY SH, 1983, BIOTECHNOL LETT, V5, P487, DOI 10.1007/BF00132233; Stein LY, 2010, J BACTERIOL, V192, P6497, DOI 10.1128/JB.01144-10; Svenning MM, 2011, J BACTERIOL, V193, P6418, DOI 10.1128/JB.05380-11; Tate S, 1999, MICROBIOL-UK, V145, P159, DOI 10.1099/13500872-145-1-159; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Ve T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043146; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Vorholt JA, 1999, J BACTERIOL, V181, P5750, DOI 10.1128/JB.181.18.5750-5757.1999; Wang YT, 2003, BIOCHEMISTRY-US, V42, P7318, DOI 10.1021/bi034243q; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Yang W, 2002, PROTEINS, V47, P344, DOI 10.1002/prot.10093; Zahn JA, 2001, J BACTERIOL, V183, P6832, DOI 10.1128/JB.183.23.6832-6840.2001	67	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87750	10.1371/journal.pone.0087750	http://dx.doi.org/10.1371/journal.pone.0087750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498370	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900116
J	Martelli, D; Luppi, M; Cerri, M; Tupone, D; Mastrotto, M; Perez, E; Zamboni, G; Amici, R				Martelli, Davide; Luppi, Marco; Cerri, Matteo; Tupone, Domenico; Mastrotto, Marco; Perez, Emanuele; Zamboni, Giovanni; Amici, Roberto			The Direct Cooling of the Preoptic-Hypothalamic Area Elicits the Release of Thyroid Stimulating Hormone during Wakefulness but Not during REM Sleep	PLOS ONE			English	Article							PARAVENTRICULAR NUCLEUS; AMBIENT-TEMPERATURE; GROWTH-HORMONE; SPRAGUE-DAWLEY; COLD-EXPOSURE; RAT; THYROTROPIN; RESPONSES; CYCLE; DEPRIVATION	Thermoregulatory responses to temperature changes are not operant during REM sleep (REMS), but fully operant in non-REM sleep and wakefulness. The specificity of the relationship between REMS and the impairment of thermoregulation was tested by eliciting the reflex release of Thyrotropin Releasing Hormone (TRH), which is integrated at hypothalamic level. By inducing the sequential secretion of Thyroid Stimulating Hormone (TSH) and Thyroid Hormone, TRH intervenes in the regulation of obligatory and non-shivering thermogenesis. Experiments were performed on male albino rats implanted with epidural electrodes for EEG recording and 2 silver-copper wire thermodes, bilaterally placed in the preoptic-hypothalamic area (POA) and connected to small thermoelectric heat pumps driven by a low-voltage high current DC power supply. In preliminary experiments, a thermistor was added in order to measure hypothalamic temperature. The activation of TRH hypophysiotropic neurons by the thermode cooling of POA was indirectly assessed, in conditions in which thermoregulation was either fully operant (wakefulness) or not operant (REMS), by a radioimmunoassay determination of plasmatic levels of TSH. Different POA cooling were performed for 120 s or 40 s at current intensities of 80 mA and 125 mA, respectively. At both current intensities, POA cooling elicited, with respect to control values (no cooling current), a significant increase in plasmatic TSH levels in wakefulness, but not during REMS. These results confirm the inactivation of POA thermal sensitivity during REMS and show, for the first time, that this inactivation concerns also the fundamental endocrine control of non-shivering thermogenesis.	[Martelli, Davide; Luppi, Marco; Cerri, Matteo; Tupone, Domenico; Mastrotto, Marco; Perez, Emanuele; Zamboni, Giovanni; Amici, Roberto] Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy; [Martelli, Davide] Univ Melbourne, Syst Neurophysiol Div, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Tupone, Domenico] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Mastrotto, Marco] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Mastrotto, Marco] Yale Univ, Sch Med, Ctr Neurodegenerat & Repair, New Haven, CT USA	University of Bologna; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Oregon Health & Science University; Yale University; Yale University	Zamboni, G (corresponding author), Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy.	giovanni.zamboni@unibo.it	Tupone, Domenico/M-8079-2016; Cerri, Matteo/F-5009-2017; Martelli, Davide/Q-7375-2016; Luppi, Marco/AGH-3155-2022	Tupone, Domenico/0000-0002-4238-1011; Cerri, Matteo/0000-0003-3556-305X; Luppi, Marco/0000-0002-9462-5014; Martelli, Davide/0000-0001-6523-9598	Ministero dell'Universita e della Ricerca Scientifica (MIUR), Italy	Ministero dell'Universita e della Ricerca Scientifica (MIUR), Italy(Ministry of Education, Universities and Research (MIUR))	This work has been supported by the Ministero dell'Universita e della Ricerca Scientifica (MIUR), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici R, 1994, J SLEEP RES, V3, P195; ANDERSSON B, 1963, ACTA PHYSIOL SCAND, V59, P67, DOI 10.1111/j.1748-1716.1963.tb02724.x; Baracchi F, 2008, J SLEEP RES, V17, P166, DOI 10.1111/j.1365-2869.2008.00658.x; Bertani S, 2010, IN VIVO, V24, P827; BRUHN TO, 1992, ENDOCRINOLOGY, V131, P2615, DOI 10.1210/en.131.6.2615; CALASSO M, 1993, AM J PHYSIOL, V265, pR1060; Cerri M, 2005, SLEEP, V28, P694, DOI 10.1093/sleep/28.6.694; Choksi NY, 2003, BIRTH DEFECTS RES B, V68, P479, DOI 10.1002/bdrb.10045; CONNORS JM, 1984, ENDOCRINOLOGY, V114, P1930, DOI 10.1210/endo-114-5-1930; Fail PA, 1999, TOXICOL SCI, V52, P107, DOI 10.1093/toxsci/52.1.107; FEWELL JE, 1990, J DEV PHYSIOL, V13, P223; FLORANT GL, 1978, AM J PHYSIOL, V235, pR82, DOI 10.1152/ajpregu.1978.235.1.R82; GALE CC, 1970, AM J PHYSIOL, V219, P193, DOI 10.1152/ajplegacy.1970.219.1.193; GLOTZBACH SF, 1976, SCIENCE, V194, P537, DOI 10.1126/science.973138; Koban M, 2006, ENDOCRINOLOGY, V147, P421, DOI 10.1210/en.2005-0695; LARSEN PJ, 1994, J COMP NEUROL, V342, P299, DOI 10.1002/cne.903420211; Luppi H, 2012, PFLUG ARCH EUR J PHY, V463, P43; Luppi M, 2010, J SLEEP RES, V19, P394, DOI 10.1111/j.1365-2869.2009.00810.x; Marti O, 1996, EUR J ENDOCRINOL, V135, P703, DOI 10.1530/eje.0.1350703; Morrison SF, 2011, CENTRAL REGULATION A, P324; Parmeggiani P.L., 2011, SYSTEMIC HOMEOSTASIS; PARMEGGIANI PL, 1973, BRAIN RES, V52, P189, DOI 10.1016/0006-8993(73)90658-6; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; RECHTSCHAFFEN A, 1989, SLEEP, V12, P68; Savage VM, 2007, P NATL ACAD SCI USA, V104, P1051, DOI 10.1073/pnas.0610080104; SCHMIDEK WR, 1983, BRAIN RES, V288, P261, DOI 10.1016/0006-8993(83)90102-6; SICHIERI R, 1984, PHYSIOL BEHAV, V33, P871, DOI 10.1016/0031-9384(84)90221-X; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; SILVA JE, 1978, ENDOCRINOLOGY, V102, P1783, DOI 10.1210/endo-102-6-1783; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; Simon E, 1999, JPN J PHYSIOL, V49, P297, DOI 10.2170/jjphysiol.49.297	31	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87793	10.1371/journal.pone.0087793	http://dx.doi.org/10.1371/journal.pone.0087793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498374	Green Published, gold			2022-12-25	WOS:000330626900120
J	Michta, E; Ding, W; Zhu, SC; Blin, K; Ruan, HQ; Wang, R; Wohlleben, W; Mast, Y				Michta, Ewelina; Ding, Wei; Zhu, Shaochun; Blin, Kai; Ruan, Hongqiang; Wang, Rui; Wohlleben, Wolfgang; Mast, Yvonne			Proteomic Approach to Reveal the Regulatory Function of Aconitase AcnA in Oxidative Stress Response in the Antibiotic Producer Streptomyces viridochromogenes Tu494	PLOS ONE			English	Article							BACILLUS-SUBTILIS ACONITASE; ESCHERICHIA-COLI ACONITASES; FACTOR EF-TU; LACTOCOCCUS-LACTIS; RNA-BINDING; POSTTRANSCRIPTIONAL REGULATION; SACCHAROMYCES-CEREVISIAE; MYCOBACTERIUM-SMEGMATIS; SALMONELLA-TYPHIMURIUM; THIOREDOXIN SYSTEM	The aconitase AcnA from the phosphinothricin tripeptide producing strain Streptomyces viridochromogenes Tu494 is a bifunctional protein: under iron-sufficiency conditions AcnA functions as an enzyme of the tricarboxylic acid cycle, whereas under iron depletion it is a regulator of iron metabolism and oxidative stress response. As a member of the family of iron regulatory proteins (IRP), AcnA binds to characteristic iron responsive element (IRE) binding motifs and post-transcriptionally controls the expression of respective target genes. A S. viridochromogenes aconitase mutant (MacnA) has previously been shown to be highly sensitive to oxidative stress. In the present paper, we performed a comparative proteomic approach with the S. viridochromogenes wild-type and the MacnA mutant strain under oxidative stress conditions to identify proteins that are under control of the AcnA-mediated regulation. We identified up to 90 differentially expressed proteins in both strains. In silico analysis of the corresponding gene sequences revealed the presence of IRE motifs on some of the respective target mRNAs. From this proteome study we have in vivo evidences for a direct AcnA-mediated regulation upon oxidative stress.	[Michta, Ewelina; Blin, Kai; Wohlleben, Wolfgang; Mast, Yvonne] Univ Tubingen, Dept Microbiol Biotechnol, Interfaculty Inst Microbiol & Infect Med, Tubingen, Germany; [Ding, Wei; Zhu, Shaochun; Ruan, Hongqiang; Wang, Rui] Shanghai Appl Prot Technol Co Ltd, Shanghai, Peoples R China; [Wang, Rui] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai, Peoples R China	Eberhard Karls University of Tubingen; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Mast, Y (corresponding author), Univ Tubingen, Dept Microbiol Biotechnol, Interfaculty Inst Microbiol & Infect Med, Tubingen, Germany.	yvonne.mast@biotech.uni-tuebingen.de	Mast, Yvonne/AAC-8145-2019; Blin, Kai/ABD-5377-2021	Mast, Yvonne/0000-0003-3099-5777; Blin, Kai/0000-0003-3764-6051	Deutsche Forschungsgemeinschaft [SPP1152: Wo 485/7-1, SPP1152: Wo 485/7-2, SPP1152: Wo 485/7-3]; Federal Ministry of Education and Research (GenBioCom) [0315585A]; ministry of Baden-Wurttemberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (GenBioCom); ministry of Baden-Wurttemberg	This research was supported by grants from the Deutsche Forschungsgemeinschaft (SPP1152: Wo 485/7-1,2,3) and the Federal Ministry of Education and Research (GenBioCom #0315585A). EM acknowledges the scholarship Aufenthalt fur anwendungsorientierte Biowissenschaftler(innen) und Biotechnolog(inn)en in Shanghai und Jiangsu/China from the ministry of Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal H, 2012, PLOS NEGLECT TROP D, V6, P1831; Alen C, 1999, P NATL ACAD SCI USA, V96, P10412, DOI 10.1073/pnas.96.18.10412; Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; Ballal A, 2009, J BACTERIOL, V191, P3301, DOI 10.1128/JB.01496-08; Banerjee S, 2007, J BACTERIOL, V189, P4046, DOI 10.1128/JB.00026-07; Biswas T, 2010, STRUCTURE, V18, P1353, DOI 10.1016/j.str.2010.06.017; Boes N, 2006, J BACTERIOL, V188, P6529, DOI 10.1128/JB.00308-06; Borsetti F, 2005, RES MICROBIOL, V156, P807, DOI 10.1016/j.resmic.2005.03.011; Bougdour A, 2007, P NATL ACAD SCI USA, V104, P12896, DOI 10.1073/pnas.0705561104; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN OR, 1983, FUND APPL TOXICOL, V3, P209, DOI 10.1016/S0272-0590(83)80127-4; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Comtois SL, 2003, MICROBIOL-SGM, V149, P121, DOI 10.1099/mic.0.25896-0; De Mot R, 2007, ARCH MICROBIOL, V188, P257, DOI 10.1007/s00203-007-0243-8; Dupuy J, 2006, STRUCTURE, V14, P129, DOI 10.1016/j.str.2005.09.009; Duwat P, 1999, MOL MICROBIOL, V31, P845, DOI 10.1046/j.1365-2958.1999.01222.x; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Hammad Y, 2001, CAN J MICROBIOL, V47, P541, DOI 10.1139/cjm-47-6-541; Han WD, 1998, GENE, V217, P31, DOI 10.1016/S0378-1119(98)00378-3; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Herbert D., 1971, METHODS MICROBIOLOGY, V5, P290, DOI [DOI 10.1016/S0580-9517(08)70641-X, 10.1007/978-3-030-30515-4_14]; HINDLE Z, 1994, MOL MICROBIOL, V12, P737, DOI 10.1111/j.1365-2958.1994.tb01061.x; ILETT KF, 1974, TOXICOL APPL PHARM, V28, P216, DOI 10.1016/0041-008X(74)90007-6; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Karavolos MH, 2009, MICROBIOLOGY, V149, P2749; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; Kim JH, 1999, BIOTECHNOL LETT, V21, P759, DOI 10.1023/A:1005547328500; Krab IM, 1998, BBA-GENE STRUCT EXPR, V1443, P1, DOI 10.1016/S0167-4781(98)00169-9; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Langlois P, 2003, APPL ENVIRON MICROB, V69, P1884, DOI 10.1128/AEM.69.4.1884-1889.2003; Liedert C, 2012, J BACTERIOL, V194, P1552, DOI 10.1128/JB.06429-11; Michta E, 2012, ENVIRON MICROBIOL, V14, P3203, DOI 10.1111/1462-2920.12006; Miyamoto Y, 2003, BIOL CHEM, V384, P567, DOI 10.1515/BC.2003.064; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Muela A, 2008, FEMS MICROBIOL ECOL, V64, P28, DOI 10.1111/j.1574-6941.2008.00453.x; Muschko K, 2002, ARCH MICROBIOL, V178, P499, DOI 10.1007/s00203-002-0483-6; Nunez MT, 2003, BIOMETALS, V16, P83, DOI 10.1023/A:1020743405347; O'Toole R, 2003, J BACTERIOL, V185, P1543, DOI 10.1128/JB.185.5.1543-1554.2003; ONEAL CR, 1994, J BACTERIOL, V176, P4610, DOI 10.1128/JB.176.15.4610-4616.1994; Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Perez JFC, 2007, ARCH LATINOAM NUTR, V57, P211; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Qi Y, 1997, J BACTERIOL, V179, P2534, DOI 10.1128/jb.179.8.2534-2539.1997; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Ritz D, 2000, J BIOL CHEM, V275, P2505, DOI 10.1074/jbc.275.4.2505; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; Schinko E, 2009, PHYTOCHEMISTRY, V70, P1787, DOI 10.1016/j.phytochem.2009.09.002; Schwartz D, 1999, J BACTERIOL, V181, P7131, DOI 10.1128/JB.181.22.7131-7135.1999; Serio AW, 2006, J BACTERIOL, V188, P6396, DOI 10.1128/JB.00249-06; SHIM MS, 1993, FEMS MICROBIOL LETT, V108, P11; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Son MW, 1998, ARCH PHARM RES, V21, P531, DOI 10.1007/BF02975370; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; SPECTOR MP, 1986, J BACTERIOL, V168, P420, DOI 10.1128/jb.168.1.420-424.1986; STEELS EL, 1994, MICROBIOL-SGM, V140, P569, DOI 10.1099/00221287-140-3-569; Stefankova P, 2006, J BASIC MICROB, V46, P47, DOI 10.1002/jobm.200510036; SUUTARI M, 1992, BIOCHIM BIOPHYS ACTA, V1126, P119, DOI 10.1016/0005-2760(92)90281-Y; Tang Y, 1999, MICROBIOL-SGM, V145, P3069, DOI 10.1099/00221287-145-11-3069; Tang Y, 2002, MICROBIOL-SGM, V148, P1027, DOI 10.1099/00221287-148-4-1027; Turner MS, 2007, APPL ENVIRON MICROB, V73, P6144, DOI 10.1128/AEM.00413-07; VANBOGELEN RA, 1987, J BACTERIOL, V169, P26, DOI 10.1128/jb.169.1.26-32.1987; WEBB DC, 1992, J BIOL CHEM, V267, P24661; Wieles B, 1997, INFECT IMMUN, V65, P2537, DOI 10.1128/IAI.65.7.2537-2541.1997; Xiao M, 2011, MICROBIOL-SGM, V157, P1573, DOI 10.1099/mic.0.044297-0; Yao YA, 2011, PLANTA, V233, P523, DOI 10.1007/s00425-010-1311-x; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1	72	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87905	10.1371/journal.pone.0087905	http://dx.doi.org/10.1371/journal.pone.0087905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498397	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900143
J	Noujaim, M; Bechstedt, S; Wieczorek, M; Brouhard, GJ				Noujaim, Michael; Bechstedt, Susanne; Wieczorek, Michal; Brouhard, Gary J.			Microtubules Accelerate the Kinase Activity of Aurora-B by a Reduction in Dimensionality	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; CENTROMERE PROTEIN INCENP; INNER CENTROMERE; PHOSPHORYLATION GRADIENT; BINDING PROTEINS; URACIL-EXCISION; SPINDLE; KINETOCHORE; ACTIVATION; DYNAMICS	Aurora-B is the kinase subunit of the Chromosome Passenger Complex (CPC), a key regulator of mitotic progression that corrects improper kinetochore attachments and establishes the spindle midzone. Recent work has demonstrated that the CPC is a microtubule-associated protein complex and that microtubules are able to activate the CPC by contributing to Aurora-B auto-phosphorylation in trans. Aurora-B activation is thought to occur when the local concentration of Aurora-B is high, as occurs when Aurora-B is enriched at centromeres. It is not clear, however, whether distributed binding to large structures such as microtubules would increase the local concentration of Aurora-B. Here we show that microtubules accelerate the kinase activity of Aurora-B by a "reduction in dimensionality." We find that microtubules increase the kinase activity of Aurora-B toward microtubule-associated substrates while reducing the phosphorylation levels of substrates not associated to microtubules. Using the single molecule assay for microtubule-associated proteins, we show that a minimal CPC construct binds to microtubules and diffuses in a one-dimensional (1D) random walk. The binding of Aurora-B to microtubules is salt-dependent and requires the C-terminal tails of tubulin, indicating that the interaction is electrostatic. We show that the rate of Aurora-B auto-activation is faster with increasing concentrations of microtubules. Finally, we demonstrate that microtubules lose their ability to stimulate Aurora-B when their C-terminal tails are removed by proteolysis. We propose a model in which microtubules act as scaffolds for the enzymatic activity of Aurora-B. The scaffolding activity of microtubules enables rapid Aurora-B activation and efficient phosphorylation of microtubule-associated substrates.	[Noujaim, Michael; Bechstedt, Susanne; Wieczorek, Michal; Brouhard, Gary J.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Brouhard, GJ (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	gary.brouhard@mcgill.ca	Brouhard, Gary/AAZ-7789-2021	Wieczorek, Michal/0000-0003-3067-7314; Noujaim, Michael/0000-0001-9329-5765	Canadian Institutes of Health Research [CIHR MOP-104150, MOP-111265]; Natural Sciences and Engineering Research Council (NSERC) [372593-09]; NSERC Canada Graduate Scholarship; CIHR New Investigator Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grants from the Canadian Institutes of Health Research (CIHR MOP-104150 and MOP-111265 to G.J.B.) and the Natural Sciences and Engineering Research Council (NSERC #372593-09 to G.J.B.). M.W. is supported by an NSERC Canada Graduate Scholarship. G.J.B. is the recipient of a CIHR New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam G., 1968, REDUCTION DIMENSIONA, P198; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Bitinaite J, 2007, NUCLEIC ACIDS RES, V35, P1992, DOI 10.1093/nar/gkm041; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Campbell CS, 2013, NATURE, V497, P118, DOI 10.1038/nature12057; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; CHAN CSM, 1993, GENETICS, V135, P677; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; CHOI KY, 1994, CELL, V78, P499; COOKE CA, 1987, J CELL BIOL, V105, P2053, DOI 10.1083/jcb.105.5.2053; Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; Cormier A, 2013, J BIOL CHEM; Elkins JM, 2012, J MED CHEM, V55, P7841, DOI 10.1021/jm3008954; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gold MG, 2006, CURR OPIN STRUC BIOL, V16, P693, DOI 10.1016/j.sbi.2006.10.006; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; HYMAN AA, 1991, J CELL SCI, P125; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lewellyn L, 2011, J CELL BIOL, V193, P155, DOI 10.1083/jcb.201008138; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; MCCLOSKEY MA, 1986, J CELL BIOL, V102, P88, DOI 10.1083/jcb.102.1.88; Morishita J, 2001, GENES CELLS, V6, P743, DOI 10.1046/j.1365-2443.2001.00459.x; Nakajima Y, 2011, J CELL BIOL, V194, P137, DOI 10.1083/jcb.201009137; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Skoufias DA, 2000, J CELL BIOL, V151, P1575, DOI 10.1083/jcb.151.7.1575; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tseng BS, 2010, DEV CELL, V18, P903, DOI 10.1016/j.devcel.2010.05.018; Wang EX, 2011, J CELL BIOL, V194, P538, DOI 10.1083/jcb.201103044; Wang ZX, 2002, BIOCHEM J, V368, P947, DOI 10.1042/BJ20020557; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	53	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86786	10.1371/journal.pone.0086786	http://dx.doi.org/10.1371/journal.pone.0086786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498282	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900028
J	Shimizu, K; Asakawa, T; Harada, N; Fukumoto, D; Tsukada, H; Asai, T; Yamada, S; Kan, T; Oku, N				Shimizu, Kosuke; Asakawa, Tomohiro; Harada, Norihiro; Fukumoto, Dai; Tsukada, Hideo; Asai, Tomohiro; Yamada, Shizuo; Kan, Toshiyuki; Oku, Naoto			Use of Positron Emission Tomography for Real-Time Imaging of Biodistribution of Green Tea Catechin	PLOS ONE			English	Article							(-)-EPIGALLOCATECHIN GALLATE; RECEPTOR; EPIGALLOCATECHIN-3-GALLATE; ENZYMOLOGY; APOPTOSIS	The aim of this study was to achieve real-time imaging of the in vivo behavior of a green tea polyphenol, catechin, by positron emission tomography (PET). Positron-labeled 4 ''-[C-11] methyl-epigallocatechin gallate ([C-11]Me-EGCG) was orally administered to rats, and its biodistribution was imaged for 60 min by using a small animal PET system. As the result, images of [C-11] Me-EGCG passing through the stomach into the small intestines were observed; and a portion of it was quantitatively detected in the liver. On the other hand, intravenous injection of [C-11] Me-EGCG resulted in a temporal accumulation of the labeled catechin in the liver, after which almost all of it was transferred to the small intestines within 60 min. In the present study, we succeeded in obtaining real-time imaging of the absorption and biodistribution of [C-11]Me-EGCG with a PET system.	[Shimizu, Kosuke; Asai, Tomohiro; Oku, Naoto] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Shizuoka 4228526, Japan; [Asakawa, Tomohiro; Kan, Toshiyuki] Univ Shizuoka, Sch Pharmaceut Sci, Dept Synthet Organ & Med Chem, Shizuoka 4228526, Japan; [Harada, Norihiro; Fukumoto, Dai; Tsukada, Hideo] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Yamada, Shizuo] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacokinet & Pharmacodynam, Shizuoka 4228526, Japan	University of Shizuoka; University of Shizuoka; Hamamatsu Photonics; University of Shizuoka	Oku, N (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Shizuoka 4228526, Japan.	oku@u-shizuoka-ken.ac.jp	Harada, Norihiro/Q-2592-2018	Harada, Norihiro/0000-0003-4558-6917; Shimizu, Kosuke/0000-0003-3789-2447; Kan, Toshiyuki/0000-0002-9709-6365	Shizuoka Prefecture; Shizuoka City Collaboration of Regional Entities for the Advancement of Technological Excellence; Japan Science and Technology Agency (JST); University of Shizuoka; Grants-in-Aid for Scientific Research [26102736] Funding Source: KAKEN	Shizuoka Prefecture; Shizuoka City Collaboration of Regional Entities for the Advancement of Technological Excellence; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); University of Shizuoka; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a project of the Shizuoka Prefecture and Shizuoka City Collaboration of Regional Entities for the Advancement of Technological Excellence, by the Japan Science and Technology Agency (JST), and by University of Shizuoka.	Aihara Y, 2009, BIOORG MED CHEM LETT, V19, P4171, DOI 10.1016/j.bmcl.2009.05.111; Asakawa T, 2011, CHEM COMMUN, V47, P2868, DOI 10.1039/c0cc04936k; Chen LS, 1997, DRUG METAB DISPOS, V25, P1045; Gulyas B, 2002, EUR J NUCL MED MOL I, V29, P1031, DOI 10.1007/s00259-002-0823-4; Hatanaka K, 2010, BIOCONJUGATE CHEM, V21, P756, DOI 10.1021/bc9005267; Kang TH, 2007, CANCER RES, V67, P802, DOI 10.1158/0008-5472.CAN-06-2638; Kumazoe M, 2013, FEBS LETT, V587, P3052, DOI 10.1016/j.febslet.2013.07.041; Kumazoe M, 2013, J CLIN INVEST, V123, P787, DOI 10.1172/JCI64768; Lambert JD, 2003, J NUTR, V133, P4172, DOI 10.1093/jn/133.12.4172; Lu H, 2003, DRUG METAB DISPOS, V31, P452, DOI 10.1124/dmd.31.4.452; Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572; Misaka S, 2013, BIOMED CHROMATOGR, V27, P1, DOI 10.1002/bmc.2740; SUZUKI K, 1990, APPL RADIAT ISOTOPES, V41, P593; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Urakami T, 2009, ARTIF ORGANS, V33, P164, DOI 10.1111/j.1525-1594.2008.00702.x; Yamakawa S, 2004, CANCER LETT, V210, P47, DOI 10.1016/j.canlet.2004.03.008; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yoshida A, 2011, CHEM COMMUN, V47, P1794, DOI 10.1039/c0cc03676e	18	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e85520	10.1371/journal.pone.0085520	http://dx.doi.org/10.1371/journal.pone.0085520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498262	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900008
J	St Amand, MM; Tran, K; Radhakrishnan, D; Robinson, AS; Ogunnaike, BA				St Amand, Melissa M.; Tran, Kevin; Radhakrishnan, Devesh; Robinson, Anne S.; Ogunnaike, Babatunde A.			Controllability Analysis of Protein Glycosylation in Cho Cells	PLOS ONE			English	Article							ANTIBODY EFFECTOR FUNCTIONS; MATHEMATICAL-MODEL; BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE III; THERAPEUTIC ANTIBODIES; GENE-EXPRESSION; OVEREXPRESSION	To function as intended in vivo, a majority of biopharmaceuticals require specific glycan distributions. However, achieving a precise glycan distribution during manufacturing can be challenging because glycosylation is a non-template driven cellular process, with the potential for significant uncontrolled variability in glycan distributions. As important as the glycan distribution is to the end-use performance of biopharmaceuticals, to date, no strategy exists for controlling glycosylation on-line. However, before expending the significant amount of effort and expense required to develop and implement on-line control strategies to address the problem of glycosylation heterogeneity, it is imperative to assess first the extent to which the very complex process of glycosylation is controllable, thereby establishing what is theoretically achievable prior to any experimental attempts. In this work, we present a novel methodology for assessing the output controllability of glycosylation, a prototypical example of an extremely high-dimensional and very non-linear system. We first discuss a method for obtaining the process gain matrix for glycosylation that involves performing model simulations and data analysis systematically and judiciously according to a statistical design of experiments (DOE) scheme and then employing Analysis of Variance (ANOVA) to determine the elements of process gain matrix from the resulting simulation data. We then discuss how to use the resulting high-dimensional gain matrix to assess controllability. The utility of this method is demonstrated with a practical example where we assess the controllability of various classes of glycans and of specific glycoforms that are typically found in recombinant biologics produced with Chinese Hamster Ovary (CHO) cells. In addition to providing useful insight into the extent to which on-line glycosylation control is achievable in actual manufacturing processes, the results also have important implications for genetically engineering cell lines design for enhanced glycosylation controllability.	[St Amand, Melissa M.; Tran, Kevin; Radhakrishnan, Devesh; Robinson, Anne S.; Ogunnaike, Babatunde A.] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19716 USA; [Robinson, Anne S.] Tulane Univ, Dept Chem & Biomol Engn, New Orleans, LA 70118 USA	University of Delaware; Tulane University	Ogunnaike, BA (corresponding author), Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19716 USA.	ogunnaike@udel.edu	Ogunnaike, Babatunde/A-4894-2008; Robinson, Anne Skaja/H-7894-2012	Robinson, Anne Skaja/0000-0001-7235-1481; Ogunnaike, Babatunde/0000-0002-8246-070X	NSF- CBET [1034213]; NSF [2008067497]	NSF- CBET(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported by: NSF- CBET Grant # 1034213 and NSF Graduate Research Fellowship- 2008067497. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A, 2008, CURR PHARM BIOTECHNO, V9, P482, DOI 10.2174/138920108786786411; Box GE., 1978, STAT EXPT; Butler M, 2006, CYTOTECHNOLOGY, V50, P57, DOI 10.1007/s10616-005-4537-x; Chen PF, 2006, METAB ENG, V8, P123, DOI 10.1016/j.ymben.2005.10.002; del Val IJ, 2011, BIOTECHNOL PROGR, V27, P1730, DOI 10.1002/btpr.688; [FDA CDER C], 2009, PHARM DEV REVISION 1; Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777; Garcia VM, 2010, INT J HYDROGEN ENERG, V35, P9768, DOI 10.1016/j.ijhydene.2009.09.064; Geyer H, 2006, BBA-PROTEINS PROTEOM, V1764, P1853, DOI 10.1016/j.bbapap.2006.10.007; GOOCHEE CF, 1991, BIO-TECHNOL, V9, P1347, DOI 10.1038/nbt1291-1347; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Hossler P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000713; Kaymak DB, 2008, COMPUT CHEM ENG, V32, P1456, DOI 10.1016/j.compchemeng.2007.06.022; Kontoravdi C, 2007, COMPUT CHEM ENG, V31, P392, DOI 10.1016/j.compchemeng.2006.04.009; Krambeck FJ, 2005, BIOTECHNOL BIOENG, V92, P711, DOI 10.1002/bit.20645; Lay D, 2006, LINEAR ALGEBRA ITS A, P471; Lewin DR, 1996, COMPUT CHEM ENG, V20, pS871, DOI 10.1016/0098-1354(96)00153-6; Montgomery D.C., 2009, DESIGN ANAL EXPT, V7th; MORARI M, 1983, CHEM ENG SCI, V38, P1881, DOI 10.1016/0009-2509(83)85044-1; Ogunnaike BA, 2009, RANDOM PHENOMENA FUN, P789; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Ray WH., 1981, ADV PROCESS CONTROL; Satoh M, 2006, EXPERT OPIN BIOL TH, V6, P1161, DOI 10.1517/14712598.6.11.1161; Sburlati AR, 1998, BIOTECHNOL PROGR, V14, P189, DOI 10.1021/bp970118s; St Amand MM, UNPUB; Umana P, 1999, BIOTECHNOL BIOENG, V65, P542, DOI 10.1002/(SICI)1097-0290(19991205)65:5<542::AID-BIT7>3.3.CO;2-Q; Umana P, 1997, BIOTECHNOL BIOENG, V55, P890, DOI 10.1002/(SICI)1097-0290(19970920)55:6<890::AID-BIT7>3.0.CO;2-B; Vinson DR, 2000, J PROCESS CONTR, V10, P185, DOI 10.1016/S0959-1524(99)00045-1; Wong DCF, 2010, BIOTECHNOL BIOENG, V107, P516, DOI 10.1002/bit.22828; Wong NSC, 2010, BIOTECHNOL BIOENG, V107, P321, DOI 10.1002/bit.22812; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Zhao Y, 1997, IND ENG CHEM RES, V36, P697, DOI 10.1021/ie960123l	32	22	23	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87973	10.1371/journal.pone.0087973	http://dx.doi.org/10.1371/journal.pone.0087973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498415	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900161
J	Anastasia, A; Deinhardt, K; Wang, SY; Martin, L; Nichol, D; Irmady, K; Trinh, J; Parada, L; Rafii, S; Hempstead, BL; Kermani, P				Anastasia, Agustin; Deinhardt, Katrin; Wang, Shiyang; Martin, Laura; Nichol, Donna; Irmady, Krithi; Trinh, Jasmine; Parada, Luis; Rafii, Shahin; Hempstead, Barbara L.; Kermani, Pouneh			Trkb Signaling in Pericytes Is Required for Cardiac Microvessel Stabilization	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; PDGF-B; RECEPTOR; GROWTH; CELLS	Pericyte and vascular smooth muscle cell (SMC) recruitment to the developing vasculature is an important step in blood vessel maturation. Brain-derived neurotrophic factor (BDNF), expressed by endothelial cells, activates the receptor tyrosine kinase TrkB to stabilize the cardiac microvasculature in the perinatal period. However, the effects of the BDNF/TrkB signaling on pericytes/SMCs and the mechanisms downstream of TrkB that promote vessel maturation are unknown. To confirm the involvement of TrkB in vessel maturation, we evaluated TrkB deficient (trkb(-/-)) embryos and observed severe cardiac vascular abnormalities leading to lethality in late gestation to early prenatal life. Ultrastructural analysis demonstrates that trkb(-/-) embryos exhibit defects in endothelial cell integrity and perivascular edema. As TrkB is selectively expressed by pericytes and SMCs in the developing cardiac vasculature, we generated mice deficient in TrkB in these cells. Mice with TrkB deficiency in perivascular cells exhibit reduced pericyte/SMC coverage of the cardiac microvasculature, abnormal endothelial cell ultrastructure, and increased vascular permeability. To dissect biological actions and the signaling pathways downstream of TrkB in pericytes/SMCs, human umbilical SMCs were treated with BDNF. This induced membranous protrusions and cell migration, events dependent on myosin light chain phosphorylation. Moreover, inhibition of Rho GTPase and the Rho-associated protein kinase (ROCK) prevented membrane protrusion and myosin light chain phosphorylation in response to BDNF. These results suggest an important role for BDNF in regulating migration of TrkB-expressing pericytes/SMCs to promote cardiac blood vessel ensheathment and functional integrity during development.	[Anastasia, Agustin; Wang, Shiyang; Martin, Laura; Irmady, Krithi; Trinh, Jasmine; Hempstead, Barbara L.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Deinhardt, Katrin] Skirball Inst, Dept Mol Neurobiol, New York, NY USA; [Deinhardt, Katrin] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Deinhardt, Katrin] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Nichol, Donna; Kermani, Pouneh] Weill Cornell Med Coll, New York, NY 10021 USA; [Parada, Luis] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Rafii, Shahin] Howard Hughes Med Inst, Ansary Stem Cell Inst, New York, NY USA; [Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA	Cornell University; University of Southampton; University of Southampton; Cornell University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Cornell University	Kermani, P (corresponding author), Weill Cornell Med Coll, New York, NY 10021 USA.	rap2008@med.cornell.edu		Anastasia, Agustin/0000-0001-7238-9041; Irmady, Krithi/0000-0003-2034-1809; Andres-Martin, Laura/0000-0003-2677-1025; Deinhardt, Katrin/0000-0002-6473-5298	National Institutes of Health [NIH/NHLBI5 P01 HL46403]; Qatar Research Foundation [NPRP 08 165-3-054]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH/NHLBI5 P01 HL46403) and Qatar Research Foundation (NPRP 08 165-3-054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Botchkarev VA, 1999, LAB INVEST, V79, P557; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; Coppola V, 2004, DEVELOPMENT, V131, P5185, DOI 10.1242/dev.01383; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; GROTENDORST GR, 1981, P NATL ACAD SCI-BIOL, V78, P3669, DOI 10.1073/pnas.78.6.3669; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kutcher ME, 2007, AM J PATHOL, V171, P693, DOI 10.2353/ajpath.2007.070102; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Nemoto E, 1998, BIOCHEM BIOPH RES CO, V245, P284, DOI 10.1006/bbrc.1998.8418; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405	22	33	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87406	10.1371/journal.pone.0087406	http://dx.doi.org/10.1371/journal.pone.0087406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498100	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000330621900108
J	Fang, KY; Wilmking, M; Davi, N; Zhou, FF; Liu, CZ				Fang, Keyan; Wilmking, Martin; Davi, Nicole; Zhou, Feifei; Liu, Changzhi			An Ensemble Weighting Approach for Dendroclimatology: Drought Reconstructions for the Northeastern Tibetan Plateau	PLOS ONE			English	Article							TREE-RINGS; PRECIPITATION VARIATION; CHINA; CLIMATE; GROWTH; AD; MONSOON; SERIES; RIVER; PART	Traditional detrending methods assign equal mean value to all tree-ring series for chronology developments, despite that the mean annual growth changes in different time periods. We find that the strength of a tree-ring model can be improved by giving more weights to tree-ring series that have a stronger climate signal and less weight to series that have a weaker signal. We thus present an ensemble weighting method to mitigate these potential biases and to more accurately extract the climate signals in dendroclimatology studies. This new method has been used to develop the first annual precipitation reconstruction (previous August to current July) at the Songmingyan Mountain and to recalculate the tree-ring chronology from Shenge site in Dulan area in northeastern Tibetan Plateau (TP), a marginal area of Asian summer monsoon. The ensemble weighting method explains 31.7% of instrumental variance for the reconstructions at Songmingyan Mountain and 57.3% of the instrumental variance in the Dulan area, which are higher than those developed using traditional methods. We focus on the newly introduced reconstruction at Songmingyan Mountain, which showsextremely dry (wet) epochs from 1862-1874, 1914-1933 and 1991-1999 (1882-1905). These dry/wet epochs were also found in the marginal areas of summer monsoon and the Indian subcontinent, indicating the linkages between regional hydroclimate changes and the Indian summer monsoon.	[Fang, Keyan; Zhou, Feifei] Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc, Minist Educ, Coll Geog Sci, Fuzhou, Fujian Province, Peoples R China; [Fang, Keyan; Liu, Changzhi] Lanzhou Univ, Key Lab Western Chinas Environm Syst, Res Sch Arid Environm & Climate Change, Minist Educ, Lanzhou 730000, Gansu, Peoples R China; [Fang, Keyan] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland; [Wilmking, Martin] Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Mecklenburg Vor, Germany; [Davi, Nicole] Columbia Univ, Tree Ring Lab, Lamont Doherty Earth Observ, Palisades, NY USA; [Davi, Nicole] William Paterson Univ, Dept Environm Sci, Wayne, NJ USA	Fujian Normal University; Lanzhou University; University of Helsinki; Ernst Moritz Arndt Universitat Greifswald; Columbia University	Fang, KY (corresponding author), Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc, Minist Educ, Coll Geog Sci, Fuzhou, Fujian Province, Peoples R China.	kujanfang@gmail.com	Wilmking, Martin/AAV-9310-2020	Wilmking, Martin/0000-0003-4964-2402; Fang, Keyan/0000-0002-0207-0112; Davi, Nicole/0000-0002-4529-5418	National Basic Research Program of China [2012CB955301]; National Science Foundation of China [41001115, 41171039]; Minjiang Special-term Professor fellowship; NSF AGS [1137729]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Minjiang Special-term Professor fellowship; NSF AGS	This research is financed by National Basic Research Program of China (2012CB955301), the National Science Foundation of China (41001115 and 41171039), and the Minjiang Special-term Professor fellowship. Support for Davi comes from NSF AGS # 1137729. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00388; Bollasina MA, 2011, SCIENCE, V334, P502, DOI 10.1126/science.1204994; Briffa KR, 2009, DENDROCLIMATOLOGY PR; Bunn AG, 2011, CLIMATIC CHANGE, V105, P627, DOI 10.1007/s10584-010-0005-5; Chen FH, 2010, QUATERNARY SCI REV, V29, P1055, DOI 10.1016/j.quascirev.2010.01.005; Cook E, 1990, METHODS DENDROCHOLOG; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; Cook ER, 1990, METHODS DENDROCHRONO, DOI DOI 10.1007/978-94-015-7879-0; Cook ER, 1985, THESIS U ARIZONA TUC; D'Arrigo RD, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002249; Davi NK, 2009, INT J CLIMATOL, V29, P1508, DOI 10.1002/joc.1798; Davi NK, 2013, WATER RESOUR RES, V49, P151, DOI 10.1029/2012WR011834; Ding YH, 2008, INT J CLIMATOL, V28, P1139, DOI 10.1002/joc.1615; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Fan ZX, 2008, INT J CLIMATOL, V28, P1879, DOI 10.1002/joc.1689; Fang KY, 2012, CLIM DYNAM, V39, P1697, DOI 10.1007/s00382-012-1371-7; Fang KY, 2010, CLIM DYNAM, V35, P577, DOI 10.1007/s00382-009-0636-2; Fang KY, 2010, INT J CLIMATOL, V30, P1137, DOI 10.1002/joc.1974; Fang KY, 2009, CLIM RES, V38, P129, DOI 10.3354/cr00781; Fritts H.C, 1976, TREE RINGS CLIMATE; Gong DY, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032409; Gou XH, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005705; Gou XH, 2010, CHINESE SCI BULL, V55, P4179, DOI 10.1007/s11434-010-4215-z; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Li JB, 2007, INT J CLIMATOL, V27, P903, DOI 10.1002/joc.1450; Liang EY, 2006, CLIMATIC CHANGE, V79, P403, DOI 10.1007/s10584-006-9082-x; Liu Y, 2006, SCI CHINA SER D, V49, P408, DOI 10.1007/s11430-006-0408-3; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; MEKO D, 1995, WATER RESOUR BULL, V31, P605; Melvin TM, 2008, DENDROCHRONOLOGIA, V26, P71, DOI 10.1016/j.dendro.2007.12.001; Pederson N, 2001, J CLIMATE, V14, P872, DOI 10.1175/1520-0442(2001)014<0872:HRFNMD>2.0.CO;2; Ramage C.S., 1971, MONSOON METEOROLOGY; Ran YH, 2012, INT J GEOGR INF SCI, V26, P169, DOI 10.1080/13658816.2011.577745; Sachs J, 2009, NATURE GEOSCIENCE, DOI [10.1038/NGEO1554, DOI 10.1038/NGE01554]; Shao XM, 2005, SCI CHINA SER D, V48, P939, DOI 10.1360/03yd0146; Sheppard PR, 2004, CLIM DYNAM, V23, P869, DOI 10.1007/s00382-004-0473-2; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sontakke NA, 2008, HOLOCENE, V18, P1055, DOI 10.1177/0959683608095576; Tan LC, 2008, CLIM PAST, V4, P19; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; YANG B, 2002, GEOPHYS RES LETT, V29, DOI DOI 10.1029/2001GL014485; Zhang PZ, 2008, SCIENCE, V322, P940, DOI 10.1126/science.1163965; Zhang QB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017425; 张德二, 2003, [应用气象学报, Journal of Applied Meteorolgical Science], V14, P379	48	8	11	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86689	10.1371/journal.pone.0086689	http://dx.doi.org/10.1371/journal.pone.0086689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497967	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900034
J	von Gillhaussen, P; Rascher, U; Jablonowski, ND; Pluckers, C; Beierkuhnlein, C; Temperton, VM				von Gillhaussen, Philipp; Rascher, Uwe; Jablonowski, Nicolai D.; Plueckers, Christine; Beierkuhnlein, Carl; Temperton, Vicky M.			Priority Effects of Time of Arrival of Plant Functional Groups Override Sowing Interval or Density Effects: A Grassland Experiment	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; BIODIVERSITY EXPERIMENT; DIVERSITY; COMMUNITIES; COMPETITION; PRODUCTIVITY; FACILITATION; RESTORATION; MIXTURES; RICHNESS	Priority effects occur when species that arrive first in a habitat significantly affect the establishment, growth, or reproduction of species arriving later and thus affect functioning of communities. However, we know little about how the timing of arrival of functionally different species may alter structure and function during assembly. Even less is known about how plant density might interact with initial assembly. In a greenhouse experiment legumes, grasses or forbs were sown a number of weeks before the other two plant functional types were sown (PFT) in combination with a sowing density treatment. Legumes, grasses or non-legume forbs were sown first at three different density levels followed by sowing of the remaining PFTs after three or six-weeks. We found that the order of arrival of different plant functional types had a much stronger influence on aboveground productivity than sowing density or interval between the sowing events. The sowing of legumes before the other PFTs produced the highest aboveground biomass. The larger sowing interval led to higher asymmetric competition, with highest dominance of the PFT sown first. It seems that legumes were better able to get a head-start and be productive before the later groups arrived, but that their traits allowed for better subsequent establishment of non-legume PFTs. Our study indicates that the manipulation of the order of arrival can create priority effects which favour functional groups of plants differently and thus induce different assembly routes and affect community composition and functioning.	[von Gillhaussen, Philipp; Rascher, Uwe; Jablonowski, Nicolai D.; Plueckers, Christine; Temperton, Vicky M.] Forschungszentrum Julich, Inst Bio & Geosci Plant Sci IBG 2, D-52425 Julich, Germany; [von Gillhaussen, Philipp; Plueckers, Christine; Beierkuhnlein, Carl; Temperton, Vicky M.] Univ Bayreuth, Dept Biogeog, Bayreuth, Germany	Helmholtz Association; Research Center Julich; University of Bayreuth	von Gillhaussen, P (corresponding author), Forschungszentrum Julich, Inst Bio & Geosci Plant Sci IBG 2, D-52425 Julich, Germany.	p.von.gillhaussen@fz-juelich.de	Beierkuhnlein, Carl/ABF-8797-2021; Beierkuhnlein, Carl/ABF-9693-2021; Rascher, Uwe/D-5457-2009; Jablonowski, Nicolai David/AAA-8672-2022	Beierkuhnlein, Carl/0000-0002-6456-4628; Rascher, Uwe/0000-0002-9993-4588; Jablonowski, Nicolai David/0000-0002-5298-5521; Temperton, Vicky/0000-0003-0543-4521	Plant Sciences (IBG-2); Forschungszentrum Julich; Tenure Track group of Vicky Temperton	Plant Sciences (IBG-2); Forschungszentrum Julich(Helmholtz Association); Tenure Track group of Vicky Temperton	This research was funded by Plant Sciences (IBG-2) and the Forschungszentrum Julich and Philipp von Gillhaussen was funded within the Tenure Track group of Vicky Temperton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Belyea LR, 1999, OIKOS, V86, P402, DOI 10.2307/3546646; Bessler H, 2012, PLANT SOIL, V358, P301, DOI 10.1007/s11104-012-1181-z; Bezemer TM, 2007, NATURE, V446, pE6, DOI 10.1038/nature05749; Bullock JM, 2007, J APPL ECOL, V44, P6, DOI 10.1111/j.1365-2664.2006.01252.x; Carter DL, 2012, ECOL APPL, V22, P1308, DOI 10.1890/11-1970.1; Chalk PM, 1998, AUST J AGR RES, V49, P303, DOI 10.1071/A97013; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Deng JM, 2006, J ECOL, V94, P953, DOI 10.1111/j.1365-2745.2006.01141.x; DRAKE JA, 1993, J ANIM ECOL, V62, P117, DOI 10.2307/5487; DREW TJ, 1977, FOREST SCI, V23, P517; Eisenhauer N, 2012, PLANT SOIL, V351, P1, DOI 10.1007/s11104-011-1027-0; Ejrnaes R, 2006, ECOLOGY, V87, P1225, DOI 10.1890/0012-9658(2006)87[1225:CAIEGS]2.0.CO;2; ELLENBERG H, 1979, Scripta Geobotanica, V9, P1; Ellenberg H., 1988, VEGETATION ECOLOGY C; FACELLI JM, 1993, OECOLOGIA, V95, P277, DOI 10.1007/BF00323500; Finn JA, 2013, J APPL ECOL, V50, P365, DOI 10.1111/1365-2664.12041; Fukami T, 2004, ECOLOGY, V85, P3234, DOI 10.1890/04-0340; Grman E, 2010, RESTOR ECOL, V18, P664, DOI 10.1111/j.1526-100X.2008.00497.x; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kardol P, 2013, OIKOS, V122, P84, DOI 10.1111/j.1600-0706.2012.20546.x; Kirwan L, 2007, J ECOL, V95, P530, DOI 10.1111/j.1365-2745.2007.01225.x; Kirwan L, 2009, ECOLOGY, V90, P2032, DOI 10.1890/08-1684.1; Korner C, 2008, NEW PHYTOL, V177, P698, DOI 10.1111/j.1469-8137.2007.02287.x; LONDO G, 1976, VEGETATIO, V33, P61, DOI 10.1007/BF00055300; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Matthiessen B, 2006, ECOL LETT, V9, P652, DOI 10.1111/j.1461-0248.2006.00916.x; Oelmann Y, 2007, SOIL SCI SOC AM J, V71, P720, DOI 10.2136/sssaj2006.0205; Oelmann Y, 2011, GEODERMA, V167-68, P178, DOI 10.1016/j.geoderma.2011.09.012; Pluckers C, 2013, ACTA OECOL, V53, P110, DOI 10.1016/j.actao.2013.09.004; Roscher C, 2008, J ECOL, V96, P477, DOI 10.1111/j.1365-2745.2008.01353.x; Roscher C, 2011, PLANT SOIL, V341, P333, DOI 10.1007/s11104-010-0647-0; SHULMAN MJ, 1983, ECOLOGY, V64, P1508, DOI 10.2307/1937505; TEMPERTON V. M., 2004, ASSEMBLY RULES RESTO; Temperton VM, 2007, OECOLOGIA, V151, P190, DOI 10.1007/s00442-006-0576-z; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U	41	51	52	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86906	10.1371/journal.pone.0086906	http://dx.doi.org/10.1371/journal.pone.0086906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497995	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900047
J	Fecteau, RE; Lutterbaugh, J; Markowitz, SD; Willis, J; Guda, K				Fecteau, Ryan E.; Lutterbaugh, James; Markowitz, Sanford D.; Willis, Joseph; Guda, Kishore			GNAS Mutations Identify a Set of Right-Sided, RAS Mutant, Villous Colon Cancers	PLOS ONE			English	Article							ACTIVATING MUTATION; COLORECTAL CANCERS; HUMAN BREAST; ADENOMAS; TUMORS; ALPHA; GS	The purpose of this study is to determine the genetic frequency of GNAS activating mutations in colorectal cancer and the corresponding pathology of GNAS mutant tumors. Oncogenic mutations in GNAS have been described in a number of neoplasms including those of the pituitary, kidney, pancreas, and, more recently, in colon cancer. To ascertain the frequency in colon cancer we employed a sensitive pyrosequencing platform for mutation detection of the R201C and R201H GNAS hotspots in tumor samples representing all clinical stages. We additionally assayed for KRAS and BRAF mutations as previous reports have shown that these often co-occur with activating GNAS mutations. Of the 428 colon tumors assayed, mutations in GNAS were present in 10 of the samples (2.3%), indicating this is a significant, albeit infrequent, mutation in colorectal tumors. Nine GNAS mutant tumors (90%) harbored concomitant activating mutations in either the KRAS or BRAF oncogene, which was significantly greater than the mutation frequency of these genes in the tumor population (56%, p<0.0305). All ten of the GNAS mutant tumors arose in the right (proximal) colon (p<0.007), and 7 of 8 reviewed cases exhibited a marked villous morphology. Taken together, these data indicate that GNAS mutant colon tumors commonly have synchronous mutations in KRAS or BRAF, are right-sided in location, and are associated with a villous morphology.	[Fecteau, Ryan E.; Willis, Joseph] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Fecteau, Ryan E.; Lutterbaugh, James; Markowitz, Sanford D.; Willis, Joseph; Guda, Kishore] Case Med Ctr, Cleveland, OH USA; [Lutterbaugh, James; Markowitz, Sanford D.; Willis, Joseph; Guda, Kishore] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Markowitz, Sanford D.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Markowitz, Sanford D.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Guda, Kishore] Case Western Reserve Univ, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Markowitz, SD (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	Sanford.Markowitz@case.edu	Fecteau, Ryan/GXI-0446-2022	Fecteau, Ryan/0000-0002-3744-2924	PHS grants [1P50CA150964, CA148980, P30CA43703, T32GM007250, CA059366]; NATIONAL CANCER INSTITUTE [K08CA148980, P30CA043703, T32CA059366, P50CA150964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	PHS grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by PHS grants 1P50CA150964 (SDM, JW, KG), CA148980 (KG), P30CA43703, T32GM007250 (REF) and CA059366 (REF) and by gifts from the Marguerite Wilson Foundation (S.D.M), the Leonard and Joan Horvitz Foundation (S. D. M). the Richard Horvitz and Erica Hartman-Horvitz Foundation (S.D.M.), and the National Colorectal Cancer Research Alliance (S.D.M.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Fragoso MCBV, 1998, J CLIN ENDOCR METAB, V83, P2074, DOI 10.1210/jc.83.6.2074; Grady WM, 1998, CANCER RES, V58, P3101; Guda K, 2009, CANCER RES, V69, P4959, DOI 10.1158/0008-5472.CAN-09-0225; Idziaszczyk S, 2010, CANCER GENET CYTOGEN, V202, P67, DOI 10.1016/j.cancergencyto.2010.04.023; Kalfa N, 2006, J UROLOGY, V176, P891, DOI 10.1016/j.juro.2006.04.023; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Loy TS, 2004, AM J SURG PATHOL, V28, P1460, DOI 10.1097/01.pas.0000141394.64707.02; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; Palos-Paz F, 2008, EUR J ENDOCRINOL, V159, P623, DOI 10.1530/EJE-08-0313; Rubio CA, 1998, ANTICANCER RES, V18, P2649; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Vaughn CP, 2011, GENE CHROMOSOME CANC, V50, P307, DOI 10.1002/gcc.20854; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Wilson CH, 2010, ONCOGENE, V29, P4567, DOI 10.1038/onc.2010.202; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yamada M, 2012, J PATHOL	20	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87966	10.1371/journal.pone.0087966	http://dx.doi.org/10.1371/journal.pone.0087966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498230	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100123
J	Garcia-Morales, L; Gonzalez-Gonzalez, L; Costa, M; Querol, E; Pinol, J				Garcia-Morales, Luis; Gonzalez-Gonzalez, Luis; Costa, Manuela; Querol, Enrique; Pinol, Jaume			Quantitative Assessment of Mycoplasma Hemadsorption Activity by Flow Cytometry	PLOS ONE			English	Article							LARGE-COLONY TYPE; GLIDING MOTILITY; TERMINAL-ORGANELLE; UROGENITAL TRACT; CELL-ADHESION; BROTH MEDIUM; GENITALIUM; PNEUMONIAE; ERYTHROCYTES; INHIBITION	A number of adherent mycoplasmas have developed highly complex polar structures that are involved in diverse aspects of the biology of these microorganisms and play a key role as virulence factors by promoting adhesion to host cells in the first stages of infection. Attachment activity of mycoplasma cells has been traditionally investigated by determining their hemadsorption ability to red blood cells and it is a distinctive trait widely examined when characterizing the different mycoplasma species. Despite the fact that protocols to qualitatively determine the hemadsorption or hemagglutination of mycoplasmas are straightforward, current methods when investigating hemadsorption at the quantitative level are expensive and poorly reproducible. By using flow cytometry, we have developed a procedure to quantify rapidly and accurately the hemadsorption activity of mycoplasmas in the presence of SYBR Green I, a vital fluorochrome that stains nucleic acids, allowing to resolve erythrocyte and mycoplasma cells by their different size and fluorescence. This method is very reproducible and permits the kinetic analysis of the obtained data and a precise hemadsorption quantification based on standard binding parameters such as the dissociation constant K-d. The procedure we developed could be easily implemented in a standardized assay to test the hemadsorption activity of the growing number of clinical isolates and mutant strains of different mycoplasma species, providing valuable data about the virulence of these microorganisms.	[Garcia-Morales, Luis; Gonzalez-Gonzalez, Luis; Querol, Enrique; Pinol, Jaume] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Garcia-Morales, Luis; Gonzalez-Gonzalez, Luis; Querol, Enrique; Pinol, Jaume] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Costa, Manuela] Univ Autonoma Barcelona, Serv Cultius Cellulars Prod Anticossos & Citometr, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona	Pinol, J (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.	jaume.pinyol@uab.es	Garcia-Morales, Luis/Q-7461-2018	Garcia-Morales, Luis/0000-0002-3037-4519; Pinol, Jaume/0000-0002-9055-8934	Ministerio de Ciencia e Innovacion [BFU2010-22209-C02-01]; Centre de Referencia de R+D de Biotecnologia (Generalitat de Catalunya, Spain)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Centre de Referencia de R+D de Biotecnologia (Generalitat de Catalunya, Spain)(Generalitat de Catalunya)	This work was supported by Ministerio de Ciencia e Innovacion: BFU2010-22209-C02-01 (http://www.idi.mineco.gob.es/) and Centre de Referencia de R+D de Biotecnologia (Generalitat de Catalunya, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P603; Arnal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061887; Assuncao P, 2006, J APPL MICROBIOL, V100, P878, DOI 10.1111/j.1365-2672.2005.02858.x; Assuncao P, 2006, FRONT BIOSCI, V11, P492, DOI 10.2741/1812; Assuncao P, 2007, CYTOM PART A, V71A, P1034, DOI 10.1002/cyto.a.20476; Assuncao P, 2006, ANTIMICROB AGENTS CH, V50, P2845, DOI 10.1128/AAC.01582-05; BASEMAN JB, 1982, INFECT IMMUN, V38, P389, DOI 10.1128/IAI.38.1.389-391.1982; Bossuyt X, 1997, CYTOMETRY, V30, P124; Burgos R, 2007, J BACTERIOL, V189, P7014, DOI 10.1128/JB.00975-07; Burgos R, 2006, J BACTERIOL, V188, P8627, DOI 10.1128/JB.00978-06; FRIIS NF, 1975, NORD VET MED, V27, P337; Hamasuna R, 2007, J CLIN MICROBIOL, V45, P847, DOI 10.1128/JCM.02056-06; Hasselbring BM, 2007, MOL MICROBIOL, V63, P44, DOI 10.1111/j.1365-2958.2006.05507.x; HORNER PJ, 1993, LANCET, V342, P582, DOI 10.1016/0140-6736(93)91411-E; Jensen JS, 1996, J CLIN MICROBIOL, V34, P286, DOI 10.1128/JCM.34.2.286-291.1996; Jordan JL, 2007, INFECT IMMUN, V75, P518, DOI 10.1128/IAI.01344-06; Kasai T, 2013, J BACTERIOL, V195, P429, DOI 10.1128/JB.01141-12; KRAUSE DC, 1982, INFECT IMMUN, V35, P809, DOI 10.1128/IAI.35.3.809-817.1982; Krunkosky TM, 2007, MICROB PATHOGENESIS, V42, P98, DOI 10.1016/j.micpath.2006.11.003; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; LO SC, 1992, INT J SYST BACTERIOL, V42, P357, DOI 10.1099/00207713-42-3-357; Ma L, 2012, J MED MICROBIOL, V61, P191, DOI 10.1099/jmm.0.030858-0; Ma LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015660; McGowin CL, 2010, INFECT IMMUN, V78, P726, DOI 10.1128/IAI.00840-09; MERNAUGH GR, 1993, CLIN INFECT DIS, V17, pS69, DOI 10.1093/clinids/17.Supplement_1.S69; Miyata M, 2000, MICROBIOL-UK, V146, P1311, DOI 10.1099/00221287-146-6-1311; Miyata M, 2010, ANNU REV MICROBIOL, V64, P519, DOI 10.1146/annurev.micro.112408.134116; Nagai R, 2006, J BACTERIOL, V188, P6469, DOI 10.1128/JB.00754-06; Pich OQ, 2006, MICROBIOL-SGM, V152, P519, DOI 10.1099/mic.0.28287-0; Pich OQ, 2008, MICROBIOL-SGM, V154, P3188, DOI 10.1099/mic.0.2008/020636-0; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; RAZIN S, 1992, J GEN MICROBIOL, V138, P407, DOI 10.1099/00221287-138-3-407; ROBERTS DD, 1989, J BIOL CHEM, V264, P9289; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Sanchez-Perez A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-158; Soehnlen MK, 2011, J VET DIAGN INVEST, V23, P547, DOI 10.1177/1040638711404155; Spergser J, 2013, VET MICROBIOL, V164, P299, DOI 10.1016/j.vetmic.2013.02.007; Theron M, 2010, CYTOM PART A, V77A, P1067, DOI 10.1002/cyto.a.20972; TULLY JG, 1983, INT J SYST BACTERIOL, V33, P387, DOI 10.1099/00207713-33-2-387; TULLY JG, 1979, J INFECT DIS, V139, P478, DOI 10.1093/infdis/139.4.478; Willby MJ, 2002, J BACTERIOL, V184, P3061, DOI 10.1128/JB.184.11.3061-3068.2002; YOUNG TF, 1989, AM J VET RES, V50, P1052	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87500	10.1371/journal.pone.0087500	http://dx.doi.org/10.1371/journal.pone.0087500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498118	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100089
J	Gargiulo, P; Apostolo, A; Perrone-Filardi, P; Sciomer, S; Palange, P; Agostoni, P				Gargiulo, Paola; Apostolo, Anna; Perrone-Filardi, Pasquale; Sciomer, Susanna; Palange, Paolo; Agostoni, Piergiuseppe			A Non Invasive Estimate of Dead Space Ventilation from Exercise Measurements	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC HEART-FAILURE; ANAEROBIC THRESHOLD; PROGNOSTIC VALUE; VE/VCO2 SLOPE; EFFICIENCY; MANAGEMENT; RESPONSES; RISK	Rationale: During exercise, heart failure patients (HF) show an out-of-proportion ventilation increase, which in patients with COPD is blunted. When HF and COPD coexist, the ventilatory response to exercise is unpredictable. Objectives: We evaluated a human model of respiratory impairment in 10 COPD-free HF patients and in 10 healthy subjects, tested with a progressive workload exercise with different added dead space. We hypothesized that increased serial dead space upshifts the VE vs. VCO2 relationship and that the VE-axis intercept might be an index of dead space ventilation. Measurements: All participants performed a cardiopulmonary exercise test with 0, 250 and 500 mL of additional dead space. Since DS does not contribute to gas exchange, ventilation relative to dead space is ventilation at VCO2 = 0, i.e. VE-axis intercept. We compared dead space volume, estimated dividing VE-axis intercept by the intercept on respiratory rate axis of the respiratory rate vs. VCO2 relationship with standard method measured DS. Main results: In HF, adding dead space increased VE-axis intercept (+0 mL = 4.98 +/- 1.63 L; +250 mL = 9.69 +/- 2.91 L; +500 mL = 13.26 +/- 3.18 L; p<0.001) and upshifted the VE vs. VCO2 relationship, with a minor slope rise (+0 mL=27 +/- 4 L; +250 = 28 +/- 5; +500 = 29 +/- 4; p<0.05). In healthy, adding dead space increased VE-axis intercept (+0 mL = 4.9 +/- 1.4 L; +250 = 9.3 +/- 2.4; +500 = 13.1 +/- 3.04; p<0.001) without slope changes. Measured and estimated dead space volumes were similar both in HF and healthy subjects. Conclusions: VE-axis intercept is related to dead space ventilation and dead space volume can be non-invasively estimated.	[Gargiulo, Paola] SDN Fdn, Inst Diagnost & Nucl Dev, Naples, Italy; [Apostolo, Anna; Agostoni, Piergiuseppe] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Perrone-Filardi, Pasquale] Univ Naples Federico II, Dept Adv Biomed Sci, Div Cardiol, Naples, Italy; [Sciomer, Susanna] Univ Roma La Sapienza, Dept Cardiovasc & Resp Sci, I-00185 Rome, Italy; [Palange, Paolo] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Div Pulm Res, I-00185 Rome, Italy; [Agostoni, Piergiuseppe] Univ Milan, Dept Clin Sci & Community Hlth, Cardiovasc Sect, Milan, Italy; [Agostoni, Piergiuseppe] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA USA	IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); IRCCS Centro Cardiologico Monzino; University of Naples Federico II; Sapienza University Rome; Sapienza University Rome; University of Milan; University of Washington; University of Washington Seattle	Agostoni, P (corresponding author), IRCCS, Ctr Cardiol Monzino, Milan, Italy.	piergiuseppe.agostoni@unimi.it	Corrà, Ugo/AAF-8322-2020; Gargiulo, Paola/K-6885-2016; apostolo, anna/ABH-4679-2020; Agostoni, Piergiuseppe/ABG-9556-2020; Perrone Filardi, Pasquale/AAC-7590-2022	Corrà, Ugo/0000-0002-9229-3298; Gargiulo, Paola/0000-0003-4622-1725; Agostoni, Piergiuseppe/0000-0002-8345-6382; Sciomer, Susanna/0000-0001-9487-833X; Apostolo, Anna/0000-0002-5003-700X	Italian Society of Cardiology (SIC)	Italian Society of Cardiology (SIC)	Dr. Paola Gargiulo was supported by an educational grant of Italian Society of Cardiology (SIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena R, 2007, CIRCULATION, V115, P2410, DOI 10.1161/CIRCULATIONAHA.107.686576; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BROWN HV, 1981, MED CLIN N AM, V65, P525, DOI 10.1016/S0025-7125(16)31512-7; Chua TP, 1997, J AM COLL CARDIOL, V29, P147, DOI 10.1016/S0735-1097(96)00446-9; Corra U, 2002, AM HEART J, V143, P418, DOI 10.1067/mhj.2002.120772; Deboeck G, 2012, EUR RESPIR J, V40, P1410, DOI 10.1183/09031936.00217911; ELBORN JS, 1990, EUR HEART J, V11, P75, DOI 10.1093/oxfordjournals.eurheartj.a059596; Francis DP, 2000, EUR HEART J, V21, P154, DOI 10.1053/euhj.1999.1863; Gitt AK, 2002, CIRCULATION, V106, P3079, DOI 10.1161/01.CIR.0000041428.99427.06; Guazzi M, 1995, J Card Fail, V1, P401, DOI 10.1016/S1071-9164(05)80009-0; Guazzi M, 2010, AM HEART J, V160, P900, DOI 10.1016/j.ahj.2010.07.014; Hawkins NM, 2010, EUR J HEART FAIL, V12, P557, DOI 10.1093/eurjhf/hfq040; Kleber FX, 2000, CIRCULATION, V101, P2803, DOI 10.1161/01.CIR.101.24.2803; Laveneziana P, 2011, AM J RESP CRIT CARE, V184, P1367, DOI 10.1164/rccm.201106-1128OC; Laveneziana P, 2009, J APPL PHYSIOL, V106, P1574, DOI 10.1152/japplphysiol.90744.2008; Metra M, 1996, CARDIOLOGY, V91, P31; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Paoletti P, 2011, RESP PHYSIOL NEUROBI, V179, P167, DOI 10.1016/j.resp.2011.07.013; Paolillo S, 2012, EUR J PREV CARDIOL, V19, P960, DOI 10.1177/1741826711426635; Piepoli M, 1996, CIRCULATION, V93, P940, DOI 10.1161/01.CIR.93.5.940; PIERCE AK, 1968, J APPL PHYSIOL, V25, P249, DOI 10.1152/jappl.1968.25.3.249; Qaseem A, 2007, ANN INTERN MED, V147, P633, DOI 10.7326/0003-4819-147-9-200711060-00008; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; ROBBINS PA, 1990, J APPL PHYSIOL, V68, P1727, DOI 10.1152/jappl.1990.68.4.1727; Rutten FH, 2006, EUR J HEART FAIL, V8, P706, DOI 10.1016/j.ejheart.2006.01.010; Schwaiblmair M, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-23; Sun XG, 2002, AM J RESP CRIT CARE, V166, P1443, DOI 10.1164/rccm.2202033; Tabet JY, 2003, EUR J CARDIOV PREV R, V10, P267, DOI 10.1097/00149831-200308000-00008; Teopompi E., 2013, RESP CARE; Wasserman K, 1997, CIRCULATION, V96, P2221, DOI 10.1161/01.cir.96.7.2221; Wasserman K, 2012, PRINCIPLES EXERCISE, V5th; WHIPP BJ, 1989, RESP PHYSIOL, V76, P357, DOI 10.1016/0034-5687(89)90076-5	33	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87395	10.1371/journal.pone.0087395	http://dx.doi.org/10.1371/journal.pone.0087395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498096	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100082
J	Perez, V; Ibernon, M; Lopez, D; Pastor, MC; Navarro, M; Navarro-Munoz, M; Bonet, J; Romero, R				Perez, Vanessa; Ibernon, Meritxell; Lopez, Dolores; Cruz Pastor, Maria; Navarro, Maruja; Navarro-Munoz, Maribel; Bonet, Josep; Romero, Ramon			Urinary Peptide Profiling to Differentiate between Minimal Change Disease and Focal Segmental Glomerulosclerosis	PLOS ONE			English	Article							MAGNETIC BEAD SEPARATION; GLOMERULAR-DISEASES; UROMODULIN; ALPHA-1-ANTITRYPSIN; CANCER; FLUID	Background: Minimal change disease (MCD) and primary focal segmental glomerulosclerosis (FSGS) are the main causes of primary idiopathic nephrotic syndrome in children and adults, with diagnosis being essential for the appropriate choice of therapy and requiring renal biopsy. However, the presence of only normal glomeruli on renal biopsy of FSGS patients may lead to the misclassification of these patients as having MCD. The aim of this study was to (i) compare the peptide profile of MCD and FSGS patients with that of a group of healthy subjects, (ii) generate and validate a class prediction model to classify MCD and FSGS patients and (ii) identify candidate biomarkers of these glomerular entities by analysis of the urinary peptidome. Methods: The urinary peptide profile was analyzed by magnetic bead-based technology combined with MALDI-TOF mass spectrometry in 44 patients diagnosed of MCD (n = 22) and FSGS (n = 22). The resulting spectra were compiled and analyzed using ClinProTools software. Results: A class prediction model was developed to differentiate MCD and FSGS patients. The validation of this model correctly classified 81.8% (9/11) of MCD patients and 72.7% (8/11) of FSGS patients. Moreover, the signal with m/z 1913.60, identified as a fragment of uromodulin, and the signal with m/z 2392.54, identified as a fragment of alpha-1-antitrypsin, showed higher and lower peak areas, respectively, in FSGS patients compared with MCD patients. Conclusions: The simple, non-invasive technique described in the present study may be a useful tool to help clinicians by confirming diagnoses achieved by renal biopsy, thereby reducing misdiagnoses and avoiding the implementation of inappropriate therapies.	[Perez, Vanessa; Ibernon, Meritxell; Navarro, Maruja; Navarro-Munoz, Maribel; Bonet, Josep; Romero, Ramon] Univ Autonoma Barcelona, Esfera UAB, Hosp Univ Germans Trias & Pujol, Dept Nephrol, Badalona, Spain; [Perez, Vanessa; Navarro-Munoz, Maribel; Romero, Ramon] Univ Autonoma Barcelona, Esfera UAB, Lab Expt Nephrol, Inst Invest Ciencies Salut Germans Trias & Pujol, Badalona, Spain; [Lopez, Dolores] Univ Autonoma Barcelona, Esfera UAB, Hosp Univ Germans Trias & Pujol, Dept Pathol, Badalona, Spain; [Cruz Pastor, Maria] Univ Autonoma Barcelona, Esfera UAB, Hosp Univ Germans Trias & Pujol, Dept Clin Biochem, Badalona, Spain; [Romero, Ramon] Univ Autonoma Barcelona, Esfera UAB, Dept Med, Badalona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Autonomous University of Barcelona	Romero, R (corresponding author), Univ Autonoma Barcelona, Esfera UAB, Hosp Univ Germans Trias & Pujol, Dept Nephrol, Badalona, Spain.	Ramon.romero@uab.es	NAVARRO MUÑOZ, MARIBEL/AAE-7844-2022	romero, ramon/0000-0001-9053-2649	Fondo de Investigacion Sanitaria [PI10/01424]; Instituto de Salud Carlos III from Spain [ISCIII-RETICS REDinREN RD06/0016]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de Salud Carlos III from Spain(Instituto de Salud Carlos III)	This work was supported by grants from the Fondo de Investigacion Sanitaria (PI10/01424) and the Instituto de Salud Carlos III (ISCIII-RETICS REDinREN RD06/0016) from Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud R T, 2001, Can Respir J, V8, P81; Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; Baumann S, 2005, CLIN CHEM, V51, P973, DOI 10.1373/clinchem.2004.047308; Braden GL, 2000, AM J KIDNEY DIS, V35, P878, DOI 10.1016/S0272-6386(00)70258-7; Candiano G, 2006, J AM SOC NEPHROL, V17, P3139, DOI 10.1681/ASN.2006050486; Cheng AJ, 2005, CLIN CHEM, V51, P2236, DOI 10.1373/clinchem.2005.052324; Corapi KM, 2012, AM J KIDNEY DIS, V60, P62, DOI 10.1053/j.ajkd.2012.02.330; CORWIN HL, 1988, AM J NEPHROL, V8, P85, DOI 10.1159/000167563; Drube J, 2009, NEPHROL DIAL TRANSPL, V24, P2161, DOI 10.1093/ndt/gfp063; Eiro Masaaki, 2005, Clin Exp Nephrol, V9, P40, DOI 10.1007/s10157-004-0326-7; ERIKSSON S, 1986, NEW ENGL J MED, V314, P736, DOI 10.1056/NEJM198603203141202; Fiedler GM, 2007, CLIN CHEM, V53, P421, DOI 10.1373/clinchem.2006.077834; Fogo AB, 2003, AM J KIDNEY DIS, V42, P826, DOI 10.1053/S0272-6386(03)01054-0; Garin EH, 2010, KIDNEY INT, V78, P296, DOI 10.1038/ki.2010.143; Good DM, 2007, J PROTEOME RES, V6, P4549, DOI 10.1021/pr070529w; Haubitz M, 2005, KIDNEY INT, V67, P2313, DOI 10.1111/j.1523-1755.2005.00335.x; Jimenez CR, 2007, PROTEOM CLIN APPL, V1, P1385, DOI 10.1002/prca.200700330; Lapolla A, 2009, J MASS SPECTROM, V44, P1754, DOI 10.1002/jms.1685; Lapolla A, 2009, J MASS SPECTROM, V44, P419, DOI 10.1002/jms.1520; MADAIO MP, 1990, KIDNEY INT, V38, P529, DOI 10.1038/ki.1990.236; Mak SK, 1996, NEPHROL DIAL TRANSPL, V11, P2192, DOI 10.1093/oxfordjournals.ndt.a027136; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; Navarro-Munoz M, 2012, KIDNEY BLOOD PRESS R, V35, P314, DOI 10.1159/000335383; Perez V, 2010, TRANSPL P, V42, P2924, DOI 10.1016/j.transproceed.2010.07.077; Perez V, 2013, EUR J PHARM; Perez V, 2011, PHARMACOLOGY, V87, P161, DOI 10.1159/000324311; Prajczer S, 2010, NEPHROL DIAL TRANSPL, V25, P1896, DOI 10.1093/ndt/gfp748; RINDLER MJ, 1990, J BIOL CHEM, V265, P20784; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Surin B, 2013, PROTEOMICS, V13, P142, DOI 10.1002/pmic.201200267; Taneja S, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-5; Varghese SA, 2007, J AM SOC NEPHROL, V18, P913, DOI 10.1681/ASN.2006070767; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; Waldman M, 2007, CLIN J AM SOC NEPHRO, V2, P445, DOI 10.2215/CJN.03531006; Wu J, 2010, RAPID COMMUN MASS SP, V24, P1971, DOI 10.1002/rcm.4601; Zhang JN, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-63; Zhang Xinyi, 2004, J Biomol Tech, V15, P167	37	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87731	10.1371/journal.pone.0087731	http://dx.doi.org/10.1371/journal.pone.0087731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498182	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100110
J	Stahley, SN; Saito, M; Faundez, V; Koval, M; Mattheyses, AL; Kowalczyk, AP				Stahley, Sara N.; Saito, Masataka; Faundez, Victor; Koval, Michael; Mattheyses, Alexa L.; Kowalczyk, Andrew P.			Desmosome Assembly and Disassembly Are Membrane Raft-Dependent	PLOS ONE			English	Article							LIPID RAFTS; PEMPHIGUS-VULGARIS; PLASMA-MEMBRANE; IMMUNOLOGICAL SYNAPSE; DISEASE; MICRODOMAINS; DESMOGLEIN; JUNCTIONS; AUTOANTIBODIES; ASSOCIATION	Strong intercellular adhesion is critical for tissues that experience mechanical stress, such as the skin and heart. Desmosomes provide adhesive strength to tissues by anchoring desmosomal cadherins of neighboring cells to the intermediate filament cytoskeleton. Alterations in assembly and disassembly compromise desmosome function and may contribute to human diseases, such as the autoimmune skin blistering disease pemphigus vulgaris (PV). We previously demonstrated that PV auto-antibodies directed against the desmosomal cadherin desmoglein 3 (Dsg3) cause loss of adhesion by triggering membrane raft-mediated Dsg3 endocytosis. We hypothesized that raft membrane microdomains play a broader role in desmosome homeostasis by regulating the dynamics of desmosome assembly and disassembly. In human keratinocytes, Dsg3 is raft associated as determined by biochemical and super resolution immunofluorescence microscopy methods. Cholesterol depletion, which disrupts rafts, prevented desmosome assembly and adhesion, thus functionally linking rafts to desmosome formation. Interestingly, Dsg3 did not associate with rafts in cells lacking desmosomal proteins. Additionally, PV IgG-induced desmosome disassembly occurred by redistribution of Dsg3 into raft-ontaining endocytic membrane domains, resulting in cholesterol-dependent loss of adhesion. These findings demonstrate that membrane rafts are required for desmosome assembly and disassembly dynamics, suggesting therapeutic potential for raft targeting agents in desmosomal diseases such as PV.	[Stahley, Sara N.; Saito, Masataka; Faundez, Victor; Koval, Michael; Mattheyses, Alexa L.; Kowalczyk, Andrew P.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Stahley, Sara N.] Emory Univ, Sch Med, Grad Program Biochem Cell & Dev Biol, Atlanta, GA USA; [Kowalczyk, Andrew P.] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA; [Koval, Michael] Emory Univ, Sch Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA USA; [Kowalczyk, Andrew P.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA	Emory University; Emory University; Emory University; Emory University; Emory University	Kowalczyk, AP (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	akowalc@emory.edu	Koval, Michael/C-6366-2015	Koval, Michael/0000-0002-5422-5614; Faundez, Victor/0000-0002-2114-5271; Mattheyses, Alexa L/0000-0002-5119-7750	National Institutes of Health [R01AR048266]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM077569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant (R01AR048266) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Amagai M, 2011, J INVEST DERMATOL; Amagai M, 2010, P JPN ACAD B-PHYS, V86, P524, DOI 10.2183/pjab.86.524; Anhalt GJ, 2004, J AM ACAD DERMATOL, V51, pS20, DOI 10.1016/j.jaad.2004.01.011; Balamuth F, 2004, J IMMUNOL, V172, P5887, DOI 10.4049/jimmunol.172.10.5887; Bang B, 2005, EXP DERMATOL, V14, P266, DOI 10.1111/j.0906-6705.2005.00283.x; Bi K, 2001, SEMIN IMMUNOL, V13, P139, DOI 10.1006/smim.2000.0305; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Desai BV, 2009, J CELL SCI, V122, P4401, DOI 10.1242/jcs.037457; Dodelet-Devillers A, 2009, J MOL MED, V87, P765, DOI 10.1007/s00109-009-0488-6; DROCHMANS P, 1978, J CELL BIOL, V79, P427, DOI 10.1083/jcb.79.2.427; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Getsios Spiro, 2010, J Invest Dermatol, V130, P1764, DOI 10.1038/jid.2010.111; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hogue IB, 2011, J VIROL, V85, P9749, DOI 10.1128/JVI.00743-11; Holthofer B, 2007, INT REV CYTOL, V264, P65, DOI 10.1016/S0074-7696(07)64003-0; Ishii Ken, 2013, Methods Mol Biol, V961, P219, DOI 10.1007/978-1-62703-227-8_13; Jennings JM, 2011, J INVEST DERMATOL, V131, P706, DOI 10.1038/jid.2010.389; Kabouridis PS, 2006, MOL MEMBR BIOL, V23, P49, DOI 10.1080/09687860500453673; Kitajima Y, 2013, KAOHSIUNG J MED SCI, V29, P1, DOI 10.1016/j.kjms.2012.08.001; Kottke MD, 2006, J CELL SCI, V119, P797, DOI 10.1242/jcs.02888; Kowalczyk A. P., 2007, J INVEST DERMATOL, V127, pE1; Lai-Cheong JE, 2007, J INVEST DERMATOL, V127, P2713, DOI 10.1038/sj.jid.5700727; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Morel E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003000; Nakai Y, 2002, J CELL BIOL, V159, P1097, DOI 10.1083/jcb.200209077; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Nusrat A, 2000, J CELL SCI, V113, P1771; Oktarina DAM, 2011, BRIT J DERMATOL, V165, P552, DOI 10.1111/j.1365-2133.2011.10463.x; Pato C, 2008, CHEM-BIOL INTERACT, V175, P64, DOI 10.1016/j.cbi.2008.03.020; Payne AS, 2004, CURR OPIN CELL BIOL, V16, P536, DOI 10.1016/j.ceb.2004.07.006; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Resnik N, 2011, J BIOL CHEM, V286, P1499, DOI 10.1074/jbc.M110.189464; Saito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050696; Saito M, 2012, J CELL SCI, V125, P2547, DOI 10.1242/jcs.066654; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; SKERROW CJ, 1974, J CELL BIOL, V63, P524, DOI 10.1083/jcb.63.2.524; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Vogt AB, 2002, IMMUNOL REV, V189, P136, DOI 10.1034/j.1600-065X.2002.18912.x; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Yamamoto Y, 2007, J BIOL CHEM, V282, P17866, DOI 10.1074/jbc.M607963200; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	55	59	59	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87809	10.1371/journal.pone.0087809	http://dx.doi.org/10.1371/journal.pone.0087809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498201	gold, Green Submitted, Green Published			2022-12-25	WOS:000330617100116
J	Velasco-de-Castro, CA; Grinsztejn, B; Veloso, VG; Bastos, FI; Pilotto, JH; Fernandes, N; Morgado, MG				Velasco-de-Castro, Carlos A.; Grinsztejn, Beatriz; Veloso, Valdilea G.; Bastos, Francisco I.; Pilotto, Jose H.; Fernandes, Nilo; Morgado, Mariza G.			HIV-1 Diversity and Drug Resistance Mutations among People Seeking HIV Diagnosis in Voluntary Counseling and Testing Sites in Rio de Janeiro, Brazil	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; MODERATE PREVALENCE; GENETIC DIVERSITY; SURVEILLANCE; INDIVIDUALS; SUBTYPES; NAIVE; NETWORK; DRIVEN	The remarkable viral diversity remains a big challenge to the development of HIV vaccines and optimal therapy worldwide. In the latest years, as a consequence of the large expansion of highly active antiretroviral therapy (HAART) availability worldwide, an increase in transmitted drug resistance mutations (TDRM) has been observed, varying according the region. This study assessed HIV-1 diversity and TDRM profile over time among newly HIV-1 diagnosed individuals from Rio de Janeiro, Brazil. Blood samples were collected from individuals seeking HIV diagnosis in four voluntary counseling and testing (VCTs) sites located in the Rio de Janeiro Metropolitan Area, in 2005-2007. Recent (RS) and long-term (LTS) HIV-1 seroconverters were distinguished using BED-CEIA. Pol viral sequences were obtained for 102 LTS identified in 2005 and 144 RS from 2005-2007. HIV-1 subtype and pol recombinant genomes were determined using Rega HIV-1 Subtyping Tool and by phylogenetic inferences and bootscanning analyses. Surveillance of HIV-1 TDRM to protease and reverse transcriptase inhibitors were performed according to the Calibrated Population Resistance (CPR) Tool 6.0. Overall, subtype B remains the most prevalent in Rio de Janeiro in both LTS and RS HIV-1 infected individuals. An increased proportion of recombinant samples was detected over time, especially in RS heterosexual men, due to the emergence of CRF02_AG and URF samples bearing a subtype K fragment. The prevalence of HIV-1 samples carrying TDRM was high and similar between LTS and RS (15.7% vs 14.6%) or age (<25yo 17.9% vs >25yo 16.6%) along the study period. The high resistance levels detected in both populations are of concern, especially considering the dynamics of HIV-1 diversity over time. Our results suggest that the incorporation of resistance testing prior to HAART initiation should be highly considered, as well as permanent surveillance, aiming to carefully monitoring HIV-1 diversity, with focus on CRF/URF emergence and putative transmission.	[Velasco-de-Castro, Carlos A.; Pilotto, Jose H.; Morgado, Mariza G.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil; [Velasco-de-Castro, Carlos A.; Grinsztejn, Beatriz; Veloso, Valdilea G.; Fernandes, Nilo] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, RJ, Brazil; [Velasco-de-Castro, Carlos A.] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Dept Patol Clin, Virol Lab, Rio De Janeiro, RJ, Brazil; [Bastos, Francisco I.] Fundacao Oswaldo Cruz, Inst Comunicacao & Informacao Cient & Tecnol Saud, Rio De Janeiro, RJ, Brazil; [Bastos, Francisco I.] Fundacao Oswaldo Cruz, Lab Informacao Saude, Rio De Janeiro, RJ, Brazil; [Pilotto, Jose H.] Hosp Geral Nova Iguacu, Nova Iguacu, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Velasco-de-Castro, CA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.	cavcastro@fiocruz.br; mmorgado@ioc.fiocruz.brand	Pilotto, Jose Henrique/AAD-9773-2019	Pilotto, Jose Henrique/0000-0003-0521-8597; Bastos, Francisco/0000-0001-5970-8896	Brazilian Research Council (CNPq); Faperj; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI106701] Funding Source: NIH RePORTER	Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Brazilian Research Council (CNPq) and Faperj. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SEM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-306; [Anonymous], 2012, GLOB REP UNAIDS REP; Arruda E, 2011, AIDS RES HUM RETROV, V27, P153, DOI 10.1089/aid.2010.0028; Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bermudez-Aza EH, 2011, JAIDS-J ACQ IMM DEF, V57, pS186, DOI 10.1097/QAI.0b013e31821e9c36; Brindeiro R, 1999, ANTIMICROB AGENTS CH, V43, P1674, DOI 10.1128/AAC.43.7.1674; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Burland T G, 2000, Methods Mol Biol, V132, P71; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Delatorre EO, 2012, AIDS RES HUM RETROV, V28, P1369, DOI 10.1089/aid.2011.0381; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Dobbs T, 2003, MLO MED LAB OBS, V35, P19; Dobbs T, 2003, MLO MED LAB OBS, V35, P24; Dobbs T, 2003, MLO MED LAB OBS, V35, P16; Dobbs Trudy, 2003, MLO Med Lab Obs, V35, P12; Dumans AT, 2002, ANTIMICROB AGENTS CH, V46, P3075, DOI 10.1128/AAC.46.9.3075-3079.2002; Ever-Silva WA, 2006, JAIDS-J ACQ IMM DEF, V41, P664, DOI 10.1097/01.qai.0000194736.66322.02; Ferreira AS, 2011, J MED VIROL, V83, P1301, DOI 10.1002/jmv.22128; Ferreira FGF, 2010, AIDS RES HUM RETROV, V26, P229, DOI 10.1089/aid.2009.0146; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Graf T, 2011, J CLIN VIROL, V51, P186, DOI 10.1016/j.jcv.2011.04.011; Guimaraes ML, 2010, INFECT GENET EVOL, V10, P1094, DOI 10.1016/j.meegid.2010.07.001; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20; Johnston KM, 2010, AIDS, V24, P1929, DOI 10.1097/QAD.0b013e32833af85d; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Machado LFA, 2009, AIDS RES HUM RETROV, V25, P961, DOI 10.1089/aid.2009.0027; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pilotto JH, 2013, AIDS RES HUM RETROV, V29, P681, DOI [10.1089/aid.2011.0333, 10.1089/AID.2011.0333]; Pires IL, 2004, J CLIN MICROBIOL, V42, P426, DOI 10.1128/JCM.42.1.426-430.2004; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scott P, 2004, J ANTIMICROB CHEMOTH, V53, P469, DOI 10.1093/jac/dkh102; Shafer RW, 2008, ANTIVIR THER, V13, P59; Sprinz E, 2009, AIDS RES HUM RETROV, V25, P861, DOI 10.1089/aid.2009.0012; Szwarcwald CL, 2008, BRAZ J INFECT DIS, V12, P167, DOI 10.1590/S1413-86702008000300002; Tamalet C, 2003, AIDS, V17, P2383, DOI 10.1097/00002030-200311070-00014; Taniguchi T, 2012, AIDS RES HUM RETROV, V28, P259, DOI 10.1089/aid.2011.0022; Triques K, 2000, AIDS RES HUM RETROV, V16, P139, DOI 10.1089/088922200309485; UNAIDS, 2010, GLOB REP UNAIDS REP; de Castro CAV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-224; Vicente ACP, 2000, J ACQ IMMUN DEF SYND, V23, P327; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390	46	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87622	10.1371/journal.pone.0087622	http://dx.doi.org/10.1371/journal.pone.0087622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498155	gold, Green Submitted, Green Published			2022-12-25	WOS:000330617100102
J	Liu, Y; Dai, Q; Liu, JB; Liu, SB; Yang, J				Liu, Yang; Dai, Qin; Liu, JianBo; Liu, ShiBin; Yang, Jin			Study of Burn Scar Extraction Automatically Based on Level Set Method using Remote Sensing Data	PLOS ONE			English	Article							ACTIVE CONTOURS; TIME-SERIES; VEGETATION; INDEXES; FOREST; AREAS; MAPS	Burn scar extraction using remote sensing data is an efficient way to precisely evaluate burn area and measure vegetation recovery. Traditional burn scar extraction methodologies have no well effect on burn scar image with blurred and irregular edges. To address these issues, this paper proposes an automatic method to extract burn scar based on Level Set Method (LSM). This method utilizes the advantages of the different features in remote sensing images, as well as considers the practical needs of extracting the burn scar rapidly and automatically. This approach integrates Change Vector Analysis (CVA), Normalized Difference Vegetation Index (NDVI) and the Normalized Burn Ratio (NBR) to obtain difference image and modifies conventional Level Set Method Chan-Vese (C-V) model with a new initial curve which results from a binary image applying K-means method on fitting errors of two near-infrared band images. Landsat 5 TM and Landsat 8 OLI data sets are used to validate the proposed method. Comparison with conventional C-V model, OSTU algorithm, Fuzzy C-mean (FCM) algorithm are made to show that the proposed approach can extract the outline curve of fire burn scar effectively and exactly. The method has higher extraction accuracy and less algorithm complexity than that of the conventional C-V model.	[Liu, Yang; Dai, Qin; Liu, JianBo; Liu, ShiBin; Yang, Jin] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijinng, Peoples R China; [Liu, Yang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Dai, Q (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijinng, Peoples R China.	qdai@ceode.ac.cn			135 Strategy Planning of Institute of Remote Sensing and Digital Earth, CAS; project of Youth Innovation Promotion Association, CAS	135 Strategy Planning of Institute of Remote Sensing and Digital Earth, CAS; project of Youth Innovation Promotion Association, CAS	This work was supported in part by (1). 135 Strategy Planning of Institute of Remote Sensing and Digital Earth, CAS; (2). The project of Youth Innovation Promotion Association, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa PM, 1999, REMOTE SENS ENVIRON, V69, P253, DOI 10.1016/S0034-4257(99)00026-7; Biao C, 2007, CHINA MEASUREMENT TE, V33, P114; Cao X, 2009, INT J REMOTE SENS, V30, P577, DOI 10.1080/01431160802220219; CASELLES V, 1993, NUMER MATH, V66, P1, DOI 10.1007/BF01385685; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chuvieco E, 2002, INT J REMOTE SENS, V23, P5103, DOI 10.1080/01431160210153129; Chuvieco E, 2008, REMOTE SENS ENVIRON, V112, P2381, DOI 10.1016/j.rse.2007.11.007; D'Addabbo A, 2004, INT GEOSCI REMOTE SE, P1980; Fernandez A, 1997, REMOTE SENS ENVIRON, V60, P153, DOI 10.1016/S0034-4257(96)00178-2; Gong P, 2006, PHOTOGRAMM ENG REM S, V72, P139, DOI 10.14358/PERS.72.2.139; Hichri H, 2013, IEEE GEOSCI REMOTE S, V10, P298, DOI 10.1109/LGRS.2012.2204953; Kimmel R, 2003, GEOMETRIC LEVEL SET METHODS IN IMAGING, VISION AND GRAPHICS, P59, DOI 10.1007/0-387-21810-6_4; Kontoes CC, 2009, INT J APPL EARTH OBS, V11, P299, DOI 10.1016/j.jag.2009.04.001; Li Zhanqing, 2001, P199; Miller JD, 2007, REMOTE SENS ENVIRON, V109, P66, DOI 10.1016/j.rse.2006.12.006; MUMFORD D, 1989, COMMUN PUR APPL MATH, V42, P577, DOI 10.1002/cpa.3160420503; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Pereira JMC, 1999, IEEE T GEOSCI REMOTE, V37, P217, DOI 10.1109/36.739156; Sedano F, 2013, INT J APPL EARTH OBS, V20, P52, DOI 10.1016/j.jag.2011.08.003; Sedano F, 2012, REMOTE SENS-BASEL, V4, P726, DOI 10.3390/rs4030726; Silva JMN, 2005, REMOTE SENS ENVIRON, V96, P188, DOI 10.1016/j.rse.2005.02.004; SINGH A, 1989, INT J REMOTE SENS, V10, P989, DOI 10.1080/01431168908903939; Vafeidis AT, 2005, INT J REMOTE SENS, V26, P2441, DOI 10.1080/01431160500034102; van Wagtendonk JW, 2004, REMOTE SENS ENVIRON, V92, P397, DOI 10.1016/j.rse.2003.12.015; Zhao YS, 2003, PRINCIPLES METHODS A	25	7	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87480	10.1371/journal.pone.0087480	http://dx.doi.org/10.1371/journal.pone.0087480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503563	Green Published, Green Submitted, gold			2022-12-25	WOS:000330631800041
J	Toon, CW; Chou, A; Clarkson, A; DeSilva, K; Houang, M; Chan, JCY; Sioson, LL; Jankova, L; Gill, AJ				Toon, Christopher W.; Chou, Angela; Clarkson, Adele; DeSilva, Keshani; Houang, Michelle; Chan, Joseph C. Y.; Sioson, Loretta L.; Jankova, Lucy; Gill, Anthony J.			Immunohistochemistry for Myc Predicts Survival in Colorectal Cancer	PLOS ONE			English	Article							B-CELL LYMPHOMA; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; C-MYC; EXPRESSION; CARCINOMA; ONCOGENE; COEXPRESSION; VINCRISTINE; DOXORUBICIN; MUTATION	MYC over-expression as determined by molecular means has been reported as a favorable prognostic biomarker in colorectal carcinoma (CRC). However MYC expression analysis is not available in the routine clinical setting. We investigated whether immunohistochemistry (IHC) for the myc protein using a novel commercially available rabbit monoclonal antibody [clone Y69] which is currently in widespread clinical use for lymphoma diagnosis could be used to predict outcome in resected CRC. Myc IHC was performed on a tissue microarray (TMA) comprising a retrospective cohort of 1421 CRC patients and scored blinded as to all clinical and pathological data. IHC was also performed on a subcohort of whole section CRCs to assess staining characteristics and concordance with TMA expression. MYC over-expression was found in 980 (69%) of CRCs and was associated with tumor stage and DNA mismatch repair/BRAF status. There was substantial agreement between TMA and whole section myc IHC (kappa = 0.742, p < 0.01). CRCs with MYC over-expression demonstrated improved 5-year survival (93.2% vs. 57.3%), with the effect significantly modulated by the dominant effect of tumor stage, age at diagnosis and lymphovascular space invasion status on survival. We conclude that myc status as determined by IHC alone can be used to predict overall survival in patients with CRC undergoing surgical resection.	[Toon, Christopher W.; Chou, Angela; Clarkson, Adele; Houang, Michelle; Sioson, Loretta L.; Gill, Anthony J.] Kolling Inst Med Res, Canc Diag & Pathol Grp, Sydney, NSW, Australia; [Toon, Christopher W.] Histopath Pathol, N Ryde, NSW, Australia; [Chou, Angela] St Vincents Hosp, SYDPATH, Dept Anat Pathol, Darlinghurst, NSW 2010, Australia; [Clarkson, Adele; DeSilva, Keshani; Houang, Michelle; Sioson, Loretta L.; Gill, Anthony J.] Royal N Shore Hosp, Dept Anat Pathol, St Leonards, NSW 2065, Australia; [Chan, Joseph C. Y.; Jankova, Lucy; Gill, Anthony J.] Univ Sydney, Camperdown, NSW, Australia; [Chan, Joseph C. Y.; Jankova, Lucy] Kolling Inst Med Res, Bill Walsh Canc Res Lab, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; St Vincents Hospital Sydney; Royal North Shore Hospital; University of Sydney; University of Sydney; Kolling Institute of Medical Research	Toon, CW (corresponding author), Kolling Inst Med Res, Canc Diag & Pathol Grp, Sydney, NSW, Australia.	ctoon@med.usyd.edu.au	Gill, Anthony/D-4215-2015; Gill, Anthony J./M-5015-2019	Gill, Anthony/0000-0002-9447-1967; Toon, Christopher/0000-0002-0750-918X; Chou, Angela/0000-0001-9212-6927	Pathology North Staff Specialist Trust Fund	Pathology North Staff Specialist Trust Fund	Pathology North Staff Specialist Trust Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kuraya K, 2007, J CLIN PATHOL, V60, P768, DOI 10.1136/jcp.2006.038281; Bhatavdekar JM, 1997, DIS COLON RECTUM, V40, P785, DOI 10.1007/BF02055433; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Edge SB, 2009, AJCC CANC STAGING MA, V7; ERISMAN MD, 1988, CANCER RES, V48, P1350; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hu SM, 2013, BLOOD, V121, P4021, DOI 10.1182/blood-2012-10-460063; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Lochhead P, 2013, JNCI-J NATL CANCER I, V105, P1151, DOI 10.1093/jnci/djt173; MILLER F, 1992, DIS COLON RECTUM, V35, P430, DOI 10.1007/BF02049398; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NAGAI MA, 1992, DIS COLON RECTUM, V35, P444, DOI 10.1007/BF02049400; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Smith DR, 1996, CLIN CANCER RES, V2, P1049; Toon CW, 2013, AM J SURG PATHOL, V37, P1592, DOI 10.1097/PAS.0b013e31828f233d; Toon CW, 2013, MOD PATHOL; WILLIAMS ARW, 1990, J PATHOL, V160, P287, DOI 10.1002/path.1711600404	19	37	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87456	10.1371/journal.pone.0087456	http://dx.doi.org/10.1371/journal.pone.0087456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503701	gold, Green Published, Green Submitted			2022-12-25	WOS:000330631800039
J	Ezougou, CN; Ben-Rached, F; Moss, DK; Lin, JW; Black, S; Knuepfer, E; Green, JL; Khan, SM; Mukhopadhyay, A; Janse, CJ; Coppens, I; Yera, H; Holder, AA; Langsley, G				Ezougou, Carinne Ndjembo; Ben-Rached, Fathia; Moss, David K.; Lin, Jing-wen; Black, Sally; Knuepfer, Ellen; Green, Judith L.; Khan, Shahid M.; Mukhopadhyay, Amitabha; Janse, Chris J.; Coppens, Isabelle; Yera, Helene; Holder, Anthony A.; Langsley, Gordon			Plasmodium falciparum Rab5B Is an N-Terminally Myristoylated Rab GTPase That Is Targeted to the Parasite's Plasma and Food Vacuole Membranes	PLOS ONE			English	Article							MALARIA PARASITE; PROTEIN PALMITOYLATION; FAMILY; IDENTIFICATION; PATHWAY; BIOGENESIS; EXPRESSION	Plasmodium falciparum (Pf) has a family of 11 Rab GTPases to regulate its vesicular transport. However, PfRab5B is unique in lacking a C-terminal geranyl-geranylation motif, while having N-terminal palmitoylation and myristoylation motifs. We show that the N-terminal glycine is required for PfRab5B myristoylation in vitro and when an N-terminal PfRab5B fragment possessing both acylation motifs is fused to GFP and expressed in transgenic P. falciparum parasites, the chimeric PfRab5B protein localizes to the plasma membrane. Upon substitution of the modified glycine by alanine the staining becomes diffuse and GFP is found in soluble subcellular fractions. Immuno-electron microscopy shows endogenous PfRab5B decorating the parasite's plasma and food vacuole membranes. Using reverse genetics rab5b couldn't be deleted from the haploid genome of asexual blood stage P. berghei parasites. The failure of PbRab5A or PbRab5C to complement for loss of PbRab5B function indicates non-overlapping roles for the three Plasmodium Rab5s, with PfRab5B involved in trafficking MSP1 to the food vacuole membrane and CK1 to the plasma membrane. We discuss similarities between Plasmodium Rab5B and Arabidopsis thaliana ARA6, a similarly unusual Rab5-like GTPase of plants.	[Ezougou, Carinne Ndjembo; Ben-Rached, Fathia; Yera, Helene; Langsley, Gordon] Univ Paris 05, Lab Biol Cellulaire Comparat Apicomplex, Dept Immunol Inflammat & Infect, Sorbonne Paris Cite,Fac Med, Paris, France; [Ezougou, Carinne Ndjembo; Ben-Rached, Fathia; Yera, Helene; Langsley, Gordon] Inst Cochin Genet Mol, Inst Natl Rech Med, Ctr Natl Rech Sci, U1016,UMR8104, F-75014 Paris, France; [Lin, Jing-wen; Khan, Shahid M.; Janse, Chris J.] Leiden Univ, Ctr Infect Dis, Med Ctr, Leiden, Netherlands; [Moss, David K.; Lin, Jing-wen; Black, Sally; Knuepfer, Ellen; Green, Judith L.; Holder, Anthony A.] MRC Natl Inst Med Res, Div Parasitol, London, England; [Mukhopadhyay, Amitabha] Natl Inst Immunol, New Delhi 110067, India; [Coppens, Isabelle] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; MRC National Institute for Medical Research; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Holder, AA (corresponding author), MRC Natl Inst Med Res, Div Parasitol, Mill Hill, London, England.	aholder@nimr.mrc.ac.uk; gordon.langsley@inserm.fr	Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; Khan, Shahid/0000-0002-0533-4670; Ben Rached, Fathia/0000-0001-6601-3080; Green, Judith/0000-0001-6825-9404; Lin, Jing-wen/0000-0003-3338-8788; Janse, Chris J/0000-0002-6410-6205; Knuepfer, Ellen/0000-0002-6090-1877	Fondation de France; CNE by an AUF fellowship; INSERM; CNRS; Labex ParaFrap [ANR-11-LABX-0024]; CEFIPRA [3303-3]; UK Medical Research Council [U117532067]; European Union through the EviMalaR Network of Excellence [Health-2009-2.3.2-1-242095]; Medical Research Council [MC_U117532067] Funding Source: researchfish; MRC [MC_U117532067] Funding Source: UKRI	Fondation de France(Fondation de France); CNE by an AUF fellowship; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Labex ParaFrap; CEFIPRA; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union through the EviMalaR Network of Excellence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	FBR was supported by a fellowship from the Fondation de France and CNE by an AUF fellowship. GL acknowledges INSERM, the CNRS, the Labex ParaFrap ANR-11-LABX-0024 and CEFIPRA (grant No. 3303-3) for support. The study was funded in part by the UK Medical Research Council (file reference number U117532067) and the European Union through the EviMalaR Network of Excellence Health-2009-2.3.2-1-242095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agop-Nersesian C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001029; Agop-Nersesian C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000270; [Anonymous], LANCET; Ayong L, 2007, MOL BIOCHEM PARASIT, V152, P113, DOI 10.1016/j.molbiopara.2006.12.007; Barik S, 1997, J BIOL CHEM, V272, P26132, DOI 10.1074/jbc.272.42.26132; Ben Rached F, 2012, BIOL CELL, V104, P34, DOI 10.1111/boc.201100081; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; deCastro FA, 1996, MOL BIOCHEM PARASIT, V80, P77, DOI 10.1016/0166-6851(96)02670-9; Dluzewski AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003085; Donald RGK, 2005, MOL BIOCHEM PARASIT, V141, P15, DOI 10.1016/j.molbiopara.2005.01.011; Ebine Kazuo, 2012, Small GTPases, V3, P23, DOI 10.4161/sgtp.18299; Ebine K, 2011, NAT CELL BIOL, V13, P853, DOI 10.1038/ncb2270; Elliott DA, 2008, P NATL ACAD SCI USA, V105, P2463, DOI 10.1073/pnas.0711067105; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gunaratne RS, 2000, BIOCHEM J, V348, P459, DOI 10.1042/0264-6021:3480459; Hirota Y, 2007, BIOCHEM BIOPH RES CO, V364, P40, DOI 10.1016/j.bbrc.2007.09.089; Holder AA, 2009, PARASITOLOGY, V136, P1445, DOI 10.1017/S0031182009990515; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Jones ML, 2012, TRENDS PARASITOL, V28, P496, DOI 10.1016/j.pt.2012.08.009; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Knuepfer E, 2013, CELL MICROBIOL; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; Langsley G, 2008, MICROBES INFECT, V10, P462, DOI 10.1016/j.micinf.2008.01.017; NOVICK PJ, 1988, COLD SPRING HARB SYM, V53, P637, DOI 10.1101/SQB.1988.053.01.073; Parish LA, 2009, MOL BIOCHEM PARASIT, V164, P153, DOI 10.1016/j.molbiopara.2008.11.011; Pfeffer S, 2001, MOL CELL, V8, P729, DOI 10.1016/S1097-2765(01)00371-9; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Quevillon E, 2003, GENE, V306, P13, DOI 10.1016/S0378-1119(03)00381-0; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Ridzuan MAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033845; Stafford WHL, 1996, EUR J BIOCHEM, V242, P104, DOI 10.1111/j.1432-1033.1996.0104r.x; Stenmark H, 2001, GENOME BIOL, V2; Tomlins AM, 2013, AUTOPHAGY, V9, P1540, DOI 10.4161/auto.25832; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Ward GE, 1997, PARASITOL TODAY, V13, P57, DOI 10.1016/S0169-4758(96)10080-6; Wright MH, 2013, NATURE CHEM; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	43	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87695	10.1371/journal.pone.0087695	http://dx.doi.org/10.1371/journal.pone.0087695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498355	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900101
J	Gundersen, H; Leinaas, HP; Thaulow, C				Gundersen, Hakon; Leinaas, Hans Petter; Thaulow, Christian			Surface Structure and Wetting Characteristics of Collembola Cuticles	PLOS ONE			English	Article							CONTACT-ANGLE HYSTERESIS; SUPERHYDROPHOBIC SURFACES; CASSIE; REDUCTION; SLIPPERY	The cuticles of the arthropods Collembola (springtails) are known to be superhydrophobic, displaying such properties as water-repellence and plastron formation; overhanging surface structures have been suggested as the source of these properties. Superhydrophobicity is closely related to surface structuring and other surfaces with overhanging structures have been shown to possess robust superhydrophobic properties. In effort to correlate the wetting performance and surface structuring of the cuticles, from both a technical and evolutionary point of view, we investigated a selection of Collembola species including species from several families and covering habitats ranging from aquatic to very dry. The observed contact angles of wetting was in general larger than those predicted by the conventional models. Not all the studied Collembola were found to have superhydrophobic properties, indicating that superhydrophobicity is common, but not a universal trait in Collembola. Overhanging structures were found in some, but not all Collembola species with superhydrophobic cuticles; which leads to the conclusion that there is no direct link between overhanging surface structures and superhydrophobicity in Collembola.	[Gundersen, Hakon; Thaulow, Christian] Norwegian Univ Sci & Technol NTNU, Dept Engn Design & Mat, Trondheim, Norway; [Leinaas, Hans Petter] Univ Oslo UIO, Dept Biosci, Oslo, Norway	Norwegian University of Science & Technology (NTNU); University of Oslo	Gundersen, H (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Engn Design & Mat, Trondheim, Norway.	hakon.gundersen@ntnu.no			Norwegian University of Science and Technology, NTNU	Norwegian University of Science and Technology, NTNU	The funding was provided by the Norwegian University of Science and Technology, NTNU, through a program for strategic funding of materials-related research projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bhushan B, 2011, PROG MATER SCI, V56, P1, DOI 10.1016/j.pmatsci.2010.04.003; Blow ML, 2010, LANGMUIR, V26, P16071, DOI 10.1021/la101847b; Bush JWM, 2007, ADV INSECT PHYSIOL, V34, P117, DOI 10.1016/S0065-2806(07)34003-4; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Choi W, 2009, J COLLOID INTERF SCI, V339, P208, DOI 10.1016/j.jcis.2009.07.027; CRISP DJ, 1948, DISCUSS FARADAY SOC, V3, P210, DOI 10.1039/df9480300210; Ditsche-Kuru P, 2011, BEILSTEIN J NANOTECH, V2, P137, DOI 10.3762/bjnano.2.17; Dufour R, 2011, SOFT MATTER, V7, P9380, DOI 10.1039/c1sm05832k; Fjellberg A., 2007, COLLEMBOLA FENNOSC 2, V42; Fjellberg Arne, 1998, FAUNA ENTOMOL SCAD, V35, P42; Gao LC, 2007, LANGMUIR, V23, P3762, DOI 10.1021/la062634a; Gao LC, 2009, LANGMUIR, V25, P14105, DOI 10.1021/la902206c; GHIRADELLA H, 1974, J INSECT PHYSIOL, V20, P301, DOI 10.1016/0022-1910(74)90062-6; Guo ZG, 2011, J COLLOID INTERF SCI, V353, P335, DOI 10.1016/j.jcis.2010.08.047; Helbig R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025105; Hobk TC, 2011, BIONANOSCIENCE, V1, P63, DOI 10.1007/s12668-011-0014-5; HOLDGATE MW, 1955, J EXP BIOL, V32, P591; Jung YC, 2009, ACS NANO, V3, P4155, DOI 10.1021/nn901509r; KING PE, 1990, J NAT HIST, V24, P673, DOI 10.1080/00222939000770461; Leinaas HP, 2009, PHYSIOL ENTOMOL, V34, P325, DOI 10.1111/j.1365-3032.2009.00693.x; LEINAAS HP, 1985, OIKOS, V44, P448, DOI 10.2307/3565786; Liu KS, 2010, CHEM SOC REV, V39, P3240, DOI 10.1039/b917112f; Luo C, 2011, MICROFLUID NANOFLUID, V10, P831, DOI 10.1007/s10404-010-0714-0; Massoud Lawrence, 1973, REV ECOLOGIE BIOL SO, V10, P73; McHale G, 2011, SOFT MATTER, V7, P10100, DOI 10.1039/c1sm06140b; Milne AJB, 2012, ADV COLLOID INTERFAC, V170, P48, DOI 10.1016/j.cis.2011.12.001; NOBLENESBITT J, 1963, J EXP BIOL, V40, P681; Nosonovsky M, 2007, LANGMUIR, V23, P3157, DOI 10.1021/la062301d; Nosonovsky M, 2011, NATURE, V477, P412, DOI 10.1038/477412a; Nosonovsky M, 2009, CURR OPIN COLLOID IN, V14, P270, DOI 10.1016/j.cocis.2009.05.004; Roach P, 2008, SOFT MATTER, V4, P224, DOI 10.1039/b712575p; Shirtcliffe NJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2347266; Shirtcliffe NJ, 2010, ADV COLLOID INTERFAC, V161, P124, DOI 10.1016/j.cis.2009.11.001; Srinivasan S, 2011, LANGMUIR, V27, P13582, DOI 10.1021/la2031208; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Tuteja A, 2008, P NATL ACAD SCI USA, V105, P18200, DOI 10.1073/pnas.0804872105; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Yan YY, 2011, ADV COLLOID INTERFAC, V169, P80, DOI 10.1016/j.cis.2011.08.005; Zheng QS, 2010, SCI CHINA PHYS MECH, V53, P2245, DOI 10.1007/s11433-010-4172-1; Zimmermann J, 2007, COLLOID SURFACE A, V302, P234, DOI 10.1016/j.colsurfa.2007.02.033	42	20	20	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e86783	10.1371/journal.pone.0086783	http://dx.doi.org/10.1371/journal.pone.0086783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498281	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900027
J	Knudsen, NN; Kjaerulff, TM; Ward, LC; Saebye, D; Holst, C; Heitmann, BL				Knudsen, Nikoline Nygard; Kjaerulff, Thora Majlund; Ward, Leigh Cordwin; Saebye, Ditte; Holst, Claus; Heitmann, Berit Lilienthal			Body Water Distribution and Risk of Cardiovascular Morbidity and Mortality in a Healthy Population: A Prospective Cohort Study	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; CLINICAL-PRACTICE IMPLICATIONS; PERITONEAL-DIALYSIS PATIENTS; PHASE-ANGLE; HEMODIALYSIS-PATIENTS; BIOIMPEDANCE SPECTROSCOPY; PROGNOSTIC INDICATOR; EXTRACELLULAR FLUID; HEART-FAILURE; ADULT DANES	Background: Early alterations in the cardiovascular structure and function may change normal body water distribution. The resulting fluid shifts may thus serve as an early marker for cardiovascular disease. However, studies examining this in healthy populations are absent. Objective: This study examined the association between the proportion of total body water that is extracellular water and subsequent development of non-fatal or fatal cardiovascular disease in a healthy population. Method: Bioelectrical impedance spectroscopy is an easy-to-use, non-invasive and relatively inexpensive technique to evaluate changes in body water distribution. A random subset (n = 2120) of Danes aged 41-71 years, examined in 1993-1994 for body water distribution by bioelectrical impedance spectroscopy was included. Cox-proportional hazard models and linear splines were performed. The ratio between resistance estimates from an infinite-frequency and from no-frequency (R-infinity/R-0) was used as a surrogate measure of ratio between extracellular water and total body water. The outcome was 13.5 years of follow-up for cardiovascular morbidity and mortality. Results: A high proportion of total body water that is extracellular water was associated with increased risk of incident cardiovascular disease. A threshold effect was evident, with greatly increased risk of cardiovascular morbidity and mortality above R-infinity/R-0 = 0.68. Below the threshold there seemed to be no additional benefit of having a low ratio. Conclusion: Our findings suggest that non-clinically evident oedema, measured as an increased proportion of total body water that is extracellular, above a threshold of 0.68, may be an early marker of pre-clinical cardiovascular disease. This simple, safe, cheap and easily obtainable measure of R-infinity/R-0 from bioelectrical impedance may help the early identification of these otherwise clinically healthy individuals who are at an increased risk of future cardiovascular disease. However, more studies are needed before it can be concluded that bioelectrical impedance spectroscopy improves clinical risk prediction.	[Knudsen, Nikoline Nygard; Kjaerulff, Thora Majlund; Saebye, Ditte; Holst, Claus; Heitmann, Berit Lilienthal] Bispebjerg Hosp, Inst Prevent Med, Res Unit Dietary Studies, DK-2400 Copenhagen, Denmark; [Knudsen, Nikoline Nygard; Kjaerulff, Thora Majlund; Saebye, Ditte; Holst, Claus; Heitmann, Berit Lilienthal] Frederiksberg Univ Hosp, Inst Prevent Med, Res Unit Dietary Studies, Copenhagen, Denmark; [Ward, Leigh Cordwin] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Heitmann, Berit Lilienthal] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Kjaerulff, Thora Majlund; Heitmann, Berit Lilienthal] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Heitmann, Berit Lilienthal] Copenhagen Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Queensland; University of Sydney; University of Southern Denmark; University of Copenhagen	Heitmann, BL (corresponding author), Bispebjerg Hosp, Inst Prevent Med, Res Unit Dietary Studies, DK-2400 Copenhagen, Denmark.	berit.lilienthal.heitmann@regionh.dkmailto	Ward, Leigh C/A-4834-2010; Ward, Leigh C/L-4461-2019	Ward, Leigh C/0000-0003-2378-279X; Heitmann, Berit Lilienthal/0000-0002-6809-4504				Barbosa-Silva MCG, 2005, CURR OPIN CLIN NUTR, V8, P311, DOI 10.1097/01.mco.0000165011.69943.39; CHA KC, 1995, J APPL PHYSIOL, V79, P1316, DOI 10.1152/jappl.1995.79.4.1316; Chan J, 2002, AM J EPIDEMIOL, V155, P827, DOI 10.1093/aje/155.9.827; Chen W, 2007, BLOOD PURIFICAT, V25, P260, DOI 10.1159/000101699; Chumlea W.C., 2005, HUMAN BODY COMPOSITI, V2nd, P79; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; CORNISH BH, 1993, PHYS MED BIOL, V38, P337, DOI 10.1088/0031-9155/38/3/001; Danish Nephrology Register, 2011, ANN REP 2010 DAN NEP; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Gupta D, 2004, BRIT J NUTR, V92, P957, DOI 10.1079/BJN20041292; Gupta D, 2004, AM J CLIN NUTR, V80, P1634, DOI 10.1093/ajcn/80.6.1634; Gupta D, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-249; Gupta D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-37; HEITMANN BL, 1992, J CLIN EPIDEMIOL, V45, P693, DOI 10.1016/0895-4356(92)90046-P; Heitmann BL, 2002, AM J CLIN NUTR, V75, P840, DOI 10.1093/ajcn/75.5.840; HEITMANN BL, 1990, INT J OBESITY, V14, P789; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; Jones CH, 2004, PERITON DIALYSIS INT, V24, P353; Kahraman A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-191; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Libraty DH, 2002, T ROY SOC TROP MED H, V96, P295, DOI 10.1016/S0035-9203(02)90104-5; Lin YP, 2003, AM J KIDNEY DIS, V42, P990, DOI 10.1016/j.ajkd.2003.07.002; Liu MH, 2012, J CARDIOVASC MED, V13, P299, DOI 10.2459/JCM.0b013e328351677f; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; McDonagh TA, 2004, EUR J HEART FAIL, V6, P269, DOI 10.1016/j.ejheart.2004.01.010; Nescolarde L, 2004, PHYSIOL MEAS, V25, P1271, DOI 10.1088/0967-3334/25/5/016; Park J, 2009, BLOOD PURIFICAT, V28, P61, DOI 10.1159/000210663; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schwenk A, 1998, INFECTION, V26, P277, DOI 10.1007/BF02962247; Schwenk A, 2000, AM J CLIN NUTR, V72, P496; Seeley R, 2008, ANATOMY PHYSL, P1004; Slinde F, 2005, RESP MED, V99, P1004, DOI 10.1016/j.rmed.2004.09.024; Therneau T, 2000, MODELLING SURVIVAL D, P79; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Ward L, 2009, OPEN MED DEVICE J, V1, P3; World Health Organization, 1989, MEAS OB CLASSDESCR A	40	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87466	10.1371/journal.pone.0087466	http://dx.doi.org/10.1371/journal.pone.0087466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498327	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900073
J	Lee, S; Park, Y; Kim, J; Han, SJ				Lee, Sangchul; Park, Youngsam; Kim, Junghwan; Han, Sung-Jun			A Fluorescence-Based Assay for Measuring the Redox Potential of 5-Lipoxygenase Inhibitors	PLOS ONE			English	Article							LIPOXYGENASE; IDENTIFICATION; ACID	The activities and side effects of 5-lipoxygenase (5-LO) inhibitors can be predicted by identifying their redox mechanisms. In this study, we developed a fluorescence-based method to measure the redox potential of 5-LO inhibitors and compared it to the conventional, absorbance-based method. After the pseudo-peroxidase reaction, the amount of remaining lipid peroxide was quantified using the H2DCFDA (2',7'-dichlorodihydrofluorescein diacetate) fluorescence dye. Our method showed large signal windows and provided comparable redox potential values. Importantly, the redox mechanisms of known inhibitors were accurately measured with the fluorescence assay, whereas the conventional, absorbance-based method showed contradictory results. Our findings suggest that our developed method is a better alternative for classifying the redox potential of 5-LO inhibitors, and the fluorescence assay can be effectively used to study the mechanisms of action that are related to redox cycling.	[Lee, Sangchul; Park, Youngsam; Kim, Junghwan; Han, Sung-Jun] Inst Pasteur Korea, Songnam, Gyeonggi Do, South Korea	Institut Pasteur Korea	Kim, J (corresponding author), Inst Pasteur Korea, Songnam, Gyeonggi Do, South Korea.	junghkim@ip-korea.org; han@ip-korea.org		LEE, Sangchul/0000-0002-7002-1179	National Research foundation of Korea (NRF); Korea government (MSIP) [2007-00559]; Gyeonggi-do; KISTI	National Research foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MSIP); Gyeonggi-do; KISTI(Korea Institute of Science & Technology Information (KISTI))	This work was supported by the National Research foundation of Korea (NRF) grant funded by the Korea government (MSIP)(No. 2007-00559), Gyeonggi-do and KISTI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brock TG, 2005, J CELL BIOCHEM, V96, P1203, DOI 10.1002/jcb.20662; Czapski GA, 2012, PHARMACOL REP, V64, P1179, DOI 10.1016/S1734-1140(12)70914-3; Czubowicz K, 2010, FOLIA NEUROPATHOL, V48, P283; Dahlen SE, 2006, EUR J PHARMACOL, V533, P40, DOI 10.1016/j.ejphar.2005.12.070; FALGUEYRET JP, 1993, BIOCHEM PHARMACOL, V45, P978, DOI 10.1016/0006-2952(93)90185-Y; GIBIAN MJ, 1987, ANAL BIOCHEM, V163, P343, DOI 10.1016/0003-2697(87)90234-X; Gulcin I, 2006, TOXICOLOGY, V217, P213, DOI 10.1016/j.tox.2005.09.011; Hofmann B, 2011, J MED CHEM, V54, P1943, DOI 10.1021/jm101165z; Huntington J, 2009, CELL MOL LIFE SCI, V66, P113, DOI 10.1007/s00018-008-8371-0; Karg EM, 2009, J MED CHEM, V52, P3474, DOI 10.1021/jm900212y; Kim J, 2013, MOL CELLS, V36, P212, DOI 10.1007/s10059-013-2348-z; Lu JM, 2010, MED SCI MONITOR, V16, pRA93; Masferrer JL, 2010, J PHARMACOL EXP THER, V334, P294, DOI 10.1124/jpet.110.166967; MCMILLAN RM, 1992, TRENDS PHARMACOL SCI, V13, P323, DOI 10.1016/0165-6147(92)90100-K; Pergola C, 2011, J PHARMACOL EXP THER, V338, P205, DOI 10.1124/jpet.111.180794; Pergola C, 2010, EXPERT OPIN THER PAT, V20, P355, DOI 10.1517/13543771003602012; Pufahl RA, 2007, ANAL BIOCHEM, V364, P204, DOI 10.1016/j.ab.2007.02.009; RIENDEAU D, 1991, BIOCHEM J, V274, P287, DOI 10.1042/bj2740287; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Werz O, 2005, BIOCHEM PHARMACOL, V70, P327, DOI 10.1016/j.bcp.2005.04.018; Werz O, 1998, MOL PHARMACOL, V54, P445, DOI 10.1124/mol.54.2.445; Werz O, 2008, J MED CHEM, V51, P5449, DOI 10.1021/jm800588x; Werz O, 2006, PHARMACOL THERAPEUT, V112, P701, DOI 10.1016/j.pharmthera.2006.05.009; Zweifel BS, 2008, EUR J PHARMACOL, V584, P166, DOI 10.1016/j.ejphar.2008.01.021	24	2	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87708	10.1371/journal.pone.0087708	http://dx.doi.org/10.1371/journal.pone.0087708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498359	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900105
J	Liu, H; Li, Y; Hung, KKH; Wang, N; Wang, C; Chen, XC; Sheng, DL; Fu, X; See, K; Foo, JN; Low, H; Liany, H; Irwan, ID; Liu, J; Yang, BQ; Chen, MF; Yu, YX; Yu, GQ; Niu, GY; You, JB; Zhou, Y; Ma, SS; Wang, T; Yan, XX; Goh, BK; Common, JEA; Lane, BE; Sun, YH; Zhou, GZ; Lu, XM; Wang, ZH; Tian, HQ; Cao, YH; Chen, SM; Liu, QJ; Liu, JJ; Zhang, FR				Liu, Hong; Li, Yi; Hung, Ken Kwok Hon; Wang, Na; Wang, Chuan; Chen, Xuechao; Sheng, Donglai; Fu, Xi'an; See, Kelvin; Foo, Jia Nee; Low, Huiqi; Liany, Herty; Irwan, Ishak Darryl; Liu, Jian; Yang, Baoqi; Chen, Mingfei; Yu, Yongxiang; Yu, Gongqi; Niu, Guiye; You, Jiabao; Zhou, Yan; Ma, Shanshan; Wang, Ting; Yan, Xiaoxiao; Goh, Boon Kee; Common, John E. A.; Lane, Birgitte E.; Sun, Yonghu; Zhou, Guizhi; Lu, Xianmei; Wang, Zhenhua; Tian, Hongqing; Cao, Yuanhua; Chen, Shumin; Liu, Qiji; Liu, Jianjun; Zhang, Furen			Genome-Wide Linkage, Exome Sequencing and Functional Analyses Identify ABCB6 as the Pathogenic Gene of Dyschromatosis Universalis Hereditaria	PLOS ONE			English	Article							ZEBRAFISH; IDENTIFICATION; TRANSPORTER; MELANOSOME; MUTATIONS; LOCUS; MAPS	Background: As a genetic disorder of abnormal pigmentation, the molecular basis of dyschromatosis universalis hereditaria (DUH) had remained unclear until recently when ABCB6 was reported as a causative gene of DUH. Methodology: We performed genome-wide linkage scan using Illumina Human 660W-Quad BeadChip and exome sequencing analyses using Agilent SureSelect Human All Exon Kits in a multiplex Chinese DUH family to identify the pathogenic mutations and verified the candidate mutations using Sanger sequencing. Quantitative RT-PCR and Immunohistochemistry was performed to verify the expression of the pathogenic gene, Zebrafish was also used to confirm the functional role of ABCB6 in melanocytes and pigmentation. Results: Genome-wide linkage (assuming autosomal dominant inheritance mode) and exome sequencing analyses identified ABCB6 as the disease candidate gene by discovering a coding mutation (c.1358C>T; p.Ala453Val) that co-segregates with the disease phenotype. Further mutation analysis of ABCB6 in four other DUH families and two sporadic cases by Sanger sequencing confirmed the mutation (c.1358C>T; p.Ala453Val) and discovered a second, co-segregating coding mutation (c.964A>C; p.Ser322Lys) in one of the four families. Both mutations were heterozygous in DUH patients and not present in the 1000 Genome Project and dbSNP database as well as 1,516 unrelated Chinese healthy controls. Expression analysis in human skin and mutagenesis interrogation in zebrafish confirmed the functional role of ABCB6 in melanocytes and pigmentation. Given the involvement of ABCB6 mutations in coloboma, we performed ophthalmological examination of the DUH carriers of ABCB6 mutations and found ocular abnormalities in them. Conclusion: Our study has advanced our understanding of DUH pathogenesis and revealed the shared pathological mechanism between pigmentary DUH and ocular coloboma.	[Liu, Hong; Wang, Na; Wang, Chuan; Chen, Xuechao; Fu, Xi'an; Liu, Jian; Chen, Mingfei; Yu, Yongxiang; Yu, Gongqi; Niu, Guiye; You, Jiabao; Zhou, Yan; Ma, Shanshan; Sun, Yonghu; Zhou, Guizhi; Lu, Xianmei; Chen, Shumin; Zhang, Furen] Prov Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Shandong, Peoples R China; [Liu, Hong; Yang, Baoqi; Yan, Xiaoxiao; Tian, Hongqing; Zhang, Furen] Shandong Univ, Shandong Prov Hosp Skin Dis, Jinan, Shandong, Peoples R China; [Liu, Hong; Wang, Na; Wang, Chuan; Chen, Xuechao; Fu, Xi'an; Liu, Jian; Chen, Mingfei; Yu, Yongxiang; Yu, Gongqi; Niu, Guiye; You, Jiabao; Zhou, Yan; Ma, Shanshan; Sun, Yonghu; Zhou, Guizhi; Lu, Xianmei; Chen, Shumin; Zhang, Furen] Shandong Prov Key Lab Dermatovenereol, Jinan, Shandong, Peoples R China; [Liu, Hong; Yang, Baoqi; Yan, Xiaoxiao; Tian, Hongqing; Zhang, Furen] Shandong Prov Med Ctr Dermatovenereol, Jinan, Shandong, Peoples R China; [Li, Yi; Hung, Ken Kwok Hon; Sheng, Donglai; See, Kelvin; Foo, Jia Nee; Low, Huiqi; Liany, Herty; Irwan, Ishak Darryl; Liu, Jianjun] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Wang, Ting] Shandong Prov Eye Hosp, Jinan, Shandong, Peoples R China; [Goh, Boon Kee] Natl Skin Ctr, Singapore, Singapore; [Common, John E. A.; Lane, Birgitte E.] ASTAR, Inst Med Biol, Singapore, Singapore; [Wang, Zhenhua] Weifang Peoples Hosp, Weifang, Shandong, Peoples R China; [Cao, Yuanhua] Chinese Acad Med Sci, Inst Dermatol, Beijing, Jiangsu, Peoples R China; [Cao, Yuanhua] Peking Union Med Coll Nanjing, Nanjing, Jiangsu, Peoples R China; [Liu, Qiji] Shandong Univ, Jinan 250100, Shandong, Peoples R China; [Liu, Jianjun] Anhui Med Univ, Sch Life Sci, Hefei, Anhui, Peoples R China; [Zhang, Furen] Anhui Med Univ, Shandong Clin Coll, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National Skin Centre; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Shandong University; Anhui Medical University; Anhui Medical University	Liu, JJ (corresponding author), ASTAR, Genome Inst Singapore, Singapore, Singapore.	liuj3@gis.a-star.edu.sg; zhangfuren@hotmail.com	Foo, Jia Nee/D-6069-2014; Common, John/Q-6412-2018; Liu, Jianjun/AAK-4989-2020	Foo, Jia Nee/0000-0001-9899-2308; Common, John/0000-0002-3280-7365; Liu, Jianjun/0000-0002-3255-3019; See, Kelvin/0000-0003-0647-6977; Sun, Yonghu/0000-0003-4553-2871; Wang, Ting/0000-0002-6569-4395	Natural Science Foundation of Shandong Province [ZR2011HQ003, ZR2011HQ037]; Project of Taishan scholar; Project of clinical center for Dermatology and Venereology of Shandong Province; Research Foundation of Shandong Provincial Institute of Dermatology and Venereology [2008-7]; Agency of Science, Technology and Research (A*STAR) of Singapore	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Project of Taishan scholar; Project of clinical center for Dermatology and Venereology of Shandong Province; Research Foundation of Shandong Provincial Institute of Dermatology and Venereology; Agency of Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by a grant from Natural Science Foundation of Shandong Province (ZR2011HQ003, ZR2011HQ037). Project of Taishan scholar (2008- ), Project of clinical center for Dermatology and Venereology of Shandong Province (2010-), Project of Research Foundation of Shandong Provincial Institute of Dermatology and Venereology (2008-7). L J-J, L-Y, K H-H, S D-L, EBL, JEAC were supported by the Agency of Science, Technology and Research (A*STAR) of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; Al Hawsawi K, 2002, PEDIATR DERMATOL, V19, P523, DOI 10.1046/j.1525-1470.2002.00225.x; Colanesi S, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00977.x; Ichigawa T, 1933, JAPANESE J DERMATOLO, V34, P360; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Krishnamurthy P, 2011, CURR PHARM BIOTECHNO, V12, P647, DOI 10.2174/138920111795163995; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Richardson J, 2008, ZEBRAFISH, V5, P289, DOI 10.1089/zeb.2008.0541; Stuhrmann M, 2008, CLIN GENET, V73, P566, DOI 10.1111/j.1399-0004.2008.01000.x; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Wang LJ, 2012, AM J HUM GENET, V90, P40, DOI 10.1016/j.ajhg.2011.11.026; Xing QH, 2003, AM J HUM GENET, V73, P377, DOI 10.1086/377007; Zhang CE, 2013, J INVEST DERMATOL, V133, P2221, DOI 10.1038/jid.2013.145	19	23	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87250	10.1371/journal.pone.0087250	http://dx.doi.org/10.1371/journal.pone.0087250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498303	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900049
J	Shiroto, T; Romero, N; Sugiyama, T; Sartoretto, JL; Kalwa, H; Yan, ZH; Shimokawa, H; Michel, T				Shiroto, Takashi; Romero, Natalia; Sugiyama, Toru; Sartoretto, Juliano L.; Kalwa, Hermann; Yan, Zhonghua; Shimokawa, Hiroaki; Michel, Thomas			Caveolin-1 Is a Critical Determinant of Autophagy, Metabolic Switching, and Oxidative Stress in Vascular Endothelium	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVATED PROTEIN-KINASE; HYDROGEN-PEROXIDE; REACTIVE OXYGEN; PULMONARY-HYPERTENSION; INSULIN-RESISTANCE; CELLS; MICE; MITOCHONDRIA; DYSFUNCTION	Caveolin-1 is a scaffolding/regulatory protein that interacts with diverse signaling molecules. Caveolin-1 null mice have marked metabolic abnormalities, yet the underlying molecular mechanisms are incompletely understood. We found the redox stress plasma biomarker plasma 8-isoprostane was elevated in caveolin-1 null mice, and discovered that siRNA-mediated caveolin-1 knockdown in endothelial cells promoted significant increases in intracellular H2O2. Mitochondrial ROS production was increased in endothelial cells after caveolin-1 knockdown; 2-deoxy-D-glucose attenuated this increase, implicating caveolin-1 in control of glycolytic pathways. We performed unbiased metabolomic characterizations of endothelial cell lysates following caveolin-1 knockdown, and discovered strikingly increased levels (up to 30-fold) of cellular dipeptides, consistent with autophagy activation. Metabolomic analyses revealed that caveolin-1 knockdown led to a decrease in glycolytic intermediates, accompanied by an increase in fatty acids, suggesting a metabolic switch. Taken together, these results establish that caveolin-1 plays a central role in regulation of oxidative stress, metabolic switching, and autophagy in the endothelium, and may represent a critical target in cardiovascular diseases.	[Shiroto, Takashi; Romero, Natalia; Sugiyama, Toru; Sartoretto, Juliano L.; Kalwa, Hermann; Yan, Zhonghua; Michel, Thomas] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan	Harvard University; Brigham & Women's Hospital; Tohoku University	Michel, T (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA.	thomas_michel@harvard.edu	Kalwa, Hermann/ABG-2323-2021	Shimokawa, Hiroaki/0000-0001-7534-4826	National Institutes of Health [HL46457, HL48743, GM36259]; Japan Heart Foundation; Uehara Memorial Foundation; Fonds National de Recherche, Luxembourg; American Heart Association; Bayer Yakuhin, Ltd.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, R01HL046457, R29HL046457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036259, R01GM036259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Heart Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Fonds National de Recherche, Luxembourg; American Heart Association(American Heart Association); Bayer Yakuhin, Ltd.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HL46457, HL48743, and GM36259 (to TM). TS was supported by fellowship grants from the Japan Heart Foundation and the Uehara Memorial Foundation. NR had sabbatical support from the Facultad de Medicina, Universidad de la Republica (Uruguay), and by a Pew Latinoamerican Fellowship. HK had support from a postdoctoral fellowship from the Fonds National de Recherche, Luxembourg and from a postdoctoral fellowship from the American Heart Association. Partial support for these studies was also provided by an unrestricted gift from Bayer Yakuhin, Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004; Bosch M, 2011, CURR BIOL, V21, P681, DOI 10.1016/j.cub.2011.03.030; Chaudhri VK, 2013, MOL CANC RES; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Filomeni G, 2010, AUTOPHAGY, V6, P999, DOI 10.4161/auto.6.7.12754; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fridolfsson HN, 2012, FASEB J, V26, P4637, DOI 10.1096/fj.12-215798; GIULIVI C, 1994, FREE RADICAL BIO MED, V16, P123, DOI 10.1016/0891-5849(94)90249-6; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Gurusamy N, 2009, ANTIOXID REDOX SIGN, V11, P1975, DOI [10.1089/ars.2009.2524, 10.1089/ARS.2009.2524]; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li WP, 2001, J CELL SCI, V114, P1397; Malinouski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014564; Milburn MV, 2013, ANNU REV MED, V64, P291, DOI 10.1146/annurev-med-061511-134747; Morrow JD, 2005, ARTERIOSCL THROM VAS, V25, P279, DOI 10.1161/01.ATV.0000152605.64964.c0; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Park H, 2000, AM J PHYSIOL-HEART C, V278, pH1285, DOI 10.1152/ajpheart.2000.278.4.H1285; Pase L, 2012, METHOD ENZYMOL, V506, P135, DOI 10.1016/B978-0-12-391856-7.00032-9; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Quijano C, 2007, AM J PHYSIOL-HEART C, V293, pH3404, DOI 10.1152/ajpheart.00761.2007; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Razani B, 2001, J BIOL CHEM, V276, P38121; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Sotgia F, 2012, ANNU REV PATHOL-MECH, V7, P423, DOI 10.1146/annurev-pathol-011811-120856; TAYLOR PD, 1994, BRIT J PHARMACOL, V111, P42, DOI 10.1111/j.1476-5381.1994.tb14021.x; Vicent D, 2003, J CLIN INVEST, V111, P1373, DOI 10.1172/JCI200315211; Wang H, 2009, MOL ENDOCRINOL, V23, P1613, DOI 10.1210/me.2009-0115; White CR, 1996, P NATL ACAD SCI USA, V93, P8745, DOI 10.1073/pnas.93.16.8745; Widlansky ME, 2011, ANTIOXID REDOX SIGN, V15, P1517, DOI 10.1089/ars.2010.3642; Zafari AM, 1998, HYPERTENSION, V32, P488, DOI 10.1161/01.HYP.32.3.488; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	45	87	91	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87871	10.1371/journal.pone.0087871	http://dx.doi.org/10.1371/journal.pone.0087871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498385	gold, Green Submitted, Green Published			2022-12-25	WOS:000330626900131
J	Du, YP; Wei, C; Wang, ZX; Li, S; He, HB; Jia, GX				Du, Yun-peng; Wei, Chi; Wang, Zhong-xuan; Li, Shuang; He, Heng-bin; Jia, Gui-xia			Lilium spp. pollen in China (Liliaceae): Taxonomic and Phylogenetic Implications and Pollen Evolution Related to Environmental Conditions	PLOS ONE			English	Article							TRANSCRIBED SPACER REGION; MOLECULAR PHYLOGENY; POLLINATION; NUCLEAR; MORPHOLOGY	Recent molecular and karyologic studies have significantly modified delimitation of Lilium. However, despite the importance of pollen evolution in the genus comprehensive studies with electron microscopy and evaluation of pollen evolution are lacking. Therefore, we studied pollen morphology in a sample of 65 individuals from 37 taxa covering all the sections distributed in the world, using scanning electron microscopy. Our collection of 49 individuals from 21 taxa covering all five sections in China was also included in the database. We found pollen tetrads in L. bakerianum. Based on present and previous studies, our results suggest that pollen from L. formosanum should be classified as a new type, Formosanum. Combined with morphological and molecular evidence, pollen sculpture patterns appear to reflect phylogenetic relationships and are useful for species or subsection delimitation. Based on a comprehensive survey and correlation with potential functional implications, we propose the following hypothesis: evolution of an exine sculpture shows pollen type trends from Martagon R Callose R Concolor R Formosanum. The evolutionary trend regarding pollen sculpture and size could be related to selective pressure to adapt to environmental conditions. Pollen size and shape showed a significantly positive correlation with annual precipitation, and smaller pollen grains appear to adapt better in habitats with extreme conditions. Evolution trends in exine sculpture do not appear to be definitively correlated with pollen size and shape.	[Du, Yun-peng; Wei, Chi; Wang, Zhong-xuan; Li, Shuang; He, Heng-bin; Jia, Gui-xia] Beijing Forestry Univ, Coll Landscape Architecture, Natl Engn Res Ctr Flowers, Beijing, Peoples R China	Beijing Forestry University	Jia, GX (corresponding author), Beijing Forestry Univ, Coll Landscape Architecture, Natl Engn Res Ctr Flowers, Beijing, Peoples R China.	gxjia@bjfu.edu.cn			Fundamental Research Funds for the Central Universities [BLYJ201207]; National Natural Science Foundation of China [31071819]; Special Fund for Forestry Scientific Research in the Public Interest [201204609]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Forestry Scientific Research in the Public Interest	This research was supported by Fundamental Research Funds for the Central Universities (Project No.BLYJ201207) (http://www.dost.moe.edu.cn/dostmoe/), the project from the National Natural Science Foundation of China (Project No. 31071819) (http://www.nsfc.gov.cn/Portal0/default152.htm), and Special Fund for Forestry Scientific Research in the Public Interest (Project No. 201204609) (http://www.forestry.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], C GEOGRAPHICUM; ARROYO MTK, 1985, PLANT SYST EVOL, V149, P187, DOI 10.1007/BF00983305; Avetissian EM, 1950, ZH RUSSK BOT OBSHCH, V35, P6; Baker J. G., 1871, GARD CHRON, P104; Baranova M.V., 1985, BOT ZURN, V70, P297; BRANTJES NBM, 1980, NEW PHYTOL, V84, P139, DOI 10.1111/j.1469-8137.1980.tb00756.x; Chiba S, 2004, B BOT SOC NAGANO, V37, P1; Comber HF, 1949, LILY YB, V15, P86; De Jong PC, 1974, N AM LILY SOC, V27, P23; Du YP, 2013, MOL PHYLOGENY GENETI, DOI [10.1007/s10265-013-0600-4, DOI 10.1007/S10265-013-0600-4]; Dubouzet JG, 1999, THEOR APPL GENET, V98, P954, DOI 10.1007/s001220051155; Endlicher M, 1836, GENERA PLANTARUM SEC; Gao YD, 2011, NORD J BOT, V29, P746, DOI 10.1111/j.1756-1051.2011.01069.x; Gao YD, 2012, PLANT SYST EVOL, V298, P69, DOI 10.1007/s00606-011-0524-1; Gao YD, 2012, J PLANT RES, V125, P55, DOI 10.1007/s10265-011-0422-1; Gottsberger Gerhard, 1999, Plant Species Biology, V14, P143, DOI 10.1046/j.1442-1984.1999.00018.x; HALBRITTER H, 1993, GRANA, V32, P87, DOI 10.1080/00173139309429459; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HAW SG, 1986, LILIES CHINA; Hayashi K, 2007, LIFE HIST MONOGRAPHS, P1; Hayashi Kazuhiko, 2000, Plant Species Biology, V15, P73, DOI 10.1046/j.1442-1984.2000.00025.x; Hedberg O, 1964, ACTA PHYTOGEOGRAPHIC, V49, P5; Hidalgo O, 2008, BOT J LINN SOC, V158, P499, DOI 10.1111/j.1095-8339.2008.00878.x; Ikinci Nursel, 2006, Willdenowia, V36, P647, DOI 10.3372/wi.36.36201; Kawano Shoichi, 1995, Plant Species Biology, V10, P169, DOI 10.1111/j.1442-1984.1995.tb00137.x; Knudsen Jette T., 1999, Plant Species Biology, V14, P137, DOI 10.1046/j.1442-1984.1999.00017.x; Kosenko VN, 1999, GRANA, V38, P20, DOI 10.1080/001731300750044672; Li JQ, 1993, J WUHAN BOT RES, V11, P120; Liang S.Y., 2000, FLORA CHINA, V24, P135; Liang S. Y, 1980, FLORA REIPUBLICAE PO, V14, P116; Liang SY, 1984, ACTA PHYTOTAX SINICA, V22, P297; Liang SY, 1985, ACTA PHYTOTAX SINICA, V23, P405; Liang SY, 1980, FLORA REIPUBLICAE PO, V14, P116; Liu DY, 2011, THESIS BEIJING FORES; McRae E. A., 1998, LILIES, P105; Morinaga SI, 2009, POPUL ECOL, V51, P187, DOI 10.1007/s10144-008-0097-1; MULLER J, 1979, ANN MO BOT GARD, V66, P593, DOI 10.2307/2398913; Muratovic Edina, 2010, Phytologia Balcanica, V16, P285; Nair PKK, 1965, J PALYNOLOGY, V1, P38; Nishikawa T, 1999, J MOL EVOL, V49, P238, DOI 10.1007/PL00006546; Nishikawa T, 2001, BREEDING SCI, V51, P39, DOI 10.1270/jsbbs.51.39; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Patterson TB, 2002, EVOLUTION, V56, P233, DOI 10.1111/j.0014-3820.2002.tb01334.x; Peruzzi L, 2009, ANN BOT-LONDON, V103, P459, DOI 10.1093/aob/mcn230; Resetnik I, 2007, PLANT SYST EVOL, V265, P45, DOI 10.1007/s00606-006-0513-y; Rodger JG, 2010, INT J PLANT SCI, V171, P382, DOI 10.1086/651226; Skinner MW, 1988, THESIS HARVARD U CAM; SMYTH DR, 1989, PLANT SYST EVOL, V163, P53, DOI 10.1007/BF00936153; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEWART RN, 1947, AM J BOT, V34, P9, DOI 10.2307/2437190; SWOFFORD DL, 2000, PAUP 4 0 PHYLOGENETI; Tate JA, 2004, AM J BOT, V91, P207, DOI 10.3732/ajb.91.2.207; Thien L., 1998, MAGNOLIAS THEIR ALLI, P37; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang X, 2007, HEILONGJIANG AGR SCI, V1, P47; Williams Norris H., 1999, Plant Species Biology, V14, P129, DOI 10.1046/j.1442-1984.1999.00016.x; Wilson E.H., 1925, LILIES E ASIA; Wodehouse RP, 1935, POLLEN GRAINS, P323; Wu ZhuHua, 2007, Journal of Zhejiang Forestry College, V24, P406; ZAVADA MS, 1983, BOT REV, V49, P331, DOI 10.1007/BF02861086; [张丽娜 Zhang Lina], 2006, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V15, P174; [张延龙 ZHANG Yanlong], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P144; ZHOU SD, 2008, THESIS SICHUAN U	63	14	14	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87841	10.1371/journal.pone.0087841	http://dx.doi.org/10.1371/journal.pone.0087841			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498208	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900181
J	Galardo, MN; Regueira, M; Riera, MF; Pellizzari, EH; Cigorraga, SB; Meroni, SB				Noel Galardo, Maria; Regueira, Mariana; Fernanda Riera, Maria; Herminia Pellizzari, Eliana; Beatriz Cigorraga, Selva; Beatriz Meroni, Silvina			Lactate Regulates Rat Male Germ Cell Function through Reactive Oxygen Species	PLOS ONE			English	Article							MONOCARBOXYLATE TRANSPORTER; MESSENGER-RNA; NADPH OXIDASE; DIFFERENTIATION; SPERMATOCYTES; DEHYDROGENASE; CLONING; MCT2; NOX4	Besides giving structural support, Sertoli cells regulate the fate of germ cells by supplying a variety of factors. These factors include hormones, several pro- and anti-apoptotic agents and also energetic substrates. Lactate is one of the compounds produced by Sertoli cells, which is utilized as an energetic substrate by germ cells, particularly spermatocytes and spermatids. Beyond its function as an energy source, some studies have proposed a role of lactate in the regulation of gene expression not strictly related to the energetic state of the cells. The general hypothesis that motivated this investigation was that lactate affects male germ cell function, far beyond its well-known role as energetic substrate. To evaluate this hypothesis we investigated: 1) if lactate was able to regulate germ cell gene expression and if reactive oxygen species (ROS) participated in this regulation, 2) if different signal transduction pathways were modified by the production of ROS in response to lactate and 3) possible mechanisms that may be involved in lactate stimulation of ROS production. In order to achieve these goals, cultures of germ cells obtained from male 30-day old rats were exposed to 10 or 20 mM lactate. Increases in lactate dehydrogenase (LDH) C and monocarboxylate transporter (MCT)2 expression, in Akt and p38-MAPK phosphorylation levels and in ROS production were observed. These effects were impaired in the presence of a ROS scavenger. Lactate stimulated ROS production was also inhibited by a LDH inhibitor or a NAD(P)H oxidase (NOX) inhibitor. NOX4 expression was identified in male germ cells. The results obtained herein are consistent with a scenario where lactate, taken up by germ cells, becomes oxidized to pyruvate with the resultant increase in NADH, which is a substrate for NOX4. ROS, products of NOX4 activity, may act as second messengers regulating signal transduction pathways and gene expression.	[Noel Galardo, Maria; Regueira, Mariana; Fernanda Riera, Maria; Herminia Pellizzari, Eliana; Beatriz Cigorraga, Selva; Beatriz Meroni, Silvina] Consejo Nacl Invest Cient & Tecn CONICET, Ctr Invest Endocrinol Dr Cesar Bergada, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Meroni, SB (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Ctr Invest Endocrinol Dr Cesar Bergada, Buenos Aires, DF, Argentina.	smeroni@cedie.org.ar	Riera, María/GPG-1287-2022	Regueira, Mariana/0000-0002-5164-0425; Riera, Maria Fernanda/0000-0003-0762-1662; Pellizzari, Eliana/0000-0002-5381-621X; Galardo, Maria Noel/0000-0002-2678-622X; Meroni, Silvina Beatriz/0000-0002-0313-7075	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2011/0677, PICT 2012/0666]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2008/806]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2011/0677 and PICT 2012/0666) and the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (PIP 2008/806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Bassenge E, 2000, AM J PHYSIOL-HEART C, V279, pH2431, DOI 10.1152/ajpheart.2000.279.5.H2431; BATTELLINO LJ, 1968, J BIOL CHEM, V243, P5185; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bouzier-Sore AK, 2002, J PHYSIOL-PARIS, V96, P273, DOI 10.1016/S0928-4257(02)00016-5; Brauchi S, 2005, AM J PHYSIOL-CELL PH, V288, pC523, DOI 10.1152/ajpcell.00448.2003; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Courtens JL, 1999, BIOL REPROD, V61, P154, DOI 10.1095/biolreprod61.1.154; Cuff MA, 2002, J PHYSIOL-LONDON, V539, P361, DOI 10.1113/jphysiol.2001.014241; CUMMINGS JH, 1984, SCAND J GASTROENTERO, V19, P89; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; GROOTEGOED JA, 1986, J REPROD FERTIL, V77, P99, DOI 10.1530/jrf.0.0770099; Han KY, 2007, BIOCHEM PHARMACOL, V74, P911, DOI 10.1016/j.bcp.2007.06.044; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Hu SX, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-123; Ji AR, 2010, EXP MOL MED, V42, P175, DOI 10.3858/emm.2010.42.3.018; JUTTE NHPM, 1981, J REPROD FERTIL, V62, P399, DOI 10.1530/jrf.0.0620399; JUTTE NHPM, 1982, J REPROD FERTIL, V65, P431, DOI 10.1530/jrf.0.0650431; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKERT CL, 1975, SCIENCE, V189, P102, DOI 10.1126/science.1138367; MERONI SB, 1995, MOL CELL ENDOCRINOL, V112, P69, DOI 10.1016/0303-7207(95)03587-W; MILES MF, 1981, J BIOL CHEM, V256, P2545; MITA M, 1982, BIOL REPROD, V26, P445, DOI 10.1095/biolreprod26.3.445; NAKAMURA M, 1984, AM J PHYSIOL, V247, pE234, DOI 10.1152/ajpendo.1984.247.2.E234; Oeckler RA, 2005, AM J PHYSIOL-LUNG C, V288, pL1017, DOI 10.1152/ajplung.00223.2004; Opitz N, 2007, FREE RADICAL BIO MED, V42, P175, DOI 10.1016/j.freeradbiomed.2006.11.003; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; SCHTEINGART HF, 1989, MOL CELL ENDOCRINOL, V67, P73, DOI 10.1016/0303-7207(89)90232-3; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Tai P, 2011, MOL ENDOCRINOL, V25, P885, DOI 10.1210/me.2010-0489; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; WASSERMAN K, 1984, AM REV RESPIR DIS, V129, pS35, DOI 10.1164/arrd.1984.129.2P2.S35	44	40	44	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e88024	10.1371/journal.pone.0088024	http://dx.doi.org/10.1371/journal.pone.0088024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498241	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900207
J	Picciocchi, A; Siauciunaitee-Gaubard, L; Petit-Hartlein, I; Sadir, R; Revilloud, J; Caro, L; Vivaudou, M; Fieschi, F; Moreau, C; Vives, C				Picciocchi, Antoine; Siauciunaitee-Gaubard, Lina; Petit-Hartlein, Isabelle; Sadir, Rabia; Revilloud, Jean; Caro, Lydia; Vivaudou, Michel; Fieschi, Franck; Moreau, Christophe; Vives, Corinne			C-Terminal Engineering of CXCL12 and CCL5 Chemokines: Functional Characterization by Electrophysiological Recordings	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; DRUG DISCOVERY; FLUORESCENT LIGANDS; ESCHERICHIA-COLI; RANTES; CELL; INTERNALIZATION; PURIFICATION; DESIGN; ASSAYS	Chemokines are chemotactic cytokines comprised of 70-100 amino acids. The chemokines CXCL12 and CCL5 are the endogenous ligands of the CXCR4 and CCR5 G protein-coupled receptors that are also HIV co-receptors. Biochemical, structural and functional studies of receptors are ligand-consuming and the cost of commercial chemokines hinders their use in such studies. Here, we describe methods for the expression, refolding, purification, and functional characterization of CXCL12 and CCL5 constructs incorporating C-terminal epitope tags. The model tags used were hexahistidines and Strep-Tag for affinity purification, and the double lanthanoid binding tag for fluorescence imaging and crystal structure resolution. The ability of modified and purified chemokines to bind and activate CXCR4 and CCR5 receptors was tested in Xenopus oocytes expressing the receptors, together with a Kir3 G-protein activated K+ channel that served as a reporter of receptor activation. Results demonstrate that tags greatly influence the biochemical properties of the recombinant chemokines. Besides, despite the absence of any evidence for CXCL12 or CCL5 C-terminus involvement in receptor binding and activation, we demonstrated unpredictable effects of tag insertion on the ligand apparent affinity and efficacy or on the ligand dissociation. These tagged chemokines should constitute useful tools for the selective purification of properly-folded chemokines receptors and the study of their native quaternary structures.	[Picciocchi, Antoine; Siauciunaitee-Gaubard, Lina; Petit-Hartlein, Isabelle; Sadir, Rabia; Revilloud, Jean; Caro, Lydia; Vivaudou, Michel; Fieschi, Franck; Moreau, Christophe; Vives, Corinne] Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France; [Picciocchi, Antoine; Siauciunaitee-Gaubard, Lina; Petit-Hartlein, Isabelle; Sadir, Rabia; Revilloud, Jean; Caro, Lydia; Vivaudou, Michel; Fieschi, Franck; Moreau, Christophe; Vives, Corinne] CEA, DSV IBS, Grenoble, France; [Picciocchi, Antoine; Siauciunaitee-Gaubard, Lina; Petit-Hartlein, Isabelle; Sadir, Rabia; Revilloud, Jean; Caro, Lydia; Vivaudou, Michel; Fieschi, Franck; Moreau, Christophe; Vives, Corinne] CNRS, IBS, Grenoble, France; [Fieschi, Franck] Inst Univ France, Paris, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France	Moreau, C (corresponding author), Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France.	christophe.moreau@ibs.fr; corinne.vives@ibs.fr	MOREAU, Christophe J/D-3736-2009; Vivaudou, Michel/C-5338-2008; MOREAU, Christophe/AAC-7912-2020; Fieschi, Franck/W-2748-2019	MOREAU, Christophe J/0000-0002-5463-9593; Vivaudou, Michel/0000-0002-9777-3127; MOREAU, Christophe/0000-0002-5463-9593; FIESCHI, Franck/0000-0003-1194-8107	European Community; ITN 'Structural Biology of Membrane Proteins'; Agence Nationale de la Recherche [ANR-09-PIRI-0010, ANR-07-BLAN-0092]; Laboratory of Excellence 'Ion Channel Science and Therapeutics'	European Community(European Commission); ITN 'Structural Biology of Membrane Proteins'; Agence Nationale de la Recherche(French National Research Agency (ANR)); Laboratory of Excellence 'Ion Channel Science and Therapeutics'	This work was supported by the European Community (fellowship from ITN 'Structural Biology of Membrane Proteins' to L. S.); Agence Nationale de la Recherche (ANR-09-PIRI-0010 to F. F. and M. V.; ANR-07-BLAN-0092 to A. P.); and Laboratory of Excellence 'Ion Channel Science and Therapeutics' (network grant to M. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albizu L, 2007, J MED CHEM, V50, P4976, DOI 10.1021/jm061404q; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Briddon SJ, 2011, METHODS MOL BIOL, V746, P211, DOI 10.1007/978-1-61779-126-0_11; Cho HJ, 2008, PROTEIN EXPRES PURIF, V60, P37, DOI 10.1016/j.pep.2008.03.018; Cottet M, 2013, BIOCHEM SOC T, V41, P148, DOI 10.1042/BST20120237; Cox BM, 2004, MOL PHARMACOL, V65, P492, DOI 10.1124/mol.65.3.492; Granas C, 2005, COMB CHEM HIGH T SCR, V8, P301, DOI 10.2174/1386207054020741; Holmes WD, 2001, PROTEIN EXPRES PURIF, V21, P367, DOI 10.1006/prep.2001.1402; Jin HJ, 2010, PROTEINS, V78, P295, DOI 10.1002/prot.22542; Labrecque J, 2009, METHODS MOL BIOL, V552, P153, DOI 10.1007/978-1-60327-317-6_11; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Martin LJ, 2007, J AM CHEM SOC, V129, P7106, DOI 10.1021/ja070480v; Peters MF, 2007, J BIOMOL SCREEN, V12, P312, DOI 10.1177/1087057106298637; Polo S, 2000, EUR J IMMUNOL, V30, P3190, DOI 10.1002/1521-4141(200011)30:11<3190::AID-IMMU3190>3.0.CO;2-E; Proudfoot AEI, 2000, METH MOL B, V138, P75; Robertson GA, 1996, NEUROPHARMACOLOGY, V35, P841, DOI 10.1016/0028-3908(96)00113-X; Sabbe R, 2001, J VIROL, V75, P661, DOI 10.1128/JVI.75.2.661-671.2001; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Zhan WQ, 2007, J MED CHEM, V50, P5655, DOI 10.1021/jm070679i	20	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87394	10.1371/journal.pone.0087394	http://dx.doi.org/10.1371/journal.pone.0087394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498095	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900105
J	Ward, A; Hudson, JW				Ward, Alejandra; Hudson, John W.			p53-Dependent and Cell Specific Epigenetic Regulation of the Polo-like kinases under Oxidative Stress	PLOS ONE			English	Article							GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; DNA METHYLTRANSFERASES; CPG ISLANDS; TUMOR-DEVELOPMENT; OVARIAN-CANCER; P53; METHYLATION; PROMOTER; HYPOXIA	The polo-like kinase (PLKs) family, consisting of five known members, are key regulators of important cell cycle processes, which include mitotic entry, centrosome duplication, spindle assembly, and cytokinesis. The PLKs have been implicated in a variety of cancers, such as hepatocellular carcinoma (HCC), with PLK1 typically overexpressed and PLKs 2-5 often downregulated. Altered expression of the PLKs in malignancy is often correlated with aberrant promoter methylation. Epigenetic marks are dynamic and can be modified in response to external environmental stimuli. The aim of our study was to determine if oxidative stress, a common feature of solid tumours, would induce changes to the promoter methylation of the PLKs resulting in changes in expression. We examined the promoter methylation status via MSP and subsequent expression levels of the PLK family members under exposure to hypoxic conditions or reactive oxygen species (ROS). Interestingly, murine embryonic fibroblasts exposed to hypoxia and ROS displayed significant hypermethylation of Plk1 and Plk4 promoter regions post treatment. Corresponding proteins were also depleted by 40% after treatment. We also examined the HCC-derived cell lines HepG2 and Hep3B and found that for PLK1 and PLK4, the increase in hypermethylation was correlated with the presence of functional p53. In p53 wild-type cells, HepG2, both PLK1 and PLK4 were repressed with treatment, while in the p53 null cell line, Hep3B, PLK4 protein was elevated in the presence of hypoxia and ROS. This was also the case for ROS-treated, p53 null, osteosarcoma cells, Saos-2, where the PLK4 promoter became hypomethylated and protein levels were elevated. Our data supports a model in which the PLKs are susceptible to epigenetic changes induced by microenvironmental cues and these modifications may be p53-dependent. This has important implications in HCC and other cancers, where epigenetic alterations of the PLKs could contribute to tumourigenesis and disease progression.	[Ward, Alejandra; Hudson, John W.] Univ Windsor, Dept Biol, Windsor, ON N9B 3P4, Canada	University of Windsor	Hudson, JW (corresponding author), Univ Windsor, Dept Biol, Windsor, ON N9B 3P4, Canada.	jhudson@uwindsor.ca			National Science and Engineering Council of Canada (NSERC) [298476-2010]	National Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	National Science and Engineering Council of Canada (NSERC) #298476-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Andrysik Z, 2010, NUCLEIC ACIDS RES, V38, P2931, DOI 10.1093/nar/gkq011; Bapat SA, 2010, EPIGENETICS-US, V5, P716, DOI 10.4161/epi.5.8.13014; Berglind H, 2008, CANCER BIOL THER, V7, P699, DOI 10.4161/cbt.7.5.5712; Brigati C, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/263914; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; Campos ACE, 2007, NEOPLASIA, V9, P1111, DOI 10.1593/neo.07712; Coley HM, 2012, ONCOTARGET, V3, P78; de Carcer G, 2011, CELL CYCLE, V10, P2255, DOI 10.4161/cc.10.14.16494; de Carcer G, 2011, MOL CELL BIOL, V31, P1225, DOI 10.1128/MCB.00607-10; Garuti L, 2012, CURR MED CHEM, V19, P3937, DOI 10.2174/092986712802002455; Grewal P, 2012, CLIN LIVER DIS, V16, P839, DOI 10.1016/j.cld.2012.08.011; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Huth A, 2013, INT J LEGAL MED, V127, P335, DOI 10.1007/s00414-012-0787-2; Joeckel TE, 2012, SEMIN HEMATOL, V49, P330, DOI 10.1053/j.seminhematol.2012.08.001; Kang KA, 2012, TUMOR BIOL, V33, P403, DOI 10.1007/s13277-012-0322-6; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Knecht R, 1999, CANCER RES, V59, P2794; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Le Gac G, 2006, J BIOL CHEM, V281, P24161, DOI 10.1074/jbc.M603724200; Li J, 2005, NEOPLASIA, V7, P312, DOI 10.1593/neo.04325; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Liu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041293; Lu YH, 2011, MOL CELL BIOL, V31, P3339, DOI 10.1128/MCB.01121-10; Macmillan JC, 2001, ANN SURG ONCOL, V8, P729, DOI 10.1245/aso.2001.8.9.729; Martin BT, 2006, CELL CYCLE, V5, P2881, DOI 10.4161/cc.5.24.3538; Matthew EM, 2009, CELL CYCLE, V8, P4168, DOI 10.4161/cc.8.24.10800; McInnes C, 2011, DRUG DISCOV TODAY, V16, P619, DOI 10.1016/j.drudis.2011.05.002; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; Morettin A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-319; Murugan RN, 2011, MOL CELLS, V32, P209, DOI 10.1007/s10059-011-0126-3; Nakamura T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2752; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Park IY, 2005, J CELL BIOCHEM, V94, P585, DOI 10.1002/jcb.20263; Pellegrino R, 2010, HEPATOLOGY, V51, P857, DOI 10.1002/hep.23467; Postovit LM, 2006, CANCER RES, V66, P7833, DOI 10.1158/0008-5472.CAN-06-0731; Rofstad EK, 2002, CANCER RES, V62, P1847; Shahrzad S, 2007, EPIGENETICS-US, V2, P119, DOI 10.4161/epi.2.2.4613; Shemirani B, 2002, ORAL ONCOL, V38, P251, DOI 10.1016/S1368-8375(01)00052-5; Skowronski K, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12400; Sosa V, 2013, AGEING RES REV, V12, P376, DOI 10.1016/j.arr.2012.10.004; Swallow CJ, 2005, ONCOGENE, V24, P306, DOI 10.1038/sj.onc.1208275; Syed N, 2006, BLOOD, V107, P250, DOI 10.1182/blood-2005-03-1194; Syed N, 2011, CANCER RES, V71, P3317, DOI 10.1158/0008-5472.CAN-10-2048; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Valenti F, 2011, CELL CYCLE, V10, P4330, DOI 10.4161/cc.10.24.18682; van Malenstein H, 2010, CLIN CANCER RES, V16, P4278, DOI 10.1158/1078-0432.CCR-09-3274; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang R, 2013, CLIN TRANSL ONCOL, V15, P626, DOI 10.1007/s12094-012-0978-9; Ward A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-71; Watanabe T, 2012, MUTAT RES-GEN TOX EN, V747, P164, DOI 10.1016/j.mrgentox.2012.04.011; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Zhang HL, 2013, FASEB J, V27, P232, DOI 10.1096/fj.12-215491; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015; Zochbauer-Muller S, 2001, CANCER RES, V61, P249	62	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87918	10.1371/journal.pone.0087918	http://dx.doi.org/10.1371/journal.pone.0087918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498222	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900193
J	Ye, J; Vives-Pi, M; Gillespie, KM				Ye, Jody; Vives-Pi, Marta; Gillespie, Kathleen M.			Maternal Microchimerism: Increased in the Insulin Positive Compartment of Type 1 Diabetes Pancreas but Not in Infiltrating Immune Cells or Replicating Islet Cells	PLOS ONE			English	Article							BETA-CELLS; T-CELLS; ENDOCRINE; EXPANSION; ANTIGENS	Background: Maternal microchimeric cells (MMc) transfer across the placenta during pregnancy. Increased levels of MMc have been observed in several autoimmune diseases including type 1 diabetes but their role is unknown. It has been suggested that MMc are 1) effector cells of the immune response, 2) targets of the autoimmune response or 3) play a role in tissue repair. The aim of this study was to define the cellular phenotype of MMc in control (n = 14) and type 1 diabetes pancreas (n = 8). Methods: Using sex chromosome-based fluorescence in-situ hybridization, MMc were identified in male pancreas and their phenotype determined by concomitant immunofluorescence. Results: In normal pancreas, MMc positive for endocrine, exocrine, duct and acinar markers were identified suggesting that these cells are derived from maternal progenitors. Increased frequencies of MMc were observed in type 1 diabetes pancreas (p = 0.03) with particular enrichment in the insulin positive fraction (p = 0.01). MMc did not contribute to infiltrating immune cells or Ki67+ islet cell populations in type 1 diabetes. Conclusion: These studies provide support for the hypothesis that MMc in human pancreas are derived from pancreatic precursors. Increased frequencies of MMc beta cells may contribute to the initiation of autoimmunity or to tissue repair but do not infiltrate islets in type 1 diabetes.	[Ye, Jody; Gillespie, Kathleen M.] Univ Bristol, Sch Clin Sci, Diabet & Metab Unit, Bristol, Avon, England; [Vives-Pi, Marta] Inst Recerca Germans Trias & Pujol, Dept Immunol, Badalona, Spain	University of Bristol	Gillespie, KM (corresponding author), Univ Bristol, Sch Clin Sci, Diabet & Metab Unit, Bristol, Avon, England.	K.M.Gillespie@bristol.ac.uk	Vives-Pi, Marta/AAM-8158-2020	Vives-Pi, Marta/0000-0003-3735-0779; Ye, Jody/0000-0003-0926-6107	Diabetes United Kingdom PhD studentship; Diabetes UK [12/0004564] Funding Source: researchfish	Diabetes United Kingdom PhD studentship(Diabetes UK); Diabetes UK(Diabetes UK)	This study was funded by a Diabetes United Kingdom PhD studentship to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner-Weir S, 2008, BIOCHEM SOC T, V36, P353, DOI 10.1042/BST0360353; Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; Dutta Partha, 2010, Chimerism, V1, P2, DOI 10.4161/chim.1.1.12667; EHRIE MG, 1974, DIABETES, V23, P583, DOI 10.2337/diab.23.7.583; Gallo R, 2007, CELL DEATH DIFFER, V14, P1860, DOI 10.1038/sj.cdd.4402199; Karafin MS, 2010, INT J CLIN EXP PATHO, V3, P47; Ketola I, 2004, MOL CELL ENDOCRINOL, V226, P51, DOI 10.1016/j.mce.2004.06.007; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Neelson JL, 2008, SCI AM, V298, P72; Nelson JL, 2007, P NATL ACAD SCI USA, V104, P1637, DOI 10.1073/pnas.0606169104; Nelson JL, 2012, TRENDS IMMUNOL, V33, P421, DOI 10.1016/j.it.2012.03.002; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; Parikka V, 2012, DIABETOLOGIA, V55, P1926, DOI 10.1007/s00125-012-2523-3; Reed AM, 2004, J IMMUNOL, V172, P5041, DOI 10.4049/jimmunol.172.8.5041; Roy E, 2011, J AUTOIMMUN, V36, P253, DOI 10.1016/j.jaut.2011.02.003; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Stene LC, 2013, DIABETOLOGIA; Stevens AM, 2003, LANCET, V362, P1617, DOI 10.1016/S0140-6736(03)14795-2; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Vanzyl Berendine, 2010, Chimerism, V1, P45, DOI 10.4161/chim.1.2.13891; Ziegler AG, 2012, DIABETOLOGIA, V55, P1937, DOI 10.1007/s00125-012-2472-x	24	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86985	10.1371/journal.pone.0086985	http://dx.doi.org/10.1371/journal.pone.0086985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498006	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900054
J	Kim, TH; Yang, CS; Oh, JH; Ouchi, K				Kim, Tae-Ho; Yang, Chan-Su; Oh, Jeong-Hwan; Ouchi, Kazuo			Analysis of the Contribution of Wind Drift Factor to Oil Slick Movement under Strong Tidal Condition: Hebei Spirit Oil Spill Case	PLOS ONE			English	Article							SURFACE DRIFT; SEA; TRANSPORT; SATELLITE; PREDICTION; DISPERSAL; CURRENTS; RADAR; WAVES; FILMS	The purpose of this study is to investigate the effects of the wind drift factor under strong tidal conditions in the western coastal area of Korea on the movement of oil slicks caused by the Hebei Spirit oil spill accident in 2007. The movement of oil slicks was computed using a simple simulation model based on the empirical formula as a function of surface current, wind speed, and the wind drift factor. For the simulation, the Environmental Fluid Dynamics Code (EFDC) model and Automatic Weather System (AWS) were used to generate tidal and wind fields respectively. Simulation results were then compared with 5 sets of spaceborne optical and synthetic aperture radar (SAR) data. From the present study, it was found that highest matching rate between the simulation results and satellite imagery was obtained with different values of the wind drift factor, and to first order, this factor was linearly proportional to the wind speed. Based on the results, a new modified empirical formula was proposed for forecasting the movement of oil slicks on the coastal area.	[Kim, Tae-Ho; Yang, Chan-Su] Univ Sci & Technol, Dept Ocean Environm Syst Sci, Taejon, South Korea; [Kim, Tae-Ho; Yang, Chan-Su; Ouchi, Kazuo] Korea Inst Ocean Sci & Technol, Korea Ocean Satellite Ctr, Ansan, South Korea; [Yang, Chan-Su] Korea Maritime & Ocean Univ, Ocean Sci & Technol Sch, Dept Convergence Study Ocean Sci & Technol, Pusan, South Korea; [Oh, Jeong-Hwan] Korea Res Inst Ships & Ocean Engn, Maritime Safety Res Div, Taejon, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Maritime & Ocean University; Korea Institute of Ocean Science & Technology (KIOST); Korea Research Institute of Ships & Ocean Engineering	Yang, CS (corresponding author), Univ Sci & Technol, Dept Ocean Environm Syst Sci, Taejon, South Korea.	yangcs@kiost.ac			Ministry of Oceans and Fisheries, Korea; KIOST [PE98911, PG47770]; Brain Pool Project of Korea;  [KOOS/PM57701];  [PM57541];  [PM57420]	Ministry of Oceans and Fisheries, Korea; KIOST; Brain Pool Project of Korea; ; ; 	This research was a part of the projects (KOOS/PM57701, PM57541, PM57420), funded by the Ministry of Oceans and Fisheries, Korea. This work was also supported in part by the KIOST (www.kiost.ac) Projects (PE98911, PG47770) and the Brain Pool Project of Korea (brainpool.or.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal AJ, 2009, J COASTAL RES, V25, P80, DOI 10.2112/07-0849.1; ALPERS W, 1989, J GEOPHYS RES-OCEANS, V94, P6251, DOI 10.1029/JC094iC05p06251; AMSTUTZ DE, 1984, J PHYS OCEANOGR, V14, P484, DOI 10.1175/1520-0485(1984)014<0484:COWAWI>2.0.CO;2; Angeles Camacho C., 2011, USED IN THE EXTRAPOL; Brekke C, 2005, REMOTE SENS ENVIRON, V95, P1, DOI 10.1016/j.rse.2004.11.015; Brostrom G, 2011, OCEAN SCI, V7, P805, DOI 10.5194/os-7-805-2011; Castanedo S, 2006, J COASTAL RES, V22, P1474, DOI 10.2112/04-0364.1; CHURCHILL JH, 1983, J PHYS OCEANOGR, V13, P1669, DOI 10.1175/1520-0485(1983)013<1669:NSMOQL>2.0.CO;2; Craig P.M., 2012, USERS MANUAL EFDC EX; Dietrich JC, 2012, CONT SHELF RES, V41, P17, DOI 10.1016/j.csr.2012.03.015; Dougherty E. R., 1992, INTRO MORPHOLOGICAL; Fay JA., 1969, SPREAD OIL SLICKS CA; Fay JA, 1971, P JOINT C PREV CONTR, P653; Fingas M, 2011, OIL SPILL SCIENCE AND TECHNOLOGY: PREVENTION, RESPONSE, AND CLEANUP, P1; Fingas MF, 1997, SPILL SCI TECHNOL B, V4, P199, DOI 10.1016/S1353-2561(98)00023-1; Fingas MF, 2005, INT OIL SPILL C P, P2659, DOI [DOI 10.7901/2169-3358-1999-1-281, 10.7901/2169-3358-1999-1-281]; Gade M, 1998, J GEOPHYS RES-OCEANS, V103, P18851, DOI 10.1029/97JC01915; HOULT DP, 1972, ANNU REV FLUID MECH, V4, P341, DOI 10.1146/annurev.fl.04.010172.002013; Hunter J.R., 1987, NUMERICAL MODELLING, P257; IMO, 1988, MAN OIL POLL MAN OIL POLL; ITOPF, 2011, ITOPF HDB 2011 2012; Jung T. S., 2009, J KOR SOC MAR ENV EN, V12, p264~272; Kim DJ, 2010, IEEE T GEOSCI REMOTE, V48, P852, DOI 10.1109/TGRS.2009.2036253; Korotenko KA, 2004, J MARINE SYST, V48, P159, DOI 10.1016/j.jmarsys.2003.11.023; LANGE P, 1978, J PHYS OCEANOGR, V8, P142, DOI 10.1175/1520-0485(1978)008<0142:DROMST>2.0.CO;2; LARSEN LH, 1985, CONT SHELF RES, V4, P77, DOI 10.1016/0278-4343(85)90023-8; LEE HJ, 1989, MAR GEOL, V87, P195, DOI 10.1016/0025-3227(89)90061-3; Lehr WJ, 2000, SPILL SCI TECHNOL B, V6, P247; Leifer I, 2012, REMOTE SENS ENVIRON, V124, P185, DOI 10.1016/j.rse.2012.03.024; Liu Y., 2011, EOS T AM GEOPHYS UN, V92, P45, DOI [10.1029/2011EO060001, DOI 10.1029/2011EO060001]; Mackay D., 1977, EPS3EC7719 FISH ENV; Mariano AJ, 2011, DYNAM ATMOS OCEANS, V52, P322, DOI 10.1016/j.dynatmoce.2011.06.001; Migliaccio M, 2005, IEEE J OCEANIC ENG, V30, P496, DOI 10.1109/JOE.2005.857518; Migliaccio M, 2007, IEEE T GEOSCI REMOTE, V45, P506, DOI 10.1109/TGRS.2006.888097; Nirchio F, 2005, INT J REMOTE SENS, V26, P1157, DOI 10.1080/01431160512331326558; Ouchi K, 2013, REMOTE SENS-BASEL, V5, P716, DOI 10.3390/rs5020716; Perrie W, 2003, J PHYS OCEANOGR, V33, P2126, DOI 10.1175/1520-0485(2003)033<2126:TIOWOS>2.0.CO;2; PROCTOR R, 1994, CONT SHELF RES, V14, P531, DOI 10.1016/0278-4343(94)90102-3; Reed M, 1999, SPILL SCI TECHNOL B, V5, P3, DOI 10.1016/S1353-2561(98)00029-2; Smith J, 2013, TLS-TIMES LIT SUPPL, P13; Spaulding M.L., 1988, OIL CHEM POLLUT, V4, P39, DOI [DOI 10.1016/S0269-8579(88)80009-1, 10.1016/S0269-8579(88)80009-1]; Tomczak G, 1964, OCEANOGRAPHIZE, V10, P129; Topouzelis KN, 2008, SENSORS-BASEL, V8, P6642, DOI 10.3390/s8106642; Uehara K, 2003, SEDIMENT GEOL, V162, P25, DOI 10.1016/S0037-0738(03)00234-3; Van Cooten S, 2011, B AM METEOROL SOC, V92, P1427, DOI 10.1175/2011BAMS3150.1; WEBER JE, 1983, J PHYS OCEANOGR, V13, P524, DOI 10.1175/1520-0485(1983)013<0524:SWAWIC>2.0.CO;2; WU J, 1983, J PHYS OCEANOGR, V13, P1441, DOI 10.1175/1520-0485(1983)013<1441:SSDCIB>2.0.CO;2; Yang CS, 2009, KOREAN J REMOTE SENS, V25, P435; Yang CS, 2013, ACTA OCEANOL SIN, V32, P59, DOI 10.1007/s13131-013-0267-7; Yim UH, 2012, ENVIRON SCI TECHNOL, V46, P6431, DOI 10.1021/es3004156	50	23	23	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87393	10.1371/journal.pone.0087393	http://dx.doi.org/10.1371/journal.pone.0087393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498094	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100081
J	Ren, XS; Sato, Y; Harada, K; Sasaki, M; Furubo, S; Song, JY; Nakanuma, Y				Ren, Xiang Shan; Sato, Yasunori; Harada, Kenichi; Sasaki, Motoko; Furubo, Shinichi; Song, Jing Yu; Nakanuma, Yasuni			Activation of the PI3K/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; MAMMALIAN TARGET; RAPAMYCIN INHIBITOR; CAROLIS-DISEASE; MTOR; GROWTH; CYSTOGENESIS; NVP-BEZ235; SIROLIMUS	The polycystic kidney (PCK) rat is an animal model of Caroli's disease as well as autosomal recessive polycystic kidney disease (ARPKD). The signaling pathways involving the mammalian target of rapamycin (mTOR) are aberrantly activated in ARPKD. This study investigated the effects of inhibitors for the cell signaling pathways including mTOR on cholangiocyte proliferation of the PCK rat. Cultured PCK cholangiocytes were treated with rapamycin and everolimus [inhibitors of mTOR complex 1 (mTOC1)], LY294002 [an inhibitor of phosphatidylinositol 3-kinase (PI3K)] and NVP-BEZ235 (an inhibitor of PI3K and mTORC1/2), and the cell proliferative activity was determined in relation to autophagy and apoptosis. The expression of phosphorylated (p)-mTOR, p-Akt, and PI3K was increased in PCK cholangiocytes compared to normal cholangiocytes. All inhibitors significantly inhibited the cell proliferative activity of PCK cholangiocytes, where NVP-BEZ235 had the most prominent effect. NVP-BEZ235, but not rapamycin and everolimus, further inhibited biliary cyst formation in the three-dimensional cell culture system. Rapamycin and everolimus induced apoptosis in PCK cholangiocytes, whereas NVP-BEZ235 inhibited cholangiocyte apoptosis. Notably, the autophagic response was significantly induced following the treatment with NVP-BEZ235, but not rapamycin and everolimus. Inhibition of autophagy using siRNA against protein-light chain3 and 3-methyladenine significantly increased the cell proliferative activity of PCK cholangiocytes treated with NVP-BEZ235. In vivo, treatment of the PCK rat with NVP-BEZ235 attenuated cystic dilatation of the intrahepatic bile ducts, whereas renal cyst development was unaffected. These results suggest that the aberrant activation of the PI3K/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat, and inhibition of the pathway can reduce cholangiocyte proliferation via the mechanism involving apoptosis and/or autophagy.	[Ren, Xiang Shan; Sato, Yasunori; Harada, Kenichi; Sasaki, Motoko; Furubo, Shinichi; Nakanuma, Yasuni] Kanazawa Univ, Dept Human Pathol, Grad Sch Med, Kanazawa, Ishikawa, Japan; [Ren, Xiang Shan; Song, Jing Yu] Yanbian Univ, Coll Med, Dept Pathol, Yanji, Peoples R China; [Nakanuma, Yasuni] Shizuoka Canc Ctr, Dept Pathol, Shizuoka, Japan	Kanazawa University; Yanbian University; Shizuoka Cancer Center	Nakanuma, Y (corresponding author), Kanazawa Univ, Dept Human Pathol, Grad Sch Med, Kanazawa, Ishikawa, Japan.	nakanuma@staff.kanazawa-u.ac.jp	Sasaki, Motoko/K-5913-2015	Sasaki, Motoko/0000-0003-2514-760X	Ministry of Health, Labor, and Welfare, Japan; Grants-in-Aid for Scientific Research [23590392] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid from the Ministry of Health, Labor, and Welfare, Japan (Y.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belibi F, 2011, AM J PHYSIOL-RENAL, V300, pF1235, DOI 10.1152/ajprenal.00348.2010; Chiarini F, 2010, CANCER RES, V70, P8097, DOI 10.1158/0008-5472.CAN-10-1814; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Edelstein CL, 2008, CLIN J AM SOC NEPHRO, V3, P1219, DOI 10.2215/CJN.05611207; Evert M, 2012, HEPATOLOGY, V55, P1473, DOI 10.1002/hep.25600; Fischer DC, 2009, NEPHROL DIAL TRANSPL, V24, P1819, DOI 10.1093/ndt/gfn744; Foster DA, 2009, CELL CYCLE, V8, P1026, DOI 10.4161/cc.8.7.8044; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hu B, 2011, EXP CELL RES, V317, P173, DOI 10.1016/j.yexcr.2010.09.012; Lanoix J, 1996, ONCOGENE, V13, P1153; Liu TJ, 2009, MOL CANCER THER, V8, P2204, DOI 10.1158/1535-7163.MCT-09-0160; Masuda M, 2011, ONCOL REP, V26, P1273, DOI 10.3892/or.2011.1370; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Nakanuma Y, 2010, HISTOL HISTOPATHOL, V25, P223, DOI 10.14670/HH-25.223; Nawroth R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027509; Ren XS, 2011, AM J PATHOL, V179, P2845, DOI 10.1016/j.ajpath.2011.08.028; Renken C, 2011, NEPHROL DIAL TRANSPL, V26, P92, DOI 10.1093/ndt/gfq384; Santiskulvong C, 2011, CLIN CANCER RES, V17, P2373, DOI 10.1158/1078-0432.CCR-10-2289; Sanzen T, 2001, AM J PATHOL, V158, P1605, DOI 10.1016/S0002-9440(10)64116-8; Sato Y, 2005, AM J PATHOL, V166, P49, DOI 10.1016/S0002-9440(10)62231-6; Sato Y, 2006, AM J PATHOL, V169, P1238, DOI 10.2353/ajpath.2006.051136; Sato Y, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/107945; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Sini P, 2010, AUTOPHAGY, V6, P553, DOI 10.4161/auto.6.4.11671; Spirli C, 2010, HEPATOLOGY, V51, P1778, DOI 10.1002/hep.23511; Walz G, 2006, NEPHROL DIAL TRANSPL, V21, P1752, DOI 10.1093/ndt/gfl246; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wang XM, 2011, J MOL CELL BIOL, V3, P206, DOI 10.1093/jmcb/mjq038; WOO D, 1995, NEW ENGL J MED, V333, P18, DOI 10.1056/NEJM199507063330104; Zafar I, 2010, KIDNEY INT, V78, P754, DOI 10.1038/ki.2010.250; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093; Zhou XJ, 1998, DIAGN MOL PATHOL, V7, P65, DOI 10.1097/00019606-199804000-00001	34	27	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87660	10.1371/journal.pone.0087660	http://dx.doi.org/10.1371/journal.pone.0087660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498161	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100105
J	Wang, W; Wang, SY; Hou, CL; Xing, YP; Cao, JW; Wu, KF; Liu, CX; Zhang, D; Zhang, L; Zhang, YR; Zhou, HM				Wang, Wei; Wang, Shenyuan; Hou, Chenglin; Xing, Yanping; Cao, Junwei; Wu, Kaifeng; Liu, Chunxia; Zhang, Dong; Zhang, Li; Zhang, Yanru; Zhou, Huanmin			Genome-Wide Detection of Copy Number Variations among Diverse Horse Breeds by Array CGH	PLOS ONE			English	Article							SCALE VARIATION; GENE; VARIANTS; MAP; IDENTIFICATION; POLYMORPHISM; SEQUENCE	Recent studies have found that copy number variations (CNVs) are widespread in human and animal genomes. CNVs are a significant source of genetic variation, and have been shown to be associated with phenotypic diversity. However, the effect of CNVs on genetic variation in horses is not well understood. In the present study, CNVs in 6 different breeds of mare horses, Mongolia horse, Abaga horse, Hequ horse and Kazakh horse (all plateau breeds) and Debao pony and Thoroughbred, were determined using aCGH. In total, seven hundred CNVs were identified ranging in size from 6.1 Kb to 0.57 Mb across all autosomes, with an average size of 43.08 Kb and a median size of 15.11 Kb. By merging overlapping CNVs, we found a total of three hundred and fifty-three CNV regions (CNVRs). The length of the CNVRs ranged from 6.1 Kb to 1.45 Mb with average and median sizes of 38.49 Kb and 13.1 Kb. Collectively, 13.59 Mb of copy number variation was identified among the horses investigated and accounted for approximately 0.61% of the horse genome sequence. Five hundred and eighteen annotated genes were affected by CNVs, which corresponded to about 2.26% of all horse genes. Through the gene ontology (GO), genetic pathway analysis and comparison of CNV genes among different breeds, we found evidence that CNVs involving 7 genes may be related to the adaptation to severe environment of these plateau horses. This study is the first report of copy number variations in Chinese horses, which indicates that CNVs are ubiquitous in the horse genome and influence many biological processes of the horse. These results will be helpful not only in mapping the horse whole-genome CNVs, but also to further research for the adaption to the high altitude severe environment for plateau horses.	[Wang, Wei; Wang, Shenyuan; Hou, Chenglin; Xing, Yanping; Cao, Junwei; Wu, Kaifeng; Liu, Chunxia; Zhang, Dong; Zhang, Li; Zhang, Yanru; Zhou, Huanmin] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Peoples R China; [Wang, Wei; Wang, Shenyuan; Hou, Chenglin; Xing, Yanping; Cao, Junwei; Wu, Kaifeng; Liu, Chunxia; Zhang, Dong; Zhang, Li; Zhang, Yanru; Zhou, Huanmin] Key Lab Biol Mfg, Hohhot, Peoples R China	Inner Mongolia Agricultural University	Zhang, YR (corresponding author), Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Peoples R China.	yanru1964@hotmail.com; huanminzhou@263.net	zhou, huan/GYJ-4398-2022; Zhang, Dong/AAZ-1678-2020		Chinese Inner Mongol Agricultural University	Chinese Inner Mongol Agricultural University	Financial support was provided by the Chinese Inner Mongol Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Charchar FJ, 2010, HYPERTENSION, V55, P1231, DOI 10.1161/HYPERTENSIONAHA.109.141663; Cicconardi F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-124; Clop A, 2012, ANIM GENET, V43, P503, DOI 10.1111/j.1365-2052.2012.02317.x; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Doan R, 2012, GENOME RES, V22, P899, DOI 10.1101/gr.128991.111; Dupuis MC, 2013, ANIM GENET, V44, P206, DOI 10.1111/j.1365-2052.2012.02373.x; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Fontanesi L, 2011, GENOMICS, V97, P158, DOI 10.1016/j.ygeno.2010.11.005; Fontanesi L, 2009, CYTOGENET GENOME RES, V126, P333, DOI 10.1159/000268089; Fontanesi L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-639; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jiang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-131; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Li XB, 2010, GENETICA, V138, P1221, DOI 10.1007/s10709-010-9521-5; Li Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-725; Lin CH, 2009, GENOMICS, V94, P241, DOI 10.1016/j.ygeno.2009.06.004; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Metzger J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-487; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Molla M, 2007, THESIS U WISCONSIN M; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sykulski Maciej, 2013, J Clin Bioinforma, V3, P12, DOI 10.1186/2043-9113-3-12; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808; WORKMAN C, 2002, GENOME BIOL, V0003; Yang Hong, 2010, Yichuan, V32, P211, DOI 10.3724/SP.J.1005.2010.00211; Yu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-372	42	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86860	10.1371/journal.pone.0086860	http://dx.doi.org/10.1371/journal.pone.0086860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497987	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100035
J	Wong, JWY; Lucas, C; Kolliker, M				Wong, Janine W. Y.; Lucas, Christophe; Koelliker, Mathias			Cues of Maternal Condition Influence Offspring Selfishness	PLOS ONE			English	Article							EARWIGS FORFICULA-AURICULARIA; EUROPEAN EARWIG; PARENTAL BEHAVIOR; BURYING BEETLES; QUALITY AFFECTS; FAMILY-LIFE; CONFLICT; CARE; COADAPTATION; SIGNALS	The evolution of parent-offspring communication was mostly studied from the perspective of parents responding to begging signals conveying information about offspring condition. Parents should respond to begging because of the differential fitness returns obtained from their investment in offspring that differ in condition. For analogous reasons, offspring should adjust their behavior to cues/signals of parental condition: parents that differ in condition pay differential costs of care and, hence, should provide different amounts of food. In this study, we experimentally tested in the European earwig (Forficula auricularia) if cues of maternal condition affect offspring behavior in terms of sibling cannibalism. We experimentally manipulated female condition by providing them with different amounts of food, kept nymph condition constant, allowed for nymph exposure to chemical maternal cues over extended time, quantified nymph survival (deaths being due to cannibalism) and extracted and analyzed the females' cuticular hydrocarbons (CHC). Nymph survival was significantly affected by chemical cues of maternal condition, and this effect depended on the timing of breeding. Cues of poor maternal condition enhanced nymph survival in early broods, but reduced nymph survival in late broods, and vice versa for cues of good condition. Furthermore, female condition affected the quantitative composition of their CHC profile which in turn predicted nymph survival patterns. Thus, earwig offspring are sensitive to chemical cues of maternal condition and nymphs from early and late broods show opposite reactions to the same chemical cues. Together with former evidence on maternal sensitivities to condition-dependent nymph chemical cues, our study shows context-dependent reciprocal information exchange about condition between earwig mothers and their offspring, potentially mediated by cuticular hydrocarbons.	[Wong, Janine W. Y.; Koelliker, Mathias] Univ Basel, Dept Environm Sci Zool & Evolut, Basel, Switzerland; [Lucas, Christophe] Univ Tours, CNRS, UMR 7261, Inst Rech Biol Insecte, Tours, France	University of Basel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours	Kolliker, M (corresponding author), Univ Basel, Dept Environm Sci Zool & Evolut, Basel, Switzerland.	mathias.koelliker@unibas.ch	Lucas, Christophe/A-4186-2011	Lucas, Christophe/0000-0003-2839-7583	Swiss National Science Foundation [PP00P3-139188]; Fonds zur Forderung von Lehre und Forschung (Freie Akademische Gesellschaft FAG Basel); Nikolaus und Bertha Burckhardt-Burgin-Stiftung; PRES Centre Val de Loire Universite [APR-IA2012]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fonds zur Forderung von Lehre und Forschung (Freie Akademische Gesellschaft FAG Basel); Nikolaus und Bertha Burckhardt-Burgin-Stiftung; PRES Centre Val de Loire Universite	The study was financially supported by the Swiss National Science Foundation (grant-no. PP00P3-139188 to MK), the Fonds zur Forderung von Lehre und Forschung (Freie Akademische Gesellschaft FAG Basel), the Nikolaus und Bertha Burckhardt-Burgin-Stiftung (PhD support to JWYW), and the PRES Centre Val de Loire Universite (APR-IA2012 to CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATESON P, 1994, TRENDS ECOL EVOL, V9, P399, DOI 10.1016/0169-5347(94)90066-3; Biedermann PHW, 2011, P NATL ACAD SCI USA, V108, P17064, DOI 10.1073/pnas.1107758108; Bize P, 2006, P R SOC B, V273, P2063, DOI 10.1098/rspb.2006.3546; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; BLOMQVIST GJ, 2003, INSECT PHEROMONE BIO; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Clutton-Brock T. H., 1988, REPROD SUCCESS; Cocroft RB, 1999, BEHAVIOUR, V136, P1, DOI 10.1163/156853999500640; D'Ettorre P, 2008, SOCIOBIOLOGY COMMUNI; Dobler R, 2011, ANIM BEHAV, V82, P667, DOI 10.1016/j.anbehav.2011.06.017; Dobler R, 2010, BEHAV ECOL, V21, P257, DOI 10.1093/beheco/arp184; Falk J, AM NAT; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; Godfray HCJ, 2000, PHILOS T ROY SOC B, V355, P1581, DOI 10.1098/rstb.2000.0719; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; Gomez Y, 2013, J EVOLUTION BIOL, V26, P1903, DOI 10.1111/jeb.12184; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Hamel JA, 2012, P ROY SOC B-BIOL SCI, V279, P3820, DOI 10.1098/rspb.2012.1181; Hinde CA, 2010, SCIENCE, V327, P1373, DOI 10.1126/science.1186056; Holman L, 2012, EVOLUTION, V66, P2094, DOI 10.1111/j.1558-5646.2012.01603.x; Johnstone RA, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P1, DOI 10.1007/0-306-47660-6_1; Johnstone RA, 1996, P ROY SOC B-BIOL SCI, V263, P1677, DOI 10.1098/rspb.1996.0245; Kilner RM, 2008, ADV STUD BEHAV, V38, P283, DOI 10.1016/S0065-3454(08)00006-5; Kolliker M, 2007, ECOL ENTOMOL, V32, P24, DOI 10.1111/j.1365-2311.2006.00831.x; Kolliker M, 2012, EVOLUTION OF PARENTAL CARE, P285; Kolliker M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1489, DOI 10.1007/s00265-007-0381-7; KOVATS E, 1958, HELV CHIM ACTA, V41, P1915, DOI 10.1002/hlca.19580410703; Krause J, 2002, LIVING GROUPS; LAMB RJ, 1976, CAN ENTOMOL, V108, P609, DOI 10.4039/Ent108609-6; Lynch M., 1998, GENETICS ANAL QUANTI; Mas F, 2011, BIOL LETTERS, V7, P352, DOI 10.1098/rsbl.2010.1094; Mas F, 2009, P R SOC B, V276, P2847, DOI 10.1098/rspb.2009.0498; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; MCCARTHY ED, 1968, ANAL CHEM, V40, P1475, DOI 10.1021/ac60266a021; Meunier J, 2012, P ROY SOC B-BIOL SCI, V279, P3981, DOI 10.1098/rspb.2012.1416; Meunier J, 2012, BIOL LETTERS, V8, P547, DOI 10.1098/rsbl.2012.0151; Meunier J, 2012, EVOL ECOL, V26, P669, DOI 10.1007/s10682-011-9510-x; Mock D. W., 1997, EVOLUTION SIBLING RI; Mock DW, 2011, BEHAV ECOL, V22, P909, DOI 10.1093/beheco/arr091; MOCK DW, 1984, SCIENCE, V225, P731, DOI 10.1126/science.225.4663.731; Morales J, 2013, ANIM BEHAV, V86, P11, DOI 10.1016/j.anbehav.2013.04.001; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Muller JK, 2003, BEHAV ECOL, V14, P212, DOI 10.1093/beheco/14.2.212; Muller W, 2007, AM NAT, V169, pE84, DOI 10.1086/511962; Nelson DR, 1978, ADV INSECT PHYSL, P1; OCONNOR RJ, 1978, ANIM BEHAV, V26, P79, DOI 10.1016/0003-3472(78)90008-8; PARKER GA, 1989, AM NAT, V133, P846, DOI 10.1086/284956; Parker GA, 2002, PHILOS T R SOC B, V357, P295, DOI 10.1098/rstb.2001.0950; Promonis JG, 1980, J CHEM ECOL, V6, P965; RADL RC, 1991, ETHOLOGY, V89, P287, DOI 10.1111/j.1439-0310.1991.tb00374.x; Roulin A, 2012, EVOLUTION OF PARENTAL CARE, P133; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P327; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; Rutter M., 2006, GENES BEHAV; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; Smiseth PT, 2010, BEHAV ECOL, V21, P526, DOI 10.1093/beheco/arq019; Staerkle M, 2008, ETHOLOGY, V114, P844, DOI 10.1111/j.1439-0310.2008.01526.x; Steiger S, 2007, P R SOC B, V274, P2211, DOI 10.1098/rspb.2007.0656; TRIVERS RL, 1974, AM ZOOL, V14, P249; VANCASSEL M, 1984, ADV STUD BEHAV, V14, P51, DOI 10.1016/S0065-3454(08)60299-5; Weyrauch WK, 1927, BIOL ZENTRALBLATT, V49, P553; Wong JWY, 2013, ECOL ENTOMOL, V38, P123, DOI 10.1111/een.12000; Wong JWY, 2012, ETHOLOGY, V118, P450, DOI 10.1111/j.1439-0310.2012.02030.x; Yip EC, 2013, ANIM BEHAV, V85, P1161, DOI 10.1016/j.anbehav.2013.03.016	67	12	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87214	10.1371/journal.pone.0087214	http://dx.doi.org/10.1371/journal.pone.0087214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498046	Green Published, Green Accepted, gold			2022-12-25	WOS:000330617100061
J	Jones, P; Ovenden, N; Dauger, S; Peters, MJ				Jones, Peter; Ovenden, Nick; Dauger, Stephane; Peters, Mark J.			Estimating 'Lost Heart Beats' Rather than Reductions in Heart Rate during the Intubation of Critically-Ill Children	PLOS ONE			English	Article							UNDER-THE-CURVE; ENDOTRACHEAL INTUBATION; REFLEX BRADYCARDIA; STROKE VOLUME; INFANTS; COMPLICATIONS; AREA; REMIFENTANIL; ATROPINE; OUTPUT	Purpose: Reductions in heart rate occur frequently in children during critical care intubation and are currently considered the gold standard for haemodynamic instability. Our objective was to estimate loss of heart beats during intubation and compare this to reduction in heart rate alone whilst testing the impact of atropine pre-medication. Methods: Data were extracted from a prospective 2-year cohort study of intubation ECGs from critically ill children in PICU/Paediatric Transport. A three step algorithm was established to exclude variation in pre-intubation heart rate (using a 95%CI limit derived from pre-intubation heart rate variation of the children included), measure the heart rate over time and finally the estimate the numbers of lost beats. Results: 333 intubations in children were eligible for inclusion of which 245 were available for analysis (74%). Intubations where the fall in heart rate was less than 50 bpm were accompanied almost exclusively by less than 25 lost beats (n = 175, median 0 [0-1]). When there was a reduction of >50 bpm there was a poor correlation with numbers of lost beats (n = 70, median 42 [15-83]). During intubation the median number of lost beats was 8 [1-32] when atropine was not used compared to 0 [0-0] when atropine was used (p<0.001). Conclusions: A reduction in heart rate during intubation of <50 bpm reliably predicted a minimal loss of beats. When the reduction in heart rate was >50 bpm the heart rate was poorly predictive of lost beats. A study looking at the relationship between lost beats and cardiac output needs to be performed. Atropine reduces both fall in heart rate and loss of beats. Similar area-under-the-curve methodology may be useful for estimating risk when biological parameters deviate outside normal range.	[Jones, Peter; Peters, Mark J.] UCL, Inst Child Hlth, Portex Unit, Crit Care Grp, London, England; [Jones, Peter; Dauger, Stephane] Hop Robert Debre, AP HP, F-75019 Paris, France; [Ovenden, Nick] UCL, Dept Math, London, England; [Dauger, Stephane] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; UDICE-French Research Universities; Universite Paris Cite	Jones, P (corresponding author), UCL, Inst Child Hlth, Portex Unit, Crit Care Grp, London, England.	sejjprj@live.ucl.ac.uk	Dauger, Stéphane/AAX-9669-2021; Peters, Mark/AAD-7518-2019	Peters, Mark/0000-0003-3653-4808	UK Department of Health's NIHR Biomedical Research Centre Funding Scheme; Smiths Medical Ltd.	UK Department of Health's NIHR Biomedical Research Centre Funding Scheme; Smiths Medical Ltd.	Peter Jones is an Honorary Lecturer and Mark Peters a Reader at the Institute of Child Health (University College London) which receives a proportion of its funding from the UK Department of Health's NIHR Biomedical Research Centre Funding Scheme and Smiths Medical Ltd. None of the above funding was for this specific study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Bachmann C, 2003, EUR J PEDIATR, V162, P410, DOI 10.1007/s00431-003-1188-9; BARCLAY ML, 1995, AUST NZ J MED, V25, P230, DOI 10.1111/j.1445-5994.1995.tb01529.x; Carroll CL, 2010, PEDIATR CRIT CARE ME, V11, P343, DOI 10.1097/PCC.0b013e3181c51426; Chanavaz C, 2005, BRIT J ANAESTH, V94, P74, DOI 10.1093/bja/aeh293; Chow LTC, 2001, ANAT RECORD, V264, P169, DOI 10.1002/ar.1158; DOYLE DJ, 1989, ANAESTHESIA, V44, P448, DOI 10.1111/j.1365-2044.1989.tb11358.x; Fastle RK, 2004, PEDIATR EMERG CARE, V20, P651, DOI 10.1097/01.pec.0000142947.35394.81; Fekedulegn DB, 2007, PSYCHOSOM MED, V69, P651, DOI 10.1097/PSY.0b013e31814c405c; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Griesdale DEG, 2008, INTENS CARE MED, V34, P1835, DOI 10.1007/s00134-008-1205-6; Hamilton, 2003, DECOMPRESSION PRACTI; Hanna CM, 2004, ANN EMERG MED, V43, P699, DOI 10.1016/j.annemergmed.2003.10.002; ICoRUaM, 2010, REFERENCE DATA VALID; Jaber S, 2006, CRIT CARE MED, V34, P2355, DOI 10.1097/01.CCM.0000233879.58720.87; Jones P, 2013, PEDIATR CRIT CARE ME, V14, pE289, DOI 10.1097/PCC.0b013e31828a8624; Jones P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057478; KEENAN RL, 1994, ANESTHESIOLOGY, V80, P976, DOI 10.1097/00000542-199405000-00005; LEIGH MD, 1957, ANESTHESIOLOGY, V18, P698, DOI 10.1097/00000542-195709000-00004; Miller JD, 2007, CURR OPIN PEDIATR, V19, P142, DOI 10.1097/MOP.0b013e3280895e12; Nishisaki A, 2013, CRIT CARE MED, V41, P874, DOI 10.1097/CCM.0b013e3182746736; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; SCHWARTZ DE, 1995, ANESTHESIOLOGY, V82, P367, DOI 10.1097/00000542-199502000-00007; Simma B, 1997, INTENS CARE MED, V23, P982, DOI 10.1007/s001340050442; Sing RF, 1996, ACAD EMERG MED, V3, P41, DOI 10.1111/j.1553-2712.1996.tb03301.x; Steur RJ, 2004, PEDIATR ANESTH, V14, P462, DOI 10.1111/j.1460-9592.2004.01238.x; Thompson M, 2009, ARCH DIS CHILD, V94, P361, DOI 10.1136/adc.2008.145011; Tirel O, 2005, ANAESTHESIA, V60, P982, DOI 10.1111/j.1365-2044.2005.04298.x; Venkatesh V, 2013, BRIT J HAEMATOL, V160, P421, DOI 10.1111/bjh.12095; Venkatesh V, 2011, EUR J PEDIATR, V170, P223, DOI 10.1007/s00431-010-1290-8; WENNERGREN G, 1989, ACTA PAEDIATR SCAND, V78, P11, DOI 10.1111/j.1651-2227.1989.tb10879.x; WINBERG P, 1992, PEDIATR RES, V31, P117, DOI 10.1203/00006450-199202000-00005; WINBERG P, 1990, AM J PERINAT, V7, P223, DOI 10.1055/s-2007-999487	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e86766	10.1371/journal.pone.0086766	http://dx.doi.org/10.1371/journal.pone.0086766			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503645	Green Submitted, Green Published, gold			2022-12-25	WOS:000330631800011
J	Hall, AJ; Maw, R; Midgley, E; Golding, J; Steer, C				Hall, Amanda J.; Maw, Richard; Midgley, Elizabeth; Golding, Jean; Steer, Colin			Glue Ear, Hearing Loss and IQ: An Association Moderated by the Child's Home Environment	PLOS ONE			English	Article							OTITIS-MEDIA; INTELLECTUAL-DEVELOPMENT; ACADEMIC-PERFORMANCE; COGNITIVE OUTCOMES; AGE; LANGUAGE; BEHAVIOR; EFFUSION; FREQUENCY; THRESHOLD	Background: Glue ear or otitis media with effusion (OME) is common in children and may be associated with hearing loss (HL). For most children it has no long lasting effects on cognitive development but it is unclear whether there are subgroups at higher risk of sequelae. Objectives: To examine the association between a score comprising the number of times a child had OME and HL (OME/HL score) in the first four/five years of life and IQ at age 4 and 8. To examine whether any association between OME/HL and IQ is moderated by socioeconomic, child or family factors. Methods: Prospective, longitudinal cohort study: the Avon Longitudinal Study of Parents and Children (ALSPAC). 1155 children tested using tympanometry on up to nine occasions and hearing for speech (word recognition) on up to three occasions between age 8 months and 5 years. An OME/HL score was created and associations with IQ at ages 4 and 8 were examined. Potential moderators included a measure of the child's cognitive stimulation at home (HOME score). Results: For the whole sample at age 4 the group with the highest 10% OME/HL scores had performance IQ 5 points lower [95% CI -9, -1] and verbal IQ 6 points lower [95% CI -10, -3] than the unaffected group. By age 8 the evidence for group differences was weak. There were significant interactions between OME/HL and the HOME score: those with high OME/HL scores and low 18 month HOME scores had lower IQ at age 4 and 8 than those with high OME/HL scores and high HOME scores. Adjusted mean differences ranged from 5 to 8 IQ points at age 4 and 8. Conclusions: The cognitive development of children from homes with lower levels of cognitive stimulation is susceptible to the effects of glue ear and hearing loss.	[Hall, Amanda J.; Midgley, Elizabeth] Univ Hosp Bristol NHS Fdn Trust, Childrens Hearing Ctr, Bristol, Avon, England; [Hall, Amanda J.] Univ Bristol, Ctr Hearing & Balance Studies, Bristol, Avon, England; [Maw, Richard; Golding, Jean; Steer, Colin] Univ Bristol, Ctr Child & Adolescent Hlth, Bristol, Avon, England	University of Bristol; University of Bristol; University of Bristol	Hall, AJ (corresponding author), Univ Hosp Bristol NHS Fdn Trust, Childrens Hearing Ctr, Bristol, Avon, England.	Amanda.Hall@bristol.ac.uk	Hall, Amanda/AAB-7570-2022	Hall, Amanda/0000-0001-8520-6005; Golding, Jean/0000-0003-2826-3307	UK Medical Research Council [74882]; Wellcome Trust [076467]; Above and Beyond Charity, University Hospitals Bristol NHS Trust; Smith's Charity; Deafness Research UK; Medical Research Council [G9815508, MC_PC_15018] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Above and Beyond Charity, University Hospitals Bristol NHS Trust; Smith's Charity; Deafness Research UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council (Grant ref: 74882) the Wellcome Trust (Grant ref: 076467) and the University of Bristol currently provide core support for ALSPAC. This research was specifically funded by the Above and Beyond Charity, University Hospitals Bristol NHS Trust. The Children in Focus hearing data collection was funded by Smith's Charity and the Hearing Research Trust (now Deafness Research UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett KE, 1999, ARCH DIS CHILD, V80, P28, DOI 10.1136/adc.80.1.28; Bennett KE, 2001, ARCH DIS CHILD, V85, P91, DOI 10.1136/adc.85.2.91; Boyd A, 2012, INT J EPIDEMIOL; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Byford M, 2012, INT J EPIDEMIOL, V41, P263, DOI 10.1093/ije/dyr188; Caldwell BM, 1984, HOME OBSERVATION MEA; Fieullau-Nikolajsen M, 1983, ACTA OTO-LARYNGOL, V394, P1; GRAVEL JS, 1992, J SPEECH HEAR RES, V35, P588, DOI 10.1044/jshr.3503.588; Guo G, 2000, DEMOGRAPHY, V37, P431, DOI 10.2307/2648070; Hall AJ, 2007, INT J AUDIOL, V46, P355, DOI 10.1080/14992020701331570; Hall AJ, 2011, INT J AUDIOL, V50, P809, DOI 10.3109/14992027.2011.599869; Hicks CB, 2002, J SPEECH LANG HEAR R, V45, P573, DOI 10.1044/1092-4388(2002/046); Hogan SCM, 2003, JARO, V4, P123, DOI 10.1007/s10162-002-3007-9; Johnson DL, 2000, J PEDIATR PSYCHOL, V25, P5, DOI 10.1093/jpepsy/25.1.5; Lugo-Gil J, 2008, CHILD DEV, V79, P1065, DOI 10.1111/j.1467-8624.2008.01176.x; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Midgley EJ, 2000, CLIN OTOLARYNGOL, V25, P485, DOI 10.1046/j.1365-2273.2000.00360.x; Roberts JE, 2004, PEDIATRICS, V113, pE238, DOI 10.1542/peds.113.3.e238; ROBERTS JE, 1995, J PEDIATR PSYCHOL, V20, P645, DOI 10.1093/jpepsy/20.5.645; ROBERTS JE, 1994, J PEDIATR PSYCHOL, V19, P347, DOI 10.1093/jpepsy/19.3.347; Roberts JE, 1998, PEDIATRICS, V102, P346, DOI 10.1542/peds.102.2.346; ROBERTS JE, 1986, PEDIATRICS, V78, P423; SUMMERFIELD Q, 1994, BRIT J AUDIOL, V28, P165, DOI 10.3109/03005369409086564; TEELE DW, 1990, J INFECT DIS, V162, P685, DOI 10.1093/infdis/162.3.685; Vernon-Feagans L, 2003, EVIDENCE BASED OTITI; Wechsler D., 1992, WECHSLER INTELLIGENC; WECHSLER D, 1990, WECHSLER PRESCHOOL P; Whitton JP, 2011, JARO-J ASSOC RES OTO, V12, P535, DOI 10.1007/s10162-011-0271-6; Wilson R., 2009, IMPACT GLUE EAR CHIL	29	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87021	10.1371/journal.pone.0087021	http://dx.doi.org/10.1371/journal.pone.0087021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302TD	24498289	gold, Green Published, Green Accepted			2022-12-25	WOS:000330626900035
J	Hecker, MT; Fox, CJ; Son, AH; Cydulka, RK; Siff, JE; Emerman, CL; Sethi, AK; Muganda, CP; Donskey, CJ				Hecker, Michelle T.; Fox, Clinton J.; Son, Andrea H.; Cydulka, Rita K.; Siff, Jonathan E.; Emerman, Charles L.; Sethi, Ajay K.; Muganda, Christine P.; Donskey, Curtis J.			Effect of a Stewardship Intervention on Adherence to Uncomplicated Cystitis and Pyelonephritis Guidelines in an Emergency Department Setting	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; CLINICAL-PRACTICE GUIDELINE; RANDOMIZED CONTROLLED-TRIAL; WOMEN; CARE; DIAGNOSIS; MANAGEMENT; SYMPTOMS; DISEASES; AMERICA	Objective: To evaluate adherence to uncomplicated urinary tract infections (UTI) guidelines and UTI diagnostic accuracy in an emergency department (ED) setting before and after implementation of an antimicrobial stewardship intervention. Methods: The intervention included implementation of an electronic UTI order set followed by a 2 month period of audit and feedback. For women age 18 - 65 with a UTI diagnosis seen in the ED with no structural or functional abnormalities of the urinary system, we evaluated adherence to guidelines, antimicrobial use, and diagnostic accuracy at baseline, after implementation of the order set (period 1), and after audit and feedback (period 2). Results: Adherence to UTI guidelines increased from 44% (baseline) to 68% (period 1) to 82% (period 2) (P <=.015 for each successive period). Prescription of fluoroquinolones for uncomplicated cystitis decreased from 44% (baseline) to 14% (period 1) to 13% (period 2) (P<.001 and P = .7 for each successive period). Unnecessary antibiotic days for the 200 patients evaluated in each period decreased from 250 days to 119 days to 52 days (P,. 001 for each successive period). For 40% to 42% of cases diagnosed as UTI by clinicians, the diagnosis was deemed unlikely or rejected with no difference between the baseline and intervention periods. Conclusions: A stewardship intervention including an electronic order set and audit and feedback was associated with increased adherence to uncomplicated UTI guidelines and reductions in unnecessary antibiotic therapy and fluoroquinolone therapy for cystitis. Many diagnoses were rejected or deemed unlikely, suggesting a need for studies to improve diagnostic accuracy for UTI.	[Hecker, Michelle T.] Case Western Reserve Univ, Metrohlth Med Ctr, Div Infect Dis, Dept Med, Cleveland, OH 44106 USA; [Fox, Clinton J.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Son, Andrea H.] Metrohlth Med Ctr, Dept Pharm, Cleveland, OH USA; [Cydulka, Rita K.; Siff, Jonathan E.; Emerman, Charles L.] Case Western Reserve Univ, Metrohlth Med Ctr, Dept Emergency Med, Cleveland, OH USA; [Sethi, Ajay K.; Muganda, Christine P.] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI USA; [Donskey, Curtis J.] Louis Stokes Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Hecker, MT (corresponding author), Case Western Reserve Univ, Metrohlth Med Ctr, Div Infect Dis, Dept Med, Cleveland, OH 44106 USA.	mhecker@metrohealth.org			Centers for Disease Control and Prevention [R01 CI000614-01]; Department of Veterans Affairs; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000614] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Centers for Disease Control and Prevention (R01 CI000614-01 to C.J.D.) and by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MH, 2006, J ANTIMICROB CHEMOTH, V57, P959, DOI 10.1093/jac/dkl076; Berg E, 1996, ACAD EMERG MED, V3, P1030, DOI 10.1111/j.1553-2712.1996.tb03349.x; Christiaens TCM, 2002, BRIT J GEN PRACT, V52, P729; Flottorp S, 2002, BMJ-BRIT MED J, V32, P51; Foxman B, 2002, AM J MED, V113, p5S; Gordon LB, 2013, J AM GERIATR SOC, V61, P788, DOI 10.1111/jgs.12203; Grover ML, 2007, MAYO CLIN PROC, V82, P181; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Huang ES, 2002, ARCH INTERN MED, V162, P41, DOI 10.1001/archinte.162.1.41; Hummers-Pradier E, 1999, FAM PRACT, V16, P605, DOI 10.1093/fampra/16.6.605; Huppert JS, 2007, J ADOLESCENT HEALTH, V40, P418, DOI 10.1016/j.jadohealth.2006.12.010; Johansen TEB, 2011, INT J ANTIMICROB AG, V38, P64, DOI 10.1016/j.ijantimicag.2011.09.009; Kahan E, 2003, EUR J CLIN PHARMACOL, V59, P663, DOI 10.1007/s00228-003-0673-4; Kahan NR, 2005, PHARMACOEPIDEM DR S, V14, P357, DOI 10.1002/pds.1044; Kahan NR, 2004, ISR MED ASSOC J, V6, P588; Kahan NR, 2004, J CLIN PHARM THER, V29, P59, DOI 10.1111/j.1365-2710.2003.00537.x; Llor C, 2011, FAM PRACT, V28, P294, DOI 10.1093/fampra/cmq107; Lundborg CS, 1999, J CLIN EPIDEMIOL, V52, P801, DOI 10.1016/S0895-4356(99)00036-0; May L, 2013, ANN EMERG MED, V62, P69, DOI 10.1016/j.annemergmed.2012.09.002; Nesher L, 2007, INT J INFECT DIS, V11, P245, DOI 10.1016/j.ijid.2006.03.004; Nicolle LE, 2000, J ANTIMICROB CHEMOTH, V46, P35, DOI 10.1093/jac/46.suppl_1.35; Niska Richard, 2010, Natl Health Stat Report, P1; OConnor PJ, 1996, JOINT COMM J QUAL IM, V22, P673, DOI 10.1016/S1070-3241(16)30274-7; Paterson DL, 2004, CLIN INFECT DIS, V38, pS341, DOI 10.1086/382690; RUBIN RH, 1992, CLIN INFECT DIS, V15, pS216, DOI 10.1093/clind/15.Supplement_1.S216; Saint S, 1999, AM J MED, V106, P636, DOI 10.1016/S0002-9343(99)00122-9; Shapiro T, 2005, ACAD EMERG MED, V12, P38, DOI 10.1197/j.aem.2004.08.051; Swami SK, 2012, MAYO CLIN PROC, V87, P753, DOI 10.1016/j.mayocp.2012.02.025; Taur Y, 2007, CLIN INFECT DIS, V44, P769, DOI 10.1086/511866; Warren JW, 1999, CLIN INFECT DIS, V29, P745, DOI 10.1086/520427	30	64	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87899	10.1371/journal.pone.0087899	http://dx.doi.org/10.1371/journal.pone.0087899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498394	Green Published, gold			2022-12-25	WOS:000330626900140
J	Files, DC; Xiao, KH; Zhang, T; Liu, C; Qian, J; Zhao, WL; Morris, PE; Delbono, O; Feng, X				Files, D. Clark; Xiao, Kunhong; Zhang, Tan; Liu, Chun; Qian, Jiang; Zhao, Weiling; Morris, Peter E.; Delbono, Osvaldo; Feng, Xin			The Posterior Cricoarytenoid Muscle Is Spared from MuRF1-Mediated Muscle Atrophy in Mice with Acute Lung Injury	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; RESPIRATORY-DISTRESS-SYNDROME; INTRINSIC LARYNGEAL MUSCLES; EXTRAOCULAR-MUSCLE; MYOSIN; EXPRESSION; MODEL	Background: Skeletal muscle wasting in acute lung injury (ALI) patients increases the morbidity and mortality associated with this critical illness. The contribution of laryngeal muscle wasting to these outcomes is unknown, though voice impairments and aspiration are common in intensive care unit (ICU) survivors. We evaluated the intrinsic laryngeal abductor (PCA, posterior cricoarytenoid), adductor (CT, cricothyroid) and limb (EDL, extensor digitorum longus) muscles in a mouse model of ALI. Methods: Escherichia coli lipopolysaccharides were instilled into the lungs of adult male C57Bl6J mice (ALI mice). Limb and intrinsic laryngeal muscles were analyzed for fiber size, type, protein expression and myosin heavy chain (MyHC) composition by SDS-PAGE and mass spectroscopy. Results: Marked muscle atrophy occurred in the CT and EDL muscles, while the PCA was spared. The E3 ubiquitin ligase muscle ring finger-1 protein (MuRF1), a known mediator of limb muscle atrophy in this model, was upregulated in the CT and EDL, but not in the PCA. Genetic inhibition of MuRF1 protected the CT and EDL from ALI-induced muscle atrophy. MyHC-Extraocular (MyHC-EO) comprised 27% of the total MyHC in the PCA, distributed as hybrid fibers throughout 72% of PCA muscle fibers. Conclusion: The vocal cord abductor (PCA) contains a large proportion of fibers expressing MyHC-EO and is spared from muscle atrophy in ALI mice. The lack of MuRF1 expression in the PCA suggests a previously unrecognized mechanism whereby this muscle is spared from atrophy. Atrophy of the vocal cord adductor (CT) may contribute to the impaired voice and increased aspiration observed in ICU survivors. Further evaluation of the sparing of muscles involved in systemic wasting diseases may lead to potential therapeutic targets for these illnesses.	[Files, D. Clark; Zhang, Tan; Liu, Chun; Morris, Peter E.; Delbono, Osvaldo] Wake Forest Sch Med, Winston Salem, NC USA; [Files, D. Clark; Morris, Peter E.] Wake Forest Sch Med, Wake Forest Crit Care Translat Res Ctr, Winston Salem, NC USA; [Xiao, Kunhong; Qian, Jiang] Duke Univ, Dept Med, Durham, NC USA; [Zhao, Weiling] Wake Forest Sch Med, Dept Radiat Oncol, Winston Salem, NC USA; [Zhao, Weiling] Wake Forest Sch Med, Brain Tumor Ctr Excellence, Winston Salem, NC USA; [Feng, Xin] Wake Forest Sch Med, Dept Otolaryngol, Winston Salem, NC 27106 USA	Wake Forest University; Wake Forest University; Duke University; Wake Forest University; Wake Forest University; Wake Forest University	Feng, X (corresponding author), Wake Forest Sch Med, Dept Otolaryngol, Winston Salem, NC 27106 USA.	xfeng@wakehealth.edu	Xiao, Kunhong/AAG-4275-2020	Xiao, Kunhong/0000-0002-1069-1226; Files, Daniel Clark/0000-0002-1595-4080	Wake Forest School of Medicine, Department of Otolaryngology; Department of Medicine; Claude D. Pepper Older Americans Independence Center [P30-AG21332]; Parker B. Francis Foundation [2P01-HL-075443]; NIH/NIA [AG13934, AG15820]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013934, R01AG015820, P30AG021332] Funding Source: NIH RePORTER	Wake Forest School of Medicine, Department of Otolaryngology; Department of Medicine; Claude D. Pepper Older Americans Independence Center; Parker B. Francis Foundation; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by Institutional Funds from the Wake Forest School of Medicine, Department of Otolaryngology (XF), the Department of Medicine (DCF), the Claude D. Pepper Older Americans Independence Center P30-AG21332 (DCF, OD, XF), the Parker B. Francis Foundation (DCF), 2P01-HL-075443 Proteomics Core (KHX), NIH/NIA AG13934 (OD) and AG15820 (OD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aare S, 2009, NEUROMUSCULAR DISORD, V19, P560, DOI 10.1016/j.nmd.2009.06.057; Aare S, 2011, PHYSIOL GENOMICS, V43, P1334, DOI 10.1152/physiolgenomics.00116.2011; Ali NA, 2008, AM J RESP CRIT CARE, V178, P261, DOI 10.1164/rccm.200712-1829OC; [Anonymous], 2008, OPERATIVE TECHNIQUES, P3, DOI [10.1007/978-3-540-68107-6_1, DOI 10.1007/978-3-540-68107-6_1]; Augusto V, 2004, BRAZ J MORPHOL SCI, V21, P89; Bloemink MJ, 2013, J BIOL CHEM, V288, P27469, DOI 10.1074/jbc.M113.488130; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Chen DH, 2010, LARYNGOSCOPE, V120, P353, DOI 10.1002/lary.20796; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; Feng X, 2012, EXP GERONTOL, V47, P601, DOI 10.1016/j.exger.2012.05.007; Feng X, 2012, LARYNGOSCOPE, V122, P1093, DOI 10.1002/lary.23218; Ferretti R, 2009, MUSCLE NERVE, V39, P609, DOI 10.1002/mus.21154; Files DC, 2012, AM J RESP CRIT CARE, V185, P825, DOI 10.1164/rccm.201106-1150OC; Fischer MD, 2005, PHYSIOL GENOMICS, V22, P283, DOI 10.1152/physiolgenomics.00158.2004; Fletcher SN, 2003, CRIT CARE MED, V31, P1012, DOI 10.1097/01.CCM.0000053651.38421.D9; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hafner G, 2008, EUR ARCH OTO-RHINO-L, V265, P441, DOI 10.1007/s00405-007-0507-6; Hager M, 2009, MUSCLE NERVE, V39, P91, DOI 10.1002/mus.21209; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; HINRICHSEN C, 1982, J MUSCLE RES CELL M, V3, P169, DOI 10.1007/BF00711941; Jensen CB, 2007, J CLIN ENDOCR METAB, V92, P1530, DOI 10.1210/jc.2006-2360; Lacomis David, 2011, J Clin Neuromuscul Dis, V12, P197, DOI 10.1097/CND.0b013e3181b5e14d; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Langen RCJ, 2012, AM J RESP CELL MOL, V47, P288, DOI 10.1165/rcmb.2011-0119OC; Marques MJ, 2007, MUSCLE NERVE, V35, P349, DOI 10.1002/mus.20697; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Moriscot AS, 2010, J STRUCTURAL BIOL, V170, P344; Nixon I, 2010, J LARYNGOL OTOL, V124, P515, DOI 10.1017/S0022215109992556; Ochala J, 2011, J PHYSIOL-LONDON, V589, P2007, DOI 10.1113/jphysiol.2010.202044; Plant PJ, 2010, AM J RESP CELL MOL, V42, P461, DOI 10.1165/rcmb.2008-0382OC; Polge C, 2011, FASEB J, V25, P3790, DOI 10.1096/fj.11-180968; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; ROSENFIELD DB, 1982, ARCH OTOLARYNGOL, V108, P662; Sciote JJ, 2002, ANN OTO RHINOL LARYN, V111, P120, DOI 10.1177/000348940211100203; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smythe GM, 2009, J OTOLARYNGOL-HEAD N, V38, P323, DOI 10.2310/7070.2009.080102; Stevens Robert D, 2009, Crit Care Med, V37, pS299, DOI 10.1097/CCM.0b013e3181b6ef67; Treggiari MM, 2004, CRIT CARE MED, V32, P327, DOI 10.1097/01.CCM.0000108870.09693.42; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weinert CR, 1997, AM J RESP CRIT CARE, V156, P1120, DOI 10.1164/ajrccm.156.4.9611047; Xu W, 2009, ANN OTO RHINOL LARYN, V118, P656, DOI 10.1177/000348940911800910; Zhang T, 2011, AGE DORDR; Zhou YF, 2010, INVEST OPHTH VIS SCI, V51, P6355, DOI 10.1167/iovs.10-5937	52	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87587	10.1371/journal.pone.0087587	http://dx.doi.org/10.1371/journal.pone.0087587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498144	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900138
J	Fontes, MSC; Raaijmakers, AJA; van Doorn, T; Kok, B; Nieuwenhuis, S; van der Nagel, R; Vos, MA; de Boer, TP; van Rijen, HVM; Bierhuizen, MFA				Fontes, Magda S. C.; Raaijmakers, Antonia J. A.; van Doorn, Tessa; Kok, Bart; Nieuwenhuis, Sylvia; van der Nagel, Roel; Vos, Marc A.; de Boer, Teun P.; van Rijen, Harold V. M.; Bierhuizen, Marti F. A.			Changes in Cx43 and Na(V)1.5 Expression Precede the Occurrence of Substantial Fibrosis in Calcineurin-Induced Murine Cardiac Hypertrophy	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; HUMAN HEART-FAILURE; CONNECTIVE-TISSUE; MICRORNA THERAPEUTICS; GENE-EXPRESSION; SODIUM-CHANNEL; GAP-JUNCTIONS; CONNEXIN43; CARDIOMYOPATHY; MECHANISMS	In mice, the calcium-dependent phosphatase calcineurin A (CnA) induces a transcriptional pathway leading to pathological cardiac hypertrophy. Interestingly, induction of CnA has been frequently noticed in human hypertrophic and failing hearts. Independently, the arrhythmia vulnerability of such hearts has been regularly associated with remodeling of parameters determining electrical conduction (expression level of connexin43 (Cx43) and Na(V)1.5, connective tissue architecture), for which the precise molecular basis and sequence of events is still unknown. Recently, we observed reduced Cx43 and Na(V)1.5 expression in 4-week old mouse hearts, overexpressing a constitutively active form of CnA (MHC-CnA model), but the order of events is still unknown. Therefore, three key parameters of conduction (Cx43, Na(V)1.5 and connective tissue expression) were characterized in MHC-CnA ventricles versus wild-type (WT) during postnatal development on a weekly basis. At postnatal week 1, CnA overexpression induced cardiac hypertrophy in MHC-CnA. Moreover, protein and RNA levels of both Cx43 and Na(V)1.5 were reduced by at least 50% as compared to WT. Cx43 immunoreactive signal was reduced at week 2 in MHC-CnA. At postnatal week 3, Cx43 was less phosphorylated and RNA level of Cx43 normalized to WT values, although the protein level was still reduced. Additionally, MHC-CnA hearts displayed substantial fibrosis relative to WT, which was accompanied by increased RNA levels for genes previously associated with fibrosis such as Col1a1, Col1a2, Col3a1, Tgfb1, Ctgf, Timp1 and microRNA miR-21. In MHC-CnA, reduction in Cx43 and Na(V)1.5 expression thus coincided with overexpression of CnA and hypertrophy development and preceded significant presence of fibrosis. At postnatal week 4 the alterations in conductional parameters observed in the MHC-CnA model lead to abnormal conduction and arrhythmias, similar to those observed in cardiac remodeling in heart failure patients. The MHC-CnA model, therefore, provides for a unique model to resolve the molecular origin of conductional remodeling in detail.	[Fontes, Magda S. C.; Raaijmakers, Antonia J. A.; van Doorn, Tessa; Kok, Bart; Nieuwenhuis, Sylvia; van der Nagel, Roel; Vos, Marc A.; de Boer, Teun P.; van Rijen, Harold V. M.; Bierhuizen, Marti F. A.] Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Bierhuizen, MFA (corresponding author), Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, Utrecht, Netherlands.	m.f.a.bierhuizen@umcutrecht.nl		de Boer, Teun/0000-0002-0561-6491; van Rijen, Harold/0000-0001-6740-7428	Dutch Heart Foundation [2009B072, 2010T045]	Dutch Heart Foundation(Netherlands Heart Foundation)	This study was supported by the Dutch Heart Foundation (grant numbers 2009B072 and 2010T045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam O, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0278-0; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Arnolds DE, 2012, J CLIN INVEST, V122, P2509, DOI 10.1172/JCI62617; Bierhuizen MFA, 2008, J MOL CELL CARDIOL, V45, P373, DOI 10.1016/j.yjmcc.2008.06.011; Borlak J, 2003, FASEB J, V17, P1592, DOI 10.1096/fj.02-0889com; Camelliti P, 2004, CIRC RES, V94, P828, DOI 10.1161/01.RES.0000122382.19400.14; Chu GX, 2002, CARDIOVASC RES, V54, P105, DOI 10.1016/S0008-6363(02)00230-4; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; de Boer TP, 2007, DIFFERENTIATION, V75, P208, DOI 10.1111/j.1432-0436.2006.00133.x; Diedrichs H, 2004, EUR J HEART FAIL, V6, P3, DOI 10.1016/j.ejheart.2003.07.007; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Fabritz L, 2011, J AM COLL CARDIOL, V57, P740, DOI 10.1016/j.jacc.2010.09.046; Fieller E., 1940, J ROYAL STAT SOC S, V7, P1, DOI [10.2307/2983630, DOI 10.2307/2983630]; Fontes MSC, 2012, BBA-BIOMEMBRANES, V1818, P2020, DOI 10.1016/j.bbamem.2011.07.039; Guo J, 2006, AM J PHYSIOL-HEART C, V291, pH2669, DOI 10.1152/ajpheart.01247.2005; Haq S, 2001, CIRCULATION, V103, P670; Hatanka K, 2004, JPN HEART J, V45, P1007, DOI 10.1536/jhj.45.1007; Jansen JA, 2012, CIRC-ARRHYTHMIA ELEC, V5, P380, DOI 10.1161/CIRCEP.111.966580; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Leoni AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009298; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi R, 2003, CIRCULATION, V108, P1455, DOI 10.1161/01.CIR.0000090687.97972.10; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Oxford EM, 2007, CIRC RES, V101, P703, DOI 10.1161/CIRCRESAHA.107.154252; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Pauschinger M, 1998, CARDIOVASC RES, V37, P123, DOI 10.1016/S0008-6363(97)00217-4; R Core Team, 2012, R LANG ENV STAT COMP; Rook MB, 2012, CARDIOVASC RES, V93, P12, DOI 10.1093/cvr/cvr252; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Shang LJL, 2007, CIRC RES, V101, P1146, DOI 10.1161/CIRCRESAHA.107.152918; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; SWEAT F, 1964, ARCH PATHOL, V78, P69; Teunissen BEJ, 2007, DNA CELL BIOL, V26, P108, DOI 10.1089/dna.2006.0540; Thum T, 2012, EMBO MOL MED, V4, P3, DOI 10.1002/emmm.201100191; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; van Veen TAB, 2002, J MOL CELL CARDIOL, V34, P1411, DOI 10.1006/jmcc.2002.2102	46	29	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87226	10.1371/journal.pone.0087226	http://dx.doi.org/10.1371/journal.pone.0087226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498049	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900077
J	Saulnier-Talbot, E; Gregory-Eaves, I; Simpson, KG; Efitre, J; Nowlan, TE; Taranu, ZE; Chapman, LJ				Saulnier-Talbot, Emilie; Gregory-Eaves, Irene; Simpson, Kyle G.; Efitre, Jackson; Nowlan, Tobias E.; Taranu, Zofia E.; Chapman, Lauren J.			Small Changes in Climate Can Profoundly Alter the Dynamics and Ecosystem Services of Tropical Crater Lakes	PLOS ONE			English	Article							WATER-RESOURCES; TANGANYIKA; AFRICA; SEDIMENTS	African tropical lakes provide vital ecosystem services including food and water to some of the fastest growing human populations, yet they are among the most understudied ecosystems in the world. The consequences of climate change and other stressors on the tropical lakes of Africa have been informed by long-term analyses, but these studies have largely focused on the massive Great Rift Valley lakes. Our objective was to evaluate how recent climate change has altered the functioning and services of smaller tropical lakes, which are far more abundant on the landscape. Based on a paired analysis of 20 years of high-resolution water column data and a paleolimnological record from a small crater lake in western Uganda, we present evidence that even a modest warming of the air (similar to 0.9 degrees C increase over 20 years) and changes in the timing and intensity of rainfall can have significant consequences on the dynamics of this common tropical lake type. For example, we observed a significant nonlinear increase (R-adj(2) = 0.23, e.d.f. = 7, p < 0.0001) in thermal stability over the past 20 years. This resulted in the expansion of anoxic waters and consequent deterioration of fish habitat and appears to have abated primary production; processes that may impair ecosystem services for a vulnerable human population. This study on a system representative of small tropical crater lakes highlights the far-reaching effects of global climatic change on tropical waters. Increased research efforts into tropical aquatic ecosystem health and the development of sound management practices are necessary in order to strengthen adaptive capabilities in tropical regions.	[Saulnier-Talbot, Emilie; Gregory-Eaves, Irene; Simpson, Kyle G.; Nowlan, Tobias E.; Taranu, Zofia E.; Chapman, Lauren J.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Efitre, Jackson] Makerere Univ, Sch Biosci, Dept Biol Sci, Coll Nat Sci, Kampala, Uganda	McGill University; Makerere University	Saulnier-Talbot, E (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	emiliest@hotmail.com	Gregory-Eaves, Irene/U-9325-2019	Gregory-Eaves, Irene/0000-0002-0380-5061	National Science Foundation (NSF); Wildlife Conservation Society; National Science and Engineering Research Council of Canada (NSERC); Canada Research Chair in Respiratory Ecology; NSERC; Canadian Foundation for Innovation (CFI); Fonds quebecois pour la Recherche sur la Nature et les Technologies (FQRNT); Percy Sladen Memorial Fund	National Science Foundation (NSF)(National Science Foundation (NSF)); Wildlife Conservation Society; National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Respiratory Ecology; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds quebecois pour la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT); Percy Sladen Memorial Fund	This research was supported by grants from the National Science Foundation (NSF; http://www.nsf.gov/), the Wildlife Conservation Society (http://www.wcs.org/), the National Science and Engineering Research Council of Canada (NSERC; http://www.nserc-crsng.gc.ca/) and the Canada Research Chair in Respiratory Ecology to LJC, and by NSERC and the Canadian Foundation for Innovation (CFI) grants to IGE. EST and ZET benefitted from postdoctoral and doctoral fellowships from Fonds quebecois pour la Recherche sur la Nature et les Technologies (FQRNT; http://www.fqrnt.gouv.qc.ca/) and EST from a grant from the Percy Sladen Memorial Fund (http://www.linnean.org/The-Society/awards_and_grants/Awards+and+Grants). No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, TRACKING ENV CHANGE, DOI DOI 10.1007/0-306-47668-1_15; Appleby PG, 2008, HOLOCENE, V18, P83, DOI 10.1177/0959683607085598; Arnell NW, 1999, GLOBAL ENVIRON CHANG, V9, pS31, DOI 10.1016/S0959-3780(99)00017-5; Chapman LJ, 1998, HYDROBIOLOGIA, V385, P201, DOI 10.1023/A:1003527016384; Chapman LJ, 2003, CONSERV ECOL, P474; Efitre J, 2007, THESIS U FLORIDA; Efitre J, 2009, ENVIRON BIOL FISH, V85, P63, DOI 10.1007/s10641-009-9461-z; Guilizzoni P, 2002, ENCY ENV MICROBIOLOG, P2306, DOI DOI 10.1002/0471263397.ENV313; Hartter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032408; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Kizito Yusuf S., 1993, Limnologica, V23, P335; KLING GW, 1988, LIMNOL OCEANOGR, V33, P27, DOI 10.4319/lo.1988.33.1.0027; Kundzewicz ZW, 2008, HYDROLOG SCI J, V53, P3, DOI 10.1623/hysj.53.1.3; Lewis William M. Jr., 2000, Lakes Reservoirs Research and Management, V5, P35, DOI 10.1046/j.1440-1770.2000.00091.x; Lewis WM, 1996, PERSPECTIVES IN TROPICAL LIMNOLOGY, P43; LEWIS WM, 1973, LIMNOL OCEANOGR, V18, P200, DOI 10.4319/lo.1973.18.2.0200; Margalef R, 1983, LIMNOLOGIA; MELACK JM, 1978, ARCH HYDROBIOL, V84, P430; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Sarmento H, 2013, FRESHWATER BIOL, V58, P2208, DOI 10.1111/fwb.12140; Schneider P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045059; Taranu ZE, 2012, GLOBAL CHANGE BIOL, V18, P3477, DOI 10.1111/gcb.12015; Tierney JE, 2010, NAT GEOSCI, V3, P422, DOI [10.1038/ngeo865, 10.1038/NGEO865]; Verburg P, 2003, SCIENCE, V301, P505, DOI 10.1126/science.1084846; Vollmer MK, 2005, LIMNOL OCEANOGR, V50, P727, DOI 10.4319/lo.2005.50.2.0727; Washington R, 2006, B AM METEOROL SOC, V87, P1355, DOI 10.1175/BAMS-87-10-1355; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	29	36	37	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86561	10.1371/journal.pone.0086561	http://dx.doi.org/10.1371/journal.pone.0086561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497954	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900026
J	Sun, YX; Ming, DM				Sun, Yunxiang; Ming, Dengming			Energetic Frustrations in Protein Folding at Residue Resolution: A Homologous Simulation Study of Im9 Proteins	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; TRANSITION-STATE ENSEMBLE; NONNATIVE INTERACTIONS; NATIVE CONTACTS; MODEL PROTEINS; KEY RESIDUES; GO-LIKE; LANDSCAPE; KINETICS; FUNNELS	Energetic frustration is becoming an important topic for understanding the mechanisms of protein folding, which is a long-standing big biological problem usually investigated by the free energy landscape theory. Despite the significant advances in probing the effects of folding frustrations on the overall features of protein folding pathways and folding intermediates, detailed characterizations of folding frustrations at an atomic or residue level are still lacking. In addition, how and to what extent folding frustrations interact with protein topology in determining folding mechanisms remains unclear. In this paper, we tried to understand energetic frustrations in the context of protein topology structures or native-contact networks by comparing the energetic frustrations of five homologous Im9 alpha-helix proteins that share very similar topology structures but have a single hydrophilic-to-hydrophobic mutual mutation. The folding simulations were performed using a coarse-grained Go-like model, while non-native hydrophobic interactions were introduced as energetic frustrations using a Lennard-Jones potential function. Energetic frustrations were then examined at residue level based on Q-value analyses of the transition state ensemble structures and mapped back to native-contact networks. Our calculations show that energetic frustrations have highly heterogeneous influences on the folding of the four helices of the examined structures depending on the local environment of the frustration centers. Also, the closer the introduced frustration is to the center of the native-contact network, the larger the changes in the protein folding. Our findings add a new dimension to the understanding of protein folding the topology determination in that energetic frustrations works closely with native-contact networks to affect the protein folding.	[Sun, Yunxiang; Ming, Dengming] Fudan Univ, Dept Physiol & Biophys, Sch Life Sci, Shanghai 200433, Peoples R China	Fudan University	Ming, DM (corresponding author), Fudan Univ, Dept Physiol & Biophys, Sch Life Sci, Shanghai 200433, Peoples R China.	dming@fudan.edu.cn		Sun, Yunxiang/0000-0001-9799-7131	National Natural Science Foundation of China [30870509, 31270759]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported, in part, by the National Natural Science Foundation of China (Grant No. 30870509 and 31270759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABKEVICH VI, 1995, J MOL BIOL, V252, P460, DOI 10.1006/jmbi.1995.0511; Alm E, 1999, P NATL ACAD SCI USA, V96, P11305, DOI 10.1073/pnas.96.20.11305; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; [Anonymous], 1992, J CARDIOVASCULAR S3, V20, pS1; Bartlett AI, 2010, J MOL BIOL, V396, P1329, DOI 10.1016/j.jmb.2009.12.048; Baumketner A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011905; Best RB, 2013, P NATL ACAD SCI USA, V110, P17874, DOI 10.1073/pnas.1311599110; BOCZKO EM, 1995, SCIENCE, V269, P393, DOI 10.1126/science.7618103; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; CAMACHO CJ, 1993, P NATL ACAD SCI USA, V90, P6369, DOI 10.1073/pnas.90.13.6369; Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757; Chen YT, 2010, PROTEINS, V78, P2090, DOI 10.1002/prot.22724; Cho SS, 2009, P NATL ACAD SCI USA, V106, P434, DOI 10.1073/pnas.0810218105; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Clementi C, 2004, PROTEIN SCI, V13, P1750, DOI 10.1110/ps.03580104; Contessoto VG, 2013, PROTEINS, V81, P1727, DOI 10.1002/prot.24309; Dennis CA, 1998, BIOCHEM J, V333, P183, DOI 10.1042/bj3330183; Dinner AR, 1996, P NATL ACAD SCI USA, V93, P8356, DOI 10.1073/pnas.93.16.8356; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Faisca PFN, 2010, PROTEIN SCI, V19, P2196, DOI 10.1002/pro.498; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; FERSHT AR, 1995, CURR OPIN STRUC BIOL, V5, P79, DOI 10.1016/0959-440X(95)80012-P; Frauenfelder JD, 1999, SIMPLICITY COMPLEXIT; Friel CT, 2004, J MOL BIOL, V342, P261, DOI 10.1016/j.jmb.2004.06.076; Friel CT, 2003, J MOL BIOL, V326, P293, DOI 10.1016/S0022-2836(02)01249-4; Galzitskaya OV, 1999, P NATL ACAD SCI USA, V96, P11299, DOI 10.1073/pnas.96.20.11299; Gorski SA, 2004, J MOL BIOL, V337, P183, DOI 10.1016/j.jmb.2004.01.004; Guerois R, 2000, J MOL BIOL, V304, P967, DOI 10.1006/jmbi.2000.4234; Hills RD, 2008, BIOPHYS J, V95, pL57, DOI 10.1529/biophysj.108.143388; Hills RD, 2010, J MOL BIOL, V398, P332, DOI 10.1016/j.jmb.2010.03.001; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karanicolas J, 2003, J MOL BIOL, V334, P309, DOI 10.1016/j.jmb.2003.09.047; Karanicolas J, 2002, PROTEIN SCI, V11, P2351, DOI 10.1110/ps.0205402; Knowling S, 2011, PROTEIN ENG DES SEL, V24, P517, DOI 10.1093/protein/gzr009; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; LI AJ, 1994, P NATL ACAD SCI USA, V91, P10430, DOI 10.1073/pnas.91.22.10430; Li L, 2000, NAT STRUCT BIOL, V7, P336; Ming DM, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.021902; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Morton VL, 2007, J MOL BIOL, V371, P554, DOI 10.1016/j.jmb.2007.05.010; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakagawa N, 2006, P NATL ACAD SCI USA, V103, P5279, DOI 10.1073/pnas.0600102103; Neudecker P, 2006, J MOL BIOL, V363, P958, DOI 10.1016/j.jmb.2006.08.047; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; Nickson AA, 2010, METHODS, V52, P38, DOI 10.1016/j.ymeth.2010.06.003; Nymeyer H, 2000, P NATL ACAD SCI USA, V97, P634, DOI 10.1073/pnas.97.2.634; Nymeyer H, 1998, P NATL ACAD SCI USA, V95, P5921, DOI 10.1073/pnas.95.11.5921; Oliveira RJ, 2010, BIOPHYS J, V99, P600, DOI 10.1016/j.bpj.2010.04.041; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Onuchic JN, 1996, FOLD DES, V1, P441, DOI 10.1016/S1359-0278(96)00060-0; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Paci E, 2004, PROTEINS, V54, P513, DOI 10.1002/prot.10595; Pande VS, 1999, P NATL ACAD SCI USA, V96, P9062, DOI 10.1073/pnas.96.16.9062; Plotkin SS, 2001, PROTEINS, V45, P337, DOI 10.1002/prot.1154; Schaeffer RD, 2011, PROTEIN ENG DES SEL, V24, P11, DOI 10.1093/protein/gzq096; Shea JE, 2000, J CHEM PHYS, V113, P7663, DOI 10.1063/1.1313792; Shea JE, 1999, P NATL ACAD SCI USA, V96, P12512, DOI 10.1073/pnas.96.22.12512; Sutto L, 2007, P NATL ACAD SCI USA, V104, P19825, DOI 10.1073/pnas.0709922104; TAKETOMI H, 1975, INT J PEPT PROT RES, V7, P445; Thirumalai D., 2007, V350, P277; Treptow WL, 2002, PROTEINS, V49, P167, DOI 10.1002/prot.10166; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Viguera AR, 2002, P NATL ACAD SCI USA, V99, P5349, DOI 10.1073/pnas.072387799; Wensley BG, 2010, NATURE, V463, P685, DOI 10.1038/nature08743; Zarrine-Afsar A, 2008, P NATL ACAD SCI USA, V105, P9999, DOI 10.1073/pnas.0801874105; Zhang ZQ, 2010, P NATL ACAD SCI USA, V107, P2920, DOI 10.1073/pnas.0911844107	68	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87719	10.1371/journal.pone.0087719	http://dx.doi.org/10.1371/journal.pone.0087719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498176	gold, Green Published			2022-12-25	WOS:000330621900159
J	Semenyuk, EG; Laning, ML; Foley, J; Johnston, PF; Knight, KL; Gerding, DN; Driks, A				Semenyuk, Ekaterina G.; Laning, Michelle L.; Foley, Jennifer; Johnston, Pehga F.; Knight, Katherine L.; Gerding, Dale N.; Driks, Adam			Spore Formation and Toxin Production in Clostridium difficile Biofilms	PLOS ONE			English	Article							INFECTION; HAMSTERS; LAYER; RECURRENCE; EXOSPORIUM; PROTEINS; STRAINS; PILI	The ability to grow as a biofilm can facilitate survival of bacteria in the environment and promote infection. To better characterize biofilm formation in the pathogen Clostridium difficile, we established a colony biofilm culture method for this organism on a polycarbonate filter, and analyzed the matrix and the cells in biofilms from a variety of clinical isolates over several days of biofilm culture. We found that biofilms readily formed in all strains analyzed, and that spores were abundant within about 6 days. We also found that extracellular DNA (eDNA), polysaccharide and protein was readily detected in the matrix of all strains, including the major toxins A and/or B, in toxigenic strains. All the strains we analyzed formed spores. Apart from strains 630 and VPI10463, which sporulated in the biofilm at relatively low frequencies, the frequencies of biofilm sporulation varied between 46 and 65%, suggesting that variations in sporulation levels among strains is unlikely to be a major factor in variation in the severity of disease. Spores in biofilms also had reduced germination efficiency compared to spores obtained by a conventional sporulation protocol. Transmission electron microscopy revealed that in 3 day-old biofilms, the outermost structure of the spore is a lightly staining coat. However, after 6 days, material that resembles cell debris in the matrix surrounds the spore, and darkly staining granules are closely associated with the spores surface. In 14 day-old biofilms, relatively few spores are surrounded by the apparent cell debris, and the surface-associated granules are present at higher density at the coat surface. Finally, we showed that biofilm cells possess 100-fold greater resistance to the antibiotic metronidazole then do cells cultured in liquid media. Taken together, our data suggest that C. difficile cells and spores in biofilms have specialized properties that may facilitate infection.	[Semenyuk, Ekaterina G.; Laning, Michelle L.; Foley, Jennifer; Johnston, Pehga F.; Knight, Katherine L.; Driks, Adam] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA; [Gerding, Dale N.] Hines Vet Affairs Hosp, Hines, IL USA	Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Driks, A (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA.	adriks@lumc.edu			Falk Foundation; National Institutes of Health [R21AI097934]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050260, R21AI097934] Funding Source: NIH RePORTER	Falk Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants from the Falk Foundation and the National Institutes of Health (R21AI097934) to A.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Buckley AM, 2011, J MED MICROBIOL, V60, P1174, DOI 10.1099/jmm.0.028514-0; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Carter GP, 2010, GUT MICROBES, V1, P58, DOI 10.4161/gmic.1.1.10768; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; CUTTING SM, 1990, MOL BIOL METHODS BAC; Daniel M, 2012, INT J PEDIATR OTORHI, V76, P1416, DOI 10.1016/j.ijporl.2012.06.013; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Dawson LF, 2012, PLOS ONE; De Rezende CLE, 2003, J FOOD SAFETY, V23, P25, DOI 10.1111/j.1745-4565.2003.tb00349.x; DESROSIER JP, 1981, J BACTERIOL, V145, P613, DOI 10.1128/JB.145.1.613-619.1981; Donelli G, 2012, FEMS IMMUNOL MED MIC, V65, P318, DOI 10.1111/j.1574-695X.2012.00962.x; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Earl AM, 2007, J BACTERIOL, V189, P1163, DOI 10.1128/JB.01343-06; Ejrnaes K, 2011, VIRULENCE, V2, P528, DOI 10.4161/viru.2.6.18189; Escobar-Cortes K, 2013, J MICROBIOL METH, V93, P25, DOI 10.1016/j.mimet.2013.01.016; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; GEORGE WL, 1979, J CLIN MICROBIOL, V9, P214; Giorno R, 2007, J BACTERIOL, V189, P691, DOI 10.1128/JB.00921-06; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hookman P, 2009, WORLD J GASTROENTERO, V15, P1554, DOI 10.3748/wjg.15.1554; Johnson PF, INFECT IMMU IN PRESS; Joshi LT, 2012, APPL ENVIRON MICROB, V78, P7671, DOI 10.1128/AEM.01862-12; Kostakioti M., 2013, COLD SPRING HARB PER, V3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; Lee K, 2007, MICROBIOL-SGM, V153, P1693, DOI 10.1099/mic.0.2006/003376-0; LEVETT PN, 1991, J ANTIMICROB CHEMOTH, V27, P55, DOI 10.1093/jac/27.1.55; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Margolis P, 1993, ESTABLISHMENT CELL T; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; McKenney PT, 2010, CURR BIOL, V20, P934, DOI 10.1016/j.cub.2010.03.060; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Merritt JH, 2011, GROWING ANAL STATIC, V22; Napoli F, 2010, J IND MICROBIOL BIOT, V37, P603, DOI 10.1007/s10295-010-0707-8; O'Connor J, 2009, GEOJOURNAL LIB, V98, P1, DOI 10.1007/978-1-4020-9949-6_1; Pepin J, 2006, CLIN INFECT DIS, V42, P758, DOI 10.1086/501126; Petrella LA, 2012, CLIN INFECT DIS, V55, P351, DOI 10.1093/cid/cis430; Razaq N, 2007, J INFECT DIS, V196, P1813, DOI 10.1086/523106; REED RW, 1948, CAN J RES E, V26, P317, DOI 10.1139/cjr48e-020; Roland Peter S, 2002, Ear Nose Throat J, V81, P8; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Rybtke Morten T., 2011, Inflammation & Allergy Drug Targets, V10, P141; Sambol SP, 2001, J INFECT DIS, V183, P1760, DOI 10.1086/320736; Steichen CT, 2007, MOL MICROBIOL, V64, P359, DOI 10.1111/j.1365-2958.2007.05658.x; Steinberger RE, 2004, BIOFILMS, V1, P37; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Traag BA, 2010, P NATL ACAD SCI USA, V107, P878, DOI 10.1073/pnas.0911299107; Varga JJ, 2008, INFECT IMMUN, V76, P4944, DOI 10.1128/IAI.00692-08; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Vohra P, 2011, MICROBIOL-SGM, V157, P1343, DOI 10.1099/mic.0.046243-0; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127; Wang ZW, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-30; WARTH AD, 1963, J CELL BIOL, V16, P579, DOI 10.1083/jcb.16.3.579; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; WILCOX MH, 1992, J HOSP INFECT, V22, P85, DOI 10.1016/0195-6701(92)90092-Z; Williams DD, 2004, J BACTERIOL, V186, P566, DOI 10.1128/JB.186.2.566-569.2004; Wright A, 2005, PROTEOMICS, V5, P2443, DOI 10.1002/pmic.200401179	63	73	76	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87757	10.1371/journal.pone.0087757	http://dx.doi.org/10.1371/journal.pone.0087757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498186	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100112
J	Telisinghe, L; Fielding, KL; Malden, JL; Hanifa, Y; Churchyard, GJ; Grant, AD; Charalambous, S				Telisinghe, Lilanganee; Fielding, Katherine L.; Malden, Justin L.; Hanifa, Yasmeen; Churchyard, Gavin J.; Grant, Alison D.; Charalambous, Salome			High Tuberculosis Prevalence in a South African Prison: The Need for Routine Tuberculosis Screening	PLOS ONE			English	Article							POSITIVE PULMONARY TUBERCULOSIS; LOW-INCOME; STRATEGIES; EXPERIENCE; ADMISSION; HIV	Background: Tuberculosis is a major health concern in prisons, particularly where HIV prevalence is high. Our objective was to determine the undiagnosed pulmonary tuberculosis ("undiagnosed tuberculosis") prevalence in a representative sample of prisoners in a South African prison. In addition we investigated risk factors for undiagnosed tuberculosis, to explore if screening strategies could be targeted to high risk groups, and, the performance of screening tools for tuberculosis. Methods and Findings: In this cross-sectional survey, male prisoners were screened for tuberculosis using symptoms, chest radiograph (CXR) and two spot sputum specimens for microscopy and culture. Anonymised HIV antibody testing was performed on urine specimens. The sensitivity, specificity and predictive values of symptoms and investigations were calculated, using Mycobacterium tuberculosis isolated on sputum culture as the gold standard. From September 2009 to October 2010, 1046 male prisoners were offered enrolment to the study. A total of 981 (93.8%) consented (median age was 32 years; interquartile range [IQR] 27-37 years) and were screened for tuberculosis. Among 968 not taking tuberculosis treatment and with sputum culture results, 34 (3.5%; 95% confidence interval [CI] 2.4-4.9%) were culture positive for Mycobacterium tuberculosis. HIV prevalence was 25.3% (242/957; 95% CI 22.6-28.2%). Positive HIV status (adjusted odds ratio [aOR] 2.0; 95% CI 1.0-4.2) and being an ex-smoker (aOR 2.6; 95% CI 1.2-5.9) were independently associated with undiagnosed tuberculosis. Compared to the gold standard of positive sputum culture, cough of any duration had a sensitivity of 35.3% and specificity of 79.6%. CXR was the most sensitive single screening modality (sensitivity 70.6%, specificity 92.2%). Adding CXR to cough of any duration gave a tool with sensitivity of 79.4% and specificity of 73.8%. Conclusions: Undiagnosed tuberculosis and HIV prevalence was high in this prison, justifying routine screening for tuberculosis at entry into the prison, and intensified case finding among existing prisoners.	[Telisinghe, Lilanganee; Malden, Justin L.; Hanifa, Yasmeen; Churchyard, Gavin J.; Charalambous, Salome] Aurum Inst, Johannesburg, South Africa; [Telisinghe, Lilanganee; Malden, Justin L.; Hanifa, Yasmeen; Churchyard, Gavin J.] Univ KwaZulu Natal, CAPRISA, Durban, South Africa; [Fielding, Katherine L.; Churchyard, Gavin J.; Grant, Alison D.] London Sch Hyg & Trop Med, London WC1, England; [Charalambous, Salome] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	University of Kwazulu Natal; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand	Telisinghe, L (corresponding author), Aurum Inst, Johannesburg, South Africa.	lily.telisinghe@phe.gov.uk	Harding, Richard/G-9729-2012	HANIFA, YASMEEN/0000-0002-1677-0697; Charalambous, Salome/0000-0001-7143-1009; Churchyard, Gavin/0000-0002-4269-3699	Department of Health and Human Services/Centers for Disease Control and Prevention (CDC) [PS024055]; National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP); Medical Research Council [MR/K012126/1] Funding Source: researchfish; National Institute for Health Research [ACF-2012-25-011] Funding Source: researchfish; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U62PS024055] Funding Source: NIH RePORTER	Department of Health and Human Services/Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Subjects in this study were enrolled in treatment programmes supported by the U.S. President's Emergency Plan for AIDS Relief and by Cooperative Agreement Number PS024055 from the Department of Health and Human Services/Centers for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP). The content of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe DS, 2011, INT J TUBERC LUNG D, V15, P668, DOI 10.5588/ijtld.10.0363; Al-Darraji HAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073717; Andrews JR, 2012, AIDS, V26, P987, DOI 10.1097/QAD.0b013e3283522d47; [Anonymous], 1901, PRISONS RULES LOCAL, P4; [Anonymous], 2011, GUID INT TUB CAS FIN; Banda HT, 2009, INT J TUBERC LUNG D, V13, P1557; Banu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010759; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P250; Churchyard GJ, 2012, CROI C WASH; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Corbett EL, 2010, B WORLD HEALTH ORGAN, V88, P13, DOI 10.2471/BLT.08.055467; Den Boon S, 2008, EPIDEMIOL INFECT, V136, P1342, DOI 10.1017/S0950268807000106; Department of Correctional Services - Republic of South Africa, 2011, DEP CORR SERV ANN RE; Department of Health (South Africa), 2013, S AFR ANT TREATM GUI; Department of Health South Africa, 2004, S AFR NAT TUB CONTR; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Dorman SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043307; Fournet N, 2006, PUBLIC HEALTH, V120, P976, DOI 10.1016/j.puhe.2006.06.004; Gow J, 2004, INT C AIDS; Habeenzu C, 2007, INT J TUBERC LUNG D, V11, P1216; Kimerling Michael E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Koffi N, 1997, INT J TUBERC LUNG D, V1, P250; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Layton MC, 1997, AM J PUBLIC HEALTH, V87, P1335, DOI 10.2105/AJPH.87.8.1335; Legrand J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002100; Leung CC, 2005, INT J TUBERC LUNG D, V9, P627; Maxim Biomedical Inc, 2009, ENZ IMM DET ANT HUM; Melchers NVSV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053644; Noeske J, 2006, East Afr Med J, V83, P25; Noeske J, 2011, INT J TUBERC LUNG D, V15, P223; Nyangulu DS, 1997, LANCET, V350, P1284, DOI 10.1016/S0140-6736(97)05023-X; Pillay M, 2003, 34 WORLD C LUNG HLTH; Puisis M, 1996, PUBLIC HEALTH REP, V111, P330; Rieder HL, 1997, INT J TUBERC LUNG D, V1, P339; Sanchez A, 2005, INT J TUBERC LUNG D, V9, P633; Sanchez A, 2009, INT J TUBERC LUNG D, V13, P1247; Tuberculosis Coalition for Technical Assistance and International Committee of the Red Cross, 2009, GUID CONTR TUB PRIS; UNAIDS, 2009, EP FACT SHEET HIV AD; United Nations Office on Drugs and Crime, 2006, HIV AIDS PREV CAR TR; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Walmsley R, 2011, WORLD PRISON POPULAT; Ward HA, 2004, INT J TUBERC LUNG D, V8, P593; WHO, 2011, WHO GLOBAL TUBERCULO; Winetsky DE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001348; World Health Organization, 2008, JOINT WHO HIV AIDS T; World Health Organization, 2007, STAT PAP TUB PRIS	48	57	59	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87262	10.1371/journal.pone.0087262	http://dx.doi.org/10.1371/journal.pone.0087262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302PJ	24498059	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000330617100070
J	Kilander, MBC; Petersen, J; Andressen, KW; Ganji, RS; Levy, FO; Schuster, J; Dahl, N; Bryja, V; Schulte, G				Kilander, Michaela B. C.; Petersen, Julian; Andressen, Kjetil Wessel; Ganji, Ranjani Sri; Levy, Finn Olav; Schuster, Jens; Dahl, Niklas; Bryja, Vitezslav; Schulte, Gunnar			Disheveled regulates precoupling of heterotrimeric G proteins to Frizzled 6	FASEB JOURNAL			English	Article						GPCR; WNT-5A; GNAI1; GNAQ	COUPLED-RECEPTOR ACTIVATION; F9 TERATOCARCINOMA CELLS; C-TERMINAL REGION; LIVING CELLS; ADRENERGIC-RECEPTOR; SIGNALING PATHWAYS; WNT/BETA-CATENIN; PLASMA-MEMBRANE; RAT FRIZZLED-1; WNT	Frizzleds (FZDs) are classified as G-protein-coupling receptors, but how signals are initiated and specified through heterotrimeric G proteins is unknown. FZD(6) regulates convergent extension movements, and its C-terminal Arg511Cys mutation causes nail dysplasia in humans. We investigated the functional relationship between FZD(6), Disheveled (DVL), and heterotrimeric G proteins. Live cell imaging combined with fluorescence recovery after photobleaching (FRAP) revealed that inactive human FZD(6) precouples to G(i1) and G(q) but not to G(oA),G(s), and G(12) proteins. G-protein coupling is measured as a 10-20% reduction in the mobile fraction of fluorescently tagged G proteins on chemical receptor surface cross-linking. The FZD(6) Arg511Cys mutation is incapable of G-protein precoupling, even though it still binds DVL. Using both FRAP and Forster resonance energy transfer (FRET) technology, we showed that the FZD(6)-G(i1) and FZD-G(q) complexes dissociate on WNT-5A stimulation. Most important, G-protein precoupling of FZD(6) and WNT-5A-induced signaling to extracellular signal-regulated kinase1/2 were impaired by DVL knockdown or overexpression, arguing for a strict dependence of FZD(6)-G-protein coupling on DVL levels and identifying DVL as a master regulator of FZD/G-protein signaling. In summary, we propose a mechanistic connection between DVL and G proteins integrating WNT, FZD, G-protein, and DVL function.Kilander, M. B. C., Petersen, J., Andressen, K. W., Ganji, R. S. Levy, F. O., Schuster, J., Dahl N., Bryja, V., Schulte, G. Disheveled regulates precoupling of heterotrimeric G proteins to Frizzled 6.	[Kilander, Michaela B. C.; Petersen, Julian; Schulte, Gunnar] Karolinska Inst, Sect Receptor Biol & Signaling, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Andressen, Kjetil Wessel; Levy, Finn Olav] Univ Oslo, Inst Clin Med, Dept Pharmacol, Oslo, Norway; [Andressen, Kjetil Wessel; Levy, Finn Olav] Oslo Univ Hosp, Oslo, Norway; [Andressen, Kjetil Wessel; Levy, Finn Olav] Univ Oslo, Fac Med, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Andressen, Kjetil Wessel; Levy, Finn Olav] Univ Oslo, Fac Med, Ctr Heart Failure Res, Oslo, Norway; [Ganji, Ranjani Sri; Bryja, Vitezslav; Schulte, Gunnar] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Schuster, Jens; Dahl, Niklas] Uppsala Univ, Dept Immunol Genet & Pathol, Biomedicinskt Ctr BMC, Uppsala, Sweden; [Bryja, Vitezslav] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, Prague, Czech Republic	Karolinska Institutet; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Masaryk University Brno; Uppsala University; Czech Academy of Sciences	Schulte, G (corresponding author), Karolinska Inst, Sect Receptor Biol & Signaling, Dept Physiol & Pharmacol, Nanna Svartz Vag 2, S-17177 Stockholm, Sweden.	gunnar.schulte@ki.se	Ganji, Ranjani/AGD-5702-2022; Bryja, Vítězslav/P-4217-2019; Bryja, Vít?zslav/H-1925-2014; Schuster, Jens/D-2005-2010; Petersen, Julian/ABE-6060-2021	Bryja, Vítězslav/0000-0002-9136-5085; Bryja, Vít?zslav/0000-0002-9136-5085; Schuster, Jens/0000-0002-4383-9880; Petersen, Julian/0000-0002-7444-0610; Schulte, Gunnar/0000-0002-2700-7013; Andressen, Kjetil Wessel/0000-0003-1094-1501; Kilander, Michaela/0000-0001-5166-4614	Karolinska Institutet; Swedish Research Council [K2008-68P-20810-01-4, K2008-333 68X-20805-01-4, K2012-67X-20805-05-3]; Swedish Cancer Society [CAN 2008/539, 2011/690]; Knut and Alice Wallenberg Foundation [KAW2008.0149]; Board of Doctoral Education at Karolinska Institutet; Engkvist's Foundations; Foundation Lars Hiertas Minne; Swedish Royal Academy of Sciences/Foundation Hierta-Retzius Fond; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Czech Science Foundation [204/09/H058, 204/09/0498, 13-32990S]; Ministry of Education, Youth and Sports of The Czech Republic [MSM0021622430]; Program KI-MU - European Social Fund [CZ.1.07/2.3.00/20.0180]; state budget of the Czech Republic	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Board of Doctoral Education at Karolinska Institutet; Engkvist's Foundations; Foundation Lars Hiertas Minne; Swedish Royal Academy of Sciences/Foundation Hierta-Retzius Fond; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of The Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Program KI-MU - European Social Fund; state budget of the Czech Republic	The authors thank Madelon M. Maurice (University Medical Center, Utrecht, The Netherlands), Robert J. Lefkowitz (Duke University Medical Center, Durham, NC, USA), Randall T. Moon (University of Washington School of Medicine, Seattle, WA, USA), Jyrki Kukkonen (Turku University Hospital, Turku, Finland), Mark Rasenick (University of Chicago, Chicago, IL, USA), Nevin A. Lambert (Georgia Health Sciences University, Augusta, GA, USA), and Zsolt Lenkei (Ecole Superieure de Physique et Chimie Industrielle-Paristech, Paris, France) for reagents. The work was supported by grants from Karolinska Institutet, the Swedish Research Council (K2008-68P-20810-01-4, K2008-333 68X-20805-01-4, and K2012-67X-20805-05-3), the Swedish Cancer Society (CAN 2008/539, 2011/690), the Knut and Alice Wallenberg Foundation (KAW2008.0149), the Board of Doctoral Education at Karolinska Institutet (to M. B. C. K. and J. P.), Engkvist's Foundations, Foundation Lars Hiertas Minne, Swedish Royal Academy of Sciences/Foundation Hierta-Retzius Fond, the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), the Czech Science Foundation (204/09/H058, 204/09/0498, and 13-32990S), the Ministry of Education, Youth and Sports of The Czech Republic (MSM0021622430), and the Program KI-MU (CZ.1.07/2.3.00/20.0180), cofinanced by the European Social Fund and the state budget of the Czech Republic. The authors declare no conflicts of interest.	Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Ayoub Mohammed Akli, 2012, Front Endocrinol (Lausanne), V3, P82, DOI 10.3389/fendo.2012.00082; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Bryja V, 2008, EMBO REP, V9, P1244, DOI 10.1038/embor.2008.193; Cui CY, 2013, J INVEST DERMATOL, V133, P1990, DOI 10.1038/jid.2013.84; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Frojmark AS, 2011, AM J HUM GENET, V88, P852, DOI 10.1016/j.ajhg.2011.05.013; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gayen S, 2013, MOLECULES, V18, P8579, DOI 10.3390/molecules18078579; Halleskog C, 2013, CELL SIGNAL, V25, P822, DOI 10.1016/j.cellsig.2012.12.006; Halleskog C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-111; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2009, N-S ARCH PHARMACOL, V379, P435, DOI 10.1007/s00210-008-0383-7; Katanaev V. L., 2009, NAT PREC; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kilander MBC, 2011, ACTA PHYSIOL, V203, P363, DOI 10.1111/j.1748-1716.2011.02324.x; Kilander MBC, 2011, CELL SIGNAL, V23, P550, DOI 10.1016/j.cellsig.2010.11.004; Koval A, 2011, BIOCHEM PHARMACOL, V82, P1311, DOI 10.1016/j.bcp.2011.06.005; Koval A, 2011, BIOCHEM J, V433, P435, DOI 10.1042/BJ20101878; Liu T, 1999, J BIOL CHEM, V274, P33539, DOI 10.1074/jbc.274.47.33539; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Malbon CC, 2011, BIOCHEM J, V434, P575; Malbon CC, 2001, BIOCHEM BIOPH RES CO, V287, P589, DOI 10.1006/bbrc.2001.5630; Malbon Craig C, 2011, Biochem J, V433, pe3, DOI 10.1042/BJ20102111; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; NEUBIG RR, 1988, BIOCHEMISTRY-US, V27, P2374, DOI 10.1021/bi00407a019; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Vasquez C, 1999, J NEUROSCI, V19, P9271; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352	63	42	42	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2293	2305		10.1096/fj.13-246363	http://dx.doi.org/10.1096/fj.13-246363			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24500924				2022-12-25	WOS:000335336000031
J	Hah, YS; Cheon, YH; Lim, HS; Cho, HY; Park, BH; Ka, SO; Lee, YR; Jeong, DW; Kim, HO; Han, MK; Lee, SI				Hah, Young-Sool; Cheon, Yun-Hong; Lim, Hye Song; Cho, Hee Young; Park, Byung-Hyun; Ka, Sun-O; Lee, Young-Rae; Jeong, Dong-Won; Kim, Hyun-Ok; Han, Myung-Kwan; Lee, Sang-Il			Myeloid Deletion of SIRT1 Aggravates Serum Transfer Arthritis in Mice via Nuclear Factor-kappa B Activation	PLOS ONE			English	Article							SUPPRESSES INFLAMMATORY RESPONSES; COLLAGEN-INDUCED ARTHRITIS; BONE DESTRUCTION; OVEREXPRESSION; EXPRESSION; APOPTOSIS	Objective: SIRT1 modulates the acetylation of the p65 subunit of nuclear factor-kappa B (NF-kappa B) and plays a pivotal role in the inflammatory response. This study sought to assess the role of SIRT1 in rheumatoid arthritis (RA) using a myeloid cell-specific SIRT1 knockout (mSIRT1 KO) mouse. Methods: mSIRT1 KO mice were generated using the loxP/Cre recombinase system. K/BxN serum transfer arthritis was induced in mSIRT1 KO mice and age-matched littermate loxP control mice. Arthritis severity was assessed by clinical and pathological scoring. The levels of inflammatory cytokines in the serum and joints were measured by ELISA. Migration, M1 polarization, cytokine production, osteoclastogenesis, and p65 acetylation were assessed in bone marrow-derived monocytes/macrophages (BMMs). Results: mSIRT1 KO mice showed more severe inflammatory arthritis and aggravated pathological findings than control mice. These effects were paralleled by increases in IL-1, TNF-alpha, TRAP-positive osteoclasts, and F4/80(+) macrophages in the ankles of mSIRT1 KO mice. In addition, BMMs from mSIRT1 KO mice displayed hyperacetylated p65 and increased NF-kappa B binding activity when compared to control mice, which resulted in increased M1 polarization, migration, pro-inflammatory cytokine production, and osteoclastogenesis. Conclusion: Our study provides in vivo evidence that myeloid cell-specific deletion of SIRT1 exacerbates inflammatory arthritis via the hyperactivation of NF-kappa B signaling, which suggests that SIRT1 activation may be beneficial in the treatment of inflammatory arthritis.	[Hah, Young-Sool; Cho, Hee Young; Jeong, Dong-Won] Gyeongsang Natl Univ Hosp, Clin Res Inst, Jinju, South Korea; [Cheon, Yun-Hong; Lim, Hye Song; Kim, Hyun-Ok; Lee, Sang-Il] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Jinju, South Korea; [Cheon, Yun-Hong; Lim, Hye Song; Kim, Hyun-Ok; Lee, Sang-Il] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju, South Korea; [Park, Byung-Hyun; Ka, Sun-O] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju, South Korea; [Lee, Young-Rae] Wonkwang Univ, Sch Dent, Dept Oral Biochmistry, Iksan, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ, Sch Med, Dept Microbiol, Chonju, South Korea	Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University; Jeonbuk National University; Wonkwang University; Jeonbuk National University	Han, MK (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Microbiol, Chonju, South Korea.	iamtom@chonbuk.ac.kr; goldgu@gnu.ac.kr		Han, Myung-Kwan/0000-0003-1931-8898	National Research Foundation of Korea; Korean Government [NRF-2011-013-E00020]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2011-013-E00020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Engler A, 2012, ARTHRITIS RHEUM-US, V64, pS189; Hah YS, 2010, ARTHRITIS RHEUM-US, V62, P2313, DOI 10.1002/art.27545; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Kennedy A, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00052; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Lee HS, 2013, ARTHRITIS RHEUM-US, V65, P1776, DOI 10.1002/art.37963; Lee JH, 2009, DIABETES, V58, P344, DOI 10.2337/db07-1795; Lee SM, 2011, DIABETOLOGIA, V54, P1136, DOI 10.1007/s00125-011-2064-1; Lee SI, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3750; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Niederer F, 2011, ANN RHEUM DIS, V70, P1866, DOI 10.1136/ard.2010.148957; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Xie J, 2013, PHARMACOL RES, V67, P60, DOI 10.1016/j.phrs.2012.10.010; Yang H, 2013, J BIOL CHEM IN PRESS; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zainabadi K, 2009, THESIS MIT; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902	20	49	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87733	10.1371/journal.pone.0087733	http://dx.doi.org/10.1371/journal.pone.0087733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498364	gold, Green Submitted, Green Published			2022-12-25	WOS:000330626900110
J	Italiani, P; Mazza, EMC; Lucchesi, D; Cifola, I; Gemelli, C; Grande, A; Battaglia, C; Bicciato, S; Boraschi, D				Italiani, Paola; Mazza, Emilia M. C.; Lucchesi, Davide; Cifola, Ingrid; Gemelli, Claudia; Grande, Alexis; Battaglia, Cristina; Bicciato, Silvio; Boraschi, Diana			Transcriptomic Profiling of the Development of the Inflammatory Response in Human Monocytes In Vitro	PLOS ONE			English	Article							MACROPHAGE ACTIVATION; POLARIZATION; EXPRESSION; PLASTICITY; DIFFERENTIATION; METABOLISM; RESOLUTION; SUBSETS; SYSTEM; BLOOD	Monocytes/macrophages are key players in all phases of physiological and pathological inflammation. To understanding the regulation of macrophage functional differentiation during inflammation, we designed an in vitro model that recapitulates the different phases of the reaction (recruitment, initiation, development, and resolution), based on human primary blood monocytes exposed to sequential changes in microenvironmental conditions. All reaction phases were profiled by transcriptomic microarray analysis. Distinct clusters of genes were identified that are differentially regulated through the different phases of inflammation. The gene sets defined by GSEA analysis revealed that the inflammatory phase was enriched in inflammatory pathways, while the resolution phase comprised pathways related to metabolism and gene rearrangement. By comparing gene clusters differentially expressed in monocytes vs. M1 and vs. M2 macrophages extracted from an in-house created meta-database, it was shown that cells in the model resemble M1 during the inflammatory phase and M2 during resolution. The validation of inflammatory and transcriptional factors by qPCR and ELISA confirmed the transcriptomic profiles in the different phases of inflammation. The accurate description of the development of the human inflammatory reaction provided by this in vitro kinetic model can help in identifying regulatory mechanisms in physiological conditions and during pathological derangements.	[Italiani, Paola; Lucchesi, Davide; Cifola, Ingrid; Battaglia, Cristina; Boraschi, Diana] CNR, Inst Biomed Technol, Pisa, Italy; [Mazza, Emilia M. C.; Gemelli, Claudia; Grande, Alexis; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Battaglia, Cristina] Univ Milan, Dept Med Biotechnol & Translat Med, Segrate, Italy; [Boraschi, Diana] CNR, Inst Prot Biochem, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Universita di Modena e Reggio Emilia; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Italiani, P (corresponding author), CNR, Inst Biomed Technol, Pisa, Italy.	italianipaola@gmail.com	Bicciato, Silvio/C-9825-2009; Mazza, Emilia Maria Cristina/HHZ-8915-2022; BICCIATO, Silvio/J-4466-2019; Grande, Alexis/D-5816-2015; Battaglia, Cristina/E-5166-2017; Boraschi, Diana/AAA-7171-2020	Bicciato, Silvio/0000-0002-1944-7078; Mazza, Emilia Maria Cristina/0000-0003-2424-3640; BICCIATO, Silvio/0000-0002-1944-7078; Grande, Alexis/0000-0003-3319-1707; Battaglia, Cristina/0000-0003-3025-9657; Boraschi, Diana/0000-0002-3953-4056; CIFOLA, INGRID/0000-0003-2819-1171; Lucchesi, Davide/0000-0002-8019-556X	Ministero dell'Istruzione, dell'Universita della Ricerca [Y84HTJ]; Fondo Italiano per la Ricerca di Base [RBAP11T3WB]; Fondazione Cariplo grant	Ministero dell'Istruzione, dell'Universita della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondo Italiano per la Ricerca di Base; Fondazione Cariplo grant(Fondazione Cariplo)	This work was supported by Ministero dell'Istruzione, dell'Universita della Ricerca (PRIN 2007 Y84HTJ) and Fondo Italiano per la Ricerca di Base 2011 (RBAP11T3WB), and by a Fondazione Cariplo grant 2011 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bisognin A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-201; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Laukens D, 2009, CRIT REV EUKAR GENE, V19, P301, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.40; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2011, EUR J IMMUNOL, V41, P1531, DOI 10.1002/eji.201141670; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Ploeger DTA, 2012, IMMUNOBIOLOGY, V217, P299, DOI 10.1016/j.imbio.2011.10.007; Robert C, 2011, IMMUNOBIOLOGY, V216, P1203, DOI 10.1016/j.imbio.2011.07.025; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Stevenson CS, 2006, IN VIVO MODELS INFLA; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor PR, 2003, IMMUNITY, V19, P2, DOI 10.1016/S1074-7613(03)00178-X; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verschoor CP, 2012, METHODS MOL BIOL, V844, P139, DOI 10.1007/978-1-61779-527-5_10; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3	47	54	58	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87680	10.1371/journal.pone.0087680	http://dx.doi.org/10.1371/journal.pone.0087680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498352	Green Submitted, Green Published, gold			2022-12-25	WOS:000330626900098
J	Lakshminarayanan, R; Liu, SP; Li, JG; Nandhakumar, M; Aung, TT; Goh, E; Chang, JYT; Saraswathi, P; Tang, C; Safie, SRB; Lin, LY; Riezman, H; Lei, Z; Verma, CS; Beuerman, RW				Lakshminarayanan, Rajamani; Liu, Shouping; Li, Jianguo; Nandhakumar, Muruganantham; Aung, Thet Tun; Goh, Eunice; Chang, Jamie Ya Ting; Saraswathi, Padhmanaban; Tang, Charles; Safie, Siti Radiah Binte; Lin, Lim Yih; Riezman, Howard; Lei, Zhou; Verma, Chandra S.; Beuerman, Roger W.			Synthetic Multivalent Antifungal Peptides Effective against Fungi	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ANTIMICROBIAL PEPTIDES; CANDIDA-ALBICANS; AMPHOTERICIN-B; UNITED-STATES; YEAST-CELLS; FORCE-FIELD; IN-VITRO; MEMBRANE; DISEASES	Taking advantage of the cluster effect observed in multivalent peptides, this work describes antifungal activity and possible mechanism of action of tetravalent peptide (B4010) which carries 4 copies of the sequence RGRKVVRR through a branched lysine core. B4010 displayed better antifungal properties than natamycin and amphotericin B. The peptide retained significant activity in the presence of monovalent/divalent cations, trypsin and serum and tear fluid. Moreover, B4010 is non-haemolytic and non-toxic to mice by intraperitoneal (200 mg/kg) or intravenous (100 mg/kg) routes. S. cerevisiae mutant strains with altered membrane sterol structures and composition showed hyper senstivity to B4010. The peptide had no affinity for cell wall polysaccharides and caused rapid dissipation of membrane potential and release of vital ions and ATP when treated with C. albicans. We demonstrate that additives which alter the membrane potential or membrane rigidity protect C. albicans from B4010-induced lethality. Calcein release assay and molecular dynamics simulations showed that the peptide preferentially binds to mixed bilayer containing ergosterol over phophotidylcholine-cholesterol bilayers. The studies further suggested that the first arginine is important for mediating peptide-bilayer interactions. Replacing the first arginine led to a 2-4 fold decrease in antifungal activities and reduced membrane disruption properties. The combined in silico and in vitro approach should facilitate rational design of new tetravalent antifungal peptides.	[Lakshminarayanan, Rajamani; Liu, Shouping; Li, Jianguo; Nandhakumar, Muruganantham; Aung, Thet Tun; Goh, Eunice; Chang, Jamie Ya Ting; Saraswathi, Padhmanaban; Safie, Siti Radiah Binte; Lin, Lim Yih; Lei, Zhou; Beuerman, Roger W.] Singapore Eye Res Inst, Singapore, Singapore; [Lakshminarayanan, Rajamani; Liu, Shouping; Lei, Zhou; Beuerman, Roger W.] Duke NUS Grad Med Sch, Dept Neurosci & Behav Disorders, Singapore, Singapore; [Li, Jianguo; Verma, Chandra S.] Bioinformat Inst A STAR, Singapore, Singapore; [Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Riezman, Howard] Univ Geneva, NCCR Chem Biol, Geneva, Switzerland; [Tang, Charles] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Verma, Chandra S.; Beuerman, Roger W.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Verma, Chandra S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); University of Geneva; University of Geneva; Singapore General Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Lakshminarayanan, R (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.	lakshminarayanan.rajamani@seri.com.sg; rwbeuerman@gmail.com	Rajamani, Lakshminarayanan/AAG-5541-2019	Rajamani, Lakshminarayanan/0000-0001-8214-5315; aung, thet/0000-0003-0960-2860; Riezman, Howard/0000-0003-4680-9422	Singapore Ministry of Health's National Medical Research Council [NMRC/TCR/002-SERI/2008, NMRC/NIG/1020/2010]	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	This research is supported by the Singapore Ministry of Health's National Medical Research Council under its Translational Research Innovations in Ocular Surgery (TRIOS) Programme: Defensins project NMRC/TCR/002-SERI/2008 (RWB) and NMRC/NIG/1020/2010 (RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnusch CJ, 2012, J MED CHEM, V55, P1296, DOI 10.1021/jm2014474; Arora R, 2011, CLIN EXP OPHTHALMOL, V39, P434, DOI 10.1111/j.1442-9071.2010.02473.x; Bai Y, 2009, BIOCHEMISTRY-US, V48, P7229, DOI 10.1021/bi900670d; Bals R, 2001, AM J RESP CELL MOL, V25, P21, DOI 10.1165/ajrcmb.25.1.4436; Bassetti M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-21; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Canuto MM, 2002, LANCET INFECT DIS, V2, P550, DOI 10.1016/S1473-3099(02)00371-7; Chongsiriwatana NP, 2011, ANTIMICROB AGENTS CH, V55, P5399, DOI 10.1128/AAC.00578-11; CROSSON CE, 1986, INVEST OPHTH VIS SCI, V27, P464; Diebold Y, 2003, INVEST OPHTH VIS SCI, V44, P4263, DOI 10.1167/iovs.03-0560; Eckert R, 2011, FUTURE MICROBIOL, V6, P635, DOI [10.2217/fmb.11.27, 10.2217/FMB.11.27]; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Falciani C, 2007, CHEM BIOL DRUG DES, V69, P216, DOI 10.1111/j.1747-0285.2007.00487.x; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gaskova D, 1998, YEAST, V14, P1189, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1189::AID-YEA320>3.3.CO;2-B; Giuliani A, 2011, CELL MOL LIFE SCI, V68, P2255, DOI 10.1007/s00018-011-0717-3; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang LC, 2007, CURR EYE RES, V32, P595, DOI 10.1080/02713680701446653; Kelly SL, 1997, FEBS LETT, V400, P80, DOI 10.1016/S0014-5793(96)01360-9; Kindrachuk J, 2011, BIOPOLYMERS, V96, P14, DOI 10.1002/bip.21441; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Knappe D, 2010, ANTIMICROB AGENTS CH, V54, P4003, DOI 10.1128/AAC.00300-10; Koshlukova SE, 1999, J BIOL CHEM, V274, P18872, DOI 10.1074/jbc.274.27.18872; Li J, 2012, BIOCHIM BIOPHYS ACTA, V1828, P1112; Li JG, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4768899; Li XWS, 2003, J BIOL CHEM, V278, P28553, DOI 10.1074/jbc.M300680200; Liu ZG, 2007, CHEMBIOCHEM, V8, P2063, DOI 10.1002/cbic.200700502; Lupi O, 2005, J AM ACAD DERMATOL, V53, P931, DOI 10.1016/j.jaad.2004.10.883; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Mintzer MA, 2012, MOL PHARMACEUT, V9, P342, DOI 10.1021/mp2005033; Mukhopadhyay K, 2002, ANTIMICROB AGENTS CH, V46, P3695, DOI 10.1128/AAC.46.12.3695-3705.2002; Nguyen LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012684; Niederhafner P, 2010, AMINO ACIDS, V39, P1553, DOI 10.1007/s00726-010-0626-z; Nolte FS, 1997, ANTIMICROB AGENTS CH, V41, P196, DOI 10.1128/AAC.41.1.196; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Oh JE, 1999, BIOORGAN MED CHEM, V7, P2985, DOI 10.1016/S0968-0896(99)00247-3; Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; PRASAD R, 1986, BIOCHIM BIOPHYS ACTA, V861, P377, DOI 10.1016/0005-2736(86)90442-6; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Stach M, 2012, MEDCHEMCOMM, V3, P86, DOI 10.1039/c1md00272d; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Tang JX, 2005, AM J PHYSIOL-LUNG C, V289, pL599, DOI 10.1152/ajplung.00061.2005; Tsai CW, 2009, J MOL BIOL, V392, P837, DOI 10.1016/j.jmb.2009.06.071; VACATA V, 1981, BIOCHIM BIOPHYS ACTA, V643, P265, DOI 10.1016/0005-2736(81)90241-8; van der Weerden NL, 2010, J BIOL CHEM, V285, P37513, DOI 10.1074/jbc.M110.134882; Veerman ECI, 2007, J BIOL CHEM, V282, P18831, DOI 10.1074/jbc.M610555200; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; Verwer PEB, 2011, J ANTIMICROB CHEMOTH, V66, P1649, DOI 10.1093/jac/dkr175; Wang Y, 2012, BBA-BIOMEMBRANES, V1818, P1402, DOI 10.1016/j.bbamem.2012.02.017; Welscher YMT, 2008, J BIOL CHEM, V283, P6393, DOI 10.1074/jbc.M707821200; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922; Zhou L, 2011, AMINO ACIDS, V40, P123, DOI 10.1007/s00726-010-0565-8	59	24	25	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87730	10.1371/journal.pone.0087730	http://dx.doi.org/10.1371/journal.pone.0087730			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498363	Green Published, gold			2022-12-25	WOS:000330626900109
J	Landgraf, P; Mikhaylova, M; Macharadze, T; Borutzki, C; Zenclussen, AC; Wahle, P; Kreutz, MR				Landgraf, Peter; Mikhaylova, Marina; Macharadze, Tamar; Borutzki, Corinna; Zenclussen, Ana-Claudia; Wahle, Petra; Kreutz, Michael R.			Binding of Y-P30 to Syndecan 2/3 Regulates the Nuclear Localization of CASK	PLOS ONE			English	Article							SURVIVAL-PROMOTING PEPTIDE; HEPARAN-SULFATE PROTEOGLYCAN; WALLABY MACROPUS-EUGENII; TUMOR-BEARING RATS; CELL-LINES; EXPRESSION; CANCER; CASK/LIN-2; PROTEIN; MATRIX	The survival promoting peptide Y-P30 has documented neuroprotective effects as well as cell survival and neurite outgrowth promoting activity in vitro and in vivo. Previous work has shown that multimerization of the peptide with pleiotrophin (PTN) and subsequent binding to syndecan (SDC) -2 and -3 is involved in its neuritogenic effects. In this study we show that Y-P30 application regulates the nuclear localization of the SDC binding partner Calcium/calmodulin-dependent serine kinase (CASK) in neuronal primary cultures during development. In early development at day in vitro (DIV) 8 when mainly SDC-3 is expressed supplementation of the culture medium with Y-P30 reduces nuclear CASK levels whereas it has the opposite effect at DIV 18 when SDC-2 is the dominant isoform. In the nucleus CASK regulates gene expression via its association with the T-box transcription factor T-brain-1 (Tbr-1) and we indeed found that gene expression of downstream targets of this complex, like the GluN2B NMDA-receptor, exhibits a corresponding down-or up-regulation at the mRNA level. The differential effect of Y-P30 on the nuclear localization of CASK correlates with its ability to induce shedding of the ectodomain of SDC-2 but not -3. shRNA knockdown of SDC-2 at DIV 18 and SDC-3 at DIV 8 completely abolished the effect of Y-P30 supplementation on nuclear CASK levels. During early development a protein knockdown of SDC-3 also attenuated the effect of Y-P30 on axon outgrowth. Taken together these data suggest that Y-P30 can control the nuclear localization of CASK in a SDC-dependent manner.	[Landgraf, Peter; Mikhaylova, Marina; Macharadze, Tamar; Borutzki, Corinna; Kreutz, Michael R.] Leibniz Inst Neurobiol, Res Grp Neuroplast, Magdeburg, Germany; [Zenclussen, Ana-Claudia] Univ Magdeburg, Fac Med, Dept Expt Obstet & Gynaecol, Magdeburg, Germany; [Wahle, Petra] Ruhr Univ Bochum, Fac Biol & Biotechnol, Bochum, Germany	Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Ruhr University Bochum	Kreutz, MR (corresponding author), Leibniz Inst Neurobiol, Res Grp Neuroplast, Magdeburg, Germany.	kreutz@lin-magdeburg.de	Zenclussen, Ana/AAE-8760-2020; Mikhaylova, Marina/AAM-4368-2020; Zenclussen, Ana C/G-2186-2013	Zenclussen, Ana/0000-0003-3544-4552; Mikhaylova, Marina/0000-0001-7646-1346; Zenclussen, Ana C/0000-0003-3544-4552	Deutsche Forschungsgemeinschaft [SFB854 TP7/MRK]; Leibniz Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz Foundation	Supported by the Deutsche Forschungsgemeinschaft (SFB854 TP7/MRK, ACZ) and the Leibniz Foundation (Pakt fur Forschung/MRK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambatipudi K, 2007, COMP BIOCHEM PHYS D, V2, P322, DOI 10.1016/j.cbd.2007.07.001; Ambatipudi K, 2008, MOL IMMUNOL, V45, P690, DOI 10.1016/j.molimm.2007.07.006; Asundi VK, 2003, J NEUROSCI RES, V73, P593, DOI 10.1002/jnr.10699; Basille-Dugay M, 2013, EXP NEUROL, V247, P537, DOI 10.1016/j.expneurol.2013.02.004; Choi S, 2012, BIOCHEM BIOPH RES CO, V417, P1260, DOI 10.1016/j.bbrc.2011.12.120; Cunningham TJ, 1998, J NEUROSCI, V18, P7047; Dash-Wagh S, 2011, MOL CELL NEUROSCI, V48, P195, DOI 10.1016/j.mcn.2011.07.005; de Lima C, 2008, EUR J APPL PHYSIOL, V104, P957, DOI 10.1007/s00421-008-0849-9; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Hsueh YP, 2006, CURR MED CHEM, V13, P1915, DOI 10.2174/092986706777585040; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Karpova A, 2013, CELL, V152, P1119, DOI 10.1016/j.cell.2013.02.002; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Landgraf P, 2004, FASEB J, V18, P225, DOI 10.1096/fj.04-1789fje; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Macharadze T, 2011, NEUROREPORT, V22, P544, DOI 10.1097/WNR.0b013e328348b512; Motoyama JPL, 2007, BIOCHEM BIOPH RES CO, V357, P828, DOI 10.1016/j.bbrc.2007.03.112; Park SY, 2010, ARCH PHARM RES, V33, P247, DOI 10.1007/s12272-010-0210-9; Porter D, 2003, P NATL ACAD SCI USA, V100, P10931, DOI 10.1073/pnas.1932980100; Reizes O, 2006, BIOCHEMISTRY-US, V45, P5703, DOI 10.1021/bi052263h; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Sakurada K, 2010, FORENSIC SCI INT, V194, P80, DOI 10.1016/j.forsciint.2009.10.015; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schittek B, 2012, J INNATE IMMUN, V4, P349, DOI 10.1159/000336844; Schneeberg J, 2009, EUR J PHARMACOL, V616, P81, DOI 10.1016/j.ejphar.2009.05.029; Schulz JG, 2003, J BIOL CHEM, V278, P48651, DOI 10.1074/jbc.M308424200; Stewart GD, 2008, BRIT J CANCER, V99, P126, DOI 10.1038/sj.bjc.6604458; Stranahan AM, 2013, AGEING RES REV; Todorov P, 1996, NATURE, V379, P739, DOI 10.1038/379739a0; Volta M, 2010, BIOCHEM BIOPH RES CO, V391, P1216, DOI 10.1016/j.bbrc.2009.12.043; Wang GS, 2004, NEURON, V42, P113, DOI 10.1016/S0896-6273(04)00139-4; Yano CL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-24	38	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e85924	10.1371/journal.pone.0085924	http://dx.doi.org/10.1371/journal.pone.0085924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498267	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900013
J	Liu, XH; Yang, YT; Sun, ZJ; Chen, J; Ai, J; Dun, C; Fu, ZF; Niu, XF; Guo, XF				Liu, Xiaohui; Yang, Youtian; Sun, Zhaojin; Chen, Jing; Ai, Jun; Dun, Can; Fu, Zhen F.; Niu, Xuefeng; Guo, Xiaofeng			A Recombinant Rabies Virus Encoding Two Copies of the Glycoprotein Gene Confers Protection in Dogs against a Virulent Challenge	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; VACCINE-INDUCED RABIES; CLONED CDNA; ADULT MICE; IMMUNOGENICITY; PATHOGENICITY; APOPTOSIS; CHINA; CELLS; IDENTIFICATION	The rabies virus (RABV) glycoprotein (G) is the principal antigen responsible for the induction of virus neutralizing antibodies (VNA) and is the major modality of protective immunity in animals. A recombinant RABV HEP-Flury strain was generated by reverse genetics to encode two copies of the G-gene (referred to as HEP-dG). The biological properties of HEP-dG were compared to those of the parental virus (HEP-Flury strain). The HEP-dG recombinant virus grew 100 times more efficiently in BHK-21 cell than the parental virus, yet the virulence of the dG recombinant virus in suckling mice was lower than the parental virus. The HEP-dG virus can improve the expression of G-gene mRNA and the G protein and produce more offspring viruses in cells. The amount of G protein revealed a positive relationship with immunogenicity in mice and dogs. The inactivated HEP-dG recombinant virus induced higher levels of VNA and conferred better protection against virulent RABV in mice and dogs than the inactivated parental virus and a commercial vaccine. The protective antibody persisted for at least 12 months. These data demonstrate that the HEP-dG is stable, induces a strong VNA response and confers protective immunity more effectively than the RABV HEP-Flury strain. HEP-dG could be a potential candidate in the development of novel inactivated rabies vaccines	[Liu, Xiaohui; Yang, Youtian; Sun, Zhaojin; Chen, Jing; Ai, Jun; Dun, Can; Niu, Xuefeng; Guo, Xiaofeng] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Fu, Zhen F.] Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Vet Med, Wuhan, Peoples R China; [Fu, Zhen F.; Niu, Xuefeng] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	South China Agricultural University; Huazhong Agricultural University; University System of Georgia; University of Georgia	Guo, XF (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	xfguo@scau.edu.cn		Guo, Xiaofeng/0000-0003-2896-3629	National Nature Science Foundation of China [30671565, 31172322]; High-tech Research Development Plan of China (863 plan) [2006AA10A204]; Special Fund for Agro-scientific Research in the Public Interest [201103032]; Guangdong Province; Ministry of Education [2010A090200083]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); High-tech Research Development Plan of China (863 plan); Special Fund for Agro-scientific Research in the Public Interest; Guangdong Province; Ministry of Education	This study was partially supported by a grant from the National Nature Science Foundation of China (Nos. 30671565 and 31172322) and High-tech Research Development Plan of China (863 plan, Nos. 2006AA10A204) and Special Fund for Agro-scientific Research in the Public Interest (Nos. 201103032) and Research of Guangdong Province and Ministry of Education (No. 2010A090200083). Otherwise no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM G, 1976, P NATL ACAD SCI USA, V73, P1504, DOI 10.1073/pnas.73.5.1504; BALL LA, 1976, P NATL ACAD SCI USA, V73, P442, DOI 10.1073/pnas.73.2.442; Cenna J, 2008, VACCINE, V26, P6405, DOI 10.1016/j.vaccine.2008.08.069; Cleaveland S, 2002, B WORLD HEALTH ORGAN, V80, P304; CONZELMANN KK, 1990, VIROLOGY, V175, P485, DOI 10.1016/0042-6822(90)90433-R; DERBYSHIRE JB, 1984, CAN VET J, V25, P383; DIETZSCHOLD B, 1982, J VIROL, V44, P595, DOI 10.1128/JVI.44.2.595-602.1982; Dodet B, 2001, RABIES CONTROL IN ASIA, P191; ESH JB, 1982, J AM VET MED ASSOC, V180, P1336; Faber M, 2004, P NATL ACAD SCI USA, V101, P16328, DOI 10.1073/pnas.0407289101; Faber M, 2002, J VIROL, V76, P3374, DOI 10.1128/JVI.76.7.3374-3381.2002; Faber M, 2009, ZOONOSES PUBLIC HLTH, V56, P262, DOI 10.1111/j.1863-2378.2008.01215.x; Faber M, 2009, P NATL ACAD SCI USA, V106, P11300, DOI 10.1073/pnas.0905640106; Fehiner-Gardiner C, 2008, J WILDLIFE DIS, V44, P71, DOI 10.7589/0090-3558-44.1.71; Horowitz A, 2010, J IMMUNOL, V185, P2808, DOI 10.4049/jimmunol.1000844; Hosokawa-Muto J, 2006, MICROBIOL IMMUNOL, V50, P187, DOI 10.1111/j.1348-0421.2006.tb03785.x; Inoue K, 2003, J VIROL METHODS, V107, P229, DOI 10.1016/S0166-0934(02)00249-5; Ito N, 2003, MICROBIOL IMMUNOL, V47, P613, DOI 10.1111/j.1348-0421.2003.tb03424.x; Ito N, 2001, J VIROL, V75, P9121, DOI 10.1128/JVI.75.19.9121-9128.2001; Kallel H, 2006, VACCINE, V24, P4856, DOI 10.1016/j.vaccine.2006.03.012; Kammer AR, 2002, HYBRIDOMA HYBRIDOM, V21, P123, DOI 10.1089/153685902317401726; Lay S, 2003, ANN NY ACAD SCI, V1010, P577, DOI 10.1196/annals.1299.108; Li JW, 2012, J VIROL, V86, P3200, DOI 10.1128/JVI.06699-11; Martinez L, 2000, Int J Infect Dis, V4, P222, DOI 10.1016/S1201-9712(00)90114-0; Meng SL, 2007, VIRUS RES, V124, P125, DOI 10.1016/j.virusres.2006.10.011; Minke JM, 2009, VET MICROBIOL, V133, P283, DOI 10.1016/j.vetmic.2008.06.024; Morimoto K, 1998, P NATL ACAD SCI USA, V95, P3152, DOI 10.1073/pnas.95.6.3152; Morimoto K, 2001, VACCINE, V19, P3543, DOI 10.1016/S0264-410X(01)00064-0; Muller T, 2009, ARCH VIROL, V154, P1081, DOI 10.1007/s00705-009-0408-7; Pulmanausahakul R, 2008, J VIROL, V82, P2330, DOI 10.1128/JVI.02327-07; Rupprecht CE, 2008, DEV BIOLOGICALS, V131, P95; Sarmento L, 2006, VIRUS RES, V121, P144, DOI 10.1016/j.virusres.2006.05.002; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Sugiyama M, 2007, COMP IMMUNOL MICROB, V30, P273, DOI 10.1016/j.cimid.2007.05.007; Takayama-Ito M, 2006, VIRUS RES, V115, P169, DOI 10.1016/j.virusres.2005.08.004; Takayama-Ito M, 2006, VIRUS RES, V119, P208, DOI 10.1016/j.virusres.2006.01.014; Tan YP, 2010, BIOLOGICALS, V38, P586, DOI 10.1016/j.biologicals.2010.06.001; Tang XC, 2005, EMERG INFECT DIS, V11, P1970, DOI 10.3201/eid1112.050271; TORDO N, 2004, VIRUS TAXONOMY, P623; Wagner R.R., 1987, RHABDOVIRUSES, P129; WHETSTONE CA, 1984, J AM VET MED ASSOC, V185, P285; WHO Expert Committee on Biological Standardization, 1985, WHO TECH REP SER, V725, P1; Wirblich C, 2011, J VIROL, V85, P697, DOI 10.1128/JVI.01309-10; World Health Organization (WHO), 2002, WKLY EPIDEMIOL REC, V14, P109; Wu XF, 2008, VIRUS RES, V131, P95, DOI 10.1016/j.virusres.2007.07.018; Yin Z, 1997, ANIMAL VIROLOGY, P329; Zhang YZ, 2005, EMERG INFECT DIS, V11, P1983; Zhao L, 2010, J VIROL, V84, P9642, DOI 10.1128/JVI.00326-10	48	26	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87105	10.1371/journal.pone.0087105	http://dx.doi.org/10.1371/journal.pone.0087105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498294	Green Published, gold, Green Submitted			2022-12-25	WOS:000330626900040
J	Gao, SQ; Pan, X; Cui, QG; Hu, YK; Ye, XH; Dong, M				Gao, Shuqin; Pan, Xu; Cui, Qingguo; Hu, Yukun; Ye, Xuehua; Dong, Ming			Plant Interactions with Changes in Coverage of Biological Soil Crusts and Water Regime in Mu Us Sandland, China	PLOS ONE			English	Article							POSITIVE INTERACTIONS; DRYLAND ECOSYSTEMS; COMPETITION; ESTABLISHMENT; FACILITATION; GERMINATION; SUCCESSION; PRODUCTIVITY; MECHANISMS; VEGETATION	Plant interactions greatly affect plant community structure. Dryland ecosystems are characterized by low amounts of unpredictable precipitation as well as by often having biological soil crusts (BSCs) on the soil surface. In dryland plant communities, plants interact mostly as they compete for water resources, and the direction and intensity of plant interaction varies as a function of the temporal fluctuation in water availability. Since BSCs influence water redistribution to some extent, a greenhouse experiment was conducted to test the hypothesis that the intensity and direction of plant interactions in a dryland plant community can be modified by BSCs. In the experiment, 14 combinations of four plant species (Artemisia ordosica, Artemisia sphaerocephala, Chloris virgata and Setaria viridis) were subjected to three levels of coverage of BSCs and three levels of water supply. The results show that: 1) BSCs affected plant interaction intensity for the four plant species: a 100% coverage of BSCs significantly reduced the intensity of competition between neighboring plants, while it was highest with a 50% coverage of BSCs in combination with the target species of A. sphaerocephala and C. virgata; 2) effects of the coverage of BSCs on plant interactions were modified by water regime when the target species were C. virgata and S. viridis; 3) plant interactions were species-specific. In conclusion, the percent coverage of BSCs affected plant interactions, and the effects were species-specific and could be modified by water regimes. Further studies should focus on effects of the coverage of BSCs on plant-soil hydrological processes.	[Gao, Shuqin; Pan, Xu; Cui, Qingguo; Hu, Yukun; Ye, Xuehua; Dong, Ming] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Dong, Ming] Hangzhou Normal Univ, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou, Zhejiang, Peoples R China; [Pan, Xu; Hu, Yukun] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Hangzhou Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, XH (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	yexuehua@ibcas.ac.cn	Ye, Xuehua/I-3116-2013	Ye, Xuehua/0000-0002-5625-9877	CAS Knowledge Innovation Project [KSCX2-EW-J-1]; National Basic Research Program of China [2010CB951304-2]	CAS Knowledge Innovation Project(Knowledge Innovation Program of the Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China)	This research was founded by CAS Knowledge Innovation Project (KSCX2-EW-J-1) and National Basic Research Program of China (2010CB951304-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas C, 2005, J ECOL, V93, P978, DOI 10.1111/j.1365-2745.2005.01033.x; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Belnap J, 2005, ECOLOGY, V86, P298, DOI 10.1890/03-0567; Belnap J, 2006, HYDROL PROCESS, V20, P3159, DOI 10.1002/hyp.6325; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bowker MA, 2007, RESTOR ECOL, V15, P13, DOI 10.1111/j.1526-100X.2006.00185.x; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Cui Y, 2004, SOILS, V36, P197; Deines L, 2007, PLANT SOIL, V295, P23, DOI 10.1007/s11104-007-9256-y; Dettweiler-Robinson E, 2013, J ARID ENVIRON, V94, P96, DOI 10.1016/j.jaridenv.2013.01.013; Ehleringer JR, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P347; Gao SQ, 2010, J PLANT ECOL, V3, P279, DOI 10.1093/jpe/rtq015; Graff P, 2007, ECOLOGY, V88, P188, DOI 10.1890/0012-9658(2007)88[188:SIPANP]2.0.CO;2; Holmgren M, 1997, ECOLOGY, V78, P1966; Holzapfel C, 1999, ECOLOGY, V80, P1747, DOI 10.2307/176564; Huang ZY, 1998, J ARID ENVIRON, V38, P27, DOI 10.1006/jare.1997.0329; Langhans TM, 2009, FLORA, V204, P157, DOI 10.1016/j.flora.2008.01.001; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Li SL, 2011, J ECOL, V99, P610, DOI 10.1111/j.1365-2745.2010.01777.x; Li XR, 2005, PLANT SOIL, V277, P375, DOI 10.1007/s11104-005-8162-4; Li XR, 2001, J ARID ENVIRON, V47, P271, DOI 10.1006/jare.2000.0707; Loik ME, 2004, OECOLOGIA, V141, P269, DOI 10.1007/s00442-004-1570-y; Lortie CJ, 2008, OIKOS, V117, P1511, DOI 10.1111/j.0030-1299.2008.16664.x; Maestre FT, 2011, J ARID ENVIRON, V75, P1282, DOI 10.1016/j.jaridenv.2010.12.008; McCluney KE, 2012, BIOL REV, V87, P563, DOI 10.1111/j.1469-185X.2011.00209.x; Oksanen L, 2006, OIKOS, V112, P149, DOI 10.1111/j.0030-1299.2006.13379.x; Pendleton RL, 2003, ARID LAND RES MANAG, V17, P271, DOI 10.1080/15324980301598; Potvin C, 2009, ECOLOGY, V90, P321, DOI 10.1890/08-0353.1; Pugnaire FI, 1996, ECOLOGY, V77, P1420, DOI 10.2307/2265539; Rodriguez-Iturbe I, 1999, WATER RESOUR RES, V35, P3709, DOI 10.1029/1999WR900255; ROUGHGARDEN J., 1986, COMMUNITY ECOLOGY, P333; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Sher AA, 2004, OECOLOGIA, V141, P353, DOI 10.1007/s00442-003-1435-9; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; VANANDEL J, 1993, ACTA BOT NEERL, V42, P413; Weigelt A, 2002, BASIC APPL ECOL, V3, P85, DOI 10.1078/1439-1791-00080; Yang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034597; Zhang X., 1994, ACTA ECOL SIN, V18, P1, DOI DOI 10.1111/1365-2745.12089	41	6	9	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87713	10.1371/journal.pone.0087713	http://dx.doi.org/10.1371/journal.pone.0087713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498173	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900157
J	Guo, MJ; Sun, Y; Zhang, Y; Bughio, S; Dai, XH; Ren, WL; Wang, LP				Guo, Mengjie; Sun, Yong; Zhang, Yu; Bughio, Shamsuddin; Dai, Xiaohua; Ren, Weilong; Wang, Liping			E. coli Infection Modulates the Pharmacokinetics of Oral Enrofloxacin by Targeting P-Glycoprotein in Small Intestine and CYP450 3A in Liver and Kidney of Broilers	PLOS ONE			English	Article							ABC TRANSPORTERS; EPITHELIAL-CELLS; GENE-EXPRESSION; LIPOPOLYSACCHARIDE; CIPROFLOXACIN; MRP2; ACTIVATION; PLASMA; MILK; MICE	P-glycoprotein (P-gp) expression determines the absorption, distribution, metabolism and excretion of many drugs in the body. Also, up-regulation of P-gp acts as a defense mechanism against acute inflammation. This study examined expression levels of abcb1 mRNA and localization of P-gp protein in the liver, kidney, duodenum, jejunum and ileum in healthy and E. coli infected broilers by real time RT-PCR and immunohistochemistry. Meanwhile, pharmacokinetics of orally administered enrofloxacin was also investigated in healthy and infected broilers by HPLC. The results indicated that E. coli infection upregulated expression of abcb1 mRNA levels significantly in the kidney, jejunum and ileum (P, 0.05), but not significantly in the liver and duodenum (P>0.05). However, the expression level of CYP 3A37 mRNA were observed significantly decreased only in liver and kidney of E. coli infected broilers (P<0.05) compared with healthy birds. Furthermore, the infection reduced absorption of orally administered enrofloxacin, significantly decreased C-max (0.34 vs 0.98 mu g mL(-1), P = 0.000) and AUC(0-12h) (4.37 vs 8.88 mu g mL(-1) h, P = 0.042) of enrofloxacin, but increased T-max (8.32 vs 3.28 h, P = 0.040), T-1/2a(2.66 vs 1.64 h 21, P = 0.050) and V/F (26.7 vs 5.2 L, P = 0.040). Treatment with verapamil, an inhibitor of P-gp, significantly improved the absorption of enrofloxacin in both healthy and infected broilers. The results suggest that the E. coli infection induces intestine P-gp expression, altering the absorption of orally administered enrofloxacin in broilers.	[Guo, Mengjie; Sun, Yong; Zhang, Yu; Bughio, Shamsuddin; Dai, Xiaohua; Ren, Weilong; Wang, Liping] Nanjing Agr Univ, Lab Vet Pharmacol & Toxicol, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Dai, Xiaohua] Xinjiang Agr Univ, Coll Food Sci & Pharm, Urumqi, Peoples R China	Nanjing Agricultural University; Xinjiang Agricultural University	Wang, LP (corresponding author), Nanjing Agr Univ, Lab Vet Pharmacol & Toxicol, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	wlp71@163.com			National Natural Science Foundation of China [30972220]; Natural Science Foundation of Jiangsu Province of China [BK2012771]; Fundamental Research Funds for the Central Universities [KYZ201105]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The study was supported in part by the National Natural Science Foundation of China (No. 30972220), Natural Science Foundation of Jiangsu Province of China (No. BK2012771), the Fundamental Research Funds for the Central Universities (KYZ201105), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bataineh MM, 2012, J VET PHARMACOL THER, V35, P209, DOI 10.1111/j.1365-2885.2011.01309.x; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Bregante MA, 1999, AM J VET RES, V60, P1111; Bugyei K, 1999, CAN J VET RES, V63, P193; Cherrington NJ, 2004, DRUG METAB DISPOS, V32, P734, DOI 10.1124/dmd.32.7.734; Cox DS, 2002, J PHARMACOL EXP THER, V302, P1096, DOI 10.1124/jpet.102.035436; Cox SK, 2004, J VET PHARMACOL THER, V27, P139, DOI 10.1111/j.1365-2885.2004.00560.x; Crowe A, 2012, EUR J PHARMACOL, V689, P204, DOI 10.1016/j.ejphar.2012.05.047; Elferink MGL, 2004, AM J PHYSIOL-GASTR L, V287, pG1008, DOI 10.1152/ajpgi.00071.2004; Elmas M, 2001, CAN J VET RES, V65, P64; Ghose R, 2011, DRUG METAB DISPOS, V39, P874, DOI 10.1124/dmd.110.037382; Ghose R, 2009, ARCH BIOCHEM BIOPHYS, V481, P123, DOI 10.1016/j.abb.2008.10.003; Guo MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074150; Haritova AM, 2008, AVIAN PATHOL, V37, P465, DOI 10.1080/03079450802272945; Hawkins BT, 2010, J CEREBR BLOOD F MET, V30, P1593, DOI 10.1038/jcbfm.2010.117; Idowu OR, 2004, J PHARMACEUT BIOMED, V35, P143, DOI 10.1016/j.jpba.2004.01.006; Lee CGL, 2000, FASEB J, V14, P516, DOI 10.1096/fasebj.14.3.516; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Li RJ, 2011, COMP BIOCHEM PHYS A, V160, P200, DOI 10.1016/j.cbpa.2011.06.001; Lin JH, 2003, CLIN PHARMACOKINET, V42, P59, DOI 10.2165/00003088-200342010-00003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKellar QA, 1996, J VET PHARMACOL THER, V19, P331, DOI 10.1111/j.1365-2885.1996.tb00062.x; Molento MB, 2004, PARASITOL RES, V92, P121, DOI 10.1007/s00436-003-1022-3; Moriguchi J, 2007, EUR J PHARMACOL, V565, P220, DOI 10.1016/j.ejphar.2007.02.058; Ourlin JC, 2000, ARCH BIOCHEM BIOPHYS, V373, P375, DOI 10.1006/abbi.1999.1566; Panwala CM, 1998, J IMMUNOL, V161, P5733; Post LO, 2003, J PHARMACOL EXP THER, V304, P889, DOI 10.1124/jpet.102.042416; Pulido MM, 2006, J VET PHARMACOL THER, V29, P279, DOI 10.1111/j.1365-2885.2006.00744.x; Quesnell RR, 2007, AM J PHYSIOL-CELL PH, V292, pC305, DOI 10.1152/ajpcell.00567.2005; Raviv Y, 2000, FASEB J, V14, P511, DOI 10.1096/fasebj.14.3.511; Rigor RR, 2010, J CEREBR BLOOD F MET, V30, P1373, DOI 10.1038/jcbfm.2010.21; Russel FGM, 2010, ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, P27, DOI 10.1007/978-1-4419-0840-7_2; Schrickx JA, 2008, EUR J PHARMACOL, V585, P510, DOI 10.1016/j.ejphar.2008.03.014; Schwab D, 2003, J MED CHEM, V46, P1716, DOI 10.1021/jm021012t; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Tomita M, 2010, INT J PHARMACEUT, V392, P35, DOI 10.1016/j.ijpharm.2010.03.019; TYCZKOWSKA K, 1989, J CHROMATOGR-BIOMED, V493, P337, DOI 10.1016/S0378-4347(00)82739-5; VANCUTSEM PM, 1990, CORNELL VET, V80, P173; Zhao YL, 2002, BRAIN RES, V956, P246, DOI 10.1016/S0006-8993(02)03546-1	39	21	23	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87781	10.1371/journal.pone.0087781	http://dx.doi.org/10.1371/journal.pone.0087781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498193	Green Submitted, gold, Green Published			2022-12-25	WOS:000330621900171
J	King, IFG; Eddison, M; Kaun, KR; Heberlein, U				King, Ian F. G.; Eddison, Mark; Kaun, Karla R.; Heberlein, Ulrike			EGFR and FGFR Pathways Have Distinct Roles in Drosophila Mushroom Body Development and Ethanol-Induced Behavior	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SENSORY AXON GUIDANCE; N-TERMINAL KINASE; SIGNALING PATHWAY; FACTOR RECEPTOR; GENETIC-ANALYSIS; NERVOUS-SYSTEM; MELANOGASTER; SENSITIVITY; ACTIVATION	Epidermal Growth Factor Receptor (EGFR) signaling has a conserved role in ethanol-induced behavior in flies and mice, affecting ethanol-induced sedation in both species. However it is not known what other effects EGFR signaling may have on ethanol-induced behavior, or what roles other Receptor Tyrosine Kinase (RTK) pathways may play in ethanol induced behaviors. We examined the effects of both the EGFR and Fibroblast Growth Factor Receptor (FGFR) RTK signaling pathways on ethanol-induced enhancement of locomotion, a behavior distinct from sedation that may be associated with the rewarding effects of ethanol. We find that both EGFR and FGFR genes influence ethanol-induced locomotion, though their effects are opposite - EGFR signaling suppresses this behavior, while FGFR signaling promotes it. EGFR signaling affects development of the Drosophila mushroom bodies in conjunction with the JNK MAP kinase basket (bsk), and with the Ste20 kinase tao, and we hypothesize that the EGFR pathway affects ethanol-induced locomotion through its effects on neuronal development. We find, however, that FGFR signaling most likely affects ethanol-induced behavior through a different mechanism, possibly through acute action in adult neurons.	[King, Ian F. G.; Eddison, Mark; Kaun, Karla R.; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	King, IFG (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.	ifking@email.unc.edu		Kaun, Karla/0000-0002-8756-9528; King, Ian/0000-0003-3405-9767; Eddison, Mark/0000-0003-0280-8137	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism [P50 AA017072]; Ruth Kirschstein National Research Service Award fellowship from the National Institute on Drug Abuse [5F32DA19731-3]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA019731] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Ruth Kirschstein National Research Service Award fellowship from the National Institute on Drug Abuse; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (P50 AA017072) to UH. IFGK was supported by a Ruth Kirschstein National Research Service Award fellowship (5F32DA19731-3) from the National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonyak MA, 1998, J BIOL CHEM, V273, P2817, DOI 10.1074/jbc.273.5.2817; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Doroquez D, CRITICAL REV BIOCH M; Dumstrei K, 1998, DEVELOPMENT, V125, P3417; Eddison M, 2011, NEURON, V70, P979, DOI 10.1016/j.neuron.2011.03.030; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Garcia-Alonso L, 2000, NEURON, V28, P741, DOI 10.1016/S0896-6273(00)00150-1; Gelernter J, 2009, HUM GENET, V126, P91, DOI 10.1007/s00439-009-0701-2; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Grigorian M, 2011, DEV BIOL, V353, P105, DOI 10.1016/j.ydbio.2011.02.024; Heberlein U, 2009, NEUROPHARMACOLOGY, V56, P97, DOI 10.1016/j.neuropharm.2008.07.023; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Kapfhamer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050594; Kaun KR, 2012, HUM GENET, V131, P959, DOI 10.1007/s00439-012-1146-6; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Kristiansen LV, 2005, MOL CELL NEUROSCI, V28, P141, DOI 10.1016/j.mcn.2004.09.003; Lanoue BR, 2000, GENOME, V43, P564, DOI 10.1139/gen-43-3-564; Lasek AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022636; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Logan SK, 1997, MOL CELL BIOL, V17, P5784, DOI 10.1128/MCB.17.10.5784; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Michelson AM, 1998, DEV GENET, V22, P212, DOI 10.1002/(SICI)1520-6408(1998)22:3<212::AID-DVG4>3.0.CO;2-9; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Rallis A, 2010, DEV BIOL, V339, P65, DOI 10.1016/j.ydbio.2009.12.016; Reaume CJ, 2006, CURR BIOL, V16, pR623, DOI 10.1016/j.cub.2006.07.042; Rodan AR, 2002, J NEUROSCI, V22, P9490; Rodan AR, 2010, INT REV NEUROBIOL, V91, P25, DOI 10.1016/S0074-7742(10)91002-7; Rothenfluh A, 2002, CURR OPIN NEUROBIOL, V12, P639, DOI 10.1016/S0959-4388(02)00380-X; Scholz H, 2013, CURR TOP BEHAV NEURO, V13, P433, DOI 10.1007/7854_2011_128; Schuckit MA, 2009, J SUBST ABUSE TREAT, V36, pS5, DOI 10.1016/j.jsat.2008.05.012; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; Sepp KJ, 2003, J NEUROSCI, V23, P8221; Simon MA, 2000, CELL, V103, P13, DOI 10.1016/S0092-8674(00)00100-8; Srahna M, 2006, PLOS BIOL, V4, P2076, DOI 10.1371/journal.pbio.0040348; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Tan Y, 2013, CELL REP, V4, P1082, DOI 10.1016/j.celrep.2013.08.007; Tassi E, 1999, J BIOL CHEM, V274, P33287, DOI 10.1074/jbc.274.47.33287; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; Wolf FW, 2002, J NEUROSCI, V22, P11035; Zhu MY, 2005, GENETICS, V170, P767, DOI 10.1534/genetics.104.039750	52	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87714	10.1371/journal.pone.0087714	http://dx.doi.org/10.1371/journal.pone.0087714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498174	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900158
J	Memmel, S; Sukhorukov, VL; Horing, M; Westerling, K; Fiedler, V; Katzer, A; Krohne, G; Flentje, M; Djuzenova, CS				Memmel, Simon; Sukhorukov, Vladimir L.; Hoering, Marcus; Westerling, Katherine; Fiedler, Vanessa; Katzer, Astrid; Krohne, Georg; Flentje, Michael; Djuzenova, Cholpon S.			Cell Surface Area and Membrane Folding in Glioblastoma Cell Lines Differing in PTEN and p53 Status	PLOS ONE			English	Article							SWELLING-ACTIVATED PATHWAYS; FATTY-ACID SYNTHASE; GAIN-OF-FUNCTION; DIELECTRIC-PROPERTIES; GLIOMA-CELLS; T-LYMPHOCYTES; TUMOR-CELLS; CHLORIDE CHANNELS; HSP90 INHIBITORS; EXPRESSION	Glioblastoma multiforme (GBM) is characterized by rapid growth, invasion and resistance to chemo-/radiotherapy. The complex cell surface morphology with abundant membrane folds, microvilli, filopodia and other membrane extensions is believed to contribute to the highly invasive behavior and therapy resistance of GBM cells. The present study addresses the mechanisms leading to the excessive cell membrane area in five GBM lines differing in mutational status for PTEN and p53. In addition to scanning electron microscopy (SEM), the membrane area and folding were quantified by dielectric measurements of membrane capacitance using the single-cell electrorotation (ROT) technique. The osmotic stability and volume regulation of GBM cells were analyzed by video microscopy. The expression of PTEN, p53, mTOR and several other marker proteins involved in cell growth and membrane synthesis were examined by Western blotting. The combined SEM, ROT and osmotic data provided independent lines of evidence for a large variability in membrane area and folding among tested GBM lines. Thus, DK-MG cells (wild type p53 and wild type PTEN) exhibited the lowest degree of membrane folding, probed by the area-specific capacitance C-m = 1.9 mu F/cm(2). In contrast, cell lines carrying mutations in both p53 and PTEN (U373-MG and SNB19) showed the highest C-m values of 3.7-4.0 mu F/cm(2), which corroborate well with their heavily villated cell surface revealed by SEM. Since PTEN and p53 are well-known inhibitors of mTOR, the increased membrane area/folding in mutant GBM lines may be related to the enhanced protein and lipid synthesis due to a deregulation of the mTOR-dependent downstream signaling pathway. Given that membrane folds and extensions are implicated in tumor cell motility and metastasis, the dielectric approach presented here provides a rapid and simple tool for screening the biophysical cell properties in studies on targeting chemo-or radiotherapeutically the migration and invasion of GBM and other tumor types.	[Memmel, Simon; Sukhorukov, Vladimir L.; Hoering, Marcus; Westerling, Katherine] Univ Wurzburg, Lehrstuhl Biotechnol & Biophys, D-97070 Wurzburg, Germany; [Fiedler, Vanessa; Katzer, Astrid; Flentje, Michael; Djuzenova, Cholpon S.] Univ Hosp Wurzburg, Dept Radiat Oncol, Wurzburg, Germany; [Krohne, Georg] Univ Wurzburg, Biozentrum, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Sukhorukov, VL (corresponding author), Univ Wurzburg, Lehrstuhl Biotechnol & Biophys, Hubland, D-97070 Wurzburg, Germany.	sukhorukov@biozentrum.uni-wuerzburg.de; djuzenova@ukw.de	Sukhorukov, Vladimir L/ACO-0333-2022; Katzer, Astrid/GQZ-8457-2022	Horing, Marcus/0000-0002-3651-392X	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto Jiro, 2005, Brain Tumor Pathol, V22, P21, DOI 10.1007/s10014-005-0173-6; ARNOLD WM, 1988, J ELECTROSTAT, V21, P151, DOI 10.1016/0304-3886(88)90027-7; Asami K, 2013, BIOELECTROCHEMISTRY, V92, P14, DOI 10.1016/j.bioelechem.2013.02.003; Asami K, 2011, BIOELECTROCHEMISTRY, V81, P28, DOI 10.1016/j.bioelechem.2011.01.002; BIGNER DD, 1981, J NEUROPATH EXP NEUR, V40, P201, DOI 10.1097/00005072-198105000-00001; BILZER T, 1991, VIRCHOWS ARCH A, V418, P281, DOI 10.1007/BF01600156; BLACK PM, 1982, J NEUROSURG, V56, P62, DOI 10.3171/jns.1982.56.1.0062; Blagosklonny MV, 2000, FASEB J, V14, P1901, DOI 10.1096/fj.99-1078rev; Bliesath J, 2012, CANCER LETT, V322, P113, DOI 10.1016/j.canlet.2012.02.032; Bordey A, 2000, J MEMBRANE BIOL, V176, P31, DOI 10.1007/s002320001073; Bostrom J, 1998, CANCER RES, V58, P29; Catacuzzeno L, 2011, J CELL PHYSIOL, V226, P1926, DOI 10.1002/jcp.22523; Chan KL, 1997, BBA-LIPID LIPID MET, V1349, P182, DOI 10.1016/S0005-2760(97)00092-1; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; Djuzenova CS, 2009, MOL MED REP, V2, P633, DOI 10.3892/mmr_00000149; Drappatz J, 2009, EXPERT REV NEUROTHER, V9, P519, DOI [10.1586/ern.09.10, 10.1586/ERN.09.10]; Duncan CD, 2010, ADVANCED CRIME SCENE PHOTOGRAPHY, P1; Ernest NJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1451, DOI 10.1152/ajpcell.00503.2004; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gascoyne PRC, 2013, ELECTROPHORESIS, V34, P1042, DOI 10.1002/elps.201200496; Gascoyne PRC, 2009, ANAL CHEM, V81, P8878, DOI 10.1021/ac901470z; Gassert E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000623; Giannini C, 1997, BRAIN PATHOL, V7, P785, DOI 10.1111/j.1750-3639.1997.tb01064.x; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gimsa J, 1996, BIOPHYS J, V71, P495, DOI 10.1016/S0006-3495(96)79251-2; Han SI, 2013, ANALYST, V138, P1529, DOI 10.1039/c3an36261b; Hess MW, 2010, METHOD CELL BIOL, V96, P649, DOI 10.1016/S0091-679X(10)96027-5; Hoa N, 2010, J IMMUNOL, V185, P4793, DOI 10.4049/jimmunol.1001526; Hofer S, 2001, J CANCER RES CLIN, V127, P91, DOI 10.1007/s004320000171; Jones T. B., 2005, ELECTROMECHANICS PAR; KENNEDY PGE, 1987, NEUROPATH APPL NEURO, V13, P327, DOI 10.1111/j.1365-2990.1987.tb00190.x; Kiesel M, 2006, BIOPHYS J, V90, P4720, DOI 10.1529/biophysj.105.078725; Knobbe CB, 2003, BRAIN PATHOL, V13, P507; Kraus JA, 2000, J NEURO-ONCOL, V48, P89, DOI 10.1023/A:1006402614838; Kuger S, 2013, TRANSL ONCOL, V6, P169, DOI 10.1593/tlo.12364; Lange K, 2011, J CELL PHYSIOL, V226, P896, DOI 10.1002/jcp.22302; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lei U, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3659282; Li YQ, 2008, CANCER RES, V68, P1723, DOI 10.1158/0008-5472.CAN-07-1963; Machado CML, 2009, MICROSC RES TECHNIQ, V72, P310, DOI 10.1002/jemt.20653; Lucio AD, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041906; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; Mise-Omata S, 2005, BIOCHEM BIOPH RES CO, V328, P1034, DOI 10.1016/j.bbrc.2005.01.066; Niewidok N, 2012, TRANSL ONCOL, V5, P356, DOI 10.1593/tlo.12211; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohira K, 2006, BIOCHEM BIOPH RES CO, V342, P867, DOI 10.1016/j.bbrc.2006.02.033; Pethig R, 2002, ELECTROPHORESIS, V23, P2057, DOI 10.1002/1522-2683(200207)23:13<2057::AID-ELPS2057>3.0.CO;2-X; Quick QA, 2006, J NEUROSURG, V105, P111, DOI 10.3171/jns.2006.105.1.111; Reardon DA, 2008, EXPERT OPIN INV DRUG, V17, P1225, DOI 10.1517/13543784.17.8.1225 ; ROSS PE, 1994, BIOPHYS J, V66, P169, DOI 10.1016/S0006-3495(94)80754-4; RUTKA JT, 1987, ACTA NEUROPATHOL, V75, P92, DOI 10.1007/BF00686798; SCHROEDER TE, 1979, DEV BIOL, V70, P306, DOI 10.1016/0012-1606(79)90030-7; Scott KEN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029761; Shennan DB, 2008, CELL PHYSIOL BIOCHEM, V21, P15, DOI 10.1159/000113743; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Stingl L, 2010, BRIT J CANCER, V102, P1578, DOI 10.1038/sj.bjc.6605683; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; SUKHORUKOV VL, 1994, J MEMBRANE BIOL, V142, P77; Sukhorukov VL, 2009, BBA-BIOMEMBRANES, V1788, P1841, DOI 10.1016/j.bbamem.2009.06.016; Teodori L, 2006, CYTOM PART A, V69A, P75, DOI 10.1002/cyto.a.20208; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; WESTPHAL M, 1988, CANCER RES, V48, P731; Yamanaka R, 2009, ANN NEUROL, V66, P717, DOI 10.1002/ana.21793; Zaguia F, 2011, CANCER BIOL THER, V11, P1, DOI 10.4161/cbt.11.1.14498; Zhao W, 2006, BRIT J CANCER, V95, P869, DOI 10.1038/sj.bjc.6603350	68	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87052	10.1371/journal.pone.0087052	http://dx.doi.org/10.1371/journal.pone.0087052			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498019	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900063
J	Jonsson, AL; Granqvist, A; Elvin, J; Johansson, ME; Haraldsson, B; Nystrom, J				Jonsson, Annika Lindskog; Granqvist, Anna; Elvin, Johannes; Johansson, Martin E.; Haraldsson, Borje; Nystrom, Jenny			Effects of Melanocortin 1 Receptor Agonists in Experimental Nephropathies	PLOS ONE			English	Article							MINIMAL CHANGE DISEASE; ADRIAMYCIN NEPHROPATHY; MOUSE; ACTH; MICE	Nephrotic syndrome, characterized by massive proteinuria, is caused by a large group of diseases including membranous nephropathy (MN) and focal segmental glomerulosclerosis (FSGS). Although the underlying mechanisms are beginning to unravel, therapy is unspecific and far from efficient. It has been suggested that adrenocorticotropic hormone (ACTH) has beneficial effects in patients with MN and possibly in other nephrotic diseases. We have previously reported that ACTH may act directly on podocytes through the melanocortin 1 receptor (MC1R). In the present study, we evaluate the effect of highly specific MC1R agonists in two different nephrotic disease models. Experimental MN: Passive Heymann nephritis (PHN) was induced in rats that were treated for four weeks with MS05, a selective MC1R agonist, or saline. The degree of albuminuria was significantly reduced over time and the effect was sustained one week after treatment withdrawal (p<0.05). Experimental FSGS: Based on a dose-response study, two doses of adriamycin were used for induction of nephropathy in Balb/c mice. Mice were treated with either a synthetic MC1R agonist (BMS-470539), with alpha-melanocyte stimulating hormone (alpha-MSH) or with saline. There was no beneficial effect of treatment. In summary, MC1R agonists reduce albuminuria and improve morphology in experimentally induced MN whereas they have no effect in experimental FSGS. The results illustrate the differences in these podocytopathies in terms of signaling mechanisms underlying proteinuria, and progression of disease.	[Jonsson, Annika Lindskog; Granqvist, Anna; Elvin, Johannes; Haraldsson, Borje] Univ Gothenburg, Dept Mol & Clin Med Nephrol, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden; [Johansson, Martin E.] Lund Univ, SUS Malmo, Dept Lab Med, Ctr Mol Pathol, S-22100 Lund, Sweden; [Nystrom, Jenny] Univ Gothenburg, Sahlgrenska Acad, Dept Physiol, Inst Neurosci & Physiol, Gothenburg, Sweden	University of Gothenburg; Lund University; University of Gothenburg	Jonsson, AL (corresponding author), Univ Gothenburg, Dept Mol & Clin Med Nephrol, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden.	annika.lindskogjonsson@wlab.gu.se	Haraldsson, Borje/B-3871-2010	Haraldsson, Borje/0000-0002-7536-973X	Swedish Medical Research Council grants [9898, 14764]; Vinnova; National Association for Kidney Diseases; John and Brit Wennerstrom Research Foundation; IngaBritt and Arne Lundberg Research Foundation; Gambro AB; Sahlgrenska University Hospital Grant [LUA75450]; Marianne & Marcus Wallenberg Foundation; Malmo Hospital	Swedish Medical Research Council grants(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Vinnova(Vinnova); National Association for Kidney Diseases; John and Brit Wennerstrom Research Foundation; IngaBritt and Arne Lundberg Research Foundation; Gambro AB; Sahlgrenska University Hospital Grant; Marianne & Marcus Wallenberg Foundation; Malmo Hospital	This study was supported by the Swedish Medical Research Council grants 9898 and 14764, Vinnova, the National Association for Kidney Diseases, the John and Brit Wennerstrom Research Foundation, IngaBritt and Arne Lundberg Research Foundation, Gambro AB and Sahlgrenska University Hospital Grant LUA75450 and the Marianne & Marcus Wallenberg Foundation and Malmo Hospital Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck LH, 2010, SEMIN NEPHROL, V30, P635, DOI 10.1016/j.semnephrol.2010.09.011; Berg AL, 1999, KIDNEY INT, V56, P1534, DOI 10.1046/j.1523-1755.1999.00675.x; Berg AL, 2004, NEPHROL DIAL TRANSPL, V19, P1305, DOI 10.1093/ndt/gfh110; Bjornson A, 2005, AM J PHYSIOL-RENAL, V288, pF748, DOI 10.1152/ajprenal.00202.2004; Chugh SS, 2012, AM J KIDNEY DIS, V59, P284, DOI 10.1053/j.ajkd.2011.07.024; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; D'Agati VD, 2012, CURR OPIN NEPHROL HY, V21, P243, DOI 10.1097/MNH.0b013e32835200df; Daehn I, 2011, AM SOC NEPHR ANN M K; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; FARQUHAR MG, 1995, J AM SOC NEPHROL, V6, P35; Guo JC, 2008, J AM SOC NEPHROL, V19, P961, DOI 10.1681/ASN.2007101109; Herpin TF, 2003, J MED CHEM, V46, P1123, DOI 10.1021/jm025600i; Ishimoto T, 2011, SEMIN NEPHROL, V31, P320, DOI 10.1016/j.semnephrol.2011.06.002; Jackson IJ, 2007, HUM MOL GENET, V16, P2341, DOI 10.1093/hmg/ddm191; Jeansson M, 2003, J AM SOC NEPHROL, V14, P1756, DOI 10.1097/01.ASN.0000072742.02714.6E; Kang LY, 2006, J LEUKOCYTE BIOL, V80, P897, DOI 10.1189/jlb.1204748; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Leoni G, 2010, BRIT J PHARMACOL, V160, P171, DOI 10.1111/j.1476-5381.2010.00688.x; Lindskog A, 2010, J AM SOC NEPHROL, V21, P1290, DOI 10.1681/ASN.2009101025; Meyrier A, 2005, NAT CLIN PRACT NEPHR, V1, P44, DOI 10.1038/ncpneph0025; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Ponticelli C, 2006, AM J KIDNEY DIS, V47, P233, DOI 10.1053/j.ajkd.2005.10.016; SALANT DJ, 1988, METHOD ENZYMOL, V162, P421; Sun YBY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055027; Szardenings M, 2000, PEPTIDES, V21, P239, DOI 10.1016/S0196-9781(99)00207-7; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411	31	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87816	10.1371/journal.pone.0087816	http://dx.doi.org/10.1371/journal.pone.0087816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498203	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100117
J	Kaku, Y; Imaoka, H; Morimatsu, Y; Komohara, Y; Ohnishi, K; Oda, H; Takenaka, S; Matsuoka, M; Kawayama, T; Takeya, M; Hoshino, T				Kaku, Yoichiro; Imaoka, Haruki; Morimatsu, Yoshitaka; Komohara, Yoshihiro; Ohnishi, Koji; Oda, Hanako; Takenaka, Shinichi; Matsuoka, Masanobu; Kawayama, Tomotaka; Takeya, Motohiro; Hoshino, Tomoaki			Overexpression of CD163, CD204 and CD206 on Alveolar Macrophages in the Lungs of Patients with Severe Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; T-CELLS; RECEPTOR; COPD; PHENOTYPE; SMOKERS; MONOCYTES; SMOKING; SPUTUM	We have previously reported that the lungs of patients with very severe chronic obstructive pulmonary disease (COPD) contain significantly higher numbers of alveolar macrophages than those of non-smokers or smokers. M1 and M2 macrophages represent pro-and anti-inflammatory populations, respectively. However, the roles of M1 and M2 alveolar macrophages in COPD remain unclear. Immunohistochemical techniques were used to examine CD163, CD204 and CD206, as M2 markers, expressed on alveolar macrophages in the lungs of patients with mild to very severe COPD (Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage I (mild) n = 11, II (moderate) n = 9, III (severe) n = 2, and IV (very severe) n = 16). Fifteen smokers and 10 non-smokers were also examined for comparison. There were significantly higher numbers of alveolar macrophages in COPD patients than in smokers and non-smokers. The numbers and percentages of CD163(+), CD204(+) or CD206(+) alveolar macrophages in patients with COPD at GOLD stages III and IV were significantly higher than in those at GOLD stages I and II, and those in smokers and non-smokers. In patients with COPD, there was a significant negative correlation between the number of CD163(+), CD204(+) or CD206(+) alveolar macrophages and the predicted forced expiratory volume in one second. Overexpression of CD163, CD204 and CD206 on lung alveolar macrophages may be involved in the pathogenesis of COPD.	[Kaku, Yoichiro; Imaoka, Haruki; Morimatsu, Yoshitaka; Oda, Hanako; Takenaka, Shinichi; Matsuoka, Masanobu; Kawayama, Tomotaka; Hoshino, Tomoaki] Kurume Univ, Sch Med, Dept Med 1, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 830, Japan; [Komohara, Yoshihiro; Ohnishi, Koji; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto, Japan	Kurume University; Kumamoto University	Imaoka, H (corresponding author), Kurume Univ, Sch Med, Dept Med 1, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 830, Japan.	haruki@med.kurume-u.ac.jp		Ohnishi, Koji/0000-0002-6790-6902	Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Science, Sports, and Culture of Japan [25461201]; Kato Memorial Fund for Incurable Diseases Research (Tokyo, Japan); Kaibara Morikazu Medical Science Promotion Foundation; Allergy Foundation; Takeda Science Foundation (Tokyo, Japan); Grants-in-Aid for Scientific Research [23659204] Funding Source: KAKEN	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kato Memorial Fund for Incurable Diseases Research (Tokyo, Japan); Kaibara Morikazu Medical Science Promotion Foundation(Kaibara Morikazu Medical Science Promotion Foundation); Allergy Foundation; Takeda Science Foundation (Tokyo, Japan)(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan (T. H.), a Grant-in-Aid for Scientific Research (C) (no. 25461201: T. H.) from the Ministry of Education, Science, Sports, and Culture of Japan, Kato Memorial Fund for Incurable Diseases Research (Tokyo, Japan) (T. H.), Kaibara Morikazu Medical Science Promotion Foundation (HI), Allergy Foundation (T. H. and H. I.) and Takeda Science Foundation (Tokyo, Japan) (H. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akila P, 2012, CLIN CHIM ACTA, V413, P669, DOI 10.1016/j.cca.2012.01.028; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Blumenthal RL, 2001, J ALLERGY CLIN IMMUN, V107, P258, DOI 10.1067/mai.2001.112845; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Domagala-Kulawik J, 2003, CHEST, V123, P1054, DOI 10.1378/chest.123.4.1054; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; GOLD, GLOB STRAT DIAGN MAN; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hogger P, 1998, J IMMUNOL, V161, P1883; Hoshino T, 2007, AM J RESP CRIT CARE, V176, P49, DOI 10.1164/rccm.200603-316OC; Imaoka H, 2008, EUR RESPIR J, V31, P287, DOI 10.1183/09031936.00019207; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Komohara Y, 2009, CANCER SCI, V100, P2160, DOI 10.1111/j.1349-7006.2009.01296.x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; Ohar JA, 2010, CHEST, V137, P1098, DOI 10.1378/chest.09-1655; Ohnishi K, 2011, BIOCHEM BIOPH RES CO, V411, P516, DOI 10.1016/j.bbrc.2011.06.161; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; SAETTA M, 1993, AM REV RESPIR DIS, V147, P301, DOI 10.1164/ajrccm/147.2.301; Sakashita N, 2011, PATHOL INT, V61, P306, DOI 10.1111/j.1440-1827.2011.02652.x; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Schonkeren D, 2011, AM J PATHOL, V178, P709, DOI 10.1016/j.ajpath.2010.10.011; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Stanescu D, 1996, THORAX, V51, P267, DOI 10.1136/thx.51.3.267; THEPEN T, 1989, J EXP MED, V170, P499, DOI 10.1084/jem.170.2.499; Thomsen M, 2011, J INTERN MED, V269, P340, DOI 10.1111/j.1365-2796.2010.02308.x; Van den Heuvel MM, 1999, J LEUKOCYTE BIOL, V66, P858, DOI 10.1002/jlb.66.5.858; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144	39	93	99	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87400	10.1371/journal.pone.0087400	http://dx.doi.org/10.1371/journal.pone.0087400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498098	Green Submitted, gold, Green Published			2022-12-25	WOS:000330617100083
J	Lyskowski, A; Gruber, C; Steinkellner, G; Schurmann, M; Schwab, H; Gruber, K; Steiner, K				Lyskowski, Andrzej; Gruber, Christian; Steinkellner, Georg; Schuermann, Martin; Schwab, Helmut; Gruber, Karl; Steiner, Kerstin			Crystal Structure of an (R)-Selective omega-Transaminase from Aspergillus terreus	PLOS ONE			English	Article							AMINO-ACID AMINOTRANSFERASE; SUBSTRATE RECOGNITION; ASYMMETRIC-SYNTHESIS; CHIRAL AMINES; PARACOCCUS-DENITRIFICANS; ENZYME CONTROLS; ACTIVE-SITE; PROTEIN; CRYSTALLIZATION; CLASSIFICATION	Chiral amines are important building blocks for the synthesis of pharmaceutical products, fine chemicals, and agrochemicals. omega-Transaminases are able to directly synthesize enantiopure chiral amines by catalysing the transfer of an amino group from a primary amino donor to a carbonyl acceptor with pyridoxal 5'-phosphate (PLP) as cofactor. In nature, (S)-selective amine transaminases are more abundant than the (R)-selective enzymes, and therefore more information concerning their structures is available. Here, we present the crystal structure of an (R)-omega-transaminase from Aspergillus terreus determined by X-ray crystallography at a resolution of 1.6 angstrom. The structure of the protein is a homodimer that displays the typical class IV fold of PLP-dependent aminotransferases. The PLP-cofactor observed in the structure is present in two states (i) covalently bound to the active site lysine (the internal aldimine form) and (ii) as substrate/product adduct (the external aldimine form) and free lysine. Docking studies revealed that (R)-transaminases follow a dual binding mode, in which the large binding pocket can harbour the bulky substituent of the amine or ketone substrate and the a-carboxylate of pyruvate or amino acids, and the small binding pocket accommodates the smaller substituent.	[Lyskowski, Andrzej; Gruber, Christian; Steinkellner, Georg; Schwab, Helmut; Gruber, Karl; Steiner, Kerstin] Graz Univ Technol, ACIB GmbH, Graz, Austria; [Schuermann, Martin] DSM, Innovat Synth, Geleen, Netherlands; [Schwab, Helmut] Graz Univ Technol, Inst Mol Biotechnol, Graz, Austria; [Gruber, Karl] Graz Univ, Inst Mol Biosci, Graz, Austria	Austrian Centre of Industrial Biotechnology; Graz University of Technology; DSM NV; Graz University of Technology; University of Graz	Lyskowski, A (corresponding author), Graz Univ Technol, ACIB GmbH, Graz, Austria.	andrzej.lyskowski@acib.at; kerstin.steiner@acib.at	Gruber, Christian C/B-3818-2011; Gruber, Karl/GPP-6706-2022	Gruber, Karl/0000-0002-3485-9740; Schwab, Helmut/0000-0003-2746-0624	Federal Ministry of Economy, Family and Youth (BMWFJ); Federal Ministry of Traffic, Innovation and Technology (bmvit); Styrian Business Promotion Agency SFG; Standortagentur Tirol; ZIT - Technology Agency of the City of Vienna through COMET	Federal Ministry of Economy, Family and Youth (BMWFJ); Federal Ministry of Traffic, Innovation and Technology (bmvit); Styrian Business Promotion Agency SFG; Standortagentur Tirol; ZIT - Technology Agency of the City of Vienna through COMET	This work has been supported by the Federal Ministry of Economy, Family and Youth (BMWFJ), the Federal Ministry of Traffic, Innovation and Technology (bmvit) and the Styrian Business Promotion Agency SFG. Additional funding was provided by the Standortagentur Tirol and ZIT - Technology Agency of the City of Vienna through the COMET-Funding Program managed by the Austrian Research Promotion Agency FFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson MJ, 2013, ADV SYNTH CATAL, V355, P1780, DOI 10.1002/adsc.201201030; Abrahamson MJ, 2012, ANGEW CHEM INT EDIT, V51, P3969, DOI 10.1002/anie.201107813; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BALZER D, 1992, NUCLEIC ACIDS RES, V20, P1851, DOI 10.1093/nar/20.8.1851; Breuer M, 2004, ANGEW CHEM INT EDIT, V43, P788, DOI 10.1002/anie.200300599; Carr R, 2005, CHEMBIOCHEM, V6, P637, DOI 10.1002/cbic.200400329; Cassimjee KE, 2011, ACS CATAL, V1, P1051, DOI 10.1021/cs200315h; Denesyuk AI, 2002, J MOL BIOL, V316, P155, DOI 10.1006/jmbi.2001.5310; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fesko K, 2013, J MOL CATAL B-ENZYM, V96, P103, DOI 10.1016/j.molcatb.2013.06.015; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gille C, 2003, BIOINFORMATICS, V19, P2489, DOI 10.1093/bioinformatics/btg354; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Goto M, 2003, BIOCHEMISTRY-US, V42, P3725, DOI 10.1021/bi026722f; Griswold WR, 2011, J AM CHEM SOC, V133, P14823, DOI 10.1021/ja2061006; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hanson RL, 2008, ADV SYNTH CATAL, V350, P1367, DOI 10.1002/adsc.200800084; Hayashi H, 2003, J BIOL CHEM, V278, P9481, DOI 10.1074/jbc.M209235200; Hirotsu K, 2005, CHEM REC, V5, P160, DOI 10.1002/tcr.20042; Hohn M, 2009, CHEMCATCHEM, V1, P42, DOI 10.1002/cctc.200900110; Hohne M, 2010, NAT CHEM BIOL, V6, P807, DOI [10.1038/nchembio.447, 10.1038/NCHEMBIO.447]; Humble MS, 2012, FEBS J, V279, P779, DOI 10.1111/j.1742-4658.2012.08468.x; Ismail H, 2008, ADV SYNTH CATAL, V350, P1511, DOI 10.1002/adsc.200800091; Iwasaki A, 2012, APPL MICROBIOL BIOT, V93, P1563, DOI 10.1007/s00253-011-3580-0; Jang TH, 2010, ACTA CRYSTALLOGR F, V66, P923, DOI 10.1107/S1744309110021573; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koszelewski D, 2010, CHEMCATCHEM, V2, P73, DOI 10.1002/cctc.200900220; Koszelewski D, 2009, ORG LETT, V11, P4810, DOI 10.1021/ol901834x; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Malik MS, 2012, APPL MICROBIOL BIOT, V94, P1163, DOI 10.1007/s00253-012-4103-3; Mathew S, 2012, ACS CATAL, V2, P993, DOI 10.1021/cs300116n; Midelfort KS, 2013, PROTEIN ENG DES SEL, V26, P25, DOI 10.1093/protein/gzs065; Mugford PF, 2008, ANGEW CHEM INT EDIT, V47, P8782, DOI 10.1002/anie.200705159; Mutti FG, 2012, EUR J ORG CHEM, V2012, P1003, DOI 10.1002/ejoc.201101476; Mutti FG, 2011, ADV SYNTH CATAL, V353, P3227, DOI 10.1002/adsc.201100558; Newman J, 2004, ACTA CRYSTALLOGR D, V60, P610, DOI 10.1107/S0907444903029640; Okamoto A, 1998, J MOL BIOL, V280, P443, DOI 10.1006/jmbi.1998.1869; Park ES, 2014, APPL MICROBIOL BIOT, V98, P651, DOI 10.1007/s00253-013-4846-5; Park ES, 2012, APPL MICROBIOL BIOT, V93, P2425, DOI 10.1007/s00253-011-3584-9; Park ES, 2011, ENZYME MICROB TECH, V49, P380, DOI 10.1016/j.enzmictec.2011.06.019; Park E, 2010, ADV SYNTH CATAL, V352, P3391, DOI 10.1002/adsc.201000601; Peisach D, 1998, BIOCHEMISTRY-US, V37, P4958, DOI 10.1021/bi972884d; Percudani R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-273; Rausch C, 2013, PROTEINS, V81, P774, DOI 10.1002/prot.24233; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Sayer C, 2013, ACTA CRYSTALLOGR D, V69, P564, DOI 10.1107/S0907444912051670; Schatzle S, 2011, ADV SYNTH CATAL, V353, P2439, DOI 10.1002/adsc.201100435; Schatzle S, 2009, ANAL CHEM, V81, P8244, DOI 10.1021/ac901640q; Shin JS, 2002, J ORG CHEM, V67, P2848, DOI 10.1021/jo016115i; Steffen-Munsberg F, 2013, CHEMCATCHEM, V5, P154, DOI 10.1002/cctc.201200545; Steffen-Munsberg F, 2013, CHEMCATCHEM, V5, P150, DOI 10.1002/cctc.201200544; SUGIO S, 1995, BIOCHEMISTRY-US, V34, P9661, DOI 10.1021/bi00030a002; Thomsen M, 2013, ACTA CRYSTALLOGR F, V69, P1415, DOI 10.1107/S1744309113030923; Tufvesson P, 2011, BIOTECHNOL BIOENG, V108, P1479, DOI 10.1002/bit.23154; van Ophem PW, 1999, BIOCHEMISTRY-US, V38, P1323, DOI 10.1021/bi982414z; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yennawar NH, 2002, BIOCHEMISTRY-US, V41, P11592, DOI 10.1021/bi020221c; Yun H, 2004, BIOTECHNOL BIOENG, V87, P772, DOI 10.1002/bit.20186	61	48	51	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87350	10.1371/journal.pone.0087350	http://dx.doi.org/10.1371/journal.pone.0087350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498081	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100077
J	Zhang, LM; Liang, SL; Zhang, GJ; Liu, ZZ; Lv, H; Fang, F; Wang, YJ; Zhang, SH; Kang, XX				Zhang, Limin; Liang, Shuli; Zhang, Guojun; Liu, Zhizhong; Lv, Hong; Fang, Fang; Wang, Yajie; Zhang, Shaohui; Kang, Xixiong			Seizure Control of Current Shunt on Rats with Temporal Lobe Epilepsy and Neocortical Epilepsy	PLOS ONE			English	Article							INDUCED FOCAL EPILEPSY; ELECTRICAL-STIMULATION; LONG-TERM; BRAIN-STIMULATION; ANTERIOR NUCLEUS; THALAMUS; SUPPRESSION; EEG	Purpose: To examine the effects of current shunt on rats with temporal lobe epilepsy and neocortex epilepsy. Experimental Design: A kainic acid (KA)-induced model of temporal lobe seizure and a penicillin-induced model of neocortical partial seizure were used in this study. Rats of each model were randomly allocated into two groups: control and model groups. The model group was further divided into the KA or penicillin group, sham conduction group and conduction group. The current shunt was realized through the implantation of a customized conduction electrode. After surgery, electroencephalogram (EEG) was recorded for two hours for each rat under anesthesia. Subsequently, the rats were video monitored for 72 h to detect the occurrence of behavioral seizures upon awakening. The average number and duration of seizures on EEG and the number of behavioral seizures were measured. Results: In KA model, the number of total EEG seizures in conduction group (9.57 +/- 2.46) was significantly less than that in sham conduction group (15.13 +/- 3.45) (p<0.01). The duration of EEG seizures in conduction group (26.13 +/- 7.81 s) was significantly shorter than that in sham conduction group (34.17 +/- 7.25 s) (p=0.001). A significant reduction of behavioral seizures was observed in the conduction group compared with KA (p=0.000) and sham conduction groups (p=0.000). In penicillin model, there was a 61% reduction in total EEG seizures in conduction group compared with sham conduction group (p<0.01), and the duration of EEG seizures in conduction group (6.29 +/- 2.64 s) was significantly shorter than that in the sham conduction group (12.07 +/- 3.81 s) (p=0.002). A significant reduction of behavioral seizures was observed in conduction group compared with penicillin (p<0.01) and sham conduction groups (p<0.01). Conclusion: Current shunt effectively reduces the onset and severity of seizures. Current shunt therapy could be an effective alternative minimally invasive approach for temporal lobe epilepsy and neocortex epilepsy.	[Zhang, Limin; Zhang, Guojun; Liu, Zhizhong; Lv, Hong; Fang, Fang; Wang, Yajie; Kang, Xixiong] Capital Med Univ, Beijing Tiantan Hosp, Lab Diag Ctr, Beijing, Peoples R China; [Zhang, Limin; Liang, Shuli; Zhang, Shaohui] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Capital Epilepsy Therapy Ctr, Dept Neurosurg, Beijing, Peoples R China	Capital Medical University; Chinese People's Liberation Army General Hospital	Liang, SL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Capital Epilepsy Therapy Ctr, Dept Neurosurg, Beijing, Peoples R China.	liangsl_304@sina.com; kangxx@vip.sina.com	Liang, Shuli/GWC-5028-2022		National Natural Science Foundation of China [81000555]; Beijing Science & Technology New-star Training Program [2010B084]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science & Technology New-star Training Program	This work was supported by National Natural Science Foundation of China (Grant No. 81000555, http://www.nsfc.gov.cn/Portal0/default152.htm) and Beijing Science & Technology New-star Training Program (2010B084, http://www.bjast.ac.cn/Html/List/list173.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Barz H, 2013, MED HYPOTHESES, V81, P768, DOI 10.1016/j.mehy.2013.07.049; Bear M.F., 2007, NEUROSCIENCE, Vthird; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; Boon P, 2007, EPILEPSIA, V48, P1551, DOI 10.1111/j.1528-1167.2007.01005.x; Canan S, 2008, EPILEPSY RES, V82, P7, DOI 10.1016/j.eplepsyres.2008.06.005; DeGiorgio CM, 2000, EPILEPSIA, V41, P1195, DOI 10.1111/j.1528-1157.2000.tb00325.x; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; GEORGE R, 1995, NEUROLOGY, V45, P224, DOI 10.1212/wnl.45.2.224; Gross RE, 2000, NEUROL RES, V22, P247; Hodaie M, 2002, EPILEPSIA, V43, P603, DOI 10.1046/j.1528-1157.2002.26001.x; Jan MM, 2010, CAN J NEUROL SCI, V37, P439, DOI 10.1017/S0317167100010441; Javidan M, 2012, EPILEPSY RES TREAT, DOI [10.1155/2012/637430, DOI 10.1155/2012/637430.EPUB2012]; Kortelainen J, 2010, IEEE ENG MED BIO, P6674, DOI 10.1109/IEMBS.2010.5627154; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Leach JP, 2013, CLIN MED, V13, P84, DOI 10.7861/clinmedicine.13-1-84; Liang SL, 2010, STEREOT FUNCT NEUROS, V88, P246, DOI 10.1159/000315462; Liang SL, 2010, EPILEPSY RES, V90, P60, DOI 10.1016/j.eplepsyres.2010.03.008; Lim SN, 2007, EPILEPSIA, V48, P342, DOI 10.1111/j.1528-1167.2006.00898.x; Longo DL, 2011, HARRISONS PRINCIP 17; Makiranta M, 2005, NEUROIMAGE, V27, P715, DOI 10.1016/j.neuroimage.2005.05.025; Paxinos G., 1998, RAT BRAIN STEROTAXIC; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raghavendra S, 2012, EPILEPSY RES TREAT, DOI [10.1155/2012/204693, DOI 10.1155/2012/204693.EPUB]; Sakamoto Americo C, 2004, Suppl Clin Neurophysiol, V57, P383; SANDER JW, 2003, EPILEPSIA S1, V44, P17; Silfverhuth MJ, 2011, SEIZURE-EUR J EPILEP, V20, P513, DOI 10.1016/j.seizure.2011.03.006; Theodore WH, 2004, LANCET NEUROL, V3, P111, DOI 10.1016/S1474-4422(03)00664-1; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Wyckhuys T, 2010, EPILEPSIA, V51, P2297, DOI 10.1111/j.1528-1167.2010.02750.x	31	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86477	10.1371/journal.pone.0086477	http://dx.doi.org/10.1371/journal.pone.0086477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497949	gold, Green Submitted, Green Published			2022-12-25	WOS:000330617100016
J	Gibb, B; Ye, LF; Gergoudis, SC; Kwon, YH; Niu, HY; Sung, P; Greene, EC				Gibb, Bryan; Ye, Ling F.; Gergoudis, Stephanie C.; Kwon, YoungHo; Niu, Hengyao; Sung, Patrick; Greene, Eric C.			Concentration-Dependent Exchange of Replication Protein A on Single-Stranded DNA Revealed by Single-Molecule Imaging	PLOS ONE			English	Article							RAD52 PROTEIN; BINDING-PROTEIN; HOMOLOGOUS RECOMBINATION; END-RESECTION; YEAST RAD51; RPA; CURTAINS; MECHANISM; MEDIATOR; REPAIR	Replication protein A (RPA) is a ubiquitous eukaryotic single-stranded DNA (ssDNA) binding protein necessary for all aspects of DNA metabolism involving an ssDNA intermediate, including DNA replication, repair, recombination, DNA damage response and checkpoint activation, and telomere maintenance [1,2,3]. The role of RPA in most of these reactions is to protect the ssDNA until it can be delivered to downstream enzymes. Therefore a crucial feature of RPA is that it must bind very tightly to ssDNA, but must also be easily displaced from ssDNA to allow other proteins to gain access to the substrate. Here we use total internal reflection fluorescence microscopy and nanofabricated DNA curtains to visualize the behavior of Saccharomyces cerevisiae RPA on individual strands of ssDNA in real-time. Our results show that RPA remains bound to ssDNA for long periods of time when free protein is absent from solution. In contrast, RPA rapidly dissociates from ssDNA when free RPA is present in solution allowing rapid exchange between the free and bound states. In addition, the S. cerevisiae DNA recombinase Rad51 and E. coli single-stranded binding protein (SSB) also promote removal of RPA from ssDNA. These results reveal an unanticipated exchange between bound and free RPA suggesting a binding mechanism that can confer exceptionally slow off rates, yet also enables rapid displacement through a direct exchange mechanism that is reliant upon the presence of free ssDNA-binding proteins in solution. Our results indicate that RPA undergoes constant microscopic dissociation under all conditions, but this is only manifested as macroscopic dissociation (i.e. exchange) when free proteins are present in solution, and this effect is due to mass action. We propose that the dissociation of RPA from ssDNA involves a partially dissociated intermediate, which exposes a small section of ssDNA allowing other proteins to access to the DNA.	[Gibb, Bryan; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Ye, Ling F.; Gergoudis, Stephanie C.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Kwon, YoungHo; Niu, Hengyao; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Greene, Eric C.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Yale University; Columbia University; Howard Hughes Medical Institute	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.	ecg2108@columbia.edu	Niu, Hengyao/J-4593-2013; Niu, Hengyao/AAE-9269-2020; Gibb, Bryan/AAW-5554-2020	Gibb, Bryan/0000-0002-2094-344X	NIH [GM074739, RO1ES007061, CA146940]; NATIONAL CANCER INSTITUTE [R01CA146940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by NIH grants GM074739 (E.C.G.), RO1ES007061 (P.S.), and CA146940 (E.C.G. and P.S.). E.C.G. is an Early Career Scientist with the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Bianco P R, 1998, Front Biosci, V3, pD570; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Brill SJ, 1998, MOL CELL BIOL, V18, P7225, DOI 10.1128/MCB.18.12.7225; Broderick S, 2010, SUBCELL BIOCHEM, V50, P143, DOI 10.1007/978-90-481-3471-7_8; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Dickson AM, 2009, NUCLEIC ACIDS RES, V37, P2313, DOI 10.1093/nar/gkp090; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fazio T, 2008, LANGMUIR, V24, P10524, DOI 10.1021/la801762h; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fortin GS, 2002, EMBO J, V21, P3160, DOI 10.1093/emboj/cdf293; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibb B, 2012, ANAL CHEM, V84, P7607, DOI 10.1021/ac302117z; Gorman J, 2010, LANGMUIR, V26, P1372, DOI 10.1021/la902443e; Graham JS, 2011, NUCLEIC ACIDS RES, V39, P2249, DOI 10.1093/nar/gkq1140; Graneli A, 2006, P NATL ACAD SCI USA, V103, P1221, DOI 10.1073/pnas.0508366103; Greene EC, 2010, METHOD ENZYMOL, V472, P293, DOI 10.1016/S0076-6879(10)72006-1; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; Jacobs DM, 1999, J BIOMOL NMR, V14, P321, DOI 10.1023/A:1008373009786; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kunzelmann S, 2010, BIOCHEMISTRY-US, V49, P843, DOI 10.1021/bi901743k; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2009, DNA REPAIR, V8, P1068, DOI 10.1016/j.dnarep.2009.04.007; Liu J, 2011, P NATL ACAD SCI USA, V108, P441, DOI 10.1073/pnas.1016614108; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Plate I, 2008, J BIOL CHEM, V283, P29077, DOI 10.1074/jbc.M804881200; Prasad TK, 2006, J MOL BIOL, V363, P713, DOI 10.1016/j.jmb.2006.08.046; Robertson RB, 2009, P NATL ACAD SCI USA, V106, P12688, DOI 10.1073/pnas.0811465106; Robertson RB, 2009, J MOL BIOL, V388, P703, DOI 10.1016/j.jmb.2009.03.049; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sidorova NY, 2013, BIOPHYS J, V104, P1296, DOI 10.1016/j.bpj.2013.01.041; Solomon DA, 2004, J CELL BIOL, V166, P455, DOI 10.1083/jcb.200312048; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 2009, J MOL BIOL, V390, P45, DOI 10.1016/j.jmb.2009.05.009; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Visnapuu ML, 2008, LANGMUIR, V24, P11293, DOI 10.1021/la8017634; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	55	117	117	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87922	10.1371/journal.pone.0087922	http://dx.doi.org/10.1371/journal.pone.0087922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498402	Green Submitted, gold, Green Published			2022-12-25	WOS:000330626900148
J	Liu, MY; Jiang, J; Han, XJ; Qiao, GR; Zhuo, RY				Liu, Mingying; Jiang, Jing; Han, Xiaojiao; Qiao, Guirong; Zhuo, Renying			Validation of Reference Genes Aiming Accurate Normalization of qRT-PCR Data in Dendrocalamus latiflorus Munro	PLOS ONE			English	Article							TIME RT-PCR; POLYMERASE-CHAIN-REACTION; HOUSEKEEPING GENES; QUANTITATIVE-PCR; INTERNAL CONTROL; SYSTEMATIC VALIDATION; QPCR DATA; EXPRESSION; IDENTIFICATION; SELECTION	Background: Dendrocalamus latiflorus Munro distributes widely in subtropical areas and plays vital roles as valuable natural resources. The transcriptome sequencing for D. latiflorus Munro has been performed and numerous genes especially those predicted to be unique to D. latiflorus Munro were revealed. qRT-PCR has become a feasible approach to uncover gene expression profiling, and the accuracy and reliability of the results obtained depends upon the proper selection of stable reference genes for accurate normalization. Therefore, a set of suitable internal controls should be validated for D. latiflorus Munro. Results: In this report, twelve candidate reference genes were selected and the assessment of gene expression stability was performed in ten tissue samples and four leaf samples from seedlings and anther-regenerated plants of different ploidy. The PCR amplification efficiency was estimated, and the candidate genes were ranked according to their expression stability using three software packages: geNorm, NormFinder and Bestkeeper. GAPDH and EF1 alpha were characterized to be the most stable genes among different tissues or in all the sample pools, while CYP showed low expression stability. RPL3 had the optimal performance among four leaf samples. The application of verified reference genes was illustrated by analyzing ferritin and laccase expression profiles among different experimental sets. The analysis revealed the biological variation in ferritin and laccase transcript expression among the tissues studied and the individual plants. Conclusions: geNorm, NormFinder, and BestKeeper analyses recommended different suitable reference gene(s) for normalization according to the experimental sets. GAPDH and EF1 alpha had the highest expression stability across different tissues and RPL3 for the other sample set. This study emphasizes the importance of validating superior reference genes for qRT-PCR analysis to accurately normalize gene expression of D. latiflorus Munro.	[Liu, Mingying; Jiang, Jing; Han, Xiaojiao; Qiao, Guirong; Zhuo, Renying] Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Liu, Mingying; Jiang, Jing; Han, Xiaojiao; Qiao, Guirong; Zhuo, Renying] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Peoples R China	Chinese Academy of Forestry; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Zhuo, RY (corresponding author), Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	zhuory@gmail.com	Liu, Mingying/U-7104-2018; Liu, Mingying/ABE-3277-2020	Liu, Mingying/0000-0001-6261-8832; zhuo, renying/0000-0002-7063-3714	National Natural Science Foundation of China [31200508]; Science and Technology Project of Zhejiang Province [2012C22099, 2012C12908-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Zhejiang Province	This work was supported by National Natural Science Foundation of China (No. 31200508), Science and Technology Project of Zhejiang Province (No. 2012C22099 and No. 2012C12908-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahi EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066389; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bezier A, 2002, EUR J PLANT PATHOL, V108, P111, DOI 10.1023/A:1015061108045; Briat JF, 2010, ANN BOT-LONDON, V105, P811, DOI 10.1093/aob/mcp128; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bystriakova N, 2004, UNEP WCMC BIODIVERSI, V19; Bystriakova N, 2003, UNEP WCMC BIODIVERSI, V14; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Keyser E, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-13; Dean JD, 2002, PLANT MOL BIOL REP, V20, P347, DOI 10.1007/BF02772122; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Faccioli P, 2007, PLANT MOL BIOL, V63, P679, DOI 10.1007/s11103-006-9116-9; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hilton-Taylor C., 2000, IUCN RED LIST THREAT; Hoenemann C, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue1-fulltext-8; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Hsu YH, 2000, PLANT PATHOL, V49, P101, DOI 10.1046/j.1365-3059.2000.00433.x; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; MARIVET J, 1992, PLANT SCI, V84, P171, DOI 10.1016/0168-9452(92)90131-5; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Miranda Vivian de Jesus, 2013, BMC Res Notes, V6, P196, DOI 10.1186/1756-0500-6-196; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pilcher H. R., 2004, NATURE, DOI [10.1038/news040510-2, DOI 10.1038/NEWS040510-2]; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Qiao GR, 2013, IN VITRO CELL DEV-PL, V49, P375, DOI 10.1007/s11627-013-9498-8; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Scurlock JMO, 2000, BIOMASS BIOENERG, V19, P229, DOI 10.1016/S0961-9534(00)00038-6; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Thomas C, 2003, PLANT MOL BIOL, V52, P1025, DOI 10.1023/A:1025482432486; Tian B, 2005, CHINESE SCI BULL, V50, P145; Tian B, 2006, DNA SEQUENCE, V17, P143, DOI 10.1080/10425170600699877; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanRaay TJ, 1996, GENOMICS, V37, P172, DOI 10.1006/geno.1996.0538; Walter KS, 1998, 1997 IUCN RED LIST T; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Wu ZY, 2006, FLORAL CHINA POACEAE; Xu H, 2010, BIOTECHNOL LETT, V32, P1961, DOI 10.1007/s10529-010-0362-1; Yang LT, 2005, J AGR FOOD CHEM, V53, P183, DOI 10.1021/jf0493730; Yoo WG, 2009, PARASITOL RES, V104, P321, DOI 10.1007/s00436-008-1195-x; Zhao WJ, 2011, J IND MICROBIOL BIOT, V38, P1279, DOI 10.1007/s10295-010-0906-3	75	12	16	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87417	10.1371/journal.pone.0087417	http://dx.doi.org/10.1371/journal.pone.0087417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498321	gold, Green Published, Green Submitted			2022-12-25	WOS:000330626900067
J	Manzano-Piedras, E; Marcer, A; Alonso-Blanco, C; Pico, FX				Manzano-Piedras, Esperanza; Marcer, Arnald; Alonso-Blanco, Carlos; Pico, F. Xavier			Deciphering the Adjustment between Environment and Life History in Annuals: Lessons from a Geographically-Explicit Approach in Arabidopsis thaliana	PLOS ONE			English	Article							FLOWERING TIME; CLIMATE-CHANGE; GENETIC DIFFERENTIATION; NATURAL-SELECTION; DESERT ANNUALS; SEED DORMANCY; REGRESSION-ANALYSIS; EMPIRICAL-EVIDENCE; LOCAL ADAPTATION; ANNUAL PLANT	The role that different life-history traits may have in the process of adaptation caused by divergent selection can be assessed by using extensive collections of geographically-explicit populations. This is because adaptive phenotypic variation shifts gradually across space as a result of the geographic patterns of variation in environmental selective pressures. Hence, large-scale experiments are needed to identify relevant adaptive life-history traits as well as their relationships with putative selective agents. We conducted a field experiment with 279 geo-referenced accessions of the annual plant Arabidopsis thaliana collected across a native region of its distribution range, the Iberian Peninsula. We quantified variation in life-history traits throughout the entire life cycle. We built a geographic information system to generate an environmental data set encompassing climate, vegetation and soil data. We analysed the spatial autocorrelation patterns of environmental variables and life-history traits, as well as the relationship between environmental and phenotypic data. Almost all environmental variables were significantly spatially autocorrelated. By contrast, only two life-history traits, seed weight and flowering time, exhibited significant spatial autocorrelation. Flowering time, and to a lower extent seed weight, were the life-history traits with the highest significant correlation coefficients with environmental factors, in particular with annual mean temperature. In general, individual fitness was higher for accessions with more vigorous seed germination, higher recruitment and later flowering times. Variation in flowering time mediated by temperature appears to be the main life-history trait by which A. thaliana adjusts its life history to the varying Iberian environmental conditions. The use of extensive geographically-explicit data sets obtained from field experiments represents a powerful approach to unravel adaptive patterns of variation. In a context of current global warming, geographically-explicit approaches, evaluating the match between organisms and the environments where they live, may contribute to better assess and predict the consequences of global warming.	[Manzano-Piedras, Esperanza; Pico, F. Xavier] CSIC, EBD, Dept Ecol Integrat, Seville, Spain; [Marcer, Arnald] CREAF, Cerdanyola Del Valles, Spain; [Marcer, Arnald] Univ Autonoma Barcelona, Cerdanyola Del Valles, Spain; [Alonso-Blanco, Carlos] CSIC, CNB, Dept Genet Mol Plantas, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Pico, FX (corresponding author), CSIC, EBD, Dept Ecol Integrat, Seville, Spain.	xpico@ebd.csic.es	Pico, Xavier/E-5697-2016; Alonso-Blanco, Carlos/F-8864-2016	Pico, Xavier/0000-0003-2849-4922; Alonso-Blanco, Carlos/0000-0002-4738-5556	Ministerio de Educacion y Ciencia [CGL2009-07847/BOS]; Ministerio de Economia y Competitividad of Spain [CGL2012-33220/BOS]	Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Economia y Competitividad of Spain(Spanish Government)	This work was supported by grants from the Ministerio de Educacion y Ciencia (CGL2009-07847/BOS) and the Ministerio de Economia y Competitividad (CGL2012-33220/BOS) of Spain to FXP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Amano T, 2010, P ROY SOC B-BIOL SCI, V277, P2451, DOI 10.1098/rspb.2010.0291; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Anderson JT, 2012, P ROY SOC B-BIOL SCI, V279, P3843, DOI 10.1098/rspb.2012.1051; Anderson JT, 2011, EVOLUTION, V65, P771, DOI 10.1111/j.1558-5646.2010.01175.x; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; BASKIN CC, 1988, AM J BOT, V75, P286, DOI 10.2307/2443896; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Brachi B, 2013, MOL ECOL, V22, P4222, DOI 10.1111/mec.12396; Brachi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032069; Childs DZ, 2010, P ROY SOC B-BIOL SCI, V277, P3055, DOI 10.1098/rspb.2010.0707; Clauss MJ, 2000, AM NAT, V155, P168, DOI 10.1086/303314; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Craufurd PQ, 2009, J EXP BOT, V60, P2529, DOI 10.1093/jxb/erp196; Debieu M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061075, 10.1371/journal.pone.0082943]; Donohue K, 2005, NEW PHYTOL, V166, P83, DOI 10.1111/j.1469-8137.2005.01357.x; Donohue K, 2002, ECOLOGY, V83, P1006, DOI 10.1890/0012-9658(2002)083[1006:GTINSO]2.0.CO;2; Donohue K, 2008, NEW PHYTOL, V177, P367, DOI 10.1111/j.1469-8137.2007.02281.x; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Earley EJ, 2009, AM J BOT, V96, P786, DOI 10.3732/ajb.0800149; Endler J.A., 1977, Monographs in Population Biology, pi; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Fisher R.A., 1930, GENETICAL THEORY NAT, P272; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Fournier-Level A, 2013, MOL ECOL, V22, P3552, DOI 10.1111/mec.12285; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; FREAS KE, 1983, J ECOL, V71, P211, DOI 10.2307/2259973; Gomaa NH, 2011, MOL ECOL, V20, P3540, DOI 10.1111/j.1365-294X.2011.05193.x; Gordo O, 2009, GLOBAL CHANGE BIOL, V15, P1930, DOI 10.1111/j.1365-2486.2009.01851.x; HALDANE JBS, 1948, J GENET, V48, P277, DOI 10.1007/BF02986626; Heschel MS, 2005, AM J BOT, V92, P37, DOI 10.3732/ajb.92.1.37; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; KALISZ S, 1991, ECOLOGY, V72, P575, DOI 10.2307/2937197; KAUFFMAN S, 1987, J THEOR BIOL, V128, P11, DOI 10.1016/S0022-5193(87)80029-2; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kluth C, 2005, J ECOL, V93, P584, DOI 10.1111/j.1365-2745.2005.00997.x; Lebrija-Trejos E, 2011, ISR J ECOL EVOL, V57, P73, DOI 10.1560/IJEE.57.1-2.73; Legendre P, 2002, ECOGRAPHY, V25, P601, DOI 10.1034/j.1600-0587.2002.250508.x; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; McKay JK, 2003, MOL ECOL, V12, P1137, DOI 10.1046/j.1365-294X.2003.01833.x; ME N, 2013, NEW PHYTOL, V197, P1332, DOI DOI 10.1111/NPH.12082; ME N, 2010, J EXP BOT, V61, P1611, DOI DOI 10.1093/JXB/ERQ032; ME N, 2011, PLANT PHYSIOL, V157, P1942, DOI DOI 10.1104/PP.111.183426; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; MITCHELLOLDS T, 1987, EVOLUTION, V41, P1149, DOI 10.1111/j.1558-5646.1987.tb02457.x; Montesinos A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007213; Montesinos-Navarro A, 2011, NEW PHYTOL, V189, P282, DOI 10.1111/j.1469-8137.2010.03479.x; Ninyerola M, 2007, THEOR APPL CLIMATOL, V89, P195, DOI 10.1007/s00704-006-0264-2; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Pake CE, 1996, ECOLOGY, V77, P1427, DOI 10.2307/2265540; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Paul-Victor C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006917; Penuelas J, 2002, GLOBAL CHANGE BIOL, V8, P531, DOI 10.1046/j.1365-2486.2002.00489.x; Petru M, 2006, ECOGRAPHY, V29, P66, DOI 10.1111/j.2005.0906-7590.04310.x; PHILIPPI T, 1993, AM NAT, V142, P488, DOI 10.1086/285551; Pico FX, 2008, GENETICS, V180, P1009, DOI 10.1534/genetics.108.089581; Pigliucci M, 1998, J EVOLUTION BIOL, V11, P285, DOI 10.1007/s000360050089; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; RATCLIFFE D, 1959, J ECOL, V47, P241, DOI 10.2307/2257255; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.2307/2409632; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Roux F, 2006, TRENDS PLANT SCI, V11, P375, DOI 10.1016/j.tplants.2006.06.006; RUBIO D, 2012, NEW PHYTOL, V194, P868, DOI DOI 10.1111/J.1469-8137.2012.04097.X; SA N, 2012, PLANT CELL ENVIRON, V35, P1672, DOI DOI 10.1111/J.1365-3040.2012.02518.X; Simons AM, 2011, P ROY SOC B-BIOL SCI, V278, P1601, DOI 10.1098/rspb.2011.0176; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; TIELBO R, 2012, OIKOS, V121, P1860, DOI DOI 10.1111/J.1600-0706.2011.20236.X; VANTIENDEREN PH, 1991, J ECOL, V79, P27, DOI 10.2307/2260782; Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Volis S, 2002, BIOL J LINN SOC, V77, P479, DOI 10.1046/j.1095-8312.2002.00120.x; Wagmann K, 2012, ANN BOT-LONDON, V110, P1205, DOI 10.1093/aob/mcs194; Weigel D, 2012, PLANT PHYSIOL, V158, P2, DOI 10.1104/pp.111.189845; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Pico FX, 2012, J ECOL, V100, P1009, DOI 10.1111/j.1365-2745.2012.01979.x	85	38	39	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87836	10.1371/journal.pone.0087836	http://dx.doi.org/10.1371/journal.pone.0087836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498381	Green Published, gold			2022-12-25	WOS:000330626900127
J	Maurin, H; Chong, SA; Kraev, I; Davies, H; Kremer, A; Seymour, CM; Lechat, B; Jaworski, T; Borghgraef, P; Devijver, H; Callewaert, G; Stewart, MG; Van Leuven, F				Maurin, Herve; Chong, Seon-Ah; Kraev, Igor; Davies, Heather; Kremer, Anna; Seymour, Claire Marie; Lechat, Benoit; Jaworski, Tomasz; Borghgraef, Peter; Devijver, Herman; Callewaert, Geert; Stewart, Michael G.; Van Leuven, Fred			Early Structural and Functional Defects in Synapses and Myelinated Axons in Stratum Lacunosum Moleculare in Two Preclinical Models for Tauopathy	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CEREBROSPINAL-FLUID LEVELS; PERFORANT PATH INPUT; ALZHEIMERS-DISEASE; ENTORHINAL CORTEX; DIFFERENTIAL-DIAGNOSIS; DORSAL HIPPOCAMPUS; COGNITIVE DECLINE; DENDRITIC SPINES; MEMORY DEFICITS	The stratum lacunosum moleculare (SLM) is the connection hub between entorhinal cortex and hippocampus, two brain regions that are most vulnerable in Alzheimer's disease. We recently identified a specific synaptic deficit of Nectin-3 in transgenic models for tauopathy. Here we defined cognitive impairment and electrophysiological problems in the SLM of Tau.P301L mice, which corroborated the structural defects in synapses and dendritic spines. Reduced diffusion of DiI from the ERC to the hippocampus indicated defective myelinated axonal pathways. Ultrastructurally, myelinated axons in the temporoammonic pathway (TA) that connects ERC to CA1 were damaged in Tau.P301L mice at young age. Unexpectedly, the myelin defects were even more severe in bigenic biGT mice that co-express GSK3 beta with Tau.P301L in neurons. Combined, our data demonstrate that neuronal expression of protein Tau profoundly affected the functional and structural organization of the entorhinal-hippocampal complex, in particular synapses and myelinated axons in the SLM. White matter pathology deserves further attention in patients suffering from tauopathy and Alzheimer's disease.	[Maurin, Herve; Chong, Seon-Ah; Kremer, Anna; Seymour, Claire Marie; Lechat, Benoit; Jaworski, Tomasz; Borghgraef, Peter; Devijver, Herman; Van Leuven, Fred] Katholieke Univ Leuven VIB, Dept Human Genet, Expt Genet Grp LEGTEGG, B-3000 Louvain, Belgium; [Kraev, Igor; Davies, Heather; Stewart, Michael G.] Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England; [Callewaert, Geert] KULAK, Res Grp Neurodegenerat, Kortrijk, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Open University - UK; KU Leuven	Van Leuven, F (corresponding author), Katholieke Univ Leuven VIB, Dept Human Genet, Expt Genet Grp LEGTEGG, B-3000 Louvain, Belgium.	fred.vanleuven@med.kuleuven.be	Seymour, Claire M/B-6758-2008; Kraev, Igor V/J-2528-2015	Kraev, Igor V/0000-0003-1822-278X; Jaworski, Tomasz/0000-0002-6387-9249	Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen); Instituut Wetenschap Techniek (IWT); EEC 6th Framework Program; EEC 7th Framework Program; MEMStick, neuroGSK3, EURON, NEURAD; KULeuven-Research Fund; KULeuven-ResearchDevelopment; Marie Curie fellowship MEST [CT 2005/020013 NEURAD]	Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen)(FWO); Instituut Wetenschap Techniek (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); EEC 6th Framework Program(European Commission); EEC 7th Framework Program; MEMStick, neuroGSK3, EURON, NEURAD; KULeuven-Research Fund(KU Leuven); KULeuven-ResearchDevelopment; Marie Curie fellowship MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	The investigations were funded and supported by Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen); Instituut Wetenschap & Techniek (IWT); EEC 6th & 7th Framework Programs: MEMStick, neuroGSK3, EURON, NEURAD; KULeuven-Research Fund; KULeuven-Research&Development. HM acknowledges Marie Curie fellowship MEST CT 2005/020013 NEURAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix JJP, 2011, NEUROLOGY, V76, P397, DOI 10.1212/WNL.0b013e3182088273; [Anonymous], [No title captured]; Bartzokis G, 2004, NEUROBIOL AGING, V25, P843, DOI 10.1016/j.neurobiolaging.2003.09.005; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Bendlin BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037720; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Braak E, 1997, ACTA NEUROPATHOL, V93, P323, DOI 10.1007/s004010050622; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Bronge L, 2002, DEMENT GERIATR COGN, V13, P205, DOI 10.1159/000057698; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Buerger K, 2002, ARCH NEUROL-CHICAGO, V59, P1267, DOI 10.1001/archneur.59.8.1267; Buerger K, 2002, NEUROLOGY, V59, P627, DOI 10.1212/WNL.59.4.627; Capetillo-Zarate E, 2006, BRAIN, V129, P2992, DOI 10.1093/brain/awl176; CHANPALAY V, 1986, J COMP NEUROL, V248, P376, DOI 10.1002/cne.902480307; Chen BK, 2006, J NEUROSCI METH, V154, P256, DOI 10.1016/j.jneumeth.2005.12.025; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Chong SA, 2011, NEUROBIOL DIS, V44, P284, DOI 10.1016/j.nbd.2011.07.006; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Deipolyi AR, 2007, NEUROLOGY, V69, P986, DOI 10.1212/01.wnl.0000271376.19515.c6; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Deng JB, 2007, INT J DEV NEUROSCI, V25, P251, DOI 10.1016/j.ijdevneu.2007.03.002; Desai MK, 2009, GLIA, V57, P54, DOI 10.1002/glia.20734; Dewachter I, 2002, J NEUROSCI, V22, P3445; Donohue HS, 2006, NEUROSCIENCE, V140, P597, DOI 10.1016/j.neuroscience.2006.02.072; Dutschmann M, 2010, J NEUROSCI, V30, P1810, DOI 10.1523/JNEUROSCI.5261-09.2010; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V81, P1036, DOI 10.1152/jn.1999.81.3.1036; ELBERGER AJ, 1990, J HISTOCHEM CYTOCHEM, V38, P735, DOI 10.1177/38.5.2110209; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fidzinski P, 2012, BRAIN RES, V1430, P1, DOI 10.1016/j.brainres.2011.10.040; Gold BT, 2012, BBA-MOL BASIS DIS, V1822, P416, DOI 10.1016/j.bbadis.2011.07.009; Hampel H, 2005, ARCH NEUROL-CHICAGO, V62, P770, DOI 10.1001/archneur.62.5.770; Harris JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045881; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Jaworski T, 2010, INT J ALZHEIMERS DIS, V2010; Jaworski T, 2011, AM J PATHOL, V179, P2001, DOI 10.1016/j.ajpath.2011.06.025; Jaworski T, 2010, BBA-MOL BASIS DIS, V1802, P808, DOI 10.1016/j.bbadis.2010.03.005; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; Kerchner GA, 2012, NEUROIMAGE, V63, P194, DOI 10.1016/j.neuroimage.2012.06.048; Kraev I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023433; Kremer A, 2011, J NEUROSCI, V31, P18036, DOI 10.1523/JNEUROSCI.4859-11.2011; Lace G, 2009, BRAIN, V132, P1324, DOI 10.1093/brain/awp059; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Leuba G, 2008, NEUROBIOL DIS, V30, P408, DOI 10.1016/j.nbd.2008.02.012; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Ludvigson AE, 2011, BRAIN STRUCT FUNCT, V216, P31, DOI 10.1007/s00429-010-0295-4; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; Maurin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063589; Menuet C, 2011, RESP PHYSIOL NEUROBI, V178, P290, DOI 10.1016/j.resp.2011.06.030; Menuet C, 2011, J APPL PHYSIOL, V110, P1572, DOI 10.1152/japplphysiol.00117.2011; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Monacelli AM, 2003, NEUROLOGY, V61, P1491, DOI 10.1212/WNL.61.11.1491; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Niederkofler V, 2010, DEVELOPMENT, V137, P427, DOI 10.1242/dev.042515; O'Dwyer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021745; Palani D, 2010, NEUROSCIENCE, V167, P1004, DOI 10.1016/j.neuroscience.2010.03.021; Parente DB, 2008, AM J ROENTGENOL, V190, P1369, DOI 10.2214/AJR.07.2617; Peters A, 2000, J COMP NEUROL, V419, P364, DOI 10.1002/(SICI)1096-9861(20000410)419:3<364::AID-CNE8>3.0.CO;2-R; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rasband MN, 2005, GLIA, V50, P86, DOI 10.1002/glia.20165; REINIKAINEN KJ, 1989, NEUROSCI LETT, V106, P229, DOI 10.1016/0304-3940(89)90230-9; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Remondes M, 2003, LEARN MEMORY, V10, P247, DOI 10.1101/lm.59103; Ringman JM, 2007, BRAIN, V130, P1767, DOI 10.1093/brain/awm102; Schmued LC, 2013, CURR ALZHEIMER RES, V10, P30; Speed HE, 2009, HIPPOCAMPUS, V19, P187, DOI 10.1002/hipo.20496; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; Stys PK, 2012, NAT REV NEUROSCI, V13, P507, DOI 10.1038/nrn3275; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TERRY RD, 1964, AM J PATHOL, V44, P269; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Tsukamoto M, 2003, J PHYSIOL-LONDON, V546, P665, DOI 10.1113/jphysiol.2002.033803; Vago DR, 2008, BEHAV BRAIN RES, V189, P273, DOI 10.1016/j.bbr.2008.01.002; Vago DR, 2007, HIPPOCAMPUS, V17, P977, DOI 10.1002/hipo.20329; Van Cauter T, 2013, CEREB CORTEX, V23, P451, DOI 10.1093/cercor/bhs033; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vlkolinsky R, 2001, NEUROBIOL AGING, V22, P547, DOI 10.1016/S0197-4580(01)00218-4; Wang CN, 2010, J HISTOCHEM CYTOCHEM, V58, P611, DOI 10.1369/jhc.2010.954842; Wang XD, 2013, NAT NEUROSCI, V16, P706, DOI 10.1038/nn.3395; WIGSTROM H, 1981, BRAIN RES, V229, P507, DOI 10.1016/0006-8993(81)91013-1; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	95	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87605	10.1371/journal.pone.0087605	http://dx.doi.org/10.1371/journal.pone.0087605			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498342	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000330626900088
J	Poulard, C; Rambaud, J; Hussein, N; Corbo, L; Le Romancer, M				Poulard, Coralie; Rambaud, Juliette; Hussein, Nader; Corbo, Laura; Le Romancer, Muriel			JMJD6 Regulates ER alpha Methylation on Arginine	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; IN-VIVO METHYLATION; PROTEIN; COMPLEX; RNA; SRC	ER alpha functions are tightly controlled by numerous post-translational modifications including arginine methylation, which is required to mediate the extranuclear functions of the receptor. We report that upon oestrogenic stimulation, JMJD6, the only arginine demethylase described so far, interacts with and regulates methylated ER alpha (metER alpha) function. Moreover, by combining the silencing of JMJD6 with demethylation assays, we show that metER alpha is a new substrate for JMJD6. We propose that the demethylase activity of JMJD6 is a decisive regulator of the rapid physiological responses to oestrogen.	[Poulard, Coralie; Rambaud, Juliette; Corbo, Laura; Le Romancer, Muriel] Univ Lyon, F-69000 Lyon, France; [Poulard, Coralie; Rambaud, Juliette; Corbo, Laura; Le Romancer, Muriel] Univ Lyon 1, F-69000 Lyon, France; [Poulard, Coralie; Rambaud, Juliette; Corbo, Laura; Le Romancer, Muriel] Ctr Rech Cancerol Lyon, INSERM, U1052, F-69000 Lyon, France; [Poulard, Coralie; Rambaud, Juliette; Corbo, Laura; Le Romancer, Muriel] Ctr Rech Cancerol Lyon, CNRS, UMR5286, F-69000 Lyon, France; [Poulard, Coralie; Rambaud, Juliette; Corbo, Laura; Le Romancer, Muriel] Equipe Labellise Ligue, Paris, France; [Hussein, Nader] Lebanese Univ, Fac Sci, Doctoral Sch Sci & Technol, PRASE, Hadath, Lebanon	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; Lebanese University	Le Romancer, M (corresponding author), Univ Lyon, F-69000 Lyon, France.	muriel.leromancer@lyon.unicancer.fr		Poulard, coralie/0000-0003-4821-908X; Le Romancer, Muriel/0000-0002-8491-4015	Fondation Arc Cancer; Ligue Nationale Contre le Cancer; Fondation de France; Ministere de la Recherche	Fondation Arc Cancer; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	Funding for this study was provided by: Fondation Arc Cancer, Ligue Nationale Contre le Cancer, Fondation de France, and Ministere de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Belyanskaya LL, 2001, J BIOL CHEM, V276, P18681, DOI 10.1074/jbc.M011446200; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Ho MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057008; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Jung SY, 2008, ANAL CHEM, V80, P1721, DOI 10.1021/ac7021025; Kolbel K, 2009, J BIOL CHEM, V284, P8274, DOI 10.1074/jbc.M809547200; LAPEYRE B, 1986, J BIOL CHEM, V261, P9167; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee YF, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3200; Mantri M, 2010, J MOL BIOL, V401, P211, DOI 10.1016/j.jmb.2010.05.054; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Pahlich S, 2005, PROTEINS, V61, P164, DOI 10.1002/prot.20579; Poulard C, 2012, EMBO MOL MED, V4, P1200, DOI 10.1002/emmm.201201615; Robin-Lespinasse Y, 2007, J CELL SCI, V120, P638, DOI 10.1242/jcs.03357; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Unoki M, 2013, J BIOL CHEM, V288, P6053, DOI 10.1074/jbc.M112.433284; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865	31	62	63	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87982	10.1371/journal.pone.0087982	http://dx.doi.org/10.1371/journal.pone.0087982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498420	Green Published, Green Submitted, gold			2022-12-25	WOS:000330626900166
J	Wang, YP; Speier, JS; Engram-Pearl, J; Wilson, RB				Wang, Yongping; Speier, Jacqueline S.; Engram-Pearl, Jessica; Wilson, Robert B.			Introduction of Mismatches in a Random shRNA-Encoding Library Improves Potency for Phenotypic Selection	PLOS ONE			English	Article							SMALL INTERFERING RNA; HUMAN-CELLS; SATURATION MUTAGENESIS; MOLECULAR EVOLUTION; MAMMALIAN-CELLS; SIRNA; DEOXYINOSINE; MICRORNAS; PATHWAY; GENES	RNA interference (RNAi) is a mechanism for interfering with gene expression through the action of small, non-coding RNAs. We previously constructed a short-hairpin-loop RNA (shRNA) encoding library that is random at the nucleotide level [1]. In this library, the stems of the hairpin are completely complementary. To improve the potency of initial hits, and therefore signal-to-noise ratios in library screening, as well as to simplify hit-sequence retrieval by PCR, we constructed a second-generation library in which we introduced random mismatches between the two halves of the stem of each hairpin, on a random template background. In a screen for shRNAs that protect an interleukin-3 (IL3) dependent cell line from IL3 withdrawal, our second-generation library yielded hit sequences with significantly higher potencies than those from the first-generation library in the same screen. Our method of random mutagenesis was effective for a random template and is likely suitable, therefore, for any DNA template of interest. The improved potency of our second-generation library expands the range of possible unbiased screens for small-RNA therapeutics and biologic tools.	[Wang, Yongping; Engram-Pearl, Jessica; Wilson, Robert B.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wang, Yongping; Speier, Jacqueline S.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Wilson, RB (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	wilsonr@mail.med.upenn.edu			National Institute for General Medical Sciences [1R01GM090304]; Friedreich's Ataxia Research Alliance; Netscientific; National Institute of Diabetes and Digestive and Kidney Diseases [K08-DK-085152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK085152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090304] Funding Source: NIH RePORTER	National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Friedreich's Ataxia Research Alliance; Netscientific; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by research grants (to RBW) from the National Institute for General Medical Sciences (1R01GM090304), the Friedreich's Ataxia Research Alliance, and Netscientific. It was also funded by a research grant (to YW) from the National Institute of Diabetes and Digestive and Kidney Diseases (K08-DK-085152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Among the funding sources for this work, Netscientific is a commercial source. None of the authors have any ties with Netscientific in terms of employment or consultancy. There are no products in development or being marketed. Netscientific does not have a license to the aforementioned patent or any rights in the technology. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ali HM, 2012, EXPERT REV CLIN PHAR, V5, P403, DOI [10.1586/ECP.12.33, 10.1586/ecp.12.33]; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; CASEGREEN SC, 1994, NUCLEIC ACIDS RES, V22, P131, DOI 10.1093/nar/22.2.131; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chen J, 2012, INT J NANOMED, V7, P3971, DOI 10.2147/IJN.S31897; Chen MH, 2005, P NATL ACAD SCI USA, V102, P2356, DOI 10.1073/pnas.0401549101; Gooding M, 2012, CHEM BIOL DRUG DES, V80, P787, DOI 10.1111/cbdd.12052; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Hill F, 1998, P NATL ACAD SCI USA, V95, P4258, DOI 10.1073/pnas.95.8.4258; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Hu MR, 2007, BIOMOL ENG, V24, P619, DOI 10.1016/j.bioeng.2007.08.020; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; KAWASE Y, 1986, NUCLEIC ACIDS RES, V14, P7727, DOI 10.1093/nar/14.19.7727; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; LEHTOVAARA PM, 1988, PROTEIN ENG, V2, P63, DOI 10.1093/protein/2.1.63; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; MARTIN FH, 1985, NUCLEIC ACIDS RES, V13, P8927, DOI 10.1093/nar/13.24.8927; McAnuff MA, 2007, J PHARM SCI-US, V96, P2922, DOI 10.1002/jps.20968; MCKEARN JP, 1985, P NATL ACAD SCI USA, V82, P7414, DOI 10.1073/pnas.82.21.7414; Mohan U, 2008, CHEMBIOCHEM, V9, P2238, DOI 10.1002/cbic.200800259; MYERS RM, 1985, SCIENCE, V229, P242, DOI 10.1126/science.2990046; Nichols M, 2009, J BIOTECHNOL, V143, P79, DOI 10.1016/j.jbiotec.2009.06.010; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Vander Heiden MG, 1999, MOL CELL, V3, P159; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003171; Wong TS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh028; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	41	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2014	9	2							e87390	10.1371/journal.pone.0087390	http://dx.doi.org/10.1371/journal.pone.0087390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302TD	24498319	gold, Green Submitted, Green Published			2022-12-25	WOS:000330626900065
J	Foresta, M; Izzotti, A; La Maestra, S; Micale, R; Poggi, A; Vecchio, D; Frosina, G				Foresta, Mara; Izzotti, Alberto; La Maestra, Sebastiano; Micale, Rosanna; Poggi, Alessandro; Vecchio, Donatella; Frosina, Guido			Accelerated Repair and Reduced Mutagenicity of DNA Damage Induced by Cigarette Smoke in Human Bronchial Cells Transfected with E.coli Formamidopyrimidine DNA Glycosylase	PLOS ONE			English	Article							ESCHERICHIA-COLI FPG; INCREASED RESISTANCE; COCKAYNE-SYNDROME; MAMMALIAN-CELLS; GUANINE ADDUCT; EXCISION; PROTEIN; GENE; EXPRESSION; AGENTS	Cigarette smoke (CS) is associated to a number of pathologies including lung cancer. Its mutagenic and carcinogenic effects are partially linked to the presence of reactive oxygen species and polycyclic aromatic hydrocarbons (PAH) inducing DNA damage. The bacterial DNA repair enzyme formamidopyrimidine DNA glycosylase (FPG) repairs both oxidized bases and different types of bulky DNA adducts. We investigated in vitro whether FPG expression may enhance DNA repair of CS-damaged DNA and counteract the mutagenic effects of CS in human lung cells. NCI-H727 non small cell lung carcinoma cells were transfected with a plasmid vector expressing FPG fused to the Enhanced Green Fluorescent Protein (EGFP). Cells expressing the fusion protein EGFP-FPG displayed accelerated repair of adducts and DNA breaks induced by CS condensate. The mutant frequencies induced by low concentrations of CS condensate to the Na+ K+-ATPase locus (oua(r)) were significantly reduced in cells expressing EGFP-FPG. Hence, expression of the bacterial DNA repair protein FPG stably protects human lung cells from the mutagenic effects of CS by improving cells' capacity to repair damaged DNA.	[Foresta, Mara; Izzotti, Alberto; La Maestra, Sebastiano; Micale, Rosanna] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Poggi, Alessandro] IRCCS Azienda Osped Univ San Martino, IST Ist Nazl Ric Cancro, Mol Oncol & Angiogenesis Unit, Genoa, Italy; [Foresta, Mara; Izzotti, Alberto; Vecchio, Donatella; Frosina, Guido] IRCCS Azienda Osped Univ San Martino, IST Ist Nazl Ric Cancro, Mutagenesis Unit, Genoa, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Frosina, G (corresponding author), IRCCS Azienda Osped Univ San Martino, IST Ist Nazl Ric Cancro, Mutagenesis Unit, Genoa, Italy.	guido.frosina@hsanmartino.it	Poggi, Alessandro/K-6664-2016; Frosina, Guido/Z-2382-2019	Poggi, Alessandro/0000-0002-1860-430X; Frosina, Guido/0000-0002-6717-5097; LA MAESTRA, SEBASTIANO/0000-0003-4939-2124; izzotti, alberto/0000-0002-8588-0347	Compagnia San Paolo, Turin, Italy [2009.1974, 2010.1944]; "Young Investigator Programme'' fellowship from Fondazione Umberto Veronesi, Milan, Italy	Compagnia San Paolo, Turin, Italy(Compagnia di San Paolo); "Young Investigator Programme'' fellowship from Fondazione Umberto Veronesi, Milan, Italy(Fondazione Umberto Veronesi)	This work was partially supported by Compagnia San Paolo, Turin, Italy - Grant numbers 2009.1974 and 2010.1944. D. V. is the recipient of a "Young Investigator Programme'' fellowship from Fondazione Umberto Veronesi, Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagoshi K, 2000, J BIOL CHEM, V275, P4956, DOI 10.1074/jbc.275.7.4956; BASU AK, 1993, BIOCHEMISTRY-US, V32, P12793, DOI 10.1021/bi00210a031; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; BOITEUX S, 1984, NUCLEIC ACIDS RES, V12, P5429, DOI 10.1093/nar/12.13.5429; BOITEUX S, 1989, CARCINOGENESIS, V10, P1905, DOI 10.1093/carcin/10.10.1905; Canitrot Y, 1999, FASEB J, V13, P1107, DOI 10.1096/fasebj.13.9.1107; COQUERELLE T, 1995, MUTAT RES-DNA REPAIR, V336, P9, DOI 10.1016/0921-8777(94)00035-5; Cortes-Sempere M, 2009, CANCER LETT, V286, P206, DOI 10.1016/j.canlet.2009.05.029; Coste F, 2004, J BIOL CHEM, V279, P44074, DOI 10.1074/jbc.M405928200; Coste F, 2008, CHEM BIOL, V15, P706, DOI 10.1016/j.chembiol.2008.05.014; DeFlora S, 1996, MUTAT RES-REV GENET, V366, P197, DOI 10.1016/S0165-1110(96)00043-7; DeFlora S, 1997, MUTAGENESIS, V12, P431, DOI 10.1093/mutage/12.6.431; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Foresta M, 2011, FREE RADICAL RES, V45, P751, DOI 10.3109/10715762.2011.579122; Foresta M, 2010, FREE RADICAL BIO MED, V48, P681, DOI 10.1016/j.freeradbiomed.2009.12.007; Frosina G, 2006, INT J CANCER, V119, P1, DOI 10.1002/ijc.21793; Gill RD, 1996, CANCER RES, V56, P3721; Glaab WE, 1997, CARCINOGENESIS, V18, P1, DOI 10.1093/carcin/18.1.1; HEMMINKI K, 1986, J CANCER RES CLIN, V112, P181, DOI 10.1007/BF00395910; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC MONOGR EVAL CAR, V100, P1; Izzotti A, 1999, CARCINOGENESIS, V20, P1499, DOI 10.1093/carcin/20.8.1499; IZZOTTI A, 1995, CARCINOGENESIS, V16, P669, DOI 10.1093/carcin/16.3.669; Kim KC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/863720; Kobune M, 2001, CANCER RES, V61, P5116; LAVAL F, 1994, NUCLEIC ACIDS RES, V22, P4943, DOI 10.1093/nar/22.23.4943; Li QO, 1997, CARCINOGENESIS, V18, P1035, DOI 10.1093/carcin/18.5.1035; Lundin A, 2013, CANCER LETT, V338, P89, DOI 10.1016/j.canlet.2012.08.014; Migliaccio AR, 2000, GENE, V256, P197, DOI 10.1016/S0378-1119(00)00353-X; Paul S, 2006, ENVIRON MOL MUTAGEN, V47, P311, DOI 10.1002/em.20208; Phillips DH, 2000, ENVIRON MOL MUTAGEN, V35, P222, DOI 10.1002/(SICI)1098-2280(2000)35:3<222::AID-EM9>3.0.CO;2-E; Pitt SC, 2009, J AM COLL SURGEONS, V209, P82, DOI 10.1016/j.jamcollsurg.2009.03.006; Ropolo M, 2006, INT J CANCER, V118, P1628, DOI 10.1002/ijc.21554; Ropolo M, 2007, FREE RADICAL BIO MED, V42, P1807, DOI 10.1016/j.freeradbiomed.2007.03.008; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Sidorkina OM, 2000, J BIOL CHEM, V275, P9924, DOI 10.1074/jbc.275.14.9924; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Speina E, 2001, J BIOL CHEM, V276, P21821, DOI 10.1074/jbc.M100998200; Tudek B, 1998, MUTAT RES-DNA REPAIR, V407, P169, DOI 10.1016/S0921-8777(98)00005-6; Xu Y, 2001, J PHARMACOL EXP THER, V296, P825; Zharkov DO, 1997, J BIOL CHEM, V272, P5335, DOI 10.1074/jbc.272.8.5335	40	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87984	10.1371/journal.pone.0087984	http://dx.doi.org/10.1371/journal.pone.0087984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498234	Green Submitted, Green Published, gold			2022-12-25	WOS:000330621900202
J	Jia, W; Zhang, R; Wu, B; Dai, ZX; Zhu, YS; Li, PP; Zhu, F				Jia, Wei; Zhang, Rui; Wu, Bin; Dai, Zun-xiao; Zhu, Yong-sheng; Li, Ping-ping; Zhu, Feng			Metabotropic Glutamate Receptor 3 Is Associated with Heroin Dependence but Not Depression or Schizophrenia in a Chinese Population	PLOS ONE			English	Article							CUE-INDUCED REINSTATEMENT; VENTRAL TEGMENTAL AREA; TYPE-3 GENE GRM3; GROUP-II; NUCLEUS-ACCUMBENS; MOOD DISORDERS; JAPANESE POPULATION; AGONIST LY379268; COCAINE; SEEKING	Metabotropic glutamate receptor subtype 3 (mGluR3, encoded by GRM3) plays important roles in the pathophysiology of schizophrenia, depression, and drug dependence. GRM3 polymorphisms were reported to be associated with prefrontal activity, cognitive shifting, and memory capability in healthy subjects, as well as susceptibility to schizophrenia and depression. The goal of this study was to replicate the association of GRM3 with schizophrenia and depression and to explore GRM3's potential association with heroin dependence (HD) in a Chinese population. Seventeen SNPs throughout the GRM3 gene were genotyped using MALDI-TOF within the MassARRAY system, and the allele and genotype distributions were compared between 619 healthy controls and 433 patients with schizophrenia, 409 patients with major depression, and 584 unrelated addicts. We found that GRM3 polymorphisms modulate the susceptibility to HD but do not significantly influence the risk for schizophrenia or depression. An increased risk of HD was significantly associated with the minor alleles of two GRM3 SNPs, including the T allele of rs274618 (Odds ratio (OR) = 1.631, 95% confidence interval (95% CI): 1.317-2.005), the T allele of rs274622 (OR = 1.652, 95% CI: 1.336-2.036), compared with the major alleles. The addicts carrying the minor allele of rs274618 or rs274622 had a shortened duration for transition from first use to dependence (DTFUD) in comparison to homozygote for major allele (P<0.0001 for each SNP using log rank test). Additionally, a 6-SNP haplotype within 5' region of the GRM3 including the minor alleles of the two aforementioned SNPs was significantly associated with an increased risk of HD (P = 0.00001, OR = 1.668, 95% CI: 1.335-2.084). Our data indicated that GRM3 polymorphisms do not contribute to genetic susceptibility to schizophrenia and depression, but they confer an increased risk of HD in a Chinese population.	[Jia, Wei; Zhang, Rui; Wu, Bin; Dai, Zun-xiao] Xian Mental Hlth Ctr, Methadone Maintenance Treatment Clin, Xian, Shannxi, Peoples R China; [Zhu, Yong-sheng] Xi An Jiao Tong Univ, Coll Med, Forens Dept, Xian 710049, Shaanxi, Peoples R China; [Li, Ping-ping; Zhu, Feng] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Ctr Translat Med, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Zhu, YS (corresponding author), Xi An Jiao Tong Univ, Coll Med, Forens Dept, West Yanta Rd, Xian 710049, Shaanxi, Peoples R China.	zhuyongsheng3000@aliyun.com; zhufeng0714@gmail.com	Zhu, Feng/CAH-0203-2022; Li, Ping/GYV-4914-2022	Zhu, Feng/0000-0003-3986-8803; 	Research and Development foundation of Science and Technology of Shaanxi Province [2011k15-01-01]	Research and Development foundation of Science and Technology of Shaanxi Province	The project was supported by the Research and Development foundation of Science and Technology of Shaanxi Province (2011k15-01-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Adewale AS, 2006, J PHARMACOL EXP THER, V318, P922, DOI 10.1124/jpet.106.105387; Albalushi T, 2008, AM J MED GENET B, V147B, P392, DOI 10.1002/ajmg.b.30610; Backstrom P, 2005, EUR J PHARMACOL, V528, P110, DOI 10.1016/j.ejphar.2005.10.051; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baune BT, GENES BRAIN BEHAV, V9, P459; Beneyto M, 2007, NEUROPSYCHOPHARMACOL, V32, P1888, DOI 10.1038/sj.npp.1301312; Bespalov AY, 2008, EUR J PHARMACOL, V592, P96, DOI 10.1016/j.ejphar.2008.06.089; Bishop JR, 2011, HUM PSYCHOPHARM CLIN, V26, P7; Bossert JM, 2005, NEUROREPORT, V16, P1013, DOI 10.1097/00001756-200506210-00026; Bossert JM, 2004, J NEUROSCI, V24, P10726, DOI 10.1523/JNEUROSCI.3207-04.2004; Chen Q, 2005, SCHIZOPHR RES, V73, P21, DOI 10.1016/j.schres.2004.07.002; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Corti C, 2001, BIOCHEM BIOPH RES CO, V286, P381, DOI 10.1006/bbrc.2001.5391; Dalvie S, AFR J PSYCHIAT JOHAN, V13, P297; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Fujii Y, 2003, PSYCHIAT GENET, V13, P71, DOI 10.1097/01.ypg.0000056682.82896.b0; Hashimoto K, 2007, BIOL PSYCHIAT, V62, P1310, DOI 10.1016/j.biopsych.2007.03.017; Herman E J, 2012, Handb Exp Pharmacol, P297, DOI 10.1007/978-3-642-25758-2_11; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kawakubo Y, PLOS ONE, V6; Kenny PJ, 2004, TRENDS PHARMACOL SCI, V25, P265, DOI 10.1016/j.tips.2004.03.009; Kenny PJ, 2003, J PHARMACOL EXP THER, V306, P1068, DOI 10.1124/jpet.103.052027; Kim JH, 2005, EUR J NEUROSCI, V21, P295, DOI 10.1111/j.1460-9568.2004.03822.x; Liechti ME, 2007, J NEUROSCI, V27, P9077, DOI 10.1523/JNEUROSCI.1766-07.2007; Marenco S, 2006, AM J PSYCHIAT, V163, P740, DOI 10.1176/appi.ajp.163.4.740; Marti SB, 2002, AM J MED GENET, V114, P46, DOI 10.1002/ajmg.1624; Martin G, 1999, J PHARMACOL EXP THER, V288, P30; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Morishima Y, 2005, P NATL ACAD SCI USA, V102, P4170, DOI 10.1073/pnas.0500914102; Moussawi K, 2010, EUR J PHARMACOL, V639, P115, DOI 10.1016/j.ejphar.2010.01.030; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Neugebauer V, 2000, J NEUROPHYSIOL, V84, P759, DOI 10.1152/jn.2000.84.2.759; Norton N, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-23; Parsons CG, 2005, HANDB EXP PHARM, V169, P249; Paul IA, 2003, ANN NY ACAD SCI, V1003, P250, DOI 10.1196/annals.1300.016; Peters J, 2006, PSYCHOPHARMACOLOGY, V186, P143, DOI 10.1007/s00213-006-0372-9; Robbe D, 2002, EUR J NEUROSCI, V16, P2231, DOI 10.1046/j.1460-9568.2002.02273.x; Scherer SW, 1996, GENOMICS, V31, P230, DOI 10.1006/geno.1996.0036; Stone JM, 2007, J PSYCHOPHARMACOL, V21, P440, DOI 10.1177/0269881106073126; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; Tochigi M, 2006, SCHIZOPHR RES, V88, P260, DOI 10.1016/j.schres.2006.07.008; Tsunoka T, 2009, PROG NEURO-PSYCHOPH, V33, P875, DOI 10.1016/j.pnpbp.2009.04.007; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Witkin Jeffrey M., 2007, CNS & Neurological Disorders-Drug Targets, V6, P87, DOI 10.2174/187152707780363302; Wright RA, 2001, J PHARMACOL EXP THER, V298, P453; Xi ZX, 2006, J NEUROSCI, V26, P8531, DOI 10.1523/JNEUROSCI.0726-06.2006; Xi ZX, 2002, J PHARMACOL EXP THER, V303, P608, DOI 10.1124/jpet.102.039735; Xi ZX, NEUROPHARMACOLOGY, V58, P304; Zhu F-C, 2013, PLOS ONE IN PRESS	54	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87247	10.1371/journal.pone.0087247	http://dx.doi.org/10.1371/journal.pone.0087247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498053	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900078
J	Wang, F; An, GY; Zhang, Y; Liu, HL; Cui, XS; Kim, NH; Sun, SC				Wang, Fei; An, Ga-Young; Zhang, Yu; Liu, Hong-Lin; Cui, Xiang-Shun; Kim, Nam-Hyung; Sun, Shao-Chen			Arp2/3 Complex Inhibition Prevents Meiotic Maturation in Porcine Oocytes	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; ASYMMETRIC DIVISION; CUMULUS EXPANSION; CORTICAL POLARITY; MOUSE; SPINDLE; NUCLEATOR; FILOPODIA; NETWORK; CELLS	The Arp2/3 complex regulates actin nucleation, which is critical for a wide range of cellular processes, such as cell polarity, cell locomotion, and endocytosis. In the present study, we investigated the possible roles of the Arp2/3 complex in porcine oocytes during meiotic maturation. Immunofluorescent staining showed the Arp2/3 complex to localize mainly to the cortex of porcine oocytes, colocalizing with actin. Treatment with an Arp2/3 complex specific inhibitor, CK666, resulted in a decrease in Arp2/3 complex localization at the oocyte cortex. The maturation rate of porcine oocytes decreased significantly after CK666 treatment, concomitant with the failure of cumulus cell expansion and oocyte polar body extrusion. The fluorescence intensity of F-actin decreased in the cytoplasm, and CK666 also disrupted actin cap formation. In summary, our results illustrate that the Arp2/3 complex is required for the meiotic maturation of porcine oocytes and that actin nucleation is critical for meiotic maturation.	[Wang, Fei; Liu, Hong-Lin; Sun, Shao-Chen] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [An, Ga-Young; Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea; [Zhang, Yu] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Chungbuk National University; Nanjing Agricultural University	Sun, SC (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	sunsc@njau.edu.cn	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	National Basic Research Program of China [2014CB138503]; Natural Science Foundation of Jiangsu Province, China [BK20130671]; BioGreen 21 Program, RDA, Republic of Korea [PJ009594, PJ00909801]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); BioGreen 21 Program, RDA, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the National Basic Research Program of China (2014CB138503); the Natural Science Foundation of Jiangsu Province (BK20130671), China; and the BioGreen 21 Program (PJ009594 & PJ00909801), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; CHEN L, 1993, MOL REPROD DEV, V34, P87, DOI 10.1002/mrd.1080340114; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Deng MQ, 2003, DEV BIOL, V257, P166, DOI 10.1016/S0012-1606(03)00045-9; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Halet G, 2007, DEV CELL, V12, P309, DOI 10.1016/j.devcel.2006.12.010; Hess KA, 1999, BIOL REPROD, V61, P436, DOI 10.1095/biolreprod61.2.436; Johnston SA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-65; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052277; Liu R, 2009, DEVELOPMENT, V136, P2849, DOI 10.1242/dev.035246; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Maddox AS, 2012, CYTOSKELETON, V69, P855, DOI 10.1002/cm.21064; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Moreau V, 1997, MOL BIOL CELL, V8, P1361, DOI 10.1091/mbc.8.7.1361; Na J, 2006, CURR BIOL, V16, P1249, DOI 10.1016/j.cub.2006.05.023; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221; Sun SC, 2013, MICROSC MICROANAL, V19, P883, DOI 10.1017/S1431927613001566; Sun SC, 2011, MOL HUM REPROD, V17, P296, DOI 10.1093/molehr/gar006; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; VANBLERKOM J, 1986, J EMBRYOL EXP MORPH, V93, P213; VANDERHYDEN BC, 1989, BIOL REPROD, V40, P720, DOI 10.1095/biolreprod40.4.720; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87700	10.1371/journal.pone.0087700	http://dx.doi.org/10.1371/journal.pone.0087700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498171	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900155
J	Wang, JC; Guo, XJ; Yi, L; Guo, G; Tu, WZ; Wu, WY; Yang, L; Xiao, R; Li, Y; Chu, HY; He, DY; Jin, L; Mayes, MD; Zou, HJ; Zhou, XD				Wang, Jiucun; Guo, Xinjian; Yi, Lin; Guo, Gang; Tu, Wenzhen; Wu, Wenyu; Yang, Li; Xiao, Rong; Li, Yuan; Chu, Haiyan; He, Dongyi; Jin, Li; Mayes, Maureen D.; Zou, Hejian; Zhou, Xiaodong			Association of HLA-DPB1 with Scleroderma and Its Clinical Features in Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SYSTEMIC-SCLEROSIS; AUTOANTIBODIES; SUSCEPTIBILITY; GENETICS	Human leukocyte antigen DPB1 was reported to contain singly nucleotide polymorphisms conferring the strongest susceptibility to systemic sclerosis in Korean population. However, associations of specific DPB1 alleles with SSc vary in different ethnic populations. The aim of this study was to profile DPB1 alleles in Chinese population and to identify specific DPB1 alleles in association with SSc and clinical and serological features of SSc in Han Chinese. A cohort containing 338 patients with SSc and 480 gender-matched and unrelated controls were examined in the study. The HLA-DPB1 genotyping was performed with sequence-based typing method. Exact p-values were obtained (Fisher's test) from 2x2 tables of allele counts or allele carriers and disease status. Thirty eight DPB1 alleles were found in the cohort. DPB1*05:01 was the most common allele in this cohort. DPB1*03:01 and *13:01 were significantly increased in SSc. DPB1*13:01 association had already been described in other ethnic populations, whereas DPB1*03:01 was specific to Han Chinese patients with SSc. In addition, comparisons between SSc subsets indicated that patients carrying DPB1*03:01 were more likely to develop pulmonary fibrosis, DPB1*04 carriers were increased in SSc patients with anti-centromere autoantibodies and in contrast, SSc patients with homozygous DPB1*05:01 showed an opposite association with marginal significance.	[Wang, Jiucun; Li, Yuan; Chu, Haiyan; Jin, Li] Fudan Univ, MOE, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Wang, Jiucun; Li, Yuan; Chu, Haiyan; Jin, Li] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Jiucun; Zou, Hejian] Fudan Univ, Inst Rheumatol Immunol & Allergy, Shanghai 200433, Peoples R China; [Guo, Xinjian; Yi, Lin; Mayes, Maureen D.; Zhou, Xiaodong] Univ Texas Med Sch Houston, Div Rheumatol & Clin Immunogenet, Houston, TX 77030 USA; [Yi, Lin] Gansu Coll Tradit Chinese Med, Lanzhou, Gansu, Peoples R China; [Guo, Gang] Yiling Hosp, Shijiazhuang, Hebei Province, Peoples R China; [Tu, Wenzhen] Shanghai Tradit Chinese Med Integrated Hosp, Shanghai, Peoples R China; [Wu, Wenyu] Fudan Univ, Huashan Hosp, Div Dermatol, Shanghai 200433, Peoples R China; [Yang, Li] Chengdu Univ TCM, Teaching Hosp, Div Rheumatol, Chengdu, Sichuan Provinc, Peoples R China; [Xiao, Rong] Cent S Univ, Xiangya Hosp 2, Dept Dermatol, Changsha, Hunan, Peoples R China; [He, Dongyi] Shanghai Guanghua Hosp, Dept Rheumatol, Shanghai, Peoples R China; [Zou, Hejian] Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; University of Texas System; University of Texas Health Science Center Houston; Gansu University of Chinese Medicine; Fudan University; Chengdu University of Traditional Chinese Medicine; Central South University; Fudan University	Zhou, XD (corresponding author), Univ Texas Med Sch Houston, Div Rheumatol & Clin Immunogenet, Houston, TX 77030 USA.	xiaodong.zhou@uth.tmc.edu	Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; Wang, Jiucun/J-8744-2012	Jin, Li/0000-0002-4546-2415; Wang, Jiucun/0000-0003-2765-0620	US NIH NIAID UO1 [1U01AI09090]; Science and Technology Committee of Shanghai Municipality [11410701800]; International S&T Cooperation Program of China [2013DFA30870]; National Basic Research Program [2012CB944600]; Ministry of Science and Technology [2011BAI09B00]; Ministry of Health [201002007]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI090909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055258] Funding Source: NIH RePORTER	US NIH NIAID UO1; Science and Technology Committee of Shanghai Municipality(Shanghai Science & Technology Committee); International S&T Cooperation Program of China; National Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The studies were supported by research grants from the US NIH NIAID UO1, 1U01AI09090 and the Science and Technology Committee of Shanghai Municipality (11410701800), International S&T Cooperation Program of China (2013DFA30870), the National Basic Research Program (2012CB944600), Ministry of Science and Technology (2011BAI09B00), Ministry of Health (201002007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Arnett FC, 2010, ANN RHEUM DIS, V69, P822, DOI 10.1136/ard.2009.111906; Broen JCA, 2012, CURR RHEUMATOL REP, V14, P11, DOI 10.1007/s11926-011-0221-7; Bunn CC, 1999, CLIN EXP IMMUNOL, V117, P207; Gilchrist FC, 2001, GENES IMMUN, V2, P76, DOI 10.1038/sj.gene.6363734; Kuwana M, 1999, INTERNAL MED, V38, P336, DOI 10.2169/internalmedicine.38.336; LEROY EC, 1988, J RHEUMATOL, V15, P202; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Romano E, 2011, CLIN EXP RHEUMATOL, V29, pS75; Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; Tikly M, 2004, TISSUE ANTIGENS, V63, P487, DOI 10.1111/j.0001-2815.2004.00199.x; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Wang JC, 2013, CLIN RHEUMATOL, V32, P617, DOI 10.1007/s10067-012-2145-7; Zhou XD, 2013, INT J IMMUNOPATH PH, V26, P747, DOI 10.1177/039463201302600318; Zhou XD, 2009, ARTHRITIS RHEUM-US, V60, P3807, DOI 10.1002/art.24982	15	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87363	10.1371/journal.pone.0087363	http://dx.doi.org/10.1371/journal.pone.0087363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498086	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900099
J	White, M; Webster, G; O'Sullivan, D; Stone, S; La Flamme, AC				White, Madeleine; Webster, Gill; O'Sullivan, David; Stone, Sarrabeth; La Flamme, Anne Camille			Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; IFN-GAMMA; INTERFERON-GAMMA; CELL-FUNCTION; IMMUNE-RESPONSES; IN-VIVO; MICE; DNA	Modification of the innate immune cell environment has recently been recognized as a viable treatment strategy for reducing autoimmune disease pathology. MIS416 is a microparticulate immune response modifier that targets myeloid cells, activating cytosolic receptors NOD2 and TLR9, and has completed a phase 1b/2a trial for the treatment of secondary progressive multiple sclerosis. Using a mouse model of multiple sclerosis, we are investigating the pathways by which activation of TLR9 and NOD2 may modify the innate immune environment and the subsequent T cell-mediated autoimmune responses. We have found that MIS416 has profound effects on the Th subset balance by depressing antigen-specific Th1, Th17, and Th2 development. These effects coincided with an expansion of specific myeloid subpopulations and increased levels of MIS416-stimulated IFN-gamma by splenocytes. Additionally, systemic IFN-gamma serum levels were enhanced and correlated strongly with disease reduction, and the protective effect of MIS416 was abrogated in IFN-gamma-deficient animals. Finally, treatment of secondary progressive MS patients with MIS416 similarly elevated the levels of IFN-gamma and IFN-gamma-associated proteins in the serum. Together, these studies demonstrate that administration of MIS416, which targets innate cells, reshapes autoimmune T cell responses and leads to a significant reduction in CNS inflammation and disease.	[White, Madeleine; O'Sullivan, David; Stone, Sarrabeth; La Flamme, Anne Camille] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Webster, Gill] Innate Immunotherapeut, Auckland, New Zealand; [La Flamme, Anne Camille] Malaghan Inst Med Res, Wellington, New Zealand	Victoria University Wellington; Malaghan Institute; Victoria University Wellington	La Flamme, AC (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	anne.laflamme@vuw.ac.nz		White, Madeleine/0000-0002-0152-1110; Stone, Sarrabeth/0000-0001-7866-8228	Great New Zealand Trek; Innate Immunotherapeutics, a New Zealand unlisted public biotechnology company	Great New Zealand Trek; Innate Immunotherapeutics, a New Zealand unlisted public biotechnology company	This work was supported primarily by generous donations from the Great New Zealand Trek. Funds were also provided by Innate Immunotherapeutics, a New Zealand unlisted public biotechnology company. GW, who is an employee of Innate Immunotherapeutics, contributed to the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Arora M, 2011, INT IMMUNOPHARMACOL, V11, P827, DOI 10.1016/j.intimp.2011.01.034; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Balashov KE, 2010, ANN NEUROL, V68, P899, DOI 10.1002/ana.22136; Berghmans N, 2011, J INTERF CYTOK RES, V31, P575, DOI 10.1089/jir.2010.0137; BILLIAU A, 1988, J IMMUNOL, V140, P1506; Boccaccio GL, 1999, INT IMMUNOL, V11, P289, DOI 10.1093/intimm/11.2.289; Bronstein-Sitton N, 2003, NAT IMMUNOL, V4, P957, DOI 10.1038/ni975; Carty M, 2011, BIOCHEM PHARMACOL, V81, P825, DOI 10.1016/j.bcp.2011.01.003; Castellaneta A, 2009, J IMMUNOL, V183, P6922, DOI 10.4049/jimmunol.0900582; Ferber IA, 1996, J IMMUNOL, V156, P5; Furlan R, 2001, J IMMUNOL, V167, P1821, DOI 10.4049/jimmunol.167.3.1821; Girvan RC, 2011, VACCINE, V29, P545, DOI 10.1016/j.vaccine.2010.10.040; Gran B, 2004, J NEUROIMMUNOL, V156, P123, DOI 10.1016/j.jneuroim.2004.07.019; Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486; Haas J, 2009, J NEUROIMMUNOL, V216, P113, DOI 10.1016/j.jneuroim.2009.06.011; Hayashi T, 2009, P NATL ACAD SCI USA, V106, P2764, DOI 10.1073/pnas.0813037106; Hedegaard CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020253; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Kwidzinski E, 2005, FASEB J, V19, P1347, DOI 10.1096/fj.04-3228fje; La Flamme AC, 2006, IMMUNOL CELL BIOL, V84, P522, DOI 10.1111/j.1440-1711.2006.01464.x; Lobell A, 1999, J IMMUNOL, V163, P4754; Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187; Minguela A, 2007, J IMMUNOL, V178, P134, DOI 10.4049/jimmunol.178.1.134; Miranda-Hernandez S, 2011, J IMMUNOL, V187, P791, DOI 10.4049/jimmunol.1001992; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; O'Brien K, 2010, J NEUROIMMUNOL, V221, P107, DOI 10.1016/j.jneuroim.2010.01.006; Palma E, 2007, J CONTROL RELEASE, V120, P95, DOI 10.1016/j.jconrel.2007.03.016; PANITCH HS, 1987, NEUROLOGY, V37, P1097, DOI 10.1212/WNL.37.7.1097; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; ROOTBERNSTEIN RS, 1986, BRAIN RES BULL, V17, P473, DOI 10.1016/0361-9230(86)90213-3; Sabatino JJ, 2008, J IMMUNOL, V180, P4451, DOI 10.4049/jimmunol.180.7.4451; Satoh J, 2005, NEUROBIOL DIS, V18, P537, DOI 10.1016/j.nbd.2004.10.007; Sawcer S, 2003, J NEUROL NEUROSUR PS, V74, P1157, DOI 10.1136/jnnp.74.8.1157; Schrijver IA, 2001, BRAIN, V124, P1544, DOI 10.1093/brain/124.8.1544; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Slaney CY, 2011, IMMUNOL CELL BIOL, V89, P7, DOI 10.1038/icb.2010.110; Sriram S, 2005, ANN NEUROL, V58, P939, DOI 10.1002/ana.20743; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Tierney JB, 2009, IMMUNOL CELL BIOL, V87, P235, DOI 10.1038/icb.2008.99; Touil T, 2006, J IMMUNOL, V177, P7505, DOI 10.4049/jimmunol.177.11.7505; Tsunoda I, 1999, BRAIN PATHOL, V9, P481, DOI 10.1111/j.1750-3639.1999.tb00537.x; VOORTHUIS JAC, 1990, CLIN EXP IMMUNOL, V81, P183; WALDER P, 1991, IMMUNOPHARM IMMUNOT, V13, P101, DOI 10.3109/08923979109019694; Waldner H, 2009, AUTOIMMUN REV, V8, P400, DOI 10.1016/j.autrev.2008.12.019; Weiner HL, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-1002-8; Weir C, 2006, J NEUROIMMUNOL, V179, P18, DOI 10.1016/j.jneuroim.2006.06.021; Willenborg DO, 1999, J IMMUNOL, V163, P5278; Zhang JW, 2007, J CLIN INVEST, V117, P871, DOI 10.1172/JCI31860; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029	51	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87712	10.1371/journal.pone.0087712	http://dx.doi.org/10.1371/journal.pone.0087712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498172	Green Submitted, gold, Green Published			2022-12-25	WOS:000330621900156
J	Ezcurra, MD				Ezcurra, Martin D.			The Osteology of the Basal Archosauromorph Tasmaniosaurus triassicus from the Lower Triassic of Tasmania, Australia	PLOS ONE			English	Article							TEMNOSPONDYL AMPHIBIANS; AXIAL SKELETON; KAROO BASIN; REPTILE; SKULL; PHYLOGENY; EVOLUTION; REDESCRIPTION; REVISION; REAPPRAISAL	Proterosuchidae are the most taxonomically diverse archosauromorph reptiles sampled in the immediate aftermath of the Permo-Triassic mass extinction and represent the earliest radiation of Archosauriformes (archosaurs and closely related species). Proterosuchids are potentially represented by approximately 15 nominal species collected from South Africa, China, Russia, Australia and India, but the taxonomic content of the group is currently in a state of flux because of the poor anatomic and systematic information available for several of its putative members. Here, the putative proterosuchid Tasmaniosaurus triassicus from the Lower Triassic of Hobart, Tasmania (Australia), is redescribed. The holotype and currently only known specimen includes cranial and postcranial remains and the revision of this material sheds new light on the anatomy of the animal, including new data on the cranial endocast. Several bones are re-identified or reinterpreted, contrasting with the descriptions of previous authors. The new information provided here shows that Tasmaniosaurus closely resembles the South African proterosuchid Proterosuchus, but it differed in the presence of, for example, a slightly downturned premaxilla, a shorter anterior process of maxilla, and a diamond-shaped anterior end of interclavicle. Previous claims for the presence of gut contents in the holotype of Tasmaniosaurus are considered ambiguous. The description of the cranial endocast of Tasmaniosaurus provides for the first time information about the anatomy of this region in proterosuchids. The cranial endocast preserves possibly part of the vomero-nasal (= Jacobson's) system laterally to the olfactory bulbs. Previous claims of the absence of the vomero-nasal organs in archosaurs, which is suggested by the extant phylogenetic bracket, are questioned because its absence in both clades of extant archosaurs seems to be directly related with the independent acquisition of a non-ground living mode of life.	[Ezcurra, Martin D.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Ezcurra, Martin D.] Univ Munich, GeoBioctr, Munich, Germany	University of Birmingham; University of Munich	Ezcurra, MD (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.	martindezcurra@yahoo.com.ar			DFG Emmy Noether Programme [BU 2587/3-1]	DFG Emmy Noether Programme(German Research Foundation (DFG))	The research was funded by a grant of the DFG Emmy Noether Programme to Richard Butler (BU 2587/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcucci A, 1998, J VERTEBR PALEONTOL, V18, P228, DOI 10.1080/02724634.1998.10011046; Banks M.R., 1978, Australian Natural History, V19, P150; BANKS MR, 1967, PAPERS P ROYAL SOC T, V101, P17; Bennett SC, 1996, ZOOL J LINN SOC-LOND, V118, P261, DOI 10.1111/j.1096-3642.1996.tb01267.x; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; BENTON MJ, 1985, ZOOL J LINN SOC-LOND, V84, P97, DOI 10.1111/j.1096-3642.1985.tb01796.x; BERTMAR G, 1981, EVOLUTION, V35, P359, DOI 10.1111/j.1558-5646.1981.tb04893.x; Bhatnagar KP, 1998, MICROSC RES TECHNIQ, V43, P465, DOI 10.1002/(SICI)1097-0029(19981215)43:6<465::AID-JEMT1>3.0.CO;2-1; Botha-Brink J, 2011, J VERTEBR PALEONTOL, V31, P1238, DOI 10.1080/02724634.2011.621797; Broili F, 1934, SITZUNGSBERICHTE BAY, V3, P225; Broom R, 1906, P ZOOL SOC LOND, V1906, P591; Butler RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025693; Butler RJ, 2009, J VERTEBR PALEONTOL, V29, P1022, DOI 10.1671/039.029.0404; Camp CL, 1978, ALCHERINGA, V2, P143, DOI 10.1080/03115517808619085; CAMP CHARLES L., 1930, MEM UNIV CALIFORNIA, V10, P1; CARROLL R L, 1976, Annals of the South African Museum, V72, P37; Charig A. J, 1970, Biol. J., V2, P125, DOI 10.1111/j.1095-8312.1970.tb01708.x; Charig AJ, 1976, HDB PALAOHERPETOLOGI, V13, P11; Cheng ZW, 1980, MESOZOIC STRATIGRAPH, P114; Chiappe L.M., 2007, GLORIFIED DINOSAURS; Cosgriff J.W., 1974, Special Pap geol Soc Am, VNo. 149, P1; Cruickshank A.R.I., 1972, P89; Damiani RJ, 2004, GONDWANA RES, V7, P165, DOI 10.1016/S1342-937X(05)70315-4; Damiani RJ, 2001, ZOOL J LINN SOC-LOND, V133, P379, DOI 10.1006/zjls.2001.0304; Desojo JB, 2011, J VERTEBR PALEONTOL, V31, P596, DOI 10.1080/02724634.2011.572936; Dias-da-Silva S, 2011, J SYST PALAEONTOL, V9, P305, DOI 10.1080/14772019.2010.492664; Dilkes D, 2009, J VERTEBR PALEONTOL, V29, P58, DOI 10.1080/02724634.2009.10010362; Dilkes DW, 1998, PHILOS T ROY SOC B, V353, P501, DOI 10.1098/rstb.1998.0225; DZIEWA T J, 1980, Papers and Proceedings of the Royal Society of Tasmania, V114, P145; Edinger L, 1908, J COMP NEUROL PSYCHO, V18, P437, DOI 10.1002/cne.920180502; EVANS SE, 1981, ZOOL J LINN SOC-LOND, V73, P81, DOI 10.1111/j.1096-3642.1981.tb01580.x; EVANS SE, 1980, ZOOL J LINN SOC-LOND, V70, P203, DOI 10.1111/j.1096-3642.1980.tb00852.x; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Ezcurra MD, 2010, J VERTEBR PALEONTOL, V30, P1433, DOI 10.1080/02724634.2010.501446; Ezcurra MD, 2013, GEOL SOC LOND SPEC P, DOI [10.1144/SP379.11, DOI 10.1144/SP379.11)]; Ezcurra MD, 2012, REUN AN EST PAL 2012, P18; Forsyth S., 1974, PAP P R SOC TASMANIA, V108, P107, DOI [10.26749/rstpp.108.107, DOI 10.26749/RSTPP.108.107]; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gauthier J, 1984, THESIS U CALIFORNIA; GITTLEMAN JL, 1991, J ZOOL, V225, P253, DOI 10.1111/j.1469-7998.1991.tb03815.x; Gorman M.L., 1989, P57; Gottmann-Quesada A, 2009, PALAEONTOGR ABT A, V287, P123; GOW C E, 1975, Palaeontologia Africana, V18, P89; Gower David J., 2000, P140; Gower David John, 2003, Annals of the South African Museum, V110, P1; Gower DJ, 1997, J VERTEBR PALEONTOL, V17, P60, DOI 10.1080/02724634.1997.10010954; Gower DJ, 1996, ZOOL J LINN SOC-LOND, V116, P347, DOI 10.1006/zjls.1996.0024; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Heckert AB, 2006, PALAEONTOLOGY, V49, P621, DOI 10.1111/j.1475-4983.2006.00556.x; Hewison RH, 1996, PALAEONTOLOGY, V39, P305; Hopson J.A., 1979, P39; Huene F. F. von, 1960, Palaeontographica A, V114, P105; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Juul Lars, 1994, Palaeontologia Africana, V31, P1; LAURIN M, 1991, ZOOL J LINN SOC-LOND, V101, P59, DOI 10.1111/j.1096-3642.1991.tb00886.x; Macdonald D.W., 1985, P619; Maier W., 1980, P219; Martinelli AG, 2008, CR PALEVOL, V7, P371, DOI 10.1016/j.crpv.2008.05.002; Meyer H.von., 1830, ISIS OKEN, V1830, P517; Modesto SR, 2004, ZOOL J LINN SOC-LOND, V140, P335, DOI 10.1111/j.1096-3642.2003.00102.x; Negus V., 1958, COMP ANATOMY PHYSL N; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2010, EARTH ENV SCI T R SO, V101, P271, DOI 10.1017/S1755691011020044; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2009, ZOOL J LINN SOC-LOND, V157, P814, DOI 10.1111/j.1096-3642.2009.00530.x; Nosotti Stefania, 2007, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V35, P1; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Osborn HF, 1903, MEM AM MUS NAT HIST, V1, P449; Parrington F. R., 1935, Annals & Magazine of Natural History, V16, P197; Piechowski R, 2010, J VERTEBR PALEONTOL, V30, P1127, DOI 10.1080/02724634.2010.483547; PRITZ MB, 1975, J COMP NEUROL, V164, P323, DOI 10.1002/cne.901640305; REIG O, 1970, Bulletin of the Museum of Comparative Zoology, V139, P229; RIEPPEL O, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V208, P123; Romer A. S., 1971, Breviora, VNo. 379, P1; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Sampson SD, 2010, MEM SOC VERT PALEONT, V8, P32; Sennikov A.G., 1997, PALEONTOL J, V31, P94; Sennikov AG, 1996, PALAEOGEOGR PALAEOCL, V120, P331, DOI 10.1016/0031-0182(95)00041-0; Senter P, 2002, PALEOBIOLOGY, V28, P544, DOI 10.1666/0094-8373(2002)028<0544:LOAPSI>2.0.CO;2; SHUBIN NH, 1991, PALEOBIOLOGY, V17, P214, DOI 10.1017/S0094837300010575; Spielmann J.A., 2008, NEW MEXICO MUSEUM NA, V43, P1; Spielmann Justin A., 2009, Palaeodiversity, P283; Steyer JS, 2003, J VERTEBR PALEONTOL, V23, P544, DOI 10.1671/1740; Stocker MR, 2013, GEOL SOC LOND SPEC P, P379, DOI [10.1144/SP379.5, DOI 10.1144/SP379.5)]; Sues H-D, 2013, GEOL SOC LOND SPEC P, V379, DOI [10.1144/SP379.13, DOI 10.1144/SP379.13)]; Sues HD, 2003, CAN J EARTH SCI, V40, P635, DOI 10.1139/E02-048; Sulej T, 2010, ZOOL J LINN SOC-LOND, V158, P860, DOI 10.1111/j.1096-3642.2009.00566.x; Tatarinov LP., 1961, PALEONTOL ZH, V1961, P117; Tatarinov LP., 1960, PALEONTOL J, V1960, P74; THULBORN R A, 1979, Memoirs of the Queensland Museum, V19, P331; Thulborn R.A., 1986, Journal of Vertebrate Paleontology, V6, P123; von Huene FRF, 1946, BIOL ZBL, V65, P268; Warren A, 2000, J VERTEBR PALEONTOL, V20, P462, DOI 10.1671/0272-4634(2000)020[0462:APOTBT]2.0.CO;2; Warren A., 1972, Australian nat Hist, V17, P279; Warren AA, 2006, GEOL MAG, V143, P877, DOI 10.1017/S0016756806002524; WARREN AA, 1990, ALCHERINGA, V14, P149, DOI 10.1080/03115519008527816; WEEMS RE, 1980, T AM PHILOS SOC, V70, P3; Welman J, 1998, J VERTEBR PALEONTOL, V18, P340, DOI 10.1080/02724634.1998.10011062; Whitfield A, 2010, THESIS U TASMANIA HO; WIBLE JR, 1990, ZOOL J LINN SOC-LOND, V98, P203, DOI 10.1111/j.1096-3642.1990.tb01207.x; Wild R., 1973, ABHANDLUNGEN SCHWEIZ, V95, P1; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; WITMER LM, 1995, J MORPHOL, V225, P269, DOI 10.1002/jmor.1052250304; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 1999, J VERTEBR PALEONTOL, V19, P302, DOI 10.1080/02724634.1999.10011143; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; Young C. C., 1936, Bulletin of the Geological Society of China, V15, P291; Young C. C., 1964, Palaeontologia Sinica No 151 NS G, VNo. 19, P1	111	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86864	10.1371/journal.pone.0086864	http://dx.doi.org/10.1371/journal.pone.0086864			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497988	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100036
J	Lukasz, A; Hoffmeister, B; Graf, B; Wolk, B; Noeckler, K; Bode-Boger, SM; Hadem, J; Pischke, S; Kielstein, JT				Lukasz, Alexander; Hoffmeister, Bodo; Graf, Barbara; Woelk, Benno; Noeckler, Karsten; Bode-Boeger, Stefanie M.; Hadem, Johannes; Pischke, Sven; Kielstein, Jan T.			Association of Angiopoietin-2 and Dimethylarginines with Complicated Course in Patients with Leptospirosis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; CIRCULATING ANGIOPOIETIN-2; PLASMA-EXCHANGE; ADMA	Leptospirosis is one of the most relevant zoonosis worldwide and a potentially life-threatening infectious disease. While it is frequent in tropic regions, it is uncommon in European industrialized countries. Angiopoietin-2 (Angpt-2) and asymmetric and symmetric dimethylarginine (ADMA and SDMA) are markers of endothelial activation and systemic inflammation. These parameters have been studied recently in the context of sepsis and MODS showing potential to determine disease severity and outcome specific parameters like acute kidney injury (AKI) and survival. These biomarkers were measured in 13 patients with leptospirosis. High levels of Angpt-2 were statistically significant associated with a complicated clinical course with occurrence of AKI, Sepsis and intensive care unit treatment. ADMA was significantly associated with occurrence of AKI and ICU treatment whereas SDMA was associated with AKI. Therefore these endothelial markers may serve as additional tools for risk stratification in these patients.	[Lukasz, Alexander; Kielstein, Jan T.] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany; [Lukasz, Alexander] Univ Hosp Muenster, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany; [Hoffmeister, Bodo] Charite, Dept Infect Dis & Pulmonol, D-13353 Berlin, Germany; [Graf, Barbara] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Woelk, Benno] Hannover Med Sch, Inst Virol, Hannover, Germany; [Noeckler, Karsten] Bundesinst Risikobewertung, Abt Biol Sicherheit, Berlin, Germany; [Bode-Boeger, Stefanie M.] Otto Von Guericke Univ, Inst Clin Pharmacol, Magdeburg, Germany; [Hadem, Johannes; Pischke, Sven] Hannover Med Sch, Dept Gastroenterol & Hepatol, Hannover, Germany	Hannover Medical School; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School; Federal Institute for Risk Assessment; Otto von Guericke University; Hannover Medical School	Lukasz, A (corresponding author), Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany.	alexander-henrik.lukasz@ukmuenster.de	Kielstein, Jan T./I-2956-2019	Kielstein, Jan T./0000-0001-8110-9064	department of Nephrology & Hypertension (Hannover Medical School); DFG	department of Nephrology & Hypertension (Hannover Medical School); DFG(German Research Foundation (DFG))	The funding of this study exists in measuring circulating biomarkers in patients' sera. The measurements were financed by remaining capital of a research account of the department of Nephrology & Hypertension (Hannover Medical School). The publication of the study is also supported by the DFG-project "Open Access Publication." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Cerdas-Quesada C, 2011, TRANSFUS APHER SCI, V45, P191, DOI 10.1016/j.transci.2011.07.012; Davis JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017260; Hoffmeister B, 2010, AM J TROP MED HYG, V83, P326, DOI 10.4269/ajtmh.2010.10-0040; Kielstein JT, 2011, AM J PHYSIOL-RENAL, V301, pF1042, DOI 10.1152/ajprenal.00640.2010; Kielstein JT, 2011, NEPHROL DIAL TRANSPL, V26, P324, DOI 10.1093/ndt/gfq395; Lovric S, 2010, THROMB HAEMOSTASIS, V104, P1038, DOI 10.1160/TH10-02-0138; Lukasz A, 2008, CRIT CARE, V12, DOI 10.1186/cc6966; Martin J, 2006, CONTEMP PSYCHOANAL, V42, P488; Martinez-Lopez DG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000918; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Plank R, 2000, MICROBES INFECT, V2, P1265, DOI 10.1016/S1286-4579(00)01280-6; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; Velissaris D, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/532376; Zoccali C, 2007, NEPHROL DIAL TRANSPL, V22, P801, DOI 10.1093/ndt/gfl719	15	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87490	10.1371/journal.pone.0087490	http://dx.doi.org/10.1371/journal.pone.0087490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498116	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100087
J	Megison, ML; Gillory, LA; Stewart, JE; Nabers, HC; Mroczek-Musulman, E; Waters, AM; Coleman, JM; Kelly, V; Markert, JM; Gillespie, GY; Friedman, GK; Beierle, EA				Megison, Michael L.; Gillory, Lauren A.; Stewart, Jerry E.; Nabers, Hugh C.; Mroczek-Musulman, Elizabeth; Waters, Alicia M.; Coleman, Jennifer M.; Kelly, Virginia; Markert, James M.; Gillespie, G. Yancey; Friedman, Gregory K.; Beierle, Elizabeth A.			Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors	PLOS ONE			English	Article							PRIMITIVE NEUROECTODERMAL TUMOR; IONIZING-RADIATION; RENAL TUMORS; RHABDOID TUMORS; REPLICATION; THERAPY; CANCER; KIDNEY; HEPATOBLASTOMA; EXPERIENCE	Recently, investigators showed that mice with syngeneic murine gliomas that were treated with a neuroattenuated oncolytic herpes simplex virus-1 (oHSV), M002, had a significant increase in survival. M002 has deletions in both copies of the gamma(1)34.5 gene, enabling replication in tumor cells but precluding infection of normal cells. Previous studies have shown antitumor effects of other oHSV against a number of adult tumors including hepatocellular carcinoma and renal cell carcinoma. The purpose of the current study was to investigate the oncolytic potential of M002 against difficult to treat pediatric liver and kidney tumors. We showed that the oHSV, M002, infected, replicated, and decreased cell survival in hepatoblastoma, malignant rhabdoid kidney tumor, and renal sarcoma cell lines. In addition, we showed that in murine xenografts, treatment with M002 significantly increased survival and decreased tumor growth. Finally, these studies showed that the primary entry protein for oHSV, CD111 (nectin-1) was present in human hepatoblastoma and malignant rhabdoid kidney tumor specimens. We concluded that M002 effectively targeted these rare aggressive tumor types and that M002 may have potential for use in children with unresponsive or relapsed pediatric solid tumors.	[Megison, Michael L.; Gillory, Lauren A.; Stewart, Jerry E.; Nabers, Hugh C.; Waters, Alicia M.; Beierle, Elizabeth A.] Univ Alabama Birmingham, Dept Surg, Div Pediat Surg, Birmingham, AL 35294 USA; [Mroczek-Musulman, Elizabeth] Childrens Alabama, Dept Pathol, Birmingham, AL USA; [Coleman, Jennifer M.; Markert, James M.; Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA; [Kelly, Virginia; Friedman, Gregory K.] Univ Alabama Birmingham, Div Hematol Oncol, Dept Pediat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Beierle, EA (corresponding author), Univ Alabama Birmingham, Dept Surg, Div Pediat Surg, Birmingham, AL 35294 USA.	elizabeth.beierle@childrensal.org		Gillespie, George/0000-0001-6436-9542; Beierle, Elizabeth/0000-0002-4613-0527; Friedman, Gregory/0000-0002-6653-7420	National Cancer Institute [T32CA091078, K08CA118178, P20CA151129]; St. Baldrick's Foundation; UAB [P30 AR048311, P30 AI027767]; NATIONAL CANCER INSTITUTE [P20CA151129, T32CA091078, K08CA118178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St. Baldrick's Foundation; UAB; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Cancer Institute including T32CA091078 (M. L. M., L. A. G. and A. M. W.), K08CA118178 (E. A. B.) and P20CA151129 (G.Y.G., J.M.M.). The content of this manuscript was solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute. G. K. F. is supported by a grant from St. Baldrick's Foundation. The authors would also like to thank the support of the UAB Comprehensive Flow Cytometry Core (Grants P30 AR048311 and P30 AI027767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adusumilli PS, 2007, ANN SURG ONCOL, V14, P258, DOI 10.1245/s10434-006-9127-4; Adusumilli PS, 2005, ANN THORAC SURG, V80, P409, DOI 10.1016/j.athoracsur.2005.01.048; Advani SJ, 2011, GENE THER, V18, P1098, DOI 10.1038/gt.2011.61; Advani SJ, 1998, GENE THER, V5, P160, DOI 10.1038/sj.gt.3300546; Allan BJ, 2013, HPB OXFORD, DOI [10.1111/hpb.12112, DOI 10.1111/HPB.12112.[]; Amar AM, 2001, J PEDIAT HEMATOL ONC, V23, P105, DOI 10.1097/00043426-200102000-00007; Andreansky S, 1998, GENE THER, V5, P121, DOI 10.1038/sj.gt.3300550; Argnani R, 2011, LIVER INT, V31, P1542, DOI 10.1111/j.1478-3231.2011.02628.x; Beierle EA, 2010, CELL CYCLE, V9, P1005, DOI 10.4161/cc.9.5.10936; Bharatan NS, 2002, J PEDIAT HEMATOL ONC, V24, P447, DOI 10.1097/00043426-200208000-00008; Blank SV, 2002, HUM GENE THER, V13, P627, DOI 10.1089/10430340252837224; Chung SM, 2002, GENE THER, V9, P75, DOI 10.1038/sj.gt.3301620; Dome JS, 2013, PEDIATR BLOOD CANCER, V60, P994, DOI 10.1002/pbc.24419; Friedman GK, 2009, J NEURO-ONCOL, V95, P199, DOI 10.1007/s11060-009-9926-0; Friedman GK, 2009, MOL THER, V17, P1125, DOI 10.1038/mt.2009.73; Fu XP, 2007, INT J ONCOL, V30, P1561; GARVIN AJ, 1993, AM J PATHOL, V142, P375; GIACOMANTONIO M, 1984, J PEDIATR SURG, V19, P523, DOI 10.1016/S0022-3468(84)80095-0; Gillory LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077753; Gillory LA, 2013, TRANSL ONCOL, V6, P206, DOI 10.1593/tlo.12505; Hellums EK, 2005, NEURO-ONCOLOGY, V7, P213, DOI 10.1215/S1152851705000074; Isaacs H, 2008, J PEDIATR SURG, V43, P1587, DOI 10.1016/j.jpedsurg.2008.03.052; Jana SS, 2002, FEBS LETT, V515, P184, DOI 10.1016/S0014-5793(02)02467-5; JURGENS H, 1988, CANCER, V61, P349, DOI 10.1002/1097-0142(19880115)61:2<349::AID-CNCR2820610226>3.0.CO;2-0; KELLEHER L, 1994, APPL IMMUNOHISTOCHEM, V2, P164; Krummenacher C, 2004, VIROLOGY, V322, P286, DOI 10.1016/j.virol.2004.02.005; Kuroda T, 2006, CANCER RES, V66, P10127, DOI 10.1158/0008-5472.CAN-06-2744; KUSHNER BH, 1991, CANCER, V67, P1825, DOI 10.1002/1097-0142(19910401)67:7<1825::AID-CNCR2820670702>3.0.CO;2-3; LAGUNOFF M, 1995, J VIROL, V69, P3615, DOI 10.1128/JVI.69.6.3615-3623.1995; MARINA NM, 1989, CANCER-AM CANCER SOC, V64, P1952, DOI 10.1002/1097-0142(19891101)64:9<1952::AID-CNCR2820640931>3.0.CO;2-W; Markert JM, 2012, J VIROL, V86, P5304, DOI 10.1128/JVI.06998-11; Mathew SS, 2009, J VIROL, V83, P9304, DOI 10.1128/JVI.01826-08; Megison ML, 2013, CLIN EXP METASTAS, V30, P555, DOI 10.1007/s10585-012-9560-7; Mezhir JJ, 2005, CANCER RES, V65, P9479, DOI 10.1158/0008-5472.CAN-05-1927; Morton CL, 2010, PEDIATR BLOOD CANCER, V55, P295, DOI 10.1002/pbc.22535; Parker JN, 2000, P NATL ACAD SCI USA, V97, P2208, DOI 10.1073/pnas.040557897; Pressey JG, 2013, PEDIATR BLOOD CANCER, V60, P45, DOI 10.1002/pbc.24117; RodriguezGalindo C, 1997, CANCER-AM CANCER SOC, V79, P2243, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2243::AID-CNCR24>3.0.CO;2-V; Smith MA, 2008, PEDIATR BLOOD CANCER, V50, P703, DOI 10.1002/pbc.21099; STOCKER JT, 1994, SEMIN DIAGN PATHOL, V11, P136; van den Heuvel-Eibrink MM, 2011, PEDIATR BLOOD CANCER, V56, P733, DOI 10.1002/pbc.22922; Yamamoto M, 2011, CLIN EXP IMMUNOL, V165, P211, DOI 10.1111/j.1365-2249.2011.04421.x; Zhang SC, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-427; Zhuge Y, 2010, J SURG RES, V163, P257, DOI 10.1016/j.jss.2010.03.061	44	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86843	10.1371/journal.pone.0086843	http://dx.doi.org/10.1371/journal.pone.0086843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497984	gold, Green Submitted, Green Published			2022-12-25	WOS:000330617100034
J	Qiu, SL; Chen, J; Qin, T; Hu, YL; Wang, DY; Fan, Q; Zhang, CS; Chen, XY; Chen, XL; Liu, C; Gao, ZZ; Li, XP				Qiu, Shulei; Chen, Jin; Qin, Tao; Hu, Yuanliang; Wang, Deyun; Fan, Qiang; Zhang, Cunshuai; Chen, Xingying; Chen, Xiaolan; Liu, Cui; Gao, Zhenzhen; Li, Xiuping			Effects of Selenylation Modification on Immune-Enhancing Activity of Garlic Polysaccharide	PLOS ONE			English	Article							CHINESE; ADJUVANTICITY	The garlic polysaccharide was modified by HNO3-Na2SeO3 method according to orthogonal design L-9(3(4)) to obtain nine selenizing garlic polysaccharides, sGPS(1)-sGPS(9). Their effects on chicken peripheral lymphocytes proliferation in vitro were compared by MTT assay. The results showed that sGPSs could significantly promote lymphocytes proliferation, sGPS(3), sGPS(5) and sGPS(6) presented stronger efficacy. In vivo experiment, 14-day-old chickens were injected respectively with sGPS(3), sGPS(5) and sGPS(6) when they were vaccinated with ND vaccine taking unmodified GPS as control. The results showed that three sGPSs could significantly promote lymphocyte proliferation, enhance serum antibody titer, IFN-gamma and IL-2 contents. These results indicated that selenylation modification could significantly enhance the immune-enhancing activity of GPS, sGPS(6) possessed the best efficacy and could be as a candidate drug of immunoenhancer. Its optimal modification conditions were 400 mg of sodium selenite for 500 mg of GPS, reaction temperature of 70 degrees C and reaction time of 6 h.	[Qiu, Shulei; Qin, Tao; Hu, Yuanliang; Wang, Deyun; Chen, Xingying; Chen, Xiaolan; Liu, Cui; Gao, Zhenzhen; Li, Xiuping] Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing, Jiangsu, Peoples R China; [Chen, Jin] Jiangsu Acad Agr Sci, Natl Res Ctr Vet Biol Engn & Technol, Nanjing, Jiangsu, Peoples R China; [Fan, Qiang; Zhang, Cunshuai] China Inst Vet Drug Control, Beijing, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; China Institute of Veterinary Drug Control	Hu, YL (corresponding author), Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing, Jiangsu, Peoples R China.	ylhu@njau.edu.cn			National Natural Science Foundation of China [31272596]; National Technological Supporting Program of China [2011BAD34B02]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Technological Supporting Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	The project was supported by National Natural Science Foundation of China (31272596), National Technological Supporting Program of China (2011BAD34B02), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abula S, 2011, CARBOHYD POLYM, V85, P687, DOI 10.1016/j.carbpol.2011.03.032; ADETUMBI MA, 1983, MED HYPOTHESES, V12, P227, DOI 10.1016/0306-9877(83)90040-3; Basinski TM, 2009, J ALLERGY CLIN IMMUN, V124, P74, DOI 10.1016/j.jaci.2009.04.019; Cao J., 2010, CHINESE FOLK MED, V19, P61; Cui Q, 2003, CHINESE J BIOCH PHAR, V24, P155; Decker T, 2005, NAT REV IMMUNOL, V19, P1; [高建忠 GAO Jianzhong], 2006, [分析科学学报, Journal of Analytical Science], V22, P157; Gong X, 1997, J SHENZHEN U, V14, P68; Guichard E, 2000, FOOD CHEM, V71, P301, DOI 10.1016/S0308-8146(00)00181-3; Guo LW, 2012, INT J BIOL MACROMOL, V50, P512, DOI 10.1016/j.ijbiomac.2012.01.002; Hu Q, 2001, J CHINESE MARINE DRU, V5, P20; Irie T, 2003, DEV COMP IMMUNOL, V27, P413, DOI 10.1016/S0145-305X(02)00137-4; Koch H. P., 1996, GARLIC SCI THERAPEUT, P1; Kong XF, 2004, INT IMMUNOPHARMACOL, V4, P975, DOI 10.1016/j.intimp.2004.03.008; LAU BHS, 1983, NUTR RES, V3, P119, DOI 10.1016/S0271-5317(83)80128-6; Li CR, 2007, CELL IMMUNOL, V250, P40, DOI 10.1016/j.cellimm.2008.01.003; [李公斌 Li Gongbin], 2008, [东北林业大学学报, Journal of North-East Forestry University], V36, P66; Li X., 2008, HUBEI J NATL I NATUR, V26, P456; Li X, 2006, CHINESE HERBAL MED, V37, P7; Liang L.J., 2008, THESIS NANCHANG U; Liu J, 2003, BEVE FAST FROZEN FOO, V9, P27; Liu J, 2013, J NUTR, V35, P36; Lu ZQ, 2013, CARBOHYD POLYM, V96, P131, DOI 10.1016/j.carbpol.2013.03.063; Piraprez G, 1998, FOOD CHEM, V61, P119, DOI 10.1016/S0308-8146(97)00120-9; Qin T, 2013, CARBOHYD POLYM, V95, P183, DOI 10.1016/j.carbpol.2013.02.072; Qin T, 2013, CARBOHYD POLYM, V92, P645, DOI 10.1016/j.carbpol.2012.08.097; [邱妍 QIU Yan], 2007, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V38, P723; Staaf M, 2000, CARBOHYD RES, V326, P113, DOI 10.1016/S0008-6215(00)00027-6; Tang J, 1988, BIOCH BIOPHYSICS, V20, P259; Thekisoe MMO, 2004, VET MICROBIOL, V101, P23, DOI 10.1016/j.vetmic.2004.03.011; Veterinary Pharmacopoeia Commission of the People's Republic of China, 2010, VET PHARM PEOPL RE 1, V72-73; Wang DY, 2005, VACCINE, V23, P3704, DOI 10.1016/j.vaccine.2005.02.011; [王红连 WANG Hong-lian], 2009, [食品科学, Food Science], V30, P316; Wang Y., 2009, ANIMAL HUSBANDRY VET, V41, P71; Yang H C, 1997, ANIMAL IMMUNOLOGY, P129; Yang J., 2009, CHINESE PATENT MED, V32, P1065; Yu W., 2009, FOOD SCI TECHNOLOGY, V10, P262; Yu W., 2009, J FOOD SCI TECH MYS, V10, P256; Zhang X., 2000, OCEANOLOGY LIMNOLOGY, V31, P643; Zheng M, 2003, J XIANNING COLL, V17, P85; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	41	33	41	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86377	10.1371/journal.pone.0086377	http://dx.doi.org/10.1371/journal.pone.0086377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497946	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100014
J	Weston-Bell, NJ; Forconi, F; Kluin-Nelemans, HC; Sahota, SS				Weston-Bell, Nicola J.; Forconi, Francesco; Kluin-Nelemans, Hanneke C.; Sahota, Surinder S.			Variant B Cell Receptor Isotype Functions Differ in Hairy Cell Leukemia with Mutated BRAF and IGHV Genes	PLOS ONE			English	Article							ANTIGEN RECEPTOR; TUMOR-CELLS; ACTIVATION; RAF; IMMUNOGLOBULIN; CD27; SURVIVAL; SIGNALS; PHOSPHORYLATION; INHIBITION	A functional B-cell receptor (BCR) is critical for survival of normal B-cells, but whether it plays a comparable role in B-cell malignancy is as yet not fully delineated. Typical Hairy Cell Leukemia (HCL) is a rare B-cell tumor, and unique in expressing multiple surface immunoglobulin (sIg) isotypes on individual tumor cells (mult-HCL), to raise questions as to their functional relevance. Typical mult-HCL also displays a mutated BRAF V(600) E lesion. Since wild type BRAF is a primary conduit for transducing normal BCR signals, as revealed by deletion modelling studies, it is as yet not apparent if mutated BRAF alters BCR signal transduction in mult-HCL. To address these questions, we examined BCR signalling in mult-HCL cases uniformly displaying mutated BRAF and IGHV genes. Two apparent functional sets were delineated by IgD co-expression. In sIgD(+ve) mult-HCL, IgD mediated persistent Ca2+ flux, also evident via >1 sIgH isotype, linked to increased ERK activation and BCR endocytosis. In sIgD(-ve) mult-HCL however, BCR-mediated signals and downstream effects were restricted to a single sIgH isotype, with sIgM notably dysfunctional and remaining immobilised on the cell surface. These observations reveal discordance between expression and function of individual isotypes in mult-HCL. In dual sIgL expressing cases, only a single sIgL was fully functional. We examined effects of anti-BCR stimuli on mult-HCL survival ex-vivo. Significantly, all functional non-IgD isotypes increased ERK1/2 phosphorylation but triggered apoptosis of tumor cells, in both subsets. IgD stimuli, in marked contrast retained tumor viability. Despite mutant BRAF, BCR signals augment ERK1/2 phosphorylation, but isotype dictates functional downstream outcomes. In mult-HCL, sIgD retains a potential to transduce BCR signals for tumor survival in-vivo. The BCR in mult-HCL emerges as subject to complex regulation, with apparent conflicting signalling by individual isotypes when co-expressed with sIgD. This suggests the possibility that mutant BRAF by-passes BCR constraints in mult-HCL.	[Weston-Bell, Nicola J.; Sahota, Surinder S.] Univ Southampton, Fac Med, Canc Sci Acad Unit, Tumour Immunogenet Grp, Southampton SO9 5NH, Hants, England; [Forconi, Francesco] Univ Southampton, Fac Med, Canc Sci Acad Unit, Haematol Oncol Grp, Southampton SO9 5NH, Hants, England; [Kluin-Nelemans, Hanneke C.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Haematol, Div Haematol, NL-9713 AV Groningen, Netherlands	University of Southampton; University of Southampton; University of Groningen	Sahota, SS (corresponding author), Univ Southampton, Fac Med, Canc Sci Acad Unit, Tumour Immunogenet Grp, Southampton SO9 5NH, Hants, England.	s.s.sahota@soton.ac.uk	Kluin-Nelemans, Johanna C/F-8658-2018; Forconi, Francesco/AAO-2694-2021	Kluin-Nelemans, Johanna C/0000-0003-2617-9427; Forconi, Francesco/0000-0002-2211-1831; Weston-Bell, Nicola/0000-0003-0075-7276	Leukaemia & Lymphoma Research (UK); Hairy Cell Leukemia Foundation (USA)	Leukaemia & Lymphoma Research (UK); Hairy Cell Leukemia Foundation (USA)	This work was funded by Leukaemia & Lymphoma Research (UK). Additional support funding was provided by the Hairy Cell Leukemia Foundation (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brummer T, 2002, EMBO J, V21, P5611, DOI 10.1093/emboj/cdf588; Chen K, 2010, IMMUNOL REV, V237, P160, DOI 10.1111/j.1600-065X.2010.00929.x; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Clark MR, 2003, ANN NY ACAD SCI, V987, P26, DOI 10.1111/j.1749-6632.2003.tb06030.x; Defrance T, 2011, CURR OPIN IMMUNOL, V23, P330, DOI 10.1016/j.coi.2011.03.004; Dietrich S, 2012, NEW ENGL J MED, V366, P2038, DOI 10.1056/NEJMc1202124; Eeva J, 2003, EUR J IMMUNOL, V33, P2783, DOI 10.1002/eji.200324227; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Follows GA, 2013, BRIT J HAEMATOL, V161, P150, DOI 10.1111/bjh.12201; Forconi F, 2005, HAEMATOLOGICA, V90, P266; Forconi F, 2004, BLOOD, V104, P3312, DOI 10.1182/blood-2004-03-0950; Forconi F, 2001, BLOOD, V98, P1174, DOI 10.1182/blood.V98.4.1174; Forconi F, 2011, HEMATOL ONCOL, V29, P55, DOI 10.1002/hon.975; Hase H, 2002, J BIOL CHEM, V277, P46950, DOI 10.1074/jbc.M209050200; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; KIM KM, 1995, J EXP MED, V181, P1005, DOI 10.1084/jem.181.3.1005; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; KLUINNELEMANS HC, 1990, BLOOD, V75, P972; Koncz G, 2002, IMMUNOL LETT, V82, P41, DOI 10.1016/S0165-2478(02)00017-2; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; MAYUMI M, 1994, J ALLERGY CLIN IMMUN, V94, P612, DOI 10.1016/0091-6749(94)90137-6; Morabito F, 2010, BRIT J HAEMATOL, V149, P160, DOI 10.1111/j.1365-2141.2009.08032.x; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Petlickovski A, 2005, BLOOD, V105, P4820, DOI 10.1182/blood-2004-07-2669; Peyrade F, 2013, HAEMATOLOGICA, V98, pE20, DOI 10.3324/haematol.2012.082404; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Richards S, 2008, IMMUNOL REV, V224, P183, DOI 10.1111/j.1600-065X.2008.00652.x; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Schweighoffer E, 2013, IMMUNITY, V38, P475, DOI 10.1016/j.immuni.2012.11.015; Slupsky JR, 2007, AM J PATHOL, V170, P745, DOI 10.2353/ajpath.2007.060557; Smith SH, 2004, MOL CELL, V14, P696, DOI 10.1016/j.molcel.2004.06.015; Sozzi E, 2011, HEMATOL ONCOL, V29, P31, DOI 10.1002/hon.952; Tiacci E, 2001, NEW ENGL J MED, V364, P2305; Tiacci E, 2013, HAEMATOLOGICA, V98, P635, DOI 10.3324/haematol.2012.078071; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weston-Bell N, 2009, LEUKEMIA, V23, P2075, DOI 10.1038/leu.2009.178; Weston-Bell NJ, 2013, LEUKEMIA, V27, P241, DOI 10.1038/leu.2012.163; Weston-Bell NJ, 2011, BLOOD, V118, P681, DOI 10.1182/blood.V118.21.1567.1567; Xi LQ, 2012, BLOOD, V119, P3330, DOI 10.1182/blood-2011-09-379339; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	43	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86556	10.1371/journal.pone.0086556	http://dx.doi.org/10.1371/journal.pone.0086556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497953	Green Accepted, gold, Green Published			2022-12-25	WOS:000330617100019
J	Liu, X; Zhang, JL; Gu, TY; Zhang, WM; Shen, QR; Yin, SX; Qiu, HZ				Liu, Xing; Zhang, Junlian; Gu, Tianyu; Zhang, Wenming; Shen, Qirong; Yin, Shixue; Qiu, Huizhen			Microbial Community Diversities and Taxa Abundances in Soils along a Seven-Year Gradient of Potato Monoculture Using High Throughput Pyrosequencing Approach	PLOS ONE			English	Article							CROPPING SYSTEMS; BACTERIAL COMMUNITIES; SOILBORNE DISEASES; TILLAGE; POPULATIONS; MANAGEMENT; CULTIVARS; DYNAMICS; ROTATION; PLANT	Background: Previous studies have focused on linking soil community structure, diversity, or specific taxa to disturbances. Relatively little attention has been directed to crop monoculture soils, particularly potato monoculture. Information about microbial community changes over time between monoculture and non-monoculture treatments is lacking. Furthermore, few studies have examined microbial communities in potato monoculture soils using a high throughput pyrosequencing approach. Methodology/Principal Findings: Soils along a seven-year gradient of potato monoculture were collected and microbial communities were characterized using high throughput pyrosequencing approach. Principal findings are as follows. First, diversity (H-Shannon) and richness (S-Chao1) indices of bacterial community, but not of fungal community, were linearly decreased over time and corresponded to a decline of soil sustainability represented by yield decline and disease incidence increase. Second, Fusarium, the only soilborne pathogen-associated fungal genus substantially detected, was linearly increased over time in abundance and was closely associated with yield decline. Third, Fusarium abundance was negatively correlated with soil organic matter (OM) and total nitrogen (TN) but positively with electrical conductivity (EC). Fourth, Fusarium was correlated in abundances with 6 bacterial taxa over time. Conclusions: Soil bacterial and fungal communities exhibited differential responses to the potato monoculture. The overall soil bacterial communities were shaped by potato monoculture. Fusarium was the only soilborne pathogen-associated genus associated with disease incidence increase and yield decline. The changes of soil OM, TN and EC were responsible for Fusarium enrichment, in addition to selections by the monoculture crop. Acidobacteria and Nitrospirae were linearly decreased over time in abundance, corresponding to the decrease of OM, suggesting their similar ecophysiologial trait. Correlations between abundance of Fusarium with several other bacterial taxa suggested their similar behaviors in responses to potato monoculture and/or soil variables, providing insights into the ecological behaviors of these taxa in the environment.	[Liu, Xing; Zhang, Wenming; Qiu, Huizhen] Gansu Agr Univ, Coll Resources & Environm Sci, Lanzhou, Gansu, Peoples R China; [Liu, Xing; Zhang, Wenming; Qiu, Huizhen] Gansu Agr Univ, Gansu Prov Key Lab Aridland Crop Sci, Lanzhou, Gansu, Peoples R China; [Zhang, Junlian] Gansu Agr Univ, Coll Agron, Lanzhou, Gansu, Peoples R China; [Zhang, Junlian] Gansu Agr Univ, Gansu Key Lab Crop Genet & Germplasm Enhancement, Lanzhou, Gansu, Peoples R China; [Gu, Tianyu; Yin, Shixue] Yangzhou Univ, Coll Environm Sci & Engn, Yangzhou, Jaingsu Provinc, Peoples R China; [Shen, Qirong] Nanjing Agr Univ, Jiangsu Prov Key Lab Organ Solid Waste Utilizat, Nanjing, Jiangsu, Peoples R China	Gansu Agricultural University; Gansu Agricultural University; Gansu Agricultural University; Gansu Agricultural University; Yangzhou University; Nanjing Agricultural University	Yin, SX (corresponding author), Yangzhou Univ, Coll Environm Sci & Engn, Yangzhou, Jaingsu Provinc, Peoples R China.	sxyin@yzu.edu.cn; hzqiu@gsau.edu.cn	Shen, Qirong/AAB-6531-2020; Liu, Xing/GPG-3245-2022	Liu, Xing/0000-0001-8578-3769; Liu, Xinting/0000-0002-2798-448X; zhang, wenming/0000-0001-6567-8099	Agricultural Ministry of China [201103004]; Natural Science Foundation of China [31360500]; National Nature Science Foundation of China [41071177]	Agricultural Ministry of China(Ministry of Agriculture & Rural Affairs); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Agricultural Ministry of China (201103004), the Natural Science Foundation of China (31360500) and the National Nature Science Foundation of China (41071177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Acosta-Martinez V., 2010, Diversity, V2, P910; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Arroita M, 2013, J HAZARD MATER, V263, P139, DOI 10.1016/j.jhazmat.2013.06.049; Bernard E, 2012, APPL SOIL ECOL, V52, P29, DOI 10.1016/j.apsoil.2011.10.002; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Cardenas E, 2010, APPL ENVIRON MICROB, V76, P6778, DOI 10.1128/AEM.01097-10; Ceja-Navarro JA, 2010, PLANT SOIL, V329, P127, DOI 10.1007/s11104-009-0140-9; Cook RJ, 2006, P NATL ACAD SCI USA, V103, P18389, DOI 10.1073/pnas.0605946103; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Xuan DT, 2012, BIOL FERT SOILS, V48, P217, DOI 10.1007/s00374-011-0618-5; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fiers M, 2012, AGRON SUSTAIN DEV, V32, P93, DOI 10.1007/s13593-011-0035-z; Garbeva P, 2006, ENVIRON MICROBIOL, V8, P233, DOI 10.1111/j.1462-2920.2005.00888.x; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Govaerts B, 2007, APPL SOIL ECOL, V37, P18, DOI 10.1016/j.apsoil.2007.03.006; Hilton S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059859; HOPKINS DL, 1992, PHYTOPATHOLOGY, V82, P290, DOI 10.1094/Phyto-82-290; HOPKINS DL, 1984, PLANT DIS, V68, P129, DOI 10.1094/PD-69-129; Jansa J, 2003, ECOL APPL, V13, P1164, DOI 10.1890/1051-0761(2003)13[1164:STATCS]2.0.CO;2; Jeger MJ, 1996, POTATO RES, V39, P437, DOI 10.1007/BF02357949; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jumpponen A, 2010, MYCOLOGIA, V102, P1027, DOI 10.3852/09-316; Larkin RP, 2008, SOIL BIOL BIOCHEM, V40, P1341, DOI 10.1016/j.soilbio.2007.03.005; Larkin RP, 2011, PHYTOPATHOLOGY, V101, P58, DOI 10.1094/PHYTO-04-10-0100; Larkin RP, 2010, PLANT DIS, V94, P1491, DOI 10.1094/PDIS-03-10-0172; Larkin RP, 2006, PHYTOPATHOLOGY, V96, P68, DOI 10.1094/PHYTO-96-0068; Larkin RP, 2003, SOIL BIOL BIOCHEM, V35, P1451, DOI 10.1016/S0038-0717(03)00240-2; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LEACH SS, 1981, PHYTOPATHOLOGY, V71, P623, DOI 10.1094/Phyto-71-623; Lee J, 2011, BIODEGRADATION, V22, P687, DOI 10.1007/s10532-010-9429-x; Li CG, 2010, PLANT SOIL, V330, P423, DOI 10.1007/s11104-009-0216-6; Lu LH, 2013, SOIL BIOL BIOCHEM, V65, P186, DOI 10.1016/j.soilbio.2013.05.025; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Luo J, 2010, SOIL SCI SOC AM J, V74, P2039, DOI 10.2136/sssaj2009.0437; McGuire KL, 2012, MICROB ECOL, V63, P804, DOI 10.1007/s00248-011-9973-x; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Norris TB, 2002, APPL ENVIRON MICROB, V68, P6300, DOI 10.1128/AEM.68.12.6300-6309.2002; Silva MCPE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051554; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schramm A, 1999, APPL ENVIRON MICROB, V65, P3690; Sessitsch A, 2001, APPL ENVIRON MICROB, V67, P4215, DOI 10.1128/AEM.67.9.4215-4224.2001; SHIPTON PJ, 1977, ANNU REV PHYTOPATHOL, V15, P387, DOI 10.1146/annurev.py.15.090177.002131; Silva MCPE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00077; Stark C, 2007, APPL SOIL ECOL, V35, P79, DOI 10.1016/j.apsoil.2006.05.001; van Bruggen AHC, 2006, EUR J PLANT PATHOL, V115, P105, DOI 10.1007/s10658-005-1250-8; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Yin CT, 2010, SOIL BIOL BIOCHEM, V42, P2111, DOI 10.1016/j.soilbio.2010.08.006	52	95	113	7	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86610	10.1371/journal.pone.0086610	http://dx.doi.org/10.1371/journal.pone.0086610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497959	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100022
J	Lin, H; Qu, YLW; Geng, ZX; Li, C; Wu, HP; Dong, N; Liu, ZG; Li, W				Lin, Hui; Qu, Yangluowa; Geng, Zhixin; Li, Cheng; Wu, Huping; Dong, Nuo; Liu, Zuguo; Li, Wei			Air Exposure Induced Characteristics of Dry Eye in Conjunctival Tissue Culture	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; OCULAR SURFACE EPITHELIUM; FLOW-CYTOMETRIC ANALYSIS; MUCIN GENE-EXPRESSION; KERATOCONJUNCTIVITIS SICCA; SQUAMOUS METAPLASIA; LACRIMAL GLAND; MATRIX METALLOPROTEINASES; BENZALKONIUM CHLORIDE; INFLAMMATORY MARKERS	There are several animal models illustrating dry eye pathophysiology. Current study would like to establish an ex vivo tissue culture model for characterizing dry eye. Human conjunctival explants were cultured under airlift or submerged conditions for up to 2 weeks, and only airlifted conjunctival cultures underwent increased epithelial stratification. Starting on day 4, the suprabasal cells displayed decreased K19 expression whereas K10 keratin became evident in airlift group. Pax6 nuclear expression attenuated already at 2 days, while its perinuclear and cytoplasmic expression gradually increased. MUC5AC and MUC19 expression dramatically decreased whereas the full thickness MUC4 and MUC16 expression pattern disappeared soon after initiating the airlift condition. Real time PCR showed K16, K10 and MUC16 gene up-regulated while K19, MUC5AC, MUC19 and MUC4 down-regulated on day 8 and day 14. On day 2 was the appearance of apoptotic epithelial and stromal cells appeared. The Wnt signaling pathway was transiently activated from day 2 to day 10. The inflammatory mediators IL-1 beta, TNF-alpha, and MMP-9 were detected in the conditioned media after 6 to 8 days. In conclusion, airlifted conjunctival tissue cultures demonstrated Wnt signaling pathway activation, coupled with squamous metaplasia, mucin pattern alteration, apoptosis and upregulation of proinflammatory cytokine expression. These changes mimic the pathohistological alterations described in dry eye. This correspondence suggests that insight into the pathophysiology of dry eye may be aided through the use of airlifted conjunctival tissue cultures.	[Lin, Hui; Qu, Yangluowa; Geng, Zhixin; Li, Cheng; Liu, Zuguo; Li, Wei] Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China; [Geng, Zhixin; Wu, Huping; Dong, Nuo; Liu, Zuguo; Li, Wei] Xiamen Univ, Affiliated Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China; [Lin, Hui; Qu, Yangluowa; Li, Cheng; Liu, Zuguo; Li, Wei] Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Liu, ZG (corresponding author), Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China.	zuguoliu@xmu.edu.cn; wei1018@gmail.com	Li, Wei/P-8985-2015; Lin, Hui/N-6947-2018	Li, Wei/0000-0001-7458-2590; 	Chinese National Key Scientific Research Project [2013CB967003]; National Natural Science Foundation of China (NSFC) [81270977, 81000403, U1205025, 81270978]	Chinese National Key Scientific Research Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research described was supported in part by the grants from Chinese National Key Scientific Research Project (2013CB967003 [to WL]), the National Natural Science Foundation of China (NSFC, No. 81270977 [to WL], 81000403 [to HL], U1205025 [to ZL], 81270978 [to ZL]). The funders had no role in study design, data collection and analysis.	Acera A, 2008, OPHTHALMIC RES, V40, P315, DOI 10.1159/000150445; Afonso AA, 1999, INVEST OPHTH VIS SCI, V40, P2506; Barabino S, 2005, INVEST OPHTH VIS SCI, V46, P2766, DOI 10.1167/iovs.04-1326; Barabino S, 2004, INVEST OPHTH VIS SCI, V45, P1641, DOI 10.1167/iovs.03-1055; Brignole F, 2000, INVEST OPHTH VIS SCI, V41, P1356; Caffery B, 2008, MOL VIS, V14, P2547; Chen W, 2008, INVEST OPHTH VIS SCI, V49, P1386, DOI 10.1167/iovs.07-0744; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Chikama T, 2008, AM J PATHOL, V172, P638, DOI 10.2353/ajpath.2008.070897; Corrales RM, 2011, INVEST OPHTH VIS SCI, V52, P8363, DOI 10.1167/iovs.11-7655; Dogru M, 2008, ALLERGY, V63, P1324, DOI 10.1111/j.1398-9995.2008.01781.x; Dong N, 2009, INVEST OPHTHALMOL VI; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P5130, DOI 10.1167/iovs.03-0584; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fini ME, 1996, AM J PATHOL, V149, P1287; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Guo ZJ, 2000, EXP EYE RES, V71, P23, DOI 10.1006/exer.2000.0855; JESTER JV, 1989, INVEST OPHTH VIS SCI, V30, P936; Jones DT, 1998, ADV EXP MED BIOL, V438, P533; KASWAN R, 1994, ADV EXP MED BIOL, V350, P583; KASWAN RL, 1989, ARCH OPHTHALMOL-CHIC, V107, P1210, DOI 10.1001/archopht.1989.01070020276038; Kawakita T, 2008, J CELL MOL MED, V12, P1303, DOI 10.1111/j.1582-4934.2008.00297.x; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; Li DQ, 2001, EXP EYE RES, V73, P449, DOI 10.1006/exer.2001.1054; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Li W, 2008, INVEST OPHTH VIS SCI, V49, P154, DOI 10.1167/iovs.07-0883; Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820; Lin ZR, 2011, MOL VIS, V17, P257; LIU SH, 1987, INVEST OPHTH VIS SCI, V28, P270; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Ma X, 2009, INVEST OPHTH VIS SCI, V50, P2716, DOI 10.1167/iovs.08-2139; Maas-Szabowski N, 2001, J INVEST DERMATOL, V116, P816, DOI 10.1046/j.1523-1747.2001.01349.x; Mantelli F, 2008, CURR OPIN ALLERGY CL, V8, P477, DOI 10.1097/ACI.0b013e32830e6b04; Marko CK, 2013, AM J PATHOL, V183, P35, DOI 10.1016/j.ajpath.2013.03.017; Miyoshi K, 2002, P NATL ACAD SCI USA, V99, P219, DOI 10.1073/pnas.012414099; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Murube J, 2003, EUR J OPHTHALMOL, V13, P115, DOI 10.1177/112067210301300201; Paulsen F, 2008, ANN ANAT, V190, P59, DOI 10.1016/j.aanat.2007.05.001; Pearton DJ, 2005, P NATL ACAD SCI USA, V102, P3714, DOI 10.1073/pnas.0500344102; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; Pisella PJ, 2000, OPHTHALMOLOGY, V107, P1841, DOI 10.1016/S0161-6420(00)00347-X; Pitz S, 2002, PROG RETIN EYE RES, V21, P241, DOI 10.1016/S1350-9462(01)00025-8; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; SCHERMER A, 1989, DIFFERENTIATION, V42, P103, DOI 10.1111/j.1432-0436.1989.tb00611.x; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Song XJ, 2003, INVEST OPHTH VIS SCI, V44, P4223, DOI 10.1167/iovs.02-1319; Tei M, 2000, INVEST OPHTH VIS SCI, V41, P82; Tsubota K, 2003, EXP EYE RES, V76, P233, DOI 10.1016/S0014-4835(02)00279-8; Wang BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002186; Xiong C, 2008, INVEST OPHTH VIS SCI, V49, P1850, DOI 10.1167/iovs.07-0720; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581; Yu DF, 2008, EXP EYE RES, V86, P403, DOI 10.1016/j.exer.2007.11.013; 2007, OCUL SURF, V5, P93; 2007, OCUL SURF, V5, P179	56	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87368	10.1371/journal.pone.0087368	http://dx.doi.org/10.1371/journal.pone.0087368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24671174	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900100
J	Filho, MAM; Dutra, JDL; Rocha, GB; Simas, AM; Freire, RO				Filho, Manoel A. M.; Dutra, Jose Diogo L.; Rocha, Gerd B.; Simas, Alfredo M.; Freire, Ricardo O.			Semiempirical Quantum Chemistry Model for the Lanthanides: RM1 (Recife Model 1) Parameters for Dysprosium, Holmium and Erbium	PLOS ONE			English	Article							CAMBRIDGE STRUCTURAL DATABASE; CHEMICAL AM1 CALCULATION; SINGLE-MOLECULE MAGNET; SPARKLE MODEL; COORDINATION POLYHEDRON; COMPLEXES; EUROPIUM(III); PHOTOLUMINESCENCE; PSEUDOPOTENTIALS; PREDICTION	Complexes of dysprosium, holmium, and erbium find many applications as single-molecule magnets, as contrast agents for magnetic resonance imaging, as anti-cancer agents, in optical telecommunications, etc. Therefore, the development of tools that can be proven helpful to complex design is presently an active area of research. In this article, we advance a major improvement to the semiempirical description of lanthanide complexes: the Recife Model 1, RM1, model for the lanthanides, parameterized for the trications of Dy, Ho, and Er. By representing such lanthanide in the RM1 calculation as a three-electron atom with a set of 5 d, 6 s, and 6 p semiempirical orbitals, the accuracy of the previous sparkle models, mainly concentrated on lanthanide-oxygen and lanthanide-nitrogen distances, is extended to other types of bonds in the trication complexes' coordination polyhedra, such as lanthanide-carbon, lanthanide-chlorine, etc. This is even more important as, for example, lanthanide-carbon atom distances in the coordination polyhedra of the complexes comprise about 30% of all distances for all complexes of Dy, Ho, and Er considered. Our results indicate that the average unsigned mean error for the lanthanide-carbon distances dropped from an average of 0.30 angstrom, for the sparkle models, to 0.04 angstrom for the RM1 model for the lanthanides; for a total of 509 such distances for the set of all Dy, Ho, and Er complexes considered. A similar behavior took place for the other distances as well, such as lanthanide-chlorine, lanthanide-bromine, lanthanide, phosphorus and lanthanide-sulfur. Thus, the RM1 model for the lanthanides, being advanced in this article, broadens the range of application of semiempirical models to lanthanide complexes by including comprehensively many other types of bonds not adequately described by the previous models.	[Filho, Manoel A. M.; Dutra, Jose Diogo L.; Freire, Ricardo O.] Univ Fed Sergipe, Dept Quim, Pople Computat Chem Lab, Sao Cristovao, SE, Brazil; [Rocha, Gerd B.] Univ Fed Paraiba, CCEN, Dept Quim, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Simas, Alfredo M.] Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil	Universidade Federal de Sergipe; Universidade Federal da Paraiba; Universidade Federal de Pernambuco	Freire, RO (corresponding author), Univ Fed Sergipe, Dept Quim, Pople Computat Chem Lab, Sao Cristovao, SE, Brazil.	rfreire@ufs.br	Lisboa Dutra, José Diogo/I-7088-2013; Freire, Ricardo O/B-7685-2008; Rocha, Gerd B/G-5115-2010; Freire, Ricardo/AGR-4537-2022; Filho, Manoel Alves Machado/R-2505-2019; DUTRA, JOSE DIOGO LISBOA/AAJ-9870-2021; Simas, Alfredo M/B-1096-2008; Cominetti, Marcia Regina/B-8080-2012; Vieira, Paulo Cezar/B-9504-2012; Franceschini Sarria, Andre Lucio/C-8189-2012	Freire, Ricardo O/0000-0002-3603-3184; Rocha, Gerd B/0000-0001-9805-9497; Freire, Ricardo/0000-0002-3603-3184; DUTRA, JOSE DIOGO LISBOA/0000-0003-2123-2209; Simas, Alfredo M/0000-0003-3653-6328; Cominetti, Marcia Regina/0000-0001-6385-7392; Vieira, Paulo Cezar/0000-0003-4207-6217; Paranhos, Caio M./0000-0002-2261-0585; Franceschini Sarria, Andre Lucio/0000-0003-0616-624X; Blanque Becceneri, Amanda/0000-0001-5223-961X	CNPq; FAPITEC-SE; FACEPE (Pronex); INAMI	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPITEC-SE; FACEPE (Pronex)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); INAMI	This work received financial support from the Brazilian agencies, institutes and networks: CNPq, FAPITEC-SE, FACEPE (Pronex), and INAMI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlDamen MA, 2009, INORG CHEM, V48, P3467, DOI 10.1021/ic801630z; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P407, DOI 10.1107/S0108768102004895; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; BAYOUTH JE, 1995, J NUCL MED, V36, P730; Conover WJ, 1999, PRACTICAL NONPARAMET; da Costa NB, 2005, POLYHEDRON, V24, P3046, DOI 10.1016/j.poly.2005.06.027; da Costa NB, 2005, INORG CHEM COMMUN, V8, P831, DOI 10.1016/j.inoche.2005.06.014; DEANDRADE AVM, 1994, CHEM PHYS LETT, V227, P349, DOI 10.1016/0009-2614(94)00829-9; deAndrade AVM, 1996, J CHEM SOC FARADAY T, V92, P1835, DOI 10.1039/ft9969201835; DEANDRADE AVM, 1995, J ALLOY COMPD, V225, P55, DOI 10.1016/0925-8388(94)07009-1; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; DOLG M, 1989, THEOR CHIM ACTA, V75, P173, DOI 10.1007/BF00528565; DOLG M, 1989, J CHEM PHYS, V90, P1730, DOI 10.1063/1.456066; Dolg M, 2012, CHEM REV, V112, P403, DOI 10.1021/cr2001383; Dutra JDL, 2013, J CHEM THEORY COMPUT, V9, P3333, DOI 10.1021/ct301012h; Ertl P, 2003, J CHEM INF COMP SCI, V43, P374, DOI 10.1021/ci0255782; Faustino WM, 2006, J PHYS CHEM A, V110, P2510, DOI 10.1021/jp056180m; Faustino WM, 2000, J MOL STRUC-THEOCHEM, V527, P245, DOI 10.1016/S0166-1280(00)00497-8; Filho MAM, 2013, RSC ADV, V3, P16747, DOI 10.1039/c3ra41406j; Freire RO, 2006, J ORGANOMET CHEM, V691, P2584, DOI 10.1016/j.jorganchem.2006.01.044; Freire RO, 2006, CHEM PHYS LETT, V425, P138, DOI 10.1016/j.cplett.2006.04.103; Freire RO, 2010, J CHEM THEORY COMPUT, V6, P2019, DOI 10.1021/ct100192c; Freire RO, 2009, J BRAZIL CHEM SOC, V20, P1638, DOI 10.1590/S0103-50532009000900011; Freire RO, 2006, J MOL MODEL, V12, P373, DOI 10.1007/s00894-005-0027-5; Freire RO, 2005, J COMPUT CHEM, V26, P1524, DOI 10.1002/jcc.20288; Freire RO, 2005, INORG CHEM, V44, P3299, DOI 10.1021/ic048530+; Freire RO, 2005, J LUMIN, V111, P81, DOI 10.1016/j.jlumin.2004.07.001; Ishikawa N, 2003, J AM CHEM SOC, V125, P8694, DOI 10.1021/ja029629n; Ishikawa N, 2008, INORG CHEM, V47, P10217, DOI 10.1021/ic8014892; Kaufman L., 2009, FINDING GROUPS DATA; Lin PH, 2009, ANGEW CHEM INT EDIT, V48, P9489, DOI 10.1002/anie.200903199; Nilsson S, 1996, ACTA RADIOL, V37, P27; Norek M, 2011, PROG NUCL MAG RES SP, V59, P64, DOI 10.1016/j.pnmrs.2010.08.002; Orpen AG, 2002, ACTA CRYSTALLOGR B, V58, P398, DOI 10.1107/S0108768102002446; Park OH, 2003, J MATER RES, V18, P1039, DOI 10.1557/JMR.2003.0143; Rinehart JD, 2011, NAT CHEM, V3, P538, DOI 10.1038/nchem.1063; Rocha GB, 2004, INORG CHEM, V43, P2346, DOI 10.1021/ic034882p; Rocha GB, 2006, J COMPUT CHEM, V27, P1101, DOI 10.1002/jcc.20425; Simas AM, 2008, J ORGANOMET CHEM, V693, P1952, DOI 10.1016/j.jorganchem.2008.01.029; Stewart J. J. P., 2012, MOPAC2012; STEWART JPP, 2007, MOPAC2007; Sun LN, 2005, ADV FUNCT MATER, V15, P1041, DOI 10.1002/adfm.200400386; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; WIKSTROM M, 1992, ACTA RADIOL, V33, P1; Zhang P, 2013, COORDIN CHEM REV, V257, P1728, DOI 10.1016/j.ccr.2013.01.012	45	28	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86376	10.1371/journal.pone.0086376	http://dx.doi.org/10.1371/journal.pone.0086376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497945	gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900023
J	Huang, YJ; Li, JN; Garcia, JM; Lin, H; Wang, YZ; Yan, P; Wang, LQ; Tan, Y; Luo, JH; Qiu, ZQ; Chen, JA; Shu, WQ				Huang, Yujing; Li, Junnan; Garcia, Jose M.; Lin, Hui; Wang, Yanzhou; Yan, Ping; Wang, Lingqiao; Tan, Yao; Luo, Jiaohua; Qiu, Zhiqun; Chen, Ji-an; Shu, Weiqun			Phthalate Levels in Cord Blood Are Associated with Preterm Delivery and Fetal Growth Parameters in Chinese Women	PLOS ONE			English	Article							EXPOSURE; METABOLITES; DISRUPTION; RECEPTORS; INCREASES; ESTERS; ALPHA	Data concerning the effects of phthalate exposure on preterm delivery and fetal growth are limited in humans. In this paper, we assessed the relationship between 15 phthalate levels in cord blood and preterm delivery and fetal growth parameters in 207 Chinese women going into labor. Exposure to phthalates except DCHP was associated with gestational age reduction and preterm delivery (p < 0.05). There were associations between phthalates and fetal growth parameters, many of which disappeared when analyses were adjusted for gestational age, especially in male infants (Only DEEP was associated with birth weight; DEP, DNHP, BBP, DNP with abdominal circumference; DEP, DBP, DCHP, DEHP with femur length in female infants. And DPP, DBEP was associated with birth length in male infants. p < 0.05). This study indicates that prenatal exposure to phthalates is associated with younger gestational age and preterm delivery. Also, phthalate exposure may adversely affect fetal growth parameters via gestational age reduction and preterm delivery with a significant gender effect.	[Huang, Yujing; Wang, Lingqiao; Tan, Yao; Luo, Jiaohua; Qiu, Zhiqun; Chen, Ji-an; Shu, Weiqun] Third Mil Med Univ, Coll Prevent Med, Dept Environm Hyg, Chongqing, Peoples R China; [Li, Junnan; Wang, Yanzhou; Yan, Ping] Third Mil Med Univ, Southwest Hosp, Dept Gynecol & Obstet, Chongqing, Peoples R China; [Garcia, Jose M.; Chen, Ji-an] Baylor Coll Med, Michael E DeBakey VAMC, Ctr Translat Res Inflammatory Dis, Div Endocrinol, Houston, TX 77030 USA; [Lin, Hui] Third Mil Med Univ, Coll Prevent Med, Dept Epidemiol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Baylor College of Medicine; Army Medical University	Chen, JA (corresponding author), Third Mil Med Univ, Coll Prevent Med, Dept Environm Hyg, Chongqing, Peoples R China.	cjatmmu@hotmail.com; west2003@sohu.com	huang, yujing/HHD-3530-2022	huang, yujing/0000-0002-5214-2495; wang, yanzhou/0000-0002-5985-5244	Natural Science Foundation of China [81072262, 81372944]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the Natural Science Foundation of China (Grant No. 81072262 and 81372944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, CHINA J MODERN MED, V16, P1096; Chen JA, 2008, CHEMOSPHERE, V70, P1545, DOI 10.1016/j.chemosphere.2007.08.063; Chen JA, 2008, ENVIRON POLLUT, V156, P849, DOI 10.1016/j.envpol.2008.05.019; Ferguson KK, 2011, ENVIRON RES, V111, P718, DOI 10.1016/j.envres.2011.02.002; Han SW, 2005, J BIOL CHEM, V280, P33240, DOI 10.1074/jbc.M507617200; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788; Holdsworth-Carson SJ, 2009, REPRODUCTION, V137, P1007, DOI 10.1530/REP-08-0496; Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2; Lampen A, 2003, TOXICOL APPL PHARM, V188, P14, DOI 10.1016/S0041-008X(03)00014-0; Liu LBLJ, 2008, CHIN J OBS GYNE PEDI, V4, P46; Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522; Nakagawa T, 2008, J MOL GRAPH MODEL, V27, P45, DOI 10.1016/j.jmgm.2008.02.003; Philippat C, 2012, ENVIRON HEALTH PERSP, V120, P464, DOI 10.1289/ehp.1103634; Rose RJ, 2012, ANAESTHESIA, V67, P514, DOI 10.1111/j.1365-2044.2011.07006.x; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Stanley M, 2003, SERIES ANTHROPOGENIC, P1; Strac I.V., 2011, J APPL TOXICOL; Suzuki Y, 2010, ENVIRON INT, V36, P699, DOI 10.1016/j.envint.2010.05.003; von Rettberg H, 2009, PEDIATRICS, V124, P710, DOI 10.1542/peds.2008-1765; Witorsch RJ, 2010, CRIT REV TOXICOL, V40, P1, DOI 10.3109/10408444.2010.515563; Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007; Xu CA, 2010, TOXICOL LETT, V199, P323, DOI 10.1016/j.toxlet.2010.09.015; Yao PL, 2009, BIOL REPROD, V80, P581, DOI 10.1095/biolreprod.108.073122; Yen TH, 2011, J FORMOS MED ASSOC, V110, P671, DOI 10.1016/j.jfma.2011.09.002; Zhang YH, 2009, J PEDIATR-US, V155, P500, DOI 10.1016/j.jpeds.2009.04.007	26	104	112	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87430	10.1371/journal.pone.0087430	http://dx.doi.org/10.1371/journal.pone.0087430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	25058491	Green Published, Green Submitted, gold			2022-12-25	WOS:000330631800035
J	Tanaka, K; Kanno, T; Yanagisawa, Y; Yasutake, K; Inoue, S; Hirayama, N; Ikeda, JE				Tanaka, Kazunori; Kanno, Takuya; Yanagisawa, Yoshiko; Yasutake, Kaori; Inoue, Satoshi; Hirayama, Noriaki; Ikeda, Joh-E			A Novel Acylaminoimidazole Derivative, WN1316, Alleviates Disease Progression via Suppression of Glial Inflammation in ALS Mouse Model	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; OXIDATIVE STRESS; SPINAL-CORD; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; NRF2-ARE PATHWAY; FAMILIAL ALS; ACTIVATION; ASTROCYTES; GENES	Amyotrophic lateral sclerosis (ALS) is an adult-onset motor neuron degenerative disease. Given that oxidative stress and resulting chronic neuronal inflammation are thought to be central pathogenic, anti-oxidative agents and modulators of neuronal inflammation could be potential therapies for ALS. We report here that the novel small molecular compound, 2-[mesityl(methyl) amino]-N-[4-(pyridin-2-yl)-1H-imidazol-2-yl] acetamide trihydrochloride (WN1316) selectively suppresses oxidative stress-induced cell death and neuronal inflammation in the late-stage ALS mice. WN1316 has high blood-brain-barrier permeability and water solubility, and boosts both neuronal apoptosis inhibitory protein (NAIP) and NF-E2-related factor 2 (Nrf2) which governed glutathione (GSH)-related anti-oxidation pathway protecting motor neurons against oxidative injuries. Post-onset oral administration of low dose (1-100 mu g/kg/day) WN1316 in ALS(SOD1(H46R)) and ALS(SOD1(G93A)) mice resulted in sustained improved motor function and post onset survival rate. Immunohistochemical analysis revealed less DNA oxidative damage and motor neuronal inflammation as well as repression of both microgliosis and astrocytosis, concomitant down regulation of interleukin-1 beta and inducible nitric oxide synthase, and preservation of the motoneurons in anterior horn of lumbar spinal cord and skeletal muscle (quadriceps femoris). Thus, WN1316 would be a novel therapeutic agent for ALS.	[Tanaka, Kazunori; Kanno, Takuya; Yanagisawa, Yoshiko; Yasutake, Kaori; Ikeda, Joh-E] Kitasato Univ, Sch Med, NGP Biomed Res Inst, Neugen Pharma Inc, Sagamihara, Kanagawa 228, Japan; [Inoue, Satoshi] Wakunaga Pharmaceut Co Ltd, Hiroshima, Japan; [Hirayama, Noriaki; Ikeda, Joh-E] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Ikeda, Joh-E] Kitasato Univ, Sch Med, Dept Mol Neurol, Sagamihara, Kanagawa 228, Japan; [Ikeda, Joh-E] Univ Ottawa, Dept Pediat, Childrens Hosp Eastern Ontario, Apoptosis Res Ctr,Fac Med, Ottawa, ON K1N 6N5, Canada	Kitasato University; Wakunaga Pharmaceutical Co., Ltd.; Tokai University; Kitasato University; University of Ottawa; Children's Hospital of Eastern Ontario	Ikeda, JE (corresponding author), Kitasato Univ, Sch Med, NGP Biomed Res Inst, Neugen Pharma Inc, Sagamihara, Kanagawa 228, Japan.	alspd@med.kitasato-u.ac.jp	Coppola, Vincenzo/D-5352-2014	Coppola, Vincenzo/0000-0001-6163-1779	National Institute of Biomedical Innovation (NIBIO)	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	This work was supported by the National Institute of Biomedical Innovation (NIBIO) (JEI). The funders had no role in study design, data cellection and analysis, decision to publish, or preparation of the manuscript.	Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Esposito Emilio Xavier, 2004, Methods Mol Biol, V275, P131; Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704; Fitzmaurice PS, 1996, MUSCLE NERVE, V19, P797; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Horio K, 2007, CHEM PHARM BULL, V55, P980, DOI 10.1248/cpb.55.980; Imhoff BR, 2009, BIOCHEM J, V424, P491, DOI 10.1042/BJ20091286; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Kanno T, 2012, FREE RADICAL BIO MED, V53, P2028, DOI 10.1016/j.freeradbiomed.2012.09.010; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kim KH, 2010, NUCLEIC ACIDS RES, V38, P48, DOI 10.1093/nar/gkp865; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee M, 2010, FASEB J, V24, P2533, DOI 10.1096/fj.09-149997; Lewis CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/803701; Limpert AS, 2013, BEILSTEIN J ORG CHEM, V9, P717, DOI 10.3762/bjoc.9.82; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu Y, 2009, J BIOL CHEM, V284, P3691, DOI 10.1074/jbc.M804446200; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; McGeer Patrick L, 2002, Sci Aging Knowledge Environ, V2002, pre3, DOI 10.1126/sageke.2002.29.re3; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Moisse K, 2006, BBA-MOL BASIS DIS, V1762, P1083, DOI 10.1016/j.bbadis.2006.03.001; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Okada Y, 2005, J CEREBR BLOOD F MET, V25, P794, DOI 10.1038/sj.jcbfm.9600078; Pratt AJ, 2012, DEGENER NEUROL NEURO, V2, P1, DOI 10.2147/DNND.S19803; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Schiffer D, 1996, J NEUROL SCI, V139, P27, DOI 10.1016/0022-510X(96)00073-1; Tanaka K, 2008, EXP NEUROL, V211, P378, DOI 10.1016/j.expneurol.2008.02.004; Tanaka K, 2011, EXP NEUROL, V232, P41, DOI 10.1016/j.expneurol.2011.08.001; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Wang XJ, 2010, CHEM BIOL, V17, P75, DOI 10.1016/j.chembiol.2009.12.013; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	44	53	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87728	10.1371/journal.pone.0087728	http://dx.doi.org/10.1371/journal.pone.0087728			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498180	Green Submitted, gold, Green Published			2022-12-25	WOS:000330621900162
J	Liu, Y; Wang, FY; Wu, Y; Tan, SN; Wen, QL; Wang, J; Zhu, XM; Wang, X; Li, CM; Ma, X; Pan, H				Liu, Yan; Wang, Fengyu; Wu, Yuan; Tan, Sainan; Wen, Qiaolian; Wang, Jing; Zhu, Xiaomei; Wang, Xi; Li, Congmin; Ma, Xu; Pan, Hong			Variations of CITED2 Are Associated with Congenital Heart Disease (CHD) in Chinese Population	PLOS ONE			English	Article							PITX2C EXPRESSION; DEFECTS; MUTATIONS; MICE; MALFORMATIONS; HIF-1-ALPHA; ATRIAL; GROWTH; CELLS; GATA4	CITED2 was identified as a cardiac transcription factor which is essential to the heart development. Cited2-deficient mice showed cardiac malformations, adrenal agenesis and neural crest defects. To explore the potential impact of mutations in CITED2 on congenital heart disease (CHD) in humans, we screened the coding region of CITED2 in a total of 700 Chinese people with congenital heart disease and 250 healthy individuals as controls. We found five potential disease-causing mutations, p.P140S, p.S183L, p.S196G, p.Ser161delAGC and p.Ser192_Gly193delAGCGGC. Two mammalian two-hybrid assays showed that the last four mutations significantly affected the interaction between p300CH1 and CITED2 or HIF1A. Further studies showed that four CITED2 mutations recovered the promoter activity of VEGF by decreasing its competitiveness with HIF1A for binding to p300CH1 and three mutations decreased the consociation of TFAP2C and CITED2 in the transactivation of PITX2C. Both VEGF and PITX2C play very important roles in cardiac development. In conclusion, we demonstrated that CITED2 has a potential causative impact on congenital heart disease.	[Liu, Yan; Wen, Qiaolian; Zhu, Xiaomei; Wang, Xi; Ma, Xu; Pan, Hong] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Liu, Yan; Wen, Qiaolian; Zhu, Xiaomei; Wang, Xi; Ma, Xu; Pan, Hong] Natl Res Inst Family Planning, Beijing, Peoples R China; [Wang, Fengyu; Li, Congmin] Henan Res Inst Populat & Family Planning, Key Lab Populat Defects Intervent Technol Henan P, Zhengzhou, Peoples R China; [Wu, Yuan] Xiamen Univ, Dept Cardiac Surg, Xiamen Heart Ctr, Organ Transplantat Inst, Xiamen, Peoples R China; [Tan, Sainan] Family Planning Inst Hunan Prov, Key Lab Genet & Birth Hlth Hunan Prov, Chang Sha, Peoples R China; [Wang, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Med Genet, Beijing, Peoples R China; [Ma, Xu] World Hlth Org, Collaborating Ctr Res Human Reprod, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Research Institute for Family Planning - China; Xiamen University; Capital Medical University; World Health Organization	Li, CM (corresponding author), Henan Res Inst Populat & Family Planning, Key Lab Populat Defects Intervent Technol Henan P, Zhengzhou, Peoples R China.	13838377996@163.com; nicgr@263.net; 13174483538@126.com		Liu, Yali/0000-0003-0037-6326; Zhang, Junjie/0000-0001-8809-1485; Liu, Yehao/0000-0002-6381-6440; Li, Yuhui/0000-0002-9778-4512	National Basic Research Program of China [2010CB529504]; National Natural Science Foundation of China [81300131]; Applied Basic Research Program of Qinghai Province [QH2013-z-744]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Program of Qinghai Province	This work was supported by the National Basic Research Program of China (2010CB529504), the National Natural Science Foundation of China (81300131) and the Applied Basic Research Program of Qinghai Province (QH2013-z-744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, ARTHRITIS RHEUM-US, V58, P3798, DOI 10.1002/art.24073; Amati F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-497; Andrews JE, 2000, MECH DEVELOP, V95, P305, DOI 10.1016/S0925-4773(00)00362-2; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bentham J, 2010, HUM MOL GENET, V19, P3394, DOI 10.1093/hmg/ddq251; Bhattacherjee V, 2009, INT J DEV BIOL, V53, P1097, DOI 10.1387/ijdb.072489vb; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Chen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046256; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Crider KS, 2011, GENOME MED, V3, DOI 10.1186/gm223; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Li DY, 2010, STROKE, V41, pS92, DOI 10.1161/STROKEAHA.110.594929; Li Q, 2012, BIOCHEM BIOPH RES CO, V423, P895, DOI 10.1016/j.bbrc.2012.06.099; MacDonald ST, 2013, EUR HEART J, V34, P2557, DOI 10.1093/eurheartj/ehs056; Ruiz-Perez VL, 2007, DEVELOPMENT, V134, P2903, DOI 10.1242/dev.007542; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Xiong F, 2013, CARDIOVASC PATHOL, V22, P141, DOI 10.1016/j.carpath.2012.07.001; Xu B, 2007, DEV BIOL, V301, P130, DOI 10.1016/j.ydbio.2006.08.072; Xu M, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-7; Yang Xiao-fei, 2010, Zhonghua Er Ke Za Zhi, V48, P293; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799	26	255	264	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98157	10.1371/journal.pone.0098157	http://dx.doi.org/10.1371/journal.pone.0098157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	25237849	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600093
J	He, XL; Huang, X; Shen, YZ; Huang, ZJ				He, Xiaoliang; Huang, Xi; Shen, Yinzhu; Huang, Zhanjing			Wheat V-H+-ATPase Subunit Genes Significantly Affect Salt Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							PROTON TRANSPORT; NACL REGULATION; OSMOTIC-STRESS; EXPRESSION; PLANT; CLONING; MECHANISM; GROWTH; LEAVES	Genes for V-H+-ATPase subunits were identified and cloned from the salt-tolerant wheat mutant RH8706-49. Sequences of these genes are highly conserved in plants. Overexpression of these genes in Arabidopsis thaliana improved its salt tolerance, and increased the activities of V-H+-ATPase and Na+/H+ exchange, with the largest increase in plants carrying the c subunit of V-H+-ATPase. Results from quantitative RT-PCR analysis indicated that the mRNA level of each V-H+-ATPase subunit in the Arabidopsis increased under salt stress. Overall, our results suggest that each V-H+-ATPase subunit plays a key role in enhancing salt tolerance in plants.	[Huang, Xi; Shen, Yinzhu; Huang, Zhanjing] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China; [He, Xiaoliang] Hebei Univ Sci & Technol, Sch Biol Sci & Engn, Shijiazhuang, Hebei, Peoples R China	Hebei Normal University; Hebei University of Science & Technology	Huang, ZJ (corresponding author), Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China.	huangzhanjing@sohu.com	TANG, Rui/GRS-5116-2022	He, Xing/0000-0001-7676-9930	National Natural Science Fund [30971766]; Hebei Provincial Natural Science Fund [C2009000278]; Doctor Fund of Hebei University of Science and Technology [QD201046]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Hebei Provincial Natural Science Fund; Doctor Fund of Hebei University of Science and Technology	This work was supported by National Natural Science Fund (30971766), Hebei Provincial Natural Science Fund (No. C2009000278), and Doctor Fund of Hebei University of Science and Technology (QD201046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baisakh N, 2012, PLANT BIOTECHNOL J, V10, P453, DOI 10.1111/j.1467-7652.2012.00678.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dietz KJ, 2001, J EXP BOT, V52, P1969, DOI 10.1093/jexbot/52.363.1969; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; Forgac M, 2000, J EXP BIOL, V203, P71; Gao CQ, 2011, MOL BIOL REP, V38, P957, DOI 10.1007/s11033-010-0189-9; Ge RC, 2007, PLANT SCI, V173, P55, DOI 10.1016/j.plantsci.2007.04.005; Golldack D, 2001, PLANT PHYSIOL, V125, P1643, DOI 10.1104/pp.125.4.1643; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; He XL, 2012, PLANT MOL BIOL REP, V30, P807, DOI 10.1007/s11105-011-0390-6; Hou XN, 2013, PLANT MOL BIOL REP, V31, P791, DOI 10.1007/s11105-012-0549-9; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Kirsch M, 1996, PLANT MOL BIOL, V32, P543, DOI 10.1007/BF00019107; Lee S, 2004, PLANT CELL, V16, P1378, DOI 10.1105/tpc.021683; Lehr A, 1999, PLANT MOL BIOL, V39, P463, DOI 10.1023/A:1006158310891; Li PH, 2004, ACTA BOT SIN, V46, P93; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Muller ML, 1996, J BIOL CHEM, V271, P1916; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NARASIMHAN ML, 1991, PLANT PHYSIOL, V97, P562, DOI 10.1104/pp.97.2.562; NIU XM, 1993, PLANT PHYSIOL, V103, P713, DOI 10.1104/pp.103.3.713; Ratajczak R, 2000, BBA-BIOMEMBRANES, V1465, P17, DOI 10.1016/S0005-2736(00)00129-2; Sze H, 2002, TRENDS PLANT SCI, V7, P157, DOI 10.1016/S1360-1385(02)02240-9; Wang BS, 2001, J EXP BOT, V52, P2355, DOI 10.1093/jexbot/52.365.2355; Wang L, 2011, PLANTA, V234, P1, DOI 10.1007/s00425-011-1383-2; WARD JM, 1992, PLANT PHYSIOL, V99, P925, DOI 10.1104/pp.99.3.925; Xu CX, 2011, PLANT MOL BIOL REP, V29, P424, DOI 10.1007/s11105-010-0247-4; Xu T, 2000, J BIOL CHEM, V275, P22075, DOI 10.1074/jbc.M002983200; Zhao Q, 2009, PLANT MOL BIOL, V69, P33, DOI 10.1007/s11103-008-9403-8; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	30	96	108	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86982	10.1371/journal.pone.0086982	http://dx.doi.org/10.1371/journal.pone.0086982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498005	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100043
J	He, X; Pu, GB; Tang, R; Zhang, DM; Pan, WQ				He, Xing; Pu, Guangbin; Tang, Rui; Zhang, Dongmei; Pan, Weiqing			Activation of Nuclear Factor Kappa B in the Hepatic Stellate Cells of Mice with Schistosomiasis Japonica	PLOS ONE			English	Article							MICRORNAS; LIVER; EXPRESSION; FIBROSIS; DISEASE; FIBROGENESIS	Schistosomiasis japonica is a serious tropical parasitic disease in humans, which causes inflammation and fibrosis of the liver. Hepatic stellate cells (HSCs) are known to play an important role in schistosome-induced fibrosis, but their role in schistosome-induced inflammation is still largely unknown. Here, we use a murine model of schistosomiasis japonica to investigate the role that nuclear factor kappa B (NF-kappa B), a critical mediator of inflammatory responses, plays in schistosome-induced inflammation. We revealed that NF-kappa B was significantly activated in HSCs at the early stage of infection, but not at later stages. We also show that the expression levels of several chemokines regulated by NF-kappa B signaling (Ccl2, Ccl3 and Ccl5) were similarly elevated at early infection. TLR4 signaling, one of the strongest known inducers of NF-kappa B activation, seemed not activated in HSCs post-infection. Importantly, we found that levels of miR-146 (a known negative regulator of NF-kappa B signaling) in HSCs opposed those of NF-kappa B signaling, elevating at later stage of infection. These results indicate that HSCs might play an important role in the progression of hepatic schistosomiasis japonica by linking liver inflammation to fibrosis via NF-kappa B signaling. Moreover, our work suggests that miR-146 appeared to regulate this process. These findings are significant and imply that manipulating the function of HSCs by targeting either NF-kappa B signaling or miR-146 expression may provide a novel method of treating hepatic schistosomiasis japonica.	[He, Xing; Pu, Guangbin; Tang, Rui; Zhang, Dongmei; Pan, Weiqing] Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China	Naval Medical University	Zhang, DM (corresponding author), Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China.	dmzhangcn@gmail.com; wqpan0912@aliyun.com	TANG, Rui/GRS-5116-2022	He, Xing/0000-0001-7676-9930	National Basic Research Program (973 Program) [2007CB513100]; National Science and Technology Program of China [2012ZX10004220]	National Basic Research Program (973 Program)(National Basic Research Program of China); National Science and Technology Program of China	This study was supported by grants from the National Basic Research Program (973 Program) (2007CB513100) and the National Science and Technology Program of China (2012ZX10004220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-60; Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000598; Cai PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067037; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; CHEEVER A W, 1968, Bulletin of the World Health Organization, V39, P328; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chuah C, 2014, TRENDS PARA IN PRESS; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Do H, 1999, J BIOL CHEM, V274, P19587, DOI 10.1074/jbc.274.28.19587; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; He X, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-272; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kelada S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003451; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Liang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042490; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Ramm GA, 2009, HEPATOLOGY, V49, P533, DOI 10.1002/hep.22637; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Wang ZX, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000596; Winau F, 2008, CURR OPIN IMMUNOL, V20, P68, DOI 10.1016/j.coi.2007.10.006	35	96	108	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104323	10.1371/journal.pone.0104323	http://dx.doi.org/10.1371/journal.pone.0104323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	24498005	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230400042
J	Yang, YC; Huang, YT; Hsieh, CW; Yang, PM; Wung, BS				Yang, Yan-Chang; Huang, Yu-Ting; Hsieh, Chia-Wen; Yang, Po-Min; Wung, Being-Sun			Carbon Monoxide Induces Heme Oxygenase-1 to Modulate STAT3 Activation in Endothelial Cells via S-Glutathionylation	PLOS ONE			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM-STRESS; CO-RELEASING MOLECULES; THERAPEUTIC APPLICATIONS; GENE-EXPRESSION; UP-REGULATION; JNK PATHWAY; PHOSPHORYLATION; INHIBITION; APOPTOSIS	IL-6/STAT3 pathway is involved in a variety of biological responses, including cell proliferation, differentiation, apoptosis, and inflammation. In our present study, we found that CO releasing molecules (CORMs) suppress IL-6-induced STAT3 phosphorylation, nuclear translocation and transactivity in endothelial cells (ECs). CO is a byproduct of heme degradation mediated by heme oxygenase (HO-1). However, CORMs can induce HO-1 expression and then inhibit STAT3 phosphorylation. CO has been found to increase a low level ROS and which may induce protein glutathionylation. We hypothesized that CORMs increases protein glutathionylation and inhibits STAT3 activation. We found that CORMs increase the intracellular GSSG level and induce the glutathionylation of multiple proteins including STAT3. GSSG can inhibit STAT3 phosphorylation and increase STAT3 glutathionylation whereas the antioxidant enzyme catalase can suppress the glutathionylation. Furthermore, catalase blocks the inhibition of STAT3 phosphorylation by CORMs treatment. The inhibition of glutathione synthesis by BSO was also found to attenuate STAT3 glutathionylation and its inhibition of STAT3 phosphorylation. We further found that HO-1 increases STAT3 glutathionylation and that HO-1 siRNA attenuates CORM-induced STAT3 glutathionylation. Hence, the inhibition of STAT3 activation is likely to occur via a CO-mediated increase in the GSSG level, which augments protein glutathionylation, and CO-induced HO-1 expression, which may enhance and maintain its effects in IL-6-treated ECs.	[Yang, Yan-Chang; Huang, Yu-Ting; Hsieh, Chia-Wen; Wung, Being-Sun] Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Yang, Po-Min] Chiayi Christian Hosp, Dept Ophthalmol, Chiayi, Taiwan	National Chiayi University; Chia-Yi Christian Hospital	Wung, BS (corresponding author), Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan.	bswung@mail.ncyu.edu.tw	; Herrup, Karl/C-5313-2014	Chen, Ji-hua/0000-0002-1151-0693; wung, being sun/0000-0002-9378-2798; Hsieh, Chia-Wen/0000-0003-1188-1934; Herrup, Karl/0000-0001-7786-5844; Li, Jiali/0000-0002-0039-3671	National Science Council, Taiwan [102-2320-B-415-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants (102-2320-B-415-002-MY3) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EMG, 2012, ANTIOXID REDOX SIGN, V17, P1748, DOI 10.1089/ars.2012.4644; Bannenberg GL, 2009, EXPERT OPIN THER PAT, V19, P663, DOI 10.1517/13543770902858824; Brennan JP, 2006, MOL CELL PROTEOMICS, V5, P215, DOI 10.1074/mcp.M500212-MCP200; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Clark JE, 2000, AM J PHYSIOL-HEART C, V278, pH643, DOI 10.1152/ajpheart.2000.278.2.H643; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; GOSPODAROWICZ D, 1976, P NATL ACAD SCI USA, V73, P4120, DOI 10.1073/pnas.73.11.4120; GYLLENHAMMAR H, 1987, J IMMUNOL METHODS, V97, P209, DOI 10.1016/0022-1759(87)90461-3; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lian KC, 2010, TOXICOL APPL PHARM, V245, P21, DOI 10.1016/j.taap.2010.01.003; Liao BC, 2010, TOXICOL SCI, V116, P151, DOI 10.1093/toxsci/kfq098; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Morita T, 2005, ARTERIOSCL THROM VAS, V25, P1786, DOI 10.1161/01.ATV.0000178169.95781.49; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Pimentel D, 2012, ANTIOXID REDOX SIGN, V16, P524, DOI 10.1089/ars.2011.4336; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schipper HM, 2004, FREE RADICAL BIO MED, V37, P1995, DOI 10.1016/j.freeradbiomed.2004.09.015; Schuringa JJ, 2001, J BIOL CHEM, V276, P27709, DOI 10.1074/jbc.M009821200; Schwer CI, 2010, MOL PHARMACOL, V77, P660, DOI 10.1124/mol.109.059519; Shin DY, 2012, BLOOD, V119, P2523, DOI 10.1182/blood-2011-07-366690; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Wu CC, 2006, TOXICOL APPL PHARM, V214, P244, DOI 10.1016/j.taap.2005.12.013; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Wung BS, 2006, LIFE SCI, V78, P3035, DOI 10.1016/j.lfs.2005.12.013; Wung BS, 2005, LIFE SCI, V78, P389, DOI 10.1016/j.lfs.2005.04.052; Wung BS, 2005, J BIOMED SCI, V12, P91, DOI 10.1007/s11373-004-8170-z; Wung BS, 1997, CIRC RES, V81, P1, DOI 10.1161/01.RES.81.1.1; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yeh PY, 2014, FREE RADICAL BIO MED, V70, P1, DOI 10.1016/j.freeradbiomed.2014.01.042; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	40	112	121	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e100677	10.1371/journal.pone.0100677	http://dx.doi.org/10.1371/journal.pone.0100677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	24498369	Green Submitted, Green Published, gold			2022-12-25	WOS:000341307600004
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24941042	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon R. T., 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/NCLIMATE1958, 10.1038/nclimate1958]; R Core Team, 2021, R LANG ENV STAT COMP; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24941042	Green Published, gold, Green Accepted			2022-12-25	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000343943100017
